Oral	O	O
treponemes	B-bacteria	B-bacteria
are	O	O
considered	O	O
to	O	O
be	O	O
important	O	O
in	O	O
the	O	O
development	O	O
and	O	O
progression	O	O
of	O	O
periodontal	O	O
diseases	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
mechanisms	O	O
of	O	O
recognition	O	O
and	O	O
activation	O	O
of	O	O
human	O	O
gingival	O	O
epithelial	O	O
cells	O	O
(	O	O
HGEC	O	O
)	O	O
with	O	O
the	O	O
oral	O	O
treponemes	B-bacteria	B-bacteria
Treponema	I-bacteria	I-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
medium	E-bacteria	I-bacteria
and	O	O
their	O	O
outer	O	O
membrane	O	O
extracts	O	O
(	O	O
OMEs	O	O
)	O	O
.	O	O

T.	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
medium	E-bacteria	I-bacteria
but	O	O
not	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
produced	O	O
interleukin	O	O
8	O	O
(	O	O
IL-8	O	O
)	O	O
in	O	O
an	O	O
HGEC	O	O
culture	O	O
.	O	O

Further	O	O
,	O	O
all	O	O
three	O	O
treponemes	B-bacteria	B-bacteria
induced	O	O
IL-8	O	O
mRNA	O	O
expression	O	O
and	O	O
NF-kappaB	O	O
activation	O	O
in	O	O
HGEC	O	O
.	O	O

Among	O	O
them	O	O
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
especially	O	O
exhibited	O	O
trypsin-	O	O
and	O	O
chymotrypsin-like	O	O
protease	O	O
activities	O	O
,	O	O
and	O	O
the	O	O
addition	O	O
of	O	O
chymostatin	O	O
,	O	O
a	O	O
chymotrypsin	O	O
protease	O	O
inhibitor	O	O
,	O	O
resulted	O	O
in	O	O
detectable	O	O
IL-8	O	O
production	O	O
by	O	O
HGEC	O	O
cultured	O	O
with	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

Additionally	O	O
,	O	O
IL-8	O	O
mRNA	O	O
expression	O	O
in	O	O
HGEC	O	O
cultured	O	O
with	O	O
the	O	O
three	O	O
treponemes	O	O
and	O	O
their	O	O
OMEs	O	O
was	O	O
definitely	O	O
inhibited	O	O
by	O	O
the	O	O
mouse	O	O
anti-human	O	O
Toll-like	O	O
receptor	O	O
2	O	O
(	O	O
TLR2	O	O
)	O	O
monoclonal	O	O
antibody	O	O
TL2.1	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
oral	O	O
treponemes	B-bacteria	B-bacteria
and	O	O
their	O	O
OMEs	O	O
activate	O	O
HGEC	O	O
through	O	O
TLR2	O	O
.	O	O

Although	O	O
bacterial	O	O
DNA	O	O
(	O	O
bDNA	O	O
)	O	O
containing	O	O
unmethylated	O	O
CpG	O	O
motifs	O	O
stimulates	O	O
innate	O	O
immune	O	O
cells	O	O
through	O	O
Toll-like	O	O
receptor	O	O
9	O	O
(	O	O
TLR-9	O	O
)	O	O
,	O	O
its	O	O
precise	O	O
role	O	O
in	O	O
the	O	O
pathophysiology	O	O
of	O	O
diseases	O	O
is	O	O
still	O	O
equivocal	O	O
.	O	O

Here	O	O
we	O	O
examined	O	O
the	O	O
immunostimulatory	O	O
effects	O	O
of	O	O
DNA	O	O
extracted	O	O
from	O	O
periodontopathogenic	O	O
bacteria	O	O
.	O	O

A	O	O
major	O	O
role	O	O
in	O	O
the	O	O
etiology	O	O
of	O	O
periodontal	O	O
diseases	O	O
has	O	O
been	O	O
attributed	O	O
to	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
.	O	O

We	O	O
therefore	O	O
isolated	O	O
DNA	O	O
from	O	O
these	O	O
bacteria	O	O
and	O	O
stimulated	O	O
murine	O	O
macrophages	O	O
and	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
(	O	O
HGF	O	O
)	O	O
in	O	O
vitro	O	O
.	O	O

Furthermore	O	O
,	O	O
HEK	O	O
293	O	O
cells	O	O
transfected	O	O
with	O	O
human	O	O
TLR-9	O	O
were	O	O
also	O	O
stimulated	O	O
with	O	O
these	O	O
DNA	O	O
preparations	O	O
.	O	O

We	O	O
observed	O	O
that	O	O
DNA	O	O
from	O	O
these	O	O
pathogens	O	O
stimulates	O	O
macrophages	O	O
and	O	O
gingival	O	O
fibroblasts	O	O
to	O	O
produce	O	O
tumor	O	O
necrosis	O	O
factor	O	O
alpha	O	O
and	O	O
interleukin-6	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
.	O	O

Methylation	O	O
of	O	O
the	O	O
CpG	O	O
motifs	O	O
abolished	O	O
the	O	O
observed	O	O
effects	O	O
.	O	O

Activation	O	O
of	O	O
HEK	O	O
293	O	O
cells	O	O
expressing	O	O
TLR-9	O	O
which	O	O
were	O	O
responsive	O	O
to	O	O
bDNA	O	O
but	O	O
not	O	O
to	O	O
lipopolysaccharide	O	O
confirmed	O	O
that	O	O
immunostimulation	O	O
was	O	O
achieved	O	O
by	O	O
bDNA	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
examined	O	O
bDNA	O	O
differed	O	O
in	O	O
the	O	O
ability	O	O
to	O	O
stimulate	O	O
murine	O	O
macrophages	O	O
,	O	O
HGF	O	O
,	O	O
and	O	O
TLR-9-transfected	O	O
cells	O	O
.	O	O

DNA	O	O
from	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
elicited	O	O
a	O	O
potent	O	O
cytokine	O	O
response	O	O
,	O	O
while	O	O
DNA	O	O
from	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
showed	O	O
lower	O	O
immunostimulatory	O	O
activity	O	O
.	O	O

Taken	O	O
together	O	O
,	O	O
the	O	O
results	O	O
strongly	O	O
suggest	O	O
that	O	O
DNA	O	O
from	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
possesses	O	O
immunostimulatory	O	O
properties	O	O
in	O	O
regard	O	O
to	O	O
cytokine	O	O
secretion	O	O
by	O	O
macrophages	O	O
and	O	O
fibroblasts	O	O
.	O	O

These	O	O
stimulatory	O	O
effects	O	O
are	O	O
due	O	O
to	O	O
unmethylated	O	O
CpG	O	O
motifs	O	O
within	O	O
bDNA	O	O
and	O	O
differ	O	O
between	O	O
distinct	O	O
periodontopathogenic	O	O
bacteria	O	O
strains	O	O
.	O	O

Hence	O	O
,	O	O
immunostimulation	O	O
by	O	O
DNA	O	O
from	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
could	O	O
contribute	O	O
to	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontal	O	O
diseases	O	O
.	O	O

Immunosuppressants	O	O
play	O	O
an	O	O
essential	O	O
role	O	O
in	O	O
transplantation	O	O
therapy	O	O
.	O	O

In	O	O
view	O	O
of	O	O
the	O	O
side	O	O
effects	O	O
,	O	O
e.g	O	O
.	O	O

gingival	O	O
overgrowth	O	O
,	O	O
the	O	O
present	O	O
in	O	O
vitro	O	O
study	O	O
was	O	O
performed	O	O
in	O	O
order	O	O
to	O	O
investigate	O	O
the	O	O
effect	O	O
of	O	O
selected	O	O
immunosuppressants	O	O
on	O	O
metabolic	O	O
activities	O	O
of	O	O
gingival	O	O
fibroblasts	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
effect	O	O
on	O	O
the	O	O
growth	O	O
of	O	O
six	O	O
oral	O	O
microorganisms	O	O
was	O	O
investigated	O	O
.	O	O

Human	O	O
gingival	O	O
fibroblasts	O	O
were	O	O
incubated	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
azathioprine	O	O
(	O	O
Aza	O	O
)	O	O
,	O	O
cyclosporin	O	O
A	O	O
(	O	O
CsA	O	O
)	O	O
,	O	O
tacrolimus	O	O
(	O	O
Tac	O	O
)	O	O
or	O	O
mycophenolatmofetil	O	O
(	O	O
Myc	O	O
)	O	O
.	O	O

PGE	O	O
subset	O	O
2	O	O
release	O	O
was	O	O
determined	O	O
by	O	O
means	O	O
of	O	O
a	O	O
specific	O	O
competitive	O	O
enzyme	O	O
immunoassay	O	O
,	O	O
using	O	O
monoclonal	O	O
antibodies	O	O
specific	O	O
for	O	O
PGE	O	O
subset	O	O
2	O	O
(	O	O
clone	O	O
E2R1	O	O
)	O	O
.	O	O

The	O	O
protein	O	O
content	O	O
was	O	O
measured	O	O
spectrophotometrically	O	O
.	O	O

A	O	O
redox	O	O
indicator	O	O
system	O	O
was	O	O
employed	O	O
to	O	O
assess	O	O
the	O	O
proliferation	O	O
activity	O	O
.	O	O

In	O	O
an	O	O
additional	O	O
trial	O	O
the	O	O
growth	O	O
of	O	O
six	O	O
strains	O	O
of	O	O
oral	O	O
bacteria	O	O
(	O	O
A.	B-bacteria	B-bacteria
viscosus	I-bacteria	I-bacteria
T14V	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
H1	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
10449	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
DR2001	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
Y4	E-bacteria	I-bacteria
,	O	O
and	O	O
M.	B-bacteria	B-bacteria
micros	I-bacteria	I-bacteria
33270	E-bacteria	I-bacteria
)	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
immunosuppressants	O	O
was	O	O
measured	O	O
.	O	O

In	O	O
comparison	O	O
with	O	O
the	O	O
controls	O	O
,	O	O
the	O	O
PGE	O	O
subset	O	O
2	O	O
release	O	O
was	O	O
increased	O	O
by	O	O
39.3	O	O
%	O	O
following	O	O
incubation	O	O
with	O	O
Aza	O	O
,	O	O
and	O	O
by	O	O
77.0	O	O
%	O	O
with	O	O
CsA	O	O
.	O	O

The	O	O
protein	O	O
concentrations	O	O
(	O	O
1	O	O
g	O	O
immunosuppressant	O	O
/	O	O
ml	O	O
medium	O	O
)	O	O
were	O	O
reduced	O	O
by	O	O
26.0	O	O
%	O	O
for	O	O
Aza	O	O
and	O	O
17.0	O	O
%	O	O
for	O	O
Myc	O	O
.	O	O

Furthermore	O	O
,	O	O
a	O	O
drug-dependent	O	O
inhibition	O	O
in	O	O
the	O	O
cell	O	O
proliferation	O	O
rate	O	O
was	O	O
noted	O	O
after	O	O
an	O	O
incubation	O	O
period	O	O
of	O	O
6	O	O
hours	O	O
(	O	O
Aza	O	O
70.7	O	O
%	O	O
,	O	O
CsA	O	O
78.2	O	O
%	O	O
,	O	O
Myc	O	O
69.8	O	O
%	O	O
,	O	O
Tac	O	O
64.0	O	O
%	O	O
)	O	O
.	O	O

The	O	O
most	O	O
pronounced	O	O
growth-inhibiting	O	O
effects	O	O
were	O	O
observed	O	O
for	O	O
CsA	O	O
at	O	O
values	O	O
ranging	O	O
from	O	O
21.0	O	O
%	O	O
(	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
10449	E-bacteria	I-bacteria
)	O	O
to	O	O
48.6	O	O
%	O	O
(	O	O
A.	B-bacteria	B-bacteria
viscosus	I-bacteria	I-bacteria
T14V	E-bacteria	I-bacteria
)	O	O
growth	O	O
inhibition	O	O
.	O	O

The	O	O
present	O	O
study	O	O
with	O	O
common	O	O
immunsuppresants	O	O
demonstrated	O	O
both	O	O
a	O	O
medication-	O	O
and	O	O
dose-dependent	O	O
alteration	O	O
in	O	O
the	O	O
metabolic	O	O
activity	O	O
of	O	O
gingival	O	O
fibroblasts	O	O
.	O	O

Furthermore	O	O
,	O	O
growth-inhibitory	O	O
effects	O	O
on	O	O
the	O	O
selected	O	O
bacterial	O	O
strains	O	O
could	O	O
be	O	O
observed	O	O
.	O	O

The	O	O
in	O	O
vitro	O	O
activity	O	O
of	O	O
faropenem	O	O
,	O	O
an	O	O
oral	O	O
penem	O	O
,	O	O
was	O	O
compared	O	O
with	O	O
those	O	O
of	O	O
penicillin	O	O
,	O	O
co-amoxiclav	O	O
,	O	O
cefoxitin	O	O
,	O	O
clindamycin	O	O
,	O	O
erythromycin	O	O
and	O	O
metronidazole	O	O
against	O	O
106	O	O
isolates	O	O
of	O	O
anaerobic	O	O
pathogens	O	O
involved	O	O
in	O	O
systemic	O	O
infections	O	O
.	O	O

The	O	O
organisms	O	O
tested	O	O
comprised	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
29	O	O
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
eight	O	O
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
(	O	O
seven	O	O
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
five	O	O
)	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
25	O	O
)	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
14	O	O
)	O	O
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
11	O	O
)	O	O
,	O	O
Bacteroides	B-bacteria	B-bacteria
ureolyticus	E-bacteria	I-bacteria
(	O	O
five	O	O
)	O	O
and	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
(	O	O
two	O	O
)	O	O
.	O	O

The	O	O
antimicrobial	O	O
properties	O	O
of	O	O
faropenem	O	O
were	O	O
investigated	O	O
by	O	O
studying	O	O
MICs	O	O
,	O	O
MBCs	O	O
,	O	O
time-kill	O	O
kinetics	O	O
and	O	O
post-antibiotic	O	O
effect	O	O
(	O	O
PAE	O	O
)	O	O
.	O	O

faropenem	O	O
highly	O	O
active	O	O
against	O	O
all	O	O
the	O	O
anaerobes	B-bacteria	B-bacteria
tested	O	O
(	O	O
MIC	O	O
(	O	O
90	O	O
)	O	O
<	O	O
or	O	O
=	O	O
0.5	O	O
mg/L	O	O
)	O	O
and	O	O
was	O	O
bactericidal	O	O
against	O	O
both	O	O
beta-lactamase-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
-negative	I-bacteria	I-bacteria
anaerobes	E-bacteria	I-bacteria
,	O	O
with	O	O
a	O	O
maximum	O	O
bactericidal	O	O
effect	O	O
at	O	O
10	O	O
x	O	O
MIC	O	O
at	O	O
between	O	O
12	O	O
and	O	O
24	O	O
h.	O	O
In	O	O
addition	O	O
,	O	O
faropenem	O	O
had	O	O
an	O	O
in	O	O
vitro	O	O
PAE	O	O
on	O	O
all	O	O
the	O	O
tested	O	O
isolates	O	O
and	O	O
this	O	O
was	O	O
not	O	O
influenced	O	O
by	O	O
beta-lactamase	O	O
production	O	O
.	O	O

faropenem	O	O
be	O	O
useful	O	O
for	O	O
treating	O	O
infections	O	O
caused	O	O
by	O	O
periodontal	O	O
bacteria	O	O
or	O	O
oral	O	O
flora	O	O
.	O	O

Members	O	O
of	O	O
the	O	O
uncultivated	O	O
bacterial	O	O
division	O	O
TM7	B-bacteria	B-bacteria
have	O	O
been	O	O
detected	O	O
in	O	O
the	O	O
human	O	O
mouth	O	O
,	O	O
but	O	O
little	O	O
information	O	O
is	O	O
available	O	O
regarding	O	O
their	O	O
prevalence	O	O
and	O	O
diversity	O	O
at	O	O
this	O	O
site	O	O
.	O	O

Human	O	O
subgingival	O	O
plaque	O	O
samples	O	O
from	O	O
healthy	O	O
sites	O	O
and	O	O
sites	O	O
exhibiting	O	O
various	O	O
stages	O	O
of	O	O
periodontal	O	O
disease	O	O
were	O	O
analyzed	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
TM7	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

TM7	B-bacteria	B-bacteria
ribosomal	O	O
DNA	O	O
(	O	O
rDNA	O	O
)	O	O
was	O	O
found	O	O
in	O	O
96	O	O
%	O	O
of	O	O
the	O	O
samples	O	O
,	O	O
and	O	O
it	O	O
accounted	O	O
for	O	O
approximately	O	O
0.3	O	O
%	O	O
,	O	O
on	O	O
average	O	O
,	O	O
of	O	O
all	O	O
bacterial	O	O
rDNA	O	O
in	O	O
the	O	O
samples	O	O
as	O	O
determined	O	O
by	O	O
real-time	O	O
quantitative	O	O
PCR	O	O
.	O	O

Two	O	O
new	O	O
phylotypes	O	O
of	O	O
this	O	O
division	O	O
were	O	O
identified	O	O
,	O	O
and	O	O
members	O	O
of	O	O
the	O	O
division	O	O
were	O	O
found	O	O
to	O	O
exhibit	O	O
filamentous	O	O
morphology	O	O
by	O	O
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
.	O	O

The	O	O
abundance	O	O
of	O	O
TM7	B-bacteria	B-bacteria
rDNA	O	O
relative	O	O
to	O	O
total	O	O
bacterial	O	O
rDNA	O	O
was	O	O
higher	O	O
in	O	O
sites	O	O
with	O	O
mild	O	O
periodontitis	O	O
(	O	O
0.54	O	O
%	O	O
+/-	O	O
0.1	O	O
%	O	O
)	O	O
than	O	O
in	O	O
either	O	O
healthy	O	O
sites	O	O
(	O	O
0.21	O	O
%	O	O
+/-	O	O
0.05	O	O
%	O	O
,	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
or	O	O
sites	O	O
with	O	O
severe	O	O
periodontitis	O	O
(	O	O
0.29	O	O
%	O	O
+/-	O	O
0.06	O	O
%	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

One	O	O
division	O	O
subgroup	O	O
,	O	O
the	O	O
I025	O	O
phylotype	O	O
,	O	O
was	O	O
detected	O	O
in	O	O
1	O	O
of	O	O
18	O	O
healthy	O	O
samples	O	O
and	O	O
38	O	O
of	O	O
58	O	O
disease	O	O
samples	O	O
.	O	O

These	O	O
data	O	O
suggest	O	O
that	O	O
this	O	O
phylotype	O	O
,	O	O
and	O	O
the	O	O
TM7	B-bacteria	B-bacteria
bacterial	O	O
division	O	O
in	O	O
general	O	O
,	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
multifactorial	O	O
process	O	O
leading	O	O
to	O	O
periodontitis	O	O
.	O	O

Dental	O	O
diseases	O	O
are	O	O
among	O	O
the	O	O
most	O	O
prevalent	O	O
and	O	O
costly	O	O
diseases	O	O
affecting	O	O
industrialized	O	O
societies	O	O
,	O	O
and	O	O
yet	O	O
are	O	O
highly	O	O
preventable	O	O
.	O	O

The	O	O
microflora	O	O
of	O	O
dental	O	O
plaque	O	O
biofilms	O	O
from	O	O
diseased	O	O
sites	O	O
is	O	O
distinct	O	O
from	O	O
that	O	O
found	O	O
in	O	O
health	O	O
,	O	O
although	O	O
the	O	O
putative	O	O
pathogens	O	O
can	O	O
often	O	O
be	O	O
detected	O	O
in	O	O
low	O	O
numbers	O	O
at	O	O
normal	O	O
sites	O	O
.	O	O

In	O	O
dental	O	O
caries	O	O
,	O	O
there	O	O
is	O	O
a	O	O
shift	O	O
towards	O	O
community	O	O
dominance	O	O
by	O	O
acidogenic	O	O
and	O	O
acid-tolerant	B-bacteria	B-bacteria
Gram-positive	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
e.g	O	O
.	O	O

mutans	O	O
streptococci	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
)	O	O
at	O	O
the	O	O
expense	O	O
of	O	O
the	O	O
acid-sensitive	O	O
species	O	O
associated	O	O
with	O	O
sound	O	O
enamel	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
the	O	O
numbers	O	O
and	O	O
proportions	O	O
of	O	O
obligately	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
including	O	O
Gram-negative	O	O
proteolytic	O	O
species	O	O
,	O	O
increase	O	O
in	O	O
periodontal	O	O
diseases	O	O
.	O	O

Modelling	O	O
studies	O	O
using	O	O
defined	O	O
consortia	O	O
of	O	O
oral	O	O
bacteria	O	O
grown	O	O
in	O	O
planktonic	O	O
and	O	O
biofilm	O	O
systems	O	O
have	O	O
been	O	O
undertaken	O	O
to	O	O
identify	O	O
environmental	O	O
factors	O	O
responsible	O	O
for	O	O
driving	O	O
these	O	O
deleterious	O	O
shifts	O	O
in	O	O
the	O	O
plaque	O	O
microflora	O	O
.	O	O

Repeated	O	O
conditions	O	O
of	O	O
low	O	O
pH	O	O
(	O	O
rather	O	O
than	O	O
sugar	O	O
availability	O	O
per	O	O
se	O	O
)	O	O
selected	O	O
for	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
while	O	O
the	O	O
introduction	O	O
of	O	O
novel	O	O
host	O	O
proteins	O	O
and	O	O
glycoproteins	O	O
(	O	O
as	O	O
occurs	O	O
during	O	O
the	O	O
inflammatory	O	O
response	O	O
to	O	O
plaque	O	O
)	O	O
,	O	O
and	O	O
the	O	O
concomitant	O	O
rise	O	O
in	O	O
local	O	O
pH	O	O
,	O	O
enriched	O	O
for	O	O
Gram-negative	B-bacteria	B-bacteria
anaerobic	E-bacteria	I-bacteria
and	O	O
asaccharolytic	O	O
species	O	O
.	O	O

These	O	O
studies	O	O
emphasized	O	O
(	O	O
a	O	O
)	O	O
.	O	O

significant	O	O
properties	O	O
of	O	O
dental	O	O
plaque	O	O
as	O	O
both	O	O
a	O	O
biofilm	O	O
and	O	O
a	O	O
microbial	O	O
community	O	O
,	O	O
and	O	O
(	O	O
b	O	O
)	O	O
.	O	O

the	O	O
dynamic	O	O
relationship	O	O
existing	O	O
between	O	O
the	O	O
environment	O	O
and	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
.	O	O

This	O	O
research	O	O
resulted	O	O
in	O	O
a	O	O
novel	O	O
hypothesis	O	O
(	O	O
the	O	O
'ecological	O	O
plaque	O	O
hypothesis	O	O
'	O	O
)	O	O
to	O	O
better	O	O
describe	O	O
the	O	O
relationship	O	O
between	O	O
plaque	O	O
bacteria	O	O
and	O	O
the	O	O
host	O	O
in	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

Implicit	O	O
in	O	O
this	O	O
hypothesis	O	O
is	O	O
the	O	O
concept	O	O
that	O	O
disease	O	O
can	O	O
be	O	O
prevented	O	O
not	O	O
only	O	O
by	O	O
directly	O	O
inhibiting	O	O
the	O	O
putative	O	O
pathogens	O	O
,	O	O
but	O	O
also	O	O
by	O	O
interfering	O	O
with	O	O
the	O	O
environmental	O	O
factors	O	O
driving	O	O
the	O	O
selection	O	O
and	O	O
enrichment	O	O
of	O	O
these	O	O
bacteria	O	O
.	O	O

Thus	O	O
,	O	O
a	O	O
more	O	O
holistic	O	O
approach	O	O
can	O	O
be	O	O
taken	O	O
in	O	O
disease	O	O
control	O	O
and	O	O
management	O	O
strategies	O	O
.	O	O

Sample	O	O
groups	O	O
of	O	O
children	O	O
(	O	O
n=50	O	O
)	O	O
and	O	O
adults	O	O
(	O	O
n=38	O	O
)	O	O
were	O	O
selected	O	O
from	O	O
pools	O	O
of	O	O
207	O	O
children	O	O
,	O	O
(	O	O
11-13-year	O	O
olds	O	O
from	O	O
two	O	O
primary	O	O
schools	O	O
)	O	O
and	O	O
94	O	O
adults	O	O
(	O	O
25-44-year	O	O
olds	O	O
from	O	O
four	O	O
governmental	O	O
agencies	O	O
)	O	O
who	O	O
were	O	O
the	O	O
subjects	O	O
of	O	O
an	O	O
oral	O	O
health	O	O
survey	O	O
among	O	O
Tibetans	O	O
living	O	O
in	O	O
Lhasa	O	O
,	O	O
Tibet	O	O
Autonomous	O	O
Region	O	O
.	O	O

Mean	O	O
ages	O	O
of	O	O
the	O	O
study	O	O
groups	O	O
of	O	O
children	O	O
(	O	O
38	O	O
%	O	O
females	O	O
)	O	O
and	O	O
adults	O	O
(	O	O
61	O	O
%	O	O
females	O	O
)	O	O
were	O	O
11.6+/-0.9	O	O
and	O	O
37.1+/-6.1	O	O
years	O	O
,	O	O
respectively	O	O
.	O	O

All	O	O
had	O	O
lived	O	O
in	O	O
Tibet	O	O
since	O	O
birth	O	O
.	O	O

Oral	O	O
rinse	O	O
samples	O	O
were	O	O
selective	O	O
cultured	O	O
to	O	O
isolate	O	O
,	O	O
quantify	O	O
and	O	O
speciate	O	O
aerobic	O	O
and	O	O
facultatively	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
Gram-negative	O	O
rods	E-bacteria	I-bacteria
(	O	O
using	O	O
the	O	O
API	O	O
20E	O	O
kit	O	O
)	O	O
and	O	O
yeasts	O	O
(	O	O
using	O	O
API	O	O
20C	O	O
AUX	O	O
and	O	O
API	O	O
ZYM	O	O
kits	O	O
)	O	O
.	O	O

For	O	O
children	O	O
,	O	O
the	O	O
isolation	O	O
rates	O	O
for	O	O
oral	O	O
coliform	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
yeasts	O	O
were	O	O
84	O	O
and	O	O
14	O	O
%	O	O
,	O	O
respectively	O	O
,	O	O
for	O	O
adults	O	O
,	O	O
the	O	O
respective	O	O
rates	O	O
were	O	O
26	O	O
and	O	O
40	O	O
%	O	O
.	O	O

The	O	O
corresponding	O	O
quantities	O	O
of	O	O
coliforms/yeasts	O	O
for	O	O
children	O	O
and	O	O
adults	O	O
were	O	O
0.4+/-1.6	O	O
x	O	O
10	O	O
(	O	O
3	O	O
)	O	O
c.f.u./15.8+/-72.3	O	O
and	O	O
0.2+/-0.6	O	O
x	O	O
10	O	O
(	O	O
3	O	O
)	O	O
c.f.u./57.2+/-137.5c.f.u	O	O
.	O	O

per	O	O
millilitre	O	O
oral	O	O
rinse	O	O
,	O	O
respectively	O	O
.	O	O

Aerobic	O	O
and	O	O
facultatively	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
and	O	O
Stenotrophomonas	B-bacteria	B-bacteria
maltophilia	E-bacteria	I-bacteria
,	O	O
a	O	O
free-living	O	O
saprophytic	O	O
and	O	O
ubiquitous	O	O
bacterial	O	O
species	O	O
of	O	O
wide	O	O
geographic	O	O
distribution	O	O
,	O	O
were	O	O
significantly	O	O
more	O	O
frequently	O	O
recovered	O	O
from	O	O
the	O	O
children	O	O
's	O	O
oral	O	O
rinses	O	O
.	O	O

The	O	O
isolation	O	O
rates	O	O
of	O	O
facultatively	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
in	O	O
adults	O	O
and	O	O
yeasts	O	O
in	O	O
both	O	O
groups	O	O
were	O	O
similar	O	O
to	O	O
those	O	O
found	O	O
in	O	O
similar	O	O
cohorts	O	O
from	O	O
southern	O	O
China	O	O
in	O	O
earlier	O	O
studies	O	O
.	O	O

Randomly	O	O
amplified	O	O
polymeric	O	O
DNA	O	O
analysis	O	O
showed	O	O
that	O	O
the	O	O
S.	B-bacteria	B-bacteria
maltophilia	I-bacteria	I-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

isolated	O	O
from	O	O
children	O	O
were	O	O
of	O	O
several	O	O
different	O	O
clonal	O	O
types	O	O
and	O	O
were	O	O
school	O	O
specific	O	O
.	O	O

This	O	O
study	O	O
shows	O	O
that	O	O
the	O	O
colonisation	O	O
rate	O	O
of	O	O
facultatively	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
in	O	O
adults	O	O
and	O	O
yeasts	O	O
in	O	O
both	O	O
groups	O	O
are	O	O
similar	O	O
to	O	O
those	O	O
in	O	O
populations	O	O
living	O	O
at	O	O
lower	O	O
altitudes	O	O
,	O	O
the	O	O
native	O	O
young	O	O
,	O	O
urban	O	O
Tibetans	O	O
appear	O	O
to	O	O
exhibit	O	O
a	O	O
high	O	O
oral	O	O
carriage	O	O
rate	O	O
of	O	O
S.	B-bacteria	B-bacteria
maltophilia	I-bacteria	I-bacteria
spp	E-bacteria	I-bacteria
.	O	O

The	O	O
objectives	O	O
of	O	O
the	O	O
study	O	O
were	O	O
to	O	O
investigate	O	O
the	O	O
antimicrobial	O	O
efficacy	O	O
,	O	O
over	O	O
time	O	O
,	O	O
of	O	O
combining	O	O
antibacterial	O	O
agents	O	O
with	O	O
a	O	O
glass	O	O
ionomer	O	O
cement	O	O
(	O	O
GIC	O	O
)	O	O
.	O	O

This	O	O
was	O	O
assessed	O	O
using	O	O
an	O	O
agar	O	O
diffusion	O	O
test	O	O
.	O	O

Chlorhexidine	O	O
hydrochloride	O	O
,	O	O
cetylpyridinium	O	O
chloride	O	O
,	O	O
cetrimide	O	O
and	O	O
benzalkonium	O	O
chloride	O	O
were	O	O
added	O	O
to	O	O
Fuji	O	O
IX	O	O
GIC	O	O
at	O	O
0	O	O
,	O	O
1	O	O
,	O	O
2	O	O
and	O	O
4	O	O
%	O	O
w/w	O	O
.	O	O

Antibacterial-GIC	O	O
specimens	O	O
were	O	O
placed	O	O
onto	O	O
agar	O	O
plates	O	O
inoculated	O	O
with	O	O
one	O	O
of	O	O
six	O	O
bacterial	O	O
species	O	O
(	O	O
Streptococcis	B-bacteria	B-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
,	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
two	O	O
each	O	O
)	O	O
and	O	O
the	O	O
area	O	O
of	O	O
inhibition	O	O
calculated	O	O
after	O	O
24	O	O
h	O	O
incubation	O	O
.	O	O

The	O	O
experiment	O	O
was	O	O
repeated	O	O
weekly	O	O
and	O	O
at	O	O
week	O	O
11	O	O
the	O	O
surface	O	O
of	O	O
the	O	O
specimen	O	O
was	O	O
abraded	O	O
prior	O	O
to	O	O
replacing	O	O
on	O	O
inoculated	O	O
agar	O	O
plates	O	O
.	O	O

Control	O	O
specimens	O	O
of	O	O
the	O	O
GIC	O	O
produced	O	O
no	O	O
bacterial	O	O
inhibition	O	O
.	O	O

The	O	O
antibacterial-GIC	O	O
combination	O	O
specimens	O	O
showed	O	O
significant	O	O
inhibition	O	O
which	O	O
decreased	O	O
at	O	O
different	O	O
rates	O	O
over	O	O
the	O	O
test	O	O
period	O	O
.	O	O

Resurfacing	O	O
of	O	O
the	O	O
specimens	O	O
showed	O	O
a	O	O
dramatic	O	O
increase	O	O
of	O	O
antibacterial	O	O
action	O	O
similar	O	O
to	O	O
levels	O	O
produced	O	O
on	O	O
week	O	O
1	O	O
.	O	O

CT-GIC	O	O
showed	O	O
the	O	O
greatest	O	O
(	O	O
p	O	O
<	O	O
0.005	O	O
)	O	O
inhibitory	O	O
effect	O	O
throughout	O	O
the	O	O
experimental	O	O
period	O	O
for	O	O
4	O	O
out	O	O
of	O	O
6	O	O
test	O	O
bacteria	O	O
.	O	O

The	O	O
addition	O	O
of	O	O
antibacterial	O	O
agents	O	O
to	O	O
Fuji	O	O
IX	O	O
creates	O	O
a	O	O
GIC	O	O
material	O	O
with	O	O
significant	O	O
antimicrobial	O	O
action	O	O
in	O	O
vitro	O	O
which	O	O
is	O	O
dependent	O	O
on	O	O
concentration	O	O
and	O	O
type	O	O
of	O	O
antibacterial	O	O
agent	O	O
,	O	O
and	O	O
appears	O	O
to	O	O
be	O	O
associated	O	O
primarily	O	O
with	O	O
a	O	O
release	O	O
of	O	O
the	O	O
antibacterial	O	O
from	O	O
the	O	O
surface	O	O
layer	O	O
of	O	O
the	O	O
specimen	O	O
.	O	O

We	O	O
immunohistologically	O	O
examined	O	O
the	O	O
prevalence	O	O
and	O	O
localization	O	O
of	O	O
bacteria	O	O
invading	O	O
dentinal	O	O
tubules	O	O
of	O	O
the	O	O
roots	O	O
of	O	O
teeth	O	O
with	O	O
infected	O	O
canals	O	O
.	O	O

Forty	O	O
extracted	O	O
teeth	O	O
with	O	O
apical	O	O
lesions	O	O
were	O	O
selected	O	O
and	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
:	O	O
a	O	O
group	O	O
of	O	O
untreated	O	O
teeth	O	O
and	O	O
a	O	O
group	O	O
of	O	O
canal-enlarged	O	O
teeth	O	O
.	O	O

The	O	O
bacteria	O	O
in	O	O
the	O	O
specimens	O	O
were	O	O
detected	O	O
by	O	O
Brown-Brenn	O	O
stain	O	O
and	O	O
the	O	O
labeled-streptavidin-biotin	O	O
method	O	O
with	O	O
specific	O	O
antisera	O	O
for	O	O
16-bacteria	O	O
.	O	O

Seventy	O	O
percent	O	O
of	O	O
the	O	O
examined	O	O
teeth	O	O
showed	O	O
bacteria	O	O
invading	O	O
the	O	O
dentinal	O	O
tubules	O	O
of	O	O
the	O	O
roots	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Eubacterium	B-bacteria	B-bacteria
alactolyticum	E-bacteria	I-bacteria
,	O	O
E.	B-bacteria	B-bacteria
nodatum	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
,	O	O
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
were	O	O
abundant	O	O
.	O	O

Even	O	O
in	O	O
the	O	O
canal-enlarged	O	O
group	O	O
,	O	O
invasion	O	O
of	O	O
bacteria	O	O
was	O	O
observed	O	O
in	O	O
65	O	O
%	O	O
of	O	O
teeth	O	O
.	O	O

This	O	O
study	O	O
revealed	O	O
the	O	O
actual	O	O
condition	O	O
of	O	O
bacteria	O	O
in	O	O
infected	O	O
root	O	O
dentin	O	O
and	O	O
suggested	O	O
that	O	O
the	O	O
canal-enlargement	O	O
procedure	O	O
could	O	O
not	O	O
completely	O	O
remove	O	O
all	O	O
the	O	O
bacteria	O	O
in	O	O
the	O	O
infected	O	O
dentinal	O	O
tubules	O	O
of	O	O
the	O	O
root	O	O
.	O	O

Mucositis	O	O
is	O	O
an	O	O
acute	O	O
inflammation	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
because	O	O
of	O	O
radiotherapy	O	O
and/or	O	O
chemotherapy	O	O
.	O	O

All	O	O
patients	O	O
receiving	O	O
radiotherapy	O	O
in	O	O
the	O	O
head	O	O
and	O	O
neck	O	O
region	O	O
develop	O	O
oral	O	O
mucositis	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
analyse	O	O
the	O	O
effects	O	O
of	O	O
selective	O	O
oral	O	O
flora	O	O
elimination	O	O
on	O	O
radiotherapy-induced	O	O
oral	O	O
mucositis	O	O
,	O	O
in	O	O
a	O	O
double-blind	O	O
,	O	O
randomised	O	O
,	O	O
placebo-controlled	O	O
trial	O	O
.	O	O

Sixty-five	O	O
patients	O	O
with	O	O
a	O	O
malignant	O	O
tumour	O	O
in	O	O
the	O	O
head	O	O
and	O	O
neck	O	O
regions	O	O
to	O	O
be	O	O
treated	O	O
with	O	O
primary	O	O
curative	O	O
or	O	O
postoperative	O	O
radiotherapy	O	O
participated	O	O
in	O	O
this	O	O
study	O	O
.	O	O

The	O	O
patients	O	O
received	O	O
either	O	O
the	O	O
active	O	O
lozenges	O	O
of	O	O
1	O	O
g	O	O
containing	O	O
polymyxin	O	O
E	O	O
2	O	O
mg	O	O
,	O	O
tobramycin	O	O
1.8	O	O
mg	O	O
and	O	O
amphotericin	O	O
B	O	O
10	O	O
mg	O	O
(	O	O
PTA	O	O
)	O	O
(	O	O
33	O	O
patients	O	O
)	O	O
or	O	O
the	O	O
placebo	O	O
lozenges	O	O
(	O	O
32	O	O
patients	O	O
)	O	O
,	O	O
four	O	O
times	O	O
daily	O	O
during	O	O
the	O	O
full	O	O
course	O	O
of	O	O
radiotherapy	O	O
.	O	O

Mucositis	O	O
,	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
flora	O	O
,	O	O
quality	O	O
of	O	O
feeding	O	O
and	O	O
changes	O	O
of	O	O
total	O	O
body	O	O
weight	O	O
were	O	O
assessed	O	O
.	O	O

Mucositis	O	O
score	O	O
did	O	O
not	O	O
differ	O	O
between	O	O
the	O	O
groups	O	O
during	O	O
the	O	O
first	O	O
5	O	O
weeks	O	O
of	O	O
radiotherapy	O	O
.	O	O

Nasogastric	O	O
tube	O	O
feeding	O	O
was	O	O
needed	O	O
in	O	O
six	O	O
patients	O	O
(	O	O
19	O	O
%	O	O
)	O	O
of	O	O
the	O	O
placebo	O	O
group	O	O
and	O	O
two	O	O
patients	O	O
(	O	O
6	O	O
%	O	O
)	O	O
of	O	O
the	O	O
PTA	O	O
group	O	O
(	O	O
P=0.08	O	O
)	O	O
.	O	O

Mean	O	O
weight	O	O
loss	O	O
after	O	O
5	O	O
weeks	O	O
of	O	O
radiation	O	O
was	O	O
less	O	O
in	O	O
the	O	O
PTA	O	O
group	O	O
(	O	O
1.3	O	O
kg	O	O
)	O	O
(	O	O
s.d	O	O
.	O	O

:	O	O
3.0	O	O
)	O	O
than	O	O
in	O	O
the	O	O
placebo	O	O
group	O	O
(	O	O
2.8	O	O
kg	O	O
)	O	O
(	O	O
s.d	O	O
.	O	O

:	O	O
2.9	O	O
)	O	O
(	O	O
P=0.05	O	O
)	O	O
.	O	O

Colonisation	O	O
index	O	O
of	O	O
Candida	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
and	O	O
Gram-negative	B-bacteria	B-bacteria
bacilli	E-bacteria	I-bacteria
was	O	O
reduced	O	O
in	O	O
the	O	O
PTA	O	O
group	O	O
and	O	O
not	O	O
in	O	O
the	O	O
placebo	O	O
group	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

No	O	O
effect	O	O
on	O	O
other	O	O
microorganisms	O	O
was	O	O
detected	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
selective	O	O
oral	O	O
flora	O	O
elimination	O	O
in	O	O
head	O	O
and	O	O
neck	O	O
irradiation	O	O
patients	O	O
does	O	O
not	O	O
prevent	O	O
the	O	O
development	O	O
of	O	O
severe	O	O
mucositis	O	O
.	O	O

Treponema	B-bacteria	B-bacteria
have	O	O
been	O	O
implicated	O	O
recently	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
digital	O	O
dermatitis	O	O
(	O	O
DD	O	O
)	O	O
and	O	O
contagious	O	O
ovine	O	O
digital	O	O
dermatitis	O	O
(	O	O
CODD	O	O
)	O	O
that	O	O
are	O	O
infectious	O	O
diseases	O	O
of	O	O
bovine	O	O
and	O	O
ovine	O	O
foot	O	O
tissues	O	O
,	O	O
respectively	O	O
.	O	O

Previous	O	O
analyses	O	O
of	O	O
treponemal	B-bacteria	B-bacteria
16S	O	O
rDNA	O	O
sequences	O	O
,	O	O
PCR-amplified	O	O
directly	O	O
from	O	O
DD	O	O
or	O	O
CODD	O	O
lesions	O	O
,	O	O
have	O	O
suggested	O	O
relatedness	O	O
of	O	O
animal	B-bacteria	B-bacteria
Treponema	E-bacteria	I-bacteria
to	O	O
some	O	O
human	O	O
oral	O	O
Treponema	B-bacteria	B-bacteria
species	O	O
isolated	O	O
from	O	O
periodontal	O	O
tissues	O	O
.	O	O

In	O	O
this	O	O
study	O	O
a	O	O
range	O	O
of	O	O
adhesion	O	O
and	O	O
virulence-related	O	O
properties	O	O
of	O	O
three	O	O
animal	B-bacteria	B-bacteria
Treponema	E-bacteria	I-bacteria
isolates	O	O
have	O	O
been	O	O
compared	O	O
with	O	O
representative	O	O
human	O	O
oral	O	O
strains	O	O
of	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
.	O	O

In	O	O
adhesion	O	O
assays	O	O
using	O	O
biotinylated	O	O
treponemal	O	O
cells	O	O
,	O	O
T.	O	O
denticola	O	O
cells	O	O
bound	O	O
in	O	O
consistently	O	O
higher	O	O
numbers	O	O
to	O	O
fibronectin	O	O
,	O	O
laminin	O	O
,	O	O
collagen	O	O
type	O	O
I	O	O
,	O	O
gelatin	O	O
,	O	O
keratin	O	O
and	O	O
lactoferrin	O	O
than	O	O
did	O	O
T.	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
or	O	O
animal	B-bacteria	B-bacteria
Treponema	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
animal	O	O
DD	O	O
strains	O	O
adhered	O	O
to	O	O
fibrinogen	O	O
at	O	O
equivalent	O	O
or	O	O
greater	O	O
levels	O	O
than	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

All	O	O
Treponema	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
bound	O	O
to	O	O
the	O	O
amino-terminal	O	O
heparin	O	O
I/fibrin	O	O
I	O	O
domain	O	O
of	O	O
fibronectin	O	O
.	O	O

16S	O	O
rDNA	O	O
sequence	O	O
analyses	O	O
placed	O	O
ovine	O	O
strain	O	O
UB1090	O	O
and	O	O
bovine	O	O
strain	O	O
UB1467	O	O
within	O	O
a	O	O
cluster	O	O
that	O	O
was	O	O
phylogenetically	O	O
related	O	O
to	O	O
T.	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
,	O	O
while	O	O
ovine	O	O
strain	O	O
UB1466	O	O
appeared	O	O
more	O	O
closely	O	O
related	O	O
to	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

These	O	O
observations	O	O
correlated	O	O
with	O	O
phenotypic	O	O
properties	O	O
.	O	O

Thus	O	O
,	O	O
T.	B-bacteria	B-bacteria
denticola	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
35405	E-bacteria	I-bacteria
,	O	O
GM-1	B-bacteria	B-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
UB1466	E-bacteria	I-bacteria
had	O	O
similar	O	O
outer-membrane	O	O
protein	O	O
profiles	O	O
,	O	O
produced	O	O
chymotrypsin-like	O	O
protease	O	O
(	O	O
CTLP	O	O
)	O	O
,	O	O
trypsin-like	O	O
protease	O	O
and	O	O
high	O	O
levels	O	O
of	O	O
proline	O	O
iminopeptidase	O	O
,	O	O
and	O	O
co-aggregated	O	O
with	O	O
human	O	O
oral	O	O
bacteria	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
crista	E-bacteria	I-bacteria
.	O	O

Conversely	O	O
,	O	O
T.	B-bacteria	B-bacteria
vincentii	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
35580	E-bacteria	I-bacteria
,	O	O
D2A-2	B-bacteria	B-bacteria
,	O	O
and	O	O
animal	B-bacteria	B-bacteria
strains	I-bacteria	I-bacteria
UB1090	E-bacteria	I-bacteria
and	O	O
UB1467	B-bacteria	B-bacteria
did	O	O
not	O	O
express	O	O
CTLP	O	O
or	O	O
trypsin-like	O	O
protease	O	O
and	O	O
did	O	O
not	O	O
co-aggregate	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
or	O	O
S.	B-bacteria	B-bacteria
crista	E-bacteria	I-bacteria
.	O	O

Taken	O	O
collectively	O	O
,	O	O
these	O	O
results	O	O
suggest	O	O
that	O	O
human	O	O
oral-related	O	O
Treponema	B-bacteria	B-bacteria
have	O	O
broad	O	O
host	O	O
specificity	O	O
and	O	O
that	O	O
similar	O	O
control	O	O
or	O	O
preventive	O	O
strategies	O	O
might	O	O
be	O	O
developed	O	O
for	O	O
human	O	O
and	O	O
animal	O	O
Treponema-associated	O	O
infections	O	O
.	O	O

Whether	O	O
micro-organisms	O	O
can	O	O
live	O	O
in	O	O
periapical	O	O
endodontic	O	O
lesions	O	O
of	O	O
asymptomatic	O	O
teeth	O	O
is	O	O
under	O	O
debate	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
visualize	O	O
and	O	O
identify	O	O
micro-organisms	O	O
within	O	O
periapical	O	O
lesions	O	O
directly	O	O
,	O	O
using	O	O
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
in	O	O
combination	O	O
with	O	O
epifluorescence	O	O
and	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
(	O	O
CLSM	O	O
)	O	O
.	O	O

Thirty-nine	O	O
periapical	O	O
lesions	O	O
were	O	O
surgically	O	O
removed	O	O
,	O	O
fixed	O	O
,	O	O
embedded	O	O
in	O	O
cold	O	O
polymerizing	O	O
resin	O	O
and	O	O
sectioned	O	O
.	O	O

The	O	O
probe	O	O
EUB	O	O
338	O	O
,	O	O
specific	O	O
for	O	O
the	O	O
domain	O	O
Bacteria	O	O
,	O	O
was	O	O
used	O	O
together	O	O
with	O	O
a	O	O
number	O	O
of	O	O
species-specific	O	O
16S	O	O
rRNA-directed	O	O
oligonucleotide	O	O
probes	O	O
to	O	O
identify	O	O
bacteria	O	O
.	O	O

To	O	O
control	O	O
non-specific	O	O
binding	O	O
of	O	O
EUB	O	O
338	O	O
,	O	O
probe	O	O
NON	O	O
338	O	O
was	O	O
used	O	O
.	O	O

Alternatively	O	O
,	O	O
DAPI	O	O
(	O	O
4',6'-diamidino-2-phenylindole	O	O
)	O	O
staining	O	O
was	O	O
applied	O	O
to	O	O
record	O	O
prokaryotic	O	O
and	O	O
eukaryotic	O	O
DNA	O	O
in	O	O
the	O	O
specimens	O	O
.	O	O

Hybridization	O	O
with	O	O
NON	O	O
338	O	O
gave	O	O
no	O	O
signals	O	O
despite	O	O
background	O	O
fluorescence	O	O
of	O	O
the	O	O
tissue	O	O
.	O	O

The	O	O
eubacterial	O	O
probe	O	O
showed	O	O
bacteria	O	O
of	O	O
different	O	O
morphotypes	O	O
in	O	O
50	O	O
%	O	O
of	O	O
the	O	O
lesions	O	O
.	O	O

Rods	B-bacteria	B-bacteria
,	O	O
spirochaetes	B-bacteria	B-bacteria
and	O	O
cocci	B-bacteria	B-bacteria
were	O	O
spread	O	O
out	O	O
in	O	O
areas	O	O
of	O	O
the	O	O
tissue	O	O
while	O	O
other	O	O
parts	O	O
seemed	O	O
bacteria-free	O	O
.	O	O

Bacteria	O	O
were	O	O
also	O	O
seen	O	O
to	O	O
co-aggregate	O	O
inside	O	O
the	O	O
tissue	O	O
,	O	O
forming	O	O
microcolonies	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
and	O	O
treponemes	O	O
of	O	O
phylogenetic	O	O
Group	O	O
I	O	O
were	O	O
detected	O	O
with	O	O
specific	O	O
probes	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
colonies	O	O
with	O	O
Streptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
seen	O	O
in	O	O
some	O	O
lesions	O	O
.	O	O

A	O	O
number	O	O
of	O	O
morphotypes	O	O
occurred	O	O
that	O	O
could	O	O
not	O	O
be	O	O
identified	O	O
with	O	O
the	O	O
specific	O	O
probes	O	O
used	O	O
,	O	O
indicating	O	O
the	O	O
presence	O	O
of	O	O
additional	O	O
bacterial	O	O
species	O	O
.	O	O

CLSM	O	O
confirmed	O	O
that	O	O
bacteria	O	O
were	O	O
located	O	O
in	O	O
different	O	O
layers	O	O
of	O	O
the	O	O
tissue	O	O
.	O	O

Accordingly	O	O
,	O	O
the	O	O
FISH	O	O
technique	O	O
demonstrated	O	O
mixed	O	O
consortia	O	O
of	O	O
bacteria	O	O
consisting	O	O
of	O	O
rods	B-bacteria	B-bacteria
,	O	O
spirochaetes	B-bacteria	B-bacteria
and	O	O
cocci	B-bacteria	B-bacteria
in	O	O
asymptomatic	O	O
periapical	O	O
lesions	O	O
of	O	O
root-filled	O	O
teeth	O	O
.	O	O

Nearly	O	O
all	O	O
infections	O	O
begin	O	O
at	O	O
a	O	O
mucous	O	O
membrane	O	O
site	O	O
.	O	O

Also	O	O
,	O	O
the	O	O
human	O	O
mucous	O	O
membranes	O	O
are	O	O
a	O	O
reservoir	O	O
for	O	O
many	O	O
pathogenic	O	O
bacteria	O	O
found	O	O
in	O	O
the	O	O
environment	O	O
(	O	O
that	O	O
is	O	O
,	O	O
pneumococci	B-bacteria	B-bacteria
,	O	O
staphylococci	B-bacteria	B-bacteria
,	O	O
streptococci	B-bacteria	B-bacteria
)	O	O
,	O	O
some	O	O
of	O	O
which	O	O
are	O	O
resistant	O	O
to	O	O
antibiotics	O	O
.	O	O

Clearly	O	O
,	O	O
if	O	O
this	O	O
human	O	O
reservoir	O	O
can	O	O
be	O	O
reduced	O	O
or	O	O
eliminated	O	O
,	O	O
the	O	O
incidence	O	O
of	O	O
disease	O	O
will	O	O
be	O	O
markedly	O	O
reduced	O	O
.	O	O

However	O	O
,	O	O
compounds	O	O
designed	O	O
to	O	O
eliminate	O	O
this	O	O
reservoir	O	O
are	O	O
not	O	O
available	O	O
.	O	O

Towards	O	O
this	O	O
goal	O	O
,	O	O
we	O	O
have	O	O
exploited	O	O
the	O	O
highly	O	O
lethal	O	O
effects	O	O
of	O	O
bacteriophage	O	O
lytic	O	O
enzymes	O	O
(	O	O
lysins	O	O
)	O	O
to	O	O
specifically	O	O
destroy	O	O
disease	O	O
bacteria	O	O
on	O	O
mucous	O	O
membranes	O	O
.	O	O

Such	O	O
lysins	O	O
are	O	O
used	O	O
by	O	O
the	O	O
phage	O	O
to	O	O
release	O	O
their	O	O
progeny	O	O
at	O	O
the	O	O
end	O	O
of	O	O
their	O	O
replicative	O	O
cycle	O	O
.	O	O

We	O	O
have	O	O
identified	O	O
and	O	O
purified	O	O
these	O	O
enzymes	O	O
and	O	O
found	O	O
that	O	O
when	O	O
applied	O	O
externally	O	O
to	O	O
gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
they	O	O
are	O	O
killed	O	O
seconds	O	O
after	O	O
contact	O	O
.	O	O

For	O	O
example	O	O
,	O	O
10	O	O
(	O	O
7	O	O
)	O	O
S.	O	O
pyogenes	O	O
are	O	O
reduced	O	O
to	O	O
undetectable	O	O
levels	O	O
10	O	O
s	O	O
after	O	O
enzyme	O	O
addition	O	O
.	O	O

A	O	O
feature	O	O
of	O	O
these	O	O
enzymes	O	O
is	O	O
their	O	O
high	O	O
specificity	O	O
;	O	O
that	O	O
is	O	O
,	O	O
streptococcal	O	O
lysins	O	O
kill	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
streptococcal	O	O
lysins	O	O
kill	O	O
pneumococci	B-bacteria	B-bacteria
without	O	O
effects	O	O
on	O	O
the	O	O
normal	O	O
flora	O	O
organisms	O	O
.	O	O

In	O	O
vivo	O	O
,	O	O
an	O	O
oral	O	O
colonization	O	O
model	O	O
for	O	O
S.	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
and	O	O
a	O	O
nasal	O	O
colonization	O	O
model	O	O
for	O	O
S.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
were	O	O
developed	O	O
to	O	O
test	O	O
the	O	O
capacity	O	O
of	O	O
the	O	O
lysins	O	O
to	O	O
kill	O	O
organisms	O	O
on	O	O
these	O	O
surfaces	O	O
.	O	O

In	O	O
both	O	O
cases	O	O
,	O	O
when	O	O
the	O	O
animals	O	O
were	O	O
pre-colonized	O	O
with	O	O
their	O	O
respective	O	O
bacteria	O	O
then	O	O
treated	O	O
with	O	O
a	O	O
small	O	O
amount	O	O
of	O	O
lysin	O	O
,	O	O
specific	O	O
for	O	O
the	O	O
colonizing	O	O
organism	O	O
,	O	O
all	O	O
the	O	O
animals	O	O
were	O	O
found	O	O
to	O	O
be	O	O
free	O	O
of	O	O
colonizing	O	O
bacteria	O	O
shortly	O	O
after	O	O
lysin	O	O
treatment	O	O
.	O	O

Thus	O	O
,	O	O
lysins	O	O
may	O	O
be	O	O
added	O	O
to	O	O
our	O	O
armamentarium	O	O
to	O	O
control	O	O
antibiotic-resistant	O	O
bacteria	O	O
.	O	O

To	O	O
date	O	O
,	O	O
there	O	O
have	O	O
been	O	O
relatively	O	O
few	O	O
studies	O	O
addressing	O	O
the	O	O
presence	O	O
and	O	O
expression	O	O
of	O	O
the	O	O
plasminogen-plasmin	O	O
system	O	O
at	O	O
the	O	O
site	O	O
of	O	O
bacterial	O	O
infection	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
effect	O	O
of	O	O
black-pigmented	O	O
bacteria	O	O
on	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
plasminogen-plasmin	O	O
system	O	O
in	O	O
human	O	O
pulp	O	O
and	O	O
osteoblastic	O	O
cells	O	O
.	O	O

The	O	O
supernatants	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
endodontalis	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
were	O	O
used	O	O
to	O	O
evaluate	O	O
tissue-type	O	O
plasminogen	O	O
activator	O	O
(	O	O
t-PA	O	O
)	O	O
and	O	O
type	O	O
1	O	O
plasminogen	O	O
activator	O	O
inhibitor	O	O
(	O	O
PAI-1	O	O
)	O	O
gene	O	O
expression	O	O
in	O	O
human	O	O
pulp	O	O
and	O	O
osteoblastic	O	O
cells	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
mRNA	O	O
were	O	O
quantitatively	O	O
measured	O	O
by	O	O
using	O	O
reverse	O	O
transcription-polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
black-pigmented	O	O
bacteria	O	O
induced	O	O
not	O	O
only	O	O
t-PA	O	O
but	O	O
also	O	O
PAI-1	O	O
gene	O	O
expression	O	O
in	O	O
human	O	O
pulp	O	O
and	O	O
osteoblastic	O	O
cells	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
ratio	O	O
of	O	O
t-PA	O	O
to	O	O
PAI-1	O	O
was	O	O
higher	O	O
in	O	O
human	O	O
pulp	O	O
and	O	O
osteoblastic	O	O
cells	O	O
stimulated	O	O
by	O	O
black-pigmented	O	O
bacteria	O	O
than	O	O
in	O	O
untreated	O	O
cell	O	O
cultures	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
)	O	O
.	O	O

A	O	O
fine	O	O
balance	O	O
exists	O	O
in	O	O
the	O	O
expression	O	O
of	O	O
components	O	O
of	O	O
the	O	O
plasminogen-plasmin	O	O
system	O	O
,	O	O
whereby	O	O
tissue	O	O
homeostasis	O	O
is	O	O
maintained	O	O
.	O	O

Black-pigmented	O	O
bacteria	O	O
activate	O	O
the	O	O
activator-inhibitor	O	O
system	O	O
in	O	O
human	O	O
pulp	O	O
and	O	O
osteoblastic	O	O
cells	O	O
through	O	O
unbalance	O	O
regulation	O	O
of	O	O
t-PA	O	O
and	O	O
PAI-1	O	O
,	O	O
which	O	O
might	O	O
result	O	O
in	O	O
an	O	O
uncontrolled	O	O
degradation	O	O
of	O	O
pulpal	O	O
and	O	O
periapical	O	O
tissues	O	O
.	O	O

The	O	O
oral	O	O
epithelium	O	O
is	O	O
continuously	O	O
exposed	O	O
to	O	O
a	O	O
variety	O	O
of	O	O
microbial	O	O
challenges	O	O
that	O	O
can	O	O
cause	O	O
infectious	O	O
diseases	O	O
such	O	O
as	O	O
periodontal	O	O
disease	O	O
.	O	O

Human	O	O
B	O	O
Defensin-2	O	O
(	O	O
hBD-2	O	O
)	O	O
is	O	O
a	O	O
cationic	O	O
antimicrobial	O	O
peptide	O	O
with	O	O
low	O	O
molecular	O	O
weight	O	O
,	O	O
which	O	O
is	O	O
inducible	O	O
from	O	O
oral	O	O
epithelial	O	O
cells	O	O
upon	O	O
either	O	O
bacterial	O	O
infection	O	O
or	O	O
stimulation	O	O
with	O	O
inflammatory	O	O
cytokines	O	O
.	O	O

This	O	O
peptide	O	O
has	O	O
a	O	O
broad	O	O
antimicrobial	O	O
spectrum	O	O
that	O	O
includes	O	O
gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
and	O	O
fungi	O	O
.	O	O

Therefore	O	O
,	O	O
it	O	O
is	O	O
thought	O	O
that	O	O
hBD-2	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
as	O	O
one	O	O
of	O	O
natural	O	O
immunities	O	O
to	O	O
bacterial	O	O
infection	O	O
.	O	O

However	O	O
,	O	O
its	O	O
activity	O	O
is	O	O
inhibited	O	O
by	O	O
body	O	O
fluids	O	O
such	O	O
as	O	O
serum	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
assess	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
synthetic	O	O
hBD-2	O	O
against	O	O
oral	O	O
bacteria	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
saliva	O	O
or	O	O
serum	O	O
.	O	O

The	O	O
antibacterial	O	O
activity	O	O
of	O	O
synthetic	O	O
hBD-2	O	O
was	O	O
tested	O	O
against	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

Antibacterial	O	O
broth	O	O
assay	O	O
and	O	O
diffusion	O	O
assay	O	O
were	O	O
performed	O	O
in	O	O
vitro	O	O
.	O	O

The	O	O
antibacterial	O	O
activity	O	O
of	O	O
hBD-2	O	O
was	O	O
approximately	O	O
equal	O	O
to	O	O
that	O	O
of	O	O
minocycline	O	O
at	O	O
equimolar	O	O
concentrations	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
activity	O	O
of	O	O
hBD-2	O	O
remained	O	O
at	O	O
60	O	O
%	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
80	O	O
%	O	O
saliva	O	O
,	O	O
whereas	O	O
no	O	O
activity	O	O
remained	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
20	O	O
%	O	O
serum	O	O
.	O	O

Our	O	O
results	O	O
suggest	O	O
the	O	O
possibility	O	O
that	O	O
synthetic	O	O
hBD-2	O	O
could	O	O
be	O	O
useful	O	O
to	O	O
prevent	O	O
infection	O	O
by	O	O
periodontal	O	O
disease	O	O
.	O	O

Viable	O	O
counts	O	O
and	O	O
activities	O	O
of	O	O
sulfate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
SRB	B-bacteria	B-bacteria
)	O	O
and	O	O
methanogenic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
determined	O	O
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
eight	O	O
volunteers	O	O
.	O	O

Of	O	O
these	O	O
,	O	O
seven	O	O
harbored	O	O
viable	O	O
SRB	B-bacteria	B-bacteria
populations	O	O
,	O	O
and	O	O
six	O	O
harbored	O	O
viable	O	O
methanogenic	O	O
bacterial	O	O
populations	O	O
.	O	O

Two	O	O
volunteers	O	O
classified	O	O
as	O	O
type	O	O
III	O	O
periodontal	O	O
patients	O	O
had	O	O
both	O	O
SRB	B-bacteria	B-bacteria
and	O	O
methanogenic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Six	O	O
separate	O	O
sites	O	O
were	O	O
sampled	O	O
:	O	O
posterior	O	O
tongue	O	O
,	O	O
anterior	O	O
tongue	O	O
,	O	O
mid-buccal	O	O
mucosa	O	O
,	O	O
vestibular	O	O
mucosa	O	O
,	O	O
supragingival	O	O
plaque	O	O
,	O	O
and	O	O
subgingival	O	O
plaque	O	O
.	O	O

The	O	O
SRB	B-bacteria	B-bacteria
was	O	O
found	O	O
in	O	O
all	O	O
areas	O	O
in	O	O
one	O	O
volunteer	O	O
,	O	O
and	O	O
it	O	O
was	O	O
mostly	O	O
present	O	O
in	O	O
posterior	O	O
tongue	O	O
,	O	O
anterior	O	O
tongue	O	O
,	O	O
supragingival	O	O
,	O	O
and	O	O
subgingival	O	O
plaques	O	O
in	O	O
many	O	O
volunteers	O	O
.	O	O

The	O	O
methanogenic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
mostly	O	O
found	O	O
in	O	O
supragingival	O	O
and	O	O
subgingival	O	O
plaques	O	O
.	O	O

The	O	O
activities	O	O
of	O	O
sulfate	O	O
reduction	O	O
and	O	O
methane	O	O
production	O	O
were	O	O
determined	O	O
in	O	O
randomly	O	O
selected	O	O
isolates	O	O
.	O	O

A	O	O
clinical	O	O
procedure	O	O
was	O	O
developed	O	O
to	O	O
examine	O	O
the	O	O
effects	O	O
of	O	O
short-term	O	O
and	O	O
extended	O	O
use	O	O
of	O	O
a	O	O
triclosan/copolymer	O	O
dentifrice	O	O
and	O	O
a	O	O
commercial	O	O
fluoride	O	O
dentifrice	O	O
on	O	O
oral	O	O
bacteria	O	O
,	O	O
including	O	O
those	O	O
producing	O	O
hydrogen	O	O
sulfide	O	O
.	O	O

Healthy	O	O
adults	O	O
volunteered	O	O
for	O	O
this	O	O
double-blind	O	O
,	O	O
crossover	O	O
design	O	O
clinical	O	O
study	O	O
and	O	O
provided	O	O
saliva	O	O
samples	O	O
for	O	O
culturing	O	O
on	O	O
enriched	O	O
and	O	O
indicator	O	O
media	O	O
to	O	O
enumerate	O	O
all	O	O
salivary	O	O
bacteria	O	O
and	O	O
those	O	O
producing	O	O
hydrogen	O	O
sulfide	O	O
(	O	O
odorigenic	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

Subjects	O	O
brushed	O	O
with	O	O
an	O	O
assigned	O	O
dentifrice	O	O
for	O	O
7	O	O
d	O	O
and	O	O
were	O	O
sampled	O	O
on	O	O
day	O	O
8	O	O
to	O	O
assess	O	O
the	O	O
long-term	O	O
effects	O	O
on	O	O
bacteria	O	O
.	O	O

Extended	O	O
use	O	O
of	O	O
the	O	O
triclosan/copolymer	O	O
dentifrice	O	O
resulted	O	O
in	O	O
a	O	O
49	O	O
%	O	O
and	O	O
66	O	O
%	O	O
reduction	O	O
of	O	O
salivary	O	O
and	O	O
odorigenic	O	O
bacteria	O	O
,	O	O
respectively	O	O
,	O	O
compared	O	O
with	O	O
the	O	O
fluoride	O	O
dentifrice	O	O
.	O	O

To	O	O
examine	O	O
short-term	O	O
effects	O	O
,	O	O
subjects	O	O
subsequently	O	O
brushed	O	O
with	O	O
their	O	O
assigned	O	O
dentifrice	O	O
and	O	O
were	O	O
sampled	O	O
at	O	O
2	O	O
h	O	O
and	O	O
4	O	O
h	O	O
post-brushing	O	O
.	O	O

At	O	O
2	O	O
h	O	O
and	O	O
4	O	O
h	O	O
post-brushing	O	O
,	O	O
the	O	O
triclosan/copolymer	O	O
dentifrice	O	O
resulted	O	O
in	O	O
a	O	O
62	O	O
%	O	O
and	O	O
52	O	O
%	O	O
decrease	O	O
for	O	O
salivary	O	O
bacteria	O	O
and	O	O
79	O	O
%	O	O
and	O	O
72	O	O
%	O	O
decrease	O	O
for	O	O
odorigenic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
respectively	O	O
,	O	O
vs.	O	O
the	O	O
fluoride	O	O
dentifrice	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
a	O	O
significant	O	O
decrease	O	O
of	O	O
all	O	O
salivary	O	O
bacteria	O	O
and	O	O
hydrogen	O	O
sulfide-producing	O	O
odorigenic	O	O
bacteria	O	O
following	O	O
use	O	O
of	O	O
the	O	O
triclosan/copolymer	O	O
dentifrice	O	O
and	O	O
explain	O	O
previous	O	O
results	O	O
on	O	O
the	O	O
efficacy	O	O
of	O	O
this	O	O
dentifrice	O	O
on	O	O
oral	O	O
malodor	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
predominant	O	O
flora	O	O
associated	O	O
with	O	O
pericoronitis	O	O
in	O	O
third	O	O
molars	O	O
and	O	O
to	O	O
investigate	O	O
the	O	O
presence	O	O
of	O	O
beta-lactamase-producing	O	O
strains	E-bacteria	O	O
.	O	O

The	O	O
third	O	O
molars	O	O
in	O	O
26	O	O
adults	O	O
were	O	O
evaluated	O	O
by	O	O
cultures	O	O
with	O	O
nonselective	O	O
media	O	O
and	O	O
with	O	O
selective	O	O
media	O	O
containing	O	O
amoxicillin	O	O
,	O	O
pristinamycin	O	O
,	O	O
spiramycin	O	O
,	O	O
metronidazole	O	O
,	O	O
and	O	O
spiramycin	O	O
plus	O	O
metronidazole	O	O
.	O	O

In	O	O
the	O	O
majority	O	O
of	O	O
cases	O	O
(	O	O
19/26	O	O
)	O	O
,	O	O
the	O	O
flora	O	O
found	O	O
in	O	O
an	O	O
anaerobic	O	O
atmosphere	O	O
predominated	O	O
.	O	O

Obligate	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
were	O	O
present	O	O
in	O	O
21	O	O
of	O	O
the	O	O
26	O	O
samples	O	O
.	O	O

The	O	O
bacteria	O	O
most	O	O
commonly	O	O
detected	O	O
were	O	O
alpha-hemolytic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
26/26	O	O
)	O	O
and	O	O
the	O	O
genera	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
(	O	O
15/26	O	O
)	O	O
,	O	O
Veillonella	B-bacteria	B-bacteria
(	O	O
15/26	O	O
)	O	O
,	O	O
Bacteroides	B-bacteria	B-bacteria
(	O	O
9/26	O	O
)	O	O
,	O	O
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
(	O	O
9/26	O	O
)	O	O
.	O	O

Amoxicillin	O	O
and	O	O
pristinamycin	O	O
were	O	O
the	O	O
most	O	O
active	O	O
in	O	O
reducing	O	O
the	O	O
anaerobic	O	O
cultivable	O	O
counts	O	O
.	O	O

beta-Lactamase-producing	O	O
strains	O	O
were	O	O
detected	O	O
in	O	O
9	O	O
samples	O	O
and	O	O
were	O	O
mostly	O	O
bacteria	O	O
of	O	O
the	O	O
genera	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
,	O	O
and	O	O
Bacteroides	B-bacteria	B-bacteria
.	O	O

These	O	O
results	O	O
highlight	O	O
(	O	O
1	O	O
)	O	O
the	O	O
diversity	O	O
of	O	O
the	O	O
microflora	O	O
associated	O	O
with	O	O
pericoronitis	O	O
and	O	O
the	O	O
importance	O	O
of	O	O
the	O	O
anaerobic	O	O
flora	O	O
and	O	O
(	O	O
2	O	O
)	O	O
the	O	O
existence	O	O
of	O	O
selection	O	O
pressure	O	O
related	O	O
to	O	O
the	O	O
use	O	O
of	O	O
beta-lactams	O	O
that	O	O
may	O	O
culminate	O	O
in	O	O
failure	O	O
of	O	O
prescribed	O	O
penicillins	O	O
.	O	O

In	O	O
a	O	O
previous	O	O
study	O	O
,	O	O
we	O	O
screened	O	O
149	O	O
subjects	O	O
and	O	O
established	O	O
four	O	O
groups	O	O
high	O	O
or	O	O
low	O	O
for	O	O
salivary	O	O
killing	O	O
of	O	O
oral	O	O
bacteria	O	O
,	O	O
and	O	O
for	O	O
aggregation	O	O
and	O	O
live	O	O
and	O	O
dead	O	O
adherence	O	O
of	O	O
oral	O	O
bacteria	O	O
(	O	O
as	O	O
a	O	O
combined	O	O
factor	O	O
)	O	O
.	O	O

Caries	O	O
scores	O	O
were	O	O
significantly	O	O
lower	O	O
in	O	O
both	O	O
High	O	O
Aggregation-Adherence	O	O
groups	O	O
.	O	O

In	O	O
this	O	O
study	O	O
we	O	O
looked	O	O
at	O	O
the	O	O
effects	O	O
of	O	O
those	O	O
differences	O	O
in	O	O
salivary	O	O
function	O	O
on	O	O
the	O	O
quantity	O	O
and	O	O
diversity	O	O
of	O	O
oral	O	O
biofilm	O	O
streptococci	O	O
.	O	O

Subjects	O	O
from	O	O
those	O	O
four	O	O
groups	O	O
were	O	O
recalled	O	O
for	O	O
collection	O	O
of	O	O
overnight	O	O
oral	O	O
biofilm	O	O
from	O	O
buccal	O	O
upper	O	O
centra	O	O
incisors	O	O
,	O	O
lingual	O	O
lower	O	O
central	O	O
incisors	O	O
,	O	O
buccal	O	O
upper	O	O
and	O	O
lower	O	O
first	O	O
molars	O	O
,	O	O
and	O	O
lingual	O	O
upper	O	O
and	O	O
lower	O	O
first	O	O
molars	O	O
.	O	O

At	O	O
each	O	O
site	O	O
,	O	O
groups	O	O
were	O	O
compared	O	O
for	O	O
total	O	O
biofilm	O	O
(	O	O
by	O	O
DNA	O	O
concentration	O	O
)	O	O
,	O	O
total	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
by	O	O
quantitative	O	O
PCR	O	O
)	O	O
,	O	O
and	O	O
streptococcal	O	O
diversity	O	O
(	O	O
by	O	O
Streptococcus-specific	O	O
denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
)	O	O
.	O	O

Total	O	O
biofilm	O	O
DNA	O	O
and	O	O
total	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
correlated	O	O
.	O	O

Both	O	O
were	O	O
highest	O	O
on	O	O
buccal	O	O
molar	O	O
surfaces	O	O
and	O	O
lowest	O	O
on	O	O
lingual	O	O
lower	O	O
central	O	O
incisors	O	O
,	O	O
and	O	O
both	O	O
were	O	O
significantly	O	O
lower	O	O
in	O	O
the	O	O
High	O	O
Aggregation-Adherence	O	O
groups	O	O
(	O	O
particularly	O	O
at	O	O
the	O	O
buccal	O	O
molar	O	O
site	O	O
)	O	O
.	O	O

Fifty	O	O
distinct	O	O
bands	O	O
were	O	O
observed	O	O
in	O	O
denaturing	O	O
gradient	O	O
gels	O	O
.	O	O

There	O	O
was	O	O
great	O	O
diversity	O	O
within	O	O
and	O	O
between	O	O
sites	O	O
.	O	O

Three	O	O
major	O	O
bands	O	O
were	O	O
present	O	O
in	O	O
almost	O	O
every	O	O
person	O	O
at	O	O
every	O	O
site	O	O
.	O	O

Densities	O	O
for	O	O
two	O	O
of	O	O
those	O	O
bands	O	O
were	O	O
significantly	O	O
lower	O	O
in	O	O
both	O	O
High	O	O
Aggregation-Adherence	O	O
groups	O	O
.	O	O

Other	O	O
less-prevalent	O	O
bands	O	O
also	O	O
showed	O	O
the	O	O
same	O	O
pattern	O	O
.	O	O

These	O	O
findings	O	O
are	O	O
consistent	O	O
with	O	O
our	O	O
caries	O	O
results	O	O
in	O	O
suggesting	O	O
that	O	O
differences	O	O
in	O	O
salivary	O	O
function	O	O
can	O	O
influence	O	O
the	O	O
quantity	O	O
and	O	O
composition	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
oral	O	O
biofilms	O	O
.	O	O

Dental	O	O
plaque	O	O
from	O	O
76	O	O
children	O	O
without	O	O
amalgam	O	O
restorations	O	O
was	O	O
screened	O	O
for	O	O
bacteria	O	O
resistant	O	O
to	O	O
mercuric	O	O
chloride	O	O
.	O	O

Seventy-one	O	O
per	O	O
cent	O	O
of	O	O
the	O	O
children	O	O
harboured	O	O
mercury-resistant	O	O
oral	O	O
bacteria	O	O
and	O	O
the	O	O
median	O	O
percentage	O	O
of	O	O
the	O	O
total	O	O
oral	O	O
microflora	O	O
resistant	O	O
to	O	O
mercuric	O	O
chloride	O	O
was	O	O
0.007	O	O
%	O	O
(	O	O
range	O	O
0-5.3	O	O
%	O	O
)	O	O
.	O	O

Eighty-seven	O	O
mercury-resistant	O	O
bacteria	O	O
were	O	O
isolated	O	O
and	O	O
86	O	O
%	O	O
of	O	O
these	O	O
were	O	O
streptococci	B-bacteria	B-bacteria
with	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
predominating	O	O
.	O	O

Sixty	O	O
per	O	O
cent	O	O
of	O	O
the	O	O
mercury-resistant	O	O
isolates	O	O
were	O	O
also	O	O
resistant	O	O
to	O	O
at	O	O
least	O	O
one	O	O
of	O	O
the	O	O
four	O	O
antibiotics	O	O
tested	O	O
(	O	O
penicillin	O	O
,	O	O
ampicillin	O	O
,	O	O
erythromycin	O	O
and	O	O
tetracycline	O	O
)	O	O
with	O	O
resistance	O	O
to	O	O
tetracycline	O	O
(	O	O
40	O	O
%	O	O
of	O	O
isolates	O	O
)	O	O
most	O	O
frequently	O	O
encountered	O	O
.	O	O

Chronic	O	O
maxillary	O	O
sinusitis	O	O
is	O	O
a	O	O
chronic	O	O
inflammatory	O	O
condition	O	O
in	O	O
which	O	O
the	O	O
role	O	O
of	O	O
microbial	O	O
infection	O	O
remains	O	O
undefined	O	O
.	O	O

Bacteria	O	O
have	O	O
been	O	O
isolated	O	O
from	O	O
chronically	O	O
inflamed	O	O
sinuses	O	O
;	O	O
however	O	O
,	O	O
their	O	O
role	O	O
in	O	O
the	O	O
chronicity	O	O
of	O	O
inflammation	O	O
is	O	O
unknown	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
whether	O	O
bacteria	O	O
are	O	O
present	O	O
in	O	O
clinical	O	O
samples	O	O
from	O	O
chronic	O	O
maxillary	O	O
sinusitis	O	O
and	O	O
to	O	O
assess	O	O
the	O	O
diversity	O	O
of	O	O
the	O	O
flora	O	O
present	O	O
.	O	O

Washes	O	O
and/or	O	O
tissue	O	O
samples	O	O
from	O	O
endoscopic	O	O
sinus	O	O
surgery	O	O
on	O	O
11	O	O
patients	O	O
with	O	O
chronic	O	O
maxillary	O	O
sinusitis	O	O
were	O	O
subjected	O	O
to	O	O
PCR	O	O
amplification	O	O
of	O	O
bacterial	O	O
16S	O	O
rDNA	O	O
using	O	O
three	O	O
universal	O	O
primer	O	O
pairs	O	O
,	O	O
followed	O	O
by	O	O
cloning	O	O
and	O	O
sequencing	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
also	O	O
assessed	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
bacteria	O	O
and	O	O
fungi	O	O
by	O	O
conventional	O	O
culture	O	O
methods	O	O
.	O	O

Viable	O	O
bacteria	O	O
and/or	O	O
bacterial	O	O
16S	O	O
rDNA	O	O
were	O	O
detected	O	O
from	O	O
maxillary	O	O
sinus	O	O
samples	O	O
of	O	O
five	O	O
of	O	O
the	O	O
11	O	O
patients	O	O
examined	O	O
(	O	O
45	O	O
%	O	O
)	O	O
.	O	O

Three	O	O
sinus	O	O
samples	O	O
were	O	O
positive	O	O
by	O	O
both	O	O
PCR	O	O
and	O	O
culture	O	O
methods	O	O
,	O	O
one	O	O
was	O	O
positive	O	O
only	O	O
by	O	O
PCR	O	O
,	O	O
and	O	O
one	O	O
only	O	O
by	O	O
culture	O	O
.	O	O

Thirteen	O	O
bacterial	O	O
species	O	O
were	O	O
identified	O	O
:	O	O
Abiotrophia	B-bacteria	B-bacteria
defectiva	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
avium	E-bacteria	I-bacteria
,	O	O
Eubacterium	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
elegans	E-bacteria	I-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
Serratia	B-bacteria	B-bacteria
marcescens	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Stenotrophomonas	B-bacteria	B-bacteria
maltophilia	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis/Streptococcus	I-bacteria	I-bacteria
oralis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

Fungi	O	O
were	O	O
not	O	O
detected	O	O
.	O	O

In	O	O
one	O	O
patient	O	O
Streptococcus	B-bacteria	B-bacteria
mitis/Streptococcus	I-bacteria	I-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
and	O	O
in	O	O
another	O	O
patient	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
were	O	O
detected	O	O
from	O	O
both	O	O
the	O	O
sinus	O	O
and	O	O
the	O	O
oral	O	O
cavity	O	O
using	O	O
species-specific	O	O
PCR	O	O
primers	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
both	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
can	O	O
be	O	O
detected	O	O
in	O	O
nearly	O	O
half	O	O
of	O	O
chronic	O	O
maxillary	O	O
sinusitis	O	O
cases	O	O
.	O	O

In	O	O
a	O	O
previous	O	O
study	O	O
we	O	O
showed	O	O
that	O	O
prolonged	O	O
nasogastric	O	O
tube	O	O
feeding	O	O
is	O	O
associated	O	O
with	O	O
pathogenic	O	O
oral	O	O
flora	O	O
.	O	O

To	O	O
reexamine	O	O
the	O	O
impact	O	O
of	O	O
prolonged	O	O
nasogastric	O	O
tube	O	O
feeding	O	O
on	O	O
the	O	O
oral	O	O
microbiota	O	O
and	O	O
to	O	O
explore	O	O
the	O	O
salivary	O	O
flow	O	O
and	O	O
composition	O	O
in	O	O
elderly	O	O
patients	O	O
in	O	O
long-term	O	O
care	O	O
.	O	O

We	O	O
compared	O	O
a	O	O
group	O	O
of	O	O
elderly	O	O
patients	O	O
fed	O	O
by	O	O
nasogastric	O	O
tube	O	O
with	O	O
a	O	O
control	O	O
group	O	O
of	O	O
elderly	O	O
patients	O	O
in	O	O
long-term	O	O
care	O	O
who	O	O
are	O	O
fed	O	O
orally	O	O
.	O	O

Bacteriologic	O	O
studies	O	O
were	O	O
performed	O	O
by	O	O
culturing	O	O
samples	O	O
from	O	O
the	O	O
oropharynx	O	O
.	O	O

Saliva	O	O
studies	O	O
included	O	O
quantitative	O	O
and	O	O
biochemical	O	O
analysis	O	O
of	O	O
basal	O	O
and	O	O
stimulated	O	O
salivary	O	O
flow	O	O
.	O	O

Bacteriologic	O	O
studies	O	O
performed	O	O
in	O	O
90	O	O
patients	O	O
revealed	O	O
a	O	O
significantly	O	O
higher	O	O
prevalence	O	O
of	O	O
gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
prolonged	O	O
nasogastric	O	O
tube	O	O
feeding	O	O
patients	O	O
(	O	O
73	O	O
%	O	O
vs.	O	O
13	O	O
%	O	O
,	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

It	O	O
is	O	O
emphasized	O	O
that	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
were	O	O
commonly	O	O
and	O	O
exclusively	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
flora	O	O
of	O	O
the	O	O
nasogastric-tube	O	O
fed	O	O
patients	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

In	O	O
the	O	O
saliva	O	O
studies	O	O
performed	O	O
on	O	O
23	O	O
nasogastric-tube	O	O
fed	O	O
and	O	O
21	O	O
control	O	O
patients	O	O
,	O	O
basal	O	O
and	O	O
stimulated	O	O
salivary	O	O
flow	O	O
was	O	O
not	O	O
significantly	O	O
different	O	O
in	O	O
the	O	O
two	O	O
groups	O	O
,	O	O
however	O	O
the	O	O
ratio	O	O
of	O	O
stimulated	O	O
to	O	O
basal	O	O
flow	O	O
was	O	O
reduced	O	O
in	O	O
the	O	O
nasogastric-tube	O	O
fed	O	O
group	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Significant	O	O
differences	O	O
were	O	O
also	O	O
found	O	O
in	O	O
the	O	O
concentrations	O	O
of	O	O
sodium	O	O
,	O	O
amylase	O	O
,	O	O
phosphor	O	O
and	O	O
magnesium	O	O
.	O	O

Noteworthy	O	O
was	O	O
the	O	O
concentration	O	O
of	O	O
uric	O	O
acid	O	O
,	O	O
the	O	O
main	O	O
non-enzymatic	O	O
antioxidant	O	O
of	O	O
saliva	O	O
,	O	O
which	O	O
was	O	O
significantly	O	O
lower	O	O
in	O	O
nasogastric-tube	O	O
fed	O	O

patients	O	O
(	O	O
P	O	O
<	O	O
0.002	O	O
)	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
prolonged	O	O
nasogastric	O	O
tube	O	O
feeding	O	O
is	O	O
associated	O	O
with	O	O
pathologic	O	O
colonization	O	O
of	O	O
the	O	O
oroparynx	O	O
and	O	O
with	O	O
alterations	O	O
in	O	O
the	O	O
saliva	O	O
that	O	O
are	O	O
related	O	O
to	O	O
the	O	O
risk	O	O
of	O	O
aspiration	O	O
pneumonia	O	O
.	O	O

Further	O	O
research	O	O
is	O	O
called	O	O
for	O	O
,	O	O
as	O	O
well	O	O
as	O	O
a	O	O
thorough	O	O
revision	O	O
of	O	O
the	O	O
existing	O	O
oral	O	O
cleansing	O	O
procedures	O	O
in	O	O
these	O	O
patients	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
were	O	O
considered	O	O
the	O	O
prime	O	O
cariogenic	O	O
microorganisms	O	O
until	O	O
phylogenetic	O	O
related	O	O
bacteria	O	O
,	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
were	O	O
associated	O	O
with	O	O
caries	O	O
.	O	O

Today	O	O
,	O	O
lactobacilli	B-bacteria	B-bacteria
are	O	O
still	O	O
considered	O	O
a	O	O
factor	O	O
in	O	O
determining	O	O
the	O	O
predisposition	O	O
to	O	O
develop	O	O
cavities	O	O
.	O	O

As	O	O
a	O	O
first	O	O
step	O	O
in	O	O
colonization	O	O
,	O	O
microorganisms	O	O
adhere	O	O
to	O	O
oral	O	O
tissues	O	O
.	O	O

Based	O	O
on	O	O
this	O	O
fact	O	O
,	O	O
the	O	O
purpose	O	O
of	O	O
our	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
if	O	O
there	O	O
was	O	O
a	O	O
statistical	O	O
association	O	O
or	O	O
difference	O	O
related	O	O
to	O	O
the	O	O
state	O	O
of	O	O
oral	O	O
health	O	O
with	O	O
the	O	O
surface	O	O
characteristics	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
.	O	O

Patients	O	O
were	O	O
classified	O	O
as	O	O
caries-free	O	O
and	O	O
caries-active	O	O
.	O	O

Interviews	O	O
were	O	O
performed	O	O
to	O	O
establish	O	O
the	O	O
nutritional	O	O
and	O	O
oral	O	O
hygiene	O	O
habits	O	O
.	O	O

The	O	O
previously	O	O
reported	O	O
characteristics	O	O
of	O	O
isolated	O	O
lactobacilli	O	O
's	O	O
quantification	O	O
and	O	O
association	O	O
to	O	O
dental	O	O
tissues	O	O
were	O	O
determined	O	O
.	O	O

Although	O	O
the	O	O
nutritional	O	O
habits	O	O
for	O	O
caries-free	O	O
and	O	O
caries-active	O	O
patients	O	O
were	O	O
similar	O	O
,	O	O
the	O	O
patients'	O	O
oral	O	O
hygiene	O	O
and	O	O
dental	O	O
care	O	O
determined	O	O
differences	O	O
in	O	O
risk	O	O
indices	O	O
.	O	O

The	O	O
number	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
was	O	O
statistically	O	O
lower	O	O
in	O	O
saliva	O	O
of	O	O
subjects	O	O
with	O	O
good	O	O
oral	O	O
health	O	O
.	O	O

Certain	O	O
species	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
could	O	O
not	O	O
be	O	O
associated	O	O
to	O	O
specific	O	O
areas	O	O
of	O	O
the	O	O
mouth	O	O
,	O	O
although	O	O
some	O	O
species	O	O
could	O	O
be	O	O
localized	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
from	O	O
caries	O	O
active	O	O
(	O	O
CA	O	O
)	O	O
subjects	O	O
showed	O	O
a	O	O
greater	O	O
ability	O	O
to	O	O
adhere	O	O
to	O	O
hydrophobic	O	O
substances	O	O
,	O	O
had	O	O
a	O	O
greater	O	O
salt	O	O
agglutination	O	O
property	O	O
,	O	O
and	O	O
showed	O	O
lower	O	O
production	O	O
of	O	O
inhibitory	O	O
substances	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
from	O	O
caries	O	O
free	O	O
(	O	O
CF	O	O
)	O	O
subjects	O	O
were	O	O
better	O	O
able	O	O
to	O	O
inhibit	O	O
oral	O	O
,	O	O
potentially	O	O
pathogenic	O	O
,	O	O
microorganisms	O	O
.	O	O

These	O	O
studies	O	O
prove	O	O
that	O	O
preliminary	O	O
differences	O	O
between	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
CF	O	O
and	O	O
CA	O	O
patients	O	O
exist	O	O
.	O	O

Non-specific	O	O
and	O	O
specific	O	O
adhesion	O	O
mechanisms	O	O
in	O	O
bacteria	O	O
should	O	O
be	O	O
further	O	O
demonstrated	O	O
.	O	O

Mucosal	O	O
immunization	O	O
should	O	O
be	O	O
an	O	O
excellent	O	O
method	O	O
of	O	O
preventing	O	O
respiratory	O	O
infections	O	O
because	O	O
the	O	O
local	O	O
immunoglobulin	O	O
A	O	O
antibodies	O	O
can	O	O
neutralize	O	O
the	O	O
invading	O	O
pathogens	O	O
at	O	O
the	O	O
site	O	O
of	O	O
entry	O	O
.	O	O

Because	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
a	O	O
normal	O	O
inhabitant	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
,	O	O
can	O	O
naturally	O	O
elicit	O	O
a	O	O
mucosal	O	O
immune	O	O
response	O	O
,	O	O
it	O	O
has	O	O
been	O	O
a	O	O
prime	O	O
candidate	O	O
for	O	O
investigations	O	O
as	O	O
a	O	O
live	O	O
oral	O	O
vaccine	O	O
vector	O	O
for	O	O
immunization	O	O
against	O	O
respiratory	O	O
infections	O	O
.	O	O

Antigens	O	O
from	O	O
a	O	O
number	O	O
of	O	O
respiratory	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
such	O	O
as	O	O
Bordetella	B-bacteria	B-bacteria
pertussis	E-bacteria	I-bacteria
,	O	O
and	O	O
one	O	O
virus	O	O
have	O	O
been	O	O
expressed	O	O
extracellularly	O	O
or	O	O
on	O	O
the	O	O
cell	O	O
surface	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

The	O	O
antigens	O	O
expressed	O	O
were	O	O
single	O	O
or	O	O
multiple	O	O
proteins	O	O
from	O	O
one	O	O
or	O	O
more	O	O
pathogens	O	O
.	O	O

The	O	O
recombinant	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
expressing	O	O
surface-localized	O	O
heterologous	O	O
antigens	O	O
could	O	O
colonize	O	O
and	O	O
persist	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
mice	O	O
and	O	O
rats	O	O
.	O	O

Oral	O	O
colonization	O	O
induced	O	O
a	O	O
mucosal	O	O
immunoglobulin	O	O
A	O	O
response	O	O
and	O	O
,	O	O
in	O	O
some	O	O
instances	O	O
,	O	O
also	O	O
a	O	O
systemic	O	O
immunoglobulin	O	O
G	O	O
response	O	O
to	O	O
the	O	O
heterologous	O	O
antigens	O	O
.	O	O

When	O	O
given	O	O
parenterally	O	O
,	O	O
the	O	O
heterologous	O	O
antigens	O	O
generated	O	O
a	O	O
systemic	O	O
immunoglobulin	O	O
G	O	O
response	O	O
.	O	O

These	O	O
findings	O	O
indicate	O	O
that	O	O
antigens	O	O
expressed	O	O
by	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
are	O	O
immunogenic	O	O
.	O	O

A	O	O
new	O	O
approach	O	O
to	O	O
the	O	O
use	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
as	O	O
a	O	O
vaccine	O	O
vector	O	O
is	O	O
to	O	O
modulate	O	O
immune	O	O
responses	O	O
by	O	O
co-expressing	O	O
cytokines	O	O
with	O	O
the	O	O
antigen	O	O
.	O	O

The	O	O
ability	O	O
to	O	O
express	O	O
antigens	O	O
from	O	O
respiratory	O	O
pathogens	O	O
and	O	O
induce	O	O
immune	O	O
responses	O	O
during	O	O
oral	O	O
colonization	O	O
suggests	O	O
that	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
may	O	O
be	O	O
developed	O	O
into	O	O
a	O	O
live	O	O
vector	O	O
for	O	O
oral	O	O
immunization	O	O
against	O	O
respiratory	O	O
infections	O	O
.	O	O

The	O	O
major	O	O
challenge	O	O
ahead	O	O
is	O	O
to	O	O
find	O	O
ways	O	O
to	O	O
achieve	O	O
a	O	O
high	O	O
level	O	O
of	O	O
immune	O	O
response	O	O
following	O	O
oral	O	O
colonization	O	O
.	O	O

Chavez	O	O
de	O	O
Paz	O	O
LE	O	O
,	O	O
Dahlen	O	O
G	O	O
,	O	O
Molander	O	O
A	O	O
,	O	O
Moller	O	O
A	O	O
,	O	O
Bergenholtz	O	O
G.	O	O
Bacteria	O	O
recovered	O	O
from	O	O
teeth	O	O
with	O	O
apical	O	O
periodontitis	O	O
after	O	O
antimicrobial	O	O
endodontic	O	O
treatment	O	O
.	O	O

International	O	O
Endodontic	O	O
Journal	O	O
,	O	O
36	O	O
,	O	O
500-508	O	O
,	O	O
2003	O	O
.	O	O

To	O	O
determine	O	O
whether	O	O
there	O	O
is	O	O
a	O	O
pattern	O	O
for	O	O
certain	O	O
bacteria	O	O
to	O	O
remain	O	O
after	O	O
chemo-mechanical	O	O
treatment	O	O
of	O	O
root	O	O
canals	O	O
in	O	O
teeth	O	O
with	O	O
apical	O	O
periodontitis	O	O
.	O	O

Consecutive	O	O
root-canal	O	O
samples	O	O
of	O	O
200	O	O
teeth	O	O
receiving	O	O
root-canal	O	O
treatment	O	O
,	O	O
referred	O	O
from	O	O
general	O	O
practitioners	O	O
and	O	O
endodontic	O	O
specialists	O	O
for	O	O
analyses	O	O
of	O	O
cultivable	O	O
microbes	O	O
,	O	O
were	O	O
studied	O	O
prospectively	O	O
.	O	O

To	O	O
be	O	O
included	O	O
,	O	O
samples	O	O
had	O	O
to	O	O
be	O	O
taken	O	O
at	O	O
a	O	O
treatment	O	O
session	O	O
subsequent	O	O
to	O	O
the	O	O
one	O	O
at	O	O
which	O	O
endodontic	O	O
therapy	O	O
was	O	O
initiated	O	O
.	O	O

All	O	O
samples	O	O
were	O	O
from	O	O
teeth	O	O
that	O	O
either	O	O
presented	O	O
with	O	O
clinical	O	O
or	O	O
radiographic	O	O
evidence	O	O
of	O	O
apical	O	O
periodontitis	O	O
or	O	O
both	O	O
.	O	O

Bacteriological	O	O
findings	O	O
were	O	O
linked	O	O
to	O	O
clinical	O	O
and	O	O
radiographic	O	O
parameters	O	O
including	O	O
status	O	O
of	O	O
the	O	O
root	O	O
canal	O	O
prior	O	O
to	O	O
treatment	O	O
,	O	O
namely	O	O
,	O	O
vital	O	O
pulp	O	O
,	O	O
necrotic	O	O
pulp	O	O
or	O	O
root	O	O
filled	O	O
.	O	O

A	O	O
total	O	O
of	O	O
248	O	O
strains	O	O
were	O	O
isolated	O	O
from	O	O
107	O	O
teeth	O	O
giving	O	O
bacterial	O	O
growth	O	O
.	O	O

Gram-positives	O	O
predominated	O	O
(	O	O
85	O	O
%	O	O
)	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
22	O	O
%	O	O
)	O	O
,	O	O
nonmutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
18	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Enterococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
12	O	O
%	O	O
)	O	O
were	O	O
the	O	O
most	O	O
common	O	O
isolates	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
were	O	O
relatively	O	O
sporadic	O	O
.	O	O

Large	O	O
radiographic	O	O
bone	O	O
lesions	O	O
,	O	O
persistent	O	O
pain	O	O
and	O	O
use	O	O
of	O	O
intracanal	O	O
calcium	O	O
hydroxide	O	O
dressing	O	O
correlated	O	O
with	O	O
bacterial	O	O
presence	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Once	O	O
established	O	O
,	O	O
nonmutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
enterococci	B-bacteria	B-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
appear	O	O
to	O	O
survive	O	O
commonly	O	O
following	O	O
root-canal	O	O
treatment	O	O
of	O	O
teeth	O	O
with	O	O
clinical	O	O
and	O	O
radiographical	O	O
signs	O	O
of	O	O
apical	O	O
periodontitis	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
present	O	O
in	O	O
large	O	O
numbers	O	O
in	O	O
dental	O	O
plaque	O	O
and	O	O
several	O	O
types	O	O
interact	O	O
with	O	O
the	O	O
enamel	O	O
salivary	O	O
pellicle	O	O
to	O	O
form	O	O
a	O	O
biofilm	O	O
on	O	O
tooth	O	O
surfaces	O	O
.	O	O

The	O	O
respective	O	O
affinity	O	O
of	O	O
individual	O	O
streptococci	B-bacteria	B-bacteria
for	O	O
salivary	O	O
components	O	O
has	O	O
an	O	O
influence	O	O
on	O	O
the	O	O
etiologic	O	O
properties	O	O
of	O	O
oral	O	O
biofilm	O	O
in	O	O
the	O	O
development	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

We	O	O
studied	O	O
real-time	O	O
biospecific	O	O
interactions	O	O
between	O	O
oral	O	O
streptococci	O	O
and	O	O
salivary	O	O
components	O	O
utilizing	O	O
biosensor	O	O
technology	O	O
to	O	O
analyze	O	O
surface	O	O
plasmon	O	O
resonance	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
showed	O	O
significant	O	O
responses	O	O
for	O	O
binding	O	O
to	O	O
salivary	O	O
components	O	O
,	O	O
in	O	O
comparison	O	O
with	O	O
other	O	O
bacteria	O	O
.	O	O

Further	O	O
,	O	O
the	O	O
association	O	O
rates	O	O
(	O	O
4.1	O	O
x	O	O
10-11/bacterium	O	O
)	O	O
and	O	O
dissociation	O	O
rate	O	O
(	O	O
5.7	O	O
+/-	O	O
0.9	O	O
x	O	O
10-3	O	O
Second	O	O
(	O	O
s	O	O
)	O	O
-1	O	O
)	O	O
were	O	O
higher	O	O
for	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
than	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
2.4	O	O
x	O	O
10-11	O	O
and	O	O
2.9	O	O
+/-	O	O
0.8	O	O
x	O	O
10-3	O	O
)	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
(	O	O
1.3	O	O
x	O	O
10-11	O	O
and	O	O
3.5	O	O
+/-	O	O
1.3	O	O
x	O	O
10-3	O	O
)	O	O
.	O	O

However	O	O
,	O	O
the	O	O
association	O	O
equilibrium	O	O
constants	O	O
(	O	O
8.2	O	O
S/bacterium	O	O
)	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
2	O	O
times	O	O
higher	O	O
in	O	O
than	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
(	O	O
3.8	O	O
)	O	O
and	O	O
slightly	O	O
higher	O	O
than	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
(	O	O
7.2	O	O
)	O	O
.	O	O

These	O	O
findings	O	O
may	O	O
provide	O	O
useful	O	O
information	O	O
regarding	O	O
the	O	O
mechanism	O	O
of	O	O
early	O	O
biofilm	O	O
formation	O	O
by	O	O
streptococci	B-bacteria	B-bacteria
on	O	O
the	O	O
tooth	O	O
surface	O	O
.	O	O

This	O	O
article	O	O
describes	O	O
the	O	O
microbiology	O	O
,	O	O
diagnosis	O	O
,	O	O
and	O	O
management	O	O
of	O	O
human	O	O
and	O	O
animal	O	O
bite	O	O
wound	O	O
infections	O	O
.	O	O

Various	O	O
organisms	O	O
can	O	O
be	O	O
recovered	O	O
from	O	O
bite	O	O
wounds	O	O
that	O	O
generally	O	O
result	O	O
from	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
microbial	O	O
flora	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
the	O	O
biting	O	O
animal	O	O
,	O	O
rather	O	O
than	O	O
the	O	O
victim	O	O
's	O	O
own	O	O
skin	O	O
flora	O	O
.	O	O

The	O	O
role	O	O
of	O	O
anaerobes	B-bacteria	B-bacteria
in	O	O
bite	O	O
wound	O	O
infections	O	O
has	O	O
been	O	O
increasingly	O	O
appreciated	O	O
.	O	O

Anaerobes	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
more	O	O
than	O	O
two	O	O
thirds	O	O
of	O	O
human	O	O
and	O	O
animal	O	O
bite	O	O
wound	O	O
infections	O	O
,	O	O
especially	O	O
those	O	O
associated	O	O
with	O	O
abscess	O	O
formation	O	O
.	O	O

This	O	O
article	O	O
describes	O	O
several	O	O
of	O	O
the	O	O
organisms	O	O
found	O	O
in	O	O
the	O	O
bites	O	O
of	O	O
various	O	O
species	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
local	O	O
wound	O	O
infection	O	O
,	O	O
other	O	O
complications	O	O
may	O	O
occur	O	O
,	O	O
including	O	O
lymphangitis	O	O
,	O	O
local	O	O
abscess	O	O
,	O	O
septic	O	O
arthritis	O	O
,	O	O
tenosynovitis	O	O
,	O	O
and	O	O
osteomyelitis	O	O
.	O	O

Rare	O	O
complications	O	O
include	O	O
endocarditis	O	O
,	O	O
meningitis	O	O
,	O	O
brain	O	O
abscess	O	O
,	O	O
and	O	O
sepsis	O	O
with	O	O
disseminated	O	O
intravascular	O	O
coagulation	O	O
,	O	O
especially	O	O
in	O	O
immunocompromised	O	O
individuals	O	O
.	O	O

Wound	O	O
management	O	O
includes	O	O
the	O	O
administration	O	O
of	O	O
proper	O	O
local	O	O
care	O	O
and	O	O
the	O	O
use	O	O
of	O	O
proper	O	O
antimicrobial	O	O
agents	O	O
when	O	O
needed	O	O
.	O	O

The	O	O
mucosal	O	O
secretory	O	O
proteins	O	O
,	O	O
such	O	O
as	O	O
the	O	O
salivary	O	O
proteins	O	O
,	O	O
play	O	O
a	O	O
key	O	O
role	O	O
in	O	O
the	O	O
acquisition	O	O
and	O	O
regulation	O	O
of	O	O
the	O	O
mucosal	O	O
microflora	O	O
.	O	O

Most	O	O
notably	O	O
,	O	O
some	O	O
microorganisms	O	O
utilize	O	O
the	O	O
host	O	O
's	O	O
secretory	O	O
proteins	O	O
to	O	O
adhere	O	O
to	O	O
the	O	O
mucosa	O	O
;	O	O
a	O	O
first	O	O
step	O	O
in	O	O
colonization	O	O
and	O	O
infection	O	O
.	O	O

The	O	O
secretory	O	O
proteins	O	O
also	O	O
influence	O	O
colonization	O	O
by	O	O
affecting	O	O
the	O	O
binding	O	O
among	O	O
microorganisms	O	O
,	O	O
a	O	O
process	O	O
denoted	O	O
as	O	O
coadherence	O	O
.	O	O

Previously	O	O
we	O	O
reported	O	O
that	O	O
acute	O	O
stressors	O	O
cause	O	O
specific	O	O
changes	O	O
in	O	O
saliva	O	O
composition	O	O
.	O	O

The	O	O
present	O	O
study	O	O
investigated	O	O
to	O	O
what	O	O
extent	O	O
these	O	O
changes	O	O
influence	O	O
saliva-mediated	O	O
microbial	O	O
adherence	O	O
and	O	O
coadherence	O	O
(	O	O
ex	O	O
vivo	O	O
)	O	O
.	O	O

Thirty-two	O	O
male	O	O
undergraduates	O	O
provided	O	O
unstimulated	O	O
saliva	O	O
before	O	O
and	O	O
during	O	O
a	O	O
control	O	O
condition	O	O
and	O	O
two	O	O
stressors	O	O
:	O	O
A	O	O
memory	O	O
test	O	O
and	O	O
a	O	O
surgery	O	O
video	O	O
presentation	O	O
.	O	O

We	O	O
used	O	O
saliva-coated	O	O
microplates	O	O
to	O	O
test	O	O
the	O	O
adherence	O	O
of	O	O
bacteria	O	O
for	O	O
which	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
either	O	O
a	O	O
natural	O	O
reservoir	O	O
(	O	O
eg	O	O
,	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
)	O	O
or	O	O
a	O	O
portal	O	O
of	O	O
entry	O	O
(	O	O
eg	O	O
,	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
)	O	O
.	O	O

We	O	O
also	O	O
tested	O	O
the	O	O
saliva-mediated	O	O
co-adherence	O	O
between	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
the	O	O
yeast	O	O
Candida	O	O
albicans	O	O
.	O	O

Correlation	O	O
analyses	O	O
were	O	O
performed	O	O
to	O	O
determine	O	O
the	O	O
relationships	O	O
between	O	O
changes	O	O
in	O	O
microbial	O	O
adherence	O	O
and	O	O
the	O	O
concentrations	O	O
of	O	O
potential	O	O
salivary	O	O
ligands	O	O
,	O	O
viz	O	O
.	O	O

cystatin	O	O
S	O	O
,	O	O
the	O	O
mucins	O	O
MUC5B	O	O
and	O	O
MUC7	O	O
,	O	O
S-IgA	O	O
,	O	O
lactoferrin	O	O
,	O	O
alpha-amylase	O	O
,	O	O
and	O	O
total	O	O
salivary	O	O
protein	O	O
.	O	O

During	O	O
the	O	O
memory	O	O
test	O	O
,	O	O
saliva-mediated	O	O
adhesion	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
and	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
increased	O	O
,	O	O
whereas	O	O
the	O	O
coadherence	O	O
of	O	O
C.	O	O
albicans	O	O
with	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
decreased	O	O
.	O	O

During	O	O
the	O	O
surgical	O	O
video	O	O
presentation	O	O
the	O	O
saliva-mediated	O	O
adherence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
increased	O	O
.	O	O

These	O	O
changes	O	O
were	O	O
independent	O	O
of	O	O
salivary	O	O
flow	O	O
rate	O	O
,	O	O
but	O	O
correlated	O	O
with	O	O
specific	O	O
changes	O	O
in	O	O
salivary	O	O
protein	O	O
composition	O	O
.	O	O

The	O	O
results	O	O
show	O	O
that	O	O
even	O	O
moderate	O	O
stressors	O	O
,	O	O
by	O	O
altering	O	O
the	O	O
activity	O	O
of	O	O
the	O	O
mucosal	O	O
secretory	O	O
glands	O	O
,	O	O
may	O	O
affect	O	O
microbial	O	O
colonization	O	O
processes	O	O
such	O	O
as	O	O
adherence	O	O
and	O	O
coadherence	O	O
.	O	O

This	O	O
study	O	O
hereby	O	O
presents	O	O
a	O	O
mechanism	O	O
by	O	O
which	O	O
stress	O	O
may	O	O
affect	O	O
the	O	O
mucosal	O	O
microflora	O	O
and	O	O
susceptibility	O	O
to	O	O
infectious	O	O
disease	O	O
.	O	O

The	O	O
accurate	O	O
classification	O	O
of	O	O
oral	O	O
Actinomyces	B-bacteria	B-bacteria
isolates	O	O
as	O	O
one	O	O
species	O	O
is	O	O
difficult	O	O
.	O	O

Out	O	O
of	O	O
18	O	O
Actinomyces	B-bacteria	B-bacteria
isolates	O	O
forming	O	O
red	O	O
colonies	O	O
on	O	O
brain	O	O
heart	O	O
blood	O	O
agar	O	O
,	O	O
12	O	O
could	O	O
be	O	O
straightforwardly	O	O
assigned	O	O
as	O	O
Actinomyces	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
by	O	O
biochemical	O	O
,	O	O
morphological	O	O
,	O	O
and	O	O
chemotaxonomic	O	O
characteristics	O	O
.	O	O

For	O	O
the	O	O
remaining	O	O
six	O	O
isolates	O	O
,	O	O
the	O	O
results	O	O
of	O	O
the	O	O
different	O	O
identification	O	O
methods	O	O
were	O	O
inconsistent	O	O
.	O	O

By	O	O
sequencing	O	O
a	O	O
16S	O	O
ribosomal	O	O
DNA	O	O
fragment	O	O
by	O	O
a	O	O
rapid	O	O
mass	O	O
spectrometric	O	O
method	O	O
,	O	O
all	O	O
isolates	O	O
could	O	O
be	O	O
identified	O	O
unambiguously	O	O
as	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
.	O	O

This	O	O
result	O	O
proves	O	O
the	O	O
importance	O	O
of	O	O
red	O	O
colony	O	O
pigmentation	O	O
on	O	O
brain	O	O
heart	O	O
blood	O	O
agar	O	O
together	O	O
with	O	O
the	O	O
characteristic	O	O
cell	O	O
morphology	O	O
for	O	O
unequivocal	O	O
assignment	O	O
of	O	O
oral	O	O
Actinomyces	B-bacteria	B-bacteria
isolates	O	O
to	O	O
the	O	O
species	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
.	O	O

The	O	O
oral	O	O
cavity	O	O
is	O	O
a	O	O
reservoir	O	O
for	O	O
colonization	O	O
and	O	O
infection	O	O
of	O	O
systemic	O	O
organs	O	O
by	O	O
pathogenic	O	O
bacteria	O	O
.	O	O

It	O	O
is	O	O
understood	O	O
that	O	O
aging	O	O
,	O	O
tooth	O	O
eruption	O	O
,	O	O
hormonal	O	O
changes	O	O
,	O	O
active	O	O
disease	O	O
,	O	O
oral	O	O
hygiene	O	O
,	O	O
and	O	O
other	O	O
factors	O	O
have	O	O
an	O	O
influence	O	O
on	O	O
biofilm	O	O
formation	O	O
and	O	O
bacterial	O	O
accumulation	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

To	O	O
understand	O	O
the	O	O
influence	O	O
of	O	O
systemic	O	O
health	O	O
care	O	O
on	O	O
microfloral	O	O
changes	O	O
,	O	O
we	O	O
conducted	O	O
epidemiological	O	O
studies	O	O
of	O	O
nursing	O	O
home	O	O
residents	O	O
in	O	O
an	O	O
attempt	O	O
to	O	O
elucidate	O	O
the	O	O
relationship	O	O
between	O	O
underlying	O	O
systemic	O	O
diseases	O	O
and	O	O
the	O	O
isolation	O	O
frequency	O	O
of	O	O
oral	O	O
opportunistic	O	O
pathogens	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
bacteria	O	O
and	O	O
fungi	O	O
causing	O	O
pneumonia	O	O
in	O	O
association	O	O
with	O	O
oral	O	O
biofilm	O	O
bacteria	O	O
were	O	O
determined	O	O
using	O	O
detection	O	O
culture	O	O
plates	O	O
.	O	O

The	O	O
influences	O	O
of	O	O
gender	O	O
,	O	O
age	O	O
,	O	O
denture-wearing	O	O
status	O	O
,	O	O
number	O	O
of	O	O
teeth	O	O
,	O	O
and	O	O
bedridden	O	O
status	O	O
in	O	O
the	O	O
patients	O	O
residing	O	O
in	O	O
nursing	O	O
homes	O	O
were	O	O
then	O	O
analyzed	O	O
.	O	O

The	O	O
isolation	O	O
frequency	O	O
rates	O	O
of	O	O
Candida	O	O
albicans	O	O
,	O	O
Pseudomonadaceae	B-bacteria	B-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
some	O	O
strains	O	O
of	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
in	O	O
plaque	O	O
samples	O	O
,	O	O
as	O	O
well	O	O
as	O	O
C.	O	O
albicans	O	O
and	O	O
Xanthomonas	B-bacteria	B-bacteria
maltophilia	E-bacteria	I-bacteria
in	O	O
samples	O	O
from	O	O
the	O	O
pharynx	O	O
,	O	O
were	O	O
significantly	O	O
higher	O	O
in	O	O
those	O	O
requiring	O	O
systemic	O	O
care	O	O
(	O	O
mean	O	O
age	O	O
83.9	O	O
years	O	O
)	O	O
than	O	O
in	O	O
those	O	O
who	O	O
did	O	O
not	O	O
require	O	O
such	O	O
care	O	O
(	O	O
mean	O	O
71.0	O	O
years	O	O
)	O	O
.	O	O

In	O	O
particular	O	O
,	O	O
the	O	O
frequencies	O	O
of	O	O
Pseudomonas	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
C.	O	O
albicans	O	O
,	O	O
and	O	O
Serratia	B-bacteria	B-bacteria
marcescens	E-bacteria	I-bacteria
in	O	O
plaque	O	O
were	O	O
significantly	O	O
higher	O	O
in	O	O
those	O	O
who	O	O
were	O	O
bedridden	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
isolation	O	O
of	O	O
Pseudomonas	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
and/or	O	O
C.	O	O
albicans	O	O
in	O	O
plaque	O	O
was	O	O
significantly	O	O
associated	O	O
with	O	O
heart	O	O
disease	O	O
.	O	O

The	O	O
coexistence	O	O
of	O	O
Pseudomonas	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
C.	O	O
albicans	O	O
in	O	O
elderly	O	O
with	O	O
10-19	O	O
teeth	O	O
is	O	O
a	O	O
potential	O	O
indicator	O	O
of	O	O
high	O	O
risk	O	O
for	O	O
pneumonia	O	O
and	O	O
heart	O	O
disease	O	O
.	O	O

Therefore	O	O
,	O	O
attention	O	O
to	O	O
oral	O	O
hygiene	O	O
and	O	O
professional	O	O
care	O	O
for	O	O
removing	O	O
the	O	O
indicators	O	O
may	O	O
diminish	O	O
the	O	O
occurrence	O	O
of	O	O
systemic	O	O
disease	O	O
in	O	O
the	O	O
elderly	O	O
requiring	O	O
systemic	O	O
care	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
oral	O	O
status	O	O
of	O	O
children	O	O
suffering	O	O
from	O	O
end-stage	O	O
renal	O	O
disease	O	O
(	O	O
ESRD	O	O
)	O	O
with	O	O
the	O	O
aim	O	O
of	O	O
determining	O	O
the	O	O
causes	O	O
of	O	O
low	O	O
caries	O	O
prevalence	O	O
in	O	O
this	O	O
population	O	O
(	O	O
using	O	O
the	O	O
CRT	O	O
bacteria	O	O
and	O	O
buffer	O	O
test	O	O
)	O	O
,	O	O
and	O	O
compared	O	O
results	O	O
with	O	O
a	O	O
control	O	O
group	O	O
(	O	O
n=38	O	O
)	O	O
.	O	O

In	O	O
the	O	O
study	O	O
group	O	O
,	O	O
there	O	O
were	O	O
38	O	O
children	O	O
(	O	O
aged	O	O
4-17	O	O
years	O	O
)	O	O
who	O	O
were	O	O
being	O	O
treated	O	O
in	O	O
pediatric	O	O
nephrology	O	O
units	O	O
at	O	O
three	O	O
different	O	O
hospitals	O	O
in	O	O
Izmir	O	O
,	O	O
Turkey	O	O
.	O	O

The	O	O
study	O	O
and	O	O
control	O	O
groups	O	O
did	O	O
not	O	O
significantly	O	O
differ	O	O
in	O	O
daily	O	O
tooth	O	O
brushing	O	O
frequency	O	O
and	O	O
periodic	O	O
dental	O	O
check-up	O	O
frequency	O	O
.	O	O

Severe	O	O
enamel	O	O
hypoplasia	O	O
was	O	O
present	O	O
in	O	O
the	O	O
study	O	O
group	O	O
.	O	O

Dmft	O	O
,	O	O
DMFT	O	O
,	O	O
gingival	O	O
and	O	O
plaque	O	O
indices	O	O
were	O	O
compared	O	O
statistically	O	O
in	O	O
mixed	O	O
dentition	O	O
stage	O	O
with	O	O
the	O	O
control	O	O
group	O	O
and	O	O
dmft	O	O
and	O	O
gingival	O	O
status	O	O
showed	O	O
a	O	O
statistically	O	O
significant	O	O
difference	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
differences	O	O
among	O	O
groups	O	O
for	O	O
DMFT	O	O
and	O	O
plaque	O	O
indices	O	O
were	O	O
not	O	O
statistically	O	O
significant	O	O
.	O	O

In	O	O
the	O	O
study	O	O
group	O	O
,	O	O
high	O	O
salivary	O	O
buffer	O	O
capacity	O	O
was	O	O
found	O	O
in	O	O
89.5	O	O
%	O	O
of	O	O
patients	O	O
.	O	O

Salivary	O	O
levels	O	O
of	O	O
cariogenic	O	O
streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
the	O	O
study	O	O
group	O	O
were	O	O
significantly	O	O
lower	O	O
than	O	O
in	O	O
the	O	O
control	O	O
group	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
probably	O	O
due	O	O
to	O	O
increased	O	O
concentrations	O	O
of	O	O
antibacterial	O	O
chemicals	O	O
such	O	O
as	O	O
urea	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
children	O	O
with	O	O
ESRD	O	O
,	O	O
decreased	O	O
levels	O	O
of	O	O
cariogenic	O	O
microorganisms	O	O
were	O	O
detected	O	O
.	O	O

Therefore	O	O
,	O	O
although	O	O
dental	O	O
treatment	O	O
need	O	O
is	O	O
not	O	O
high	O	O
,	O	O
these	O	O
children	O	O
should	O	O
receive	O	O
dental	O	O
health	O	O
education	O	O
,	O	O
including	O	O
oral	O	O
hygiene	O	O
instruction	O	O
,	O	O
in	O	O
order	O	O
to	O	O
improve	O	O
their	O	O
overall	O	O
oral	O	O
health	O	O
.	O	O

It	O	O
has	O	O
been	O	O
suggested	O	O
that	O	O
between	O	O
3	O	O
%	O	O
and	O	O
13	O	O
%	O	O
of	O	O
the	O	O
cerebral	O	O
abscesses	O	O
(	O	O
CA	O	O
)	O	O
are	O	O
presumably	O	O
associated	O	O
to	O	O
oral	O	O
infections	O	O
or	O	O
dental	O	O
procedures	O	O
.	O	O

Determine	O	O
the	O	O
prevalence	O	O
of	O	O
CA	O	O
of	O	O
oral	O	O
origin	O	O
,	O	O
discussing	O	O
their	O	O
clinical	O	O
and	O	O
microbiological	O	O
characteristics	O	O
.	O	O

Retrospectively	O	O
,	O	O
54	O	O
cases	O	O
of	O	O
CA	O	O
diagnosed	O	O
in	O	O
3	O	O
hospitals	O	O
of	O	O
Galicia	O	O
between	O	O
2001	O	O
and	O	O
2002	O	O
were	O	O
reviewed	O	O
.	O	O

A	O	O
presumed	O	O
oral	O	O
portal	O	O
of	O	O
entry	O	O
was	O	O
recorded	O	O
in	O	O
6	O	O
patients	O	O
(	O	O
11.1	O	O
%	O	O
)	O	O
;	O	O
4	O	O
cases	O	O
were	O	O
associated	O	O
to	O	O
oral	O	O
infections	O	O
and	O	O
the	O	O
remaining	O	O
2	O	O
had	O	O
received	O	O
dental	O	O
treatment	O	O
in	O	O
the	O	O
months	O	O
prior	O	O
to	O	O
the	O	O
onset	O	O
of	O	O
symptoms	O	O
.	O	O

Half	O	O
of	O	O
the	O	O
patients	O	O
showed	O	O
irrelevant	O	O
medical	O	O
record	O	O
,	O	O
2	O	O
had	O	O
had	O	O
previous	O	O
extracranial	O	O
abscesses	O	O
and	O	O
1	O	O
presented	O	O
a	O	O
type	O	O
A	O	O
immunoglobulin	O	O
deficiency	O	O
.	O	O

In	O	O
4	O	O
cases	O	O
,	O	O
the	O	O
microbiological	O	O
analysis	O	O
was	O	O
positive	O	O
and	O	O
typical	O	O
oral	O	O
bacteria	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
viridans	E-bacteria	I-bacteria
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O
)	O	O

were	O	O
identified	O	O
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
study	O	O
suggest	O	O
that	O	O
a	O	O
significant	O	O
number	O	O
of	O	O
CA	O	O
are	O	O
probably	O	O
of	O	O
oral	O	O
origin	O	O
.	O	O

In	O	O
consequence	O	O
,	O	O
to	O	O
maintain	O	O
a	O	O
good	O	O
oral	O	O
health	O	O
status	O	O
is	O	O
important	O	O
and	O	O
specific	O	O
prophylactic	O	O
measures	O	O
before	O	O
any	O	O
dental	O	O
procedure	O	O
should	O	O
be	O	O
applied	O	O
,	O	O
especially	O	O
in	O	O
patients	O	O
with	O	O
risk	O	O
recognized	O	O
factors	O	O
.	O	O

Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

are	O	O
early	O	O
colonizing	O	O
inhabitants	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

As	O	O
part	O	O
of	O	O
studies	O	O
on	O	O
penicillin	O	O
resistance	O	O
among	O	O
oral	O	O
indigenous	O	O
anaerobic	O	O
microbiota	O	O
in	O	O
childhood	O	O
,	O	O
the	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
longitudinal	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
emergence	O	O
of	O	O
resistant	O	O
strains	O	O
in	O	O
Veillonella	B-bacteria	B-bacteria
populations	O	O
.	O	O

Altogether	O	O
305	O	O
Veillonella	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
from	O	O
saliva	O	O
of	O	O
49	O	O
healthy	O	O
infants	O	O
followed	O	O
from	O	O
2	O	O
to	O	O
24	O	O
months	O	O
of	O	O
age	O	O
were	O	O
examined	O	O
for	O	O
their	O	O
in	O	O
vitro	O	O
susceptibility	O	O
to	O	O
penicillin	O	O
G	O	O
and	O	O
,	O	O
further	O	O
,	O	O
20	O	O
penicillin-resistant	O	O
isolates	O	O
representing	O	O
5	O	O
MIC	O	O
categories	O	O
to	O	O
ampicillin	O	O
,	O	O
amoxicillin	O	O
,	O	O
amoxicillin/clavulanate	O	O
,	O	O
cefoxitin	O	O
,	O	O
and	O	O
beta-lactamase	O	O
production	O	O
.	O	O

In	O	O
infants	O	O
positive	O	O
for	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
the	O	O
recovery	O	O
rate	O	O
of	O	O
penicillin-resistant	O	O
(	O	O
MIC	O	O
>	O	O
/=2	O	O
microg/ml	O	O
)	O	O
strains	O	O
increased	O	O
with	O	O
age	O	O
up	O	O
to	O	O
68	O	O
%	O	O
,	O	O
however	O	O
,	O	O
most	O	O
infants	O	O
simultaneously	O	O
harbored	O	O
penicillin-susceptible	O	O
strains	O	O
.	O	O

During	O	O
the	O	O
follow-up	O	O
,	O	O
the	O	O
MIC	O	O
(	O	O
50	O	O
)	O	O
increased	O	O
from	O	O
0.5	O	O
microg/ml	O	O
to	O	O
2	O	O
microg/ml	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
penicillin	O	O
G	O	O
,	O	O
8/20	O	O
strains	O	O
also	O	O
showed	O	O
reduced	O	O
susceptibility	O	O
to	O	O
ampicillin	O	O
and/or	O	O
amoxicillin	O	O
but	O	O
none	O	O
produced	O	O
beta-lactamase	O	O
.	O	O

Our	O	O
study	O	O
suggests	O	O
other	O	O
mechanisms	O	O
than	O	O
enzymatic	O	O
degradation	O	O
of	O	O
beta-lactam	O	O
ring	O	O
for	O	O
resistance	O	O
of	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
to	O	O
penicillin	O	O
.	O	O

The	O	O
complete	O	O
2,343,479-bp	O	O
genome	O	O
sequence	O	O
of	O	O
the	O	O
gram-negative	B-bacteria	B-bacteria
,	B-bacteria	B-bacteria
pathogenic	I-bacteria	I-bacteria
oral	I-bacteria	I-bacteria
bacterium	E-bacteria	I-bacteria
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
W83	E-bacteria	I-bacteria
,	O	O
a	O	O
major	O	O
contributor	O	O
to	O	O
periodontal	O	O
disease	O	O
,	O	O
was	O	O
determined	O	O
.	O	O

Whole-genome	O	O
comparative	O	O
analysis	O	O
with	O	O
other	O	O
available	O	O
complete	O	O
genome	O	O
sequences	O	O
confirms	O	O
the	O	O
close	O	O
relationship	O	O
between	O	O
the	O	O
Cytophaga-Flavobacteria-Bacteroides	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
CFB	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
phylum	E-bacteria	I-bacteria
and	O	O
the	O	O
green-sulfur	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Within	O	O
the	O	O
CFB	B-bacteria	B-bacteria
phyla	E-bacteria	I-bacteria
,	O	O
the	O	O
genomes	O	O
most	O	O
similar	O	O
to	O	O
that	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
are	O	O
those	O	O
of	O	O
Bacteroides	B-bacteria	B-bacteria
thetaiotaomicron	E-bacteria	I-bacteria
and	O	O
B.	B-bacteria	B-bacteria
fragilis	E-bacteria	I-bacteria
.	O	O

Outside	O	O
of	O	O
the	O	O
CFB	B-bacteria	B-bacteria
phyla	E-bacteria	I-bacteria
the	O	O
most	O	O
similar	O	O
genome	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
is	O	O
that	O	O
of	O	O
Chlorobium	B-bacteria	B-bacteria
tepidum	E-bacteria	I-bacteria
,	O	O
supporting	O	O
the	O	O
previous	O	O
phylogenetic	O	O
studies	O	O
that	O	O
indicated	O	O
that	O	O
the	O	O
Chlorobia	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
CFB	I-bacteria	I-bacteria
phyla	E-bacteria	I-bacteria
are	O	O
related	O	O
,	O	O
albeit	O	O
distantly	O	O
.	O	O

Genome	O	O
analysis	O	O
of	O	O
strain	B-bacteria	B-bacteria
W83	E-bacteria	I-bacteria
reveals	O	O
a	O	O
range	O	O
of	O	O
pathways	O	O
and	O	O
virulence	O	O
determinants	O	O
that	O	O
relate	O	O
to	O	O
the	O	O
novel	O	O
biology	O	O
of	O	O
this	O	O
oral	O	O
pathogen	O	O
.	O	O

Among	O	O
these	O	O
determinants	O	O
are	O	O
at	O	O
least	O	O
six	O	O
putative	O	O
hemagglutinin-like	O	O
genes	O	O
and	O	O
36	O	O
previously	O	O
unidentified	O	O
peptidases	O	O
.	O	O

Genome	O	O
analysis	O	O
also	O	O
reveals	O	O
that	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
can	O	O
metabolize	O	O
a	O	O
range	O	O
of	O	O
amino	O	O
acids	O	O
and	O	O
generate	O	O
a	O	O
number	O	O
of	O	O
metabolic	O	O
end	O	O
products	O	O
that	O	O
are	O	O
toxic	O	O
to	O	O
the	O	O
human	O	O
host	O	O
or	O	O
human	O	O
gingival	O	O
tissue	O	O
and	O	O
contribute	O	O
to	O	O
the	O	O
development	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

It	O	O
has	O	O
recently	O	O
been	O	O
shown	O	O
that	O	O
human	O	O
salivary	O	O
glands	O	O
constitutively	O	O
express	O	O
CD14	O	O
,	O	O
an	O	O
important	O	O
molecule	O	O
in	O	O
innate	O	O
immunity	O	O
,	O	O
and	O	O
that	O	O
a	O	O
soluble	O	O
form	O	O
of	O	O
CD14	O	O
is	O	O
secreted	O	O
in	O	O
saliva	O	O
.	O	O

The	O	O
concentration	O	O
of	O	O
CD14	O	O
in	O	O
parotid	O	O
(	O	O
a	O	O
serous	O	O
gland	O	O
)	O	O
saliva	O	O
was	O	O
comparable	O	O
to	O	O
that	O	O
in	O	O
normal	O	O
serum	O	O
and	O	O
10-fold	O	O
the	O	O
amount	O	O
in	O	O
whole	O	O
saliva	O	O
,	O	O
although	O	O
the	O	O
physiological	O	O
function	O	O
of	O	O
saliva	O	O
CD14	O	O
remained	O	O
unclear	O	O
.	O	O

Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	B-bacteria	B-bacteria
is	O	O
a	O	O
periodontopathic	O	O
bacterium	O	O
and	O	O
is	O	O
able	O	O
to	O	O
invade	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
present	O	O
study	O	O
showed	O	O
that	O	O
upon	O	O
exposure	O	O
to	O	O
live	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
Y4	E-bacteria	I-bacteria
for	O	O
2	O	O
h	O	O
,	O	O
human	O	O
oral	O	O
epithelial	O	O
HSC-2	O	O
cells	O	O
produced	O	O
interleukin-8	O	O
(	O	O
IL-8	O	O
)	O	O
for	O	O
a	O	O
further	O	O
24	O	O
h	O	O
and	O	O
whole	O	O
saliva	O	O
augmented	O	O
the	O	O
production	O	O
induced	O	O
by	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
Y4	E-bacteria	I-bacteria
.	O	O

Parotid	O	O
saliva	O	O
showed	O	O
a	O	O
more	O	O
pronounced	O	O
effect	O	O
on	O	O
the	O	O
production	O	O
of	O	O
IL-8	O	O
than	O	O
whole	O	O
saliva	O	O
.	O	O

Neither	O	O
saliva	O	O
preparation	O	O
itself	O	O
had	O	O
IL-8-inducing	O	O
activity	O	O
.	O	O

Parotid	O	O
saliva	O	O
exhibited	O	O
antibacterial	O	O
activity	O	O
against	O	O
a	O	O
low	O	O
concentration	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
Y4	E-bacteria	I-bacteria
,	O	O
but	O	O
recombinant	O	O
CD14	O	O
did	O	O
not	O	O
show	O	O
the	O	O
activity	O	O
.	O	O

The	O	O
internalization	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
Y4	E-bacteria	I-bacteria
into	O	O
HSC-2	O	O
cells	O	O
was	O	O
inhibited	O	O
by	O	O
cytochalasin	O	O
B	O	O
,	O	O
indicating	O	O
that	O	O
the	O	O
process	O	O
was	O	O
actin	O	O
dependent	O	O
,	O	O
and	O	O
depletion	O	O
of	O	O
CD14	O	O
from	O	O
parotid	O	O
saliva	O	O
inhibited	O	O
the	O	O
invasion	O	O
and	O	O
,	O	O
as	O	O
a	O	O
consequence	O	O
,	O	O
inhibited	O	O
production	O	O
of	O	O
IL-8	O	O
.	O	O

Furthermore	O	O
,	O	O
human	O	O
recombinant	O	O
CD14	O	O
augmented	O	O
invasion	O	O
and	O	O
IL-8	O	O
production	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
saliva	O	O
CD14	O	O
promoted	O	O
the	O	O
invasion	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
by	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
consequently	O	O
augmented	O	O
the	O	O
production	O	O
of	O	O
IL-8	O	O
,	O	O
playing	O	O
an	O	O
important	O	O
role	O	O
in	O	O
innate	O	O
immunity	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
in	O	O
vitro	O	O
activities	O	O
of	O	O
human	O	O
beta-defensin	O	O
3	O	O
(	O	O
hBD-3	O	O
)	O	O
alone	O	O
or	O	O
combined	O	O
with	O	O
lysozyme	O	O
,	O	O
metronidazole	O	O
,	O	O
amoxicillin	O	O
,	O	O
and	O	O
chlorhexidine	O	O
were	O	O
investigated	O	O
with	O	O
the	O	O
oral	O	O
bacteria	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

hBD-3	O	O
showed	O	O
bactericidal	O	O
activity	O	O
against	O	O
all	O	O
of	O	O
the	O	O
bacterial	O	O
species	O	O
tested	O	O
.	O	O

The	O	O
bactericidal	O	O
effect	O	O
was	O	O
enhanced	O	O
when	O	O
the	O	O
peptide	O	O
was	O	O
used	O	O
in	O	O
combination	O	O
with	O	O
the	O	O
antimicrobial	O	O
agents	O	O
mentioned	O	O
above	O	O
.	O	O

Cysteine	O	O
proteinases	O	O
(	O	O
gingipains	O	O
)	O	O
from	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
are	O	O
considered	O	O
key	O	O
virulence	O	O
factors	O	O
of	O	O
severe	O	O
periodontitis	O	O
and	O	O
host	O	O
immune	O	O
evasion	O	O
.	O	O

Since	O	O
expression	O	O
of	O	O
intercellular	O	O
adhesion	O	O
molecule-1	O	O
(	O	O
ICAM-1	O	O
)	O	O
on	O	O
gingival	O	O
epithelium	O	O
is	O	O
indispensable	O	O
in	O	O
polymorphonuclear	O	O
leukocyte	O	O
(	O	O
PMN	O	O
)	O	O
migration	O	O
at	O	O
the	O	O
site	O	O
of	O	O
periodontitis	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
effects	O	O
of	O	O
gingipains	O	O
on	O	O
the	O	O
expression	O	O
of	O	O
ICAM-1	O	O
on	O	O
human	O	O
oral	O	O
epithelial	O	O
cell	O	O
lines	O	O
(	O	O
KB	O	O
and	O	O
HSC-2	O	O
)	O	O
by	O	O
flow	O	O
cytometry	O	O
and	O	O
Western	O	O
blotting	O	O
.	O	O

We	O	O
found	O	O
that	O	O
three	O	O
purified	O	O
forms	O	O
of	O	O
gingipains	O	O
efficiently	O	O
reduced	O	O
ICAM-1	O	O
expression	O	O
on	O	O
the	O	O
cells	O	O
in	O	O
a	O	O
time-	O	O
and	O	O
dose-dependent	O	O
manner	O	O
.	O	O

Gingipains	O	O
reduced	O	O
the	O	O
expression	O	O
on	O	O
fixed	O	O
cells	O	O
and	O	O
degraded	O	O
the	O	O
ICAM-1	O	O
in	O	O
the	O	O
cell	O	O
membranes	O	O
,	O	O
indicating	O	O
that	O	O
the	O	O
reduction	O	O
resulted	O	O
from	O	O
direct	O	O
proteolysis	O	O
.	O	O

They	O	O
then	O	O
disturbed	O	O
the	O	O
ICAM-1-dependent	O	O
adhesion	O	O
of	O	O
PMNs	O	O
to	O	O
the	O	O
cells	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
gingipains	O	O
cleave	O	O
ICAM-1	O	O
on	O	O
oral	O	O
epithelial	O	O
cells	O	O
,	O	O
consequently	O	O
disrupting	O	O
PMN-oral	O	O
epithelial	O	O
cell	O	O
interaction	O	O
,	O	O
and	O	O
are	O	O
involved	O	O
in	O	O
immune	O	O
evasion	O	O
by	O	O
the	O	O
bacterium	O	O
in	O	O
periodontal	O	O
tissues	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
describe	O	O
a	O	O
16S	O	O
rDNA-based	O	O
nested	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
nPCR	O	O
)	O	O
assay	O	O
to	O	O
investigate	O	O
the	O	O
occurrence	O	O
of	O	O
Campylobacter	B-bacteria	B-bacteria
gracilis	E-bacteria	I-bacteria
in	O	O
oral	O	O
infections	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
ten	O	O
infected	O	O
root	O	O
canals	O	O
,	O	O
ten	O	O
cases	O	O
of	O	O
acute	O	O
periradicular	O	O
abscesses	O	O
and	O	O
eight	O	O
cases	O	O
of	O	O
adult	O	O
marginal	O	O
periodontitis	O	O
.	O	O

DNA	O	O
extracted	O	O
from	O	O
the	O	O
samples	O	O
was	O	O
initially	O	O
amplified	O	O
using	O	O
universal	O	O
16S	O	O
rDNA	O	O
primers	O	O
.	O	O

A	O	O
second	O	O
round	O	O
of	O	O
amplification	O	O
used	O	O
the	O	O
first	O	O
PCR	O	O
products	O	O
to	O	O
detect	O	O
C.	B-bacteria	B-bacteria
gracilis	E-bacteria	I-bacteria
using	O	O
oligonucleotide	O	O
primers	O	O
designed	O	O
from	O	O
species-specific	O	O
16S	O	O
rDNA	O	O
signature	O	O
sequences	O	O
.	O	O

The	O	O
nPCR	O	O
assay	O	O
used	O	O
in	O	O
this	O	O
study	O	O
showed	O	O
a	O	O
detection	O	O
limit	O	O
of	O	O
10	O	O
C.	B-bacteria	B-bacteria
gracilis	E-bacteria	I-bacteria
cells	O	O
and	O	O
no	O	O
cross-reactivity	O	O
was	O	O
observed	O	O
with	O	O
nontarget	O	O
bacteria	O	O
.	O	O

C.	B-bacteria	B-bacteria
gracilis	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
the	O	O
three	O	O
types	O	O
of	O	O
oral	O	O
infections	O	O
investigated	O	O
-	O	O
4/10	O	O
infected	O	O
root	O	O
canals	O	O
;	O	O
2/10	O	O
acute	O	O
periradicular	O	O
abscesses	O	O
;	O	O
and	O	O
1/8	O	O
subgingival	O	O
specimens	O	O
from	O	O
adult	O	O
periodontitis	O	O
.	O	O

The	O	O
method	O	O
proposed	O	O
in	O	O
this	O	O
study	O	O
showed	O	O
both	O	O
high	O	O
sensitivity	O	O
and	O	O
high	O	O
specificity	O	O
to	O	O
directly	O	O
detect	O	O
C.	B-bacteria	B-bacteria
gracilis	E-bacteria	I-bacteria
in	O	O
samples	O	O
from	O	O
root	O	O
canal	O	O
infections	O	O
,	O	O
abscesses	O	O
,	O	O
and	O	O
subgingival	O	O
plaque	O	O
.	O	O

Our	O	O
findings	O	O
confirmed	O	O
that	O	O
C.	B-bacteria	B-bacteria
gracilis	E-bacteria	I-bacteria
may	O	O
be	O	O
a	O	O
member	O	O
of	O	O
the	O	O
microbiota	O	O
associated	O	O
with	O	O
distinct	O	O
oral	O	O
infections	O	O
,	O	O
and	O	O
its	O	O
specific	O	O
role	O	O
in	O	O
such	O	O
diseases	O	O
requires	O	O
further	O	O
clarification	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
perform	O	O
a	O	O
quantitative	O	O
and	O	O
qualitative	O	O
analysis	O	O
of	O	O
oral	O	O
carriage	O	O
of	O	O
staphylococci	B-bacteria	B-bacteria
in	O	O
a	O	O
range	O	O
of	O	O
oral	O	O
specimens	O	O
from	O	O
patients	O	O
admitted	O	O
to	O	O
a	O	O
regional	O	O
burns	O	O
unit	O	O
.	O	O

The	O	O
study	O	O
recruited	O	O
28	O	O
patients	O	O
and	O	O
reasons	O	O
for	O	O
admittance	O	O
were	O	O
:	O	O
burns	O	O
(	O	O
46	O	O
%	O	O
)	O	O
,	O	O
skin	O	O
grafting	O	O
(	O	O
39	O	O
%	O	O
)	O	O
,	O	O
lacerations	O	O
(	O	O
7	O	O
%	O	O
)	O	O
,	O	O
scalding	O	O
(	O	O
4	O	O
%	O	O
)	O	O
and	O	O
necrotizing	O	O
fasciitis	O	O
(	O	O
4	O	O
%	O	O
)	O	O
.	O	O

No	O	O
patient	O	O
had	O	O
smoke	O	O
inhalation	O	O
injuries	O	O
or	O	O
trauma	O	O
to	O	O
the	O	O
oro-pharynx	O	O
.	O	O

There	O	O
were	O	O
five	O	O
patients	O	O
from	O	O
whom	O	O
methicillin-sensitive	B-bacteria	B-bacteria
S.	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
could	O	O
be	O	O
detected	O	O
in	O	O
oral	O	O
specimens	O	O
.	O	O

For	O	O
three	O	O
patients	O	O
only	O	O
the	O	O
wound	O	O
and	O	O
oral	O	O
specimens	O	O
were	O	O
positive	O	O
for	O	O
MRSA	B-bacteria	B-bacteria
.	O	O

In	O	O
one	O	O
patient	O	O
only	O	O
the	O	O
oral	O	O
specimens	O	O
were	O	O
positive	O	O
for	O	O
MRSA	B-bacteria	B-bacteria
.	O	O

There	O	O
were	O	O
five	O	O
patients	O	O
from	O	O
whom	O	O
methicillin-sensitive	B-bacteria	B-bacteria
S.	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
could	O	O
be	O	O
detected	O	O
in	O	O
the	O	O
oral	O	O
specimens	O	O
.	O	O

In	O	O
one	O	O
patient	O	O
only	O	O
the	O	O
oral	O	O
specimens	O	O
were	O	O
positive	O	O
for	O	O
MSSA	B-bacteria	B-bacteria
.	O	O

Staphylococci	B-bacteria	B-bacteria
could	O	O
be	O	O
recovered	O	O
from	O	O
the	O	O
dental	O	O
plaque	O	O
,	O	O
denture	O	O
and	O	O
toothbrush	O	O
specimens	O	O
with	O	O
a	O	O
mean	O	O
count	O	O
of	O	O
1.1	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
cfu/mL	O	O
(	O	O
range	O	O
20-5.3	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
)	O	O
,	O	O
5.4	O	O
x	O	O
10	O	O
(	O	O
3	O	O
)	O	O
(	O	O
range	O	O
40-2.1	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
)	O	O
and	O	O
264	O	O
cfu/mL	O	O
(	O	O
range	O	O
20-500	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

Both	O	O
MSSA	B-bacteria	B-bacteria
and	O	O
MRSA	B-bacteria	B-bacteria
could	O	O
be	O	O
recovered	O	O
from	O	O
these	O	O
specimen	O	O
types	O	O
.	O	O

In	O	O
one	O	O
patient	O	O
only	O	O
the	O	O
toothbrush	O	O
was	O	O
positive	O	O
for	O	O
MRSA	B-bacteria	B-bacteria
and	O	O
all	O	O
other	O	O
oral	O	O
specimens	O	O
were	O	O
negative	O	O
.	O	O

This	O	O
study	O	O
suggests	O	O
that	O	O
staphylococci	B-bacteria	B-bacteria
are	O	O
not	O	O
infrequent	O	O
colonizers	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
that	O	O
this	O	O
site	O	O
may	O	O
serve	O	O
as	O	O
a	O	O
potential	O	O
reservoir	O	O
for	O	O
transmission	O	O
to	O	O
other	O	O
body	O	O
sites	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
tetracycline-resistant	O	O
oral	O	O
bacteria	O	O
in	O	O
healthy	O	O
4-	O	O
and	O	O
6-year-old	O	O
children	O	O
who	O	O
had	O	O
not	O	O
received	O	O
antibiotics	O	O
during	O	O
the	O	O
3	O	O
months	O	O
prior	O	O
to	O	O
sampling	O	O
was	O	O
investigated	O	O
.	O	O

Of	O	O
the	O	O
47	O	O
children	O	O
sampled	O	O
,	O	O
46	O	O
harboured	O	O
tetracycline-resistant	O	O
bacteria	O	O
.	O	O

The	O	O
median	O	O
proportion	O	O
of	O	O
cultivable	O	O
anaerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
aerobic	I-bacteria	I-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
resistant	O	O
to	O	O
tetracycline	O	O
was	O	O
1.1	O	O
%	O	O
and	O	O
the	O	O
MIC50	O	O
of	O	O
these	O	O
was	O	O
64	O	O
microg	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

The	O	O
majority	O	O
(	O	O
56	O	O
%	O	O
)	O	O
of	O	O
tetracycline-resistant	O	O
bacteria	O	O
were	O	O
resistant	O	O
to	O	O
at	O	O
least	O	O
one	O	O
other	O	O
antibiotic	O	O
,	O	O
usually	O	O
erythromycin	O	O
.	O	O

The	O	O
most	O	O
commonly	O	O
identified	O	O
tetracycline-resistant	O	O
bacteria	O	O
were	O	O
the	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
65	O	O
%	O	O
)	O	O
,	O	O
the	O	O
next	O	O
most	O	O
prevalent	O	O
groups	O	O
were	O	O
Veillonella	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

(	O	O
10	O	O
%	O	O
)	O	O
and	O	O
Neisseria	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
9	O	O
%	O	O
)	O	O
.	O	O

The	O	O
most	O	O
frequently	O	O
identified	O	O
tetracycline	O	O
resistance	O	O
determinant	O	O
was	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
study	O	O
have	O	O
shown	O	O
that	O	O
tetracycline-resistant	O	O
oral	O	O
bacteria	O	O
were	O	O
widespread	O	O
amongst	O	O
the	O	O
children	O	O
studied	O	O
.	O	O

Naturally	O	O
occurring	O	O
antimicrobial	O	O
peptides	O	O
have	O	O
emerged	O	O
as	O	O
alternative	O	O
classes	O	O
of	O	O
antimicrobials	O	O
.	O	O

In	O	O
general	O	O
,	O	O
these	O	O
antimicrobial	O	O
peptides	O	O
exhibit	O	O
selectivity	O	O
for	O	O
prokaryotes	O	O
and	O	O
minimize	O	O
the	O	O
problems	O	O
of	O	O
engendering	O	O
microbial	O	O
resistance	O	O
.	O	O

As	O	O
an	O	O
alternative	O	O
method	O	O
to	O	O
search	O	O
for	O	O
more	O	O
effective	O	O
broad-spectrum	O	O
peptide	O	O
antimicrobials	O	O
,	O	O
investigators	O	O
have	O	O
developed	O	O
peptide	O	O
libraries	O	O
by	O	O
using	O	O
synthetic	O	O
combinatorial	O	O
technology	O	O
.	O	O

A	O	O
novel	O	O
decapeptide	O	O
,	O	O
KKVVFKVKFK	O	O
(	O	O
KSL	O	O
)	O	O
,	O	O
has	O	O
been	O	O
identified	O	O
that	O	O
shows	O	O
a	O	O
broad	O	O
range	O	O
of	O	O
antibacterial	O	O
activity	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
test	O	O
the	O	O
efficacy	O	O
of	O	O
this	O	O
antimicrobial	O	O
peptide	O	O
in	O	O
killing	O	O
selected	O	O
strains	O	O
of	O	O
oral	O	O
pathogens	O	O
and	O	O
resident	O	O
saliva	O	O
bacteria	O	O
collected	O	O
from	O	O
human	O	O
subjects	O	O
.	O	O

Cytotoxic	O	O
activity	O	O
of	O	O
KSL	O	O
against	O	O
mammalian	O	O
cells	O	O
and	O	O
the	O	O
structural	O	O
features	O	O
of	O	O
this	O	O
decapeptide	O	O
were	O	O
also	O	O
investigated	O	O
,	O	O
the	O	O
latter	O	O
by	O	O
using	O	O
two-dimensional	O	O
NMR	O	O
in	O	O
aqueous	O	O
and	O	O
DMSO	O	O
solutions	O	O
.	O	O

MICs	O	O
of	O	O
KSL	O	O
for	O	O
the	O	O
majority	O	O
of	O	O
oral	O	O
bacteria	O	O
tested	O	O
in	O	O
vitro	O	O
ranged	O	O
from	O	O
3	O	O
to	O	O
100	O	O
microg	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

Minimal	O	O
bactericidal	O	O
concentrations	O	O
of	O	O
KSL	O	O
were	O	O
,	O	O
in	O	O
general	O	O
,	O	O
within	O	O
one	O	O
to	O	O
two	O	O
dilutions	O	O
of	O	O
the	O	O
MICs	O	O
.	O	O

KSL	O	O
exhibited	O	O
an	O	O
ED	O	O
(	O	O
99	O	O
)	O	O
(	O	O
the	O	O
dose	O	O
at	O	O
which	O	O
99	O	O
%	O	O
killing	O	O
was	O	O
observed	O	O
after	O	O
15	O	O
min	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
)	O	O
of	O	O
6.25	O	O
microg	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
against	O	O
selected	O	O
strains	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

In	O	O
addition	O	O
,	O	O
KSL	O	O
damaged	O	O
bacterial	O	O
cell	O	O
membranes	O	O
and	O	O
caused	O	O
1.05	O	O
log	O	O
units	O	O
reduction	O	O
of	O	O
viability	O	O
counts	O	O
of	O	O
saliva	O	O
bacteria	O	O
.	O	O

In	O	O
vitro	O	O
toxicity	O	O
studies	O	O
showed	O	O
that	O	O
KSL	O	O
,	O	O
at	O	O
concentrations	O	O
up	O	O
to	O	O
1	O	O
mg	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
,	O	O
did	O	O
not	O	O
induce	O	O
cell	O	O
death	O	O
or	O	O
compromise	O	O
the	O	O
membrane	O	O
integrity	O	O
of	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
.	O	O

NMR	O	O
studies	O	O
suggest	O	O
that	O	O
KSL	O	O
adopts	O	O
an	O	O
alpha-helical	O	O
structure	O	O
in	O	O
DMSO	O	O
solution	O	O
,	O	O
which	O	O
mimics	O	O
the	O	O
polar	O	O
aprotic	O	O
membrane	O	O
environment	O	O
,	O	O
whereas	O	O
it	O	O
remains	O	O
unstructured	O	O
in	O	O
aqueous	O	O
medium	O	O
.	O	O

This	O	O
study	O	O
shows	O	O
that	O	O
KSL	O	O
may	O	O
be	O	O
a	O	O
useful	O	O
antimicrobial	O	O
agent	O	O
for	O	O
inhibiting	O	O
the	O	O
growth	O	O
of	O	O
oral	O	O
bacteria	O	O
that	O	O
are	O	O
associated	O	O
with	O	O
caries	O	O
development	O	O
and	O	O
early	O	O
plaque	O	O
formation	O	O
.	O	O

Microbial	O	O
interactions	O	O
with	O	O
host	O	O
molecules	O	O
,	O	O
and	O	O
programmed	O	O
responses	O	O
to	O	O
host	O	O
environmental	O	O
stimuli	O	O
,	O	O
are	O	O
critical	O	O
for	O	O
colonization	O	O
and	O	O
initiation	O	O
of	O	O
pathogenesis	O	O
.	O	O

Bacteria	O	O
of	O	O
the	O	O
genus	O	O
Streptococcus	B-bacteria	B-bacteria
are	O	O
primary	O	O
colonizers	O	O
of	O	O
the	O	O
human	O	O
mouth	O	O
.	O	O

They	O	O
express	O	O
multiple	O	O
cell-surface	O	O
adhesins	O	O
that	O	O
bind	O	O
salivary	O	O
components	O	O
and	O	O
other	O	O
oral	O	O
bacteria	O	O
and	O	O
enable	O	O
the	O	O
development	O	O
of	O	O
polymicrobial	O	O
biofilms	O	O
associated	O	O
with	O	O
tooth	O	O
decay	O	O
and	O	O
periodontal	O	O
disease	O	O
.	O	O

However	O	O
,	O	O
the	O	O
mechanisms	O	O
by	O	O
which	O	O
streptococci	B-bacteria	B-bacteria
invade	O	O
dentine	O	O
to	O	O
infect	O	O
the	O	O
tooth	O	O
pulp	O	O
and	O	O
periapical	O	O
tissues	O	O
are	O	O
poorly	O	O
understood	O	O
.	O	O

Here	O	O
we	O	O
show	O	O
that	O	O
production	O	O
of	O	O
the	O	O
antigen	O	O
I/II	O	O
(	O	O
AgI/II	O	O
)	O	O
family	O	O
polypeptide	O	O
adhesin	O	O
and	O	O
invasin	O	O
SspA	O	O
in	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
is	O	O
specifically	O	O
upregulated	O	O
in	O	O
response	O	O
to	O	O
a	O	O
collagen	O	O
type	O	O
I	O	O
signal	O	O
,	O	O
minimally	O	O
the	O	O
tri-peptide	O	O
Gly-Pro-Xaa	O	O
(	O	O
where	O	O
Xaa	O	O
is	O	O
hydroxyproline	O	O
or	O	O
alanine	O	O
)	O	O
.	O	O

Increased	O	O
AgI/II	O	O
polypeptide	O	O
expression	O	O
promotes	O	O
bacterial	O	O
adhesion	O	O
and	O	O
extended	O	O
growth	O	O
of	O	O
streptococcal	O	O
cell	O	O
chains	O	O
along	O	O
collagen	O	O
type	O	O
I	O	O
fibrils	O	O
that	O	O
are	O	O
characteristically	O	O
found	O	O
within	O	O
dentinal	O	O
tubules	O	O
.	O	O

These	O	O
observations	O	O
define	O	O
a	O	O
new	O	O
model	O	O
of	O	O
host	O	O
matrix	O	O
signal-induced	O	O
tissue	O	O
penetration	O	O
by	O	O
bacteria	O	O
and	O	O
open	O	O
the	O	O
way	O	O
for	O	O
novel	O	O
therapy	O	O
opportunities	O	O
for	O	O
oral	O	O
invasive	O	O
diseases	O	O
.	O	O

Oral	O	O
epithelium	O	O
may	O	O
play	O	O
a	O	O
regulatory	O	O
role	O	O
in	O	O
local	O	O
immune	O	O
responses	O	O
when	O	O
interacting	O	O
with	O	O
bacteria	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
undertaken	O	O
to	O	O
investigate	O	O
the	O	O
effects	O	O
of	O	O
selected	O	O
bacterial	O	O
pathogens	O	O
found	O	O
in	O	O
periodontal	O	O
and	O	O
endodontic	O	O
infections	O	O
on	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Expression	O	O
of	O	O
cell	O	O
surface	O	O
molecules	O	O
(	O	O
major	O	O
histocompatibility	O	O
complex	O	O
(	O	O
MHC	O	O
)	O	O
Class	O	O
II	O	O
,	O	O
CD54	O	O
,	O	O
CD70	O	O
,	O	O
CD80	O	O
and	O	O
CD86	O	O
)	O	O
and	O	O
secretion	O	O
of	O	O
inflammatory	O	O
cytokines	O	O
(	O	O
interleukin	O	O
(	O	O
IL	O	O
)	O	O
-1beta	O	O
,	O	O
IL-6	O	O
,	O	O
and	O	O
tumor	O	O
necrosis	O	O
factor	O	O
(	O	O
TNF	O	O
)	O	O
-alpha	O	O
)	O	O
in	O	O
response	O	O
to	O	O
selected	O	O
bacterial	O	O
challenge	O	O
were	O	O
examined	O	O
on	O	O
an	O	O
immortalized	O	O
oral	O	O
epithelial	O	O
cell	O	O
line	O	O
,	O	O
HOK-18A	O	O
and	O	O
a	O	O
skin	O	O
epithelial	O	O
cell	O	O
line	O	O
,	O	O
HaCaT	O	O
.	O	O

Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
or	O	O
primary	O	O
human	O	O
periradicular	O	O
exudate	O	O
from	O	O
a	O	O
granuloma	O	O
were	O	O
co-cultured	O	O
with	O	O
epithelial	O	O
cells	O	O
for	O	O
4	O	O
or	O	O
24	O	O
h.	O	O
Subsequently	O	O
,	O	O
cell	O	O
surface	O	O
expression	O	O
of	O	O
MHC	O	O
Class	O	O
II	O	O
,	O	O
CD54	O	O
,	O	O
CD70	O	O
,	O	O
CD80	O	O
and	O	O
CD86	O	O
,	O	O
along	O	O
with	O	O
pro-inflammatory	O	O
cytokine	O	O
levels	O	O
were	O	O
determined	O	O
using	O	O
flow	O	O
cytometry	O	O
,	O	O
ELISA	O	O
and	O	O
RT-PCR	O	O
.	O	O

Results	O	O
indicated	O	O
that	O	O
the	O	O
selected	O	O
oral	O	O
bacteria	O	O
have	O	O
greater	O	O
effects	O	O
on	O	O
oral	O	O
versus	O	O
skin	O	O
epithelial	O	O
cells	O	O
.	O	O

F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
increased	O	O
MHC	O	O
Class	O	O
II	O	O
and	O	O
CD54	O	O
(	O	O
ICAM-1	O	O
)	O	O
cell	O	O
surface	O	O
expression	O	O
on	O	O
HOK-18A	O	O
and	O	O
HaCaT	O	O
cells	O	O
.	O	O

A.	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
also	O	O
had	O	O
enhancing	O	O
effects	O	O
on	O	O
the	O	O
expression	O	O
of	O	O
CD54	O	O
and	O	O
MHC	O	O
Class	O	O
II	O	O
.	O	O

A.	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
and	O	O
LPS	O	O
induced	O	O
a	O	O
2.8-fold	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
and	O	O
4.4-fold	O	O
(	O	O
P	O	O
<	O	O
0.005	O	O
)	O	O
TNF-alpha	O	O
secretion	O	O
,	O	O
respectively	O	O
,	O	O
while	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
LPS	O	O
induced	O	O
a	O	O
10-fold	O	O
(	O	O
P	O	O
<	O	O
0.0004	O	O
)	O	O
and	O	O
6-fold	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
IL-1beta	O	O
secretion	O	O
,	O	O
respectively	O	O
by	O	O
HOK-18A	O	O
.	O	O

Interestingly	O	O
,	O	O
CD70	O	O
,	O	O
CD80	O	O
,	O	O
and	O	O
CD86	O	O
were	O	O
generally	O	O
decreased	O	O
upon	O	O
bacteria	O	O
and	O	O
LPS	O	O
challenge	O	O
on	O	O
HOK-18A	O	O
.	O	O

The	O	O
effects	O	O
of	O	O
increased	O	O
MHC	O	O
Class	O	O
II	O	O
and	O	O
decreased	O	O
CD70	O	O
were	O	O
also	O	O
evident	O	O
with	O	O
challenge	O	O
of	O	O
human	O	O
periradicular	O	O
exudate	O	O
on	O	O
HOK-18A	O	O
.	O	O

The	O	O
implications	O	O
of	O	O
the	O	O
study	O	O
are	O	O
unique	O	O
in	O	O
that	O	O
oral	O	O
epithelial	O	O
cells	O	O
may	O	O
play	O	O
both	O	O
activating	O	O
and	O	O
inhibitory	O	O
roles	O	O
in	O	O
the	O	O
host	O	O
immune	O	O
response	O	O
towards	O	O
infection	O	O
by	O	O
oral	O	O
bacteria	O	O
.	O	O

We	O	O
introduce	O	O
a	O	O
concept	O	O
of	O	O
'dormancy	O	O
'	O	O
where	O	O
the	O	O
differential	O	O
expression	O	O
of	O	O
key	O	O
cell	O	O
surface	O	O
antigens	O	O
on	O	O
oral	O	O
epithelial	O	O
cells	O	O
may	O	O
keep	O	O
the	O	O
recruited	O	O
immune	O	O
effector	O	O
cells	O	O
in	O	O
a	O	O
state	O	O
of	O	O
unresponsiveness	O	O
,	O	O
thus	O	O
contributing	O	O
to	O	O
the	O	O
long	O	O
term	O	O
quiescent	O	O
period	O	O
observed	O	O
in	O	O
many	O	O
periodontal	O	O
and	O	O
endodontic	O	O
lesions	O	O
.	O	O

Human	O	O
beta-defensin-2	O	O
,	O	O
and	O	O
-3	O	O
(	O	O
hBD-2	O	O
,	O	O
-3	O	O
)	O	O
are	O	O
small	O	O
inducible	O	O
antimicrobial	O	O
peptides	O	O
involved	O	O
in	O	O
host	O	O
defense	O	O
.	O	O

Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
a	O	O
gram-negative	B-bacteria	B-bacteria
facultative	I-bacteria	I-bacteria
anaerobe	E-bacteria	I-bacteria
,	O	O
is	O	O
frequently	O	O
associated	O	O
with	O	O
oral	O	O
disease	O	O
in	O	O
humans	O	O
.	O	O

A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
strain	B-bacteria	B-bacteria
JP2	E-bacteria	I-bacteria
,	O	O
was	O	O
examined	O	O
for	O	O
its	O	O
ability	O	O
to	O	O
modulate	O	O
hBD-2	O	O
and	O	O
-3	O	O
gene	O	O
expression	O	O
in	O	O
normal	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
(	O	O
NHOECs	O	O
)	O	O
and	O	O
in	O	O
OKF6/Tert	O	O
cells	O	O
,	O	O
an	O	O
immortalized	O	O
cell	O	O
line	O	O
derived	O	O
from	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Stimulation	O	O
of	O	O
both	O	O
cell	O	O
types	O	O
by	O	O
live	O	O
bacteria	O	O
,	O	O
at	O	O
a	O	O
minimal	O	O
bacteria/cell	O	O
ratio	O	O
of	O	O
500	O	O
:	O	O
1	O	O
,	O	O
resulted	O	O
in	O	O
increased	O	O
hBD-3	O	O
gene	O	O
expression	O	O
.	O	O

This	O	O
was	O	O
not	O	O
evinced	O	O
for	O	O
hBD-2	O	O
in	O	O
either	O	O
cell	O	O
type	O	O
with	O	O
live	O	O
bacteria	O	O
,	O	O
even	O	O
at	O	O
bacteria/cell	O	O
ratios	O	O
exceeding	O	O
500	O	O
:	O	O
1	O	O
.	O	O

The	O	O
increased	O	O
hBD-3	O	O
gene	O	O
expression	O	O
was	O	O
dependent	O	O
upon	O	O
viable	O	O
bacteria	O	O
,	O	O
and	O	O
not	O	O
their	O	O
lipopolysaccharides	O	O
(	O	O
LPS	O	O
)	O	O
,	O	O
since	O	O
heat-killed	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
did	O	O
not	O	O
induce	O	O
hBD-3	O	O
transcript	O	O
expression	O	O
.	O	O

The	O	O
overall	O	O
similarity	O	O
between	O	O
results	O	O
obtained	O	O
in	O	O
OKF6/Tert	O	O
cells	O	O
and	O	O
NHOECs	O	O
suggest	O	O
that	O	O
the	O	O
OKF6/Tert	O	O
cell	O	O
line	O	O
may	O	O
be	O	O
a	O	O
useful	O	O
tool	O	O
in	O	O
the	O	O
study	O	O
of	O	O
beta-defensin	O	O
expression	O	O
in	O	O
oral	O	O
epithelium	O	O
.	O	O

The	O	O
in	O	O
vitro	O	O
activity	O	O
of	O	O
Melaleuca	O	O
alternifolia	O	O
(	O	O
tea	O	O
tree	O	O
)	O	O
oil	O	O
against	O	O
161	O	O
isolates	O	O
of	O	O
oral	O	O
bacteria	O	O
from	O	O
15	O	O
genera	O	O
was	O	O
determined	O	O
.	O	O

Minimum	O	O
inhibitory	O	O
concentrations	O	O
(	O	O
MIC	O	O
)	O	O
and	O	O
minimum	O	O
bactericidal	O	O
concentrations	O	O
(	O	O
MBC	O	O
)	O	O
ranged	O	O
from	O	O
0.003	O	O
to	O	O
2.0	O	O
%	O	O
(	O	O
v/v	O	O
)	O	O
.	O	O

MIC90	O	O
values	O	O
were	O	O
1.0	O	O
%	O	O
(	O	O
v/v	O	O
)	O	O
for	O	O
Actinomyces	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
and	O	O
0.1	O	O
%	O	O
(	O	O
v/v	O	O
)	O	O
for	O	O
Prevotella	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

Isolates	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
and	O	O
Veillonella	B-bacteria	B-bacteria
had	O	O
the	O	O
lowest	O	O
MICs	O	O
and	O	O
MBCs	O	O
,	O	O
and	O	O
isolates	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
had	O	O
the	O	O
highest	O	O
.	O	O

Time	O	O
kill	O	O
studies	O	O
with	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
showed	O	O
that	O	O
treatment	O	O
with	O	O
>	O	O
or	O	O
=	O	O
0.5	O	O
%	O	O
tea	O	O
tree	O	O
oil	O	O
caused	O	O
decreases	O	O
in	O	O
viability	O	O
of	O	O
>	O	O
3	O	O
log	O	O
colony	O	O
forming	O	O
units/ml	O	O
after	O	O
only	O	O
30	O	O
s	O	O
,	O	O
and	O	O
viable	O	O
organisms	O	O
were	O	O
not	O	O
detected	O	O
after	O	O
5	O	O
min	O	O
.	O	O

These	O	O
studies	O	O
indicate	O	O
that	O	O
a	O	O
range	O	O
of	O	O
oral	O	O
bacteria	O	O
are	O	O
susceptible	O	O
to	O	O
tea	O	O
tree	O	O
oil	O	O
,	O	O
suggesting	O	O
that	O	O
tea	O	O
tree	O	O
oil	O	O
may	O	O
be	O	O
of	O	O
use	O	O
in	O	O
oral	O	O
healthcare	O	O
products	O	O
and	O	O
in	O	O
the	O	O
maintenance	O	O
of	O	O
oral	O	O
hygiene	O	O
.	O	O

Bacterial	O	O
effects	O	O
on	O	O
in	O	O
vitro	O	O
mineralization	O	O
of	O	O
human	O	O
periodontal	O	O
fibroblasts	O	O
(	O	O
HPF	O	O
)	O	O
have	O	O
not	O	O
yet	O	O
been	O	O
examined	O	O
in	O	O
great	O	O
detail	O	O
.	O	O

In	O	O
our	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
effects	O	O
of	O	O
soluble	O	O
extracts	O	O
of	O	O
the	O	O
periodontopathic	O	O
bacteria	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
and	O	O
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
on	O	O
cell	O	O
proliferation	O	O
,	O	O
mineralization	O	O
,	O	O
as	O	O
well	O	O
as	O	O
on	O	O
osteoblastic	O	O
markers	O	O
present	O	O
in	O	O
HPF	O	O
cultured	O	O
in	O	O
vitro	O	O
,	O	O
such	O	O
as	O	O
alkaline	O	O
phosphatase	O	O
(	O	O
ALP	O	O
)	O	O
activity	O	O
and	O	O
collagen	O	O
content	O	O
.	O	O

Periodontal	O	O
fibroblasts	O	O
stimulated	O	O
by	O	O
B-glycerophosphate	O	O
,	O	O
ascorbic	O	O
acid	O	O
and	O	O
dexamethasone	O	O
(	O	O
BAD	O	O
)	O	O
or	O	O
by	O	O
dexamethasone	O	O
and	O	O
ascorbic	O	O
acid	O	O
(	O	O
DA	O	O
)	O	O
were	O	O
compared	O	O
to	O	O
unstimulated	O	O
cells	O	O
.	O	O

During	O	O
the	O	O
cultivation	O	O
period	O	O
,	O	O
the	O	O
stimulation	O	O
of	O	O
HPF	O	O
by	O	O
combined	O	O
dexamethasone	O	O
and	O	O
ascorbic	O	O
acid	O	O
(	O	O
DA	O	O
)	O	O
had	O	O
a	O	O
strong	O	O
inductive	O	O
effect	O	O
on	O	O
proliferation	O	O
,	O	O
ALP	O	O
activity	O	O
and	O	O
collagen	O	O
formation	O	O
.	O	O

The	O	O
extracts	O	O
obtained	O	O
from	O	O
the	O	O
periodontal	O	O
pathogens	O	O
had	O	O
a	O	O
suppressing	O	O
effect	O	O
on	O	O
the	O	O
proliferation	O	O
rate	O	O
of	O	O
HPF	O	O
.	O	O

The	O	O
extracts	O	O
from	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
B.	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
caused	O	O
a	O	O
decrease	O	O
in	O	O
ALP	O	O
activity	O	O
within	O	O
24	O	O
h	O	O
of	O	O
application	O	O
.	O	O

While	O	O
extracts	O	O
obtained	O	O
from	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
B.	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
induced	O	O
a	O	O
reduction	O	O
in	O	O
collagen	O	O
content	O	O
in	O	O
BAD-	O	O
and	O	O
DA-stimulated	O	O
HPF	O	O
cells	O	O
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
extracts	O	O
led	O	O
to	O	O
an	O	O
increase	O	O
in	O	O
collagen	O	O
.	O	O

Our	O	O
data	O	O
suggest	O	O
that	O	O
specific	O	O
periodontopathic	O	O
bacteria	O	O
may	O	O
suppress	O	O
tissue	O	O
regeneration	O	O
in	O	O
vivo	O	O
not	O	O
only	O	O
by	O	O
activating	O	O
host	O	O
defense	O	O
mechanisms	O	O
but	O	O
also	O	O
directly	O	O
via	O	O
a	O	O
suppression	O	O
of	O	O
growth	O	O
and	O	O
differentiation	O	O
of	O	O
HPF	O	O
and	O	O
a	O	O
reduction	O	O
in	O	O
the	O	O
extracellular	O	O
collagen	O	O
matrix	O	O
.	O	O

For	O	O
the	O	O
process	O	O
of	O	O
pocket	O	O
formation	O	O
,	O	O
not	O	O
even	O	O
the	O	O
direct	O	O
influence	O	O
of	O	O
viable	O	O
bacteria	O	O
seems	O	O
to	O	O
be	O	O
necessary	O	O
.	O	O

Additionally	O	O
,	O	O
long-distance	O	O
effects	O	O
of	O	O
bacteria	O	O
harboured	O	O
in	O	O
periodontal	O	O
pockets	O	O
or	O	O
in	O	O
root	O	O
canals	O	O
may	O	O
be	O	O
of	O	O
importance	O	O
.	O	O

Six	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
coccobacilli	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
root	O	O
canals	O	O
of	O	O
patients	O	O
with	O	O
endodontic	O	O
infections	O	O
(	O	O
five	O	O
strains	O	O
)	O	O
and	O	O
from	O	O
a	O	O
deep	O	O
periodontal	O	O
pocket	O	O
(	O	O
one	O	O
strain	O	O
)	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genetic	O	O
tests	O	O
and	O	O
were	O	O
found	O	O
to	O	O
comprise	O	O
a	O	O
homogeneous	O	O
group	O	O
.	O	O

Following	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
,	O	O
they	O	O
were	O	O
found	O	O
to	O	O
be	O	O
most	O	O
closely	O	O
related	O	O
to	O	O
Dialister	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
,	O	O
with	O	O
93	O	O
%	O	O
sequence	O	O
similarity	O	O
between	O	O
the	O	O
two	O	O
taxa	O	O
.	O	O

A	O	O
novel	O	O
species	O	O
,	O	O
Dialister	B-bacteria	B-bacteria
invisus	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
is	O	O
proposed	O	O
.	O	O

Biochemically	O	O
,	O	O
the	O	O
species	O	O
is	O	O
largely	O	O
unreactive	O	O
and	O	O
is	O	O
asaccharolytic	O	O
,	O	O
with	O	O
only	O	O
traces	O	O
of	O	O
acetate	O	O
and	O	O
propionate	O	O
detected	O	O
as	O	O
metabolic	O	O
end-products	O	O
.	O	O

The	O	O
G+C	O	O
content	O	O
of	O	O
the	O	O
DNA	O	O
of	O	O
D.	O	O
invisus	O	O
strains	O	O
is	O	O
45-46	O	O
mol	O	O
%	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
is	O	O
E7.25	O	O
(	O	O
T	O	O
)	O	O
(	O	O
=CCUG	B-bacteria	B-bacteria
47026	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=DSM	B-bacteria	B-bacteria
15470	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
.	O	O

To	O	O
investigate	O	O
whether	O	O
human	O	O
breast	O	O
milk	O	O
contains	O	O
potentially	O	O
probiotic	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
and	O	O
therefore	O	O
,	O	O
whether	O	O
it	O	O
can	O	O
be	O	O
considered	O	O
a	O	O
synbiotic	O	O
food	O	O
.	O	O

Study	O	O
design	O	O
Lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
milk	O	O
,	O	O
mammary	O	O
areola	O	O
,	O	O
and	O	O
breast	O	O
skin	O	O
of	O	O
eight	O	O
healthy	O	O
mothers	O	O
and	O	O
oral	O	O
swabs	O	O
and	O	O
feces	O	O
of	O	O
their	O	O
respective	O	O
breast-fed	O	O
infants	O	O
.	O	O

Some	O	O
isolates	O	O
(	O	O
178	O	O
from	O	O
each	O	O
mother	O	O
and	O	O
newborn	O	O
pair	O	O
)	O	O
were	O	O
randomly	O	O
selected	O	O
and	O	O
submitted	O	O
to	O	O
randomly	O	O
amplified	O	O
polymorphic	O	O
DNA	O	O
(	O	O
RAPD	O	O
)	O	O
polymerase	O	O
chain	O	O
reaction	O	O
analysis	O	O
,	O	O
and	O	O
those	O	O
that	O	O
displayed	O	O
identical	O	O
RAPD	O	O
patterns	O	O
were	O	O
identified	O	O
by	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
.	O	O

Within	O	O
each	O	O
mother	O	O
and	O	O
newborn	O	O
pair	O	O
,	O	O
some	O	O
rod-shaped	B-bacteria	B-bacteria
lactic	I-bacteria	I-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
isolated	O	O
from	O	O
mammary	O	O
areola	O	O
,	O	O
breast	O	O
milk	O	O
,	O	O
and	O	O
infant	O	O
oral	O	O
swabs	O	O
and	O	O
feces	O	O
displayed	O	O
identical	O	O
RAPD	O	O
profiles	O	O
.	O	O

All	O	O
of	O	O
them	O	O
,	O	O
independently	O	O
from	O	O
the	O	O
mother	O	O
and	O	O
child	O	O
pair	O	O
,	O	O
were	O	O
identified	O	O
as	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
.	O	O

Similarly	O	O
,	O	O
among	O	O
coccoid	B-bacteria	B-bacteria
lactic	I-bacteria	I-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
from	O	O
these	O	O
different	O	O
sources	O	O
,	O	O
some	O	O
shared	O	O
an	O	O
identical	O	O
RAPD	O	O
pattern	O	O
and	O	O
were	O	O
identified	O	O
as	O	O
Enterococcus	B-bacteria	B-bacteria
faecium	E-bacteria	I-bacteria
.	O	O

In	O	O
contrast	O	O
,	O	O
none	O	O
of	O	O
the	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
isolated	O	O
from	O	O
breast	O	O
skin	O	O
shared	O	O
RAPD	O	O
profiles	O	O
with	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
of	O	O
the	O	O
other	O	O
sources	O	O
.	O	O

Breast-feeding	O	O
can	O	O
be	O	O
a	O	O
significant	O	O
source	O	O
of	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
to	O	O
the	O	O
infant	O	O
gut	O	O
.	O	O

Lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
present	O	O
in	O	O
milk	O	O
may	O	O
have	O	O
an	O	O
endogenous	O	O
origin	O	O
and	O	O
may	O	O
not	O	O
be	O	O
the	O	O
result	O	O
of	O	O
contamination	O	O
from	O	O
the	O	O
surrounding	O	O
breast	O	O
skin	O	O
.	O	O

To	O	O
analyze	O	O
the	O	O
relationship	O	O
between	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
Hp	B-bacteria	B-bacteria
)	O	O
in	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
Hp	O	O
infection	O	O
in	O	O
stomach	O	O
.	O	O

102	O	O
patients	O	O
with	O	O
gastric	O	O
Hp	B-bacteria	B-bacteria
infection	O	O
and	O	O
periodontitis	O	O
were	O	O
enrolled	O	O
in	O	O
this	O	O
study	O	O
.	O	O

DNA	O	O
was	O	O
extracted	O	O
from	O	O
subgingival	O	O
plaques	O	O
,	O	O
mouthwashes	O	O
and	O	O
stomach	O	O
mucosa	O	O
samples	O	O
by	O	O
using	O	O
the	O	O
glass-milk	O	O
(	O	O
SiO2	O	O
)	O	O
purification	O	O
method	O	O
.	O	O

To	O	O
identify	O	O
the	O	O
presence	O	O
of	O	O
Hp	B-bacteria	B-bacteria
in	O	O
these	O	O
samples	O	O
,	O	O
PCR	O	O
(	O	O
polymerase	O	O
chain	O	O
reaction	O	O
)	O	O
was	O	O
carried	O	O
out	O	O
,	O	O
and	O	O
two	O	O
pairs	O	O
of	O	O
oligonucleotide	O	O
primer	O	O
were	O	O
used	O	O
to	O	O
amplify	O	O
a	O	O
portion	O	O
of	O	O
gene	O	O
urease	O	O
C	O	O
and	O	O
gene	O	O
cag	O	O
A	O	O
of	O	O
Hp	B-bacteria	B-bacteria
.	O	O

The	O	O
rate	O	O
of	O	O
Hp	B-bacteria	B-bacteria
detected	O	O
in	O	O
oral	O	O
cavity	O	O
was	O	O
significantly	O	O
higher	O	O
in	O	O
patients	O	O
with	O	O
positive	O	O
Hp	B-bacteria	B-bacteria
in	O	O
stomach	O	O
(	O	O
43.1	O	O
%	O	O
,	O	O
n=58	O	O
)	O	O
than	O	O
in	O	O
those	O	O
with	O	O
negative	O	O
Hp	B-bacteria	B-bacteria
in	O	O
stomach	O	O
(	O	O
22.7	O	O
%	O	O
,	O	O
n=44	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

After	O	O
the	O	O
treatment	O	O
for	O	O
gastric	O	O
Hp	B-bacteria	B-bacteria
infection	O	O
for	O	O
4	O	O
weeks	O	O
,	O	O
the	O	O
eradication	O	O
rate	O	O
of	O	O
Hp	B-bacteria	B-bacteria
in	O	O
stomach	O	O
was	O	O
lower	O	O
,	O	O
but	O	O
only	O	O
slightly	O	O
in	O	O
patients	O	O
with	O	O
positive	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
Hp	E-bacteria	I-bacteria
(	O	O
16/25	O	O
,	O	O
64	O	O
%	O	O
)	O	O
than	O	O
in	O	O
those	O	O
with	O	O
negative	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
Hp	E-bacteria	I-bacteria
(	O	O
24/33	O	O
,	O	O
72.7	O	O
%	O	O
)	O	O
.	O	O

However	O	O
,	O	O
this	O	O
difference	O	O
became	O	O
apparent	O	O
(	O	O
36.0	O	O
%	O	O
vs	O	O
63.6	O	O
%	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
after	O	O
one	O	O
year	O	O
of	O	O
the	O	O
treatment	O	O
.	O	O

The	O	O
effectiveness	O	O
of	O	O
the	O	O
eradication	O	O
therapy	O	O
for	O	O
gastric	O	O
Hp	B-bacteria	B-bacteria
infection	O	O
is	O	O
affected	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
Hp	B-bacteria	B-bacteria
in	O	O
oral	O	O
cavity	O	O
.	O	O

Oral	O	O
colonization	O	O
of	O	O
Hp	B-bacteria	B-bacteria
may	O	O
imply	O	O
that	O	O
there	O	O
is	O	O
a	O	O
risk	O	O
of	O	O
the	O	O
relapses	O	O
of	O	O
gastric	O	O
and	O	O
duodenal	O	O
Hp	B-bacteria	B-bacteria
infection	O	O
and	O	O
ulcer	O	O
after	O	O
the	O	O
antibiotics	O	O
treatment	O	O
for	O	O
the	O	O
eradication	O	O
of	O	O
Hp	B-bacteria	B-bacteria
.	O	O

The	O	O
feasibility	O	O
of	O	O
recovering	O	O
and	O	O
genotypically	O	O
comparing	O	O
oral	O	O
bacteria	O	O
from	O	O
bitemarks	O	O
for	O	O
forensic	O	O
purposes	O	O
was	O	O
assessed	O	O
experimentally	O	O
.	O	O

Volunteers	O	O
firmly	O	O
bit	O	O
their	O	O
own	O	O
upper	O	O
arms	O	O
and	O	O
bitemarks	O	O
were	O	O
sampled	O	O
at	O	O
intervals	O	O
to	O	O
recover	O	O
viable	O	O
Streptococcus	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
.	O	O

The	O	O
recoverability	O	O
of	O	O
bacteria	O	O
decreased	O	O
over	O	O
time	O	O
but	O	O
an	O	O
average	O	O
of	O	O
more	O	O
than	O	O
one	O	O
thousand	O	O
viable	O	O
organisms	O	O
was	O	O
recovered	O	O
24	O	O
hrs	O	O
after	O	O
biting	O	O
,	O	O
provided	O	O
the	O	O
site	O	O
remained	O	O
relatively	O	O
undisturbed	O	O
.	O	O

Physical	O	O
exertion	O	O
,	O	O
manual	O	O
rubbing	O	O
and	O	O
application	O	O
of	O	O
moisturizing	O	O
lotion	O	O
all	O	O
decreased	O	O
bacterial	O	O
recoverability	O	O
compared	O	O
to	O	O
controls	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
could	O	O
also	O	O
be	O	O
recovered	O	O
from	O	O
bites	O	O
inflicted	O	O
on	O	O
various	O	O
fabrics	O	O
.	O	O

Genomic	O	O
profiles	O	O
(	O	O
DNA	O	O
``	O	O
fingerprints	O	O
''	O	O
)	O	O
of	O	O
bacteria	O	O
recovered	O	O
from	O	O
bitemarks	O	O
could	O	O
be	O	O
identified	O	O
exclusively	O	O
with	O	O
those	O	O
from	O	O
the	O	O
teeth	O	O
of	O	O
the	O	O
individual	O	O
responsible	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
a	O	O
bacterial	O	O
genotyping	O	O
approach	O	O
to	O	O
bitemark	O	O
analysis	O	O
could	O	O
have	O	O
forensic	O	O
application	O	O
in	O	O
situations	O	O
where	O	O
the	O	O
perpetrator	O	O
's	O	O
DNA	O	O
can	O	O
not	O	O
be	O	O
recovered	O	O
from	O	O
an	O	O
oral	O	O
contact	O	O
site	O	O
.	O	O

The	O	O
innate	O	O
immune	O	O
response	O	O
is	O	O
critical	O	O
for	O	O
the	O	O
epithelial	O	O
antimicrobial	O	O
barrier	O	O
.	O	O

The	O	O
human	O	O
beta-defensins	O	O
are	O	O
small	O	O
,	O	O
cationic	O	O
antimicrobial	O	O
peptides	O	O
that	O	O
are	O	O
made	O	O
by	O	O
epithelial	O	O
cells	O	O
and	O	O
that	O	O
play	O	O
a	O	O
role	O	O
in	O	O
mucosal	O	O
and	O	O
skin	O	O
defenses	O	O
.	O	O

Human	O	O
beta-defensin	O	O
1	O	O
(	O	O
hBD-1	O	O
)	O	O
is	O	O
expressed	O	O
constitutively	O	O
in	O	O
epithelial	O	O
tissues	O	O
,	O	O
whereas	O	O
hBD-2	O	O
and	O	O
hBD-3	O	O
are	O	O
expressed	O	O
in	O	O
response	O	O
to	O	O
bacterial	O	O
stimuli	O	O
or	O	O
inflammation	O	O
.	O	O

Previous	O	O
studies	O	O
showed	O	O
that	O	O
hBD-2	O	O
was	O	O
induced	O	O
by	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
cell	O	O
wall	O	O
extract	O	O
without	O	O
the	O	O
involvement	O	O
of	O	O
the	O	O
NF-kappaB	O	O
transcription	O	O
factors	O	O
,	O	O
which	O	O
typically	O	O
are	O	O
associated	O	O
with	O	O
innate	O	O
immunity	O	O
and	O	O
inflammation	O	O
.	O	O

The	O	O
goal	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
characterize	O	O
signaling	O	O
pathways	O	O
involved	O	O
in	O	O
hBD-2	O	O
induction	O	O
in	O	O
response	O	O
to	O	O
commensal	O	O
and	O	O
pathogenic	O	O
bacteria	O	O
.	O	O

Cultured	O	O
human	O	O
oral	O	O
and	O	O
foreskin	O	O
keratinocytes	O	O
were	O	O
treated	O	O
separately	O	O
with	O	O
inhibitors	O	O
of	O	O
NF-kappaB	O	O
,	O	O
c-Jun	O	O
N-terminal	O	O
kinase	O	O
(	O	O
JNK	O	O
)	O	O
,	O	O
and	O	O
p38	O	O
and	O	O
then	O	O
stimulated	O	O
with	O	O
oral	O	O
commensal	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	B-bacteria	B-bacteria
,	O	O
oral	O	O
pathogens	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
skin	O	O
commensal	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
,	O	O
or	O	O
skin	O	O
pathogen	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
.	O	O

Different	O	O
bacteria	O	O
induced	O	O
different	O	O
levels	O	O
of	O	O
hBD-2	O	O
and	O	O
in	O	O
response	O	O
to	O	O
the	O	O
various	O	O
inhibitors	O	O
tested	O	O
,	O	O
although	O	O
certain	O	O
common	O	O
patterns	O	O
were	O	O
observed	O	O
for	O	O
commensal-	O	O
and	O	O
pathogen-stimulated	O	O
cells	O	O
.	O	O

hBD-2	O	O
induction	O	O
by	O	O
all	O	O
bacteria	O	O
tested	O	O
was	O	O
partially	O	O
or	O	O
completely	O	O
blocked	O	O
by	O	O
inhibitors	O	O
of	O	O
the	O	O
JNK	O	O
and	O	O
p38	O	O
pathways	O	O
.	O	O

However	O	O
,	O	O
in	O	O
addition	O	O
,	O	O
hBD-2	O	O
induction	O	O
by	O	O
pathogenic	O	O
bacteria	O	O
in	O	O
both	O	O
oral	O	O
and	O	O
foreskin	O	O
keratinocytes	O	O
was	O	O
blocked	O	O
by	O	O
inhibitors	O	O
of	O	O
NF-kappaB	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
that	O	O
commensal	O	O
and	O	O
pathogenic	O	O
bacteria	O	O
utilize	O	O
different	O	O
pathways	O	O
in	O	O
hBD-2	O	O
induction	O	O
and	O	O
suggest	O	O
that	O	O
epithelial	O	O
cells	O	O
from	O	O
different	O	O
body	O	O
sites	O	O
have	O	O
common	O	O
signaling	O	O
mechanisms	O	O
to	O	O
distinguish	O	O
between	O	O
commensal	O	O
and	O	O
pathogenic	O	O
bacteria	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
organisms	O	O
are	O	O
occasionally	O	O
isolated	O	O
from	O	O
the	O	O
blood	O	O
of	O	O
patients	O	O
with	O	O
infective	O	O
endocarditis	O	O
,	O	O
though	O	O
the	O	O
mechanisms	O	O
of	O	O
invasion	O	O
and	O	O
survival	O	O
remain	O	O
to	O	O
be	O	O
elucidated	O	O
.	O	O

Two	O	O
of	O	O
four	O	O
blood	O	O
isolates	O	O
from	O	O
patients	O	O
with	O	O
bacteremia	O	O
or	O	O
infective	O	O
endocarditis	O	O
(	O	O
strains	B-bacteria	B-bacteria
TW295	E-bacteria	I-bacteria
and	O	O
TW871	B-bacteria	B-bacteria
)	O	O
were	O	O
serologically	O	O
untypeable	O	O
by	O	O
immunodiffusion	O	O
testing	O	O
,	O	O
which	O	O
was	O	O
due	O	O
to	O	O
a	O	O
lack	O	O
of	O	O
the	O	O
glucose	O	O
side	O	O
chain	O	O
of	O	O
the	O	O
serotype-specific	O	O
polysaccharide	O	O
antigen	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Immunodiffusion	O	O
analyses	O	O
using	O	O
antisera	O	O
against	O	O
these	O	O
strains	O	O
demonstrated	O	O
that	O	O
2	O	O
of	O	O
100	O	O
isolates	O	O
from	O	O
100	O	O
subjects	O	O
showed	O	O
a	O	O
positive	O	O
reaction	O	O
,	O	O
while	O	O
further	O	O
analysis	O	O
of	O	O
2500	O	O
isolates	O	O
from	O	O
50	O	O
subjects	O	O
revealed	O	O
that	O	O
all	O	O
50	O	O
isolates	O	O
from	O	O
a	O	O
single	O	O
subject	O	O
were	O	O
not	O	O
reactive	O	O
with	O	O
anti-c	O	O
,	O	O
-e	O	O
,	O	O
and	O	O
-f	O	O
antisera	O	O
,	O	O
though	O	O
they	O	O
were	O	O
reactive	O	O
with	O	O
anti-TW295	O	O
and	O	O
-TW871	O	O
antisera	O	O
.	O	O

The	O	O
oral	O	O
isolates	O	O
showed	O	O
biological	O	O
properties	O	O
similar	O	O
to	O	O
those	O	O
of	O	O
the	O	O
reference	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
MT8148	E-bacteria	I-bacteria
,	O	O
including	O	O
high	O	O
levels	O	O
of	O	O
sucrose-dependent	O	O
adhesion	O	O
and	O	O
cellular	O	O
hydrophobicity	O	O
,	O	O
along	O	O
with	O	O
expression	O	O
of	O	O
glucosyltransferases	O	O
and	O	O
a	O	O
protein	O	O
antigen	O	O
,	O	O
PA.	O	O
We	O	O
designated	O	O
these	O	O
organisms	O	O
serotype	O	O
k.	O	O
A	O	O
glucose	O	O
side	O	O
chain-defective	O	O
mutant	O	O
strain	O	O
was	O	O
then	O	O
constructed	O	O
by	O	O
insertional	O	O
inactivation	O	O
of	O	O
the	O	O
gluA	O	O
gene	O	O
of	O	O
strain	B-bacteria	B-bacteria
MT8148	E-bacteria	I-bacteria
,	O	O
which	O	O
showed	O	O
biological	O	O
properties	O	O
similar	O	O
to	O	O
those	O	O
of	O	O
serotype	O	O
k	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	B-bacteria	B-bacteria
.	O	O

Serotype	O	O
k	O	O
oral	O	O
isolates	O	O
were	O	O
less	O	O
susceptible	O	O
to	O	O
phagocytosis	O	O
,	O	O
as	O	O
were	O	O
the	O	O
gluA-inactivated	B-bacteria	B-bacteria
mutant	I-bacteria	I-bacteria
of	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
MT8148	E-bacteria	I-bacteria
and	O	O
blood	O	O
isolates	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
serotype	I-bacteria	I-bacteria
k	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
are	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
humans	O	O
and	O	O
may	O	O
be	O	O
able	O	O
to	O	O
survive	O	O
longer	O	O
in	O	O
blood	O	O
owing	O	O
to	O	O
their	O	O
low	O	O
susceptibility	O	O
to	O	O
phagocytosis	O	O
.	O	O

A	O	O
retrospective	O	O
analysis	O	O
of	O	O
laboratory	O	O
data	O	O
to	O	O
investigate	O	O
the	O	O
isolation	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
from	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
facial	O	O
area	O	O
in	O	O
specimens	O	O
submitted	O	O
to	O	O
a	O	O
regional	O	O
diagnostic	O	O
oral	O	O
microbiology	O	O
laboratory	O	O
.	O	O

A	O	O
hand	O	O
search	O	O
of	O	O
laboratory	O	O
records	O	O
for	O	O
a	O	O
three-year	O	O
period	O	O
(	O	O
1998-2000	O	O
)	O	O
was	O	O
performed	O	O
for	O	O
specimens	O	O
submitted	O	O
to	O	O
the	O	O
regional	O	O
diagnostic	O	O
oral	O	O
microbiology	O	O
laboratory	O	O
based	O	O
at	O	O
Glasgow	O	O
Dental	O	O
Hospital	O	O
and	O	O
School	O	O
.	O	O

Data	O	O
were	O	O
collected	O	O
from	O	O
forms	O	O
where	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
isolated	O	O
.	O	O

These	O	O
data	O	O
included	O	O
demographics	O	O
,	O	O
referral	O	O
source	O	O
,	O	O
specimen	O	O
type	O	O
,	O	O
methicillin	O	O
susceptibility	O	O
and	O	O
clinical	O	O
details	O	O
.	O	O

For	O	O
the	O	O
period	O	O
1998-2000	O	O
,	O	O
there	O	O
were	O	O
5,005	O	O
specimens	O	O
submitted	O	O
to	O	O
the	O	O
laboratory	O	O
.	O	O

S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
isolated	O	O
from	O	O
1,017	O	O
specimens	O	O
,	O	O
of	O	O
which	O	O
967	O	O
(	O	O
95	O	O
%	O	O
)	O	O
were	O	O
sensitive	O	O
to	O	O
methicillin	O	O
(	O	O
MSSA	B-bacteria	B-bacteria
)	O	O
and	O	O
50	O	O
(	O	O
5	O	O
%	O	O
)	O	O
were	O	O
resistant	O	O
to	O	O
methicillin	O	O
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
.	O	O

The	O	O
1,017	O	O
specimens	O	O
were	O	O
provided	O	O
from	O	O
615	O	O
patients	O	O
.	O	O

MRSA	B-bacteria	B-bacteria
was	O	O
isolated	O	O
from	O	O
37	O	O
(	O	O
6	O	O
%	O	O
)	O	O
of	O	O
patients	O	O
.	O	O

There	O	O
was	O	O
an	O	O
increasing	O	O
incidence	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
with	O	O
age	O	O
,	O	O
particularly	O	O
in	O	O
the	O	O
>	O	O
70	O	O
years	O	O
age	O	O
group	O	O
.	O	O

The	O	O
most	O	O
common	O	O
specimen	O	O
from	O	O
which	O	O
MSSA	B-bacteria	B-bacteria
was	O	O
isolated	O	O
was	O	O
an	O	O
oral	O	O
rinse	O	O
(	O	O
38	O	O
%	O	O
)	O	O
whilst	O	O
for	O	O
MRSA	B-bacteria	B-bacteria
isolates	O	O
this	O	O
was	O	O
a	O	O
tongue	O	O
swab	O	O
(	O	O
28	O	O
%	O	O
)	O	O
.	O	O

The	O	O
clinical	O	O
condition	O	O
most	O	O
commonly	O	O
reported	O	O
for	O	O
MSSA	B-bacteria	B-bacteria
isolates	O	O
was	O	O
angular	O	O
cheilitis	O	O
(	O	O
22	O	O
%	O	O
)	O	O
.	O	O

Erythema	O	O
,	O	O
swelling	O	O
,	O	O
pain	O	O
or	O	O
burning	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
was	O	O
the	O	O
clinical	O	O
condition	O	O
most	O	O
commonly	O	O
reported	O	O
for	O	O
MRSA	B-bacteria	B-bacteria
isolates	O	O
(	O	O
16	O	O
%	O	O
)	O	O
.	O	O

Patients	O	O
from	O	O
whom	O	O
the	O	O
MSSA	B-bacteria	B-bacteria
isolates	O	O
were	O	O
recovered	O	O
were	O	O
most	O	O
commonly	O	O
(	O	O
55	O	O
%	O	O
)	O	O
seen	O	O
in	O	O
the	O	O
oral	O	O
medicine	O	O
clinic	O	O
at	O	O
the	O	O
dental	O	O
hospital	O	O
,	O	O
whilst	O	O
patients	O	O
with	O	O
MRSA	B-bacteria	B-bacteria
were	O	O
more	O	O
commonly	O	O
seen	O	O
in	O	O
primary	O	O
care	O	O
settings	O	O
such	O	O
as	O	O
nursing	O	O
homes	O	O
,	O	O
hospices	O	O
and	O	O
general	O	O
dental	O	O
practice	O	O
(	O	O
51	O	O
%	O	O
)	O	O
.	O	O

In	O	O
line	O	O
with	O	O
more	O	O
recent	O	O
surveys	O	O
,	O	O
this	O	O
retrospective	O	O
study	O	O
suggests	O	O
that	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
may	O	O
be	O	O
a	O	O
more	O	O
frequent	O	O
isolate	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
than	O	O
hitherto	O	O
suspected	O	O
.	O	O

A	O	O
small	O	O
proportion	O	O
of	O	O
the	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
isolates	O	O
were	O	O
MRSA	B-bacteria	B-bacteria
.	O	O

There	O	O
were	O	O
insufficient	O	O
data	O	O
available	O	O
to	O	O
determine	O	O
whether	O	O
the	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
isolates	O	O
were	O	O
colonising	O	O
or	O	O
infecting	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

However	O	O
,	O	O
the	O	O
role	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
in	O	O
several	O	O
diseases	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
merits	O	O
further	O	O
investigation	O	O
.	O	O

Calcific	O	O
aortic	O	O
stenosis	O	O
is	O	O
a	O	O
major	O	O
public	O	O
health	O	O
problem	O	O
in	O	O
the	O	O
United	O	O
States	O	O
.	O	O

The	O	O
mechanism	O	O
of	O	O
calcification	O	O
remains	O	O
unclear	O	O
.	O	O

The	O	O
hypothesis	O	O
that	O	O
low	O	O
grade	O	O
chronic	O	O
or	O	O
recurrent	O	O
bacterial	O	O
endocarditis	O	O
with	O	O
specific	O	O
calcifiable	O	O
bacteria	O	O
is	O	O
a	O	O
cause	O	O
of	O	O
calcification	O	O
of	O	O
the	O	O
aortic	O	O
valves	O	O
was	O	O
investigated	O	O
using	O	O
an	O	O
animal	O	O
model	O	O
.	O	O

Such	O	O
bacteria	O	O
are	O	O
typically	O	O
present	O	O
as	O	O
part	O	O
of	O	O
the	O	O
normal	O	O
human	O	O
oral	O	O
flora	O	O
.	O	O

Forty	O	O
New	O	O
Zealand	O	O
white	O	O
rabbits	O	O
were	O	O
divided	O	O
into	O	O
four	O	O
groups	O	O
:	O	O
group	O	O
1	O	O
,	O	O
control	O	O
(	O	O
1	O	O
ml	O	O
of	O	O
normal	O	O
saline	O	O
)	O	O
;	O	O
group	O	O
2	O	O
,	O	O
Corynebacterium	B-bacteria	B-bacteria
matruchotti	E-bacteria	I-bacteria
100,000	O	O
colonies	O	O
;	O	O
group	O	O
3	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	I-bacteria	I-bacteria
II	I-bacteria	I-bacteria
10	E-bacteria	I-bacteria
colonies	O	O
;	O	O
and	O	O
group	O	O
4	O	O
,	O	O
C	B-bacteria	B-bacteria
matruchotti	E-bacteria	I-bacteria
100,000	O	O
colonies	O	O
plus	O	O
S	B-bacteria	B-bacteria
sanguis	I-bacteria	I-bacteria
II	I-bacteria	I-bacteria
10	E-bacteria	I-bacteria
colonies	O	O
.	O	O

Animals	O	O
were	O	O
inoculated	O	O
with	O	O
bacteria	O	O
through	O	O
a	O	O
flexible	O	O
catheter	O	O
placed	O	O
through	O	O
the	O	O
aortic	O	O
valve	O	O
through	O	O
a	O	O
right	O	O
carotid	O	O
cut	O	O
down	O	O
.	O	O

Inoculations	O	O
were	O	O
repeated	O	O
every	O	O
3	O	O
days	O	O
the	O	O
first	O	O
2	O	O
weeks	O	O
and	O	O
then	O	O
twice	O	O
a	O	O
week	O	O
thereafter	O	O
.	O	O

At	O	O
postmortem	O	O
examination	O	O
the	O	O
aortic	O	O
valves	O	O
were	O	O
harvested	O	O
,	O	O
embedded	O	O
in	O	O
paraffin	O	O
,	O	O
and	O	O
stained	O	O
with	O	O
von	O	O
Kossa	O	O
stain	O	O
.	O	O

They	O	O
were	O	O
also	O	O
examined	O	O
by	O	O
scanning	O	O
and	O	O
transmission	O	O
electron	O	O
micrography	O	O
.	O	O

Group	O	O
4	O	O
had	O	O
93.3	O	O
%	O	O
large	O	O
calcifications	O	O
(	O	O
confluent	O	O
calcium	O	O
densities	O	O
that	O	O
are	O	O
easily	O	O
recognized	O	O
with	O	O
minimal	O	O
magnification	O	O
)	O	O
and	O	O
6.6	O	O
%	O	O
small	O	O
microcalcifications	O	O
(	O	O
dustlike	O	O
microscopic	O	O
particles	O	O
requiring	O	O
a	O	O
compound	O	O
microscope	O	O
to	O	O
appreciate	O	O
)	O	O
of	O	O
the	O	O
aortic	O	O
valves	O	O
.	O	O

Group	O	O
3	O	O
exhibited	O	O
large	O	O
calcification	O	O
in	O	O
20	O	O
%	O	O
and	O	O
small	O	O
in	O	O
40	O	O
%	O	O
of	O	O
the	O	O
aortic	O	O
valves	O	O
.	O	O

Group	O	O
1	O	O
and	O	O
group	O	O
2	O	O
had	O	O
no	O	O
evidence	O	O
of	O	O
calcification	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
recurrent	O	O
low-grade	O	O
endocarditis	O	O
from	O	O
calcifying	O	O
oral	O	O
bacteria	O	O
,	O	O
particularly	O	O
when	O	O
occurring	O	O
with	O	O
synergistic	O	O
strains	O	O
,	O	O
may	O	O
be	O	O
one	O	O
cause	O	O
of	O	O
calcific	O	O
aortic	O	O
stenosis	O	O
.	O	O

Some	O	O
oral	O	O
anaerobes	B-bacteria	B-bacteria
from	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
milleri	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
group	O	O
were	O	O
found	O	O
to	O	O
secrete	O	O
human	O	O
specific	O	O
hemolytic	O	O
toxin	O	O
,	O	O
which	O	O
was	O	O
detected	O	O
when	O	O
bacteria	O	O
were	O	O
cultured	O	O
in	O	O
Todd-Hewitt	O	O
broth	O	O
and	O	O
Brain	O	O
Heart	O	O
Infusion	O	O
broth	O	O
.	O	O

The	O	O
toxin	O	O
elicited	O	O
by	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
intermedius	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
was	O	O
partially	O	O
fractionated	O	O
by	O	O
ammonium	O	O
sulfate	O	O
precipitation	O	O
.	O	O

Preincubation	O	O
with	O	O
glutathione	O	O
or	O	O
cysteine	O	O
showed	O	O
significant	O	O
inhibiting	O	O
effects	O	O
;	O	O
however	O	O
,	O	O
no	O	O
effects	O	O
were	O	O
seen	O	O
with	O	O
dithiothreitol	O	O
or	O	O
beta-mercaptoethanol	O	O
,	O	O
and	O	O
cholesterol	O	O
was	O	O
a	O	O
weak	O	O
inhibitor	O	O
.	O	O

Five	O	O
kinds	O	O
of	O	O
protease	O	O
inhibitor	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
the	O	O
hemolytic	O	O
activity	O	O
,	O	O
and	O	O
rabbit	O	O
preimmune	O	O
and	O	O
immune	O	O
sera	O	O
against	O	O
the	O	O
bacterial	O	O
cells	O	O
showed	O	O
weak	O	O
inhibition	O	O
at	O	O
a	O	O
similar	O	O
level	O	O
.	O	O

Digestion	O	O
with	O	O
trypsin	O	O
,	O	O
chymotrypsin	O	O
,	O	O
proteinase-K	O	O
,	O	O
subtilisin	O	O
and	O	O
pronase-P	O	O
brought	O	O
about	O	O
a	O	O
rise	O	O
in	O	O
activity	O	O
,	O	O
followed	O	O
by	O	O
a	O	O
decrease	O	O
during	O	O
long-term	O	O
incubation	O	O
.	O	O

Other	O	O
enzymes	O	O
tested	O	O
showed	O	O
no	O	O
effects	O	O
.	O	O

Further	O	O
,	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
intermedilysin	O	O
gene	O	O
in	O	O
the	O	O
portion	O	O
with	O	O
hemolytic	O	O
activity	O	O
was	O	O
not	O	O
identified	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

The	O	O
authors	O	O
studied	O	O
the	O	O
bacterial	O	O
flora	O	O
of	O	O
the	O	O
dog	O	O
oral	O	O
cavity	O	O
and	O	O
of	O	O
bite	O	O
wounds	O	O
,	O	O
Aerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
mouth	O	O
swabs	O	O
of	O	O
16	O	O
normal	O	O
and	O	O
5	O	O
rabid	O	O
dogs	O	O
as	O	O
well	O	O
as	O	O
from	O	O
infected	O	O
dog-bite	O	O
wounds	O	O
from	O	O
18	O	O
patients	O	O
.	O	O

A	O	O
total	O	O
of	O	O
20	O	O
different	O	O
microbial	O	O
species	O	O
were	O	O
recovered	O	O
from	O	O
mouth	O	O
swab	O	O
cultures	O	O
.	O	O

The	O	O
most	O	O
frequently	O	O
isolated	O	O
organisms	O	O
were	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	I-bacteria	I-bacteria
ssp	I-bacteria	I-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Citrobacter	B-bacteria	B-bacteria
freundii	E-bacteria	I-bacteria
,	O	O
Enterobacter	B-bacteria	B-bacteria
cloacae	E-bacteria	I-bacteria
,	O	O
Acinetobacter	B-bacteria	B-bacteria
calcoaceticus	E-bacteria	I-bacteria
,	O	O
and	O	O
Pasteurella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

There	O	O
were	O	O
no	O	O
differences	O	O
in	O	O
the	O	O
aerobic	O	O
bacterial	O	O
flora	O	O
between	O	O
rabid	O	O
and	O	O
nonrabid	O	O
dogs	O	O
.	O	O

From	O	O
the	O	O
cultures	O	O
of	O	O
the	O	O
bite	O	O
wound	O	O
swabs	O	O
,	O	O
the	O	O
authors	O	O
found	O	O
that	O	O
almost	O	O
all	O	O
of	O	O
the	O	O
organisms	O	O
identified	O	O
were	O	O
part	O	O
of	O	O
the	O	O
normal	O	O
oral	O	O
flora	O	O
of	O	O
the	O	O
dog	O	O
.	O	O

One	O	O
or	O	O
more	O	O
aerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
the	O	O
infected	O	O
dog-bite	O	O
wounds	O	O
.	O	O

Two	O	O
patients	O	O
had	O	O
four	O	O
,	O	O
3	O	O
had	O	O
three	O	O
,	O	O
4	O	O
had	O	O
two	O	O
,	O	O
and	O	O
6	O	O
had	O	O
one	O	O
of	O	O
the	O	O
nine	O	O
organisms	O	O
in	O	O
their	O	O
wounds	O	O
.	O	O

The	O	O
predominant	O	O
species	O	O
of	O	O
bacteria	O	O
involved	O	O
in	O	O
infection	O	O
of	O	O
bite	O	O
wounds	O	O
were	O	O
,	O	O
as	O	O
follows	O	O
:	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Pasteurella	B-bacteria	B-bacteria
multocida	E-bacteria	I-bacteria
,	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Moraxella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Pasteurella	B-bacteria	B-bacteria
canis	E-bacteria	I-bacteria
,	O	O
and	O	O
Enterobacter	B-bacteria	B-bacteria
cloacae	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
three	O	O
wound	O	O
cultures	O	O
had	O	O
no	O	O
aerobic	O	O
bacterial	O	O
growth	O	O
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
study	O	O
show	O	O
that	O	O
the	O	O
infected	O	O
bite	O	O
wounds	O	O
may	O	O
contain	O	O
a	O	O
mixed	O	O
bacterial	O	O
flora	O	O
that	O	O
colonize	O	O
human	O	O
skin	O	O
and	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
dogs	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
primary	O	O
colonisers	O	O
of	O	O
the	O	O
tooth	O	O
surface	O	O
and	O	O
are	O	O
abundant	O	O
in	O	O
dental	O	O
plaque	O	O
biofilms	O	O
.	O	O

Bacteria	O	O
growing	O	O
in	O	O
these	O	O
relatively	O	O
dense	O	O
,	O	O
surface-associated	O	O
communities	O	O
are	O	O
phenotypically	O	O
quite	O	O
distinct	O	O
from	O	O
their	O	O
planktonic	O	O
counterparts	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
develop	O	O
a	O	O
method	O	O
to	O	O
investigate	O	O
biofilm-specific	O	O
surface	O	O
protein	O	O
expression	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
to	O	O
help	O	O
provide	O	O
a	O	O
better	O	O
understanding	O	O
of	O	O
the	O	O
critical	O	O
events	O	O
in	O	O
plaque	O	O
development	O	O
.	O	O

Biofilm	O	O
cells	O	O
were	O	O
grown	O	O
on	O	O
the	O	O
surface	O	O
of	O	O
glass	O	O
beads	O	O
in	O	O
a	O	O
biofilm	O	O
device	O	O
fed	O	O
with	O	O
mucin-containing	O	O
artificial	O	O
saliva	O	O
.	O	O

Planktonic	O	O
cells	O	O
were	O	O
grown	O	O
in	O	O
continuous	O	O
culture	O	O
at	O	O
approximately	O	O
the	O	O
same	O	O
growth	O	O
rate	O	O
.	O	O

Surface	O	O
hydrophobicity	O	O
of	O	O
biofilm	O	O
and	O	O
planktonic	O	O
cells	O	O
was	O	O
determined	O	O
by	O	O
hexadecane	O	O
partitioning	O	O
,	O	O
and	O	O
expression	O	O
of	O	O
streptococcal	O	O
fibronectin	O	O
adhesin	O	O
CshA	O	O
was	O	O
determined	O	O
in	O	O
ELISA	O	O
using	O	O
specific	O	O
antiserum	O	O
.	O	O

Antisera	O	O
raised	O	O
to	O	O
glutaraldehyde-fixed	O	O
whole	O	O
biofilm	O	O
or	O	O
planktonic	O	O
grown	O	O
cells	O	O
were	O	O
used	O	O
to	O	O
screen	O	O
an	O	O
expression	O	O
library	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
genomic	O	O
DNA	O	O
,	O	O
and	O	O
isolated	O	O
clones	O	O
were	O	O
sequenced	O	O
.	O	O

Phenotypic	O	O
analysis	O	O
of	O	O
biofilm	O	O
and	O	O
planktonic	O	O
cells	O	O
confirmed	O	O
that	O	O
mode	O	O
of	O	O
growth	O	O
affected	O	O
surface	O	O
properties	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
.	O	O

Thus	O	O
,	O	O
hydrophobicity	O	O
and	O	O
CshA	O	O
expression	O	O
was	O	O
significantly	O	O
elevated	O	O
in	O	O
biofilm	O	O
cells	O	O
.	O	O

Library	O	O
screening	O	O
with	O	O
biofilm	O	O
antiserum	O	O
yielded	O	O
32	O	O
recombinant	O	O
clones	O	O
representing	O	O
21	O	O
different	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
proteins	O	O
involved	O	O
in	O	O
adhesion	O	O
and	O	O
colonisation	O	O
,	O	O
carbohydrate	O	O
utilisation	O	O
or	O	O
bacterial	O	O
metabolism	O	O
.	O	O

In	O	O
differential	O	O
analysis	O	O
of	O	O
four	O	O
selected	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
clones	O	O
,	O	O
biofilm	O	O
antiserum	O	O
reacted	O	O
five	O	O
times	O	O
stronger	O	O
than	O	O
planktonic	O	O
antiserum	O	O
with	O	O
cell-free	O	O
extracts	O	O
of	O	O
clones	O	O
encoding	O	O
homologues	O	O
of	O	O
CshA	O	O
and	O	O
Cna	O	O
collagen	O	O
adhesin	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
suggesting	O	O
that	O	O
these	O	O
surface	O	O
proteins	O	O
are	O	O
up-regulated	O	O
in	O	O
biofilm	O	O
cells	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
both	O	O
antisera	O	O
reacted	O	O
equally	O	O
strongly	O	O
with	O	O
cell-free	O	O
extracts	O	O
of	O	O
the	O	O
remaining	O	O
two	O	O
clones	O	O
(	O	O
encoding	O	O
dihydrofolate	O	O
synthase	O	O
and	O	O
an	O	O
unknown	O	O
protein	O	O
)	O	O
.	O	O

The	O	O
method	O	O
described	O	O
represents	O	O
a	O	O
useful	O	O
means	O	O
for	O	O
determining	O	O
bacterial	O	O
protein	O	O
expression	O	O
in	O	O
biofilms	O	O
based	O	O
on	O	O
a	O	O
combination	O	O
of	O	O
molecular	O	O
and	O	O
immunological	O	O
techniques	O	O
.	O	O

Surface	O	O
expression	O	O
of	O	O
putative	O	O
fibronectin	O	O
and	O	O
collagen	O	O
adhesins	O	O
was	O	O
up-regulated	O	O
in	O	O
biofilm	O	O
cells	O	O
.	O	O

Human	O	O
beta-defensins	O	O
2	O	O
and	O	O
3	O	O
(	O	O
HBD-2	O	O
and	O	O
HBD-3	O	O
)	O	O
are	O	O
inducible	O	O
peptides	O	O
present	O	O
at	O	O
sites	O	O
of	O	O
infection	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

A	O	O
few	O	O
studies	O	O
have	O	O
reported	O	O
broad-spectrum	O	O
antimicrobial	O	O
activity	O	O
for	O	O
both	O	O
peptides	O	O
.	O	O

However	O	O
,	O	O
no	O	O
comprehensive	O	O
study	O	O
has	O	O
thoroughly	O	O
investigated	O	O
their	O	O
potential	O	O
against	O	O
oral	O	O
pathogens	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
test	O	O
the	O	O
effectiveness	O	O
of	O	O
HBD-2	O	O
and	O	O
HBD-3	O	O
against	O	O
a	O	O
collection	O	O
of	O	O
oral	O	O
organisms	O	O
(	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Candida	O	O
tropicalis	O	O
,	O	O
Candida	O	O
parapsilosis	O	O
,	O	O
Candida	O	O
krusei	O	O
,	O	O
Candida	O	O
glabrata	O	O
,	O	O
and	O	O
Candida	O	O
albicans	O	O
)	O	O
.	O	O

Radial	O	O
diffusion	O	O
assays	O	O
were	O	O
used	O	O
to	O	O
test	O	O
HBD-2	O	O
and	O	O
HBD-3	O	O
activities	O	O
against	O	O
at	O	O
least	O	O
three	O	O
strains	O	O
of	O	O
each	O	O
species	O	O
.	O	O

There	O	O
was	O	O
significant	O	O
variability	O	O
in	O	O
MICs	O	O
,	O	O
which	O	O
was	O	O
strain	O	O
specific	O	O
rather	O	O
than	O	O
species	O	O
specific	O	O
.	O	O

MICs	O	O
ranged	O	O
from	O	O
3.9	O	O
to	O	O
>	O	O
250	O	O
micro	O	O
g/ml	O	O
for	O	O
HBD-2	O	O
and	O	O
from	O	O
1.4	O	O
to	O	O
>	O	O
250	O	O
micro	O	O
g/ml	O	O
for	O	O
HBD-3	O	O
.	O	O

HBD-3	O	O
demonstrated	O	O
greater	O	O
antimicrobial	O	O
activity	O	O
and	O	O
was	O	O
effective	O	O
against	O	O
a	O	O
broader	O	O
array	O	O
of	O	O
organisms	O	O
.	O	O

Overall	O	O
,	O	O
aerobes	O	O
were	O	O
100	O	O
%	O	O
susceptible	O	O
to	O	O
HBD-2	O	O
and	O	O
HBD-3	O	O
,	O	O
whereas	O	O
only	O	O
21.4	O	O
and	O	O
50	O	O
%	O	O
of	O	O
the	O	O
anaerobes	O	O
were	O	O
susceptible	O	O
to	O	O
HBD-2	O	O
and	O	O
HBD-3	O	O
,	O	O
respectively	O	O
.	O	O

HBD-2	O	O
and	O	O
HBD-3	O	O
also	O	O
demonstrated	O	O
strain-specific	O	O
activity	O	O
against	O	O
the	O	O
Candida	O	O
species	O	O
evaluated	O	O
.	O	O

Interestingly	O	O
,	O	O
an	O	O
association	O	O
between	O	O
HBD-2	O	O
and	O	O
HBD-3	O	O
activities	O	O
was	O	O
noted	O	O
.	O	O

This	O	O
suggests	O	O
that	O	O
the	O	O
two	O	O
peptides	O	O
may	O	O
have	O	O
similar	O	O
mechanisms	O	O
yet	O	O
utilize	O	O
distinct	O	O
pathways	O	O
.	O	O

The	O	O
lack	O	O
of	O	O
activity	O	O
against	O	O
specific	O	O
anaerobic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
and	O	O
Candida	O	O
warrants	O	O
further	O	O
investigation	O	O
of	O	O
the	O	O
potential	O	O
resistance	O	O
mechanisms	O	O
of	O	O
these	O	O
organisms	O	O
.	O	O

Finally	O	O
,	O	O
the	O	O
significant	O	O
variability	O	O
between	O	O
strains	O	O
underlies	O	O
the	O	O
importance	O	O
of	O	O
testing	O	O
multiple	O	O
strains	O	O
when	O	O
evaluating	O	O
activities	O	O
of	O	O
antimicrobial	O	O
peptides	O	O
.	O	O

To	O	O
compare	O	O
the	O	O
protective	O	O
activity	O	O
of	O	O
liver	O	O
injury	O	O
induced	O	O
by	O	O
D-galactosamine	O	O
(	O	O
GalN	O	O
)	O	O
between	O	O
Huangqin-Tang	O	O
and	O	O
their	O	O
metabolites	O	O
by	O	O
human	B-bacteria	B-bacteria
intestinal	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
HIB	B-bacteria	B-bacteria
)	O	O
.	O	O

The	O	O
liver	O	O
injuries	O	O
in	O	O
conventional	O	O
and	O	O
pseudo-germfree	O	O
mice	O	O
were	O	O
induced	O	O
by	O	O
GalN	O	O
.	O	O

After	O	O
oral	O	O
administration	O	O
of	O	O
Huangqin-Tang	O	O
and	O	O
their	O	O
metabolites	O	O
mixtures	O	O
by	O	O
HIB	O	O
,	O	O
the	O	O
serum	O	O
transaminase	O	O
(	O	O
ALT	O	O
and	O	O
AST	O	O
)	O	O
activities	O	O
were	O	O
detected	O	O
.	O	O

In	O	O
conventional	O	O
mice	O	O
,	O	O
large	O	O
and	O	O
medium	O	O
doses	O	O
(	O	O
20	O	O
and	O	O
10	O	O
g.kg-1	O	O
)	O	O
of	O	O
Huangqin-Tang	O	O
decoction	O	O
significantly	O	O
reduced	O	O
the	O	O
increase	O	O
of	O	O
serum	O	O
ALT	O	O
activity	O	O
after	O	O
18	O	O
h	O	O
GalN	O	O
treatment	O	O
.	O	O

In	O	O
pseudo-germfree	O	O
mice	O	O
,	O	O
metabolites	O	O
significantly	O	O
reduced	O	O
the	O	O
ALT	O	O
levels	O	O
.	O	O

However	O	O
,	O	O
Huangqing-Tang	O	O
did	O	O
n't	O	O
affect	O	O
the	O	O
ALT	O	O
levels	O	O
in	O	O
this	O	O
kind	O	O
of	O	O
mice	O	O
.	O	O

To	O	O
all	O	O
of	O	O
the	O	O
animals	O	O
,	O	O
AST	O	O
levels	O	O
remained	O	O
the	O	O
same	O	O
after	O	O
oral	O	O
Huangqin-tang	O	O
or	O	O
their	O	O
metabolites	O	O
.	O	O

The	O	O
metabolism	O	O
by	O	O
intestinal	O	O
bacteria	O	O
plays	O	O
a	O	O
role	O	O
in	O	O
pharmacological	O	O
effects	O	O
of	O	O
constituents	O	O
of	O	O
Chinese	O	O
herbal	O	O
medicine	O	O
.	O	O

The	O	O
metabolites	O	O
of	O	O
the	O	O
constituents	O	O
by	O	O
intestinal	O	O
bacteria	O	O
were	O	O
the	O	O
real	O	O
active	O	O
components	O	O
in	O	O
vivo	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
major	O	O
constituents	O	O
of	O	O
dental	O	O
plaque	O	O
,	O	O
and	O	O
their	O	O
prevalence	O	O
is	O	O
implicated	O	O
in	O	O
various	O	O
pathologies	O	O
.	O	O

Therefore	O	O
,	O	O
accurate	O	O
identification	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
would	O	O
be	O	O
valuable	O	O
for	O	O
studies	O	O
of	O	O
cariogenic	O	O
plaque	O	O
and	O	O
for	O	O
diagnostic	O	O
use	O	O
in	O	O
infective	O	O
endocarditis	O	O
.	O	O

Many	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
possess	O	O
glucosyltransferase	O	O
enzymes	O	O
that	O	O
synthesize	O	O
glucan	O	O
,	O	O
which	O	O
is	O	O
an	O	O
obligate	O	O
component	O	O
of	O	O
dental	O	O
plaque	O	O
.	O	O

We	O	O
established	O	O
a	O	O
rapid	O	O
and	O	O
precise	O	O
method	O	O
to	O	O
identify	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
by	O	O
PCR	O	O
using	O	O
the	O	O
species-specific	O	O
region	O	O
from	O	O
the	O	O
glucosyltransferase	O	O
gene	O	O
.	O	O

With	O	O
the	O	O
species-specific	O	O
primers	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
could	O	O
be	O	O
successfully	O	O
distinguished	O	O
.	O	O

Further	O	O
,	O	O
we	O	O
developed	O	O
a	O	O
simple	O	O
method	O	O
to	O	O
extract	O	O
the	O	O
bacterial	O	O
DNA	O	O
from	O	O
saliva	O	O
.	O	O

Using	O	O
the	O	O
resultant	O	O
DNA	O	O
as	O	O
a	O	O
template	O	O
,	O	O
the	O	O
proposed	O	O
PCR	O	O
detection	O	O
was	O	O
performed	O	O
.	O	O

Their	O	O
distribution	O	O
was	O	O
in	O	O
accord	O	O
with	O	O
results	O	O
of	O	O
conventional	O	O
biochemical	O	O
tests	O	O
.	O	O

These	O	O
findings	O	O
indicate	O	O
that	O	O
the	O	O
present	O	O
PCR	O	O
method	O	O
is	O	O
useful	O	O
for	O	O
the	O	O
analysis	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
can	O	O
be	O	O
successfully	O	O
used	O	O
in	O	O
clinical	O	O
applications	O	O
to	O	O
identify	O	O
pathogenic	O	O
bacteria	O	O
associated	O	O
with	O	O
oral	O	O
infectious	O	O
disease	O	O
and/or	O	O
endocarditis	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
is	O	O
a	O	O
gram-negative	B-bacteria	B-bacteria
anaerobe	E-bacteria	I-bacteria
ubiquitous	O	O
to	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

It	O	O
is	O	O
associated	O	O
with	O	O
periodontal	O	O
disease	O	O
.	O	O

It	O	O
is	O	O
also	O	O
associated	O	O
with	O	O
preterm	O	O
birth	O	O
and	O	O
has	O	O
been	O	O
isolated	O	O
from	O	O
the	O	O
amniotic	O	O
fluid	O	O
,	O	O
placenta	O	O
,	O	O
and	O	O
chorioamnionic	O	O
membranes	O	O
of	O	O
women	O	O
delivering	O	O
prematurely	O	O
.	O	O

Periodontal	O	O
disease	O	O
is	O	O
a	O	O
newly	O	O
recognized	O	O
risk	O	O
factor	O	O
for	O	O
preterm	O	O
birth	O	O
.	O	O

This	O	O
study	O	O
examined	O	O
the	O	O
possible	O	O
mechanism	O	O
underlying	O	O
the	O	O
link	O	O
between	O	O
these	O	O
two	O	O
diseases	O	O
.	O	O

F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
amniotic	O	O
fluids	O	O
and	O	O
placentas	O	O
along	O	O
with	O	O
those	O	O
isolated	O	O
from	O	O
orally	O	O
related	O	O
sources	O	O
invaded	O	O
both	O	O
epithelial	O	O
and	O	O
endothelial	O	O
cells	O	O
.	O	O

The	O	O
invasive	O	O
ability	O	O
may	O	O
enable	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
to	O	O
colonize	O	O
and	O	O
infect	O	O
the	O	O
pregnant	O	O
uterus	O	O
.	O	O

Transient	O	O
bacteremia	O	O
caused	O	O
by	O	O
periodontal	O	O
infection	O	O
may	O	O
facilitate	O	O
bacterial	O	O
transmission	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
to	O	O
the	O	O
uterus	O	O
.	O	O

To	O	O
test	O	O
this	O	O
hypothesis	O	O
,	O	O
we	O	O
intravenously	O	O
injected	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
into	O	O
pregnant	O	O
CF-1	O	O
mice	O	O
.	O	O

The	O	O
injection	O	O
resulted	O	O
in	O	O
premature	O	O
delivery	O	O
,	O	O
stillbirths	O	O
,	O	O
and	O	O
nonsustained	O	O
live	O	O
births	O	O
.	O	O

The	O	O
bacterial	O	O
infection	O	O
was	O	O
restricted	O	O
inside	O	O
the	O	O
uterus	O	O
,	O	O
without	O	O
spreading	O	O
systemically	O	O
.	O	O

F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
first	O	O
detected	O	O
in	O	O
the	O	O
blood	O	O
vessels	O	O
in	O	O
murine	O	O
placentas	O	O
.	O	O

Invasion	O	O
of	O	O
the	O	O
endothelial	O	O
cells	O	O
lining	O	O
the	O	O
blood	O	O
vessels	O	O
was	O	O
observed	O	O
.	O	O

The	O	O
bacteria	O	O
then	O	O
crossed	O	O
the	O	O
endothelium	O	O
,	O	O
proliferated	O	O
in	O	O
surrounding	O	O
tissues	O	O
,	O	O
and	O	O
finally	O	O
spread	O	O
to	O	O
the	O	O
amniotic	O	O
fluid	O	O
.	O	O

The	O	O
pattern	O	O
of	O	O
infection	O	O
paralleled	O	O
that	O	O
in	O	O
humans	O	O
.	O	O

This	O	O
study	O	O
represents	O	O
the	O	O
first	O	O
evidence	O	O
that	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
may	O	O
be	O	O
transmitted	O	O
hematogenously	O	O
to	O	O
the	O	O
placenta	O	O
and	O	O
cause	O	O
adverse	O	O
pregnancy	O	O
outcomes	O	O
.	O	O

The	O	O
results	O	O
strengthen	O	O
the	O	O
link	O	O
between	O	O
periodontal	O	O
disease	O	O
and	O	O
preterm	O	O
birth	O	O
.	O	O

Our	O	O
study	O	O
also	O	O
indicates	O	O
that	O	O
invasion	O	O
may	O	O
be	O	O
an	O	O
important	O	O
virulence	O	O
mechanism	O	O
for	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
to	O	O
infect	O	O
the	O	O
placenta	O	O
.	O	O

We	O	O
examined	O	O
the	O	O
antimicrobial	O	O
effects	O	O
of	O	O
human	O	O
beta-defensin-2	O	O
(	O	O
hBD-2	O	O
)	O	O
on	O	O
17	O	O
species	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
to	O	O
investigate	O	O
the	O	O
involvement	O	O
of	O	O
antimicrobial	O	O
peptide	O	O
activity	O	O
in	O	O
oral	O	O
microflora	O	O
development	O	O
and	O	O
the	O	O
clinical	O	O
use	O	O
of	O	O
the	O	O
antimicrobial	O	O
peptide	O	O
for	O	O
oral	O	O
microflora	O	O
control	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
exhibit	O	O
diverse	O	O
levels	O	O
of	O	O
susceptibility	O	O
to	O	O
human	O	O
beta-defensin-2	O	O
(	O	O
hBD-2	O	O
)	O	O
.	O	O

Two	O	O
major	O	O
cariogenic	O	O
bacterial	O	O
species	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
)	O	O
and	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
were	O	O
found	O	O
to	O	O
be	O	O
susceptible	O	O
to	O	O
the	O	O
peptide	O	O
,	O	O
indicating	O	O
that	O	O
it	O	O
is	O	O
a	O	O
potential	O	O
therapeutic	O	O
agent	O	O
for	O	O
preventing	O	O
dental	O	O
caries	O	O
.	O	O

S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
exhibited	O	O
the	O	O
lowest	O	O
susceptibility	O	O
to	O	O
the	O	O
peptide	O	O
.	O	O

S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
is	O	O
a	O	O
major	O	O
indigenous	O	O
bacterium	O	O
in	O	O
the	O	O
oral	O	O
microflora	O	O
,	O	O
and	O	O
our	O	O
results	O	O
suggest	O	O
that	O	O
it	O	O
might	O	O
possess	O	O
a	O	O
certain	O	O
resistance	O	O
mechanism	O	O
against	O	O
hBD-2	O	O
.	O	O

To	O	O
study	O	O
dynamic	O	O
relation	O	O
between	O	O
periodontal	O	O
pathogens	O	O
and	O	O
cariogenic	O	O
bacteria	O	O
under	O	O
analogous	O	O
oral	O	O
environment	O	O
.	O	O

Eight	O	O
periodontopathic	O	O
and	O	O
cariogenic	O	O
bacteria	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
Pg	B-bacteria	B-bacteria
)	O	O
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
Aa	B-bacteria	B-bacteria
)	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
Fn	B-bacteria	B-bacteria
)	O	O
,	O	O
Provotella	B-bacteria	B-bacteria
intermedium	E-bacteria	I-bacteria
(	O	O
Pi	B-bacteria	B-bacteria
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
Sm	B-bacteria	B-bacteria
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
(	O	O
Ss	B-bacteria	B-bacteria
)	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
(	O	O
Av	B-bacteria	B-bacteria
)	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
(	O	O
La	B-bacteria	B-bacteria
)	O	O
were	O	O
used	O	O
.	O	O

These	O	O
eight	O	O
strains	O	O
were	O	O
cultured	O	O
in	O	O
modified	O	O
chemostat	O	O
under	O	O
analogous	O	O
oral	O	O
environment	O	O
which	O	O
contained	O	O
600	O	O
ml	O	O
modified	O	O
BM	O	O
medium	O	O
supplemented	O	O
with	O	O
2.5	O	O
g/L	O	O
porcine	O	O
gastric	O	O
mucin	O	O
,	O	O
respectively	O	O
.	O	O

After	O	O
1	O	O
,	O	O
24	O	O
,	O	O
48	O	O
and	O	O
96	O	O
h	O	O
,	O	O
optical	O	O
sectioning	O	O
of	O	O
plaque	O	O
biofilms	O	O
on	O	O
removable	O	O
and	O	O
replaceable	O	O
hydroxyapatite	O	O
disks	O	O
was	O	O
analyzed	O	O
by	O	O
the	O	O
combination	O	O
of	O	O
live	O	O
bacterial	O	O
Gram	O	O
fluorescence	O	O
staining	O	O
and	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
.	O	O

Biofilm	O	O
thickness	O	O
and	O	O
reconstruction	O	O
of	O	O
the	O	O
three-dimensional	O	O
architecture	O	O
of	O	O
plaque	O	O
biofilms	O	O
were	O	O
made	O	O
.	O	O

Biofilm	O	O
thickness	O	O
increased	O	O
significantly	O	O
with	O	O
time	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Biofilms	O	O
of	O	O
Aa	B-bacteria	B-bacteria
were	O	O
thinner	O	O
than	O	O
those	O	O
of	O	O
Ss	B-bacteria	B-bacteria
and	O	O
eight-specie	O	O
biofilms	O	O
were	O	O
thicker	O	O
than	O	O
those	O	O
formed	O	O
by	O	O
Ss	B-bacteria	B-bacteria
and	O	O
Aa	B-bacteria	B-bacteria
per	O	O
time	O	O
point	O	O
.	O	O

Three-dimensional	O	O
images	O	O
showed	O	O
periodontal	O	O
pathogens	O	O
mainly	O	O
occurred	O	O
in	O	O
cariogenic	O	O
bacterial	O	O
complex	O	O
or	O	O
on	O	O
the	O	O
biofilm	O	O
surface	O	O
.	O	O

Gram-positive	O	O
cariogenic	O	O
species	O	O
initially	O	O
predominated	O	O
in	O	O
artificial	O	O
plaque	O	O
,	O	O
followed	O	O
by	O	O
the	O	O
increasing	O	O
proportions	O	O
of	O	O
Gram-negative	O	O
periodontal	O	O
pathogens	O	O
.	O	O

The	O	O
relation	O	O
between	O	O
microecological	O	O
balance	O	O
among	O	O
bacteria	O	O
and	O	O
diseases	O	O
is	O	O
worthy	O	O
of	O	O
further	O	O
studies	O	O
.	O	O

It	O	O
is	O	O
difficult	O	O
to	O	O
permanently	O	O
change	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
complex	O	O
intestinal	O	O
microflora	O	O
of	O	O
the	O	O
adult	O	O
.	O	O

Orally	O	O
administered	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
produce	O	O
only	O	O
temporary	O	O
colonization	O	O
of	O	O
the	O	O
intestine	O	O
in	O	O
patients	O	O
with	O	O
a	O	O
fully	O	O
developed	O	O
gut	O	O
microflora	O	O
.	O	O

The	O	O
gastrointestinal	O	O
tract	O	O
of	O	O
a	O	O
healthy	O	O
fetus	O	O
is	O	O
sterile	O	O
.	O	O

During	O	O
the	O	O
birth	O	O
process	O	O
and	O	O
rapidly	O	O
thereafter	O	O
,	O	O
microbes	O	O
from	O	O
the	O	O
mother	O	O
and	O	O
the	O	O
surrounding	O	O
environment	O	O
colonize	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
until	O	O
a	O	O
dense	O	O
,	O	O
complex	O	O
microflora	O	O
develops	O	O
.	O	O

Probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
have	O	O
been	O	O
shown	O	O
to	O	O
beneficially	O	O
influence	O	O
the	O	O
intestinal	O	O
and	O	O
systemic	O	O
immune	O	O
system	O	O
and	O	O
mediate	O	O
protection	O	O
against	O	O
nosocomial	O	O
infections	O	O
affecting	O	O
the	O	O
neonate	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
whether	O	O
oral	O	O
administration	O	O
of	O	O
the	O	O
probiotic	O	O
micro-organism	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
GG	E-bacteria	I-bacteria
(	O	O
L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
)	O	O
to	O	O
the	O	O
pregnant	O	O
woman	O	O
leads	O	O
to	O	O
colonization	O	O
of	O	O
the	O	O
newborn	O	O
infant	O	O
.	O	O

The	O	O
authors	O	O
identified	O	O
six	O	O
women	O	O
who	O	O
were	O	O
taking	O	O
L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
during	O	O
late	O	O
pregnancy	O	O
.	O	O

None	O	O
of	O	O
the	O	O
children	O	O
received	O	O
L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
after	O	O
birth	O	O
,	O	O
and	O	O
their	O	O
mothers	O	O
discontinued	O	O
its	O	O
consumption	O	O
at	O	O
the	O	O
time	O	O
of	O	O
delivery	O	O
.	O	O

L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
concentration	O	O
in	O	O
fecal	O	O
samples	O	O
was	O	O
determined	O	O
by	O	O
colony	O	O
morphology	O	O
and	O	O
molecular	O	O
analysis	O	O
.	O	O

In	O	O
all	O	O
four	O	O
children	O	O
delivered	O	O
vaginally	O	O
and	O	O
in	O	O
one	O	O
of	O	O
two	O	O
children	O	O
delivered	O	O
by	O	O
cesarean	O	O
section	O	O
,	O	O
L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
was	O	O
present	O	O
in	O	O
fecal	O	O
samples	O	O
at	O	O
1	O	O
and	O	O
6	O	O
months	O	O
of	O	O
age	O	O
.	O	O

Three	O	O
children	O	O
remained	O	O
colonized	O	O
for	O	O
at	O	O
least	O	O
12	O	O
months	O	O
,	O	O
and	O	O
in	O	O
two	O	O
children	O	O
L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
fecal	O	O
samples	O	O
at	O	O
24	O	O
months	O	O
of	O	O
age	O	O
.	O	O

Three	O	O
mothers	O	O
were	O	O
tested	O	O
1	O	O
month	O	O
post	O	O
partum	O	O
and	O	O
no	O	O
L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
was	O	O
present	O	O
in	O	O
fecal	O	O
samples	O	O
.	O	O

No	O	O
L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
was	O	O
found	O	O
in	O	O
one	O	O
of	O	O
these	O	O
women	O	O
24	O	O
months	O	O
post	O	O
partum	O	O
.	O	O

There	O	O
was	O	O
no	O	O
L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
detectable	O	O
in	O	O
stools	O	O
of	O	O
the	O	O
siblings	O	O
of	O	O
two	O	O
children	O	O
at	O	O
the	O	O
2-year	O	O
and	O	O
3-years	O	O
after	O	O
birth	O	O
of	O	O
the	O	O
index	O	O
child	O	O
.	O	O

L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
was	O	O
not	O	O
isolated	O	O
from	O	O
the	O	O
stools	O	O
of	O	O
children	O	O
whose	O	O
mothers	O	O
were	O	O
not	O	O
taking	O	O
L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
.	O	O

Temporary	O	O
colonization	O	O
of	O	O
an	O	O
infant	O	O
with	O	O
L.	B-bacteria	B-bacteria
GG	E-bacteria	I-bacteria
may	O	O
be	O	O
possible	O	O
by	O	O
colonizing	O	O
the	O	O
pregnant	O	O
mother	O	O
before	O	O
delivery	O	O
.	O	O

Colonization	O	O
is	O	O
stable	O	O
for	O	O
as	O	O
long	O	O
as	O	O
6	O	O
months	O	O
,	O	O
and	O	O
in	O	O
unexplained	O	O
circumstances	O	O
may	O	O
persist	O	O
for	O	O
as	O	O
long	O	O
as	O	O
24	O	O
months	O	O
.	O	O

Peculiarities	O	O
of	O	O
quantitative	O	O
and	O	O
qualitative	O	O
composition	O	O
of	O	O
microbiocenosis	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
healthy	O	O
children	O	O
and	O	O
children	O	O
with	O	O
chronic	O	O
aphthous	O	O
recurrent	O	O
stomatitis	O	O
have	O	O
been	O	O
studied	O	O
.	O	O

Strains	O	O
of	O	O
microorganisms	O	O
(	O	O
n	O	O
=	O	O
259	O	O
)	O	O
have	O	O
been	O	O
isolated	O	O
and	O	O
identified	O	O
.	O	O

The	O	O
results	O	O
obtained	O	O
showed	O	O
that	O	O
the	O	O
studied	O	O
biotope	O	O
is	O	O
characterised	O	O
by	O	O
a	O	O
wide	O	O
spectrum	O	O
of	O	O
isolated	O	O
microflora	O	O
.	O	O

The	O	O
growth	O	O
of	O	O
microorganism	O	O
association	O	O
is	O	O
observed	O	O
in	O	O
all	O	O
the	O	O
studied	O	O
samples	O	O
.	O	O

The	O	O
analysis	O	O
of	O	O
genus	O	O
and	O	O
species	O	O
composition	O	O
of	O	O
microbiocenosis	O	O
of	O	O
the	O	O
mucous	O	O
membrane	O	O
indicated	O	O
that	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
neiserii	B-bacteria	B-bacteria
,	O	O
corynebacteria	B-bacteria	B-bacteria
,	O	O
enterococci	B-bacteria	B-bacteria
,	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
epidermal	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
and	O	O
candidas	O	O
were	O	O
distinguished	O	O
as	O	O
to	O	O
isolation	O	O
frequency	O	O
among	O	O
the	O	O
isolated	O	O
strains	O	O
.	O	O

These	O	O
bacteria	O	O
were	O	O
isolated	O	O
from	O	O
oral	O	O
cavity	O	O
of	O	O
healthy	O	O
and	O	O
sick	O	O
children	O	O
,	O	O
but	O	O
their	O	O
quantity	O	O
in	O	O
1	O	O
mm2	O	O
of	O	O
sick	O	O
children	O	O
mucosa	O	O
prevailed	O	O
,	O	O
except	O	O
for	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

their	O	O
quantity	O	O
was	O	O
far	O	O
less	O	O
.	O	O

Golden	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
,	O	O
escherichia	B-bacteria	B-bacteria
,	O	O
klebsiella	B-bacteria	B-bacteria
,	O	O
clostridia	B-bacteria	B-bacteria
,	O	O
hemophilic	B-bacteria	B-bacteria
rods	E-bacteria	I-bacteria
and	O	O
campylobacteria	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
sick	O	O
children	O	O
only	O	O
.	O	O

Microflora	O	O
of	O	O
oral	O	O
cavity	O	O
of	O	O
people	O	O
of	O	O
45-65	O	O
years	O	O
with	O	O
removable	O	O
denture	O	O
and	O	O
children	O	O
with	O	O
acute	O	O
herpetic	O	O
stomatitis	O	O
,	O	O
its	O	O
dependence	O	O
upon	O	O
the	O	O
degree	O	O
of	O	O
local	O	O
immunity	O	O
,	O	O
presence	O	O
and	O	O
severity	O	O
of	O	O
inflammatory	O	O
process	O	O
have	O	O
been	O	O
studied	O	O
.	O	O

Percentage	O	O
of	O	O
leucocyte	O	O
subpopulations	O	O
activity	O	O
of	O	O
bactericide	O	O
enzymes	O	O
of	O	O
granulocytes	O	O
,	O	O
average	O	O
anticolonization	O	O
ratio	O	O
,	O	O
correlation	O	O
of	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
degree	O	O
of	O	O
colonization	O	O
with	O	O
Candida	O	O
fungi	O	O
have	O	O
been	O	O
determined	O	O
is	O	O
smear-simprints	O	O
of	O	O
mucous	O	O
membrane	O	O
.	O	O

The	O	O
intensity	O	O
of	O	O
growth	O	O
of	O	O
optional	O	O
anaerobic	O	O
microorganisms	O	O
has	O	O
been	O	O
investigated	O	O
in	O	O
bacteriological	O	O
studies	O	O
of	O	O
material	O	O
taken	O	O
from	O	O
mucous	O	O
membrane	O	O
.	O	O

Their	O	O
identification	O	O
has	O	O
been	O	O
performed	O	O
using	O	O
morphological-cultural	O	O
and	O	O
biochemical	O	O
indices	O	O
.	O	O

Significant	O	O
changes	O	O
in	O	O
microbiocenosis	O	O
of	O	O
oral	O	O
cavity	O	O
such	O	O
as	O	O
disappearance	O	O
of	O	O
autochthonous	O	O
microflora	O	O
,	O	O
appearance	O	O
and	O	O
intensive	O	O
growth	O	O
of	O	O
pathogenic	O	O
and	O	O
opportunistic	O	O
microorganisms	O	O
are	O	O
to	O	O
be	O	O
observed	O	O
in	O	O
conditions	O	O
of	O	O
decrease	O	O
of	O	O
non-specific	O	O
resistance	O	O
and	O	O
presence	O	O
of	O	O
inflammatory	O	O
process	O	O
in	O	O
persons	O	O
with	O	O
removable	O	O
denture	O	O
and	O	O
acute	O	O
herpetic	O	O
stomatitis	O	O
.	O	O

Cranberry	O	O
juice	O	O
is	O	O
known	O	O
to	O	O
inhibit	O	O
bacterial	O	O
adhesion	O	O
.	O	O

We	O	O
examined	O	O
the	O	O
inhibitory	O	O
effect	O	O
of	O	O
cranberry	O	O
juice	O	O
on	O	O
the	O	O
adhesion	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
labeled	O	O
with	O	O
[	O	O
3H	O	O
]	O	O
-thymidine	O	O
to	O	O
saliva-coated	O	O
hydroxyapatite	O	O
beads	O	O
(	O	O
s-HA	O	O
)	O	O
.	O	O

When	O	O
the	O	O
bacterial	O	O
cells	O	O
were	O	O
momentarily	O	O
exposed	O	O
to	O	O
cranberry	O	O
juice	O	O
,	O	O
their	O	O
adherence	O	O
to	O	O
s-HA	O	O
decreased	O	O
significantly	O	O
compared	O	O
with	O	O
the	O	O
control	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Their	O	O
hydrophobicity	O	O
also	O	O
decreased	O	O
dependently	O	O
with	O	O
the	O	O
concentration	O	O
of	O	O
cranberry	O	O
juice	O	O
.	O	O

We	O	O
also	O	O
evaluated	O	O
the	O	O
inhibitory	O	O
effect	O	O
of	O	O
cranberry	O	O
juice	O	O
on	O	O
biofilm	O	O
formation	O	O
.	O	O

By	O	O
using	O	O
a	O	O
microplate	O	O
system	O	O
,	O	O
we	O	O
found	O	O
that	O	O
the	O	O
high	O	O
molecular	O	O
mass	O	O
constituents	O	O
of	O	O
cranberry	O	O
juice	O	O
inhibited	O	O
the	O	O
biofilm	O	O
formation	O	O
of	O	O
the	O	O
tested	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

The	O	O
inhibitory	O	O
activity	O	O
was	O	O
related	O	O
to	O	O
the	O	O
reduction	O	O
of	O	O
the	O	O
hydrophobicity	O	O
.	O	O

The	O	O
present	O	O
findings	O	O
suggest	O	O
that	O	O
cranberry	O	O
juice	O	O
component	O	O
(	O	O
s	O	O
)	O	O
can	O	O
inhibit	O	O
colonization	O	O
by	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
to	O	O
the	O	O
tooth	O	O
surface	O	O
and	O	O
can	O	O
thus	O	O
slow	O	O
development	O	O
of	O	O
dental	O	O
plaque	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
effect	O	O
of	O	O
triclosan	O	O
exposure	O	O
on	O	O
the	O	O
antimicrobial	O	O
susceptibilities	O	O
of	O	O
numerically	O	O
important	O	O
dental	O	O
bacteria	O	O
.	O	O

A	O	O
gradient	O	O
plate	O	O
technique	O	O
was	O	O
used	O	O
to	O	O
expose	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
subflava	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Veillonella	B-bacteria	B-bacteria
dispar	E-bacteria	I-bacteria
repeatedly	O	O
to	O	O
escalating	O	O
,	O	O
sublethal	O	O
concentrations	O	O
of	O	O
triclosan	O	O
.	O	O

Escherichia	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
8739	E-bacteria	I-bacteria
was	O	O
included	O	O
as	O	O
an	O	O
organism	O	O
showing	O	O
the	O	O
triclosan	O	O
resistance	O	O
development	O	O
trait	O	O
.	O	O

MIC	O	O
values	O	O
towards	O	O
chlorhexidine	O	O
,	O	O
metronidazole	O	O
and	O	O
tetracycline	O	O
were	O	O
determined	O	O
before	O	O
and	O	O
after	O	O
biocide	O	O
exposure	O	O
.	O	O

N.	B-bacteria	B-bacteria
subflava	E-bacteria	I-bacteria
,	O	O
Pr	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
nigrescens	E-bacteria	I-bacteria
Po	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
gingivalis	B-bacteria	B-bacteria
and	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
were	O	O
highly	O	O
susceptible	O	O
to	O	O
triclosan	O	O
(	O	O
MIC	O	O
range	O	O
0.1-3.9	O	O
mg/L	O	O
)	O	O
,	O	O
whereas	O	O
the	O	O
lactobacillus	B-bacteria	B-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
less	O	O
susceptible	O	O
(	O	O
MIC	O	O
range	O	O
15.6-20.8	O	O
mg/L	O	O
)	O	O
.	O	O

Triclosan	O	O
exposure	O	O
resulted	O	O
in	O	O
a	O	O
highly	O	O
significant	O	O
(	O	O
approximately	O	O
400-fold	O	O
)	O	O
reduction	O	O
in	O	O
triclosan	O	O
susceptibility	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
for	O	O
the	O	O
positive	O	O
control	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
although	O	O
its	O	O
MICs	O	O
towards	O	O
chlorhexidine	O	O
,	O	O
metronidazole	O	O
and	O	O
tetracycline	O	O
were	O	O
not	O	O
significantly	O	O
altered	O	O
.	O	O

Minor	O	O
(	O	O
approximately	O	O
two-fold	O	O
)	O	O
decreases	O	O
in	O	O
triclosan	O	O
susceptibility	O	O
(	O	O
MIC	O	O
)	O	O
occurred	O	O
for	O	O
Pr	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
nigrescens	E-bacteria	I-bacteria
and	O	O
in	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
(	O	O
MBC	O	O
)	O	O
.	O	O

Mean	O	O
changes	O	O
in	O	O
susceptibilities	O	O
(	O	O
MIC	O	O
and	O	O
MBC	O	O
)	O	O
of	O	O
the	O	O
oral	O	O
species	O	O
to	O	O
chlorhexidine	O	O
,	O	O
metronidazole	O	O
and	O	O
tetracycline	O	O
did	O	O
not	O	O
exceed	O	O
two-fold	O	O
,	O	O
although	O	O
chlorhexidine	O	O
MBCs	O	O
for	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
were	O	O
markedly	O	O
,	O	O
but	O	O
transiently	O	O
,	O	O
increased	O	O
.	O	O

These	O	O
data	O	O
fail	O	O
to	O	O
demonstrate	O	O
biologically	O	O
significant	O	O
drug	O	O
resistance	O	O
in	O	O
triclosan-exposed	O	O
bacteria	O	O
and	O	O
suggest	O	O
that	O	O
markedly	O	O
decreased	O	O
triclosan	O	O
susceptibility	O	O
,	O	O
although	O	O
confirmed	O	O
for	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
is	O	O
not	O	O
a	O	O
universal	O	O
phenomenon	O	O
.	O	O

Other	O	O
bacteria	O	O
possibly	O	O
possess	O	O
more	O	O
susceptible	O	O
targets	O	O
than	O	O
FabI	O	O
that	O	O
are	O	O
highly	O	O
conserved	O	O
,	O	O
which	O	O
may	O	O
govern	O	O
triclosan	O	O
activity	O	O
.	O	O

Previously	O	O
,	O	O
we	O	O
screened	O	O
149	O	O
subjects	O	O
and	O	O
established	O	O
four	O	O
groups	O	O
high	O	O
or	O	O
low	O	O
for	O	O
salivary	O	O
killing	O	O
of	O	O
oral	O	O
bacteria	O	O
,	O	O
and	O	O
for	O	O
aggregation	O	O
and	O	O
live	O	O
and	O	O
dead	O	O
adherence	O	O
of	O	O
oral	O	O
bacteria	O	O
(	O	O
as	O	O
a	O	O
combined	O	O
factor	O	O
)	O	O
.	O	O

Caries	O	O
scores	O	O
were	O	O
significantly	O	O
lower	O	O
in	O	O
both	O	O
High	O	O
Aggregation-Adherence	O	O
groups	O	O
.	O	O

Subsequently	O	O
,	O	O
we	O	O
found	O	O
that	O	O
supragingival	O	O
total	O	O
biofilm	O	O
DNA	O	O
,	O	O
total	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
two	O	O
major	O	O
streptococcal	O	O
rRNA	O	O
variants	O	O
also	O	O
were	O	O
significantly	O	O
lower	O	O
in	O	O
the	O	O
High	O	O
Aggregation-Adherence	O	O
groups	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
looked	O	O
at	O	O
the	O	O
effects	O	O
of	O	O
those	O	O
differences	O	O
in	O	O
salivary	O	O
function	O	O
on	O	O
three	O	O
periodontal	O	O
pathogens	O	O
.	O	O

Quantitative	O	O
PCR	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
levels	O	O
of	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
(	O	O
formerly	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
)	O	O
in	O	O
stored	O	O
DNA	O	O
extracts	O	O
of	O	O
overnight	O	O
supragingival	O	O
biofilm	O	O
collected	O	O
from	O	O
buccal	O	O
upper	O	O
central	O	O
incisors	O	O
(	O	O
UC	O	O
)	O	O
,	O	O
lingual	O	O
lower	O	O
central	O	O
incisors	O	O
(	O	O
LC	O	O
)	O	O
and	O	O
buccal	O	O
upper	O	O
and	O	O
lower	O	O
first	O	O
molars	O	O
(	O	O
BM	O	O
)	O	O
and	O	O
lingual	O	O
upper	O	O
and	O	O
lower	O	O
first	O	O
molars	O	O
(	O	O
LM	O	O
)	O	O
of	O	O
subjects	O	O
in	O	O
the	O	O
four	O	O
groups	O	O
.	O	O

A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
almost	O	O
completely	O	O
absent	O	O
from	O	O
these	O	O
samples	O	O
.	O	O

T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
was	O	O
found	O	O
in	O	O
11	O	O
of	O	O
35	O	O
persons	O	O
at	O	O
the	O	O
buccal	O	O
molar	O	O
site	O	O
.	O	O

Only	O	O
two	O	O
of	O	O
those	O	O
subjects	O	O
were	O	O
in	O	O
the	O	O
High	O	O
Aggregation-Adherence	O	O
groups	O	O
,	O	O
and	O	O
that	O	O
difference	O	O
was	O	O
statistically	O	O
significant	O	O
.	O	O

The	O	O
mean	O	O
quantity	O	O
of	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
also	O	O
was	O	O
significantly	O	O
lower	O	O
in	O	O
the	O	O
High	O	O
Aggregation-Adherence	O	O
groups	O	O
.	O	O

The	O	O
difference	O	O
between	O	O
the	O	O
Low	O	O
and	O	O
High	O	O
Aggregation-Adherence	O	O
groups	O	O
might	O	O
reflect	O	O
direct	O	O
interactions	O	O
of	O	O
salivary	O	O
proteins	O	O
with	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
.	O	O

Alternatively	O	O
,	O	O
the	O	O
higher	O	O
levels	O	O
of	O	O
total	O	O
biofilm	O	O
and	O	O
total	O	O
streptococci	B-bacteria	B-bacteria
seen	O	O
in	O	O
the	O	O
Low	O	O
Aggregation-Adherence	O	O
groups	O	O
might	O	O
create	O	O
a	O	O
favourable	O	O
environment	O	O
for	O	O
early	O	O
secondary	O	O
colonization	O	O
of	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
.	O	O

The	O	O
incidence	O	O
of	O	O
oral	O	O
candidosis	O	O
has	O	O
increased	O	O
in	O	O
recent	O	O
years	O	O
,	O	O
largely	O	O
as	O	O
a	O	O
result	O	O
of	O	O
the	O	O
emergence	O	O
of	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
infection	O	O
and	O	O
the	O	O
more	O	O
widespread	O	O
use	O	O
of	O	O
immunosuppressive	O	O
chemotherapy	O	O
.	O	O

This	O	O
development	O	O
has	O	O
been	O	O
associated	O	O
with	O	O
a	O	O
need	O	O
for	O	O
more	O	O
reliable	O	O
methods	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
Candida	B-bacteria	B-bacteria
.	O	O

The	O	O
present	O	O
study	O	O
assessed	O	O
the	O	O
performance	O	O
of	O	O
a	O	O
real-time	O	O
PCR	O	O
and	O	O
two	O	O
block-based	O	O
PCRs	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
Candida	B-bacteria	B-bacteria
in	O	O
193	O	O
concentrated	O	O
oral	O	O
rinse	O	O
culture	O	O
(	O	O
CRC	O	O
)	O	O
specimens	O	O
.	O	O

A	O	O
total	O	O
of	O	O
102	O	O
CRC	O	O
specimens	O	O
were	O	O
positive	O	O
by	O	O
culture	O	O
for	O	O
Candida	B-bacteria	B-bacteria
;	O	O
and	O	O
96	O	O
,	O	O
90	O	O
,	O	O
and	O	O
75	O	O
of	O	O
these	O	O
were	O	O
also	O	O
positive	O	O
by	O	O
real-time	O	O
,	O	O
N18-specific	O	O
,	O	O
and	O	O
internal	O	O
transcribed	O	O
spacer	O	O
(	O	O
ITS	O	O
)	O	O
-specific	O	O
PCRs	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
five	O	O
false-negative	O	O
results	O	O
by	O	O
the	O	O
real-time	O	O
PCR	O	O
were	O	O
all	O	O
non-Candida	O	O
albicans	O	O
positive	O	O
by	O	O
culture	O	O
.	O	O

Of	O	O
the	O	O
91	O	O
culture-negative	O	O
CRC	O	O
specimens	O	O
,	O	O
20	O	O
,	O	O
41	O	O
,	O	O
and	O	O
44	O	O
were	O	O
positive	O	O
by	O	O
the	O	O
real-time	O	O
PCR	O	O
and	O	O
the	O	O
N18-	O	O
and	O	O
ITS-specific	O	O
PCRs	O	O
,	O	O
respectively	O	O
.	O	O

All	O	O
three	O	O
PCRs	O	O
detected	O	O
fungal	O	O
DNA	O	O
in	O	O
8	O	O
culture-negative	O	O
CRC	O	O
specimens	O	O
,	O	O
with	O	O
a	O	O
further	O	O
30	O	O
being	O	O
positive	O	O
by	O	O
two	O	O
of	O	O
the	O	O
three	O	O
PCRs	O	O
.	O	O

A	O	O
total	O	O
of	O	O
32	O	O
CRC	O	O
specimens	O	O
were	O	O
Candida	B-bacteria	B-bacteria
free	O	O
by	O	O
all	O	O
methods	O	O
.	O	O

In	O	O
summary	O	O
,	O	O
a	O	O
real-time	O	O
PCR	O	O
that	O	O
provides	O	O
a	O	O
sensitive	O	O
,	O	O
specific	O	O
,	O	O
and	O	O
rapid	O	O
alternative	O	O
technique	O	O
for	O	O
detection	O	O
of	O	O
Candida	O	O
in	O	O
the	O	O
mouth	O	O
is	O	O
described	O	O
.	O	O

The	O	O
mouths	O	O
of	O	O
three	O	O
human	O	O
infants	O	O
were	O	O
examined	O	O
from	O	O
birth	O	O
to	O	O
age	O	O
2	O	O
years	O	O
to	O	O
detect	O	O
colonization	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
genospecies	I-bacteria	I-bacteria
1	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
2	E-bacteria	I-bacteria
.	O	O

These	O	O
bacteria	O	O
did	O	O
not	O	O
colonize	O	O
until	O	O
after	O	O
tooth	O	O
eruption	O	O
.	O	O

The	O	O
diversity	O	O
of	O	O
posteruption	O	O
isolates	O	O
was	O	O
determined	O	O
by	O	O
ribotyping	O	O
.	O	O

Using	O	O
immunoblotting	O	O
and	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
,	O	O
we	O	O
determined	O	O
the	O	O
reactivity	O	O
of	O	O
secretory	O	O
immunoglobulin	O	O
A	O	O
(	O	O
SIgA	O	O
)	O	O
antibodies	O	O
in	O	O
saliva	O	O
samples	O	O
collected	O	O
from	O	O
each	O	O
infant	O	O
before	O	O
and	O	O
after	O	O
colonization	O	O
against	O	O
cell	O	O
wall	O	O
proteins	O	O
from	O	O
their	O	O
own	O	O
A.	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
and	O	O
carbohydrates	O	O
from	O	O
standard	O	O
A.	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
genospecies	I-bacteria	I-bacteria
1	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
2	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

A.	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
genospecies	I-bacteria	I-bacteria
1	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
2	E-bacteria	I-bacteria
carbohydrate-reactive	O	O
SIgA	O	O
antibodies	O	O
were	O	O
not	O	O
detected	O	O
in	O	O
any	O	O
saliva	O	O
sample	O	O
.	O	O

However	O	O
,	O	O
SIgA	O	O
antibodies	O	O
reactive	O	O
with	O	O
cell	O	O
wall	O	O
proteins	O	O
were	O	O
present	O	O
in	O	O
saliva	O	O
before	O	O
these	O	O
bacteria	O	O
colonized	O	O
the	O	O
mouth	O	O
.	O	O

These	O	O
antibodies	O	O
could	O	O
be	O	O
almost	O	O
completely	O	O
removed	O	O
by	O	O
absorption	O	O
with	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
,	O	O
a	O	O
species	O	O
known	O	O
to	O	O
colonize	O	O
the	O	O
human	O	O
mouth	O	O
shortly	O	O
after	O	O
birth	O	O
.	O	O

However	O	O
,	O	O
after	O	O
colonization	O	O
by	O	O
A.	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
genospecies	I-bacteria	I-bacteria
1	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
2	E-bacteria	I-bacteria
,	O	O
specific	O	O
antibodies	O	O
were	O	O
induced	O	O
that	O	O
could	O	O
not	O	O
be	O	O
removed	O	O
by	O	O
absorption	O	O
with	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
.	O	O

Cluster	O	O
analysis	O	O
of	O	O
the	O	O
patterns	O	O
of	O	O
reactivity	O	O
of	O	O
postcolonization	O	O
salivary	O	O
antibodies	O	O
from	O	O
each	O	O
infant	O	O
with	O	O
antigens	O	O
from	O	O
their	O	O
own	O	O
strains	O	O
showed	O	O
that	O	O
not	O	O
only	O	O
could	O	O
these	O	O
antibodies	O	O
discriminate	O	O
among	O	O
strains	O	O
but	O	O
antibodies	O	O
in	O	O
saliva	O	O
samples	O	O
collected	O	O
at	O	O
different	O	O
times	O	O
showed	O	O
different	O	O
reactivity	O	O
patterns	O	O
.	O	O

Overall	O	O
,	O	O
these	O	O
data	O	O
suggest	O	O
that	O	O
,	O	O
although	O	O
much	O	O
of	O	O
the	O	O
salivary	O	O
SIgA	O	O
antibodies	O	O
reactive	O	O
with	O	O
A.	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
genospecies	I-bacteria	I-bacteria
1	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
2	E-bacteria	I-bacteria
are	O	O
directed	O	O
against	O	O
genus-specific	O	O
or	O	O
more	O	O
broadly	O	O
cross-reactive	O	O
antigens	O	O
,	O	O
species	O	O
,	O	O
genospecies	O	O
,	O	O
and	O	O
possibly	O	O
strain-specific	O	O
antibodies	O	O
are	O	O
induced	O	O
in	O	O
response	O	O
to	O	O
colonization	O	O
.	O	O

Hydrolytic	O	O
degradation	O	O
by-products	O	O
associated	O	O
with	O	O
the	O	O
constitutive	O	O
monomers	O	O
2,2-bis	O	O
[	O	O
4-	O	O
(	O	O
2-hydroxy-3-methacryloxypropoxy	O	O
)	O	O
phenyl	O	O
]	O	O
propane	O	O
(	O	O
bis-GMA	O	O
)	O	O
,	O	O
bisphenol	O	O
A	O	O
polyethylene	O	O
glycol	O	O
diether	O	O
dimethacrylate	O	O
(	O	O
bis-EMA	O	O
)	O	O
,	O	O
and	O	O
triethylene	O	O
glycol	O	O
dimethacrylate	O	O
(	O	O
TEDGMA	O	O
)	O	O
used	O	O
in	O	O
dental	O	O
restorative	O	O
composites	O	O
include	O	O
bis-hydroxy-propoxyphenyl	O	O
propane	O	O
(	O	O
bis-HPPP	O	O
)	O	O
,	O	O
ethoxylated	O	O
bisphenol	O	O
A	O	O
(	O	O
E-bisPA	O	O
)	O	O
,	O	O
methacrylic	O	O
acid	O	O
(	O	O
MA	O	O
)	O	O
,	O	O
and	O	O
triethylene	O	O
glycol	O	O
(	O	O
TEG	O	O
)	O	O
.	O	O

These	O	O
products	O	O
are	O	O
generated	O	O
from	O	O
the	O	O
interaction	O	O
of	O	O
human	O	O
salivary	O	O
esterases	O	O
with	O	O
the	O	O
composites	O	O
.	O	O

Recent	O	O
findings	O	O
have	O	O
indicated	O	O
that	O	O
TEGDMA	O	O
has	O	O
the	O	O
ability	O	O
to	O	O
modulate	O	O
oral	O	O
bacteria	O	O
but	O	O
it	O	O
is	O	O
unclear	O	O
which	O	O
components	O	O
of	O	O
TEGDMA	O	O
are	O	O
related	O	O
to	O	O
the	O	O
observed	O	O
effects	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
the	O	O
current	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
influence	O	O
of	O	O
TEGDMA	O	O
derived	O	O
degradation	O	O
products	O	O
MA	O	O
and	O	O
TEG	O	O
on	O	O
the	O	O
growth	O	O
of	O	O
three	O	O
strains	O	O
of	O	O
oral	O	O
bacteria	O	O
:	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	I-bacteria	I-bacteria
NG8	E-bacteria	I-bacteria
and	O	O
JH1005	B-bacteria	B-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
AT2	E-bacteria	I-bacteria
.	O	O

Bacterial	O	O
growth	O	O
rates	O	O
were	O	O
measured	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
,	O	O
and	O	O
pH	O	O
values	O	O
of	O	O
5.5	O	O
(	O	O
representative	O	O
of	O	O
cariogenic	O	O
state	O	O
)	O	O
or	O	O
7.0	O	O
at	O	O
concentrations	O	O
of	O	O
0-50mmol/l	O	O
for	O	O
MA	O	O
(	O	O
Sigma	O	O
,	O	O
US	O	O
)	O	O
and	O	O
0-100mmol/l	O	O
for	O	O
TEG	O	O
(	O	O
Sigma	O	O
,	O	O
US	O	O
)	O	O
.	O	O

It	O	O
was	O	O
found	O	O
that	O	O
at	O	O
pH	O	O
5.5	O	O
TEG	O	O
significantly	O	O
stimulated	O	O
the	O	O
growth	O	O
of	O	O
both	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
in	O	O
the	O	O
concentration	O	O
range	O	O
of	O	O
0.5-10.0mmol/l	O	O
and	O	O
stimulated	O	O
the	O	O
growth	O	O
of	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
AT2	E-bacteria	I-bacteria
for	O	O
the	O	O
entire	O	O
concentration	O	O
range	O	O
tested	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

TEG	O	O
(	O	O
above	O	O
50mmol/1	O	O
)	O	O
did	O	O
not	O	O
significantly	O	O
affect	O	O
the	O	O
doubling	O	O
times	O	O
of	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
at	O	O
pH	O	O
of	O	O
7.0	O	O
and	O	O
it	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
both	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
above	O	O
50mmol/l	O	O
at	O	O
the	O	O
same	O	O
pH	O	O
value	O	O
.	O	O

At	O	O
pH	O	O
5.5	O	O
MA	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
all	O	O
three	O	O
strains	O	O
with	O	O
increasing	O	O
concentration	O	O
.	O	O

At	O	O
neutral	O	O
pH	O	O
,	O	O
the	O	O
growth	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
NG8	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
was	O	O
significantly	O	O
reduced	O	O
by	O	O
MA	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
above	O	O
10mmol/l	O	O
.	O	O

In	O	O
summary	O	O
,	O	O
these	O	O
results	O	O
indicate	O	O
that	O	O
TEG	O	O
and	O	O
MA	O	O
modulate	O	O
the	O	O
growth	O	O
rate	O	O
of	O	O
important	O	O
oral	O	O
bacteria	O	O
in	O	O
a	O	O
concentration	O	O
and	O	O
pH	O	O
dependent	O	O
manner	O	O
.	O	O

Two	O	O
bacterial	O	O
strains	O	O
,	O	O
EHS11	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
EPSA11	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
,	O	O
which	O	O
were	O	O
isolated	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
,	O	O
were	O	O
characterized	O	O
in	O	O
terms	O	O
of	O	O
phenotypic	O	O
and	O	O
biochemical	O	O
characteristics	O	O
,	O	O
cellular	O	O
fatty	O	O
acid	O	O
profiles	O	O
and	O	O
phylogenetic	O	O
position	O	O
based	O	O
on	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
showed	O	O
that	O	O
each	O	O
of	O	O
the	O	O
isolates	O	O
belonged	O	O
to	O	O
a	O	O
novel	O	O
species	O	O
of	O	O
the	O	O
genus	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
.	O	O

Strain	B-bacteria	B-bacteria
EHS11	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
was	O	O
related	O	O
to	O	O
Prevotella	B-bacteria	B-bacteria
loescheii	E-bacteria	I-bacteria
(	O	O
about	O	O
95	O	O
%	O	O
similarity	O	O
)	O	O
,	O	O
whereas	O	O
strain	B-bacteria	B-bacteria
EPSA11	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
was	O	O
related	O	O
to	O	O
Prevotella	B-bacteria	B-bacteria
oris	E-bacteria	I-bacteria
(	O	O
about	O	O
94	O	O
%	O	O
similarity	O	O
)	O	O
.	O	O

Both	O	O
strains	O	O
were	O	O
obligately	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
non-pigmented	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
non-spore-forming	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
non-motile	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
.	O	O

The	O	O
cellular	O	O
fatty	O	O
acid	O	O
composition	O	O
of	O	O
strain	B-bacteria	B-bacteria
EPSA11	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
was	O	O
very	O	O
similar	O	O
to	O	O
that	O	O
of	O	O
P.	B-bacteria	B-bacteria
oris	I-bacteria	I-bacteria
JCM	I-bacteria	I-bacteria
8540	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
.	O	O

On	O	O
the	O	O
other	O	O
hand	O	O
,	O	O
the	O	O
cellular	O	O
fatty	O	O
acid	O	O
composition	O	O
of	O	O
strain	B-bacteria	B-bacteria
EHS11	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
was	O	O
significantly	O	O
different	O	O
from	O	O
those	O	O
of	O	O
other	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

The	O	O
predominant	O	O
fatty	O	O
acids	O	O
in	O	O
strain	B-bacteria	B-bacteria
EHS11	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
are	O	O
C	O	O
(	O	O
18	O	O
:	O	O
1	O	O
)	O	O
omega9c	O	O
,	O	O
C	O	O
(	O	O
16	O	O
:	O	O
0	O	O
)	O	O
and	O	O
C	O	O
(	O	O
16	O	O
:	O	O
0	O	O
)	O	O
3-OH	O	O
,	O	O
whereas	O	O
other	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
except	O	O
for	O	O
P.	B-bacteria	B-bacteria
loescheii	I-bacteria	I-bacteria
JCM	I-bacteria	I-bacteria
8530	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
,	O	O
possess	O	O
anteiso-C	O	O
(	O	O
15	O	O
:	O	O
0	O	O
)	O	O
,	O	O
iso-C	O	O
(	O	O
17	O	O
:	O	O
0	O	O
)	O	O
3-OH	O	O
and	O	O
C	O	O
(	O	O
18	O	O
:	O	O
1	O	O
)	O	O
omega9c	O	O
.	O	O

The	O	O
predominant	O	O
fatty	O	O
acids	O	O
in	O	O
P.	B-bacteria	B-bacteria
loescheii	I-bacteria	I-bacteria
JCM	I-bacteria	I-bacteria
8530	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
are	O	O
anteiso-C	O	O
(	O	O
15	O	O
:	O	O
0	O	O
)	O	O
,	O	O
C	O	O
(	O	O
16	O	O
:	O	O
0	O	O
)	O	O
and	O	O
C	O	O
(	O	O
18	O	O
:	O	O
1	O	O
)	O	O
omega9c	O	O
.	O	O

DNA-DNA	O	O
hybridization	O	O
experiments	O	O
revealed	O	O
a	O	O
genomic	O	O
distinction	O	O
of	O	O
strains	B-bacteria	B-bacteria
EHS11	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
EPSA11	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
from	O	O
P.	B-bacteria	B-bacteria
loescheii	I-bacteria	I-bacteria
JCM	I-bacteria	I-bacteria
8530	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
P.	B-bacteria	B-bacteria
oris	I-bacteria	I-bacteria
JCM	I-bacteria	I-bacteria
8540	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
.	O	O

On	O	O
the	O	O
basis	O	O
of	O	O
these	O	O
data	O	O
,	O	O
two	O	O
novel	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
are	O	O
proposed	O	O
:	O	O
Prevotella	B-bacteria	B-bacteria
shahii	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
salivae	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov	E-bacteria	I-bacteria
.	O	O

The	O	O
type	O	O
strains	O	O
of	O	O
P.	B-bacteria	B-bacteria
shahii	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
salivae	E-bacteria	I-bacteria
are	O	O
EHS11	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
=JCM	B-bacteria	B-bacteria
12083	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=DSM	O	O
15611	O	O
(	O	O
T	O	O
)	O	O
)	O	O
and	O	O
EPSA11	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
=JCM	B-bacteria	B-bacteria
12084	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=DSM	O	O
15606	O	O
(	O	O
T	O	O
)	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

Terminal	O	O
RFLP	O	O
(	O	O
T-RFLP	O	O
)	O	O
analysis	O	O
was	O	O
used	O	O
to	O	O
investigate	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
microbiota	O	O
in	O	O
saliva	O	O
and	O	O
subgingival	O	O
plaque	O	O
samples	O	O
from	O	O
one	O	O
patient	O	O
with	O	O
aggressive	O	O
periodontitis	O	O
(	O	O
subject	O	O
A	O	O
)	O	O
and	O	O
two	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
(	O	O
subjects	O	O
B	O	O
and	O	O
C	O	O
)	O	O
before	O	O
and	O	O
3	O	O
months	O	O
after	O	O
periodontal	O	O
treatment	O	O
.	O	O

Substantial	O	O
changes	O	O
in	O	O
the	O	O
T-RFLP	O	O
patterns	O	O
of	O	O
subgingival	O	O
plaque	O	O
samples	O	O
of	O	O
subjects	O	O
B	O	O
and	O	O
C	O	O
were	O	O
noted	O	O
after	O	O
3	O	O
months	O	O
of	O	O
improved	O	O
oral	O	O
hygiene	O	O
and	O	O
full-mouth	O	O
supra-	O	O
and	O	O
subgingival	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
.	O	O

However	O	O
,	O	O
there	O	O
was	O	O
little	O	O
change	O	O
in	O	O
the	O	O
subgingival	O	O
microbiota	O	O
of	O	O
subject	O	O
A	O	O
.	O	O

Although	O	O
the	O	O
proportions	O	O
of	O	O
terminal	O	O
restriction	O	O
fragments	O	O
(	O	O
T-RFs	O	O
)	O	O
larger	O	O
than	O	O
1000	O	O
bp	O	O
were	O	O
notable	O	O
in	O	O
the	O	O
T-RFLP	O	O
patterns	O	O
generated	O	O
after	O	O
digestion	O	O
with	O	O
HhaI	O	O
of	O	O
the	O	O
samples	O	O
from	O	O
two	O	O
subjects	O	O
before	O	O
treatment	O	O
(	O	O
subject	O	O
B	O	O
,	O	O
35.5	O	O
%	O	O
;	O	O
subject	O	O
C	O	O
,	O	O
29.6	O	O
%	O	O
)	O	O
,	O	O
the	O	O
proportions	O	O
of	O	O
these	O	O
T-RFs	O	O
were	O	O
significantly	O	O
reduced	O	O
or	O	O
not	O	O
detected	O	O
after	O	O
treatment	O	O
(	O	O
subject	O	O
B	O	O
,	O	O
none	O	O
;	O	O
subject	O	O
C	O	O
,	O	O
4.1	O	O
%	O	O
)	O	O
.	O	O

Real-time	O	O
PCR	O	O
showed	O	O
a	O	O
significant	O	O
change	O	O
in	O	O
the	O	O
proportions	O	O
of	O	O
target	O	O
bacteria	O	O
in	O	O
subgingival	O	O
plaque	O	O
samples	O	O
of	O	O
subject	O	O
B	O	O
.	O	O

After	O	O
3	O	O
months	O	O
,	O	O
the	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
population	O	O
was	O	O
markedly	O	O
reduced	O	O
(	O	O
3.1	O	O
x	O	O
10	O	O
(	O	O
-3	O	O
)	O	O
%	O	O
)	O	O
,	O	O
whereas	O	O
the	O	O
proportion	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
before	O	O
treatment	O	O
was	O	O
7.6	O	O
%	O	O
.	O	O

The	O	O
proportions	O	O
of	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
socranskii	E-bacteria	I-bacteria
were	O	O
also	O	O
markedly	O	O
diminished	O	O
after	O	O
treatment	O	O
.	O	O

Similarly	O	O
,	O	O
the	O	O
proportion	O	O
of	O	O
the	O	O
T-RF	O	O
presumed	O	O
to	O	O
represent	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
5.9	O	O
%	O	O
and	O	O
became	O	O
undetectable	O	O
after	O	O
3	O	O
months	O	O
.	O	O

Analysis	O	O
of	O	O
16S	O	O
rRNA	O	O
gene	O	O
clone	O	O
libraries	O	O
from	O	O
subgingival	O	O
plaque	O	O
samples	O	O
of	O	O
subject	O	O
B	O	O
before	O	O
and	O	O
after	O	O
treatment	O	O
showed	O	O
a	O	O
notable	O	O
change	O	O
in	O	O
the	O	O
subgingival	O	O
microbiota	O	O
.	O	O

These	O	O
results	O	O
were	O	O
in	O	O
agreement	O	O
with	O	O
the	O	O
T-RFLP	O	O
analysis	O	O
data	O	O
and	O	O
showed	O	O
that	O	O
the	O	O
T-RFs	O	O
larger	O	O
than	O	O
1000	O	O
bp	O	O
represent	O	O
Peptostreptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
T-RFLP	O	O
analysis	O	O
is	O	O
useful	O	O
for	O	O
evaluation	O	O
of	O	O
the	O	O
effects	O	O
of	O	O
medical	O	O
treatment	O	O
of	O	O
periodontitis	O	O
.	O	O

Once	O	O
established	O	O
,	O	O
early-colonizing	B-bacteria	B-bacteria
bacterial	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
tend	O	O
to	O	O
persist	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

To	O	O
obtain	O	O
detailed	O	O
information	O	O
on	O	O
the	O	O
population	O	O
dynamics	O	O
of	O	O
early-colonizing	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
anaerobes	E-bacteria	I-bacteria
,	O	O
we	O	O
examined	O	O
the	O	O
clonal	O	O
diversity	O	O
and	O	O
persistence	O	O
of	O	O
clones	O	O
among	O	O
oral	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
populations	O	O
during	O	O
the	O	O
first	O	O
2	O	O
yrs	O	O
of	O	O
life	O	O
.	O	O

Consecutive	O	O
salivary	O	O
samples	O	O
from	O	O
12	O	O
infants	O	O
,	O	O
collected	O	O
at	O	O
2	O	O
,	O	O
6	O	O
,	O	O
12	O	O
,	O	O
18	O	O
,	O	O
and	O	O
24	O	O
mos	O	O
of	O	O
age	O	O
,	O	O
yielded	O	O
a	O	O
total	O	O
of	O	O
546	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
for	O	O
clonal	O	O
typing	O	O
with	O	O
arbitrarily	O	O
primed	O	O
PCR	O	O
(	O	O
AP-PCR	O	O
)	O	O
.	O	O

Up	O	O
to	O	O
7	O	O
AP-PCR	O	O
types	O	O
were	O	O
simultaneously	O	O
detected	O	O
in	O	O
each	O	O
sample	O	O
.	O	O

In	O	O
11	O	O
out	O	O
of	O	O
the	O	O
12	O	O
infants	O	O
examined	O	O
,	O	O
AP-PCR	O	O
types	O	O
persisted	O	O
for	O	O
up	O	O
to	O	O
1	O	O
yr.	B-bacteria	B-bacteria
Strain	E-bacteria	I-bacteria
turnover	O	O
rate	O	O
was	O	O
high	O	O
during	O	O
the	O	O
first	O	O
year	O	O
of	O	O
life	O	O
,	O	O
but	O	O
then	O	O
the	O	O
occurrence	O	O
of	O	O
persistent	O	O
clones	O	O
increased	O	O
.	O	O

This	O	O
study	O	O
indicates	O	O
a	O	O
wide	O	O
genetic	O	O
diversity	O	O
within	O	O
the	O	O
species	O	O
and	O	O
provides	O	O
evidence	O	O
for	O	O
the	O	O
increasing	O	O
persistence	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
clones	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
with	O	O
age	O	O
.	O	O

Colonization	O	O
of	O	O
the	O	O
tooth	O	O
surface	O	O
by	O	O
actinomyces	B-bacteria	B-bacteria
and	O	O
viridans	B-bacteria	B-bacteria
group	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
involves	O	O
the	O	O
attachment	O	O
of	O	O
these	O	O
bacteria	O	O
to	O	O
adsorbed	O	O
salivary	O	O
components	O	O
of	O	O
the	O	O
acquired	O	O
enamel	O	O
pellicle	O	O
.	O	O

The	O	O
hypothesis	O	O
that	O	O
this	O	O
attachment	O	O
depends	O	O
on	O	O
specific	O	O
adhesins	O	O
has	O	O
now	O	O
been	O	O
assessed	O	O
from	O	O
the	O	O
binding	O	O
of	O	O
bacteria	O	O
with	O	O
well-defined	O	O
adhesive	O	O
properties	O	O
to	O	O
blots	O	O
of	O	O
SDS-PAGE-separated	O	O
parotid	O	O
and	O	O
submandibular-sublingual	O	O
(	O	O
SM-SL	O	O
)	O	O
saliva	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
and	O	O
type	O	O
2	O	O
fimbriated	B-bacteria	B-bacteria
Actinomyces	I-bacteria	I-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
which	O	O
bound	O	O
terminal	O	O
sialic	O	O
acid	O	O
and	O	O
Galbeta1-3GalNAc	O	O
,	O	O
respectively	O	O
,	O	O
recognized	O	O
only	O	O
a	O	O
few	O	O
SM-SL	O	O
salivary	O	O
components	O	O
,	O	O
primarily	O	O
MG2	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
type	O	O
1	O	O
fimbriated	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
which	O	O
bound	O	O
purified	O	O
proline-rich	O	O
proteins	O	O
(	O	O
PRPs	O	O
)	O	O
,	O	O
recognized	O	O
several	O	O
other	O	O
components	O	O
from	O	O
both	O	O
SM-SL	O	O
and	O	O
parotid	O	O
saliva	O	O
.	O	O

Significantly	O	O
,	O	O
bacteria	O	O
that	O	O
lacked	O	O
PRP-binding	O	O
and	O	O
the	O	O
lectin-like	O	O
activities	O	O
detected	O	O
by	O	O
binding	O	O
to	O	O
MG2	O	O
failed	O	O
to	O	O
bind	O	O
any	O	O
immobilized	O	O
salivary	O	O
component	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
the	O	O
involvement	O	O
of	O	O
specific	O	O
adhesins	O	O
in	O	O
bacterial	O	O
recognition	O	O
of	O	O
many	O	O
adsorbed	O	O
salivary	O	O
proteins	O	O
and	O	O
glycoproteins	O	O
.	O	O

The	O	O
oral	O	O
environment	O	O
contains	O	O
many	O	O
different	O	O
types	O	O
of	O	O
microorganisms	O	O
,	O	O
including	O	O
both	O	O
Gram-negative	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-positive	I-bacteria	I-bacteria
cocci	E-bacteria	I-bacteria
,	O	O
bacilli	B-bacteria	B-bacteria
,	O	O
and	O	O
spirochetes	B-bacteria	B-bacteria
.	O	O

From	O	O
the	O	O
ecological	O	O
point	O	O
of	O	O
view	O	O
,	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
a	O	O
perfect	O	O
niche	O	O
for	O	O
certain	O	O
bacteria	O	O
such	O	O
as	O	O
lactobacilli	B-bacteria	B-bacteria
because	O	O
they	O	O
interact	O	O
,	O	O
forming	O	O
different	O	O
types	O	O
of	O	O
communities	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
have	O	O
been	O	O
associated	O	O
with	O	O
the	O	O
generation	O	O
of	O	O
caries	O	O
in	O	O
some	O	O
reports	O	O
,	O	O
secondary	O	O
to	O	O
the	O	O
cariogenic	O	O
Streptococcus	B-bacteria	B-bacteria
.	O	O

In	O	O
previous	O	O
papers	O	O
,	O	O
the	O	O
isolation	O	O
and	O	O
identification	O	O
of	O	O
145	O	O
strains	O	O
from	O	O
healthy	O	O
subjects	O	O
and	O	O
from	O	O
subjects	O	O
with	O	O
active	O	O
caries	O	O
were	O	O
performed	O	O
.	O	O

Strains	O	O
were	O	O
characterized	O	O
by	O	O
their	O	O
surface	O	O
properties	O	O
and	O	O
also	O	O
by	O	O
the	O	O
production	O	O
of	O	O
inhibitory	O	O
substances	O	O
.	O	O

From	O	O
all	O	O
the	O	O
strains	O	O
,	O	O
one	O	O
isolated	O	O
from	O	O
the	O	O
teeth	O	O
of	O	O
healthy	O	O
patients	O	O
and	O	O
another	O	O
from	O	O
a	O	O
patient	O	O
with	O	O
caries	O	O
,	O	O
sharing	O	O
some	O	O
surface	O	O
properties	O	O
,	O	O
were	O	O
selected	O	O
for	O	O
further	O	O
study	O	O
of	O	O
their	O	O
adhesion	O	O
properties	O	O
in	O	O
an	O	O
experimental	O	O
model	O	O
by	O	O
using	O	O
hydroxylapatite	O	O
beads	O	O
.	O	O

Adhesion	O	O
is	O	O
the	O	O
first	O	O
step	O	O
in	O	O
the	O	O
association	O	O
of	O	O
microorganisms	O	O
with	O	O
surfaces	O	O
or	O	O
mucous	O	O
membranes	O	O
.	O	O

The	O	O
first	O	O
approach	O	O
is	O	O
a	O	O
nonspecific	O	O
interaction	O	O
of	O	O
both	O	O
surfaces	O	O
;	O	O
later	O	O
some	O	O
other	O	O
types	O	O
of	O	O
interactions	O	O
can	O	O
occur	O	O
,	O	O
involving	O	O
more	O	O
specific	O	O
mediators	O	O
of	O	O
adhesions	O	O
.	O	O

Many	O	O
different	O	O
assays	O	O
are	O	O
available	O	O
to	O	O
study	O	O
the	O	O
adhesion	O	O
phenomenon	O	O
;	O	O
some	O	O
of	O	O
them	O	O
use	O	O
predictive	O	O
characteristics	O	O
,	O	O
and	O	O
others	O	O
use	O	O
experimental	O	O
models	O	O
resembling	O	O
the	O	O
in	O	O
vivo	O	O
situation	O	O
.	O	O

Two	O	O
model	O	O
systems	O	O
predominate	O	O
.	O	O

The	O	O
most	O	O
widely	O	O
used	O	O
has	O	O
been	O	O
saliva-coated	O	O
hydroxylapatite	O	O
or	O	O
hydroxylapatite	O	O
coated	O	O
with	O	O
buffers	O	O
,	O	O
proteins	O	O
,	O	O
and	O	O
other	O	O
substances	O	O
.	O	O

In	O	O
an	O	O
attempt	O	O
to	O	O
increase	O	O
knowledge	O	O
of	O	O
the	O	O
mechanisms	O	O
of	O	O
adhesion	O	O
of	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
with	O	O
hard	O	O
surfaces	O	O
,	O	O
this	O	O
chapter	O	O
describes	O	O
an	O	O
experimental	O	O
model	O	O
for	O	O
studing	O	O
the	O	O
adhesion	O	O
between	O	O
lactobacilli	B-bacteria	B-bacteria
and	O	O
hard	O	O
tissues	O	O
represented	O	O
by	O	O
hydroxylapatite	O	O
,	O	O
the	O	O
component	O	O
most	O	O
abundant	O	O
in	O	O
the	O	O
teeth	O	O
.	O	O

The	O	O
following	O	O
steps	O	O
were	O	O
performed	O	O
:	O	O
1	O	O
.	O	O

Obtaining	O	O
the	O	O
microorganisms	O	O
.	O	O

2	O	O
.	O	O

Preparation	O	O
of	O	O
the	O	O
hydroxylapatite	O	O
beads	O	O
.	O	O

3	O	O
.	O	O

Adhesion	O	O
assay	O	O
.	O	O

Commensal	O	O
microflora	O	O
(	O	O
normal	O	O
microflora	O	O
,	O	O
indigenous	O	O
microbiota	O	O
)	O	O
consists	O	O
of	O	O
those	O	O
micro-organisms	O	O
,	O	O
which	O	O
are	O	O
present	O	O
on	O	O
body	O	O
surfaces	O	O
covered	O	O
by	O	O
epithelial	O	O
cells	O	O
and	O	O
are	O	O
exposed	O	O
to	O	O
the	O	O
external	O	O
environment	O	O
(	O	O
gastrointestinal	O	O
and	O	O
respiratory	O	O
tract	O	O
,	O	O
vagina	O	O
,	O	O
skin	O	O
,	O	O
etc	O	O
.	O	O
)	O	O
.	O	O

The	O	O
number	O	O
of	O	O
bacteria	O	O
colonising	O	O
mucosal	O	O
and	O	O
skin	O	O
surfaces	O	O
exceeds	O	O
the	O	O
number	O	O
of	O	O
cells	O	O
forming	O	O
human	O	O
body	O	O
.	O	O

Commensal	O	O
bacteria	O	O
co-evolved	O	O
with	O	O
their	O	O
hosts	O	O
,	O	O
however	O	O
,	O	O
under	O	O
specific	O	O
conditions	O	O
they	O	O
are	O	O
able	O	O
to	O	O
overcome	O	O
protective	O	O
host	O	O
responses	O	O
and	O	O
exert	O	O
pathologic	O	O
effects	O	O
.	O	O

Resident	O	O
bacteria	O	O
form	O	O
complex	O	O
ecosystems	O	O
,	O	O
whose	O	O
diversity	O	O
is	O	O
enormous	O	O
.	O	O

The	O	O
most	O	O
abundant	O	O
microflora	O	O
is	O	O
present	O	O
in	O	O
the	O	O
distal	O	O
parts	O	O
of	O	O
the	O	O
gut	O	O
;	O	O
the	O	O
majority	O	O
of	O	O
the	O	O
intestinal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
are	O	O
Gram-negative	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
.	O	O

More	O	O
than	O	O
50	O	O
%	O	O
of	O	O
intestinal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
can	O	O
not	O	O
be	O	O
cultured	O	O
by	O	O
conventional	O	O
microbiological	O	O
techniques	O	O
.	O	O

Molecular	O	O
biological	O	O
methods	O	O
help	O	O
in	O	O
analysing	O	O
the	O	O
structural	O	O
and	O	O
functional	O	O
complexity	O	O
of	O	O
the	O	O
microflora	O	O
and	O	O
in	O	O
identifying	O	O
its	O	O
components	O	O
.	O	O

Resident	O	O
microflora	O	O
contains	O	O
a	O	O
number	O	O
of	O	O
components	O	O
able	O	O
to	O	O
activate	O	O
innate	O	O
and	O	O
adaptive	O	O
immunity	O	O
.	O	O

Unlimited	O	O
immune	O	O
activation	O	O
in	O	O
response	O	O
to	O	O
signals	O	O
from	O	O
commensal	O	O
bacteria	O	O
could	O	O
pose	O	O
the	O	O
risk	O	O
of	O	O
inflammation	O	O
;	O	O
immune	O	O
responses	O	O
to	O	O
mucosal	O	O
microbiota	O	O
therefore	O	O
require	O	O
a	O	O
precise	O	O
regulatory	O	O
control	O	O
.	O	O

The	O	O
mucosal	O	O
immune	O	O
system	O	O
has	O	O
developed	O	O
specialised	O	O
regulatory	O	O
,	O	O
anti-inflammatory	O	O
mechanisms	O	O
for	O	O
eliminating	O	O
or	O	O
tolerating	O	O
non-dangerous	O	O
,	O	O
food	O	O
and	O	O
airborne	O	O
antigens	O	O
and	O	O
commensal	O	O
micro-organisms	O	O
(	O	O
oral	O	O
,	O	O
mucosal	O	O
tolerance	O	O
)	O	O
.	O	O

However	O	O
,	O	O
at	O	O
the	O	O
same	O	O
time	O	O
the	O	O
mucosal	O	O
immune	O	O
system	O	O
must	O	O
provide	O	O
local	O	O
defense	O	O
mechanisms	O	O
against	O	O
environmental	O	O
threats	O	O
(	O	O
e.g	O	O
.	O	O

invading	O	O
pathogens	O	O
)	O	O
.	O	O

This	O	O
important	O	O
requirement	O	O
is	O	O
fulfilled	O	O
by	O	O
several	O	O
mechanisms	O	O
of	O	O
mucosal	O	O
immunity	O	O
:	O	O
strongly	O	O
developed	O	O
innate	O	O
defense	O	O
mechanisms	O	O
ensuring	O	O
appropriate	O	O
function	O	O
of	O	O
the	O	O
mucosal	O	O
barrier	O	O
,	O	O
existence	O	O
of	O	O
unique	O	O
types	O	O
of	O	O
lymphocytes	O	O
and	O	O
their	O	O
products	O	O
,	O	O
transport	O	O
of	O	O
polymeric	O	O
immunoglobulins	O	O
through	O	O
epithelial	O	O
cells	O	O
into	O	O
secretions	O	O
(	O	O
sIgA	O	O
)	O	O
and	O	O
migration	O	O
and	O	O
homing	O	O
of	O	O
cells	O	O
originating	O	O
from	O	O
the	O	O
mucosal	O	O
organised	O	O
tissues	O	O
in	O	O
mucosae	O	O
and	O	O
exocrine	O	O
glands	O	O
.	O	O

The	O	O
important	O	O
role	O	O
of	O	O
commensal	O	O
bacteria	O	O
in	O	O
development	O	O
of	O	O
optimally	O	O
functioning	O	O
mucosal	O	O
immune	O	O
system	O	O
was	O	O
demonstrated	O	O
in	O	O
germ-free	O	O
animals	O	O
(	O	O
using	O	O
gnotobiological	O	O
techniques	O	O
)	O	O
.	O	O

Involvement	O	O
of	O	O
commensal	O	O
microflora	O	O
and	O	O
its	O	O
components	O	O
with	O	O
strong	O	O
immunoactivating	O	O
properties	O	O
(	O	O
e.g	O	O
.	O	O

LPS	O	O
,	O	O
peptidoglycans	O	O
,	O	O
superantigens	O	O
,	O	O
bacterial	O	O
DNA	O	O
,	O	O
Hsp	O	O
)	O	O
in	O	O
etiopathogenetic	O	O
mechanism	O	O
of	O	O
various	O	O
complex	O	O
,	O	O
multifactorial	O	O
and	O	O
multigenic	O	O
diseases	O	O
,	O	O
including	O	O
inflammatory	O	O
bowel	O	O
diseases	O	O
,	O	O
periodontal	O	O
disease	O	O
,	O	O
rheumatoid	O	O
arthritis	O	O
,	O	O
atherosclerosis	O	O
,	O	O
allergy	O	O
,	O	O
multiorgan	O	O
failure	O	O
,	O	O
colon	O	O
cancer	O	O
has	O	O
been	O	O
recently	O	O
suggested	O	O
.	O	O

Animal	O	O
models	O	O
of	O	O
human	O	O
diseases	O	O
reared	O	O
in	O	O
defined	O	O
gnotobiotic	O	O
conditions	O	O
are	O	O
helping	O	O
to	O	O
elucidate	O	O
the	O	O
aetiology	O	O
of	O	O
these	O	O
frequent	O	O
disorders	O	O
.	O	O

An	O	O
improved	O	O
understanding	O	O
of	O	O
commensal	O	O
bacteria-host	O	O
interactions	O	O
employing	O	O
germ-free	O	O
animal	O	O
models	O	O
with	O	O
selective	O	O
colonisation	O	O
strategies	O	O
combined	O	O
with	O	O
modern	O	O
molecular	O	O
techniques	O	O
could	O	O
bring	O	O
new	O	O
insights	O	O
into	O	O
the	O	O
mechanisms	O	O
of	O	O
mucosal	O	O
immunity	O	O
and	O	O
also	O	O
into	O	O
pathogenetic	O	O
mechanisms	O	O
of	O	O
several	O	O
infectious	O	O
,	O	O
inflammatory	O	O
,	O	O
autoimmune	O	O
and	O	O
neoplastic	O	O
diseases	O	O
.	O	O

Regulation	O	O
of	O	O
microflora	O	O
composition	O	O
(	O	O
e.g	O	O
.	O	O

by	O	O
probiotics	B-bacteria	B-bacteria
and	O	O
prebiotics	B-bacteria	B-bacteria
)	O	O
offers	O	O
the	O	O
possibility	O	O
to	O	O
influence	O	O
the	O	O
development	O	O
of	O	O
mucosal	O	O
and	O	O
systemic	O	O
immunity	O	O
but	O	O
it	O	O
can	O	O
play	O	O
a	O	O
role	O	O
also	O	O
in	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
some	O	O
diseases	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
sampling	O	O
methods	O	O
for	O	O
recovery	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
and	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
LB	B-bacteria	B-bacteria
)	O	O
in	O	O
children	O	O
9	O	O
to	O	O
36	O	O
months	O	O
of	O	O
age	O	O
.	O	O

Tongue	O	O
and	O	O
plaque	O	O
specimens	O	O
collected	O	O
on	O	O
cotton	O	O
swabs	O	O
and	O	O
stimulated	O	O
saliva	O	O
were	O	O
diluted	O	O
and	O	O
plated	O	O
on	O	O
selective	O	O
and	O	O
nonselective	O	O
media	O	O
.	O	O

Tongue	O	O
specimens	O	O
on	O	O
a	O	O
swab	O	O
and	O	O
mouth	O	O
mirror	O	O
were	O	O
inoculated	O	O
directly	O	O
on	O	O
selective	O	O
agar	O	O
media	O	O
(	O	O
MS	B-bacteria	B-bacteria
only	O	O
)	O	O
.	O	O

Sampling	O	O
methods	O	O
were	O	O
compared	O	O
by	O	O
frequency	O	O
of	O	O
recovery	O	O
of	O	O
MS	B-bacteria	B-bacteria
or	O	O
LB	B-bacteria	B-bacteria
,	O	O
correlation	O	O
of	O	O
microbial	O	O
counts	O	O
with	O	O
dmfs	O	O
scores	O	O
,	O	O
and	O	O
potential	O	O
of	O	O
specific	O	O
microbial	O	O
counts	O	O
to	O	O
predict	O	O
caries	O	O
presence	O	O
or	O	O
absence	O	O
.	O	O

The	O	O
mean	O	O
dmfs	O	O
score	O	O
of	O	O
87	O	O
subjects	O	O
was	O	O
6.3	O	O
;	O	O
48	O	O
subjects	O	O
were	O	O
caries	O	O
free	O	O
.	O	O

Levels	O	O
of	O	O
MS	B-bacteria	B-bacteria
and	O	O
LB	B-bacteria	B-bacteria
were	O	O
consistently	O	O
higher	O	O
in	O	O
plaque	O	O
than	O	O
in	O	O
other	O	O
sampling	O	O
techniques	O	O
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
,	O	O
and	O	O
frequencies	O	O
of	O	O
recovery	O	O
of	O	O
MS	B-bacteria	B-bacteria
were	O	O
highest	O	O
in	O	O
plaque	O	O
(	O	O
P	O	O
<	O	O
.041	O	O
)	O	O
and	O	O
tongue	O	O
(	O	O
P	O	O
<	O	O
.006	O	O
)	O	O
.	O	O

Frequency	O	O
of	O	O
LB	B-bacteria	B-bacteria
recovery	O	O
did	O	O
not	O	O
differ	O	O
significantly	O	O
between	O	O
sampling	O	O
methods	O	O
.	O	O

Counts	O	O
of	O	O
MS	B-bacteria	B-bacteria
or	O	O
LB	B-bacteria	B-bacteria
in	O	O
total	O	O
subjects	O	O
and	O	O
subjects	O	O
aged	O	O
9	O	O
to	O	O
24	O	O
months	O	O
correlated	O	O
positively	O	O
with	O	O
dmfs	O	O
scores	O	O
(	O	O
P	O	O
<	O	O
.028	O	O
)	O	O
.	O	O

Threshold	O	O
levels	O	O
of	O	O
MS	B-bacteria	B-bacteria
which	O	O
were	O	O
predictive	O	O
of	O	O
presence	O	O
of	O	O
caries	O	O
were	O	O
:	O	O
(	O	O
1	O	O
)	O	O
plaque=	O	O
>	O	O
2x10	O	O
(	O	O
5	O	O
)	O	O
;	O	O
(	O	O
2	O	O
)	O	O
tongue=	O	O
>	O	O
10	O	O
(	O	O
4	O	O
)	O	O
;	O	O
(	O	O
3	O	O
)	O	O
saliva=	O	O
>	O	O
10	O	O
(	O	O
5	O	O
)	O	O
;	O	O
(	O	O
4	O	O
)	O	O
mirror=	O	O
>	O	O
50	O	O
;	O	O
and	O	O
(	O	O
5	O	O
)	O	O
swab=	O	O
>	O	O
50	O	O
.	O	O

Comparable	O	O
levels	O	O
of	O	O
LB	B-bacteria	B-bacteria
were	O	O
:	O	O
plaque	O	O
,	O	O
>	O	O
10	O	O
(	O	O
3	O	O
)	O	O
;	O	O
tongue	O	O
,	O	O
>	O	O
10	O	O
(	O	O
2	O	O
)	O	O
and	O	O
saliva	O	O
,	O	O
>	O	O
10	O	O
(	O	O
3	O	O
)	O	O
.	O	O

Specificities	O	O
associated	O	O
with	O	O
these	O	O
predictions	O	O
were	O	O
higher	O	O
than	O	O
sensitivities	O	O
for	O	O
all	O	O
sampling	O	O
methods	O	O
.	O	O

(	O	O
1	O	O
)	O	O
All	O	O
sampling	O	O
methods	O	O
were	O	O
adequate	O	O
for	O	O
microbial	O	O
risk	O	O
assessment	O	O
tests	O	O
in	O	O
children	O	O
under	O	O
3	O	O
years	O	O
of	O	O
age	O	O
;	O	O
(	O	O
2	O	O
)	O	O
MS	B-bacteria	B-bacteria
was	O	O
a	O	O
stronger	O	O
indicator	O	O
of	O	O
caries	O	O
status	O	O
than	O	O
LB	B-bacteria	B-bacteria
.	O	O

Recent	O	O
studies	O	O
suggest	O	O
that	O	O
normal	O	O
human	O	O
oral	O	O
keratinocytes	O	O
(	O	O
NHOKs	O	O
)	O	O
can	O	O
be	O	O
infected	O	O
by	O	O
HIV-1	O	O
,	O	O
and	O	O
alcohol	O	O
can	O	O
enhance	O	O
HIV	O	O
infection	O	O
and	O	O
replication	O	O
in	O	O
lymphocytes	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
possibility	O	O
that	O	O
alcohol	O	O
might	O	O
facilitate	O	O
HIV-1	O	O
infection	O	O
of	O	O
NHOKs	O	O
by	O	O
up-regulating	O	O
cell	O	O
surface	O	O
expression	O	O
of	O	O
the	O	O
coreceptor	O	O
,	O	O
CXCR4	O	O
.	O	O

Alcohol	O	O
enhanced	O	O
in	O	O
vitro	O	O
infection	O	O
of	O	O
NHOKs	O	O
by	O	O
CXCR4-tropic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
of	O	O
HIV-1	O	O
as	O	O
indicated	O	O
by	O	O
synthesis	O	O
of	O	O
viral	O	O
reverse	O	O
transcripts	O	O
and	O	O
production	O	O
of	O	O
p24gag	O	O
protein	O	O
.	O	O

Alcohol	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
CXCR4	O	O
gene	O	O
expression	O	O
or	O	O
on	O	O
total	O	O
cellular	O	O
complements	O	O
of	O	O
CXCR4	O	O
protein	O	O
.	O	O

However	O	O
,	O	O
alcohol	O	O
did	O	O
enhance	O	O
the	O	O
fraction	O	O
of	O	O
total	O	O
CXCR4	O	O
expressed	O	O
on	O	O
the	O	O
cell	O	O
surface	O	O
relative	O	O
to	O	O
intracellular	O	O
stores	O	O
.	O	O

Alcohol-induced	O	O
up-regulation	O	O
of	O	O
cell	O	O
surface	O	O
CXCR4	O	O
expression	O	O
and	O	O
HIV-1	O	O
infectivity	O	O
could	O	O
be	O	O
blocked	O	O
by	O	O
SDF-1alpha-mediated	O	O
internalization	O	O
.	O	O

These	O	O
data	O	O
suggest	O	O
that	O	O
alcohol	O	O
may	O	O
influence	O	O
oral	O	O
HIV	O	O
transmission	O	O
by	O	O
altering	O	O
the	O	O
cellular	O	O
compartmentalization	O	O
of	O	O
CXCR4	O	O
in	O	O
cells	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

To	O	O
observe	O	O
the	O	O
dynamic	O	O
changes	O	O
of	O	O
oral	O	O
microflora	O	O
early	O	O
colonized	O	O
in	O	O
infants	O	O
.	O	O

The	O	O
oral	O	O
swab	O	O
samples	O	O
for	O	O
the	O	O
study	O	O
were	O	O
taken	O	O
in	O	O
1	O	O
day	O	O
,	O	O
1	O	O
,	O	O
3	O	O
,	O	O
6	O	O
,	O	O
9	O	O
,	O	O
12	O	O
months	O	O
after	O	O
birth	O	O
from	O	O
12	O	O
healthy	O	O
neonates	O	O
.	O	O

By	O	O
choosing	O	O
suitable	O	O
diluted	O	O
concentration	O	O
,	O	O
the	O	O
samples	O	O
were	O	O
incubated	O	O
aerobically	O	O
,	O	O
facultative	O	O
anaerobically	O	O
and	O	O
anaerobically	O	O
.	O	O

The	O	O
strains	O	O
were	O	O
identified	O	O
by	O	O
observing	O	O
colony	O	O
characteristics	O	O
,	O	O
Gram	O	O
staining	O	O
and	O	O
biochemical	O	O
tests	O	O
.	O	O

S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
frequent	O	O
microflora	O	O
,	O	O
followed	O	O
by	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
occurred	O	O
in	O	O
oral	O	O
cavity	O	O
after	O	O
tooth	O	O
eruption	O	O
.	O	O

Veillonella	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	E-bacteria	I-bacteria

can	O	O
be	O	O
detected	O	O
in	O	O
oral	O	O
cavity	O	O
of	O	O
1-month-old	O	O
babies	O	O
,	O	O
A.	O	O
odontolyticus	O	O
was	O	O
isolated	O	O
from	O	O
8.3	O	O
%	O	O
infants	O	O
of	O	O
more	O	O
than	O	O
3	O	O
months	O	O
old	O	O
.	O	O

L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
maintained	O	O
the	O	O
lower	O	O
prevalence	O	O
in	O	O
oral	O	O
cavity	O	O
of	O	O
babies	O	O
.	O	O

Leptotrichia	B-bacteria	B-bacteria
buccalis	E-bacteria	I-bacteria
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

occurred	O	O
in	O	O
oral	O	O
cavity	O	O
of	O	O
some	O	O
dentate	O	O
infants	O	O
.	O	O

S.	B-bacteria	B-bacteria
solivarius	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
are	O	O
predominant	O	O
species	O	O
in	O	O
oral	O	O
cavity	O	O
of	O	O
the	O	O
infants	O	O
,	O	O
Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

is	O	O
the	O	O
first	O	O
and	O	O
the	O	O
most	O	O
anaerobic	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
appeared	O	O
in	O	O
oral	O	O
cavity	O	O
of	O	O
healthy	O	O
babies	O	O
.	O	O

A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
is	O	O
the	O	O
first	O	O
actinomyces	O	O
detected	O	O
in	O	O
oral	O	O
cavity	O	O
.	O	O

With	O	O
the	O	O
increasing	O	O
months	O	O
,	O	O
kind	O	O
and	O	O
amount	O	O
of	O	O
microflora	O	O
increase	O	O
dramatically	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
effect	O	O
of	O	O
ozonated	O	O
water	O	O
on	O	O
oral	O	O
microorganisms	O	O
and	O	O
dental	O	O
plaque	O	O
.	O	O

Almost	O	O
no	O	O
microorganisms	O	O
were	O	O
detected	O	O
after	O	O
being	O	O
treated	O	O
with	O	O
ozonated	O	O
water	O	O
(	O	O
4	O	O
mg/l	O	O
)	O	O
for	O	O
10	O	O
s.	O	O
To	O	O
estimate	O	O
the	O	O
ozonated	O	O
water-treated	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
bacterial	O	O
cells	O	O
were	O	O
stained	O	O
with	O	O
LIVE/DEAD	O	O
BacLight	O	O
Bacterial	O	O
Viability	O	O
Kit	O	O
.	O	O

Fluorescence	O	O
microscopic	O	O
analysis	O	O
revealed	O	O
that	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
cells	O	O
were	O	O
killed	O	O
instantaneously	O	O
in	O	O
ozonated	O	O
water	O	O
.	O	O

Some	O	O
breakage	O	O
of	O	O
ozonated	O	O
water-treated	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
found	O	O
by	O	O
electron	O	O
microscopy	O	O
.	O	O

When	O	O
the	O	O
experimental	O	O
dental	O	O
plaque	O	O
was	O	O
exposed	O	O
to	O	O
ozonated	O	O
water	O	O
,	O	O
the	O	O
number	O	O
of	O	O
viable	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
remarkably	O	O
decreased	O	O
.	O	O

Ozonated	O	O
water	O	O
strongly	O	O
inhibited	O	O
the	O	O
accumulation	O	O
of	O	O
experimental	O	O
dental	O	O
plaque	O	O
in	O	O
vitro	O	O
.	O	O

After	O	O
the	O	O
dental	O	O
plaque	O	O
samples	O	O
from	O	O
human	O	O
subjects	O	O
were	O	O
exposed	O	O
to	O	O
ozonated	O	O
water	O	O
in	O	O
vitro	O	O
,	O	O
almost	O	O
no	O	O
viable	O	O
bacterial	O	O
cells	O	O
were	O	O
detected	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
ozonated	O	O
water	O	O
should	O	O
be	O	O
useful	O	O
in	O	O
reducing	O	O
the	O	O
infections	O	O
caused	O	O
by	O	O
oral	O	O
microorganisms	O	O
in	O	O
dental	O	O
plaque	O	O
.	O	O

Dental	B-bacteria	B-bacteria
plaque	E-bacteria	I-bacteria
is	O	O
composed	O	O
of	O	O
a	O	O
biofilm	O	O
community	O	O
of	O	O
microorganisms	O	O
on	O	O
teeth	O	O
that	O	O
coats	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
including	O	O
attaching	O	O
to	O	O
the	O	O
teeth	O	O
,	O	O
and	O	O
provides	O	O
a	O	O
protective	O	O
reservoir	O	O
for	O	O
oral	O	O
microbial	O	O
pathogens	O	O
,	O	O
which	O	O
are	O	O
the	O	O
primary	O	O
cause	O	O
of	O	O
persistent	O	O
and	O	O
chronic	O	O
infectious	O	O
diseases	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
pioneering	O	O
organisms	O	O
that	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
biofilm	O	O
formation	O	O
on	O	O
tooth	O	O
surfaces	O	O
as	O	O
well	O	O
as	O	O
being	O	O
primary	O	O
causative	O	O
agents	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
clarify	O	O
the	O	O
role	O	O
of	O	O
the	O	O
E2f1	O	O
gene	O	O
in	O	O
susceptibility	O	O
to	O	O
dry	O	O
mouth	O	O
and	O	O
bacterial	O	O
adherence	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
to	O	O
tooth	O	O
surfaces	O	O
in	O	O
animal	O	O
model	O	O
experiments	O	O
.	O	O

A	O	O
mutation	O	O
of	O	O
the	O	O
E2f1	O	O
gene	O	O
in	O	O
mice	O	O
is	O	O
known	O	O
to	O	O
cause	O	O
enhanced	O	O
T-lymphocyte	O	O
proliferation	O	O
,	O	O
leading	O	O
to	O	O
testicular	O	O
atrophy	O	O
,	O	O
splenomegaly	O	O
,	O	O
salivary	O	O
gland	O	O
dysplasia	O	O
,	O	O
and	O	O
other	O	O
systemic	O	O
and	O	O
organ-specific	O	O
autoimmunity	O	O
.	O	O

We	O	O
found	O	O
a	O	O
decreased	O	O
volume	O	O
of	O	O
saliva	O	O
production	O	O
and	O	O
protein	O	O
production	O	O
rate	O	O
,	O	O
along	O	O
with	O	O
increased	O	O
amylase	O	O
activity	O	O
,	O	O
IgA	O	O
concentration	O	O
,	O	O
and	O	O
mucin	O	O
1	O	O
concentration	O	O
in	O	O
E2F-1	O	O
(	O	O
-/-	O	O
)	O	O
mice	O	O
as	O	O
compared	O	O
with	O	O
the	O	O
control	O	O
C57BL/6	O	O
mice	O	O
.	O	O

Further	O	O
,	O	O
we	O	O
quantified	O	O
the	O	O
recolonization	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
E2F-1	O	O
(	O	O
-/-	O	O
)	O	O
mice	O	O
and	O	O
found	O	O
that	O	O
a	O	O
higher	O	O
number	O	O
of	O	O
some	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
colonized	O	O
on	O	O
the	O	O
teeth	O	O
of	O	O
these	O	O
mice	O	O
.	O	O

In	O	O
particular	O	O
,	O	O
following	O	O
oral	O	O
ingestion	O	O
of	O	O
1	O	O
%	O	O
sucrose	O	O
in	O	O
water	O	O
,	O	O
the	O	O
colonization	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
increased	O	O
in	O	O
comparison	O	O
with	O	O
other	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Our	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
E2f1	O	O
gene	O	O
may	O	O
affect	O	O
susceptibility	O	O
for	O	O
oral	O	O
biofilm	O	O
formation	O	O
by	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
humans	O	O
with	O	O
dry	O	O
mouth	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
is	O	O
an	O	O
important	O	O
gastrointestinal	O	O
pathogen	O	O
associated	O	O
with	O	O
gastritis	O	O
,	O	O
peptic	O	O
ulcers	O	O
,	O	O
and	O	O
an	O	O
increased	O	O
risk	O	O
of	O	O
gastric	O	O
carcinoma	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
has	O	O
been	O	O
indicated	O	O
as	O	O
a	O	O
possible	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
reservoir	O	O
,	O	O
and	O	O
may	O	O
therefore	O	O
be	O	O
involved	O	O
in	O	O
the	O	O
reinfection	O	O
of	O	O
the	O	O
stomach	O	O
which	O	O
sometimes	O	O
follows	O	O
treatment	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
prevalence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
as	O	O
detected	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
periodontitis	O	O
patients	O	O
testing	O	O
positive	O	O
for	O	O
this	O	O
bacterium	O	O
in	O	O
the	O	O
stomach	O	O
.	O	O

Thirty	O	O
adult	O	O
patients	O	O
with	O	O
alterations	O	O
of	O	O
the	O	O
superior	O	O
digestive	O	O
tract	O	O
,	O	O
testing	O	O
urease	O	O
positive	O	O
after	O	O
endoscopy	O	O
and	O	O
biopsy	O	O
,	O	O
were	O	O
selected	O	O
.	O	O

A	O	O
full-mouth	O	O
periodontal	O	O
examination	O	O
was	O	O
performed	O	O
in	O	O
every	O	O
patient	O	O
and	O	O
the	O	O
subjects	O	O
were	O	O
allocated	O	O
to	O	O
two	O	O
groups	O	O
:	O	O
gingivitis	O	O
(	O	O
15	O	O
patients	O	O
)	O	O
and	O	O
chronic	O	O
periodontitis	O	O
(	O	O
15	O	O
patients	O	O
)	O	O
.	O	O

plaque	O	O
and	O	O
saliva	O	O
samples	O	O
collected	O	O
from	O	O
each	O	O
patient	O	O
were	O	O
stored	O	O
in	O	O
0.5	O	O
ml	O	O
of	O	O
TE	O	O
buffer	O	O
.	O	O

DNA	O	O
was	O	O
extracted	O	O
from	O	O
the	O	O
samples	O	O
by	O	O
the	O	O
boiling	O	O
method	O	O
and	O	O
was	O	O
evaluated	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
using	O	O
the	O	O
PCR	O	O
method	O	O
.	O	O

JW	O	O
22/23	O	O
primers	O	O
were	O	O
used	O	O
.	O	O

The	O	O
DNA	O	O
of	O	O
ATCC	O	O
H.	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
43629	E-bacteria	I-bacteria
(	O	O
positive	O	O
control	O	O
)	O	O
and	O	O
water	O	O
(	O	O
negative	O	O
control	O	O
)	O	O
were	O	O
used	O	O
for	O	O
controlling	O	O
the	O	O
reactions	O	O
.	O	O

Of	O	O
the	O	O
30	O	O
evaluated	O	O
patients	O	O
,	O	O
13	O	O
(	O	O
43.3	O	O
%	O	O
)	O	O
harbored	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
mouth	O	O
.	O	O

The	O	O
bacterium	O	O
was	O	O
not	O	O
found	O	O
on	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
of	O	O
any	O	O
patient	O	O
,	O	O
but	O	O
was	O	O
found	O	O
in	O	O
saliva	O	O
in	O	O
three	O	O
patients	O	O
(	O	O
10	O	O
%	O	O
)	O	O
,	O	O
in	O	O
the	O	O
supragingival	O	O
plaque	O	O
in	O	O
six	O	O
patients	O	O
(	O	O
20	O	O
%	O	O
)	O	O
,	O	O
and	O	O
in	O	O
the	O	O
subgingival	O	O
plaque	O	O
in	O	O
eight	O	O
patients	O	O
(	O	O
26.6	O	O
%	O	O
)	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
similar	O	O
in	O	O
the	O	O
gingivitis	O	O
and	O	O
chronic	O	O
periodontitis	O	O
groups	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
a	O	O
high	O	O
percentage	O	O
of	O	O
patients	O	O
harbored	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
their	O	O
mouth	O	O
.	O	O

The	O	O
bacterium	O	O
was	O	O
detected	O	O
in	O	O
saliva	O	O
,	O	O
supragingival	O	O
and	O	O
subgingival	O	O
plaque	O	O
,	O	O
suggesting	O	O
that	O	O
these	O	O
sites	O	O
may	O	O
be	O	O
considered	O	O
reservoirs	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
urease-positive	O	O
patients	O	O
.	O	O

The	O	O
comparative	O	O
in	O	O
vitro	O	O
activities	O	O
of	O	O
11	O	O
iodonium	O	O
salt	O	O
compounds	O	O
,	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
,	O	O
and	O	O
four	O	O
antimicrobial	O	O
agents	O	O
against	O	O
322	O	O
anaerobic	O	O
and	O	O
fastidious	O	O
potential	O	O
dental	O	O
and	O	O
periodontal	B-bacteria	B-bacteria
bacterial	I-bacteria	I-bacteria
pathogens	E-bacteria	I-bacteria
were	O	O
studied	O	O
.	O	O

Iodonium	O	O
salts	O	O
3	O	O
,	O	O
4	O	O
,	O	O
5	O	O
,	O	O
9	O	O
,	O	O
and	O	O
10	O	O
had	O	O
in	O	O
vitro	O	O
activities	O	O
comparable	O	O
to	O	O
that	O	O
of	O	O
chlorhexidine	O	O
against	O	O
most	O	O
isolates	O	O
.	O	O

These	O	O
compounds	O	O
may	O	O
be	O	O
suitable	O	O
for	O	O
incorporation	O	O
into	O	O
an	O	O
oral	O	O
mouthwash	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
relationship	O	O
between	O	O
oral	O	O
bacteria	O	O
species	O	O
detection	O	O
and	O	O
volatile	O	O
sulphide	O	O
compounds	O	O
(	O	O
VSC	O	O
)	O	O
concentration	O	O
in	O	O
the	O	O
elderly	O	O
.	O	O

Cross-sectional	O	O
microbiological	O	O
and	O	O
clinical	O	O
VSC	O	O
examination	O	O
of	O	O
elderly	O	O
.	O	O

Sixty-seven	O	O
elderly	O	O
people	O	O
aged	O	O
75	O	O
,	O	O
who	O	O
were	O	O
functionally	O	O
independent	O	O
and	O	O
dentate	O	O
.	O	O

VSC	O	O
(	O	O
H2S	O	O
and	O	O
CH3SH	O	O
)	O	O
concentrations	O	O
in	O	O
the	O	O
mouth	O	O
air	O	O
of	O	O
subjects	O	O
were	O	O
measured	O	O
using	O	O
portable	O	O
gas	O	O
chromatography	O	O
.	O	O

Oral	O	O
bacteria	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
dental	O	O
plaque	O	O
and	O	O
identification	O	O
of	O	O
bacteria	O	O
species	O	O
was	O	O
accomplished	O	O
using	O	O
standard	O	O
methods	O	O
.	O	O

Fewer	O	O
than	O	O
20	O	O
%	O	O
of	O	O
subjects	O	O
showed	O	O
more	O	O
than	O	O
10	O	O
ng/10	O	O
ml	O	O
of	O	O
H2S	O	O
(	O	O
severe	O	O
odour	O	O
level	O	O
)	O	O
.	O	O

The	O	O
detection	O	O
rate	O	O
of	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
was	O	O
significantly	O	O
higher	O	O
in	O	O
elderly	O	O
people	O	O
with	O	O
more	O	O
than	O	O
10	O	O
ng/10	O	O
ml	O	O
(	O	O
p=0.043	O	O
)	O	O
levels	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
had	O	O
a	O	O
tendency	O	O
to	O	O
be	O	O
found	O	O
in	O	O
those	O	O
with	O	O
more	O	O
than	O	O
10	O	O
ng/10	O	O
ml	O	O
,	O	O
but	O	O
a	O	O
significant	O	O
relation	O	O
was	O	O
not	O	O
found	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
Fusobacterium	B-bacteria	B-bacteria
and	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
may	O	O
be	O	O
involved	O	O
in	O	O
the	O	O
production	O	O
of	O	O
H2S	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
elderly	O	O
people	O	O
.	O	O

Microbial	O	O
communities	O	O
within	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
are	O	O
dynamic	O	O
associations	O	O
of	O	O
more	O	O
than	O	O
500	O	O
bacterial	O	O
species	O	O
that	O	O
form	O	O
biofilms	O	O
on	O	O
the	O	O
soft	O	O
and	O	O
hard	O	O
tissues	O	O
of	O	O
the	O	O
mouth	O	O
.	O	O

Understanding	O	O
the	O	O
development	O	O
and	O	O
spatial	O	O
organization	O	O
of	O	O
oral	O	O
biofilms	O	O
has	O	O
been	O	O
facilitated	O	O
by	O	O
the	O	O
use	O	O
of	O	O
in	O	O
vitro	O	O
models	O	O
.	O	O

We	O	O
used	O	O
a	O	O
saliva-conditioned	O	O
flow	O	O
cell	O	O
,	O	O
with	O	O
saliva	O	O
as	O	O
the	O	O
sole	O	O
nutritional	O	O
source	O	O
,	O	O
as	O	O
a	O	O
model	O	O
to	O	O
examine	O	O
the	O	O
development	O	O
of	O	O
multispecies	O	O
biofilm	O	O
communities	O	O
from	O	O
an	O	O
inoculum	O	O
containing	O	O
the	O	O
coaggregation	O	O
partners	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
atypica	E-bacteria	I-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Biofilms	O	O
inoculated	O	O
with	O	O
individual	O	O
species	O	O
in	O	O
a	O	O
sequential	O	O
order	O	O
were	O	O
compared	O	O
with	O	O
biofilms	O	O
inoculated	O	O
with	O	O
coaggregates	O	O
of	O	O
the	O	O
four	O	O
species	O	O
.	O	O

Our	O	O
results	O	O
indicated	O	O
that	O	O
flow	O	O
cells	O	O
inoculated	O	O
sequentially	O	O
produced	O	O
biofilms	O	O
with	O	O
larger	O	O
biovolumes	O	O
compared	O	O
to	O	O
those	O	O
biofilms	O	O
inoculated	O	O
with	O	O
coaggregates	O	O
.	O	O

Individual-species	O	O
biovolumes	O	O
within	O	O
the	O	O
four-species	O	O
communities	O	O
also	O	O
differed	O	O
between	O	O
the	O	O
two	O	O
modes	O	O
of	O	O
inoculation	O	O
.	O	O

Fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
with	O	O
genus-	O	O
and	O	O
species-specific	O	O
probes	O	O
revealed	O	O
that	O	O
the	O	O
majority	O	O
of	O	O
cells	O	O
in	O	O
both	O	O
sequentially	O	O
and	O	O
coaggregate-inoculated	O	O
biofilms	O	O
were	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
regardless	O	O
of	O	O
the	O	O
inoculation	O	O
order	O	O
.	O	O

However	O	O
,	O	O
the	O	O
representation	O	O
of	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
V.	B-bacteria	B-bacteria
atypica	E-bacteria	I-bacteria
was	O	O
significantly	O	O
higher	O	O
in	O	O
biofilms	O	O
inoculated	O	O
with	O	O
coaggregates	O	O
compared	O	O
to	O	O
sequentially	O	O
inoculated	O	O
biofilms	O	O
.	O	O

Thus	O	O
,	O	O
these	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
development	O	O
of	O	O
multispecies	O	O
biofilm	O	O
communities	O	O
is	O	O
influenced	O	O
by	O	O
coaggregations	O	O
preformed	O	O
in	O	O
planktonic	O	O
phase	O	O
.	O	O

Coaggregating	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
such	O	O
as	O	O
certain	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
are	O	O
especially	O	O
adapted	O	O
to	O	O
primary	O	O
colonization	O	O
of	O	O
saliva-conditioned	O	O
surfaces	O	O
independent	O	O
of	O	O
the	O	O
mode	O	O
of	O	O
inoculation	O	O
and	O	O
order	O	O
of	O	O
addition	O	O
in	O	O
the	O	O
multispecies	O	O
inoculum	O	O
.	O	O

Preformed	O	O
coaggregations	O	O
favor	O	O
other	O	O
bacterial	O	O
strains	O	O
and	O	O
may	O	O
facilitate	O	O
symbiotic	O	O
relationships	O	O
.	O	O

To	O	O
isolate	O	O
bacteriophages	O	O
lytic	O	O
for	O	O
oral	O	O
pathogens	O	O
from	O	O
human	O	O
saliva	O	O
,	O	O
dental	O	O
plaque	O	O
and	O	O
mature	O	O
biofilms	O	O
constituted	O	O
from	O	O
saliva-derived	O	O
bacteria	O	O
.	O	O

Saliva	O	O
and	O	O
dental	O	O
plaque	O	O
samples	O	O
from	O	O
healthy	O	O
volunteers	O	O
and	O	O
from	O	O
patients	O	O
with	O	O
gingivitis	O	O
and	O	O
periodontitis	O	O
were	O	O
examined	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
lytic	O	O
bacteriophages	O	O
using	O	O
a	O	O
panel	O	O
of	O	O
oral	O	O
pathogens	O	O
and	O	O
bacteria	O	O
isolated	O	O
from	O	O
the	O	O
samples	O	O
.	O	O

Samples	O	O
were	O	O
also	O	O
enriched	O	O
for	O	O
bacteriophage	O	O
using	O	O
static	O	O
culture	O	O
techniques	O	O
and	O	O
mature	O	O
biofilms	O	O
.	O	O

A	O	O
limited	O	O
number	O	O
of	O	O
samples	O	O
contained	O	O
bacteriophage	O	O
particles	O	O
that	O	O
were	O	O
visualized	O	O
using	O	O
electron	O	O
microscopy	O	O
.	O	O

Cultures	O	O
yielded	O	O
phage	O	O
infecting	O	O
non-oral	O	O
bacteria	O	O
(	O	O
Proteus	B-bacteria	B-bacteria
mirabilis	E-bacteria	I-bacteria
)	O	O
but	O	O
no	O	O
bacteriophage	O	O
specific	O	O
for	O	O
recognized	O	O
oral	O	O
pathogens	O	O
were	O	O
found	O	O
.	O	O

Some	O	O
micro-organisms	O	O
from	O	O
the	O	O
oral	O	O
microflora	O	O
elaborated	O	O
antibacterial	O	O
substances	O	O
that	O	O
inhibited	O	O
growth	O	O
of	O	O
other	O	O
residents	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Unlike	O	O
other	O	O
ecosystems	O	O
,	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
does	O	O
not	O	O
appear	O	O
to	O	O
be	O	O
heavily	O	O
influenced	O	O
by	O	O
interactions	O	O
between	O	O
bacteriophages	O	O
and	O	O
their	O	O
hosts	O	O
.	O	O

Bacteriophage	O	O
for	O	O
control	O	O
of	O	O
oral	O	O
infections	O	O
may	O	O
need	O	O
to	O	O
be	O	O
obtained	O	O
from	O	O
other	O	O
sources	O	O
.	O	O

Antibacterial	O	O
substances	O	O
derived	O	O
from	O	O
some	O	O
members	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
warrant	O	O
investigation	O	O
as	O	O
potential	O	O
antibiotics	O	O
.	O	O

Mercury-resistant	O	O
bacteria	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
children	O	O
carried	O	O
one	O	O
of	O	O
two	O	O
types	O	O
of	O	O
merA	O	O
gene	O	O
that	O	O
appear	O	O
to	O	O
have	O	O
evolved	O	O
from	O	O
a	O	O
common	O	O
ancestor	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
a	O	O
few	O	O
other	O	O
species	O	O
had	O	O
merA	O	O
genes	O	O
that	O	O
were	O	O
very	O	O
similar	O	O
to	O	O
merA	O	O
of	O	O
Bacillus	B-bacteria	B-bacteria
cereus	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
RC607	E-bacteria	I-bacteria
.	O	O

Unlike	O	O
the	O	O
B.	B-bacteria	B-bacteria
cereus	I-bacteria	I-bacteria
RC607	E-bacteria	I-bacteria
merA	O	O
gene	O	O
,	O	O
however	O	O
,	O	O
the	O	O
streptococcal	O	O
merA	O	O
genes	O	O
were	O	O
not	O	O
carried	O	O
on	O	O
Tn5084-like	O	O
transposons	O	O
.	O	O

Instead	O	O
,	O	O
comparisons	O	O
with	O	O
microbial	O	O
genomic	O	O
sequences	O	O
suggest	O	O
the	O	O
merA	O	O
gene	O	O
is	O	O
located	O	O
on	O	O
a	O	O
novel	O	O
type	O	O
II	O	O
transposon	O	O
.	O	O

Coagulase-negative	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
parasanguis	E-bacteria	I-bacteria
had	O	O
identical	O	O
merA	O	O
genes	O	O
that	O	O
represent	O	O
a	O	O
new	O	O
merA	O	O
variant	O	O
.	O	O

The	O	O
alanine-rich	O	O
repeating	O	O
region	O	O
(	O	O
A-region	O	O
)	O	O
in	O	O
the	O	O
surface	O	O
protein	O	O
antigen	O	O
(	O	O
PAc	O	O
)	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
has	O	O
received	O	O
much	O	O
attention	O	O
as	O	O
an	O	O
antigenic	O	O
component	O	O
for	O	O
vaccines	O	O
against	O	O
dental	O	O
caries	O	O
.	O	O

The	O	O
PAc	O	O
(	O	O
residue	O	O
361-386	O	O
)	O	O
peptide	O	O
in	O	O
the	O	O
A-region	O	O
possesses	O	O
a	O	O
multiple	O	O
binding	O	O
motif	O	O
(	O	O
L-	O	O
-V-K-	O	O
-A	O	O
)	O	O
to	O	O
various	O	O
HLA-DR	O	O
molecules	O	O
and	O	O
a	O	O
B-cell	O	O
core	O	O
epitope	O	O
(	O	O
-	O	O
Y-	O	O
-	O	O
-L-	O	O
-Y-	O	O
-	O	O
-	O	O
-	O	O
)	O	O
that	O	O
recognizes	O	O
the	O	O
inhibiting	O	O
antibody	O	O
to	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
immunogenicity	O	O
of	O	O
the	O	O
PAc	O	O
(	O	O
361-386	O	O
)	O	O
peptide	O	O
in	O	O
humans	O	O
and	O	O
regulators	O	O
of	O	O
induction	O	O
of	O	O
the	O	O
anti-PAc	O	O
(	O	O
361-386	O	O
)	O	O
peptide	O	O
IgA	O	O
antibody	O	O
(	O	O
aPPA	O	O
)	O	O
in	O	O
saliva	O	O
.	O	O

The	O	O
PAc	O	O
(	O	O
361-386	O	O
)	O	O
peptide	O	O
was	O	O
confirmed	O	O
as	O	O
an	O	O
ideal	O	O
peptide	O	O
antigen	O	O
for	O	O
induction	O	O
of	O	O
the	O	O
inhibiting	O	O
antibody	O	O
to	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
151	O	O
healthy	O	O
human	O	O
subjects	O	O
(	O	O
36.6	O	O
+/-	O	O
12.6	O	O
years	O	O
old	O	O
)	O	O
by	O	O
quantitative	O	O
analyses	O	O
of	O	O
oral	O	O
bacteria	O	O
and	O	O
ELISA	O	O
,	O	O
as	O	O
the	O	O
aPPA	O	O
titre	O	O
in	O	O
human	O	O
saliva	O	O
decreased	O	O
significantly	O	O
in	O	O
an	O	O
age-dependent	O	O
manner	O	O
.	O	O

Homozygous	O	O
DRB1*0405	O	O
and	O	O
1502	O	O
,	O	O
and	O	O
heterozygous	O	O
DRB1*0405/1502	O	O
showed	O	O
a	O	O
negative	O	O
association	O	O
with	O	O
production	O	O
of	O	O
aPPA	O	O
and	O	O
tended	O	O
to	O	O
reduce	O	O
the	O	O
number	O	O
of	O	O
total	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
saliva	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
the	O	O
DRB1*1501	O	O
allele	O	O
was	O	O
significantly	O	O
correlated	O	O
with	O	O
a	O	O
high	O	O
level	O	O
of	O	O
induction	O	O
of	O	O
the	O	O
antibodies	O	O
,	O	O
and	O	O
also	O	O
tended	O	O
to	O	O
reduce	O	O
lactobacilli	B-bacteria	B-bacteria
and	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

Further	O	O
,	O	O
peptide	O	O
immunogenicity	O	O
was	O	O
confirmed	O	O
in	O	O
NOD-SCID	O	O
mice	O	O
grafted	O	O
with	O	O
human	O	O
peripheral	O	O
blood	O	O
mononuclear	O	O
cells	O	O
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
interplay	O	O
between	O	O
regulators	O	O
such	O	O
as	O	O
age	O	O
,	O	O
DRB1	O	O
genotype	O	O
,	O	O
cytokines	O	O
,	O	O
and	O	O
peptide	O	O
immunogenicity	O	O
may	O	O
provide	O	O
a	O	O
potential	O	O
means	O	O
for	O	O
developing	O	O
a	O	O
vaccine	O	O
useful	O	O
for	O	O
the	O	O
prevention	O	O
of	O	O
dental	O	O
caries	O	O
as	O	O
well	O	O
as	O	O
their	O	O
diagnosis	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
play	O	O
a	O	O
large	O	O
role	O	O
in	O	O
dental	O	O
biofilm	O	O
formation	O	O
,	O	O
and	O	O
several	O	O
types	O	O
interact	O	O
as	O	O
early	O	O
colonizers	O	O
with	O	O
the	O	O
enamel	O	O
salivary	O	O
pellicle	O	O
to	O	O
form	O	O
the	O	O
primary	O	O
biofilm	O	O
,	O	O
as	O	O
well	O	O
as	O	O
to	O	O
incorporate	O	O
other	O	O
bacteria	O	O
on	O	O
tooth	O	O
surfaces	O	O
.	O	O

Interactions	O	O
of	O	O
surface	O	O
molecules	O	O
of	O	O
individual	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
with	O	O
the	O	O
salivary	O	O
pellicle	O	O
on	O	O
the	O	O
tooth	O	O
surface	O	O
have	O	O
an	O	O
influence	O	O
on	O	O
the	O	O
etiological	O	O
properties	O	O
of	O	O
an	O	O
oral	O	O
biofilm	O	O
.	O	O

To	O	O
elucidate	O	O
the	O	O
molecular	O	O
interactions	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
with	O	O
salivary	O	O
components	O	O
,	O	O
binding	O	O
between	O	O
surface	O	O
protein	O	O
(	O	O
SspB	O	O
and	O	O
PAg	O	O
)	O	O
peptides	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
were	O	O
investigated	O	O
by	O	O
utilizing	O	O
BIAcore	O	O
biosensor	O	O
technology	O	O
.	O	O

The	O	O
analogous	O	O
peptide	O	O
[	O	O
change	O	O
of	O	O
T	O	O
at	O	O
position	O	O
400	O	O
to	O	O
K	O	O
in	O	O
SspB	O	O
(	O	O
390-402	O	O
)	O	O
,	O	O
resulting	O	O
in	O	O
the	O	O
SspB	O	O
(	O	O
390-T400K-402	O	O
)	O	O
peptide	O	O
]	O	O
from	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
showed	O	O
the	O	O
greatest	O	O
response	O	O
for	O	O
binding	O	O
to	O	O
salivary	O	O
components	O	O
and	O	O
inhibited	O	O
the	O	O
binding	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
by	O	O
more	O	O
than	O	O
50	O	O
%	O	O
in	O	O
a	O	O
competitive	O	O
inhibition	O	O
assay	O	O
in	O	O
a	O	O
comparison	O	O
with	O	O
other	O	O
SspB	O	O
and	O	O
PAg	O	O
peptides	O	O
.	O	O

This	O	O
peptide	O	O
also	O	O
bound	O	O
to	O	O
the	O	O
high-molecular-weight	O	O
protein	O	O
complex	O	O
of	O	O
salivary	O	O
components	O	O
and	O	O
the	O	O
agglutinin	O	O
(	O	O
gp340/DMBT1	O	O
)	O	O
peptide	O	O
(	O	O
scavenger	O	O
receptor	O	O
cysteine-rich	O	O
domain	O	O
peptide	O	O
2	O	O
[	O	O
SRCRP	O	O
2	O	O
]	O	O
)	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
SspB	O	O
(	O	O
390-T400K-402	O	O
)	O	O
peptide	O	O
was	O	O
visualized	O	O
by	O	O
two	O	O
surface	O	O
positive	O	O
charges	O	O
in	O	O
connection	O	O
with	O	O
the	O	O
positively	O	O
charged	O	O
residues	O	O
,	O	O
in	O	O
which	O	O
lysine	O	O
was	O	O
a	O	O
key	O	O
residue	O	O
for	O	O
binding	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
region	O	O
containing	O	O
lysine	O	O
may	O	O
have	O	O
binding	O	O
activity	O	O
in	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
SRCRP	O	O
2	O	O
region	O	O
may	O	O
function	O	O
as	O	O
a	O	O
receptor	O	O
for	O	O
the	O	O
binding	O	O
.	O	O

These	O	O
findings	O	O
may	O	O
provide	O	O
useful	O	O
information	O	O
regarding	O	O
the	O	O
molecular	O	O
mechanism	O	O
of	O	O
early	O	O
biofilm	O	O
formation	O	O
by	O	O
streptococci	B-bacteria	B-bacteria
on	O	O
tooth	O	O
surfaces	O	O
.	O	O

Dental	O	O
plaque	O	O
samples	O	O
from	O	O
40	O	O
children	O	O
were	O	O
screened	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
bacteria	O	O
resistant	O	O
to	O	O
amoxicillin	O	O
.	O	O

Fifteen	O	O
children	O	O
had	O	O
used	O	O
amoxicillin	O	O
and	O	O
25	O	O
had	O	O
not	O	O
used	O	O
any	O	O
antibiotic	O	O
in	O	O
the	O	O
3	O	O
months	O	O
prior	O	O
to	O	O
sample	O	O
collection	O	O
.	O	O

All	O	O
(	O	O
100	O	O
%	O	O
)	O	O
of	O	O
the	O	O
children	O	O
harbored	O	O
amoxicillin-resistant	O	O
oral	O	O
bacteria	O	O
.	O	O

The	O	O
median	O	O
percentage	O	O
of	O	O
the	O	O
total	O	O
cultivable	O	O
oral	O	O
microbiota	O	O
resistant	O	O
to	O	O
amoxicillin	O	O
was	O	O
2.4	O	O
%	O	O
(	O	O
range	O	O
,	O	O
0.1	O	O
to	O	O
14.3	O	O
%	O	O
)	O	O
in	O	O
children	O	O
without	O	O
amoxicillin	O	O
use	O	O
and	O	O
10.9	O	O
%	O	O
(	O	O
range	O	O
,	O	O
0.8	O	O
to	O	O
97.3	O	O
%	O	O
)	O	O
in	O	O
children	O	O
with	O	O
amoxicillin	O	O
use	O	O
,	O	O
with	O	O
the	O	O
latter	O	O
value	O	O
being	O	O
significantly	O	O
higher	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

A	O	O
total	O	O
of	O	O
224	O	O
amoxicillin-resistant	O	O
bacteria	O	O
were	O	O
isolated	O	O
and	O	O
comprised	O	O
three	O	O
main	O	O
genera	O	O
:	O	O
Haemophilus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

The	O	O
biodiversity	O	O
of	O	O
the	O	O
amoxicillin-resistant	O	O
microbiota	O	O
was	O	O
similar	O	O
among	O	O
the	O	O
isolates	O	O
from	O	O
children	O	O
with	O	O
and	O	O
without	O	O
previous	O	O
antibiotic	O	O
use	O	O
.	O	O

The	O	O
amoxicillin	O	O
MIC	O	O
at	O	O
which	O	O
90	O	O
%	O	O
of	O	O
the	O	O
isolates	O	O
were	O	O
inhibited	O	O
for	O	O
isolates	O	O
from	O	O
children	O	O
who	O	O
had	O	O
used	O	O
amoxicillin	O	O
in	O	O
the	O	O
previous	O	O
3	O	O
months	O	O
was	O	O
higher	O	O
(	O	O
64	O	O
mg	O	O
liter	O	O
(	O	O
-1	O	O
)	O	O
)	O	O
than	O	O
that	O	O
obtained	O	O
for	O	O
the	O	O
isolates	O	O
from	O	O
subjects	O	O
who	O	O
had	O	O
not	O	O
used	O	O
antibiotics	O	O
(	O	O
16	O	O
mg	O	O
liter	O	O
(	O	O
-1	O	O
)	O	O
)	O	O
.	O	O

The	O	O
majority	O	O
of	O	O
the	O	O
amoxicillin-resistant	O	O
isolates	O	O
(	O	O
65	O	O
%	O	O
)	O	O
were	O	O
also	O	O
resistant	O	O
to	O	O
at	O	O
least	O	O
one	O	O
of	O	O
the	O	O
three	O	O
antibiotics	O	O
tested	O	O
(	O	O
penicillin	O	O
,	O	O
erythromycin	O	O
,	O	O
and	O	O
tetracycline	O	O
)	O	O
,	O	O
with	O	O
resistance	O	O
to	O	O
penicillin	O	O
(	O	O
51	O	O
%	O	O
of	O	O
isolates	O	O
)	O	O
being	O	O
the	O	O
most	O	O
frequently	O	O
encountered	O	O
.	O	O

However	O	O
,	O	O
significantly	O	O
more	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
of	O	O
the	O	O
amoxicillin-resistant	O	O
isolates	O	O
from	O	O
subjects	O	O
with	O	O
previous	O	O
amoxicillin	O	O
use	O	O
were	O	O
also	O	O
resistant	O	O
to	O	O
erythromycin	O	O
.	O	O

This	O	O
study	O	O
has	O	O
demonstrated	O	O
that	O	O
a	O	O
diverse	O	O
collection	O	O
of	O	O
amoxicillin-resistant	O	O
bacteria	O	O
is	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
that	O	O
the	O	O
number	O	O
,	O	O
proportions	O	O
,	O	O
MICs	O	O
,	O	O
and	O	O
resistance	O	O
to	O	O
erythromycin	O	O
can	O	O
significantly	O	O
increase	O	O
with	O	O
amoxicillin	O	O
use	O	O
.	O	O

Motile	O	O
bacteria	O	O
often	O	O
use	O	O
sophisticated	O	O
chemotaxis	O	O
signaling	O	O
systems	O	O
to	O	O
direct	O	O
their	O	O
movements	O	O
.	O	O

In	O	O
general	O	O
,	O	O
bacterial	O	O
chemotactic	O	O
signal	O	O
transduction	O	O
pathways	O	O
have	O	O
three	O	O
basic	O	O
elements	O	O
:	O	O
(	O	O
1	O	O
)	O	O
signal	O	O
reception	O	O
by	O	O
bacterial	O	O
chemoreceptors	O	O
located	O	O
on	O	O
the	O	O
membrane	O	O
;	O	O
(	O	O
2	O	O
)	O	O
signal	O	O
transduction	O	O
to	O	O
relay	O	O
the	O	O
signals	O	O
from	O	O
membrane	O	O
receptors	O	O
to	O	O
the	O	O
motor	O	O
;	O	O
and	O	O
(	O	O
3	O	O
)	O	O
signal	O	O
adaptation	O	O
to	O	O
desensitize	O	O
the	O	O
initial	O	O
signal	O	O
input	O	O
.	O	O

The	O	O
chemotaxis	O	O
proteins	O	O
involved	O	O
in	O	O
these	O	O
signal	O	O
transduction	O	O
pathways	O	O
have	O	O
been	O	O
identified	O	O
and	O	O
extensively	O	O
studied	O	O
,	O	O
especially	O	O
in	O	O
the	O	O
enterobacteria	B-bacteria	B-bacteria
Escherichia	I-bacteria	I-bacteria
coli	E-bacteria	I-bacteria
and	O	O
Salmonella	B-bacteria	B-bacteria
enterica	E-bacteria	I-bacteria
serovar	O	O
typhimurium	O	O
.	O	O

Chemotaxis-guided	O	O
bacterial	O	O
movements	O	O
enable	O	O
bacteria	O	O
to	O	O
adapt	O	O
better	O	O
to	O	O
their	O	O
natural	O	O
habitats	O	O
via	O	O
moving	O	O
toward	O	O
favorable	O	O
conditions	O	O
and	O	O
away	O	O
from	O	O
hostile	O	O
surroundings	O	O
.	O	O

A	O	O
variety	O	O
of	O	O
oral	O	O
microbes	O	O
exhibits	O	O
motility	O	O
and	O	O
chemotaxis	O	O
,	O	O
behaviors	O	O
that	O	O
may	O	O
play	O	O
important	O	O
roles	O	O
in	O	O
bacterial	O	O
survival	O	O
and	O	O
pathogenesis	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
innate	O	O
immune	O	O
response	O	O
is	O	O
of	O	O
pivotal	O	O
importance	O	O
in	O	O
defending	O	O
the	O	O
mucosal	O	O
barriers	O	O
of	O	O
the	O	O
body	O	O
against	O	O
pathogenic	O	O
attack	O	O
.	O	O

The	O	O
list	O	O
of	O	O
proteins	O	O
that	O	O
contribute	O	O
to	O	O
this	O	O
defense	O	O
mechanism	O	O
is	O	O
constantly	O	O
being	O	O
updated	O	O
.	O	O

In	O	O
this	O	O
review	O	O
we	O	O
introduce	O	O
a	O	O
novel	O	O
family	O	O
of	O	O
secreted	O	O
proteins	O	O
,	O	O
palate	O	O
,	O	O
lung	O	O
,	O	O
and	O	O
nasal	O	O
epithelium	O	O
clones	O	O
(	O	O
PLUNCs	O	O
)	O	O
,	O	O
that	O	O
are	O	O
expressed	O	O
in	O	O
the	O	O
mouth	O	O
,	O	O
nose	O	O
and	O	O
upper	O	O
airways	O	O
of	O	O
humans	O	O
,	O	O
mice	O	O
,	O	O
rats	O	O
and	O	O
cows	O	O
.	O	O

In	O	O
humans	O	O
,	O	O
PLUNC	O	O
genes	O	O
are	O	O
located	O	O
in	O	O
a	O	O
compact	O	O
cluster	O	O
on	O	O
chromosome	O	O
20	O	O
,	O	O
with	O	O
similar	O	O
loci	O	O
being	O	O
found	O	O
in	O	O
synteneic	O	O
locations	O	O
in	O	O
other	O	O
species	O	O
.	O	O

The	O	O
protein	O	O
products	O	O
of	O	O
this	O	O
gene	O	O
cluster	O	O
are	O	O
predicted	O	O
to	O	O
be	O	O
structural	O	O
homologues	O	O
of	O	O
the	O	O
human	O	O
lipopolysaccharide	O	O
binding	O	O
proteins	O	O
,	O	O
lipopolysaccharide	O	O
binding-protein	O	O
(	O	O
LBP	O	O
)	O	O
and	O	O
bacterial	O	O
permeability-increasing	O	O
protein	O	O
(	O	O
BPI	O	O
)	O	O
,	O	O
which	O	O
are	O	O
known	O	O
mediators	O	O
of	O	O
host	O	O
defense	O	O
against	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

On	O	O
the	O	O
basis	O	O
of	O	O
these	O	O
observations	O	O
we	O	O
outline	O	O
why	O	O
we	O	O
believe	O	O
PLUNC	O	O
proteins	O	O
mediate	O	O
host	O	O
defense	O	O
functions	O	O
in	O	O
the	O	O
oral	O	O
,	O	O
nasal	O	O
and	O	O
respiratory	O	O
epithelia	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
analyze	O	O
the	O	O
relationship	O	O
between	O	O
oral	O	O
bacterial	O	O
colonization	O	O
and	O	O
oral	O	O
motor	O	O
dysfunction	O	O
.	O	O

Oral	O	O
motor	O	O
dysfunction	O	O
(	O	O
swallowing	O	O
and	O	O
speech	O	O
disorders	O	O
)	O	O
and	O	O
detection	O	O
of	O	O
oral	O	O
bacterial	O	O
species	O	O
from	O	O
dental	O	O
plaque	O	O
in	O	O
55	O	O
elderly	O	O
persons	O	O
who	O	O
had	O	O
remained	O	O
hospitalized	O	O
for	O	O
more	O	O
than	O	O
3	O	O
months	O	O
were	O	O
investigated	O	O
and	O	O
statistically	O	O
analyzed	O	O
.	O	O

The	O	O
detection	O	O
rates	O	O
of	O	O
methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
agalactiae	E-bacteria	I-bacteria
,	O	O
and	O	O
Stenotrophomonas	B-bacteria	B-bacteria
maltophilia	E-bacteria	I-bacteria
were	O	O
significantly	O	O
higher	O	O
in	O	O
subjects	O	O
with	O	O
than	O	O
in	O	O
those	O	O
without	O	O
a	O	O
swallowing	O	O
disorder	O	O
.	O	O

A	O	O
similar	O	O
result	O	O
was	O	O
found	O	O
with	O	O
regard	O	O
to	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
speech	O	O
disorder	O	O
.	O	O

About	O	O
half	O	O
of	O	O
subjects	O	O
who	O	O
had	O	O
oral	O	O
motor	O	O
dysfunction	O	O
and	O	O
hypoalbuminemia	O	O
had	O	O
colonization	O	O
by	O	O
MRSA	B-bacteria	B-bacteria
and/or	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
combination	O	O
of	O	O
oral	O	O
motor	O	O
dysfunction	O	O
and	O	O
hypoalbminemia	O	O
elevated	O	O
the	O	O
risk	O	O
of	O	O
opportunistic	O	O
microorganisms	O	O
colonization	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
elderly	O	O
patients	O	O
hospitalized	O	O
over	O	O
the	O	O
long	O	O
term	O	O
.	O	O

Clinical	O	O
studies	O	O
have	O	O
demonstrated	O	O
the	O	O
considerable	O	O
effects	O	O
of	O	O
chlorhexidine	O	O
on	O	O
dental	O	O
plaque	O	O
and	O	O
oral	O	O
microbiota	O	O
as	O	O
well	O	O
as	O	O
improvements	O	O
in	O	O
indices	O	O
of	O	O
oral	O	O
health	O	O
.	O	O

This	O	O
investigation	O	O
examined	O	O
the	O	O
efficacy	O	O
of	O	O
lower	O	O
concentrations	O	O
of	O	O
chlorhexidine	O	O
.	O	O

Mouthrinses	O	O
with	O	O
0.03	O	O
%	O	O
,	O	O
0.06	O	O
%	O	O
,	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
and	O	O
a	O	O
control	O	O
rinse	O	O
without	O	O
chlorhexidine	O	O
were	O	O
examined	O	O
.	O	O

Alamar	O	O
blue	O	O
,	O	O
an	O	O
oxidation-reduction	O	O
dye	O	O
with	O	O
fluorescent	O	O
end-points	O	O
proportional	O	O
to	O	O
bacterial	O	O
viability	O	O
,	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
bacterial	O	O
viability	O	O
.	O	O

Further	O	O
clinical	O	O
studies	O	O
examined	O	O
the	O	O
effects	O	O
of	O	O
these	O	O
rinses	O	O
on	O	O
salivary	O	O
bacteria	O	O
and	O	O
on	O	O
bacteria	O	O
producing	O	O
hydrogen	O	O
sulfide	O	O
(	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
)	O	O
and	O	O
implicated	O	O
in	O	O
halitosis	O	O
.	O	O

In	O	O
laboratory	O	O
tests	O	O
,	O	O
a	O	O
significant	O	O
dose-dependent	O	O
effect	O	O
was	O	O
observed	O	O
with	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
as	O	O
a	O	O
model	O	O
system	O	O
using	O	O
the	O	O
Alamar	O	O
blue	O	O
procedure	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Clinical	O	O
studies	O	O
examined	O	O
the	O	O
effects	O	O
1.5	O	O
h	O	O
and	O	O
3	O	O
h	O	O
post-treatment	O	O
on	O	O
salivary	O	O
bacteria	O	O
and	O	O
bacteria	O	O
producing	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
.	O	O

The	O	O
first	O	O
study	O	O
compared	O	O
the	O	O
control	O	O
rinse	O	O
with	O	O
the	O	O
0.03	O	O
%	O	O
and	O	O
0.06	O	O
%	O	O
chlorhexidine	O	O
rinses	O	O
;	O	O
a	O	O
second	O	O
study	O	O
compared	O	O
the	O	O
effects	O	O
of	O	O
the	O	O
control	O	O
rinse	O	O
and	O	O
the	O	O
0.06	O	O
%	O	O
and	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
mouthrinses	O	O
.	O	O

In	O	O
both	O	O
studies	O	O
,	O	O
chlorhexidine	O	O
rinses	O	O
demonstrated	O	O
significant	O	O
dose-dependent	O	O
effects	O	O
post-treatment	O	O
on	O	O
salivary	O	O
bacteria	O	O
vs.	O	O
the	O	O
control	O	O
rinse	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Significant	O	O
decreases	O	O
in	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S-producing	O	O
bacteria	O	O
were	O	O
noted	O	O
with	O	O
these	O	O
chlorhexidine	O	O
rinses	O	O
vs.	O	O
the	O	O
control	O	O
rinse	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
results	O	O
highlight	O	O
the	O	O
dose-dependent	O	O
relationships	O	O
noted	O	O
in	O	O
laboratory	O	O
and	O	O
clinical	O	O
tests	O	O
which	O	O
have	O	O
potential	O	O
implications	O	O
for	O	O
the	O	O
use	O	O
of	O	O
lower	O	O
doses	O	O
of	O	O
chlorhexidine	O	O
to	O	O
inhibit	O	O
oral	O	O
bacteria	O	O
,	O	O
including	O	O
those	O	O
implicated	O	O
in	O	O
halitosis	O	O
.	O	O

Four	O	O
oral	O	O
bacterial	O	O
strains	O	O
,	O	O
of	O	O
which	O	O
two	O	O
are	O	O
considered	O	O
aciduric	O	O
and	O	O
two	O	O
are	O	O
considered	O	O
acid-sensitive	O	O
,	O	O
were	O	O
grown	O	O
under	O	O
glucose-limiting	O	O
conditions	O	O
in	O	O
chemostats	O	O
to	O	O
determine	O	O
whether	O	O
their	O	O
membrane	O	O
fatty	O	O
acid	O	O
profiles	O	O
were	O	O
altered	O	O
in	O	O
response	O	O
to	O	O
environmental	O	O
acidification	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
DL1	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
aciduric	B-bacteria	B-bacteria
strains	I-bacteria	I-bacteria
S.	I-bacteria	I-bacteria
salivarius	I-bacteria	I-bacteria
57.I	E-bacteria	I-bacteria
,	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	I-bacteria	I-bacteria
4646	E-bacteria	I-bacteria
increased	O	O
the	O	O
levels	O	O
of	O	O
mono-unsaturated	O	O
membrane	O	O
fatty	O	O
acids	O	O
.	O	O

The	O	O
non-aciduric	B-bacteria	B-bacteria
strain	I-bacteria	I-bacteria
S.	I-bacteria	I-bacteria
sanguis	I-bacteria	I-bacteria
10904	E-bacteria	I-bacteria
did	O	O
not	O	O
alter	O	O
its	O	O
membrane	O	O
composition	O	O
in	O	O
response	O	O
to	O	O
pH	O	O
values	O	O
examined	O	O
here	O	O
.	O	O

Thus	O	O
,	O	O
in	O	O
response	O	O
to	O	O
low	O	O
pH	O	O
,	O	O
aciduric	O	O
oral	O	O
bacteria	O	O
alter	O	O
their	O	O
membrane	O	O
composition	O	O
to	O	O
contain	O	O
increased	O	O
levels	O	O
of	O	O
long-chained	O	O
,	O	O
mono-unsaturated	O	O
fatty	O	O
acids	O	O
.	O	O

This	O	O
suggests	O	O
that	O	O
membrane	O	O
fatty	O	O
acid	O	O
adaptation	O	O
is	O	O
a	O	O
common	O	O
mechanism	O	O
utilized	O	O
by	O	O
bacteria	O	O
to	O	O
withstand	O	O
environmental	O	O
stress	O	O
.	O	O

Fourteen	O	O
strains	O	O
of	O	O
Gram-negative	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
fluoroquinolone-resistant	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
non-sporulating	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
various	O	O
infections	O	O
in	O	O
cats	O	O
and	O	O
dogs	O	O
,	O	O
as	O	O
well	O	O
as	O	O
from	O	O
wounds	O	O
in	O	O
humans	O	O
after	O	O
cat-	O	O
or	O	O
dog-bites	O	O
.	O	O

These	O	O
strains	O	O
were	O	O
characterized	O	O
by	O	O
sequencing	O	O
of	O	O
the	O	O
16S-23S	O	O
rDNA	O	O
internal	O	O
transcribed	O	O
spacer	O	O
(	O	O
ITS	O	O
)	O	O
regions	O	O
,	O	O
16S	O	O
rDNA	O	O
,	O	O
DNA-DNA	O	O
hybridization	O	O
,	O	O
phylogenetic	O	O
analysis	O	O
,	O	O
and	O	O
phenotypic	O	O
tests	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
novel	O	O
strains	O	O
belong	O	O
to	O	O
a	O	O
distinct	O	O
species	O	O
,	O	O
closely	O	O
related	O	O
to	O	O
Fusobacterium	O	O
nucleatum	O	O
.	O	O

The	O	O
species	O	O
Fusobacterium	B-bacteria	B-bacteria
canifelinum	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
is	O	O
proposed	O	O
,	O	O
with	O	O
strain	B-bacteria	B-bacteria
ATCC	I-bacteria	I-bacteria
BAA	I-bacteria	I-bacteria
689T	E-bacteria	I-bacteria
as	O	O
the	O	O
type	O	O
strain	O	O
.	O	O

The	O	O
control	O	O
of	O	O
oral	O	O
malodor	O	O
is	O	O
well-recognized	O	O
in	O	O
efforts	O	O
to	O	O
improve	O	O
oral	O	O
health	O	O
.	O	O

Antimicrobial	O	O
formulations	O	O
can	O	O
mitigate	O	O
oral	O	O
malodor	O	O
,	O	O
however	O	O
,	O	O
procedures	O	O
to	O	O
assess	O	O
effects	O	O
on	O	O
oral	O	O
bacteria	O	O
including	O	O
those	O	O
implicated	O	O
in	O	O
halitosis	O	O
are	O	O
unavailable	O	O
.	O	O

This	O	O
investigation	O	O
examined	O	O
the	O	O
antimicrobial	O	O
effects	O	O
of	O	O
a	O	O
new	O	O
liquid	O	O
triclosan/copolymer	O	O
dentifrice	O	O
(	O	O
test	O	O
)	O	O
formulation	O	O
that	O	O
demonstrated	O	O
significant	O	O
inhibition	O	O
of	O	O
oral	O	O
malodor	O	O
in	O	O
previous	O	O
organoleptic	O	O
clinical	O	O
studies	O	O
.	O	O

Procedures	O	O
compared	O	O
antimicrobial	O	O
effects	O	O
of	O	O
the	O	O
test	O	O
and	O	O
control	O	O
formulations	O	O
on	O	O
a	O	O
range	O	O
of	O	O
oral	O	O
micro-organisms	O	O
including	O	O
members	O	O
implicated	O	O
in	O	O
halitosis	O	O
,	O	O
substantive	O	O
antimicrobial	O	O
effects	O	O
of	O	O
formulations	O	O
with	O	O
hydroxyapatite	O	O
as	O	O
a	O	O
surrogate	O	O
for	O	O
human	O	O
teeth	O	O
and	O	O
ex	O	O
vivo	O	O
effects	O	O
on	O	O
oral	O	O
bacteria	O	O
from	O	O
human	O	O
volunteers	O	O
.	O	O

With	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
,	O	O
as	O	O
a	O	O
model	O	O
system	O	O
,	O	O
the	O	O
test	O	O
formulation	O	O
demonstrated	O	O
a	O	O
dose-dependent	O	O
effect	O	O
.	O	O

At	O	O
these	O	O
concentrations	O	O
the	O	O
test	O	O
formulation	O	O
provided	O	O
significant	O	O
antimicrobial	O	O
effects	O	O
on	O	O
13	O	O
strains	O	O
of	O	O
oral	O	O
bacteria	O	O
including	O	O
those	O	O
implicated	O	O
in	O	O
bad	O	O
breath	O	O
at	O	O
selected	O	O
posttreatment	O	O
time	O	O
points	O	O
.	O	O

Treatment	O	O
of	O	O
hydroxyapatite	O	O
by	O	O
the	O	O
test	O	O
dentifrice	O	O
resulted	O	O
in	O	O
a	O	O
significant	O	O
and	O	O
substantive	O	O
antimicrobial	O	O
effect	O	O
vs.	O	O
controls	O	O
.	O	O

Oral	O	O
bacteria	O	O
from	O	O
subjects	O	O
treated	O	O
ex	O	O
vivo	O	O
with	O	O
the	O	O
test	O	O
dentifrice	O	O
resulted	O	O
in	O	O
significant	O	O
reductions	O	O
in	O	O
cultivable	O	O
oral	O	O
bacteria	O	O
and	O	O
odorigenic	O	O
bacteria	O	O
producing	O	O
hydrogen	O	O
sulfide	O	O
.	O	O

In	O	O
summary	O	O
,	O	O
microbiological	O	O
methods	O	O
adapted	O	O
to	O	O
study	O	O
odorigenic	O	O
bacteria	O	O
demonstrate	O	O
the	O	O
significant	O	O
antimicrobial	O	O
effects	O	O
of	O	O
the	O	O
test	O	O
(	O	O
triclosan/copolymer	O	O
)	O	O
dentifrice	O	O
with	O	O
laboratory	O	O
and	O	O
clinical	O	O
strains	O	O
of	O	O
oral	O	O
bacteria	O	O
implicated	O	O
in	O	O
bad	O	O
breath	O	O
.	O	O

A	O	O
range	O	O
of	O	O
opportunistic	O	O
pathogens	O	O
have	O	O
been	O	O
associated	O	O
with	O	O
dental	O	O
unit	O	O
water	O	O
systems	O	O
(	O	O
DUWS	O	O
)	O	O
,	O	O
particularly	O	O
in	O	O
the	O	O
biofilms	O	O
that	O	O
can	O	O
line	O	O
the	O	O
tubing	O	O
.	O	O

This	O	O
study	O	O
therefore	O	O
aimed	O	O
to	O	O
assess	O	O
the	O	O
microbiology	O	O
of	O	O
DUWS	O	O
and	O	O
biofilms	O	O
in	O	O
general	O	O
dental	O	O
practices	O	O
across	O	O
seven	O	O
European	O	O
countries	O	O
,	O	O
including	O	O
the	O	O
United	O	O
Kingdom	O	O
(	O	O
UK	O	O
)	O	O
,	O	O
Ireland	O	O
(	O	O
IRL	O	O
)	O	O
,	O	O
Greece	O	O
(	O	O
GR	O	O
)	O	O
,	O	O
Spain	O	O
(	O	O
ES	O	O
)	O	O
,	O	O
Germany	O	O
(	O	O
D	O	O
)	O	O
,	O	O
Denmark	O	O
(	O	O
DK	O	O
)	O	O
and	O	O
the	O	O
Netherlands	O	O
(	O	O
NL	O	O
)	O	O
.	O	O

Water	O	O
supplied	O	O
by	O	O
51	O	O
%	O	O
of	O	O
237	O	O
dental	O	O
unit	O	O
water	O	O
lines	O	O
exceeded	O	O
current	O	O
American	O	O
Dental	O	O
Association	O	O
recommendations	O	O
of	O	O
<	O	O
or	O	O
=	O	O
200	O	O
colony-forming	O	O
units	O	O
(	O	O
CFU	O	O
)	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

Microbiological	O	O
loading	O	O
of	O	O
the	O	O
source	O	O
waters	O	O
was	O	O
between	O	O
0	O	O
(	O	O
Denmark	O	O
,	O	O
the	O	O
Netherlands	O	O
and	O	O
Spain	O	O
)	O	O
and	O	O
4.67	O	O
(	O	O
IRL	O	O
)	O	O
log	O	O
CFU	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
;	O	O
water	O	O
line	O	O
samples	O	O
from	O	O
the	O	O
DUWS	O	O
ranged	O	O
from	O	O
1.52	O	O
(	O	O
ES	O	O
)	O	O
to	O	O
2.79	O	O
(	O	O
GR	O	O
)	O	O
log	O	O
CFU	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
;	O	O
and	O	O
biofilm	O	O
counts	O	O
ranged	O	O
from	O	O
1.49	O	O
(	O	O
GR	O	O
)	O	O
to	O	O
3.22	O	O
(	O	O
DK	O	O
)	O	O
log	O	O
CFU.cm	O	O
(	O	O
-2	O	O
)	O	O
.	O	O

Opportunistic	O	O
pathogens	O	O
such	O	O
as	O	O
legionellae	B-bacteria	B-bacteria
(	O	O
DK	O	O
and	O	O
ES	O	O
)	O	O
,	O	O
including	O	O
Legionella	B-bacteria	B-bacteria
pneumophila	I-bacteria	I-bacteria
SG1	E-bacteria	I-bacteria
(	O	O
DK	O	O
and	O	O
GR	O	O
)	O	O
,	O	O
and	O	O
Mycobacterium	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
DK	O	O
,	O	O
NL	O	O
,	O	O
GR	O	O
,	O	O
D	O	O
and	O	O
ES	O	O
)	O	O
were	O	O
recovered	O	O
occasionally	O	O
.	O	O

Presumptive	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
ES	O	O
and	O	O
NL	O	O
)	O	O
,	O	O
oral	O	O
anaerobes	B-bacteria	B-bacteria
(	O	O
GR	O	O
)	O	O
,	O	O
Candida	O	O
spp	O	O
.	O	O

(	O	O
UK	O	O
,	O	O
NL	O	O
and	O	O
ES	O	O
)	O	O
and	O	O
blood	O	O
(	O	O
GR	O	O
and	O	O
IRL	O	O
)	O	O
were	O	O
detected	O	O
at	O	O
relatively	O	O
low	O	O
frequencies	O	O
,	O	O
but	O	O
their	O	O
presence	O	O
indicated	O	O
a	O	O
failure	O	O
of	O	O
the	O	O
3-in-1	O	O
antiretraction	O	O
valve	O	O
,	O	O
leading	O	O
to	O	O
back	O	O
siphonage	O	O
of	O	O
oral	O	O
fluids	O	O
into	O	O
the	O	O
water	O	O
and	O	O
biofilm	O	O
phase	O	O
.	O	O

These	O	O
findings	O	O
confirm	O	O
that	O	O
a	O	O
substantial	O	O
proportion	O	O
of	O	O
DUWS	O	O
have	O	O
high	O	O
levels	O	O
of	O	O
microbial	O	O
contamination	O	O
,	O	O
irrespective	O	O
of	O	O
country	O	O
,	O	O
type	O	O
of	O	O
equipment	O	O
and	O	O
source	O	O
water	O	O
.	O	O

The	O	O
study	O	O
emphasizes	O	O
the	O	O
need	O	O
for	O	O
effective	O	O
mechanisms	O	O
to	O	O
reduce	O	O
the	O	O
microbial	O	O
burden	O	O
within	O	O
DUWS	O	O
,	O	O
and	O	O
highlights	O	O
the	O	O
risk	O	O
of	O	O
occupational	O	O
exposure	O	O
and	O	O
cross-infection	O	O
in	O	O
general	O	O
dental	O	O
practice	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
involvement	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
via	O	O
two	O	O
cytokines	O	O
(	O	O
IL-6	O	O
and	O	O
TNF-alpha	O	O
)	O	O
and	O	O
one	O	O
chemokine	O	O
(	O	O
IL-8	O	O
)	O	O
in	O	O
local	O	O
defences	O	O
against	O	O
live	O	O
yeast	O	O
(	O	O
Candida	O	O
albicans	O	O
)	O	O
and	O	O
bacteria	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
)	O	O
using	O	O
an	O	O
engineered	O	O
human	O	O
oral	O	O
mucosa	O	O
model	O	O
.	O	O

We	O	O
report	O	O
that	O	O
the	O	O
yeast	O	O
changed	O	O
from	O	O
the	O	O
blastospore	O	O
to	O	O
the	O	O
hyphal	O	O
form	O	O
and	O	O
induced	O	O
significant	O	O
tissue	O	O
disorganization	O	O
at	O	O
later	O	O
contact	O	O
periods	O	O
(	O	O
24	O	O
and	O	O
48	O	O
h	O	O
)	O	O
compared	O	O
to	O	O
the	O	O
bacteria	O	O
.	O	O

However	O	O
,	O	O
this	O	O
effect	O	O
did	O	O
not	O	O
reduce	O	O
the	O	O
viability	O	O
or	O	O
total	O	O
number	O	O
of	O	O
epithelial	O	O
cells	O	O
.	O	O

Gene	O	O
activation	O	O
analyses	O	O
revealed	O	O
that	O	O
IL-6	O	O
,	O	O
IL-8	O	O
and	O	O
TNF-alpha	O	O
mRNA	O	O
levels	O	O
rose	O	O
in	O	O
tissues	O	O
in	O	O
contact	O	O
with	O	O
live	O	O
C.	O	O
albicans	O	O
or	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
.	O	O

Gene	O	O
activation	O	O
was	O	O
followed	O	O
by	O	O
an	O	O
upregulation	O	O
of	O	O
protein	O	O
secretion	O	O
.	O	O

IL-6	O	O
levels	O	O
were	O	O
higher	O	O
after	O	O
contact	O	O
with	O	O
C.	O	O
albicans	O	O
than	O	O
with	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
.	O	O

IL-8	O	O
levels	O	O
after	O	O
contact	O	O
with	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
were	O	O
higher	O	O
than	O	O
with	O	O
C.	O	O
albicans	O	O
.	O	O

Our	O	O
study	O	O
suggests	O	O
that	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
is	O	O
more	O	O
efficient	O	O
at	O	O
inducing	O	O
proinflammatory	O	O
mediator	O	O
release	O	O
than	O	O
C.	O	O
albicans	O	O
.	O	O

These	O	O
results	O	O
provide	O	O
additional	O	O
evidence	O	O
for	O	O
the	O	O
contribution	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
to	O	O
the	O	O
inflammatory	O	O
response	O	O
against	O	O
fungi	O	O
and	O	O
bacteria	O	O
.	O	O

Controversy	O	O
exists	O	O
concerning	O	O
the	O	O
association	O	O
between	O	O
oral	O	O
bacteria	O	O
and	O	O
infection	O	O
of	O	O
hemodialysis	O	O
(	O	O
HD	O	O
)	O	O
shunts	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
extent	O	O
to	O	O
which	O	O
oral	O	O
bacteria	O	O
are	O	O
associated	O	O
with	O	O
vascular	O	O
access	O	O
site	O	O
infections	O	O
in	O	O
a	O	O
group	O	O
of	O	O
HD	O	O
patients	O	O
.	O	O

STUDY	O	O
Microbial	O	O
blood	O	O
culture	O	O
data	O	O
for	O	O
87	O	O
HD	O	O
patients	O	O
were	O	O
collected	O	O
:	O	O
53	O	O
via	O	O
chart	O	O
review	O	O
(	O	O
retrospective	O	O
)	O	O
,	O	O
and	O	O
34	O	O
with	O	O
newly	O	O
suspected	O	O
vascular	O	O
access	O	O
infections	O	O
(	O	O
prospective	O	O
)	O	O
.	O	O

The	O	O
primary	O	O
outcome	O	O
was	O	O
the	O	O
nature	O	O
(	O	O
i.e.	O	O
,	O	O
species	O	O
)	O	O
of	O	O
the	O	O
bacteria	O	O
recovered	O	O
from	O	O
blood	O	O
cultures	O	O
of	O	O
subjects	O	O
with	O	O
vascular	O	O
access	O	O
infection	O	O
,	O	O
specifically	O	O
those	O	O
bacteria	O	O
considered	O	O
to	O	O
be	O	O
oral	O	O
flora	O	O
.	O	O

The	O	O
predominant	O	O
bacteria	O	O
reported	O	O
to	O	O
cause	O	O
HD	O	O
vascular	O	O
access	O	O
infections	O	O
were	O	O
Staphylococcus	B-bacteria	B-bacteria
(	O	O
48.6	O	O
%	O	O
)	O	O
and	O	O
Enterococcus	B-bacteria	B-bacteria
(	O	O
17.6	O	O
%	O	O
)	O	O
species	O	O
.	O	O

Most	O	O
infections	O	O
occurred	O	O
in	O	O
hemodialysis	O	O
catheters	O	O
(	O	O
89	O	O
%	O	O
)	O	O
compared	O	O
with	O	O
AV	O	O
grafts	O	O
(	O	O
11	O	O
%	O	O
)	O	O
and	O	O
AV	O	O
fistulas	O	O
(	O	O
0	O	O
%	O	O
)	O	O
.	O	O

The	O	O
subclavian	O	O
venous	O	O
access	O	O
(	O	O
41	O	O
%	O	O
)	O	O
and	O	O
the	O	O
internal	O	O
jugular	O	O
venous	O	O
access	O	O
(	O	O
38.9	O	O
%	O	O
)	O	O
were	O	O
more	O	O
commonly	O	O
infected	O	O
than	O	O
other	O	O
sites	O	O
.	O	O

None	O	O
of	O	O
the	O	O
bacteria	O	O
identified	O	O
by	O	O
blood	O	O
cultures	O	O
were	O	O
considered	O	O
to	O	O
be	O	O
oral	O	O
flora	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
oral	O	O
bacteria	O	O
rarely	O	O
,	O	O
if	O	O
ever	O	O
,	O	O
cause	O	O
vascular	O	O
access	O	O
infections	O	O
in	O	O
hemodialysis	O	O
patients	O	O
.	O	O

It	O	O
is	O	O
not	O	O
well	O	O
known	O	O
how	O	O
periodontopathic	O	O
bacteria	O	O
colonize	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
during	O	O
childhood	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
distribution	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
in	O	O
oral	O	O
cavities	O	O
of	O	O
children	O	O
and	O	O
their	O	O
parents	O	O
and	O	O
the	O	O
relationship	O	O
between	O	O
the	O	O
bacterial	O	O
findings	O	O
and	O	O
clinical	O	O
parameters	O	O
.	O	O

Fifty-six	O	O
children	O	O
(	O	O
mean	O	O
age	O	O
:	O	O
8.3	O	O
+/-	O	O
3.5	O	O
,	O	O
range	O	O
:	O	O
1-15	O	O
years	O	O
)	O	O
,	O	O
including	O	O
15	O	O
with	O	O
deciduous	O	O
dentition	O	O
,	O	O
26	O	O
with	O	O
mixed	O	O
dentition	O	O
and	O	O
15	O	O
with	O	O
permanent	O	O
dentition	O	O
,	O	O
and	O	O
their	O	O
parents	O	O
participated	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Whole	O	O
saliva	O	O
and	O	O
dental	O	O
plaque	O	O
of	O	O
the	O	O
children	O	O
and	O	O
whole	O	O
saliva	O	O
of	O	O
their	O	O
parents	O	O
were	O	O
collected	O	O
for	O	O
detection	O	O
of	O	O
seven	O	O
species	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
(	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
(	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
)	O	O
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
using	O	O
the	O	O
polymerase	O	O
chain	O	O
reaction	O	O
method	O	O
.	O	O

Clinical	O	O
parameters	O	O
including	O	O
simplified	O	O
Oral	O	O
Hygiene	O	O
Index	O	O
and	O	O
Papillary-Marginal-Attachment	O	O
Index	O	O
were	O	O
recorded	O	O
for	O	O
the	O	O
children	O	O
and	O	O
their	O	O
accompanied	O	O
parents	O	O
.	O	O

The	O	O
detection	O	O
frequencies	O	O
of	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
children	O	O
were	O	O
42.9	O	O
%	O	O
,	O	O
94.6	O	O
%	O	O
,	O	O
42.9	O	O
%	O	O
,	O	O
48.2	O	O
%	O	O
,	O	O
1.8	O	O
%	O	O
and	O	O
8.9	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
were	O	O
detected	O	O
more	O	O
frequently	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
parents	O	O
(	O	O
54.8	O	O
%	O	O
,	O	O
54.8	O	O
%	O	O
,	O	O
88.1	O	O
%	O	O
,	O	O
respectively	O	O
)	O	O
than	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
children	O	O
(	O	O
25.5	O	O
%	O	O
,	O	O
7.3	O	O
%	O	O
,	O	O
41.8	O	O
%	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Different	O	O
detection	O	O
frequencies	O	O
of	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
were	O	O
found	O	O
among	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
children	O	O
with	O	O
deciduous	O	O
,	O	O
mixed	O	O
and	O	O
permanent	O	O
dentitions	O	O
.	O	O

In	O	O
mixed	O	O
dentition	O	O
,	O	O
females	O	O
harbored	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
more	O	O
frequently	O	O
than	O	O
males	O	O
did	O	O
.	O	O

Children	O	O
who	O	O
harbored	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
showed	O	O
high	O	O
scores	O	O
for	O	O
oral	O	O
debris	O	O
measurement	O	O
by	O	O
simplified	O	O
Oral	O	O
Hygiene	O	O
Index	O	O
.	O	O

T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
were	O	O
detected	O	O
more	O	O
frequently	O	O
in	O	O
children	O	O
whose	O	O
parents	O	O
were	O	O
positive	O	O
for	O	O
these	O	O
pathogens	O	O
than	O	O
in	O	O
children	O	O
whose	O	O
parents	O	O
were	O	O
negative	O	O
.	O	O

High	O	O
plaque	O	O
retention	O	O
seems	O	O
to	O	O
promote	O	O
the	O	O
colonization	O	O
of	O	O
periodontal	O	O
pathogens	O	O
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
children	O	O
.	O	O

T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
were	O	O
detected	O	O
more	O	O
frequently	O	O
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
children	O	O
whose	O	O
parents	O	O
already	O	O
harbored	O	O
these	O	O
bacteria	O	O
.	O	O

Familial	O	O
transmission	O	O
of	O	O
these	O	O
bacteria	O	O
is	O	O
suggested	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
isolate	O	O
and	O	O
identify	O	O
alkali-resistant	O	O
bacteria	O	O
from	O	O
the	O	O
dentin	O	O
of	O	O
infected	O	O
root	O	O
canals	O	O
.	O	O

Bacteria	O	O
from	O	O
homogenized	O	O
dentin	O	O
powder	O	O
made	O	O
up	O	O
from	O	O
infected	O	O
root	O	O
canal	O	O
walls	O	O
from	O	O
human	O	O
teeth	O	O
were	O	O
cultured	O	O
on	O	O
buffer-enriched	O	O
Brain	O	O
Heart	O	O
Infusion	O	O
agar	O	O
supplemented	O	O
with	O	O
4	O	O
%	O	O
sheep	O	O
blood	O	O
(	O	O
BHI-blood	O	O
agar	O	O
)	O	O
,	O	O
adjusted	O	O
to	O	O
pH	O	O
7.0	O	O
,	O	O
9.0	O	O
or	O	O
10.0	O	O
.	O	O

Incubation	O	O
took	O	O
place	O	O
for	O	O
7	O	O
days	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
in	O	O
an	O	O
anaerobic	O	O
glove	O	O
box	O	O
.	O	O

Bacterial	O	O
strains	O	O
selected	O	O
according	O	O
to	O	O
colony	O	O
and	O	O
morphology	O	O
were	O	O
subcultured	O	O
in	O	O
buffer-enriched	O	O
BHI	O	O
broth	O	O
adjusted	O	O
to	O	O
pH	O	O
9.0	O	O
,	O	O
10.0	O	O
or	O	O
11.0	O	O
to	O	O
confirm	O	O
their	O	O
growth	O	O
as	O	O
alkali-resistant	O	O
bacteria	O	O
.	O	O

Polymerase	O	O
chain	O	O
reaction	O	O
amplification	O	O
using	O	O
specific	O	O
primer	O	O
sets	O	O
and	O	O
16S	O	O
rDNA	O	O
sequence	O	O
analysis	O	O
was	O	O
performed	O	O
for	O	O
identification	O	O
of	O	O
alkali-resistant	O	O
isolates	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
37	O	O
teeth	O	O
extracted	O	O
from	O	O
37	O	O
patients	O	O
were	O	O
used	O	O
for	O	O
preparation	O	O
of	O	O
the	O	O
dentin	O	O
powder	O	O
samples	O	O
.	O	O

Bacteria	O	O
were	O	O
detected	O	O
in	O	O
25	O	O
samples	O	O
when	O	O
standard	O	O
BHI-blood	O	O
agars	O	O
(	O	O
pH	O	O
7.0	O	O
)	O	O
were	O	O
used	O	O
.	O	O

Of	O	O
these	O	O
,	O	O
29	O	O
strains	O	O
from	O	O
15	O	O
samples	O	O
were	O	O
alkali	O	O
resistant	O	O
,	O	O
25	O	O
strains	O	O
growing	O	O
at	O	O
pH	O	O
9.0	O	O
and	O	O
4	O	O
at	O	O
pH	O	O
10.0	O	O
.	O	O

The	O	O
alkali-resistant	O	O
strains	E-bacteria	O	O
included	O	O
Enterococcus	B-bacteria	B-bacteria
faecium	E-bacteria	I-bacteria
(	O	O
10	O	O
strains	O	O
)	O	O
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
(	O	O
2	O	O
strains	O	O
)	O	O
,	O	O
Enterobacter	B-bacteria	B-bacteria
cancerogenus	E-bacteria	I-bacteria
(	O	O
1	O	O
strains	O	O
)	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
1	O	O
strains	O	O
)	O	O
,	O	O
Klebsiella	B-bacteria	B-bacteria
ornithinolytica	E-bacteria	I-bacteria
(	O	O
2	O	O
strains	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
(	O	O
2	O	O
strains	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
(	O	O
2	O	O
strains	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
constellatus	E-bacteria	I-bacteria
(	O	O
3	O	O
strains	O	O
)	O	O
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
(	O	O
2	O	O
strains	O	O
)	O	O
.	O	O

Three	O	O
strains	O	O
were	O	O
also	O	O
identified	O	O
as	O	O
bacteria	O	O
of	O	O
genus	B-bacteria	B-bacteria
Firmicutes	E-bacteria	I-bacteria
or	O	O
Staphylococcus	B-bacteria	B-bacteria
at	O	O
the	O	O
genus	O	O
level	O	O
.	O	O

The	O	O
present	O	O
study	O	O
showed	O	O
that	O	O
many	O	O
bacterial	O	O
species	O	O
in	O	O
infected	O	O
root	O	O
canal	O	O
dentin	O	O
were	O	O
alkali-resistant	O	O
at	O	O
pH	O	O
9.0	O	O
and/or	O	O
pH	O	O
10.0	O	O
,	O	O
and	O	O
belonged	O	O
mainly	O	O
to	O	O
the	O	O
genus	B-bacteria	B-bacteria
Enterococcus	E-bacteria	I-bacteria
.	O	O

oral	O	O
treponemes	B-bacteria	B-bacteria
are	O	O
implicated	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

We	O	O
have	O	O
previously	O	O
shown	O	O
that	O	O
Treponema	B-bacteria	B-bacteria
denticola	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
type	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
and	O	O
strain	B-bacteria	B-bacteria
GM-1	E-bacteria	I-bacteria
are	O	O
resistant	O	O
to	O	O
killing	O	O
by	O	O
human	O	O
beta-defensins	O	O
(	O	O
hbetaD	O	O
)	O	O
-1	O	O
and	O	O
-2	O	O
.	O	O

We	O	O
hypothesize	O	O
that	O	O
resistance	O	O
to	O	O
beta-defensins	O	O
is	O	O
a	O	O
common	O	O
feature	O	O
of	O	O
oral	O	O
treponemes	B-bacteria	B-bacteria
,	O	O
which	O	O
allows	O	O
colonization	O	O
and	O	O
persistence	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
tested	O	O
additional	O	O
isolates	O	O
of	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
six	O	O
other	O	O
species	O	O
of	O	O
treponemes	B-bacteria	B-bacteria
,	O	O
for	O	O
resistance	O	O
to	O	O
hbetaD-1	O	O
,	O	O
-2	O	O
and	O	O
-3	O	O
.	O	O

We	O	O
also	O	O
examined	O	O
the	O	O
four	O	O
ATCC	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
of	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
strain	B-bacteria	B-bacteria
GM-1	E-bacteria	I-bacteria
for	O	O
resistance	O	O
to	O	O
hbetaD-3	O	O
.	O	O

Resistance	O	O
was	O	O
determined	O	O
by	O	O
motility	O	O
and	O	O
Blue	O	O
assays	O	O
for	O	O
metabolic	O	O
activity	O	O
.	O	O

All	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
strains	O	O
tested	O	O
were	O	O
resistant	O	O
to	O	O
hbetaD-1	O	O
,	O	O
-2	O	O
and	O	O
-3	O	O
,	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
strain	O	O
Ambigua	O	O
,	O	O
which	O	O
was	O	O
sensitive	O	O
to	O	O
hbetaD-2	O	O
and	O	O
-3	O	O
.	O	O

All	O	O
other	O	O
treponemes	O	O
except	O	O
Treponema	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
were	O	O
resistant	O	O
to	O	O
hbetaD-1	O	O
.	O	O

Treponema	B-bacteria	B-bacteria
pectinovorum	E-bacteria	I-bacteria
sensitive	O	O
to	O	O
hbetaD-2	O	O
,	O	O
while	O	O
T.	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
pectinovorum	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
maltophilum	E-bacteria	I-bacteria
were	O	O
sensitive	O	O
to	O	O
hbetaD-3	O	O
.	O	O

Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
was	O	O
used	O	O
as	O	O
a	O	O
control	O	O
organism	O	O
and	O	O
was	O	O
killed	O	O
by	O	O
all	O	O
three	O	O
defensins	O	O
.	O	O

Resistance	O	O
to	O	O
the	O	O
constitutively	O	O
expressed	O	O
hbetaD-1	O	O
may	O	O
assist	O	O
treponemes	O	O
in	O	O
initial	O	O
colonization	O	O
of	O	O
epithelial	O	O
surfaces	O	O
,	O	O
while	O	O
resistance	O	O
to	O	O
the	O	O
inducible	O	O
hbetaD-2	O	O
and	O	O
-3	O	O
would	O	O
allow	O	O
some	O	O
treponemes	B-bacteria	B-bacteria
to	O	O
survive	O	O
in	O	O
active	O	O
periodontal	O	O
lesions	O	O
.	O	O

Dental	O	O
caries	O	O
prevention	O	O
programs	O	O
using	O	O
chlorhexidine	O	O
(	O	O
CHX	O	O
)	O	O
have	O	O
been	O	O
proposed	O	O
,	O	O
but	O	O
CHX	O	O
's	O	O
effect	O	O
in	O	O
reducing	O	O
levels	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
)	O	O
appears	O	O
to	O	O
last	O	O
for	O	O
only	O	O
a	O	O
few	O	O
months	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
attempt	O	O
to	O	O
eradicate	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
from	O	O
the	O	O
oral	O	O
cavity	O	O
using	O	O
intensive	O	O
professional	O	O
mechanical	O	O
tooth	O	O
cleaning	O	O
(	O	O
PMTC	O	O
)	O	O
and	O	O
topical	O	O
application	O	O
of	O	O
CHX	O	O
in	O	O
custom-made	O	O
trays	O	O
.	O	O

Seven	O	O
adult	O	O
dentate	O	O
subjects	O	O
participated	O	O
in	O	O
this	O	O
study	O	O
(	O	O
mean	O	O
age	O	O
53.7+/-5.6	O	O
,	O	O
age	O	O
range	O	O
46	O	O
to	O	O
62	O	O
,	O	O
mean	O	O
DMFT	O	O
,	O	O
9.1+/-4.2	O	O
)	O	O
.	O	O

For	O	O
each	O	O
subject	O	O
,	O	O
PMTC	O	O
was	O	O
carried	O	O
out	O	O
eight	O	O
times	O	O
within	O	O
ten	O	O
days	O	O
.	O	O

After	O	O
each	O	O
PMTC	O	O
,	O	O
1	O	O
%	O	O
CHX	O	O
was	O	O
applied	O	O
twice	O	O
to	O	O
the	O	O
tooth	O	O
surface	O	O
using	O	O
custom-made	O	O
trays	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
as	O	O
home	O	O
treatment	O	O
,	O	O
subjects	O	O
were	O	O
required	O	O
to	O	O
carry	O	O
out	O	O
tooth	O	O
brushing	O	O
three	O	O
times	O	O
a	O	O
day	O	O
,	O	O
and	O	O
apply	O	O
0.2	O	O
%	O	O
CHX	O	O
in	O	O
custom	O	O
trays	O	O
after	O	O
brushing	O	O
in	O	O
the	O	O
morning	O	O
and	O	O
evening	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
subjects	O	O
rinsed	O	O
with	O	O
0.2	O	O
%	O	O
CHX	O	O
solution	O	O
after	O	O
lunch	O	O
.	O	O

Salivary	O	O
levels	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
evaluated	O	O
using	O	O
Dentocult-SM	O	O
at	O	O
baseline	O	O
and	O	O
on	O	O
days	O	O
9	O	O
,	O	O
20	O	O
,	O	O
70	O	O
,	O	O
120	O	O
.	O	O

Mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
eradicated	O	O
by	O	O
day	O	O
120	O	O
from	O	O
4	O	O
of	O	O
the	O	O
7	O	O
seven	O	O
subjects	O	O
participating	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Those	O	O
3	O	O
subjects	O	O
still	O	O
harboring	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
exhibited	O	O
deep	O	O
periodontal	O	O
pocketing	O	O
.	O	O

Eradication	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
from	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
feasible	O	O
using	O	O
a	O	O
combination	O	O
of	O	O
CHX	O	O
application	O	O
in	O	O
custom-made	O	O
trays	O	O
and	O	O
intensive	O	O
PMTC	O	O
.	O	O

During	O	O
investigation	O	O
of	O	O
adhesive	O	O
properties	O	O
of	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
it	O	O
was	O	O
found	O	O
out	O	O
that	O	O
11	O	O
strains	O	O
adhered	O	O
to	O	O
buccal	O	O
intestinal	O	O
and	O	O
vaginal	O	O
epithelium	O	O
of	O	O
human	O	O
.	O	O

The	O	O
highest	O	O
adhesive	O	O
activity	O	O
was	O	O
detected	O	O
in	O	O
enterococci	B-bacteria	B-bacteria
(	O	O
adhesive	O	O
index	O	O
7.75-14.26	O	O
)	O	O
,	O	O
lower	O	O
one	O	O
--	O	O
in	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
6.40-9.16	O	O
)	O	O
.	O	O

In	O	O
lactobacilli	B-bacteria	B-bacteria
adhesive	O	O
properties	O	O
manifested	O	O
in	O	O
different	O	O
ways	O	O
:	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
adhered	O	O
more	O	O
often	O	O
to	O	O
buccal	O	O
epithelium	O	O
(	O	O
2.58-4.60	O	O
)	O	O
and	O	O
rarely	O	O
--	O	O
to	O	O
intestinal	O	O
and	O	O
vaginal	O	O
.	O	O

L.	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
manifested	O	O
high	O	O
adhesive	O	O
activity	O	O
(	O	O
8.03	O	O
-9.69	O	O
)	O	O
to	O	O
buccal	O	O
epithelium	O	O
and	O	O
lower	O	O
one	O	O
--	O	O
to	O	O
the	O	O
rest	O	O
of	O	O
epithelium	O	O
types	O	O
.	O	O

Monosaccharide	O	O
composition	O	O
of	O	O
glycocalix	O	O
of	O	O
6	O	O
strains	O	O
of	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
was	O	O
studied	O	O
to	O	O
understand	O	O
the	O	O
adhesion	O	O
mechanism	O	O
.	O	O

It	O	O
was	O	O
shown	O	O
that	O	O
surface	O	O
structures	O	O
of	O	O
this	O	O
microorganism	O	O
interact	O	O
with	O	O
plant	O	O
lectins	O	O
,	O	O
specific	O	O
to	O	O
certain	O	O
monosaccharides	O	O
.	O	O

Nosocomial	O	O
pneumonia	O	O
remains	O	O
a	O	O
common	O	O
complication	O	O
in	O	O
patients	O	O
undergoing	O	O
endotracheal	O	O
intubation	O	O
.	O	O

This	O	O
study	O	O
examined	O	O
the	O	O
transport	O	O
of	O	O
bacteria	O	O
into	O	O
the	O	O
trachea	O	O
during	O	O
endotracheal	O	O
intubation	O	O
,	O	O
and	O	O
evaluated	O	O
the	O	O
effects	O	O
of	O	O
gargling	O	O
with	O	O
povidone-iodine	O	O
on	O	O
bacterial	O	O
contamination	O	O
of	O	O
the	O	O
tip	O	O
of	O	O
the	O	O
intubation	O	O
tube	O	O
.	O	O

In	O	O
the	O	O
gargling	O	O
group	O	O
,	O	O
patients	O	O
gargled	O	O
with	O	O
25	O	O
mL	O	O
of	O	O
povidone-iodine	O	O
(	O	O
2.5	O	O
mg.mL	O	O
(	O	O
-1	O	O
)	O	O
)	O	O
.	O	O

In	O	O
the	O	O
control	O	O
group	O	O
,	O	O
patients	O	O
gargled	O	O
with	O	O
25	O	O
mL	O	O
of	O	O
tap	O	O
water	O	O
.	O	O

Before	O	O
tracheal	O	O
intubation	O	O
,	O	O
microorganisms	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
posterior	O	O
wall	O	O
of	O	O
the	O	O
patient	O	O
's	O	O
pharynx	O	O
using	O	O
sterile	O	O
cotton	O	O
swabs	O	O
.	O	O

After	O	O
anesthesia	O	O
,	O	O
all	O	O
patients	O	O
were	O	O
extubated	O	O
and	O	O
bacteria	O	O
contaminating	O	O
the	O	O
tip	O	O
of	O	O
the	O	O
tracheal	O	O
tube	O	O
were	O	O
sampled	O	O
and	O	O
cultured	O	O
.	O	O

Before	O	O
orotracheal	O	O
intubation	O	O
,	O	O
all	O	O
19	O	O
patients	O	O
who	O	O
gargled	O	O
with	O	O
tap	O	O
water	O	O
(	O	O
control	O	O
group	O	O
)	O	O
had	O	O
bacterial	O	O
colonization	O	O
on	O	O
the	O	O
posterior	O	O
walls	O	O
of	O	O
the	O	O
pharynx	O	O
.	O	O

This	O	O
group	O	O
included	O	O
five	O	O
patients	O	O
who	O	O
had	O	O
methicillin-resistant	B-bacteria	B-bacteria
staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
in	O	O
their	O	O
nasal	O	O
cavity	O	O
preoperatively	O	O
and	O	O
MRSA	B-bacteria	B-bacteria
was	O	O
also	O	O
detected	O	O
in	O	O
the	O	O
pharynx	O	O
of	O	O
four	O	O
patients	O	O
.	O	O

Bacterial	O	O
colonization	O	O
was	O	O
observed	O	O
in	O	O
all	O	O
19	O	O
patients	O	O
who	O	O
gargled	O	O
with	O	O
povidone-iodine	O	O
(	O	O
gargling	O	O
group	O	O
)	O	O
and	O	O
four	O	O
patients	O	O
carried	O	O
MRSA	B-bacteria	B-bacteria
in	O	O
their	O	O
nasal	O	O
cavity	O	O
,	O	O
although	O	O
no	O	O
MRSA	B-bacteria	B-bacteria
was	O	O
detected	O	O
in	O	O
the	O	O
pharynx	O	O
.	O	O

In	O	O
the	O	O
control	O	O
group	O	O
,	O	O
all	O	O
the	O	O
patients	O	O
had	O	O
bacterial	O	O
colonization	O	O
at	O	O
the	O	O
tip	O	O
of	O	O
the	O	O
tube	O	O
after	O	O
extubation	O	O
.	O	O

Additionally	O	O
,	O	O
MRSA	B-bacteria	B-bacteria
was	O	O
detected	O	O
in	O	O
two	O	O
of	O	O
the	O	O
four	O	O
patients	O	O
.	O	O

In	O	O
the	O	O
gargling	O	O
group	O	O
,	O	O
povidone-iodine	O	O
eradicated	O	O
general	O	O
bacteria	O	O
and	O	O
MRSA	B-bacteria	B-bacteria
colonies	O	O
in	O	O
the	O	O
pharynx	O	O
before	O	O
intubation	O	O
and	O	O
at	O	O
the	O	O
tip	O	O
of	O	O
the	O	O
tube	O	O
after	O	O
extubation	O	O
.	O	O

Gargling	O	O
with	O	O
povidone-iodine	O	O
before	O	O
oral	O	O
intubation	O	O
reduces	O	O
the	O	O
transport	O	O
of	O	O
bacteria	O	O
into	O	O
the	O	O
trachea	O	O
.	O	O

Previous	O	O
analysis	O	O
of	O	O
the	O	O
microbiology	O	O
of	O	O
advanced	O	O
caries	O	O
by	O	O
culture	O	O
and	O	O
real-time	O	O
PCR	O	O
emphasized	O	O
the	O	O
high	O	O
incidence	O	O
and	O	O
abundance	O	O
of	O	O
gram-negative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
,	O	O
particularly	O	O
Prevotella-like	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

The	O	O
diversity	O	O
of	O	O
Prevotella-like	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
was	O	O
further	O	O
explored	O	O
by	O	O
analyzing	O	O
pooled	O	O
bacterial	O	O
DNA	O	O
from	O	O
lesions	O	O
of	O	O
carious	O	O
dentine	O	O
.	O	O

This	O	O
was	O	O
achieved	O	O
by	O	O
amplification	O	O
of	O	O
a	O	O
region	O	O
of	O	O
the	O	O
16S	O	O
ribosomal	O	O
DNA	O	O
with	O	O
a	O	O
Prevotella	B-bacteria	B-bacteria
genus-specific	O	O
forward	O	O
primer	O	O
and	O	O
a	O	O
universal	O	O
bacterial	O	O
reverse	O	O
primer	O	O
,	O	O
followed	O	O
by	O	O
cloning	O	O
and	O	O
sequencing	O	O
.	O	O

Cultured	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
commonly	O	O
associated	O	O
with	O	O
oral	O	O
tissues	O	O
constituted	O	O
only	O	O
12	O	O
%	O	O
of	O	O
the	O	O
Prevotella	B-bacteria	B-bacteria
clones	O	O
isolated	O	O
from	O	O
advanced	O	O
carious	O	O
lesions	O	O
.	O	O

The	O	O
remaining	O	O
88	O	O
%	O	O
consisted	O	O
of	O	O
a	O	O
diverse	O	O
range	O	O
of	O	O
phylotypes	O	O
.	O	O

These	O	O
included	O	O
five	O	O
clusters	O	O
of	O	O
previously	O	O
recognized	O	O
but	O	O
uncultured	O	O
oral	O	O
Prevotella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
a	O	O
major	O	O
cluster	O	O
containing	O	O
Prevotella-like	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
most	O	O
closely	O	O
related	O	O
to	O	O
uncharacterized	O	O
rumen	O	O
bacteria	O	O
.	O	O

Cluster-specific	O	O
primers	O	O
were	O	O
designed	O	O
,	O	O
and	O	O
the	O	O
numbers	O	O
of	O	O
bacteria	O	O
within	O	O
clusters	O	O
were	O	O
quantified	O	O
by	O	O
real-time	O	O
PCR	O	O
,	O	O
confirming	O	O
the	O	O
abundance	O	O
of	O	O
these	O	O
organisms	O	O
.	O	O

The	O	O
data	O	O
indicated	O	O
that	O	O
advanced	O	O
dental	O	O
caries	O	O
provides	O	O
a	O	O
unique	O	O
environment	O	O
for	O	O
a	O	O
complex	O	O
array	O	O
of	O	O
novel	O	O
and	O	O
uncultured	O	O
Prevotella	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Prevotella-like	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
which	O	O
,	O	O
in	O	O
some	O	O
cases	O	O
,	O	O
may	O	O
dominate	O	O
the	O	O
diverse	O	O
polymicrobial	O	O
community	O	O
associated	O	O
with	O	O
the	O	O
disease	O	O
.	O	O

To	O	O
compare	O	O
five	O	O
different	O	O
commercial	O	O
mouth	O	O
rinses	O	O
with	O	O
chlorhexidine	O	O
(	O	O
CHX	O	O
)	O	O
with	O	O
respect	O	O
to	O	O
their	O	O
anti-halitosis	O	O
effect	O	O
and	O	O
anti-microbial	O	O
activity	O	O
on	O	O
salivary	B-bacteria	B-bacteria
bacterial	E-bacteria	I-bacteria
counts	O	O
,	O	O
following	O	O
a	O	O
standardised	O	O
research	O	O
protocol	O	O
.	O	O

And	O	O
secondly	O	O
,	O	O
to	O	O
validate	O	O
the	O	O
study	O	O
model	O	O
proposed	O	O
in	O	O
the	O	O
evaluation	O	O
of	O	O
patients	O	O
suffering	O	O
from	O	O
halitosis	O	O
.	O	O

PATIENTS	O	O
AND	O	O
Ten	O	O
volunteers	O	O
,	O	O
with	O	O
a	O	O
healthy	O	O
oral	O	O
status	O	O
,	O	O
were	O	O
enrolled	O	O
in	O	O
a	O	O
double-blind	O	O
,	O	O
cross-over	O	O
design	O	O
,	O	O
using	O	O
sterile	O	O
saline	O	O
as	O	O
negative	O	O
control	O	O
and	O	O
five	O	O
CHX-containing	O	O
mouth	O	O
rinses	O	O
:	O	O
0.12	O	O
%	O	O
CHX	O	O
alone	O	O
(	O	O
CHX+NO	O	O
)	O	O
,	O	O
plus	O	O
alcohol	O	O
(	O	O
CHX+ALC	O	O
)	O	O
,	O	O
plus	O	O
0.05	O	O
%	O	O
cetylpiridinium	O	O
chloride	O	O
(	O	O
CHX+CPC	O	O
)	O	O
,	O	O
plus	O	O
sodium	O	O
fluoride	O	O
(	O	O
CHX+NaF	O	O
)	O	O
,	O	O
and	O	O
0.05	O	O
%	O	O
CHX	O	O
plus	O	O
0.05	O	O
%	O	O
CPC	O	O
,	O	O
plus	O	O
0.14	O	O
%	O	O
zinc	O	O
lactate	O	O
(	O	O
CHX+Zn	O	O
)	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
whole-mouth	O	O
volatile	O	O
sulphur	O	O
compounds	O	O
(	O	O
VSCs	O	O
)	O	O
were	O	O
measured	O	O
by	O	O
means	O	O
of	O	O
a	O	O
sulphide	O	O
monitor	O	O
at	O	O
baseline	O	O
,	O	O
1	O	O
and	O	O
5	O	O
h	O	O
after	O	O
rinsing	O	O
with	O	O
the	O	O
assigned	O	O
product	O	O
.	O	O

Baseline	O	O
measurements	O	O
also	O	O
included	O	O
an	O	O
organoleptic	O	O
assessment	O	O
and	O	O
the	O	O
recording	O	O
of	O	O
the	O	O
tongue-coating	O	O
index	O	O
.	O	O

Aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
salivary	I-bacteria	I-bacteria
bacterial	E-bacteria	I-bacteria
counts	O	O
were	O	O
also	O	O
obtained	O	O
by	O	O
collecting	O	O
unstimulated	O	O
saliva	O	O
samples	O	O
at	O	O
the	O	O
same	O	O
evaluation	O	O
times	O	O
,	O	O
and	O	O
processed	O	O
by	O	O
culturing	O	O
techniques	O	O
.	O	O

Analysis	O	O
of	O	O
variance	O	O
was	O	O
used	O	O
to	O	O
evaluate	O	O
whether	O	O
significant	O	O
differences	O	O
existed	O	O
among	O	O
groups	O	O
,	O	O
at	O	O
each	O	O
evaluation	O	O
point	O	O
,	O	O
or	O	O
in	O	O
changes	O	O
between	O	O
evaluations	O	O
.	O	O

No	O	O
significant	O	O
differences	O	O
were	O	O
detected	O	O
at	O	O
baseline	O	O
,	O	O
with	O	O
VSC	O	O
levels	O	O
ranging	O	O
between	O	O
190	O	O
and	O	O
227	O	O
parts	O	O
per	O	O
billion	O	O
(	O	O
p.p.b	O	O
.	O	O
)	O	O

After	O	O
rinsing	O	O
,	O	O
VSC	O	O
levels	O	O
were	O	O
reduced	O	O
with	O	O
all	O	O
products	O	O
(	O	O
except	O	O
saline	O	O
)	O	O
,	O	O
after	O	O
1	O	O
h.	O	O
Significant	O	O
differences	O	O
at	O	O
1	O	O
h	O	O
were	O	O
detected	O	O
(	O	O
p=0.04	O	O
)	O	O
,	O	O
corresponding	O	O
to	O	O
a	O	O
lower	O	O
amount	O	O
of	O	O
p.p.b	O	O
.	O	O

(	O	O
109	O	O
)	O	O
in	O	O
(	O	O
CHX+Zn	O	O
)	O	O
as	O	O
compared	O	O
with	O	O
the	O	O
other	O	O
groups	O	O
(	O	O
except	O	O
CHX+NO	O	O
)	O	O
.	O	O

At	O	O
5	O	O
h	O	O
,	O	O
VSC	O	O
levels	O	O
were	O	O
lower	O	O
for	O	O
CHX+CPC	O	O
and	O	O
CHX+Zn	O	O
(	O	O
155	O	O
and	O	O
169	O	O
,	O	O
respectively	O	O
)	O	O
,	O	O
while	O	O
the	O	O
other	O	O
groups	O	O
showed	O	O
levels	O	O
higher	O	O
than	O	O
220	O	O
p.p.b	O	O
.	O	O

With	O	O
respect	O	O
to	O	O
aerobic	B-bacteria	B-bacteria
salivary	I-bacteria	I-bacteria
bacterial	E-bacteria	I-bacteria
counts	O	O
,	O	O
CHX+CPC	O	O
demonstrated	O	O
the	O	O
lowest	O	O
percentage	O	O
of	O	O
survival	O	O
(	O	O
6	O	O
%	O	O
after	O	O
1	O	O
h	O	O
and	O	O
18	O	O
%	O	O
after	O	O
5	O	O
h	O	O
)	O	O
.	O	O

For	O	O
anaerobic	B-bacteria	B-bacteria
bacterial	E-bacteria	I-bacteria
counts	O	O
,	O	O
again	O	O
CHX+CPC	O	O
demonstrated	O	O
the	O	O
lowest	O	O
percentage	O	O
of	O	O
survival	O	O
(	O	O
10	O	O
%	O	O
at	O	O
1	O	O
h	O	O
and	O	O
23	O	O
%	O	O
at	O	O
5	O	O
h	O	O
)	O	O
,	O	O
together	O	O
with	O	O
CHX+ALC	O	O
(	O	O
18	O	O
%	O	O
of	O	O
survival	O	O
at	O	O
5	O	O
h	O	O
)	O	O
.	O	O

However	O	O
,	O	O
salivary	O	O
counts	O	O
and	O	O
VSCs	O	O
were	O	O
only	O	O
significantly	O	O
correlated	O	O
at	O	O
baseline	O	O
,	O	O
but	O	O
not	O	O
after	O	O
treatment	O	O
.	O	O

Important	O	O
differences	O	O
can	O	O
be	O	O
expected	O	O
from	O	O
different	O	O
CHX	O	O
formulations	O	O
,	O	O
in	O	O
relation	O	O
to	O	O
both	O	O
their	O	O
anti-halitosis	O	O
effect	O	O
and	O	O
anti-microbial	O	O
activity	O	O
in	O	O
saliva	O	O
.	O	O

Formulations	O	O
that	O	O
combine	O	O
CHX	O	O
and	O	O
CPC	O	O
achieved	O	O
the	O	O
best	O	O
results	O	O
,	O	O
and	O	O
a	O	O
formulation	O	O
combining	O	O
CHX	O	O
with	O	O
NaF	O	O
resulted	O	O
in	O	O
the	O	O
poorest	O	O
.	O	O

Glucansucrases	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
Leuconostoc	B-bacteria	B-bacteria
mesenteroides	E-bacteria	I-bacteria
have	O	O
a	O	O
common	O	O
pattern	O	O
of	O	O
structural	O	O
organization	O	O
and	O	O
characteristically	O	O
contain	O	O
a	O	O
domain	O	O
with	O	O
a	O	O
series	O	O
of	O	O
tandem	O	O
amino	O	O
acid	O	O
repeats	O	O
in	O	O
which	O	O
certain	O	O
residues	O	O
are	O	O
highly	O	O
conserved	O	O
,	O	O
particularly	O	O
aromatic	O	O
amino	O	O
acids	O	O
and	O	O
glycine	O	O
.	O	O

In	O	O
some	O	O
glucosyltransferases	O	O
(	O	O
GTFs	O	O
)	O	O
the	O	O
repeat	O	O
region	O	O
has	O	O
been	O	O
identified	O	O
as	O	O
a	O	O
glucan	O	O
binding	O	O
domain	O	O
(	O	O
GBD	O	O
)	O	O
.	O	O

Such	O	O
GBDs	O	O
are	O	O
also	O	O
found	O	O
in	O	O
several	O	O
glucan	O	O
binding	O	O
proteins	O	O
(	O	O
GBP	O	O
)	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
that	O	O
do	O	O
not	O	O
have	O	O
glucansucrase	O	O
activity	O	O
.	O	O

Alignment	O	O
of	O	O
the	O	O
amino	O	O
acid	O	O
sequences	O	O
of	O	O
20	O	O
glucansucrases	O	O
and	O	O
GBP	O	O
showed	O	O
the	O	O
widespread	O	O
conservation	O	O
of	O	O
the	O	O
33-residue	O	O
A	O	O
repeat	O	O
first	O	O
identified	O	O
in	O	O
GtfI	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
downei	E-bacteria	I-bacteria
.	O	O

Site-directed	O	O
mutagenesis	O	O
of	O	O
individual	O	O
highly	O	O
conserved	O	O
residues	O	O
in	O	O
recombinant	O	O
GBD	O	O
of	O	O
GtfI	O	O
demonstrated	O	O
the	O	O
importance	O	O
of	O	O
the	O	O
first	O	O
tryptophan	O	O
and	O	O
the	O	O
tyrosine-phenylalanine	O	O
pair	O	O
in	O	O
the	O	O
binding	O	O
of	O	O
dextran	O	O
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
essential	O	O
contribution	O	O
of	O	O
a	O	O
basic	O	O
residue	O	O
(	O	O
arginine	O	O
or	O	O
lysine	O	O
)	O	O
.	O	O

A	O	O
microplate	O	O
binding	O	O
assay	O	O
was	O	O
developed	O	O
to	O	O
measure	O	O
the	O	O
binding	O	O
affinity	O	O
of	O	O
recombinant	O	O
GBDs	O	O
.	O	O

GBD	O	O
of	O	O
GtfI	O	O
was	O	O
shown	O	O
to	O	O
be	O	O
capable	O	O
of	O	O
binding	O	O
glucans	O	O
with	O	O
predominantly	O	O
alpha-1,3	O	O
or	O	O
alpha-1,6	O	O
links	O	O
,	O	O
as	O	O
well	O	O
as	O	O
alternating	O	O
alpha-1,3	O	O
and	O	O
alpha-1,6	O	O
links	O	O
(	O	O
alternan	O	O
)	O	O
.	O	O

Western	O	O
blot	O	O
experiments	O	O
using	O	O
biotinylated	O	O
dextran	O	O
or	O	O
alternan	O	O
as	O	O
probes	O	O
demonstrated	O	O
a	O	O
difference	O	O
between	O	O
the	O	O
binding	O	O
of	O	O
streptococcal	O	O
GTF	O	O
and	O	O
GBP	O	O
and	O	O
that	O	O
of	O	O
Leuconostoc	B-bacteria	B-bacteria
glucansucrases	O	O
.	O	O

Experimental	O	O
data	O	O
and	O	O
bioinformatics	O	O
analysis	O	O
showed	O	O
that	O	O
the	O	O
A	O	O
repeat	O	O
motif	O	O
is	O	O
distinct	O	O
from	O	O
the	O	O
20-residue	O	O
CW	O	O
motif	O	O
,	O	O
which	O	O
also	O	O
has	O	O
conserved	O	O
aromatic	O	O
amino	O	O
acids	O	O
and	O	O
glycine	O	O
and	O	O
which	O	O
occurs	O	O
in	O	O
the	O	O
choline-binding	O	O
proteins	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
and	O	O
other	O	O
organisms	O	O
.	O	O

Because	O	O
oral	O	O
infections	O	O
are	O	O
common	O	O
,	O	O
the	O	O
physician	O	O
must	O	O
understand	O	O
the	O	O
underlying	O	O
etiology	O	O
,	O	O
pathogeny	O	O
,	O	O
and	O	O
other	O	O
variables	O	O
that	O	O
determine	O	O
how	O	O
these	O	O
processes	O	O
evolve	O	O
in	O	O
order	O	O
to	O	O
choose	O	O
the	O	O
most	O	O
appropriate	O	O
antibiotic	O	O
drug	O	O
.	O	O

The	O	O
special	O	O
characteristics	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
determine	O	O
the	O	O
make-up	O	O
of	O	O
the	O	O
microflora	O	O
that	O	O
lives	O	O
there	O	O
.	O	O

Different	O	O
anaerobic	O	O
species	O	O
belonging	O	O
to	O	O
the	O	O
Peptostreptococcus	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
genera	E-bacteria	I-bacteria
are	O	O
of	O	O
particular	O	O
interest	O	O
,	O	O
as	O	O
are	O	O
the	O	O
aerobic	O	O
species	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
,	O	O
and	O	O
Corynebacterium	B-bacteria	B-bacteria
.	O	O

Each	O	O
of	O	O
these	O	O
microorganisms	O	O
occupies	O	O
a	O	O
different	O	O
microniche	O	O
within	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
the	O	O
prevailing	O	O
balance	O	O
is	O	O
upset	O	O
when	O	O
conditions	O	O
become	O	O
modified	O	O
as	O	O
a	O	O
result	O	O
of	O	O
illness	O	O
or	O	O
due	O	O
to	O	O
dental	O	O
interventions	O	O
such	O	O
as	O	O
tooth	O	O
extraction	O	O
or	O	O
tooth	O	O
scaling	O	O
and	O	O
polishing	O	O
.	O	O

Pathogenic	O	O
or	O	O
opportunistic	O	O
bacteria	O	O
(	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
,	O	O
etc	O	O
.	O	O
)	O	O

can	O	O
develop	O	O
in	O	O
these	O	O
conditions	O	O
,	O	O
as	O	O
can	O	O
yeasts	O	O
(	O	O
Candida	O	O
sp.	O	O
,	O	O
Histoplasma	O	O
capsulatum	O	O
)	O	O
,	O	O
virus	O	O
(	O	O
herpes	O	O
simplex	O	O
,	O	O
papilomavirus	O	O
)	O	O
,	O	O
and	O	O
parasites	O	O
(	O	O
Entamoeba	O	O
gingivalis	O	O
,	O	O
Trichomonas	O	O
tenax	O	O
)	O	O
.	O	O

When	O	O
infection	O	O
occurs	O	O
,	O	O
the	O	O
patients	O	O
s	O	O
immune	O	O
system	O	O
reacts	O	O
by	O	O
means	O	O
of	O	O
inborn	O	O
immunity	O	O
(	O	O
non-specific	O	O
)	O	O
and	O	O
acquired	O	O
immunity	O	O
(	O	O
specific	O	O
)	O	O
.	O	O

Empirical	O	O
treatment	O	O
is	O	O
administered	O	O
that	O	O
should	O	O
be	O	O
based	O	O
on	O	O
etiological	O	O
data	O	O
and	O	O
on	O	O
the	O	O
antimicrobial	O	O
sensitivity	O	O
of	O	O
the	O	O
pathogen	O	O
that	O	O
is	O	O
causing	O	O
the	O	O
infection	O	O
.	O	O

However	O	O
,	O	O
oral	O	O
microflora	O	O
sensitivity	O	O
to	O	O
different	O	O
antibiotics	O	O
is	O	O
currently	O	O
declining	O	O
and	O	O
there	O	O
is	O	O
a	O	O
noticeable	O	O
trend	O	O
towards	O	O
resistances	O	O
.	O	O

As	O	O
a	O	O
consequence	O	O
of	O	O
all	O	O
this	O	O
,	O	O
the	O	O
treatment	O	O
of	O	O
oral	O	O
infections	O	O
must	O	O
also	O	O
aim	O	O
to	O	O
restore	O	O
the	O	O
ecological	O	O
balance	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
to	O	O
minimize	O	O
the	O	O
emergence	O	O
of	O	O
resistance	O	O
in	O	O
the	O	O
microorganisms	O	O
present	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

Hence	O	O
,	O	O
epidemiological	O	O
oral	O	O
pathogen	O	O
sensitivity	O	O
studies	O	O
must	O	O
be	O	O
conducted	O	O
,	O	O
fostering	O	O
the	O	O
administration	O	O
of	O	O
appropriate	O	O
antibiotics	O	O
at	O	O
proper	O	O
doses	O	O
and	O	O
keeping	O	O
specialists	O	O
abreast	O	O
of	O	O
the	O	O
latest	O	O
trends	O	O
.	O	O

In	O	O
recent	O	O
decades	O	O
,	O	O
oral	O	O
infections	O	O
comprise	O	O
one	O	O
of	O	O
the	O	O
most	O	O
common	O	O
pathologies	O	O
in	O	O
the	O	O
general	O	O
population	O	O
,	O	O
due	O	O
in	O	O
large	O	O
part	O	O
to	O	O
infectious	O	O
complications	O	O
associated	O	O
with	O	O
poor	O	O
oral	O	O
hygiene	O	O
.	O	O

This	O	O
in	O	O
turn	O	O
,	O	O
translates	O	O
into	O	O
an	O	O
increased	O	O
need	O	O
and	O	O
demand	O	O
for	O	O
dental	O	O
care	O	O
,	O	O
while	O	O
at	O	O
the	O	O
same	O	O
time	O	O
,	O	O
it	O	O
requires	O	O
that	O	O
the	O	O
professional	O	O
accurately	O	O
understand	O	O
the	O	O
etiological	O	O
factors	O	O
involved	O	O
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
pathogeny	O	O
and	O	O
different	O	O
variables	O	O
that	O	O
determine	O	O
the	O	O
specificity	O	O
of	O	O
these	O	O
kinds	O	O
of	O	O
infections	O	O
,	O	O
so	O	O
as	O	O
to	O	O
be	O	O
able	O	O
to	O	O
choose	O	O
the	O	O
appropriate	O	O
antimicrobial	O	O
drugs	O	O
for	O	O
proper	O	O
treatment	O	O
.	O	O

Halitosis	O	O
refers	O	O
to	O	O
the	O	O
condition	O	O
of	O	O
offensive	O	O
mouth	O	O
odour	O	O
.	O	O

More	O	O
than	O	O
90	O	O
%	O	O
of	O	O
cases	O	O
of	O	O
halitosis	O	O
originate	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
implicated	O	O
bacteria	O	O
(	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
are	O	O
located	O	O
in	O	O
stagnant	O	O
areas	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
such	O	O
as	O	O
the	O	O
dorsal	O	O
surface	O	O
of	O	O
tongue	O	O
,	O	O
periodontal	O	O
pockets	O	O
,	O	O
and	O	O
interproximal	O	O
areas	O	O
.	O	O

These	O	O
bacteria	O	O
proteolyse	O	O
the	O	O
amino	O	O
acids	O	O
releasing	O	O
volatile	O	O
sulphur	O	O
compounds	O	O
.	O	O

The	O	O
management	O	O
of	O	O
halitosis	O	O
involves	O	O
determining	O	O
and	O	O
eliminating	O	O
the	O	O
causes	O	O
,	O	O
which	O	O
includes	O	O
identifying	O	O
any	O	O
contributory	O	O
factors	O	O
,	O	O
because	O	O
certain	O	O
medical	O	O
conditions	O	O
are	O	O
also	O	O
associated	O	O
with	O	O
characteristic	O	O
smells	O	O
.	O	O

Professional	O	O
advice	O	O
should	O	O
be	O	O
given	O	O
on	O	O
oral	O	O
hygiene	O	O
and	O	O
diet	O	O
,	O	O
and	O	O
treatments	O	O
should	O	O
include	O	O
dental	O	O
scaling	O	O
,	O	O
and	O	O
root	O	O
planing	O	O
of	O	O
the	O	O
associated	O	O
periodontal	O	O
pockets	O	O
to	O	O
reduce	O	O
the	O	O
bacterial	O	O
loading	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
the	O	O
normal	O	O
oral	O	O
hygiene	O	O
practice	O	O
,	O	O
tongue	O	O
cleaning	O	O
and	O	O
use	O	O
of	O	O
mouthwash	O	O
are	O	O
advocated	O	O
.	O	O

This	O	O
paper	O	O
discusses	O	O
the	O	O
common	O	O
aetiological	O	O
factors	O	O
,	O	O
classification	O	O
of	O	O
oral	O	O
halitosis	O	O
,	O	O
and	O	O
its	O	O
treatment	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
is	O	O
a	O	O
gram-negative	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
microaerophilic	I-bacteria	I-bacteria
rod-shaped	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
that	O	O
lives	O	O
beneath	O	O
the	O	O
gastric	O	O
mucous	O	O
layer	O	O
,	O	O
on	O	O
the	O	O
surface	O	O
of	O	O
epithelial	O	O
cells	O	O
.	O	O

Stomach	O	O
infection	O	O
with	O	O
this	O	O
organism	O	O
causes	O	O
inflammation	O	O
of	O	O
the	O	O
gastric	O	O
mucosa	O	O
,	O	O
which	O	O
can	O	O
lead	O	O
to	O	O
gastritis	O	O
,	O	O
duodenal	O	O
or	O	O
gastric	O	O
ulcer	O	O
and	O	O
even	O	O
in	O	O
rare	O	O
cases	O	O
to	O	O
gastric	O	O
carcinoma	O	O
or	O	O
MALT	O	O
lymphoma	O	O
.	O	O

Approximately	O	O
50	O	O
%	O	O
of	O	O
the	O	O
world	O	O
's	O	O
population	O	O
is	O	O
believed	O	O
to	O	O
be	O	O
infected	O	O
with	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

Most	O	O
infections	O	O
is	O	O
probably	O	O
acquired	O	O
in	O	O
childhood	O	O
,	O	O
but	O	O
the	O	O
exact	O	O
route	O	O
of	O	O
transmission	O	O
is	O	O
unknown	O	O
.	O	O

It	O	O
has	O	O
been	O	O
speculated	O	O
that	O	O
dental	O	O
plaque	O	O
might	O	O
harbour	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
and	O	O
,	O	O
therefore	O	O
,	O	O
might	O	O
be	O	O
a	O	O
source	O	O
of	O	O
gastric	O	O
infection	O	O
.	O	O

In	O	O
order	O	O
to	O	O
address	O	O
this	O	O
issue	O	O
we	O	O
studied	O	O
the	O	O
relationships	O	O
between	O	O
oral	O	O
and	O	O
gastric	O	O
infections	O	O
with	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
100	O	O
subjects	O	O
.	O	O

Gastric	B-bacteria	B-bacteria
H.	I-bacteria	I-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
was	O	O
determined	O	O
by	O	O
(	O	O
13	O	O
)	O	O
C-urea	O	O
breath	O	O
test	O	O
(	O	O
UBT	O	O
)	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
bacteria	O	O
in	O	O
oral	O	O
cavity	O	O
was	O	O
monitored	O	O
by	O	O
the	O	O
culture	O	O
from	O	O
the	O	O
saliva	O	O
and	O	O
from	O	O
dental	O	O
plaque	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
found	O	O
in	O	O
the	O	O
stomach	O	O
in	O	O
51	O	O
%	O	O
of	O	O
studied	O	O
individuals	O	O
,	O	O
while	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
found	O	O
in	O	O
54	O	O
%	O	O
(	O	O
in	O	O
saliva	O	O
)	O	O
and	O	O
in	O	O
48.3	O	O
%	O	O
(	O	O
in	O	O
gingival	O	O
pockets	O	O
)	O	O
,	O	O
the	O	O
difference	O	O
was	O	O
not	O	O
statistical	O	O
significant	O	O
(	O	O
p=NS	O	O
)	O	O
.	O	O

Interestingly	O	O
,	O	O
anti-Hp	O	O
IgA	O	O
was	O	O
found	O	O
in	O	O
84	O	O
%	O	O
of	O	O
studied	O	O
individuals	O	O
.	O	O

No	O	O
relationship	O	O
was	O	O
found	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
gastric	O	O
infection	O	O
.	O	O

54.9	O	O
%	O	O
of	O	O
subjects	O	O
with	O	O
stomach	O	O
infection	O	O
showed	O	O
concomitant	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
saliva	O	O
.	O	O

52.3	O	O
%	O	O
of	O	O
examined	O	O
subjects	O	O
with	O	O
negative	O	O
UBT-test	O	O
revealed	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	B-bacteria	B-bacteria
in	O	O
culture	O	O
from	O	O
the	O	O
saliva	O	O
.	O	O

The	O	O
X	O	O
(	O	O
2	O	O
)	O	O
value	O	O
of	O	O
relationship	O	O
between	O	O
UBT	O	O
and	O	O
culture	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
saliva	O	O
was	O	O
0.029	O	O
(	O	O
p=0.9	O	O
)	O	O
.	O	O

Similarly	O	O
,	O	O
no	O	O
relationship	O	O
was	O	O
found	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
stomach	O	O
and	O	O
in	O	O
the	O	O
dental	O	O
plaque	O	O
(	O	O
X2=0.6	O	O
)	O	O
;	O	O
p=0.4	O	O
)	O	O
.	O	O

As	O	O
expected	O	O
,	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	B-bacteria	B-bacteria
in	O	O
the	O	O
dental	O	O
plaque	O	O
was	O	O
significantly	O	O
correlated	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
saliva	O	O
(	O	O
X2=18.4	O	O
;	O	O
p=0.0002	O	O
)	O	O
.	O	O

We	O	O
also	O	O
compared	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	B-bacteria	B-bacteria
in	O	O
the	O	O
saliva	O	O
of	O	O
patients	O	O
with	O	O
and	O	O
without	O	O
teeth	O	O
.	O	O

The	O	O
cultured	O	O
H.	B-bacteria	B-bacteria
pylori	B-bacteria	B-bacteria
was	O	O
found	O	O
in	O	O
63.7	O	O
%	O	O
of	O	O
patients	O	O
without	O	O
teeth	O	O
and	O	O
in	O	O
52.9	O	O
%	O	O
of	O	O
patients	O	O
with	O	O
teeth	O	O
.	O	O

This	O	O
indicates	O	O
that	O	O
the	O	O
presence	O	O
of	O	O
teeth	O	O
does	O	O
not	O	O
seem	O	O
to	O	O
affect	O	O
the	O	O
occurrence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
saliva	O	O
.	O	O

We	O	O
conclude	O	O
that	O	O
oral	O	O
activity	O	O
contamination	O	O
with	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
occurs	O	O
at	O	O
similar	O	O
degree	O	O
to	O	O
that	O	O
in	O	O
the	O	O
stomach	O	O
.	O	O

However	O	O
,	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
correlation	O	O
between	O	O
the	O	O
occurrence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
stomach	O	O
and	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
indicating	O	O
that	O	O
other	O	O
factors	O	O
,	O	O
like	O	O
susceptibility	O	O
to	O	O
infection	O	O
due	O	O
to	O	O
acid	O	O
environment	O	O
in	O	O
the	O	O
stomach	O	O
may	O	O
be	O	O
the	O	O
major	O	O
factor	O	O
in	O	O
gastric	O	O
infection	O	O
with	O	O
that	O	O
bacteria	O	O
,	O	O
while	O	O
oral	O	O
cavity	O	O
may	O	O
serve	O	O
only	O	O
as	O	O
transient	O	O
food-related	O	O
contamination	O	O
without	O	O
clear	O	O
relation	O	O
to	O	O
gastric	O	O
infection	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
are	O	O
a	O	O
major	O	O
component	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
and	O	O
some	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
various	O	O
forms	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

Despite	O	O
the	O	O
importance	O	O
of	O	O
understanding	O	O
the	O	O
prevalence	O	O
of	O	O
these	O	O
organisms	O	O
in	O	O
the	O	O
oral	O	O
microflora	O	O
,	O	O
no	O	O
rapid	O	O
,	O	O
simultaneous	O	O
detection	O	O
system	O	O
for	O	O
these	O	O
species	O	O
has	O	O
been	O	O
reported	O	O
.	O	O

This	O	O
study	O	O
developed	O	O
a	O	O
multiplex	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assay	O	O
for	O	O
the	O	O
simultaneous	O	O
detection	O	O
of	O	O
four	O	O
oral	O	O
black-pigmented	B-bacteria	B-bacteria
Prevotella	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
in	O	O
various	O	O
oral	O	O
specimens	O	O
.	O	O

This	O	O
assay	O	O
will	O	O
be	O	O
useful	O	O
for	O	O
determining	O	O
the	O	O
prevalence	O	O
of	O	O
these	O	O
organisms	O	O
in	O	O
the	O	O
oral	O	O
ecosystem	O	O
.	O	O

Furthermore	O	O
,	O	O
this	O	O
assay	O	O
system	O	O
should	O	O
prove	O	O
a	O	O
useful	O	O
tool	O	O
for	O	O
analyzing	O	O
the	O	O
role	O	O
of	O	O
black-pigmented	B-bacteria	B-bacteria
Prevotella	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
in	O	O
the	O	O
mouth	O	O
.	O	O

Previously	O	O
,	O	O
we	O	O
used	O	O
in	O	O
situ	O	O
hybridization	O	O
and	O	O
confocal	O	O
microscopy	O	O
to	O	O
detect	O	O
the	O	O
periodontal	O	O
pathogens	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
within	O	O
buccal	O	O
epithelial	O	O
cells	O	O
taken	O	O
directly	O	O
from	O	O
the	O	O
mouth	O	O
.	O	O

This	O	O
study	O	O
tested	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
intracellular	O	O
flora	O	O
of	O	O
buccal	O	O
cells	O	O
is	O	O
polymicrobial	O	O
.	O	O

Mixtures	O	O
containing	O	O
a	O	O
red	O	O
fluorescent	O	O
universal	O	O
probe	O	O
paired	O	O
with	O	O
green	O	O
fluorescent	O	O
versions	O	O
of	O	O
either	O	O
A.	O	O
actinomycetemcomitans-	O	O
,	O	O
P.	O	O
gingivalis-	O	O
,	O	O
or	O	O
T.	O	O
forsythensis-specific	O	O
probes	O	O
were	O	O
hybridized	O	O
with	O	O
buccal	O	O
cells	O	O
collected	O	O
from	O	O
each	O	O
of	O	O
38	O	O
healthy	O	O
humans	O	O
.	O	O

We	O	O
verified	O	O
co-localization	O	O
of	O	O
probe	O	O
pairs	O	O
within	O	O
cells	O	O
by	O	O
generating	O	O
three-dimensional	O	O
reconstructions	O	O
.	O	O

Intracellular	O	O
bacteria	O	O
were	O	O
detected	O	O
in	O	O
every	O	O
subject	O	O
.	O	O

Each	O	O
cell	O	O
that	O	O
was	O	O
labeled	O	O
with	O	O
a	O	O
species-specific	O	O
probe	O	O
also	O	O
contained	O	O
bacteria	O	O
recognized	O	O
only	O	O
by	O	O
the	O	O
universal	O	O
probe	O	O
.	O	O

Bacteria	O	O
labeled	O	O
with	O	O
specific	O	O
probes	O	O
often	O	O
occupied	O	O
smaller	O	O
regions	O	O
within	O	O
larger	O	O
masses	O	O
of	O	O
bacteria	O	O
.	O	O

Those	O	O
findings	O	O
suggest	O	O
that	O	O
future	O	O
studies	O	O
of	O	O
invasion	O	O
by	O	O
oral	O	O
bacteria	O	O
may	O	O
need	O	O
to	O	O
include	O	O
microbial	O	O
consortia	O	O
.	O	O

Induction	O	O
of	O	O
resistance	O	O
of	O	O
oral	O	O
anaerobes	B-bacteria	B-bacteria
to	O	O
the	O	O
effects	O	O
of	O	O
human	O	O
beta-defensin	O	O
1	O	O
(	O	O
hbetaD-1	O	O
)	O	O
to	O	O
hbetaD-4	O	O
was	O	O
investigated	O	O
by	O	O
pretreating	O	O
cells	O	O
with	O	O
either	O	O
sublethal	O	O
levels	O	O
of	O	O
defensins	O	O
or	O	O
environmental	O	O
factors	O	O
,	O	O
followed	O	O
by	O	O
a	O	O
challenge	O	O
with	O	O
lethal	O	O
levels	O	O
of	O	O
defensins	O	O
.	O	O

Cultures	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
(	O	O
i	O	O
)	O	O
pretreated	O	O
with	O	O
defensins	O	O
at	O	O
1	O	O
ng/ml	O	O
,	O	O
(	O	O
ii	O	O
)	O	O
heated	O	O
to	O	O
42	O	O
degrees	O	O
C	O	O
(	O	O
heat	O	O
stress	O	O
)	O	O
,	O	O
(	O	O
iii	O	O
)	O	O
exposed	O	O
to	O	O
normal	O	O
atmosphere	O	O
(	O	O
oxidative	O	O
stress	O	O
)	O	O
,	O	O
or	O	O
(	O	O
iv	O	O
)	O	O
exposed	O	O
to	O	O
1	O	O
mM	O	O
hydrogen	O	O
peroxide	O	O
(	O	O
peroxide	O	O
stress	O	O
)	O	O
.	O	O

Samples	O	O
(	O	O
10	O	O
microl	O	O
)	O	O
were	O	O
distributed	O	O
among	O	O
the	O	O
wells	O	O
of	O	O
sterile	O	O
384-well	O	O
plates	O	O
containing	O	O
hbetaD-1	O	O
to	O	O
-4	O	O
(	O	O
100	O	O
microg/ml	O	O
)	O	O
.	O	O

Plates	O	O
were	O	O
incubated	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
36	O	O
h	O	O
in	O	O

an	O	O
anaerobe	B-bacteria	B-bacteria
chamber	O	O
.	O	O

Growth	O	O
inhibition	O	O
was	O	O
determined	O	O
by	O	O
a	O	O
system	O	O
that	O	O
measures	O	O
the	O	O
total	O	O
nucleic	O	O
acid	O	O
of	O	O
a	O	O
sample	O	O
with	O	O
a	O	O
DNA	O	O
binding	O	O
dye	O	O
.	O	O

The	O	O
MICs	O	O
of	O	O
the	O	O
four	O	O
defensins	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
3	O	O
to	O	O
12	O	O
microg/ml	O	O
.	O	O

We	O	O
found	O	O
that	O	O
sublethal	O	O
levels	O	O
of	O	O
the	O	O
defensins	O	O
and	O	O
heat	O	O
and	O	O
peroxide	O	O
stress	O	O
,	O	O
but	O	O
not	O	O
oxidative	O	O
stress	O	O
,	O	O
induced	O	O
resistance	O	O
to	O	O
100	O	O
microg	O	O
of	O	O
defensin	O	O
per	O	O
ml	O	O
in	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Resistance	O	O
induced	O	O
by	O	O
sublethal	O	O
levels	O	O
of	O	O
hbetaD-2	O	O
lasted	O	O
90	O	O
min	O	O
,	O	O
and	O	O
the	O	O
resistance	O	O
induced	O	O
by	O	O
each	O	O
defensin	O	O
was	O	O
effective	O	O
against	O	O
the	O	O
other	O	O
three	O	O
.	O	O

Multiple	O	O
strains	O	O
exposed	O	O
to	O	O
hbetaD-2	O	O
all	O	O
evidenced	O	O
resistance	O	O
induction	O	O
.	O	O

Defensin	O	O
resistance	O	O
is	O	O
vital	O	O
to	O	O
the	O	O
pathogenic	O	O
potential	O	O
of	O	O
several	O	O
human	O	O
pathogens	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
report	O	O
describing	O	O
the	O	O
induction	O	O
of	O	O
defensin	O	O
resistance	O	O
in	O	O
the	O	O
oral	O	O
periodontal	O	O
pathogen	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Such	O	O
resistance	O	O
may	O	O
have	O	O
an	O	O
effect	O	O
on	O	O
the	O	O
ability	O	O
of	O	O
oral	O	O
pathogens	O	O
to	O	O
persist	O	O
in	O	O
the	O	O
mouth	O	O
and	O	O
to	O	O
withstand	O	O
innate	O	O
human	O	O
immunity	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
has	O	O
been	O	O
recognized	O	O
as	O	O
an	O	O
important	O	O
etiological	O	O
agent	O	O
in	O	O
human	O	O
dental	O	O
caries	O	O
.	O	O

Some	O	O
strains	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
also	O	O
produce	O	O
bacteriocins	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
sought	O	O
to	O	O
demonstrate	O	O
that	O	O
bacteriocin	O	O
production	O	O
by	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	I-bacteria	I-bacteria
GS5	E-bacteria	I-bacteria
and	O	O
BM71	B-bacteria	B-bacteria
was	O	O
mediated	O	O
by	O	O
quorum	O	O
sensing	O	O
,	O	O
which	O	O
is	O	O
dependent	O	O
on	O	O
a	O	O
competence-stimulating	O	O
peptide	O	O
(	O	O
CSP	O	O
)	O	O
signaling	O	O
system	O	O
encoded	O	O
by	O	O
the	O	O
com	O	O
genes	O	O
.	O	O

We	O	O
also	O	O
demonstrated	O	O
that	O	O
interactions	O	O
with	O	O
some	O	O
other	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
interfered	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
bacteriocin	O	O
production	O	O
both	O	O
in	O	O
broth	O	O
and	O	O
in	O	O
biofilms	O	O
.	O	O

The	O	O
inhibition	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
bacteriocin	O	O
production	O	O
by	O	O
oral	O	O
bacteria	O	O
was	O	O
stronger	O	O
in	O	O
biofilms	O	O
than	O	O
in	O	O
broth	O	O
.	O	O

Using	O	O
transposon	O	O
Tn916	O	O
mutagenesis	O	O
,	O	O
we	O	O
identified	O	O
a	O	O
gene	O	O
(	O	O
sgc	O	O
;	O	O
named	O	O
for	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
challisin	E-bacteria	I-bacteria
)	O	O
responsible	O	O
for	O	O
the	O	O
inhibition	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
bacteriocin	O	O
production	O	O
by	O	O
S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
Challis	E-bacteria	I-bacteria
.	O	O

Interruption	O	O
of	O	O
the	O	O
sgc	O	O
gene	O	O
in	O	O
S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
Challis	E-bacteria	I-bacteria
resulted	O	O
in	O	O
attenuated	O	O
inhibition	O	O
of	O	O
S.	O	O
mutans	O	O
bacteriocin	O	O
production	O	O
.	O	O

The	O	O
supernatant	O	O
fluids	O	O
from	O	O
the	O	O
sgc	O	O
mutant	O	O
did	O	O
not	O	O
inactivate	O	O
the	O	O
exogenous	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
CSP	O	O
as	O	O
did	O	O
those	O	O
from	O	O
the	O	O
parent	O	O
strain	O	O
Challis	O	O
.	O	O

S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
Challis	E-bacteria	I-bacteria
did	O	O
not	O	O
inactivate	O	O
bacteriocin	O	O
produced	O	O
by	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
GS5	E-bacteria	I-bacteria
.	O	O

Because	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
uses	O	O
quorum	O	O
sensing	O	O
to	O	O
regulate	O	O
virulence	O	O
,	O	O
strategies	O	O
designed	O	O
to	O	O
interfere	O	O
with	O	O
these	O	O
signaling	O	O
systems	O	O
may	O	O
have	O	O
broad	O	O
applicability	O	O
for	O	O
biological	O	O
control	O	O
of	O	O
this	O	O
caries-causing	O	O
organism	O	O
.	O	O

Direct	O	O
person-to-person	O	O
transmission	O	O
of	O	O
periodontal	O	O
bacteria	O	O
through	O	O
saliva	O	O
has	O	O
recently	O	O
been	O	O
widely	O	O
reported	O	O
and	O	O
dental	O	O
units	O	O
have	O	O
been	O	O
demonstrated	O	O
to	O	O
retract	O	O
saliva	O	O
from	O	O
patients	O	O
under	O	O
treatment	O	O
and	O	O
to	O	O
release	O	O
it	O	O
into	O	O
the	O	O
mouths	O	O
of	O	O
subjects	O	O
undergoing	O	O
the	O	O
next	O	O
operation	O	O
.	O	O

In	O	O
this	O	O
study	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
group	O	O
of	O	O
periodontal	O	O
pathogenic	O	O
bacteria	O	O
inside	O	O
waterlines	O	O
in	O	O
dental	O	O
units	O	O
was	O	O
investigated	O	O
using	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
based	O	O
methods	O	O
.	O	O

Briefly	O	O
,	O	O
18	O	O
dental	O	O
units	O	O
of	O	O
three	O	O
different	O	O
manufacturers	O	O
were	O	O
studied	O	O
.	O	O

Dental	O	O
units	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
according	O	O
to	O	O
their	O	O
prevalent	O	O
use	O	O
in	O	O
routine	O	O
practice	O	O
.	O	O

The	O	O
first	O	O
group	O	O
consisted	O	O
of	O	O
nine	O	O
dental	O	O
units	O	O
characterized	O	O
by	O	O
the	O	O
frequent	O	O
use	O	O
of	O	O
high-speed	O	O
dental	O	O
hand-pieces	O	O
directly	O	O
inside	O	O
the	O	O
mouth	O	O
and	O	O
in	O	O
contact	O	O
with	O	O
patients	O	O
'	O	O
saliva	O	O
.	O	O

The	O	O
second	O	O
group	O	O
,	O	O
as	O	O
a	O	O
control	O	O
,	O	O
consisted	O	O
of	O	O
nine	O	O
dental	O	O
units	O	O
where	O	O
high-speed	O	O
dental	O	O
hand-pieces	O	O
were	O	O
not	O	O
in	O	O
use	O	O
.	O	O

A	O	O
one	O	O
cm	O	O
section	O	O
of	O	O
the	O	O
waterline	O	O
tubing	O	O
connected	O	O
to	O	O
the	O	O
high-speed	O	O
hand-piece	O	O
was	O	O
removed	O	O
from	O	O
each	O	O
dental	O	O
unit	O	O
to	O	O
evaluate	O	O
the	O	O
presence	O	O
of	O	O
DNA	O	O
of	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

Two	O	O
specimens	O	O
were	O	O
positive	O	O
for	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
DNA	O	O
.	O	O

All	O	O
the	O	O
positive	O	O
results	O	O
were	O	O
from	O	O
samples	O	O
obtained	O	O
from	O	O
dental	O	O
units	O	O
categorised	O	O
in	O	O
the	O	O
first	O	O
group	O	O
.	O	O

These	O	O
findings	O	O
clearly	O	O
suggest	O	O
that	O	O
dental	O	O
units	O	O
have	O	O
the	O	O
potential	O	O
to	O	O
transmit	O	O
periodontal	O	O
pathogens	O	O
.	O	O

Manufacturers	O	O
should	O	O
be	O	O
invited	O	O
to	O	O
design	O	O
dental	O	O
units	O	O
that	O	O
incorporate	O	O
automated	O	O
devices	O	O
to	O	O
disinfect	O	O
DUWLs	O	O
between	O	O
patients	O	O
with	O	O
minimal	O	O
effort	O	O
by	O	O
dental	O	O
staff	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
investigation	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
prevalence	O	O
of	O	O
Candida	O	O
and	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
in	O	O
a	O	O
group	O	O
of	O	O
adolescents	O	O
during	O	O
fixed	O	O
orthodontic	O	O
appliance	O	O
(	O	O
FOA	O	O
)	O	O
therapy	O	O
.	O	O

The	O	O
experimental	O	O
group	O	O
was	O	O
recruited	O	O
from	O	O
a	O	O
larger	O	O
sample	O	O
of	O	O
orthodontic	O	O
patients	O	O
who	O	O
were	O	O
clinically	O	O
examined	O	O
once	O	O
to	O	O
obtain	O	O
baseline	O	O
data	O	O
before	O	O
active	O	O
treatment	O	O
.	O	O

The	O	O
group	O	O
comprised	O	O
27	O	O
subjects	O	O
;	O	O
13	O	O
males	O	O
,	O	O
14	O	O
females	O	O
(	O	O
mean	O	O
age	O	O
15.5	O	O
+/-	O	O
2.3	O	O
years	O	O
)	O	O
.	O	O

Thereafter	O	O
,	O	O
the	O	O
experimental	O	O
group	O	O
was	O	O
examined	O	O
three	O	O
times	O	O
during	O	O
a	O	O
3	O	O
month	O	O
follow-up	O	O
period	O	O
after	O	O
insertion	O	O
of	O	O
the	O	O
FOA	O	O
.	O	O

The	O	O
whole	O	O
mouth	O	O
plaque	O	O
score	O	O
was	O	O
obtained	O	O
,	O	O
and	O	O
the	O	O
oral	O	O
cavity	O	O
was	O	O
then	O	O
sampled	O	O
for	O	O
Candida	O	O
species	O	O
and	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
using	O	O
three	O	O
different	O	O
microbiological	O	O
culture	O	O
techniques	O	O
,	O	O
namely	O	O
the	O	O
oral	O	O
rinse	O	O
,	O	O
pooled	O	O
plaque	O	O
and	O	O
the	O	O
imprint	O	O
culture.	O	O
A	O	O
significant	O	O
increase	O	O
in	O	O
candidal	O	O
numbers	O	O
was	O	O
observed	O	O
after	O	O
FOA	O	O
insertion	O	O
when	O	O
the	O	O
imprint	O	O
technique	O	O
was	O	O
used	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
although	O	O
the	O	O
overall	O	O
candidal	O	O
prevalence	O	O
rates	O	O
obtained	O	O
using	O	O
the	O	O
oral	O	O
rinse	O	O
and	O	O
pooled	O	O
plaque	O	O
techniques	O	O
did	O	O
not	O	O
demonstrate	O	O
such	O	O
a	O	O
change	O	O
.	O	O

The	O	O
predominant	O	O
Candida	O	O
species	O	O
isolated	O	O
was	O	O
C.	O	O
albicans	O	O
and	O	O
the	O	O
number	O	O
of	O	O
coliform	B-bacteria	B-bacteria
carriers	O	O
significantly	O	O
increased	O	O
after	O	O
the	O	O
insertion	O	O
of	O	O
a	O	O
FOA	O	O
,	O	O
as	O	O
detected	O	O
by	O	O
the	O	O
oral	O	O
rinse	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
and	O	O
the	O	O
pooled	O	O
plaque	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
techniques	O	O
.	O	O

In	O	O
total	O	O
,	O	O
eight	O	O
coliform	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
isolated	O	O
following	O	O
FOA	O	O
therapy	O	O
compared	O	O
with	O	O
the	O	O
three	O	O
species	O	O
isolated	O	O
before	O	O
insertion	O	O
of	O	O
the	O	O
appliance	O	O
.	O	O

The	O	O
results	O	O
also	O	O
revealed	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
plaque	O	O
index	O	O
due	O	O
to	O	O
the	O	O
introduction	O	O
of	O	O
a	O	O
FOA	O	O
.	O	O

Taken	O	O
together	O	O
,	O	O
these	O	O
data	O	O
imply	O	O
that	O	O
insertion	O	O
of	O	O
a	O	O
FOA	O	O
is	O	O
likely	O	O
to	O	O
promote	O	O
oral	O	O
carriage	O	O
of	O	O
Candida	O	O
and	O	O
coliform	B-bacteria	B-bacteria
species	B-bacteria	B-bacteria
.	O	O

Furthermore	O	O
,	O	O
it	O	O
appears	O	O
that	O	O
routine	O	O
oral	O	O
hygiene	O	O
instruction	O	O
and	O	O
information	O	O
on	O	O
appliance	O	O
hygiene	O	O
given	O	O
to	O	O
these	O	O
patients	O	O
may	O	O
not	O	O
necessarily	O	O
reduce	O	O
plaque	O	O
accumulation	O	O
and	O	O
possible	O	O
attendant	O	O
effects	O	O
.	O	O

Further	O	O
work	O	O
with	O	O
a	O	O
larger	O	O
cohort	O	O
is	O	O
required	O	O
to	O	O
confirm	O	O
these	O	O
findings	O	O
.	O	O

Cecropin-XJ	O	O
belongs	O	O
to	O	O
cecropin-B	O	O
,	O	O
which	O	O
is	O	O
the	O	O
most	O	O
potent	O	O
antibacterial	O	O
peptide	O	O
found	O	O
naturally	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
effects	O	O
of	O	O
cecropin-XJ	O	O
on	O	O
growth	O	O
and	O	O
adherence	O	O
of	O	O
oral	O	O
cariogenic	O	O
bacteria	O	O
.	O	O

Four	O	O
oral	O	O
cariogenic	O	O
bacteria	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
)	O	O
were	O	O
chosen	O	O
for	O	O
this	O	O
experiment	O	O
.	O	O

The	O	O
minimal	O	O
inhibitory	O	O
concentrations	O	O
(	O	O
MICs	O	O
)	O	O
and	O	O
reductive	O	O
percent	O	O
of	O	O
bacterial	O	O
growth	O	O
were	O	O
used	O	O
to	O	O
assay	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
cecropin-XJ	O	O
.	O	O

Mammalian	O	O
cytotoxicity	O	O
of	O	O
cecropin-XJ	O	O
was	O	O
tested	O	O
with	O	O
human	O	O
periodontal	O	O
membrane	O	O
fibroblasts	O	O
by	O	O
tetrazolium	O	O
(	O	O
MTT	O	O
)	O	O
colorimetric	O	O
assay	O	O
.	O	O

The	O	O
bacterial	O	O
morphological	O	O
changes	O	O
induced	O	O
by	O	O
cecropin-XJ	O	O
were	O	O
examined	O	O
on	O	O
scanning	O	O
electron	O	O
microscope	O	O
(	O	O
SEM	O	O
)	O	O
.	O	O

The	O	O
influence	O	O
of	O	O
cecropin-XJ	O	O
on	O	O
bacterial	O	O
adhesion	O	O
to	O	O
saliva-coated	O	O
hydroxyapatite	O	O
(	O	O
S-HA	O	O
)	O	O
was	O	O
measured	O	O
by	O	O
scintillation	O	O
counting	O	O
.	O	O

The	O	O
MICs	O	O
of	O	O
cecropin-XJ	O	O
for	O	O
inhibition	O	O
of	O	O
the	O	O
growth	O	O
of	O	O
four	O	O
bacteria	O	O
ranged	O	O
from	O	O
4.0	O	O
to	O	O
42.8	O	O
micromol/L	O	O
with	O	O
the	O	O
highest	O	O
susceptible	O	O
to	O	O
A.	O	O
naeslundii	O	O
and	O	O
the	O	O
lowest	O	O
susceptible	O	O
to	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
.	O	O

At	O	O
pH	O	O
6.8	O	O
,	O	O
5.5	O	O
and	O	O
8.2	O	O
,	O	O
1/2	O	O
MIC	O	O
of	O	O
cecropin-XJ	O	O
reduced	O	O
the	O	O
number	O	O
of	O	O
viable	O	O
bacteria	O	O
by	O	O
40.9	O	O
%	O	O
,	O	O
67.8	O	O
%	O	O
and	O	O
32.8	O	O
%	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
by	O	O
28.1	O	O
%	O	O
,	O	O
57.2	O	O
%	O	O
and	O	O
37.9	O	O
%	O	O
for	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
.	O	O

The	O	O
activities	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
increased	O	O
at	O	O
pH	O	O
5.5	O	O
compared	O	O
with	O	O
pH	O	O
6.8	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

In	O	O
present	O	O
of	O	O
50	O	O
%	O	O
saliva	O	O
,	O	O
1/2	O	O
MIC	O	O
of	O	O
the	O	O
peptide	O	O
decreased	O	O
the	O	O
direct	O	O
count	O	O
of	O	O
viable	O	O
cells	O	O
by	O	O
29.2	O	O
%	O	O
and	O	O
14.4	O	O
%	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
respectively	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
and	O	O
P	O	O
>	O	O
0.05	O	O
,	O	O
respectively	O	O
)	O	O
,	O	O
whereas	O	O
almost	O	O
no	O	O
reduction	O	O
counts	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
20	O	O
%	O	O
serum	O	O
for	O	O
both	O	O
bacteria	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Mammalian	O	O
cytotoxicity	O	O
of	O	O
cecropin-XJ	O	O
from	O	O
1.0	O	O
to	O	O
100	O	O
micromol/L	O	O
exhibited	O	O
no	O	O
cytotoxicity	O	O
against	O	O
human	O	O
periodontal	O	O
membrane	O	O
fibroblasts	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Bacterial	O	O
morphological	O	O
changes	O	O
induced	O	O
by	O	O
MIC	O	O
of	O	O
cecropin-XJ	O	O
examined	O	O
on	O	O
SEM	O	O
showed	O	O
cell	O	O
surface	O	O
disruption	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
ability	O	O
of	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
adhesion	O	O
to	O	O
S-HA	O	O
decreased	O	O
significantly	O	O
with	O	O
MIC	O	O
of	O	O
cecropin-XJ	O	O
for	O	O
10	O	O
and	O	O
20	O	O
minutes	O	O
(	O	O
P	O	O
=	O	O
0.001	O	O
and	O	O
0.000	O	O
,	O	O
respectively	O	O
)	O	O
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
to	O	O
S-HA	O	O
decreased	O	O
significantly	O	O
with	O	O
MIC	O	O
of	O	O
cecropin-XJ	O	O
for	O	O
20	O	O
minutes	O	O
(	O	O
P	O	O
=	O	O
0.000	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Cecropin-XJ	O	O
exhibited	O	O
bactericidal	O	O
action	O	O
against	O	O
cariogenic	O	O
pathogens	O	O
,	O	O
and	O	O
the	O	O
antibacterial	O	O
activity	O	O
enhanced	O	O
in	O	O
the	O	O
acid	O	O
environment	O	O
.	O	O

The	O	O
results	O	O
also	O	O
demonstrate	O	O
that	O	O
cecropin-XJ	O	O
prevents	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
actinomyces	B-bacteria	B-bacteria
adsorption	O	O
to	O	O
S-HA	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
Cecropin-XJ	O	O
may	O	O
have	O	O
potential	O	O
to	O	O
prevent	O	O
caries	O	O
.	O	O

It	O	O
is	O	O
hypothesized	O	O
that	O	O
the	O	O
enterosalivary	O	O
nitrate	O	O
circulation	O	O
encourages	O	O
nitrate	B-bacteria	B-bacteria
reducing	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
to	O	O
reside	O	O
within	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Nitrite	O	O
production	O	O
may	O	O
then	O	O
limit	O	O
the	O	O
growth	O	O
of	O	O
acidogenic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
as	O	O
a	O	O
result	O	O
of	O	O
the	O	O
production	O	O
of	O	O
antimicrobial	O	O
oxides	O	O
of	O	O
nitrogen	O	O
,	O	O
including	O	O
nitric	O	O
oxide	O	O
.	O	O

This	O	O
study	O	O
was	O	O
carried	O	O
out	O	O
with	O	O
10	O	O
subjects	O	O
to	O	O
characterize	O	O
oral	O	O
nitrate	O	O
reduction	O	O
and	O	O
identify	O	O
the	O	O
bacteria	O	O
responsible	O	O
.	O	O

Nitrate	O	O
reduction	O	O
varied	O	O
between	O	O
individuals	O	O
(	O	O
mean	O	O
85.4	O	O
+/-	O	O
15.9	O	O
nmol	O	O
nitrite	O	O
min	O	O
(	O	O
-1	O	O
)	O	O
with	O	O
10	O	O
ml	O	O
1	O	O
mm	O	O
KNO	O	O
(	O	O
3	O	O
)	O	O
mouth	O	O
wash	O	O
)	O	O
and	O	O
was	O	O
found	O	O
to	O	O
be	O	O
concentrated	O	O
at	O	O
the	O	O
rear	O	O
of	O	O
the	O	O
tongue	O	O
dorsal	O	O
surface	O	O
.	O	O

Nitrate	B-bacteria	B-bacteria
reductase	I-bacteria	I-bacteria
positive	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
identified	O	O
,	O	O
using	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
,	O	O
from	O	O
the	O	O
tongue	O	O
comprised	O	O
Veillonella	B-bacteria	B-bacteria
atypica	E-bacteria	I-bacteria
(	O	O
34	O	O
%	O	O
)	O	O
,	O	O
Veillonella	B-bacteria	B-bacteria
dispar	E-bacteria	I-bacteria
(	O	O
24	O	O
%	O	O
)	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
(	O	O
21	O	O
%	O	O
)	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
(	O	O
2	O	O
%	O	O
)	O	O
,	O	O
Rothia	B-bacteria	B-bacteria
mucilaginosa	E-bacteria	I-bacteria
(	O	O
10	O	O
%	O	O
)	O	O
,	O	O
Rothia	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
(	O	O
3	O	O
%	O	O
)	O	O
and	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
(	O	O
5	O	O
%	O	O
)	O	O
.	O	O

Nitrite	O	O
production	O	O
rates	O	O
,	O	O
using	O	O
intact	O	O
and	O	O
permeabilized	O	O
cells	O	O
,	O	O
of	O	O
the	O	O
major	O	O
tongue	O	O
nitrate	O	O
reducers	O	O
were	O	O
determined	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
methyl	O	O
and	O	O
benzyl	O	O
viologen	O	O
.	O	O

Under	O	O
anaerobic	O	O
conditions	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
nitrate	O	O
,	O	O
rates	O	O
in	O	O
decreasing	O	O
order	O	O
were	O	O
:	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
>	O	O
R.	B-bacteria	B-bacteria
mucilaginosa	E-bacteria	I-bacteria
>	O	O
R.	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
>	O	O
V.	B-bacteria	B-bacteria
dispar	E-bacteria	I-bacteria
>	O	O
V.	B-bacteria	B-bacteria
atypica	E-bacteria	I-bacteria
.	O	O

In	O	O
conclusion	O	O
,	O	O
Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
found	O	O
to	O	O
be	O	O
the	O	O
most	O	O
prevalent	O	O
taxa	O	O
isolated	O	O
and	O	O
thus	O	O
may	O	O
make	O	O
a	O	O
major	O	O
contribution	O	O
to	O	O
nitrate	O	O
reduction	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Bone	O	O
necrosis	O	O
secondary	O	O
to	O	O
radiation	O	O
was	O	O
previously	O	O
attributed	O	O
to	O	O
trauma	O	O
of	O	O
devitalized	O	O
bone	O	O
and	O	O
microbiological	O	O
sepsis	O	O
.	O	O

However	O	O
,	O	O
conventional	O	O
microbiological	O	O
technique	O	O
has	O	O
failed	O	O
to	O	O
demonstrate	O	O
microorganisms	O	O
throughout	O	O
osteoradionecrotic	O	O
bone	O	O
,	O	O
claimed	O	O
to	O	O
be	O	O
hypoxic	O	O
,	O	O
hypovascular	O	O
and	O	O
hypocellular	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
such	O	O
bone	O	O
for	O	O
bacteria	O	O
using	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

Compared	O	O
to	O	O
standard	O	O
culture	O	O
methods	O	O
this	O	O
technique	O	O
enables	O	O
the	O	O
investigation	O	O
of	O	O
a	O	O
vast	O	O
number	O	O
of	O	O
bacteria	O	O
in	O	O
a	O	O
fairly	O	O
short	O	O
time	O	O
.	O	O

Twelve	O	O
deep	O	O
medullary	O	O
specimens	O	O
from	O	O
resected	O	O
radionecrotic	O	O
mandibles	O	O
were	O	O
studied	O	O
.	O	O

A	O	O
multitude	O	O
of	O	O
bacterial	O	O
species	O	O
were	O	O
detected	O	O
,	O	O
most	O	O
of	O	O
them	O	O
anaerobic	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
predominant	O	O
organism	O	O
,	O	O
followed	O	O
by	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
subspecies	I-bacteria	I-bacteria
polymorphum	E-bacteria	I-bacteria
.	O	O

All	O	O
samples	O	O
contained	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
study	O	O
indicate	O	O
that	O	O
bacteria	O	O
,	O	O
particularly	O	O
anaerobes	B-bacteria	B-bacteria
,	O	O
may	O	O
play	O	O
a	O	O
more	O	O
fundamental	O	O
role	O	O
in	O	O
the	O	O
pathophysiology	O	O
of	O	O
osteoradionecrosis	O	O
than	O	O
being	O	O
merely	O	O
surface	O	O
contaminants	O	O
.	O	O

Glycoproteins	O	O
display	O	O
carbohydrate	O	O
facets	O	O
that	O	O
serve	O	O
as	O	O
adhesion	O	O
receptors	O	O
for	O	O
cells	O	O
including	O	O
leukocytes	O	O
and	O	O
bacterial	O	O
cells	O	O
.	O	O

Our	O	O
aim	O	O
was	O	O
to	O	O
understand	O	O
the	O	O
role	O	O
of	O	O
the	O	O
specialized	O	O
carbohydrate	O	O
motifs	O	O
carried	O	O
by	O	O
highly	O	O
glycosylated	O	O
human	O	O
salivary	O	O
proteins	O	O
in	O	O
regulating	O	O
the	O	O
oral	O	O
ecology	O	O
.	O	O

To	O	O
date	O	O
,	O	O
our	O	O
structural	O	O
studies	O	O
suggest	O	O
that	O	O
these	O	O
molecules	O	O
display	O	O
a	O	O
wide	O	O
array	O	O
of	O	O
oligosaccharide	O	O
structures	O	O
,	O	O
including	O	O
many	O	O
species	O	O
with	O	O
highly	O	O
charged	O	O
and/or	O	O
fucosylated	O	O
termini	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
used	O	O
an	O	O
immunoblot	O	O
approach	O	O
to	O	O
gain	O	O
additional	O	O
information	O	O
about	O	O
the	O	O
nature	O	O
of	O	O
these	O	O
oligosaccharides	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
MG1	O	O
and	O	O
the	O	O
salivary	O	O
agglutinin	O	O
express	O	O
the	O	O
MECA-79	O	O
epitope	O	O
,	O	O
an	O	O
unusual	O	O
sulfated	O	O
carbohydrate	O	O
structure	O	O
that	O	O
belongs	O	O
to	O	O
an	O	O
important	O	O
class	O	O
of	O	O
high-affinity	O	O
(	O	O
endothelial	O	O
)	O	O
L-selectin	O	O
ligands	O	O
.	O	O

Unexpectedly	O	O
,	O	O
we	O	O
discovered	O	O
that	O	O
in	O	O
many	O	O
women	O	O
the	O	O
expression	O	O
of	O	O
this	O	O
epitope	O	O
is	O	O
hormonally	O	O
regulated	O	O
.	O	O

Additional	O	O
experiments	O	O
revealed	O	O
that	O	O
MG1	O	O
,	O	O
MG2	O	O
,	O	O
and	O	O
the	O	O
salivary	O	O
agglutinin	O	O
also	O	O
present	O	O
Lewis	O	O
blood	O	O
group	O	O
antigens	O	O
,	O	O
the	O	O
exact	O	O
repertoire	O	O
varying	O	O
on	O	O
an	O	O
individual	O	O
basis	O	O
.	O	O

In	O	O
parallel	O	O
,	O	O
we	O	O
explored	O	O
the	O	O
functions	O	O
of	O	O
these	O	O
carbohydrate	O	O
motifs	O	O
.	O	O

Using	O	O
an	O	O
assay	O	O
that	O	O
detects	O	O
L-selectin	O	O
ligands	O	O
,	O	O
we	O	O
found	O	O
that	O	O
the	O	O
subset	O	O
of	O	O
MECA-79-reactive	O	O
oligosaccharides	O	O
displayed	O	O
on	O	O
salivary	O	O
molecules	O	O
specifically	O	O
bind	O	O
an	O	O
L-selectin/Fc	O	O
chimera	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
the	O	O
Lewis	O	O
blood	O	O
group	O	O
structures	O	O
are	O	O
receptors	O	O
for	O	O
many	O	O
strains	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
an	O	O
organism	O	O
that	O	O
is	O	O
implicated	O	O
in	O	O
the	O	O
development	O	O
of	O	O
gastric	O	O
ulcers	O	O
and	O	O
cancer	O	O
.	O	O

Together	O	O
,	O	O
these	O	O
results	O	O
suggest	O	O
that	O	O
MG1	O	O
,	O	O
MG2	O	O
,	O	O
and	O	O
the	O	O
salivary	O	O
agglutinin	O	O
play	O	O
important	O	O
roles	O	O
in	O	O
governing	O	O
leukocyte	O	O
and	O	O
bacterial	O	O
adhesion	O	O
.	O	O

Our	O	O
findings	O	O
suggest	O	O
novel	O	O
strategies	O	O
,	O	O
based	O	O
on	O	O
the	O	O
relevant	O	O
carbohydrate	O	O
structures	O	O
,	O	O
for	O	O
promoting	O	O
or	O	O
inhibiting	O	O
these	O	O
processes	O	O
.	O	O

Expression	O	O
of	O	O
the	O	O
phosphorylcholine	O	O
(	O	O
PC	O	O
)	O	O
epitope	O	O
was	O	O
examined	O	O
in	O	O
48	O	O
viridans	B-bacteria	B-bacteria
streptococcal	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
including	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	I-bacteria	I-bacteria
R36a	E-bacteria	I-bacteria
as	O	O
the	O	O
positive	O	O
control	O	O
,	O	O
and	O	O
their	O	O
immunogenicity	O	O
to	O	O
induce	O	O
an	O	O
S.	O	O
pneumoniae-cross-reactive	O	O
response	O	O
was	O	O
evaluated	O	O
in	O	O
mice	O	O
.	O	O

Thirteen	O	O
strains	O	O
were	O	O
found	O	O
to	O	O
express	O	O
the	O	O
PC	O	O
epitope	O	O
,	O	O
while	O	O
no	O	O
obvious	O	O
association	O	O
was	O	O
found	O	O
between	O	O
the	O	O
taxonomic	O	O
categories	O	O
and	O	O
PC	O	O
expression	O	O
.	O	O

Serum	O	O
antibody	O	O
responses	O	O
to	O	O
S.	O	O
pneumoniae	O	O
cells	O	O
were	O	O
induced	O	O
in	O	O
mice	O	O
by	O	O
intraperitoneal	O	O
injection	O	O
of	O	O
the	O	O
PC-positive	O	O
,	O	O
but	O	O
not	O	O
PC-negative	O	O
,	O	O
strains	O	O
.	O	O

The	O	O
cross-reactive	O	O
antibodies	O	O
induced	O	O
by	O	O
non-pneumococcal	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
readily	O	O
inhibited	O	O
by	O	O
free	O	O
hapten	O	O
PC	O	O
.	O	O

IgM	O	O
was	O	O
the	O	O
sole	O	O
isotype	O	O
of	O	O
the	O	O
anti-pneumococcal	O	O
and	O	O
anti-PC	O	O
antibodies	O	O
,	O	O
and	O	O
the	O	O
phenomenon	O	O
of	O	O
immunological	O	O
memory	O	O
was	O	O
not	O	O
observed	O	O
.	O	O

Since	O	O
the	O	O
anti-PC	O	O
antibody	O	O
is	O	O
critically	O	O
important	O	O
for	O	O
resistance	O	O
against	O	O
pneumococcal	O	O
infection	O	O
in	O	O
mice	O	O
,	O	O
the	O	O
present	O	O
results	O	O
indicate	O	O
the	O	O
possibility	O	O
that	O	O
PC-expressing	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
commensal	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
have	O	O
a	O	O
significant	O	O
influence	O	O
on	O	O
the	O	O
hosts	O	O
'	O	O
responsiveness	O	O
to	O	O
S.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
.	O	O

Antifungal	O	O
prophylactic	O	O
therapy	O	O
in	O	O
oncology	O	O
patients	O	O
has	O	O
favors	O	O
the	O	O
emergence	O	O
of	O	O
diverse	O	O
species	O	O
of	O	O
Candida	B-bacteria	B-bacteria
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
32	O	O
clinic	O	O
isolates	O	O
of	O	O
Candida	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
recovered	O	O
from	O	O
oral	O	O
cavity	O	O
,	O	O
were	O	O
evaluated	O	O
testing	O	O
their	O	O
susceptibility	O	O
to	O	O
diverse	O	O
antifungals	O	O
by	O	O
means	O	O
of	O	O
the	O	O
microdilution	O	O
method	O	O
according	O	O
with	O	O
the	O	O
document	O	O
M-27A	O	O
of	O	O
the	O	O
National	O	O
Committee	O	O
for	O	O
Clinical	O	O
Laboratory	O	O
Standards	O	O
(	O	O
NCCLS	O	O
)	O	O
.	O	O

The	O	O
response	O	O
to	O	O
antifungals	O	O
was	O	O
then	O	O
compared	O	O
with	O	O
SSCP	O	O
patterns	O	O
of	O	O
the	O	O
gene	O	O
ERG11	O	O
,	O	O
hoping	O	O
to	O	O
find	O	O
mutations	O	O
in	O	O
this	O	O
gene	O	O
linked	O	O
to	O	O
resistance	O	O
to	O	O
the	O	O
azole	O	O
antifungals	O	O
from	O	O
samples	O	O
of	O	O
clinical	O	O
origin	O	O
.	O	O

Three	O	O
SSCP	O	O
genotypes	O	O
with	O	O
diverse	O	O
response	O	O
to	O	O
different	O	O
antifungals	O	O
were	O	O
found	O	O
.	O	O

This	O	O
study	O	O
suggested	O	O
that	O	O
a	O	O
link	O	O
of	O	O
mutations	O	O
in	O	O
the	O	O
ERG11	O	O
gene	O	O
of	O	O
Candida	B-bacteria	B-bacteria
albicans	E-bacteria	I-bacteria
and	O	O
antifungal	O	O
resistance	O	O
was	O	O
not	O	O
supported	O	O
by	O	O
this	O	O
data	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
isolates	O	O
were	O	O
also	O	O
classified	O	O
by	O	O
conventional	O	O
methods	O	O
and	O	O
their	O	O
genetic	O	O
diversity	O	O
evaluated	O	O
by	O	O
means	O	O
of	O	O
SSCP	O	O
analysis	O	O
and	O	O
evaluation	O	O
of	O	O
their	O	O
ITS2	O	O
regions	O	O
,	O	O
identifying	O	O
eight	O	O
SSCP	O	O
genotypes	O	O
.	O	O

This	O	O
technique	O	O
has	O	O
the	O	O
potential	O	O
to	O	O
be	O	O
a	O	O
more	O	O
sensitive	O	O
method	O	O
for	O	O
taxonomic	O	O
classification	O	O
.	O	O

To	O	O
validate	O	O
perfused	O	O
,	O	O
inline	O	O
,	O	O
filter-based	O	O
fermentation	O	O
systems	O	O
(	O	O
multiple	O	O
Sorbarod	O	O
devices	O	O
,	O	O
MSD	O	O
)	O	O
for	O	O
their	O	O
ability	O	O
to	O	O
maintain	O	O
stable	O	O
oral	O	O
bacterial	O	O
communities	O	O
.	O	O

MSD	O	O
enable	O	O
replicate	O	O
(	O	O
n=5	O	O
)	O	O
microcosm	O	O
biofilms	O	O
(	O	O
BF	O	O
)	O	O
to	O	O
be	O	O
established	O	O
and	O	O
sampled	O	O
,	O	O
together	O	O
with	O	O
their	O	O
perfusates	O	O
(	O	O
PA	O	O
,	O	O
cells	O	O
in	O	O
eluted	O	O
medium	O	O
)	O	O
.	O	O

Fresh	O	O
saliva	O	O
from	O	O
human	O	O
volunteers	O	O
was	O	O
used	O	O
to	O	O
inoculate	O	O
MSD	O	O
,	O	O
incubated	O	O
in	O	O
an	O	O
anaerobic	O	O
cabinet	O	O
and	O	O
perfused	O	O
with	O	O
artificial	O	O
saliva	O	O
at	O	O
7	O	O
ml	O	O
h	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

BF	O	O
within	O	O
Sorbarod	O	O
filters	O	O
and	O	O
cells	O	O
eluted	O	O
in	O	O
the	O	O
PA	O	O
were	O	O
analysed	O	O
at	O	O
24-h	O	O
intervals	O	O
by	O	O
differential	O	O
bacteriological	O	O
culture	O	O
and	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
(	O	O
CKB	O	O
,	O	O
40	O	O
oral	O	O
species	O	O
)	O	O
.	O	O

Dynamic	O	O
stability	O	O
was	O	O
apparent	O	O
after	O	O
2-3	O	O
days	O	O
within	O	O
both	O	O
BF	O	O
and	O	O
PA	O	O
as	O	O
evidenced	O	O
by	O	O
culture	O	O
,	O	O
CKB	O	O
data	O	O
and	O	O
pH	O	O
measurements	O	O
.	O	O

BF	O	O
harboured	O	O
large	O	O
numbers	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
and	O	O
facultative	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
[	O	O
ca	O	O
10-11	O	O
log10	O	O
colony-forming	O	O
units	O	O
(	O	O
CFU	O	O
)	O	O
/filter	O	O
]	O	O
comprising	O	O
considerable	O	O
numbers	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
Gram-negative	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

PA	O	O
contained	O	O
ca	O	O
9-10	O	O
log	O	O
(	O	O
10	O	O
)	O	O
CFU	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
suggesting	O	O
an	O	O
apparent	O	O
mean	O	O
growth	O	O
rate	O	O
of	O	O
0.1	O	O
h	O	O
(	O	O
-1	O	O
)	O	O
for	O	O
the	O	O
BF	O	O
,	O	O
as	O	O
a	O	O
whole	O	O
corresponding	O	O
to	O	O
a	O	O
mean	O	O
generation	O	O
time	O	O
of	O	O
10	O	O
h.	O	O
CKB	O	O
analysis	O	O
revealed	O	O
considerable	O	O
bacterial	O	O
diversity	O	O
within	O	O
the	O	O
respective	O	O
MSD	O	O
.	O	O

Inter-individual	O	O
variations	O	O
in	O	O
the	O	O
relative	O	O
species	O	O
abundance	O	O
of	O	O
inocula	O	O
was	O	O
broadly	O	O
reproduced	O	O
in	O	O
the	O	O
MSD	O	O
(	O	O
BF	O	O
and	O	O
PA	O	O
)	O	O
,	O	O
although	O	O
considerable	O	O
variation	O	O
was	O	O
apparent	O	O
between	O	O
triplicate	O	O
models	O	O
established	O	O
using	O	O
saliva	O	O
from	O	O
one	O	O
saliva	O	O
donor	O	O
or	O	O
from	O	O
three	O	O
individual	O	O
donors	O	O
.	O	O

The	O	O
dominance	O	O
of	O	O
Gram-negative	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
indicated	O	O
by	O	O
culture	O	O
was	O	O
supported	O	O
by	O	O
CKB	O	O
analysis	O	O
(	O	O
major	O	O
species	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
)	O	O
.	O	O

Data	O	O
obtained	O	O
from	O	O
the	O	O
various	O	O
analytical	O	O
approaches	O	O
showed	O	O
a	O	O
high	O	O
degree	O	O
of	O	O
congruence	O	O
.	O	O

The	O	O
MSD	O	O
enables	O	O
the	O	O
maintenance	O	O
of	O	O
complex	O	O
,	O	O
stable	O	O
salivary	O	O
microcosms	O	O
and	O	O
represents	O	O
a	O	O
simple	O	O
,	O	O
reproducible	O	O
tool	O	O
for	O	O
modelling	O	O
individual	O	O
oral	O	O
bacterial	O	O
ecosystems	O	O
.	O	O

This	O	O
study	O	O
demonstrates	O	O
the	O	O
utility	O	O
of	O	O
the	O	O
MSD	O	O
for	O	O
studying	O	O
the	O	O
micro-ecology	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
main	O	O
cause	O	O
of	O	O
acute	O	O
diverticulitis	O	O
is	O	O
the	O	O
abnormal	O	O
accumulation	O	O
of	O	O
fecal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
within	O	O
the	O	O
diverticular	O	O
lumen	O	O
,	O	O
leading	O	O
to	O	O
a	O	O
balancing	O	O
between	O	O
normal	O	O
probiotic	B-bacteria	B-bacteria
microflora	O	O
and	O	O
pathogenic	O	O
species	O	O
;	O	O
Gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
Entero-bacteriaceae	E-bacteria	I-bacteria
,	O	O
mainly	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
Proteus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
,	O	O
are	O	O
the	O	O
genders	O	O
that	O	O
usually	O	O
cause	O	O
the	O	O
disease-related	O	O
symptoms	O	O
,	O	O
due	O	O
to	O	O
their	O	O
ability	O	O
to	O	O
adhere	O	O
to	O	O
intestinal	O	O
mucosa	O	O
.	O	O

The	O	O
intestine	O	O
is	O	O
well	O	O
known	O	O
as	O	O
the	O	O
largest	O	O
human	O	O
lymphoepithelial	O	O
organ	O	O
and	O	O
daily	O	O
produces	O	O
more	O	O
antibodies	O	O
,	O	O
mainly	O	O
secretory	O	O
IgAs	O	O
,	O	O
than	O	O
do	O	O
all	O	O
other	O	O
lymphoid	O	O
tissues	O	O
.	O	O

IgAs	O	O
have	O	O
different	O	O
immune	O	O
and	O	O
anti-inflammatory	O	O
properties	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
verify	O	O
the	O	O
efficacy	O	O
of	O	O
an	O	O
oral	O	O
immunostimulant	O	O
highly-purified	O	O
,	O	O
polymicrobial	O	O
lysate	O	O
in	O	O
the	O	O
prevention	O	O
of	O	O
recurrent	O	O
attacks	O	O
of	O	O
diverticulitis	O	O
and	O	O
in	O	O
the	O	O
improvement	O	O
of	O	O
symptoms	O	O
.	O	O

The	O	O
study	O	O
was	O	O
carried	O	O
out	O	O
on	O	O
83	O	O
consecutive	O	O
patients	O	O
suffering	O	O
from	O	O
recurrent	O	O
symptomatic	O	O
acute	O	O
diverticulitis	O	O
and	O	O
with	O	O
at	O	O
least	O	O
2	O	O
attacks	O	O
in	O	O
the	O	O
previous	O	O
year	O	O
;	O	O
patients	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
receive	O	O
(	O	O
group	O	O
A	O	O
)	O	O
an	O	O
oral	O	O
polybacterial	O	O
lysate	O	O
suspension	O	O
or	O	O
to	O	O
a	O	O
no-treatment	O	O
clinical	O	O
follow-up	O	O
as	O	O
controls	O	O
(	O	O
group	O	O
B	O	O
)	O	O
.	O	O

A	O	O
total	O	O
of	O	O
76	O	O
patients	O	O
(	O	O
41	O	O
in	O	O
group	O	O
A	O	O
and	O	O
35	O	O
in	O	O
group	O	O
B	O	O
)	O	O
terminated	O	O
the	O	O
study	O	O
period	O	O
.	O	O

the	O	O
sums	O	O
of	O	O
the	O	O
scores	O	O
for	O	O
symptoms	O	O
,	O	O
reported	O	O
on	O	O
day	O	O
schedules	O	O
,	O	O
were	O	O
calculated	O	O
and	O	O
examined	O	O
by	O	O
means	O	O
of	O	O
ANOVA	O	O
statistical	O	O
analysis	O	O
.	O	O

Statistical	O	O
differences	O	O
between	O	O
group	O	O
A	O	O
vs	O	O
group	O	O
B	O	O
were	O	O
recorded	O	O
after	O	O
1	O	O
month	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
and	O	O
3	O	O
months	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
of	O	O
treatment	O	O
with	O	O
the	O	O
oral	O	O
polybacterial	O	O
lysate	O	O
suspension	O	O
.	O	O

Our	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
administration	O	O
of	O	O
an	O	O
oral	O	O
enterovaccine	O	O
for	O	O
the	O	O
prophylaxis	O	O
of	O	O
recurrent	O	O
diverticulitis	O	O
is	O	O
effective	O	O
and	O	O
well	O	O
tolerated	O	O
,	O	O
probably	O	O
due	O	O
to	O	O
a	O	O
direct	O	O
stimulation	O	O
of	O	O
IgA-mediated	O	O
mucosal	O	O
defences	O	O
.	O	O

We	O	O
studied	O	O
the	O	O
pheno-	O	O
and	O	O
genotypes	O	O
of	O	O
an	O	O
oral	O	O
Granulicatella	B-bacteria	B-bacteria
elegans	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
in	O	O
comparison	O	O
with	O	O
those	O	O
of	O	O
a	O	O
blood-derived	O	O
isolate	O	O
which	O	O
caused	O	O
infective	O	O
endocarditis	O	O
.	O	O

The	O	O
two	O	O
isolates	O	O
exhibited	O	O
identical	O	O
biochemical	O	O
characteristics	O	O
and	O	O
had	O	O
the	O	O
same	O	O
drug	O	O
MICs	O	O
.	O	O

Their	O	O
genotypes	O	O
were	O	O
indistinguishable	O	O
,	O	O
indicating	O	O
that	O	O
these	O	O
were	O	O
from	O	O
the	O	O
same	O	O
clone	O	O
.	O	O

The	O	O
transmission	O	O
of	O	O
G.	B-bacteria	B-bacteria
elegans	E-bacteria	I-bacteria
from	O	O
the	O	O
oral	O	O
cavity	O	O
thus	O	O
should	O	O
be	O	O
noted	O	O
as	O	O
a	O	O
possible	O	O
cause	O	O
of	O	O
infective	O	O
endocarditis	O	O
.	O	O

It	O	O
is	O	O
well-known	O	O
that	O	O
some	O	O
periodontopathic	O	O
bacteria	O	O
,	O	O
especially	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
formerly	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
or	O	O
Tan	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

forsythensis	E-bacteria	I-bacteria
)	O	O
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
actively	O	O
produce	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSCs	O	O
)	O	O
,	O	O
such	O	O
as	O	O
H2S	O	O
and	O	O
CH3SH	O	O
.	O	O

We	O	O
previously	O	O
reported	O	O
a	O	O
qualitative	O	O
relationship	O	O
between	O	O
periodontopathic	O	O
bacteria	O	O
and	O	O
VSCs	O	O
;	O	O
however	O	O
,	O	O
a	O	O
quantitative	O	O
analysis	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
in	O	O
oral	O	O
specimens	O	O
is	O	O
required	O	O
for	O	O
further	O	O
characterization	O	O
of	O	O
the	O	O
relationship	O	O
between	O	O
oral	O	O
bacteria	O	O
and	O	O
VSCs	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
report	O	O
a	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
method	O	O
for	O	O
the	O	O
quantitative	O	O
analysis	O	O
of	O	O
VSC-producing	O	O
bacteria	O	O
in	O	O
oral	O	O
specimens	O	O
.	O	O

Specimens	O	O
were	O	O
collected	O	O
from	O	O
22	O	O
patients	O	O
who	O	O
visited	O	O
the	O	O
Preventive	O	O
Dentistry	O	O
and	O	O
Breath	O	O
Odor	O	O
Clinic	O	O
of	O	O
Kyushu	O	O
Dental	O	O
College	O	O
.	O	O

A	O	O
real-time	O	O
PCR	O	O
assay	O	O
using	O	O
the	O	O
TaqMan	O	O
system	O	O
,	O	O
based	O	O
on	O	O
the	O	O
5'-3	O	O
'	O	O
exonuclease	O	O
activity	O	O
of	O	O
Taq	O	O
polymerase	O	O
,	O	O
was	O	O
employed	O	O
for	O	O
the	O	O
quantitative	O	O
analysis	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
that	O	O
produce	O	O
VSCs	O	O
.	O	O

Using	O	O
real-time	O	O
PCR	O	O
,	O	O
we	O	O
performed	O	O
a	O	O
quantitative	O	O
analysis	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Tan	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
in	O	O
the	O	O
saliva	O	O
,	O	O
on	O	O
the	O	O
tongue	O	O
coat	O	O
,	O	O
and	O	O
in	O	O
the	O	O
subgingival	O	O
plaque	O	O
of	O	O
patients	O	O
with	O	O
oral	O	O
malodor	O	O
.	O	O

Real-time	O	O
PCR	O	O
using	O	O
the	O	O
TaqMan	O	O
system	O	O
can	O	O
be	O	O
used	O	O
for	O	O
the	O	O
quantitative	O	O
analysis	O	O
of	O	O
VSC-producing	O	O
oral	O	O
bacteria	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
efficacy	O	O
of	O	O
antimicrobial	O	O
therapy	O	O
in	O	O
oral	O	O
odontogenic	O	O
infections	O	O
using	O	O
estimated	O	O
pharmacokinetic/pharmacodynamic	O	O
parameters	O	O
or	O	O
efficacy	O	O
indices	O	O
,	O	O
and	O	O
to	O	O
compare	O	O
pharmacokinetic/pharmacodynamic	O	O
breakpoints	O	O
with	O	O
National	O	O
Committee	O	O
for	O	O
Clinical	O	O
Laboratory	O	O
Standards	O	O
'	O	O
(	O	O
NCCLS	O	O
)	O	O
breakpoints	O	O
.	O	O

Retrospective	O	O
literature	O	O
search	O	O
to	O	O
obtain	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
values	O	O
,	O	O
pharmacokinetic	O	O
parameters	O	O
of	O	O
antimicrobials	O	O
and	O	O
NCCLS	O	O
breakpoints	O	O
.	O	O

Pharmacokinetic	O	O
simulations	O	O
were	O	O
carried	O	O
out	O	O
using	O	O
WinNonlin	O	O
software	O	O
(	O	O
Pharsight	O	O
Corporation	O	O
,	O	O
Mountain	O	O
View	O	O
,	O	O
CA	O	O
,	O	O
USA	O	O
)	O	O
.	O	O

For	O	O
antimicrobials	O	O
with	O	O
time-dependent	O	O
activity	O	O
,	O	O
the	O	O
time	O	O
that	O	O
the	O	O
plasma	O	O
drug	O	O
concentration	O	O
exceeds	O	O
the	O	O
MIC	O	O
as	O	O
the	O	O
percentage	O	O
of	O	O
dose	O	O
interval	O	O
at	O	O
steady	O	O
state	O	O
was	O	O
calculated	O	O
.	O	O

For	O	O
antimicrobials	O	O
with	O	O
concentration-dependent	O	O
activity	O	O
,	O	O
the	O	O
total	O	O
area	O	O
under	O	O
the	O	O
plasma	O	O
concentration-time	O	O
curve	O	O
over	O	O
24	O	O
hours	O	O
at	O	O
steady	O	O
state	O	O
divided	O	O
by	O	O
the	O	O
MIC	O	O
was	O	O
calculated	O	O
.	O	O

Pharmacokinetic/pharmacodynamic	O	O
breakpoints	O	O
were	O	O
calculated	O	O
according	O	O
to	O	O
these	O	O
parameters	O	O
.	O	O

Only	O	O
amoxicillin/clavulanic	O	O
acid	O	O
and	O	O
clindamycin	O	O
showed	O	O
adequate	O	O
efficacy	O	O
indices	O	O
against	O	O
the	O	O
most	O	O
commonly	O	O
isolated	O	O
bacteria	O	O
in	O	O
odontogenic	O	O
infections	O	O
.	O	O

Metronidazole	O	O
reached	O	O
good	O	O
indices	O	O
against	O	O
anaerobes	B-bacteria	B-bacteria
only	O	O
.	O	O

Pharmacokinetic/pharmacodynamic	O	O
susceptibility	O	O
breakpoints	O	O
do	O	O
not	O	O
coincide	O	O
exactly	O	O
with	O	O
NCCLS	O	O
breakpoints	O	O
.	O	O

Owing	O	O
to	O	O
the	O	O
scarcity	O	O
of	O	O
double-blind	O	O
,	O	O
clinical	O	O
trials	O	O
on	O	O
the	O	O
use	O	O
of	O	O
antimicrobials	O	O
in	O	O
endodontics	O	O
,	O	O
this	O	O
study	O	O
may	O	O
be	O	O
useful	O	O
in	O	O
determining	O	O
the	O	O
best	O	O
antimicrobial	O	O
treatment	O	O
in	O	O
these	O	O
infections	O	O
.	O	O

However	O	O
,	O	O
as	O	O
we	O	O
have	O	O
not	O	O
used	O	O
concentration	O	O
data	O	O
in	O	O
infected	O	O
tissue	O	O
to	O	O
determine	O	O
pharmacokinetic/pharmacodynamic	O	O
indices	O	O
,	O	O
it	O	O
would	O	O
be	O	O
necessary	O	O
to	O	O
design	O	O
clinical	O	O
trials	O	O
in	O	O
order	O	O
to	O	O
confirm	O	O
these	O	O
results	O	O
.	O	O

Apoptosis	O	O
is	O	O
critical	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
several	O	O
infectious	O	O
diseases	O	O
.	O	O

The	O	O
induction	O	O
of	O	O
apoptosis	O	O
was	O	O
assessed	O	O
in	O	O
mouse	O	O
lymph	O	O
node	O	O
cells	O	O
by	O	O
four	O	O
bacteria	O	O
recovered	O	O
from	O	O
infected	O	O
human	O	O
dental	O	O
pulp	O	O
:	O	O
Gemella	B-bacteria	B-bacteria
morbillorum	E-bacteria	I-bacteria
,	O	O
Clostridium	B-bacteria	B-bacteria
butyricum	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
adolescentis	E-bacteria	I-bacteria
.	O	O

Smaller	O	O
lymph	O	O
nodes	O	O
and	O	O
smaller	O	O
numbers	O	O
of	O	O
cells	O	O
were	O	O
observed	O	O
after	O	O
experimental	O	O
dental	O	O
pulp	O	O
infection	O	O
with	O	O
C.	B-bacteria	B-bacteria
butyricum	E-bacteria	I-bacteria
,	O	O
suggesting	O	O
that	O	O
this	O	O
bacterium	O	O
induces	O	O
cell	O	O
death	O	O
.	O	O

Apoptosis	O	O
was	O	O
evaluated	O	O
by	O	O
determination	O	O
of	O	O
cell	O	O
ploidy	O	O
and	O	O
detection	O	O
of	O	O
DNA	O	O
degradation	O	O
in	O	O
cells	O	O
cultured	O	O
with	O	O
killed	O	O
bacteria	O	O
.	O	O

Paraformaldehyde-killed	O	O
C.	B-bacteria	B-bacteria
butyricum	E-bacteria	I-bacteria
and	O	O
heat-killed	O	O
G.	B-bacteria	B-bacteria
morbillorum	E-bacteria	I-bacteria
induced	O	O
substantial	O	O
cell	O	O
death	O	O
,	O	O
while	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
B.	B-bacteria	B-bacteria
adolescentis	E-bacteria	I-bacteria
induced	O	O
cell	O	O
death	O	O
at	O	O
lower	O	O
levels	O	O
.	O	O

No	O	O
bacterial	O	O
preparations	O	O
induced	O	O
apoptosis	O	O
in	O	O
cells	O	O
from	O	O
mice	O	O
genetically	O	O
deficient	O	O
for	O	O
tumour	O	O
necrosis	O	O
factor	O	O
receptor	O	O
p55	O	O
(	O	O
TNFRp55	O	O
)	O	O
,	O	O
implicating	O	O
this	O	O
receptor	O	O
directly	O	O
or	O	O
indirectly	O	O
as	O	O
a	O	O
mediator	O	O
in	O	O
the	O	O
process	O	O
.	O	O

It	O	O
was	O	O
concluded	O	O
that	O	O
apoptosis	O	O
may	O	O
be	O	O
induced	O	O
during	O	O
periapical	O	O
lesions	O	O
of	O	O
pulpal	O	O
origin	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
randomized	O	O
,	O	O
crossover	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
the	O	O
effectiveness	O	O
of	O	O
a	O	O
newly	O	O
designed	O	O
manual	O	O
toothbrush	O	O
(	O	O
Colgate	O	O
360	O	O
degrees	O	O
)	O	O
to	O	O
two	O	O
commercially	O	O
available	O	O
manual	O	O
toothbrushes	O	O
(	O	O
Oral-B	O	O
Indicator	O	O
and	O	O
Oral-B	O	O
CrossAction	O	O
)	O	O
and	O	O
a	O	O
battery-powered	O	O
toothbrush	O	O
(	O	O
Crest	O	O
SpinBrush	O	O
PRO	O	O
)	O	O
for	O	O
their	O	O
ability	O	O
to	O	O
reduce	O	O
hydrogen-sulfide-forming	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
on	O	O
the	O	O
tongue	O	O
.	O	O

After	O	O
a	O	O
washout	O	O
period	O	O
,	O	O
subjects	O	O
arrived	O	O
at	O	O
the	O	O
clinical	O	O
site	O	O
for	O	O
baseline	O	O
sampling	O	O
without	O	O
performing	O	O
dental	O	O
hygiene	O	O
,	O	O
eating	O	O
,	O	O
or	O	O
drinking	O	O
.	O	O

Subjects	O	O
sampled	O	O
the	O	O
left	O	O
side	O	O
of	O	O
their	O	O
tongue	O	O
with	O	O
a	O	O
cotton	O	O
swab	O	O
.	O	O

Subjects	O	O
brushed	O	O
for	O	O
1	O	O
minute	O	O
with	O	O
the	O	O
assigned	O	O
test	O	O
toothbrush	O	O
and	O	O
regular	O	O
fluoride	O	O
toothpaste	O	O
.	O	O

Those	O	O
using	O	O
the	O	O
Colgate	O	O
360	O	O
degrees	O	O
toothbrush	O	O
were	O	O
instructed	O	O
to	O	O
clean	O	O
their	O	O
tongue	O	O
with	O	O
the	O	O
implement	O	O
on	O	O
the	O	O
back	O	O
of	O	O
the	O	O
brush	O	O
head	O	O
for	O	O
10	O	O
seconds	O	O
.	O	O

After	O	O
2	O	O
hours	O	O
,	O	O
the	O	O
subjects	O	O
returned	O	O
to	O	O
the	O	O
clinical	O	O
site	O	O
having	O	O
refrained	O	O
from	O	O
dental	O	O
hygiene	O	O
,	O	O
eating	O	O
,	O	O
and	O	O
drinking	O	O
for	O	O
posttreatment	O	O
sampling	O	O
,	O	O
this	O	O
time	O	O
sampling	O	O
the	O	O
right	O	O
side	O	O
of	O	O
their	O	O
tongue	O	O
.	O	O

After	O	O
a	O	O
minimum	O	O
2-day	O	O
washout	O	O
period	O	O
,	O	O
subjects	O	O
repeated	O	O
the	O	O
same	O	O
regimen	O	O
using	O	O
the	O	O
other	O	O
toothbrushes	O	O
.	O	O

Collected	O	O
tongue	O	O
samples	O	O
were	O	O
dispersed	O	O
in	O	O
sterile	O	O
water	O	O
,	O	O
serially	O	O
diluted	O	O
in	O	O
sterile	O	O
phosphate-buffered	O	O
saline	O	O
,	O	O
and	O	O
plated	O	O
in	O	O
duplicate	O	O
onto	O	O
lead	O	O
acetate	O	O
agar	O	O
.	O	O

When	O	O
plated	O	O
on	O	O
this	O	O
medium	O	O
,	O	O
bacteria	O	O
that	O	O
produce	O	O
hydrogen	O	O
sulfide	O	O
appear	O	O
as	O	O
dark-pigmented	O	O
colonies	O	O
.	O	O

After	O	O
72	O	O
hours	O	O
of	O	O
incubation	O	O
,	O	O
the	O	O
dark	O	O
colonies	O	O
were	O	O
counted	O	O
,	O	O
expressed	O	O
as	O	O
log	O	O
colony-forming	O	O
units/mL	O	O
,	O	O
and	O	O
reduction	O	O
from	O	O
baseline	O	O
was	O	O
calculated	O	O
.	O	O

Thirty-one	O	O
adult	O	O
men	O	O
and	O	O
women	O	O
completed	O	O
the	O	O
clinical	O	O
study	O	O
.	O	O

There	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
between	O	O
baseline	O	O
hydrogen-sulfide-forming	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
levels	O	O
.	O	O

Posttreatment	O	O
,	O	O
the	O	O
log	O	O
reduction	O	O
of	O	O
bacteria	O	O
was	O	O
0.80	O	O
,	O	O
0.41	O	O
,	O	O
0.33	O	O
,	O	O
and	O	O
0.44	O	O
for	O	O
the	O	O
Colgate	O	O
360	O	O
degrees	O	O
,	O	O
Oral-B	O	O
Indicator	O	O
,	O	O
Crest	O	O
SpinBrush	O	O
PRO	O	O
,	O	O
and	O	O
Oral-B	O	O
CrossAction	O	O
,	O	O
respectively	O	O
.	O	O

Statistical	O	O
analysis	O	O
indicated	O	O
that	O	O
the	O	O
Colgate	O	O
360	O	O
toothbrush	O	O
was	O	O
statistically	O	O
significantly	O	O
better	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
)	O	O
than	O	O
the	O	O
3	O	O
commercial	O	O
toothbrushes	O	O
in	O	O
reducing	O	O
the	O	O
levels	O	O
of	O	O
hydrogen-sulfide-forming	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
on	O	O
the	O	O
tongue	O	O
.	O	O

We	O	O
have	O	O
found	O	O
that	O	O
broadband	O	O
light	O	O
(	O	O
380	O	O
to	O	O
520	O	O
nm	O	O
)	O	O
rapidly	O	O
and	O	O
selectively	O	O
kills	O	O
oral	O	O
black-pigmented	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
BPB	B-bacteria	B-bacteria
)	O	O
in	O	O
pure	O	O
cultures	O	O
and	O	O
in	O	O
dental	O	O
plaque	O	O
samples	O	O
obtained	O	O
from	O	O
human	O	O
subjects	O	O
with	O	O
chronic	O	O
periodontitis	O	O
.	O	O

We	O	O
hypothesize	O	O
that	O	O
this	O	O
killing	O	O
effect	O	O
is	O	O
a	O	O
result	O	O
of	O	O
light	O	O
excitation	O	O
of	O	O
their	O	O
endogenous	O	O
porphyrins	O	O
.	O	O

Cultures	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
were	O	O
killed	O	O
by	O	O
4.2	O	O
J/cm2	O	O
,	O	O
whereas	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
required	O	O
21	O	O
J/cm2	O	O
.	O	O

Exposure	O	O
to	O	O
light	O	O
with	O	O
a	O	O
fluence	O	O
of	O	O
42	O	O
J/cm2	O	O
produced	O	O
99	O	O
%	O	O
killing	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

High-performance	O	O
liquid	O	O
chromatography	O	O
demonstrated	O	O
the	O	O
presence	O	O
of	O	O
various	O	O
amounts	O	O
of	O	O
different	O	O
porphyrin	O	O
molecules	O	O
in	O	O
BPB	B-bacteria	B-bacteria
.	O	O

The	O	O
amounts	O	O
of	O	O
endogenous	O	O
porphyrin	O	O
in	O	O
BPB	B-bacteria	B-bacteria
were	O	O
267	O	O
(	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
)	O	O
,	O	O
47	O	O
(	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
)	O	O
,	O	O
41	O	O
(	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
)	O	O
,	O	O
and	O	O
2.2	O	O
(	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
ng/mg	O	O
.	O	O

Analysis	O	O
of	O	O
bacteria	O	O
in	O	O
dental	O	O
plaque	O	O
samples	O	O
by	O	O
DNA-DNA	O	O
hybridization	O	O
for	O	O
40	O	O
taxa	O	O
before	O	O
and	O	O
after	O	O
phototherapy	O	O
showed	O	O
that	O	O
the	O	O
growth	O	O
of	O	O
the	O	O
four	O	O
BPB	B-bacteria	B-bacteria
was	O	O
decreased	O	O
by	O	O
2	O	O
and	O	O
3	O	O
times	O	O
after	O	O
irradiation	O	O
at	O	O
energy	O	O
fluences	O	O
of	O	O
4.2	O	O
and	O	O
21	O	O
J/cm2	O	O
,	O	O
respectively	O	O
,	O	O
whereas	O	O
the	O	O
growth	O	O
of	O	O
the	O	O
remaining	O	O
36	O	O
microorganisms	O	O
was	O	O
decreased	O	O
by	O	O
1.5	O	O
times	O	O
at	O	O
both	O	O
energy	O	O
fluences	O	O
.	O	O

The	O	O
present	O	O
study	O	O
suggests	O	O
that	O	O
intraoral	O	O
light	O	O
exposure	O	O
may	O	O
be	O	O
used	O	O
to	O	O
control	O	O
BPB	B-bacteria	B-bacteria
growth	O	O
and	O	O
possibly	O	O
benefit	O	O
patients	O	O
with	O	O
periodontal	O	O
disease	O	O
.	O	O

Autologous	O	O
stem	O	O
cell	O	O
transplantation	O	O
has	O	O
augmented	O	O
treatment	O	O
successes	O	O
.	O	O

However	O	O
,	O	O
high-dose	O	O
chemotherapy	O	O
is	O	O
still	O	O
accompanied	O	O
by	O	O
dose-limiting	O	O
toxicities	O	O
,	O	O
for	O	O
example	O	O
,	O	O
severe	O	O
mucositis	O	O
.	O	O

Mucosal	O	O
lesions	O	O
serve	O	O
as	O	O
portals	O	O
of	O	O
entry	O	O
for	O	O
infections	O	O
.	O	O

In	O	O
order	O	O
to	O	O
reduce	O	O
the	O	O
oral	O	O
microbial	O	O
burden	O	O
,	O	O
we	O	O
prospectively	O	O
evaluated	O	O
the	O	O
microbiological	O	O
impact	O	O
of	O	O
a	O	O
complex	O	O
regimen	O	O
of	O	O
mouth	O	O
rinses	O	O
consisting	O	O
of	O	O
concomitantly	O	O
applied	O	O
polyene	O	O
antifungals	O	O
,	O	O
povidone-iodine	O	O
,	O	O
chlorhexidine	O	O
,	O	O
sage	O	O
tea	O	O
,	O	O
and	O	O
prophylactic	O	O
ciprofloxacin	O	O
and	O	O
fluconazole	O	O
.	O	O

A	O	O
total	O	O
of	O	O
15	O	O
patients	O	O
were	O	O
enrolled	O	O
into	O	O
this	O	O
longitudinal	O	O
evaluation	O	O
.	O	O

Colony-forming	O	O
units	O	O
(	O	O
CFU	O	O
)	O	O
were	O	O
quantitated	O	O
from	O	O
saliva	O	O
,	O	O
buccal	O	O
and	O	O
palatinal	O	O
swabs	O	O
during	O	O
high-dose	O	O
chemotherapy	O	O
and	O	O
autologous	O	O
stem	O	O
cell	O	O
transplantation	O	O
.	O	O

The	O	O
number	O	O
of	O	O
CFU	O	O
did	O	O
not	O	O
show	O	O
any	O	O
significant	O	O
changes	O	O
after	O	O
initiation	O	O
of	O	O
the	O	O
mouth	O	O
rinses	O	O
and	O	O
the	O	O
prophylactic	O	O
antibiotics	O	O
.	O	O

The	O	O
median	O	O
CFU	O	O
count	O	O
was	O	O
268	O	O
x	O	O
10	O	O
(	O	O
6	O	O
)	O	O
/ml	O	O
saliva	O	O
before	O	O
chemotherapy	O	O
and	O	O
decreased	O	O
after	O	O
initiation	O	O
of	O	O
intravenous	O	O
antibiotics	O	O
only	O	O
.	O	O

Neither	O	O
prophylactic	O	O
nor	O	O
therapeutic	O	O
antifungals	O	O
significantly	O	O
reduced	O	O
the	O	O
number	O	O
of	O	O
cultures	O	O
positive	O	O
for	O	O
yeasts	O	O
.	O	O

Since	O	O
90	O	O
%	O	O
of	O	O
our	O	O
patients	O	O
had	O	O
febrile	O	O
neutropenia	O	O
at	O	O
some	O	O
time	O	O
point	O	O
during	O	O
the	O	O
observation	O	O
period	O	O
,	O	O
the	O	O
approach	O	O
evaluated	O	O
can	O	O
not	O	O
be	O	O
recommended	O	O
as	O	O
prophylaxis	O	O
of	O	O
febrile	O	O
neutropenia	O	O
as	O	O
such	O	O
.	O	O

Two	O	O
studies	O	O
were	O	O
conducted	O	O
to	O	O
determine	O	O
the	O	O
antimicrobial	O	O
effect	O	O
of	O	O
rinsing	O	O
with	O	O
an	O	O
essential	O	O
oil-containing	O	O
mouth	O	O
rinse	O	O
12	O	O
h	O	O
after	O	O
a	O	O
single	O	O
rinse	O	O
and	O	O
12	O	O
h	O	O
after	O	O
2	O	O
weeks	O	O
of	O	O
twice	O	O
daily	O	O
rinsing	O	O
,	O	O
during	O	O
the	O	O
daytime	O	O
and	O	O
overnight	O	O
.	O	O


These	O	O
studies	O	O
utilized	O	O
a	O	O
randomized	O	O
,	O	O
double-blind	O	O
,	O	O
controlled	O	O
crossover	O	O
design	O	O
.	O	O

Following	O	O
baseline	O	O
sampling	O	O
of	O	O
bacteria	O	O
from	O	O
supragingival	O	O
plaque	O	O
and	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
,	O	O
subjects	O	O
began	O	O
twice-daily	O	O
rinsing	O	O
with	O	O
either	O	O
an	O	O
essential	O	O
oil	O	O
mouth	O	O
rinse	O	O
containing	O	O
0.09	O	O
%	O	O
zinc	O	O
chloride	O	O
(	O	O
Tartar	O	O
Control	O	O
Listerine	O	O
Antiseptic	O	O
)	O	O
or	O	O
a	O	O
negative	O	O
control	O	O
rinse	O	O
.	O	O

Bacterial	O	O
sampling	O	O
was	O	O
repeated	O	O
12	O	O
h	O	O
after	O	O
the	O	O
first	O	O
rinse	O	O
,	O	O
and	O	O
again	O	O
12	O	O
h	O	O
after	O	O
the	O	O
final	O	O
rinse	O	O
14	O	O
days	O	O
later	O	O
.	O	O

The	O	O
sampling	O	O
schedule	O	O
was	O	O
adjusted	O	O
according	O	O
to	O	O
whether	O	O
the	O	O
study	O	O
was	O	O
investigating	O	O
daytime	O	O
or	O	O
overnight	O	O
activity	O	O
.	O	O

Samples	O	O
were	O	O
plated	O	O
on	O	O
Schaedlers	O	O
medium	O	O
(	O	O
total	O	O
anaerobes	B-bacteria	B-bacteria
)	O	O
,	O	O
Schaedlers	O	O
Nalidixic/Vancomycin	O	O
medium	O	O
(	O	O
Gram-negative	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
)	O	O
,	O	O
and	O	O
OOPS	O	O
medium	O	O
(	O	O
volatile	O	O
sulphur	O	O
compound	O	O
(	O	O
VSC	O	O
)	O	O
-producing	O	O
organisms	O	O
)	O	O
.	O	O

Inter-group	O	O
log10	O	O
transformed	O	O
colony-forming	O	O
units/ml	O	O
counts	O	O
from	O	O
samples	O	O
of	O	O
supragingival	O	O
plaque	O	O
and	O	O
tongue	O	O
swabs	O	O
on	O	O
each	O	O
of	O	O
the	O	O
three	O	O
media	O	O
were	O	O
compared	O	O
by	O	O
analysis	O	O
of	O	O
covariance	O	O
.	O	O

The	O	O
mean	O	O
bacterial	O	O
counts	O	O
in	O	O
subjects	O	O
using	O	O
the	O	O
essential	O	O
oil	O	O
mouth	O	O
rinse	O	O
were	O	O
significantly	O	O
lower	O	O
(	O	O
p	O	O
<	O	O
or	O	O
=0.005	O	O
)	O	O
than	O	O
mean	O	O
counts	O	O
in	O	O
subjects	O	O
using	O	O
the	O	O
control	O	O
rinse	O	O
in	O	O
all	O	O
the	O	O
comparisons	O	O
,	O	O
i.e.	O	O
,	O	O
tongue	O	O
and	O	O
supragingival	O	O
plaque	O	O
samples	O	O
on	O	O
each	O	O
of	O	O
three	O	O
media	O	O
at	O	O
two	O	O
sampling	O	O
periods	O	O
in	O	O
the	O	O
daytime	O	O
and	O	O
overnight	O	O
study	O	O
,	O	O
respectively	O	O
.	O	O

Mean	O	O
bacterial	O	O
count	O	O
percent	O	O
reductions	O	O
for	O	O
plaque	O	O
samples	O	O
ranged	O	O
from	O	O
56.3	O	O
to	O	O
95.3	O	O
;	O	O
percent	O	O
reductions	O	O
for	O	O
tongue	O	O
samples	O	O
ranged	O	O
from	O	O
61.1	O	O
to	O	O
96.1	O	O
.	O	O

There	O	O
was	O	O
a	O	O
trend	O	O
to	O	O
higher	O	O
reductions	O	O
after	O	O
14	O	O
days	O	O
'	O	O
rinsing	O	O
than	O	O
after	O	O
the	O	O
initial	O	O
rinse	O	O
.	O	O

Rinsing	O	O
with	O	O
the	O	O
essential	O	O
oil	O	O
mouth	O	O
rinse	O	O
can	O	O
have	O	O
long-lasting	O	O
effects	O	O
in	O	O
reducing	O	O
anaerobic	O	O
bacteria	O	O
overall	O	O
as	O	O
well	O	O
as	O	O
Gram-negative	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
and	O	O
VSC-producing	O	O
bacteria	O	O
.	O	O

The	O	O
significant	O	O
reductions	O	O
in	O	O
numbers	O	O
of	O	O
these	O	O
bacteria	O	O
produced	O	O
by	O	O
the	O	O
essential	O	O
oil	O	O
mouth	O	O
rinse	O	O
,	O	O
both	O	O
in	O	O
plaque	O	O
and	O	O
on	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
,	O	O
can	O	O
play	O	O
a	O	O
key	O	O
role	O	O
in	O	O
explaining	O	O
the	O	O
essential	O	O
oil	O	O
mouth	O	O
rinse	O	O
's	O	O
effectiveness	O	O
in	O	O
reducing	O	O
supragingival	O	O
plaque	O	O
and	O	O
gingivitis	O	O
as	O	O
well	O	O
as	O	O
its	O	O
effectiveness	O	O
in	O	O
controlling	O	O
intrinsic	O	O
oral	O	O
malodor	O	O
over	O	O
prolonged	O	O
periods	O	O
.	O	O

Psychological	O	O
stress	O	O
is	O	O
known	O	O
to	O	O
increase	O	O
the	O	O
circulating	O	O
levels	O	O
of	O	O
the	O	O
catecholamine	O	O
hormones	O	O
noradrenaline	O	O
and	O	O
adrenaline	O	O
,	O	O
which	O	O
have	O	O
been	O	O
shown	O	O
to	O	O
influence	O	O
the	O	O
growth	O	O
of	O	O
a	O	O
large	O	O
number	O	O
of	O	O
bacterial	O	O
species	O	O
by	O	O
acting	O	O
in	O	O
a	O	O
siderophore-like	O	O
manner	O	O
or	O	O
by	O	O
inducing	O	O
the	O	O
production	O	O
of	O	O
novel	O	O
autoinducers	O	O
of	O	O
growth	O	O
.	O	O

As	O	O
we	O	O
have	O	O
previously	O	O
demonstrated	O	O
that	O	O
periodontal	O	O
organisms	O	O
display	O	O
differing	O	O
growth	O	O
responses	O	O
to	O	O
noradrenaline	O	O
and	O	O
adrenaline	O	O
,	O	O
the	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
whether	O	O
these	O	O
growth	O	O
effects	O	O
were	O	O
based	O	O
upon	O	O
either	O	O
siderophore-like	O	O
or	O	O
autoinducer	O	O
mechanisms	O	O
.	O	O

Initial	O	O
inocula	O	O
of	O	O
43	O	O
microbial	O	O
organisms	O	O
normally	O	O
found	O	O
within	O	O
the	O	O
subgingival	O	O
biofilm	O	O
were	O	O
established	O	O
under	O	O
anaerobic	O	O
conditions	O	O
(	O	O
35	O	O
degrees	O	O
C	O	O
)	O	O
.	O	O

Each	O	O
strain	O	O
was	O	O
re-inoculated	O	O
into	O	O
a	O	O
serum-based	O	O
minimal	O	O
medium	O	O
and	O	O
growth	O	O
was	O	O
assessed	O	O
by	O	O
optical	O	O
density	O	O
(	O	O
OD	O	O
(	O	O
600	O	O
nm	O	O
)	O	O
)	O	O
with	O	O
test	O	O
and	O	O
control	O	O
cultures	O	O
performed	O	O
in	O	O
triplicate	O	O
.	O	O

Test	O	O
cultures	O	O
were	O	O
supplemented	O	O
with	O	O
either	O	O
50	O	O
mum	O	O
ferric	O	O
nitrate	O	O
or	O	O
a	O	O
previously	O	O
described	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
autoinducer	O	O
of	O	O
growth	O	O
.	O	O

Significant	O	O
growth	O	O
effects	O	O
for	O	O
supplementation	O	O
with	O	O
ferric	O	O
nitrate	O	O
(	O	O
13	O	O
species	O	O
responding	O	O
positively	O	O
)	O	O
and	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
autoinducer	O	O
(	O	O
24	O	O
species	O	O
responding	O	O
positively	O	O
)	O	O
were	O	O
observed	O	O
,	O	O
with	O	O
differences	O	O
in	O	O
growth	O	O
response	O	O
within	O	O
bacterial	O	O
species	O	O
and	O	O
within	O	O
microbial	O	O
complexes	O	O
.	O	O

When	O	O
data	O	O
for	O	O
all	O	O
organisms	O	O
were	O	O
compared	O	O
with	O	O
published	O	O
responses	O	O
to	O	O
catecholamines	O	O
there	O	O
were	O	O
only	O	O
weak	O	O
correlations	O	O
with	O	O
Fe	O	O
(	O	O
r	O	O
=	O	O
0.28	O	O
)	O	O
and	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
autoinducer	O	O
(	O	O
r	O	O
=	O	O
0.34	O	O
)	O	O
responses	O	O
.	O	O

However	O	O
,	O	O
large	O	O
positive	O	O
responses	O	O
(	O	O
>	O	O
25	O	O
%	O	O
increase	O	O
)	O	O
to	O	O
free	O	O
Fe	O	O
and/or	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
autoinducer	O	O
were	O	O
significantly	O	O
more	O	O
prevalent	O	O
in	O	O
the	O	O
group	O	O
of	O	O
organisms	O	O
(	O	O
n	O	O
=	O	O
12	O	O
)	O	O
known	O	O
to	O	O
exhibit	O	O
similar	O	O
responses	O	O
to	O	O
catecholamine	O	O
hormones	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
;	O	O
chi2	O	O
=	O	O
4.56	O	O
)	O	O
.	O	O

The	O	O
results	O	O
support	O	O
the	O	O
view	O	O
that	O	O
catecholamines	O	O
may	O	O
exert	O	O
their	O	O
effects	O	O
on	O	O
subgingival	O	O
organisms	O	O
by	O	O
initiating	O	O
autoinducer	O	O
production	O	O
,	O	O
or	O	O
simply	O	O
by	O	O
acting	O	O
in	O	O
a	O	O
siderophore-like	O	O
manner	O	O
,	O	O
scavenging	O	O
bound	O	O
iron	O	O
from	O	O
the	O	O
local	O	O
environment	O	O
.	O	O

It	O	O
is	O	O
possible	O	O
that	O	O
autoinducer	O	O
mechanisms	O	O
may	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
response	O	O
of	O	O
oral	O	O
microorganisms	O	O
to	O	O
stress	O	O
hormones	O	O
,	O	O
thereby	O	O
contributing	O	O
to	O	O
the	O	O
clinical	O	O
course	O	O
of	O	O
stress-associated	O	O
periodontal	O	O
diseases	O	O
.	O	O

We	O	O
isolated	O	O
bacteria	O	O
from	O	O
periodontal	O	O
sites	O	O
and	O	O
mixed	O	O
saliva	O	O
in	O	O
eight	O	O
patients	O	O
with	O	O
Behcet	O	O
's	O	O
disease	O	O
and	O	O
surveyed	O	O
them	O	O
to	O	O
determine	O	O
whether	O	O
they	O	O
produced	O	O
heat	O	O
shock	O	O
proteins	O	O
(	O	O
HSPs	O	O
)	O	O
and	O	O
superantigen	O	O
.	O	O

Cultivable	O	O
bacterial	O	O
compositions	O	O
from	O	O
periodontal	O	O
sites	O	O
and	O	O
saliva	O	O
were	O	O
examined	O	O
by	O	O
anaerobic	O	O
culture	O	O
using	O	O
blood	O	O
agar	O	O
plates	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
such	O	O
as	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
predominant	O	O
in	O	O
the	O	O
isolates	O	O
from	O	O
the	O	O
subgingival	O	O
plaque	O	O
samples	O	O
.	O	O

The	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
group	O	O
was	O	O
the	O	O
most	O	O
common	O	O
type	O	O
isolated	O	O
from	O	O
the	O	O
saliva	O	O
samples	O	O
.	O	O

To	O	O
detect	O	O
the	O	O
production	O	O
of	O	O
HSPs	O	O
,	O	O
Western	O	O
blot	O	O
analyses	O	O
were	O	O
performed	O	O
using	O	O
a	O	O
polyclonal	O	O
rabbit	O	O
antibody	O	O
to	O	O
Escherichia	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
DnaK	E-bacteria	I-bacteria
and	O	O
a	O	O
monoclonal	O	O
antibody	O	O
to	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
Gro-EL	E-bacteria	I-bacteria
.	O	O

Sonic	O	O
extracts	O	O
of	O	O
27	O	O
of	O	O
the	O	O
strains	O	O
(	O	O
79.4	O	O
%	O	O
)	O	O
reacted	O	O
with	O	O
the	O	O
antibody	O	O
against	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
DnaK	E-bacteria	I-bacteria
.	O	O

Nine	O	O
of	O	O
these	O	O
34	O	O
strains	O	O
(	O	O
26.5	O	O
%	O	O
)	O	O
were	O	O
found	O	O
to	O	O
produce	O	O
HSPs	O	O
that	O	O
reacted	O	O
with	O	O
antibody	O	O
to	O	O
H.	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
Gro-EL	E-bacteria	I-bacteria
.	O	O

A	O	O
total	O	O
of	O	O
54	O	O
isolates	O	O
were	O	O
examined	O	O
for	O	O
superantigen	O	O
activity	O	O
against	O	O
human	O	O
peripheral	O	O
leukocytes	O	O
.	O	O

Twenty-five	O	O
gram-negative	B-bacteria	B-bacteria
clinical	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
chronic	O	O
periodontitis	O	O
lesions	O	O
and	O	O
20	O	O
ATCC	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
of	O	O
microorganisms	O	O
were	O	O
also	O	O
examined	O	O
.	O	O

We	O	O
could	O	O
not	O	O
detect	O	O
any	O	O
superantigen	O	O
activity	O	O
in	O	O
500x	O	O
diluted	O	O
supernatant	O	O
of	O	O
the	O	O
strains	O	O
isolated	O	O
from	O	O
the	O	O
eight	O	O
patients	O	O
with	O	O
Behcet	O	O
's	O	O
disease	O	O
.	O	O

The	O	O
present	O	O
study	O	O
indicates	O	O
that	O	O
the	O	O
anaerobic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
these	O	O
patients	O	O
produce	O	O
HSPs	O	O
,	O	O
the	O	O
production	O	O
being	O	O
related	O	O
to	O	O
Bechet	O	O
's	O	O
disease	O	O
.	O	O

Peptidoglycan	O	O
recognition	O	O
proteins	O	O
(	O	O
PGRPs	O	O
)	O	O
,	O	O
a	O	O
novel	O	O
family	O	O
of	O	O
pattern	O	O
recognition	O	O
molecules	O	O
(	O	O
PRMs	O	O
)	O	O
in	O	O
innate	O	O
immunity	O	O
conserved	O	O
from	O	O
insects	O	O
to	O	O
mammals	O	O
,	O	O
recognize	O	O
bacterial	O	O
cell	O	O
wall	O	O
peptidoglycan	O	O
(	O	O
PGN	O	O
)	O	O
and	O	O
are	O	O
suggested	O	O
to	O	O
act	O	O
as	O	O
anti-bacterial	O	O
factors	O	O
.	O	O

In	O	O
humans	O	O
,	O	O
four	O	O
kinds	O	O
of	O	O
PGRPs	O	O
(	O	O
PGRP-L	O	O
,	O	O
-Ialpha	O	O
,	O	O
-Ibeta	O	O
and	O	O
-S	O	O
)	O	O
have	O	O
been	O	O
cloned	O	O
and	O	O
all	O	O
four	O	O
human	O	O
PGRPs	O	O
bind	O	O
PGN	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
possible	O	O
regulation	O	O
of	O	O
the	O	O
expression	O	O
of	O	O
PGRPs	O	O
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
upon	O	O
stimulation	O	O
with	O	O
chemically	O	O
synthesized	O	O
pathogen-associated	O	O
molecular	O	O
patterns	O	O
(	O	O
PAMPs	O	O
)	O	O
in	O	O
bacterial	O	O
cell	O	O
surface	O	O
components	O	O
:	O	O
Escherichia	B-bacteria	B-bacteria
coli-type	O	O
tryacyl	O	O
lipopeptide	O	O
(	O	O
Pam3CSSNA	O	O
)	O	O
,	O	O
E.	B-bacteria	B-bacteria
coli-type	O	O
lipid	O	O
A	O	O
(	O	O
LA-15-PP	O	O
)	O	O
,	O	O
diaminopimelic	O	O
acid	O	O
containing	O	O
desmuramyl	O	O
peptide	O	O
(	O	O
gamma-D-glutamyl-meso-DAP	O	O
;	O	O
iE-DAP	O	O
)	O	O
,	O	O
and	O	O
muramyldipeptide	O	O
(	O	O
MDP	O	O
)	O	O
.	O	O

These	O	O
synthetic	O	O
PAMPs	O	O
markedly	O	O
upregulated	O	O
the	O	O
mRNA	O	O
expression	O	O
of	O	O
the	O	O
four	O	O
PGRPs	O	O
and	O	O
cell	O	O
surface	O	O
expression	O	O
of	O	O
PGRP-Ialpha	O	O
and	O	O
-Ibeta	O	O
,	O	O
but	O	O
did	O	O
not	O	O
induce	O	O
either	O	O
mRNA	O	O
expression	O	O
or	O	O
secretion	O	O
of	O	O
inflammatory	O	O
cytokines	O	O
,	O	O
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Suppression	O	O
of	O	O
the	O	O
expression	O	O
of	O	O
Toll-like	O	O
receptor	O	O
(	O	O
TLR	O	O
)	O	O
2	O	O
,	O	O
TLR4	O	O
,	O	O
nucleotide-binding	O	O
oligomerization	O	O
domain	O	O
(	O	O
NOD	O	O
)	O	O
1	O	O
and	O	O
NOD2	O	O
by	O	O
RNA	O	O
interference	O	O
specifically	O	O
inhibited	O	O
the	O	O
upregulation	O	O
of	O	O
PGRP	O	O
mRNA	O	O
expression	O	O
induced	O	O
by	O	O
Pam3CSSNA	O	O
,	O	O
LA-15-PP	O	O
,	O	O
iE-DAP	O	O
and	O	O
MDP	O	O
respectively	O	O
.	O	O

These	O	O
PAMPs	O	O
definitely	O	O
activated	O	O
nuclear	O	O
factor	O	O
(	O	O
NF	O	O
)	O	O
-kappaB	O	O
in	O	O
the	O	O
epithelial	O	O
cells	O	O
,	O	O
and	O	O
suppression	O	O
of	O	O
NF-kappaB	O	O
activation	O	O
clearly	O	O
prevented	O	O
the	O	O
induction	O	O
of	O	O
PGRP	O	O
mRNA	O	O
expression	O	O
induced	O	O
by	O	O
these	O	O
PAMPs	O	O
in	O	O
the	O	O
cells	O	O
.	O	O

These	O	O
findings	O	O
suggested	O	O
that	O	O
bacterial	O	O
PAMPs	O	O
induced	O	O
the	O	O
expression	O	O
of	O	O
PGRPs	O	O
,	O	O
but	O	O
not	O	O
proinflammatory	O	O
cytokines	O	O
,	O	O
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
,	O	O
and	O	O
the	O	O
PGRPs	O	O
might	O	O
be	O	O
involved	O	O
in	O	O
host	O	O
defence	O	O
against	O	O
bacterial	O	O
invasion	O	O
without	O	O
accompanying	O	O
inflammatory	O	O
responses	O	O
.	O	O

oral	O	O
treponemes	B-bacteria	B-bacteria
are	O	O
well-known	O	O
as	O	O
causative	O	O
agents	O	O
of	O	O
periodontal	O	O
disease	O	O
;	O	O
however	O	O
,	O	O
the	O	O
details	O	O
have	O	O
not	O	O
been	O	O
fully	O	O
clarified	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
effects	O	O
of	O	O
Treponema	B-bacteria	B-bacteria
medium	O	O
glycoconjugate	O	O
on	O	O
the	O	O
activation	O	O
of	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
using	O	O
phenol-water	O	O
extracts	O	O
from	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

The	O	O
phenol-water	O	O
extracts	O	O
activated	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
to	O	O
mediate	O	O
IL-8	O	O
production	O	O
,	O	O
as	O	O
well	O	O
as	O	O
IL-8	O	O
mRNA	O	O
expression	O	O
,	O	O
phosphorylation	O	O
of	O	O
p38	O	O
mitogen-activated	O	O
protein	O	O
kinase	O	O
,	O	O
and	O	O
expression	O	O
of	O	O
intercellular	O	O
adhesion	O	O
molecule-1	O	O
.	O	O

T.	B-bacteria	B-bacteria
medium	E-bacteria	I-bacteria
glycoconjugate	O	O
exhibited	O	O
no	O	O
activation	O	O
of	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
,	O	O
while	O	O
phenol-water	O	O
extract-induced	O	O
activation	O	O
of	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
was	O	O
clearly	O	O
inhibited	O	O
by	O	O
T.	B-bacteria	B-bacteria
medium	O	O
glycoconjugate	O	O
.	O	O

Furthermore	O	O
,	O	O
binding	O	O
of	O	O
biotinylated	O	O
phenol-water	O	O
extracts	O	O
to	O	O
CD14	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
LPS-binding	O	O
protein	O	O
was	O	O
blocked	O	O
with	O	O
T.	B-bacteria	B-bacteria
medium	O	O
glycoconjugate	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
T.	B-bacteria	B-bacteria
medium	O	O
glycoconjugate	O	O
has	O	O
an	O	O
inhibitory	O	O
effect	O	O
on	O	O
host	O	O
cell	O	O
activation	O	O
by	O	O
periodontopathic	O	O
bacteria	O	O
caused	O	O
by	O	O
binding	O	O
to	O	O
CD14-	O	O
and	O	O
LPS-binding	O	O
protein	O	O
.	O	O

Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
is	O	O
consistently	O	O
associated	O	O
with	O	O
recurrent	O	O
root	O	O
canal	O	O
infections	O	O
.	O	O

Only	O	O
low	O	O
concentrations	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
in	O	O
the	O	O
human	O	O
mouth	O	O
have	O	O
been	O	O
demonstrated	O	O
by	O	O
culture	O	O
techniques	O	O
.	O	O

Quantitative	O	O
detection	O	O
strategies	O	O
more	O	O
sensitive	O	O
than	O	O
culturing	O	O
,	O	O
such	O	O
as	O	O
quantitative	O	O
PCR	O	O
(	O	O
qPCR	O	O
)	O	O
,	O	O
could	O	O
provide	O	O
more	O	O
illuminating	O	O
data	O	O
.	O	O

Thirty	O	O
outpatients	O	O
attending	O	O
the	O	O
University	O	O
of	O	O
Michigan	O	O
Graduate	O	O
Endodontic	O	O
Clinic	O	O
for	O	O
endodontic	O	O
treatment	O	O
provided	O	O
oral	O	O
rinse	O	O
samples	O	O
that	O	O
were	O	O
analysed	O	O
for	O	O
E.	B-bacteria	B-bacteria
faecalis	B-bacteria	B-bacteria
using	O	O
qPCR	O	O
and	O	O
microbiological	O	O
culturing	O	O
.	O	O

A	O	O
SYBR	O	O
Green	O	O
I	O	O
qPCR	O	O
protocol	O	O
was	O	O
developed	O	O
for	O	O
the	O	O
quantifiable	O	O
detection	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
total	O	O
bacteria	O	O
in	O	O
oral	O	O
rinse	O	O
samples	O	O
using	O	O
primers	O	O
designed	O	O
to	O	O
target	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
.	O	O

Annealing	O	O
temperature	O	O
and	O	O
primer	O	O
,	O	O
magnesium	O	O
ion	O	O
,	O	O
and	O	O
dimethyl	O	O
sulfoxide	O	O
concentrations	O	O
were	O	O
investigated	O	O
for	O	O
optimisation	O	O
of	O	O
the	O	O
protocol	O	O
;	O	O
a	O	O
minimum	O	O
sensitivity	O	O
limit	O	O
of	O	O
23	O	O
rRNA	O	O
copies	O	O
(	O	O
an	O	O
estimated	O	O
six	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
cells	O	O
)	O	O
was	O	O
established	O	O
for	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
in	O	O
pure	O	O
culture	O	O
,	O	O
and	O	O
104	O	O
rRNA	O	O
copies	O	O
(	O	O
an	O	O
estimated	O	O
26	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
cells	O	O
)	O	O
in	O	O
mixed	O	O
culture	O	O
.	O	O

In	O	O
qPCR	O	O
assays	O	O
,	O	O
based	O	O
on	O	O
extrapolation	O	O
from	O	O
estimated	O	O
rRNA	O	O
gene	O	O
copy	O	O
numbers	O	O
,	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
comprised	O	O
0.0006-0.0047	O	O
%	O	O
of	O	O
a	O	O
total	O	O
bacteria	O	O
load	O	O
that	O	O
ranged	O	O
from	O	O
5.92	O	O
x	O	O
10	O	O
(	O	O
5	O	O
)	O	O
to	O	O
5.69	O	O
x	O	O
10	O	O
(	O	O
7	O	O
)	O	O
cells/ml	O	O
of	O	O
oral	O	O
rinse	O	O
.	O	O

E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
five	O	O
(	O	O
17	O	O
%	O	O
)	O	O
samples	O	O
in	O	O
concentrations	O	O
from	O	O
114	O	O
to	O	O
490	O	O
cells/ml	O	O
.	O	O

In	O	O
parallel	O	O
culture	O	O
assays	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
only	O	O
two	O	O
samples	O	O
(	O	O
7	O	O
%	O	O
)	O	O
of	O	O
the	O	O
five	O	O
identified	O	O
by	O	O
qPCR	O	O
and	O	O
in	O	O
concentrations	O	O
30	O	O
and	O	O
240	O	O
CFU/ml	O	O
.	O	O

qPCR	O	O
reported	O	O
a	O	O
higher	O	O
incidence	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
in	O	O
oral	O	O
rinse	O	O
samples	O	O
than	O	O
culture	O	O
techniques	O	O
and	O	O
afforded	O	O
greater	O	O
sensitivity	O	O
.	O	O

The	O	O
application	O	O
of	O	O
molecular	O	O
,	O	O
mainly	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
(	O	O
rRNA	O	O
)	O	O
-based	O	O
approaches	O	O
enables	O	O
researchers	O	O
to	O	O
bypass	O	O
the	O	O
cultivation	O	O
step	O	O
and	O	O
has	O	O
proven	O	O
its	O	O
usefulness	O	O
in	O	O
studying	O	O
the	O	O
microbial	O	O
composition	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
ecosystems	O	O
,	O	O
including	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
this	O	O
mini-review	O	O
,	O	O
we	O	O
describe	O	O
the	O	O
impact	O	O
of	O	O
these	O	O
culture-independent	O	O
approaches	O	O
on	O	O
our	O	O
knowledge	O	O
of	O	O
the	O	O
ecology	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
and	O	O
provide	O	O
directions	O	O
for	O	O
future	O	O
studies	O	O
that	O	O
should	O	O
emphasize	O	O
the	O	O
role	O	O
of	O	O
specific	O	O
strains	O	O
,	O	O
species	O	O
and	O	O
groups	O	O
of	O	O
microbes	O	O
in	O	O
periodontal	O	O
disease	O	O
.	O	O

Recent	O	O
findings	O	O
are	O	O
summarized	O	O
to	O	O
elucidate	O	O
the	O	O
relationship	O	O
between	O	O
periodontal	O	O
disease	O	O
and	O	O
human	O	O
oral	O	O
microbiota	O	O
,	O	O
including	O	O
as-yet-to-be-cultured	O	O
organisms	O	O
.	O	O

The	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
method	O	O
was	O	O
developed	O	O
to	O	O
detect	O	O
and	O	O
quantify	O	O
periodontopathic	O	O
bacteria	O	O
,	O	O
such	O	O
as	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
(	O	O
formerly	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
)	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

The	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
technique	O	O
allowed	O	O
enumeration	O	O
of	O	O
large	O	O
numbers	O	O
of	O	O
species	O	O
in	O	O
very	O	O
large	O	O
numbers	O	O
of	O	O
samples	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
clone	O	O
library	O	O
analysis	O	O
revealed	O	O
the	O	O
diversity	O	O
of	O	O
human	O	O
oral	O	O
microbiota	O	O
and	O	O
the	O	O
existence	O	O
of	O	O
as-yet-to-be-cultured	O	O
organisms	O	O
that	O	O
are	O	O
presumed	O	O
periodontal	O	O
pathogens	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
terminal	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
(	O	O
T-RFLP	O	O
)	O	O
analysis	O	O
was	O	O
applied	O	O
for	O	O
assessment	O	O
of	O	O
diversity	O	O
of	O	O
human	O	O
oral	O	O
microbiota	O	O
.	O	O

Culture-independent	O	O
approaches	O	O
are	O	O
useful	O	O
for	O	O
studying	O	O
the	O	O
microbial	O	O
ecology	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
and	O	O
should	O	O
be	O	O
useful	O	O
in	O	O
the	O	O
future	O	O
to	O	O
elucidate	O	O
the	O	O
etiology	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

The	O	O
description	O	O
of	O	O
the	O	O
new	O	O
species	O	O
Cardiobacterium	B-bacteria	B-bacteria
valvarum	E-bacteria	I-bacteria
prompted	O	O
a	O	O
search	O	O
for	O	O
additional	O	O
strains	O	O
of	O	O
the	O	O
organism	O	O
.	O	O

Here	O	O
we	O	O
report	O	O
characterization	O	O
of	O	O
four	O	O
oral	O	O
Cardiobacterium	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
from	O	O
the	O	O
Culture	O	O
Collection	O	O
of	O	O
the	O	O
University	O	O
of	O	O
Goteborg	O	O
.	O	O

The	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
of	O	O
the	O	O
organisms	O	O
exhibited	O	O
99.6	O	O
%	O	O
to	O	O
99.3	O	O
%	O	O
homology	O	O
with	O	O
Cardiobacterium	B-bacteria	B-bacteria
valvarum	E-bacteria	I-bacteria
.	O	O

The	O	O
cellular	O	O
fatty	O	O
acid	O	O
profiles	O	O
,	O	O
electrophoretic	O	O
patterns	O	O
of	O	O
whole-cell	O	O
proteins	O	O
,	O	O
growth	O	O
rate	O	O
and	O	O
nutritional	O	O
requirement	O	O
,	O	O
colonial	O	O
and	O	O
cellular	O	O
morphology	O	O
,	O	O
and	O	O
biochemical	O	O
reactions	O	O
were	O	O
also	O	O
similar	O	O
to	O	O
those	O	O
of	O	O
C.	B-bacteria	B-bacteria
valvarum	E-bacteria	I-bacteria
.	O	O

These	O	O
results	O	O
thus	O	O
classify	O	O
these	O	O
organisms	O	O
as	O	O
oral	O	O
strains	O	O
of	O	O
C.	B-bacteria	B-bacteria
valvarum	E-bacteria	I-bacteria
.	O	O

All	O	O
strains	O	O
were	O	O
susceptible	O	O
to	O	O
many	O	O
antibiotics	O	O
tested	O	O
.	O	O

The	O	O
description	O	O
of	O	O
the	O	O
species	O	O
was	O	O
emended	O	O
.	O	O

C.	B-bacteria	B-bacteria
valvarum	E-bacteria	I-bacteria
is	O	O
a	O	O
rare	O	O
cause	O	O
of	O	O
endocarditis	O	O
,	O	O
and	O	O
its	O	O
relationship	O	O
with	O	O
periodontal	O	O
diseases	O	O
may	O	O
need	O	O
investigation	O	O
.	O	O

Oral	O	O
Campylobacter	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
are	O	O
rarely	O	O
reported	O	O
to	O	O
cause	O	O
extraoral	O	O
infections	O	O
.	O	O

Here	O	O
we	O	O
present	O	O
three	O	O
cases	O	O
of	O	O
extraoral	O	O
abscess	O	O
caused	O	O
by	O	O
an	O	O
oral	B-bacteria	B-bacteria
Campylobacter	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
a	O	O
Streptococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

The	O	O
Campylobacter	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
all	O	O
isolated	O	O
anaerobically	O	O
and	O	O
identified	O	O
by	O	O
sequencing	O	O
analysis	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
.	O	O

The	O	O
cases	O	O
included	O	O
a	O	O
breast	O	O
abscess	O	O
caused	O	O
by	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
and	O	O
a	O	O
non-group	O	O
A	B-bacteria	B-bacteria
beta-hemolytic	I-bacteria	I-bacteria
streptococcus	E-bacteria	I-bacteria
in	O	O
a	O	O
patient	O	O
with	O	O
lymphoma	O	O
,	O	O
a	O	O
liver	O	O
abscess	O	O
caused	O	O
by	O	O
Campylobacter	B-bacteria	B-bacteria
curvus	E-bacteria	I-bacteria
and	O	O
an	O	O
alpha-hemolytic	B-bacteria	B-bacteria
streptococcus	E-bacteria	I-bacteria
in	O	O
a	O	O
patient	O	O
with	O	O
complicated	O	O
ovarian	O	O
cancer	O	O
,	O	O
and	O	O
a	O	O
postobstructive	O	O
bronchial	O	O
abscess	O	O
caused	O	O
by	O	O
C.	B-bacteria	B-bacteria
curvus	E-bacteria	I-bacteria
and	O	O
group	B-bacteria	B-bacteria
C	I-bacteria	I-bacteria
beta-hemolytic	I-bacteria	I-bacteria
Streptococcus	I-bacteria	I-bacteria
constellatus	E-bacteria	I-bacteria
in	O	O
a	O	O
patient	O	O
with	O	O
lung	O	O
cancer	O	O
.	O	O

The	O	O
abscesses	O	O
were	O	O
drained	O	O
or	O	O
resected	O	O
,	O	O
and	O	O
the	O	O
patients	O	O
were	O	O
treated	O	O
with	O	O
antibiotics	O	O
with	O	O
full	O	O
resolution	O	O
of	O	O
the	O	O
lesions	O	O
.	O	O

The	O	O
C.	B-bacteria	B-bacteria
curvus	E-bacteria	I-bacteria
cases	O	O
are	O	O
likely	O	O
the	O	O
first	O	O
reported	O	O
infections	O	O
by	O	O
this	O	O
organism	O	O
,	O	O
and	O	O
the	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
case	O	O
represents	O	O
the	O	O
second	O	O
such	O	O
reported	O	O
extraoral	O	O
infection	O	O
.	O	O

This	O	O
paper	O	O
describes	O	O
some	O	O
of	O	O
the	O	O
work	O	O
done	O	O
in	O	O
the	O	O
author	O	O
's	O	O
laboratory	O	O
over	O	O
the	O	O
past	O	O
35	O	O
years	O	O
.	O	O

The	O	O
research	O	O
covers	O	O
the	O	O
following	O	O
areas	O	O
:	O	O
the	O	O
physiology	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
their	O	O
interactions	O	O
;	O	O
the	O	O
physiology	O	O
of	O	O
some	O	O
Gram-negative	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
and	O	O
their	O	O
interactions	O	O
in	O	O
relation	O	O
to	O	O
periodontal	O	O
diseases	O	O
;	O	O
preventing	O	O
the	O	O
major	O	O
dental	O	O
diseases	O	O
;	O	O
and	O	O
the	O	O
future	O	O
of	O	O
oral	O	O
microbiology	O	O
.	O	O

Antimicrobial	O	O
peptides	O	O
are	O	O
one	O	O
of	O	O
the	O	O
factors	O	O
involved	O	O
in	O	O
innate	O	O
immunity	O	O
.	O	O

The	O	O
susceptibility	O	O
of	O	O
periodontopathogenic	O	O
and	O	O
cariogenic	O	O
bacteria	O	O
to	O	O
the	O	O
major	O	O
antimicrobial	O	O
peptides	O	O
produced	O	O
by	O	O
epithelia	O	O
was	O	O
investigated	O	O
.	O	O

Synthetic	O	O
antimicrobial	O	O
peptides	O	O
of	O	O
human	O	O
beta-defensin-1	O	O
(	O	O
hBD1	O	O
)	O	O
,	O	O
hBD2	O	O
,	O	O
hBD3	O	O
and	O	O
LL37	O	O
(	O	O
CAP18	O	O
)	O	O
were	O	O
evaluated	O	O
for	O	O
their	O	O
antimicrobial	O	O
activity	O	O
against	O	O
oral	O	O
bacteria	O	O
.	O	O

They	O	O
included	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
20	O	O
strains	O	O
)	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
6	O	O
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
7	O	O
)	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
7	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
5	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
(	O	O
5	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
(	O	O
5	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
(	O	O
4	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
(	O	O
2	O	O
)	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
(	O	O
1	O	O
)	O	O
.	O	O

Although	O	O
the	O	O
four	O	O
peptides	O	O
had	O	O
bactericidal	O	O
activity	O	O
against	O	O
all	O	O
bacteria	O	O
tested	O	O
,	O	O
the	O	O
degree	O	O
of	O	O
antibacterial	O	O
activity	O	O
was	O	O
variable	O	O
against	O	O
the	O	O
different	O	O
strains	O	O
and	O	O
species	O	O
.	O	O

The	O	O
antibacterial	O	O
activity	O	O
of	O	O
hBD1	O	O
was	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
the	O	O
other	O	O
peptides	O	O
.	O	O

Among	O	O
the	O	O
bacteria	O	O
tested	O	O
in	O	O
this	O	O
study	O	O
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
highly	O	O
susceptible	O	O
to	O	O
hBD3	O	O
and	O	O
LL37	O	O
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
highly	O	O
susceptible	O	O
to	O	O
hBD3	O	O
.	O	O

We	O	O
measured	O	O
the	O	O
Zeta-potential	O	O
,	O	O
representing	O	O
the	O	O
net	O	O
charge	O	O
of	O	O
whole	O	O
bacteria	O	O
,	O	O
to	O	O
study	O	O
the	O	O
relationship	O	O
between	O	O
susceptibility	O	O
to	O	O
cationic	O	O
peptide	O	O
and	O	O
the	O	O
net	O	O
charge	O	O
of	O	O
the	O	O
bacteria	O	O
.	O	O

Although	O	O
we	O	O
found	O	O
some	O	O
correlation	O	O
in	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
we	O	O
did	O	O
not	O	O
find	O	O
a	O	O
definite	O	O
correlation	O	O
with	O	O
all	O	O
the	O	O
bacterial	O	O
species	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
beta-defensins	O	O
and	O	O
LL37	O	O
have	O	O
versatile	O	O
antibacterial	O	O
activity	O	O
against	O	O
oral	O	O
bacteria	O	O
.	O	O

Transcriptional	O	O
profiling	O	O
,	O	O
bioinformatics	O	O
,	O	O
statistical	O	O
and	O	O
ontology	O	O
tools	O	O
were	O	O
used	O	O
to	O	O
uncover	O	O
and	O	O
dissect	O	O
genes	O	O
and	O	O
pathways	O	O
of	O	O
human	O	O
gingival	O	O
epithelial	O	O
cells	O	O
that	O	O
are	O	O
modulated	O	O
upon	O	O
interaction	O	O
with	O	O
the	O	O
periodontal	O	O
pathogens	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Consistent	O	O
with	O	O
their	O	O
biological	O	O
and	O	O
clinical	O	O
differences	O	O
,	O	O
the	O	O
common	O	O
core	O	O
transcriptional	O	O
response	O	O
of	O	O
epithelial	O	O
cells	O	O
to	O	O
both	O	O
organisms	O	O
was	O	O
very	O	O
limited	O	O
,	O	O
and	O	O
organism-specific	O	O
responses	O	O
predominated	O	O
.	O	O

A	O	O
large	O	O
number	O	O
of	O	O
differentially	O	O
regulated	O	O
genes	O	O
linked	O	O
to	O	O
the	O	O
P53	O	O
apoptotic	O	O
network	O	O
were	O	O
found	O	O
with	O	O
both	O	O
organisms	O	O
,	O	O
which	O	O
was	O	O
consistent	O	O
with	O	O
the	O	O
pro-apoptotic	O	O
phenotype	O	O
observed	O	O
with	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
anti-apoptotic	O	O
phenotype	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Furthermore	O	O
,	O	O
with	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
the	O	O
induction	O	O
of	O	O
apoptosis	O	O
did	O	O
not	O	O
appear	O	O
to	O	O
be	O	O
Fas-	O	O
or	O	O
TNF	O	O
(	O	O
alpha	O	O
)	O	O
-mediated	O	O
.	O	O

Linkage	O	O
of	O	O
specific	O	O
bacterial	O	O
components	O	O
to	O	O
host	O	O
pathways	O	O
and	O	O
networks	O	O
provided	O	O
additional	O	O
insight	O	O
into	O	O
the	O	O
pathogenic	O	O
process	O	O
.	O	O

Comparison	O	O
of	O	O
the	O	O
transcriptional	O	O
responses	O	O
of	O	O
epithelial	O	O
cells	O	O
challenged	O	O
with	O	O
parental	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
or	O	O
with	O	O
a	O	O
mutant	B-bacteria	B-bacteria
of	I-bacteria	I-bacteria
P.	I-bacteria	I-bacteria
gingivalis	E-bacteria	I-bacteria
deficient	O	O
in	O	O
production	O	O
of	O	O
major	O	O
fimbriae	O	O
,	O	O
which	O	O
are	O	O
required	O	O
for	O	O
optimal	O	O
invasion	O	O
,	O	O
showed	O	O
major	O	O
expression	O	O
differences	O	O
that	O	O
reverberated	O	O
throughout	O	O
the	O	O
host	O	O
cell	O	O
transcriptome	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
gene	O	O
ORF859	O	O
in	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
which	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
intracellular	O	O
homeostasis	O	O
,	O	O
had	O	O
a	O	O
more	O	O
subtle	O	O
effect	O	O
on	O	O
the	O	O
transcriptome	O	O
.	O	O

These	O	O
studies	O	O
help	O	O
unravel	O	O
the	O	O
complex	O	O
and	O	O
dynamic	O	O
interactions	O	O
between	O	O
host	O	O
epithelial	O	O
cells	O	O
and	O	O
endogenous	O	O
bacteria	O	O
that	O	O
can	O	O
cause	O	O
opportunistic	O	O
infections	O	O
.	O	O

Garlic	O	O
(	O	O
Allium	O	O
sativum	O	O
)	O	O
has	O	O
long	O	O
been	O	O
known	O	O
to	O	O
have	O	O
antibacterial	O	O
,	O	O
antifungal	O	O
and	O	O
antiviral	O	O
properties	O	O
but	O	O
there	O	O
are	O	O
few	O	O
data	O	O
on	O	O
its	O	O
effects	O	O
against	O	O
oral	O	O
bacterial	O	O
species	O	O
particularly	O	O
putative	O	O
periodontal	O	O
pathogens	O	O
or	O	O
their	O	O
enzymes	O	O
.	O	O

Filter	O	O
sterilised	O	O
,	O	O
aqueous	O	O
extract	O	O
of	O	O
garlic	O	O
was	O	O
tested	O	O
for	O	O
ability	O	O
to	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
a	O	O
range	O	O
of	O	O
oral	O	O
species	O	O
and	O	O
to	O	O
inhibit	O	O
the	O	O
trypsin-like	O	O
and	O	O
total	O	O
protease	O	O
activity	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
garlic	O	O
extract	O	O
(	O	O
57.1	O	O
%	O	O
(	O	O
w/v	O	O
)	O	O
,	O	O
containing	O	O
220	O	O
microg/ml	O	O
allicin	O	O
)	O	O
inhibited	O	O
the	O	O
growth	O	O
and	O	O
killed	O	O
most	O	O
of	O	O
the	O	O
organisms	O	O
tested	O	O
.	O	O

In	O	O
general	O	O
,	O	O
the	O	O
minimal	O	O
inhibitory	O	O
and	O	O
minimum	O	O
bactericidal	O	O
concentrations	O	O
for	O	O
the	O	O
Gram-negative	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
(	O	O
garlic	O	O
MIC	O	O
range	O	O
35.7-1.1	O	O
mg/ml	O	O
;	O	O
allicin	O	O
mean	O	O
MIC	O	O
4.1	O	O
microg/ml	O	O
;	O	O
mean	O	O
MBC	O	O
7.9	O	O
microg/ml	O	O
)	O	O
were	O	O
lower	O	O
than	O	O
those	O	O
for	O	O
the	O	O
Gram-positive	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
tested	O	O
(	O	O
garlic	O	O
MIC	O	O
range	O	O
142.7-35.7	O	O
mg/ml	O	O
;	O	O
allicin	O	O
mean	O	O
MIC	O	O
27.5	O	O
microg/ml	O	O
;	O	O
mean	O	O
MBC	O	O
91.9	O	O
microg/ml	O	O
)	O	O
.	O	O

Also	O	O
,	O	O
of	O	O
the	O	O
organisms	O	O
tested	O	O
,	O	O
the	O	O
putative	O	O
periodontal	O	O
pathogens	O	O
had	O	O
among	O	O
the	O	O
lowest	O	O
MICs	O	O
(	O	O
17.8-1.1	O	O
mg/ml	O	O
garlic	O	O
)	O	O
and	O	O
MBCs	O	O
(	O	O
35.7-1.1	O	O
mg/ml	O	O
garlic	O	O
)	O	O
.	O	O

Time-kill	O	O
curves	O	O
for	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
ginigvalis	E-bacteria	I-bacteria
,	O	O
showed	O	O
that	O	O
killing	O	O
of	O	O
the	O	O
latter	O	O
started	O	O
almost	O	O
immediately	O	O
,	O	O
whereas	O	O
there	O	O
was	O	O
a	O	O
delay	O	O
before	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
killed	O	O
.	O	O

The	O	O
garlic	O	O
extract	O	O
also	O	O
inhibited	O	O
the	O	O
trypsin-like	O	O
and	O	O
total	O	O
protease	O	O
activity	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
by	O	O
92.7	O	O
%	O	O
and	O	O
94.88	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

These	O	O
data	O	O
indicate	O	O
that	O	O
garlic	O	O
extract	O	O
inhibits	O	O
the	O	O
growth	O	O
of	O	O
oral	O	O
pathogens	O	O
and	O	O
certain	O	O
proteases	O	O
and	O	O
so	O	O
may	O	O
have	O	O
therapeutic	O	O
value	O	O
,	O	O
particularly	O	O
for	O	O
periodontitis	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
are	O	O
to	O	O
describe	O	O
the	O	O
relationships	O	O
between	O	O
IgG	O	O
antibodies	O	O
to	O	O
17	O	O
oral	O	O
organisms	O	O
and	O	O
atherosclerosis	O	O
as	O	O
indexed	O	O
by	O	O
carotid	O	O
intima-medial	O	O
wall	O	O
thickness	O	O
(	O	O
IMT	O	O
)	O	O
and	O	O
to	O	O
evaluate	O	O
the	O	O
role	O	O
of	O	O
smoking	O	O
.	O	O

Our	O	O
study	O	O
is	O	O
based	O	O
on	O	O
a	O	O
subset	O	O
of	O	O
participants	O	O
in	O	O
the	O	O
Atherosclerosis	O	O
Risk	O	O
in	O	O
Communities	O	O
(	O	O
ARIC	O	O
)	O	O
Study	O	O
,	O	O
who	O	O
received	O	O
a	O	O
complete	O	O
periodontal	O	O
examination	O	O
during	O	O
visit	O	O
4	O	O
(	O	O
1996-1998	O	O
)	O	O
.	O	O

The	O	O
outcome	O	O
was	O	O
mean	O	O
carotid	O	O
IMT	O	O
>	O	O
/=1mm	O	O
assessed	O	O
by	O	O
B-mode	O	O
ultrasound	O	O
.	O	O

The	O	O
exposures	O	O
were	O	O
serum	O	O
IgG	O	O
antibody	O	O
levels	O	O
against	O	O
17	O	O
periodontal	O	O
organisms	O	O
using	O	O
a	O	O
whole	O	O
bacterial	O	O
checkerboard	O	O
immunoblotting	O	O
technique	O	O
.	O	O

Evaluation	O	O
of	O	O
all	O	O
17	O	O
antibodies	O	O
indicated	O	O
that	O	O
antibody	O	O
to	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
resulted	O	O
in	O	O
the	O	O
best-fitting	O	O
model	O	O
(	O	O
OR=2.3	O	O
,	O	O
95	O	O
%	O	O
CI=1.83-2.84	O	O
)	O	O
and	O	O
individuals	O	O
with	O	O
both	O	O
high	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
titers	O	O
had	O	O
almost	O	O
twice	O	O
the	O	O
prevalence	O	O
of	O	O
IMT	O	O
>	O	O
/=1mm	O	O
than	O	O
those	O	O
with	O	O
only	O	O
a	O	O
high	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
antibody	O	O
(	O	O
8.3	O	O
%	O	O
versus	O	O
16.3	O	O
%	O	O
)	O	O
.	O	O

Stratification	O	O
by	O	O
smoking	O	O
indicated	O	O
that	O	O
all	O	O
microbial	O	O
models	O	O
significant	O	O
for	O	O
smokers	O	O
were	O	O
also	O	O
significant	O	O
for	O	O
never	O	O
smokers	O	O
except	O	O
for	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
p=0.08	O	O
)	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
study	O	O
to	O	O
report	O	O
a	O	O
relationship	O	O
between	O	O
IgG	O	O
antibody	O	O
reactive	O	O
to	O	O
oral	O	O
organisms	O	O
and	O	O
subclinical	O	O
atherosclerosis	O	O
with	O	O
significant	O	O
relationships	O	O
evident	O	O
in	O	O
both	O	O
ever	O	O
and	O	O
never	O	O
smokers	O	O
.	O	O

To	O	O
detect	O	O
enterococci	B-bacteria	B-bacteria
,	O	O
enteric	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
yeast	O	O
species	O	O
from	O	O
the	O	O
canals	O	O
of	O	O
teeth	O	O
with	O	O
primary	O	O
endodontic	O	O
infections	O	O
before	O	O
and	O	O
after	O	O
canal	O	O
preparation	O	O
and	O	O
to	O	O
test	O	O
the	O	O
antibiotic	O	O
susceptibility	O	O
of	O	O
enterococcal	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
infected	O	O
root	O	O
canals	O	O
.	O	O

Twenty-five	O	O
single-rooted	O	O
teeth	O	O
with	O	O
pulp	O	O
necrosis	O	O
,	O	O
intact	O	O
pulp	O	O
chambers	O	O
and	O	O
periradicular	O	O
lesions	O	O
were	O	O
selected	O	O
for	O	O
study	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
canals	O	O
before	O	O
and	O	O
after	O	O
instrumentation	O	O
.	O	O

Amongst	O	O
isolated	O	O
microorganisms	O	O
from	O	O
infected	O	O
root	O	O
canals	O	O
only	O	O
enterococci	B-bacteria	B-bacteria
,	O	O
enteric	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
yeasts	O	O
were	O	O
identified	O	O
by	O	O
biochemical	O	O
tests	O	O
.	O	O

The	O	O
in	O	O
vitro	O	O
antimicrobial	O	O
susceptibility	O	O
of	O	O
isolated	O	O
enterococci	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
was	O	O
evaluated	O	O
by	O	O
the	O	O
Etest	O	O
system	O	O
.	O	O

Microorganisms	O	O
were	O	O
isolated	O	O
from	O	O
92	O	O
%	O	O
of	O	O
the	O	O
samples	O	O
following	O	O
intracoronal	O	O
access	O	O
,	O	O
22	O	O
%	O	O
were	O	O
enterococci	B-bacteria	B-bacteria
,	O	O
enteric	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
or	O	O
yeast	O	O
species	O	O
.	O	O

After	O	O
biomechanical	O	O
preparation	O	O
,	O	O
these	O	O
species	O	O
were	O	O
no	O	O
longer	O	O
detected	O	O
.	O	O

After	O	O
7	O	O
days	O	O
without	O	O
intracanal	O	O
dressing	O	O
,	O	O
100	O	O
%	O	O
of	O	O
the	O	O
canals	O	O
contained	O	O
microorganisms	O	O
,	O	O
52	O	O
%	O	O
of	O	O
which	O	O
were	O	O
target	O	O
species	O	O
.	O	O

However	O	O
,	O	O
after	O	O
using	O	O
paramonochlorophenol	O	O
[	O	O
PRP	O	O
(	O	O
2.0	O	O
g	O	O
)	O	O
,	O	O
Rinosoro	O	O
and	O	O
polyethylene	O	O
glycol	O	O
(	O	O
400	O	O
equal	O	O
parts	O	O
up	O	O
to	O	O
100	O	O
mL	O	O
)	O	O
]	O	O
as	O	O
an	O	O
intracanal	O	O
dressing	O	O
for	O	O
7	O	O
days	O	O
,	O	O
enteric	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
yeasts	O	O
were	O	O
not	O	O
detected	O	O
;	O	O
only	O	O
enterococci	B-bacteria	B-bacteria
were	O	O
still	O	O
present	O	O
.	O	O

All	O	O
strains	O	O
of	O	O
enterococci	B-bacteria	B-bacteria
were	O	O
susceptible	O	O
to	O	O
ampicillin	O	O
,	O	O
but	O	O
exhibited	O	O
variable	O	O
susceptibility	O	O
to	O	O
rifampin	O	O
and	O	O
ciprofloxacin	O	O
.	O	O

Enterococci	B-bacteria	B-bacteria
,	O	O
enteric	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
yeasts	O	O
were	O	O
present	O	O
in	O	O
primary	O	O
endodontic	O	O
infections	O	O
.	O	O

Enterococci	B-bacteria	B-bacteria
,	O	O
particularly	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
E.	B-bacteria	B-bacteria
faecium	E-bacteria	I-bacteria
were	O	O
resistant	O	O
to	O	O
removal	O	O
by	O	O
root	O	O
canal	O	O
preparation	O	O
followed	O	O
by	O	O
intracanal	O	O
dressing	O	O
.	O	O

To	O	O
inquire	O	O
into	O	O
the	O	O
effect	O	O
of	O	O
different	O	O
of	O	O
Nidus	O	O
Vespae	O	O
extract	O	O
(	O	O
NVE	O	O
)	O	O
on	O	O
growth	O	O
and	O	O
acid	O	O
production	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25175	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
10556	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
19246	E-bacteria	I-bacteria
were	O	O
chosen	O	O
as	O	O
the	O	O
experimental	O	O
bacteria	O	O
.	O	O

Four	O	O
extracts	O	O
of	O	O
Nidus	O	O
Vespae	O	O
were	O	O
prepared	O	O
and	O	O
then	O	O
the	O	O
effects	O	O
of	O	O
these	O	O
Nidus	O	O
Vespae	O	O
extracts	O	O
on	O	O
the	O	O
acid	O	O
production	O	O
were	O	O
determined	O	O
.	O	O

All	O	O
of	O	O
Nidus	O	O
Vespae	O	O
extracts	O	O
could	O	O
inhibit	O	O
the	O	O
growth	O	O
the	O	O
of	O	O
the	O	O
three	O	O
strains	O	O
,	O	O
and	O	O
NVE1	O	O
,	O	O
NVE3	O	O
,	O	O
NVE4	O	O
could	O	O
inhibit	O	O
the	O	O
acid	O	O
production	O	O
of	O	O
the	O	O
three	O	O
strains	O	O
,	O	O
NVE2	O	O
could	O	O
inhibit	O	O
the	O	O
acid	O	O
production	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
.	O	O

Four	O	O
extracts	O	O
of	O	O
Nidus	O	O
Vespae	O	O
could	O	O
inhibit	O	O
the	O	O
acid	O	O
production	O	O
of	O	O
three	O	O
bacteria	O	O
strains	O	O
.	O	O

Noninvasive	O	O
in	O	O
situ	O	O
detection	O	O
of	O	O
suspected	O	O
cariogenic	O	O
bacterial	O	O
species	O	O
within	O	O
dental	O	O
biofilms	O	O
could	O	O
facilitate	O	O
monitoring	O	O
of	O	O
the	O	O
dynamic	O	O
change	O	O
of	O	O
oral	O	O
microbial	O	O
flora	O	O
and	O	O
assist	O	O
in	O	O
the	O	O
assessment	O	O
of	O	O
the	O	O
treatment	O	O
efficacy	O	O
of	O	O
therapeutic	O	O
agents	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
explore	O	O
the	O	O
possibility	O	O
to	O	O
use	O	O
three	O	O
well-characterized	O	O
monoclonal	O	O
antibodies	O	O
(	O	O
MAbs	O	O
)	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
to	O	O
identify	O	O
these	O	O
three	O	O
important	O	O
members	O	O
of	O	O
the	O	O
oral	O	O
microbial	O	O
community	O	O
in	O	O
the	O	O
complex	O	O
environment	O	O
of	O	O
oral	O	O
biofilms	O	O
.	O	O

These	O	O
MAbs	O	O
,	O	O
which	O	O
were	O	O
conjugated	O	O
to	O	O
different	O	O
fluorescent	O	O
labels	O	O
and	O	O
visualized	O	O
with	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
(	O	O
CLSM	O	O
)	O	O
,	O	O
proved	O	O
to	O	O
be	O	O
an	O	O
useful	O	O
tool	O	O
to	O	O
identify	O	O
the	O	O
three	O	O
species	O	O
of	O	O
interest	O	O
(	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
and	O	O
L.	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
)	O	O
under	O	O
various	O	O
experimental	O	O
conditions	O	O
including	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
derived	O	O
oral	O	O
biofilms	O	O
.	O	O

Manifold	O	O
addition	O	O
of	O	O
the	O	O
MAbs	O	O
on	O	O
consecutive	O	O
days	O	O
did	O	O
not	O	O
alter	O	O
the	O	O
biofilm	O	O
structure	O	O
thus	O	O
allowing	O	O
monitoring	O	O
of	O	O
the	O	O
same	O	O
biofilm	O	O
over	O	O
extended	O	O
time	O	O
periods	O	O
.	O	O

Using	O	O
this	O	O
MAb-based	O	O
method	O	O
the	O	O
effect	O	O
of	O	O
sucrose	O	O
challenge	O	O
on	O	O
the	O	O
biofilm	O	O
composition	O	O
and	O	O
the	O	O
distribution	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
and	O	O
L.	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
were	O	O
examined	O	O
.	O	O

S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
found	O	O
to	O	O
be	O	O
the	O	O
predominant	O	O
species	O	O
under	O	O
the	O	O
various	O	O
biofilm	O	O
conditions	O	O
tested	O	O
.	O	O

These	O	O
studies	O	O
indicate	O	O
that	O	O
MAbs	O	O
based	O	O
bacterial	O	O
detection	O	O
with	O	O
CLSM	O	O
is	O	O
a	O	O
versatile	O	O
tool	O	O
which	O	O
permits	O	O
new	O	O
insights	O	O
into	O	O
the	O	O
ecology	O	O
of	O	O
oral	O	O
biofilm	O	O
development	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
microbial	O	O
contents	O	O
presented	O	O
on	O	O
the	O	O
surface	O	O
of	O	O
mucosa	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
who	O	O
accepted	O	O
radiotherapy	O	O
,	O	O
and	O	O
to	O	O
provide	O	O
the	O	O
evidences	O	O
of	O	O
controlling	O	O
post-radiotherapeutic	O	O
infections	O	O
.	O	O

32	O	O
patients	O	O
(	O	O
19	O	O
males	O	O
and	O	O
13	O	O
females	O	O
)	O	O
aged	O	O
from	O	O
37	O	O
-	O	O
72	O	O
received	O	O
radiotherapy	O	O
after	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinomas	O	O
operation	O	O
were	O	O
selected	O	O
.	O	O

Samples	O	O
of	O	O
saliva	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
radiated	O	O
center	O	O
and	O	O
opposite	O	O
mucosa	O	O
before	O	O
and	O	O
after	O	O
radiotherapy	O	O
.	O	O

The	O	O
detective	O	O
amount	O	O
,	O	O
detective	O	O
ratio	O	O
and	O	O
constituent	O	O
ratio	O	O
were	O	O
analysed	O	O
by	O	O
cultivation	O	O
and	O	O
identification	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
,	O	O
Candida	O	O
albicans	O	O
and	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
significantly	O	O
increased	O	O
on	O	O
both	O	O
sides	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
while	O	O
Neisseria	B-bacteria	B-bacteria
and	O	O
Actinobacillus	B-bacteria	B-bacteria
decreased	O	O
on	O	O
radiated	O	O
region	O	O
after	O	O
the	O	O
radiotherapy	O	O
.	O	O

Radiotherapy	O	O
has	O	O
great	O	O
effects	O	O
on	O	O
oral	O	O
bacteria	O	O
and	O	O
pathogenic	O	O
organism	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
post-radiotherapy	O	O
infections	O	O
.	O	O

It	O	O
is	O	O
necessary	O	O
to	O	O
do	O	O
bacteria	O	O
culture	O	O
and	O	O
choose	O	O
sensitive	O	O
antibiotics	O	O
regularly	O	O
for	O	O
post-radiotherapeutic	O	O
patients	O	O
.	O	O

This	O	O
review	O	O
describes	O	O
current	O	O
knowledge	O	O
on	O	O
probiotic	B-bacteria	B-bacteria
bacteriotherapy	O	O
from	O	O
the	O	O
oral	O	O
health	O	O
perspective	O	O
.	O	O

Recent	O	O
experimental	O	O
studies	O	O
and	O	O
results	O	O
from	O	O
randomized	O	O
controlled	O	O
trials	O	O
have	O	O
shown	O	O
that	O	O
certain	O	O
gut	O	O
bacteria	O	O
,	O	O
in	O	O
particular	O	O
species	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
,	O	O
may	O	O
exert	O	O
beneficial	O	O
effects	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
by	O	O
inhibiting	O	O
cariogenic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
Candida	O	O
sp	O	O
.	O	O

Probiotics	B-bacteria	B-bacteria
have	O	O
been	O	O
successfully	O	O
used	O	O
to	O	O
control	O	O
gastro-intestinal	O	O
diseases	O	O
.	O	O

They	O	O
also	O	O
appear	O	O
to	O	O
alleviate	O	O
symptoms	O	O
of	O	O
allergy	O	O
and	O	O
diseases	O	O
with	O	O
immunological	O	O
pathology	O	O
.	O	O

The	O	O
mechanisms	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
action	O	O
appear	O	O
to	O	O
link	O	O
with	O	O
colonization	O	O
resistance	O	O
and	O	O
immune	O	O
modulation	O	O
.	O	O

Lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
can	O	O
produce	O	O
different	O	O
antimicrobial	O	O
components	O	O
such	O	O
as	O	O
organic	O	O
acids	O	O
,	O	O
hydrogen	O	O
peroxide	O	O
,	O	O
carbon	O	O
peroxide	O	O
,	O	O
diacetyl	O	O
,	O	O
low	O	O
molecular	O	O
weight	O	O
antimicrobial	O	O
substances	O	O
,	O	O
bacteriocins	O	O
,	O	O
and	O	O
adhesion	O	O
inhibitors	O	O
,	O	O
which	O	O
also	O	O
affect	O	O
oral	O	O
microflora	O	O
.	O	O

However	O	O
,	O	O
data	O	O
is	O	O
still	O	O
sparse	O	O
on	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
action	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

More	O	O
information	O	O
is	O	O
needed	O	O
on	O	O
the	O	O
colonization	O	O
of	O	O
probiotics	B-bacteria	B-bacteria
in	O	O
the	O	O
mouth	O	O
and	O	O
their	O	O
possible	O	O
effect	O	O
on	O	O
and	O	O
within	O	O
oral	O	O
biofilms	O	O
.	O	O

There	O	O
is	O	O
every	O	O
reason	O	O
to	O	O
believe	O	O
that	O	O
the	O	O
putative	O	O
probiotic	B-bacteria	B-bacteria
mechanisms	O	O
of	O	O
action	O	O
are	O	O
the	O	O
same	O	O
in	O	O
the	O	O
mouth	O	O
as	O	O
they	O	O
are	O	O
in	O	O
other	O	O
parts	O	O
of	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
.	O	O

Because	O	O
of	O	O
the	O	O
increasing	O	O
global	O	O
problem	O	O
with	O	O
antimicrobial	O	O
drug	O	O
resistance	O	O
,	O	O
the	O	O
concept	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
therapy	O	O
is	O	O
interesting	O	O
and	O	O
pertinent	O	O
,	O	O
and	O	O
merits	O	O
further	O	O
research	O	O
in	O	O
the	O	O
fields	O	O
of	O	O
oral	O	O
medicine	O	O
and	O	O
dentistry	O	O
.	O	O

Zinc	O	O
is	O	O
used	O	O
in	O	O
oral	O	O
care	O	O
products	O	O
as	O	O
an	O	O
antiplaque/antigingivitis	O	O
agent	O	O
.	O	O

Our	O	O
objective	O	O
was	O	O
to	O	O
assess	O	O
the	O	O
antimicrobial	O	O
actions	O	O
of	O	O
zinc	O	O
against	O	O
oral	O	O
anaerobes	B-bacteria	B-bacteria
associated	O	O
with	O	O
gingivitis	O	O
,	O	O
specifically	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
with	O	O
focus	O	O
on	O	O
catabolism	O	O
and	O	O
oxidative	O	O
metabolism	O	O
.	O	O

The	O	O
oral	O	O
anaerobes	B-bacteria	B-bacteria
were	O	O
grown	O	O
in	O	O
complex	O	O
medium	O	O
in	O	O
an	O	O
anaerobic	O	O
chamber	O	O
,	O	O
harvested	O	O
by	O	O
centrifugation	O	O
and	O	O
used	O	O
directly	O	O
for	O	O
experiments	O	O
with	O	O
suspensions	O	O
.	O	O

Biofilm	O	O
growth	O	O
involved	O	O
super-infection	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
of	O	O
an	O	O
initial	O	O
biofilm	O	O
formed	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
.	O	O

Zn	O	O
(	O	O
2+	O	O
)	O	O
inhibited	O	O
catabolism	O	O
of	O	O
glutamate	O	O
,	O	O
glutamyl-glutamate	O	O
,	O	O
glucose	O	O
and	O	O
fructose	O	O
by	O	O
F.	O	O
nucleatum	O	O
cells	O	O
in	O	O
suspensions	O	O
with	O	O
ID	O	O
(	O	O
50	O	O
)	O	O
values	O	O
,	O	O
respectively	O	O
,	O	O
of	O	O
0.05	O	O
,	O	O
0.005	O	O
,	O	O
0.01	O	O
and	O	O
0.01	O	O
mM	O	O
.	O	O

The	O	O
ID	O	O
(	O	O
50	O	O
)	O	O
value	O	O
for	O	O
inhibition	O	O
of	O	O
glutamate	O	O
catabolism	O	O
by	O	O
biofilms	O	O
was	O	O
0.10	O	O
mM	O	O
.	O	O

Inhibition	O	O
of	O	O
glutamate	O	O
catabolism	O	O
could	O	O
be	O	O
related	O	O
to	O	O
inhibition	O	O
of	O	O
substrate	O	O
uptake	O	O
and	O	O
of	O	O
2-oxoglutarate	O	O
reductase	O	O
.	O	O

Zn	O	O
(	O	O
2+	O	O
)	O	O
also	O	O
inhibited	O	O
catabolism	O	O
of	O	O
aspartate	O	O
or	O	O
aspartyl-aspartate	O	O
by	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
with	O	O
ID	O	O
(	O	O
50	O	O
)	O	O
values	O	O
of	O	O
0.07	O	O
and	O	O
about	O	O
0.03	O	O
mM	O	O
,	O	O
respectively	O	O
.	O	O

Respiration	O	O
of	O	O
intact	O	O
cells	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
NADH	O	O
oxidase	O	O
in	O	O
cell	O	O
extracts	O	O
were	O	O
sensitive	O	O
to	O	O
zinc	O	O
with	O	O
ID	O	O
(	O	O
50	O	O
)	O	O
values	O	O
,	O	O
respectively	O	O
,	O	O
of	O	O
about	O	O
1.0	O	O
and	O	O
1.4	O	O
mM	O	O
.	O	O

Zinc	O	O
also	O	O
inhibited	O	O
production	O	O
of	O	O
hydrogen	O	O
peroxide	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
ID	O	O
(	O	O
50	O	O
)	O	O
=	O	O
ca	O	O
.	O	O

0.04	O	O
mM	O	O
.	O	O
)	O	O

but	O	O
at	O	O
high	O	O
concentrations	O	O
acted	O	O
to	O	O
potentiate	O	O
and	O	O
enhance	O	O
peroxide	O	O
killing	O	O
of	O	O
the	O	O
anaerobe	B-bacteria	B-bacteria
.	O	O

Zn	O	O
(	O	O
2+	O	O
)	O	O
is	O	O
a	O	O
potent	O	O
inhibitor	O	O
of	O	O
catabolism	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
including	O	O
catabolism	O	O
of	O	O
peptides	O	O
,	O	O
which	O	O
can	O	O
be	O	O
degraded	O	O
to	O	O
yield	O	O
inflammatory	O	O
metabolic	O	O
end	O	O
products	O	O
.	O	O

Zn	O	O
(	O	O
2+	O	O
)	O	O
also	O	O
inhibits	O	O
O	O	O
(	O	O
2	O	O
)	O	O
metabolism	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
by	O	O
about	O	O
50	O	O
%	O	O
and	O	O
hydrogen	O	O
peroxide	O	O
production	O	O
nearly	O	O
completely	O	O
but	O	O
also	O	O
enhances	O	O
killing	O	O
by	O	O
peroxide	O	O
added	O	O
to	O	O
cells	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
assess	O	O
levels	O	O
of	O	O
occurrence	O	O
and	O	O
number	O	O
of	O	O
aerobic	B-bacteria	B-bacteria
bacteria	I-bacteria	I-bacteria
hemolysing	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
non-hemolysing	E-bacteria	I-bacteria
,	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
streptococci	B-bacteria	B-bacteria
hemolysing	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
non-hemolysing	E-bacteria	I-bacteria
,	O	O
staphylococci	B-bacteria	B-bacteria
,	O	O
and	O	O
bacteria	O	O
responsible	O	O
for	O	O
tooth	O	O
decay	O	O
(	O	O
Streptococcus	O	O
mutans	O	O
and	O	O
Lactobacillus	O	O
spp	O	O
.	O	O
)	O	O

on	O	O
oral	O	O
cavity	O	O
in	O	O
children	O	O
and	O	O
adults	O	O
.	O	O

The	O	O
results	O	O
obtained	O	O
indicate	O	O
the	O	O
difference	O	O
of	O	O
the	O	O
level	O	O
of	O	O
occurrence	O	O
of	O	O
,	O	O
aerobic	B-bacteria	B-bacteria
bacteria	I-bacteria	I-bacteria
hemolysing	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
non-hemolysing	E-bacteria	I-bacteria
,	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
streptococci	B-bacteria	B-bacteria
hemolysing	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
non-hemolysing	E-bacteria	I-bacteria
,	O	O
staphylococci	B-bacteria	B-bacteria
,	O	O
and	O	O
bacteria	O	O
responsible	O	O
for	O	O
tooth	O	O
decay	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
)	O	O

was	O	O
not	O	O
statistically	O	O
significant	O	O
in	O	O
either	O	O
group	O	O
.	O	O

The	O	O
counts	O	O
and	O	O
average	O	O
values	O	O
of	O	O
the	O	O
counts	O	O
for	O	O
aerobic	B-bacteria	B-bacteria
bacteria	I-bacteria	I-bacteria
non-hemolysing	E-bacteria	I-bacteria
,	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
streptococci	B-bacteria	B-bacteria
hemolysing	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
non-hemolysing	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
turned	O	O
out	O	O
to	O	O
be	O	O
statistically	O	O
significantly	O	O
larger	O	O
in	O	O
adults	O	O
than	O	O
in	O	O
children	O	O
.	O	O

However	O	O
for	O	O
aerobic	B-bacteria	B-bacteria
bacteria	I-bacteria	I-bacteria
hemolysing	E-bacteria	I-bacteria
,	O	O
staphylococci	B-bacteria	B-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

the	O	O
difference	O	O
of	O	O
the	O	O
counts	O	O
was	O	O
not	O	O
statistically	O	O
significant	O	O
in	O	O
either	O	O
group	O	O
.	O	O

The	O	O
comparative	O	O
in	O	O
vitro	O	O
potency	O	O
of	O	O
XRP2868	O	O
,	O	O
a	O	O
new	O	O
oral	O	O
semisynthetic	O	O
streptogramin	O	O
antibiotic	O	O
,	O	O
was	O	O
evaluated	O	O
against	O	O
gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

XRP2868	O	O
inhibited	O	O
all	O	O
staphylococci	B-bacteria	B-bacteria
at	O	O
<	O	O
or	O	O
=	O	O
1	O	O
microg/ml	O	O
and	O	O
all	O	O
non-pneumococcal	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
at	O	O
<	O	O
or	O	O
=	O	O
0.25	O	O
microg/ml	O	O
and	O	O
was	O	O
fourfold	O	O
more	O	O
potent	O	O
than	O	O
quinupristin-dalfopristin	O	O
against	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecium	E-bacteria	I-bacteria
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
present	O	O
investigation	O	O
was	O	O
to	O	O
determine	O	O
if	O	O
the	O	O
salivary	O	O
counts	O	O
of	O	O
40	O	O
common	O	O
oral	O	O
bacteria	O	O
in	O	O
subjects	O	O
with	O	O
an	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
(	O	O
OSCC	O	O
)	O	O
lesion	O	O
would	O	O
differ	O	O
from	O	O
those	O	O
found	O	O
in	O	O
cancer-free	O	O
(	O	O
OSCC-free	O	O
)	O	O
controls	O	O
.	O	O

Unstimulated	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
229	O	O
OSCC-free	O	O
and	O	O
45	O	O
OSCC	O	O
subjects	O	O
and	O	O
evaluated	O	O
for	O	O
their	O	O
content	O	O
of	O	O
40	O	O
common	O	O
oral	O	O
bacteria	O	O
using	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

DNA	O	O
counts	O	O
per	O	O
ml	O	O
saliva	O	O
were	O	O
determined	O	O
for	O	O
each	O	O
species	O	O
,	O	O
averaged	O	O
across	O	O
subjects	O	O
in	O	O
the	O	O
2	O	O
subject	O	O
groups	O	O
,	O	O
and	O	O
significance	O	O
of	O	O
differences	O	O
between	O	O
groups	O	O
determined	O	O
using	O	O
the	O	O
Mann-Whitney	O	O
test	O	O
and	O	O
adjusted	O	O
for	O	O
multiple	O	O
comparisons	O	O
.	O	O

Diagnostic	O	O
sensitivity	O	O
and	O	O
specificity	O	O
in	O	O
detection	O	O
of	O	O
OSCC	O	O
by	O	O
levels	O	O
of	O	O
salivary	O	O
organisms	O	O
were	O	O
computed	O	O
and	O	O
comparisons	O	O
made	O	O
separately	O	O
between	O	O
a	O	O
non-matched	O	O
group	O	O
of	O	O
45	O	O
OSCC	O	O
subjects	O	O
and	O	O
229	O	O
controls	O	O
and	O	O
a	O	O
group	O	O
of	O	O
45	O	O
OSCC	O	O
subjects	O	O
and	O	O
45	O	O
controls	O	O
matched	O	O
by	O	O
age	O	O
,	O	O
gender	O	O
and	O	O
smoking	O	O
history	O	O
.	O	O

Counts	O	O
of	O	O
3	O	O
of	O	O
the	O	O
40	O	O
species	O	O
tested	O	O
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
were	O	O
elevated	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
individuals	O	O
with	O	O
OSCC	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

When	O	O
tested	O	O
as	O	O
diagnostic	O	O
markers	O	O
the	O	O
3	O	O
species	O	O
were	O	O
found	O	O
to	O	O
predict	O	O
80	O	O
%	O	O
of	O	O
cancer	O	O
cases	O	O
(	O	O
sensitivity	O	O
)	O	O
while	O	O
excluding	O	O
83	O	O
%	O	O
of	O	O
controls	O	O
(	O	O
specificity	O	O
)	O	O
in	O	O
the	O	O
non-matched	O	O
group	O	O
.	O	O

Diagnostic	O	O
sensitivity	O	O
and	O	O
specificity	O	O
in	O	O
the	O	O
matched	O	O
group	O	O
were	O	O
80	O	O
%	O	O
and	O	O
82	O	O
%	O	O
respectively	O	O
.	O	O

High	O	O
salivary	O	O
counts	O	O
of	O	O
C.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
may	O	O
be	O	O
diagnostic	O	O
indicators	O	O
of	O	O
OSCC	O	O
.	O	O

Heat	O	O
shock	O	O
proteins	O	O
(	O	O
HSP	O	O
)	O	O
are	O	O
released	O	O
by	O	O
cells	O	O
in	O	O
response	O	O
to	O	O
stress	O	O
signals	O	O
.	O	O

It	O	O
is	O	O
hypothesized	O	O
that	O	O
pathogenic	O	O
bacteria	O	O
stimulate	O	O
the	O	O
cells	O	O
in	O	O
the	O	O
periodontium	O	O
to	O	O
up-regulate	O	O
the	O	O
expression	O	O
of	O	O
HSP60	O	O
,	O	O
which	O	O
would	O	O
stimulate	O	O
macrophages	O	O
,	O	O
and	O	O
possibly	O	O
other	O	O
cells	O	O
,	O	O
to	O	O
produce	O	O
proinflammatory	O	O
cytokines	O	O
.	O	O

We	O	O
sought	O	O
to	O	O
determine	O	O
whether	O	O
oral	O	O
keratinocytes	O	O
responded	O	O
to	O	O
recombinant	O	O
human	O	O
HSP60	O	O
and	O	O
to	O	O
identify	O	O
the	O	O
signalling	O	O
pathways	O	O
involved	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
whether	O	O
oral	O	O
keratinocytes	O	O
are	O	O
a	O	O
source	O	O
of	O	O
endogenous	O	O
HSP60	O	O
was	O	O
also	O	O
investigated	O	O
.	O	O

RT-PCR	O	O
revealed	O	O
that	O	O
rhHSP60	O	O
induced	O	O
expression	O	O
of	O	O
the	O	O
IL-1beta	O	O
gene	O	O
in	O	O
the	O	O
Human	O	O
Oral	O	O
Keratinocyte	O	O
(	O	O
HOK-16B	O	O
)	O	O
cell	O	O
line	O	O
and	O	O
it	O	O
was	O	O
highest	O	O
at	O	O
the	O	O
lowest	O	O
concentration	O	O
used	O	O
(	O	O
0.1	O	O
microg/ml	O	O
)	O	O
.	O	O

These	O	O
responses	O	O
were	O	O
mediated	O	O
via	O	O
activation	O	O
of	O	O
p44/42	O	O
MAP-kinases	O	O
and	O	O
to	O	O
a	O	O
lesser	O	O
extend	O	O
the	O	O
MAP-kinase	O	O
SAP/JNK	O	O
.	O	O

Similar	O	O
data	O	O
was	O	O
obtained	O	O
from	O	O
analysis	O	O
of	O	O
intracellular	O	O
signalling	O	O
pathways	O	O
in	O	O
HOK-16B	O	O
cells	O	O
by	O	O
rhHSP70	O	O
and	O	O
LPS	O	O
(	O	O
from	O	O
both	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
the	O	O
oral	O	O
pathogen	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
.	O	O

However	O	O
,	O	O
there	O	O
was	O	O
little	O	O
activation	O	O
of	O	O
p38	O	O
by	O	O
rhHSP60	O	O
.	O	O

Blocking	O	O
of	O	O
the	O	O
p44/42	O	O
pathway	O	O
decreased	O	O
HSP60-induced	O	O
IL-1beta	O	O
gene	O	O
expression	O	O
and	O	O
protein	O	O
secretion	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
we	O	O
discovered	O	O
that	O	O
self-HSP60	O	O
proteins	O	O
were	O	O
constitutively	O	O
secreted	O	O
by	O	O
HOK-16B	O	O
cells	O	O
.	O	O

Secretion	O	O
of	O	O
self-HSP60	O	O
was	O	O
up-regulated	O	O
in	O	O
cells	O	O
treated	O	O
with	O	O
LPS	O	O
from	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
but	O	O
down-regulated	O	O
with	O	O
LPS	O	O
from	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

To	O	O
summarize	O	O
,	O	O
oral	O	O
keratinocytes	O	O
respond	O	O
to	O	O
exogenous	O	O
HSP60	O	O
by	O	O
triggering	O	O
expression	O	O
of	O	O
the	O	O
inflammatory	O	O
cytokine	O	O
IL-1beta	O	O
through	O	O
activation	O	O
of	O	O
p44/42	O	O
MAP	O	O
kinase	O	O
.	O	O

Oral	O	O
keratinocytes	O	O
are	O	O
also	O	O
a	O	O
source	O	O
for	O	O
self-HSP60	O	O
and	O	O
the	O	O
secretion	O	O
of	O	O
this	O	O
protein	O	O
may	O	O
be	O	O
differentially	O	O
modified	O	O
by	O	O
LPS	O	O
from	O	O
different	O	O
bacterial	O	O
species	O	O
.	O	O

These	O	O
results	O	O
highlight	O	O
the	O	O
importance	O	O
of	O	O
oral	O	O
keratinocytes	O	O
and	O	O
HSPs	O	O
in	O	O
the	O	O
development	O	O
of	O	O
an	O	O
immune	O	O
response	O	O
against	O	O
bacterial	O	O
infection	O	O
.	O	O

Endodontic	O	O
infections	O	O
have	O	O
been	O	O
traditionally	O	O
studied	O	O
by	O	O
culture	O	O
methods	O	O
,	O	O
but	O	O
recent	O	O
reports	O	O
showing	O	O
that	O	O
over	O	O
50	O	O
%	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
is	O	O
still	O	O
uncultivable	O	O
(	O	O
B.	O	O
J.	O	O
Paster	O	O
et	O	O
al.	O	O
,	O	O
J.	O	O
Bacteriol	O	O
.	O	O

183:3770-3783	O	O
,	O	O
2001	O	O
)	O	O
raise	O	O
the	O	O
possibility	O	O
that	O	O
many	O	O
endodontic	O	O
pathogens	O	O
remain	O	O
unknown	O	O
.	O	O

This	O	O
study	O	O
intended	O	O
to	O	O
investigate	O	O
the	O	O
prevalence	O	O
of	O	O
several	O	O
uncultivated	O	O
oral	O	O
phylotypes	O	O
,	O	O
as	O	O
well	O	O
as	O	O
newly	O	O
named	O	O
species	O	O
in	O	O
primary	O	O
or	O	O
persistent	O	O
endodontic	O	O
infections	O	O
associated	O	O
with	O	O
chronic	O	O
periradicular	O	O
diseases	O	O
.	O	O

Samples	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
root	O	O
canals	O	O
of	O	O
21	O	O
untreated	O	O
teeth	O	O
and	O	O
22	O	O
root-filled	O	O
teeth	O	O
,	O	O
all	O	O
of	O	O
them	O	O
with	O	O
radiographic	O	O
evidence	O	O
of	O	O
periradicular	O	O
bone	O	O
destruction	O	O
.	O	O

Genomic	O	O
DNA	O	O
was	O	O
isolated	O	O
directly	O	O
from	O	O
each	O	O
sample	O	O
,	O	O
and	O	O
16S	O	O
rRNA	O	O
gene-based	O	O
nested	O	O
or	O	O
heminested	O	O
PCR	O	O
assays	O	O
were	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
presence	O	O
of	O	O
13	O	O
species	O	O
or	O	O
phylotypes	O	O
of	O	O
bacteria	O	O
.	O	O

Species-specific	O	O
primers	O	O
had	O	O
already	O	O
been	O	O
validated	O	O
in	O	O
the	O	O
literature	O	O
or	O	O
were	O	O
developed	O	O
by	O	O
aligning	O	O
closely	O	O
related	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
.	O	O

Species	O	O
specificity	O	O
for	O	O
each	O	O
primer	O	O
pair	O	O
was	O	O
confirmed	O	O
by	O	O
running	O	O
PCRs	O	O
against	O	O
a	O	O
panel	O	O
of	O	O
several	O	O
oral	O	O
bacteria	O	O
and	O	O
by	O	O
sequencing	O	O
DNA	O	O
from	O	O
representative	O	O
positive	O	O
samples	O	O
.	O	O

All	O	O
species	O	O
or	O	O
phylotypes	O	O
were	O	O
detected	O	O
in	O	O
at	O	O
least	O	O
one	O	O
case	O	O
of	O	O
primary	O	O
infections	O	O
.	O	O

The	O	O
most	O	O
prevalent	O	O
species	O	O
or	O	O
phylotypes	O	O
found	O	O
in	O	O
primary	O	O
infections	O	O
were	O	O
Dialister	B-bacteria	B-bacteria
invisus	E-bacteria	I-bacteria
(	O	O
81	O	O
%	O	O
)	O	O
,	O	O
Synergistes	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
clone	I-bacteria	I-bacteria
BA121	E-bacteria	I-bacteria
(	O	O
33	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Olsenella	B-bacteria	B-bacteria
uli	E-bacteria	I-bacteria
(	O	O
33	O	O
%	O	O
)	O	O
.	O	O

Of	O	O
the	O	O
target	O	O
bacteria	O	O
,	O	O
only	O	O
these	O	O
three	O	O
species	O	O
were	O	O
detected	O	O
in	O	O
persistent	O	O
infections	O	O
.	O	O

Detection	O	O
of	O	O
uncultivated	O	O
phylotypes	O	O
and	O	O
newly	O	O
named	O	O
species	O	O
in	O	O
infected	O	O
root	O	O
canals	O	O
suggests	O	O
that	O	O
there	O	O
are	O	O
previously	O	O
unrecognized	O	O
bacteria	O	O
that	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
periradicular	O	O
diseases	O	O
.	O	O

Diverse	O	O
methylotrophic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
the	O	O
tongue	O	O
,	O	O
and	O	O
supra-	O	O
and	O	O
subgingival	O	O
plaque	O	O
in	O	O
the	O	O
mouths	O	O
of	O	O
volunteers	O	O
and	O	O
patients	O	O
with	O	O
periodontitis	O	O
.	O	O

One-carbon	O	O
compounds	O	O
such	O	O
as	O	O
dimethylsulfide	O	O
in	O	O
the	O	O
mouth	O	O
are	O	O
likely	O	O
to	O	O
be	O	O
used	O	O
as	O	O
growth	O	O
substrates	O	O
for	O	O
these	O	O
organisms	O	O
.	O	O

Methylotrophic	O	O
strains	O	O
of	O	O
Bacillus	B-bacteria	B-bacteria
,	O	O
Brevibacterium	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
,	O	O
Hyphomicrobium	B-bacteria	B-bacteria
sulfonivorans	E-bacteria	I-bacteria
,	O	O
Methylobacterium	B-bacteria	B-bacteria
,	O	O
Micrococcus	B-bacteria	B-bacteria
luteus	E-bacteria	I-bacteria
and	O	O
Variovorax	B-bacteria	B-bacteria
paradoxus	E-bacteria	I-bacteria
were	O	O
characterized	O	O
physiologically	O	O
and	O	O
by	O	O
their	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
of	O	O
B.	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
was	O	O
shown	O	O
to	O	O
be	O	O
methylotrophic	O	O
.	O	O

Enzymes	O	O
of	O	O
methylotrophic	O	O
metabolism	O	O
were	O	O
characterized	O	O
in	O	O
some	O	O
strains	O	O
,	O	O
and	O	O
activities	O	O
consistent	O	O
with	O	O
growth	O	O
using	O	O
known	O	O
pathways	O	O
of	O	O
C1-compound	O	O
metabolism	O	O
demonstrated	O	O
.	O	O

Genomic	O	O
DNA	O	O
from	O	O
18	O	O
tongue	O	O
and	O	O
dental	O	O
plaque	O	O
samples	O	O
from	O	O
nine	O	O
volunteers	O	O
was	O	O
amplified	O	O
by	O	O
the	O	O
polymerase	O	O
chain	O	O
reaction	O	O
using	O	O
primers	O	O
for	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
of	O	O
Methylobacterium	B-bacteria	B-bacteria
and	O	O
the	O	O
mxaF	O	O
gene	O	O
of	O	O
methanol	O	O
dehydrogenase	O	O
.	O	O

MxaF	O	O
was	O	O
detected	O	O
in	O	O
all	O	O
nine	O	O
volunteers	O	O
,	O	O
and	O	O
Methylobacterium	O	O
was	O	O
detected	O	O
in	O	O
seven	O	O
.	O	O

Methylotrophic	O	O
activity	O	O
is	O	O
thus	O	O
a	O	O
feature	O	O
of	O	O
the	O	O
oral	O	O
bacterial	O	O
community	O	O
.	O	O

Recent	O	O
studies	O	O
have	O	O
suggested	O	O
that	O	O
infectious	O	O
organisms	O	O
play	O	O
a	O	O
role	O	O
in	O	O
vascular	O	O
diseases	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
to	O	O
explore	O	O
a	O	O
possible	O	O
link	O	O
between	O	O
oral	O	O
infection	O	O
and	O	O
Buerger	O	O
disease	O	O
,	O	O
we	O	O
investigated	O	O
whether	O	O
oral	O	O
(	O	O
periodontal	O	O
)	O	O
bacteria	O	O
were	O	O
present	O	O
in	O	O
occluded	O	O
arteries	O	O
removed	O	O
from	O	O
patients	O	O
with	O	O
characteristic	O	O
Buerger	O	O
disease	O	O
.	O	O

Fourteen	O	O
male	O	O
patients	O	O
with	O	O
a	O	O
smoking	O	O
history	O	O
who	O	O
had	O	O
developed	O	O
characteristics	O	O
of	O	O
Buerger	O	O
disease	O	O
before	O	O
the	O	O
age	O	O
of	O	O
50	O	O
years	O	O
were	O	O
included	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Occluded	O	O
arteries	O	O
,	O	O
including	O	O
superficial	O	O
femoral	O	O
(	O	O
n	O	O
=	O	O
4	O	O
)	O	O
,	O	O
popliteal	O	O
(	O	O
n	O	O
=	O	O
2	O	O
)	O	O
,	O	O
anterior	O	O
tibial	O	O
(	O	O
n	O	O
=	O	O
4	O	O
)	O	O
,	O	O
and	O	O
posterior	O	O
tibial	O	O
(	O	O
n	O	O
=	O	O
4	O	O
)	O	O
arteries	O	O
,	O	O
were	O	O
removed	O	O
and	O	O
studied	O	O
.	O	O

A	O	O
periodontist	O	O
performed	O	O
a	O	O
periodontal	O	O
examination	O	O
on	O	O
each	O	O
patient	O	O
and	O	O
collected	O	O
dental	O	O
plaque	O	O
and	O	O
saliva	O	O
samples	O	O
from	O	O
them	O	O
at	O	O
the	O	O
same	O	O
time	O	O
.	O	O

The	O	O
polymerase	O	O
chain	O	O
reaction	O	O
method	O	O
was	O	O
applied	O	O
to	O	O
detect	O	O
whether	O	O
seven	O	O
species	O	O
of	O	O
periodontal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
--	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
--	O	O
were	O	O
present	O	O
in	O	O
the	O	O
occluded	O	O
arteries	O	O
and	O	O
oral	O	O
samples	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
arterial	O	O
specimens	O	O
from	O	O
seven	O	O
control	O	O
patients	O	O
were	O	O
examined	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
analysis	O	O
.	O	O

DNA	O	O
of	O	O
oral	O	O
bacteria	O	O
was	O	O
detected	O	O
in	O	O
13	O	O
of	O	O
14	O	O
arterial	O	O
samples	O	O
and	O	O
all	O	O
oral	O	O
samples	O	O
of	O	O
patients	O	O
with	O	O
Buerger	O	O
disease	O	O
.	O	O

Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
was	O	O
found	O	O
in	O	O
12	O	O
arterial	O	O
and	O	O
all	O	O
oral	O	O
samples	O	O
.	O	O

Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
were	O	O
found	O	O
in	O	O
14	O	O
%	O	O
to	O	O
43	O	O
%	O	O
of	O	O
the	O	O
arterial	O	O
samples	O	O
and	O	O
71	O	O
%	O	O
to	O	O
100	O	O
%	O	O
of	O	O
the	O	O
oral	O	O
samples	O	O
.	O	O

A	O	O
pathologic	O	O
examination	O	O
revealed	O	O
that	O	O
arterial	O	O
specimens	O	O
showed	O	O
the	O	O
characteristics	O	O
of	O	O
an	O	O
intermediate-chronic-stage	O	O
or	O	O
chronic-stage	O	O
lesion	O	O
of	O	O
Buerger	O	O
disease	O	O
.	O	O

All	O	O
14	O	O
patients	O	O
with	O	O
Buerger	O	O
disease	O	O
had	O	O
moderate	O	O
to	O	O
severe	O	O
periodontitis	O	O
.	O	O

None	O	O
of	O	O
the	O	O
control	O	O
arterial	O	O
samples	O	O
was	O	O
positive	O	O
for	O	O
periodontal	O	O
bacteria	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
study	O	O
to	O	O
identify	O	O
oral	O	O
microorganisms	O	O
in	O	O
the	O	O
lesions	O	O
of	O	O
Buerger	O	O
disease	O	O
.	O	O

Our	O	O
findings	O	O
suggest	O	O
a	O	O
possible	O	O
etiologic	O	O
link	O	O
between	O	O
Buerger	O	O
disease	O	O
and	O	O
chronic	O	O
infections	O	O
such	O	O
as	O	O
oral	O	O
bacterial	O	O
infections	O	O
.	O	O

Eleven	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
Gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
and	O	O
were	O	O
found	O	O
to	O	O
comprise	O	O
two	O	O
homogeneous	O	O
groups	O	O
,	O	O
designated	O	O
E2	O	O
and	O	O
E4	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
revealed	O	O
that	O	O
members	O	O
of	O	O
both	O	O
groups	O	O
belonged	O	O
to	O	O
the	O	O
genus	O	O
Prevotella	O	O
but	O	O
were	O	O
distinct	O	O
from	O	O
any	O	O
species	O	O
with	O	O
validly	O	O
published	O	O
names	O	O
.	O	O

This	O	O
distinction	O	O
was	O	O
confirmed	O	O
by	O	O
DNA-DNA	O	O
hybridization	O	O
and	O	O
phenotypic	O	O
tests	O	O
.	O	O

Two	O	O
novel	O	O
species	O	O
are	O	O
therefore	O	O
proposed	O	O
:	O	O
Prevotella	B-bacteria	B-bacteria
marshii	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
(	O	O
group	O	O
E2	O	O
)	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
baroniae	E-bacteria	I-bacteria
(	O	O
group	O	O
E4	O	O
)	O	O
.	O	O

Both	O	O
species	O	O
are	O	O
saccharolytic	O	O
;	O	O
the	O	O
end-products	O	O
of	O	O
fermentation	O	O
for	O	O
P.	B-bacteria	B-bacteria
marshii	E-bacteria	I-bacteria
are	O	O
acetic	O	O
,	O	O
propionic	O	O
and	O	O
succinic	O	O
acids	O	O
,	O	O
while	O	O
P.	B-bacteria	B-bacteria
baroniae	E-bacteria	I-bacteria
produces	O	O
acetic	O	O
and	O	O
succinic	O	O
acids	O	O
with	O	O
minor	O	O
amounts	O	O
of	O	O
isovaleric	O	O
and	O	O
isobutyric	O	O
acids	O	O
.	O	O

The	O	O
G+C	O	O
content	O	O
of	O	O
the	O	O
DNA	O	O
of	O	O
the	O	O
type	O	O
strain	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
marshii	E-bacteria	I-bacteria
is	O	O
51	O	O
mol	O	O
%	O	O
and	O	O
that	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
baroniae	E-bacteria	I-bacteria
is	O	O
52	O	O
mol	O	O
%	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
for	O	O
P.	B-bacteria	B-bacteria
marshii	E-bacteria	I-bacteria
is	O	O
E9.34	O	O
(	O	O
T	O	O
)	O	O
(	O	O
=DSM	B-bacteria	B-bacteria
16973	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
50419	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
and	O	O
that	O	O
for	O	O
P.	B-bacteria	B-bacteria
baroniae	E-bacteria	I-bacteria
is	O	O
E9.33	O	O
(	O	O
T	O	O
)	O	O
(	O	O
=DSM	B-bacteria	B-bacteria
16972	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
50418	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
.	O	O

Timely	O	O
initiation	O	O
of	O	O
antibiotic	O	O
therapy	O	O
is	O	O
crucial	O	O
for	O	O
severe	O	O
infection	O	O
.	O	O

Appropriate	O	O
antibiotic	O	O
therapy	O	O
is	O	O
often	O	O
delayed	O	O
for	O	O
nosocomial	O	O
infections	O	O
caused	O	O
by	O	O
antibiotic-resistant	O	O
bacteria	O	O
.	O	O

The	O	O
relationship	O	O
between	O	O
knowledge	O	O
of	O	O
colonization	O	O
caused	O	O
by	O	O
antibiotic-resistant	B-bacteria	B-bacteria
gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
ABR-GNB	B-bacteria	B-bacteria
)	O	O
and	O	O
rate	O	O
of	O	O
appropriate	O	O
initial	O	O
antibiotic	O	O
therapy	O	O
for	O	O
subsequent	O	O
bacteremia	O	O
was	O	O
evaluated	O	O
.	O	O

Retrospective	O	O
cohort	O	O
study	O	O
.	O	O

Fifty-four-bed	O	O
intensive	O	O
care	O	O
unit	O	O
(	O	O
ICU	O	O
)	O	O
of	O	O
a	O	O
university	O	O
hospital	O	O
.	O	O

In	O	O
this	O	O
unit	O	O
,	O	O
colonization	O	O
surveillance	O	O
is	O	O
performed	O	O
through	O	O
routine	O	O
site-specific	O	O
surveillance	O	O
cultures	O	O
(	O	O
urine	O	O
,	O	O
mouth	O	O
,	O	O
trachea	O	O
,	O	O
and	O	O
anus	O	O
)	O	O
.	O	O

Additional	O	O
cultures	O	O
are	O	O
performed	O	O
when	O	O
presumed	O	O
clinically	O	O
relevant	O	O
.	O	O

ICU	O	O
patients	O	O
with	O	O
nosocomial	O	O
bacteremia	O	O
caused	O	O
by	O	O
ABR-GNB	B-bacteria	B-bacteria
.	O	O

Infectious	O	O
and	O	O
microbiological	O	O
characteristics	O	O
and	O	O
rates	O	O
of	O	O
appropriate	O	O
antibiotic	O	O
therapy	O	O
were	O	O
compared	O	O
between	O	O
patients	O	O
with	O	O
and	O	O
without	O	O
colonization	O	O
prior	O	O
to	O	O
bacteremia	O	O
.	O	O

Prior	O	O
colonization	O	O
was	O	O
defined	O	O
as	O	O
the	O	O
presence	O	O
(	O	O
detected	O	O
>	O	O
or	O	O
=	O	O
2	O	O
days	O	O
before	O	O
the	O	O
onset	O	O
of	O	O
bacteremia	O	O
)	O	O
of	O	O
the	O	O
same	O	O
ABR-GNB	B-bacteria	B-bacteria
in	O	O
colonization	O	O
and	O	O
subsequent	O	O
blood	O	O
cultures	O	O
.	O	O

During	O	O
the	O	O
study	O	O
period	O	O
,	O	O
157	O	O
episodes	O	O
of	O	O
bacteremia	O	O
caused	O	O
by	O	O
ABR-GNB	B-bacteria	B-bacteria
were	O	O
suitable	O	O
for	O	O
evaluation	O	O
.	O	O

One	O	O
hundred	O	O
seventeen	O	O
episodes	O	O
of	O	O
bacteremia	O	O
(	O	O
74.5	O	O
%	O	O
)	O	O
were	O	O
preceded	O	O
by	O	O
colonization	O	O
.	O	O

Appropriate	O	O
empiric	O	O
antibiotic	O	O
therapy	O	O
(	O	O
started	O	O
within	O	O
24	O	O
hours	O	O
)	O	O
was	O	O
administered	O	O
for	O	O
74.4	O	O
%	O	O
of	O	O
these	O	O
episodes	O	O
versus	O	O
55.0	O	O
%	O	O
of	O	O
the	O	O
episodes	O	O
that	O	O
occurred	O	O
without	O	O
prior	O	O
colonization	O	O
.	O	O

Appropriate	O	O
therapy	O	O
was	O	O
administered	O	O
within	O	O
48	O	O
hours	O	O
for	O	O
all	O	O
episodes	O	O
preceded	O	O
by	O	O
colonization	O	O
versus	O	O
90.0	O	O
%	O	O
of	O	O
episodes	O	O
without	O	O
prior	O	O
colonization	O	O
.	O	O

Knowledge	O	O
of	O	O
colonization	O	O
status	O	O
prior	O	O
to	O	O
infection	O	O
is	O	O
associated	O	O
with	O	O
higher	O	O
rates	O	O
of	O	O
appropriate	O	O
therapy	O	O
for	O	O
patients	O	O
with	O	O
bacteremia	O	O
caused	O	O
by	O	O
ABR-GNB	B-bacteria	B-bacteria
.	O	O

To	O	O
investigate	O	O
the	O	O
maintenance	O	O
of	O	O
tetracycline-resistant	O	O
oral	O	O
bacteria	O	O
and	O	O
the	O	O
genes	O	O
encoding	O	O
tetracycline	O	O
resistance	O	O
in	O	O
these	O	O
bacteria	O	O
in	O	O
children	O	O
(	O	O
aged	O	O
4	O	O
--	O	O
6	O	O
years	O	O
)	O	O
over	O	O
a	O	O
period	O	O
of	O	O
12	O	O
months	O	O
.	O	O

Plaque	O	O
and	O	O
saliva	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
26	O	O
children	O	O
.	O	O

Tetracycline-resistant	O	O
bacteria	O	O
were	O	O
isolated	O	O
and	O	O
identified	O	O
.	O	O

The	O	O
types	O	O
of	O	O
resistance	O	O
genes	O	O
and	O	O
their	O	O
genetic	O	O
locations	O	O
were	O	O
also	O	O
determined	O	O
.	O	O

Fifteen	O	O
out	O	O
of	O	O
18	O	O
children	O	O
harboured	O	O
tetracycline-resistant	O	O
(	O	O
defined	O	O
as	O	O
having	O	O
a	O	O
MIC	O	O
>	O	O
or=8	O	O
mg/L	O	O
)	O	O
oral	O	O
bacteria	O	O
at	O	O
all	O	O
three	O	O
time	O	O
points	O	O
.	O	O

The	O	O
median	O	O
percentage	O	O
of	O	O
tetracycline-resistant	O	O
bacteria	O	O
at	O	O
0	O	O
,	O	O
6	O	O
and	O	O
12	O	O
months	O	O
was	O	O
1.37	O	O
,	O	O
1.37	O	O
and	O	O
0.85	O	O
%	O	O
,	O	O
respectively	O	O
;	O	O
these	O	O
were	O	O
not	O	O
significantly	O	O
different	O	O
.	O	O

The	O	O
MIC	O	O
(	O	O
50	O	O
)	O	O
of	O	O
the	O	O
group	O	O
was	O	O
64	O	O
mg/L	O	O
at	O	O
all	O	O
three	O	O
time	O	O
points	O	O
compared	O	O
with	O	O
the	O	O
MIC	O	O
(	O	O
90	O	O
)	O	O
,	O	O
which	O	O
was	O	O
64	O	O
mg/L	O	O
at	O	O
0	O	O
months	O	O
,	O	O
and	O	O
128	O	O
mg/L	O	O
at	O	O
6	O	O
and	O	O
12	O	O
months	O	O
.	O	O

The	O	O
most	O	O
prevalent	O	O
resistant	O	O
species	O	O
were	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
68	O	O
%	O	O
)	O	O
,	O	O
which	O	O
were	O	O
isolated	O	O
at	O	O
all	O	O
three	O	O
time	O	O
points	O	O
in	O	O
13	O	O
children	O	O
.	O	O

The	O	O
most	O	O
prevalent	O	O
gene	O	O
encoding	O	O
tetracycline	O	O
resistance	O	O
was	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
and	O	O
this	O	O
was	O	O
found	O	O
in	O	O
different	O	O
species	O	O
at	O	O
all	O	O
three	O	O
time	O	O
points	O	O
.	O	O

For	O	O
the	O	O
first	O	O
time	O	O
,	O	O
tet	O	O
(	O	O
32	O	O
)	O	O
was	O	O
found	O	O
in	O	O
Streptococcus	B-bacteria	B-bacteria
parasanguinis	E-bacteria	I-bacteria
and	O	O
Eubacterium	B-bacteria	B-bacteria
saburreum	E-bacteria	I-bacteria
.	O	O

PCR	O	O
and	O	O
Southern-blot	O	O
analysis	O	O
(	O	O
on	O	O
isolates	O	O
from	O	O
three	O	O
of	O	O
the	O	O
children	O	O
)	O	O
showed	O	O
that	O	O
the	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
gene	O	O
was	O	O
located	O	O
on	O	O
a	O	O
Tn916-like	O	O
element	O	O
and	O	O
could	O	O
be	O	O
detected	O	O
at	O	O
all	O	O
three	O	O
time	O	O
points	O	O
,	O	O
in	O	O
four	O	O
different	O	O
genera	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
and	O	O
Neisseria	B-bacteria	B-bacteria
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
study	O	O
show	O	O
that	O	O
tetracycline-resistant	O	O
bacteria	O	O
and	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
are	O	O
maintained	O	O
within	O	O
the	O	O
indigenous	O	O
oral	O	O
microbiota	O	O
of	O	O
children	O	O
,	O	O
even	O	O
though	O	O
they	O	O
are	O	O
unlikely	O	O
to	O	O
have	O	O
been	O	O
directly	O	O
exposed	O	O
to	O	O
tetracycline	O	O
.	O	O

The	O	O
presence	O	O
and	O	O
maturity	O	O
of	O	O
the	O	O
salivary	O	O
pellicle	O	O
influences	O	O
microbial	O	O
adhesion	O	O
and	O	O
its	O	O
tenacity	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
posing	O	O
a	O	O
challenge	O	O
to	O	O
different	O	O
plaque-control	O	O
systems	O	O
.	O	O

Some	O	O
plaque-control	O	O
systems	O	O
rely	O	O
on	O	O
surface-tension	O	O
forces	O	O
arising	O	O
from	O	O
passing	O	O
microbubbles	O	O
sprayed	O	O
over	O	O
the	O	O
pellicle	O	O
.	O	O

Passage	O	O
of	O	O
such	O	O
bubbles	O	O
is	O	O
accompanied	O	O
by	O	O
a	O	O
high	O	O
fluid	O	O
flow	O	O
,	O	O
but	O	O
systematic	O	O
studies	O	O
are	O	O
lacking	O	O
on	O	O
the	O	O
contribution	O	O
of	O	O
fluid	O	O
flow	O	O
vs.	O	O
microbubbles	O	O
towards	O	O
plaque	O	O
removal	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
detachment	O	O
efficacy	O	O
of	O	O
laminar	O	O
fluid	O	O
flow	O	O
(	O	O
wall	O	O
shear	O	O
rates	O	O
11,000-16,000	O	O
s	O	O
(	O	O
-1	O	O
)	O	O
)	O	O
,	O	O
with	O	O
and	O	O
without	O	O
microbubbles	O	O
,	O	O
towards	O	O
the	O	O
detachment	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
T14V-J1	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
J22	E-bacteria	I-bacteria
,	O	O
and	O	O
their	O	O
coadhering	O	O
aggregates	O	O
,	O	O
from	O	O
salivary	O	O
pellicles	O	O
formed	O	O
over	O	O
2	O	O
h	O	O
or	O	O
16	O	O
h	O	O
from	O	O
reconstituted	O	O
human	O	O
whole	O	O
saliva	O	O
.	O	O

Microbubbles	O	O
in	O	O
a	O	O
fluid	O	O
flow	O	O
were	O	O
more	O	O
efficient	O	O
at	O	O
inducing	O	O
single	O	O
bacterial	O	O
detachment	O	O
,	O	O
resulting	O	O
in	O	O
almost	O	O
complete	O	O
(	O	O
97	O	O
%	O	O
)	O	O
removal	O	O
for	O	O
S.	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
J22	E-bacteria	I-bacteria
and	O	O
a	O	O
15-fold	O	O
increase	O	O
in	O	O
A.	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
T14V-J1	E-bacteria	I-bacteria
removal	O	O
as	O	O
compared	O	O
to	O	O
the	O	O
detachment	O	O
caused	O	O
by	O	O
fluid	O	O
flow	O	O
alone	O	O
.	O	O

A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
was	O	O
more	O	O
difficult	O	O
to	O	O
remove	O	O
and	O	O
apparently	O	O
formed	O	O
the	O	O
strongest	O	O
bonds	O	O
with	O	O
high-molecular-weight	O	O
proteins	O	O
in	O	O
16-h	O	O
pellicles	O	O
.	O	O

The	O	O
detachment	O	O
of	O	O
coaggregates	O	O
after	O	O
2	O	O
min	O	O
left	O	O
a	O	O
substantial	O	O
amount	O	O
of	O	O
adhered	O	O
bacterial	O	O
mass	O	O
,	O	O
including	O	O
more	O	O
than	O	O
60	O	O
%	O	O
of	O	O
singly	O	O
attached	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
on	O	O
the	O	O
pellicle	O	O
surface	O	O
,	O	O
providing	O	O
nucleation	O	O
sites	O	O
for	O	O
the	O	O
de	O	O
novo	O	O
adhesion	O	O
of	O	O
coadhering	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
were	O	O
to	O	O
identify	O	O
hydrogen	O	O
sulfide	O	O
(	O	O
H2S	O	O
)	O	O
-producing	O	O
bacteria	O	O
among	O	O
tongue	O	O
biofilm	O	O
microflora	O	O
and	O	O
to	O	O
investigate	O	O
the	O	O
relationship	O	O
between	O	O
bacterial	O	O
flora	O	O
and	O	O
H2S	O	O
levels	O	O
in	O	O
mouth	O	O
air	O	O
.	O	O

Oral	O	O
malodour	O	O
levels	O	O
in	O	O
10	O	O
subjects	O	O
(	O	O
age	O	O
21-56	O	O
years	O	O
)	O	O
were	O	O
assessed	O	O
by	O	O
gas	O	O
chromatography	O	O
,	O	O
and	O	O
Breathtron	O	O
and	O	O
organoleptic	O	O
scores	O	O
.	O	O

Based	O	O
on	O	O
these	O	O
assessments	O	O
,	O	O
subjects	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
:	O	O
an	O	O
odour	O	O
group	O	O
and	O	O
a	O	O
no/low	O	O
odour	O	O
group	O	O
.	O	O

Tongue	O	O
coatings	O	O
were	O	O
sampled	O	O
and	O	O
spread	O	O
onto	O	O
Fastidious	O	O
Anaerobe	B-bacteria	B-bacteria
Agar	O	O
plates	O	O
containing	O	O
0.05	O	O
%	O	O
cysteine	O	O
,	O	O
0.12	O	O
%	O	O
glutathione	O	O
and	O	O
0.02	O	O
%	O	O
lead	O	O
acetate	O	O
,	O	O
and	O	O
were	O	O
then	O	O
incubated	O	O
anaerobically	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
2	O	O
weeks	O	O
.	O	O

Bacteria	O	O
forming	O	O
black	O	O
or	O	O
grey	O	O
colonies	O	O
were	O	O
selected	O	O
as	O	O
H2S-producing	O	O
phenotypes	O	O
.	O	O

The	O	O
numbers	O	O
of	O	O
total	O	O
bacteria	O	O
(	O	O
P	O	O
<	O	O
0.005	O	O
)	O	O
and	O	O
H2S-producing	O	O
bacteria	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
in	O	O
the	O	O
odour	O	O
group	O	O
were	O	O
significantly	O	O
larger	O	O
than	O	O
those	O	O
in	O	O
the	O	O
no/low	O	O
odour	O	O
group	O	O
.	O	O

Bacteria	O	O
forming	O	O
black	O	O
or	O	O
grey	O	O
colonies	O	O
(	O	O
126	O	O
isolates	O	O
from	O	O
the	O	O
odour	O	O
group	O	O
;	O	O
242	O	O
isolates	O	O
from	O	O
the	O	O
no/low	O	O
odour	O	O
group	O	O
)	O	O
were	O	O
subcultured	O	O
,	O	O
confirmed	O	O
as	O	O
producing	O	O
H2S	O	O
and	O	O
identified	O	O
according	O	O
to	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
.	O	O

Species	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
(	O	O
38.1	O	O
%	O	O
in	O	O
odour	O	O
group	O	O
;	O	O
46.3	O	O
%	O	O
in	O	O
no/low	O	O
odour	O	O
group	O	O
)	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
(	O	O
25.4	O	O
%	O	O
;	O	O
17.7	O	O
%	O	O
)	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
(	O	O
10.3	O	O
%	O	O
;	O	O
7.8	O	O
%	O	O
)	O	O
were	O	O
the	O	O
predominant	O	O
H2S-producing	O	O
bacteria	O	O
in	O	O
both	O	O
the	O	O
odour	O	O
and	O	O
no/low	O	O
odour	O	O
groups	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
an	O	O
increase	O	O
in	O	O
the	O	O
number	O	O
of	O	O
H2S-producing	O	O
bacteria	O	O
in	O	O
the	O	O
tongue	O	O
biofilm	O	O
is	O	O
responsible	O	O
for	O	O
oral	O	O
malodour	O	O
,	O	O
although	O	O
the	O	O
bacterial	O	O
composition	O	O
of	O	O
tongue	O	O
biofilm	O	O
was	O	O
similar	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
.	O	O

Thorough	O	O
examination	O	O
of	O	O
114	O	O
young	O	O
men	O	O
of	O	O
pre-constriction	O	O
military	O	O
training	O	O
age	O	O
disclosed	O	O
that	O	O
possibility	O	O
of	O	O
oral	O	O
cavity	O	O
pathology	O	O
development	O	O
is	O	O
mainly	O	O
determined	O	O
by	O	O
the	O	O
indices	O	O
DMFT	O	O
,	O	O
PMA	O	O
,	O	O
OHI-S	O	O
and	O	O
the	O	O
following	O	O
parameters	O	O
of	O	O
mixed	O	O
saliva	O	O
--	O	O
basic	O	O
salivary	O	O
flow	O	O
,	O	O
pH	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
amounts	O	O
.	O	O

The	O	O
degree	O	O
of	O	O
these	O	O
factors	O	O
changes	O	O
expressed	O	O
in	O	O
scores	O	O
identifies	O	O
groups	O	O
of	O	O
low	O	O
,	O	O
medium	O	O
and	O	O
high	O	O
probability	O	O
of	O	O
stomatologic	O	O
pathology	O	O
development	O	O
and	O	O
basing	O	O
on	O	O
this	O	O
to	O	O
individualize	O	O
curative	O	O
and	O	O
preventive	O	O
measures	O	O
.	O	O

The	O	O
accumulation	O	O
of	O	O
microorganisms	O	O
in	O	O
dental	O	O
plaque	O	O
is	O	O
related	O	O
to	O	O
the	O	O
etiology	O	O
of	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
,	O	O
with	O	O
a	O	O
high	O	O
prevalence	O	O
worldwide	O	O
.	O	O

The	O	O
prophylactic	O	O
measures	O	O
include	O	O
the	O	O
use	O	O
of	O	O
chemical	O	O
agents	O	O
as	O	O
NaF	O	O
and	O	O
chlorhexidine	O	O
.	O	O

Lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
are	O	O
members	O	O
of	O	O
the	O	O
normal	O	O
microbiota	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
being	O	O
discussed	O	O
with	O	O
regard	O	O
to	O	O
their	O	O
beneficial	O	O
or	O	O
detrimental	O	O
effect	O	O
in	O	O
this	O	O
environment	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
performed	O	O
to	O	O
determine	O	O
the	O	O
growth	O	O
of	O	O
some	O	O
species	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
at	O	O
different	O	O
concentrations	O	O
of	O	O
NaF	O	O
and	O	O
chlorhexidine	O	O
.	O	O

The	O	O
strains	O	O
were	O	O
isolated	O	O
from	O	O
both	O	O
caries-free	O	O
and	O	O
caries	O	O
patients	O	O
.	O	O

Their	O	O
growth	O	O
parameters	O	O
were	O	O
evaluated	O	O
by	O	O
the	O	O
application	O	O
of	O	O
the	O	O
Gompertz	O	O
model	O	O
to	O	O
the	O	O
experimental	O	O
data	O	O
of	O	O
optical	O	O
density	O	O
as	O	O
a	O	O
measurement	O	O
of	O	O
growth	O	O
.	O	O

The	O	O
degree	O	O
of	O	O
inhibition	O	O
of	O	O
the	O	O
growth	O	O
of	O	O
all	O	O
of	O	O
the	O	O
lactobacilli	B-bacteria	B-bacteria
studied	O	O
was	O	O
different	O	O
,	O	O
depending	O	O
on	O	O
each	O	O
particular	O	O
strain	O	O
.	O	O

NaF	O	O
at	O	O
1	O	O
mmol	O	O
x	O	O
L	O	O
(	O	O
-1	O	O
)	O	O
inhibited	O	O
between	O	O
5	O	O
%	O	O
and	O	O
46	O	O
%	O	O
,	O	O
at	O	O
5	O	O
mmol	O	O
x	O	O
L	O	O
(	O	O
-1	O	O
)	O	O
between	O	O
13	O	O
%	O	O
and	O	O
65	O	O
%	O	O
,	O	O
and	O	O
at	O	O
20	O	O
mmol	O	O
x	O	O
L	O	O
(	O	O
-1	O	O
)	O	O
between	O	O
57	O	O
%	O	O
and	O	O
84	O	O
%	O	O
.	O	O

CHX	O	O
at	O	O
higher	O	O
concentrations	O	O
(	O	O
197	O	O
and	O	O
98	O	O
mmol	O	O
x	O	O
L	O	O
(	O	O
-1	O	O
)	O	O
showed	O	O
a	O	O
complete	O	O
inhibition	O	O
of	O	O
some	O	O
of	O	O
the	O	O
strains	O	O
.	O	O

The	O	O
significance	O	O
of	O	O
the	O	O
results	O	O
was	O	O
evaluated	O	O
by	O	O
the	O	O
application	O	O
of	O	O
a	O	O
multivariate	O	O
analysis	O	O
and	O	O
also	O	O
compared	O	O
with	O	O
the	O	O
inhibition	O	O
of	O	O
pathogenic	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
with	O	O
lactobacilli	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
from	O	O
collection	O	O
cultures	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
selected	O	O
bacteria	O	O
(	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
in	O	O
infected	O	O
root	O	O
canals	O	O
was	O	O
studied	O	O
using	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
assays	O	O
,	O	O
and	O	O
the	O	O
association	O	O
of	O	O
bacteria	O	O
with	O	O
clinical	O	O
signs	O	O
of	O	O
endodontic	O	O
disease	O	O
was	O	O
assessed	O	O
.	O	O

The	O	O
null	O	O
hypothesis	O	O
,	O	O
that	O	O
no	O	O
difference	O	O
could	O	O
be	O	O
observed	O	O
between	O	O
clinical	O	O
signs	O	O
of	O	O
apical	O	O
periodontitis	O	O
and	O	O
a	O	O
specific	O	O
bacterial	O	O
strain	O	O
,	O	O
was	O	O
tested	O	O
.	O	O

Microbial	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
62	O	O
teeth	O	O
in	O	O
54	O	O
patients	O	O
with	O	O
endodontic	O	O
disease	O	O
.	O	O

For	O	O
each	O	O
tooth	O	O
,	O	O
clinical	O	O
data	O	O
including	O	O
patient	O	O
symptoms	O	O
were	O	O
collected	O	O
.	O	O

Teeth	O	O
were	O	O
categorized	O	O
by	O	O
diagnosis	O	O
as	O	O
having	O	O
acute	O	O
apical	O	O
periodontitis	O	O
(	O	O
AAP	O	O
,	O	O
teeth	O	O
with	O	O
clinical	O	O
symptoms	O	O
but	O	O
no	O	O
periapical	O	O
radiolucency	O	O
,	O	O
n=22	O	O
)	O	O
,	O	O
chronic	O	O
apical	O	O
periodontitis	O	O
(	O	O
CAP	O	O
,	O	O
teeth	O	O
with	O	O
radiolucency	O	O
but	O	O
no	O	O
clinical	O	O
symptoms	O	O
,	O	O
n=15	O	O
)	O	O
or	O	O
exacerbated	O	O
apical	O	O
periodontitis	O	O
(	O	O
EAP	O	O
,	O	O
teeth	O	O
with	O	O
symptoms	O	O
and	O	O
radiolucency	O	O
,	O	O
n=25	O	O
)	O	O
.	O	O

Seventy-one	O	O
percent	O	O
of	O	O
cases	O	O
were	O	O
primary	O	O
endodontic	O	O
infections	O	O
,	O	O
and	O	O
29	O	O
%	O	O
were	O	O
recurrent	O	O
(	O	O
'secondary	O	O
'	O	O
)	O	O
endodontic	O	O
infections	O	O
(	O	O
failing	O	O
cases	O	O
)	O	O
.	O	O

PCR	O	O
assays	O	O
were	O	O
used	O	O
to	O	O
detect	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
selected	O	O
bacteria	O	O
.	O	O

T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
were	O	O
each	O	O
detected	O	O
in	O	O
15	O	O
of	O	O
62	O	O
samples	O	O
(	O	O
24	O	O
%	O	O
)	O	O
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
8	O	O
samples	O	O
(	O	O
13	O	O
%	O	O
)	O	O
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
in	O	O
5	O	O
samples	O	O
(	O	O
8	O	O
%	O	O
)	O	O
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
in	O	O
4	O	O
samples	O	O
(	O	O
7	O	O
%	O	O
)	O	O
.	O	O

T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
56	O	O
%	O	O
of	O	O
teeth	O	O
with	O	O
EAP	O	O
.	O	O

E.	O	O
faecalis	O	O
was	O	O
found	O	O
in	O	O
60	O	O
%	O	O
of	O	O
teeth	O	O
with	O	O
CAP	O	O
and	O	O
in	O	O
72	O	O
%	O	O
of	O	O
teeth	O	O
with	O	O
secondary	O	O
infection	O	O
.	O	O

Statistical	O	O
analysis	O	O
demonstrated	O	O
an	O	O
association	O	O
of	O	O
CAP	O	O
and	O	O
secondary	O	O
endodontic	O	O
infection	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
.	O	O

(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

EAP	O	O
was	O	O
associated	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
was	O	O
associated	O	O
with	O	O
symptomatic	O	O
endodontic	O	O
disease	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
apical	O	O
bone	O	O
resorption	O	O
.	O	O

E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
was	O	O
associated	O	O
with	O	O
treatment	O	O
failures	O	O
.	O	O

We	O	O
suggest	O	O
that	O	O
these	O	O
species	O	O
may	O	O
play	O	O
critical	O	O
roles	O	O
in	O	O
endodontic	O	O
pathology	O	O
.	O	O

Until	O	O
today	O	O
,	O	O
human	O	O
stomach	O	O
is	O	O
the	O	O
only	O	O
recognized	O	O
habitat	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
recruitment	O	O
of	O	O
DNA-based	O	O
methods	O	O
has	O	O
made	O	O
possible	O	O
the	O	O
detection	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
water	O	O
and	O	O
oral	O	O
cavity	O	O
,	O	O
thus	O	O
suggesting	O	O
fecal-oral	O	O
and	O	O
oral-oral	O	O
routes	O	O
for	O	O
transmission	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
respectively	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
yeast	O	O
has	O	O
been	O	O
proposed	O	O
as	O	O
a	O	O
common	O	O
vector	O	O
for	O	O
transmission	O	O
of	O	O
H	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

Thus	O	O
designed	O	O
primers	O	O
were	O	O
recruited	O	O
to	O	O
target	O	O
16S	O	O
rDNA	O	O
and	O	O
cagA	O	O
genes	O	O
in	O	O
the	O	O
oral	O	O
yeasts	O	O
by	O	O
PCR	O	O
.	O	O

MATERIALS	O	O
AND	O	O
Eighteen	O	O
yeasts	O	O
were	O	O
examined	O	O
microscopically	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
bacterial-like	O	O
bodies	O	O
.	O	O

DNAs	O	O
were	O	O
extracted	O	O
from	O	O
oral	O	O
yeasts	O	O
using	O	O
phenol-chloroform	O	O
method	O	O
.	O	O

Amplification	O	O
conditions	O	O
were	O	O
optimized	O	O
as	O	O
33	O	O
cycles	O	O
and	O	O
annealing	O	O
temperatures	O	O
of	O	O
63	O	O
degrees	O	O
C	O	O
for	O	O
16S	O	O
rDNA	O	O
and	O	O
51	O	O
degrees	O	O
C	O	O
and	O	O
52	O	O
degrees	O	O
C	O	O
for	O	O
cagA	O	O
gene	O	O
which	O	O
was	O	O
targeted	O	O
in	O	O
two	O	O
steps	O	O
.	O	O

DNAs	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
and	O	O
Saccharomyces	O	O
cerevisiae	O	O
were	O	O
used	O	O
as	O	O
controls	O	O
.	O	O

Polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
products	O	O
of	O	O
two	O	O
genes	O	O
from	O	O
one	O	O
yeast	O	O
and	O	O
from	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
were	O	O
cloned	O	O
in	O	O
pCAP	O	O
and	O	O
subsequently	O	O
subcloned	O	O
in	O	O
pSK+	O	O
and	O	O
were	O	O
sequenced	O	O
.	O	O

Bacterial-like	O	O
bodies	O	O
were	O	O
observed	O	O
in	O	O
all	O	O
oral	O	O
yeasts	O	O
.	O	O

The	O	O
amplified	O	O
products	O	O
of	O	O
16S	O	O
rDNA	O	O
from	O	O
all	O	O
oral	O	O
yeasts	O	O
were	O	O
homologous	O	O
in	O	O
size	O	O
with	O	O
those	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

Fifteen	O	O
out	O	O
of	O	O
eighteen	O	O
(	O	O
83	O	O
%	O	O
)	O	O
yeasts	O	O
contained	O	O
cagA	O	O
gene	O	O
,	O	O
homologous	O	O
to	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

CagA	O	O
was	O	O
not	O	O
amplified	O	O
from	O	O
three	O	O
yeasts	O	O
and	O	O
S.	O	O
cerevisiae	O	O
.	O	O

Analysis	O	O
of	O	O
the	O	O
sequenced	O	O
products	O	O
of	O	O
16S	O	O
rDNA	O	O
and	O	O
cagA	O	O
from	O	O
one	O	O
oral	O	O
yeast	O	O
showed	O	O
98	O	O
%	O	O
homology	O	O
with	O	O
those	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

The	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
inside	O	O
the	O	O
yeast	O	O
was	O	O
indicated	O	O
by	O	O
light	O	O
microscopy	O	O
and	O	O
PCR	O	O
.	O	O

It	O	O
appears	O	O
that	O	O
yeasts	O	O
,	O	O
which	O	O
are	O	O
abundant	O	O
in	O	O
nature	O	O
and	O	O
thrive	O	O
the	O	O
mucosal	O	O
surfaces	O	O
of	O	O
human	O	O
,	O	O
might	O	O
serve	O	O
as	O	O
reservoirs	O	O
and	O	O
vehicles	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

The	O	O
functions	O	O
of	O	O
epithelial	O	O
cells	O	O
are	O	O
more	O	O
than	O	O
a	O	O
physical	O	O
selective	O	O
barrier	O	O
for	O	O
protection	O	O
from	O	O
mucosal	O	O
pathogens	O	O
.	O	O

The	O	O
epithelial	O	O
response	O	O
regulated	O	O
by	O	O
host-microorganism	O	O
interaction	O	O
may	O	O
change	O	O
due	O	O
to	O	O
histological	O	O
and	O	O
physiological	O	O
differences	O	O
between	O	O
sterile	O	O
and	O	O
nonsterile	O	O
sites	O	O
.	O	O

In	O	O
this	O	O
study	O	O
we	O	O
examined	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
difference	O	O
between	O	O
bactericidal	O	O
capacities	O	O
of	O	O
urinary	O	O
and	O	O
oral	O	O
epithelial	O	O
cells	O	O
against	O	O
different	O	O
strains	O	O
of	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

Oral	O	O
epithelial	O	O
cells	O	O
were	O	O
collected	O	O
from	O	O
unstimulated	O	O
saliva	O	O
and	O	O
uroepithelial	O	O
cells	O	O
were	O	O
collected	O	O
from	O	O
urine	O	O
of	O	O
eight	O	O
healthy	O	O
volunteers	O	O
.	O	O

E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
and	O	O
O75	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
and	O	O
epithelial	O	O
cells	O	O
were	O	O
prepared	O	O
for	O	O
the	O	O
experiment	O	O
,	O	O
added	O	O
to	O	O
microplates	O	O
and	O	O
incubated	O	O
for	O	O
one	O	O
hour	O	O
.	O	O

The	O	O
growth	O	O
of	O	O
bacteria	O	O
was	O	O
detected	O	O
by	O	O
the	O	O
quantitative	O	O
colony	O	O
counting	O	O
method	O	O
.	O	O

Antibacterial	O	O
effects	O	O
of	O	O
the	O	O
oral	O	O
and	O	O
urinary	O	O
epithelial	O	O
cells	O	O
against	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
and	O	O
O75	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
49.8	O	O
%	O	O
,	O	O
34.7	O	O
%	O	O
,	O	O
45.7	O	O
%	O	O
and	O	O
29.2	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

As	O	O
a	O	O
result	O	O
,	O	O
it	O	O
was	O	O
detected	O	O
that	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
to	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
and	O	O
O75	B-bacteria	B-bacteria
were	O	O
higher	O	O
than	O	O
urinary	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
relationship	O	O
between	O	O
the	O	O
number	O	O
of	O	O
polymorphonuclear	O	O
leukocytes	O	O
(	O	O
PMNL	O	O
)	O	O
and	O	O
the	O	O
number	O	O
of	O	O
selected	O	O
bacteria	O	O
in	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

Sixty	O	O
one	O	O
healthy	O	O
people	O	O
(	O	O
periodontal	O	O
index	O	O
of	O	O
Russel	O	O
's	O	O
did	O	O
not	O	O
exceed	O	O
0.2	O	O
)	O	O
,	O	O
aged	O	O
22-26	O	O
were	O	O
investigated	O	O
.	O	O

PMNL	O	O
were	O	O
isolated	O	O
by	O	O
rinsing	O	O
oral	O	O
cavity	O	O
with	O	O
isotonic	O	O
,	O	O
buffered	O	O
NaCl	O	O
solution	O	O
.	O	O

Nonstimulated	O	O
whole	O	O
saliva	O	O
was	O	O
bacteriologically	O	O
examined	O	O
.	O	O

The	O	O
number	O	O
of	O	O
PMNL	O	O
,	O	O
which	O	O
was	O	O
obtained	O	O
from	O	O
mouth	O	O
of	O	O
examined	O	O
people	O	O
was	O	O
between	O	O
100,000	O	O
and	O	O
4,200,000	O	O
in	O	O
100	O	O
mL	O	O
of	O	O
rinsings	O	O
.	O	O

Usually	O	O
,	O	O
i.e	O	O
.	O	O

in	O	O
34	O	O
%	O	O
of	O	O
cases	O	O
,	O	O
the	O	O
number	O	O
was	O	O
between	O	O
500,000-1,000,000	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
all	O	O
tested	O	O
people	O	O
and	O	O
their	O	O
number	O	O
was	O	O
the	O	O
biggest	O	O
.	O	O

Almost	O	O
in	O	O
all	O	O
cases	O	O
there	O	O
were	O	O
isolated	O	O
cariogenic	O	O
bacteria	O	O
--	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
95	O	O
%	O	O
)	O	O
and	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
93	O	O
%	O	O
)	O	O
.	O	O

Haemophili	B-bacteria	B-bacteria
,	O	O
staphylococci	B-bacteria	B-bacteria
,	O	O
including	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
were	O	O
found	O	O
relatively	O	O
often	O	O
(	O	O
in	O	O
86	O	O
%	O	O
,	O	O
86	O	O
%	O	O
and	O	O
52	O	O
%	O	O
respectively	O	O
)	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
enteric	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
were	O	O
rarely	O	O
isolated	O	O
(	O	O
33	O	O
%	O	O
)	O	O
and	O	O
were	O	O
the	O	O
least	O	O
numerous	O	O
group	O	O
of	O	O
all	O	O
.	O	O

It	O	O
has	O	O
been	O	O
stated	O	O
,	O	O
that	O	O
there	O	O
is	O	O
a	O	O
comparatively	O	O
strong	O	O
negative	O	O
correlation	O	O
between	O	O
the	O	O
number	O	O
of	O	O
PMNL	O	O
in	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
number	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
r=-0.55	O	O
;	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
,	O	O
haemophili	B-bacteria	B-bacteria
(	O	O
r=-0.564	O	O
;	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
,	O	O
staphylococci	B-bacteria	B-bacteria
(	O	O
r=-0.538	O	O
;	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
,	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
r=-0.407	O	O
;	O	O
p=0.0017	O	O
)	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
r=-0.483	O	O
;	O	O
p=0.0002	O	O
)	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
PMNL	O	O
are	O	O
one	O	O
of	O	O
the	O	O
factors	O	O
controlling	O	O
the	O	O
number	O	O
of	O	O
some	O	O
bacteria	O	O
in	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

To	O	O
examine	O	O
the	O	O
isolation	O	O
frequency	O	O
and	O	O
the	O	O
carriage	O	O
of	O	O
yeasts	O	O
,	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
and	O	O
Enterococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
in	O	O
oral	O	O
samples	O	O
from	O	O
elderly	O	O
Greeks	O	O
living	O	O
alone	O	O
or	O	O
in	O	O
institutions	O	O
.	O	O

Ageing	O	O
may	O	O
promote	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
ecosystem	O	O
,	O	O
which	O	O
lead	O	O
to	O	O
colonisation	O	O
of	O	O
the	O	O
mouth	O	O
by	O	O
microbes	O	O
found	O	O
less	O	O
commonly	O	O
or	O	O
only	O	O
transiently	O	O
in	O	O
younger	O	O
subjects	O	O
.	O	O

Previous	O	O
studies	O	O
indicate	O	O
a	O	O
geographical	O	O
variation	O	O
in	O	O
the	O	O
isolation	O	O
frequency	O	O
of	O	O
such	O	O
bacteria	O	O
in	O	O
elderly	O	O
populations	O	O
.	O	O

Medical	O	O
and	O	O
dental	O	O
records	O	O
were	O	O
obtained	O	O
from	O	O
66	O	O
attenders	O	O
at	O	O
elderly	O	O
people	O	O
's	O	O
day	O	O
centres	O	O
(	O	O
EPDC	O	O
)	O	O
,	O	O
and	O	O
82	O	O
residents	O	O
of	O	O
elderly	O	O
people	O	O
's	O	O
homes	O	O
(	O	O
EPH	O	O
)	O	O
,	O	O
66-95	O	O
years	O	O
old	O	O
.	O	O

Mucosa	O	O
smear	O	O
samples	O	O
were	O	O
cultured	O	O
on	O	O
appropriate	O	O
media	O	O
for	O	O
enumeration	O	O
of	O	O
the	O	O
above	O	O
species	O	O
.	O	O

Microbial	O	O
identification	O	O
was	O	O
performed	O	O
by	O	O
conventional	O	O
microbiological	O	O
tests	O	O
.	O	O

The	O	O
results	O	O
were	O	O
analysed	O	O
using	O	O
the	O	O
Multiple	O	O
Correspondence	O	O
Analysis	O	O
(	O	O
MCA	O	O
)	O	O
,	O	O
ANOVA	O	O
and	O	O
other	O	O
traditional	O	O
statistical	O	O
tests	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
association	O	O
was	O	O
found	O	O
between	O	O
the	O	O
place	O	O
of	O	O
residence	O	O
and	O	O
the	O	O
wearing	O	O
of	O	O
dentures	O	O
.	O	O

The	O	O
isolation	O	O
frequencies	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
and	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
21.6	O	O
,	O	O
20.3	O	O
and	O	O
7.4	O	O
%	O	O
respectively	O	O
.	O	O

MCA	O	O
,	O	O
and	O	O
further	O	O
statistical	O	O
analysis	O	O
,	O	O
revealed	O	O
that	O	O
the	O	O
place	O	O
of	O	O
residence	O	O
affected	O	O
the	O	O
isolation	O	O
frequency	O	O
of	O	O
years	O	O
(	O	O
54.9	O	O
%	O	O
in	O	O
EPH	O	O
vs.	O	O
37.9	O	O
%	O	O
in	O	O
EPDC	O	O
)	O	O
.	O	O

Moreover	O	O
,	O	O
ANOVA	O	O
showed	O	O
that	O	O
living	O	O
in	O	O
EPH	O	O
increased	O	O
the	O	O
carriage	O	O
of	O	O
yeasts	O	O
.	O	O

Elderly	O	O
Greeks	O	O
exhibit	O	O
a	O	O
moderate	O	O
to	O	O
high	O	O
oral	O	O
carriage	O	O
of	O	O
transient	O	O
bacteria	O	O
compared	O	O
with	O	O
other	O	O
elderly	O	O
populations	O	O
.	O	O

Living	O	O
in	O	O
EPH	O	O
seems	O	O
to	O	O
increase	O	O
both	O	O
the	O	O
isolation	O	O
frequency	O	O
and	O	O
carriage	O	O
of	O	O
yeasts	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
antimicrobial	O	O
effect	O	O
of	O	O
essential	O	O
oil-containing	O	O
oral	O	O
strips	O	O
on	O	O
different	O	O
species	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
20	O	O
subjects	O	O
with	O	O
good	O	O
oral	O	O
health	O	O
,	O	O
diluted	O	O
and	O	O
plated	O	O
onto	O	O
blood	O	O
agar	O	O
medium	O	O
.	O	O

The	O	O
subjects	O	O
were	O	O
asked	O	O
to	O	O
place	O	O
the	O	O
strip	O	O
(	O	O
Listerine	O	O
PocketPaks	O	O
)	O	O
on	O	O
the	O	O
tongue	O	O
allowing	O	O
it	O	O
to	O	O
dissolve	O	O
.	O	O

After	O	O
30	O	O
minutes	O	O
,	O	O
new	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
again	O	O
and	O	O
the	O	O
plates	O	O
with	O	O
the	O	O
samples	O	O
were	O	O
incubated	O	O
under	O	O
anaerobic	O	O
conditions	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
seven	O	O
days	O	O
.	O	O

Colony	O	O
counts	O	O
(	O	O
CFU/mL	O	O
)	O	O
were	O	O
determined	O	O
for	O	O
each	O	O
sample	O	O
.	O	O

The	O	O
colonies	O	O
on	O	O
the	O	O
plates	O	O
were	O	O
washed	O	O
with	O	O
1	O	O
mL	O	O
of	O	O
TE	O	O
buffer	O	O
,	O	O
and	O	O
the	O	O
bacterial	O	O
suspensions	O	O
were	O	O
processed	O	O
for	O	O
the	O	O
identification	O	O
of	O	O
24	O	O
species	O	O
by	O	O
DNA	O	O
probes	O	O
and	O	O
the	O	O
Checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
method	O	O
.	O	O

Differences	O	O
in	O	O
total	O	O
counts	O	O
,	O	O
prevalence	O	O
,	O	O
and	O	O
levels	O	O
of	O	O
the	O	O
species	O	O
evaluated	O	O
before	O	O
and	O	O
after	O	O
placement	O	O
of	O	O
the	O	O
strips	O	O
were	O	O
determined	O	O
by	O	O
Wilcoxon	O	O
sign	O	O
rank	O	O
and	O	O
Chi-square	O	O
tests	O	O
.	O	O

A	O	O
modest	O	O
increase	O	O
in	O	O
the	O	O
total	O	O
bacterial	O	O
number	O	O
in	O	O
saliva	O	O
from	O	O
1.4	O	O
x	O	O
10	O	O
(	O	O
8	O	O
)	O	O
to	O	O
1.7	O	O
x	O	O
10	O	O
(	O	O
8	O	O
)	O	O
bacterial	O	O
cells	O	O
was	O	O
observed	O	O
30	O	O
minutes	O	O
after	O	O
the	O	O
strip	O	O
placement	O	O
,	O	O
although	O	O
this	O	O
change	O	O
was	O	O
not	O	O
significant	O	O
(	O	O
p	O	O
=	O	O
0.632	O	O
)	O	O
.	O	O

Most	O	O
of	O	O
the	O	O
species	O	O
reduced	O	O
in	O	O
frequency	O	O
and/or	O	O
levels	O	O
,	O	O
including	O	O
the	O	O
pathogens	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
E.	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
spp.	B-bacteria	B-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
noxia	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
beneficial	O	O
species	O	O
A.	B-bacteria	B-bacteria
meyeri	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
georgia	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
gerencseriae	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
after	O	O
strip	O	O
placement	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
A.	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
and	O	O
V.	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
presented	O	O
an	O	O
increase	O	O
in	O	O
prevalence	O	O
and/or	O	O
levels	O	O
.	O	O

These	O	O
changes	O	O
were	O	O
not	O	O
statistically	O	O
significant	O	O
after	O	O
adjusting	O	O
for	O	O
multiple	O	O
comparisons	O	O
(	O	O
p	O	O
>	O	O
0.0022	O	O
)	O	O
.	O	O

The	O	O
use	O	O
of	O	O
the	O	O
essential	O	O
oil-containing	O	O
oral	O	O
strips	O	O
resulted	O	O
in	O	O
a	O	O
short-term	O	O
small	O	O
increase	O	O
in	O	O
the	O	O
total	O	O
number	O	O
of	O	O
salivary	O	O
microorganisms	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
a	O	O
not	O	O
significant	O	O
decrease	O	O
of	O	O
certain	O	O
periodontopathogens	O	O
,	O	O
and	O	O
an	O	O
increase	O	O
in	O	O
species	O	O
compatible	O	O
with	O	O
oral	O	O
health	O	O
were	O	O
observed	O	O
.	O	O

To	O	O
analyse	O	O
the	O	O
microbial	O	O
flora	O	O
in	O	O
specific	O	O
sites	O	O
in	O	O
20	O	O
dentate	O	O
(	O	O
>	O	O
or	O	O
=	O	O
16	O	O
teeth	O	O
)	O	O
subjects	O	O
with	O	O
hyposalivation	O	O
due	O	O
to	O	O
medicines	O	O
or	O	O
of	O	O
unknown	O	O
origin	O	O
and	O	O
in	O	O
20	O	O
controls	O	O
matched	O	O
according	O	O
to	O	O
age	O	O
,	O	O
sex	O	O
and	O	O
number	O	O
of	O	O
teeth	O	O
.	O	O

The	O	O
microbial	O	O
samples	O	O
were	O	O
analysed	O	O
for	O	O
the	O	O
following	O	O
micro-organisms	O	O
:	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Actinomyces	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
associated	O	O
with	O	O
the	O	O
development	O	O
of	O	O
caries	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia/Prevotella	I-bacteria	I-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
associated	O	O
with	O	O
plaque	O	O
accumulation	O	O
and	O	O
gingivitis	O	O
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
frequently	O	O
found	O	O
in	O	O
elevated	O	O
numbers	O	O
in	O	O
periodontitis	O	O
sites	O	O
and	O	O
Candida	O	O
albicans	O	O
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
enterics	B-bacteria	B-bacteria
and	O	O
enterococci	B-bacteria	B-bacteria
,	O	O
associated	O	O
with	O	O
mucosal	O	O
infections	O	O
.	O	O

The	O	O
total	O	O
microbial	O	O
count	O	O
was	O	O
also	O	O
registered	O	O
,	O	O
together	O	O
with	O	O
the	O	O
total	O	O
number	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
associated	O	O
with	O	O
good	O	O
oral	O	O
health	O	O
.	O	O

In	O	O
the	O	O
hyposalivation	O	O
group	O	O
,	O	O
the	O	O
mean	O	O
age	O	O
was	O	O
54	O	O
+/-	O	O
8	O	O
years	O	O
and	O	O
the	O	O
mean	O	O
number	O	O
of	O	O
teeth	O	O
25	O	O
+/-	O	O
3	O	O
.	O	O

The	O	O
unstimulated	O	O
secretion	O	O
rate	O	O
was	O	O
0.04	O	O
+/-	O	O
0.04	O	O
mL/min	O	O
and	O	O
the	O	O
stimulated	O	O
secretion	O	O
rate	O	O
0.98	O	O
+/-	O	O
0.51	O	O
mL/min	O	O
.	O	O

Compared	O	O
with	O	O
the	O	O
controls	O	O
,	O	O
the	O	O
hyposalivation	O	O
group	O	O
tended	O	O
to	O	O
harbour	O	O
a	O	O
lower	O	O
number	O	O
and	O	O
proportion	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
on	O	O
the	O	O
tongue	O	O
,	O	O
and	O	O
an	O	O
increased	O	O
number	O	O
of	O	O
enterococci	B-bacteria	B-bacteria
in	O	O
the	O	O
vestibular	O	O
region	O	O
.	O	O

In	O	O
the	O	O
supragingival	O	O
plaque	O	O
,	O	O
the	O	O
numbers	O	O
of	O	O
Strepococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
significantly	O	O
increased	O	O
and	O	O
the	O	O
number	O	O
of	O	O
C.	O	O
albicans	O	O
tended	O	O
to	O	O
be	O	O
increased	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
that	O	O
subjects	O	O
with	O	O
hyposalivation	O	O
due	O	O
to	O	O
medicines	O	O
or	O	O
of	O	O
unknown	O	O
origin	O	O
have	O	O
a	O	O
supragingival	O	O
plaque	O	O
associated	O	O
with	O	O
the	O	O
development	O	O
of	O	O
caries	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
a	O	O
periodontopathic	O	O
bacterium	O	O
,	O	O
is	O	O
known	O	O
to	O	O
invade	O	O
oral	O	O
epithelial	O	O
cells	O	O
in	O	O
periodontal	O	O
lesions	O	O
,	O	O
although	O	O
the	O	O
mechanism	O	O
is	O	O
unclear	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
goat	O	O
polyclonal	O	O
anti-intercellular	O	O
adhesion	O	O
molecule	O	O
1	O	O
(	O	O
anti-ICAM-1	O	O
)	O	O
antibody	O	O
inhibited	O	O
the	O	O
invasion	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
into	O	O
KB	O	O
cells	O	O
(	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
)	O	O
.	O	O

Further	O	O
,	O	O
the	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
fimbria	O	O
,	O	O
a	O	O
pathogenic	O	O
adhesion	O	O
molecule	O	O
,	O	O
bound	O	O
to	O	O
recombinant	O	O
human	O	O
ICAM-1	O	O
,	O	O
as	O	O
shown	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
also	O	O
found	O	O
to	O	O
colocalize	O	O
with	O	O
ICAM-1	O	O
on	O	O
KB	O	O
cells	O	O
,	O	O
as	O	O
seen	O	O
with	O	O
an	O	O
immunofluorescence	O	O
microscope	O	O
,	O	O
and	O	O
the	O	O
knockdown	O	O
of	O	O
ICAM-1	O	O
in	O	O
KB	O	O
cells	O	O
resulted	O	O
in	O	O
the	O	O
inhibition	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
invasion	O	O
by	O	O
RNA	O	O
interference	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
methyl-beta-cyclodextrin	O	O
,	O	O
a	O	O
cholesterol-binding	O	O
agent	O	O
,	O	O
inhibited	O	O
the	O	O
colocalization	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
with	O	O
ICAM-1	O	O
and	O	O
invasion	O	O
by	O	O
the	O	O
microorganism	O	O
.	O	O

The	O	O
colocalization	O	O
of	O	O
caveolin-1	O	O
,	O	O
a	O	O
caveolar	O	O
marker	O	O
protein	O	O
,	O	O
on	O	O
KB	O	O
cells	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
also	O	O
shown	O	O
,	O	O
and	O	O
the	O	O
knockdown	O	O
of	O	O
caveolin-1	O	O
in	O	O
KB	O	O
cells	O	O
caused	O	O
a	O	O
reduced	O	O
level	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
invasion	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
ICAM-1	O	O
and	O	O
caveolae	O	O
are	O	O
required	O	O
for	O	O
the	O	O
invasion	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
into	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
,	O	O
and	O	O
these	O	O
molecules	O	O
appear	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
the	O	O
primary	O	O
stages	O	O
of	O	O
the	O	O
development	O	O
and	O	O
progression	O	O
of	O	O
chronic	O	O
periodontitis	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
bv	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

1	E-bacteria	I-bacteria
is	O	O
a	O	O
pioneer	O	O
colonizer	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

Studies	O	O
of	O	O
its	O	O
population	O	O
dynamics	O	O
within	O	O
parents	O	O
and	O	O
their	O	O
infants	O	O
and	O	O
within	O	O
neonates	O	O
have	O	O
shown	O	O
extensive	O	O
diversity	O	O
within	O	O
and	O	O
between	O	O
subjects	O	O
.	O	O

We	O	O
examined	O	O
the	O	O
genetic	O	O
diversity	O	O
and	O	O
clonal	O	O
turnover	O	O
of	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
bv	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

1	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
cheeks	O	O
,	O	O
tongue	O	O
,	O	O
and	O	O
primary	O	O
incisors	O	O
of	O	O
four	O	O
infants	O	O
from	O	O
birth	O	O
to	O	O
1	O	O
year	O	O
of	O	O
age	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
we	O	O
compared	O	O
the	O	O
clonotypes	O	O
of	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
bv	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

1	E-bacteria	I-bacteria
isolated	O	O
from	O	O
their	O	O
mothers	O	O
'	O	O
saliva	O	O
collected	O	O
in	O	O
parallel	O	O
to	O	O
determine	O	O
whether	O	O
the	O	O
mother	O	O
was	O	O
the	O	O
origin	O	O
of	O	O
the	O	O
clones	O	O
colonizing	O	O
her	O	O
infant	O	O
.	O	O

Of	O	O
859	O	O
isolates	O	O
obtained	O	O
from	O	O
the	O	O
infants	O	O
,	O	O
568	O	O
were	O	O
unique	O	O
clones	O	O
.	O	O

Each	O	O
of	O	O
the	O	O
surfaces	O	O
examined	O	O
,	O	O
whether	O	O
shedding	O	O
or	O	O
nonshedding	O	O
,	O	O
displayed	O	O
the	O	O
same	O	O
degree	O	O
of	O	O
diversity	O	O
.	O	O

Among	O	O
the	O	O
four	O	O
infants	O	O
it	O	O
was	O	O
rare	O	O
to	O	O
detect	O	O
the	O	O
same	O	O
clone	O	O
colonizing	O	O
more	O	O
than	O	O
one	O	O
surface	O	O
at	O	O
a	O	O
given	O	O
visit	O	O
.	O	O

There	O	O
was	O	O
little	O	O
evidence	O	O
for	O	O
persistence	O	O
of	O	O
clones	O	O
,	O	O
but	O	O
when	O	O
clones	O	O
were	O	O
isolated	O	O
on	O	O
multiple	O	O
visits	O	O
they	O	O
were	O	O
not	O	O
always	O	O
found	O	O
on	O	O
the	O	O
same	O	O
surface	O	O
.	O	O

A	O	O
similar	O	O
degree	O	O
of	O	O
clonal	O	O
diversity	O	O
of	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
bv	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

1	E-bacteria	I-bacteria
was	O	O
observed	O	O
in	O	O
the	O	O
mothers'	O	O
saliva	O	O
as	O	O
in	O	O
their	O	O
infants	O	O
'	O	O
mouths	O	O
.	O	O

Clones	O	O
common	O	O
to	O	O
both	O	O
infant	O	O
and	O	O
mothers'	O	O
saliva	O	O
were	O	O
found	O	O
infrequently	O	O
suggesting	O	O
that	O	O
this	O	O
is	O	O
not	O	O
the	O	O
origin	O	O
of	O	O
the	O	O
infants	O	O
'	O	O
clones	O	O
.	O	O

It	O	O
is	O	O
unclear	O	O
whether	O	O
mucosal	O	O
immunity	O	O
exerts	O	O
the	O	O
environmental	O	O
pressure	O	O
driving	O	O
the	O	O
genetic	O	O
diversity	O	O
and	O	O
clonal	O	O
turnover	O	O
of	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
bv	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

1	E-bacteria	I-bacteria
,	O	O
which	O	O
may	O	O
be	O	O
mechanisms	O	O
employed	O	O
by	O	O
this	O	O
bacterium	O	O
to	O	O
evade	O	O
immune	O	O
elimination	O	O
.	O	O

Bacteriocins	O	O
are	O	O
bacteriocidal	O	O
proteinaceous	O	O
molecules	O	O
produced	O	O
by	O	O
the	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
not	O	O
active	O	O
against	O	O
the	O	O
produced	O	O
strain	O	O
.	O	O

Many	O	O
investigations	O	O
have	O	O
revealed	O	O
that	O	O
certain	O	O
bacteria	O	O
using	O	O
antibacterial	O	O
or	O	O
the	O	O
inhibitory	O	O
substance	O	O
inhibit	O	O
some	O	O
other	O	O
bacteria	O	O
.	O	O

A	O	O
study	O	O
was	O	O
conducted	O	O
in	O	O
a	O	O
group	O	O
of	O	O
60	O	O
children	O	O
to	O	O
ascertain	O	O
whether	O	O
any	O	O
correlation	O	O
exists	O	O
between	O	O
the	O	O
proportion	O	O
of	O	O
salivary	O	O
bacteria	O	O
inhibiting	O	O
and	O	O
stimulating	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
the	O	O
oral	O	O
health	O	O
indices	O	O
(	O	O
DMFT	O	O
,	O	O
deft	O	O
and	O	O
Community	O	O
Periodontal	O	O
Index	O	O
of	O	O
Treatment	O	O
Needs	O	O
)	O	O
.	O	O

A	O	O
definite	O	O
inverse	O	O
correlation	O	O
was	O	O
observed	O	O
between	O	O
the	O	O
percentage	O	O
of	O	O
salivary	O	O
inhibiting	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
untreated	O	O
carious	O	O
teeth	O	O
(	O	O
UCT	O	O
)	O	O
.	O	O

Postoperative	O	O
maxillary	O	O
cyst	O	O
(	O	O
POMC	O	O
)	O	O
is	O	O
known	O	O
to	O	O
occur	O	O
as	O	O
a	O	O
delayed	O	O
complication	O	O
of	O	O
radical	O	O
maxillary	O	O
sinus	O	O
surgery	O	O
,	O	O
such	O	O
as	O	O
Caldwell-Luc	O	O
surgery	O	O
.	O	O

The	O	O
cyst	O	O
gradually	O	O
expands	O	O
with	O	O
no	O	O
symptoms	O	O
over	O	O
a	O	O
period	O	O
of	O	O
years	O	O
,	O	O
and	O	O
then	O	O
occasionally	O	O
causes	O	O
swelling	O	O
and	O	O
pain	O	O
in	O	O
the	O	O
buccal	O	O
region	O	O
and/or	O	O
the	O	O
mucogingival	O	O
fold	O	O
.	O	O

It	O	O
is	O	O
probable	O	O
that	O	O
bacterial	O	O
infection	O	O
affects	O	O
the	O	O
progression	O	O
of	O	O
POMC	O	O
symptoms	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
were	O	O
to	O	O
determine	O	O
the	O	O
bacterial	O	O
density	O	O
and	O	O
to	O	O
examine	O	O
the	O	O
presence	O	O
of	O	O
20	O	O
oral	O	O
bacteria	O	O
in	O	O
POMC	O	O
fluids	O	O
.	O	O

POMC	O	O
fluids	O	O
(	O	O
4	O	O
purulent	O	O
,	O	O
2	O	O
mucous	O	O
and	O	O
4	O	O
serous	O	O
)	O	O
were	O	O
sampled	O	O
from	O	O
10	O	O
subjects	O	O
(	O	O
aged	O	O
43-77	O	O
years	O	O
)	O	O
.	O	O

Bacterial	O	O
quantification	O	O
and	O	O
detection	O	O
were	O	O
performed	O	O
by	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
and	O	O
nested	O	O
PCR	O	O
based	O	O
on	O	O
bacterial	O	O
16S	O	O
rRNA	O	O
genes	O	O
,	O	O
respectively	O	O
.	O	O

Bacterial	O	O
DNA	O	O
was	O	O
detected	O	O
in	O	O
all	O	O
samples	O	O
and	O	O
the	O	O
average	O	O
concentrations	O	O
of	O	O
bacterial	O	O
DNA	O	O
were	O	O
5.9	O	O
(	O	O
purulent	O	O
)	O	O
,	O	O
0.5	O	O
(	O	O
mucous	O	O
)	O	O
,	O	O
and	O	O
0.7	O	O
(	O	O
serous	O	O
)	O	O
ng/mg	O	O
of	O	O
sample	O	O
.	O	O

Twelve	O	O
bacterial	O	O
species	O	O
,	O	O
including	O	O
anginosus	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
known	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
abscess	O	O
formation	O	O
,	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
purulent	O	O
fluids	O	O
,	O	O
while	O	O
two	O	O
and	O	O
five	O	O
species	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
mucous	O	O
and	O	O
serous	O	O
fluids	O	O
,	O	O
respectively	O	O
.	O	O

Purulent	O	O
fluids	O	O
contained	O	O
numerous	O	O
bacteria	O	O
of	O	O
various	O	O
types	O	O
,	O	O
thus	O	O
suggesting	O	O
that	O	O
oral	O	O
bacteria	O	O
may	O	O
cause	O	O
symptoms	O	O
such	O	O
as	O	O
pain	O	O
in	O	O
POMC	O	O
with	O	O
purulent	O	O
fluids	O	O
.	O	O

Mucous	O	O
and	O	O
serous	O	O
fluids	O	O
also	O	O
contained	O	O
bacteria	O	O
,	O	O
although	O	O
their	O	O
numbers	O	O
were	O	O
small	O	O
,	O	O
thus	O	O
suggesting	O	O
an	O	O
association	O	O
between	O	O
bacteria	O	O
and	O	O
progression	O	O
of	O	O
POMC	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
are	O	O
known	O	O
to	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
maintenance	O	O
of	O	O
health	O	O
by	O	O
stimulating	O	O
natural	O	O
immunity	O	O
and	O	O
contributing	O	O
to	O	O
the	O	O
balance	O	O
of	O	O
microflora	O	O
.	O	O

However	O	O
,	O	O
their	O	O
role	O	O
in	O	O
chronic	O	O
periodontitis	O	O
is	O	O
unclear	O	O
.	O	O

We	O	O
aimed	O	O
to	O	O
identify	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
chronic	O	O
periodontitis	O	O
and	O	O
periodontally	O	O
healthy	O	O
subjects	O	O
,	O	O
and	O	O
to	O	O
determine	O	O
their	O	O
antimicrobial	O	O
activity	O	O
against	O	O
putative	O	O
oral	O	O
pathogens	O	O
.	O	O

A	O	O
total	O	O
of	O	O
238	O	O
Lactobacillus	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
from	O	O
the	O	O
saliva	O	O
and	O	O
subgingival	O	O
sites	O	O
of	O	O
20	O	O
chronic	O	O
periodontitis	O	O
and	O	O
15	O	O
healthy	O	O
subjects	O	O
were	O	O
collected	O	O
.	O	O

In	O	O
all	O	O
,	O	O
115	O	O
strains	O	O
were	O	O
identified	O	O
using	O	O
rapid	O	O
amplified	O	O
ribosomal	O	O
DNA	O	O
restriction	O	O
analysis	O	O
.	O	O

Antimicrobial	O	O
activity	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
was	O	O
assessed	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
belonging	O	O
to	O	O
10	O	O
species	O	O
were	O	O
identified	O	O
.	O	O

The	O	O
most	O	O
prevalent	O	O
strains	O	O
in	O	O
healthy	O	O
persons	O	O
were	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
and	O	O
in	O	O
chronic	O	O
periodontitis	O	O
patients	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
.	O	O

Obligately	O	O
homofermentatives	B-bacteria	B-bacteria
,	O	O
particularly	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
,	O	O
were	O	O
less	O	O
prevalent	O	O
in	O	O
chronic	O	O
periodontitis	O	O
patients	O	O
compared	O	O
with	O	O
healthy	O	O
subjects	O	O
(	O	O
8	O	O
%	O	O
vs.	O	O
64	O	O
%	O	O
for	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
,	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Sixty-nine	O	O
percent	O	O
of	O	O
tested	O	O
lactobacilli	B-bacteria	B-bacteria
inhibited	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
88	O	O
%	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
82	O	O
%	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
65	O	O
%	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
.	O	O

The	O	O
strongest	O	O
antimicrobial	O	O
activity	O	O
was	O	O
associated	O	O
with	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
,	O	O
L.	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
,	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
.	O	O

The	O	O
strains	O	O
from	O	O
periodontally	O	O
healthy	O	O
patients	O	O
showed	O	O
a	O	O
lower	O	O
antimicrobial	O	O
activity	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
than	O	O
the	O	O
strains	O	O
from	O	O
chronic	O	O
periodontitis	O	O
patients	O	O
.	O	O

The	O	O
composition	O	O
of	O	O
oral	O	O
lactoflora	O	O
in	O	O
chronic	O	O
periodontitis	O	O
and	O	O
healthy	O	O
subjects	O	O
differs	O	O
,	O	O
with	O	O
a	O	O
higher	O	O
prevalence	O	O
of	O	O
homofermentative	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
particularly	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
,	O	O
in	O	O
the	O	O
latter	O	O
group	O	O
.	O	O

Both	O	O
homo-	O	O
and	O	O
heterofermentative	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
suppress	O	O
the	O	O
growth	O	O
of	O	O
periodontal	O	O
pathogens	O	O
,	O	O
but	O	O
the	O	O
antimicrobial	O	O
properties	O	O
are	O	O
strain	O	O
,	O	O
species	O	O
and	O	O
origin	O	O
specific	O	O
.	O	O

Recent	O	O
evidence	O	O
from	O	O
molecular	O	O
genetic	O	O
studies	O	O
has	O	O
revealed	O	O
that	O	O
oral	O	O
Treponema	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
are	O	O
involved	O	O
in	O	O
infections	O	O
of	O	O
endodontic	O	O
origin	O	O
.	O	O

This	O	O
study	O	O
assessed	O	O
the	O	O
occurrence	O	O
of	O	O
two	O	O
newly	O	O
named	O	O
oral	O	O
treponemes	B-bacteria	B-bacteria
-	O	O
Treponema	B-bacteria	B-bacteria
parvum	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
putidum	E-bacteria	I-bacteria
-	O	O
in	O	O
primary	O	O
endodontic	O	O
infections	O	O
using	O	O
a	O	O
culture-independent	O	O
identification	O	O
technique	O	O
.	O	O

Genomic	O	O
DNA	O	O
was	O	O
isolated	O	O
directly	O	O
from	O	O
clinical	O	O
samples	O	O
,	O	O
and	O	O
a	O	O
16S	O	O
rRNA	O	O
gene-based	O	O
nested	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
assay	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
presence	O	O
of	O	O
T.	B-bacteria	B-bacteria
parvum	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
putidum	E-bacteria	I-bacteria
.	O	O

Species-specific	O	O
primer	O	O
pairs	O	O
were	O	O
developed	O	O
by	O	O
aligning	O	O
closely	O	O
related	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
.	O	O

The	O	O
specificity	O	O
for	O	O
each	O	O
primer	O	O
pair	O	O
was	O	O
validated	O	O
by	O	O
running	O	O
PCR	O	O
against	O	O
a	O	O
panel	O	O
of	O	O
oral	O	O
bacteria	O	O
and	O	O
by	O	O
sequence	O	O
analysis	O	O
of	O	O
PCR	O	O
products	O	O
from	O	O
positive	O	O
clinical	O	O
samples	O	O
.	O	O

T.	B-bacteria	B-bacteria
parvum	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
52	O	O
%	O	O
of	O	O
the	O	O
root	O	O
canals	O	O
associated	O	O
with	O	O
chronic	O	O
apical	O	O
periodontitis	O	O
,	O	O
in	O	O
20	O	O
%	O	O
of	O	O
the	O	O
cases	O	O
diagnosed	O	O
as	O	O
acute	O	O
apical	O	O
periodontitis	O	O
,	O	O
and	O	O
in	O	O
no	O	O
abscessed	O	O
case	O	O
.	O	O

In	O	O
general	O	O
,	O	O
T.	B-bacteria	B-bacteria
parvum	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
26	O	O
%	O	O
of	O	O
the	O	O
samples	O	O
from	O	O
primary	O	O
endodontic	O	O
infections	O	O
.	O	O

T.	B-bacteria	B-bacteria
putidum	E-bacteria	I-bacteria
was	O	O
found	O	O
in	O	O
only	O	O
one	O	O
case	O	O
of	O	O
acute	O	O
apical	O	O
periodontitis	O	O
(	O	O
2	O	O
%	O	O
of	O	O
the	O	O
total	O	O
number	O	O
of	O	O
cases	O	O
investigated	O	O
)	O	O
.	O	O

The	O	O
devised	O	O
nested	O	O
PCR	O	O
protocol	O	O
was	O	O
able	O	O
to	O	O
identify	O	O
both	O	O
T.	B-bacteria	B-bacteria
parvum	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
putidum	E-bacteria	I-bacteria
directly	O	O
in	O	O
clinical	O	O
samples	O	O
and	O	O
demonstrated	O	O
that	O	O
these	O	O
two	O	O
treponemes	O	O
can	O	O
take	O	O
part	O	O
in	O	O
endodontic	O	O
infections	O	O
.	O	O

This	O	O
study	O	O
assessed	O	O
,	O	O
for	O	O
forensic	O	O
purposes	O	O
,	O	O
the	O	O
feasibility	O	O
of	O	O
genotypically	O	O
matching	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
recovered	O	O
from	O	O
recent	O	O
human	O	O
bite	O	O
marks	O	O
with	O	O
those	O	O
from	O	O
the	O	O
teeth	O	O
of	O	O
the	O	O
biter	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
the	O	O
incisors	O	O
of	O	O
eight	O	O
volunteers	O	O
.	O	O

Arbitrarily	O	O
primed	O	O
PCR	O	O
(	O	O
AP-PCR	O	O
)	O	O
distinguished	O	O
106	O	O
streptococcal	O	O
genotypes	O	O
among	O	O
the	O	O
participants	O	O
,	O	O
each	O	O
harbouring	O	O
at	O	O
least	O	O
eight	O	O
distinct	O	O
strains	O	O
.	O	O

In	O	O
a	O	O
crime	O	O
simulation	O	O
,	O	O
a	O	O
sample	O	O
from	O	O
an	O	O
experimental	O	O
bite	O	O
mark	O	O
was	O	O
analysed	O	O
by	O	O
an	O	O
experimenter	O	O
unaware	O	O
of	O	O
its	O	O
origin	O	O
.	O	O

The	O	O
bacteria	O	O
were	O	O
unambiguously	O	O
matched	O	O
to	O	O
the	O	O
biter	O	O
by	O	O
comparing	O	O
the	O	O
amplicon	O	O
profiles	O	O
with	O	O
those	O	O
from	O	O
the	O	O
eight	O	O
participants	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
bacteria	O	O
from	O	O
an	O	O
additional	O	O
bite	O	O
mark	O	O
(	O	O
not	O	O
generated	O	O
by	O	O
one	O	O
of	O	O
the	O	O
original	O	O
participants	O	O
)	O	O
could	O	O
not	O	O
be	O	O
matched	O	O
to	O	O
any	O	O
of	O	O
the	O	O
eight	O	O
participants	O	O
.	O	O

Between	O	O
20	O	O
and	O	O
78	O	O
%	O	O
of	O	O
catalogued	O	O
bacterial	O	O
genotypes	O	O
were	O	O
recovered	O	O
12	O	O
months	O	O
later	O	O
from	O	O
each	O	O
participant	O	O
.	O	O

Throughout	O	O
the	O	O
study	O	O
period	O	O
,	O	O
none	O	O
of	O	O
the	O	O
bacterial	O	O
genotypes	O	O
were	O	O
shared	O	O
between	O	O
participants	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
isolated	O	O
from	O	O
recent	O	O
bite	O	O
marks	O	O
can	O	O
be	O	O
catalogued	O	O
by	O	O
AP-PCR	O	O
and	O	O
matched	O	O
to	O	O
the	O	O
teeth	O	O
responsible	O	O
for	O	O
the	O	O
bite	O	O
.	O	O

The	O	O
study	O	O
provides	O	O
'proof	O	O
of	O	O
concept	O	O
'	O	O
that	O	O
genotypic	O	O
analysis	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
from	O	O
bite	O	O
marks	O	O
may	O	O
provide	O	O
valuable	O	O
forensic	O	O
evidence	O	O
in	O	O
situations	O	O
where	O	O
the	O	O
perpetrator	O	O
's	O	O
DNA	O	O
can	O	O
not	O	O
be	O	O
recovered	O	O
.	O	O

We	O	O
have	O	O
shown	O	O
that	O	O
buccal	O	O
epithelial	O	O
cells	O	O
(	O	O
BEC	O	O
)	O	O
from	O	O
humans	O	O
can	O	O
contain	O	O
a	O	O
polymicrobial	O	O
intracellular	O	O
flora	O	O
.	O	O

Members	O	O
of	O	O
that	O	O
flora	O	O
can	O	O
induce	O	O
proinflammatory	O	O
responses	O	O
.	O	O

However	O	O
,	O	O
our	O	O
subjects	O	O
all	O	O
had	O	O
healthy	O	O
oral	O	O
mucosa	O	O
.	O	O

This	O	O
might	O	O
reflect	O	O
tolerance	O	O
of	O	O
bacterial	O	O
invasion	O	O
by	O	O
live	O	O
BEC	O	O
.	O	O

Alternatively	O	O
,	O	O
inflammation	O	O
might	O	O
not	O	O
occur	O	O
if	O	O
invaded	O	O
cells	O	O
were	O	O
mostly	O	O
dead	O	O
,	O	O
and	O	O
thus	O	O
unable	O	O
to	O	O
mount	O	O
a	O	O
response	O	O
.	O	O

This	O	O
study	O	O
addressed	O	O
that	O	O
issue	O	O
,	O	O
by	O	O
determining	O	O
the	O	O
vital	O	O
status	O	O
of	O	O
BEC	O	O
and	O	O
the	O	O
bacteria	O	O
associated	O	O
with	O	O
them	O	O
.	O	O

Initial	O	O
experiments	O	O
indicated	O	O
that	O	O
BEC	O	O
were	O	O
anomalously	O	O
permeable	O	O
to	O	O
the	O	O
DNA	O	O
stain	O	O
propidium	O	O
iodide	O	O
.	O	O

We	O	O
used	O	O
that	O	O
property	O	O
to	O	O
develop	O	O
a	O	O
protocol	O	O
that	O	O
combined	O	O
the	O	O
DNA	O	O
stains	O	O
SYTO	O	O
9	O	O
and	O	O
propidium	O	O
iodide	O	O
(	O	O
indicators	O	O
of	O	O
bacterial	O	O
viability	O	O
)	O	O
with	O	O
the	O	O
esterase	O	O
substrate	O	O
calcein	O	O
blue	O	O
AM	O	O
(	O	O
an	O	O
indicator	O	O
of	O	O
BEC	O	O
viability	O	O
)	O	O
,	O	O
and	O	O
Annexin	O	O
V	O	O
Alexa	O	O
Fluor	O	O
647	O	O
conjugate	O	O
(	O	O
an	O	O
apoptosis	O	O
marker	O	O
)	O	O
.	O	O

That	O	O
protocol	O	O
was	O	O
applied	O	O
to	O	O
BEC	O	O
collected	O	O
from	O	O
36	O	O
human	O	O
subjects	O	O
.	O	O

On	O	O
average	O	O
,	O	O
70	O	O
%	O	O
of	O	O
BEC	O	O
displayed	O	O
calcein	O	O
blue	O	O
staining	O	O
,	O	O
with	O	O
no	O	O
binding	O	O
of	O	O
Annexin	O	O
V	O	O
,	O	O
25	O	O
%	O	O
showed	O	O
signs	O	O
of	O	O
apoptosis	O	O
,	O	O
and	O	O
5	O	O
%	O	O
did	O	O
not	O	O
stain	O	O
with	O	O
calcein	O	O
blue	O	O
.	O	O

The	O	O
mean	O	O
percent	O	O
of	O	O
BEC	O	O
with	O	O
live	O	O
cell-associated	O	O
bacteria	O	O
was	O	O
29	O	O
%	O	O
.	O	O

Collectively	O	O
,	O	O
25	O	O
%	O	O
of	O	O
total	O	O
BEC	O	O
displayed	O	O
calcein	O	O
blue	O	O
staining	O	O
and	O	O
live	O	O
(	O	O
SYTO	O	O
9	O	O
stained	O	O
)	O	O
bacteria	O	O
.	O	O

Only	O	O
1	O	O
%	O	O
of	O	O
total	O	O
BEC	O	O
were	O	O
negative	O	O
for	O	O
calcein	O	O
blue	O	O
and	O	O
associated	O	O
with	O	O
live	O	O
bacteria	O	O
.	O	O

Our	O	O
findings	O	O
suggest	O	O
that	O	O
live	O	O
BEC	O	O
are	O	O
tolerant	O	O
of	O	O
bacterial	O	O
invasion	O	O
.	O	O

This	O	O
may	O	O
be	O	O
due	O	O
to	O	O
complex	O	O
interactions	O	O
between	O	O
members	O	O
of	O	O
the	O	O
polymicrobial	O	O
flora	O	O
and	O	O
their	O	O
host	O	O
BEC	O	O
.	O	O

To	O	O
measure	O	O
antibacterial	O	O
action	O	O
of	O	O
photoactivated	O	O
disinfection	O	O
(	O	O
PAD	O	O
)	O	O
on	O	O
endodontic	O	O
bacteria	O	O
in	O	O
planktonic	O	O
suspension	O	O
and	O	O
root	O	O
canals	O	O
.	O	O

Four	O	O
bacteria	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
,	O	O
were	O	O
tested	O	O
in	O	O
suspension	O	O
.	O	O

After	O	O
mixing	O	O
equal	O	O
volumes	O	O
of	O	O
Tolonium	O	O
chloride	O	O
and	O	O
bacterial	O	O
suspension	O	O
for	O	O
60s	O	O
,	O	O
each	O	O
200	O	O
microL	O	O
of	O	O
concentration	O	O
(	O	O
>	O	O
10	O	O
(	O	O
6	O	O
)	O	O
cfu	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
)	O	O
was	O	O
irradiated	O	O
with	O	O
light	O	O
at	O	O
633+/-2	O	O
nm	O	O
.	O	O

Each	O	O
energy	O	O
dose/Tolonium	O	O
chloride	O	O
concentration	O	O
combination	O	O
was	O	O
tested	O	O
eight	O	O
times	O	O
,	O	O
with	O	O
controls	O	O
.	O	O

Prepared	O	O
root	O	O
canals	O	O
in	O	O
Training	O	O
Blocs	O	O
and	O	O
extracted	O	O
human	O	O
teeth	O	O
were	O	O
inoculated	O	O
with	O	O
S.	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
followed	O	O
by	O	O
10	O	O
mg	O	O
L	O	O
(	O	O
-1	O	O
)	O	O
Tolonium	O	O
chloride	O	O
or	O	O
saline	O	O
.	O	O

Bacteria	O	O
in	O	O
canals	O	O
were	O	O
sampled	O	O
before	O	O
and	O	O
after	O	O
light	O	O
irradiation	O	O
.	O	O

Student	O	O
t-test	O	O
assessed	O	O
significance	O	O
of	O	O
changes	O	O
in	O	O
viable	O	O
bacteria	O	O
produced	O	O
by	O	O
treatment	O	O
of	O	O
either	O	O
light	O	O
or	O	O
Tolonium	O	O
chloride	O	O
alone	O	O
and	O	O
light/Tolonium	O	O
chloride	O	O
combinations	O	O
.	O	O

In	O	O
suspension	O	O
,	O	O
reductions	O	O
in	O	O
bacteria	O	O
were	O	O
highly	O	O
significant	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
for	O	O
light/Tolonium	O	O
chloride	O	O
combinations	O	O
compared	O	O
to	O	O
light	O	O
or	O	O
Tolonium	O	O
chloride	O	O
alone	O	O
.	O	O

Maximum	O	O
mean	O	O
log	O	O
reductions	O	O
of	O	O
1.14	O	O
(	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
)	O	O
,	O	O
2.48	O	O
(	O	O
P.	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
)	O	O
,	O	O
2.81	O	O
(	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
)	O	O
and	O	O
6.73	O	O
(	O	O
S.	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
)	O	O
were	O	O
at	O	O
4.8	O	O
J/20	O	O
mg	O	O
L	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

Antibacterial	O	O
action	O	O
was	O	O
increased	O	O
by	O	O
energy	O	O
dose	O	O
increase	O	O
(	O	O
not	O	O
always	O	O
significantly	O	O
)	O	O
,	O	O
but	O	O
not	O	O
by	O	O
Tolonium	O	O
chloride	O	O
concentration	O	O
.	O	O

In	O	O
control	O	O
canals	O	O
mean	O	O
log	O	O
reductions	O	O
of	O	O
0.42	O	O
(	O	O
Blocs	O	O
)	O	O
and	O	O
0.38	O	O
(	O	O
teeth	O	O
)	O	O
from	O	O
initial	O	O
levels	O	O
were	O	O
not	O	O
significant	O	O
.	O	O

PAD	O	O
mean	O	O
log	O	O
reductions	O	O
of	O	O
2.40	O	O
(	O	O
Blocs	O	O
)	O	O
and	O	O
2.01	O	O
(	O	O
teeth	O	O
)	O	O
were	O	O
highly	O	O
significant	O	O
.	O	O

Changes	O	O
for	O	O
PAD/energy	O	O
dose	O	O
combinations	O	O
were	O	O
not	O	O
significant	O	O
.	O	O

PAD	O	O
killed	O	O
endodontic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
at	O	O
statistically	O	O
significant	O	O
levels	O	O
compared	O	O
to	O	O
controls	O	O
.	O	O

Kills	O	O
varied	O	O
with	O	O
bacterial	O	O
species	O	O
.	O	O

The	O	O
purposes	O	O
of	O	O
the	O	O
study	O	O
presented	O	O
are	O	O
to	O	O
identify	O	O
the	O	O
microbial	O	O
content	O	O
of	O	O
the	O	O
collected	O	O
bone	O	O
debris	O	O
and	O	O
to	O	O
determine	O	O
the	O	O
antibacterial	O	O
efficiency	O	O
of	O	O
chlorhexidine	O	O
mouth	O	O
rinse	O	O
in	O	O
reducing	O	O
the	O	O
microbial	O	O
content	O	O
of	O	O
the	O	O
collected	O	O
bone	O	O
debris	O	O
.	O	O

Twenty-five	O	O
patients	O	O
who	O	O
had	O	O
asymptomatic	O	O
fully	O	O
impacted	O	O
mandibular	O	O
third	O	O
molars	O	O
bilaterally	O	O
underwent	O	O
surgical	O	O
removal	O	O
for	O	O
prophylactic	O	O
and	O	O
orthodontic	O	O
considerations	O	O
.	O	O

Immediately	O	O
before	O	O
surgery	O	O
all	O	O
patients	O	O
rinsed	O	O
with	O	O
10	O	O
mL	O	O
of	O	O
their	O	O
assigned	O	O
solution	O	O
(	O	O
chlorhexidine	O	O
or	O	O
sterile	O	O
saline	O	O
)	O	O
for	O	O
2	O	O
minutes	O	O
.	O	O

Before	O	O
surgical	O	O
removal	O	O
of	O	O
the	O	O
teeth	O	O
,	O	O
bone	O	O
debris	O	O
was	O	O
collected	O	O
with	O	O
a	O	O
stringent	O	O
aspiration	O	O
protocol	O	O
from	O	O
the	O	O
ramus	O	O
by	O	O
bone	O	O
filter	O	O
.	O	O

The	O	O
microbial	O	O
content	O	O
of	O	O
the	O	O
bone	O	O
debris	O	O
was	O	O
assessed	O	O
and	O	O
the	O	O
bacterial	O	O
levels	O	O
between	O	O
the	O	O
2	O	O
groups	O	O
were	O	O
compared	O	O
statistically	O	O
.	O	O

All	O	O
samples	O	O
from	O	O
both	O	O
groups	O	O
(	O	O
chlorhexidine	O	O
or	O	O
sterile	O	O
saline	O	O
)	O	O
yielded	O	O
viable	O	O
microorganisms	O	O
.	O	O

There	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
between	O	O
the	O	O
mean/median	O	O
colony-forming	O	O
units	O	O
(	O	O
CFU	O	O
)	O	O
/g	O	O
values	O	O
of	O	O
both	O	O
group	O	O
samples	O	O
,	O	O
for	O	O
aerobes	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
)	O	O
and	O	O
anaerobes	B-bacteria	B-bacteria
(	O	O
Bacteroides	B-bacteria	B-bacteria
,	O	O
Peptococcus	B-bacteria	B-bacteria
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
)	O	O
.	O	O

With	O	O
regard	O	O
to	O	O
total	O	O
microorganisms	O	O
,	O	O
the	O	O
mean	O	O
CFU/g	O	O
derived	O	O
from	O	O
the	O	O
chlorhexidine	O	O
group	O	O
samples	O	O
were	O	O
1.5	O	O
x	O	O
10	O	O
(	O	O
8	O	O
)	O	O
CFU/g	O	O
per	O	O
bone	O	O
sample	O	O
compared	O	O
with	O	O
1.5	O	O
x	O	O
10	O	O
(	O	O
9	O	O
)	O	O
CFU/g	O	O
for	O	O
the	O	O
sterile	O	O
saline	O	O
control	O	O
group	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
)	O	O
.	O	O

Although	O	O
chlorhexidine	O	O
rinsing	O	O
immediately	O	O
before	O	O
surgery	O	O
reduced	O	O
the	O	O
levels	O	O
of	O	O
total	O	O
microorganisms	O	O
when	O	O
compared	O	O
with	O	O
stringent	O	O
aspiration	O	O
protocol	O	O
alone	O	O
,	O	O
it	O	O
has	O	O
not	O	O
been	O	O
found	O	O
effective	O	O
on	O	O
aerobic	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
and	O	O
,	O	O
importantly	O	O
,	O	O
on	O	O
anaerobes	B-bacteria	B-bacteria
.	O	O

The	O	O
reduced	O	O
bacterial	O	O
levels	O	O
may	O	O
still	O	O
carry	O	O
high	O	O
infectious	O	O
risk	O	O
and	O	O
may	O	O
lead	O	O
to	O	O
failure	O	O
in	O	O
autogenous	O	O
grafting	O	O
procedures	O	O
in	O	O
oral	O	O
surgery	O	O
.	O	O

Rheumatoid	O	O
arthritis	O	O
(	O	O
RA	O	O
)	O	O
and	O	O
adult	O	O
periodontitis	O	O
share	O	O
common	O	O
pathogenetic	O	O
mechanisms	O	O
and	O	O
immunologic	O	O
and	O	O
pathological	O	O
findings	O	O
.	O	O

One	O	O
oral	O	O
pathogen	O	O
strongly	O	O
implicated	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontal	O	O
disease	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
possesses	O	O
a	O	O
unique	O	O
microbial	O	O
enzyme	O	O
,	O	O
peptidylarginine	O	O
deiminase	O	O
(	O	O
PAD	O	O
)	O	O
,	O	O
the	O	O
human	O	O
equivalent	O	O
of	O	O
which	O	O
has	O	O
been	O	O
identified	O	O
as	O	O
a	O	O
susceptibility	O	O
factor	O	O
for	O	O
RA	O	O
.	O	O

We	O	O
suggest	O	O
that	O	O
individuals	O	O
predisposed	O	O
to	O	O
periodontal	O	O
infection	O	O
are	O	O
exposed	O	O
to	O	O
antigens	O	O
generated	O	O
by	O	O
PAD	O	O
,	O	O
with	O	O
de-iminated	O	O
fibrin	O	O
as	O	O
a	O	O
likely	O	O
candidate	O	O
,	O	O
which	O	O
become	O	O
systemic	O	O
immunogens	O	O
and	O	O
lead	O	O
to	O	O
intraarticular	O	O
inflammation	O	O
.	O	O

PAD	O	O
engendered	O	O
antigens	O	O
lead	O	O
to	O	O
production	O	O
of	O	O
rheumatoid	O	O
factor-containing	O	O
immune	O	O
complexes	O	O
and	O	O
provoke	O	O
local	O	O
inflammation	O	O
,	O	O
both	O	O
in	O	O
gingiva	O	O
and	O	O
synovium	O	O
via	O	O
Fc	O	O
and	O	O
C5a	O	O
receptors	O	O
.	O	O

To	O	O
assess	O	O
antimicrobial	O	O
activities	O	O
of	O	O
aqueous	O	O
crude	O	O
khat	O	O
(	O	O
Catha	O	O
edulis	O	O
)	O	O
extracts	O	O
against	O	O
a	O	O
panel	O	O
of	O	O
oral	O	O
microorganisms	O	O
and	O	O
to	O	O
test	O	O
their	O	O
ability	O	O
to	O	O
modify	O	O
bacterial	O	O
resistance	O	O
to	O	O
tetracycline	O	O
and	O	O
penicillin	O	O
in	O	O
vitro	O	O
.	O	O

Lyophilized	O	O
aqueous	O	O
extracts	O	O
were	O	O
prepared	O	O
from	O	O
three	O	O
khat	O	O
cultivars	O	O
.	O	O

The	O	O
agar	O	O
dilution	O	O
method	O	O
of	O	O
the	O	O
NCCLS	O	O
was	O	O
used	O	O
to	O	O
test	O	O
the	O	O
extracts	O	O
,	O	O
at	O	O
concentrations	O	O
of	O	O
20-1.25	O	O
mg/ml	O	O
,	O	O
against	O	O
33	O	O
oral	O	O
strains	O	O
.	O	O

MIC	O	O
was	O	O
defined	O	O
as	O	O
the	O	O
lowest	O	O
concentration	O	O
at	O	O
which	O	O
there	O	O
was	O	O
no	O	O
visible	O	O
growth	O	O
.	O	O

Slight	O	O
growth	O	O
was	O	O
defined	O	O
as	O	O
marked	O	O
growth	O	O
reduction	O	O
(	O	O
MGR	O	O
)	O	O
.	O	O

The	O	O
E-test	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
MICs	O	O
of	O	O
tetracycline	O	O
and	O	O
penicillin-G	O	O
for	O	O
three	O	O
resistant	O	O
strains	O	O
in	O	O
absence	O	O
and	O	O
presence	O	O
of	O	O
a	O	O
sub-MIC	O	O
of	O	O
the	O	O
khat	O	O
extracts	O	O
(	O	O
5mg/ml	O	O
)	O	O
.	O	O

Eighteen	O	O
strains	O	O
(	O	O
55	O	O
%	O	O
)	O	O
were	O	O
sensitive	O	O
to	O	O
the	O	O
extracts	O	O
(	O	O
MICs	O	O
5-20	O	O
mg/ml	O	O
)	O	O
.	O	O

Most	O	O
of	O	O
these	O	O
were	O	O
periodontal	O	O
pathogens	O	O
with	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
being	O	O
the	O	O
most	O	O
susceptible	O	O
(	O	O
MIC	O	O
5-10mg/ml	O	O
)	O	O
.	O	O

Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
and	O	O
some	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
not	O	O
sensitive	O	O
.	O	O

Except	O	O
for	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
that	O	O
showed	O	O
MGR	O	O
at	O	O
1mg/ml	O	O
,	O	O
cariogenic	O	O
species	O	O
were	O	O
neither	O	O
sensitive	O	O
.	O	O

The	O	O
extracts	O	O
were	O	O
active	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
(	O	O
MIC	O	O
10-20	O	O
mg/ml	O	O
)	O	O
but	O	O
not	O	O
against	O	O
Candida	O	O
albicans	O	O
and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

The	O	O
presence	O	O
of	O	O
the	O	O
khat	O	O
extracts	O	O
at	O	O
a	O	O
sub-MIC	O	O
resulted	O	O
in	O	O
a	O	O
2-4-fold	O	O
potentiation	O	O
of	O	O
the	O	O
tested	O	O
antibiotics	O	O
against	O	O
the	O	O
resistant	O	O
strains	O	O
.	O	O

Khat	O	O
has	O	O
water-soluble	O	O
constituents	O	O
possessing	O	O
selective	O	O
antibacterial	O	O
activity	O	O
against	O	O
oral	O	O
bacteria	O	O
.	O	O

There	O	O
is	O	O
preliminary	O	O
evidence	O	O
for	O	O
presence	O	O
of	O	O
an	O	O
antibiotic	O	O
resistance-modifying	O	O
component	O	O
.	O	O

Further	O	O
investigation	O	O
is	O	O
needed	O	O
to	O	O
identify	O	O
the	O	O
active	O	O
components	O	O
and	O	O
assess	O	O
their	O	O
clinical	O	O
relevance	O	O
.	O	O

We	O	O
analyzed	O	O
the	O	O
distribution	O	O
of	O	O
10	O	O
periodontal	O	O
bacteria	O	O
species	O	O
(	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
ochracea	E-bacteria	I-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
in	O	O
children	O	O
,	O	O
and	O	O
then	O	O
compared	O	O
their	O	O
distribution	O	O
in	O	O
those	O	O
children	O	O
and	O	O
their	O	O
mothers	O	O
,	O	O
with	O	O
special	O	O
attention	O	O
given	O	O
to	O	O
three	O	O
of	O	O
the	O	O
species	O	O
known	O	O
as	O	O
the	O	O
red	O	O
complex	O	O
(	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
whose	O	O
presence	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
conditions	O	O
related	O	O
to	O	O
periodontal	O	O
diseases	O	O
.	O	O

One	O	O
hundred	O	O
thirteen	O	O
pairs	O	O
of	O	O
children	O	O
and	O	O
their	O	O
mothers	O	O
were	O	O
randomly	O	O
selected	O	O
from	O	O
patients	O	O
treated	O	O
at	O	O
the	O	O
Pedodontic	O	O
Clinic	O	O
of	O	O
Osaka	O	O
University	O	O
Dental	O	O
Hospital	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
taken	O	O
at	O	O
the	O	O
second	O	O
visit	O	O
prior	O	O
to	O	O
receiving	O	O
professional	O	O
tooth	O	O
brushing	O	O
instruction	O	O
.	O	O

Genomic	O	O
DNA	O	O
was	O	O
extracted	O	O
from	O	O
each	O	O
saliva	O	O
sample	O	O
,	O	O
followed	O	O
by	O	O
a	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assay	O	O
with	O	O
species-specific	O	O
sets	O	O
of	O	O
primers	O	O
.	O	O

A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
frequently	O	O
detected	O	O
species	O	O
in	O	O
the	O	O
mothers	O	O
,	O	O
followed	O	O
by	O	O
C.	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
while	O	O
C.	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
had	O	O
the	O	O
highest	O	O
detection	O	O
rate	O	O
,	O	O
followed	O	O
by	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
in	O	O
the	O	O
children	O	O
.	O	O

The	O	O
detection	O	O
rate	O	O
of	O	O
the	O	O
red	O	O
complex	O	O
species	O	O
in	O	O
children	O	O
whose	O	O
mothers	O	O
possessed	O	O
the	O	O
same	O	O
species	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
in	O	O
those	O	O
whose	O	O
mothers	O	O
did	O	O
not	O	O
possess	O	O
them	O	O
.	O	O

Our	O	O
results	O	O
indicate	O	O
a	O	O
correlation	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
periodontal	O	O
bacteria	O	O
in	O	O
children	O	O
and	O	O
their	O	O
mothers	O	O
,	O	O
while	O	O
the	O	O
presence	O	O
of	O	O
red	O	O
complex	O	O
bacteria	O	O
in	O	O
children	O	O
was	O	O
highly	O	O
associated	O	O
with	O	O
that	O	O
in	O	O
their	O	O
mothers	O	O
.	O	O

Bacteria	O	O
were	O	O
isolated	O	O
from	O	O
the	O	O
dental	O	O
plaques	O	O
of	O	O
nine	O	O
dogs	O	O
and	O	O
a	O	O
sample	O	O
of	O	O
pooled	O	O
saliva	O	O
from	O	O
five	O	O
other	O	O
dogs	O	O
and	O	O
were	O	O
then	O	O
identified	O	O
by	O	O
comparative	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
.	O	O

Among	O	O
339	O	O
isolates	O	O
,	O	O
84	O	O
different	O	O
phylotypes	O	O
belonging	O	O
to	O	O
37	O	O
genera	O	O
were	O	O
identified	O	O
.	O	O

Approximately	O	O
half	O	O
of	O	O
the	O	O
phylotypes	O	O
were	O	O
identified	O	O
to	O	O
the	O	O
species	O	O
level	O	O
,	O	O
and	O	O
28	O	O
%	O	O
of	O	O
these	O	O
were	O	O
considered	O	O
members	O	O
of	O	O
the	O	O
indigenous	O	O
oral	O	O
microbiota	O	O
of	O	O
humans	O	O
.	O	O

The	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
of	O	O
the	O	O
remaining	O	O
44	O	O
phylotypes	O	O
were	O	O
not	O	O
represented	O	O
in	O	O
GenBank	O	O
,	O	O
and	O	O
most	O	O
of	O	O
these	O	O
phylotypes	O	O
were	O	O
tentatively	O	O
identified	O	O
as	O	O
candidate	O	O
new	O	O
species	O	O
.	O	O

The	O	O
genera	O	O
most	O	O
frequently	O	O
isolated	O	O
from	O	O
saliva	O	O
were	O	O
Actinomyces	B-bacteria	B-bacteria
(	O	O
26	O	O
%	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
(	O	O
18	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Granulicatella	B-bacteria	B-bacteria
(	O	O
17	O	O
%	O	O
)	O	O
.	O	O

The	O	O
genera	O	O
most	O	O
frequently	O	O
isolated	O	O
from	O	O
plaque	O	O
were	O	O
Porphyromonas	B-bacteria	B-bacteria
(	O	O
20	O	O
%	O	O
)	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
(	O	O
12	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Neisseria	B-bacteria	B-bacteria
(	O	O
10	O	O
%	O	O
)	O	O
.	O	O

A	O	O
comparison	O	O
of	O	O
the	O	O
DNA	O	O
sequences	O	O
from	O	O
this	O	O
study	O	O
with	O	O
sequences	O	O
of	O	O
the	O	O
human	O	O
microbiota	O	O
available	O	O
in	O	O
GenBank	O	O
showed	O	O
that	O	O
,	O	O
on	O	O
average	O	O
,	O	O
canine	O	O
and	O	O
human	O	O
microbiotas	O	O
differed	O	O
by	O	O
almost	O	O
7	O	O
%	O	O
in	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
this	O	O
study	O	O
has	O	O
shown	O	O
that	O	O
the	O	O
cultivable	O	O
oral	O	O
microbiotas	O	O
of	O	O
dogs	O	O
and	O	O
humans	O	O
show	O	O
significant	O	O
differences	O	O
.	O	O

More	O	O
than	O	O
700	O	O
bacterial	O	O
species	O	O
or	O	O
phylotypes	O	O
,	O	O
of	O	O
which	O	O
over	O	O
50	O	O
%	O	O
have	O	O
not	O	O
been	O	O
cultivated	O	O
,	O	O
have	O	O
been	O	O
detected	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Our	O	O
purposes	O	O
were	O	O
(	O	O
i	O	O
)	O	O
to	O	O
utilize	O	O
culture-independent	O	O
molecular	O	O
techniques	O	O
to	O	O
extend	O	O
our	O	O
knowledge	O	O
on	O	O
the	O	O
breadth	O	O
of	O	O
bacterial	O	O
diversity	O	O
in	O	O
the	O	O
healthy	O	O
human	O	O
oral	O	O
cavity	O	O
,	O	O
including	O	O
not-yet-cultivated	O	O
bacteria	O	O
species	O	O
,	O	O
and	O	O
(	O	O
ii	O	O
)	O	O
to	O	O
determine	O	O
the	O	O
site	O	O
and	O	O
subject	O	O
specificity	O	O
of	O	O
bacterial	O	O
colonization	O	O
.	O	O

Nine	O	O
sites	O	O
from	O	O
five	O	O
clinically	O	O
healthy	O	O
subjects	O	O
were	O	O
analyzed	O	O
.	O	O

Sites	O	O
included	O	O
tongue	O	O
dorsum	O	O
,	O	O
lateral	O	O
sides	O	O
of	O	O
tongue	O	O
,	O	O
buccal	O	O
epithelium	O	O
,	O	O
hard	O	O
palate	O	O
,	O	O
soft	O	O
palate	O	O
,	O	O
supragingival	O	O
plaque	O	O
of	O	O
tooth	O	O
surfaces	O	O
,	O	O
subgingival	O	O
plaque	O	O
,	O	O
maxillary	O	O
anterior	O	O
vestibule	O	O
,	O	O
and	O	O
tonsils	O	O
.	O	O

16S	O	O
rRNA	O	O
genes	O	O
from	O	O
sample	O	O
DNA	O	O
were	O	O
amplified	O	O
,	O	O
cloned	O	O
,	O	O
and	O	O
transformed	O	O
into	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

Sequences	O	O
of	O	O
16S	O	O
rRNA	O	O
genes	O	O
were	O	O
used	O	O
to	O	O
determine	O	O
species	O	O
identity	O	O
or	O	O
closest	O	O
relatives	O	O
.	O	O

In	O	O
2,589	O	O
clones	O	O
,	O	O
141	O	O
predominant	O	O
species	O	O
were	O	O
detected	O	O
,	O	O
of	O	O
which	O	O
over	O	O
60	O	O
%	O	O
have	O	O
not	O	O
been	O	O
cultivated	O	O
.	O	O

Thirteen	O	O
new	O	O
phylotypes	O	O
were	O	O
identified	O	O
.	O	O

Species	O	O
common	O	O
to	O	O
all	O	O
sites	O	O
belonged	O	O
to	O	O
the	O	O
genera	O	O
Gemella	B-bacteria	B-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
.	O	O

While	O	O
some	O	O
species	O	O
were	O	O
subject	O	O
specific	O	O
and	O	O
detected	O	O
in	O	O
most	O	O
sites	O	O
,	O	O
other	O	O
species	O	O
were	O	O
site	O	O
specific	O	O
.	O	O

Most	O	O
sites	O	O
possessed	O	O
20	O	O
to	O	O
30	O	O
different	O	O
predominant	O	O
species	O	O
,	O	O
and	O	O
the	O	O
number	O	O
of	O	O
predominant	O	O
species	O	O
from	O	O
all	O	O
nine	O	O
sites	O	O
per	O	O
individual	O	O
ranged	O	O
from	O	O
34	O	O
to	O	O
72	O	O
.	O	O

Species	O	O
typically	O	O
associated	O	O
with	O	O
periodontitis	O	O
and	O	O
caries	O	O
were	O	O
not	O	O
detected	O	O
.	O	O

There	O	O
is	O	O
a	O	O
distinctive	O	O
predominant	O	O
bacterial	O	O
flora	O	O
of	O	O
the	O	O
healthy	O	O
oral	O	O
cavity	O	O
that	O	O
is	O	O
highly	O	O
diverse	O	O
and	O	O
site	O	O
and	O	O
subject	O	O
specific	O	O
.	O	O

It	O	O
is	O	O
important	O	O
to	O	O
fully	O	O
define	O	O
the	O	O
human	O	O
microflora	O	O
of	O	O
the	O	O
healthy	O	O
oral	O	O
cavity	O	O
before	O	O
we	O	O
can	O	O
understand	O	O
the	O	O
role	O	O
of	O	O
bacteria	O	O
in	O	O
oral	O	O
disease	O	O
.	O	O

Oral	O	O
malodour	O	O
is	O	O
considered	O	O
to	O	O
be	O	O
caused	O	O
by	O	O
the	O	O
proteolytic	O	O
activity	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
Gram-negative	I-bacteria	I-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

In	O	O
a	O	O
previous	O	O
study	O	O
,	O	O
it	O	O
was	O	O
shown	O	O
that	O	O
these	O	O
bacteria	O	O
were	O	O
susceptible	O	O
to	O	O
blue	O	O
light	O	O
(	O	O
wavelengths	O	O
of	O	O
400-500	O	O
nm	O	O
)	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
effect	O	O
of	O	O
blue	O	O
light	O	O
on	O	O
malodour	O	O
production	O	O
by	O	O
mixed	O	O
oral	O	O
microflora	O	O
was	O	O
tested	O	O
in	O	O
a	O	O
salivary	O	O
incubation	O	O
assay	O	O
.	O	O

Whole	O	O
saliva	O	O
samples	O	O
were	O	O
exposed	O	O
to	O	O
a	O	O
xenon	O	O
light	O	O
source	O	O
for	O	O
30	O	O
,	O	O
60	O	O
,	O	O
120	O	O
and	O	O
240	O	O
s	O	O
,	O	O
equivalent	O	O
to	O	O
fluences	O	O
of	O	O
34	O	O
,	O	O
68	O	O
,	O	O
137	O	O
and	O	O
274	O	O
J	O	O
cm	O	O
(	O	O
-2	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

Malodour	O	O
was	O	O
scored	O	O
by	O	O
two	O	O
judges	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
volatile	O	O
sulfide	O	O
compounds	O	O
(	O	O
VSC	O	O
)	O	O
were	O	O
measured	O	O
using	O	O
a	O	O
sulfide	O	O
monitor	O	O
(	O	O
Halimeter	O	O
)	O	O
,	O	O
the	O	O
microbial	O	O
population	O	O
was	O	O
assessed	O	O
using	O	O
viable	O	O
counts	O	O
and	O	O
microscopy	O	O
,	O	O
salivary	O	O
protein	O	O
degradation	O	O
was	O	O
followed	O	O
by	O	O
SDS-PAGE	O	O
densitometry	O	O
and	O	O
VSC-producing	O	O
bacteria	O	O
were	O	O
demonstrated	O	O
using	O	O
a	O	O
differential	O	O
agar	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
the	O	O
exposure	O	O
of	O	O
mixed	O	O
salivary	O	O
microflora	O	O
to	O	O
blue	O	O
light	O	O
caused	O	O
a	O	O
reduction	O	O
in	O	O
malodour	O	O
production	O	O
concomitant	O	O
with	O	O
a	O	O
selective	O	O
inhibitory	O	O
effect	O	O
on	O	O
the	O	O
population	O	O
of	O	O
Gram-negative	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
light	O	O
exposure	O	O
might	O	O
have	O	O
clinical	O	O
applications	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
oral	O	O
malodour	O	O
.	O	O

Current	O	O
treatment	O	O
options	O	O
in	O	O
patients	O	O
with	O	O
primary	O	O
and	O	O
secondary	O	O
hyperoxaluria	O	O
are	O	O
limited	O	O
and	O	O
do	O	O
not	O	O
always	O	O
lead	O	O
to	O	O
sufficient	O	O
reduction	O	O
in	O	O
urinary	O	O
oxalate	O	O
excretion	O	O
.	O	O

Intestinal	O	O
oxalate	O	O
degrading	O	O
bacteria	O	O
are	O	O
capable	O	O
of	O	O
degrading	O	O
oxalate	O	O
to	O	O
CO	O	O
(	O	O
2	O	O
)	O	O
and	O	O
formate	O	O
,	O	O
the	O	O
latter	O	O
being	O	O
further	O	O
metabolized	O	O
and	O	O
excreted	O	O
via	O	O
the	O	O
feces	O	O
.	O	O

It	O	O
is	O	O
speculated	O	O
,	O	O
that	O	O
both	O	O
endogenously	O	O
produced	O	O
,	O	O
as	O	O
well	O	O
as	O	O
dietary	O	O
oxalate	O	O
can	O	O
be	O	O
significantly	O	O
removed	O	O
via	O	O
the	O	O
intestinal	O	O
tract	O	O
.	O	O

Oxalobacter	B-bacteria	B-bacteria
formigenes	E-bacteria	I-bacteria
,	O	O
an	O	O
obligate	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
microbe	E-bacteria	I-bacteria
normally	O	O
found	O	O
in	O	O
the	O	O
intestinal	O	O
tract	O	O
has	O	O
one	O	O
oxalate	O	O
degrading	O	O
enzyme	O	O
,	O	O
oxalyl-CoA	O	O
decarboxylase	O	O
,	O	O
which	O	O
is	O	O
also	O	O
found	O	O
in	O	O
Bifidobacterium	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
.	O	O

Other	O	O
bacteria	O	O
with	O	O
possible	O	O
oxalate	O	O
degrading	O	O
potency	O	O
are	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
Eubacterium	B-bacteria	B-bacteria
lentum	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
specific	O	O
therapeutic	O	O
studies	O	O
on	O	O
humans	O	O
are	O	O
scarce	O	O
and	O	O
,	O	O
except	O	O
for	O	O
Oxalobacter	B-bacteria	B-bacteria
,	O	O
data	O	O
are	O	O
not	O	O
congruent	O	O
.	O	O

We	O	O
found	O	O
the	O	O
oral	O	O
application	O	O
of	O	O
Oxalobacter	B-bacteria	B-bacteria
successful	O	O
in	O	O
patients	O	O
with	O	O
primary	O	O
hyperoxaluria	O	O
.	O	O

However	O	O
,	O	O
long-term	O	O
post-treatment	O	O
follow-up	O	O
of	O	O
1-2	O	O
years	O	O
showed	O	O
that	O	O
constant	O	O
intestinal	O	O
colonization	O	O
is	O	O
not	O	O
achieved	O	O
in	O	O
most	O	O
patients	O	O
.	O	O

In	O	O
one	O	O
patient	O	O
with	O	O
constant	O	O
colonization	O	O
,	O	O
urinary	O	O
oxalate	O	O
excretion	O	O
normalized	O	O
over	O	O
time	O	O
.	O	O

Short-term	O	O
studies	O	O
with	O	O
other	O	O
bacteria	O	O
such	O	O
as	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
did	O	O
not	O	O
show	O	O
a	O	O
specific	O	O
reduction	O	O
in	O	O
urinary	O	O
oxalate	O	O
excretion	O	O
.	O	O

O.	B-bacteria	B-bacteria
formigenes	E-bacteria	I-bacteria
might	O	O
be	O	O
a	O	O
promising	O	O
new	O	O
therapeutic	O	O
tool	O	O
in	O	O
patients	O	O
with	O	O
primary	O	O
and	O	O
secondary	O	O
hyperoxaluria	O	O
.	O	O

A	O	O
novel	O	O
mouthrinse	O	O
(	O	O
IND	O	O
61,164	O	O
)	O	O
containing	O	O
essential	O	O
oils	O	O
and	O	O
extracts	O	O
from	O	O
four	O	O
plant	O	O
species	O	O
(	O	O
Melaleuca	O	O
alternifolia	O	O
,	O	O
Leptospermum	O	O
scoparium	O	O
,	O	O
Calendula	O	O
officinalis	O	O
and	O	O
Camellia	O	O
sinensis	O	O
)	O	O
were	O	O
tested	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
evaluate	O	O
the	O	O
safety	O	O
,	O	O
palatability	O	O
and	O	O
preliminary	O	O
efficacy	O	O
of	O	O
the	O	O
rinse	O	O
.	O	O

Fifteen	O	O
subjects	O	O
completed	O	O
the	O	O
Phase	O	O
I	O	O
safety	O	O
study	O	O
.	O	O

Seventeen	O	O
subjects	O	O
completed	O	O
the	O	O
Phase	O	O
II	O	O
randomized	O	O
placebo-controlled	O	O
study	O	O
.	O	O

Plaque	O	O
was	O	O
collected	O	O
,	O	O
gingival	O	O
and	O	O
plaque	O	O
indices	O	O
were	O	O
recorded	O	O
(	O	O
baseline	O	O
,	O	O
6	O	O
weeks	O	O
,	O	O
and	O	O
12	O	O
weeks	O	O
)	O	O
.	O	O

The	O	O
relative	O	O
abundance	O	O
of	O	O
two	O	O
periodontal	O	O
pathogens	O	O
(	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Tanerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
was	O	O
determined	O	O
utilizing	O	O
digoxigenin-labeled	O	O
DNA	O	O
probes	O	O
.	O	O

ANCOVA	O	O
was	O	O
used	O	O
at	O	O
the	O	O
p	O	O
=	O	O
0.05	O	O
level	O	O
of	O	O
significance	O	O
.	O	O

Two	O	O
subjects	O	O
reported	O	O
a	O	O
minor	O	O
adverse	O	O
event	O	O
.	O	O

One	O	O
subject	O	O
withdrew	O	O
from	O	O
the	O	O
study	O	O
.	O	O

Several	O	O
subjects	O	O
objected	O	O
to	O	O
the	O	O
taste	O	O
of	O	O
the	O	O
test	O	O
rinse	O	O
but	O	O
continued	O	O
treatment	O	O
.	O	O

Differences	O	O
between	O	O
gingival	O	O
index	O	O
,	O	O
plaque	O	O
index	O	O
or	O	O
relative	O	O
abundance	O	O
of	O	O
either	O	O
bacterial	O	O
species	O	O
did	O	O
not	O	O
reach	O	O
statistical	O	O
significance	O	O
when	O	O
comparing	O	O
nine	O	O
placebo	O	O
subjects	O	O
with	O	O
eight	O	O
test	O	O
rinse	O	O
subjects	O	O
.	O	O

Subjects	O	O
exposed	O	O
to	O	O
the	O	O
test	O	O
rinse	O	O
experienced	O	O
no	O	O
abnormal	O	O
oral	O	O
lesions	O	O
,	O	O
altered	O	O
vital	O	O
signs	O	O
,	O	O
changes	O	O
in	O	O
liver	O	O
,	O	O
kidney	O	O
,	O	O
or	O	O
bone	O	O
marrow	O	O
function	O	O
.	O	O

Larger	O	O
scale	O	O
studies	O	O
would	O	O
be	O	O
necessary	O	O
to	O	O
determine	O	O
the	O	O
efficacy	O	O
and	O	O
oral	O	O
health	O	O
benefits	O	O
of	O	O
the	O	O
test	O	O
rinse	O	O
.	O	O

Human	O	O
dental	O	O
plaque	O	O
is	O	O
thought	O	O
to	O	O
contribute	O	O
to	O	O
disease	O	O
,	O	O
not	O	O
only	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
but	O	O
also	O	O
at	O	O
other	O	O
body	O	O
sites	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
pathogenicity	O	O
of	O	O
dental	O	O
plaque	O	O
in	O	O
tissues	O	O
remote	O	O
from	O	O
the	O	O
mouth	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
ability	O	O
of	O	O
human	O	O
supragingival	O	O
dental	O	O
plaque	O	O
to	O	O
induce	O	O
infective	O	O
endocarditis	O	O
(	O	O
IE	O	O
)	O	O
in	O	O
rats	O	O
.	O	O

In	O	O
total	O	O
,	O	O
15	O	O
out	O	O
of	O	O
27	O	O
catheterized	O	O
rats	O	O
survived	O	O
after	O	O
intravenous	O	O
injections	O	O
with	O	O
human	O	O
supragingival	O	O
dental	O	O
plaque	O	O
suspensions	O	O
containing	O	O
3	O	O
x	O	O
10	O	O
(	O	O
6	O	O
)	O	O
colony-forming	O	O
units	O	O
(	O	O
CFU	O	O
)	O	O
of	O	O
bacterial	O	O
cells	O	O
.	O	O

In	O	O
surviving	O	O
rats	O	O
,	O	O
infected	O	O
vegetations	O	O
were	O	O
formed	O	O
in	O	O
all	O	O
except	O	O
one	O	O
rat	O	O
.	O	O

The	O	O
microbial	O	O
composition	O	O
of	O	O
the	O	O
infected	O	O
vegetations	O	O
was	O	O
different	O	O
from	O	O
that	O	O
of	O	O
the	O	O
respective	O	O
dental	O	O
plaque	O	O
inocula	O	O
,	O	O
with	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
comprising	O	O
the	O	O
majority	O	O
of	O	O
the	O	O
isolates	O	O
.	O	O

In	O	O
rats	O	O
affected	O	O
with	O	O
endocarditis	O	O
,	O	O
the	O	O
aortic	O	O
sinus	O	O
was	O	O
filled	O	O
with	O	O
fibrinous	O	O
vegetation	O	O
containing	O	O
bacteria	O	O
.	O	O

Inflammatory	O	O
cells	O	O
infiltrated	O	O
the	O	O
aortic	O	O
valve	O	O
,	O	O
the	O	O
aorta	O	O
adjacent	O	O
to	O	O
the	O	O
valve	O	O
,	O	O
and	O	O
the	O	O
cardiac	O	O
muscles	O	O
.	O	O

The	O	O
inoculation	O	O
of	O	O
catheterized	O	O
rats	O	O
with	O	O
a	O	O
cell	O	O
suspension	O	O
of	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
isolate	O	O
(	O	O
5	O	O
x	O	O
10	O	O
(	O	O
6	O	O
)	O	O
CFU	O	O
)	O	O
was	O	O
not	O	O
lethal	O	O
but	O	O
capable	O	O
of	O	O
inducing	O	O
endocarditis	O	O
in	O	O
all	O	O
animals	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
if	O	O
dental	O	O
plaque	O	O
were	O	O
introduced	O	O
into	O	O
the	O	O
bloodstream	O	O
,	O	O
it	O	O
could	O	O
serve	O	O
as	O	O
a	O	O
potent	O	O
source	O	O
of	O	O
bacteria	O	O
causing	O	O
IE	O	O
in	O	O
humans	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
)	O	O
is	O	O
an	O	O
important	O	O
gastrointestinal	O	O
pathogen	O	O
associated	O	O
with	O	O
gastritis	O	O
as	O	O
well	O	O
as	O	O
gastric	O	O
or	O	O
duodenal	O	O
ulcers	O	O
and	O	O
gastric	O	O
cancer	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
has	O	O
been	O	O
considered	O	O
as	O	O
a	O	O
potential	O	O
reservoir	O	O
for	O	O
the	O	O
gastric	O	O
infection	O	O
and	O	O
reinfection	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
our	O	O
studies	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
influence	O	O
of	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
for	O	O
the	O	O
stomach	O	O
infection	O	O
and	O	O
the	O	O
release	O	O
of	O	O
gut	O	O
hormones	O	O
affecting	O	O
food	O	O
intake	O	O
such	O	O
as	O	O
ghrelin	O	O
and	O	O
gastric	O	O
secretion	O	O
such	O	O
as	O	O
gastrin	O	O
.	O	O

Additionally	O	O
,	O	O
the	O	O
contribution	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
periodontal	O	O
disease	O	O
has	O	O
been	O	O
examined	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
in	O	O
stomach	O	O
was	O	O
assessed	O	O
by	O	O
(	O	O
13	O	O
)	O	O
C-	O	O
Urease	O	O
Breath	O	O
Test	O	O
and	O	O
presence	O	O
of	O	O
the	O	O
bacteria	O	O
in	O	O
oral	O	O
cavity	O	O
by	O	O
culture	O	O
.	O	O

The	O	O
periodontal	O	O
status	O	O
was	O	O
measured	O	O
by	O	O
pockets	O	O
depth	O	O
with	O	O
the	O	O
periodontal	O	O
probe	O	O
.	O	O

We	O	O
estimated	O	O
the	O	O
serum	O	O
level	O	O
of	O	O
IgG	O	O
anti-H.	O	O
pylori	O	O
,	O	O
anti-VacA	O	O
,	O	O
anti-CagA	O	O
,	O	O
ghrelin	O	O
,	O	O
gastrin	O	O
,	O	O
TNF-alpha	O	O
and	O	O
IL-8	O	O
in	O	O
blood	O	O
and	O	O
the	O	O
level	O	O
of	O	O
IgA	O	O
anti-H.	O	O
pylori	O	O
in	O	O
saliva	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
cavity	O	O
was	O	O
detected	O	O
in	O	O
54.1	O	O
%	O	O
of	O	O
examined	O	O
individuals	O	O
,	O	O
whereas	O	O
the	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
gastric	O	O
infection	O	O
in	O	O
tested	O	O
group	O	O
was	O	O
found	O	O
in	O	O
51	O	O
%	O	O
cases	O	O
.	O	O

However	O	O
,	O	O
the	O	O
correlation	O	O
analysis	O	O
between	O	O
those	O	O
two	O	O
groups	O	O
of	O	O
patients	O	O
involving	O	O
together	O	O
about	O	O
100	O	O
subjects	O	O
showed	O	O
that	O	O
within	O	O
the	O	O
group	O	O
of	O	O
patients	O	O
with	O	O
positive	O	O
gastric	B-bacteria	B-bacteria
H.	I-bacteria	I-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
only	O	O
45.1	O	O
%	O	O
did	O	O
not	O	O
show	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
saliva	O	O
and	O	O
43.1	O	O
%	O	O
showed	O	O
no	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
supragingival	O	O
plaque	O	O
.	O	O

In	O	O
line	O	O
of	O	O
these	O	O
findings	O	O
patients	O	O
who	O	O
did	O	O
not	O	O
have	O	O
gastric	B-bacteria	B-bacteria
H.	I-bacteria	I-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
,	O	O
53.2	O	O
%	O	O
showed	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
saliva	O	O
and	O	O
42.9	O	O
%	O	O
in	O	O
supragingival	O	O
plaques	O	O
.	O	O

Serum	O	O
level	O	O
of	O	O
ghrelin	O	O
and	O	O
gastrin	O	O
in	O	O
subjects	O	O
with	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
inoculation	O	O
but	O	O
without	O	O
gastric	B-bacteria	B-bacteria
H.	I-bacteria	I-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
were	O	O
not	O	O
significantly	O	O
different	O	O
from	O	O
those	O	O
without	O	O
the	O	O
presence	O	O
of	O	O
this	O	O
germ	O	O
in	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
gastric	B-bacteria	B-bacteria
H.	I-bacteria	I-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
resulted	O	O
in	O	O
significant	O	O
reduction	O	O
in	O	O
serum	O	O
ghrelin	O	O
levels	O	O
and	O	O
significant	O	O
elevation	O	O
of	O	O
gastrin	O	O
as	O	O
compared	O	O
to	O	O
those	O	O
who	O	O
were	O	O
gastric	B-bacteria	B-bacteria
H.	I-bacteria	I-bacteria
pylori	E-bacteria	I-bacteria
negative	O	O
.	O	O

We	O	O
concluded	O	O
that	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
alone	O	O
does	O	O
not	O	O
seem	O	O
to	O	O
serve	O	O
as	O	O
bacterium	O	O
sanctuary	O	O
for	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
and	O	O
,	O	O
unlike	O	O
gastric	O	O
infection	O	O
,	O	O
it	O	O
fails	O	O
to	O	O
affect	O	O
serum	O	O
levels	O	O
of	O	O
hormones	O	O
stimulating	O	O
appetitive	O	O
behaviour	O	O
such	O	O
as	O	O
ghrelin	O	O
and	O	O
gastric	O	O
acid	O	O
secretion	O	O
such	O	O
as	O	O
gastrin	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
prospective	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
long	O	O
term	O	O
change	O	O
in	O	O
oral	O	O
pathogens	O	O
following	O	O
radiation	O	O
therapy	O	O
.	O	O

Twenty-two	O	O
patients	O	O
with	O	O
planned	O	O
radiation	O	O
therapy	O	O
(	O	O
>	O	O
30	O	O
Gy	O	O
)	O	O
of	O	O
head	O	O
and	O	O
neck	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
were	O	O
included	O	O
.	O	O

Before	O	O
radiation	O	O
therapy	O	O
,	O	O
after	O	O
3	O	O
,	O	O
6	O	O
,	O	O
and	O	O
12	O	O
months	O	O
samples	O	O
from	O	O
the	O	O
deepest	O	O
periodontal	O	O
pocket	O	O
were	O	O
drawn	O	O
.	O	O

Five	O	O
major	O	O
periodontal	O	O
pathogens	O	O
were	O	O
studied	O	O
using	O	O
DNA	O	O
probes	O	O
(	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Bacteriodes	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
.	O	O

Stimulated	O	O
saliva	O	O
was	O	O
sampled	O	O
for	O	O
the	O	O
microbiologic	O	O
study	O	O
of	O	O
caries	O	O
pathogens	O	O
(	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
)	O	O
.	O	O

Plaque	O	O
index	O	O
and	O	O
decayed	O	O
,	O	O
missing	O	O
,	O	O
filled	O	O
tooth	O	O
surfaces	O	O
(	O	O
DMF-S	O	O
)	O	O
were	O	O
recorded	O	O
.	O	O

A	O	O
normalisation	O	O
of	O	O
the	O	O
caries	O	O
bacteria	O	O
is	O	O
not	O	O
found	O	O
correlating	O	O
to	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
the	O	O
number	O	O
of	O	O
affected	O	O
teeth	O	O
(	O	O
DMF-S	O	O
)	O	O
from	O	O
80.7	O	O
to	O	O
88.5	O	O
after	O	O
12	O	O
months	O	O
.	O	O

The	O	O
plaque	O	O
index	O	O
remained	O	O
unchanged	O	O
.	O	O

The	O	O
incidence	O	O
of	O	O
periodontal	O	O
pathogens	O	O
did	O	O
not	O	O
significantly	O	O
change	O	O
during	O	O
the	O	O
follow	O	O
up	O	O
.	O	O

In	O	O
contrast	O	O
to	O	O
radiation	O	O
caries	O	O
there	O	O
seems	O	O
to	O	O
be	O	O
no	O	O
microbiological	O	O
evidence	O	O
for	O	O
``	O	O
radiation	O	O
periodontitis	O	O
''	O	O
.	O	O

Despite	O	O
of	O	O
the	O	O
intensive	O	O
oral	O	O
hygiene	O	O
no	O	O
reduction	O	O
of	O	O
the	O	O
high	O	O
number	O	O
of	O	O
caries	O	O
pathogens	O	O
is	O	O
found	O	O
,	O	O
which	O	O
leads	O	O
to	O	O
a	O	O
high	O	O
risk	O	O
of	O	O
tooth	O	O
decay	O	O
even	O	O
12	O	O
months	O	O
after	O	O
radiation	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
number	O	O
of	O	O
bacteria	O	O
extruded	O	O
apically	O	O
from	O	O
extracted	O	O
teeth	O	O
ex	O	O
vivo	O	O
after	O	O
canal	O	O
instrumentation	O	O
using	O	O
the	O	O
two	O	O
engine-driven	O	O
techniques	O	O
utilizing	O	O
nickel-titanium	O	O
instruments	O	O
(	O	O
ProTaper	O	O
and	O	O
System	O	O
GT	O	O
)	O	O
.	O	O

Forty	O	O
extracted	O	O
single-rooted	O	O
human	O	O
mandibular	O	O
premolar	O	O
teeth	O	O
were	O	O
used	O	O
.	O	O

Access	O	O
cavities	O	O
were	O	O
prepared	O	O
and	O	O
root	O	O
canals	O	O
were	O	O
then	O	O
contaminated	O	O
with	O	O
a	O	O
suspension	O	O
of	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
dried	O	O
.	O	O

The	O	O
contaminated	O	O
roots	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
experimental	O	O
groups	O	O
of	O	O
15	O	O
teeth	O	O
each	O	O
and	O	O
one	O	O
control	O	O
group	O	O
of	O	O
10	O	O
teeth	O	O
.	O	O

Group	O	O
1	O	O
,	O	O
ProTaper	O	O
group	O	O
:	O	O
the	O	O
root	O	O
canals	O	O
were	O	O
instrumented	O	O
using	O	O
ProTaper	O	O
instruments	O	O
.	O	O

Group	O	O
2	O	O
,	O	O
System	O	O
GT	O	O
group	O	O
:	O	O
the	O	O
root	O	O
canals	O	O
were	O	O
instrumented	O	O
using	O	O
System	O	O
GT	O	O
instruments	O	O
.	O	O

Group	O	O
3	O	O
,	O	O
control	O	O
group	O	O
:	O	O
no	O	O
instrumentation	O	O
was	O	O
attempted	O	O
.	O	O

Bacteria	O	O
extruded	O	O
from	O	O
the	O	O
apical	O	O
foramen	O	O
during	O	O
instrumentation	O	O
were	O	O
collected	O	O
into	O	O
vials	O	O
.	O	O

The	O	O
microbiological	O	O
samples	O	O
from	O	O
the	O	O
vials	O	O
were	O	O
incubated	O	O
in	O	O
culture	O	O
media	O	O
for	O	O
24	O	O
h.	O	O
Colonies	O	O
of	O	O
bacteria	O	O
were	O	O
counted	O	O
and	O	O
the	O	O
results	O	O
were	O	O
given	O	O
as	O	O
number	O	O
of	O	O
colony-forming	O	O
units	O	O
.	O	O

The	O	O
data	O	O
obtained	O	O
were	O	O
analysed	O	O
using	O	O
the	O	O
Kruskal-Wallis	O	O
one-way	O	O
analysis	O	O
of	O	O
variance	O	O
and	O	O
Mann-Whitney	O	O
U-tests	O	O
,	O	O
with	O	O
alpha	O	O
=	O	O
0.05	O	O
as	O	O
the	O	O
level	O	O
for	O	O
statistical	O	O
significance	O	O
.	O	O

There	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
as	O	O
to	O	O
the	O	O
number	O	O
of	O	O
extruded	O	O
bacteria	O	O
between	O	O
the	O	O
ProTaper	O	O
and	O	O
System	O	O
GT	O	O
engine-driven	O	O
systems	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Both	O	O
engine-driven	O	O
nickel-titanium	O	O
systems	O	O
extruded	O	O
bacteria	O	O
through	O	O
the	O	O
apical	O	O
foramen	O	O
.	O	O

This	O	O
study	O	O
was	O	O
conducted	O	O
to	O	O
determine	O	O
the	O	O
component	O	O
that	O	O
causes	O	O
the	O	O
disease	O	O
in	O	O
rheumatoid	O	O
arthritis	O	O
(	O	O
RA	O	O
)	O	O
,	O	O
which	O	O
shows	O	O
great	O	O
resemblance	O	O
to	O	O
periodontitis	O	O
in	O	O
a	O	O
pathologic	O	O
context	O	O
.	O	O

Within	O	O
this	O	O
study	O	O
,	O	O
the	O	O
pathogen-specific	O	O
IgG	O	O
levels	O	O
formed	O	O
against	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
FDC	I-bacteria	I-bacteria
381	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25845	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
Y4	E-bacteria	I-bacteria
,	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
43047	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
25611	I-bacteria	I-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
researched	O	O
from	O	O
the	O	O
blood	O	O
serum	O	O
samples	O	O
of	O	O
30	O	O
RA	O	O
patients	O	O
and	O	O
20	O	O
healthy	O	O
controls	O	O
with	O	O
the	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
(	O	O
ELISA	O	O
)	O	O
method	O	O
.	O	O

The	O	O
IgG	O	O
levels	O	O
of	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
P	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
,	O	O
and	O	O
B	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
were	O	O
found	O	O
to	O	O
be	O	O
significantly	O	O
higher	O	O
in	O	O
RA	O	O
patients	O	O
when	O	O
compared	O	O
with	O	O
those	O	O
of	O	O
the	O	O
controls	O	O
.	O	O

Of	O	O
the	O	O
other	O	O
bacteria	O	O
antibodies	O	O
,	O	O
A	O	O
actinomycetemcomitans	O	O
was	O	O
not	O	O
found	O	O
at	O	O
greater	O	O
levels	O	O
in	O	O
RA	O	O
serum	O	O
samples	O	O
in	O	O
comparison	O	O
with	O	O
the	O	O
healthy	O	O
samples	O	O
.	O	O

The	O	O
antibodies	O	O
formed	O	O
against	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
P	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
,	O	O
and	O	O
B	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
could	O	O
be	O	O
important	O	O
to	O	O
the	O	O
etiopathogenesis	O	O
of	O	O
RA	O	O
.	O	O

A	O	O
significant	O	O
proportion	O	O
of	O	O
oral	O	O
bacteria	O	O
are	O	O
unable	O	O
to	O	O
undergo	O	O
cultivation	O	O
by	O	O
existing	O	O
techniques	O	O
.	O	O

In	O	O
this	O	O
regard	O	O
,	O	O
the	O	O
microbiota	O	O
from	O	O
root	O	O
canals	O	O
still	O	O
requires	O	O
complementary	O	O
characterization	O	O
.	O	O

The	O	O
present	O	O
study	O	O
aimed	O	O
at	O	O
the	O	O
identification	O	O
of	O	O
bacteria	O	O
by	O	O
sequence	O	O
analysis	O	O
of	O	O
16S	O	O
rDNA	O	O
clone	O	O
libraries	O	O
from	O	O
seven	O	O
endodontically	O	O
infected	O	O
teeth	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
root	O	O
canals	O	O
,	O	O
subjected	O	O
to	O	O
the	O	O
PCR	O	O
with	O	O
universal	O	O
16S	O	O
rDNA	O	O
primers	O	O
,	O	O
cloned	O	O
and	O	O
partially	O	O
sequenced	O	O
.	O	O

Clones	O	O
were	O	O
clustered	O	O
into	O	O
groups	O	O
of	O	O
closely	O	O
related	O	O
sequences	O	O
(	O	O
phylotypes	O	O
)	O	O
and	O	O
identification	O	O
to	O	O
the	O	O
species	O	O
level	O	O
was	O	O
performed	O	O
by	O	O
comparative	O	O
analysis	O	O
with	O	O
the	O	O
GenBank	O	O
,	O	O
EMBL	O	O
and	O	O
DDBJ	O	O
databases	O	O
,	O	O
according	O	O
to	O	O
a	O	O
98	O	O
%	O	O
minimum	O	O
identity	O	O
.	O	O

All	O	O
samples	O	O
were	O	O
positive	O	O
for	O	O
bacteria	O	O
and	O	O
the	O	O
number	O	O
of	O	O
phylotypes	O	O
detected	O	O
per	O	O
subject	O	O
varied	O	O
from	O	O
two	O	O
to	O	O
14	O	O
.	O	O

The	O	O
majority	O	O
of	O	O
taxa	O	O
(	O	O
65.2	O	O
%	O	O
)	O	O
belonged	O	O
to	O	O
the	O	O
phylum	B-bacteria	B-bacteria
Firmicutes	E-bacteria	I-bacteria
of	O	O
the	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
followed	O	O
by	O	O
Proteobacteria	B-bacteria	B-bacteria
(	O	O
10.9	O	O
%	O	O
)	O	O
,	O	O
Spirochaetes	B-bacteria	B-bacteria
(	O	O
4.3	O	O
%	O	O
)	O	O
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
(	O	O
6.5	O	O
%	O	O
)	O	O
,	O	O
Actinobacteria	B-bacteria	B-bacteria
(	O	O
2.2	O	O
%	O	O
)	O	O
and	O	O
Deferribacteres	B-bacteria	B-bacteria
(	O	O
2.2	O	O
%	O	O
)	O	O
.	O	O

A	O	O
total	O	O
of	O	O
46	O	O
distinct	O	O
taxonomic	O	O
units	O	O
was	O	O
identified	O	O
.	O	O

Four	O	O
clones	O	O
with	O	O
low	O	O
similarity	O	O
to	O	O
sequences	O	O
previously	O	O
deposited	O	O
in	O	O
the	O	O
databases	O	O
were	O	O
sequenced	O	O
to	O	O
nearly	O	O
full	O	O
extent	O	O
and	O	O
were	O	O
classified	O	O
taxonomically	O	O
as	O	O
novel	O	O
representatives	O	O
of	O	O
the	O	O
order	O	O
Clostridiales	B-bacteria	B-bacteria
,	O	O
including	O	O
a	O	O
putative	O	O
novel	O	O
species	O	O
of	O	O
Mogibacterium	B-bacteria	B-bacteria
.	O	O

The	O	O
identification	O	O
of	O	O
novel	O	O
phylotypes	O	O
associated	O	O
with	O	O
endodontic	O	O
infections	O	O
suggests	O	O
that	O	O
the	O	O
endodontium	O	O
may	O	O
still	O	O
harbour	O	O
a	O	O
relevant	O	O
proportion	O	O
of	O	O
uncharacterized	O	O
taxa	O	O
.	O	O

An	O	O
evaluation	O	O
is	O	O
made	O	O
of	O	O
bacterial	O	O
species	O	O
and	O	O
susceptibility	O	O
to	O	O
various	O	O
antibiotics	O	O
used	O	O
in	O	O
application	O	O
to	O	O
odontogenic	O	O
infections	O	O
of	O	O
periapical	O	O
location	O	O
and	O	O
in	O	O
pericoronitis	O	O
of	O	O
the	O	O
lower	O	O
third	O	O
molar	O	O
,	O	O
with	O	O
the	O	O
aim	O	O
of	O	O
optimizing	O	O
the	O	O
antibiotherapy	O	O
of	O	O
such	O	O
infections	O	O
and	O	O
thus	O	O
preventing	O	O
unnecessary	O	O
side	O	O
effects	O	O
and	O	O
over-treatment	O	O
.	O	O

Sixty-four	O	O
patients	O	O
with	O	O
odontogenic	O	O
infection	O	O
were	O	O
selected	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
a	O	O
series	O	O
of	O	O
inclusion	O	O
and	O	O
exclusion	O	O
criteria	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
lesions	O	O
under	O	O
maximally	O	O
aseptic	O	O
conditions	O	O
,	O	O
avoiding	O	O
oral	O	O
saprophytic	O	O
contamination	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
cultured	O	O
and	O	O
incubated	O	O
under	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
conditions	O	O
,	O	O
followed	O	O
by	O	O
bacteriological	O	O
identification	O	O
and	O	O
antibiotic	O	O
susceptibility	O	O
testing	O	O
.	O	O

A	O	O
total	O	O
of	O	O
184	O	O
bacterial	O	O
strains	O	O
were	O	O
isolated	O	O
and	O	O
identified	O	O
,	O	O
comprising	O	O
grampositive	B-bacteria	B-bacteria
facultative	I-bacteria	I-bacteria
anaerobes	E-bacteria	I-bacteria
(	O	O
68	O	O
%	O	O
)	O	O
,	O	O
gramnegative	B-bacteria	B-bacteria
strict	I-bacteria	I-bacteria
anaerobes	E-bacteria	I-bacteria
(	O	O
30	O	O
%	O	O
)	O	O
and	O	O
grampositive	B-bacteria	B-bacteria
facultative	I-bacteria	I-bacteria
anaerobes	E-bacteria	I-bacteria
(	O	O
2	O	O
%	O	O
)	O	O
.	O	O

Regardless	O	O
of	O	O
the	O	O
origin	O	O
of	O	O
the	O	O
odontogenic	O	O
infection	O	O
,	O	O
the	O	O
causal	O	O
bacteria	O	O
yielded	O	O
the	O	O
best	O	O
results	O	O
in	O	O
terms	O	O
of	O	O
increased	O	O
sensitivity	O	O
and	O	O
lesser	O	O
resistance	O	O
with	O	O
amoxicillin	O	O
/	O	O
clavulanate	O	O
and	O	O
amoxicillin	O	O
,	O	O
respectively	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

There	O	O
are	O	O
increasingly	O	O
numerous	O	O
reports	O	O
in	O	O
the	O	O
literature	O	O
of	O	O
growing	O	O
bacterial	O	O
resistance	O	O
to	O	O
antibiotics	O	O
in	O	O
infectious	O	O
processes	O	O
affecting	O	O
non-buccodental	O	O
territories	O	O
.	O	O

This	O	O
same	O	O
tendency	O	O
has	O	O
not	O	O
been	O	O
observed	O	O
in	O	O
relation	O	O
to	O	O
oral	O	O
infections	O	O
,	O	O
though	O	O
important	O	O
resistance	O	O
has	O	O
been	O	O
documented	O	O
for	O	O
certain	O	O
concrete	O	O
antibiotics	O	O
.	O	O

According	O	O
to	O	O
our	O	O
results	O	O
,	O	O
the	O	O
common-use	O	O
antibiotics	O	O
with	O	O
the	O	O
greatest	O	O
sensitivity	O	O
and	O	O
lowest	O	O
resistance	O	O
were	O	O
shown	O	O
to	O	O
be	O	O
amoxicillin/clavulanate	O	O
followed	O	O
by	O	O
amoxicillin	O	O
alone	O	O
.	O	O

In	O	O
various	O	O
immunopathologic	O	O
conditions	O	O
,	O	O
bacterial	O	O
flora	O	O
induce	O	O
an	O	O
immune	O	O
response	O	O
which	O	O
results	O	O
in	O	O
inflammatory	O	O
manifestations	O	O
,	O	O
e.g	O	O
.	O	O

periapical	O	O
granuloma	O	O
.	O	O

Dendritic	O	O
cells	O	O
provide	O	O
the	O	O
main	O	O
orchestration	O	O
of	O	O
specific	O	O
immune	O	O
responses	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
our	O	O
study	O	O
was	O	O
to	O	O
test	O	O
the	O	O
capacity	O	O
of	O	O
distinct	O	O
oral	O	O
bacterial	O	O
antigens	O	O
(	O	O
prepared	O	O
from	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
,	O	O
and	O	O
Bacteroides	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
)	O	O

to	O	O
prime	O	O
human	O	O
dendritic	O	O
cells	O	O
for	O	O
stimulation	O	O
of	O	O
the	O	O
T-lymphocyte	O	O
response	O	O
.	O	O

To	O	O
assess	O	O
the	O	O
T-lymphocyte	O	O
response	O	O
,	O	O
the	O	O
expression	O	O
of	O	O
CD25	O	O
,	O	O
CD69	O	O
,	O	O
intracellular	O	O
interferon	O	O
gamma	O	O
(	O	O
cIFN-gamma	O	O
)	O	O
,	O	O
and	O	O
intracellular	O	O
interleukin	O	O
4	O	O
(	O	O
cIL-4	O	O
)	O	O
was	O	O
determined	O	O
.	O	O

Dendritic	O	O
cells	O	O
were	O	O
prepared	O	O
from	O	O
leukocyte	O	O
buffy	O	O
coat	O	O
from	O	O
healthy	O	O
blood	O	O
donors	O	O
.	O	O

Monocytes	O	O
were	O	O
stimulated	O	O
with	O	O
IL-4	O	O
and	O	O
GM-CSF	O	O
and	O	O
dendritic	O	O
cells	O	O
activated	O	O
with	O	O
bacterial	O	O
lysates	O	O
.	O	O

Cell	O	O
suspensions	O	O
contained	O	O
up	O	O
to	O	O
90	O	O
%	O	O
dendritic	O	O
cells	O	O
,	O	O
which	O	O
represented	O	O
2-12	O	O
%	O	O
of	O	O
the	O	O
initial	O	O
number	O	O
of	O	O
mononuclear	O	O
cells	O	O
.	O	O

Lymphocyte	O	O
subsets	O	O
that	O	O
developed	O	O
in	O	O
lymphocyte	O	O
cultures	O	O
after	O	O
1	O	O
week	O	O
of	O	O
stimulation	O	O
were	O	O
analyzed	O	O
by	O	O
flow	O	O
cytometry	O	O
.	O	O

Dendritic	O	O
cells	O	O
,	O	O
primed	O	O
with	O	O
antigens	O	O
of	O	O
Bacteroides	B-bacteria	B-bacteria
fragilis	E-bacteria	I-bacteria
have	O	O
shown	O	O
significantly	O	O
higher	O	O
activation	O	O
and	O	O
expression	O	O
of	O	O
intercellular	O	O
IFN-gamma	O	O
by	O	O
T	O	O
lymphocytes	O	O
compared	O	O
to	O	O
negative	O	O
controls	O	O
.	O	O

The	O	O
dendritic	O	O
cells	O	O
primed	O	O
with	O	O
antigens	O	O
of	O	O
P.	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
had	O	O
no	O	O
effect	O	O
on	O	O
T-lymphocyte	O	O
activation	O	O
or	O	O
cytokine	O	O
production	O	O
;	O	O
instead	O	O
they	O	O
induced	O	O
differentiation	O	O
of	O	O
T	O	O
lymphocytes	O	O
into	O	O
CD25bright	O	O
cells	O	O
(	O	O
regulatory	O	O
T	O	O
cells	O	O
)	O	O
with	O	O
a	O	O
potentially	O	O
inhibitory	O	O
effect	O	O
on	O	O
immune	O	O
response	O	O
.	O	O

Dendritic	O	O
cells	O	O
primed	O	O
with	O	O
antigens	O	O
of	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
induced	O	O
increased	O	O
expression	O	O
of	O	O
cIL-4	O	O
.	O	O

We	O	O
conclude	O	O
that	O	O
commensal	O	O
oral	O	O
bacteria	O	O
antigens	O	O
prepared	O	O
from	O	O
B.	B-bacteria	B-bacteria
fragilis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
prime	O	O
human	O	O
dendritic	O	O
cells	O	O
to	O	O
induce	O	O
Th1	O	O
,	O	O
Th2	O	O
,	O	O
and	O	O
T	O	O
(	O	O
reg	O	O
)	O	O
differentiation	O	O
,	O	O
respectively	O	O
.	O	O

This	O	O
may	O	O
advance	O	O
our	O	O
understanding	O	O
of	O	O
immunopathologic	O	O
manifestations	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
offer	O	O
new	O	O
possibilities	O	O
for	O	O
redirecting	O	O
immune	O	O
responses	O	O
in	O	O
mucosal	O	O
vaccination	O	O
.	O	O

To	O	O
establish	O	O
whether	O	O
an	O	O
intra-oral	O	O
lubricating	O	O
device	O	O
for	O	O
dry	O	O
mouth	O	O
alters	O	O
the	O	O
oral	O	O
environment	O	O
.	O	O

A	O	O
single-blind	O	O
randomized	O	O
cross-over	O	O
study	O	O
.	O	O

Twenty-nine	O	O
dentate	O	O
subjects	O	O
from	O	O
the	O	O
Sjogren	O	O
's	O	O
syndrome	O	O
clinic	O	O
attended	O	O
on	O	O
five	O	O
occasions	O	O
at	O	O
4-week	O	O
intervals	O	O
.	O	O

They	O	O
were	O	O
randomized	O	O
,	O	O
having	O	O
the	O	O
device	O	O
fitted	O	O
on	O	O
either	O	O
the	O	O
second	O	O
or	O	O
the	O	O
fourth	O	O
visit	O	O
for	O	O
the	O	O
experimental	O	O
period	O	O
,	O	O
whilst	O	O
using	O	O
their	O	O
preferred	O	O
method	O	O
of	O	O
lubrication	O	O
throughout	O	O
the	O	O
rest	O	O
of	O	O
the	O	O
study	O	O
.	O	O

The	O	O
preferred	O	O
methods	O	O
of	O	O
lubrication	O	O
were	O	O
either	O	O
water	O	O
(	O	O
group	O	O
1	O	O
,	O	O
n	O	O
=	O	O
10	O	O
)	O	O
or	O	O
saliva	O	O
substitute	O	O
(	O	O
group	O	O
2	O	O
,	O	O
n	O	O
=	O	O
9	O	O
)	O	O
or	O	O
sugar-free	O	O
chewing	O	O
gum	O	O
(	O	O
group	O	O
3	O	O
,	O	O
n	O	O
=	O	O
10	O	O
)	O	O
.	O	O

At	O	O
each	O	O
visit	O	O
microbiological	O	O
,	O	O
unstimulated	O	O
and	O	O
stimulated	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
.	O	O

Dry	O	O
mouth	O	O
score	O	O
,	O	O
speech	O	O
test	O	O
and	O	O
periodontal	O	O
indices	O	O
were	O	O
recorded	O	O
.	O	O

The	O	O
water	O	O
lubrication	O	O
group	O	O
(	O	O
1	O	O
)	O	O
had	O	O
a	O	O
resting	O	O
salivary	O	O
flow	O	O
greater	O	O
than	O	O
lubrication	O	O
groups	O	O
(	O	O
2	O	O
and	O	O
3	O	O
)	O	O
by	O	O
post-ANOVA	O	O
contrasts	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

The	O	O
postdevice	O	O
data	O	O
also	O	O
demonstrated	O	O
a	O	O
salivary	O	O
flow	O	O
greater	O	O
than	O	O
lubrication	O	O
group	O	O
(	O	O
3	O	O
)	O	O
by	O	O
post-ANOVA	O	O
contrasts	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
epithelial	O	O
cell	O	O
count	O	O
using	O	O
the	O	O
Spearman	O	O
correlation	O	O
was	O	O
high	O	O
,	O	O
possibly	O	O
reflecting	O	O
increased	O	O
viscosity	O	O
of	O	O
the	O	O
saliva	O	O
(	O	O
P	O	O
=	O	O
0.044	O	O
)	O	O
.	O	O

The	O	O
speech	O	O
test	O	O
indicated	O	O
that	O	O
the	O	O
experimental	O	O
subjects	O	O
had	O	O
difficulty	O	O
in	O	O
speaking	O	O
(	O	O
P	O	O
=	O	O
0.001	O	O
)	O	O
.	O	O

This	O	O
was	O	O
slightly	O	O
easier	O	O
postdevice	O	O
wear	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
0.009	O	O
)	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
(	O	O
P	O	O
=	O	O
0.058	O	O
)	O	O
increased	O	O
in	O	O
the	O	O
salivary	O	O
after	O	O
wearing	O	O
the	O	O
device	O	O
.	O	O

Salivary	O	O
flow	O	O
rate	O	O
,	O	O
Candida	O	O
albicans	O	O
,	O	O
oral	O	O
dryness	O	O
,	O	O
speaking	O	O
and	O	O
periodontal	O	O
indices	O	O
were	O	O
unchanged	O	O
.	O	O

The	O	O
oral	O	O
environment	O	O
was	O	O
altered	O	O
by	O	O
wearing	O	O
a	O	O
lubricating	O	O
device	O	O
with	O	O
an	O	O
increase	O	O
in	O	O
the	O	O
numbers	O	O
of	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
.	O	O

Clinical	O	O
dryness	O	O
and	O	O
speech	O	O
test	O	O
correlated	O	O
with	O	O
the	O	O
mean	O	O
whole	O	O
salivary	O	O
flow	O	O
suggesting	O	O
a	O	O
screening	O	O
method	O	O
for	O	O
xerostomia	O	O
.	O	O

Ecological	O	O
studies	O	O
indicate	O	O
that	O	O
most	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
found	O	O
in	O	O
the	O	O
human	O	O
gastrointestinal	O	O
tract	O	O
are	O	O
likely	O	O
to	O	O
be	O	O
transient	O	O
(	O	O
allochthonous	O	O
)	O	O
,	O	O
originating	O	O
from	O	O
either	O	O
the	O	O
oral	O	O
cavity	O	O
or	O	O
food	O	O
.	O	O

In	O	O
order	O	O
to	O	O
investigate	O	O
if	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
constitute	O	O
a	O	O
part	O	O
of	O	O
the	O	O
faecal	B-bacteria	B-bacteria
Lactobacillus	I-bacteria	I-bacteria
biota	E-bacteria	I-bacteria
,	O	O
the	O	O
Lactobacillus	B-bacteria	B-bacteria
biota	E-bacteria	I-bacteria
of	O	O
saliva	O	O
and	O	O
faeces	O	O
of	O	O
three	O	O
human	O	O
subjects	O	O
were	O	O
investigated	O	O
and	O	O
compared	O	O
at	O	O
two	O	O
time-points	O	O
in	O	O
a	O	O
3-months	O	O
interval	O	O
.	O	O

Bacteriological	O	O
culture	O	O
,	O	O
performed	O	O
by	O	O
incubation	O	O
under	O	O
standard	O	O
(	O	O
37	O	O
degrees	O	O
C	O	O
,	O	O
anaerobic	O	O
)	O	O
and	O	O
alternative	O	O
(	O	O
30	O	O
degrees	O	O
C	O	O
,	O	O
microaerobic	O	O
)	O	O
conditions	O	O
,	O	O
as	O	O
well	O	O
as	O	O
PCR-DGGE	O	O
with	O	O
group-specific	O	O
primers	O	O
were	O	O
used	O	O
to	O	O
characterize	O	O
the	O	O
predominant	O	O
lactobacilli	B-bacteria	B-bacteria
.	O	O

Cell	O	O
counts	O	O
varied	O	O
among	O	O
the	O	O
subjects	O	O
and	O	O
over	O	O
time	O	O
,	O	O
reaching	O	O
up	O	O
to	O	O
10	O	O
(	O	O
7	O	O
)	O	O
CFU/ml	O	O
in	O	O
saliva	O	O
and	O	O
5	O	O
x	O	O
10	O	O
(	O	O
6	O	O
)	O	O
CFU/g	O	O
in	O	O
faecal	O	O
samples	O	O
.	O	O

The	O	O
species	O	O
composition	O	O
of	O	O
the	O	O
Lactobacillus	B-bacteria	B-bacteria
biota	E-bacteria	I-bacteria
of	O	O
human	O	O
saliva	O	O
and	O	O
faeces	O	O
was	O	O
found	O	O
to	O	O
be	O	O
subject-specific	O	O
and	O	O
fluctuated	O	O
to	O	O
some	O	O
degree	O	O
,	O	O
but	O	O
the	O	O
species	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
vaginalis	E-bacteria	I-bacteria
were	O	O
detected	O	O
at	O	O
both	O	O
time-points	O	O
in	O	O
saliva	O	O
and	O	O
faecal	O	O
samples	O	O
of	O	O
individual	O	O
subjects	O	O
.	O	O

RAPD-PCR	O	O
analysis	O	O
indicated	O	O
that	O	O
several	O	O
strains	O	O
of	O	O
these	O	O
species	O	O
were	O	O
present	O	O
both	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
in	O	O
the	O	O
faecal	O	O
samples	O	O
of	O	O
the	O	O
same	O	O
subject	O	O
.	O	O

Oral	O	O
isolates	O	O
of	O	O
the	O	O
species	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
and	O	O
L.	B-bacteria	B-bacteria
vaginalis	E-bacteria	I-bacteria
showing	O	O
identical	O	O
RAPD	O	O
types	O	O
were	O	O
found	O	O
to	O	O
persist	O	O
over	O	O
time	O	O
,	O	O
suggesting	O	O
that	O	O
these	O	O
species	O	O
are	O	O
autochthonous	O	O
to	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Our	O	O
results	O	O
together	O	O
with	O	O
recent	O	O
published	O	O
data	O	O
give	O	O
strong	O	O
evidence	O	O
that	O	O
some	O	O
lactobacilli	B-bacteria	B-bacteria
found	O	O
in	O	O
human	O	O
faeces	O	O
are	O	O
allochthonous	O	O
to	O	O
the	O	O
intestine	O	O
and	O	O
originate	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

There	O	O
are	O	O
conflicting	O	O
data	O	O
on	O	O
the	O	O
occurrence	O	O
of	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
endodontic	O	O
patients	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
prevalence	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
in	O	O
multi-site	O	O
oral	O	O
samples	O	O
(	O	O
n	O	O
=	O	O
136	O	O
)	O	O
from	O	O
41	O	O
endodontic	O	O
patients	O	O
using	O	O
culture	O	O
and	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
.	O	O

Additionally	O	O
,	O	O
culturable	O	O
strains	O	O
were	O	O
investigated	O	O
for	O	O
virulence	O	O
traits	O	O
.	O	O

Overall	O	O
,	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
at	O	O
least	O	O
one	O	O
tongue	O	O
,	O	O
oral	O	O
rinse	O	O
,	O	O
or	O	O
gingival	O	O
sulcus	O	O
sample	O	O
in	O	O
68	O	O
%	O	O
of	O	O
patients	O	O
and	O	O
in	O	O
the	O	O
root	O	O
canals	O	O
only	O	O
in	O	O
5	O	O
%	O	O
of	O	O
patients	O	O
.	O	O

In	O	O
21	O	O
patients	O	O
from	O	O
whom	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
all	O	O
four	O	O
sites	O	O
,	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
more	O	O
tongue	O	O
than	O	O
gingival	O	O
sulcus	O	O
,	O	O
oral	O	O
rinse	O	O
,	O	O
and	O	O
root	O	O
canal	O	O
samples	O	O
(	O	O
43	O	O
,	O	O
14	O	O
,	O	O
10	O	O
,	O	O
and	O	O
10	O	O
%	O	O
,	O	O
respectively	O	O
;	O	O
p	O	O
=	O	O
0.0148	O	O
,	O	O
chi	O	O
(	O	O
2	O	O
)	O	O
)	O	O
,	O	O
and	O	O
in	O	O
proportionally	O	O
greater	O	O
numbers	O	O
of	O	O
patients	O	O
with	O	O
gingivitis/periodontitis	O	O
compared	O	O
to	O	O
healthy	O	O
periodontium	O	O
(	O	O
73	O	O
%	O	O
versus	O	O
20	O	O
%	O	O
;	O	O
p	O	O
=	O	O
0.03	O	O
,	O	O
Fisher	O	O
's	O	O
exact	O	O
test	O	O
)	O	O
.	O	O

PCR	O	O
was	O	O
more	O	O
sensitive	O	O
than	O	O
culture	O	O
in	O	O
detecting	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
in	O	O
oral	O	O
samples	O	O
(	O	O
32	O	O
%	O	O
and	O	O
4	O	O
%	O	O
,	O	O
respectively	O	O
;	O	O
p	O	O
<	O	O
0.0001	O	O
,	O	O
McNemar	O	O
's	O	O
test	O	O
)	O	O
.	O	O

Multiple	O	O
virulence	O	O
traits	O	O
were	O	O
identified	O	O
in	O	O
culturable	O	O
strains	O	O
.	O	O

The	O	O
oral	O	O
health	O	O
of	O	O
dependent	O	O
residents	O	O
at	O	O
special	O	O
facilities	O	O
has	O	O
often	O	O
been	O	O
reported	O	O
as	O	O
being	O	O
poor	O	O
,	O	O
but	O	O
it	O	O
is	O	O
difficult	O	O
to	O	O
relate	O	O
oral	O	O
health	O	O
to	O	O
general	O	O
health	O	O
and	O	O
define	O	O
the	O	O
need	O	O
for	O	O
oral	O	O
health	O	O
care	O	O
.	O	O

Microbiological	O	O
analyses	O	O
of	O	O
the	O	O
oral	O	O
flora	O	O
have	O	O
been	O	O
suggested	O	O
as	O	O
a	O	O
suitable	O	O
method	O	O
for	O	O
evaluating	O	O
oral	O	O
health	O	O
in	O	O
this	O	O
group	O	O
of	O	O
patients	O	O
.	O	O

A	O	O
study	O	O
was	O	O
performed	O	O
at	O	O
a	O	O
nursing	O	O
facility	O	O
where	O	O
33	O	O
individuals	O	O
participated	O	O
.	O	O

The	O	O
aim	O	O
was	O	O
to	O	O
describe	O	O
their	O	O
oral	O	O
flora	O	O
in	O	O
relation	O	O
to	O	O
other	O	O
health	O	O
variables	O	O
and	O	O
to	O	O
classify	O	O
the	O	O
residents	O	O
on	O	O
different	O	O
risk	O	O
levels	O	O
.	O	O

An	O	O
oral	O	O
examination	O	O
of	O	O
the	O	O
residents	O	O
was	O	O
made	O	O
at	O	O
the	O	O
facility	O	O
,	O	O
together	O	O
with	O	O
a	O	O
3-day	O	O
food	O	O
record	O	O
and	O	O
an	O	O
oral	O	O
microbiological	O	O
analysis	O	O
.	O	O

The	O	O
analysis	O	O
classified	O	O
the	O	O
residents	O	O
in	O	O
different	O	O
categories	O	O
according	O	O
to	O	O
both	O	O
acid-producing	O	O
bacteria	O	O
and	O	O
the	O	O
flora	O	O
correlated	O	O
with	O	O
a	O	O
reduction	O	O
in	O	O
general	O	O
health	O	O
.	O	O

The	O	O
categories	O	O
were	O	O
based	O	O
on	O	O
previous	O	O
studies	O	O
conducted	O	O
at	O	O
the	O	O
Department	O	O
of	O	O
Microbiology	O	O
(	O	O
Faculty	O	O
of	O	O
Odontology	O	O
in	O	O
Goteborg	O	O
)	O	O
.	O	O

The	O	O
present	O	O
study	O	O
revealed	O	O
that	O	O
the	O	O
level	O	O
for	O	O
acid-producing	O	O
bacteria	O	O
was	O	O
high	O	O
in	O	O
12	O	O
individuals	O	O
and	O	O
the	O	O
micriobial	O	O
level	O	O
according	O	O
to	O	O
decreased	O	O
general	O	O
health	O	O
was	O	O
high	O	O
in	O	O
seven	O	O
individuals	O	O
.	O	O

A	O	O
high	O	O
level	O	O
of	O	O
acid-producing	O	O
bacteria	O	O
was	O	O
related	O	O
to	O	O
functional	O	O
impairment	O	O
,	O	O
which	O	O
was	O	O
in	O	O
turn	O	O
related	O	O
to	O	O
nutritional	O	O
problems	O	O
and	O	O
help	O	O
with	O	O
oral	O	O
hygiene	O	O
.	O	O

The	O	O
microbial	O	O
level	O	O
according	O	O
to	O	O
the	O	O
reduction	O	O
in	O	O
general	O	O
health	O	O
did	O	O
not	O	O
significantly	O	O
correlate	O	O
with	O	O
other	O	O
variables	O	O
.	O	O

To	O	O
date	O	O
,	O	O
it	O	O
appears	O	O
that	O	O
the	O	O
dentists	O	O
'	O	O
war	O	O
against	O	O
dental	O	O
caries	O	O
has	O	O
no	O	O
end	O	O
in	O	O
sight	O	O
due	O	O
to	O	O
the	O	O
fact	O	O
that	O	O
dentists	O	O
lack	O	O
any	O	O
genuine	O	O
offensive	O	O
firepower	O	O
.	O	O

Make	O	O
no	O	O
mistake	O	O
,	O	O
the	O	O
defense	O	O
has	O	O
drastically	O	O
improved	O	O
as	O	O
dentists	O	O
have	O	O
shifted	O	O
the	O	O
focus	O	O
more	O	O
toward	O	O
the	O	O
preventive	O	O
aspects	O	O
of	O	O
dental	O	O
care	O	O
.	O	O

But	O	O
defense	O	O
by	O	O
itself	O	O
can	O	O
not	O	O
defeat	O	O
the	O	O
enemy	O	O
;	O	O
at	O	O
best	O	O
,	O	O
it	O	O
can	O	O
maintain	O	O
the	O	O
status	O	O
quo	O	O
.	O	O

In	O	O
order	O	O
to	O	O
defeat	O	O
the	O	O
enemy	O	O
,	O	O
one	O	O
must	O	O
study	O	O
and	O	O
understand	O	O
the	O	O
enemy	O	O
,	O	O
to	O	O
know	O	O
its	O	O
strengths	O	O
and	O	O
weaknesses	O	O
,	O	O
and	O	O
to	O	O
strike	O	O
at	O	O
those	O	O
points	O	O
of	O	O
vulnerability	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
research	O	O
is	O	O
to	O	O
identify	O	O
and	O	O
characterize	O	O
genes	O	O
that	O	O
are	O	O
responsible	O	O
for	O	O
observed	O	O
virulence	O	O
factors	O	O
in	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
which	O	O
is	O	O
the	O	O
primary	O	O
pathogen	O	O
involved	O	O
in	O	O
the	O	O
development	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

Once	O	O
there	O	O
is	O	O
a	O	O
more	O	O
defined	O	O
understanding	O	O
of	O	O
the	O	O
many	O	O
virulence	O	O
factors	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
there	O	O
will	O	O
be	O	O
a	O	O
much	O	O
more	O	O
valuable	O	O
insight	O	O
into	O	O
its	O	O
role	O	O
in	O	O
the	O	O
ecology	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Eventually	O	O
,	O	O
this	O	O
knowledge	O	O
could	O	O
enable	O	O
dentists	O	O
to	O	O
convert	O	O
the	O	O
bacterial	O	O
``	O	O
weaponry	O	O
''	O	O
into	O	O
its	O	O
own	O	O
arsenal	O	O
,	O	O
which	O	O
could	O	O
then	O	O
be	O	O
innovatively	O	O
employed	O	O
as	O	O
preventive	O	O
,	O	O
diagnostic	O	O
,	O	O
and	O	O
therapeutic	O	O
agents	O	O
to	O	O
treat	O	O
oral	O	O
bacterial-related	O	O
diseases	O	O
.	O	O

Our	O	O
study	O	O
aimed	O	O
to	O	O
evaluate	O	O
the	O	O
oral	O	O
cavity	O	O
as	O	O
a	O	O
reservoir	O	O
from	O	O
where	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
may	O	O
be	O	O
transmitted	O	O
.	O	O

Histology	O	O
and	O	O
PCR	O	O
amplification	O	O
were	O	O
performed	O	O
.	O	O

Eighty-four	O	O
percent	O	O
of	O	O
the	O	O
stomach	O	O
biopsies	O	O
tested	O	O
positive	O	O
;	O	O
however	O	O
,	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
not	O	O
detected	O	O
in	O	O
dental	O	O
samples	O	O
,	O	O
indicating	O	O
the	O	O
absence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
within	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
genus	O	O
Lactobacillus	B-bacteria	B-bacteria
has	O	O
been	O	O
associated	O	O
with	O	O
dental	O	O
caries	O	O
in	O	O
humans	O	O
,	O	O
although	O	O
it	O	O
is	O	O
seldom	O	O
speciated	O	O
due	O	O
to	O	O
lack	O	O
of	O	O
simple	O	O
and	O	O
nonlaborious	O	O
identification	O	O
methods	O	O
.	O	O

A	O	O
considerable	O	O
heterogeneity	O	O
among	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
has	O	O
been	O	O
demonstrated	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
develop	O	O
simple	O	O
methods	O	O
combining	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
analysis	O	O
of	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
-amplified	O	O
16S	O	O
rRNA	O	O
(	O	O
16S	O	O
rRNA	O	O
gene	O	O
PCR-RFLP	O	O
)	O	O
and	O	O
sodium	O	O
dodecyl	O	O
sulfate-polyacrylamide	O	O
gel	O	O
electrophoresis	O	O
(	O	O
SDS-PAGE	O	O
)	O	O
for	O	O
the	O	O
identification	O	O
of	O	O
13	O	O
reference	O	O
strains	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
.	O	O

The	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
were	O	O
amplified	O	O
by	O	O
PCR	O	O
using	O	O
universal	O	O
primers	O	O
and	O	O
digestion	O	O
of	O	O
PCR	O	O
products	O	O
with	O	O
the	O	O
restriction	O	O
endonucleases	O	O
,	O	O
HpaII	O	O
and	O	O
HaeIII	O	O
.	O	O

The	O	O
16S	O	O
rRNA	O	O
gene	O	O
PCR-RFLP	O	O
is	O	O
reproducible	O	O
and	O	O
has	O	O
been	O	O
proved	O	O
to	O	O
be	O	O
useful	O	O
for	O	O
differentiating	O	O
Lactobacillus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
to	O	O
species	O	O
level	O	O
.	O	O

Seventy-seven	O	O
Lactobacillus	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
from	O	O
a	O	O
Thai	O	O
population	O	O
were	O	O
used	O	O
to	O	O
show	O	O
the	O	O
applicability	O	O
of	O	O
the	O	O
identification	O	O
test	O	O
.	O	O

PCR-RFLP	O	O
alone	O	O
had	O	O
limitations	O	O
,	O	O
because	O	O
the	O	O
RFLP	O	O
patterns	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
and	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
crispatus	E-bacteria	I-bacteria
showed	O	O
similar	O	O
patterns	O	O
;	O	O
however	O	O
,	O	O
these	O	O
could	O	O
be	O	O
differentiated	O	O
by	O	O
SDS-PAGE	O	O
.	O	O

Of	O	O
the	O	O
77	O	O
isolates	O	O
,	O	O
38	O	O
were	O	O
identified	O	O
as	O	O
Lactobacillus	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
,	O	O
25	O	O
as	O	O
L.	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
,	O	O
5	O	O
as	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
5	O	O
as	O	O
L.	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
,	O	O
3	O	O
as	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
and	O	O
1	O	O
as	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
PCR-RFLP	O	O
,	O	O
using	O	O
HpaII	O	O
and	O	O
HaeIII	O	O
,	O	O
together	O	O
with	O	O
SDS-PAGE	O	O
protein	O	O
profiles	O	O
could	O	O
be	O	O
an	O	O
alternative	O	O
method	O	O
for	O	O
the	O	O
identification	O	O
of	O	O
oral	O	O
Lactobacillus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
to	O	O
species	O	O
level	O	O
,	O	O
and	O	O
may	O	O
be	O	O
applicable	O	O
for	O	O
large-scale	O	O
studies	O	O
on	O	O
the	O	O
association	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
to	O	O
dental	O	O
caries	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
use	O	O
terminal	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
analysis	O	O
and	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
clone	O	O
library	O	O
to	O	O
investigate	O	O
the	O	O
diversity	O	O
of	O	O
the	O	O
microbiota	O	O
associated	O	O
with	O	O
asymptomatic	O	O
and	O	O
symptomatic	O	O
endodontic	O	O
infections	O	O
and	O	O
to	O	O
compare	O	O
the	O	O
bacterial	O	O
community	O	O
structure	O	O
in	O	O
these	O	O
two	O	O
clinical	O	O
conditions	O	O
.	O	O

Samples	O	O
were	O	O
taken	O	O
from	O	O
asymptomatic	O	O
endodontic	O	O
infections	O	O
associated	O	O
with	O	O
chronic	O	O
periradicular	O	O
lesions	O	O
and	O	O
from	O	O
symptomatic	O	O
infections	O	O
clinically	O	O
diagnosed	O	O
as	O	O
acute	O	O
abscesses	O	O
.	O	O

16S	O	O
rRNA	O	O
genes	O	O
from	O	O
DNA	O	O
isolated	O	O
from	O	O
clinical	O	O
samples	O	O
were	O	O
used	O	O
to	O	O
construct	O	O
clone	O	O
libraries	O	O
or	O	O
were	O	O
subjected	O	O
to	O	O
terminal	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
analysis	O	O
.	O	O

Sequence	O	O
analysis	O	O
of	O	O
186	O	O
clones	O	O
revealed	O	O
42	O	O
taxa	O	O
;	O	O
23	O	O
(	O	O
55	O	O
%	O	O
)	O	O
were	O	O
uncultivated	O	O
phylotypes	O	O
,	O	O
of	O	O
which	O	O
seven	O	O
were	O	O
unique	O	O
to	O	O
endodontic	O	O
infections	O	O
.	O	O

Clone	O	O
sequencing	O	O
and	O	O
terminal	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
analysis	O	O
revealed	O	O
that	O	O
the	O	O
most	O	O
commonly	O	O
detected	O	O
taxa	O	O
were	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
including	O	O
terminal	O	O
restriction	O	O
fragment	O	O
types	O	O
1	O	O
and	O	O
2	O	O
)	O	O
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros/Peptostreptococcus	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

oral	I-bacteria	I-bacteria
clone	I-bacteria	I-bacteria
AJ062/BS044/FG014	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Dialister	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Mogibacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Lachnospiraceae	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
clone	I-bacteria	I-bacteria
55A-34	E-bacteria	I-bacteria
,	O	O
Filifactor	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
,	O	O
Megasphaera	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

oral	O	O
clone	O	O
CS025/BS073	O	O
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

oral	O	O
clone	B-bacteria	B-bacteria
BP1-85/Veillonella	I-bacteria	I-bacteria
dispar/V	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

parvula	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

Bacteroides-like	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

oral	O	O
clone	O	O
X083/Bacteroidales	B-bacteria	B-bacteria
oral	O	O
clone	O	O
MCE7_20	B-bacteria	B-bacteria
and	O	O
Dialister	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

oral	O	O
clone	O	O
BS016/MCE7_134	B-bacteria	B-bacteria
were	O	O
detected	O	O
only	O	O
in	O	O
asymptomatic	O	O
teeth	O	O
.	O	O

On	O	O
the	O	O
other	O	O
hand	O	O
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
terminal	O	O
restriction	O	O
fragment	O	O
type	O	O
2	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Dialister	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
,	O	O
and	O	O
some	O	O
phylotypes	O	O
were	O	O
exclusively	O	O
detected	O	O
in	O	O
symptomatic	O	O
samples	O	O
.	O	O

Bacterial	O	O
profiles	O	O
of	O	O
symptomatic	O	O
endodontic	O	O
infections	O	O
generated	O	O
by	O	O
terminal	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
analysis	O	O
were	O	O
clearly	O	O
different	O	O
from	O	O
those	O	O
of	O	O
asymptomatic	O	O
infections	O	O
.	O	O

Overall	O	O
,	O	O
the	O	O
average	O	O
number	O	O
of	O	O
terminal	O	O
restriction	O	O
fragments	O	O
in	O	O
symptomatic	O	O
samples	O	O
was	O	O
significantly	O	O
larger	O	O
than	O	O
in	O	O
asymptomatic	O	O
samples	O	O
.	O	O

Molecular	O	O
analysis	O	O
of	O	O
the	O	O
microbiota	O	O
associated	O	O
with	O	O
symptomatic	O	O
or	O	O
asymptomatic	O	O
endodontic	O	O
infections	O	O
indicates	O	O
that	O	O
the	O	O
endodontic	O	O
bacterial	O	O
diversity	O	O
is	O	O
greater	O	O
than	O	O
previously	O	O
described	O	O
by	O	O
culture	O	O
methods	O	O
and	O	O
that	O	O
the	O	O
structure	O	O
of	O	O
the	O	O
microbiota	O	O
differ	O	O
significantly	O	O
between	O	O
asymptomatic	O	O
and	O	O
symptomatic	O	O
infections	O	O
.	O	O

Lactobacillus	O	O
rhamnosus	I-bacteria	I-bacteria
GG	E-bacteria	I-bacteria
(	O	O
LGG	B-bacteria	B-bacteria
)	O	O
is	O	O
one	O	O
of	O	O
the	O	O
most	O	O
widely	O	O
studied	O	O
probiotic	B-bacteria	B-bacteria
bacterial	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
.	O	O

The	O	O
benefits	O	O
of	O	O
LGG	B-bacteria	B-bacteria
treatment	O	O
in	O	O
gastrointestinal	O	O
disorders	O	O
are	O	O
well	O	O
documented	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
whether	O	O
LGG	B-bacteria	B-bacteria
can	O	O
be	O	O
detected	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
after	O	O
discontinuation	O	O
of	O	O
administration	O	O
of	O	O
a	O	O
product	O	O
prepared	O	O
with	O	O
this	O	O
bacterium	O	O
.	O	O

56	O	O
volunteers	O	O
consumed	O	O
Gefilus	O	O
juice	O	O
(	O	O
Valio	O	O
Ltd	O	O
,	O	O
Helsinki	O	O
,	O	O
Finland	O	O
)	O	O
containing	O	O
LGG	B-bacteria	B-bacteria
during	O	O
a	O	O
14-day	O	O
trial	O	O
period	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
and	O	O
cultured	O	O
onto	O	O
MRS	O	O
agar	O	O
after	O	O
a	O	O
clearance	O	O
period	O	O
and	O	O
then	O	O
daily	O	O
after	O	O
a	O	O
2-week	O	O
intervention	O	O
period	O	O
for	O	O
as	O	O
long	O	O
as	O	O
LGG	B-bacteria	B-bacteria
was	O	O
found	O	O
.	O	O

LGG-like	O	O
colonies	O	O
were	O	O
analyzed	O	O
in	O	O
saliva	O	O
samples	O	O
,	O	O
identified	O	O
by	O	O
characteristic	O	O
colony	O	O
morphology	O	O
,	O	O
a	O	O
lactose	O	O
fermentation	O	O
test	O	O
,	O	O
and	O	O
PCR	O	O
with	O	O
specific	O	O
primers	O	O
.	O	O

LGG	B-bacteria	B-bacteria
was	O	O
not	O	O
able	O	O
to	O	O
colonize	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

It	O	O
could	O	O
only	O	O
be	O	O
temporarily	O	O
detected	O	O
.	O	O

In	O	O
one	O	O
female	O	O
subject	O	O
,	O	O
however	O	O
,	O	O
whose	O	O
medical	O	O
history	O	O
revealed	O	O
use	O	O
of	O	O
LGG	B-bacteria	B-bacteria
in	O	O
childhood	O	O
,	O	O
the	O	O
bacterium	O	O
was	O	O
detected	O	O
in	O	O
all	O	O
saliva	O	O
samples	O	O
taken	O	O
up	O	O
to	O	O
5	O	O
months	O	O
.	O	O

(	O	O
She	O	O
was	O	O
excluded	O	O
from	O	O
the	O	O
intervention	O	O
trial	O	O
)	O	O
.	O	O

Permanent	O	O
colonization	O	O
of	O	O
LGG	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
improbable	O	O
but	O	O
seems	O	O
possible	O	O
in	O	O
individual	O	O
cases	O	O
.	O	O

In	O	O
order	O	O
to	O	O
estimate	O	O
the	O	O
clinical	O	O
efficacy	O	O
of	O	O
a	O	O
povidone-iodine	O	O
oral	O	O
antiseptic	O	O
(	O	O
PVP-I	O	O
)	O	O
on	O	O
oral	O	O
bacterial	O	O
infectious	O	O
diseases	O	O
,	O	O
we	O	O
studied	O	O
the	O	O
effect	O	O
of	O	O
oral	O	O
organic	O	O
matter	O	O
on	O	O
the	O	O
in	O	O
vitro	O	O
killing	O	O
activity	O	O
of	O	O
PVP-I	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
we	O	O
compared	O	O
the	O	O
in	O	O
vitro	O	O
short-time	O	O
killing	O	O
activity	O	O
of	O	O
PVP-I	O	O
with	O	O
those	O	O
of	O	O
other	O	O
oral	O	O
antiseptics	O	O
using	O	O
mouth-washing	O	O
and	O	O
gargling	O	O
samples	O	O
collected	O	O
from	O	O
healthy	O	O
volunteers	O	O
.	O	O

When	O	O
any	O	O
of	O	O
the	O	O
mouth-washing	O	O
and	O	O
gargling	O	O
samples	O	O
was	O	O
used	O	O
,	O	O
the	O	O
standard	O	O
(	O	O
0.23-0.47	O	O
%	O	O
)	O	O
or	O	O
lower	O	O
concentrations	O	O
of	O	O
PVP-I	O	O
killed	O	O
methicillin-resistant	O	O
Staphylococcus	O	O
aureus	O	O
(	O	O
MRSA	O	O
)	O	O
and	O	O
Pseudomonas	O	O
aeruginosa	O	O
,	O	O
including	O	O
multidrug-resistant	O	O
strains	O	O
,	O	O
within	O	O
15-60	O	O
s	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
oral	O	O
organic	O	O
matter	O	O
.	O	O

0.02	O	O
%	O	O
benzethonium	O	O
chloride	O	O
(	O	O
BEC	O	O
)	O	O
and	O	O
0.002	O	O
%	O	O
chlorhexidine	O	O
gluconate	O	O
(	O	O
CHG	O	O
)	O	O
did	O	O
not	O	O
show	O	O
effects	O	O
against	O	O
MRSA	O	O
and	O	O
P.	O	O
aeruginosa	O	O
(	O	O
including	O	O
multidrug-resistant	O	O
strains	O	O
)	O	O
in	O	O
mouth-washing	O	O
and	O	O
gargling	O	O
samples	O	O
even	O	O
after	O	O
60	O	O
s.	O	O
The	O	O
above-mentioned	O	O
results	O	O
show	O	O
that	O	O
the	O	O
in	O	O
vitro	O	O
killing	O	O
activity	O	O
of	O	O
the	O	O
standard	O	O
concentration	O	O
of	O	O
PVP-I	O	O
was	O	O
hardly	O	O
affected	O	O
by	O	O
the	O	O
oral	O	O
organic	O	O
matter	O	O
and	O	O
that	O	O
a	O	O
mouth-washing	O	O
or	O	O
gargling	O	O
solution	O	O
containing	O	O
PVP-I	O	O
has	O	O
a	O	O
stronger	O	O
bactericidal	O	O
activity	O	O
than	O	O
BEC	O	O
and	O	O
CHG	O	O
.	O	O

Although	O	O
mouth-washing	O	O
and	O	O
gargling	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
healthy	O	O
individuals	O	O
in	O	O
this	O	O
study	O	O
,	O	O
PVP-I	O	O
may	O	O
be	O	O
used	O	O
for	O	O
protection	O	O
against	O	O
infections	O	O
in	O	O
patients	O	O
with	O	O
various	O	O
diseases	O	O
,	O	O
if	O	O
proper	O	O
concentrations	O	O
and	O	O
usage	O	O
are	O	O
encouraged	O	O
.	O	O

A	O	O
total	O	O
of	O	O
8	O	O
strains	O	O
of	O	O
6	O	O
bacterial	O	O
species	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC33277	E-bacteria	I-bacteria
and	O	O
TDC286	B-bacteria	B-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
ATCC29523	E-bacteria	I-bacteria
and	O	O
JP2	B-bacteria	B-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
No	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

2	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	I-bacteria	I-bacteria
ATCC43937	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
ATCC25611	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
anginosus	I-bacteria	I-bacteria
ATCC33397	E-bacteria	I-bacteria
,	O	O
were	O	O
treated	O	O
with	O	O
povidone-iodine	O	O
(	O	O
PVP-I	O	O
)	O	O
gargle	O	O
(	O	O
PVP-I	O	O
:	O	O
0.47	O	O
and	O	O
0.23	O	O
%	O	O
w/v	O	O
)	O	O
or	O	O
chlorhexidine	O	O
gluconate	O	O
(	O	O
CHG	O	O
)	O	O
gargle	O	O
(	O	O
CHG	O	O
:	O	O
0.002	O	O
%	O	O
w/v	O	O
)	O	O
for	O	O
15	O	O
,	O	O
30	O	O
or	O	O
60	O	O
s	O	O
,	O	O
after	O	O
which	O	O
they	O	O
were	O	O
inoculated	O	O
into	O	O
various	O	O
media	O	O
,	O	O
cultured	O	O
and	O	O
counted	O	O
for	O	O
residual	O	O
bacteria	O	O
.	O	O

At	O	O
both	O	O
concentrations	O	O
,	O	O
PVP-I	O	O
gargle	O	O
reduced	O	O
the	O	O
viable	O	O
cell	O	O
count	O	O
of	O	O
all	O	O
8	O	O
bacterial	O	O
strains	O	O
to	O	O
below	O	O
the	O	O
measurable	O	O
limit	O	O
within	O	O
15	O	O
s.	O	O
By	O	O
contrast	O	O
,	O	O
there	O	O
were	O	O
more	O	O
than	O	O
1,000	O	O
viable	O	O
colonies	O	O
60	O	O
s	O	O
following	O	O
treatment	O	O
with	O	O
the	O	O
CHG	O	O
gargle	O	O
.	O	O

The	O	O
results	O	O
demonstrate	O	O
that	O	O
povidone-iodine	O	O
gargle	O	O
has	O	O
rapid	O	O
bactericidal	O	O
activity	O	O
against	O	O
the	O	O
causative	O	O
bacteria	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

An	O	O
evaluation	O	O
on	O	O
the	O	O
applicability	O	O
of	O	O
Mitis	O	O
Salivarius	O	O
agar	O	O
(	O	O
MS	O	O
)	O	O
medium	O	O
,	O	O
commonly	O	O
used	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
human	O	O
and	O	O
animals	O	O
,	O	O
to	O	O
dog	O	O
specimens	O	O
and	O	O
the	O	O
development	O	O
of	O	O
a	O	O
new	O	O
selective	O	O
medium	O	O
for	O	O
isolating	O	O
streptococci	B-bacteria	B-bacteria
from	O	O
the	O	O
canine	O	O
oral	O	O
cavity	O	O
are	O	O
described	O	O
.	O	O

Oral	O	O
samples	O	O
from	O	O
dogs	O	O
were	O	O
cultured	O	O
on	O	O
MS	O	O
medium	O	O
under	O	O
anaerobic	O	O
conditions	O	O
.	O	O

The	O	O
predominant	O	O
facultative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
on	O	O
MS	O	O
plates	O	O
were	O	O
gram-negative	B-bacteria	B-bacteria
rods	E-bacteria	I-bacteria
.	O	O

Selectivity	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
on	O	O
MS	O	O
medium	O	O
was	O	O
21.2	O	O
%	O	O
.	O	O

A	O	O
new	O	O
selective	O	O
medium	O	O
,	O	O
designated	O	O
MS-CAN-AE	O	O
,	O	O
was	O	O
developed	O	O
for	O	O
the	O	O
isolation	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
from	O	O
the	O	O
canine	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
average	O	O
growth	O	O
recovery	O	O
of	O	O
laboratory	O	O
and	O	O
clinically	O	O
isolated	O	O
strains	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
on	O	O
MS-CAN-AE	O	O
medium	O	O
was	O	O
84.1	O	O
%	O	O
of	O	O
that	O	O
on	O	O
MS	O	O
medium	O	O
.	O	O

Gram-positive	B-bacteria	B-bacteria
rods	E-bacteria	I-bacteria
and	O	O
gram-negative	B-bacteria	B-bacteria
rods	E-bacteria	I-bacteria
and	O	O
cocci	B-bacteria	B-bacteria
rarely	O	O
grew	O	O
on	O	O
the	O	O
MS-CAN-AE	O	O
.	O	O

The	O	O
selectivity	O	O
of	O	O
MS-CAN-AE	O	O
was	O	O
95.0	O	O
%	O	O
for	O	O
clinical	O	O
samples	O	O
.	O	O

MS-CAN-AE	O	O
medium	O	O
will	O	O
be	O	O
helpful	O	O
for	O	O
investigations	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
the	O	O
canine	O	O
oral	O	O
cavity	O	O
.	O	O

To	O	O
study	O	O
the	O	O
inhibition	O	O
of	O	O
compound	O	O
lightyellow	O	O
sophora	O	O
root	O	O
collutory	O	O
on	O	O
oral	O	O
bacteria	O	O
.	O	O

The	O	O
standard	O	O
strains	O	O
of	O	O
common	O	O
oral	O	O
bacteria	O	O
were	O	O
cultured	O	O
and	O	O
proliferated	O	O
by	O	O
corresponding	O	O
media	O	O
in	O	O
vitro	O	O
.	O	O

The	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
,	O	O
MIC	O	O
(	O	O
50	O	O
)	O	O
,	O	O
MIC	O	O
(	O	O
90	O	O
)	O	O
of	O	O
compound	O	O
lightyellow	O	O
sophora	O	O
root	O	O
collutory	O	O
were	O	O
determined	O	O
.	O	O

The	O	O
bacteriostatic	O	O
effects	O	O
were	O	O
determined	O	O
by	O	O
the	O	O
plating	O	O
method	O	O
.	O	O

The	O	O
MIC	O	O
of	O	O
compound	O	O
lightyellow	O	O
sophora	O	O
root	O	O
collutory	O	O
were	O	O
lower	O	O
than	O	O
the	O	O
stock	O	O
solution	O	O
concentration	O	O
.	O	O

It	O	O
was	O	O
showed	O	O
that	O	O
compound	O	O
lightyellow	O	O
sophora	O	O
root	O	O
collutory	O	O
had	O	O
the	O	O
same	O	O
effect	O	O
as	O	O
tea	O	O
polyphenol	O	O
on	O	O
oral	O	O
bacteria	O	O
.	O	O

To	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
compound	O	O
lightyellow	O	O
sophora	O	O
root	O	O
collutory	O	O
inhibited	O	O
the	O	O
bacteria	O	O
growth	O	O
more	O	O
obviously	O	O
than	O	O
tea	O	O
polyphenol	O	O
.	O	O

The	O	O
result	O	O
showed	O	O
that	O	O
there	O	O
was	O	O
no	O	O
remarkable	O	O
difference	O	O
between	O	O
the	O	O
compound	O	O
lightyellow	O	O
sophora	O	O
root	O	O
collutory	O	O
and	O	O
tea	O	O
polyphenol	O	O
by	O	O
the	O	O
plating	O	O
method	O	O
.	O	O

Compound	O	O
lightyellow	O	O
sophora	O	O
root	O	O
collutory	O	O
can	O	O
inhibit	O	O
the	O	O
oral	O	O
bacteria	O	O
growth	O	O
obviously	O	O
.	O	O

To	O	O
determine	O	O
whether	O	O
dosing	O	O
with	O	O
bacteriocin-producing	B-bacteria	B-bacteria
Streptococcus	I-bacteria	I-bacteria
salivarius	E-bacteria	I-bacteria
following	O	O
an	O	O
antimicrobial	O	O
mouthwash	O	O
effects	O	O
a	O	O
change	O	O
in	O	O
oral	O	O
malodour	O	O
parameters	O	O
and	O	O
in	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
of	O	O
subjects	O	O
with	O	O
halitosis	O	O
.	O	O

Twenty-three	O	O
subjects	O	O
with	O	O
halitosis	O	O
undertook	O	O
a	O	O
3-day	O	O
regimen	O	O
of	O	O
chlorhexidine	O	O
(	O	O
CHX	O	O
)	O	O
mouth	O	O
rinsing	O	O
,	O	O
followed	O	O
at	O	O
intervals	O	O
by	O	O
the	O	O
use	O	O
of	O	O
lozenges	O	O
containing	O	O
either	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
or	O	O
placebo	O	O
.	O	O

Assessment	O	O
of	O	O
the	O	O
subjects	O	O
'	O	O
volatile	O	O
sulphur	O	O
compound	O	O
(	O	O
VSC	O	O
)	O	O
levels	O	O
1	O	O
week	O	O
after	O	O
treatment	O	O
initiation	O	O
showed	O	O
that	O	O
85	O	O
%	O	O
of	O	O
the	O	O
K12-treated	O	O
group	O	O
and	O	O
30	O	O
%	O	O
of	O	O
the	O	O
placebo	O	O
group	O	O
had	O	O
substantial	O	O
(	O	O
>	O	O
100	O	O
ppb	O	O
)	O	O
reductions	O	O
.	O	O

The	O	O
bacterial	O	O
composition	O	O
of	O	O
the	O	O
saliva	O	O
was	O	O
monitored	O	O
by	O	O
culture	O	O
and	O	O
PCR-denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
(	O	O
PCR-DGGE	O	O
)	O	O
.	O	O

Changes	O	O
in	O	O
the	O	O
PCR-DGGE	O	O
profiles	O	O
occurred	O	O
in	O	O
most	O	O
subjects	O	O
following	O	O
K12	O	O
treatment	O	O
.	O	O

In	O	O
vitro	O	O
testing	O	O
showed	O	O
that	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
suppressed	O	O
the	O	O
growth	O	O
of	O	O
black-pigmented	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
saliva	O	O
samples	O	O
and	O	O
also	O	O
in	O	O
various	O	O
reference	O	O
strains	O	O
of	O	O
bacteria	O	O
implicated	O	O
in	O	O
halitosis	O	O
.	O	O

Administration	O	O
of	O	O
bacteriocin-producing	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
after	O	O
an	O	O
oral	O	O
antimicrobial	O	O
mouthwash	O	O
reduces	O	O
oral	O	O
VSC	O	O
levels	O	O
.	O	O

The	O	O
outcome	O	O
of	O	O
this	O	O
preliminary	O	O
study	O	O
indicates	O	O
that	O	O
the	O	O
replacement	O	O
of	O	O
bacteria	O	O
implicated	O	O
in	O	O
halitosis	O	O
by	O	O
colonization	O	O
with	O	O
competitive	O	O
bacteria	O	O
such	O	O
as	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
may	O	O
provide	O	O
an	O	O
effective	O	O
strategy	O	O
to	O	O
reduce	O	O
the	O	O
severity	O	O
of	O	O
halitosis	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
)	O	O
infection	O	O
spreads	O	O
from	O	O
person-to-person	O	O
,	O	O
however	O	O
the	O	O
precise	O	O
mode	O	O
of	O	O
transmission	O	O
(	O	O
oral-oral	O	O
,	O	O
fecal-oral	O	O
or	O	O
gastro-gastric	O	O
)	O	O
is	O	O
hitherto	O	O
not	O	O
known	O	O
.	O	O

Gaining	O	O
understanding	O	O
into	O	O
the	O	O
spread	O	O
of	O	O
the	O	O
bacterium	O	O
might	O	O
be	O	O
useful	O	O
in	O	O
identifying	O	O
high-risk	O	O
populations	O	O
,	O	O
especially	O	O
in	O	O
areas	O	O
that	O	O
have	O	O
high	O	O
rates	O	O
of	O	O
gastric	O	O
malignancies	O	O
or	O	O
peptic	O	O
ulcer	O	O
.	O	O

In	O	O
this	O	O
review	O	O
,	O	O
the	O	O
authors	O	O
analyze	O	O
the	O	O
aspects	O	O
concerning	O	O
the	O	O
plausibility	O	O
for	O	O
the	O	O
fecal-oral	O	O
route	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
the	O	O
available	O	O
data	O	O
.	O	O

Since	O	O
the	O	O
discovery	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
)	O	O
,	O	O
much	O	O
progress	O	O
has	O	O
been	O	O
made	O	O
worldwide	O	O
in	O	O
the	O	O
field	O	O
of	O	O
its	O	O
epidemiology	O	O
.	O	O

In	O	O
spite	O	O
of	O	O
these	O	O
advancements	O	O
,	O	O
many	O	O
aspects	O	O
of	O	O
epidemiology	O	O
still	O	O
remain	O	O
unclear	O	O
,	O	O
particularly	O	O
among	O	O
populations	O	O
with	O	O
low	O	O
socio-economic	O	O
status	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
designed	O	O
to	O	O
elucidate	O	O
the	O	O
different	O	O
routes	O	O
of	O	O
transmission	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
Hyderabad	O	O
(	O	O
South	O	O
India	O	O
)	O	O
population	O	O
and	O	O
to	O	O
investigate	O	O
the	O	O
impact	O	O
of	O	O
certain	O	O
factors	O	O
,	O	O
such	O	O
as	O	O
age	O	O
,	O	O
gender	O	O
,	O	O
and	O	O
lifestyle	O	O
.	O	O

Samples	O	O
used	O	O
for	O	O
the	O	O
study	O	O
included	O	O
saliva	O	O
and	O	O
biopsy	O	O
samples	O	O
of	O	O
400	O	O
symptomatic	O	O
subjects	O	O
from	O	O
Hyderabad	O	O
,	O	O
India	O	O
.	O	O

The	O	O
patients	O	O
were	O	O
retrospectively	O	O
grouped	O	O
,	O	O
based	O	O
on	O	O
histopathology	O	O
of	O	O
the	O	O
biopsy	O	O
and	O	O
16S	O	O
rRNA	O	O
amplification	O	O
of	O	O
both	O	O
saliva	O	O
and	O	O
biopsy	O	O
as	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
positive	O	O
and	O	O
negative	O	O
.	O	O

This	O	O
study	O	O
showed	O	O
that	O	O
the	O	O
prevalence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
both	O	O
saliva	O	O
and	O	O
biopsy	O	O
samples	O	O
increased	O	O
with	O	O
age	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
was	O	O
found	O	O
more	O	O
commonly	O	O
in	O	O
the	O	O
saliva	O	O
and	O	O
biopsy	O	O
samples	O	O
among	O	O
males	O	O
(	O	O
64	O	O
percent	O	O
and	O	O
60	O	O
percent	O	O
,	O	O
respectively	O	O
)	O	O
than	O	O
females	O	O
(	O	O
53.3	O	O
percent	O	O
and	O	O
64	O	O
percent	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Similarly	O	O
,	O	O
71.6	O	O
percent	O	O
and	O	O
73.5	O	O
percent	O	O
of	O	O
those	O	O
who	O	O
consumed	O	O
municipal	O	O
water	O	O
acquired	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
which	O	O
were	O	O
respectively	O	O
found	O	O
in	O	O
their	O	O
saliva	O	O
and	O	O
biopsy	O	O
samples	O	O
)	O	O
compared	O	O
to	O	O
a	O	O
lesser	O	O
proportion	O	O
(	O	O
12.6	O	O
percent	O	O
and	O	O
12.6	O	O
percent	O	O
,	O	O
respectively	O	O
)	O	O
of	O	O
those	O	O
who	O	O
consumed	O	O
boiled	O	O
or	O	O
filtered	O	O
water	O	O
.	O	O

The	O	O
study	O	O
also	O	O
found	O	O
that	O	O
subjects	O	O
who	O	O
preferred	O	O
home-cooked	O	O
food	O	O
(	O	O
57.1	O	O
percent	O	O
and	O	O
57.7	O	O
percent	O	O
)	O	O
showed	O	O
a	O	O
lower	O	O
prevalence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
saliva	O	O
and	O	O
biopsy	O	O
samples	O	O
,	O	O
respectively	O	O
,	O	O
compared	O	O
to	O	O
those	O	O
(	O	O
80	O	O
percent	O	O
and	O	O
88	O	O
percent	O	O
)	O	O
who	O	O
frequently	O	O
ate	O	O
out	O	O
.	O	O

The	O	O
results	O	O
of	O	O
the	O	O
present	O	O
study	O	O
suggest	O	O
that	O	O
besides	O	O
the	O	O
oral-oral	O	O
route	O	O
,	O	O
the	O	O
transmission	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
also	O	O
takes	O	O
place	O	O
through	O	O
the	O	O
consumption	O	O
of	O	O
food	O	O
prepared	O	O
under	O	O
unhygienic	O	O
conditions	O	O
.	O	O

Consumption	O	O
of	O	O
municipal	O	O
tap	O	O
water	O	O
also	O	O
has	O	O
a	O	O
high	O	O
impact	O	O
in	O	O
the	O	O
transmission	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

Bacterial	O	O
invasion	O	O
of	O	O
host	O	O
epithelial	O	O
cells	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontal	O	O
diseases	O	O
;	O	O
however	O	O
,	O	O
the	O	O
interactions	O	O
between	O	O
subgingival	O	O
species	O	O
and	O	O
the	O	O
gingival	O	O
crevice	O	O
cells	O	O
are	O	O
not	O	O
fully	O	O
understood	O	O
.	O	O

This	O	O
study	O	O
determined	O	O
the	O	O
prevalence	O	O
of	O	O
a	O	O
group	O	O
of	O	O
oral	O	O
bacterial	O	O
species	O	O
on	O	O
or	O	O
in	O	O
epithelial	O	O
cells	O	O
derived	O	O
from	O	O
periodontal	O	O
pockets	O	O
and	O	O
the	O	O
gingival	O	O
crevice	O	O
of	O	O
subjects	O	O
with	O	O
periodontitis	O	O
.	O	O

Samples	O	O
of	O	O
epithelial	O	O
cells	O	O
were	O	O
obtained	O	O
from	O	O
120	O	O
sites	O	O
with	O	O
periodontal	O	O
pockets	O	O
>	O	O
or	O	O
=4	O	O
mm	O	O
and	O	O
92	O	O
periodontally	O	O
healthy	O	O
sites	O	O
from	O	O
49	O	O
patients	O	O
(	O	O
mean	O	O
age	O	O
46.3+/-1.4	O	O
years	O	O
;	O	O
43	O	O
%	O	O
males	O	O
)	O	O
with	O	O
chronic	O	O
periodontitis	O	O
.	O	O

Bacteria	O	O
in	O	O
or	O	O
on	O	O
epithelial	O	O
cells	O	O
were	O	O
separated	O	O
from	O	O
unattached	O	O
bacteria	O	O
by	O	O
Percoll	O	O
density-gradient	O	O
centrifugation	O	O
.	O	O

The	O	O
presence	O	O
and	O	O
levels	O	O
of	O	O
33	O	O
oral	O	O
species	O	O
were	O	O
determined	O	O
in	O	O
epithelial	O	O
cell	O	O
samples	O	O
by	O	O
whole	O	O
genomic	O	O
DNA	O	O
probes	O	O
and	O	O
the	O	O
checkerboard	O	O
method	O	O
.	O	O

The	O	O
most	O	O
frequently	O	O
detected	O	O
species	O	O
were	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
42	O	O
%	O	O
)	O	O
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
(	O	O
38	O	O
%	O	O
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
37	O	O
%	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
(	O	O
36	O	O
%	O	O
)	O	O
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
(	O	O
35	O	O
%	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
(	O	O
35	O	O
%	O	O
)	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
(	O	O
34	O	O
%	O	O
)	O	O
.	O	O

Species	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
were	O	O
found	O	O
in	O	O
low	O	O
prevalence	O	O
and	O	O
levels	O	O
.	O	O

The	O	O
data	O	O
indicated	O	O
that	O	O
there	O	O
were	O	O
more	O	O
micro-organisms	O	O
on	O	O
or	O	O
in	O	O
epithelial	O	O
cells	O	O
obtained	O	O
from	O	O
periodontal	O	O
pockets	O	O
than	O	O
from	O	O
healthy	O	O
sulci	O	O
;	O	O
however	O	O
,	O	O
no	O	O
significant	O	O
differences	O	O
regarding	O	O
the	O	O
percentage	O	O
and	O	O
level	O	O
of	O	O
any	O	O
specific	O	O
species	O	O
were	O	O
found	O	O
between	O	O
these	O	O
sites	O	O
.	O	O

Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
tended	O	O
to	O	O
be	O	O
more	O	O
prevalent	O	O
in	O	O
sites	O	O
without	O	O
disease	O	O
.	O	O

These	O	O
findings	O	O
demonstrated	O	O
that	O	O
a	O	O
wide	O	O
range	O	O
of	O	O
oral	O	O
species	O	O
may	O	O
be	O	O
detected	O	O
on	O	O
or	O	O
in	O	O
crevicular	O	O
epithelial	O	O
cells	O	O
from	O	O
sites	O	O
with	O	O
periodontitis	O	O
and	O	O
from	O	O
periodontally	O	O
healthy	O	O
sulci	O	O
.	O	O

Seven	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
Gram-positive	I-bacteria	I-bacteria
cocci	E-bacteria	I-bacteria
isolated	O	O
from	O	O
human	O	O
oral	O	O
sites	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
revealed	O	O
that	O	O
the	O	O
strains	O	O
constituted	O	O
a	O	O
homogeneous	O	O
group	O	O
that	O	O
was	O	O
distinct	O	O
from	O	O
species	O	O
with	O	O
validly	O	O
published	O	O
names	O	O
,	O	O
but	O	O
related	O	O
to	O	O
Peptostreptococcus	B-bacteria	B-bacteria
anaerobius	E-bacteria	I-bacteria
.	O	O

All	O	O
oral	O	O
strains	O	O
tested	O	O
belonged	O	O
to	O	O
this	O	O
group	O	O
,	O	O
whereas	O	O
all	O	O
non-oral	O	O
strains	O	O
studied	O	O
were	O	O
confirmed	O	O
as	O	O
P.	B-bacteria	B-bacteria
anaerobius	E-bacteria	I-bacteria
.	O	O

A	O	O
novel	O	O
species	O	O
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
stomatis	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
is	O	O
proposed	O	O
to	O	O
accommodate	O	O
these	O	O
oral	O	O
strains	O	O
.	O	O

P.	B-bacteria	B-bacteria
stomatis	E-bacteria	I-bacteria
is	O	O
weakly	O	O
saccharolytic	O	O
and	O	O
produces	O	O
acetic	O	O
,	O	O
butyric	O	O
,	O	O
isobutyric	O	O
,	O	O
isovaleric	O	O
and	O	O
isocaproic	O	O
acids	O	O
as	O	O
end	O	O
products	O	O
of	O	O
fermentation	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
of	O	O
P.	B-bacteria	B-bacteria
stomatis	E-bacteria	I-bacteria
is	O	O
W2278T	B-bacteria	B-bacteria
(	O	O
=DSM	B-bacteria	B-bacteria
17678T	E-bacteria	I-bacteria
=	O	O
CCUG	B-bacteria	B-bacteria
51858T	E-bacteria	I-bacteria
)	O	O
;	O	O
the	O	O
G+C	O	O
content	O	O
of	O	O
the	O	O
DNA	O	O
of	O	O
this	O	O
strain	O	O
is	O	O
36	O	O
mol	O	O
%	O	O
.	O	O

Intrauterine	O	O
infection	O	O
is	O	O
a	O	O
recognized	O	O
cause	O	O
of	O	O
preterm	O	O
birth	O	O
.	O	O

The	O	O
infectious	O	O
organisms	O	O
are	O	O
believed	O	O
to	O	O
originate	O	O
primarily	O	O
from	O	O
the	O	O
vaginal	O	O
tract	O	O
and	O	O
secondarily	O	O
from	O	O
other	O	O
parts	O	O
of	O	O
the	O	O
body	O	O
.	O	O

It	O	O
is	O	O
plausible	O	O
that	O	O
microbes	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
can	O	O
be	O	O
transmitted	O	O
to	O	O
the	O	O
pregnant	O	O
uterus	O	O
.	O	O

However	O	O
,	O	O
direct	O	O
evidence	O	O
supporting	O	O
such	O	O
a	O	O
transmission	O	O
is	O	O
lacking	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
amniotic	O	O
fluids	O	O
of	O	O
34	O	O
pregnant	O	O
women	O	O
were	O	O
examined	O	O
by	O	O
PCR	O	O
using	O	O
16S	O	O
and	O	O
23S	O	O
rRNA	O	O
universally	O	O
conserved	O	O
primers	O	O
.	O	O

Bacterial	O	O
DNA	O	O
was	O	O
amplified	O	O
from	O	O
the	O	O
only	O	O
patient	O	O
with	O	O
clinical	O	O
intrauterine	O	O
infection	O	O
and	O	O
histologic	O	O
necrotizing	O	O
acute	O	O
and	O	O
chronic	O	O
chorioamnionitis	O	O
.	O	O

One	O	O
strain	O	O
,	O	O
Bergeyella	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
clone	I-bacteria	I-bacteria
AF14	E-bacteria	I-bacteria
,	O	O
was	O	O
detected	O	O
and	O	O
was	O	O
99.7	O	O
%	O	O
identical	O	O
to	O	O
a	O	O
previously	O	O
reported	O	O
uncultivated	O	O
oral	O	O
Bergeyella	B-bacteria	B-bacteria
strain	E-bacteria	I-bacteria
,	O	O
clone	B-bacteria	B-bacteria
AK152	E-bacteria	I-bacteria
,	O	O
at	O	O
the	O	O
16S	O	O
rRNA	O	O
level	O	O
.	O	O

The	O	O
same	O	O
strain	O	O
was	O	O
detected	O	O
in	O	O
the	O	O
subgingival	O	O
plaque	O	O
of	O	O
the	O	O
patient	O	O
but	O	O
not	O	O
in	O	O
her	O	O
vaginal	O	O
tract	O	O
.	O	O

The	O	O
16S-23S	O	O
rRNA	O	O
sequence	O	O
of	O	O
clone	B-bacteria	B-bacteria
AF14	E-bacteria	I-bacteria
matched	O	O
exactly	O	O
with	O	O
the	O	O
sequences	O	O
amplified	O	O
from	O	O
the	O	O
patient	O	O
's	O	O
subgingival	O	O
plaque	O	O
.	O	O

These	O	O
observations	O	O
suggest	O	O
that	O	O
the	O	O
Bergeyella	B-bacteria	B-bacteria
strain	E-bacteria	I-bacteria
identified	O	O
in	O	O
the	O	O
patient	O	O
's	O	O
intrauterine	O	O
infection	O	O
originated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
direct	O	O
evidence	O	O
of	O	O
oral-utero	O	O
microbial	O	O
transmission	O	O
.	O	O

The	O	O
patient	O	O
's	O	O
periodontal	O	O
health	O	O
during	O	O
pregnancy	O	O
was	O	O
unclear	O	O
.	O	O

She	O	O
did	O	O
not	O	O
have	O	O
detectable	O	O
periodontal	O	O
disease	O	O
during	O	O
postpartum	O	O
examination	O	O
.	O	O

Bergeyella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

had	O	O
not	O	O
been	O	O
previously	O	O
associated	O	O
with	O	O
preterm	O	O
birth	O	O
and	O	O
were	O	O
detected	O	O
in	O	O
subgingival	O	O
plaque	O	O
of	O	O
women	O	O
without	O	O
clinical	O	O
levels	O	O
of	O	O
intrauterine	O	O
infection	O	O
.	O	O

Uncultivated	O	O
species	O	O
may	O	O
be	O	O
overlooked	O	O
opportunistic	O	O
pathogens	O	O
in	O	O
preterm	O	O
birth	O	O
.	O	O

This	O	O
study	O	O
sheds	O	O
new	O	O
light	O	O
on	O	O
the	O	O
implication	O	O
of	O	O
oral	O	O
bacteria	O	O
in	O	O
preterm	O	O
birth	O	O
.	O	O

The	O	O
initial	O	O
microbial	O	O
colonization	O	O
of	O	O
tooth	O	O
surfaces	O	O
is	O	O
a	O	O
repeatable	O	O
and	O	O
selective	O	O
process	O	O
,	O	O
with	O	O
certain	O	O
bacterial	O	O
species	O	O
predominating	O	O
in	O	O
the	O	O
nascent	O	O
biofilm	O	O
.	O	O

Characterization	O	O
of	O	O
the	O	O
initial	O	O
microflora	O	O
is	O	O
the	O	O
first	O	O
step	O	O
in	O	O
understanding	O	O
interactions	O	O
among	O	O
community	O	O
members	O	O
that	O	O
shape	O	O
ensuing	O	O
biofilm	O	O
development	O	O
.	O	O

Using	O	O
molecular	O	O
methods	O	O
and	O	O
a	O	O
retrievable	O	O
enamel	O	O
chip	O	O
model	O	O
,	O	O
we	O	O
characterized	O	O
the	O	O
microbial	O	O
diversity	O	O
of	O	O
early	O	O
dental	O	O
biofilms	O	O
in	O	O
three	O	O
subjects	O	O
.	O	O

A	O	O
total	O	O
of	O	O
531	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
were	O	O
analyzed	O	O
,	O	O
and	O	O
97	O	O
distinct	O	O
phylotypes	O	O
were	O	O
identified	O	O
.	O	O

Microbial	O	O
community	O	O
composition	O	O
was	O	O
shown	O	O
to	O	O
be	O	O
statistically	O	O
different	O	O
among	O	O
subjects	O	O
.	O	O

In	O	O
all	O	O
subjects	O	O
,	O	O
however	O	O
,	O	O
4-h	O	O
and	O	O
8-h	O	O
communities	O	O
were	O	O
dominated	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

belonging	O	O
to	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
oralis/Streptococcus	I-bacteria	I-bacteria
mitis	I-bacteria	I-bacteria
group	E-bacteria	I-bacteria
.	O	O

Other	O	O
frequently	O	O
observed	O	O
genera	O	O
(	O	O
comprising	O	O
at	O	O
least	O	O
5	O	O
%	O	O
of	O	O
clone	O	O
sequences	O	O
in	O	O
at	O	O
least	O	O
one	O	O
of	O	O
the	O	O
six	O	O
clone	O	O
libraries	O	O
)	O	O
were	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
.	O	O

Fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
confirmed	O	O
that	O	O
the	O	O
proportion	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

sequences	O	O
in	O	O
the	O	O
clone	O	O
libraries	O	O
coincided	O	O
with	O	O
the	O	O
proportion	O	O
of	O	O
streptococcus	B-bacteria	B-bacteria
probe-positive	O	O
organisms	O	O
on	O	O
the	O	O
chip	O	O
.	O	O

FISH	O	O
also	O	O
revealed	O	O
that	O	O
,	O	O
in	O	O
the	O	O
undisturbed	O	O
plaque	O	O
,	O	O
not	O	O
only	O	O
Streptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

but	O	O
also	O	O
the	O	O
rarer	O	O
Prevotella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
usually	O	O
seen	O	O
in	O	O
small	O	O
multigeneric	O	O
clusters	O	O
of	O	O
cells	O	O
.	O	O

This	O	O
study	O	O
shows	O	O
that	O	O
the	O	O
initial	O	O
dental	O	O
plaque	O	O
community	O	O
of	O	O
each	O	O
subject	O	O
is	O	O
unique	O	O
in	O	O
terms	O	O
of	O	O
diversity	O	O
and	O	O
composition	O	O
.	O	O

Repetitive	O	O
and	O	O
distinctive	O	O
community	O	O
composition	O	O
within	O	O
subjects	O	O
suggests	O	O
that	O	O
the	O	O
spatiotemporal	O	O
interactions	O	O
and	O	O
ecological	O	O
shifts	O	O
that	O	O
accompany	O	O
biofilm	O	O
maturation	O	O
also	O	O
occur	O	O
in	O	O
a	O	O
subject-dependent	O	O
manner	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
is	O	O
a	O	O
prominent	O	O
member	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
and	O	O
has	O	O
excellent	O	O
potential	O	O
for	O	O
use	O	O
as	O	O
a	O	O
probiotic	B-bacteria	B-bacteria
targeting	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
this	O	O
report	O	O
we	O	O
document	O	O
safety	O	O
data	O	O
relating	O	O
to	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
,	O	O
including	O	O
assessment	O	O
of	O	O
its	O	O
antibiogram	O	O
,	O	O
metabolic	O	O
profiles	O	O
,	O	O
and	O	O
virulence	O	O
determinants	O	O
,	O	O
and	O	O
we	O	O
examine	O	O
the	O	O
microbial	O	O
composition	O	O
of	O	O
saliva	O	O
following	O	O
the	O	O
dosing	O	O
of	O	O
subjects	O	O
with	O	O
K12	B-bacteria	B-bacteria
.	O	O

Ventilator-associated	O	O
pneumonia	O	O
(	O	O
VAP	O	O
)	O	O
is	O	O
the	O	O
most	O	O
frequently	O	O
occurring	O	O
nosocomial	O	O
infection	O	O
associated	O	O
with	O	O
increased	O	O
morbidity	O	O
and	O	O
mortality	O	O
.	O	O

Although	O	O
oral	O	O
decontamination	O	O
with	O	O
antibiotics	O	O
reduces	O	O
incidences	O	O
of	O	O
VAP	O	O
,	O	O
it	O	O
is	O	O
not	O	O
recommended	O	O
because	O	O
of	O	O
potential	O	O
selection	O	O
of	O	O
antibiotic-resistant	O	O
pathogens	O	O
.	O	O

We	O	O
hypothesized	O	O
that	O	O
oral	O	O
decontamination	O	O
with	O	O
either	O	O
chlorhexidine	O	O
(	O	O
CHX	O	O
,	O	O
2	O	O
%	O	O
)	O	O
or	O	O
CHX/colistin	O	O
(	O	O
CHX/COL	O	O
,	O	O
2	O	O
%	O	O
/2	O	O
%	O	O
)	O	O
would	O	O
reduce	O	O
and	O	O
postpone	O	O
development	O	O
of	O	O
VAP	O	O
,	O	O
and	O	O
oral	O	O
and	O	O
endotracheal	O	O
colonization	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
effect	O	O
of	O	O
oral	O	O
decontamination	O	O
with	O	O
CHX	O	O
or	O	O
CHX/COL	O	O
on	O	O
VAP	O	O
incidence	O	O
and	O	O
time	O	O
to	O	O
development	O	O
of	O	O
VAP	O	O
.	O	O

Consecutive	O	O
patients	O	O
needing	O	O
mechanical	O	O
ventilation	O	O
for	O	O
48	O	O
h	O	O
or	O	O
more	O	O
were	O	O
enrolled	O	O
in	O	O
a	O	O
randomized	O	O
,	O	O
double-blind	O	O
,	O	O
placebo-controlled	O	O
trial	O	O
with	O	O
three	O	O
arms	O	O
:	O	O
CHX	O	O
,	O	O
CHX/COL	O	O
,	O	O
and	O	O
placebo	O	O
(	O	O
PLAC	O	O
)	O	O
.	O	O

Trial	O	O
medication	O	O
was	O	O
applied	O	O
every	O	O
6	O	O
h	O	O
into	O	O
the	O	O
buccal	O	O
cavity	O	O
.	O	O

Oropharyngeal	O	O
swabs	O	O
were	O	O
obtained	O	O
daily	O	O
and	O	O
quantitatively	O	O
analyzed	O	O
for	O	O
gram-positive	O	O
and	O	O
gram-negative	O	O
microorganisms	O	O
.	O	O

Endotracheal	O	O
colonization	O	O
was	O	O
monitored	O	O
twice	O	O
weekly	O	O
.	O	O

Of	O	O
385	O	O
patients	O	O
included	O	O
,	O	O
130	O	O
received	O	O
PLAC	O	O
,	O	O
127	O	O
CHX	O	O
and	O	O
128	O	O
CHX/COL	O	O
.	O	O

Baseline	O	O
characteristics	O	O
were	O	O
comparable	O	O
.	O	O

The	O	O
daily	O	O
risk	O	O
of	O	O
VAP	O	O
was	O	O
reduced	O	O
in	O	O
both	O	O
treatment	O	O
groups	O	O
compared	O	O
with	O	O
PLAC	O	O
:	O	O
65	O	O
%	O	O
(	O	O
hazard	O	O
ratio	O	O
[	O	O
HR	O	O
]	O	O
=0.352	O	O
;	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
[	O	O
CI	O	O
]	O	O
,	O	O
0.160	O	O
,	O	O
0	O	O
.	O	O

791	O	O
;	O	O
p=0.012	O	O
)	O	O
for	O	O
CHX	O	O
and	O	O
55	O	O
%	O	O
(	O	O
HR=0.454	O	O
;	O	O
95	O	O
%	O	O
CI	O	O
,	O	O
0.224	O	O
,	O	O
0	O	O
.	O	O

925	O	O
;	O	O
p=0.030	O	O
)	O	O
for	O	O
CHX/COL	O	O
.	O	O

CHX/COL	O	O
provided	O	O
significant	O	O
reduction	O	O
in	O	O
oropharyngeal	O	O
colonization	O	O
with	O	O
both	O	O
gram-negative	O	O
and	O	O
gram-positive	O	O
microorganisms	O	O
,	O	O
whereas	O	O
CHX	O	O
mostly	O	O
affected	O	O
gram-positive	O	O
microorganisms	O	O
.	O	O

Endotracheal	O	O
colonization	O	O
was	O	O
reduced	O	O
for	O	O
CHX/COL	O	O
patients	O	O
and	O	O
to	O	O
a	O	O
lesser	O	O
extent	O	O
for	O	O
CHX	O	O
patients	O	O
.	O	O

No	O	O
differences	O	O
in	O	O
duration	O	O
of	O	O
mechanical	O	O
ventilation	O	O
,	O	O
intensive	O	O
care	O	O
unit	O	O
stay	O	O
,	O	O
or	O	O
intensive	O	O
care	O	O
unit	O	O
survival	O	O
could	O	O
be	O	O
demonstrated	O	O
.	O	O

Topical	O	O
oral	O	O
decontamination	O	O
with	O	O
CHX	O	O
or	O	O
CHX/COL	O	O
reduces	O	O
the	O	O
incidence	O	O
of	O	O
VAP	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
eight	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
oral	I-bacteria	I-bacteria
commensal	I-bacteria	I-bacteria
bacterial	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
on	O	O
in	O	O
vitro	O	O
Candida	O	O
albicans	O	O
biofilm	O	O
development	O	O
.	O	O

A	O	O
single	O	O
isolate	O	O
of	O	O
C.	O	O
albicans	O	O
2560	O	O
g	O	O
,	O	O
and	O	O
eight	O	O
different	O	O
species	O	O
of	O	O
oral	O	O
bacteria	O	O
comprising	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
were	O	O
studied	O	O
using	O	O
an	O	O
in	O	O
vitro	O	O
biofilm	O	O
assay	O	O
.	O	O

Biofilm	O	O
formation	O	O
was	O	O
quantified	O	O
in	O	O
terms	O	O
of	O	O
the	O	O
ability	O	O
of	O	O
Candida	O	O
to	O	O
grow	O	O
on	O	O
polystyrene	O	O
plastic	O	O
surfaces	O	O
co-cultured	O	O
with	O	O
the	O	O
foregoing	O	O
bacteria	O	O
.	O	O

A	O	O
viable	O	O
cell	O	O
count	O	O
was	O	O
used	O	O
to	O	O
quantify	O	O
the	O	O
sessile	O	O
yeast	O	O
growth	O	O
and	O	O
scanning	O	O
electron	O	O
microscopy	O	O
was	O	O
employed	O	O
to	O	O
confirm	O	O
and	O	O
visualize	O	O
biofilm	O	O
formation	O	O
.	O	O

Co-culture	O	O
with	O	O
differing	O	O
concentrations	O	O
of	O	O
bacteria	O	O
had	O	O
variable	O	O
effects	O	O
on	O	O
Candida	O	O
biofilm	O	O
formation	O	O
.	O	O

Co-culture	O	O
with	O	O
the	O	O
highest	O	O
concentrations	O	O
of	O	O
each	O	O
of	O	O
the	O	O
foregoing	O	O
bacteria	O	O
resulted	O	O
in	O	O
a	O	O
consistent	O	O
reduction	O	O
in	O	O
the	O	O
yeast	O	O
counts	O	O
in	O	O
the	O	O
candidal	O	O
biofilm	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
except	O	O
for	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
,	O	O
S.	B-bacteria	B-bacteria
intermedius	I-bacteria	I-bacteria
co-cultures	E-bacteria	I-bacteria
.	O	O

Further	O	O
,	O	O
on	O	O
regression	O	O
analysis	O	O
a	O	O
significant	O	O
negative	O	O
correlation	O	O
between	O	O
the	O	O
co-culture	O	O
concentration	O	O
of	O	O
either	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
or	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
viable	O	O
yeast	O	O
counts	O	O
in	O	O
the	O	O
biofilm	O	O
was	O	O
noted	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
although	O	O
this	O	O
was	O	O
not	O	O
evident	O	O
for	O	O
the	O	O
other	O	O
bacterial	O	O
species	O	O
.	O	O

Taken	O	O
together	O	O
,	O	O
our	O	O
data	O	O
indicate	O	O
that	O	O
,	O	O
quantitative	O	O
and	O	O
qualitative	O	O
nature	O	O
of	O	O
the	O	O
bacteria	O	O
modulate	O	O
C.	O	O
albicans	O	O
biofilm	O	O
formation	O	O
in	O	O
mixed	O	O
species	O	O
environments	O	O
such	O	O
as	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

We	O	O
investigated	O	O
cellular	O	O
and	O	O
humoral	O	O
immune	O	O
responses	O	O
to	O	O
oral	O	O
biofilm	O	O
bacteria	O	O
,	O	O
including	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
in	O	O
NOD/SCID	O	O
mice	O	O
immunized	O	O
with	O	O
human	O	O
peripheral	O	O
blood	O	O
mononuclear	O	O
cells	O	O
(	O	O
hu-PBMC-NOD/SCID	O	O
mice	O	O
)	O	O
to	O	O
explore	O	O
the	O	O
pathogenicity	O	O
of	O	O
each	O	O
of	O	O
those	O	O
organisms	O	O
in	O	O
dental	O	O
and	O	O
oral	O	O
inflammatory	O	O
diseases	O	O
.	O	O

hu-PBMC-NOD/SCID	O	O
mice	O	O
were	O	O
immunized	O	O
by	O	O
intraperitoneal	O	O
injections	O	O
with	O	O
the	O	O
whole	O	O
cells	O	O
of	O	O
the	O	O
streptococci	B-bacteria	B-bacteria
once	O	O
a	O	O
week	O	O
for	O	O
3	O	O
weeks	O	O
.	O	O

FACS	O	O
analyses	O	O
were	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
percentages	O	O
of	O	O
various	O	O
hu-T	O	O
cell	O	O
types	O	O
,	O	O
as	O	O
well	O	O
as	O	O
intracellular	O	O
cytokine	O	O
production	O	O
of	O	O
interleukin-4	O	O
and	O	O
interferon-gamma	O	O
.	O	O

Serum	O	O
IgG	O	O
and	O	O
IgM	O	O
antibody	O	O
levels	O	O
in	O	O
response	O	O
to	O	O
the	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
also	O	O
determined	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
.	O	O

S.	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
induced	O	O
a	O	O
significant	O	O
amount	O	O
of	O	O
the	O	O
proinflammatory	O	O
cytokine	O	O
interferon-gamma	O	O
in	O	O
CD4	O	O
(	O	O
+	O	O
)	O	O
and	O	O
CD8	O	O
(	O	O
+	O	O
)	O	O
T	O	O
cells	O	O
in	O	O
comparison	O	O
with	O	O
the	O	O
other	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

However	O	O
,	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
differences	O	O
between	O	O
the	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
interleukin-4	O	O
production	O	O
by	O	O
CD4	O	O
(	O	O
+	O	O
)	O	O
and	O	O
CD8	O	O
(	O	O
+	O	O
)	O	O
T	O	O
cells	O	O
after	O	O
inoculation	O	O
.	O	O

Further	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
significantly	O	O
induced	O	O
human	O	O
anti-S.	O	O
mutans	O	O
IgG	O	O
,	O	O
IgG	O	O
(	O	O
1	O	O
)	O	O
,	O	O
IgG	O	O
(	O	O
2	O	O
)	O	O
,	O	O
and	O	O
IgM	O	O
antibodies	O	O
in	O	O
comparison	O	O
with	O	O
the	O	O
other	O	O
organisms	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
S.	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
up-regulated	O	O
Th1	O	O
and	O	O
Tc1	O	O
cells	O	O
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
led	O	O
to	O	O
increasing	O	O
levels	O	O
of	O	O
their	O	O
antibodies	O	O
,	O	O
which	O	O
was	O	O
associated	O	O
with	O	O
the	O	O
induction	O	O
of	O	O
Th2	O	O
cells	O	O
.	O	O

These	O	O
results	O	O
may	O	O
contribute	O	O
to	O	O
a	O	O
better	O	O
understanding	O	O
of	O	O
human	O	O
lymphocyte	O	O
interactions	O	O
to	O	O
biofilm	O	O
bacteria	O	O
,	O	O
along	O	O
with	O	O
their	O	O
impact	O	O
on	O	O
dental	O	O
and	O	O
mucosal	O	O
inflammatory	O	O
diseases	O	O
,	O	O
as	O	O
well	O	O
as	O	O
endocarditis	O	O
.	O	O

Oropharyngeal	O	O
candidiasis	O	O
is	O	O
emerging	O	O
as	O	O
a	O	O
serious	O	O
health	O	O
problem	O	O
in	O	O
the	O	O
elderly	O	O
as	O	O
well	O	O
as	O	O
other	O	O
chronically	O	O
immunosuppressed	O	O
patient	O	O
populations	O	O
.	O	O

Several	O	O
approaches	O	O
have	O	O
been	O	O
used	O	O
to	O	O
study	O	O
the	O	O
interactions	O	O
between	O	O
Candida	O	O
and	O	O
the	O	O
oral	O	O
mucosa	O	O
in	O	O
vitro	O	O
.	O	O

Recently	O	O
,	O	O
three-dimensional	O	O
organotypic	O	O
systems	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
have	O	O
been	O	O
developed	O	O
,	O	O
which	O	O
provide	O	O
an	O	O
organizational	O	O
complexity	O	O
that	O	O
is	O	O
between	O	O
the	O	O
culture	O	O
of	O	O
single	O	O
cell	O	O
types	O	O
and	O	O
organ	O	O
cultures	O	O
in	O	O
vivo	O	O
.	O	O

In	O	O
this	O	O
report	O	O
we	O	O
describe	O	O
the	O	O
development	O	O
of	O	O
a	O	O
novel	O	O
three-dimensional	O	O
system	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
mucosa	O	O
based	O	O
on	O	O
an	O	O
immortalized	O	O
oral	O	O
keratinocyte	O	O
cell	O	O
line	O	O
.	O	O

Unlike	O	O
the	O	O
commercially	O	O
available	O	O
cell	O	O
line	O	O
systems	O	O
,	O	O
this	O	O
system	O	O
also	O	O
contains	O	O
a	O	O
connective	O	O
tissue	O	O
cell	O	O
component	O	O
,	O	O
which	O	O
ensures	O	O
the	O	O
quality	O	O
and	O	O
resemblance	O	O
of	O	O
the	O	O
tissue	O	O
model	O	O
to	O	O
the	O	O
human	O	O
oral	O	O
masticatory	O	O
mucosa	O	O
and	O	O
submucosa	O	O
.	O	O

Using	O	O
a	O	O
panel	O	O
of	O	O
Candida	O	O
albicans	O	O
strains	O	O
with	O	O
variable	O	O
virulence	O	O
in	O	O
vivo	O	O
,	O	O
we	O	O
showed	O	O
that	O	O
the	O	O
extent	O	O
of	O	O
tissue	O	O
damage	O	O
,	O	O
fungal	O	O
invasion	O	O
and	O	O
host	O	O
inflammatory	O	O
response	O	O
in	O	O
this	O	O
system	O	O
was	O	O
proportional	O	O
to	O	O
the	O	O
well-documented	O	O
in	O	O
vivo	O	O
virulence	O	O
potential	O	O
of	O	O
these	O	O
strains	O	O
.	O	O

Therefore	O	O
,	O	O
this	O	O
investigation	O	O
has	O	O
added	O	O
another	O	O
useful	O	O
tool	O	O
in	O	O
the	O	O
study	O	O
of	O	O
host	O	O
pathogen	O	O
interactions	O	O
in	O	O
oral	O	O
candidiasis	O	O
.	O	O

To	O	O
examine	O	O
the	O	O
efficacy	O	O
of	O	O
the	O	O
multiple	O	O
Sorbarod	O	O
device	O	O
(	O	O
MSD	O	O
)	O	O
for	O	O
the	O	O
reproduction	O	O
of	O	O
inter-individual	O	O
variations	O	O
in	O	O
oral	O	O
microbiotas	O	O
.	O	O

The	O	O
MSD	O	O
supports	O	O
sessile	O	O
growth	O	O
on	O	O
parallel	O	O
cellulose	O	O
filters	O	O
,	O	O
perfused	O	O
with	O	O
artificial	O	O
saliva	O	O
.	O	O

This	O	O
enables	O	O
biofilms	O	O
(	O	O
BF	O	O
)	O	O
to	O	O
be	O	O
grown	O	O
and	O	O
sampled	O	O
,	O	O
together	O	O
with	O	O
released	O	O
cells	O	O
in	O	O
eluted	O	O
medium	O	O
(	O	O
perfusates	O	O
,	O	O
PAs	O	O
)	O	O
.	O	O

Two	O	O
sets	O	O
of	O	O
triplicate	O	O
MSDs	O	O
were	O	O
established	O	O
.	O	O

One	O	O
set	O	O
was	O	O
inoculated	O	O
using	O	O
fresh	O	O
saliva	O	O
from	O	O
three	O	O
separate	O	O
volunteers	O	O
;	O	O
the	O	O
second	O	O
set	O	O
was	O	O
inoculated	O	O
from	O	O
one	O	O
saliva	O	O
donor	O	O
.	O	O

Both	O	O
were	O	O
incubated	O	O
in	O	O
an	O	O
anaerobic	O	O
cabinet	O	O
.	O	O

BF	O	O
and	O	O
PA	O	O
were	O	O
analysed	O	O
at	O	O
24-h	O	O
intervals	O	O
by	O	O
PCR-denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
(	O	O
DGGE	O	O
)	O	O
of	O	O
16S	O	O
rDNA	O	O
.	O	O

Hierarchical	O	O
dendrograms	O	O
were	O	O
constructed	O	O
in	O	O
order	O	O
to	O	O
sort	O	O
community	O	O
fingerprints	O	O
over	O	O
time	O	O
,	O	O
based	O	O
on	O	O
community	O	O
relatedness	O	O
.	O	O

The	O	O
MSD	O	O
supported	O	O
complex	O	O
oral	O	O
communities	O	O
,	O	O
as	O	O
evidenced	O	O
by	O	O
DGGE	O	O
(	O	O
>	O	O
20	O	O
distinct	O	O
DGGE	O	O
bands	O	O
)	O	O
and	O	O
confocal	O	O
scanning	O	O
laser	O	O
microscopy	O	O
.	O	O

DGGE	O	O
band	O	O
sequencing	O	O
revealed	O	O
bacteriological	O	O
diversity	O	O
and	O	O
a	O	O
high	O	O
incidence	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
including	O	O
Prevotella	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

Dendrograms	O	O
demonstrated	O	O
marked	O	O
inter-individual	O	O
variation	O	O
in	O	O
the	O	O
relative	O	O
species	O	O
abundance	O	O
within	O	O
salivary	O	O
inocula	O	O
from	O	O
different	O	O
volunteers	O	O
(	O	O
DV	O	O
)	O	O
and	O	O
each	O	O
associated	O	O
MSD	O	O
(	O	O
all	O	O
>	O	O
45	O	O
%	O	O
,	O	O
majority	O	O
c.	O	O
85	O	O
%	O	O
concordance	O	O
)	O	O
.	O	O

Less	O	O
variation	O	O
was	O	O
shown	O	O
between	O	O
triplicate	O	O
models	O	O
established	O	O
using	O	O
saliva	O	O
from	O	O
a	O	O
single	O	O
volunteer	O	O
(	O	O
SV	O	O
)	O	O
(	O	O
all	O	O
>	O	O
58	O	O
%	O	O
;	O	O
majority	O	O
c.	O	O
95	O	O
%	O	O
concordance	O	O
)	O	O
.	O	O

PAs	O	O
clustered	O	O
together	O	O
with	O	O
the	O	O
associated	O	O
biofilms	O	O
and	O	O
inocula	O	O
in	O	O
the	O	O
majority	O	O
of	O	O
cases	O	O
for	O	O
the	O	O
DV	O	O
MSDs	O	O
whilst	O	O
SV	O	O
MSD	O	O
community	O	O
profiles	O	O
clustered	O	O
between	O	O
replicate	O	O
MSDs	O	O
.	O	O

Data	O	O
indicate	O	O
that	O	O
marked	O	O
inter-individual	O	O
variations	O	O
in	O	O
human	O	O
salivary	O	O
composition	O	O
can	O	O
be	O	O
partially	O	O
replicated	O	O
in	O	O
individualized	O	O
MSD	O	O
microcosms	O	O
.	O	O
This	O	O
study	O	O
demonstrates	O	O
the	O	O
in	O	O
vitro	O	O
reproduction	O	O
of	O	O
individual	O	O
oral	O	O
microbiotas	O	O
and	O	O
suggests	O	O
that	O	O
taking	O	O
inter-individual	O	O
variability	O	O
into	O	O
account	O	O
will	O	O
increase	O	O
the	O	O
relevance	O	O
of	O	O
microcosm	O	O
studies	O	O
.	O	O

Triclosan	O	O
(	O	O
TCS	O	O
)	O	O
exposure	O	O
of	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
selects	O	O
for	O	O
tolerant	O	O
clones	O	O
,	O	O
mutated	O	O
in	O	O
their	O	O
enoyl-acyl	O	O
carrier	O	O
protein	O	O
reductase	O	O
(	O	O
FabI	O	O
)	O	O
.	O	O

It	O	O
has	O	O
been	O	O
inferred	O	O
that	O	O
this	O	O
phenomenon	O	O
is	O	O
widespread	O	O
amongst	O	O
bacterial	O	O
genera	O	O
and	O	O
might	O	O
be	O	O
associated	O	O
with	O	O
resistance	O	O
to	O	O
third	O	O
party	O	O
agents	O	O
.	O	O

Ex-situ	O	O
,	O	O
low	O	O
passage	O	O
isolates	O	O
of	O	O
enteric	O	O
,	O	O
human	O	O
axilla	O	O
,	O	O
human	O	O
oral	O	O
origin	O	O
and	O	O
bacteria	O	O
isolated	O	O
from	O	O
a	O	O
domestic	O	O
drain	O	O
,	O	O
together	O	O
with	O	O
selected	O	O
type	O	O
cultures	O	O
were	O	O
exposed	O	O
to	O	O
escalating	O	O
concentrations	O	O
of	O	O
TCS	O	O
over	O	O
10	O	O
passages	O	O
using	O	O
a	O	O
gradient	O	O
plate	O	O
technique	O	O
.	O	O

One	O	O
fresh	O	O
faecal	O	O
isolate	O	O
of	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
was	O	O
included	O	O
as	O	O
a	O	O
positive	O	O
control	O	O
.	O	O

TCS	O	O
susceptibility	O	O
was	O	O
determined	O	O
for	O	O
all	O	O
strains	O	O
before	O	O
and	O	O
after	O	O
exposure	O	O
,	O	O
whilst	O	O
enteric	O	O
isolates	O	O
were	O	O
additionally	O	O
assessed	O	O
for	O	O
susceptibility	O	O
towards	O	O
chlorhexidine	O	O
,	O	O
tetracycline	O	O
,	O	O
chloramphenicol	O	O
,	O	O
nalidixic	O	O
acid	O	O
and	O	O
ciprofloxacin	O	O
,	O	O
and	O	O
the	O	O
oral	O	O
isolates	O	O
towards	O	O
chlorhexidine	O	O
,	O	O
tetracycline	O	O
and	O	O
metronidazole	O	O
.	O	O

Triclosan	O	O
exposure	O	O
of	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
markedly	O	O
decreased	O	O
TCS	O	O
susceptibility	O	O
.	O	O

TCS	O	O
susceptibility	O	O
also	O	O
decreased	O	O
for	O	O
Klebsiella	B-bacteria	B-bacteria
oxytoca	E-bacteria	I-bacteria
,	O	O
Aranicola	B-bacteria	B-bacteria
proteolyticus	E-bacteria	I-bacteria
and	O	O
Stenotrophomonas	B-bacteria	B-bacteria
maltophilia	E-bacteria	I-bacteria
.	O	O

Susceptibility	O	O
of	O	O
the	O	O
remaining	O	O
35	O	O
strains	O	O
to	O	O
TCS	O	O
and	O	O
the	O	O
other	O	O
test	O	O
agents	O	O
remained	O	O
unchanged	O	O
.	O	O

These	O	O
data	O	O
suggest	O	O
that	O	O
selection	O	O
for	O	O
high	O	O
level	O	O
resistance	O	O
by	O	O
TCS	O	O
exposure	O	O
is	O	O
not	O	O
widespread	O	O
and	O	O
appears	O	O
to	O	O
be	O	O
confined	O	O
to	O	O
certain	O	O
enteric	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
especially	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

Change	O	O
in	O	O
TCS	O	O
susceptibility	O	O
did	O	O
not	O	O
affect	O	O
susceptibility	O	O
towards	O	O
chemically	O	O
unrelated	O	O
antimicrobials	O	O
.	O	O

Acquired	O	O
high-level	O	O
TCS	O	O
resistance	O	O
is	O	O
not	O	O
a	O	O
widespread	O	O
phenomenon	O	O
.	O	O

The	O	O
present	O	O
study	O	O
aimed	O	O
to	O	O
evaluate	O	O
if	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
chronic	O	O
periodontitis	O	O
patients	O	O
can	O	O
harbor	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
after	O	O
systemic	O	O
eradication	O	O
therapy	O	O
.	O	O

Samples	O	O
of	O	O
30	O	O
patients	O	O
(	O	O
15	O	O
with	O	O
gingivitis	O	O
and	O	O
15	O	O
with	O	O
chronic	O	O
periodontitis	O	O
)	O	O
positive	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
stomach	O	O
were	O	O
evaluated	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
3	O	O
months	O	O
after	O	O
triple	O	O
systemic	O	O
antibiotic	O	O
therapy	O	O
from	O	O
saliva	O	O
,	O	O
microbiota	O	O
from	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
,	O	O
supra-	O	O
and	O	O
sub-gingival	O	O
plaque	O	O
as	O	O
well	O	O
as	O	O
gastric	O	O
biopsies	O	O
.	O	O

DNA	O	O
of	O	O
each	O	O
sample	O	O
was	O	O
extracted	O	O
by	O	O
the	O	O
boiling	O	O
method	O	O
and	O	O
used	O	O
as	O	O
a	O	O
template	O	O
in	O	O
polymerase	O	O
chain	O	O
reaction	O	O
with	O	O
the	O	O
primers	O	O
JW22/23	O	O
.	O	O

Eighteen	O	O
patients	O	O
(	O	O
60	O	O
%	O	O
)	O	O
harboured	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
their	O	O
mouths	O	O
.	O	O

Five	O	O
patients	O	O
(	O	O
16.6	O	O
%	O	O
)	O	O
were	O	O
positive	O	O
in	O	O
saliva	O	O
,	O	O
two	O	O
(	O	O
6.6	O	O
%	O	O
)	O	O
on	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
,	O	O
nine	O	O
(	O	O
30	O	O
%	O	O
)	O	O
in	O	O
supra-gingival	O	O
plaque	O	O
,	O	O
14	O	O
(	O	O
46.6	O	O
%	O	O
)	O	O
in	O	O
sub-gingival	O	O
plaque	O	O
and	O	O
three	O	O
(	O	O
10	O	O
%	O	O
)	O	O
in	O	O
the	O	O
stomach	O	O
.	O	O

There	O	O
was	O	O
no	O	O
statistically	O	O
significant	O	O
difference	O	O
between	O	O
study	O	O
groups	O	O
.	O	O

Eradication	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
after	O	O
therapy	O	O
was	O	O
more	O	O
effective	O	O
for	O	O
the	O	O
stomach	O	O
than	O	O
for	O	O
the	O	O
mouth	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Mouths	O	O
of	O	O
patients	O	O
with	O	O
gingivitis	O	O
or	O	O
with	O	O
chronic	O	O
periodontitis	O	O
,	O	O
who	O	O
are	O	O
positive	O	O
for	O	O
H.	O	O
pylori	O	O
in	O	O
their	O	O
stomachs	O	O
,	O	O
may	O	O
be	O	O
considered	O	O
as	O	O
reservoirs	O	O
of	O	O
these	O	O
bacteria	O	O
.	O	O

To	O	O
study	O	O
the	O	O
role	O	O
of	O	O
fibrinogen	O	O
molecule	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontal	O	O
diseases	O	O
.	O	O

An	O	O
in	O	O
vitro	O	O
cell	O	O
culture	O	O
model	O	O
was	O	O
used	O	O
.	O	O

Methyl-	O	O
(	O	O
3	O	O
)	O	O
H	O	O
Thymidine	O	O
radiolabeled	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
Pg	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33277	E-bacteria	I-bacteria
were	O	O
examined	O	O
for	O	O
their	O	O
ability	O	O
to	O	O
adhere	O	O
to	O	O
and	O	O
invade	O	O
the	O	O
confluent	O	O
monolayers	O	O
of	O	O
human	O	O
oral	O	O
epithelial	O	O
KB	O	O
cells	O	O
with	O	O
or	O	O
without	O	O
exogenous	O	O
human	O	O
fibrinogens	O	O
by	O	O
scintillation	O	O
spectrometry	O	O
.	O	O

The	O	O
addition	O	O
of	O	O
exogenous	O	O
fibrinogens	O	O
made	O	O
more	O	O
amount	O	O
of	O	O
and	O	O
higher	O	O
ratios	O	O
of	O	O
adhesive	O	O
and	O	O
invasive	O	O
Pg	B-bacteria	B-bacteria
,	O	O
in	O	O
contrast	O	O
to	O	O
the	O	O
group	O	O
without	O	O
exogenous	O	O
fibrinogen	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

At	O	O
different	O	O
concentrations	O	O
of	O	O
exogenous	O	O
fibrinogen	O	O
,	O	O
the	O	O
amount	O	O
and	O	O
ratios	O	O
of	O	O
adhesive	O	O
and	O	O
invasive	O	O
Pg	B-bacteria	B-bacteria
varied	O	O
significantly	O	O
(	O	O
P	O	O
<	O	O
or	O	O
=	O	O
0.007	O	O
)	O	O
.	O	O

The	O	O
higher	O	O
concentrations	O	O
of	O	O
exogenous	O	O
fibrinogen	O	O
was	O	O
added	O	O
,	O	O
the	O	O
greater	O	O
amount	O	O
and	O	O
ratios	O	O
of	O	O
adhesive	O	O
and	O	O
invasive	O	O
Pg	B-bacteria	B-bacteria
were	O	O
found	O	O
.	O	O

Fibrinogen	O	O
promotes	O	O
the	O	O
adherence	O	O
of	O	O
Pg	O	O
to	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
and	O	O
may	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontal	O	O
diseases	O	O
.	O	O

(	O	O
1	O	O
)	O	O
To	O	O
investigate	O	O
the	O	O
prevalence	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
OS	B-bacteria	B-bacteria
)	O	O
and	O	O
biological	O	O
indicators	O	O
of	O	O
water	O	O
contamination	O	O
by	O	O
oral	O	O
fluids	O	O
in	O	O
water	O	O
from	O	O
dental	O	O
unit	O	O
water	O	O
lines	O	O
(	O	O
DUWs	O	O
)	O	O
by	O	O
detection	O	O
and	O	O
quantification	O	O
and	O	O
of	O	O
saprophytes	O	O
indigenous	O	O
to	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

(	O	O
2	O	O
)	O	O
To	O	O
test	O	O
whether	O	O
measurement	O	O
of	O	O
the	O	O
total	O	O
cultivable	O	O
mesophilic	O	O
flora	O	O
(	O	O
TCF	O	O
)	O	O
,	O	O
the	O	O
parameter	O	O
commonly	O	O
used	O	O
to	O	O
monitor	O	O
water	O	O
quality	O	O
in	O	O
DUWs	O	O
,	O	O
is	O	O
an	O	O
effective	O	O
predictor	O	O
for	O	O
OS	B-bacteria	B-bacteria
contamination	O	O
.	O	O

Survey	O	O
of	O	O
21	O	O
dental	O	O
units	O	O
equipped	O	O
with	O	O
antiretraction	O	O
devices	O	O
.	O	O

Water	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
air-water	O	O
syringes	O	O
,	O	O
cup	O	O
fillers	O	O
,	O	O
tap	O	O
water	O	O
,	O	O
and	O	O
before	O	O
and	O	O
during	O	O
the	O	O
working	O	O
day	O	O
.	O	O

Units	O	O
were	O	O
from	O	O
7	O	O
public	O	O
dental	O	O
offices	O	O
selected	O	O
for	O	O
convenience	O	O
from	O	O
among	O	O
those	O	O
in	O	O
proximity	O	O
of	O	O
the	O	O
microbiological	O	O
laboratory	O	O
.	O	O

For	O	O
detection	O	O
of	O	O
OS	B-bacteria	B-bacteria
,	O	O
samples	O	O
were	O	O
plated	O	O
on	O	O
an	O	O
enriched	O	O
medium	O	O
,	O	O
to	O	O
revitalize	O	O
the	O	O
organisms	O	O
.	O	O

Colonies	O	O
were	O	O
subcultured	O	O
on	O	O
a	O	O
selective	O	O
medium	O	O
and	O	O
biochemically	O	O
identified	O	O
(	O	O
lower	O	O
detection	O	O
limit	O	O
,	O	O
1	O	O
cfu/mL	O	O
)	O	O
.	O	O

For	O	O
measurement	O	O
of	O	O
the	O	O
TCF	B-bacteria	B-bacteria
,	O	O
samples	O	O
were	O	O
plated	O	O
on	O	O
a	O	O
nutrient-poor	O	O
medium	O	O
.	O	O

Cultures	O	O
with	O	O
colony	O	O
counts	O	O
greater	O	O
than	O	O
200	O	O
cfu/mL	O	O
were	O	O
considered	O	O
to	O	O
be	O	O
TCF	B-bacteria	B-bacteria
positive	O	O
.	O	O

The	O	O
sensitivity	O	O
and	O	O
specificity	O	O
of	O	O
TCF	B-bacteria	B-bacteria
positivity	O	O
in	O	O
predicting	O	O
OS	O	O
detection	O	O
was	O	O
calculated	O	O
.	O	O

Prevalence	O	O
rates	O	O
for	O	O
OS	B-bacteria	B-bacteria
contamination	O	O
and	O	O
for	O	O
TCF	O	O
positivity	O	O
were	O	O
,	O	O
respectively	O	O
,	O	O
34.4	O	O
%	O	O
(	O	O
11	O	O
of	O	O
32	O	O
samples	O	O
)	O	O
and	O	O
25.0	O	O
%	O	O
(	O	O
8	O	O
of	O	O
32	O	O
samples	O	O
)	O	O
for	O	O
syringes	O	O
,	O	O
27.8	O	O
%	O	O
(	O	O
10	O	O
of	O	O
36	O	O
samples	O	O
)	O	O
and	O	O
8.3	O	O
%	O	O
(	O	O
3	O	O
of	O	O
36	O	O
samples	O	O
)	O	O
for	O	O
cup	O	O
fillers	O	O
,	O	O
and	O	O
0.0	O	O
%	O	O
(	O	O
0	O	O
of	O	O
7	O	O
samples	O	O
)	O	O
for	O	O
tap	O	O
water	O	O
.	O	O

OS	O	O
contamination	O	O
levels	O	O
ranged	O	O
from	O	O
1	O	O
to	O	O
6	O	O
cfu/mL	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
differences	O	O
were	O	O
found	O	O
between	O	O
samples	O	O
obtained	O	O
before	O	O
and	O	O
during	O	O
the	O	O
working	O	O
day	O	O
.	O	O

TCF	B-bacteria	B-bacteria
positivity	O	O
did	O	O
not	O	O
predict	O	O
OS	B-bacteria	B-bacteria
contamination	O	O
effectively	O	O
,	O	O
because	O	O
of	O	O
low	O	O
sensitivity	O	O
.	O	O

Given	O	O
the	O	O
absence	O	O
of	O	O
OS	B-bacteria	B-bacteria
in	O	O
tap	O	O
water	O	O
,	O	O
the	O	O
reported	O	O
prevalence	O	O
of	O	O
OS	B-bacteria	B-bacteria
contamination	O	O
suggests	O	O
that	O	O
oral	O	O
fluids	O	O
are	O	O
aspirated	O	O
during	O	O
dental	O	O
therapy	O	O
with	O	O
relatively	O	O
high	O	O
frequency	O	O
and	O	O
that	O	O
DUWs	O	O
can	O	O
potentially	O	O
expose	O	O
successive	O	O
patients	O	O
to	O	O
bloodborne	O	O
cross-infections	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
analyse	O	O
the	O	O
prevalence	O	O
of	O	O
oral	O	O
bacteria	O	O
on	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
relationship	O	O
between	O	O
the	O	O
number	O	O
of	O	O
teeth	O	O
and	O	O
the	O	O
microflora	O	O
present	O	O
on	O	O
the	O	O
coating	O	O
of	O	O
the	O	O
tongue	O	O
in	O	O
a	O	O
population	O	O
of	O	O
85-year-old	O	O
people	O	O
was	O	O
assessed	O	O
.	O	O

Two	O	O
hundred	O	O
and	O	O
five	O	O
individuals	O	O
(	O	O
89	O	O
males	O	O
,	O	O
116	O	O
females	O	O
)	O	O
from	O	O
the	O	O
same	O	O
geographical	O	O
area	O	O
who	O	O
were	O	O
85	O	O
years	O	O
of	O	O
age	O	O
were	O	O
examined	O	O
.	O	O

Five	O	O
periodontopathic	O	O
bacteria	O	O
(	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
and	O	O
one	O	O
cariogenic	O	O
bacterium	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
)	O	O
were	O	O
analysed	O	O
using	O	O
a	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assay	O	O
of	O	O
tongue	O	O
samples	O	O
from	O	O
the	O	O
population	O	O
.	O	O

Periodontal	O	O
bacteria-positive	O	O
individuals	O	O
have	O	O
more	O	O
teeth	O	O
than	O	O
that	O	O
of	O	O
periodontal	O	O
bacteria-negative	O	O
people	O	O
.	O	O

Between	O	O
the	O	O
periodontal	O	O
bacteria-positive	O	O
and	O	O
-negative	O	O
individuals	O	O
,	O	O
there	O	O
were	O	O
significant	O	O
differences	O	O
in	O	O
the	O	O
mean	O	O
number	O	O
of	O	O
teeth	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
p=0.002	O	O
)	O	O
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
p=0.005	O	O
)	O	O
,	O	O
while	O	O
there	O	O
were	O	O
no	O	O
significant	O	O
differences	O	O
for	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
p=0.998	O	O
)	O	O
or	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
p=0.147	O	O
)	O	O
.	O	O

A	O	O
wide	O	O
range	O	O
of	O	O
species	O	O
,	O	O
including	O	O
anaerobes	B-bacteria	B-bacteria
,	O	O
was	O	O
detected	O	O
in	O	O
85-year-old	O	O
subjects	O	O
.	O	O

It	O	O
was	O	O
found	O	O
that	O	O
the	O	O
detection	O	O
of	O	O
periodontal	O	O
bacteria	O	O
on	O	O
the	O	O
tongue	O	O
coating	O	O
increased	O	O
with	O	O
the	O	O
number	O	O
of	O	O
teeth	O	O
.	O	O

There	O	O
was	O	O
a	O	O
positive	O	O
relationship	O	O
between	O	O
the	O	O
tooth	O	O
number	O	O
and	O	O
periodontopathic	O	O
bacteria	O	O
,	O	O
except	O	O
for	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
tongue	O	O
care	O	O
is	O	O
essential	O	O
for	O	O
preventing	O	O
oral	O	O
disease	O	O
and	O	O
needs	O	O
to	O	O
be	O	O
part	O	O
of	O	O
any	O	O
oral	O	O
care	O	O
programme	O	O
in	O	O
elderly	O	O
people	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
work	O	O
is	O	O
to	O	O
emphasize	O	O
that	O	O
particular	O	O
stains	O	O
on	O	O
the	O	O
third	O	O
cervical	O	O
of	O	O
the	O	O
buccal	O	O
and	O	O
lingual	O	O
surfaces	O	O
in	O	O
mixed	O	O
dentition	O	O
,	O	O
called	O	O
``	O	O
black	O	O
stain	O	O
.	O	O
''	O	O

Previous	O	O
research	O	O
showed	O	O
the	O	O
microbiological	O	O
etiology	O	O
of	O	O
this	O	O
discoloration	O	O
by	O	O
chromogen	O	O
bacterias	O	O
.	O	O

Our	O	O
study	O	O
shows	O	O
bacteria	O	O
spp	O	O
involved	O	O
in	O	O
stains	O	O
by	O	O
means	O	O
of	O	O
PCR	O	O
process	O	O
and	O	O
electrophoresis	O	O
gel	O	O
on	O	O
the	O	O
agarose	O	O
medium	O	O
.	O	O

Sample	O	O
was	O	O
formed	O	O
by	O	O
100	O	O
subject	O	O
with	O	O
black	O	O
stain	O	O
and	O	O
100	O	O
control	O	O
subjects	O	O
stain-free	O	O
.	O	O

A	O	O
statistical	O	O
analysis	O	O
(	O	O
SPSS	O	O
10.0	O	O
)	O	O
using	O	O
X2	O	O
was	O	O
performed	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
,	O	O
were	O	O
not	O	O
involved	O	O
in	O	O
both	O	O
in	O	O
black	O	O
stain	O	O
subjects	O	O
and	O	O
in	O	O
the	O	O
control	O	O
.	O	O

On	O	O
the	O	O
contrary	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
could	O	O
be	O	O
involved	O	O
in	O	O
the	O	O
pigmentation	O	O
process	O	O
.	O	O

Antimicrobial	O	O
peptides	O	O
are	O	O
components	O	O
of	O	O
the	O	O
innate	O	O
immunity	O	O
that	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
systemic	O	O
and	O	O
oral	O	O
health	O	O
.	O	O

The	O	O
antibacterial	O	O
activity	O	O
of	O	O
the	O	O
amphibian-derived	O	O
K4	O	O
-S4	O	O
(	O	O
1-15	O	O
)	O	O
a	O	O
antimicrobial	O	O
peptide	O	O
was	O	O
tested	O	O
against	O	O
oral	O	O
pathogens	O	O
associated	O	O
with	O	O
caries	O	O
and	O	O
periodontitis	O	O
and	O	O
compared	O	O
with	O	O
the	O	O
activities	O	O
of	O	O
the	O	O
human-derived	O	O
antimicrobial	O	O
peptides	O	O
LL-37	O	O
and	O	O
dhvar4a	O	O
.	O	O

Growth	O	O
inhibition	O	O
of	O	O
planktonic	O	O
bacteria	O	O
was	O	O
tested	O	O
using	O	O
standard	O	O
microdilution	O	O
assays	O	O
.	O	O

Live/Dead	O	O
staining	O	O
followed	O	O
by	O	O
confocal	O	O
scanning	O	O
laser	O	O
microscopy	O	O
(	O	O
CSLM	O	O
)	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
bactericidal	O	O
effect	O	O
of	O	O
K4	O	O
-S4	O	O
(	O	O
1-15	O	O
)	O	O
a	O	O
on	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
attached	O	O
to	O	O
a	O	O
glass	O	O
surface	O	O
or	O	O
grown	O	O
as	O	O
biofilm	O	O
.	O	O

The	O	O
cariogenic	O	O
species	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
were	O	O
resistant	O	O
to	O	O
LL-37	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
the	O	O
species	O	O
most	O	O
resistant	O	O
to	O	O
the	O	O
three	O	O
tested	O	O
peptides	O	O
.	O	O

K4	O	O
-S4	O	O
(	O	O
1-15	O	O
)	O	O
a	O	O
demonstrated	O	O
the	O	O
highest	O	O
activity	O	O
against	O	O
the	O	O
tested	O	O
planktonic	O	O
bacteria	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
K4	O	O
-S4	O	O
(	O	O
1-15	O	O
)	O	O
a	O	O
was	O	O
bactericidal	O	O
to	O	O
surface-attached	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
as	O	O
well	O	O
as	O	O
to	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
grown	O	O
in	O	O
vitro	O	O
.	O	O

However	O	O
,	O	O
surface	O	O
attachment	O	O
increased	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
resistance	O	O
to	O	O
the	O	O
antimicrobial	O	O
peptide	O	O
.	O	O

Our	O	O
results	O	O
support	O	O
growing	O	O
evidence	O	O
suggesting	O	O
the	O	O
use	O	O
of	O	O
antimicrobial	O	O
peptides	O	O
for	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
oral	O	O
disease	O	O
.	O	O

To	O	O
isolate	O	O
and	O	O
characterise	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
from	O	O
Irish	O	O
saliva	O	O
samples	O	O
and	O	O
to	O	O
assess	O	O
their	O	O
sensitivity	O	O
to	O	O
a	O	O
food-grade	O	O
preparation	O	O
of	O	O
the	O	O
lantibiotic	O	O
,	O	O
lacticin	O	O
3147	O	O
,	O	O
produced	O	O
by	O	O
Lactococcus	O	O
lactis	O	O
DPC3147	O	O
.	O	O

Saliva	O	O
samples	O	O
collected	O	O
from	O	O
children	O	O
with	O	O
varying	O	O
oral	O	O
health	O	O
status	O	O
were	O	O
screened	O	O
on	O	O
Mitis	O	O
Salivarius	O	O
agar	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
pathogenic	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Following	O	O
selective	O	O
plating	O	O
,	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
and	O	O
Pulsed	O	O
Field	O	O
Gel	O	O
Electrophoresis	O	O
(	O	O
PFGE	O	O
)	O	O
,	O	O
15	O	O
distinct	O	O
strains	O	O
of	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
identified	O	O
.	O	O

These	O	O
were	O	O
grouped	O	O
according	O	O
to	O	O
their	O	O
relative	O	O
sensitivity	O	O
to	O	O
lacticin	O	O
3147	O	O
which	O	O
ranged	O	O
from	O	O
0.78	O	O
to	O	O
6.25	O	O
%	O	O
;	O	O
relative	O	O
to	O	O
a	O	O
sensitive	O	O
indicator	O	O
strain	O	O
,	O	O
Lactococcus	B-bacteria	B-bacteria
lactis	I-bacteria	I-bacteria
ssp	E-bacteria	I-bacteria
.	O	O

lactis	B-bacteria	B-bacteria
HP	E-bacteria	I-bacteria
.	O	O

Inhibition	O	O
of	O	O
indicator	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
from	O	O
sensitive	O	O
,	O	O
intermediate	O	O
and	O	O
tolerant	O	O
groupings	O	O
were	O	O
assessed	O	O
in	O	O
microtitre	O	O
plate	O	O
assays	O	O
with	O	O
increasing	O	O
concentrations	O	O
of	O	O
lacticin	O	O
3147	O	O
.	O	O

The	O	O
concentration	O	O
of	O	O
lacticin	O	O
3147	O	O
required	O	O
to	O	O
give	O	O
50	O	O
%	O	O
growth	O	O
inhibition	O	O
correlated	O	O
with	O	O
their	O	O
relative	O	O
sensitivities	O	O
(	O	O
as	O	O
assayed	O	O
by	O	O
well	O	O
diffusion	O	O
methodology	O	O
)	O	O
and	O	O
ranged	O	O
from	O	O
1280	O	O
to	O	O
5120	O	O
AU	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

Concentrated	O	O
preparations	O	O
of	O	O
lacticin	O	O
3147	O	O
caused	O	O
a	O	O
rapid	O	O
killing	O	O
of	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
in	O	O
broth	O	O
.	O	O

Moreover	O	O
,	O	O
in	O	O
human	O	O
saliva	O	O
deliberately	O	O
spiked	O	O
with	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
the	O	O
pathogenic	O	O
was	O	O
eliminated	O	O
(	O	O
initial	O	O
inoculum	O	O
of	O	O
10	O	O
(	O	O
5	O	O
)	O	O
)	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
40,000	O	O
AU	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
of	O	O
lacticin	O	O
3147	O	O
.	O	O

Furthermore	O	O
,	O	O
a	O	O
food-grade	O	O
lacticin	O	O
3147	O	O
spray	O	O
dried	O	O
powder	O	O
ingredient	O	O
was	O	O
assessed	O	O
for	O	O
the	O	O
inhibition	O	O
of	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
human	O	O
saliva	O	O
,	O	O
spiked	O	O
with	O	O
a	O	O
strain	O	O
of	O	O
intermediate	O	O
sensitivity	O	O
,	O	O
resulting	O	O
in	O	O
up	O	O
to	O	O
a	O	O
4-log	O	O
reduction	O	O
in	O	O
counts	O	O
after	O	O
20	O	O
min	O	O
.	O	O

A	O	O
food	O	O
grade	O	O
preparation	O	O
of	O	O
lacticin	O	O
3147	O	O
was	O	O
effective	O	O
in	O	O
the	O	O
inhibition	O	O
of	O	O
oral	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

The	O	O
inhibition	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
by	O	O
food	O	O
grade	O	O
preparations	O	O
of	O	O
lacticin	O	O
3147	O	O
may	O	O
offer	O	O
novel	O	O
opportunities	O	O
for	O	O
the	O	O
development	O	O
of	O	O
lacticin	O	O
3147	O	O
as	O	O
an	O	O
anti-cariogenic	O	O
agent	O	O
particularly	O	O
in	O	O
the	O	O
area	O	O
of	O	O
functional	O	O
foods	O	O
for	O	O
the	O	O
improvement	O	O
of	O	O
oral	O	O
health	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
are	O	O
the	O	O
primary	O	O
component	O	O
of	O	O
the	O	O
multispecies	O	O
oral	O	O
biofilm	O	O
known	O	O
as	O	O
supragingival	O	O
dental	O	O
plaque	O	O
;	O	O
they	O	O
grow	O	O
by	O	O
fermentation	O	O
of	O	O
sugars	O	O
to	O	O
organic	O	O
acids	O	O
,	O	O
e.g.	O	O
,	O	O
lactic	O	O
acid	O	O
.	O	O

Veillonellae	B-bacteria	B-bacteria
,	O	O
a	O	O
ubiquitous	O	O
component	O	O
of	O	O
early	O	O
plaque	O	O
,	O	O
are	O	O
unable	O	O
to	O	O
use	O	O
sugars	O	O
;	O	O
they	O	O
ferment	O	O
organic	O	O
acids	O	O
,	O	O
such	O	O
as	O	O
lactate	O	O
,	O	O
to	O	O
a	O	O
mixture	O	O
of	O	O
shorter-chain-length	O	O
acids	O	O
,	O	O
CO	O	O
(	O	O
2	O	O
)	O	O
,	O	O
and	O	O
hydrogen	O	O
.	O	O

Certain	O	O
veillonellae	B-bacteria	B-bacteria
bind	O	O
to	O	O
(	O	O
coaggregate	O	O
with	O	O
)	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
vitro	O	O
.	O	O

We	O	O
show	O	O
that	O	O
,	O	O
between	O	O
4	O	O
and	O	O
8	O	O
hours	O	O
into	O	O
plaque	O	O
development	O	O
,	O	O
the	O	O
dominant	O	O
strains	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
change	O	O
in	O	O
their	O	O
phenotypic	O	O
characteristics	O	O
(	O	O
coaggregation	O	O
and	O	O
antibody	O	O
reactivity	O	O
)	O	O
as	O	O
well	O	O
as	O	O
in	O	O
their	O	O
genotypic	O	O
characteristics	O	O
(	O	O
16S	O	O
RNA	O	O
gene	O	O
sequences	O	O
as	O	O
well	O	O
as	O	O
strain	O	O
level	O	O
fingerprint	O	O
patterns	O	O
)	O	O
.	O	O

This	O	O
succession	O	O
is	O	O
coordinated	O	O
with	O	O
the	O	O
development	O	O
of	O	O
mixed-species	O	O
bacterial	O	O
colonies	O	O
.	O	O

Changes	O	O
in	O	O
community	O	O
structure	O	O
can	O	O
occur	O	O
very	O	O
rapidly	O	O
in	O	O
natural	O	O
biofilm	O	O
development	O	O
,	O	O
and	O	O
we	O	O
suggest	O	O
that	O	O
this	O	O
process	O	O
may	O	O
influence	O	O
evolution	O	O
within	O	O
this	O	O
ecosystem	O	O
.	O	O

Epithelial	O	O
cells	O	O
(	O	O
EC	O	O
)	O	O
have	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
constitution	O	O
of	O	O
both	O	O
innate	O	O
and	O	O
acquired	O	O
immune	O	O
responses	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
alterations	O	O
of	O	O
bactericidal	O	O
effects	O	O
and	O	O
cytokine	O	O
production	O	O
patterns	O	O
of	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
(	O	O
OEC	O	O
)	O	O
against	O	O
different	O	O
doses	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
.	O	O

For	O	O
this	O	O
purpose	O	O
,	O	O
OEC	O	O
have	O	O
been	O	O
stimulated	O	O
with	O	O
S.	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
with	O	O
an	O	O
effector/target	O	O
(	O	O
E/T	O	O
)	O	O
cell	O	O
ratio	O	O
of	O	O
1/1	O	O
,	O	O
1/100	O	O
,	O	O
1/1.000	O	O
and	O	O
1/10.000	O	O
,	O	O
and	O	O
bactericidal	O	O
effects	O	O
and	O	O
interleukin	O	O
(	O	O
IL	O	O
)	O	O
-6	O	O
,	O	O
IL-8	O	O
and	O	O
IL-10	O	O
levels	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
first	O	O
and	O	O
sixth	O	O
hours	O	O
of	O	O
incubation	O	O
.	O	O

The	O	O
mean	O	O
rates	O	O
of	O	O
bactericidal	O	O
effect	O	O
detected	O	O
in	O	O
the	O	O
first	O	O
and	O	O
sixth	O	O
hours	O	O
were	O	O
38.7	O	O
%	O	O
and	O	O
54.5	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
bactericidal	O	O
effects	O	O
observed	O	O
at	O	O
1/1	O	O
E/T	O	O
cell	O	O
ratio	O	O
in	O	O
the	O	O
first	O	O
hour	O	O
,	O	O
and	O	O
at	O	O
1/1	O	O
and	O	O
1/100	O	O
E/T	O	O
cell	O	O
ratio	O	O
in	O	O
the	O	O
the	O	O
sixth	O	O
hour	O	O
were	O	O
found	O	O
significantly	O	O
higher	O	O
then	O	O
the	O	O
other	O	O
cells	O	O
ratios	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Time-	O	O
and	O	O
dose-depended	O	O
differences	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
cytokine	O	O
responses	O	O
of	O	O
OEC	O	O
for	O	O
different	O	O
S.	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
concentrations	O	O
.	O	O

IL-6	O	O
levels	O	O
produced	O	O
by	O	O
stimulated	O	O
OEC	O	O
were	O	O
found	O	O
higher	O	O
,	O	O
and	O	O
IL-8	O	O
levels	O	O
were	O	O
found	O	O
lower	O	O
then	O	O
the	O	O
levels	O	O
which	O	O
were	O	O
produced	O	O
by	O	O
unstimulated	O	O
OEC	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
,	O	O
p	O	O
<	O	O
0.001	O	O
,	O	O
respectively	O	O
)	O	O
in	O	O
the	O	O
first	O	O
hour	O	O
,	O	O
while	O	O
there	O	O
were	O	O
no	O	O
change	O	O
in	O	O
IL-10	O	O
levels	O	O
after	O	O
stimulation	O	O
with	O	O
different	O	O
bacterial	O	O
concentrations	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

At	O	O
the	O	O
sixth	O	O
hour	O	O
there	O	O
were	O	O
no	O	O
differences	O	O
in	O	O
the	O	O
IL-6	O	O
levels	O	O
produced	O	O
by	O	O
stimulated	O	O
and	O	O
unstimulated	O	O
cells	O	O
,	O	O
while	O	O
the	O	O
levels	O	O
of	O	O
IL-8	O	O
produced	O	O
by	O	O
stimulated	O	O
cells	O	O
were	O	O
found	O	O
lower	O	O
then	O	O
the	O	O
levels	O	O
produced	O	O
by	O	O
unstimulated	O	O
cells	O	O
in	O	O
the	O	O
E/T	O	O
cell	O	O
ratio	O	O
of	O	O
1/100	O	O
,	O	O
1/1000	O	O
and	O	O
1/10.000	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
,	O	O
p	O	O
<	O	O
0.01	O	O
,	O	O
p	O	O
<	O	O
0.01	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Nevertheless	O	O
IL-10	O	O
levels	O	O
in	O	O
the	O	O
E/T	O	O
cell	O	O
ratio	O	O
of	O	O
1/100	O	O
and	O	O
1/1.000	O	O
were	O	O
statistically	O	O
higher	O	O
then	O	O
the	O	O
levels	O	O
produced	O	O
by	O	O
unstimulated	O	O
cells	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
,	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

As	O	O
a	O	O
result	O	O
OEC	O	O
stimulated	O	O
with	O	O
S.	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
showed	O	O
dose	O	O
dependent	O	O
manner	O	O
in	O	O
bactericidal	O	O
effect	O	O
and	O	O
cytokine	O	O
production	O	O
.	O	O

It	O	O
is	O	O
suggested	O	O
that	O	O
epithelial	O	O
cells	O	O
stimulation	O	O
with	O	O
different	O	O
doses	O	O
of	O	O
antigen	O	O
contributed	O	O
to	O	O
the	O	O
immune	O	O
system	O	O
activation	O	O
or	O	O
tolerance	O	O
.	O	O

Benzimidazoles	O	O
are	O	O
widely	O	O
used	O	O
as	O	O
proton-pump	O	O
inhibitors	O	O
to	O	O
control	O	O
stomach	O	O
hyperacidity	O	O
and	O	O
have	O	O
been	O	O
found	O	O
also	O	O
to	O	O
have	O	O
antimicrobial	O	O
actions	O	O
against	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
and	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Our	O	O
primary	O	O
aim	O	O
was	O	O
to	O	O
determine	O	O
if	O	O
they	O	O
are	O	O
active	O	O
also	O	O
against	O	O
oral	O	O
anaerobes	B-bacteria	B-bacteria
associated	O	O
with	O	O
gingivitis	O	O
.	O	O

Our	O	O
major	O	O
focus	O	O
was	O	O
on	O	O
catabolism	O	O
because	O	O
it	O	O
leads	O	O
to	O	O
production	O	O
of	O	O
inflammatory	O	O
metabolites	O	O
such	O	O
as	O	O
butyrate	O	O
and	O	O
ammonia	O	O
.	O	O

The	O	O
benzimidazoles	O	O
are	O	O
effective	O	O
in	O	O
the	O	O
protonated	O	O
form	O	O
at	O	O
acid	O	O
pH	O	O
values	O	O
and	O	O
cause	O	O
irreversible	O	O
inhibition	O	O
of	O	O
enzymes	O	O
associated	O	O
with	O	O
formation	O	O
of	O	O
drug-target	O	O
disulfide	O	O
bonds	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25586	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25611	E-bacteria	I-bacteria
were	O	O
grown	O	O
anaerobically	O	O
in	O	O
suspension	O	O
cultures	O	O
,	O	O
harvested	O	O
,	O	O
washed	O	O
and	O	O
exposed	O	O
to	O	O
the	O	O
benzimidazole	O	O
lansoprazole	O	O
at	O	O
pH	O	O
values	O	O
of	O	O
4	O	O
or	O	O
5	O	O
before	O	O
being	O	O
washed	O	O
and	O	O
used	O	O
for	O	O
standard	O	O
assays	O	O
to	O	O
detect	O	O
inhibition	O	O
of	O	O
catabolic	O	O
functions	O	O
,	O	O
uptake	O	O
of	O	O
the	O	O
agent	O	O
and	O	O
lethality	O	O
.	O	O

Lansoprazole	O	O
was	O	O
found	O	O
to	O	O
be	O	O
a	O	O
bacteriostatic	O	O
,	O	O
multi-target	O	O
antimicrobial	O	O
against	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
under	O	O
anaerobic	O	O
conditions	O	O
inhibitory	O	O
for	O	O
amino	O	O
acid	O	O
fermentation	O	O
and	O	O
also	O	O
for	O	O
glycolysis	O	O
of	O	O
glucose	O	O
or	O	O
fructose	O	O
.	O	O

ID	O	O
(	O	O
50	O	O
)	O	O
values	O	O
for	O	O
fermentation	O	O
of	O	O
amino	O	O
acids	O	O
and	O	O
dipeptides	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
ranged	O	O
from	O	O
0.05	O	O
mM	O	O
for	O	O
lysine	O	O
to	O	O
0.25	O	O
mM	O	O
for	O	O
serine	O	O
.	O	O

Fructose	O	O
catabolism	O	O
was	O	O
highly	O	O
sensitive	O	O
with	O	O
an	O	O
ID	O	O
(	O	O
50	O	O
)	O	O
value	O	O
of	O	O
0.03	O	O
mM	O	O
apparently	O	O
related	O	O
to	O	O
high	O	O
sensitivity	O	O
of	O	O
the	O	O
phosphoenolpyruvate	O	O
:	O	O
fructose	O	O
phosphotransferase	O	O
system	O	O
,	O	O
while	O	O
the	O	O
ID	O	O
(	O	O
50	O	O
)	O	O
for	O	O
glucose	O	O
catabolism	O	O
by	O	O
intact	O	O
cells	O	O
was	O	O
some	O	O
0.07	O	O
mM	O	O
.	O	O

Fermentation	O	O
of	O	O
aspartate	O	O
or	O	O
aspartylaspartate	O	O
by	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
was	O	O
found	O	O
to	O	O
be	O	O
lansoprazole-sensitive	O	O
with	O	O
ID	O	O
(	O	O
50	O	O
)	O	O
values	O	O
of	O	O
about	O	O
0.18	O	O
and	O	O
0.20	O	O
mM	O	O
,	O	O
respectively	O	O
.	O	O

Catabolism	O	O
of	O	O
amino	O	O
acids	O	O
,	O	O
dipeptides	O	O
and	O	O
sugars	O	O
by	O	O
oral	O	O
anaerobes	B-bacteria	B-bacteria
associated	O	O
with	O	O
gingivitis	O	O
are	O	O
sensitive	O	O
to	O	O
the	O	O
inhibitory	O	O
actions	O	O
of	O	O
lansoprazole	O	O
.	O	O

Thus	O	O
,	O	O
catabolic	O	O
pathways	O	O
are	O	O
potential	O	O
targets	O	O
for	O	O
use	O	O
of	O	O
benzimidazoles	O	O
against	O	O
bacteria	O	O
involved	O	O
in	O	O
gingivitis	O	O
.	O	O

Most	O	O
infections	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
including	O	O
the	O	O
major	O	O
dental	O	O
diseases	O	O
caries	O	O
and	O	O
periodontitis	O	O
,	O	O
are	O	O
opportunistic	O	O
in	O	O
nature	O	O
.	O	O

They	O	O
are	O	O
caused	O	O
or	O	O
maintained	O	O
by	O	O
microorganisms	O	O
of	O	O
the	O	O
resident	O	O
or	O	O
transient	O	O
flora	O	O
normally	O	O
present	O	O
in	O	O
low	O	O
numbers	O	O
and	O	O
not	O	O
pathogenic	O	O
,	O	O
but	O	O
in	O	O
certain	O	O
circumstances	O	O
develop	O	O
infections	O	O
.	O	O

Mucosal	O	O
infections	O	O
have	O	O
some	O	O
degree	O	O
of	O	O
specificity	O	O
[	O	O
e.g	O	O
.	O	O

Candida	O	O
spp.	O	O
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
and	O	O
enterics	B-bacteria	B-bacteria
]	O	O
and	O	O
a	O	O
microbiological	O	O
test	O	O
can	O	O
be	O	O
interpreted	O	O
accurately	O	O
for	O	O
clinical	O	O
diagnosis	O	O
and	O	O
choice	O	O
of	O	O
treatment	O	O
.	O	O

Subepithelial	O	O
or	O	O
deep	O	O
infections	O	O
,	O	O
however	O	O
,	O	O
include	O	O
a	O	O
number	O	O
of	O	O
species	O	O
from	O	O
the	O	O
resident	O	O
flora	O	O
,	O	O
mainly	O	O
anaerobes	B-bacteria	B-bacteria
whose	O	O
role	O	O
in	O	O
the	O	O
infections	O	O
is	O	O
difficult	O	O
to	O	O
interpret	O	O
.	O	O

However	O	O
,	O	O
microbiological	O	O
tests	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
certain	O	O
bacterial	O	O
species	O	O
could	O	O
be	O	O
used	O	O
for	O	O
treatment	O	O
control	O	O
,	O	O
risk-evaluation	O	O
and	O	O
even	O	O
for	O	O
patient	O	O
motivation	O	O
in	O	O
the	O	O
prevention	O	O
of	O	O
these	O	O
diseases	O	O
.	O	O

Microbiological	O	O
diagnosis	O	O
can	O	O
be	O	O
used	O	O
in	O	O
general	O	O
practice	O	O
for	O	O
several	O	O
purposes	O	O
and	O	O
in	O	O
various	O	O
situations	O	O
that	O	O
can	O	O
be	O	O
of	O	O
great	O	O
value	O	O
for	O	O
the	O	O
dental	O	O
patient	O	O
.	O	O

Carbohydrate	O	O
antigen	O	O
detection	O	O
,	O	O
nucleic	O	O
acid	O	O
probe	O	O
detection	O	O
,	O	O
and	O	O
bacterial	O	O
culture	O	O
are	O	O
commonly	O	O
used	O	O
to	O	O
confirm	O	O
group	B-bacteria	B-bacteria
A	I-bacteria	I-bacteria
streptococcus	E-bacteria	I-bacteria
(	O	O
GAS	B-bacteria	B-bacteria
)	O	O
pharyngitis	O	O
.	O	O

Compared	O	O
to	O	O
standard	O	O
throat	O	O
swab	O	O
specimens	O	O
,	O	O
the	O	O
sensitivities	O	O
of	O	O
these	O	O
tests	O	O
with	O	O
mouth	O	O
specimens	O	O
are	O	O
poor	O	O
.	O	O

When	O	O
testing	O	O
for	O	O
GAS	B-bacteria	B-bacteria
pharyngitis	O	O
,	O	O
the	O	O
throat	O	O
remains	O	O
the	O	O
optimum	O	O
site	O	O
for	O	O
sampling	O	O
.	O	O

Tetracycline	O	O
resistance	O	O
is	O	O
commonly	O	O
found	O	O
in	O	O
endodontic	O	O
bacteria	O	O
.	O	O

One	O	O
of	O	O
the	O	O
most	O	O
common	O	O
tetracycline-resistance	O	O
genes	O	O
is	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
,	O	O
which	O	O
is	O	O
often	O	O
encoded	O	O
on	O	O
the	O	O
broad-host-range	O	O
conjugative	O	O
transposon	O	O
Tn916	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
determine	O	O
whether	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
was	O	O
present	O	O
in	O	O
bacteria	O	O
isolated	O	O
from	O	O
endodontic	O	O
patients	O	O
at	O	O
the	O	O
Eastman	O	O
Dental	O	O
Institute	O	O
and	O	O
whether	O	O
this	O	O
gene	O	O
was	O	O
carried	O	O
on	O	O
the	O	O
transferable	O	O
conjugative	O	O
transposon	O	O
Tn916	O	O
.	O	O

The	O	O
cultivable	O	O
microflora	O	O
isolated	O	O
from	O	O
15	O	O
endodontic	O	O
patients	O	O
was	O	O
screened	O	O
for	O	O
resistance	O	O
to	O	O
tetracycline	O	O
.	O	O

Polymerase	O	O
chain	O	O
reactions	O	O
for	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
and	O	O
for	O	O
unique	O	O
regions	O	O
of	O	O
Tn916	O	O
were	O	O
carried	O	O
out	O	O
on	O	O
the	O	O
DNA	O	O
of	O	O
all	O	O
tetracycline-resistant	O	O
bacteria	O	O
.	O	O

Filter-mating	O	O
experiments	O	O
were	O	O
used	O	O
to	O	O
see	O	O
if	O	O
transfer	O	O
of	O	O
any	O	O
Tn916-like	O	O
elements	O	O
could	O	O
occur	O	O
.	O	O

Eight	O	O
out	O	O
of	O	O
15	O	O
tetracycline-resistant	O	O
bacteria	O	O
isolated	O	O
were	O	O
shown	O	O
to	O	O
possess	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
.	O	O

Furthermore	O	O
,	O	O
four	O	O
of	O	O
these	O	O
eight	O	O
were	O	O
shown	O	O
to	O	O
possess	O	O
the	O	O
Tn916-unique	O	O
regions	O	O
linked	O	O
to	O	O
the	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
gene	O	O
.	O	O

Transfer	O	O
experiments	O	O
demonstrated	O	O
that	O	O
a	O	O
Neisseria	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

donor	O	O
could	O	O
transfer	O	O
an	O	O
extremely	O	O
unstable	O	O
Tn916-like	O	O
element	O	O
to	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
.	O	O

The	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
gene	O	O
is	O	O
present	O	O
in	O	O
the	O	O
majority	O	O
of	O	O
tetracycline-resistant	O	O
bacteria	O	O
isolated	O	O
in	O	O
this	O	O
study	O	O
and	O	O
the	O	O
conjugative	O	O
transposon	O	O
Tn916	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
be	O	O
responsible	O	O
for	O	O
the	O	O
support	O	O
and	O	O
transfer	O	O
of	O	O
this	O	O
gene	O	O
in	O	O
some	O	O
of	O	O
the	O	O
bacteria	O	O
isolated	O	O
.	O	O

Opportunistic	O	O
infections	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
the	O	O
elderly	O	O
may	O	O
increase	O	O
the	O	O
incidence	O	O
of	O	O
systemic	O	O
disease	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
differences	O	O
in	O	O
the	O	O
oral	O	O
bacterial	O	O
flora	O	O
between	O	O
dependent	O	O
elderly	O	O
(	O	O
inpatients	O	O
)	O	O
and	O	O
independent	O	O
elderly	O	O
(	O	O
community-dwelling	O	O
residents	O	O
)	O	O
.	O	O

After	O	O
multiple	O	O
variables	O	O
were	O	O
taken	O	O
into	O	O
account	O	O
,	O	O
inpatients	O	O
had	O	O
significantly	O	O
lower	O	O
detection	O	O
rates	O	O
than	O	O
community-dwelling	O	O
residents	O	O
for	O	O
alpha-streptococci	B-bacteria	B-bacteria
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
and	O	O
Neisseria	B-bacteria	B-bacteria
(	O	O
p	O	O
0.004	O	O
)	O	O
,	O	O
and	O	O
higher	O	O
detection	O	O
rates	O	O
for	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
(	O	O
p	O	O
0.024	O	O
)	O	O
,	O	O
methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
(	O	O
p	O	O
0.011	O	O
)	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
p	O	O
0.005	O	O
)	O	O
.	O	O

Among	O	O
inpatients	O	O
,	O	O
the	O	O
requirement	O	O
for	O	O
a	O	O
high	O	O
degree	O	O
of	O	O
care	O	O
was	O	O
related	O	O
negatively	O	O
to	O	O
detection	O	O
of	O	O
alpha-streptococci	B-bacteria	B-bacteria
,	O	O
but	O	O
was	O	O
related	O	O
significantly	O	O
to	O	O
detection	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
(	O	O
p	O	O
0.018	O	O
)	O	O
or	O	O
MRSA	B-bacteria	B-bacteria
(	O	O
p	O	O
0.004	O	O
)	O	O
.	O	O

Tube-fed	O	O
inpatients	O	O
had	O	O
a	O	O
significantly	O	O
lower	O	O
detection	O	O
rate	O	O
for	O	O
alpha-streptococci	B-bacteria	B-bacteria
(	O	O
p	O	O
0.041	O	O
)	O	O
and	O	O
a	O	O
higher	O	O
detection	O	O
rate	O	O
for	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
(	O	O
p	O	O
0.004	O	O
)	O	O
than	O	O
those	O	O
who	O	O
did	O	O
not	O	O
require	O	O
tube	O	O
feeding	O	O
.	O	O

Inpatients	O	O
with	O	O
a	O	O
history	O	O
of	O	O
antibiotic	O	O
use	O	O
had	O	O
a	O	O
significantly	O	O
lower	O	O
detection	O	O
rate	O	O
for	O	O
alpha-streptococci	B-bacteria	B-bacteria
(	O	O
p	O	O
0.049	O	O
)	O	O
and	O	O
a	O	O
higher	O	O
detection	O	O
rate	O	O
for	O	O
MRSA	B-bacteria	B-bacteria
(	O	O
p	O	O
0.007	O	O
)	O	O
than	O	O
those	O	O
without	O	O
a	O	O
history	O	O
of	O	O
antibiotic	O	O
use	O	O
.	O	O

The	O	O
detection	O	O
rates	O	O
for	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
or	O	O
MRSA	B-bacteria	B-bacteria
in	O	O
inpatients	O	O
without	O	O
alpha-streptococci	B-bacteria	B-bacteria
were	O	O
higher	O	O
than	O	O
in	O	O
inpatients	O	O
with	O	O
alpha-streptococci	B-bacteria	B-bacteria
after	O	O
controlling	O	O
for	O	O
age	O	O
and	O	O
gender	O	O
(	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
p	O	O
0.006	O	O
;	O	O
MRSA	B-bacteria	B-bacteria
,	O	O
p	O	O
0.001	O	O
)	O	O
.	O	O

Overall	O	O
,	O	O
detection	O	O
of	O	O
alpha-streptococci	B-bacteria	B-bacteria
had	O	O
an	O	O
inverse	O	O
correlation	O	O
with	O	O
the	O	O
detection	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
MRSA	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
is	O	O
likely	O	O
to	O	O
be	O	O
an	O	O
indicator	O	O
of	O	O
pathogenic	O	O
bacterial	O	O
infection	O	O
.	O	O

Peptidoglycans	O	O
(	O	O
PGNs	O	O
)	O	O
are	O	O
ubiquitous	O	O
constituents	O	O
of	O	O
bacterial	O	O
cell	O	O
walls	O	O
and	O	O
exhibit	O	O
various	O	O
immunobiological	O	O
activities	O	O
.	O	O

Two	O	O
types	O	O
of	O	O
minimum	O	O
essential	O	O
PGN	O	O
structures	O	O
for	O	O
immunobiological	O	O
activities	O	O
were	O	O
chemically	O	O
synthesized	O	O
and	O	O
designated	O	O
as	O	O
muramyldipeptide	O	O
;	O	O
N-acetylmuramyl-L-alanyl-D-isoglutamine	O	O
(	O	O
MDP	O	O
)	O	O
and	O	O
gamma-D-glutamyl-meso-diaminopimelic	O	O
acid	O	O
(	O	O
iE-DAP	O	O
)	O	O
,	O	O
which	O	O
are	O	O
common	O	O
constituents	O	O
of	O	O
both	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
most	O	O
Gram-negative	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
some	I-bacteria	I-bacteria
Gram-positive	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
respectively	O	O
.	O	O

Recently	O	O
,	O	O
intracellular	O	O
receptors	O	O
for	O	O
MDP	O	O
and	O	O
iE-DAP	O	O
have	O	O
been	O	O
demonstrated	O	O
to	O	O
be	O	O
nucleotide-binding	O	O
oligomerization	O	O
domain	O	O
(	O	O
NOD	O	O
)	O	O
1	O	O
and	O	O
NOD2	O	O
,	O	O
respectively	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
demonstrated	O	O
that	O	O
chemically	O	O
synthesized	O	O
meso-DAP	O	O
itself	O	O
activated	O	O
human	O	O
epithelial	O	O
cells	O	O
from	O	O
various	O	O
tissues	O	O
,	O	O
through	O	O
NOD1	O	O
to	O	O
generate	O	O
antibacterial	O	O
factors	O	O
,	O	O
PGN	O	O
recognition	O	O
proteins	O	O
and	O	O
beta-defensin	O	O
2	O	O
,	O	O
and	O	O
cytokines	O	O
in	O	O
specified	O	O
cases	O	O
,	O	O
although	O	O
the	O	O
activities	O	O
of	O	O
meso-DAP	O	O
were	O	O
generally	O	O
weaker	O	O
than	O	O
those	O	O
of	O	O
known	O	O
NOD	O	O
agonists	O	O
.	O	O

However	O	O
,	O	O
stereoisomers	O	O
of	O	O
meso-DAP	O	O
,	O	O
LL-DAP	O	O
,	O	O
and	O	O
DD-DAP	O	O
were	O	O
only	O	O
slightly	O	O
activated	O	O
or	O	O
remained	O	O
inactive	O	O
,	O	O
respectively	O	O
.	O	O

Synthetic	O	O
meso-lanthionine	O	O
,	O	O
which	O	O
is	O	O
another	O	O
diamino-type	O	O
amino	O	O
acid	O	O
specific	O	O
to	O	O
PGN	O	O
of	O	O
the	O	O
specified	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
was	O	O
also	O	O
recognized	O	O
by	O	O
NOD1	O	O
.	O	O

In	O	O
human	O	O
monocytic	O	O
cells	O	O
,	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
cytochalasin	O	O
D	O	O
meso-DAP	O	O
induced	O	O
slightly	O	O
but	O	O
significantly	O	O
increased	O	O
production	O	O
of	O	O
cytokines	O	O
,	O	O
although	O	O
the	O	O
cells	O	O
did	O	O
not	O	O
respond	O	O
to	O	O
meso-DAP	O	O
in	O	O
the	O	O
absent	O	O
of	O	O
cytochalasin	O	O
D.	O	O
Our	O	O
findings	O	O
suggest	O	O
that	O	O
NOD1	O	O
is	O	O
a	O	O
special	O	O
sentinel	O	O
molecule	O	O
,	O	O
especially	O	O
in	O	O
the	O	O
epithelial	O	O
barrier	O	O
,	O	O
allowing	O	O
the	O	O
intracellular	O	O
detection	O	O
of	O	O
bacteria	O	O
through	O	O
recognizing	O	O
meso-DAP	O	O
or	O	O
comparable	O	O
moiety	O	O
of	O	O
PGN	O	O
from	O	O
specified	O	O
bacteria	O	O
in	O	O
cooperation	O	O
with	O	O
NOD2	O	O
,	O	O
thereby	O	O
playing	O	O
a	O	O
key	O	O
role	O	O
in	O	O
innate	O	O
immunity	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
serum	O	O
antibody	O	O
responses	O	O
to	O	O
periodontal	O	O
pathogens	O	O
after	O	O
single-visit	O	O
full-mouth	O	O
ultrasonic	O	O
debridement	O	O
and	O	O
quadrant-wise	O	O
therapy	O	O
.	O	O

Thirty-six	O	O
subjects	O	O
with	O	O
chronic	O	O
periodontitis	O	O
were	O	O
randomized	O	O
into	O	O
three	O	O
groups	O	O
:	O	O
quadrant-wise	O	O
debridement	O	O
in	O	O
four	O	O
visits	O	O
,	O	O
one-visit	O	O
full-mouth	O	O
debridement	O	O
with	O	O
water	O	O
and	O	O
with	O	O
povidone	O	O
iodine	O	O
.	O	O

Blood	O	O
samples	O	O
were	O	O
collected	O	O
before	O	O
and	O	O
immediately	O	O
after	O	O
treatment	O	O
and	O	O
1	O	O
,	O	O
3	O	O
and	O	O
6	O	O
months	O	O
post-therapy	O	O
.	O	O

Serum	O	O
antibody	O	O
titres	O	O
and	O	O
avidity	O	O
to	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
were	O	O
determined	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
(	O	O
ELISA	O	O
)	O	O
and	O	O
thiocyanate	O	O
ELISA	O	O
,	O	O
respectively	O	O
.	O	O

IgG	O	O
titres	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
significantly	O	O
decreased	O	O
at	O	O
1	O	O
,	O	O
3	O	O
and	O	O
6	O	O
months	O	O
in	O	O
full-mouth	O	O
debridement	O	O
with	O	O
water	O	O
group	O	O
,	O	O
while	O	O
significant	O	O
reductions	O	O
were	O	O
seen	O	O
only	O	O
at	O	O
3	O	O
and	O	O
6	O	O
months	O	O
after	O	O
quadrant-wise	O	O
debridement	O	O
.	O	O

Both	O	O
full-mouth	O	O
groups	O	O
showed	O	O
significant	O	O
reduction	O	O
in	O	O
IgG	O	O
titres	O	O
to	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
at	O	O
3	O	O
and	O	O
6	O	O
months	O	O
.	O	O

Significant	O	O
increases	O	O
in	O	O
antibody	O	O
avidity	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
were	O	O
noted	O	O
3	O	O
months	O	O
following	O	O
full-mouth	O	O
debridement	O	O
with	O	O
povidone	O	O
.	O	O

Both	O	O
full-mouth	O	O
and	O	O
quadrant	O	O
treatments	O	O
generally	O	O
resulted	O	O
in	O	O
a	O	O
decrease	O	O
in	O	O
antibody	O	O
titres	O	O
and	O	O
increase	O	O
in	O	O
antibody	O	O
avidity	O	O
.	O	O

Full-mouth	O	O
debridement	O	O
induced	O	O
an	O	O
earlier	O	O
reduction	O	O
of	O	O
IgG	O	O
titre	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
than	O	O
quadrant-wise	O	O
therapy	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
oral	O	O
cavity	O	O
condition	O	O
,	O	O
identify	O	O
microorganisms	O	O
and	O	O
evaluate	O	O
interrelation	O	O
between	O	O
protozoans	O	O
,	O	O
bacteria	O	O
and	O	O
fungi	O	O
occurring	O	O
in	O	O
mouths	O	O
of	O	O
insuline	O	O
treated	O	O
diabetics	O	O
.	O	O

30	O	O
men	O	O
and	O	O
women	O	O
,	O	O
25-60	O	O
years	O	O
old	O	O
,	O	O
were	O	O
clinically	O	O
assessed	O	O
for	O	O
their	O	O
oral	O	O
cavity	O	O
condition	O	O
including	O	O
pH	O	O
range	O	O
.	O	O

Fifteen	O	O
of	O	O
them	O	O
were	O	O
the	O	O
insuline	O	O
treated	O	O
diabetics	O	O
.	O	O

Swabs	O	O
taken	O	O
of	O	O
different	O	O
sites	O	O
of	O	O
periodontium	O	O
,	O	O
dental	O	O
plaques	O	O
and	O	O
dental	O	O
pockets	O	O
collected	O	O
from	O	O
each	O	O
patients	O	O
were	O	O
used	O	O
for	O	O
detection	O	O
and	O	O
identification	O	O
of	O	O
protozoans	O	O
,	O	O
bacteria	O	O
and	O	O
fungi	O	O
.	O	O

Mucosal	O	O
inflammation	O	O
,	O	O
dental	O	O
caries	O	O
,	O	O
loose	O	O
teeth	O	O
,	O	O
periodontitis	O	O
were	O	O
observed	O	O
in	O	O
the	O	O
diabetic	O	O
patients	O	O
,	O	O
whereas	O	O
the	O	O
oral	O	O
cavities	O	O
were	O	O
generally	O	O
in	O	O
better	O	O
condition	O	O
in	O	O
the	O	O
control	O	O
patients	O	O
.	O	O

Prevalence	O	O
of	O	O
the	O	O
protozoan	O	O
parasites	O	O
Entamoeba	O	O
gingivalis	O	O
and	O	O
Trichomonas	O	O
tenax	O	O
was	O	O
higher	O	O
in	O	O
the	O	O
control	O	O
patients	O	O
than	O	O
in	O	O
the	O	O
diabetics	O	O
(	O	O
26.6	O	O
%	O	O
and	O	O
13.3	O	O
%	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Fecal	B-bacteria	B-bacteria
bacteria	I-bacteria	I-bacteria
Enterococcus	I-bacteria	I-bacteria
fecalis	E-bacteria	I-bacteria
,	O	O
E.	B-bacteria	B-bacteria
faecium	E-bacteria	I-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
occurred	O	O
with	O	O
significantly	O	O
higher	O	O
frequency	O	O
in	O	O
the	O	O
insuline	O	O
treated	O	O
patients	O	O
(	O	O
60	O	O
%	O	O
)	O	O
than	O	O
in	O	O
the	O	O
control	O	O
(	O	O
6.6	O	O
%	O	O
)	O	O
.	O	O

Various	O	O
Candida	O	O
albicans	O	O
strains	O	O
were	O	O
more	O	O
often	O	O
found	O	O
in	O	O
the	O	O
diabetic	O	O
(	O	O
53.2	O	O
%	O	O
)	O	O
than	O	O
in	O	O
the	O	O
control	O	O
patients	O	O
(	O	O
13.3	O	O
%	O	O
)	O	O
.	O	O

The	O	O
results	O	O
of	O	O
our	O	O
studies	O	O
show	O	O
a	O	O
clear	O	O
interrelation	O	O
between	O	O
alteration	O	O
of	O	O
oral	O	O
health	O	O
and	O	O
the	O	O
occurrence	O	O
of	O	O
microorganisms	O	O
in	O	O
the	O	O
insuline	O	O
treated	O	O
diabetics	O	O
.	O	O

Metabolic	O	O
disease	O	O
that	O	O
causes	O	O
serious	O	O
multi-organ	O	O
disturbances	O	O
as	O	O
well	O	O
as	O	O
insulinotherapy	O	O
are	O	O
the	O	O
very	O	O
important	O	O
factors	O	O
changing	O	O
oral	O	O
cavity	O	O
ecology	O	O
of	O	O
the	O	O
persons	O	O
with	O	O
diabetes	O	O
mellitus	O	O
;	O	O
decresed	O	O
pH	O	O
(	O	O
the	O	O
average	O	O
5.5	O	O
)	O	O
may	O	O
inhibit	O	O
development	O	O
of	O	O
infection	O	O
with	O	O
protozoans	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
these	O	O
patients	O	O
and	O	O
favour	O	O
subclinical	O	O
infections	O	O
with	O	O
other	O	O
microorganisms	O	O
.	O	O

Thus	O	O
,	O	O
in	O	O
the	O	O
insuline	O	O
treated	O	O
diabetics	O	O
,	O	O
examination	O	O
of	O	O
mouths	O	O
with	O	O
regard	O	O
to	O	O
the	O	O
occurrence	O	O
of	O	O
opportunistic	O	O
fecal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
fungi	O	O
,	O	O
particularly	O	O
before	O	O
a	O	O
therapy	O	O
with	O	O
antibiotics	O	O
is	O	O
strongly	O	O
recommended	O	O
.	O	O

Alcohol	O	O
is	O	O
a	O	O
well	O	O
documented	O	O
risk	O	O
factor	O	O
for	O	O
upper	O	O
digestive	O	O
tract	O	O
cancers	O	O
.	O	O

It	O	O
has	O	O
been	O	O
shown	O	O
that	O	O
acetaldehyde	O	O
,	O	O
the	O	O
first	O	O
metabolite	O	O
of	O	O
ethanol	O	O
is	O	O
carcinogenic	O	O
.	O	O

The	O	O
role	O	O
of	O	O
microbes	O	O
in	O	O
the	O	O
production	O	O
of	O	O
acetaldehyde	O	O
to	O	O
the	O	O
oral	O	O
cavity	O	O
has	O	O
previously	O	O
been	O	O
described	O	O
in	O	O
several	O	O
studies	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
the	O	O
aim	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
capability	O	O
of	O	O
viridans	B-bacteria	B-bacteria
group	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
of	O	O
normal	O	O
oral	O	O
flora	O	O
to	O	O
produce	O	O
acetaldehyde	O	O
in	O	O
vitro	O	O
during	O	O
ethanol	O	O
incubation	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
aim	O	O
was	O	O
to	O	O
measure	O	O
the	O	O
alcohol	O	O
dehydrogenase	O	O
(	O	O
ADH	O	O
)	O	O
activity	O	O
of	O	O
the	O	O
bacteria	O	O
.	O	O

Eight	O	O
clinical	O	O
strains	O	O
and	O	O
eight	O	O
American	O	O
Type	O	O
Culture	O	O
Collection	O	O
(	O	O
ATCC	O	O
)	O	O
strains	O	O
of	O	O
viridans	B-bacteria	B-bacteria
group	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
selected	O	O
for	O	O
the	O	O
study	O	O
.	O	O

Bacterial	O	O
suspensions	O	O
were	O	O
incubated	O	O
in	O	O
two	O	O
different	O	O
ethanol	O	O
concentrations	O	O
,	O	O
11	O	O
mM	O	O
and	O	O
1100	O	O
mM	O	O
and	O	O
the	O	O
acetaldehyde	O	O
was	O	O
measured	O	O
by	O	O
gas	O	O
chromatography	O	O
.	O	O

ADH-activity	O	O
was	O	O
measured	O	O
by	O	O
using	O	O
a	O	O
sensitive	O	O
spectroscopy	O	O
.	O	O

The	O	O
results	O	O
show	O	O
significant	O	O
differences	O	O
between	O	O
the	O	O
bacterial	O	O
strains	O	O
regarding	O	O
acetaldehyde	O	O
production	O	O
capability	O	O
and	O	O
the	O	O
detected	O	O
ADH-activity	O	O
.	O	O

In	O	O
particular	O	O
,	O	O
clinical	O	O
strain	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
both	O	O
clinical	O	O
and	O	O
culture	O	O
collection	O	O
strains	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
and	O	O
culture	O	O
collection	O	O
strain	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
produced	O	O
high	O	O
amounts	O	O
of	O	O
acetaldehyde	O	O
in	O	O
11	O	O
mM	O	O
and	O	O
1100	O	O
mM	O	O
ethanol	O	O
incubation	O	O
.	O	O

All	O	O
these	O	O
four	O	O
bacterial	O	O
strains	O	O
also	O	O
showed	O	O
significant	O	O
ADH-enzyme	O	O
activity	O	O
.	O	O

Twelve	O	O
other	O	O
strains	O	O
were	O	O
found	O	O
to	O	O
be	O	O
low	O	O
acetaldehyde	O	O
producers	O	O
.	O	O

Consequently	O	O
,	O	O
our	O	O
study	O	O
shows	O	O
that	O	O
viridans	B-bacteria	B-bacteria
group	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
metabolizing	O	O
ethanol	O	O
to	O	O
carcinogenic	O	O
acetaldehyde	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

The	O	O
observation	O	O
supports	O	O
the	O	O
concept	O	O
of	O	O
a	O	O
novel	O	O
mechanism	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
oral	O	O
cancer	O	O
.	O	O

Twelve	O	O
out	O	O
of	O	O
96	O	O
Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

isolated	O	O
from	O	O
oral	O	O
samples	O	O
harbored	O	O
tetracycline	O	O
resistance	O	O
genes	O	O
.	O	O

The	O	O
most	O	O
common	O	O
resistance	O	O
gene	O	O
was	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
.	O	O

A	O	O
tet	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
M	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
-positive	I-bacteria	I-bacteria
Veillonella	I-bacteria	I-bacteria
dispar	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
was	O	O
shown	O	O
to	O	O
transfer	O	O
a	O	O
Tn916-like	O	O
element	O	O
to	O	O
four	O	O
Streptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

by	O	O
conjugation	O	O
at	O	O
a	O	O
frequency	O	O
of	O	O
5.2	O	O
x	O	O
10	O	O
(	O	O
-6	O	O
)	O	O
to	O	O
4.5	O	O
x	O	O
10	O	O
(	O	O
-5	O	O
)	O	O
per	O	O
recipient	O	O
.	O	O

At	O	O
this	O	O
time	O	O
in	O	O
the	O	O
USA	O	O
there	O	O
are	O	O
no	O	O
antimicrobials	O	O
with	O	O
specific	O	O
indications	O	O
for	O	O
oral	O	O
infections	O	O
,	O	O
and	O	O
many	O	O
of	O	O
those	O	O
currently	O	O
used	O	O
have	O	O
limited	O	O
efficacy	O	O
against	O	O
oral	O	O
anaerobic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
.	O	O

We	O	O
tested	O	O
the	O	O
activity	O	O
of	O	O
azithromycin	O	O
against	O	O
a	O	O
broad	O	O
range	O	O
of	O	O
anaerobic	O	O
oral	O	O
pathogens	O	O
and	O	O
,	O	O
at	O	O
pH	O	O
8	O	O
,	O	O
found	O	O
it	O	O
to	O	O
be	O	O
effective	O	O
against	O	O
98	O	O
%	O	O
of	O	O
strains	O	O
,	O	O
including	O	O
all	O	O
fusobacteria	B-bacteria	B-bacteria
and	O	O
beta-lactamase-producing	O	O
strains	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

All	O	O
strains	O	O
of	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	O	O
were	O	O
also	O	O
susceptible	O	O
to	O	O
azithromycin	O	O
but	O	O
resistant	O	O
to	O	O
erythromycin	O	O
,	O	O
clindamycin	O	O
,	O	O
metronidazole	O	O
and	O	O
cefalexin	O	O
.	O	O

Other	O	O
comparator	O	O
agents	O	O
were	O	O
penicillin	O	O
,	O	O
amoxicillin/clavulanic	O	O
acid	O	O
,	O	O
tetracycline	O	O
,	O	O
levofloxacin	O	O
and	O	O
ciprofloxacin	O	O
.	O	O

Minimum	O	O
inhibitory	O	O
concentrations	O	O
obtained	O	O
on	O	O
agar	O	O
adjusted	O	O
to	O	O
pH	O	O
8	O	O
were	O	O
generally	O	O
one	O	O
dilution	O	O
lower	O	O
than	O	O
those	O	O
obtained	O	O
on	O	O
agar	O	O
at	O	O
pH	O	O
7	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
is	O	O
common	O	O
in	O	O
people	O	O
.	O	O

However	O	O
,	O	O
the	O	O
existence	O	O
of	O	O
extra	O	O
gastric	O	O
reservoirs	O	O
and	O	O
transmission	O	O
routes	O	O
remain	O	O
controversial	O	O
in	O	O
the	O	O
field	O	O
.	O	O

Because	O	O
the	O	O
oral	O	O
cavity	O	O
has	O	O
been	O	O
proposed	O	O
as	O	O
a	O	O
reservoir	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
a	O	O
study	O	O
was	O	O
carried	O	O
out	O	O
to	O	O
determine	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
dental	O	O
plaque	O	O
and	O	O
saliva	O	O
.	O	O

The	O	O
results	O	O
were	O	O
asociated	O	O
with	O	O
those	O	O
obtained	O	O
in	O	O
the	O	O
gastric	O	O
biopsy	O	O
.	O	O

Ninety-seven	O	O
dyspeptic	O	O
and	O	O
fifty	O	O
asymptomatic	O	O
patients	O	O
were	O	O
studied	O	O
and	O	O
samples	O	O
taken	O	O
for	O	O
biopsy	O	O
,	O	O
dental	O	O
plaque	O	O
and	O	O
saliva	O	O
.	O	O

The	O	O
gastric	O	O
biopsies	O	O
were	O	O
evaluated	O	O
using	O	O
microbiology	O	O
and	O	O
histology	O	O
methods	O	O
.	O	O

Cultures	O	O
and	O	O
urease	O	O
tests	O	O
were	O	O
carried	O	O
out	O	O
on	O	O
the	O	O
oral	O	O
cavity	O	O
samples	O	O
and	O	O
included	O	O
pretreatment	O	O
methods	O	O
using	O	O
urea	O	O
and	O	O
HCl	O	O
.	O	O

The	O	O
frequency	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
for	O	O
all	O	O
the	O	O
patients	O	O
evaluated	O	O
was	O	O
75.5	O	O
%	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
not	O	O
isolated	O	O
in	O	O
saliva	O	O
or	O	O
dental	O	O
plaque	O	O
in	O	O
any	O	O
of	O	O
the	O	O
two	O	O
groups	O	O
studied	O	O
with	O	O
or	O	O
without	O	O
sample	O	O
pretreatment	O	O
.	O	O

The	O	O
urease	O	O
test	O	O
in	O	O
dental	O	O
plaque	O	O
was	O	O
positive	O	O
in	O	O
99.3	O	O
%	O	O
of	O	O
the	O	O
patients	O	O
and	O	O
89.8	O	O
%	O	O
in	O	O
saliva	O	O
.	O	O

There	O	O
was	O	O
no	O	O
statistically	O	O
significant	O	O
difference	O	O
between	O	O
the	O	O
infection	O	O
prevalence	O	O
by	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
dyspeptic	O	O
or	O	O
not	O	O
dyspeptic	O	O
patients	O	O
.	O	O

The	O	O
obtained	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
methodology	O	O
used	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
is	O	O
not	O	O
sufficiently	O	O
sensitive	O	O
for	O	O
the	O	O
determination	O	O
of	O	O
the	O	O
microorganism	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
bacterial	O	O
division	O	O
Synergistes	B-bacteria	B-bacteria
represents	O	O
a	O	O
poorly	O	O
characterized	O	O
phylotype	O	O
of	O	O
which	O	O
only	O	O
a	O	O
few	O	O
isolates	O	O
have	O	O
been	O	O
cultured	O	O
,	O	O
primarily	O	O
from	O	O
natural	O	O
environments	O	O
.	O	O

Recent	O	O
detection	O	O
of	O	O
Synergistes-like	B-bacteria	B-bacteria
sequence	I-bacteria	I-bacteria
types	E-bacteria	I-bacteria
in	O	O
periodontal	O	O
pockets	O	O
and	O	O
caries	O	O
lesions	O	O
of	O	O
humans	O	O
prompted	O	O
us	O	O
to	O	O
search	O	O
the	O	O
R.	O	O
M.	O	O
Alden	O	O
culture	O	O
collection	O	O
(	O	O
Santa	O	O
Monica	O	O
,	O	O
Calif.	O	O
)	O	O
for	O	O
biochemically	O	O
unidentifiable	O	O
,	O	O
slow-growing	O	O
,	O	O
obligately	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
.	O	O

Here	O	O
we	O	O
report	O	O
on	O	O
five	O	O
clinical	O	O
isolates	O	O
cultured	O	O
from	O	O
peritoneal	O	O
fluid	O	O
and	O	O
two	O	O
isolates	O	O
from	O	O
soft-tissue	O	O
infections	O	O
that	O	O
together	O	O
constitute	O	O
three	O	O
separate	O	O
evolutionary	O	O
lineages	O	O
within	O	O
the	O	O
phylogenetic	O	O
radiation	O	O
of	O	O
the	O	O
division	O	O
Synergistes	B-bacteria	B-bacteria
.	O	O

One	O	O
of	O	O
these	O	O
clusters	O	O
was	O	O
formed	O	O
by	O	O
the	O	O
peritoneal	O	O
isolates	O	O
and	O	O
had	O	O
an	O	O
85	O	O
%	O	O
similarity	O	O
to	O	O
Synergistes	B-bacteria	B-bacteria
jonesii	E-bacteria	I-bacteria
,	O	O
the	O	O
first	O	O
described	O	O
Synergistes	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
which	O	O
was	O	O
isolated	O	O
from	O	O
the	O	O
rumen	O	O
of	O	O
a	O	O
goat	O	O
.	O	O

The	O	O
isolates	O	O
from	O	O
soft-tissue	O	O
infections	O	O
,	O	O
on	O	O
the	O	O
other	O	O
hand	O	O
,	O	O
formed	O	O
two	O	O
distinct	O	O
lineages	O	O
moderately	O	O
related	O	O
to	O	O
each	O	O
other	O	O
with	O	O
a	O	O
similarity	O	O
of	O	O
approximately	O	O
78	O	O
%	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
by	O	O
using	O	O
a	O	O
newly	O	O
designed	O	O
16S	O	O
rRNA	O	O
gene-based	O	O
PCR	O	O
assay	O	O
with	O	O
intended	O	O
target	O	O
specificity	O	O
for	O	O
Synergistes	B-bacteria	B-bacteria
,	O	O
we	O	O
found	O	O
that	O	O
the	O	O
dominant	O	O
phylotype	O	O
from	O	O
a	O	O
fecal	O	O
sample	O	O
was	O	O
nearly	O	O
identical	O	O
to	O	O
that	O	O
of	O	O
the	O	O
strains	O	O
obtained	O	O
from	O	O
peritonitis	O	O
.	O	O

Conversely	O	O
,	O	O
sequence	O	O
types	O	O
detected	O	O
in	O	O
periodontal	O	O
pockets	O	O
formed	O	O
a	O	O
separate	O	O
cluster	O	O
that	O	O
shared	O	O
a	O	O
similarity	O	O
of	O	O
only	O	O
80	O	O
%	O	O
with	O	O
the	O	O
soft-tissue	O	O
isolates	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
a	O	O
high	O	O
diversity	O	O
of	O	O
medically	O	O
important	O	O
Synergistes	B-bacteria	B-bacteria
clades	O	O
that	O	O
apparently	O	O
are	O	O
unique	O	O
to	O	O
individual	O	O
ecological	O	O
niches	O	O
in	O	O
the	O	O
human	O	O
body	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
we	O	O
now	O	O
have	O	O
available	O	O
the	O	O
first	O	O
characterized	O	O
human	O	O
isolates	O	O
of	O	O
the	O	O
division	O	O
Synergistes	B-bacteria	B-bacteria
which	O	O
are	O	O
colonizing	O	O
,	O	O
and	O	O
probably	O	O
infecting	O	O
,	O	O
several	O	O
sites	O	O
in	O	O
the	O	O
human	O	O
body	O	O
.	O	O

Malodour	O	O
has	O	O
been	O	O
correlated	O	O
with	O	O
the	O	O
concentration	O	O
of	O	O
volatile	O	O
sulphur	O	O
compounds	O	O
produced	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
by	O	O
metabolic	O	O
activity	O	O
of	O	O
bacteria	O	O
colonizing	O	O
the	O	O
periodontal	O	O
sites	O	O
and	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
detect	O	O
malodour	O	O
in	O	O
mouth	O	O
air	O	O
organoleptically	O	O
and	O	O
using	O	O
a	O	O
portable	O	O
sulphide	O	O
monitor	O	O
and	O	O
to	O	O
correlate	O	O
it	O	O
with	O	O
the	O	O
clinical	O	O
parameters	O	O
,	O	O
halitosis	O	O
linked	O	O
toxins	O	O
and	O	O
BANA	O	O
,	O	O
using	O	O
tongue	O	O
and	O	O
subgingival	O	O
plaque	O	O
samples	O	O
.	O	O

The	O	O
halitosis	O	O
grading	O	O
is	O	O
also	O	O
correlated	O	O
with	O	O
the	O	O
microbial	O	O
colonies	O	O
of	O	O
the	O	O
subgingival	O	O
plaque	O	O
sample	O	O
.	O	O

20	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
with	O	O
5-7	O	O
mm	O	O
pocket	O	O
depth	O	O
,	O	O
radiographic	O	O
evidence	O	O
of	O	O
bone	O	O
loss	O	O
and	O	O
presence	O	O
of	O	O
oral	O	O
malodour	O	O
participated	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Assessment	O	O
of	O	O
mouth	O	O
air	O	O
was	O	O
done	O	O
organoleptically	O	O
and	O	O
by	O	O
using	O	O
a	O	O
portable	O	O
sulphide	O	O
monitor	O	O
.	O	O

The	O	O
clinical	O	O
parameter	O	O
,	O	O
plaque	O	O
index	O	O
(	O	O
PI	O	O
)	O	O
,	O	O
gingival	O	O
index	O	O
(	O	O
GI	O	O
)	O	O
,	O	O
gingival	O	O
bleeding	O	O
index	O	O
(	O	O
BI	O	O
)	O	O
,	O	O
were	O	O
obtained	O	O
from	O	O
all	O	O
the	O	O
areas	O	O
.	O	O

Samples	O	O
for	O	O
BANA	O	O
and	O	O
to	O	O
detect	O	O
halitosis	O	O
linked	O	O
toxins	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
dorsal	O	O
surface	O	O
of	O	O
the	O	O
tongue	O	O
and	O	O
periodontal	O	O
pockets	O	O
ranging	O	O
5-7	O	O
mm	O	O
.	O	O

Halitosis	O	O
related	O	O
microbial	O	O
colonies	O	O
were	O	O
identified	O	O
using	O	O
anaerobic	O	O
culturing	O	O
from	O	O
the	O	O
subgingival	O	O
plaque	O	O
.	O	O

The	O	O
scores	O	O
of	O	O
PI	O	O
,	O	O
GI	O	O
,	O	O
BI	O	O
and	O	O
sample	O	O
that	O	O
tested	O	O
positive	O	O
for	O	O
halitosis	O	O
linked	O	O
toxins	O	O
and	O	O
with	O	O
the	O	O
halitosis	O	O
grading	O	O
were	O	O
not	O	O
significant	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
tongue	O	O
coating	O	O
and	O	O
the	O	O
halitosis	O	O
grading	O	O
and	O	O
toxin	O	O
levels	O	O
were	O	O
significant	O	O
.	O	O

BANA	O	O
has	O	O
shown	O	O
to	O	O
be	O	O
non	O	O
contributory	O	O
due	O	O
to	O	O
technical	O	O
problems	O	O
.	O	O

Anaerobic	O	O
culture	O	O
has	O	O
shown	O	O
to	O	O
identify	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Bacteroides	B-bacteria	B-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
colonies	O	O
.	O	O

The	O	O
results	O	O
confirmed	O	O
that	O	O
there	O	O
was	O	O
no	O	O
correlation	O	O
between	O	O
the	O	O
clinical	O	O
parameters	O	O
,	O	O
halitosis	O	O
linked	O	O
toxins	O	O
and	O	O
halitosis	O	O
grading	O	O
.	O	O

The	O	O
microbial	O	O
colonies	O	O
have	O	O
shown	O	O
to	O	O
correlate	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
oral	O	O
malodour	O	O
.	O	O

The	O	O
degree	O	O
of	O	O
adhesion	O	O
and	O	O
colonization	O	O
was	O	O
studied	O	O
among	O	O
27	O	O
patients	O	O
with	O	O
generalized	O	O
paradontitis	O	O
of	O	O
moderate	O	O
severity	O	O
and	O	O
in	O	O
remission	O	O
stage	O	O
.	O	O

All	O	O
these	O	O
patients	O	O
had	O	O
different	O	O
material	O	O
teeth	O	O
prostheses	O	O
.	O	O

12	O	O
patients	O	O
had	O	O
acrylic	O	O
plastic	O	O
``	O	O
Ftorax	O	O
''	O	O
material	O	O
prostheses	O	O
and	O	O
15	O	O
of	O	O
them	O	O
polypropylenes	O	O
prostheses	O	O
.	O	O

Prostheses	O	O
prepared	O	O
from	O	O
acryl	O	O
plastic	O	O
were	O	O
intensively	O	O
colonized	O	O
by	O	O
stable	O	O
microflora	O	O
of	O	O
oral	O	O
cavity	O	O
,	O	O
as	O	O
well	O	O
as	O	O
by	O	O
paradontopathogens	O	O
,	O	O
whereas	O	O
usage	O	O
of	O	O
polypropylenes	O	O
prostheses	O	O
is	O	O
rather	O	O
effective	O	O
for	O	O
patients	O	O
with	O	O
paradontitis	O	O
,	O	O
because	O	O
it	O	O
is	O	O
followed	O	O
by	O	O
partial	O	O
recovery	O	O
of	O	O
stable	O	O
microflora	O	O
and	O	O
lack	O	O
of	O	O
secretion	O	O
of	O	O
parodontopathogenic	O	O
types	O	O
,	O	O
such	O	O
as	O	O
actynomycetes	B-bacteria	B-bacteria
,	O	O
prevotellae	B-bacteria	B-bacteria
,	O	O
fusobacteria	B-bacteria	B-bacteria
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
assess	O	O
the	O	O
anatomical	O	O
spaces	O	O
and	O	O
causative	O	O
micro-organisms	O	O
responsible	O	O
for	O	O
deep	O	O
fascial	O	O
space	O	O
head	O	O
and	O	O
neck	O	O
infections	O	O
and	O	O
evaluate	O	O
the	O	O
resistance	O	O
of	O	O
antibiotics	O	O
used	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
these	O	O
infections	O	O
.	O	O

A	O	O
6-year	O	O
retrospective	O	O
study	O	O
evaluated	O	O
hospital	O	O
records	O	O
of	O	O
103	O	O
patients	O	O
.	O	O

All	O	O
patients	O	O
in	O	O
this	O	O
study	O	O
underwent	O	O
surgical	O	O
incision	O	O
and	O	O
drainage	O	O
,	O	O
received	O	O
IV	O	O
antibiotics	O	O
,	O	O
and	O	O
had	O	O
culture	O	O
and	O	O
sensitivity	O	O
performed	O	O
.	O	O

Patient	O	O
demographics	O	O
reviewed	O	O
were	O	O
gender	O	O
,	O	O
age	O	O
,	O	O
involved	O	O
fascial	O	O
space	O	O
(	O	O
s	O	O
)	O	O
,	O	O
micro-organisms	O	O
identified	O	O
and	O	O
antibiotic	O	O
resistance	O	O
from	O	O
culture	O	O
and	O	O
sensitivity	O	O
testing	O	O
.	O	O

There	O	O
were	O	O
56	O	O
male	O	O
(	O	O
54	O	O
%	O	O
)	O	O
and	O	O
47	O	O
(	O	O
46	O	O
%	O	O
)	O	O
female	O	O
patients	O	O
.	O	O

The	O	O
submandibular	O	O
space	O	O
was	O	O
the	O	O
most	O	O
frequent	O	O
location	O	O
for	O	O
a	O	O
single	O	O
space	O	O
abscess	O	O
(	O	O
30	O	O
%	O	O
)	O	O
,	O	O
followed	O	O
by	O	O
the	O	O
buccal	O	O
space	O	O
(	O	O
27.5	O	O
%	O	O
)	O	O
and	O	O
the	O	O
lateral	O	O
pharyngeal	O	O
space	O	O
(	O	O
12.5	O	O
%	O	O
)	O	O
.	O	O

Sixty-three	O	O
patients	O	O
presented	O	O
with	O	O
multiple	O	O
space	O	O
involvement	O	O
,	O	O
totaling	O	O
142	O	O
spaces	O	O
involved	O	O
.	O	O

A	O	O
total	O	O
of	O	O
269	O	O
bacterial	O	O
strains	O	O
were	O	O
isolated	O	O
from	O	O
103	O	O
patients	O	O
.	O	O

The	O	O
bacteria	O	O
were	O	O
found	O	O
to	O	O
be	O	O
63.5	O	O
%	O	O
gram-positive	O	O
.	O	O

Gram-positive	B-bacteria	B-bacteria
cocci	E-bacteria	I-bacteria
were	O	O
isolated	O	O
57.7	O	O
%	O	O
of	O	O
specimens	O	O
and	O	O
gram-negative	B-bacteria	B-bacteria
rods	E-bacteria	I-bacteria
were	O	O
isolated	O	O
in	O	O
33	O	O
%	O	O
of	O	O
cultures	O	O
.	O	O

There	O	O
were	O	O
178	O	O
aerobes	O	O
(	O	O
65.7	O	O
%	O	O
)	O	O
and	O	O
91	O	O
anaerobes	B-bacteria	B-bacteria
(	O	O
34.3	O	O
%	O	O
)	O	O
isolated	O	O
.	O	O

The	O	O
most	O	O
common	O	O
bacteria	O	O
isolated	O	O
were	O	O
Viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
Provetella	B-bacteria	B-bacteria
,	O	O
Staphylococci	B-bacteria	B-bacteria
,	O	O
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
.	O	O

culture	O	O
and	O	O
sensitivity	O	O
testing	O	O
were	O	O
reviewed	O	O
on	O	O
101	O	O
patients	O	O
.	O	O

Patients	O	O
who	O	O
underwent	O	O
surgical	O	O
incision	O	O
and	O	O
drainage	O	O
in	O	O
the	O	O
operating	O	O
room	O	O
had	O	O
a	O	O
tendency	O	O
for	O	O
involvement	O	O
of	O	O
multiple	O	O
space	O	O
abscesses	O	O
with	O	O
the	O	O
submandibular	O	O
space	O	O
,	O	O
submental	O	O
,	O	O
and	O	O
lateral	O	O
pharyngeal	O	O
spaces	O	O
effected	O	O
most	O	O
frequently	O	O
.	O	O

culture	O	O
and	O	O
sensitivity	O	O
testing	O	O
commonly	O	O
showed	O	O
greater	O	O
growth	O	O
in	O	O
aerobes	O	O
(	O	O
65.7	O	O
%	O	O
)	O	O
than	O	O
in	O	O
anaerobes	B-bacteria	B-bacteria
.	O	O

Gram	B-bacteria	B-bacteria
positive	I-bacteria	I-bacteria
cocci	E-bacteria	I-bacteria
and	O	O
gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
had	O	O
the	O	O
greatest	O	O
growth	O	O
percentage	O	O
in	O	O
cultures	O	O
.	O	O

The	O	O
aim	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
30	O	O
%	O	O
ethanolic	O	O
extract	O	O
of	O	O
Bulgarian	O	O
propolis	O	O
on	O	O
94	O	O
clinical	O	O
anaerobic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
.	O	O

The	O	O
strains	O	O
were	O	O
tested	O	O
by	O	O
both	O	O
agar-well	O	O
diffusion	O	O
(	O	O
wells	O	O
,	O	O
7	O	O
mm	O	O
diameter	O	O
)	O	O
and	O	O
disk-diffusion	O	O
methods	O	O
.	O	O

Only	O	O
15	O	O
%	O	O
of	O	O
Clostridium-	B-bacteria	B-bacteria
,	O	O
3.3	O	O
%	O	O
of	O	O
other	O	O
Gram-positive-	O	O
and	O	O
9.1	O	O
%	O	O
of	O	O
Gram-negative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
were	O	O
not	O	O
inhibited	O	O
by	O	O
30	O	O
microL	O	O
propolis	O	O
extract	O	O
per	O	O
well	O	O
.	O	O

Propolis	O	O
extract	O	O
was	O	O
more	O	O
active	O	O
than	O	O
the	O	O
ethanol	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

By	O	O
30	O	O
microL	O	O
extract	O	O
per	O	O
well	O	O
,	O	O
mean	O	O
inhibitory	O	O
diameters	O	O
of	O	O
the	O	O
clostridia	B-bacteria	B-bacteria
,	O	O
other	O	O
Gram-positive-	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
anaerobes	E-bacteria	I-bacteria
were	O	O
11.5	O	O
,	O	O
13.1	O	O
,	O	O
and	O	O
11.3	O	O
mm	O	O
,	O	O
and	O	O
those	O	O
by	O	O
90	O	O
microL	O	O
were	O	O
16	O	O
,	O	O
18.1	O	O
and	O	O
15.4	O	O
mm	O	O
,	O	O
respectively	O	O
.	O	O

Mean	O	O
inhibitory	O	O
diameters	O	O
of	O	O
all	O	O
strains	O	O
by	O	O
30	O	O
and	O	O
90	O	O
microL	O	O
ethanol	O	O
were	O	O
only	O	O
8.4	O	O
and	O	O
9.5	O	O
mm	O	O
.	O	O

By	O	O
30	O	O
microL	O	O
propolis	O	O
extract	O	O
per	O	O
well	O	O
,	O	O
inhibitory	O	O
diameters	O	O
of	O	O
15	O	O
mm	O	O
or	O	O
more	O	O
were	O	O
more	O	O
common	O	O
in	O	O
Gram-positive	O	O
(	O	O
32	O	O
%	O	O
)	O	O
than	O	O
in	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
13.6	O	O
%	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Moist	O	O
propolis	O	O
disks	O	O
inhibited	O	O
more	O	O
strains	O	O
(	O	O
89.4	O	O
%	O	O
)	O	O
than	O	O
dried	O	O
disks	O	O
(	O	O
68.1	O	O
%	O	O
,	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Most	O	O
(	O	O
81.8	O	O
%	O	O
)	O	O
Bacteroides	B-bacteria	B-bacteria
fragilis	I-bacteria	I-bacteria
group	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
and	O	O
75	O	O
%	O	O
of	O	O
clostridial	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
inhibited	O	O
by	O	O
moist	O	O
EEP	O	O
disks	O	O
.	O	O

Bulgarian	O	O
propolis	O	O
was	O	O
active	O	O
against	O	O
most	O	O
anaerobic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
of	O	O
different	O	O
genera	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
oral	O	O
pathogens	O	O
,	O	O
an	O	O
activity	O	O
of	O	O
propolis	O	O
against	O	O
Clostridium	B-bacteria	B-bacteria
,	O	O
Bacteroides	B-bacteria	B-bacteria
and	O	O
Propionibacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
was	O	O
observed	O	O
.	O	O

The	O	O
results	O	O
could	O	O
motivate	O	O
a	O	O
higher	O	O
medical	O	O
interest	O	O
and	O	O
further	O	O
trials	O	O
for	O	O
evaluating	O	O
the	O	O
use	O	O
of	O	O
bee	O	O
glue	O	O
for	O	O
prophylaxis	O	O
or	O	O
treatment	O	O
of	O	O
some	O	O
anaerobic	O	O
infections	O	O
such	O	O
as	O	O
oral	O	O
,	O	O
skin	O	O
and	O	O
wound	O	O
diseases	O	O
.	O	O

Most	O	O
probiotic	B-bacteria	B-bacteria
products	O	O
are	O	O
consumed	O	O
orally	O	O
and	O	O
hence	O	O
it	O	O
is	O	O
feasible	O	O
that	O	O
the	O	O
bacteria	O	O
in	O	O
these	O	O
products	O	O
may	O	O
also	O	O
attach	O	O
to	O	O
oral	O	O
surfaces	O	O
;	O	O
however	O	O
,	O	O
the	O	O
effects	O	O
of	O	O
these	O	O
bacteria	O	O
on	O	O
the	O	O
oral	O	O
ecosystem	O	O
are	O	O
mostly	O	O
unknown	O	O
.	O	O

Our	O	O
aim	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
oral	O	O
colonization	O	O
potential	O	O
of	O	O
different	O	O
probiotic	B-bacteria	B-bacteria
,	O	O
dairy	O	O
,	O	O
and	O	O
fecal	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
in	O	O
vitro	O	O
.	O	O

The	O	O
binding	O	O
of	O	O
17	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
seven	O	O
Bifidobacterium	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
to	O	O
hydroxyapatite	O	O
and	O	O
microtitre	O	O
wells	O	O
coated	O	O
with	O	O
human	O	O
saliva	O	O
was	O	O
tested	O	O
.	O	O

Binding	O	O
of	O	O
selected	O	O
strains	O	O
to	O	O
human	O	O
buccal	O	O
epithelial	O	O
cells	O	O
and	O	O
co-adherence	O	O
with	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
were	O	O
also	O	O
investigated	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
survival	O	O
in	O	O
sterilized	O	O
human	O	O
whole	O	O
saliva	O	O
was	O	O
examined	O	O
.	O	O

There	O	O
was	O	O
a	O	O
large	O	O
variation	O	O
in	O	O
binding	O	O
to	O	O
saliva-coated	O	O
surfaces	O	O
and	O	O
buccal	O	O
epithelial	O	O
cells	O	O
but	O	O
all	O	O
strains	O	O
survived	O	O
in	O	O
saliva	O	O
.	O	O

The	O	O
binding	O	O
pattern	O	O
of	O	O
the	O	O
probiotics	B-bacteria	B-bacteria
did	O	O
not	O	O
differ	O	O
from	O	O
the	O	O
binding	O	O
of	O	O
the	O	O
fecal	O	O
strains	O	O
.	O	O

F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
altered	O	O
the	O	O
binding	O	O
of	O	O
both	O	O
the	O	O
low-binding	O	O
bifidobacteria	B-bacteria	B-bacteria
and	O	O
the	O	O
high-binding	O	O
lactobacilli	B-bacteria	B-bacteria
.	O	O

The	O	O
differences	O	O
in	O	O
binding	O	O
in	O	O
vitro	O	O
may	O	O
indicate	O	O
that	O	O
there	O	O
are	O	O
also	O	O
differences	O	O
in	O	O
the	O	O
persistence	O	O
of	O	O
the	O	O
different	O	O
probiotic	B-bacteria	B-bacteria
strains	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
vivo	O	O
.	O	O

Colonization	O	O
of	O	O
Candida	O	O
albicans	O	O
on	O	O
oral	O	O
surfaces	O	O
can	O	O
serve	O	O
as	O	O
a	O	O
reservoir	O	O
for	O	O
disseminated	O	O
infections	O	O
,	O	O
such	O	O
as	O	O
aspiration	O	O
pneumonia	O	O
and	O	O
gastrointestinal	O	O
infection	O	O
,	O	O
particularly	O	O
in	O	O
the	O	O
immunocompromised	O	O
host	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
effects	O	O
of	O	O
salivary	O	O
and	O	O
serum	O	O
pellicles	O	O
on	O	O
C.	O	O
albicans	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
colonization	O	O
on	O	O
type	O	O
I	O	O
collagen	O	O
,	O	O
a	O	O
major	O	O
organic	O	O
component	O	O
of	O	O
periodontal	O	O
ligaments	O	O
.	O	O

The	O	O
colonization	O	O
potential	O	O
of	O	O
two	O	O
isolates	O	O
each	O	O
of	O	O
C.	O	O
albicans	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
and	O	O
a	O	O
single	O	O
isolate	O	O
each	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
to	O	O
uncoated	O	O
(	O	O
control	O	O
)	O	O
,	O	O
saliva-coated	O	O
or	O	O
serum-coated	O	O
type	O	O
I	O	O
collagen	O	O
plates	O	O
(	O	O
surface	O	O
area	O	O
143	O	O
mm	O	O
(	O	O
2	O	O
)	O	O
,	O	O
Cell	O	O
Disk	O	O
;	O	O
Sumitomo	O	O
,	O	O
Tokyo	O	O
,	O	O
Japan	O	O
)	O	O
was	O	O
examined	O	O
using	O	O
a	O	O
bioluminescent	O	O
adenosine	O	O
triphosphate	O	O
assay	O	O
based	O	O
on	O	O
firefly	O	O
luciferase-luciferin	O	O
system	O	O
.	O	O

The	O	O
results	O	O
revealed	O	O
that	O	O
with	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
a	O	O
saliva	O	O
pellicle	O	O
was	O	O
significantly	O	O
more	O	O
effective	O	O
in	O	O
promoting	O	O
bacterial	O	O
colonization	O	O
compared	O	O
with	O	O
the	O	O
pellicle-free	O	O
collagen	O	O
disc	O	O
,	O	O
and	O	O
the	O	O
serum-coated	O	O
sample	O	O
significantly	O	O
inhibited	O	O
the	O	O
colonization	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
anova	O	O
;	O	O
P	O	O
<	O	O
0b01	O	O
)	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
in	O	O
the	O	O
case	O	O
of	O	O
C.	O	O
albicans	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
isolates	O	O
,	O	O
a	O	O
serum	O	O
pellicle	O	O
was	O	O
significantly	O	O
more	O	O
effective	O	O
in	O	O
promoting	O	O
the	O	O
colonization	O	O
,	O	O
followed	O	O
by	O	O
saliva	O	O
pellicle	O	O
and	O	O
uncoated	O	O
specimen	O	O
(	O	O
anova	O	O
;	O	O
P	O	O
<	O	O
0b01	O	O
)	O	O
.	O	O

These	O	O
results	O	O
suggested	O	O
that	O	O
crevicular	O	O
fluid	O	O
rich	O	O
in	O	O
seruminous	O	O
components	O	O
would	O	O
promote	O	O
the	O	O
colonization	O	O
of	O	O
Candida	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
on	O	O
type	O	O
I	O	O
collagen	O	O
as	O	O
opposed	O	O
to	O	O
streptococci	B-bacteria	B-bacteria
which	O	O
showed	O	O
greater	O	O
avidity	O	O
to	O	O
saliva-coated	O	O
collagen	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
antibacterial	O	O
effect	O	O
of	O	O
electrolyzed	O	O
water	O	O
on	O	O
oral	O	O
bacteria	O	O
both	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
.	O	O

Tap	O	O
water	O	O
was	O	O
electrolyzed	O	O
in	O	O
a	O	O
water	O	O
vessel	O	O
using	O	O
platinum	O	O
cell	O	O
technology	O	O
.	O	O

The	O	O
electrolyzed	O	O
tap	O	O
water	O	O
(	O	O
called	O	O
Puri-water	O	O
)	O	O
was	O	O
put	O	O
in	O	O
contact	O	O
with	O	O
five	O	O
major	O	O
periodontopathogens	O	O
or	O	O
toothbrushes	O	O
contaminated	O	O
with	O	O
these	O	O
bacteria	O	O
for	O	O
30	O	O
sec	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
Puri-water	O	O
was	O	O
used	O	O
as	O	O
a	O	O
mouthwash	O	O
for	O	O
30	O	O
sec	O	O
in	O	O
16	O	O
subjects	O	O
and	O	O
the	O	O
antibacterial	O	O
effect	O	O
on	O	O
salivary	O	O
bacteria	O	O
was	O	O
evaluated	O	O
.	O	O

Puri-water	O	O
significantly	O	O
reduced	O	O
the	O	O
growth	O	O
of	O	O
all	O	O
periodontopathogens	O	O
in	O	O
culture	O	O
and	O	O
on	O	O
toothbrushes	O	O
,	O	O
and	O	O
that	O	O
of	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
saliva	O	O
,	O	O
when	O	O
compared	O	O
to	O	O
the	O	O
effect	O	O
of	O	O
tap	O	O
water	O	O
.	O	O

It	O	O
also	O	O
significantly	O	O
reduced	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
growing	O	O
on	O	O
mitis	O	O
salivarius-bacitracin	O	O
agar	O	O
.	O	O

Our	O	O
results	O	O
demonstrate	O	O
that	O	O
the	O	O
electrolyzed	O	O
tap	O	O
water	O	O
is	O	O
effective	O	O
as	O	O
a	O	O
mouthwash	O	O
and	O	O
for	O	O
toothbrush	O	O
disinfection	O	O
.	O	O

Anaerobic	O	O
infections	O	O
are	O	O
common	O	O
and	O	O
can	O	O
cause	O	O
diseases	O	O
associated	O	O
with	O	O
severe	O	O
morbidity	O	O
,	O	O
but	O	O
are	O	O
easily	O	O
overlooked	O	O
in	O	O
clinical	O	O
settings	O	O
.	O	O

Both	O	O
the	O	O
relatively	O	O
small	O	O
number	O	O
of	O	O
infections	O	O
due	O	O
to	O	O
exogenous	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
and	O	O
the	O	O
much	O	O
larger	O	O
number	O	O
of	O	O
infections	O	O
involving	O	O
anaerobic	O	O
species	O	O
that	O	O
are	O	O
originally	O	O
members	O	O
of	O	O
the	O	O
normal	O	O
flora	O	O
,	O	O
may	O	O
lead	O	O
to	O	O
a	O	O
life-threatening	O	O
situation	O	O
unless	O	O
appropriate	O	O
treatment	O	O
is	O	O
instituted	O	O
.	O	O

Special	O	O
laboratory	O	O
procedures	O	O
are	O	O
needed	O	O
for	O	O
the	O	O
isolation	O	O
,	O	O
identification	O	O
and	O	O
susceptibility	O	O
testing	O	O
of	O	O
this	O	O
diverse	O	O
group	O	O
of	O	O
bacteria	O	O
.	O	O

Since	O	O
many	O	O
anaerobes	B-bacteria	B-bacteria
grow	O	O
more	O	O
slowly	O	O
than	O	O
the	O	O
facultative	B-bacteria	B-bacteria
or	I-bacteria	I-bacteria
aerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
and	O	O
particularly	O	O
since	O	O
clinical	O	O
specimens	O	O
yielding	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
commonly	O	O
contain	O	O
several	O	O
organisms	O	O
and	O	O
often	O	O
very	O	O
complex	O	O
mixtures	O	O
of	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
considerable	O	O
time	O	O
may	O	O
elapse	O	O
before	O	O
the	O	O
laboratory	O	O
is	O	O
able	O	O
to	O	O
provide	O	O
a	O	O
final	O	O
report	O	O
.	O	O

Species	O	O
definition	O	O
based	O	O
on	O	O
phenotypic	O	O
features	O	O
is	O	O
often	O	O
time-consuming	O	O
and	O	O
is	O	O
not	O	O
always	O	O
easy	O	O
to	O	O
carry	O	O
out	O	O
.	O	O

Molecular	O	O
genetic	O	O
methods	O	O
may	O	O
help	O	O
in	O	O
the	O	O
everyday	O	O
clinical	O	O
microbiological	O	O
practice	O	O
in	O	O
laboratories	O	O
dealing	O	O
with	O	O
the	O	O
diagnostics	O	O
of	O	O
anaerobic	O	O
infections	O	O
.	O	O

Methods	O	O
have	O	O
been	O	O
introduced	O	O
for	O	O
species	O	O
diagnostics	O	O
,	O	O
such	O	O
as	O	O
16S	O	O
rRNA	O	O
PCR-RFLP	O	O
profile	O	O
determination	O	O
,	O	O
which	O	O
can	O	O
help	O	O
to	O	O
distinguish	O	O
species	O	O
of	O	O
Bacteroides	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
etc	O	O
.	O	O

that	O	O
are	O	O
otherwise	O	O
difficult	O	O
to	O	O
differentiate	O	O
.	O	O

The	O	O
use	O	O
of	O	O
DNA-DNA	O	O
hybridization	O	O
and	O	O
the	O	O
sequencing	O	O
of	O	O
special	O	O
regions	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
have	O	O
revealed	O	O
fundamental	O	O
taxonomic	O	O
changes	O	O
among	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Some	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
are	O	O
extremely	O	O
slow	O	O
growing	O	O
or	O	O
not	O	O
cultivatable	O	O
at	O	O
all	O	O
.	O	O

To	O	O
detect	O	O
them	O	O
in	O	O
special	O	O
infections	O	O
involving	O	O
flora	O	O
changes	O	O
due	O	O
to	O	O
oral	O	O
malignancy	O	O
or	O	O
periodontitis	O	O
,	O	O
for	O	O
instance	O	O
,	O	O
a	O	O
PCR-based	O	O
hybridization	O	O
technique	O	O
is	O	O
used	O	O
.	O	O

Molecular	O	O
methods	O	O
have	O	O
demonstrated	O	O
the	O	O
spread	O	O
of	O	O
specific	O	O
resistance	O	O
genes	O	O
among	O	O
the	O	O
most	O	O
important	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
the	O	O
members	O	O
of	O	O
the	O	O
Bacteroides	B-bacteria	B-bacteria
genus	E-bacteria	I-bacteria
.	O	O

Their	O	O
detection	O	O
and	O	O
investigation	O	O
of	O	O
the	O	O
IS	O	O
elements	O	O
involved	O	O
in	O	O
their	O	O
expression	O	O
may	O	O
facilitate	O	O
following	O	O
of	O	O
the	O	O
spread	O	O
of	O	O
antibiotic	O	O
resistance	O	O
among	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
involved	O	O
in	O	O
infections	O	O
and	O	O
in	O	O
the	O	O
normal	O	O
flora	O	O
members	O	O
.	O	O

Molecular	O	O
methods	O	O
(	O	O
a	O	O
search	O	O
for	O	O
toxin	O	O
genes	O	O
and	O	O
ribotyping	O	O
)	O	O
may	O	O
promote	O	O
a	O	O
better	O	O
understanding	O	O
of	O	O
the	O	O
pathogenic	O	O
features	O	O
of	O	O
some	O	O
anaerobic	O	O
infections	O	O
,	O	O
such	O	O
as	O	O
the	O	O
nosocomial	O	O
diarrhoea	O	O
caused	O	O
by	O	O
C.	O	O
difficile	O	O
and	O	O
its	O	O
spread	O	O
in	O	O
the	O	O
hospital	O	O
environment	O	O
and	O	O
the	O	O
community	O	O
.	O	O

The	O	O
investigation	O	O
of	O	O
toxin	O	O
production	O	O
at	O	O
a	O	O
molecular	O	O
level	O	O
helps	O	O
in	O	O
the	O	O
detection	O	O
of	O	O
new	O	O
toxin	O	O
types	O	O
.	O	O

This	O	O
mini-review	O	O
surveys	O	O
some	O	O
of	O	O
the	O	O
results	O	O
obtained	O	O
by	O	O
our	O	O
group	O	O
and	O	O
others	O	O
using	O	O
molecular	O	O
genetic	O	O
methods	O	O
in	O	O
anaerobic	O	O
diagnostics	O	O
.	O	O

Bacillus	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
is	O	O
the	O	O
most	O	O
widely	O	O
applied	O	O
biological	O	O
insecticide	O	O
and	O	O
is	O	O
used	O	O
to	O	O
manage	O	O
insects	O	O
that	O	O
affect	O	O
forestry	O	O
and	O	O
agriculture	O	O
and	O	O
transmit	O	O
human	O	O
and	O	O
animal	O	O
pathogens	O	O
.	O	O

This	O	O
ubiquitous	O	O
spore-forming	O	O
bacterium	O	O
kills	O	O
insect	O	O
larvae	O	O
largely	O	O
through	O	O
the	O	O
action	O	O
of	O	O
insecticidal	O	O
crystal	O	O
proteins	O	O
and	O	O
is	O	O
commonly	O	O
deployed	O	O
as	O	O
a	O	O
direct	O	O
bacterial	O	O
spray	O	O
.	O	O

Moreover	O	O
,	O	O
plants	O	O
engineered	O	O
with	O	O
the	O	O
cry	O	O
genes	O	O
encoding	O	O
the	O	O
B.	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
crystal	O	O
proteins	O	O
are	O	O
the	O	O
most	O	O
widely	O	O
cultivated	O	O
transgenic	O	O
crops	O	O
.	O	O

For	O	O
decades	O	O
,	O	O
the	O	O
mechanism	O	O
of	O	O
insect	O	O
killing	O	O
has	O	O
been	O	O
assumed	O	O
to	O	O
be	O	O
toxin-mediated	O	O
lysis	O	O
of	O	O
the	O	O
gut	O	O
epithelial	O	O
cells	O	O
,	O	O
which	O	O
leads	O	O
to	O	O
starvation	O	O
,	O	O
or	O	O
B.	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
septicemia	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
report	O	O
that	O	O
B.	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
does	O	O
not	O	O
kill	O	O
larvae	O	O
of	O	O
the	O	O
gypsy	O	O
moth	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
indigenous	O	O
midgut	O	O
bacteria	O	O
.	O	O

Elimination	O	O
of	O	O
the	O	O
gut	O	O
microbial	O	O
community	O	O
by	O	O
oral	O	O
administration	O	O
of	O	O
antibiotics	O	O
abolished	O	O
B.	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
insecticidal	O	O
activity	O	O
,	O	O
and	O	O
reestablishment	O	O
of	O	O
an	O	O
Enterobacter	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

that	O	O
normally	O	O
resides	O	O
in	O	O
the	O	O
midgut	O	O
microbial	O	O
community	O	O
restored	O	O
B.	O	O
thuringiensis-mediated	O	O
killing	O	O
.	O	O

Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
engineered	O	O
to	O	O
produce	O	O
the	O	O
B.	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
insecticidal	O	O
toxin	O	O
killed	O	O
gypsy	O	O
moth	O	O
larvae	O	O
irrespective	O	O
of	O	O
the	O	O
presence	O	O
of	O	O
other	O	O
bacteria	O	O
in	O	O
the	O	O
midgut	O	O
.	O	O

However	O	O
,	O	O
when	O	O
the	O	O
engineered	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
was	O	O
heat-killed	O	O
and	O	O
then	O	O
fed	O	O
to	O	O
the	O	O
larvae	O	O
,	O	O
the	O	O
larvae	O	O
did	O	O
not	O	O
die	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
the	O	O
indigenous	O	O
midgut	O	O
bacteria	O	O
.	O	O

E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
the	O	O
Enterobacter	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

achieved	O	O
high	O	O
populations	O	O
in	O	O
hemolymph	O	O
,	O	O
in	O	O
contrast	O	O
to	O	O
B.	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
,	O	O
which	O	O
appeared	O	O
to	O	O
die	O	O
in	O	O
hemolymph	O	O
.	O	O

Our	O	O
results	O	O
demonstrate	O	O
that	O	O
B.	O	O
thuringiensis-induced	O	O
mortality	O	O
depends	O	O
on	O	O
enteric	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

In	O	O
this	O	O
investigation	O	O
,	O	O
the	O	O
urine	O	O
samples	O	O
obtained	O	O
in	O	O
a	O	O
single	O	O
oral-dose	O	O
pharmacokinetic	O	O
study	O	O
were	O	O
examined	O	O
for	O	O
their	O	O
bactericidal	O	O
activity	O	O
against	O	O
a	O	O
range	O	O
of	O	O
relevant	O	O
urinary	O	O
tract	O	O
pathogens	O	O
.	O	O

Six	O	O
healthy	O	O
volunteers	O	O
received	O	O
a	O	O
single	O	O
oral	O	O
dose	O	O
of	O	O
ten	O	O
oral	O	O
antibiotics	O	O
available	O	O
in	O	O
Croatia	O	O
.	O	O

Urine	O	O
samples	O	O
were	O	O
taken	O	O
every	O	O
2	O	O
h	O	O
during	O	O
the	O	O
whole	O	O
dosing	O	O
interval	O	O
of	O	O
the	O	O
particular	O	O
antibiotic	O	O
.	O	O

The	O	O
urinary	O	O
bactericidal	O	O
activity	O	O
was	O	O
tested	O	O
by	O	O
determination	O	O
of	O	O
urinary	O	O
bactericidal	O	O
titers	O	O
.	O	O

All	O	O
antibiotics	O	O
showed	O	O
a	O	O
significant	O	O
urinary	O	O
bactericidal	O	O
activity	O	O
against	O	O
non-extended	O	O
spectrum	O	O
beta-lactamase	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
Proteus	B-bacteria	B-bacteria
mirabilis	E-bacteria	I-bacteria
.	O	O

Fluoroquinolones	O	O
displayed	O	O
high	O	O
and	O	O
persisting	O	O
levels	O	O
of	O	O
urinary	O	O
bactericidal	O	O
activity	O	O
against	O	O
all	O	O
gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
saprophyticus	E-bacteria	I-bacteria
.	O	O

Average	O	O
urinary	O	O
bactericidal	O	O
activity	O	O
can	O	O
be	O	O
predicted	O	O
from	O	O
in	O	O
vitro	O	O
susceptibility	O	O
testing	O	O
,	O	O
but	O	O
we	O	O
expect	O	O
that	O	O
there	O	O
will	O	O
be	O	O
patients	O	O
with	O	O
a	O	O
low	O	O
level	O	O
of	O	O
urinary	O	O
bactericidal	O	O
activity	O	O
.	O	O

The	O	O
authors	O	O
compared	O	O
the	O	O
in	O	O
vivo	O	O
antimicrobial	O	O
effects	O	O
on	O	O
microorganisms	O	O
from	O	O
dental	O	O
plaque	O	O
,	O	O
saliva	O	O
and	O	O
the	O	O
tongue	O	O
in	O	O
subjects	O	O
who	O	O
used	O	O
a	O	O
triclosan/copolymer	O	O
dentifrice	O	O
and	O	O
a	O	O
fluoride	O	O
dentifrice	O	O
(	O	O
control	O	O
)	O	O
.	O	O

The	O	O
authors	O	O
assigned	O	O
15	O	O
subjects	O	O
randomly	O	O
to	O	O
the	O	O
control	O	O
dentifrice	O	O
or	O	O
the	O	O
triclosan/copolymer	O	O
dentifrice	O	O
for	O	O
twice-daily	O	O
use	O	O
for	O	O
one	O	O
week	O	O
.	O	O

They	O	O
collected	O	O
samples	O	O
of	O	O
plaque	O	O
,	O	O
saliva	O	O
and	O	O
tongue	O	O
scrapings	O	O
six	O	O
and	O	O
12	O	O
hours	O	O
after	O	O
the	O	O
final	O	O
brushing	O	O
.	O	O

They	O	O
analyzed	O	O
colony-forming	O	O
units	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Fusobacteria	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
total	O	O
cultivable	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
hydrogen	O	O
sulfide	O	O
(	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
)	O	O
-producing	O	O
bacteria	O	O
.	O	O

A	O	O
one-week	O	O
washout	O	O
followed	O	O
.	O	O

The	O	O
authors	O	O
repeated	O	O
the	O	O
protocol	O	O
with	O	O
the	O	O
second	O	O
dentifrice	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
no	O	O
differences	O	O
at	O	O
baseline	O	O
.	O	O

Significant	O	O
reductions	O	O
(	O	O
88	O	O
to	O	O
96	O	O
percent	O	O
)	O	O
in	O	O
oral	O	O
anaerobic	O	O
bacteria	O	O
were	O	O
observed	O	O
in	O	O
the	O	O
triclosan/copolymer	O	O
group	O	O
six	O	O
and	O	O
12	O	O
hours	O	O
after	O	O
brushing	O	O
compared	O	O
with	O	O
the	O	O
control	O	O
group	O	O
(	O	O
P	O	O
=	O	O
.001	O	O
)	O	O
.	O	O

Fusobacteria	B-bacteria	B-bacteria
decreased	O	O
by	O	O
77	O	O
to	O	O
92	O	O
percent	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
decreased	O	O
by	O	O
84	O	O
to	O	O
89	O	O
percent	O	O
six	O	O
and	O	O
12	O	O
hours	O	O
after	O	O
brushing	O	O
in	O	O
the	O	O
triclosan/copolymer	O	O
group	O	O
versus	O	O
the	O	O
control	O	O
group	O	O
.	O	O

The	O	O
triclosan/copolymer	O	O
group	O	O
also	O	O
demonstrated	O	O
a	O	O
significant	O	O
decrease	O	O
in	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S-producing	O	O
bacteria	O	O
six	O	O
and	O	O
12	O	O
hours	O	O
after	O	O
brushing	O	O
(	O	O
74	O	O
to	O	O
85	O	O
percent	O	O
)	O	O
(	O	O
P	O	O
=	O	O
.001	O	O
)	O	O
.	O	O

Brushing	O	O
with	O	O
the	O	O
triclosan/copolymer	O	O
dentifrice	O	O
resulted	O	O
in	O	O
significant	O	O
reductions	O	O
in	O	O
microorganisms	O	O
from	O	O
the	O	O
three	O	O
sites	O	O
compared	O	O
with	O	O
the	O	O
control	O	O
dentifrice	O	O
.	O	O


:	O	O
The	O	O
triclosan/copolymer	O	O
dentifrice	O	O
produced	O	O
sustained	O	O
effects	O	O
on	O	O
oral	O	O
bacteria	O	O
for	O	O
12	O	O
hours	O	O
.	O	O

To	O	O
determine	O	O
antibacterial	O	O
activity	O	O
of	O	O
chewing	O	O
mastic	O	O
gum	O	O
against	O	O
the	O	O
salivary	O	O
levels	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
the	O	O
total	O	O
number	O	O
of	O	O
viable	O	O
bacteria	O	O
,	O	O
and	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
patients	O	O
undergoing	O	O
therapy	O	O
with	O	O
fixed	O	O
orthodontic	O	O
appliances	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
levels	O	O
of	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
and	O	O
total	O	O
cultivated	O	O
bacteria	O	O
were	O	O
measured	O	O
before	O	O
and	O	O
after	O	O
chewing	O	O
mastic	O	O
gum	O	O
.	O	O

The	O	O
antibacterial	O	O
effects	O	O
of	O	O
chewing	O	O
mastic	O	O
gum	O	O
against	O	O
these	O	O
microorganisms	O	O
in	O	O
saliva	O	O
were	O	O
compared	O	O
with	O	O
a	O	O
placebo	O	O
gum	O	O
.	O	O

The	O	O
counts	O	O
for	O	O
orthodontically	O	O
treated	O	O
patients	O	O
were	O	O
evaluated	O	O
before	O	O
chewing	O	O
gum	O	O
;	O	O
just	O	O
after	O	O
chewing	O	O
gum	O	O
;	O	O
and	O	O
after	O	O
45	O	O
,	O	O
75	O	O
,	O	O
105	O	O
,	O	O
and	O	O
135	O	O
minutes	O	O
.	O	O

Saliva	O	O
samples	O	O
taken	O	O
from	O	O
the	O	O
patients	O	O
were	O	O
inoculated	O	O
onto	O	O
trypticase-yeast-cystine-bacitracin	O	O
agar	O	O
for	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
onto	O	O
Rogosa	O	O
agar	O	O
for	O	O
lactobacilli	B-bacteria	B-bacteria
.	O	O

The	O	O
agar	O	O
plates	O	O
were	O	O
incubated	O	O
for	O	O
48	O	O
hours	O	O
anaerobically	O	O
at	O	O
37	O	O
degrees	O	O
C.	O	O
The	O	O
total	O	O
number	O	O
of	O	O
viable	O	O
bacteria	O	O
was	O	O
then	O	O
counted	O	O
.	O	O

Just	O	O
after	O	O
chewing	O	O
the	O	O
mastic	O	O
gum	O	O
for	O	O
15	O	O
minutes	O	O
,	O	O
a	O	O
significant	O	O
decrease	O	O
of	O	O
total	O	O
bacteria	O	O
and	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
observed	O	O
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
.	O	O

The	O	O
reduction	O	O
in	O	O
lactobacilli	B-bacteria	B-bacteria
was	O	O
not	O	O
significant	O	O
at	O	O
later	O	O
first	O	O
stage	O	O
(	O	O
P	O	O
>	O	O
.05	O	O
)	O	O
.	O	O

However	O	O
,	O	O
at	O	O
the	O	O
end	O	O
of	O	O
135	O	O
minutes	O	O
,	O	O
there	O	O
were	O	O
significantly	O	O
fewer	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
,	O	O
total	O	O
viable	O	O
bacteria	O	O
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
,	O	O
and	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
after	O	O
chewing	O	O
mastic	O	O
gum	O	O
than	O	O
after	O	O
chewing	O	O
paraffin	O	O
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
.	O	O

The	O	O
results	O	O
show	O	O
that	O	O
chewing	O	O
mastic	O	O
gum	O	O
decreased	O	O
the	O	O
total	O	O
viable	O	O
bacteria	O	O
,	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
saliva	O	O
in	O	O
orthodontically	O	O
treated	O	O
patients	O	O
with	O	O
fixed	O	O
appliances	O	O
.	O	O

Chewing	O	O
mastic	O	O
gum	O	O
might	O	O
be	O	O
useful	O	O
in	O	O
preventing	O	O
caries	O	O
lesions	O	O
.	O	O

The	O	O
mode	O	O
of	O	O
acquisition	O	O
of	O	O
gastric	B-bacteria	B-bacteria
Helicobacter	I-bacteria	I-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

infection	O	O
in	O	O
dogs	O	O
has	O	O
not	O	O
been	O	O
determined	O	O
.	O	O

It	O	O
is	O	O
suspected	O	O
that	O	O
oral-oral	O	O
and	O	O
faecal-oral	O	O
transmission	O	O
may	O	O
be	O	O
involved	O	O
.	O	O

The	O	O
present	O	O
study	O	O
sought	O	O
to	O	O
determine	O	O
if	O	O
Helicobacter	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

DNA	O	O
is	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
healthy	O	O
and	O	O
vomiting	O	O
dogs	O	O
.	O	O

Thirty-eight	O	O
pet	O	O
dogs	O	O
(	O	O
27	O	O
vomiting	O	O
and	O	O
11	O	O
clinically	O	O
healthy	O	O
)	O	O
were	O	O
studied	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

was	O	O
determined	O	O
by	O	O
single	O	O
and	O	O
nested	O	O
PCR	O	O
evaluation	O	O
of	O	O
DNA	O	O
extracted	O	O
from	O	O
saliva	O	O
,	O	O
dental	O	O
plaque	O	O
and	O	O
gastric	O	O
biopsy	O	O
samples	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

DNA	O	O
was	O	O
detected	O	O
by	O	O
nested	O	O
PCR	O	O
in	O	O
36	O	O
(	O	O
94.7	O	O
%	O	O
)	O	O
gastric	O	O
biopsies	O	O
,	O	O
17	O	O
(	O	O
44.7	O	O
%	O	O
)	O	O
dental	B-bacteria	B-bacteria
plaque	O	O
and	O	O
19	O	O
(	O	O
50	O	O
%	O	O
)	O	O
saliva	O	O
samples	O	O
out	O	O
of	O	O
the	O	O
38	O	O
dogs	O	O
examined	O	O
.	O	O

Overall	O	O
27	O	O
(	O	O
71.1	O	O
%	O	O
)	O	O
dogs	O	O
screened	O	O
by	O	O
nested	O	O
PCR	O	O
were	O	O
found	O	O
to	O	O
harbour	B-bacteria	B-bacteria
Helicobacter	I-bacteria	I-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

DNA	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
(	O	O
dental	O	O
plaque	O	O
and/or	O	O
saliva	O	O
)	O	O
.	O	O

There	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

DNA	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
vomiting	O	O
and	O	O
healthy	O	O
dogs	O	O
,	O	O
and	O	O
the	O	O
time	O	O
from	O	O
vomiting	O	O
to	O	O
oral	O	O
sampling	O	O
did	O	O
not	O	O
have	O	O
significant	O	O
impact	O	O
.	O	O

This	O	O
study	O	O
confirms	O	O
the	O	O
high	O	O
prevalence	O	O
of	O	O
gastric	B-bacteria	B-bacteria
Helicobacter	I-bacteria	I-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

infection	O	O
in	O	O
dogs	O	O
,	O	O
and	O	O
reveals	O	O
that	O	O
Helicobacter	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

DNA	O	O
is	O	O
detectable	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
over	O	O
70	O	O
%	O	O
of	O	O
dogs	O	O
.	O	O

These	O	O
findings	O	O
support	O	O
the	O	O
possibility	O	O
of	O	O
oral-oral	O	O
transmission	O	O
between	O	O
dogs	O	O
and	O	O
that	O	O
the	O	O
canine	O	O
oral	O	O
cavity	O	O
may	O	O
act	O	O
as	O	O
source	O	O
of	O	O
non-pylori	B-bacteria	B-bacteria
Helicobacter	I-bacteria	I-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

infection	O	O
fors	O	O
humans	O	O
.	O	O

There	O	O
are	O	O
numerous	O	O
studies	O	O
suggesting	O	O
that	O	O
inflammation	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
caused	O	O
by	O	O
bacteria	O	O
or	O	O
fungi	O	O
is	O	O
accompanied	O	O
by	O	O
gastric	O	O
inflammation	O	O
.	O	O

This	O	O
is	O	O
particularly	O	O
relevant	O	O
in	O	O
patients	O	O
using	O	O
complete	O	O
dentures	O	O
.	O	O

Since	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
can	O	O
be	O	O
easily	O	O
discovered	O	O
by	O	O
bacteria	O	O
culture	O	O
and	O	O
that	O	O
in	O	O
the	O	O
stomach	O	O
by	O	O
(	O	O
13	O	O
)	O	O
C	O	O
urea	O	O
breath	O	O
test	O	O
(	O	O
UBT	O	O
)	O	O
and	O	O
histology	O	O
of	O	O
gastric	O	O
endoscopic	O	O
biopsy	O	O
samples	O	O
it	O	O
is	O	O
reasonably	O	O
to	O	O
state	O	O
that	O	O
the	O	O
majority	O	O
of	O	O
the	O	O
patients	O	O
show	O	O
the	O	O
presence	O	O
of	O	O
bacterium	O	O
in	O	O
oral	O	O
cavity	O	O
and	O	O
active	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
.	O	O

When	O	O
comparing	O	O
,	O	O
however	O	O
,	O	O
the	O	O
bacteria	O	O
culture	O	O
originating	O	O
from	O	O
the	O	O
oral	O	O
mucosa	O	O
to	O	O
those	O	O
from	O	O
the	O	O
gastric	O	O
mucosa	O	O
,	O	O
employing	O	O
molecular	O	O
biology	O	O
examination	O	O
,	O	O
such	O	O
as	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
,	O	O
we	O	O
found	O	O
that	O	O
the	O	O
oral	O	O
bacteria	O	O
and	O	O
those	O	O
originating	O	O
from	O	O
stomach	O	O
are	O	O
completely	O	O
different	O	O
,	O	O
suggesting	O	O
that	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
may	O	O
be	O	O
present	O	O
only	O	O
transiently	O	O
in	O	O
oral	O	O
cavity	O	O
and	O	O
does	O	O
not	O	O
play	O	O
major	O	O
role	O	O
in	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
.	O	O

Thus	O	O
,	O	O
oral	O	O
cavity	O	O
does	O	O
not	O	O
serve	O	O
as	O	O
bacterial	O	O
reservoir	O	O
to	O	O
infect	O	O
gastric	O	O
mucosa	O	O
.	O	O

Most	O	O
important	O	O
finding	O	O
of	O	O
our	O	O
study	O	O
is	O	O
that	O	O
patients	O	O
with	O	O
recognized	O	O
inflammation	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
the	O	O
form	O	O
of	O	O
stomatitis	O	O
prothetica	O	O
hyperplasica	O	O
both	O	O
fibrosa	O	O
as	O	O
well	O	O
as	O	O
papillaris	O	O
showed	O	O
in	O	O
nearly	O	O
100	O	O
%	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
,	O	O
usually	O	O
without	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
same	O	O
bacterium	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
suggesting	O	O
that	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
affects	O	O
oral	O	O
mucosa	O	O
at	O	O
distance	O	O
by	O	O
some	O	O
,	O	O
as	O	O
yet	O	O
,	O	O
unknown	O	O
mechanism	O	O
.	O	O

To	O	O
assess	O	O
caries	O	O
risk	O	O
and	O	O
check	O	O
the	O	O
presence	O	O
of	O	O
four	O	O
commonly	O	O
found	O	O
oral	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
``	O	O
8020	O	O
''	O	O
achievers	O	O
.	O	O

Initial	O	O
report	O	O
based	O	O
on	O	O
Japan	O	O
's	O	O
newly	O	O
implemented	O	O
``	O	O
8020	O	O
''	O	O
campaign	O	O
,	O	O
which	O	O
aims	O	O
to	O	O
promote	O	O
health	O	O
and	O	O
awareness	O	O
in	O	O
older	O	O
people	O	O
.	O	O

Simply	O	O
stated	O	O
,	O	O
the	O	O
goal	O	O
is	O	O
,	O	O
at	O	O
80	O	O
years	O	O
,	O	O
to	O	O
maintain	O	O
20	O	O
teeth	O	O
.	O	O

Healthy	O	O
community-dwelling	O	O
elderly	O	O
individuals	O	O
of	O	O
Okayama	O	O
Prefecture	O	O
,	O	O
Japan	O	O
.	O	O

One	O	O
hundred	O	O
sixty	O	O
individuals	O	O
aged	O	O
80	O	O
and	O	O
older	O	O
with	O	O
20	O	O
of	O	O
their	O	O
own	O	O
natural	O	O
teeth	O	O
.	O	O

General	O	O
and	O	O
oral	O	O
health	O	O
conditions	O	O
,	O	O
caries	O	O
risk	O	O
assessment	O	O
using	O	O
the	O	O
Cariostat	O	O
method	O	O
,	O	O
and	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
detection	O	O
of	O	O
four	O	O
oral	O	O
cariogenic	O	O
bacteria	O	O
.	O	O

The	O	O
participants	O	O
had	O	O
an	O	O
average	O	O
of	O	O
24.7	O	O
teeth	O	O
,	O	O
of	O	O
which	O	O
12.1	O	O
were	O	O
sound	O	O
,	O	O
12.2	O	O
were	O	O
treated	O	O
,	O	O
and	O	O
0.4	O	O
were	O	O
untreated	O	O
.	O	O

Based	O	O
on	O	O
Cariostat	O	O
scores	O	O
,	O	O
64.4	O	O
%	O	O
had	O	O
low	O	O
caries	O	O
risk	O	O
.	O	O

Using	O	O
PCR	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
,	O	O
and	O	O
L.	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
51.3	O	O
%	O	O
,	O	O
23.1	O	O
%	O	O
,	O	O
40	O	O
%	O	O
,	O	O
and	O	O
25	O	O
%	O	O
of	O	O
the	O	O
participants	O	O
,	O	O
respectively	O	O
.	O	O

S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
,	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
(	O	O
P=.002	O	O
)	O	O
,	O	O
L.	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
,	O	O
and	O	O
L.	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
(	O	O
P=.001	O	O
)	O	O
deoxyribonucleic	O	O
acid	O	O
band	O	O
was	O	O
detected	O	O
more	O	O
in	O	O
participants	O	O
with	O	O
high	O	O
caries	O	O
risk	O	O
scores	O	O
.	O	O

Participants	O	O
with	O	O
low	O	O
caries	O	O
risk	O	O
scores	O	O
had	O	O
low	O	O
prevalence	O	O
of	O	O
cariogenic	O	O
bacteria	O	O
,	O	O
20	O	O
or	O	O
more	O	O
sound	O	O
teeth	O	O
,	O	O
and	O	O
fewer	O	O
missing	O	O
teeth	O	O
.	O	O

Incorporating	O	O
caries	O	O
risk	O	O
assessment	O	O
,	O	O
using	O	O
the	O	O
Cariostat	O	O
and	O	O
PCR	O	O
analysis	O	O
,	O	O
in	O	O
the	O	O
``	O	O
8020	O	O
''	O	O
campaign	O	O
in	O	O
health	O	O
systems	O	O
worldwide	O	O
will	O	O
contribute	O	O
to	O	O
a	O	O
better	O	O
life	O	O
for	O	O
the	O	O
aging	O	O
society	O	O
,	O	O
initiate	O	O
research	O	O
interest	O	O
regarding	O	O
the	O	O
program	O	O
,	O	O
and	O	O
improve	O	O
current	O	O
health	O	O
policies	O	O
.	O	O

A	O	O
variety	O	O
of	O	O
oxalate-degrading	O	O
bacteria	O	O
including	O	O
Oxalobacter	B-bacteria	B-bacteria
formigenes	O	O
and	O	O
some	O	O
species	O	O
of	O	O
Bifidobacterium	B-bacteria	B-bacteria
are	O	O
known	O	O
to	O	O
colonize	O	O
the	O	O
human	O	O
intestinal	O	O
tract	O	O
.	O	O

Oral	O	O
lactosucrose	O	O
supplementation	O	O
promotes	O	O
the	O	O
growth	O	O
of	O	O
Bifidobacterium	B-bacteria	B-bacteria
in	O	O
the	O	O
human	O	O
intestine	O	O
.	O	O

Therefore	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
effect	O	O
of	O	O
oral	O	O
lactosucrose	O	O
supplementation	O	O
on	O	O
enteric	B-bacteria	B-bacteria
oxalate-degrading	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
twelve	O	O
healthy	O	O
men	O	O
(	O	O
age	O	O
ranging	O	O
from	O	O
25	O	O
to	O	O
39	O	O
years	O	O
)	O	O
.	O	O

Lactosucrose	O	O
was	O	O
orally	O	O
administered	O	O
10	O	O
g	O	O
daily	O	O
for	O	O
2	O	O
weeks	O	O
without	O	O
restriction	O	O
of	O	O
dietary	O	O
intake	O	O
.	O	O

The	O	O
total	O	O
number	O	O
of	O	O
oxalate-degrading	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
feces	O	O
and	O	O
the	O	O
24-hour	O	O
urinary	O	O
excretion	O	O
of	O	O
oxalate	O	O
were	O	O
examined	O	O
before	O	O
and	O	O
after	O	O
lactosucrose	O	O
supplementation	O	O
.	O	O

The	O	O
total	O	O
number	O	O
of	O	O
oxalate	B-bacteria	B-bacteria
degrading-bacteria	E-bacteria	I-bacteria
was	O	O
significantly	O	O
increased	O	O
by	O	O
lactosucrose	O	O
supplementation	O	O
(	O	O
9.20	O	O
+/-	O	O
0.44	O	O
versus	O	O
9.77	O	O
+/-	O	O
0.46	O	O
,	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
although	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
change	O	O
in	O	O
the	O	O
urinary	O	O
oxalate	O	O
excretion	O	O
.	O	O

The	O	O
oxalate	O	O
degrading-bacteria	O	O
isolated	O	O
from	O	O
feces	O	O
was	O	O
biochemically	O	O
identified	O	O
as	O	O
Bifidobacterium	B-bacteria	B-bacteria
adolescentis	E-bacteria	I-bacteria
.	O	O

In	O	O
conclusion	O	O
,	O	O
oral	O	O
supplementation	O	O
of	O	O
10	O	O
g	O	O
lactosucrose	O	O
daily	O	O
for	O	O
2	O	O
weeks	O	O
was	O	O
effective	O	O
in	O	O
multiplying	O	O
oxalate-degrading	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
in	O	O
reducing	O	O
urinary	O	O
oxalate	O	O
excretion	O	O
under	O	O
free	O	O
non-restricted	O	O
dietary	O	O
intake	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
it	O	O
was	O	O
suggested	O	O
that	O	O
various	O	O
species	O	O
of	O	O
Bifidobacterium	B-bacteria	B-bacteria
were	O	O
related	O	O
to	O	O
degradation	O	O
of	O	O
oxalate	O	O
in	O	O
the	O	O
human	O	O
intestine	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
explore	O	O
the	O	O
physiological	O	O
and	O	O
antigenic	O	O
diversity	O	O
of	O	O
a	O	O
large	O	O
number	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
biovar	I-bacteria	I-bacteria
1	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
in	O	O
order	O	O
to	O	O
begin	O	O
to	O	O
determine	O	O
whether	O	O
these	O	O
properties	O	O
contribute	O	O
to	O	O
species	O	O
persistence	O	O
.	O	O

S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
biovar	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
was	O	O
collected	O	O
from	O	O
four	O	O
infants	O	O
from	O	O
birth	O	O
to	O	O
the	O	O
first	O	O
year	O	O
of	O	O
age	O	O
.	O	O

At	O	O
each	O	O
of	O	O
eight	O	O
to	O	O
nine	O	O
visits	O	O
,	O	O
60	O	O
isolates	O	O
each	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
cheeks	O	O
,	O	O
tongue	O	O
and	O	O
incisors	O	O
(	O	O
once	O	O
erupted	O	O
)	O	O
yielding	O	O
4440	O	O
in	O	O
total	O	O
.	O	O

These	O	O
were	O	O
tested	O	O
for	O	O
production	O	O
of	O	O
neuraminidase	O	O
,	O	O
beta1-N-acetylglucosaminidase	O	O
,	O	O
beta1-N-acetylgalactosaminidase	O	O
,	O	O
IgA1	O	O
protease	O	O
and	O	O
amylase-binding	O	O
.	O	O

Antigenic	O	O
diversity	O	O
was	O	O
examined	O	O
by	O	O
ELISA	O	O
and	O	O
Western	O	O
immunoblotting	O	O
using	O	O
antisera	O	O
raised	O	O
against	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
biovar	I-bacteria	I-bacteria
1	I-bacteria	I-bacteria
NCTC	I-bacteria	I-bacteria
12261	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
SK145	B-bacteria	B-bacteria
.	O	O

Three	O	O
thousand	O	O
three	O	O
hundred	O	O
and	O	O
thirty	O	O
(	O	O
75	O	O
%	O	O
)	O	O
of	O	O
the	O	O
isolates	O	O
were	O	O
identified	O	O
as	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
biovar	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
and	O	O
3144	B-bacteria	B-bacteria
(	O	O
94.4	O	O
%	O	O
)	O	O
could	O	O
be	O	O
divided	O	O
into	O	O
four	O	O
large	O	O
phenotypic	O	O
groups	O	O
based	O	O
on	O	O
glycosidase	O	O
production	O	O
.	O	O

Fifty-four	O	O
percent	O	O
of	O	O
the	O	O
isolates	O	O
produced	O	O
IgA1	O	O
protease	O	O
,	O	O
but	O	O
production	O	O
was	O	O
disproportionate	O	O
among	O	O
the	O	O
phenotypes	O	O
.	O	O

Between	O	O
one-third	O	O
and	O	O
one-half	O	O
of	O	O
the	O	O
strains	O	O
of	O	O
each	O	O
phenotype	O	O
bound	O	O
salivary	O	O
alpha-amylase	O	O
.	O	O

Antisera	O	O
against	O	O
strains	B-bacteria	B-bacteria
NCTC	I-bacteria	I-bacteria
12261	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
SK145	B-bacteria	B-bacteria
displayed	O	O
different	O	O
patterns	O	O
of	O	O
reactivity	O	O
with	O	O
randomly	O	O
selected	O	O
representatives	O	O
of	O	O
the	O	O
four	O	O
phenotypes	O	O
.	O	O

S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
biovar	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
is	O	O
physiologically	O	O
and	O	O
antigenically	O	O
diverse	O	O
,	O	O
properties	O	O
which	O	O
could	O	O
aid	O	O
strains	O	O
in	O	O
avoiding	O	O
host	O	O
immunity	O	O
and	O	O
promote	O	O
re-colonization	O	O
of	O	O
a	O	O
habitat	O	O
or	O	O
transfer	O	O
to	O	O
a	O	O
new	O	O
habitat	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	B-bacteria	B-bacteria
plays	O	O
a	O	O
significant	O	O
role	O	O
in	O	O
gastric	O	O
disease	O	O
.	O	O

However	O	O
,	O	O
the	O	O
presence	O	O
of	O	O
this	O	O
bacterium	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
remains	O	O
controversial	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
detect	O	O
and	O	O
quantify	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
29	O	O
different	O	O
sites	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
non-dyspeptic	O	O
subjects	O	O
by	O	O
means	O	O
of	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reactions	O	O
(	O	O
PCR	O	O
)	O	O
.	O	O

Ten	O	O
subjects	O	O
without	O	O
gastric	O	O
symptoms	O	O
were	O	O
studied	O	O
.	O	O

Samples	O	O
from	O	O
unstimulated	O	O
saliva	O	O
,	O	O
three	O	O
sites	O	O
of	O	O
the	O	O
tongue	O	O
,	O	O
oral	O	O
mucosa	O	O
,	O	O
and	O	O
12	O	O
sites	O	O
of	O	O
both	O	O
supragingival	O	O
and	O	O
subgingival	O	O
plaque	O	O
were	O	O
collected	O	O
from	O	O
each	O	O
subject	O	O
.	O	O

DNA	O	O
was	O	O
extracted	O	O
from	O	O
the	O	O
oral	O	O
samples	O	O
and	O	O
analysed	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
by	O	O
real-time	O	O
PCR	O	O
(	O	O
LightCycler	O	O
)	O	O
using	O	O
JW23/22	O	O
primers	O	O
which	O	O
targeted	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
.	O	O

DNA	O	O
from	O	O
H.	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
DSM	I-bacteria	I-bacteria
4867	E-bacteria	I-bacteria
was	O	O
used	O	O
as	O	O
a	O	O
positive	O	O
control	O	O
.	O	O

Amplification	O	O
efficiency	O	O
for	O	O
the	O	O
LightCycler	O	O
2.0	O	O
runs	O	O
ranged	O	O
from	O	O
1.8	O	O
to	O	O
2.4	O	O
.	O	O

Melting	O	O
curve	O	O
analysis	O	O
identified	O	O
all	O	O
the	O	O
positive	O	O
control	O	O
capillaries	O	O
,	O	O
which	O	O
contained	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
reference	O	O
DNA	O	O
,	O	O
as	O	O
a	O	O
single	O	O
and	O	O
narrow	O	O
peak	O	O
at	O	O
a	O	O
melting	O	O
temperature	O	O
between	O	O
84.5	O	O
and	O	O
84.9	O	O
degrees	O	O
C.	O	O
All	O	O
the	O	O
negative	O	O
control	O	O
capillaries	O	O
with	O	O
no	O	O
template	O	O
control	O	O
and	O	O
the	O	O
29	O	O
oral	O	O
samples	O	O
from	O	O
each	O	O
subject	O	O
showed	O	O
either	O	O
no	O	O
melting	O	O
peaks	O	O
or	O	O
broad	O	O
melting	O	O
peaks	O	O
below	O	O
80	O	O
degrees	O	O
C	O	O
,	O	O
which	O	O
were	O	O
considered	O	O
as	O	O
primer	O	O
dimers	O	O
.	O	O

Therefore	O	O
,	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
not	O	O
detected	O	O
from	O	O
any	O	O
of	O	O
the	O	O
290	O	O
oral	O	O
samples	O	O
.	O	O

As	O	O
a	O	O
conclusion	O	O
,	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
seems	O	O
not	O	O
to	O	O
be	O	O
permanently	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
a	O	O
non-dyspeptic	O	O
population	O	O
.	O	O

The	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
are	O	O
common	O	O
aetiological	O	O
agents	O	O
of	O	O
infective	O	O
endocarditis	O	O
,	O	O
and	O	O
their	O	O
ability	O	O
to	O	O
adhere	O	O
to	O	O
and	O	O
induce	O	O
the	O	O
aggregation	O	O
of	O	O
platelets	O	O
is	O	O
thought	O	O
to	O	O
be	O	O
a	O	O
virulence	O	O
trait	O	O
.	O	O

The	O	O
platelet	O	O
glycoprotein	O	O
GPIbalpha	O	O
has	O	O
been	O	O
implicated	O	O
as	O	O
the	O	O
adhesion	O	O
receptor	O	O
for	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
but	O	O
it	O	O
is	O	O
not	O	O
known	O	O
if	O	O
this	O	O
is	O	O
the	O	O
case	O	O
for	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
and	O	O
other	O	O
species	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
GPIbalpha-interactive	O	O
capability	O	O
of	O	O
a	O	O
range	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
to	O	O
determine	O	O
the	O	O
relationship	O	O
between	O	O
this	O	O
capability	O	O
and	O	O
their	O	O
ability	O	O
to	O	O
interact	O	O
with	O	O
the	O	O
salivary	O	O
constituents	O	O
that	O	O
they	O	O
would	O	O
encounter	O	O
in	O	O
their	O	O
normal	O	O
habitat	O	O
.	O	O

All	O	O
platelet-adhesive	O	O
S.	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
and	O	O
most	O	O
S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
adhered	O	O
in	O	O
a	O	O
GPIbalpha-dependent	O	O
manner	O	O
,	O	O
but	O	O
strains	O	O
of	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
cristatus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
parasanguinis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
had	O	O
no	O	O
direct	O	O
affinity	O	O
for	O	O
platelets	O	O
.	O	O

Those	O	O
strains	O	O
that	O	O
were	O	O
able	O	O
to	O	O
bind	O	O
GPIbalpha	O	O
also	O	O
bound	O	O
to	O	O
the	O	O
low-molecular-weight	O	O
submandibular	O	O
salivary	O	O
mucin	O	O
,	O	O
MG2	O	O
,	O	O
and	O	O
this	O	O
interaction	O	O
was	O	O
sialic	O	O
acid-dependent	O	O
.	O	O

The	O	O
data	O	O
suggest	O	O
that	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
may	O	O
be	O	O
efficient	O	O
colonizers	O	O
of	O	O
platelet	O	O
vegetations	O	O
because	O	O
of	O	O
their	O	O
adaptation	O	O
to	O	O
recognize	O	O
sialylated	O	O
salivary	O	O
mucins	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
does	O	O
not	O	O
interact	O	O
with	O	O
platelets	O	O
and	O	O
so	O	O
is	O	O
likely	O	O
to	O	O
colonize	O	O
vegetations	O	O
through	O	O
an	O	O
as	O	O
yet	O	O
unidentified	O	O
mechanism	O	O
.	O	O

Halitosis	O	O
can	O	O
be	O	O
a	O	O
crippling	O	O
social	O	O
problem	O	O
,	O	O
and	O	O
standard	O	O
dental	O	O
treatments	O	O
and	O	O
mouthwashes	O	O
often	O	O
provide	O	O
only	O	O
temporary	O	O
relief	O	O
.	O	O

The	O	O
mouth	O	O
is	O	O
home	O	O
to	O	O
hundreds	O	O
of	O	O
bacterial	O	O
species	O	O
that	O	O
produce	O	O
several	O	O
fetid	O	O
substances	O	O
as	O	O
a	O	O
result	O	O
of	O	O
protein	O	O
degradation	O	O
.	O	O

Volatile	O	O
sulfur	O	O
compound	O	O
(	O	O
VSC	O	O
)	O	O
-producing	O	O
bacteria	O	O
colonizing	O	O
the	O	O
lingual	O	O
dorsum	O	O
have	O	O
recently	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
generation	O	O
of	O	O
halitosis	O	O
.	O	O

Detection	O	O
of	O	O
VSCs	O	O
,	O	O
such	O	O
as	O	O
methylmercaptan	O	O
and	O	O
hydrogen	O	O
sulfite	O	O
,	O	O
via	O	O
organoleptic	O	O
and	O	O
objective	O	O
methods	O	O
,	O	O
can	O	O
aid	O	O
in	O	O
the	O	O
identification	O	O
of	O	O
their	O	O
source	O	O
.	O	O

Following	O	O
comprehensive	O	O
evaluation	O	O
for	O	O
possible	O	O
causes	O	O
,	O	O
most	O	O
halitosis	O	O
in	O	O
patients	O	O
seen	O	O
in	O	O
an	O	O
ENT	O	O
practice	O	O
can	O	O
be	O	O
localized	O	O
to	O	O
the	O	O
tongue	O	O
.	O	O

We	O	O
review	O	O
methods	O	O
of	O	O
diagnosis	O	O
and	O	O
treatment	O	O
of	O	O
oral	O	O
malodor	O	O
from	O	O
the	O	O
overgrowth	O	O
of	O	O
proteolytic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
on	O	O
the	O	O
crevices	O	O
of	O	O
the	O	O
lingual	O	O
dorsum	O	O
.	O	O

Bacteriologic	O	O
analysis	O	O
of	O	O
biofilm	O	O
and	O	O
scraped	O	O
specimens	O	O
obtained	O	O
from	O	O
the	O	O
lingual	O	O
dorsum	O	O
and	O	O
other	O	O
oral	O	O
sites	O	O
,	O	O
primarily	O	O
gingival	O	O
pockets	O	O
and	O	O
tonsillar	O	O
crypts	O	O
,	O	O
can	O	O
identify	O	O
VSC-producing	O	O
bacteria	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
are	O	O
the	O	O
most	O	O
common	O	O
organisms	O	O
identified	O	O
.	O	O

Halitosis	O	O
is	O	O
an	O	O
oral	O	O
phenomenon	O	O
,	O	O
with	O	O
almost	O	O
no	O	O
cases	O	O
originating	O	O
distal	O	O
to	O	O
the	O	O
tonsils	O	O
.	O	O

Halitosis	O	O
arising	O	O
from	O	O
the	O	O
lingual	O	O
dorsum	O	O
secondary	O	O
to	O	O
overpopulated	O	O
VSC-producing	O	O
bacteria	O	O
can	O	O
be	O	O
successfully	O	O
managed	O	O
with	O	O
a	O	O
combination	O	O
of	O	O
mechanical	O	O
cleansing	O	O
using	O	O
tongue	O	O
brushes	O	O
or	O	O
scrapes	O	O
and	O	O
chemical	O	O
solutions	O	O
containing	O	O
essential	O	O
oils	O	O
,	O	O
zinc	O	O
chloride	O	O
,	O	O
and	O	O
cetylpyridinium	O	O
chloride	O	O
.	O	O

The	O	O
hygiene	O	O
hypothesis	O	O
contends	O	O
that	O	O
fewer	O	O
opportunities	O	O
for	O	O
infection	O	O
have	O	O
led	O	O
to	O	O
increases	O	O
in	O	O
the	O	O
prevalences	O	O
of	O	O
asthma	O	O
and	O	O
other	O	O
allergic	O	O
diseases	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
association	O	O
between	O	O
asthma	O	O
,	O	O
wheeze	O	O
,	O	O
and	O	O
hay	O	O
fever	O	O
and	O	O
antibodies	O	O
to	O	O
2	O	O
oral	O	O
bacteria	O	O
associated	O	O
with	O	O
periodontal	O	O
disease	O	O
.	O	O

Data	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
Third	O	O
National	O	O
Health	O	O
and	O	O
Nutrition	O	O
Examination	O	O
Survey	O	O
.	O	O

Serum	O	O
levels	O	O
of	O	O
IgG	O	O
antibodies	O	O
to	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
quantified	O	O
by	O	O
enzyme-linked	O	O
immunoassays	O	O
in	O	O
9385	O	O
subjects	O	O
age	O	O
12	O	O
years	O	O
and	O	O
older	O	O
.	O	O

The	O	O
outcomes	O	O
were	O	O
current	O	O
asthma	O	O
,	O	O
wheeze	O	O
,	O	O
and	O	O
hay	O	O
fever	O	O
.	O	O

Odds	O	O
ratios	O	O
(	O	O
ORs	O	O
)	O	O
representing	O	O
a	O	O
1-log-unit	O	O
increase	O	O
in	O	O
IgG	O	O
concentrations	O	O
were	O	O
estimated	O	O
with	O	O
logistic	O	O
regression	O	O
.	O	O

ORs	O	O
were	O	O
adjusted	O	O
for	O	O
8	O	O
confounders	O	O
and	O	O
weighted	O	O
to	O	O
represent	O	O
the	O	O
US	O	O
population	O	O
.	O	O

For	O	O
each	O	O
disease	O	O
outcome	O	O
,	O	O
geometric	O	O
mean	O	O
antibody	O	O
concentrations	O	O
were	O	O
higher	O	O
in	O	O
persons	O	O
without	O	O
the	O	O
disease	O	O
outcome	O	O
than	O	O
with	O	O
the	O	O
disease	O	O
outcome	O	O
.	O	O

For	O	O
a	O	O
1-log-unit	O	O
increase	O	O
in	O	O
P	B-bacteria	B-bacteria
gingivalis	O	O
antibody	O	O
concentration	O	O
,	O	O
adjusted	O	O
ORs	O	O
were	O	O
0.41	O	O
(	O	O
95	O	O
%	O	O
CI	O	O
,	O	O
0.20-0.87	O	O
)	O	O
for	O	O
asthma	O	O
,	O	O
0.43	O	O
(	O	O
0.23-0.78	O	O
)	O	O
for	O	O
wheeze	O	O
,	O	O
and	O	O
0.45	O	O
(	O	O
0.23-0.93	O	O
)	O	O
for	O	O
hay	O	O
fever	O	O
.	O	O

For	O	O
A	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
those	O	O
ORs	O	O
were	O	O
0.56	O	O
(	O	O
0.19-1.72	O	O
)	O	O
,	O	O
0.39	O	O
(	O	O
0.17-0.86	O	O
)	O	O
,	O	O
and	O	O
0.48	O	O
(	O	O
0.23-1.03	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

Consistent	O	O
with	O	O
the	O	O
hygiene	O	O
hypothesis	O	O
,	O	O
higher	O	O
concentrations	O	O
of	O	O
IgG	O	O
antibodies	O	O
to	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
significantly	O	O
associated	O	O
with	O	O
lower	O	O
prevalences	O	O
of	O	O
asthma	O	O
,	O	O
wheeze	O	O
,	O	O
and	O	O
hay	O	O
fever	O	O
,	O	O
and	O	O
higher	O	O
concentrations	O	O
of	O	O
IgG	O	O
antibodies	O	O
to	O	O
A	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
were	O	O
significantly	O	O
associated	O	O
with	O	O
a	O	O
lower	O	O
prevalence	O	O
of	O	O
wheeze	O	O
.	O	O

Colonization	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
by	O	O
bacteria	O	O
and	O	O
other	O	O
microbes	O	O
might	O	O
play	O	O
a	O	O
protective	O	O
role	O	O
in	O	O
the	O	O
etiology	O	O
of	O	O
allergic	O	O
disease	O	O
.	O	O

Aortic	O	O
aneurysms	O	O
are	O	O
common	O	O
vascular	O	O
conditions	O	O
that	O	O
cause	O	O
considerable	O	O
morbidity	O	O
and	O	O
mortality	O	O
.	O	O

Understanding	O	O
of	O	O
the	O	O
mechanisms	O	O
involved	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
the	O	O
condition	O	O
remains	O	O
limited	O	O
.	O	O

Recently	O	O
,	O	O
infection	O	O
has	O	O
been	O	O
suggested	O	O
as	O	O
possible	O	O
contributor	O	O
in	O	O
the	O	O
development	O	O
of	O	O
the	O	O
disease	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
aortic	O	O
aneurysms	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
bacterial	O	O
DNA	O	O
using	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
targeting	O	O
the	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
(	O	O
rRNA	O	O
)	O	O
gene	O	O
,	O	O
followed	O	O
by	O	O
cloning	O	O
and	O	O
sequencing	O	O
.	O	O

Universal	O	O
eubacterial	O	O
primers	O	O
were	O	O
used	O	O
to	O	O
amplify	O	O
16S	O	O
rRNA	O	O
bacterial	O	O
genes	O	O
in	O	O
10	O	O
specimens	O	O
from	O	O
arterial	O	O
walls	O	O
of	O	O
aortic	O	O
aneurysms	O	O
.	O	O

Subsequently	O	O
,	O	O
PCR	O	O
amplicons	O	O
were	O	O
cloned	O	O
into	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
sequencing	O	O
of	O	O
the	O	O
cloned	O	O
inserts	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
species	O	O
identity	O	O
or	O	O
closest	O	O
relatives	O	O
by	O	O
comparison	O	O
with	O	O
known	O	O
sequences	O	O
in	O	O
GenBank	O	O
.	O	O

Sequences	O	O
of	O	O
Stenotrophomonas	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
including	O	O
S.	B-bacteria	B-bacteria
maltophilia	E-bacteria	I-bacteria
(	O	O
formerly	O	O
Pseudomonas	B-bacteria	B-bacteria
homology	O	O
group	O	O
V	O	O
)	O	O
were	O	O
detected	O	O
in	O	O
six	O	O
aneurysm	O	O
samples	O	O
.	O	O

Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
was	O	O
identified	O	O
in	O	O
five	O	O
samples	O	O
,	O	O
and	O	O
Brevundimonas	B-bacteria	B-bacteria
diminuta	E-bacteria	I-bacteria
(	O	O
formerly	O	O
P.	B-bacteria	B-bacteria
diminuta	E-bacteria	I-bacteria
)	O	O
in	O	O
four	O	O
samples	O	O
.	O	O

Other	O	O
species	O	O
previously	O	O
assigned	O	O
to	O	O
the	O	O
Pseudomonas	B-bacteria	B-bacteria
genus	O	O
such	O	O
as	O	O
Comamonas	B-bacteria	B-bacteria
testosteroni	E-bacteria	I-bacteria
,	O	O
Delftia	B-bacteria	B-bacteria
acidovorans	E-bacteria	I-bacteria
,	O	O
Burkholderia	B-bacteria	B-bacteria
cepacia	E-bacteria	I-bacteria
,	O	O
Herbaspirillum	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
and	O	O
Acidovorax	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
also	O	O
detected	O	O
.	O	O

Some	O	O
clones	O	O
fell	O	O
into	O	O
other	O	O
environmental	O	O
species	O	O
,	O	O
including	O	O
Methylobacterium	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Bradyrhizobium	B-bacteria	B-bacteria
elkanii	E-bacteria	I-bacteria
,	O	O
and	O	O
others	O	O
represented	O	O
bacteria	O	O
that	O	O
have	O	O
not	O	O
yet	O	O
been	O	O
cultivated	O	O
.	O	O

DNA	O	O
sequences	O	O
from	O	O
oral	O	O
bacteria	O	O
,	O	O
including	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
Leptotrichia	B-bacteria	B-bacteria
buccalis	E-bacteria	I-bacteria
were	O	O
detected	O	O
.	O	O

Sequences	O	O
from	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
delbrueckii	E-bacteria	I-bacteria
,	O	O
which	O	O
are	O	O
commonly	O	O
found	O	O
in	O	O
both	O	O
mouth	O	O
and	O	O
gastrointestinal	O	O
tract	O	O
,	O	O
were	O	O
also	O	O
detected	O	O
.	O	O

Additional	O	O
species	O	O
included	O	O
Dermacoccus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Corynebacterium	B-bacteria	B-bacteria
vitaeruminis	E-bacteria	I-bacteria
.	O	O

A	O	O
wide	O	O
variety	O	O
of	O	O
bacteria	O	O
,	O	O
including	O	O
oral	O	O
bacteria	O	O
,	O	O
was	O	O
found	O	O
to	O	O
colonize	O	O
aortic	O	O
aneurysms	O	O
and	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
their	O	O
development	O	O
.	O	O

Several	O	O
of	O	O
these	O	O
microorganisms	O	O
have	O	O
not	O	O
yet	O	O
been	O	O
cultivated	O	O
.	O	O

Although	O	O
Chlamydophila	O	O
pneumoniae	O	O
has	O	O
been	O	O
detected	O	O
in	O	O
aneurysmal	O	O
walls	O	O
,	O	O
its	O	O
exact	O	O
role	O	O
in	O	O
the	O	O
condition	O	O
remains	O	O
inconclusive	O	O
.	O	O

Overall	O	O
,	O	O
there	O	O
is	O	O
scarce	O	O
information	O	O
about	O	O
the	O	O
role	O	O
of	O	O
microorganisms	O	O
in	O	O
aneurysmal	O	O
disease	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
used	O	O
molecular	O	O
genetics	O	O
to	O	O
detect	O	O
a	O	O
diversity	O	O
of	O	O
bacteria	O	O
in	O	O
arterial	O	O
walls	O	O
of	O	O
aortic	O	O
aneurysms	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
multiple	O	O
microorganisms	O	O
in	O	O
aneurysmal	O	O
disease	O	O
may	O	O
have	O	O
implications	O	O
for	O	O
chemoprophylaxis	O	O
and	O	O
antibiotic	O	O
treatment	O	O
if	O	O
directed	O	O
only	O	O
at	O	O
C.pneumoniae	B-bacteria	B-bacteria
.	O	O

We	O	O
have	O	O
already	O	O
reported	O	O
that	O	O
chitosan	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
vitro	O	O
.	O	O

This	O	O
study	O	O
was	O	O
designed	O	O
to	O	O
evaluate	O	O
whether	O	O
chewing	O	O
gum	O	O
,	O	O
containing	O	O
chitosan	O	O
,	O	O
can	O	O
effectively	O	O
suppressed	O	O
the	O	O
growth	O	O
of	O	O
oral	O	O
bacteria	O	O
(	O	O
total	O	O
bacteria	O	O
,	O	O
total	O	O
Streptococci	B-bacteria	B-bacteria
,	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
)	O	O
in	O	O
saliva	O	O
.	O	O

Fifty	O	O
healthy	O	O
subjects	O	O
,	O	O
ranging	O	O
in	O	O
age	O	O
from	O	O
19	O	O
to	O	O
32	O	O
years	O	O
,	O	O
were	O	O
recruited	O	O
from	O	O
among	O	O
the	O	O
staff	O	O
and	O	O
students	O	O
of	O	O
Nagasaki	O	O
University	O	O
School	O	O
of	O	O
Dentistry	O	O
.	O	O

For	O	O
the	O	O
slab	O	O
of	O	O
gum	O	O
study	O	O
,	O	O
the	O	O
subjects	O	O
chewed	O	O
gum	O	O
for	O	O
5	O	O
min	O	O
and	O	O
then	O	O
rested	O	O
for	O	O
5	O	O
min	O	O
.	O	O

Each	O	O
subject	O	O
chewed	O	O
a	O	O
total	O	O
of	O	O
eight	O	O
pieces	O	O
of	O	O
gum	O	O
,	O	O
which	O	O
was	O	O
either	O	O
supplemented	O	O
with	O	O
or	O	O
without	O	O
chitosan	O	O
,	O	O
for	O	O
a	O	O
total	O	O
of	O	O
80	O	O
min	O	O
.	O	O

Two	O	O
different	O	O
types	O	O
of	O	O
gums	O	O
were	O	O
examined	O	O
with	O	O
at	O	O
least	O	O
1	O	O
week	O	O
as	O	O
a	O	O
rest	O	O
period	O	O
in	O	O
between	O	O
treatments	O	O
.	O	O

This	O	O
in	O	O
vivo	O	O
study	O	O
was	O	O
carried	O	O
out	O	O
by	O	O
the	O	O
double	O	O
blind	O	O
comparison	O	O
test	O	O
.	O	O

The	O	O
amount	O	O
of	O	O
oral	O	O
bacteria	O	O
was	O	O
found	O	O
to	O	O
significantly	O	O
decrease	O	O
in	O	O
the	O	O
chitosan	O	O
group	O	O
.	O	O

Especially	O	O
,	O	O
the	O	O
number	O	O
of	O	O
MS	B-bacteria	B-bacteria
were	O	O
maintained	O	O
at	O	O
about	O	O
a	O	O
20	O	O
%	O	O
level	O	O
in	O	O
comparison	O	O
to	O	O
that	O	O
before	O	O
gum	O	O
chewing	O	O
,	O	O
even	O	O
at	O	O
1h	O	O
after	O	O
gum	O	O
chewing	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
a	O	O
supplementation	O	O
of	O	O
chitosan	O	O
to	O	O
gum	O	O
is	O	O
an	O	O
effective	O	O
method	O	O
for	O	O
controlling	O	O
the	O	O
number	O	O
of	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
situations	O	O
where	O	O
it	O	O
is	O	O
difficult	O	O
to	O	O
brush	O	O
one	O	O
's	O	O
teeth	O	O
,	O	O
such	O	O
as	O	O
when	O	O
an	O	O
individual	O	O
is	O	O
away	O	O
from	O	O
home	O	O
all	O	O
day	O	O
or	O	O
participating	O	O
in	O	O
outdoor	O	O
training	O	O
.	O	O

This	O	O
study	O	O
was	O	O
designed	O	O
to	O	O
investigate	O	O
the	O	O
impact	O	O
of	O	O
haematopoietic	O	O
stem	O	O
cell	O	O
transplantation	O	O
(	O	O
HSCT	O	O
)	O	O
on	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
colonization	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
by	O	O
nested	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
nested-PCR	O	O
)	O	O
.	O	O

Forty	O	O
six	O	O
consecutive	O	O
patients	O	O
submitted	O	O
to	O	O
HSCT	O	O
and	O	O
46	O	O
healthy	O	O
volunteers	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Oral	O	O
swabs	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
oral	O	O
mucosa	O	O
of	O	O
the	O	O
patients	O	O
and	O	O
control	O	O
group	O	O
.	O	O

The	O	O
medical	O	O
records	O	O
of	O	O
the	O	O
patients	O	O
were	O	O
reviewed	O	O
and	O	O
the	O	O
following	O	O
information	O	O
was	O	O
retrieved	O	O
:	O	O
gender	O	O
and	O	O
age	O	O
of	O	O
the	O	O
patient	O	O
,	O	O
donor	O	O
gender	O	O
,	O	O
primary	O	O
disease	O	O
,	O	O
stem	O	O
cell	O	O
source	O	O
(	O	O
bone	O	O
marrow	O	O
or	O	O
blood	O	O
stem	O	O
cells	O	O
)	O	O
,	O	O
leukocyte	O	O
,	O	O
neutrophil	O	O
and	O	O
platelet	O	O
counts	O	O
,	O	O
and	O	O
chronic	O	O
graft	O	O
versus	O	O
host	O	O
disease	O	O
(	O	O
cGVHD	O	O
)	O	O
of	O	O
salivary	O	O
glands	O	O
.	O	O

The	O	O
results	O	O
demonstrated	O	O
an	O	O
increased	O	O
frequency	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
mucosa	O	O
of	O	O
HSCT	O	O
patients	O	O
compared	O	O
to	O	O
controls	O	O
(	O	O
rho	O	O
=	O	O
0.002	O	O
)	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
mucosa	O	O
was	O	O
not	O	O
related	O	O
to	O	O
the	O	O
severity	O	O
of	O	O
cGVHD	O	O
.	O	O

The	O	O
median	O	O
counts	O	O
of	O	O
platelet/mm3	O	O
,	O	O
leukocytes/mm3	O	O
and	O	O
neutrophils/mm3	O	O
in	O	O
the	O	O
group	O	O
of	O	O
HSCT	O	O
patients	O	O
positive	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
were	O	O
not	O	O
statistically	O	O
different	O	O
from	O	O
those	O	O
of	O	O
the	O	O
patients	O	O
negative	O	O
for	O	O
it	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
the	O	O
present	O	O
study	O	O
shows	O	O
increased	O	O
frequency	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
mucosa	O	O
of	O	O
HSCT	O	O
patients	O	O
compared	O	O
to	O	O
non-transplanted	O	O
healthy	O	O
volunteers	O	O
.	O	O

Salivary	O	O
nitrate	O	O
is	O	O
positively	O	O
correlated	O	O
with	O	O
plasma	O	O
nitrate	O	O
and	O	O
its	O	O
level	O	O
is	O	O
9	O	O
times	O	O
the	O	O
plasma	O	O
level	O	O
after	O	O
nitrate	O	O
loading	O	O
.	O	O

Nitrate	O	O
in	O	O
saliva	O	O
is	O	O
known	O	O
to	O	O
be	O	O
reduced	O	O
to	O	O
nitrite	O	O
by	O	O
oral	O	O
bacteria	O	O
.	O	O

Nitrate	O	O
and	O	O
nitrite	O	O
levels	O	O
in	O	O
saliva	O	O
are	O	O
3	O	O
-	O	O
5	O	O
times	O	O
those	O	O
in	O	O
serum	O	O
in	O	O
physiological	O	O
conditions	O	O
respectively	O	O
in	O	O
our	O	O
previous	O	O
study	O	O
.	O	O

The	O	O
biological	O	O
functions	O	O
of	O	O
high	O	O
salivary	O	O
nitrate	O	O
and	O	O
nitrite	O	O
are	O	O
still	O	O
not	O	O
well	O	O
understood	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
in	O	O
vitro	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
antimicrobial	O	O
effects	O	O
of	O	O
nitrate	O	O
and	O	O
nitrite	O	O
on	O	O
main	O	O
oral	O	O
pathogens	O	O
under	O	O
acidic	O	O
conditions	O	O
.	O	O

Six	O	O
common	O	O
oral	O	O
pathogens	O	O
including	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
NCTC	I-bacteria	I-bacteria
10449	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
4646	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33277	E-bacteria	I-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33624	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
10953	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
albicans	O	O
ATCC	O	O
10231	O	O
were	O	O
cultured	O	O
in	O	O
liquid	O	O
medium	O	O
.	O	O

Sodium	O	O
nitrate	O	O
or	O	O
sodium	O	O
nitrite	O	O
was	O	O
added	O	O
to	O	O
the	O	O
medium	O	O
to	O	O
final	O	O
concentrations	O	O
of	O	O
0	O	O
,	O	O
0.5	O	O
,	O	O
1	O	O
,	O	O
2	O	O
,	O	O
and	O	O
10	O	O
mmol/L	O	O
.	O	O

All	O	O
of	O	O
the	O	O
microorganisms	O	O
were	O	O
incubated	O	O
for	O	O
24	O	O
to	O	O
48	O	O
hours	O	O
.	O	O

The	O	O
optical	O	O
densities	O	O
(	O	O
OD	O	O
)	O	O
of	O	O
cell	O	O
suspensions	O	O
were	O	O
determined	O	O
and	O	O
the	O	O
cultures	O	O
were	O	O
transferred	O	O
to	O	O
solid	O	O
nutrient	O	O
broth	O	O
medium	O	O
to	O	O
observe	O	O
the	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
and	O	O
minimum	O	O
bactericidal/fungicidal	O	O
concentration	O	O
for	O	O
the	O	O
six	O	O
tested	O	O
pathogens	O	O
.	O	O

Nitrite	O	O
at	O	O
concentrations	O	O
of	O	O
0.5	O	O
to	O	O
10	O	O
mmol/L	O	O
had	O	O
an	O	O
inhibitory	O	O
effect	O	O
on	O	O
all	O	O
tested	O	O
organisms	O	O
at	O	O
low	O	O
pH	O	O
values	O	O
.	O	O

The	O	O
antimicrobial	O	O
effect	O	O
of	O	O
nitrite	O	O
increased	O	O
with	O	O
the	O	O
acidity	O	O
of	O	O
the	O	O
medium	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
NCTC	I-bacteria	I-bacteria
10449	E-bacteria	I-bacteria
was	O	O
highly	O	O
sensitive	O	O
to	O	O
nitrite	O	O
at	O	O
low	O	O
pH	O	O
values	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
acidophilus	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
4646	E-bacteria	I-bacteria
and	O	O
Candida	O	O
albicans	O	O
ATCC	O	O
10231	O	O
were	O	O
relatively	O	O
resistant	O	O
to	O	O
acidified	O	O
nitrite	O	O
.	O	O

Nitrate	O	O
at	O	O
the	O	O
given	O	O
concentrations	O	O
and	O	O
under	O	O
acidic	O	O
conditions	O	O
had	O	O
no	O	O
inhibitory	O	O
effect	O	O
on	O	O
the	O	O
growth	O	O
of	O	O
any	O	O
of	O	O
the	O	O
tested	O	O
pathogens	O	O
.	O	O

Nitrite	O	O
,	O	O
at	O	O
a	O	O
concentration	O	O
equal	O	O
to	O	O
that	O	O
in	O	O
human	O	O
saliva	O	O
,	O	O
is	O	O
both	O	O
cytocidal	O	O
and	O	O
cytostatic	O	O
to	O	O
six	O	O
principal	O	O
oral	O	O
pathogens	O	O
in	O	O
vitro	O	O
,	O	O
whereas	O	O
nitrate	O	O
at	O	O
a	O	O
similar	O	O
concentration	O	O
has	O	O
no	O	O
antimicrobial	O	O
effect	O	O
on	O	O
these	O	O
organisms	O	O
.	O	O

As	O	O
the	O	O
result	O	O
of	O	O
the	O	O
study	O	O
of	O	O
stomatological	O	O
status	O	O
indices	O	O
in	O	O
children	O	O
with	O	O
gastroduodenal	O	O
pathology	O	O
associated	O	O
with	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
it	O	O
was	O	O
established	O	O
that	O	O
caries	O	O
incidence	O	O
in	O	O
children	O	O
did	O	O
not	O	O
depend	O	O
upon	O	O
contamination	O	O
while	O	O
caries	O	O
prevalence	O	O
in	O	O
examined	O	O
children	O	O
unlike	O	O
caries	O	O
incidence	O	O
was	O	O
associated	O	O
with	O	O
HP-status	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Patients	O	O
with	O	O
concomitant	O	O
gastroduodenal	O	O
pathology	O	O
had	O	O
frequently	O	O
periodontal	O	O
disease	O	O
(	O	O
PD	O	O
)	O	O
.	O	O

In	O	O
children	O	O
with	O	O
chronic	O	O
antral	O	O
gastritis	O	O
associated	O	O
with	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
clinical	O	O
manifestations	O	O
were	O	O
poor	O	O
and	O	O
tended	O	O
towards	O	O
inflammatory	O	O
process	O	O
chronicity	O	O
.	O	O

All	O	O
the	O	O
patients	O	O
had	O	O
chronic	O	O
catarrhal	O	O
gingivitis	O	O
.	O	O

In	O	O
children	O	O
with	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
associated	O	O
pathology	O	O
of	O	O
GIT	O	O
it	O	O
proceeded	O	O
with	O	O
100	O	O
%	O	O
contamination	O	O
of	O	O
gingival	O	O
mucous	O	O
membrane	O	O
by	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
as	O	O
shown	O	O
by	O	O
bacterioscopic	O	O
study	O	O
.	O	O

For	O	O
nearly	O	O
a	O	O
century	O	O
,	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
LB	B-bacteria	B-bacteria
)	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
have	O	O
been	O	O
generally	O	O
associated	O	O
with	O	O
dental	O	O
caries	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
characterized	O	O
the	O	O
LB	B-bacteria	B-bacteria
isolated	O	O
from	O	O
the	O	O
saliva	O	O
of	O	O
6	O	O
women	O	O
with	O	O
active	O	O
caries	O	O
using	O	O
genetic-based	O	O
taxonomical	O	O
identification	O	O
methods	O	O
.	O	O

From	O	O
each	O	O
subject	O	O
,	O	O
30	O	O
isolates	O	O
growing	O	O
on	O	O
Rogosa	O	O
medium	O	O
and	O	O
presumed	O	O
to	O	O
be	O	O
LB	B-bacteria	B-bacteria
were	O	O
analyzed	O	O
.	O	O

Of	O	O
the	O	O
180	O	O
isolates	O	O
,	O	O
176	O	O
were	O	O
further	O	O
characterized	O	O
by	O	O
biotyping	O	O
,	O	O
DNA	O	O
melting	O	O
points	O	O
,	O	O
DNA	O	O
chromosomal	O	O
fingerprinting	O	O
,	O	O
genotyping	O	O
,	O	O
and	O	O
phylogenetic	O	O
cluster	O	O
assessment	O	O
.	O	O

We	O	O
found	O	O
a	O	O
total	O	O
of	O	O
30	O	O
unique	O	O
genotypes	O	O
of	O	O
LB	B-bacteria	B-bacteria
in	O	O
the	O	O
saliva	O	O
of	O	O
caries-active	O	O
women	O	O
,	O	O
with	O	O
each	O	O
woman	O	O
harboring	O	O
between	O	O
2	O	O
and	O	O
8	O	O
distinct	O	O
genotypes	O	O
.	O	O

Although	O	O
Lactobacillus	B-bacteria	B-bacteria
vaginalis	E-bacteria	I-bacteria
,	O	O
L.	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
,	O	O
and	O	O
L.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
were	O	O
found	O	O
in	O	O
4	O	O
of	O	O
6	O	O
of	O	O
the	O	O
subjects	O	O
,	O	O
results	O	O
from	O	O
other	O	O
studies	O	O
using	O	O
comparable	O	O
methods	O	O
show	O	O
an	O	O
entirely	O	O
different	O	O
array	O	O
of	O	O
LB	B-bacteria	B-bacteria
associated	O	O
with	O	O
caries	O	O
.	O	O

These	O	O
collective	O	O
observations	O	O
lead	O	O
us	O	O
to	O	O
surmise	O	O
that	O	O
LB	B-bacteria	B-bacteria
associated	O	O
with	O	O
dental	O	O
caries	O	O
are	O	O
likely	O	O
exogenous	O	O
and	O	O
opportunistic	O	O
colonizers	O	O
,	O	O
arising	O	O
from	O	O
food	O	O
or	O	O
other	O	O
reservoirs	O	O
outside	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
this	O	O
longitudinal	O	O
study	O	O
,	O	O
patients	O	O
with	O	O
fixed	O	O
orthodontic	O	O
appliances	O	O
served	O	O
as	O	O
models	O	O
to	O	O
determine	O	O
whether	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	B-bacteria	B-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
total	O	O
streptococci	B-bacteria	B-bacteria
increased	O	O
after	O	O
treatment	O	O
,	O	O
and	O	O
whether	O	O
treatment	O	O
affected	O	O
bacterial	O	O
invasion	O	O
into	O	O
the	O	O
adjacent	O	O
buccal	O	O
epithelial	O	O
cells	O	O
(	O	O
BEC	O	O
)	O	O
.	O	O

Supragingival	O	O
plaque	O	O
,	O	O
subgingival	O	O
plaque	O	O
,	O	O
and	O	O
BEC	O	O
were	O	O
collected	O	O
from	O	O
27	O	O
patients	O	O
before	O	O
and	O	O
at	O	O
least	O	O
4	O	O
weeks	O	O
after	O	O
placement	O	O
of	O	O
orthodontic	O	O
fixed	O	O
appliances	O	O
.	O	O

Total	O	O
sample	O	O
DNA	O	O
was	O	O
determined	O	O
,	O	O
and	O	O
bacteria	O	O
were	O	O
assayed	O	O
by	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

The	O	O
BEC	O	O
were	O	O
also	O	O
examined	O	O
by	O	O
confocal	O	O
microscopy	O	O
after	O	O
fluorescent	O	O
in-situ	O	O
hybridization	O	O
to	O	O
visually	O	O
detect	O	O
the	O	O
presence	O	O
of	O	O
each	O	O
species	O	O
bacteria	O	O
in	O	O
BEC	O	O
.	O	O

Total	O	O
DNA	O	O
in	O	O
supragingival	O	O
and	O	O
subgingival	O	O
plaque	O	O
increased	O	O
after	O	O
appliance	O	O
placement	O	O
(	O	O
P	O	O
=	O	O
.005	O	O
)	O	O
.	O	O

There	O	O
was	O	O
also	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
supragingival	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
P	O	O
=	O	O
.0002	O	O
)	O	O
.	O	O

By	O	O
confocal	O	O
microscopy	O	O
,	O	O
a	O	O
trend	O	O
toward	O	O
fewer	O	O
buccal	O	O
cells	O	O
recovered	O	O
was	O	O
found	O	O
after	O	O
appliance	O	O
placement	O	O
,	O	O
and	O	O
there	O	O
was	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
the	O	O
percentage	O	O
of	O	O
buccal	O	O
cells	O	O
containing	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
.0058	O	O
)	O	O
.	O	O

Appliance	O	O
placement	O	O
appeared	O	O
to	O	O
increase	O	O
buccal	O	O
cell	O	O
susceptibility	O	O
to	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
invasion	O	O
.	O	O

This	O	O
might	O	O
be	O	O
due	O	O
to	O	O
physical	O	O
trauma	O	O
or	O	O
to	O	O
leaching	O	O
of	O	O
metals	O	O
from	O	O
the	O	O
appliances	O	O
.	O	O

High	O	O
level	O	O
of	O	O
hydrogen	O	O
peroxide	O	O
was	O	O
produced	O	O
by	O	O
S	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

oligofermentans	E-bacteria	I-bacteria
,	O	O
a	O	O
novel	O	O
oral	O	O
streptococcus	B-bacteria	B-bacteria
isolated	O	O
from	O	O
human	O	O
oral	O	O
cavity	O	O
previously	O	O
in	O	O
our	O	O
laboratory	O	O
.	O	O

To	O	O
characterize	O	O
the	O	O
hydrogen	O	O
peroxide	O	O
production	O	O
by	O	O
S.	B-bacteria	B-bacteria
oligofermentans	E-bacteria	I-bacteria
,	O	O
hydrogen	O	O
peroxide	O	O
yields	O	O
at	O	O
different	O	O
growth	O	O
phases	O	O
and	O	O
from	O	O
different	O	O
substrates	O	O
were	O	O
assayed	O	O
.	O	O

The	O	O
results	O	O
turned	O	O
out	O	O
that	O	O
hydrogen	O	O
peroxide	O	O
production	O	O
started	O	O
at	O	O
the	O	O
beginning	O	O
of	O	O
logarithmic	O	O
phase	O	O
,	O	O
and	O	O
reached	O	O
the	O	O
maximal	O	O
yield	O	O
at	O	O
the	O	O
early	O	O
stationary	O	O
phase	O	O
.	O	O

Peptone	O	O
and	O	O
yeast	O	O
extract	O	O
could	O	O
be	O	O
the	O	O
main	O	O
substrates	O	O
for	O	O
hydrogen	O	O
peroxide	O	O
production	O	O
.	O	O

Moreover	O	O
,	O	O
lactate	O	O
,	O	O
as	O	O
a	O	O
fermentative	O	O
product	O	O
of	O	O
glucose	O	O
,	O	O
can	O	O
be	O	O
another	O	O
substrate	O	O
for	O	O
hydrogen	O	O
peroxide	O	O
production	O	O
.	O	O

Furthermore	O	O
three	O	O
oxidases	O	O
activities	O	O
possibly	O	O
associated	O	O
with	O	O
H2O2	O	O
production	O	O
were	O	O
assayed	O	O
,	O	O
and	O	O
both	O	O
activities	O	O
of	O	O
lactate	O	O
oxidase	O	O
and	O	O
NADH	O	O
oxidase	O	O
were	O	O
detected	O	O
under	O	O
aerobic	O	O
condition	O	O
,	O	O
while	O	O
pyruvate	O	O
oxidase	O	O
activity	O	O
was	O	O
not	O	O
detected	O	O
in	O	O
the	O	O
permeabilized	O	O
cells	O	O
of	O	O
S.	B-bacteria	B-bacteria
oligofermentans	O	O
,	O	O
implying	O	O
that	O	O
S.	B-bacteria	B-bacteria
oligofermentans	E-bacteria	I-bacteria
could	O	O
mainly	O	O
rely	O	O
on	O	O
the	O	O
two	O	O
enzymes	O	O
activities	O	O
for	O	O
H2O2	O	O
production	O	O
.	O	O

There	O	O
is	O	O
increasing	O	O
prevalence	O	O
of	O	O
root	O	O
caries	O	O
.	O	O

We	O	O
hypothesized	O	O
different	O	O
biofilms	O	O
will	O	O
cause	O	O
varying	O	O
demineralization	O	O
in	O	O
cementum	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
extent	O	O
of	O	O
demineralization	O	O
of	O	O
cementum	O	O
by	O	O
oral	O	O
biofilm	O	O
formed	O	O
from	O	O
three	O	O
major	O	O
cariogenic	O	O
microorganisms	O	O
:	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
.	O	O

Sound	O	O
cementum	O	O
tooth	O	O
blocks	O	O
were	O	O
incubated	O	O
with	O	O
mono-	O	O
,	O	O
bi-	O	O
,	O	O
and	O	O
tri-species	O	O
combinations	O	O
of	O	O
the	O	O
bacteria	O	O
under	O	O
investigation	O	O
.	O	O

MATERIALS	O	O
AND	O	O
The	O	O
matrix	O	O
(	O	O
amide	O	O
I	O	O
)	O	O
and	O	O
phosphate	O	O
content	O	O
of	O	O
the	O	O
lesions	O	O
was	O	O
analyzed	O	O
by	O	O
Fourier-transform	O	O
infrared	O	O
spectroscopy	O	O
(	O	O
FTIR	O	O
)	O	O
,	O	O
and	O	O
calcium	O	O
and	O	O
phosphorus	O	O
levels	O	O
were	O	O
analyzed	O	O
by	O	O
scanning	O	O
electron	O	O
microscopy	O	O
and	O	O
energy-dispersive	O	O
spectroscopy	O	O
(	O	O
SEM-EDX	O	O
)	O	O
.	O	O

The	O	O
log	O	O
[	O	O
amide	O	O
I	O	O
:	O	O
HPO	O	O
(	O	O
4	O	O
)	O	O
(	O	O
2-	O	O
)	O	O
absorbance	O	O
]	O	O
values	O	O
showed	O	O
that	O	O
A.	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
mono-culture	O	O
caused	O	O
significantly	O	O
more	O	O
demineralization	O	O
than	O	O
the	O	O
other	O	O
bacterial	O	O
cultures	O	O
.	O	O

log	O	O
[	O	O
Ca	O	O
:	O	O
P	O	O
]	O	O
showed	O	O
that	O	O
all	O	O
carious	O	O
lesions	O	O
were	O	O
confined	O	O
to	O	O
the	O	O
cementum	O	O
.	O	O

Oral	O	O
biofilm	O	O
arising	O	O
from	O	O
bacterial	O	O
species	O	O
A.	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
alone	O	O
was	O	O
the	O	O
most	O	O
cariogenic	O	O
of	O	O
those	O	O
tested	O	O
and	O	O
produced	O	O
the	O	O
most	O	O
demineralization	O	O
in	O	O
incipient	O	O
carious	O	O
lesions	O	O
in	O	O
cementum	O	O
.	O	O

It	O	O
is	O	O
thought	O	O
that	O	O
the	O	O
incidence	O	O
and	O	O
severity	O	O
of	O	O
cancer	O	O
chemotherapy-associated	O	O
mucositis	O	O
is	O	O
caused	O	O
in	O	O
part	O	O
by	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
bacterial	O	O
microflora	O	O
.	O	O

This	O	O
systematic	O	O
review	O	O
examined	O	O
the	O	O
role	O	O
of	O	O
oral	O	O
bacterial	O	O
microflora	O	O
changes	O	O
in	O	O
the	O	O
development	O	O
of	O	O
oral	O	O
mucositis	O	O
during	O	O
chemotherapy	O	O
.	O	O

Thirteen	O	O
prospective	O	O
clinical	O	O
trials	O	O
were	O	O
identified	O	O
,	O	O
involving	O	O
300	O	O
patients	O	O
with	O	O
13	O	O
different	O	O
cancer	O	O
diagnoses	O	O
.	O	O

There	O	O
was	O	O
great	O	O
variability	O	O
in	O	O
patient	O	O
populations	O	O
,	O	O
bacterial	O	O
sample	O	O
collection	O	O
methodology	O	O
,	O	O
and	O	O
oral	O	O
sample	O	O
sites	O	O
.	O	O

No	O	O
clear	O	O
pattern	O	O
regarding	O	O
qualitative	O	O
and	O	O
quantitative	O	O
oral	O	O
flora	O	O
changes	O	O
emerged	O	O
among	O	O
these	O	O
studies	O	O
.	O	O

The	O	O
most	O	O
frequent	O	O
Gram-negative	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
isolated	O	O
during	O	O
chemotherapy	O	O
were	O	O
from	O	O
the	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
family	O	O
,	O	O
Pseudomonas	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

The	O	O
most	O	O
common	O	O
Gram-positive	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
isolated	O	O
were	O	O
Staphylococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Streptococcus	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

Five	O	O
studies	O	O
assessed	O	O
the	O	O
role	O	O
of	O	O
oral	O	O
flora	O	O
changes	O	O
in	O	O
the	O	O
genesis	O	O
of	O	O
oral	O	O
mucosal	O	O
changes	O	O
,	O	O
with	O	O
no	O	O
consensus	O	O
among	O	O
them	O	O
.	O	O

More	O	O
detailed	O	O
studies	O	O
are	O	O
required	O	O
to	O	O
understand	O	O
the	O	O
relationship	O	O
between	O	O
chemotherapy	O	O
,	O	O
alterations	O	O
in	O	O
the	O	O
nature	O	O
and	O	O
magnitude	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
,	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
mucositis	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
presence	O	O
of	O	O
oral	O	O
bacterial	O	O
DNAs	O	O
in	O	O
serum	O	O
and	O	O
synovial	O	O
fluid	O	O
(	O	O
SF	O	O
)	O	O
of	O	O
patients	O	O
with	O	O
active	O	O
rheumatoid	O	O
arthritis	O	O
(	O	O
RA	O	O
)	O	O
and	O	O
psoriatic	O	O
arthritis	O	O
(	O	O
PsA	O	O
)	O	O
.	O	O

Serum	O	O
and	O	O
SF	O	O
samples	O	O
from	O	O
16	O	O
RA	O	O
patients	O	O
,	O	O
14	O	O
PsA	O	O
patients	O	O
,	O	O
and	O	O
9	O	O
osteoarthritis	O	O
(	O	O
controls	O	O
)	O	O
patients	O	O
were	O	O
extracted	O	O
for	O	O
oral	O	O
bacterial	O	O
DNA	O	O
.	O	O

This	O	O
was	O	O
used	O	O
in	O	O
a	O	O
checkerboard	O	O
DNA-DNA-hybridization	O	O
set	O	O
up	O	O
,	O	O
to	O	O
identify	O	O
40	O	O
different	O	O
bacteria	O	O
.	O	O

Mean	O	O
number	O	O
+/-	O	O
standard	O	O
deviation	O	O
(	O	O
SD	O	O
)	O	O
of	O	O
oral	O	O
bacterial	O	O
species	O	O
in	O	O
sera	O	O
were	O	O
6.2	O	O
(	O	O
3.2	O	O
)	O	O
in	O	O
the	O	O
RA	O	O
group	O	O
(	O	O
p	O	O
=	O	O
0.004	O	O
)	O	O
and	O	O
5.4	O	O
(	O	O
2.7	O	O
)	O	O
in	O	O
the	O	O
PsA	O	O
group	O	O
(	O	O
p	O	O
=	O	O
0.009	O	O
)	O	O
compared	O	O
to	O	O
2.1	O	O
(	O	O
1.7	O	O
)	O	O
in	O	O
the	O	O
controls	O	O
.	O	O

Periodontitis	O	O
associated	O	O
species	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
were	O	O
exclusively	O	O
detected	O	O
in	O	O
RA	O	O
and	O	O
PsA	O	O
.	O	O

Mean	O	O
number	O	O
(	O	O
+/-	O	O
SD	O	O
)	O	O
of	O	O
oral	O	O
bacterial	O	O
species	O	O
in	O	O
SF	O	O
were	O	O
14.0	O	O
(	O	O
6.8	O	O
)	O	O
in	O	O
the	O	O
RA	O	O
(	O	O
p	O	O
=	O	O
0.001	O	O
)	O	O
and	O	O
19.4	O	O
(	O	O
7.1	O	O
)	O	O
in	O	O
the	O	O
PsA	O	O
group	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
compared	O	O
to	O	O
4.0	O	O
(	O	O
1.7	O	O
)	O	O
in	O	O
controls	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
were	O	O
exclusively	O	O
identified	O	O
in	O	O
RA	O	O
and	O	O
PsA	O	O
SF	O	O
.	O	O

Higher	O	O
means	O	O
of	O	O
DNAs	O	O
were	O	O
found	O	O
in	O	O
RA	O	O
SF	O	O
compared	O	O
to	O	O
RA	O	O
serum	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
and	O	O
in	O	O
PsA	O	O
SF	O	O
compared	O	O
to	O	O
PsA	O	O
serum	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Higher	O	O
concentrations	O	O
of	O	O
bacterial	O	O
DNAs	O	O
were	O	O
found	O	O
in	O	O
RA	O	O
and	O	O
PsA	O	O
compared	O	O
to	O	O
controls	O	O
.	O	O

Higher	O	O
variety	O	O
and	O	O
concentrations	O	O
of	O	O
oral	O	O
bacterial	O	O
DNAs	O	O
were	O	O
found	O	O
in	O	O
SF	O	O
compared	O	O
to	O	O
serum	O	O
of	O	O
RA	O	O
and	O	O
PsA	O	O
patients	O	O
.	O	O

These	O	O
findings	O	O
indicate	O	O
that	O	O
synovial	O	O
inflammation	O	O
in	O	O
RA	O	O
and	O	O
PsA	O	O
may	O	O
favor	O	O
trapping	O	O
of	O	O
oral	O	O
bacterial	O	O
DNAs	O	O
,	O	O
suggesting	O	O
a	O	O
perpetuating	O	O
effect	O	O
of	O	O
oral	O	O
pathogens	O	O
in	O	O
joint	O	O
disease	O	O
.	O	O

Nitroethane	O	O
inhibits	O	O
the	O	O
growth	O	O
of	O	O
certain	O	O
zoonotic	O	O
pathogens	O	O
such	O	O
as	O	O
Campylobacter	B-bacteria	B-bacteria
and	O	O
Salmonella	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
foodborne	O	O
pathogens	O	O
estimated	O	O
to	O	O
cause	O	O
millions	O	O
of	O	O
human	O	O
infections	O	O
each	O	O
year	O	O
,	O	O
and	O	O
enhances	O	O
the	O	O
Salmonella-	O	O
and	O	O
Escherichia	O	O
coli-killing	O	O
effect	O	O
of	O	O
an	O	O
experimental	O	O
chlorate	O	O
product	O	O
being	O	O
developed	O	O
as	O	O
a	O	O
feed	O	O
additive	O	O
to	O	O
kill	O	O
these	O	O
bacteria	O	O
immediately	O	O
pre-harvest	O	O
.	O	O

Limited	O	O
studies	O	O
have	O	O
shown	O	O
that	O	O
nitroethane	O	O
inhibits	O	O
ruminal	O	O
methane	O	O
production	O	O
,	O	O
which	O	O
represents	O	O
a	O	O
loss	O	O
of	O	O
2-12	O	O
%	O	O
of	O	O
the	O	O
host	O	O
's	O	O
gross	O	O
energy	O	O
intake	O	O
and	O	O
contributes	O	O
to	O	O
global	O	O
warming	O	O
and	O	O
destruction	O	O
of	O	O
the	O	O
ozone	O	O
layer	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
conducted	O	O
to	O	O
assess	O	O
the	O	O
effects	O	O
of	O	O
14-day	O	O
oral	O	O
nitroethane	O	O
administration	O	O
,	O	O
0	O	O
(	O	O
0X	O	O
)	O	O
,	O	O
80	O	O
(	O	O
1X	O	O
)	O	O
or	O	O
160	O	O
(	O	O
2X	O	O
)	O	O
mg	O	O
nitroethane/kg	O	O
body	O	O
weight	O	O
per	O	O
day	O	O
on	O	O
ruminal	O	O
and	O	O
fecal	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
Campylobacter	B-bacteria	B-bacteria
,	O	O
ruminal	O	O
and	O	O
fecal	O	O
methane-producing	O	O
and	O	O
nitroethane-reducing	O	O
activity	O	O
,	O	O
whole	O	O
animal	O	O
methane	O	O
emissions	O	O
,	O	O
and	O	O
ruminal	O	O
and	O	O
fecal	O	O
fermentation	O	O
balance	O	O
in	O	O
Holstein	O	O
steers	O	O
(	O	O
n=6	O	O
per	O	O
treatment	O	O
)	O	O
averaging	O	O
403+/-26	O	O
(	O	O
SD	O	O
)	O	O
kg	O	O
BW	O	O
.	O	O

An	O	O
experimental	O	O
chlorate	O	O
product	O	O
was	O	O
fed	O	O
the	O	O
day	O	O
following	O	O
the	O	O
last	O	O
nitroethane	O	O
administration	O	O
to	O	O
determine	O	O
effects	O	O
on	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
Campylobacter	B-bacteria	B-bacteria
.	O	O

The	O	O
experimental	O	O
chlorate	O	O
product	O	O
decreased	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
fecal	O	O
,	O	O
but	O	O
not	O	O
ruminal	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
concentrations	O	O
by	O	O
1000-	O	O
and	O	O
10-fold	O	O
by	O	O
24	O	O
and	O	O
48	O	O
h	O	O
,	O	O
respectively	O	O
,	O	O
after	O	O
chlorate	O	O
feeding	O	O
when	O	O
compared	O	O
to	O	O
pre-treatment	O	O
concentrations	O	O
(	O	O
>	O	O
5.7	O	O
log	O	O
(	O	O
10	O	O
)	O	O
colony	O	O
forming	O	O
units/g	O	O
)	O	O
.	O	O

No	O	O
effects	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
of	O	O
nitroethane	O	O
or	O	O
the	O	O
experimental	O	O
chlorate	O	O
product	O	O
were	O	O
observed	O	O
on	O	O
fecal	O	O
Campylobacter	B-bacteria	B-bacteria
concentrations	O	O
;	O	O
Campylobacter	B-bacteria	B-bacteria
were	O	O
not	O	O
recovered	O	O
from	O	O
ruminal	O	O
contents	O	O
.	O	O

Nitroethane	O	O
treatment	O	O
decreased	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
ruminal	O	O
(	O	O
8.46	O	O
,	O	O
7.91	O	O
and	O	O
4.74+/-0.78	O	O
micromol/g/h	O	O
)	O	O
and	O	O
fecal	O	O
(	O	O
3.90	O	O
,	O	O
1.36	O	O
and	O	O
1.38+/-0.50	O	O
micromol/g/h	O	O
)	O	O
methane-producing	O	O
activity	O	O
for	O	O
treatments	O	O
0X	O	O
,	O	O
1X	O	O
and	O	O
2X	O	O
,	O	O
respectively	O	O
.	O	O

Administration	O	O
of	O	O
nitroethane	O	O
increased	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
nitroethane-reducing	O	O
activity	O	O
in	O	O
ruminal	O	O
,	O	O
but	O	O
not	O	O
fecal	O	O
samples	O	O
.	O	O

Day	O	O
of	O	O
study	O	O
affected	O	O
ruminal	O	O
(	O	O
P	O	O
<	O	O
0.0001	O	O
)	O	O
but	O	O
not	O	O
fecal	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
methane-producing	O	O
and	O	O
nitroethane-reducing	O	O
activities	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
;	O	O
treatment	O	O
by	O	O
day	O	O
interactions	O	O
were	O	O
not	O	O
observed	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Ruminal	O	O
accumulations	O	O
of	O	O
acetate	O	O
decreased	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
in	O	O
2X-treated	O	O
steers	O	O
when	O	O
compared	O	O
with	O	O
0X-	O	O
and	O	O
1X-treated	O	O
steers	O	O
,	O	O
but	O	O
no	O	O
effect	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
of	O	O
nitroethane	O	O
was	O	O
observed	O	O
on	O	O
propionate	O	O
,	O	O
butyrate	O	O
or	O	O
the	O	O
acetate	O	O
to	O	O
propionate	O	O
ratio	O	O
.	O	O

Whole	O	O
animal	O	O
methane	O	O
emissions	O	O
,	O	O
expressed	O	O
as	O	O
L/day	O	O
or	O	O
as	O	O
a	O	O
proportion	O	O
of	O	O
gross	O	O
energy	O	O
intake	O	O
(	O	O
%	O	O
GEI	O	O
)	O	O
,	O	O
were	O	O
unaffected	O	O
by	O	O
nitroethane	O	O
treatment	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
,	O	O
and	O	O
were	O	O
not	O	O
correlated	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
with	O	O
ruminal	O	O
methane-producing	O	O
activity	O	O
.	O	O

These	O	O
results	O	O
demonstrate	O	O
that	O	O
oral	O	O
nitroethane	O	O
administration	O	O
reduces	O	O
ruminal	O	O
methane-producing	O	O
activity	O	O
but	O	O
suggest	O	O
that	O	O
a	O	O
microbial	O	O
adaptation	O	O
,	O	O
likely	O	O
due	O	O
to	O	O
an	O	O
in	O	O
situ	O	O
enrichment	O	O
of	O	O
ruminal	B-bacteria	B-bacteria
nitroethane-reducing	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
may	O	O
cause	O	O
depletion	O	O
of	O	O
nitroethane	O	O
,	O	O
at	O	O
least	O	O
at	O	O
the	O	O
1X	O	O
administration	O	O
dose	O	O
,	O	O
to	O	O
concentrations	O	O
too	O	O
low	O	O
to	O	O
be	O	O
effective	O	O
.	O	O

Further	O	O
research	O	O
is	O	O
warranted	O	O
to	O	O
determine	O	O
if	O	O
the	O	O
optimization	O	O
of	O	O
dosage	O	O
of	O	O
nitroethane	O	O
or	O	O
related	O	O
nitrocompouds	O	O
can	O	O
maintain	O	O
the	O	O
enteropathogen	O	O
control	O	O
and	O	O
anti-methanogen	O	O
effect	O	O
in	O	O
fed	O	O
steers	O	O
.	O	O

Involvement	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
can	O	O
occur	O	O
in	O	O
lepromatous	O	O
leprosy	O	O
;	O	O
however	O	O
,	O	O
lesions	O	O
in	O	O
the	O	O
oral	O	O
mucosa	O	O
of	O	O
paucibacillary	O	O
patients	O	O
have	O	O
not	O	O
been	O	O
previously	O	O
observed	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
determine	O	O
whether	O	O
clinical	O	O
and	O	O
subclinical	O	O
lesions	O	O
exist	O	O
in	O	O
oral	O	O
mucosa	O	O
in	O	O
nontreated	O	O
paucibacillary	O	O
leprosy	O	O
patients	O	O
,	O	O
using	O	O
clinical	O	O
and	O	O
histopathological	O	O
examination	O	O
.	O	O


A	O	O
clinical	O	O
and	O	O
histopathological	O	O
study	O	O
involving	O	O
30	O	O
untreated	O	O
paucibacillary	O	O
leprosy	O	O
patients	O	O
was	O	O
conducted	O	O
.	O	O

All	O	O
patients	O	O
underwent	O	O
biopsies	O	O
of	O	O
the	O	O
buccal	O	O
mucosa	O	O
,	O	O
soft	O	O
palate	O	O
,	O	O
and	O	O
tongue	O	O
.	O	O

When	O	O
acid-fast	B-bacteria	B-bacteria
bacilli	E-bacteria	I-bacteria
in	O	O
association	O	O
with	O	O
inflammatory	O	O
infiltrate	O	O
,	O	O
granulomatous	O	O
or	O	O
not	O	O
,	O	O
were	O	O
encountered	O	O
,	O	O
it	O	O
was	O	O
considered	O	O
``	O	O
specific	O	O
''	O	O
involvement	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
;	O	O
and	O	O
``	O	O
nonspecific	O	O
''	O	O
involvement	O	O
when	O	O
the	O	O
bacilli	B-bacteria	B-bacteria
were	O	O
not	O	O
encountered	O	O
.	O	O

Eight	O	O
nonspecific	O	O
chronic	O	O
inflammatory	O	O
reactions	O	O
and	O	O
1	O	O
granulomatous	O	O
inflammatory	O	O
process	O	O
without	O	O
acid-fast	B-bacteria	B-bacteria
bacilli	E-bacteria	I-bacteria
were	O	O
detected	O	O
.	O	O

Paucibacillary	O	O
leprosy	O	O
patients	O	O
do	O	O
not	O	O
exhibit	O	O
specific	O	O
,	O	O
clinical	O	O
or	O	O
subclinical	O	O
,	O	O
involvement	O	O
in	O	O
the	O	O
oral	O	O
mucosa	O	O
;	O	O
nonspecific	O	O
alterations	O	O
occur	O	O
even	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
signs	O	O
and	O	O
symptoms	O	O
.	O	O

The	O	O
bactericidal	O	O
efficacy	O	O
of	O	O
diode	O	O
lasers	O	O
has	O	O
already	O	O
been	O	O
demonstrated	O	O
in	O	O
vitro	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
reduction	O	O
of	O	O
aerobe	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
-	O	O
colonizing	O	O
rough	O	O
titanium	O	O
samples	O	O
in	O	O
biofilms	O	O
intraorally	O	O
grown	O	O
-	O	O
by	O	O
diode	O	O
lasers	O	O
of	O	O
different	O	O
wave	O	O
lengths	O	O
.	O	O

Twenty-two	O	O
volunteers	O	O
participated	O	O
in	O	O
the	O	O
trial	O	O
.	O	O

They	O	O
were	O	O
fitted	O	O
for	O	O
10	O	O
days	O	O
with	O	O
custom-made	O	O
intraoral	O	O
plastic	O	O
splints	O	O
carrying	O	O
titanium	O	O
sleeves	O	O
.	O	O

A	O	O
part	O	O
of	O	O
the	O	O
sleeves	O	O
was	O	O
then	O	O
irradiated	O	O
with	O	O
diode	O	O
lasers	O	O
in	O	O
different	O	O
modes	O	O
.	O	O

The	O	O
other	O	O
part	O	O
remained	O	O
non-irradiated	O	O
and	O	O
served	O	O
as	O	O
control	O	O
.	O	O

Directly	O	O
after	O	O
irradiation	O	O
,	O	O
the	O	O
sleeves	O	O
were	O	O
swabbed	O	O
and	O	O
the	O	O
gained	O	O
bacteria	O	O
were	O	O
first	O	O
examined	O	O
microscopically	O	O
and	O	O
then	O	O
were	O	O
cultured	O	O
under	O	O
aerobic	O	O
conditions	O	O
.	O	O

The	O	O
bacteria	O	O
in	O	O
the	O	O
controls	O	O
and	O	O
in	O	O
the	O	O
treated	O	O
samples	O	O
were	O	O
quantified	O	O
.	O	O

A	O	O
comparison	O	O
with	O	O
the	O	O
controls	O	O
revealed	O	O
a	O	O
marked	O	O
overall	O	O
reduction	O	O
of	O	O
bacterial	O	O
colonization	O	O
in	O	O
all	O	O
irradiated	O	O
sleeves	O	O
.	O	O

Continuous	O	O
irradiation	O	O
for	O	O
20	O	O
s	O	O
reduced	O	O
bacteria	O	O
counts	O	O
by	O	O
99.67	O	O
%	O	O
at	O	O
810	O	O
nm	O	O
and	O	O
99.58	O	O
%	O	O
at	O	O
980	O	O
nm	O	O
.	O	O

Repeating	O	O
the	O	O
20	O	O
s	O	O
exposure	O	O
five	O	O
times	O	O
reduced	O	O
counts	O	O
by	O	O
99.98	O	O
%	O	O
at	O	O
810	O	O
nm	O	O
and	O	O
by	O	O
99.39	O	O
%	O	O
at	O	O
980	O	O
nm	O	O
.	O	O

A	O	O
98.86	O	O
%	O	O
reduction	O	O
was	O	O
seen	O	O
after	O	O
irradiation	O	O
in	O	O
pulsed	O	O
mode	O	O
.	O	O

A	O	O
further	O	O
analysis	O	O
in	O	O
respect	O	O
of	O	O
different	O	O
isolated	O	O
bacteria	O	O
revealed	O	O
that	O	O
the	O	O
streptococci	B-bacteria	B-bacteria
group	E-bacteria	I-bacteria
was	O	O
reduced	O	O
by	O	O
99.29-99.99	O	O
%	O	O
,	O	O
while	O	O
the	O	O
staphylococci	B-bacteria	B-bacteria
group	E-bacteria	I-bacteria
was	O	O
reduced	O	O
to	O	O
a	O	O
lesser	O	O
extent	O	O
in	O	O
the	O	O
range	O	O
94.67-99.99	O	O
%	O	O
.	O	O

The	O	O
results	O	O
are	O	O
of	O	O
clinical	O	O
relevance	O	O
.	O	O

In	O	O
comparison	O	O
with	O	O
the	O	O
mean	O	O
bacterial	O	O
counts	O	O
of	O	O
the	O	O
untreated	O	O
samples	O	O
,	O	O
all	O	O
irradiation	O	O
programs	O	O
studied	O	O
in	O	O
this	O	O
investigation	O	O
reduced	O	O
mean	O	O
bacterial	O	O
colonization	O	O
in	O	O
a	O	O
biofilm	O	O
on	O	O
intraoral	O	O
rough	O	O
titanium	O	O
surfaces	O	O
by	O	O
more	O	O
than	O	O
98	O	O
%	O	O
.	O	O

The	O	O
actual	O	O
extent	O	O
of	O	O
reduction	O	O
was	O	O
dependent	O	O
on	O	O
the	O	O
bacteria	O	O
species	O	O
as	O	O
well	O	O
as	O	O
on	O	O
the	O	O
irradiation	O	O
mode	O	O
.	O	O

Under	O	O
physiological	O	O
conditions	O	O
,	O	O
matrix	O	O
metalloproteinases	O	O
(	O	O
MMPs	O	O
)	O	O
are	O	O
involved	O	O
in	O	O
the	O	O
remodeling	O	O
and	O	O
turnover	O	O
of	O	O
periodontal	O	O
tissue	O	O
and	O	O
their	O	O
activity	O	O
is	O	O
tightly	O	O
regulated	O	O
by	O	O
tissue	O	O
inhibitors	O	O
of	O	O
metalloproteinases	O	O
(	O	O
TIMPs	O	O
)	O	O
.	O	O

Disturbances	O	O
in	O	O
the	O	O
balance	O	O
between	O	O
MMPs	O	O
and	O	O
TIMPs	O	O
may	O	O
result	O	O
in	O	O
excessive	O	O
tissue	O	O
destruction	O	O
.	O	O

We	O	O
previously	O	O
used	O	O
an	O	O
engineered	O	O
human	O	O
oral	O	O
mucosa	O	O
(	O	O
EHOM	O	O
)	O	O
model	O	O
to	O	O
demonstrate	O	O
that	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
a	O	O
major	O	O
etiological	O	O
agent	O	O
of	O	O
periodontitis	O	O
,	O	O
infiltrates	O	O
connective	O	O
tissue	O	O
and	O	O
induces	O	O
significant	O	O
loss	O	O
of	O	O
attachment	O	O
of	O	O
the	O	O
stratified	O	O
epithelium	O	O
from	O	O
the	O	O
basement	O	O
membrane	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
effect	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
on	O	O
the	O	O
expression	O	O
and	O	O
production	O	O
of	O	O
MMP-2	O	O
,	O	O
MMP-9	O	O
,	O	O
TIMP-1	O	O
,	O	O
and	O	O
TIMP-2	O	O
by	O	O
oral	O	O
fibroblasts	O	O
and	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
EHOM	O	O
model	O	O
was	O	O
infected	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33277	E-bacteria	I-bacteria
or	O	O
its	O	O
derivative	O	O
gingipain-null	O	O
mutant	O	O
(	O	O
KDP128	O	O
)	O	O
for	O	O
different	O	O
periods	O	O
of	O	O
time	O	O
.	O	O

MMP	O	O
and	O	O
TIMP	O	O
mRNA	O	O
expression	O	O
was	O	O
evaluated	O	O
by	O	O
reverse	O	O
transcription-polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
RT-PCR	O	O
)	O	O
analysis	O	O
,	O	O
while	O	O
protein	O	O
secretion	O	O
into	O	O
the	O	O
culture	O	O
medium	O	O
was	O	O
assessed	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assays	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
significantly	O	O
up-regulated	O	O
MMP-2	O	O
and	O	O
MMP-9	O	O
mRNA	O	O
expression	O	O
by	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

This	O	O
MMP	O	O
gene	O	O
activation	O	O
was	O	O
paralleled	O	O
by	O	O
TIMP-2	O	O
gene	O	O
activation	O	O
.	O	O

However	O	O
,	O	O
only	O	O
MMP-9	O	O
mRNA	O	O
expression	O	O
was	O	O
significantly	O	O
enhanced	O	O
by	O	O
the	O	O
gingipain-null	O	O
mutant	O	O
.	O	O

At	O	O
8	O	O
and	O	O
24	O	O
h	O	O
post-infection	O	O
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
increased	O	O
significantly	O	O
the	O	O
MMP-9	O	O
protein	O	O
level	O	O
compared	O	O
to	O	O
the	O	O
uninfected	O	O
EHOM	O	O
model	O	O
.	O	O

The	O	O
present	O	O
study	O	O
reports	O	O
the	O	O
ability	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
to	O	O
regulate	O	O
MMP	O	O
and	O	O
TIMP	O	O
production	O	O
by	O	O
oral	O	O
cells	O	O
,	O	O
a	O	O
phenomenon	O	O
that	O	O
may	O	O
contribute	O	O
to	O	O
tissue	O	O
destruction	O	O
.	O	O

Nail	O	O
biting	O	O
is	O	O
a	O	O
common	O	O
oral	O	O
habit	O	O
in	O	O
children	O	O
and	O	O
young	O	O
adults	O	O
.	O	O

However	O	O
,	O	O
its	O	O
effect	O	O
on	O	O
the	O	O
oral	O	O
carriage	O	O
of	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
is	O	O
unclear	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
differences	O	O
in	O	O
prevalence	O	O
of	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
in	O	O
saliva	O	O
samples	O	O
from	O	O
subjects	O	O
with	O	O
and	O	O
without	O	O
a	O	O
nail-biting	O	O
habit	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
25	O	O
subjects	O	O
who	O	O
were	O	O
nail-biters	O	O
and	O	O
34	O	O
subjects	O	O
with	O	O
no	O	O
oral	O	O
habit	O	O
.	O	O

The	O	O
mean	O	O
chronological	O	O
age	O	O
for	O	O
all	O	O
subjects	O	O
was	O	O
13.5	O	O
+/-	O	O
1.9	O	O
years	O	O
.	O	O

The	O	O
saliva	O	O
samples	O	O
were	O	O
studied	O	O
microbiologically	O	O
.	O	O

A	O	O
Pearson	O	O
chi-squared	O	O
test	O	O
was	O	O
performed	O	O
to	O	O
compare	O	O
the	O	O
prevalence	O	O
of	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
in	O	O
the	O	O
saliva	O	O
samples	O	O
of	O	O
the	O	O
subjects	O	O
with	O	O
and	O	O
without	O	O
nail-biting	O	O
habits	O	O
.	O	O

Statistically	O	O
significant	O	O
differences	O	O
were	O	O
found	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
total	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
between	O	O
both	O	O
groups	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Enterobacter	B-bacteria	B-bacteria
aerogenes	E-bacteria	I-bacteria
,	O	O
Enterobacter	B-bacteria	B-bacteria
cloacae	E-bacteria	I-bacteria
and	O	O
Enterobacter	B-bacteria	B-bacteria
gergoviae	E-bacteria	I-bacteria
were	O	O
found	O	O
in	O	O
the	O	O
saliva	O	O
samples	O	O
of	O	O
19	O	O
of	O	O
the	O	O
25	O	O
nail-biting	O	O
subjects	O	O
(	O	O
76	O	O
%	O	O
)	O	O
,	O	O
whereas	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
E.	B-bacteria	B-bacteria
aerogenes	E-bacteria	I-bacteria
and	O	O
E.	B-bacteria	B-bacteria
cloacae	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
the	O	O
saliva	O	O
samples	O	O
of	O	O
only	O	O
nine	O	O
of	O	O
the	O	O
34	O	O
subjects	O	O
who	O	O
were	O	O
not	O	O
nail-biters	O	O
(	O	O
26.5	O	O
%	O	O
)	O	O
.	O	O

According	O	O
to	O	O
the	O	O
results	O	O
of	O	O
the	O	O
present	O	O
study	O	O
,	O	O
the	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
were	O	O
more	O	O
prevalent	O	O
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
children	O	O
with	O	O
nail-biting	O	O
habits	O	O
than	O	O
in	O	O
children	O	O
with	O	O
no	O	O
oral	O	O
habit	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
eradication	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
more	O	O
difficult	O	O
than	O	O
from	O	O
the	O	O
stomach	O	O
.	O	O

Thus	O	O
,	O	O
if	O	O
the	O	O
bacterium	O	O
survives	O	O
the	O	O
antibacterial	O	O
therapy	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
it	O	O
would	O	O
be	O	O
able	O	O
to	O	O
re-infect	O	O
the	O	O
stomach	O	O
within	O	O
a	O	O
few	O	O
weeks	O	O
.	O	O

Since	O	O
oral	O	O
health	O	O
status	O	O
could	O	O
correspond	O	O
to	O	O
oral	O	O
infection	O	O
with	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
the	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
whether	O	O
oral	O	O
health	O	O
and	O	O
oral	O	O
hygiene	O	O
practices	O	O
affect	O	O
the	O	O
efficacy	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
eradication	O	O
from	O	O
the	O	O
stomach	O	O
.	O	O

The	O	O
study	O	O
was	O	O
performed	O	O
in	O	O
137	O	O
patients	O	O
with	O	O
peptic	O	O
ulcer	O	O
who	O	O
had	O	O
undergone	O	O
a	O	O
7-day	O	O
course	O	O
of	O	O
eradication	O	O
treatment	O	O
with	O	O
one	O	O
of	O	O
two	O	O
sets	O	O
of	O	O
drugs	O	O
:	O	O
1	O	O
,	O	O
omeprazole	O	O
,	O	O
amoxicillin	O	O
,	O	O
and	O	O
tinidazole	O	O
or	O	O
2	O	O
,	O	O
omeprazole	O	O
,	O	O
clarithromycin	O	O
,	O	O
and	O	O
tinidazole	O	O
.	O	O

The	O	O
efficacy	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
eradication	O	O
from	O	O
the	O	O
stomach	O	O
was	O	O
evaluated	O	O
at	O	O
the	O	O
second	O	O
gastroscopy	O	O
4	O	O
weeks	O	O
after	O	O
cessation	O	O
of	O	O
eradication	O	O
therapy	O	O
by	O	O
means	O	O
of	O	O
two	O	O
methods	O	O
:	O	O
rapid	O	O
urease	O	O
test	O	O
and	O	O
histology	O	O
.	O	O

The	O	O
examination	O	O
of	O	O
natural	O	O
dentition	O	O
and	O	O
prosthetic	O	O
restorations	O	O
as	O	O
well	O	O
as	O	O
the	O	O
assessment	O	O
of	O	O
hygienic	O	O
procedures	O	O
referring	O	O
to	O	O
natural	O	O
dentition	O	O
and	O	O
dentures	O	O
accompanied	O	O
the	O	O
second	O	O
gastroscopy	O	O
.	O	O

No	O	O
association	O	O
was	O	O
found	O	O
between	O	O
the	O	O
efficacy	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
eradication	O	O
from	O	O
the	O	O
stomach	O	O
and	O	O
the	O	O
number	O	O
of	O	O
natural	O	O
teeth	O	O
,	O	O
decayed	O	O
teeth	O	O
,	O	O
use	O	O
of	O	O
dentures	O	O
,	O	O
debris	O	O
index	O	O
,	O	O
or	O	O
periodontal	O	O
index	O	O
.	O	O

However	O	O
,	O	O
an	O	O
association	O	O
between	O	O
eradication	O	O
success	O	O
and	O	O
some	O	O
oral	O	O
hygiene	O	O
procedures	O	O
were	O	O
noted	O	O
.	O	O

Unexpectedly	O	O
,	O	O
in	O	O
patients	O	O
treated	O	O
with	O	O
omeprazole	O	O
,	O	O
amoxicillin	O	O
and	O	O
tinidazole	O	O
,	O	O
the	O	O
removal	O	O
of	O	O
dental	O	O
prosthesis	O	O
for	O	O
the	O	O
night	O	O
and	O	O
brushing	O	O
the	O	O
natural	O	O
teeth	O	O
twice	O	O
a	O	O
day	O	O
or	O	O
more	O	O
reduced	O	O
the	O	O
efficacy	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
eradication	O	O
from	O	O
the	O	O
stomach	O	O
.	O	O

Oral	O	O
health	O	O
and	O	O
oral	O	O
hygiene	O	O
practices	O	O
seem	O	O
unlikely	O	O
to	O	O
increase	O	O
the	O	O
efficacy	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
eradication	O	O
from	O	O
the	O	O
stomach	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
)	O	O
is	O	O
an	O	O
important	O	O
pathogen	O	O
in	O	O
gastritis	O	O
,	O	O
peptic	O	O
ulcer	O	O
and	O	O
possibly	O	O
gastric	O	O
cancer	O	O
,	O	O
but	O	O
several	O	O
questions	O	O
remain	O	O
unanswered	O	O
.	O	O

Particularly	O	O
how	O	O
the	O	O
organism	O	O
is	O	O
transmitted	O	O
and	O	O
what	O	O
is	O	O
the	O	O
relationship	O	O
between	O	O
oral	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
and	O	O
the	O	O
gastric	O	O
infection	O	O
.	O	O

Accordingly	O	O
,	O	O
we	O	O
aimed	O	O
to	O	O
characterize	O	O
the	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
cavity	O	O
and	O	O
to	O	O
evaluate	O	O
its	O	O
relationship	O	O
to	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
.	O	O

Out	O	O
of	O	O
total	O	O
100	O	O
screened	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
female	O	O
subjects	O	O
(	O	O
40	O	O
to	O	O
85	O	O
y	O	O
)	O	O
,	O	O
49	O	O
patients	O	O
(	O	O
pts	O	O
)	O	O
,	O	O
who	O	O
had	O	O
positive	O	O
C-urea	O	O
breath	O	O
test	O	O
(	O	O
UBT	O	O
)	O	O
and	O	O
dyspeptic	O	O
symptoms	O	O
,	O	O
agreed	O	O
for	O	O
1	O	O
week	O	O
regimen	O	O
of	O	O
triple	O	O
anti-H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
therapy	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
cavity	O	O
was	O	O
assessed	O	O
using	O	O
bacterial	O	O
culture	O	O
from	O	O
saliva	O	O
and	O	O
gingival	O	O
pockets	O	O
.	O	O

Gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
was	O	O
estimated	O	O
using	O	O
capsulated	O	O
C-urea	O	O
breath	O	O
test	O	O
and	O	O
plasma	O	O
anti-H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
IgG	O	O
and	O	O
saliva	O	O
IgA	O	O
antibodies	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
plasma	O	O
gastrin	O	O
,	O	O
ghrelin	O	O
,	O	O
and	O	O
pepsinogen	O	O
I	O	O
were	O	O
measured	O	O
by	O	O
radioimmunoassay	O	O
.	O	O

In	O	O
selected	O	O
patients	O	O
,	O	O
gastroscopy	O	O
was	O	O
additionally	O	O
performed	O	O
and	O	O
gastric	O	O
biopsy	O	O
samples	O	O
were	O	O
taken	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
random	O	O
amplification	O	O
of	O	O
polymorphic	O	O
DNA	O	O
genetic	O	O
profiling	O	O
.	O	O

The	O	O
triple	O	O
therapy	O	O
resulted	O	O
in	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
eradication	O	O
in	O	O
79	O	O
%	O	O
pts	O	O
,	O	O
along	O	O
with	O	O
significant	O	O
decrease	O	O
of	O	O
plasma	O	O
gastrin	O	O
combined	O	O
with	O	O
an	O	O
increase	O	O
in	O	O
plasma	O	O
ghrelin	O	O
and	O	O
pepsinogen	O	O
I	O	O
(	O	O
PgI	O	O
)	O	O
levels	O	O
and	O	O
a	O	O
marked	O	O
alleviation	O	O
of	O	O
dyspeptic	O	O
symptoms	O	O
.	O	O

In	O	O
contrast	O	O
to	O	O
gastric	O	O
effects	O	O
,	O	O
the	O	O
eradication	O	O
therapy	O	O
failed	O	O
to	O	O
cause	O	O
any	O	O
changes	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
cavity	O	O
.	O	O

Moreover	O	O
no	O	O
relationship	O	O
was	O	O
observed	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
eradication	O	O
.	O	O

In	O	O
line	O	O
with	O	O
these	O	O
findings	O	O
,	O	O
no	O	O
relationship	O	O
between	O	O
gastric	O	O
and	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
found	O	O
using	O	O
genetic	O	O
profiling	O	O
by	O	O
random	O	O
amplification	O	O
of	O	O
polymorphic	O	O
DNA	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
detected	O	O
both	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
stomach	O	O
but	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
had	O	O
no	O	O
relation	O	O
to	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
and	O	O
remained	O	O
unaffected	O	O
by	O	O
eradication	O	O
of	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	B-bacteria	B-bacteria
.	O	O

Structure	O	O
of	O	O
bacterial	O	O
microflora	O	O
of	O	O
periodontal	O	O
pocket	O	O
using	O	O
classical	O	O
cultural	O	O
and	O	O
molecular	O	O
genetic	O	O
methods	O	O
(	O	O
PCR	O	O
and	O	O
RT-PCR	O	O
assays	O	O
)	O	O
was	O	O
studied	O	O
in	O	O
patients	O	O
with	O	O
chronic	O	O
generalized	O	O
severe	O	O
or	O	O
intermediate	O	O
periodontitis	O	O
in	O	O
acute	O	O
phase	O	O
and	O	O
in	O	O
healthy	O	O
subjects	O	O
.	O	O

Structure	O	O
of	O	O
viral	O	O
and	O	O
fungal	O	O
microflora	O	O
using	O	O
PCR	O	O
or	O	O
ELISA	O	O
assays	O	O
was	O	O
studied	O	O
also	O	O
.	O	O

Markers	O	O
of	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
B.	B-bacteria	B-bacteria
forsithus	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
actinomicetemcommitans	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
were	O	O
detected	O	O
with	O	O
different	O	O
rates	O	O
.	O	O

Rate	O	O
of	O	O
detection	O	O
of	O	O
pigment-forming	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
significantly	O	O
higher	O	O
when	O	O
PCR	O	O
assay	O	O
was	O	O
used	O	O
compared	O	O
with	O	O
traditional	O	O
bacteriologic	O	O
method	O	O
.	O	O

Detection	O	O
rate	O	O
of	O	O
Candida	O	O
albicans	O	O
DNA	O	O
in	O	O
tooth-gingival	O	O
fluid	O	O
was	O	O
virtually	O	O
not	O	O
different	O	O
from	O	O
one	O	O
when	O	O
cultural	O	O
method	O	O
was	O	O
used	O	O
.	O	O

PCR	O	O
assay	O	O
is	O	O
recommended	O	O
as	O	O
laboratory	O	O
method	O	O
for	O	O
detection	O	O
of	O	O
DNA	O	O
of	O	O
microorganisms	O	O
associated	O	O
with	O	O
inflammatory	O	O
diseases	O	O
of	O	O
oral	O	O
mucosa	O	O
and	O	O
periodontium	O	O
.	O	O

Trauma	O	O
intensive	O	O
care	O	O
unit	O	O
(	O	O
TICU	O	O
)	O	O
patients	O	O
requiring	O	O
mechanical	O	O
respiratory	O	O
support	O	O
frequently	O	O
develop	O	O
ventilator-associated	O	O
pneumonia	O	O
(	O	O
VAP	O	O
)	O	O
.	O	O

Oral	O	O
and	O	O
oropharyngeal	O	O
bacteria	O	O
are	O	O
believed	O	O
to	O	O
be	O	O
responsible	O	O
for	O	O
many	O	O
cases	O	O
of	O	O
VAP	O	O
,	O	O
but	O	O
definitive	O	O
evidence	O	O
of	O	O
this	O	O
relationship	O	O
is	O	O
lacking	O	O
.	O	O

Earlier	O	O
studies	O	O
used	O	O
conventional	O	O
culture-based	O	O
methods	O	O
for	O	O
identification	O	O
of	O	O
bacterial	O	O
pathogens	O	O
,	O	O
but	O	O
these	O	O
methods	O	O
are	O	O
insufficient	O	O
,	O	O
as	O	O
some	O	O
bacteria	O	O
may	O	O
be	O	O
uncultivable	O	O
or	O	O
difficult	O	O
to	O	O
grow	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
use	O	O
a	O	O
culture-independent	O	O
molecular	O	O
approach	O	O
to	O	O
analyze	O	O
and	O	O
compare	O	O
the	O	O
bacterial	O	O
species	O	O
colonizing	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
lungs	O	O
of	O	O
TICU	O	O
patients	O	O
who	O	O
developed	O	O
VAP	O	O
.	O	O

Bacterial	O	O
samples	O	O
were	O	O
acquired	O	O
from	O	O
the	O	O
dorsal	O	O
tongue	O	O
and	O	O
bronchoalveolar	O	O
lavage	O	O
fluid	O	O
of	O	O
16	O	O
patients	O	O
.	O	O

Bacterial	O	O
DNA	O	O
was	O	O
extracted	O	O
,	O	O
and	O	O
the	O	O
16S	O	O
rRNA	O	O
genes	O	O
were	O	O
PCR	O	O
amplified	O	O
,	O	O
cloned	O	O
into	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
and	O	O
sequenced	O	O
.	O	O

The	O	O
sequencing	O	O
data	O	O
revealed	O	O
the	O	O
following	O	O
:	O	O
(	O	O
i	O	O
)	O	O
a	O	O
wide	O	O
diversity	O	O
of	O	O
bacterial	O	O
species	O	O
in	O	O
both	O	O
the	O	O
oral	O	O
and	O	O
pulmonary	O	O
sites	O	O
,	O	O
some	O	O
of	O	O
them	O	O
novel	O	O
;	O	O
(	O	O
ii	O	O
)	O	O
known	O	O
and	O	O
putative	O	O
respiratory	O	O
pathogens	O	O
colonizing	O	O
both	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
lungs	O	O
of	O	O
14	O	O
patients	O	O
;	O	O
and	O	O
(	O	O
iii	O	O
)	O	O
a	O	O
number	O	O
of	O	O
bacterial	O	O
pathogens	O	O
(	O	O
e.g.	O	O
,	O	O
Dialister	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
segnis	E-bacteria	I-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
morbillorum	E-bacteria	I-bacteria
,	O	O
and	O	O
Pseudomonas	B-bacteria	B-bacteria
fluorescens	E-bacteria	I-bacteria
)	O	O
in	O	O
lung	O	O
samples	O	O
that	O	O
had	O	O
not	O	O
been	O	O
reported	O	O
previously	O	O
at	O	O
this	O	O
site	O	O
when	O	O
culture-based	O	O
methods	O	O
were	O	O
used	O	O
.	O	O

Our	O	O
data	O	O
indicate	O	O
that	O	O
the	O	O
dorsal	O	O
surface	O	O
of	O	O
the	O	O
tongue	O	O
serves	O	O
as	O	O
a	O	O
potential	O	O
reservoir	O	O
for	O	O
bacterial	O	O
species	O	O
involved	O	O
in	O	O
VAP	O	O
.	O	O

Furthermore	O	O
,	O	O
it	O	O
is	O	O
clear	O	O
that	O	O
the	O	O
diversity	O	O
of	O	O
bacterial	O	O
pathogens	O	O
for	O	O
VAP	O	O
is	O	O
far	O	O
more	O	O
complex	O	O
than	O	O
the	O	O
current	O	O
literature	O	O
suggests	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
cross-sectional	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
periodontal	O	O
status	O	O
and	O	O
oral	O	O
microbiological	O	O
patterns	O	O
of	O	O
a	O	O
population	O	O
with	O	O
end-stage	O	O
renal	O	O
disease	O	O
(	O	O
ESRD	O	O
)	O	O
,	O	O
undergoing	O	O
haemodialysis	O	O
(	O	O
HD	O	O
)	O	O
.	O	O

This	O	O
was	O	O
a	O	O
cross-sectional	O	O
study	O	O
,	O	O
involving	O	O
52	O	O
patients	O	O
from	O	O
the	O	O
Nephrology	O	O
Department	O	O
and	O	O
52	O	O
matched	O	O
control	O	O
subjects	O	O
.	O	O


The	O	O
subjects	O	O
had	O	O
a	O	O
periodontal	O	O
clinical	O	O
examination	O	O
;	O	O
subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
taken	O	O
and	O	O
analysed	O	O
using	O	O
a	O	O
semiquantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
test	O	O
to	O	O
detect	O	O
Porphyromas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
and	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

Subgingival	O	O
plaque	O	O
and	O	O
saliva	O	O
samples	O	O
were	O	O
studied	O	O
for	O	O
Candida	O	O
and	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
.	O	O

Most	O	O
of	O	O
the	O	O
104	O	O
subjects	O	O
had	O	O
some	O	O
degree	O	O
of	O	O
loss	O	O
of	O	O
periodontal	O	O
attachment	O	O
(	O	O
LPA	O	O
)	O	O
>	O	O
or	O	O
=3	O	O
mm	O	O
[	O	O
11	O	O
(	O	O
10.5	O	O
%	O	O
)	O	O
had	O	O
severe	O	O
LPA	O	O
;	O	O
16	O	O
(	O	O
15.4	O	O
%	O	O
)	O	O
moderate	O	O
LPA	O	O
;	O	O
and	O	O
64	O	O
(	O	O
61.5	O	O
%	O	O
)	O	O
mild	O	O
LPA	O	O
]	O	O
.	O	O

Only	O	O
13	O	O
subjects	O	O
(	O	O
12.5	O	O
%	O	O
)	O	O
presented	O	O
good	O	O
periodontal	O	O
health	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
differences	O	O
were	O	O
found	O	O
between	O	O
the	O	O
HD	O	O
patients	O	O
and	O	O
the	O	O
control	O	O
group	O	O
regarding	O	O
bleeding	O	O
index	O	O
,	O	O
number	O	O
of	O	O
teeth	O	O
,	O	O
or	O	O
percentage	O	O
of	O	O
LPA	O	O
>	O	O
or	O	O
=3	O	O
mm	O	O
.	O	O

However	O	O
,	O	O
a	O	O
statistically	O	O
significant	O	O
difference	O	O
was	O	O
seen	O	O
in	O	O
the	O	O
degree	O	O
of	O	O
oral	O	O
hygiene	O	O
.	O	O

On	O	O
the	O	O
basis	O	O
of	O	O
the	O	O
findings	O	O
presented	O	O
here	O	O
,	O	O
we	O	O
can	O	O
not	O	O
associate	O	O
ESRD	O	O
with	O	O
more	O	O
severe	O	O
periodontal	O	O
destruction	O	O
.	O	O

Although	O	O
HD	O	O
patients	O	O
presented	O	O
a	O	O
higher	O	O
number	O	O
of	O	O
periodontopathic	O	O
microorganisms	O	O
than	O	O
the	O	O
matched	O	O
controls	O	O
,	O	O
a	O	O
prolonged	O	O
duration	O	O
of	O	O
HD	O	O
did	O	O
not	O	O
bear	O	O
a	O	O
statistically	O	O
significant	O	O
relationship	O	O
with	O	O
the	O	O
percentage	O	O
of	O	O
sites	O	O
with	O	O
LPA	O	O
>	O	O
or	O	O
=3	O	O
mm	O	O
,	O	O
specific	O	O
microbiota	O	O
or	O	O
composition	O	O
of	O	O
biofilm	O	O
.	O	O

To	O	O
study	O	O
the	O	O
short-term	O	O
microbiological	O	O
changes	O	O
following	O	O
full-mouth	O	O
compared	O	O
with	O	O
quadrant	O	O
wise	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
(	O	O
FMRP	O	O
and	O	O
QRP	O	O
)	O	O
as	O	O
well	O	O
as	O	O
long-term	O	O
effects	O	O
.	O	O

Twenty	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
were	O	O
randomized	O	O
into	O	O
a	O	O
test	O	O
group	O	O
treated	O	O
in	O	O
two	O	O
sessions	O	O
with	O	O
subgingival	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
within	O	O
24	O	O
h	O	O
(	O	O
FMRP	O	O
)	O	O
and	O	O
a	O	O
control	O	O
group	O	O
treated	O	O
quadrant	O	O
by	O	O
quadrant	O	O
in	O	O
four	O	O
sessions	O	O
at	O	O
intervals	O	O
of	O	O
one	O	O
week	O	O
(	O	O
QRP	O	O
)	O	O
.	O	O

Microbiological	O	O
samples	O	O
were	O	O
taken	O	O
in	O	O
the	O	O
two	O	O
deepest	O	O
pockets	O	O
of	O	O
the	O	O
maxillary	O	O
right	O	O
quadrant	O	O
immediately	O	O
before	O	O
treatment	O	O
and	O	O
after	O	O
1	O	O
day	O	O
,	O	O
1	O	O
,	O	O
2	O	O
,	O	O
4	O	O
,	O	O
8	O	O
,	O	O
12	O	O
,	O	O
and	O	O
24	O	O
weeks	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
evaluated	O	O
by	O	O
real-time	O	O
PCR	O	O
for	O	O
quantification	O	O
of	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ssp.	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
as	O	O
well	O	O
as	O	O
for	O	O
total	O	O
bacterial	O	O
counts	O	O
(	O	O
TBC	O	O
)	O	O
.	O	O

Treatment	O	O
resulted	O	O
in	O	O
a	O	O
TBC	O	O
median	O	O
log	O	O
reduction	O	O
of	O	O
0.75	O	O
(	O	O
FMRP	O	O
)	O	O
and	O	O
0.72	O	O
(	O	O
QRP	O	O
)	O	O
.	O	O

There	O	O
were	O	O
no	O	O
differences	O	O
between	O	O
groups	O	O
either	O	O
for	O	O
the	O	O
short	O	O
term	O	O
(	O	O
1	O	O
day-4	O	O
weeks	O	O
)	O	O
(	O	O
analysis	O	O
of	O	O
variance	O	O
:	O	O
p=0.3150	O	O
)	O	O
or	O	O
for	O	O
long	O	O
term	O	O
(	O	O
4-24	O	O
weeks	O	O
)	O	O
(	O	O
analysis	O	O
of	O	O
variance	O	O
:	O	O
p=0.9671	O	O
)	O	O
.	O	O

Likewise	O	O
,	O	O
no	O	O
differences	O	O
were	O	O
detected	O	O
for	O	O
selected	O	O
target	O	O
bacteria	O	O
.	O	O

The	O	O
results	O	O
of	O	O
the	O	O
present	O	O
study	O	O
showed	O	O
similar	O	O
microbiological	O	O
outcomes	O	O
following	O	O
both	O	O
treatment	O	O
modalities	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
characterize	O	O
the	O	O
lactobacilli	B-bacteria	B-bacteria
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
as	O	O
a	O	O
potential	O	O
source	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
four	O	O
different	O	O
locations	O	O
within	O	O
the	O	O
oral	O	O
cavity	O	O
:	O	O
surface	O	O
of	O	O
healthy	O	O
tooth	O	O
,	O	O
oral	O	O
mucous	O	O
membrane	O	O
,	O	O
surface	O	O
of	O	O
tooth	O	O
decay	O	O
and	O	O
deep	O	O
tooth	O	O
decay	O	O
.	O	O

On	O	O
the	O	O
basis	O	O
of	O	O
morphological	O	O
and	O	O
biochemical	O	O
properties	O	O
eight	O	O
categories	O	O
were	O	O
formed	O	O
and	O	O
26	O	O
isolates	O	O
were	O	O
selected	O	O
for	O	O
further	O	O
characterization	O	O
.	O	O

The	O	O
isolates	O	O
were	O	O
determined	O	O
as	O	O
Lactobacillus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

using	O	O
primers	O	O
specific	O	O
for	O	O
16S	O	O
rDNA	O	O
.	O	O

Sequencing	O	O
of	O	O
16S	O	O
rDNA	O	O
genes	O	O
and	O	O
repetitive	O	O
sequence-based	O	O
polymerase	O	O
chain	O	O
reactions	O	O
were	O	O
used	O	O
for	O	O
determination	O	O
to	O	O
species	O	O
and	O	O
subspecies	O	O
levels	O	O
.	O	O

Predominant	O	O
species	O	O
were	O	O
Lactobacillus	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

paracasei	E-bacteria	I-bacteria
,	O	O
while	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
cellobiosus	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
delbrueckii	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

lactis	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
were	O	O
also	O	O
present	O	O
.	O	O

The	O	O
isolates	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
BGHO1	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
fermentum	I-bacteria	I-bacteria
BGHO36	E-bacteria	I-bacteria
and	O	O
BGHO64	B-bacteria	B-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	I-bacteria	I-bacteria
BGHO89	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
delbrueckii	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

lactis	I-bacteria	I-bacteria
BGHO99	E-bacteria	I-bacteria
exhibited	O	O
antagonistic	O	O
action	O	O
on	O	O
the	O	O
growth	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
Micrococcus	B-bacteria	B-bacteria
flavus	E-bacteria	I-bacteria
,	O	O
Salmonella	O	O
enteritidis	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
on	O	O
growth	O	O
of	O	O
Candida	O	O
albicans	O	O
.	O	O

Moreover	O	O
,	O	O
the	O	O
isolates	O	O
L.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
BGHO1	E-bacteria	I-bacteria
and	O	O
L.	B-bacteria	B-bacteria
gasseri	I-bacteria	I-bacteria
BGHO89	E-bacteria	I-bacteria
were	O	O
tolerant	O	O
to	O	O
low	O	O
pH	O	O
and	O	O
high	O	O
concentration	O	O
of	O	O
bile	O	O
salts	O	O
.	O	O

Taken	O	O
together	O	O
,	O	O
these	O	O
findings	O	O
imply	O	O
that	O	O
L.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
BGHO1	E-bacteria	I-bacteria
and	O	O
L.	B-bacteria	B-bacteria
gasseri	I-bacteria	I-bacteria
BGHO89	E-bacteria	I-bacteria
might	O	O
be	O	O
subjects	O	O
for	O	O
additional	O	O
investigation	O	O
as	O	O
potential	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
.	O	O

The	O	O
bacteriocin	O	O
producer	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
is	O	O
used	O	O
as	O	O
a	O	O
probiotic	B-bacteria	B-bacteria
targeting	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
so	O	O
our	O	O
study	O	O
aimed	O	O
to	O	O
assess	O	O
whether	O	O
its	O	O
dispersal	O	O
and	O	O
persistence	O	O
could	O	O
be	O	O
monitored	O	O
using	O	O
real-time	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

To	O	O
this	O	O
end	O	O
,	O	O
we	O	O
designed	O	O
polymerase	O	O
chain	O	O
reaction	O	O
primers	O	O
and	O	O
a	O	O
hybridization	O	O
probe	O	O
specifically	O	O
targeting	O	O
salA	O	O
,	O	O
which	O	O
encodes	O	O
for	O	O
the	O	O
prepropeptide	O	O
of	O	O
salivaricin	O	O
A	O	O
.	O	O

Using	O	O
a	O	O
single	O	O
individual	O	O
as	O	O
our	O	O
subject	O	O
,	O	O
we	O	O
administered	O	O
four	O	O
lozenges	O	O
of	O	O
K12	B-bacteria	B-bacteria
Throat	O	O
Guard	O	O
per	O	O
day	O	O
over	O	O
3	O	O
days	O	O
,	O	O
then	O	O
measured	O	O
salA	O	O
gene	O	O
levels	O	O
for	O	O
16	O	O
different	O	O
oral	O	O
sites	O	O
at	O	O
six	O	O
different	O	O
intervals	O	O
over	O	O
35	O	O
days	O	O
.	O	O

Four	O	O
samples	O	O
each	O	O
from	O	O
gingival	O	O
sulci	O	O
and	O	O
from	O	O
teeth	O	O
all	O	O
remained	O	O
negative	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
in	O	O
saliva	O	O
and	O	O
at	O	O
all	O	O
mucosal	O	O
membranes	O	O
K12	B-bacteria	B-bacteria
was	O	O
detected	O	O
,	O	O
but	O	O
with	O	O
varying	O	O
amounts	O	O
and	O	O
time	O	O
profiles	O	O
.	O	O

Relatively	O	O
high	O	O
salA	O	O
gene	O	O
copy	O	O
numbers	O	O
,	O	O
calibrated	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
colony-forming	O	O
units	O	O
,	O	O
were	O	O
seen	O	O
on	O	O
the	O	O
tongue	O	O
(	O	O
maximum	O	O
4.6	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
/swab	O	O
at	O	O
day	O	O
4	O	O
)	O	O
,	O	O
in	O	O
stimulated	O	O
saliva	O	O
(	O	O
2.4	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
/ml	O	O
,	O	O
day	O	O
4	O	O
)	O	O
and	O	O
on	O	O
buccal	O	O
membranes	O	O
(	O	O
1.3	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
/swab	O	O
,	O	O
day	O	O
8	O	O
)	O	O
.	O	O

K12	O	O
was	O	O
present	O	O
on	O	O
both	O	O
sides	O	O
of	O	O
the	O	O
pharynx	O	O
but	O	O
asymmetrically	O	O
in	O	O
both	O	O
quantity	O	O
and	O	O
duration	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
we	O	O
have	O	O
developed	O	O
a	O	O
real-time	O	O
quantitative-polymerase	O	O
chain	O	O
reaction	O	O
for	O	O
counting	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
at	O	O
various	O	O
sites	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
the	O	O
individual	O	O
studied	O	O
,	O	O
K12	B-bacteria	B-bacteria
could	O	O
be	O	O
detected	O	O
at	O	O
the	O	O
mucosal	O	O
membranes	O	O
for	O	O
as	O	O
long	O	O
as	O	O
3	O	O
weeks	O	O
,	O	O
but	O	O
with	O	O
steadily	O	O
decreasing	O	O
numbers	O	O
after	O	O
day	O	O
8	O	O
.	O	O

Thus	O	O
,	O	O
K12	B-bacteria	B-bacteria
may	O	O
have	O	O
the	O	O
potential	O	O
to	O	O
control	O	O
oral	O	O
bacterial	O	O
infections	O	O
only	O	O
when	O	O
the	O	O
uptake	O	O
is	O	O
repeated	O	O
frequently	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
pro-inflammatory	O	O
cytokines	O	O
to	O	O
promote	O	O
coagulation	O	O
prompted	O	O
the	O	O
hypothesis	O	O
that	O	O
pro-inflammatory	O	O
cytokines	O	O
induced	O	O
by	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
might	O	O
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
viridans	O	O
endocarditis	O	O
.	O	O

We	O	O
used	O	O
supernatant	O	O
fluids	O	O
from	O	O
peripheral	O	O
blood	O	O
mononuclear	O	O
monocyte	O	O
(	O	O
PBMC	O	O
)	O	O
cultures	O	O
,	O	O
stimulated	O	O
for	O	O
just	O	O
4-6	O	O
hrs	O	O
with	O	O
representative	O	O
streptococcal	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
,	O	O
to	O	O
study	O	O
cytokines	O	O
that	O	O
promoted	O	O
endothelial	O	O
tissue	O	O
factor	O	O
(	O	O
TF	O	O
)	O	O
activity	O	O
.	O	O

Neutralizing	O	O
antibodies	O	O
demonstrated	O	O
that	O	O
interleukin-1beta	O	O
(	O	O
IL-1beta	O	O
)	O	O
was	O	O
a	O	O
major	O	O
early	O	O
endothelial	O	O
TF	O	O
inducer	O	O
,	O	O
and	O	O
that	O	O
recombinant	O	O
IL-1beta	O	O
was	O	O
comparable	O	O
with	O	O
the	O	O
supernatant	O	O
fluid	O	O
in	O	O
activity	O	O
.	O	O

IL-1beta-rich	O	O
supernatant	O	O
fluids	O	O
from	O	O
oral	O	O
streptococci-stimulated	O	O
or	O	O
lipopolysaccharide-stimulated	O	O
PBMC	O	O
cultures	O	O
up-regulated	O	O
the	O	O
expression	O	O
of	O	O
endothelial	O	O
ICAM-1	O	O
and	O	O
E-selectin	O	O
.	O	O

These	O	O
molecules	O	O
could	O	O
help	O	O
trap	O	O
TF-producing	O	O
monocytes	O	O
or	O	O
dendritic	O	O
cells	O	O
bearing	O	O
streptococci	B-bacteria	B-bacteria
at	O	O
the	O	O
site	O	O
.	O	O

Thus	O	O
,	O	O
the	O	O
rapid	O	O
IL-1beta-inducing	O	O
capacity	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
could	O	O
facilitate	O	O
the	O	O
early	O	O
deposition	O	O
of	O	O
bacteria	O	O
in	O	O
fibrin	O	O
clots	O	O
and	O	O
promote	O	O
endocarditis	O	O
.	O	O

We	O	O
evaluated	O	O
the	O	O
effects	O	O
of	O	O
special	O	O
oral	O	O
care	O	O
using	O	O
a	O	O
toothbrush	O	O
with	O	O
combined	O	O
irrigation	O	O
and	O	O
suctioning	O	O
functions	O	O
,	O	O
along	O	O
with	O	O
povidone-iodine	O	O
to	O	O
treat	O	O
oral	O	O
bacteria	O	O
and	O	O
mucositis	O	O
,	O	O
in	O	O
esophageal	O	O
cancer	O	O
patients	O	O
undergoing	O	O
chemoradiotherapy	O	O
.	O	O

In	O	O
the	O	O
special	O	O
care	O	O
group	O	O
,	O	O
oral	O	O
hygiene	O	O
was	O	O
performed	O	O
3	O	O
days	O	O
a	O	O
week	O	O
after	O	O
dinner	O	O
.	O	O

Bacteria	O	O
in	O	O
saliva	O	O
and	O	O
plague	O	O
samples	O	O
were	O	O
measured	O	O
at	O	O
various	O	O
sampling	O	O
points	O	O
after	O	O
chemoradiotherapy	O	O
.	O	O

The	O	O
incidence	O	O
of	O	O
mucositis	O	O
was	O	O
significantly	O	O
reduced	O	O
in	O	O
the	O	O
special	O	O
care	O	O
group	O	O
in	O	O
comparison	O	O
with	O	O
the	O	O
control	O	O
group	O	O
.	O	O

Total	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
significantly	O	O
decreased	O	O
in	O	O
the	O	O
opportunistic	O	O
pathogens-positive	O	O
and	O	O
lower-level	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
control	O	O
group	O	O
during	O	O
chemoradiotherapy	O	O
,	O	O
but	O	O
they	O	O
were	O	O
not	O	O
reduced	O	O
in	O	O
the	O	O
opportunistic	O	O
pathogens-negative	O	O
and	O	O
higher-level	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
control	O	O
groups	O	O
or	O	O
in	O	O
the	O	O
special	O	O
care	O	O
group	O	O
.	O	O

Our	O	O
results	O	O
showed	O	O
that	O	O
a	O	O
special	O	O
oral	O	O
care	O	O
regimen	O	O
enabled	O	O
the	O	O
total	O	O
population	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
microflora	O	O
to	O	O
remain	O	O
stable	O	O
,	O	O
was	O	O
negatively	O	O
correlated	O	O
with	O	O
opportunistic	O	O
pathogens	O	O
and	O	O
positively	O	O
correlated	O	O
with	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
infection	O	O
,	O	O
and	O	O
prevented	O	O
the	O	O
development	O	O
of	O	O
mucositis	O	O
.	O	O

A	O	O
significant	O	O
amount	O	O
of	O	O
evidence	O	O
has	O	O
been	O	O
accumulated	O	O
to	O	O
show	O	O
that	O	O
Toll-like	O	O
receptors	O	O
(	O	O
TLRs	O	O
)	O	O
function	O	O
as	O	O
sensors	O	O
for	O	O
microbial	O	O
invasion	O	O
.	O	O

However	O	O
,	O	O
little	O	O
is	O	O
known	O	O
about	O	O
how	O	O
signalling	O	O
triggered	O	O
by	O	O
TLRs	O	O
leads	O	O
to	O	O
the	O	O
phagocytosis	O	O
of	O	O
pathogens	O	O
.	O	O

This	O	O
study	O	O
was	O	O
designed	O	O
to	O	O
determine	O	O
whether	O	O
stimulation	O	O
of	O	O
TLR2	O	O
mainly	O	O
with	O	O
the	O	O
lipopeptide	O	O
FSL-1	O	O
plays	O	O
a	O	O
role	O	O
in	O	O
the	O	O
phagocytosis	O	O
of	O	O
pathogens	O	O
by	O	O
macrophages	O	O
.	O	O

FSL-1	O	O
enhanced	O	O
the	O	O
phagocytosis	O	O
of	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
to	O	O
a	O	O
markedly	O	O
greater	O	O
extent	O	O
than	O	O
it	O	O
did	O	O
that	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
but	O	O
did	O	O
not	O	O
enhance	O	O
the	O	O
phagocytosis	O	O
of	O	O
latex	O	O
beads	O	O
.	O	O

FSL-1	O	O
stimulation	O	O
resulted	O	O
in	O	O
enhanced	O	O
phagocytosis	O	O
of	O	O
bacteria	O	O
by	O	O
macrophages	O	O
from	O	O
TLR2	O	O
(	O	O
+/+	O	O
)	O	O
mice	O	O
but	O	O
not	O	O
by	O	O
those	O	O
from	O	O
TLR2	O	O
(	O	O
-/-	O	O
)	O	O
mice	O	O
.	O	O

Chinese	O	O
hamster	O	O
ovary	O	O
cells	O	O
stably	O	O
expressing	O	O
TLR2	O	O
failed	O	O
to	O	O
phagocytose	O	O
these	O	O
bacteria	O	O
,	O	O
but	O	O
the	O	O
cells	O	O
expressing	O	O
CD14	O	O
did	O	O
.	O	O

FSL-1	O	O
induced	O	O
upregulation	O	O
of	O	O
the	O	O
expression	O	O
of	O	O
phagocytic	O	O
receptors	O	O
,	O	O
including	O	O
MSR1	O	O
,	O	O
CD36	O	O
,	O	O
DC-SIGN	O	O
and	O	O
Dectin-1	O	O
in	O	O
THP-1	O	O
cells	O	O
.	O	O

Human	O	O
embryonic	O	O
kidney	O	O
293	O	O
cells	O	O
transfected	O	O
with	O	O
DC-SIGN	O	O
and	O	O
MSR1	O	O
phagocytosed	O	O
these	O	O
bacteria	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
FSL-1-induced	O	O
enhancement	O	O
of	O	O
phagocytosis	O	O
of	O	O
bacteria	O	O
by	O	O
macrophages	O	O
may	O	O
be	O	O
explained	O	O
partly	O	O
by	O	O
the	O	O
upregulation	O	O
of	O	O
scavenger	O	O
receptors	O	O
and	O	O
the	O	O
C-type	O	O
lectins	O	O
through	O	O
TLR2-mediated	O	O
signalling	O	O
pathways	O	O
,	O	O
and	O	O
that	O	O
TLR2	O	O
by	O	O
itself	O	O
does	O	O
not	O	O
function	O	O
as	O	O
a	O	O
phagocytic	O	O
receptor	O	O
.	O	O

The	O	O
efficacy	O	O
of	O	O
a	O	O
novel	O	O
synthetic	O	O
antimicrobial	O	O
peptide	O	O
(	O	O
WLBU2	O	O
)	O	O
was	O	O
evaluated	O	O
against	O	O
three	O	O
oral	O	O
microorganisms	O	O
(	O	O
grown	O	O
planktonically	O	O
)	O	O
:	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

WLBU2	O	O
killed	O	O
all	O	O
three	O	O
species	O	O
,	O	O
with	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
being	O	O
the	O	O
most	O	O
susceptible	O	O
.	O	O

WLBU2	O	O
also	O	O
reduced	O	O
the	O	O
bacterial	O	O
burden	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
biofilms	O	O
.	O	O

Recently	O	O
,	O	O
the	O	O
clinical	O	O
additive	O	O
value	O	O
of	O	O
a	O	O
highly	O	O
concentrated	O	O
chlorhexidine	O	O
(	O	O
CHX	O	O
)	O	O
varnish	O	O
,	O	O
when	O	O
applied	O	O
subgingivally	O	O
as	O	O
an	O	O
adjunct	O	O
to	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
,	O	O
was	O	O
described	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
microbiological	O	O
impact	O	O
of	O	O
a	O	O
treatment	O	O
strategy	O	O
for	O	O
chronic	O	O
periodontitis	O	O
based	O	O
on	O	O
a	O	O
combination	O	O
of	O	O
same-day	O	O
full-mouth	O	O
root	O	O
planing	O	O
and	O	O
subgingival	O	O
CHX	O	O
varnish	O	O
administration	O	O
.	O	O

A	O	O
randomized	O	O
,	O	O
controlled	O	O
,	O	O
single-blind	O	O
,	O	O
parallel	O	O
trial	O	O
was	O	O
conducted	O	O
on	O	O
33	O	O
non-smoking	O	O
chronic	O	O
periodontitis	O	O
patients	O	O
.	O	O

The	O	O
control	O	O
group	O	O
received	O	O
oral	O	O
hygiene	O	O
instructions	O	O
and	O	O
same-day	O	O
full-mouth	O	O
root	O	O
planing	O	O
.	O	O

The	O	O
test	O	O
group	O	O
received	O	O
the	O	O
same	O	O
instructions	O	O
and	O	O
treatment	O	O
;	O	O
however	O	O
,	O	O
all	O	O
pockets	O	O
also	O	O
were	O	O
disinfected	O	O
using	O	O
a	O	O
supersaturated	O	O
CHX	O	O
varnish	O	O
.	O	O

Subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
deepest	O	O
site	O	O
per	O	O
quadrant	O	O
in	O	O
each	O	O
patient	O	O
at	O	O
baseline	O	O
and	O	O
after	O	O
1	O	O
,	O	O
3	O	O
,	O	O
and	O	O
6	O	O
months	O	O
.	O	O

Pooled	O	O
sample	O	O
analysis	O	O
was	O	O
performed	O	O
using	O	O
a	O	O
multiplex	O	O
polymerase	O	O
chain	O	O
reaction-based	O	O
method	O	O
for	O	O
the	O	O
identification	O	O
of	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
Aa	B-bacteria	B-bacteria
)	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
Pg	B-bacteria	B-bacteria
)	O	O
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
(	O	O
Tf	B-bacteria	B-bacteria
)	O	O
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
(	O	O
Td	B-bacteria	B-bacteria
)	O	O
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
Pi	B-bacteria	B-bacteria
)	O	O
.	O	O

In	O	O
terms	O	O
of	O	O
detection	O	O
frequency	O	O
and	O	O
bacterial	O	O
levels	O	O
,	O	O
significant	O	O
,	O	O
mainly	O	O
temporary	O	O
,	O	O
reductions	O	O
from	O	O
baseline	O	O
were	O	O
found	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

When	O	O
a	O	O
comparison	O	O
was	O	O
made	O	O
between	O	O
the	O	O
control	O	O
and	O	O
the	O	O
test	O	O
group	O	O
,	O	O
significant	O	O
differences	O	O
in	O	O
the	O	O
detection	O	O
frequency	O	O
of	O	O
Tf	B-bacteria	B-bacteria
(	O	O
P	O	O
=	O	O
0.024	O	O
)	O	O
and	O	O
Td	B-bacteria	B-bacteria
(	O	O
P	O	O
=	O	O
0.024	O	O
)	O	O
,	O	O
which	O	O
favored	O	O
the	O	O
test	O	O
group	O	O
,	O	O
were	O	O
found	O	O
at	O	O
1	O	O
month	O	O
.	O	O

A	O	O
similar	O	O
phenomenon	O	O
was	O	O
seen	O	O
for	O	O
Td	B-bacteria	B-bacteria
(	O	O
P	O	O
=	O	O
0.031	O	O
)	O	O
based	O	O
on	O	O
bacterial	O	O
levels	O	O
.	O	O

An	O	O
important	O	O
trend	O	O
toward	O	O
lower	O	O
Tf	B-bacteria	B-bacteria
levels	O	O
in	O	O
the	O	O
test	O	O
group	O	O
also	O	O
was	O	O
found	O	O
at	O	O
1	O	O
month	O	O
(	O	O
P	O	O
=	O	O
0.052	O	O
)	O	O
.	O	O

Compared	O	O
to	O	O
baseline	O	O
levels	O	O
,	O	O
microbiological	O	O
benefits	O	O
in	O	O
the	O	O
test	O	O
group	O	O
seemed	O	O
to	O	O
be	O	O
maintained	O	O
,	O	O
at	O	O
least	O	O
in	O	O
part	O	O
,	O	O
over	O	O
a	O	O
6-month	O	O
period	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
all	O	O
microbial	O	O
levels	O	O
had	O	O
relapsed	O	O
in	O	O
the	O	O
control	O	O
group	O	O
at	O	O
study	O	O
termination	O	O
.	O	O

The	O	O
microbiological	O	O
results	O	O
of	O	O
the	O	O
present	O	O
study	O	O
promote	O	O
the	O	O
subgingival	O	O
administration	O	O
of	O	O
a	O	O
highly	O	O
concentrated	O	O
CHX	O	O
varnish	O	O
as	O	O
an	O	O
adjunct	O	O
to	O	O
same-day	O	O
full-mouth	O	O
root	O	O
planing	O	O
.	O	O

By	O	O
using	O	O
fluorescence	O	O
microscopy	O	O
,	O	O
fluorescently	O	O
labeled	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
W50	E-bacteria	I-bacteria
was	O	O
shown	O	O
to	O	O
adhere	O	O
to	O	O
oral	O	O
epithelial	O	O
(	O	O
KB	O	O
)	O	O
cells	O	O
as	O	O
discrete	O	O
cells	O	O
or	O	O
small	O	O
cell	O	O
aggregates	O	O
,	O	O
whereas	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33277	E-bacteria	I-bacteria
bound	O	O
as	O	O
large	O	O
cell	O	O
aggregates	O	O
.	O	O

Flow	O	O
cytometric	O	O
analysis	O	O
showed	O	O
that	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
W50	E-bacteria	I-bacteria
there	O	O
was	O	O
a	O	O
logarithmic	O	O
relationship	O	O
between	O	O
the	O	O
bacterial	O	O
cell	O	O
ratio	O	O
(	O	O
BCR	O	O
)	O	O
,	O	O
that	O	O
is	O	O
the	O	O
number	O	O
of	O	O
bacterial	O	O
cells	O	O
to	O	O
KB	O	O
cells	O	O
,	O	O
and	O	O
the	O	O
percentage	O	O
of	O	O
KB	O	O
cells	O	O
with	O	O
W50	O	O
cells	O	O
attached	O	O
.	O	O

This	O	O
percentage	O	O
of	O	O
KB	O	O
cells	O	O
with	O	O
W50	O	O
attached	O	O
reached	O	O
a	O	O
plateau	O	O
of	O	O
approximately	O	O
84	O	O
%	O	O
cells	O	O
at	O	O
a	O	O
BCR	O	O
of	O	O
500:1	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
a	O	O
quadratic	O	O
relationship	O	O
was	O	O
observed	O	O
between	O	O
BCR	O	O
and	O	O
the	O	O
percentage	O	O
of	O	O
KB	O	O
cells	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33277	E-bacteria	I-bacteria
attached	O	O
,	O	O
reaching	O	O
a	O	O
maximum	O	O
of	O	O
47	O	O
%	O	O
at	O	O
a	O	O
BCR	O	O
of	O	O
100:1	O	O
but	O	O
decreasing	O	O
to	O	O
7	O	O
%	O	O
at	O	O
a	O	O
BCR	O	O
of	O	O
1,000:1	O	O
.	O	O

The	O	O
lower	O	O
binding	O	O
of	O	O
ATCC	B-bacteria	B-bacteria
33277	E-bacteria	I-bacteria
at	O	O
high	O	O
cell	O	O
concentrations	O	O
was	O	O
attributed	O	O
to	O	O
autoaggregation	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
W50	E-bacteria	I-bacteria
cells	O	O
treated	O	O
with	O	O
an	O	O
inhibitor	O	O
(	O	O
Nalpha-p-tosyl-L-lysine	O	O
chloromethyl	O	O
ketone	O	O
[	O	O
TLCK	O	O
]	O	O
)	O	O
of	O	O
its	O	O
RgpA-Kgp	O	O
proteinase-adhesin	O	O
complex	O	O
exhibited	O	O
significantly	O	O
reduced	O	O
binding	O	O
to	O	O
KB	O	O
cells	O	O
than	O	O
to	O	O
untreated	O	O
cells	O	O
,	O	O
suggesting	O	O
a	O	O
role	O	O
for	O	O
proteinase	O	O
activity	O	O
in	O	O
binding	O	O
to	O	O
KB	O	O
cells	O	O
.	O	O

Competitive	O	O
inhibition	O	O
with	O	O
purified	O	O
proteinase-active	O	O
and	O	O
TLCK-inactivated	O	O
RgpA-Kgp	O	O
complex	O	O
significantly	O	O
decreased	O	O
the	O	O
adherence	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
W50	E-bacteria	I-bacteria
cells	O	O
to	O	O
KB	O	O
cells	O	O
.	O	O

Furthermore	O	O
,	O	O
isogenic	O	O
mutants	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
W50	E-bacteria	I-bacteria
lacking	O	O
the	O	O
kgp	O	O
gene	O	O
product	O	O
,	O	O
but	O	O
not	O	O
the	O	O
rgpA	O	O
or	O	O
rgpB	O	O
gene	O	O
products	O	O
,	O	O
exhibited	O	O
significantly	O	O
decreased	O	O
adherence	O	O
to	O	O
KB	O	O
cells	O	O
compared	O	O
to	O	O
the	O	O
wild	O	O
type	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
molecular	O	O
effects	O	O
of	O	O
the	O	O
periodontopathogens	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
FN	B-bacteria	B-bacteria
)	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
PG	B-bacteria	B-bacteria
)	O	O
on	O	O
the	O	O
oral	O	O
epithelium	O	O
,	O	O
the	O	O
H400	O	O
oral	O	O
epithelial	O	O
cell	O	O
line	O	O
was	O	O
cultured	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
non-viable	O	O
bacteria	O	O
.	O	O

Following	O	O
confirmation	O	O
of	O	O
the	O	O
presence	O	O
of	O	O
transcripts	O	O
for	O	O
the	O	O
bacterial	O	O
pattern	O	O
recognition	O	O
receptors	O	O
in	O	O
H400	O	O
cells	O	O
,	O	O
Toll-like	O	O
receptors	O	O
-2	O	O
,	O	O
-4	O	O
and	O	O
-9	O	O
,	O	O
and	O	O
components	O	O
of	O	O
the	O	O
NF-kappaB	O	O
signalling	O	O
pathway	O	O
,	O	O
immunocytochemical	O	O
analyses	O	O
were	O	O
performed	O	O
showing	O	O
that	O	O
NF-kappaB	O	O
was	O	O
activated	O	O
within	O	O
1	O	O
h	O	O
of	O	O
exposure	O	O
to	O	O
both	O	O
periodontopathogens	O	O
.	O	O

A	O	O
significantly	O	O
greater	O	O
number	O	O
of	O	O
NF-kappaB	O	O
nuclear	O	O
translocations	O	O
were	O	O
apparent	O	O
following	O	O
H400	O	O
cell	O	O
exposure	O	O
to	O	O
FN	B-bacteria	B-bacteria
as	O	O
compared	O	O
with	O	O
PG	B-bacteria	B-bacteria
.	O	O

Gene	O	O
expression	O	O
analyses	O	O
indicated	O	O
that	O	O
transcripts	O	O
known	O	O
to	O	O
be	O	O
regulated	O	O
by	O	O
the	O	O
NF-kappaB	O	O
pathway	O	O
,	O	O
including	O	O
cytokines/chemokines	O	O
TNF-alpha	O	O
,	O	O
IL-1beta	O	O
,	O	O
IL-8	O	O
,	O	O
MCP-1/CCL2	O	O
and	O	O
GM-CSF	O	O
,	O	O
were	O	O
up-regulated	O	O
following	O	O
4	O	O
and	O	O
24	O	O
h	O	O
of	O	O
exposure	O	O
to	O	O
both	O	O
periodontopathogens	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
H400	O	O
periodontopathogen	O	O
exposure	O	O
resulted	O	O
in	O	O
differential	O	O
regulation	O	O
of	O	O
transcripts	O	O
for	O	O
several	O	O
cytokeratin	O	O
gene	O	O
family	O	O
members	O	O
.	O	O

Consistent	O	O
with	O	O
the	O	O
immunocytochemical	O	O
data	O	O
,	O	O
microarray	O	O
results	O	O
indicated	O	O
that	O	O
FN	B-bacteria	B-bacteria
induced	O	O
a	O	O
greater	O	O
number	O	O
of	O	O
gene	O	O
expression	O	O
changes	O	O
than	O	O
PG	B-bacteria	B-bacteria
following	O	O
24	O	O
h	O	O
of	O	O
exposure	O	O
,	O	O
609	O	O
and	O	O
409	O	O
genes	O	O
,	O	O
respectively	O	O
.	O	O

Ninety-one	O	O
genes	O	O
were	O	O
commonly	O	O
differentially	O	O
expressed	O	O
by	O	O
both	O	O
periodontopathogens	O	O
and	O	O
represented	O	O
biological	O	O
processes	O	O
commonly	O	O
associated	O	O
with	O	O
periodontitis	O	O
.	O	O

Gene	O	O
expression	O	O
analyses	O	O
by	O	O
reserve	O	O
transcriptase-polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
RT-PCR	O	O
)	O	O
of	O	O
molecules	O	O
identified	O	O
from	O	O
the	O	O
microarray	O	O
data	O	O
sets	O	O
,	O	O
including	O	O
Heme	O	O
oxygenase-1	O	O
,	O	O
lysyl	O	O
oxidase	O	O
,	O	O
SOD2	O	O
,	O	O
CCL20	O	O
and	O	O
calprotectin	O	O
components	O	O
,	O	O
confirmed	O	O
their	O	O
differential	O	O
expression	O	O
profiles	O	O
induced	O	O
by	O	O
the	O	O
two	O	O
periodontopathogens	O	O
.	O	O

FN	B-bacteria	B-bacteria
and	O	O
PG	B-bacteria	B-bacteria
have	O	O
clearly	O	O
different	O	O
molecular	O	O
effects	O	O
on	O	O
oral	O	O
epithelial	O	O
cells	O	O
,	O	O
potentially	O	O
highlighting	O	O
the	O	O
importance	O	O
of	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
plaque	O	O
biofilm	O	O
in	O	O
periodontitis	O	O
pathogenesis	O	O
.	O	O

In	O	O
2002	O	O
we	O	O
investigated	O	O
an	O	O
outbreak	O	O
comprising	O	O
231	O	O
patients	O	O
in	O	O
Norway	O	O
,	O	O
caused	O	O
by	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
linked	O	O
to	O	O
the	O	O
use	O	O
of	O	O
contaminated	O	O
mouth	O	O
swabs	O	O
called	O	O
Dent-O-Sept	O	O
.	O	O

Here	O	O
we	O	O
describe	O	O
the	O	O
extent	O	O
of	O	O
contamination	O	O
of	O	O
the	O	O
swabs	O	O
,	O	O
and	O	O
identify	O	O
critical	O	O
points	O	O
in	O	O
the	O	O
production	O	O
process	O	O
that	O	O
made	O	O
the	O	O
contamination	O	O
possible	O	O
,	O	O
in	O	O
order	O	O
to	O	O
prevent	O	O
future	O	O
outbreaks	O	O
.	O	O

Environmental	O	O
investigation	O	O
with	O	O
microbiological	O	O
examination	O	O
of	O	O
production	O	O
,	O	O
ingredients	O	O
and	O	O
product	O	O
,	O	O
molecular	O	O
typing	O	O
of	O	O
bacteria	O	O
and	O	O
a	O	O
system	O	O
audit	O	O
of	O	O
production	O	O
.	O	O

Of	O	O
the	O	O
1565	O	O
swabs	O	O
examined	O	O
from	O	O
149	O	O
different	O	O
production	O	O
batches	O	O
the	O	O
outbreak	O	O
strain	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
76	O	O
swabs	O	O
from	O	O
12	O	O
batches	O	O
produced	O	O
in	O	O
2001	O	O
and	O	O
2002	O	O
.	O	O

In	O	O
total	O	O
more	O	O
than	O	O
250	O	O
swabs	O	O
were	O	O
contaminated	O	O
with	O	O
one	O	O
or	O	O
more	O	O
microbial	O	O
species	O	O
.	O	O

P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
was	O	O
detected	O	O
from	O	O
different	O	O
spots	O	O
along	O	O
the	O	O
production	O	O
line	O	O
.	O	O

The	O	O
audit	O	O
revealed	O	O
serious	O	O
breeches	O	O
of	O	O
production	O	O
regulations	O	O
.	O	O

Health	O	O
care	O	O
institutions	O	O
reported	O	O
non-proper	O	O
use	O	O
of	O	O
the	O	O
swabs	O	O
and	O	O
weaknesses	O	O
in	O	O
their	O	O
purchasing	O	O
systems	O	O
.	O	O

Biofilm	O	O
formation	O	O
in	O	O
the	O	O
wet	O	O
part	O	O
of	O	O
the	O	O
production	O	O
is	O	O
the	O	O
most	O	O
plausible	O	O
explanation	O	O
for	O	O
the	O	O
continuous	O	O
contamination	O	O
of	O	O
the	O	O
swabs	O	O
with	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
over	O	O
a	O	O
period	O	O
of	O	O
at	O	O
least	O	O
30	O	O
weeks	O	O
.	O	O

When	O	O
not	O	O
abiding	O	O
to	O	O
production	O	O
regulations	O	O
fatal	O	O
consequences	O	O
for	O	O
the	O	O
users	O	O
may	O	O
ensue	O	O
.	O	O

For	O	O
the	O	O
most	O	O
vulnerable	O	O
patient	O	O
groups	O	O
only	O	O
documented	O	O
quality-controlled	O	O
,	O	O
high-level	O	O
disinfected	O	O
products	O	O
and	O	O
items	O	O
should	O	O
be	O	O
used	O	O
in	O	O
the	O	O
oropharynx	O	O
.	O	O

The	O	O
DNA	O	O
sequence	O	O
flanking	O	O
a	O	O
tet	O	O
(	O	O
W	O	O
)	O	O
gene	O	O
in	O	O
an	O	O
oral	O	O
Rothia	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

was	O	O
determined	O	O
.	O	O

The	O	O
gene	O	O
was	O	O
linked	O	O
to	O	O
two	O	O
different	O	O
transposases	O	O
,	O	O
and	O	O
these	O	O
were	O	O
flanked	O	O
by	O	O
two	O	O
almost	O	O
identical	O	O
mef	O	O
(	O	O
macrolide	O	O
efflux	O	O
)	O	O
genes	O	O
.	O	O

This	O	O
structure	O	O
was	O	O
found	O	O
in	O	O
4	O	O
out	O	O
of	O	O
20	O	O
tet	O	O
(	O	O
W	O	O
)	O	O
-containing	O	O
oral	O	O
bacteria	O	O
investigated	O	O
.	O	O

Uncaria	O	O
tomentosa	O	O
is	O	O
considered	O	O
a	O	O
medicinal	O	O
plant	O	O
used	O	O
over	O	O
centuries	O	O
by	O	O
the	O	O
peruvian	O	O
population	O	O
as	O	O
an	O	O
alternative	O	O
treatment	O	O
for	O	O
several	O	O
diseases	O	O
.	O	O

Many	O	O
microorganisms	O	O
usually	O	O
inhabit	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
and	O	O
under	O	O
certain	O	O
conditions	O	O
can	O	O
become	O	O
etiologic	O	O
agents	O	O
of	O	O
diseases	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
different	O	O
concentrations	O	O
of	O	O
Uncaria	O	O
tomentosa	O	O
on	O	O
different	O	O
strains	O	O
of	O	O
microorganisms	O	O
isolated	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

Micropulverized	O	O
Uncaria	O	O
tomentosa	O	O
was	O	O
tested	O	O
in	O	O
vitro	O	O
to	O	O
determine	O	O
the	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
on	O	O
selected	O	O
microbial	O	O
strains	O	O
.	O	O

The	O	O
tested	O	O
strains	O	O
were	O	O
oral	O	O
clinical	O	O
isolates	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
,	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
and	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
.	O	O

The	O	O
tested	O	O
concentrations	O	O
of	O	O
Uncaria	O	O
tomentosa	O	O
ranged	O	O
from	O	O
0.25-5	O	O
%	O	O
in	O	O
Mueller-Hinton	O	O
agar	O	O
.	O	O

Three	O	O
percent	O	O
Uncaria	O	O
tomentosa	O	O
inhibited	O	O
8	O	O
%	O	O
of	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
,	O	O
52	O	O
%	O	O
of	O	O
S.	O	O
mutans	O	O
and	O	O
96	O	O
%	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

The	O	O
tested	O	O
concentrations	O	O
did	O	O
not	O	O
present	O	O
inhibitory	O	O
effect	O	O
on	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
C.	O	O
albicans	O	O
.	O	O

It	O	O
could	O	O
be	O	O
concluded	O	O
that	O	O
micropulverized	O	O
Uncaria	O	O
tomentosa	O	O
presented	O	O
antimicrobial	O	O
activity	O	O
on	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	O	O

isolates	E-bacteria	I-bacteria
.	O	O

In	O	O
addition	O	O
to	O	O
saliva	O	O
,	O	O
other	O	O
oral	O	O
components	O	O
such	O	O
as	O	O
gingival	O	O
crevicular	O	O
fluid	O	O
,	O	O
epithelial	O	O
cells	O	O
,	O	O
bacteria	O	O
,	O	O
breath	O	O
,	O	O
and	O	O
dental	O	O
plaque	O	O
have	O	O
diagnostic	O	O
potential	O	O
.	O	O

For	O	O
oral	O	O
diseases	O	O
such	O	O
as	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
,	O	O
visual	O	O
diagnosis	O	O
is	O	O
usually	O	O
adequate	O	O
,	O	O
but	O	O
objective	O	O
diagnostic	O	O
tests	O	O
with	O	O
predictive	O	O
value	O	O
are	O	O
desired	O	O
.	O	O

Therefore	O	O
,	O	O
prediction	O	O
models	O	O
like	O	O
the	O	O
Cariogram	O	O
have	O	O
been	O	O
developed	O	O
that	O	O
also	O	O
include	O	O
oral	O	O
aspects	O	O
such	O	O
as	O	O
saliva	O	O
secretion	O	O
,	O	O
buffering	O	O
capacity	O	O
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
counts	O	O
for	O	O
the	O	O
prediction	O	O
of	O	O
caries	O	O
.	O	O

Correlation	O	O
studies	O	O
on	O	O
salivary	O	O
components	O	O
and	O	O
caries	O	O
have	O	O
not	O	O
been	O	O
conclusive	O	O
,	O	O
but	O	O
correlation	O	O
studies	O	O
on	O	O
functional	O	O
aspects	O	O
,	O	O
such	O	O
as	O	O
saliva-induced	O	O
bacterial	O	O
aggregation	O	O
and	O	O
caries	O	O
,	O	O
look	O	O
promising	O	O
.	O	O

Modern	O	O
proteomic	O	O
techniques	O	O
make	O	O
it	O	O
possible	O	O
to	O	O
study	O	O
simultaneously	O	O
the	O	O
many	O	O
salivary	O	O
components	O	O
involved	O	O
in	O	O
these	O	O
functions	O	O
.	O	O

Neutrophils	O	O
,	O	O
monocytes	O	O
,	O	O
and	O	O
dendritic	O	O
cells	O	O
(	O	O
DC	O	O
)	O	O
are	O	O
phenotypically	O	O
and	O	O
functionally	O	O
related	O	O
phagocytes	O	O
whose	O	O
presence	O	O
in	O	O
infected	O	O
tissues	O	O
is	O	O
critical	O	O
to	O	O
host	O	O
survival	O	O
.	O	O

Their	O	O
overlapping	O	O
expression	O	O
pattern	O	O
of	O	O
surface	O	O
molecules	O	O
,	O	O
the	O	O
differentiation	O	O
capacity	O	O
of	O	O
monocytes	O	O
,	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
monocyte	O	O
subsets	O	O
underscores	O	O
the	O	O
complexity	O	O
of	O	O
understanding	O	O
the	O	O
role	O	O
of	O	O
these	O	O
cells	O	O
during	O	O
infection	O	O
.	O	O

In	O	O
this	O	O
study	O	O
we	O	O
use	O	O
five-	O	O
to	O	O
seven-color	O	O
flow	O	O
cytometry	O	O
to	O	O
assess	O	O
the	O	O
phenotype	O	O
and	O	O
function	O	O
of	O	O
monocytes	O	O
recruited	O	O
to	O	O
Peyer	O	O
's	O	O
patches	O	O
(	O	O
PP	O	O
)	O	O
and	O	O
mesenteric	O	O
lymph	O	O
nodes	O	O
(	O	O
MLN	O	O
)	O	O
after	O	O
oral	O	O
Salmonella	B-bacteria	B-bacteria
infection	O	O
of	O	O
mice	O	O
.	O	O

The	O	O
data	O	O
show	O	O
that	O	O
CD68	O	O
(	O	O
high	O	O
)	O	O
Gr-1	O	O
(	O	O
int	O	O
)	O	O
(	O	O
intermediate	O	O
)	O	O
monocytes	O	O
,	O	O
along	O	O
with	O	O
CD68	O	O
(	O	O
int	O	O
)	O	O
Gr-1	O	O
(	O	O
high	O	O
)	O	O
neutrophils	O	O
,	O	O
rapidly	O	O
accumulate	O	O
in	O	O
PP	O	O
and	O	O
MLN	O	O
.	O	O

The	O	O
monocytes	O	O
have	O	O
increased	O	O
MHC-II	O	O
and	O	O
costimulatory	O	O
molecule	O	O
expression	O	O
and	O	O
,	O	O
in	O	O
contrast	O	O
to	O	O
neutrophils	O	O
and	O	O
DC	O	O
,	O	O
produce	O	O
inducible	O	O
NO	O	O
synthase	O	O
.	O	O

Although	O	O
neutrophils	O	O
and	O	O
monocytes	O	O
from	O	O
infected	O	O
mice	O	O
produce	O	O
TNF-alpha	O	O
and	O	O
IL-1beta	O	O
upon	O	O
ex	O	O
vivo	O	O
culture	O	O
,	O	O
DC	O	O
do	O	O
not	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
although	O	O
recruited	O	O
monocytes	O	O
internalize	O	O
Salmonella	B-bacteria	B-bacteria
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
they	O	O
did	O	O
not	O	O
induce	O	O
the	O	O
proliferation	O	O
of	O	O
OT-II	O	O
CD4	O	O
(	O	O
+	O	O
)	O	O
T	O	O
cells	O	O
after	O	O
coincubation	O	O
with	O	O
Salmonella	B-bacteria	B-bacteria
expressing	O	O
OVA	O	O
despite	O	O
their	O	O
ability	O	O
to	O	O
activate	O	O
OT-II	O	O
cells	O	O
when	O	O
pulsed	O	O
with	O	O
the	O	O
OVA	O	O
(	O	O
323-339	O	O
)	O	O
peptide	O	O
.	O	O

We	O	O
also	O	O
show	O	O
that	O	O
recruited	O	O
monocytes	O	O
enter	O	O
the	O	O
PP	O	O
of	O	O
infected	O	O
mice	O	O
independently	O	O
of	O	O
the	O	O
mucosal	O	O
address	O	O
in	O	O
cell	O	O
adhesion	O	O
molecule-1	O	O
(	O	O
MAdCAM-1	O	O
)	O	O
.	O	O

Finally	O	O
,	O	O
recruited	O	O
but	O	O
not	O	O
resident	O	O
monocytes	O	O
increase	O	O
in	O	O
the	O	O
blood	O	O
of	O	O
orally	O	O
infected	O	O
mice	O	O
,	O	O
and	O	O
MHC-II	O	O
up-regulation	O	O
,	O	O
but	O	O
not	O	O
TNF-alpha	O	O
or	O	O
iNOS	O	O
production	O	O
,	O	O
occur	O	O
already	O	O
in	O	O
the	O	O
blood	O	O
.	O	O

These	O	O
studies	O	O
are	O	O
the	O	O
first	O	O
to	O	O
describe	O	O
the	O	O
accumulation	O	O
and	O	O
function	O	O
of	O	O
monocyte	O	O
subsets	O	O
in	O	O
the	O	O
blood	O	O
and	O	O
GALT	O	O
during	O	O
oral	O	O
Salmonella	B-bacteria	B-bacteria
infection	O	O
.	O	O

Cystic	O	O
fibrosis	O	O
(	O	O
CF	O	O
)	O	O
patients	O	O
who	O	O
are	O	O
chronically	O	O
infected	O	O
with	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
make	O	O
serum	O	O
antibodies	O	O
to	O	O
bacterial	O	O
surface	O	O
LPS	O	O
as	O	O
well	O	O
as	O	O
other	O	O
pseudomonas	B-bacteria	B-bacteria
antigens	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
feasibility	O	O
of	O	O
using	O	O
oral	O	O
fluid	O	O
samples	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
pseudomonas	B-bacteria	B-bacteria
antibodies	O	O
in	O	O
CF	O	O
patients	O	O
and	O	O
compared	O	O
these	O	O
results	O	O
with	O	O
corresponding	O	O
serum	O	O
antibodies	O	O
.	O	O

Most	O	O
strains	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
produce	O	O
two	O	O
forms	O	O
of	O	O
LPS	O	O
molecule	O	O
,	O	O
termed	O	O
A-band	O	O
(	O	O
described	O	O
as	O	O
a	O	O
common	O	O
antigen	O	O
)	O	O
and	O	O
B-band	O	O
(	O	O
O-serotype-specific	O	O
antigen	O	O
)	O	O
,	O	O
apparently	O	O
bound	O	O
to	O	O
a	O	O
common	O	O
core	O	O
oligosaccharide	O	O
moiety	O	O
.	O	O

A-band	O	O
LPS	O	O
was	O	O
demonstrated	O	O
in	O	O
45	O	O
out	O	O
of	O	O
49	O	O
clinical	O	O
isolates	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
by	O	O
SDS-PAGE	O	O
and	O	O
immunoblotting	O	O
with	O	O
a	O	O
specific	O	O
antibody	O	O
.	O	O

Oral	O	O
fluids	O	O
were	O	O
collected	O	O
from	O	O
17	O	O
adult	O	O
CF	O	O
patients	O	O
,	O	O
all	O	O
of	O	O
whom	O	O
were	O	O
sputum	O	O
culture	O	O
positive	O	O
for	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
(	O	O
13	O	O
also	O	O
provided	O	O
serum	O	O
samples	O	O
)	O	O
,	O	O
11	O	O
primary	O	O
ciliary	O	O
dyskinesia	O	O
(	O	O
PCD	O	O
)	O	O
patients	O	O
and	O	O
37	O	O
healthy	O	O
volunteers	O	O
.	O	O

Antibodies	O	O
to	O	O
A-band	O	O
LPS	O	O
were	O	O
detected	O	O
by	O	O
immunoblotting	O	O
in	O	O
all	O	O
of	O	O
the	O	O
CF	O	O
patients	O	O
'	O	O
oral	O	O
fluids	O	O
but	O	O
10	O	O
of	O	O
the	O	O
volunteer	O	O
samples	O	O
gave	O	O
weak	O	O
reactions	O	O
with	O	O
immunoblotting	O	O
.	O	O

Six	O	O
of	O	O
the	O	O
PCD	O	O
patients	O	O
gave	O	O
a	O	O
weak	O	O
reaction	O	O
with	O	O
A-band	O	O
antibodies	O	O
and	O	O
only	O	O
one	O	O
demonstrated	O	O
antibodies	O	O
to	O	O
core	O	O
LPS	O	O
.	O	O

In	O	O
a	O	O
quantitative	O	O
ELISA	O	O
,	O	O
15	O	O
of	O	O
the	O	O
17	O	O
CF	O	O
patients	O	O
'	O	O
oral	O	O
fluids	O	O
were	O	O
shown	O	O
to	O	O
contain	O	O
antibodies	O	O
to	O	O
A-band	O	O
LPS	O	O
,	O	O
whilst	O	O
none	O	O
of	O	O
the	O	O
volunteer	O	O
samples	O	O
contained	O	O
antibodies	O	O
to	O	O
A-band	O	O
LPS	O	O
.	O	O

All	O	O
serum	O	O
samples	O	O
from	O	O
the	O	O
CF	O	O
patients	O	O
were	O	O
positive	O	O
by	O	O
both	O	O
methods	O	O
.	O	O

Thus	O	O
this	O	O
is	O	O
a	O	O
sensitive	O	O
procedure	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
antibodies	O	O
to	O	O
A-band	O	O
LPS	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
in	O	O
oral	O	O
fluid	O	O
and	O	O
serum	O	O
from	O	O
patients	O	O
with	O	O
CF	O	O
.	O	O

Interactions	O	O
between	O	O
oral	O	O
bacteria	O	O
and	O	O
gingival	O	O
epithelial	O	O
cells	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontal	O	O
diseases	O	O
.	O	O

This	O	O
study	O	O
used	O	O
in	O	O
situ	O	O
hybridization	O	O
with	O	O
16	O	O
rRNA	O	O
probes	O	O
and	O	O
confocal	O	O
microscopy	O	O
to	O	O
detect	O	O
the	O	O
periodontal	O	O
pathogens	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
within	O	O
epithelial	O	O
cells	O	O
from	O	O
periodontal	O	O
pockets	O	O
,	O	O
gingival	O	O
crevice	O	O
,	O	O
and	O	O
buccal	O	O
mucosa	O	O
collected	O	O
from	O	O
subjects	O	O
with	O	O
chronic	O	O
periodontitis	O	O
(	O	O
n	O	O
=	O	O
14	O	O
)	O	O
and	O	O
good	O	O
periodontal	O	O
health	O	O
(	O	O
n	O	O
=	O	O
8	O	O
)	O	O
.	O	O

Each	O	O
green	O	O
fluorescent	O	O
species-specific	O	O
and	O	O
universal	O	O
probe	O	O
was	O	O
hybridized	O	O
with	O	O
all	O	O
58	O	O
epithelial	O	O
samples	O	O
from	O	O
the	O	O
22	O	O
patients	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
observed	O	O
by	O	O
confocal	O	O
microscopy	O	O
to	O	O
confirm	O	O
the	O	O
intracellular	O	O
localization	O	O
of	O	O
oral	O	O
species	O	O
of	O	O
bacteria	O	O
.	O	O

The	O	O
mean	O	O
frequency	O	O
of	O	O
detection	O	O
and	O	O
number	O	O
of	O	O
intracellular	O	O
bacteria	O	O
per	O	O
epithelial	O	O
cell	O	O
were	O	O
computed	O	O
for	O	O
each	O	O
sample	O	O
.	O	O

The	O	O
frequency	O	O
of	O	O
cells	O	O
with	O	O
internalized	O	O
bacteria	O	O
was	O	O
higher	O	O
in	O	O
samples	O	O
from	O	O
the	O	O
gingival	O	O
crevice	O	O
than	O	O
in	O	O
samples	O	O
from	O	O
the	O	O
oral	O	O
mucosa	O	O
.	O	O

Epithelial	O	O
cells	O	O
from	O	O
all	O	O
subjects	O	O
harbored	O	O
intracellular	O	O
bacteria	O	O
;	O	O
however	O	O
,	O	O
patients	O	O
with	O	O
periodontitis	O	O
presented	O	O
significantly	O	O
higher	O	O
counts	O	O
of	O	O
bacteria	O	O
per	O	O
cell	O	O
than	O	O
periodontally	O	O
healthy	O	O
individuals	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Periodontal	O	O
pathogens	O	O
showed	O	O
a	O	O
trend	O	O
to	O	O
be	O	O
detected	O	O
in	O	O
higher	O	O
numbers	O	O
in	O	O
epithelial	O	O
cells	O	O
from	O	O
periodontitis	O	O
patients	O	O
.	O	O

In	O	O
particular	O	O
,	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
were	O	O
significantly	O	O
more	O	O
prevalent	O	O
in	O	O
periodontal	O	O
pocket	O	O
cells	O	O
than	O	O
healthy	O	O
sulci	O	O
and	O	O
buccal	O	O
cell	O	O
samples	O	O
in	O	O
the	O	O
periodontitis	O	O
group	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Those	O	O
findings	O	O
indicate	O	O
that	O	O
crevicular	O	O
and	O	O
buccal	O	O
cells	O	O
present	O	O
internalized	O	O
bacteria	O	O
,	O	O
regardless	O	O
of	O	O
periodontal	O	O
status	O	O
.	O	O

However	O	O
,	O	O
higher	O	O
bacterial	O	O
loads	O	O
are	O	O
detected	O	O
in	O	O
cells	O	O
from	O	O
subjects	O	O
with	O	O
periodontitis	O	O
.	O	O

Clinical	O	O
,	O	O
epidemiological	O	O
and	O	O
microbiological	O	O
examinations	O	O
of	O	O
adult	O	O
patients	O	O
with	O	O
periodontal	O	O
disease	O	O
.	O	O

The	O	O
study	O	O
of	O	O
population	O	O
consisted	O	O
of	O	O
21	O	O
subjects	O	O
(	O	O
13	O	O
female	O	O
and	O	O
8	O	O
male	O	O
)	O	O
aged	O	O
38-58	O	O
years	O	O
,	O	O
treated	O	O
in	O	O
the	O	O
Outpatient	O	O
Department	O	O
of	O	O
Periodontology	O	O
.	O	O

Dental	O	O
examinations	O	O
were	O	O
performed	O	O
at	O	O
an	O	O
artificial	O	O
light	O	O
and	O	O
using	O	O
a	O	O
WHO	O	O
periodontometer	O	O
,	O	O
a	O	O
mirror	O	O
and	O	O
a	O	O
probe	O	O
.	O	O

Periodontal	O	O
status	O	O
was	O	O
assessed	O	O
by	O	O
determination	O	O
of	O	O
the	O	O
probing	O	O
pocket	O	O
depth	O	O
(	O	O
CPI	O	O
)	O	O
,	O	O
gingival	O	O
state	O	O
(	O	O
GSBI	O	O
according	O	O
to	O	O
Muhlemann	O	O
and	O	O
Son	O	O
)	O	O
,	O	O
and	O	O
oral	O	O
hygiene	O	O
index	O	O
(	O	O
according	O	O
to	O	O
Silness	O	O
and	O	O
Loe	O	O
)	O	O
.	O	O

Material	O	O
for	O	O
microbiological	O	O
examination	O	O
was	O	O
collected	O	O
from	O	O
subgingival	O	O
and	O	O
supragingival	O	O
plaques	O	O
of	O	O
each	O	O
patient	O	O
.	O	O

Additionally	O	O
,	O	O
pus	O	O
was	O	O
obtained	O	O
from	O	O
8	O	O
patients	O	O
and	O	O
periodontal	O	O
pocket	O	O
fluid	O	O
from	O	O
2	O	O
patients	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
examined	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
aerobic	O	O
and	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
Candida	O	O
yeasts	O	O
.	O	O

Standard	O	O
procedures	O	O
were	O	O
used	O	O
for	O	O
culture	O	O
and	O	O
identification	O	O
of	O	O
bacteria	O	O
and	O	O
fungi	O	O
.	O	O

Candida	O	O
yeasts	O	O
were	O	O
not	O	O
isolated	O	O
from	O	O
adults	O	O
with	O	O
periodontal	O	O
disease	O	O
.	O	O

In	O	O
19/21	O	O
patients	O	O
,	O	O
cultures	O	O
of	O	O
both	O	O
aerobic	O	O
and	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
from	O	O
subgingival	O	O
and	O	O
supragingival	O	O
plaque	O	O
samples	O	O
were	O	O
positive	O	O
.	O	O

A	O	O
total	O	O
of	O	O
42	O	O
bacterial	O	O
strains	O	O
were	O	O
isolated	O	O
from	O	O
subgingival	O	O
plaques	O	O
,	O	O
of	O	O
which	O	O
24	O	O
(	O	O
57.1	O	O
%	O	O
)	O	O
belonged	O	O
to	O	O
7	O	O
anaerobic	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
and	O	O
18	O	O
(	O	O
42.9	O	O
%	O	O
)	O	O
to	O	O
12	O	O
aerobic	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

There	O	O
were	O	O
more	O	O
aerobic	O	O
(	O	O
33/53	O	O
;	O	O
62.3	O	O
%	O	O
)	O	O
than	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
20/53	O	O
;	O	O
37.7	O	O
%	O	O
)	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
in	O	O
supragingival	O	O
plaques	O	O
.	O	O

Anaerobes	B-bacteria	B-bacteria
were	O	O
isolated	O	O
more	O	O
frequently	O	O
than	O	O
aerobes	B-bacteria	B-bacteria
from	O	O
the	O	O
abscess	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

1	O	O
)	O	O
In	O	O
adult	O	O
patients	O	O
with	O	O
periodontal	O	O
disease	O	O
,	O	O
Gram-positive	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
,	O	O
including	O	O
Peptostreptococcus	B-bacteria	B-bacteria
,	O	O
were	O	O
the	O	O
predominant	O	O
bacteria	O	O
in	O	O
the	O	O
subgingival	O	O
plaque	O	O
.	O	O

2	O	O
)	O	O
While	O	O
in	O	O
the	O	O
supragingival	O	O
plaque	O	O
,	O	O
Gram-positive	B-bacteria	B-bacteria
aerobic	I-bacteria	I-bacteria
cocci	E-bacteria	I-bacteria
(	O	O
Streptococcus	B-bacteria	B-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
)	O	O
were	O	O
predominant	O	O
.	O	O

Determination	O	O
of	O	O
bacterial	O	O
composition	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
with	O	O
removable	O	O
dentures	O	O
and	O	O
with	O	O
own	O	O
dentition	O	O
(	O	O
without	O	O
dentures	O	O
)	O	O
.	O	O


Bacteriological	O	O
investigations	O	O
were	O	O
performed	O	O
in	O	O
55	O	O
patients	O	O
from	O	O
the	O	O
department	O	O
of	O	O
internal	O	O
medicine	O	O
(	O	O
32	O	O
diabetic	O	O
patients	O	O
)	O	O
and	O	O
40	O	O
patients	O	O
treated	O	O
in	O	O
surgical	O	O
department	O	O
(	O	O
25	O	O
patients	O	O
with	O	O
malignancy	O	O
)	O	O
.	O	O

Palate	O	O
mucosa	O	O
and	O	O
tongue	O	O
dorsa	O	O
swabs	O	O
were	O	O
collected	O	O
from	O	O
two	O	O
groups	O	O
of	O	O
patients	O	O
,	O	O
and	O	O
additionally	O	O
swabs	O	O
from	O	O
mucosal	O	O
part	O	O
of	O	O
denture	O	O
surfaces	O	O
in	O	O
prosthetic	O	O
patients	O	O
.	O	O

Cultures	O	O
in	O	O
oxygenic	O	O
and	O	O
microaerophilic	O	O
(	O	O
5	O	O
%	O	O
CO2	O	O
)	O	O
conditions	O	O
were	O	O
conducted	O	O
on	O	O
solid	O	O
non-selective	O	O
and	O	O
selective	O	O
media	O	O
as	O	O
well	O	O
as	O	O
media	O	O
enriched	O	O
with	O	O
5	O	O
%	O	O
sheep	O	O
blood	O	O
.	O	O

Standard	O	O
procedures	O	O
of	O	O
bacterial	O	O
culture	O	O
and	O	O
identification	O	O
were	O	O
applied	O	O
.	O	O

Among	O	O
95	O	O
of	O	O
examined	O	O
patients	O	O
,	O	O
57	O	O
(	O	O
60.0	O	O
%	O	O
)	O	O
with	O	O
removable	O	O
dentures	O	O
and	O	O
38	O	O
(	O	O
40.0	O	O
%	O	O
)	O	O
had	O	O
their	O	O
own	O	O
dentition	O	O
.	O	O

As	O	O
far	O	O
as	O	O
prosthetic	O	O
patients	O	O
were	O	O
concerned	O	O
,	O	O
the	O	O
rate	O	O
of	O	O
bacterial	O	O
isolations	O	O
from	O	O
palate	O	O
,	O	O
tongue	O	O
dorsa	O	O
and	O	O
denture	O	O
plaque	O	O
swabs	O	O
were	O	O
generally	O	O
comparable	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
;	O	O
in	O	O
number	O	O
and	O	O
species	O	O
compositions	O	O
.	O	O

Statistically	O	O
significant	O	O
differences	O	O
were	O	O
observed	O	O
in	O	O
the	O	O
bacterial	O	O
composition	O	O
of	O	O
denture	O	O
plaques	O	O
,	O	O
palate	O	O
and	O	O
tongue	O	O
dorsa	O	O
in	O	O
patients	O	O
with	O	O
and	O	O
without	O	O
abdominal	O	O
cancers	O	O
.	O	O

Patients	O	O
without	O	O
cancer	O	O
did	O	O
not	O	O
reveal	O	O
staphylococci	B-bacteria	B-bacteria
and	O	O
enteric	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
the	O	O
samples	O	O
from	O	O
a	O	O
various	O	O
sites	O	O
of	O	O
their	O	O
oral	O	O
cavities	O	O
.	O	O

These	O	O
bacteria	O	O
were	O	O
most	O	O
common	O	O
in	O	O
cancer	O	O
patients	O	O
.	O	O

Similar	O	O
(	O	O
in	O	O
number	O	O
and	O	O
species	O	O
)	O	O
composition	O	O
of	O	O
bacteria	O	O
occurred	O	O
in	O	O
palate	O	O
and	O	O
tongue	O	O
swabs	O	O
in	O	O
patients	O	O
without	O	O
dentures	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
incidence	O	O
rate	O	O
of	O	O
aerobic	O	O
bacteria	O	O
in	O	O
denture	O	O
plaques	O	O
and	O	O
palatal	O	O
mucosa	O	O
of	O	O
patients	O	O
with	O	O
(	O	O
37/57	O	O
;	O	O
64.9	O	O
%	O	O
)	O	O
and	O	O
without	O	O
(	O	O
20/57	O	O
;	O	O
35.1	O	O
%	O	O
)	O	O
denture	O	O
associated	O	O
stomatitis	O	O
were	O	O
comparable	O	O
(	O	O
except	O	O
for	O	O
Neisseria	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
)	O	O
.	O	O

1	O	O
)	O	O
Generally	O	O
,	O	O
there	O	O
were	O	O
no	O	O
statistically	O	O
significant	O	O
differences	O	O
in	O	O
species	O	O
composition	O	O
of	O	O
bacteria	O	O
isolated	O	O
from	O	O
the	O	O
hard	O	O
palate	O	O
and	O	O
tongue	O	O
dorsa	O	O
in	O	O
patients	O	O
with	O	O
and	O	O
without	O	O
removable	O	O
dentures	O	O
.	O	O

2	O	O
)	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

and	O	O
Gram-negative	B-bacteria	B-bacteria
enteric	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
were	O	O
isolated	O	O
more	O	O
often	O	O
from	O	O
denture	O	O
plaque	O	O
,	O	O
palate	O	O
and	O	O
tongue	O	O
dorsa	O	O
of	O	O
cancer	O	O
patients	O	O
than	O	O
from	O	O
patients	O	O
without	O	O
cancer	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

3	O	O
)	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

was	O	O
isolated	O	O
more	O	O
frequently	O	O
from	O	O
denture	O	O
plaques	O	O
of	O	O
diabetic	O	O
patients	O	O
compared	O	O
with	O	O
non-diabetic	O	O
patients	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

4	O	O
)	O	O
No	O	O
significant	O	O
differences	O	O
observed	O	O
in	O	O
isolation	O	O
frequencies	O	O
(	O	O
%	O	O
)	O	O
of	O	O
aerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
denture	O	O
plaques	O	O
and	O	O
palatal	O	O
mucosa	O	O
of	O	O
patients	O	O
with	O	O
and	O	O
without	O	O
denture	O	O
associated	O	O
stomatitis	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
hypothesis	O	O
that	O	O
food-borne	O	O
viable	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
cells	O	O
could	O	O
enter	O	O
the	O	O
root	O	O
canal	O	O
space	O	O
via	O	O
coronal	O	O
leakage	O	O
.	O	O

In	O	O
a	O	O
simulated	O	O
oral	O	O
environment	O	O
under	O	O
mastication	O	O
the	O	O
capacity	O	O
of	O	O
a	O	O
calcium	O	O
sulphate-based	O	O
temporary	O	O
filling	O	O
material	O	O
(	O	O
Cavit	O	O
W	O	O
)	O	O
to	O	O
prevent	O	O
leakage	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
from	O	O
a	O	O
cheese	O	O
through	O	O
the	O	O
endodontic	O	O
access	O	O
cavity	O	O
into	O	O
the	O	O
pulp	O	O
chamber	O	O
was	O	O
assessed	O	O
.	O	O

Standardized	O	O
class	O	O
I	O	O
access	O	O
cavities	O	O
were	O	O
prepared	O	O
in	O	O
human	O	O
maxillary	O	O
molars	O	O
.	O	O

These	O	O
were	O	O
filled	O	O
with	O	O
Cavit	O	O
of	O	O
either	O	O
2	O	O
or	O	O
4	O	O
mm	O	O
thickness	O	O
(	O	O
n=16	O	O
,	O	O
each	O	O
)	O	O
.	O	O

Empty	O	O
access	O	O
cavities	O	O
served	O	O
as	O	O
positive	O	O
,	O	O
teeth	O	O
filled	O	O
with	O	O
a	O	O
light-curing	O	O
composite	O	O
material	O	O
acted	O	O
as	O	O
negative	O	O
controls	O	O
(	O	O
n=8	O	O
,	O	O
each	O	O
)	O	O
.	O	O

A	O	O
cheese	O	O
containing	O	O
viable	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
cells	O	O
was	O	O
placed	O	O
on	O	O
the	O	O
occlusal	O	O
aspects	O	O
of	O	O
test	O	O
and	O	O
control	O	O
teeth	O	O
,	O	O
which	O	O
were	O	O
subsequently	O	O
subjected	O	O
to	O	O
680	O	O
mastication	O	O
loads	O	O
per	O	O
day	O	O
for	O	O
1	O	O
week	O	O
in	O	O
a	O	O
masticator	O	O
device	O	O
perfused	O	O
with	O	O
artificial	O	O
saliva	O	O
at	O	O
37	O	O
degrees	O	O
C.	O	O
Leakage	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
from	O	O
the	O	O
cheese	O	O
into	O	O
the	O	O
pulp	O	O
chamber	O	O
was	O	O
assessed	O	O
by	O	O
culture	O	O
on	O	O
a	O	O
kanamycin	O	O
aesculin	O	O
azide	O	O
agar	O	O
and	O	O
compared	O	O
between	O	O
groups	O	O
using	O	O
Fisher	O	O
's	O	O
exact	O	O
test	O	O
.	O	O

All	O	O
of	O	O
the	O	O
positive	O	O
controls	O	O
showed	O	O
pure	O	O
growth	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
.	O	O

In	O	O
addition	O	O
,	O	O
one	O	O
of	O	O
the	O	O
negative	O	O
control	O	O
teeth	O	O
leaked	O	O
.	O	O

The	O	O
4	O	O
mm	O	O
application	O	O
of	O	O
Cavit	O	O
prevented	O	O
leakage	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
significantly	O	O
better	O	O
than	O	O
the	O	O
corresponding	O	O
2	O	O
mm	O	O
application	O	O
:	O	O
1	O	O
of	O	O
16	O	O
specimens	O	O
compared	O	O
with	O	O
6	O	O
of	O	O
16	O	O
specimens	O	O
had	O	O
leakage	O	O
,	O	O
respectively	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
current	O	O
results	O	O
substantiate	O	O
the	O	O
suspicion	O	O
that	O	O
food-derived	O	O
microbiota	O	O
could	O	O
enter	O	O
the	O	O
necrotic	O	O
root	O	O
canal	O	O
system	O	O
via	O	O
microleakage	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluated	O	O
the	O	O
prevalence	O	O
rate	O	O
of	O	O
oral	O	O
viridans	B-bacteria	B-bacteria
group	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
VGS	B-bacteria	B-bacteria
)	O	O
and	O	O
their	O	O
susceptibilities	O	O
to	O	O
some	O	O
antibiotics	O	O
in	O	O
healthy	O	O
children	O	O
.	O	O

Samples	O	O
of	O	O
pharyngeal	O	O
swabs	O	O
and	O	O
supragingival	O	O
dental	O	O
plaques	O	O
for	O	O
microbiological	O	O
studies	O	O
were	O	O
collected	O	O
from	O	O
206	O	O
healthy	O	O
children	O	O
,	O	O
aged	O	O
4-18	O	O
years	O	O
.	O	O

Additionally	O	O
,	O	O
75	O	O
samples	O	O
of	O	O
carious	O	O
lesions	O	O
from	O	O
children	O	O
with	O	O
dental	O	O
caries	O	O
were	O	O
included	O	O
.	O	O

The	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
isolated	O	O
and	O	O
identified	O	O
using	O	O
standard	O	O
methods	O	O
and	O	O
commercial	O	O
identification	O	O
kits	O	O
.	O	O

For	O	O
performance	O	O
of	O	O
antibacterial	O	O
susceptibility	O	O
testing	O	O
of	O	O
VGS	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
disk	O	O
diffusion	O	O
and/or	O	O
breakpoints	O	O
procedures	O	O
were	O	O
used	O	O
according	O	O
to	O	O
NCCLS	O	O
standards	O	O
and	O	O
criteria	O	O
.	O	O

A	O	O
total	O	O
of	O	O
425	O	O
VGS	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
tested	O	O
against	O	O
penicillin	O	O
,	O	O
ampicillin	O	O
,	O	O
erythromycin	O	O
,	O	O
clindamycin	O	O
,	O	O
tetracycline	O	O
,	O	O
doxycycline	O	O
,	O	O
ciprofloxacin	O	O
and	O	O
vancomycin	O	O
.	O	O

A	O	O
total	O	O
of	O	O
239	O	O
VGS	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
belonging	O	O
to	O	O
8	O	O
species	O	O
from	O	O
pharyngeal	O	O
swabs	O	O
of	O	O
192	O	O
(	O	O
93.2	O	O
%	O	O
)	O	O
children	O	O
were	O	O
isolated	O	O
.	O	O

VGS	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
from	O	O
supragingival	O	O
plaques	O	O
were	O	O
isolated	O	O
in	O	O
149	O	O
(	O	O
72.3	O	O
%	O	O
)	O	O
healthy	O	O
children	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
and	O	O
from	O	O
carious	O	O
lesions	O	O
in	O	O
37	O	O
(	O	O
49.3	O	O
%	O	O
)	O	O
children	O	O
with	O	O
dental	O	O
caries	O	O
.	O	O

VGS	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
of	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
species	O	O
were	O	O
isolated	O	O
most	O	O
frequently	O	O
from	O	O
4-5	O	O
year	O	O
old	O	O
as	O	O
compared	O	O
to	O	O
12	O	O
and	O	O
18	O	O
year	O	O
old	O	O
children	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
while	O	O
S.	B-bacteria	B-bacteria
vestibularis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
most	O	O
often	O	O
in	O	O
12	O	O
year	O	O
old	O	O
ones	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Among	O	O
425	O	O
VGS	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
,	O	O
high	O	O
level	O	O
of	O	O
penicillin	O	O
resistance	O	O
(	O	O
MIC	O	O
>	O	O
or	O	O
=	O	O
2.0	O	O
mg/L	O	O
)	O	O
was	O	O
shown	O	O
in	O	O
71	O	O
(	O	O
16.7	O	O
%	O	O
)	O	O
strains	O	O
,	O	O
33	O	O
(	O	O
46.5	O	O
%	O	O
)	O	O
of	O	O
them	O	O
belonged	O	O
to	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
.	O	O

VGS	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
also	O	O
resistant	O	O
to	O	O
erythromycin	O	O
(	O	O
23.5	O	O
%	O	O
)	O	O
,	O	O
clindamycin	O	O
(	O	O
23.1	O	O
%	O	O
)	O	O
,	O	O
tetracyclines	O	O
(	O	O
T-52	O	O
%	O	O
,	O	O
DOX-16	O	O
%	O	O
)	O	O
,	O	O
gentamycin	O	O
(	O	O
25.9	O	O
%	O	O
)	O	O
and	O	O
ciprofloxacin	O	O
(	O	O
55.2	O	O
%	O	O
)	O	O
.	O	O

All	O	O
VGS	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
vancomycin	O	O
-	O	O
susceptible	O	O
.	O	O

1	O	O
.	O	O

In	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
healthy	O	O
children	O	O
,	O	O
approximately	O	O
98	O	O
%	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
belonged	O	O
to	O	O
two	O	O
VGS	B-bacteria	B-bacteria
groups	O	O
,	O	O
i.e	O	O
.	O	O

mitis	B-bacteria	B-bacteria
and	O	O
salivarius	B-bacteria	B-bacteria
groups	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
of	I-bacteria	I-bacteria
mutans	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
anginosus	E-bacteria	I-bacteria
groups	O	O
were	O	O
isolated	O	O
sporadically	O	O
(	O	O
2	O	O
%	O	O
)	O	O
.	O	O

2	O	O
.	O	O

We	O	O
observed	O	O
difference	O	O
in	O	O
susceptibility	O	O
to	O	O
penicillin	O	O
and	O	O
other	O	O
antibiotics	O	O
between	O	O
the	O	O
various	O	O
species	O	O
of	O	O
viridans	O	O
groups	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Mitis	B-bacteria	B-bacteria
group	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
(	O	O
except	O	O
S.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
)	O	O
were	O	O
more	O	O
frequently	O	O
penicillin-resistant	O	O
(	O	O
23	O	O
%	O	O
)	O	O
in	O	O
comparison	O	O
to	O	O
salivarius	O	O
group	O	O
of	O	O
VGS	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
(	O	O
9	O	O
%	O	O
)	O	O
(	O	O
p	O	O
=	O	O
0.0001	O	O
)	O	O
.	O	O

Respiratory	O	O
infection	O	O
is	O	O
a	O	O
major	O	O
cause	O	O
of	O	O
death	O	O
in	O	O
the	O	O
elderly	O	O
.	O	O

We	O	O
have	O	O
evaluated	O	O
the	O	O
role	O	O
of	O	O
professional	O	O
oral	O	O
health	O	O
care	O	O
(	O	O
POHC	O	O
)	O	O
by	O	O
dental	O	O
hygienists	O	O
in	O	O
reducing	O	O
respiratory	O	O
infections	O	O
in	O	O
elderly	O	O
persons	O	O
requiring	O	O
nursing	O	O
care	O	O
.	O	O

Two	O	O
populations	O	O
of	O	O
elderly	O	O
persons	O	O
,	O	O
one	O	O
receiving	O	O
POHC	O	O
and	O	O
one	O	O
not	O	O
,	O	O
were	O	O
examined	O	O
to	O	O
determine	O	O
numbers	O	O
of	O	O
microorganisms	O	O
,	O	O
potent	O	O
pathogens	O	O
of	O	O
respiratory	O	O
infection	O	O
,	O	O
enzymatic	O	O
activity	O	O
in	O	O
saliva	O	O
,	O	O
fevers	O	O
,	O	O
prevalence	O	O
of	O	O
fatal	O	O
aspiration	O	O
pneumonia	O	O
and	O	O
prevalence	O	O
of	O	O
influenza	O	O
.	O	O

In	O	O
the	O	O
first	O	O
population	O	O
,	O	O
we	O	O
found	O	O
a	O	O
high	O	O
prevalence	O	O
of	O	O
potent	O	O
respiratory	O	O
pathogens	O	O
such	O	O
as	O	O
Staphylococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Candida	O	O
albicans	O	O
.	O	O

Patients	O	O
who	O	O
received	O	O
POHC	O	O
showed	O	O
a	O	O
lower	O	O
prevalence	O	O
for	O	O
these	O	O
pathogens	O	O
than	O	O
those	O	O
who	O	O
did	O	O
not	O	O
.	O	O

The	O	O
ratio	O	O
of	O	O
fatal	O	O
aspiration	O	O
pneumonia	O	O
in	O	O
POHC	O	O
patients	O	O
was	O	O
significantly	O	O
lower	O	O
than	O	O
that	O	O
in	O	O
patients	O	O
without	O	O
POHC	O	O
(	O	O
non-POHC	O	O
)	O	O
over	O	O
a	O	O
24-month	O	O
period	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
a	O	O
fever	O	O
of	O	O
37.8	O	O
degrees	O	O
C	O	O
or	O	O
more	O	O
in	O	O
POHC	O	O
patients	O	O
was	O	O
significantly	O	O
lower	O	O
than	O	O
that	O	O
in	O	O
the	O	O
non-POHC	O	O
group	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

In	O	O
the	O	O
second	O	O
study	O	O
population	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
effects	O	O
of	O	O
POHC	O	O
on	O	O
infection	O	O
with	O	O
influenza	O	O
over	O	O
a	O	O
6-month	O	O
period	O	O
.	O	O

In	O	O
the	O	O
POHC	O	O
group	O	O
,	O	O
neuraminidase	O	O
and	O	O
trypsin-like	O	O
protease	O	O
activities	O	O
decreased	O	O
,	O	O
and	O	O
one	O	O
of	O	O
98	O	O
patients	O	O
was	O	O
diagnosed	O	O
with	O	O
influenza	O	O
;	O	O
whereas	O	O
,	O	O
in	O	O
the	O	O
non-POHC	O	O
group	O	O
,	O	O
nine	O	O
of	O	O
92	O	O
patients	O	O
were	O	O
diagnosed	O	O
with	O	O
influenza	O	O
.	O	O

The	O	O
relative	O	O
risk	O	O
of	O	O
developing	O	O
influenza	O	O
while	O	O
under	O	O
POHC	O	O
was	O	O
0.1	O	O
(	O	O
95	O	O
%	O	O
CI	O	O
0.01-0.81	O	O
,	O	O
P	O	O
=	O	O
0.008	O	O
)	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
POHC	O	O
by	O	O
dental	O	O
hygienists	O	O
is	O	O
effective	O	O
in	O	O
preventing	O	O
respiratory	O	O
infections	O	O
in	O	O
elderly	O	O
persons	O	O
requiring	O	O
nursing	O	O
care	O	O
.	O	O

A	O	O
total	O	O
of	O	O
270	O	O
viridans	B-bacteria	B-bacteria
group	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
VS	B-bacteria	B-bacteria
)	O	O
isolated	O	O
from	O	O
healthy	O	O
children	O	O
,	O	O
identified	O	O
to	O	O
the	O	O
species	O	O
level	O	O
,	O	O
were	O	O
tested	O	O
for	O	O
their	O	O
susceptibilities	O	O
to	O	O
penicillin	O	O
,	O	O
imipenem	O	O
,	O	O
erythromycin	O	O
,	O	O
and	O	O
vancomycin	O	O
.	O	O

A	O	O
total	O	O
of	O	O
270	O	O
isolates	O	O
and	O	O
1,080	O	O
organism-antibiotic	O	O
combinations	O	O
were	O	O
evaluated	O	O
.	O	O

The	O	O
overall	O	O
susceptibility	O	O
rates	O	O
of	O	O
all	O	O
isolates	O	O
obtained	O	O
by	O	O
the	O	O
Etest	O	O
(	O	O
ET	O	O
)	O	O
versus	O	O
agar	O	O
dilution	O	O
(	O	O
AD	O	O
)	O	O
were	O	O
60.4	O	O
%	O	O
versus	O	O
61.8	O	O
%	O	O
for	O	O
penicillin	O	O
,	O	O
63.8	O	O
%	O	O
versus	O	O
63.9	O	O
%	O	O
for	O	O
erythromycin	O	O
,	O	O
90.6	O	O
%	O	O
versus	O	O
96	O	O
%	O	O
for	O	O
vancomycin	O	O
,	O	O
and	O	O
99.1	O	O
%	O	O
versus	O	O
96.0	O	O
%	O	O
for	O	O
imipenem	O	O
,	O	O
respectively	O	O
.	O	O

Major	O	O
discrepancies	O	O
occurred	O	O
in	O	O
the	O	O
testing	O	O
of	O	O
the	O	O
susceptibility	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
to	O	O
vancomycin	O	O
,	O	O
with	O	O
59.5	O	O
%	O	O
(	O	O
ET	O	O
)	O	O
versus	O	O
100	O	O
%	O	O
(	O	O
AD	O	O
)	O	O
,	O	O
followed	O	O
by	O	O
S.	O	O
salivarius	O	O
,	O	O
with	O	O
84.1	O	O
%	O	O
versus	O	O
100	O	O
%	O	O
;	O	O
S.	O	O
oralis	O	O
,	O	O
with	O	O
82.1	O	O
%	O	O
versus	O	O
96.4	O	O
%	O	O
;	O	O
and	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
with	O	O
90	O	O
%	O	O
versus	O	O
100	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

There	O	O
were	O	O
also	O	O
differences	O	O
in	O	O
the	O	O
rates	O	O
of	O	O
susceptibility	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
66.5	O	O
%	O	O
(	O	O
ET	O	O
)	O	O
versus	O	O
85.1	O	O
%	O	O
(	O	O
AD	O	O
)	O	O
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
,	O	O
82.9	O	O
%	O	O
versus	O	O
72.1	O	O
%	O	O
,	O	O
respectively	O	O
,	O	O
to	O	O
penicillin	O	O
.	O	O

General	O	O
agreement	O	O
between	O	O
the	O	O
results	O	O
of	O	O
ET	O	O
and	O	O
AD	O	O
was	O	O
obtained	O	O
for	O	O
973	O	O
organism-antibiotic	O	O
combinations	O	O
out	O	O
of	O	O
1,080	O	O
antibiotic	O	O
combinations	O	O
,	O	O
i.e.	O	O
,	O	O
90.1	O	O
%	O	O
.	O	O

Very	O	O
major	O	O
errors	O	O
were	O	O
found	O	O
for	O	O
6.8	O	O
%	O	O
of	O	O
isolates	O	O
,	O	O
and	O	O
major	O	O
errors	O	O
were	O	O
found	O	O
for	O	O
3.2	O	O
%	O	O
of	O	O
isolates	O	O
;	O	O
the	O	O
minor	O	O
errors	O	O
were	O	O
negligible	O	O
.	O	O

Agreement	O	O
between	O	O
the	O	O
results	O	O
of	O	O
the	O	O
two	O	O
methods	O	O
was	O	O
98.7	O	O
%	O	O
for	O	O
penicillin	O	O
,	O	O
94.6	O	O
%	O	O
for	O	O
vancomycin	O	O
,	O	O
96.9	O	O
%	O	O
for	O	O
imipenem	O	O
,	O	O
and	O	O
99.9	O	O
%	O	O
for	O	O
erythromycin	O	O
.	O	O

The	O	O
highest	O	O
rate	O	O
of	O	O
very	O	O
major	O	O
errors	O	O
was	O	O
for	O	O
vancomycin	O	O
,	O	O
at	O	O
5.4	O	O
%	O	O
.	O	O

The	O	O
ET	O	O
appears	O	O
to	O	O
be	O	O
as	O	O
efficient	O	O
as	O	O
AD	O	O
for	O	O
susceptibility	O	O
testing	O	O
of	O	O
VS	O	O
,	O	O
except	O	O
for	O	O
vancomycin	O	O
,	O	O
where	O	O
very	O	O
major	O	O
errors	O	O
in	O	O
the	O	O
results	O	O
were	O	O
relatively	O	O
high	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
influence	O	O
of	O	O
oral	O	O
hygiene	O	O
instruction	O	O
(	O	O
OHI	O	O
)	O	O
on	O	O
oral	O	O
hygiene	O	O
status	O	O
and	O	O
on	O	O
the	O	O
reduction	O	O
of	O	O
inducing	O	O
bacteria	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
)	O	O

in	O	O
30	O	O
subjects	O	O
(	O	O
12	O	O
males	O	O
and	O	O
18	O	O
females	O	O
)	O	O
with	O	O
an	O	O
age	O	O
range	O	O
from	O	O
10	O	O
to	O	O
14	O	O
years	O	O
.	O	O

The	O	O
patients	O	O
were	O	O
instructed	O	O
on	O	O
how	O	O
to	O	O
carry	O	O
out	O	O
effective	O	O
oral	O	O
hygiene	O	O
close	O	O
to	O	O
brackets	O	O
and	O	O
ligatures	O	O
,	O	O
and	O	O
in	O	O
the	O	O
use	O	O
of	O	O
dental	O	O
floss	O	O
for	O	O
cleaning	O	O
spaces	O	O
around	O	O
brackets	O	O
,	O	O
between	O	O
the	O	O
teeth	O	O
and	O	O
under	O	O
archwires	O	O
.	O	O

The	O	O
plaque	O	O
index	O	O
(	O	O
PI	O	O
)	O	O
was	O	O
used	O	O
to	O	O
measure	O	O
oral	O	O
hygiene	O	O
status	O	O
,	O	O
and	O	O
the	O	O
level	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

was	O	O
determined	O	O
using	O	O
the	O	O
colour	O	O
reaction	O	O
time	O	O
test	O	O
before	O	O
and	O	O
after	O	O
1	O	O
month	O	O
of	O	O
OHI	O	O
.	O	O

Statistical	O	O
analysis	O	O
included	O	O
a	O	O
Student	O	O
's	O	O
t-test	O	O
and	O	O
chi-square	O	O
test	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
OHI	O	O
significantly	O	O
improved	O	O
oral	O	O
hygiene	O	O
.	O	O

The	O	O
percentage	O	O
of	O	O
patients	O	O
with	O	O
a	O	O
PI	O	O
exceeding	O	O
1	O	O
decreased	O	O
from	O	O
23.3	O	O
to	O	O
10	O	O
per	O	O
cent	O	O
and	O	O
for	O	O
those	O	O
with	O	O
a	O	O
PI	O	O
below	O	O
0.1	O	O
it	O	O
increased	O	O
from	O	O
20	O	O
to	O	O
60	O	O
per	O	O
cent	O	O
.	O	O

The	O	O
level	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

was	O	O
not	O	O
reduced	O	O
.	O	O

The	O	O
percentage	O	O
of	O	O
subjects	O	O
with	O	O
excessive	O	O
levels	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
above	O	O
10	O	O
(	O	O
6	O	O
)	O	O
bacteria	O	O
in	O	O
1	O	O
ml	O	O
of	O	O
saliva	O	O
)	O	O
decreased	O	O
after	O	O
OHI	O	O
but	O	O
only	O	O
from	O	O
73.3	O	O
to	O	O
70	O	O
per	O	O
cent	O	O
.	O	O

For	O	O
Lactobacillus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
a	O	O
level	O	O
above	O	O
10	O	O
(	O	O
5	O	O
)	O	O
of	O	O
bacteria	O	O
in	O	O
1	O	O
ml	O	O
of	O	O
saliva	O	O
was	O	O
found	O	O
for	O	O
all	O	O
subjects	O	O
at	O	O
both	O	O
time	O	O
points	O	O
.	O	O

Patients	O	O
with	O	O
fixed	O	O
appliances	O	O
,	O	O
trained	O	O
in	O	O
scrupulous	O	O
tooth	O	O
cleaning	O	O
,	O	O
remain	O	O
at	O	O
risk	O	O
of	O	O
developing	O	O
caries	O	O
and	O	O
should	O	O
be	O	O
carefully	O	O
monitored	O	O
.	O	O

Effect	O	O
of	O	O
Bactisporin	O	O
--	O	O
a	O	O
probiotic	B-bacteria	B-bacteria
,	O	O
containing	O	O
spores	O	O
of	O	O
aerobic	B-bacteria	B-bacteria
Bacillus	I-bacteria	I-bacteria
subtilis	I-bacteria	I-bacteria
3H	I-bacteria	I-bacteria
bacterium	E-bacteria	I-bacteria
--	O	O
for	O	O
complex	O	O
treatment	O	O
of	O	O
patients	O	O
with	O	O
nosocomial	O	O
urinary	O	O
tract	O	O
infections	O	O
was	O	O
studied	O	O
.	O	O

68	O	O
Cultures	O	O
of	O	O
different	O	O
species	O	O
of	O	O
conditionally	O	O
pathogenic	O	O
bacteria	O	O
were	O	O
isolated	O	O
from	O	O
urine	O	O
of	O	O
the	O	O
patients	O	O
.	O	O

Susceptibility	O	O
of	O	O
the	O	O
isolated	O	O
cultures	O	O
to	O	O
antibiotics	O	O
before	O	O
and	O	O
after	O	O
application	O	O
of	O	O
B.	B-bacteria	B-bacteria
subtilis	I-bacteria	I-bacteria
3H	E-bacteria	I-bacteria
metabolites	O	O
was	O	O
determined	O	O
.	O	O

The	O	O
metabolites	O	O
were	O	O
accumulated	O	O
on	O	O
potato-glucose	O	O
agar	O	O
(	O	O
PGA	O	O
)	O	O
while	O	O
bacterium	O	O
was	O	O
cultivated	O	O
on	O	O
kapron	O	O
membranes	O	O
placed	O	O
on	O	O
surface	O	O
of	O	O
the	O	O
medium	O	O
.	O	O

Influence	O	O
of	O	O
obtained	O	O
metabolites	O	O
on	O	O
isolated	O	O
strains	O	O
was	O	O
assessed	O	O
by	O	O
cultivation	O	O
of	O	O
each	O	O
strain	O	O
in	O	O
metabolites-rich	O	O
PGA	O	O
during	O	O
24	O	O
h.	O	O
Metabolites	O	O
of	O	O
B.	B-bacteria	B-bacteria
subtilis	E-bacteria	I-bacteria
led	O	O
to	O	O
decrease	O	O
in	O	O
resistance	O	O
of	O	O
isolated	O	O
uropathogenic	O	O
microflora	O	O
to	O	O
antibiotics	O	O
.	O	O

Use	O	O
of	O	O
Bactisporin	O	O
in	O	O
complex	O	O
treatment	O	O
of	O	O
nosocomial	O	O
urinary	O	O
tract	O	O
infections	O	O
resulted	O	O
in	O	O
accelerated	O	O
elimination	O	O
of	O	O
causative	O	O
microorganism	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
association	O	O
of	O	O
recurrent	O	O
aphthous	O	O
ulcer	O	O
(	O	O
RAU	O	O
)	O	O
with	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
Hp	B-bacteria	B-bacteria
)	O	O
infection	O	O
and	O	O
digestive	O	O
diseases	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
82	O	O
patients	O	O
with	O	O
RAU	O	O
and	O	O
74	O	O
healthy	O	O
volunteers	O	O
for	O	O
Hp	B-bacteria	B-bacteria
detection	O	O
with	O	O
PCR	O	O
.	O	O

The	O	O
positivity	O	O
rates	O	O
of	O	O
HP	B-bacteria	B-bacteria
differed	O	O
significantly	O	O
between	O	O
RAU	O	O
patients	O	O
and	O	O
healthy	O	O
volunteers	O	O
(	O	O
43.9	O	O
%	O	O
vs	O	O
16.2	O	O
%	O	O
,	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

In	O	O
the	O	O
82	O	O
RAU	O	O
patients	O	O
,	O	O
22	O	O
(	O	O
26.82	O	O
%	O	O
)	O	O
were	O	O
identified	O	O
to	O	O
have	O	O
gastritis	O	O
and	O	O
peptic	O	O
ulcer	O	O
,	O	O
whereas	O	O
only	O	O
7	O	O
out	O	O
of	O	O
the	O	O
74	O	O
healthy	O	O
volunteers	O	O
(	O	O
10.45	O	O
%	O	O
)	O	O
had	O	O
such	O	O
digestive	O	O
diseases	O	O
,	O	O
showing	O	O
significant	O	O
difference	O	O
between	O	O
them	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Hp	B-bacteria	B-bacteria
might	O	O
in	O	O
some	O	O
way	O	O
associate	O	O
with	O	O
RAU	O	O
,	O	O
which	O	O
in	O	O
turn	O	O
is	O	O
associated	O	O
with	O	O
an	O	O
increased	O	O
incidence	O	O
of	O	O
digestive	O	O
diseases	O	O
.	O	O

Wine	O	O
contains	O	O
a	O	O
number	O	O
of	O	O
biologically	O	O
active	O	O
compounds	O	O
with	O	O
beneficial	O	O
effects	O	O
on	O	O
human	O	O
health	O	O
.	O	O

The	O	O
antibacterial	O	O
action	O	O
of	O	O
commercial	O	O
red	O	O
and	O	O
white	O	O
wines	O	O
against	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
responsible	O	O
for	O	O
caries	O	O
development	O	O
and	O	O
against	O	O
S.	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
responsible	O	O
for	O	O
pharyngitis	O	O
was	O	O
studied	O	O
.	O	O

Its	O	O
postcontact	O	O
effect	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
also	O	O
studied	O	O
.	O	O

Both	O	O
wines	O	O
displayed	O	O
activity	O	O
.	O	O

The	O	O
compounds	O	O
responsible	O	O
for	O	O
such	O	O
activities	O	O
were	O	O
succinic	O	O
,	O	O
malic	O	O
,	O	O
lactic	O	O
,	O	O
tartaric	O	O
,	O	O
citric	O	O
,	O	O
and	O	O
acetic	O	O
acid	O	O
.	O	O

The	O	O
synthetic	O	O
mixtures	O	O
of	O	O
the	O	O
organic	O	O
acids	O	O
tested	O	O
at	O	O
the	O	O
concentrations	O	O
found	O	O
in	O	O
wine	O	O
had	O	O
greater	O	O
antibacterial	O	O
activity	O	O
than	O	O
the	O	O
beverages	O	O
,	O	O
indicating	O	O
that	O	O
in	O	O
wine	O	O
they	O	O
are	O	O
inhibited	O	O
by	O	O
other	O	O
components	O	O
.	O	O

Wine	O	O
polyphenols	O	O
displayed	O	O
no	O	O
activity	O	O
against	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
or	O	O
S.	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
.	O	O

Findings	O	O
show	O	O
that	O	O
wine	O	O
is	O	O
active	O	O
against	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
S.	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
and	O	O
suggest	O	O
that	O	O
it	O	O
enhances	O	O
oral	O	O
health	O	O
.	O	O

Patients	O	O
undergoing	O	O
allogeneic	O	O
stem	O	O
cell	O	O
transplantation	O	O
are	O	O
at	O	O
high	O	O
risk	O	O
for	O	O
infection	O	O
with	O	O
a	O	O
variety	O	O
of	O	O
pathogens	O	O
during	O	O
different	O	O
phases	O	O
of	O	O
the	O	O
procedure	O	O
.	O	O

Human	O	O
infections	O	O
due	O	O
to	O	O
Bartonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

are	O	O
viewed	O	O
as	O	O
emerging	O	O
diseases	O	O
typical	O	O
in	O	O
,	O	O
although	O	O
not	O	O
exclusive	O	O
to	O	O
,	O	O
immunosuppressed	O	O
patients	O	O
,	O	O
in	O	O
particular	O	O
those	O	O
with	O	O
AIDS	O	O
,	O	O
organ	O	O
transplants	O	O
and	O	O
haematological	O	O
malignancies	O	O
.	O	O

We	O	O
describe	O	O
four	O	O
patients	O	O
,	O	O
three	O	O
children	O	O
and	O	O
one	O	O
adult	O	O
,	O	O
who	O	O
developed	O	O
vegetating	O	O
papillomatous	O	O
lesions	O	O
exclusively	O	O
on	O	O
the	O	O
oral	O	O
mucosae	O	O
.	O	O

They	O	O
shared	O	O
a	O	O
history	O	O
of	O	O
haematological	O	O
malignancy	O	O
and	O	O
allogeneic	O	O
bone	O	O
marrow/stem	O	O
cell	O	O
transplantation	O	O
,	O	O
and	O	O
later	O	O
developed	O	O
chronic	O	O
graft-versus-host	O	O
disease	O	O
,	O	O
also	O	O
involving	O	O
the	O	O
oral	O	O
mucosae	O	O
.	O	O

Histopathologically	O	O
,	O	O
the	O	O
vegetating	O	O
lesions	O	O
were	O	O
characterized	O	O
by	O	O
a	O	O
diffuse	O	O
neoangiogenesis	O	O
,	O	O
granulation-like	O	O
tissue	O	O
,	O	O
and	O	O
a	O	O
mixed	O	O
cell	O	O
infiltrate	O	O
predominantly	O	O
composed	O	O
of	O	O
neutrophils	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
found	O	O
in	O	O
the	O	O
endothelial	O	O
cells	O	O
of	O	O
the	O	O
vessels	O	O
in	O	O
the	O	O
deeper	O	O
portion	O	O
of	O	O
the	O	O
corium	O	O
by	O	O
electron	O	O
microscopy	O	O
.	O	O

In	O	O
three	O	O
cases	O	O
,	O	O
DNA	O	O
of	O	O
B.	B-bacteria	B-bacteria
henselae	E-bacteria	I-bacteria
was	O	O
detected	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
,	O	O
and	O	O
confirmed	O	O
by	O	O
sequencing	O	O
of	O	O
the	O	O
PCR	O	O
products	O	O
.	O	O

All	O	O
the	O	O
lesions	O	O
healed	O	O
after	O	O
systemic	O	O
antibiotic	O	O
therapy	O	O
,	O	O
although	O	O
some	O	O
recurred	O	O
after	O	O
months	O	O
,	O	O
and	O	O
regressed	O	O
again	O	O
after	O	O
systemic	O	O
antibiotic	O	O
treatment	O	O
associated	O	O
with	O	O
conservative	O	O
surgical	O	O
excision	O	O
.	O	O

The	O	O
paper	O	O
describes	O	O
an	O	O
optimized	O	O
technique	O	O
for	O	O
DNA	O	O
isolation	O	O
from	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
cultures	O	O
and	O	O
from	O	O
the	O	O
clinical	O	O
samples	O	O
including	O	O
proteinase	O	O
K	O	O
treatment	O	O
and	O	O
detergent	O	O
lysis	O	O
,	O	O
followed	O	O
by	O	O
sorbent-based	O	O
enrichment	O	O
.	O	O

This	O	O
technique	O	O
was	O	O
employed	O	O
for	O	O
isolating	O	O
DNA	O	O
from	O	O
the	O	O
periodontal	O	O
bacteria	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
and	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
.	O	O

A	O	O
multiplex	O	O
PCR	O	O
technique	O	O
was	O	O
adapted	O	O
for	O	O
large-scale	O	O
studies	O	O
of	O	O
clinical	O	O
samples	O	O
.	O	O

An	O	O
original	O	O
PCR	O	O
method	O	O
was	O	O
developed	O	O
for	O	O
the	O	O
semiquantitative	O	O
detection	O	O
of	O	O
Str	O	O
.	O	O

mutans	O	O
,	O	O
showing	O	O
the	O	O
sensitivity	O	O
of	O	O
100	O	O
genome	O	O
copies	O	O
per	O	O
reaction	O	O
.	O	O

Extensive	O	O
studies	O	O
of	O	O
approximately	O	O
2,000	O	O
individuals	O	O
have	O	O
demonstrated	O	O
that	O	O
these	O	O
methods	O	O
are	O	O
applicable	O	O
to	O	O
the	O	O
study	O	O
of	O	O
the	O	O
dental	O	O
and	O	O
gingival	O	O
microflora	O	O
in	O	O
the	O	O
biological	O	O
sample	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
persons	O	O
with	O	O
dental	O	O
diseases	O	O
from	O	O
various	O	O
age	O	O
groups	O	O
.	O	O

This	O	O
study	O	O
was	O	O
undertaken	O	O
to	O	O
evaluate	O	O
the	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
microbiology	O	O
of	O	O
acute	O	O
maxillary	O	O
sinusitis	O	O
of	O	O
odontogenic	O	O
origin	O	O
presenting	O	O
with	O	O
periodontal	O	O
infection	O	O
in	O	O
children	O	O
.	O	O

Aspirates	O	O
of	O	O
18	O	O
acutely	O	O
infected	O	O
maxillary	O	O
sinuses	O	O
that	O	O
were	O	O
associated	O	O
with	O	O
odontogenic	O	O
infection	O	O
in	O	O
children	O	O
who	O	O
presented	O	O
with	O	O
periorbital	O	O
cellulitis	O	O
were	O	O
processed	O	O
for	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

A	O	O
total	O	O
of	O	O
54	O	O
isolates	O	O
were	O	O
recovered	O	O
(	O	O
3.0	O	O
per	O	O
specimen	O	O
)	O	O
:	O	O
13	O	O
aerobic	O	O
and	O	O
facultative	O	O
(	O	O
0.7	O	O
per	O	O
specimen	O	O
)	O	O
and	O	O
41	O	O
anaerobic	O	O
(	O	O
2.3	O	O
per	O	O
specimen	O	O
)	O	O
.	O	O

The	O	O
number	O	O
of	O	O
isolates	O	O
per	O	O
specimen	O	O
varied	O	O
from	O	O
1	O	O
to	O	O
4	O	O
.	O	O

Aerobic	O	O
and	O	O
facultative	O	O
organisms	O	O
alone	O	O
were	O	O
recovered	O	O
in	O	O
2	O	O
specimens	O	O
(	O	O
11	O	O
%	O	O
)	O	O
,	O	O
anaerobes	B-bacteria	B-bacteria
only	O	O
in	O	O
7	O	O
(	O	O
39	O	O
%	O	O
)	O	O
,	O	O
and	O	O
mixed	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
9	O	O
(	O	O
50	O	O
%	O	O
)	O	O
.	O	O

The	O	O
predominant	O	O
aerobic	O	O
and	O	O
facultative	O	O
organisms	O	O
were	O	O
alpha-hemolytic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
4	O	O
)	O	O
,	O	O
microaerophilic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
3	O	O
)	O	O
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
2	O	O
each	O	O
)	O	O
.	O	O

The	O	O
predominant	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
anaerobic	B-bacteria	B-bacteria
gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
(	O	O
17	O	O
)	O	O
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
(	O	O
11	O	O
)	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
(	O	O
8	O	O
)	O	O
,	O	O
and	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
(	O	O
2	O	O
)	O	O
.	O	O

Twelve	O	O
beta-lactamase-producing	O	O
bacteria	O	O
were	O	O
recovered	O	O
from	O	O
9	O	O
specimens	O	O
(	O	O
50	O	O
%	O	O
)	O	O
.	O	O

This	O	O
study	O	O
demonstrates	O	O
the	O	O
unique	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
microbiological	O	O
features	O	O
of	O	O
acute	O	O
maxillary	O	O
sinusitis	O	O
of	O	O
odontogenic	O	O
origin	O	O
presenting	O	O
with	O	O
periorbital	O	O
cellulitis	O	O
in	O	O
children	O	O
.	O	O

Oral	O	O
epithelia	O	O
are	O	O
constantly	O	O
exposed	O	O
to	O	O
non-pathogenic	O	O
(	O	O
commensal	O	O
)	O	O
bacteria	O	O
,	O	O
but	O	O
generally	O	O
remain	O	O
healthy	O	O
and	O	O
uninflamed	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
an	O	O
oral	O	O
commensal	O	O
bacterium	O	O
,	O	O
strongly	O	O
induces	O	O
human	O	O
beta-defensin-2	O	O
(	O	O
hBD2	O	O
)	O	O
,	O	O
an	O	O
antimicrobial	O	O
and	O	O
immunomodulatory	O	O
peptide	O	O
,	O	O
in	O	O
gingival	O	O
epithelial	O	O
cells	O	O
(	O	O
GECs	O	O
)	O	O
.	O	O

hBD2	O	O
is	O	O
also	O	O
expressed	O	O
in	O	O
normal	O	O
oral	O	O
tissue	O	O
leading	O	O
to	O	O
the	O	O
hypothesis	O	O
that	O	O
oral	O	O
epithelia	O	O
are	O	O
in	O	O
an	O	O
activated	O	O
state	O	O
with	O	O
respect	O	O
to	O	O
innate	O	O
immune	O	O
responses	O	O
under	O	O
normal	O	O
in	O	O
vivo	O	O
conditions	O	O
.	O	O

In	O	O
order	O	O
to	O	O
test	O	O
this	O	O
hypothesis	O	O
,	O	O
global	O	O
gene	O	O
expression	O	O
was	O	O
evaluated	O	O
in	O	O
GECs	O	O
in	O	O
response	O	O
to	O	O
stimulation	O	O
by	O	O
an	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
cell	O	O
wall	O	O
(	O	O
FnCW	O	O
)	O	O
preparation	O	O
and	O	O
to	O	O
hBD2	O	O
peptide	O	O
.	O	O

FnCW	O	O
treatment	O	O
altered	O	O
829	O	O
genes	O	O
,	O	O
while	O	O
hBD2	O	O
altered	O	O
209	O	O
genes	O	O
(	O	O
P	O	O
<	O	O
0.005	O	O
,	O	O
ANOVA	O	O
)	O	O
.	O	O

Many	O	O
induced	O	O
genes	O	O
were	O	O
associated	O	O
with	O	O
the	O	O
gene	O	O
ontology	O	O
categories	O	O
of	O	O
immune	O	O
responses	O	O
and	O	O
defence	O	O
responses	O	O
.	O	O

Consistent	O	O
with	O	O
the	O	O
hypothesis	O	O
,	O	O
similar	O	O
responses	O	O
were	O	O
activated	O	O
by	O	O
commensal	O	O
bacteria	O	O
and	O	O
hBD2	O	O
.	O	O

These	O	O
responses	O	O
included	O	O
up-regulation	O	O
of	O	O
common	O	O
antimicrobial	O	O
effectors	O	O
and	O	O
chemokines	O	O
,	O	O
and	O	O
down-regulation	O	O
of	O	O
proliferation	O	O
markers	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
FnCW	O	O
up-regulated	O	O
multiple	O	O
protease	O	O
inhibitors	O	O
,	O	O
and	O	O
suppressed	O	O
NF-kappaB	O	O
function	O	O
and	O	O
the	O	O
ubiquitin/proteasome	O	O
system	O	O
.	O	O

These	O	O
global	O	O
changes	O	O
may	O	O
protect	O	O
the	O	O
tissue	O	O
from	O	O
inflammatory	O	O
damage	O	O
.	O	O

Both	O	O
FnCW	O	O
and	O	O
hBD2	O	O
also	O	O
up-regulated	O	O
genes	O	O
that	O	O
may	O	O
enhance	O	O
the	O	O
epithelial	O	O
barrier	O	O
.	O	O

The	O	O
findings	O	O
suggest	O	O
that	O	O
both	O	O
commensal	O	O
bacteria	O	O
and	O	O
hBD2	O	O
activate	O	O
protective	O	O
responses	O	O
of	O	O
GECs	O	O
and	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
immune	O	O
modulation	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Antagonistic	O	O
abilities	O	O
may	O	O
confer	O	O
ecological	O	O
advantages	O	O
for	O	O
micro-organisms	O	O
in	O	O
competitive	O	O
ecosystems	O	O
.	O	O

However	O	O
,	O	O
reports	O	O
regarding	O	O
this	O	O
phenomenon	O	O
in	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
are	O	O
not	O	O
available	O	O
.	O	O

Nineteen	O	O
E.	B-bacteria	B-bacteria
corrodens	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
human	O	O
beings	O	O
without	O	O
periodontal	O	O
disease	O	O
(	O	O
n	O	O
=	O	O
5	O	O
)	O	O
and	O	O
with	O	O
aggressive	O	O
(	O	O
n	O	O
=	O	O
9	O	O
)	O	O
and	O	O
chronic	O	O
(	O	O
n	O	O
=	O	O
5	O	O
)	O	O
periodontitis	O	O
,	O	O
as	O	O
well	O	O
as	O	O
a	O	O
reference	O	O
strain	O	O
(	O	O
E.	B-bacteria	B-bacteria
corrodens	I-bacteria	I-bacteria
ATCC23834	E-bacteria	I-bacteria
)	O	O
,	O	O
were	O	O
evaluated	O	O
for	O	O
antagonistic	O	O
activity	O	O
.	O	O

The	O	O
following	O	O
indicators	O	O
were	O	O
used	O	O
:	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
FDC381	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
ATCC25611	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	I-bacteria	I-bacteria
ATCC12102	E-bacteria	I-bacteria
,	O	O
Eubacterium	B-bacteria	B-bacteria
lentum	I-bacteria	I-bacteria
ATCC25559	E-bacteria	I-bacteria
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
anaerobius	I-bacteria	I-bacteria
ATCC27337	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
FDCY4	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ATCC10953	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
ATCC10557	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
uberis	I-bacteria	I-bacteria
ATCC9927	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
IM/UFRJ	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	I-bacteria	I-bacteria
ATCC33591	E-bacteria	I-bacteria
and	O	O
Candida	O	O
albicans	O	O
ATCC18804	O	O
.	O	O

All	O	O
the	O	O
strains	O	O
showed	O	O
antagonism	O	O
against	O	O
at	O	O
least	O	O
one	O	O
of	O	O
the	O	O
indicator	O	O
strains	O	O
.	O	O

This	O	O
phenomenon	O	O
was	O	O
more	O	O
frequently	O	O
observed	O	O
for	O	O
strains	O	O
isolated	O	O
from	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
(	O	O
36.4	O	O
%	O	O
)	O	O
,	O	O
than	O	O
those	O	O
from	O	O
healthy	O	O
subjects	O	O
(	O	O
20.6	O	O
%	O	O
)	O	O
and	O	O
those	O	O
with	O	O
aggressive	O	O
periodontitis	O	O
(	O	O
10.8	O	O
%	O	O
)	O	O
.	O	O

The	O	O
heterogeneous	O	O
antagonistic	O	O
spectrum	O	O
exhibited	O	O
by	O	O
E.	B-bacteria	B-bacteria
corrodens	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
suggests	O	O
their	O	O
ability	O	O
to	O	O
produce	O	O
more	O	O
than	O	O
one	O	O
antagonistic	O	O
substance	O	O
,	O	O
whose	O	O
ecological	O	O
relevance	O	O
is	O	O
yet	O	O
to	O	O
be	O	O
demonstrated	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
description	O	O
of	O	O
antagonistic	O	O
compound	O	O
production	O	O
by	O	O
E.	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
and	O	O
its	O	O
relationships	O	O
with	O	O
the	O	O
clinical	O	O
status	O	O
of	O	O
the	O	O
patients	O	O
.	O	O

Strong	O	O
epidemiological	O	O
,	O	O
genetic	O	O
and	O	O
biochemical	O	O
evidence	O	O
indicates	O	O
that	O	O
local	O	O
acetaldehyde	O	O
exposure	O	O
is	O	O
a	O	O
major	O	O
factor	O	O
behind	O	O
gastrointestinal	O	O
cancers	O	O
especially	O	O
associated	O	O
with	O	O
alcohol	O	O
drinking	O	O
and	O	O
smoking	O	O
.	O	O

Thus	O	O
,	O	O
reducing	O	O
the	O	O
exposure	O	O
to	O	O
carcinogenic	O	O
acetaldehyde	O	O
either	O	O
by	O	O
decreasing	O	O
the	O	O
production	O	O
or	O	O
by	O	O
eliminating	O	O
acetaldehyde	O	O
locally	O	O
might	O	O
offer	O	O
a	O	O
preventive	O	O
strategy	O	O
against	O	O
acetaldehyde-induced	O	O
gastrointestinal	O	O
cancers	O	O
.	O	O

Thiol	O	O
products	O	O
,	O	O
such	O	O
as	O	O
the	O	O
amino	O	O
acid	O	O
cysteine	O	O
,	O	O
are	O	O
known	O	O
to	O	O
be	O	O
able	O	O
to	O	O
protect	O	O
against	O	O
acetaldehyde	O	O
toxicity	O	O
.	O	O

Cysteine	O	O
is	O	O
able	O	O
to	O	O
bind	O	O
acetaldehyde	O	O
efficiently	O	O
by	O	O
forming	O	O
a	O	O
stable	O	O
thiazolidine-carboxylic	O	O
acid	O	O
compound	O	O
.	O	O

Special	O	O
cysteine	O	O
preparations	O	O
(	O	O
such	O	O
as	O	O
lozenge	O	O
and	O	O
chewing	O	O
gum	O	O
)	O	O
have	O	O
already	O	O
been	O	O
developed	O	O
to	O	O
bind	O	O
smoking	O	O
and	O	O
alcohol	O	O
drinking	O	O
derived	O	O
acetaldehyde	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Most	O	O
importantly	O	O
,	O	O
these	O	O
type	O	O
of	O	O
drug	O	O
formulations	O	O
offer	O	O
a	O	O
novel	O	O
method	O	O
for	O	O
intervention	O	O
studies	O	O
aimed	O	O
to	O	O
resolve	O	O
the	O	O
eventual	O	O
role	O	O
of	O	O
acetaldehyde	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
upper	O	O
digestive	O	O
tract	O	O
cancers	O	O
.	O	O

Acetaldehyde	O	O
exposure	O	O
could	O	O
also	O	O
be	O	O
influenced	O	O
by	O	O
modifying	O	O
the	O	O
acetaldehyde	O	O
producing	O	O
microbiota	O	O
.	O	O

With	O	O
regard	O	O
to	O	O
the	O	O
upper	O	O
digestive	O	O
tract	O	O
,	O	O
acetaldehyde	O	O
production	O	O
from	O	O
ingested	O	O
ethanol	O	O
could	O	O
be	O	O
significantly	O	O
reduced	O	O
by	O	O
using	O	O
an	O	O
antiseptic	O	O
mouthwash	O	O
,	O	O
chlorhexidine	O	O
.	O	O

In	O	O
the	O	O
large	O	O
intestine	O	O
acetaldehyde	O	O
production	O	O
could	O	O
be	O	O
markedly	O	O
decreased	O	O
either	O	O
by	O	O
reducing	O	O
the	O	O
Gram-negative	B-bacteria	B-bacteria
microbes	E-bacteria	I-bacteria
by	O	O
ciprofloxacin	O	O
antibiotic	O	O
or	O	O
by	O	O
lowering	O	O
the	O	O
intraluminal	O	O
pH	O	O
by	O	O
lactulose	O	O
.	O	O

Enterococci	B-bacteria	B-bacteria
are	O	O
rarely	O	O
found	O	O
in	O	O
the	O	O
healthy	O	O
human	O	O
oral	O	O
cavity	O	O
,	O	O
yet	O	O
they	O	O
are	O	O
strongly	O	O
associated	O	O
with	O	O
filled	O	O
root	O	O
canals	O	O
.	O	O

The	O	O
origin	O	O
of	O	O
these	O	O
enterococci	B-bacteria	B-bacteria
remains	O	O
unknown	O	O
.	O	O

Our	O	O
hypothesis	O	O
is	O	O
that	O	O
they	O	O
are	O	O
transient	O	O
food-born	O	O
colonizers	O	O
under	O	O
healthy	O	O
conditions	O	O
.	O	O

This	O	O
pilot	O	O
study	O	O
reinvestigated	O	O
the	O	O
prevalence	O	O
of	O	O
enterococci	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
healthy	O	O
volunteers	O	O
,	O	O
screened	O	O
cheese	O	O
samples	O	O
for	O	O
enterococci	B-bacteria	B-bacteria
and	O	O
investigated	O	O
colonization	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
after	O	O
ingestion	O	O
of	O	O
an	O	O
enterocci-positive	O	O
cheese	O	O
.	O	O

Concentrated	O	O
oral	O	O
rinse	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
a	O	O
cohort	O	O
of	O	O
50	O	O
dental	O	O
students	O	O
and	O	O
proved	O	O
negative	O	O
for	O	O
viable	O	O
enterococci	B-bacteria	B-bacteria
.	O	O

Twenty	O	O
cheese	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
local	O	O
supermarkets	O	O
.	O	O

Enterococci	B-bacteria	B-bacteria
were	O	O
cultured	O	O
and	O	O
identified	O	O
using	O	O
standard	O	O
methods	O	O
.	O	O

Viable	O	O
enterococci	B-bacteria	B-bacteria
were	O	O
detected	O	O
in	O	O
one	O	O
of	O	O
five	O	O
specimens	O	O
of	O	O
Swiss	O	O
Tilsiter	O	O
,	O	O
three	O	O
of	O	O
five	O	O
samples	O	O
of	O	O
French	O	O
soft	O	O
cheese	O	O
,	O	O
one	O	O
of	O	O
five	O	O
Mozzarella	O	O
samples	O	O
and	O	O
one	O	O
of	O	O
five	O	O
Feta	O	O
samples	O	O
.	O	O

Eight	O	O
volunteers	O	O
from	O	O
the	O	O
cohort	O	O
consumed	O	O
10	O	O
g	O	O
of	O	O
a	O	O
cheese	O	O
with	O	O
high	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
load	O	O
.	O	O

Oral	O	O
rinse	O	O
samples	O	O
were	O	O
collected	O	O
before	O	O
and	O	O
1	O	O
,	O	O
10	O	O
and	O	O
100	O	O
min	O	O
after	O	O
cheese	O	O
ingestion	O	O
.	O	O

One	O	O
minute	O	O
after	O	O
ingestion	O	O
,	O	O
a	O	O
median	O	O
of	O	O
5,480	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
colony-forming	O	O
units	O	O
was	O	O
recovered	O	O
from	O	O
the	O	O
oral	O	O
rinse	O	O
samples	O	O
.	O	O

Bacterial	O	O
counts	O	O
were	O	O
reduced	O	O
after	O	O
10	O	O
min	O	O
,	O	O
had	O	O
dropped	O	O
after	O	O
100	O	O
min	O	O
to	O	O
levels	O	O
that	O	O
were	O	O
significantly	O	O
(	O	O
P	O	O
<	O	O
0.005	O	O
)	O	O
different	O	O
from	O	O
the	O	O
1-min	O	O
and	O	O
10-min	O	O
scores	O	O
and	O	O
were	O	O
below	O	O
the	O	O
detection	O	O
limit	O	O
after	O	O
1	O	O
week	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
colonization	O	O
of	O	O
the	O	O
healthy	O	O
oral	O	O
cavity	O	O
by	O	O
enterococci	B-bacteria	B-bacteria
is	O	O
transitional	O	O
,	O	O
but	O	O
at	O	O
the	O	O
same	O	O
time	O	O
add	O	O
weight	O	O
to	O	O
our	O	O
hypothesis	O	O
that	O	O
enterococcal	O	O
root	O	O
canal	O	O
infections	O	O
could	O	O
be	O	O
food-borne	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
current	O	O
antimicrobial	O	O
susceptibility	O	O
of	O	O
the	O	O
principle	O	O
anaerobic	O	O
pathogens	O	O
involved	O	O
in	O	O
dentoalveolar	O	O
infection	O	O
,	O	O
to	O	O
13	O	O
oral	O	O
antibiotics	O	O
,	O	O
and	O	O
to	O	O
assess	O	O
the	O	O
value	O	O
of	O	O
each	O	O
antibiotic	O	O
in	O	O
the	O	O
management	O	O
of	O	O
the	O	O
infection	O	O
.	O	O

A	O	O
total	O	O
of	O	O
800	O	O
isolates	O	O
from	O	O
patients	O	O
with	O	O
dentoalveolar	O	O
infection	O	O
(	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
)	O	O
were	O	O
tested	O	O
for	O	O
their	O	O
susceptibility	O	O
to	O	O
amoxicillin	O	O
,	O	O
amoxicillin/clavulanate	O	O
,	O	O
cefaclor	O	O
,	O	O
cefuroxime	O	O
,	O	O
cefcapene	O	O
,	O	O
cefdinir	O	O
,	O	O
erythromycin	O	O
,	O	O
azithromycin	O	O
,	O	O
telithromycin	O	O
,	O	O
minocycline	O	O
,	O	O
levofloxacin	O	O
,	O	O
clindamycin	O	O
,	O	O
and	O	O
metronidazole	O	O
using	O	O
an	O	O
agar	O	O
dilution	O	O
method	O	O
.	O	O

Although	O	O
the	O	O
majority	O	O
of	O	O
Fusobacterium	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
resistant	O	O
to	O	O
erythromycin	O	O
,	O	O
azithromycin	O	O
,	O	O
and	O	O
telithromycin	O	O
,	O	O
the	O	O
remaining	O	O
antibiotics	O	O
demonstrated	O	O
a	O	O
high	O	O
level	O	O
of	O	O
antimicrobial	O	O
activity	O	O
.	O	O

P.	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
exhibited	O	O
high	O	O
susceptibility	O	O
to	O	O
all	O	O
antibiotics	O	O
tested	O	O
in	O	O
this	O	O
study	O	O
.	O	O

In	O	O
the	O	O
case	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
resistance	O	O
to	O	O
amoxicillin	O	O
occurred	O	O
in	O	O
34	O	O
%	O	O
of	O	O
isolates	O	O
and	O	O
all	O	O
of	O	O
these	O	O
resistant	O	O
strains	O	O
were	O	O
found	O	O
to	O	O
produce	O	O
beta-lactamase	O	O
.	O	O

Susceptibility	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
to	O	O
cefaclor	O	O
,	O	O
cefuroxime	O	O
,	O	O
cefcapene	O	O
,	O	O
cefdinir	O	O
,	O	O
erythromycin	O	O
,	O	O
azithromycin	O	O
,	O	O
and	O	O
minocycline	O	O
was	O	O
found	O	O
to	O	O
correlate	O	O
with	O	O
amoxicillin	O	O
susceptibility	O	O
.	O	O

Amoxicillin/clavulanate	O	O
,	O	O
telithromycin	O	O
,	O	O
clindamycin	O	O
,	O	O
and	O	O
metronidazole	O	O
exhibited	O	O
high	O	O
antimicrobial	O	O
activity	O	O
even	O	O
against	O	O
amoxicillin-resistant	O	O
strains	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Amoxicillin	O	O
would	O	O
still	O	O
be	O	O
advocated	O	O
therefore	O	O
as	O	O
being	O	O
a	O	O
suitable	O	O
first-line	O	O
agent	O	O
,	O	O
while	O	O
reduced	O	O
susceptibility	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
remains	O	O
a	O	O
matter	O	O
of	O	O
concern	O	O
with	O	O
penicillins	O	O
.	O	O

Amoxicillin/clavulanate	O	O
,	O	O
clindamycin	O	O
,	O	O
and	O	O
metronidazole	O	O
are	O	O
useful	O	O
alternatives	O	O
in	O	O
combating	O	O
the	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
involved	O	O
in	O	O
dentoalveolar	O	O
infection	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
distribution	O	O
of	O	O
pathogens	O	O
on	O	O
cattle	O	O
hides	O	O
at	O	O
the	O	O
feedlot	O	O
,	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
six	O	O
hide	O	O
surface	O	O
locations	O	O
(	O	O
back	O	O
,	O	O
flank	O	O
,	O	O
hock	O	O
,	O	O
neck	O	O
,	O	O
perineum	O	O
,	O	O
and	O	O
ventrum	O	O
)	O	O
,	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
the	O	O
rectal-anal	O	O
junction	O	O
,	O	O
and	O	O
the	O	O
feces	O	O
of	O	O
feedlot	O	O
cattle	O	O
and	O	O
subjected	O	O
to	O	O
Escherichia	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
0157	E-bacteria	I-bacteria
detection	O	O
via	O	O
culture	O	O
methods	O	O
and	O	O
to	O	O
Salmonella	B-bacteria	B-bacteria
detection	O	O
via	O	O
PCR	O	O
.	O	O

E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
0157	E-bacteria	I-bacteria
was	O	O
isolated	O	O
from	O	O
one	O	O
or	O	O
more	O	O
of	O	O
the	O	O
sampling	O	O
locations	O	O
from	O	O
31	O	O
(	O	O
42.5	O	O
%	O	O
)	O	O
of	O	O
the	O	O
73	O	O
animals	O	O
sampled	O	O
.	O	O

Location-specific	O	O
prevalence	O	O
of	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
0157	E-bacteria	I-bacteria
was	O	O
5	O	O
%	O	O
for	O	O
back	O	O
samples	O	O
,	O	O
5	O	O
%	O	O
for	O	O
flank	O	O
samples	O	O
,	O	O
12	O	O
%	O	O
for	O	O
hock	O	O
samples	O	O
,	O	O
7	O	O
%	O	O
for	O	O
neck	O	O
samples	O	O
,	O	O
12	O	O
%	O	O
for	O	O
perineum	O	O
samples	O	O
,	O	O
8	O	O
%	O	O
for	O	O
ventrum	O	O
samples	O	O
,	O	O
1	O	O
%	O	O
for	O	O
oral	O	O
cavity	O	O
samples	O	O
,	O	O
4	O	O
%	O	O
for	O	O
rectal-anal	O	O
junction	O	O
swabs	O	O
,	O	O
and	O	O
23	O	O
%	O	O
for	O	O
fecal	O	O
grab	O	O
samples	O	O
.	O	O

Salmonella	B-bacteria	B-bacteria
was	O	O
isolated	O	O
from	O	O
one	O	O
or	O	O
more	O	O
of	O	O
these	O	O
sample	O	O
locations	O	O
from	O	O
100	O	O
%	O	O
(	O	O
50	O	O
of	O	O
50	O	O
samples	O	O
)	O	O
of	O	O
all	O	O
animals	O	O
sampled	O	O
.	O	O

Location-specific	O	O
prevalence	O	O
of	O	O
Salmonella	B-bacteria	B-bacteria
was	O	O
76	O	O
%	O	O
for	O	O
back	O	O
samples	O	O
,	O	O
74	O	O
%	O	O
for	O	O
flank	O	O
samples	O	O
,	O	O
94	O	O
%	O	O
for	O	O
hock	O	O
samples	O	O
,	O	O
76	O	O
%	O	O
for	O	O
neck	O	O
samples	O	O
,	O	O
88	O	O
%	O	O
for	O	O
perineum	O	O
samples	O	O
,	O	O
86	O	O
%	O	O
for	O	O
ventrum	O	O
samples	O	O
,	O	O
94	O	O
%	O	O
for	O	O
oral	O	O
cavity	O	O
samples	O	O
,	O	O
64	O	O
%	O	O
for	O	O
rectal-anal	O	O
junction	O	O
swabs	O	O
,	O	O
and	O	O
50	O	O
%	O	O
for	O	O
fecal	O	O
grab	O	O
samples	O	O
.	O	O

The	O	O
sampling	O	O
locations	O	O
that	O	O
maximized	O	O
the	O	O
likelihood	O	O
of	O	O
finding	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
0157	E-bacteria	I-bacteria
and	O	O
Salmonella	B-bacteria	B-bacteria
(	O	O
84	O	O
and	O	O
96	O	O
%	O	O
,	O	O
respectively	O	O
)	O	O
if	O	O
the	O	O
animal	O	O
was	O	O
positive	O	O
at	O	O
one	O	O
sampling	O	O
location	O	O
or	O	O
more	O	O
were	O	O
the	O	O
hock	O	O
,	O	O
perineum	O	O
,	O	O
and	O	O
fecal	O	O
grab	O	O
.	O	O

These	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
use	O	O
of	O	O
multiple	O	O
sample	O	O
locations	O	O
is	O	O
useful	O	O
when	O	O
isolating	O	O
these	O	O
pathogens	O	O
from	O	O
feedlot	O	O
cattle	O	O
.	O	O

Focusing	O	O
on	O	O
one	O	O
sampling	O	O
location	O	O
may	O	O
underestimate	O	O
the	O	O
prevalence	O	O
.	O	O

Enhanced	O	O
delivery	O	O
of	O	O
bifidobacteria	B-bacteria	B-bacteria
and	O	O
fecal	O	O
changes	O	O
were	O	O
compared	O	O
following	O	O
multiple	O	O
oral	O	O
administrations	O	O
of	O	O
protected	O	O
bifidobacteria-loaded	O	O
alginate	O	O
poly-l-lysine	O	O
microparticles	O	O
(	O	O
bap-microparticles	O	O
)	O	O
and	O	O
unprotected	O	O
bifidobacteria	O	O
cultures	O	O
over	O	O
a	O	O
period	O	O
of	O	O
1	O	O
month	O	O
to	O	O
healthy	O	O
human	O	O
volunteers	O	O
as	O	O
preliminary	O	O
in	O	O
vivo	O	O
studies	O	O
.	O	O

When	O	O
bap-microparticles	O	O
were	O	O
orally	O	O
administered	O	O
,	O	O
enhanced	O	O
delivery	O	O
of	O	O
bifidobacteria	O	O
was	O	O
achieved	O	O
.	O	O

The	O	O
viability	O	O
of	O	O
the	O	O
bifidobacteria	B-bacteria	B-bacteria
was	O	O
significantly	O	O
increased	O	O
approximately	O	O
11.5-30	O	O
times	O	O
(	O	O
1.06-1.48	O	O
log	O	O
cycles	O	O
)	O	O
during	O	O
the	O	O
ingestion	O	O
period	O	O
when	O	O
compared	O	O
with	O	O
the	O	O
bifidobacteria	B-bacteria	B-bacteria
culture	O	O
group	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

However	O	O
,	O	O
other	O	O
gut	O	O
microflora	O	O
such	O	O
as	O	O
bifidobacteria	B-bacteria	B-bacteria
,	O	O
enterobacteriaceae	B-bacteria	B-bacteria
,	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
and	O	O
staphylococci	B-bacteria	B-bacteria
in	O	O
feces	O	O
were	O	O
not	O	O
significantly	O	O
different	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
.	O	O

Encapsulated	O	O
bifidobacteria	B-bacteria	B-bacteria
resulted	O	O
in	O	O
more	O	O
frequent	O	O
defecation	O	O
and	O	O
decreased	O	O
fecal	O	O
viscosity	O	O
.	O	O

The	O	O
``	O	O
Synergistes	O	O
''	O	O
group	O	O
of	O	O
organisms	O	O
are	O	O
a	O	O
phylogenetic	O	O
cluster	O	O
of	O	O
Gram-negative	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
related	O	O
to	O	O
Synergistes	B-bacteria	B-bacteria
jonesii	E-bacteria	I-bacteria
,	O	O
sufficiently	O	O
distinct	O	O
from	O	O
all	O	O
other	O	O
phyla	O	O
to	O	O
be	O	O
considered	O	O
a	O	O
distinct	O	O
phylum	O	O
or	O	O
Division	O	O
.	O	O

They	O	O
are	O	O
widely	O	O
distributed	O	O
in	O	O
nature	O	O
although	O	O
normally	O	O
only	O	O
a	O	O
minor	O	O
constituent	O	O
of	O	O
the	O	O
bacterial	O	O
community	O	O
in	O	O
each	O	O
habitat	O	O
.	O	O

They	O	O
have	O	O
evolved	O	O
to	O	O
adapt	O	O
to	O	O
each	O	O
habitat	O	O
,	O	O
and	O	O
therefore	O	O
exhibit	O	O
a	O	O
wide	O	O
range	O	O
of	O	O
physiological	O	O
and	O	O
biochemical	O	O
characteristics	O	O
,	O	O
although	O	O
all	O	O
cultivable	O	O
taxa	O	O
so	O	O
far	O	O
studied	O	O
have	O	O
the	O	O
ability	O	O
to	O	O
degrade	O	O
amino	O	O
acids	O	O
.	O	O

They	O	O
are	O	O
found	O	O
in	O	O
the	O	O
human	O	O
mouth	O	O
where	O	O
they	O	O
appear	O	O
to	O	O
be	O	O
more	O	O
numerous	O	O
in	O	O
tooth	O	O
and	O	O
gum	O	O
disease	O	O
than	O	O
health	O	O
.	O	O

They	O	O
have	O	O
also	O	O
been	O	O
found	O	O
in	O	O
the	O	O
human	O	O
gut	O	O
and	O	O
soft	O	O
tissue	O	O
infections	O	O
.	O	O

Their	O	O
role	O	O
in	O	O
human	O	O
disease	O	O
has	O	O
yet	O	O
to	O	O
be	O	O
established	O	O
but	O	O
improved	O	O
knowledge	O	O
of	O	O
the	O	O
characteristics	O	O
that	O	O
enable	O	O
their	O	O
identification	O	O
should	O	O
increase	O	O
the	O	O
likelihood	O	O
of	O	O
their	O	O
recognition	O	O
when	O	O
present	O	O
at	O	O
diseased	O	O
sites	O	O
.	O	O

An	O	O
in	O	O
vitro	O	O
plaque	O	O
model	O	O
based	O	O
on	O	O
the	O	O
use	O	O
of	O	O
human	O	O
salivary	O	O
bacteria	O	O
and	O	O
tooth-like	O	O
surfaces	O	O
was	O	O
previously	O	O
developed	O	O
for	O	O
studying	O	O
the	O	O
formation	O	O
of	O	O
oral	O	O
biofilm	O	O
and	O	O
its	O	O
use	O	O
for	O	O
pre-clinical	O	O
testing	O	O
of	O	O
candidate	O	O
antimicrobial	O	O
or	O	O
antiplaque	O	O
agents	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
a	O	O
quantitative	O	O
Taqman	O	O
PCR	O	O
assay	O	O
(	O	O
QPCR	O	O
)	O	O
was	O	O
developed	O	O
to	O	O
compare	O	O
the	O	O
bacterial	O	O
compositions	O	O
of	O	O
in	O	O
vitro	O	O
biofilms	O	O
to	O	O
parent	O	O
saliva	O	O
samples	O	O
,	O	O
and	O	O
to	O	O
determine	O	O
the	O	O
relative	O	O
contributions	O	O
of	O	O
different	O	O
species	O	O
in	O	O
the	O	O
formation	O	O
of	O	O
the	O	O
oral	O	O
biofilm	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
growth	O	O
inhibition	O	O
of	O	O
saliva-derived	O	O
plaque	O	O
was	O	O
evaluated	O	O
by	O	O
chlorhexidine	O	O
.	O	O

With	O	O
this	O	O
assay	O	O
,	O	O
which	O	O
consisted	O	O
of	O	O
primer/probe	O	O
sets	O	O
targeting	O	O
either	O	O
16S	O	O
rDNA	O	O
sequences	O	O
present	O	O
in	O	O
public	O	O
databases	O	O
or	O	O
cloned	O	O
ribosomal	O	O
intergenic	O	O
spacer	O	O
region	O	O
(	O	O
ISR	O	O
)	O	O
sequences	O	O
,	O	O
15	O	O
oral	O	O
bacteria	O	O
derived	O	O
from	O	O
saliva	O	O
as	O	O
well	O	O
as	O	O
those	O	O
that	O	O
were	O	O
responsible	O	O
for	O	O
biofilm	O	O
formation	O	O
in	O	O
an	O	O
in	O	O
vitro	O	O
plaque	O	O
model	O	O
were	O	O
rapidly	O	O
identified	O	O
and	O	O
quantified	O	O
.	O	O

Among	O	O
the	O	O
target	O	O
organisms	O	O
were	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
Micromonas	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
.	O	O

Primer	O	O
and	O	O
probe	O	O
sets	O	O
developed	O	O
were	O	O
both	O	O
sensitive	O	O
and	O	O
specific	O	O
.	O	O

The	O	O
relative	O	O
profiles	O	O
of	O	O
a	O	O
number	O	O
of	O	O
bacteria	O	O
in	O	O
45-h-old	O	O
biofilms	O	O
were	O	O
determined	O	O
and	O	O
,	O	O
when	O	O
compared	O	O
to	O	O
saliva	O	O
samples	O	O
,	O	O
it	O	O
was	O	O
found	O	O
that	O	O
most	O	O
of	O	O
the	O	O
bacteria	O	O
identified	O	O
in	O	O
saliva	O	O
also	O	O
populated	O	O
the	O	O
in	O	O
vitro	O	O
plaque	O	O
,	O	O
including	O	O
some	O	O
anaerobes	B-bacteria	B-bacteria
.	O	O

Brief	O	O
exposure	O	O
of	O	O
biofilms	O	O
to	O	O
chlorhexidine	O	O
resulted	O	O
in	O	O
significant	O	O
losses	O	O
in	O	O
viability	O	O
.	O	O

This	O	O
new	O	O
broad	O	O
spectrum	O	O
QPCR	O	O
assay	O	O
in	O	O
combination	O	O
with	O	O
the	O	O
in	O	O
vitro	O	O
plaque	O	O
model	O	O
will	O	O
be	O	O
of	O	O
significant	O	O
value	O	O
in	O	O
the	O	O
quantitative	O	O
study	O	O
of	O	O
the	O	O
microbial	O	O
composition	O	O
of	O	O
human	O	O
saliva	O	O
,	O	O
saliva-derived	O	O
plaque	O	O
,	O	O
and	O	O
pre-clinical	O	O
evaluation	O	O
of	O	O
potential	O	O
antimicrobial	O	O
and	O	O
antiplaque	O	O
molecules	O	O
.	O	O

Sutures	O	O
used	O	O
in	O	O
oral	O	O
surgery	O	O
should	O	O
avoid	O	O
or	O	O
limit	O	O
bacterial	O	O
adhesion	O	O
and	O	O
proliferation	O	O
to	O	O
those	O	O
parts	O	O
exposed	O	O
to	O	O
oral	O	O
fluids	O	O
.	O	O

Hence	O	O
,	O	O
microbial	O	O
colonization	O	O
on	O	O
various	O	O
intraoral	O	O
suture	O	O
materials	O	O
from	O	O
patients	O	O
undergoing	O	O
dental	O	O
surgery	O	O
was	O	O
compared	O	O
.	O	O

PATIENTS	O	O
AND	O	O
During	O	O
dentoalveolar	O	O
surgery	O	O
,	O	O
various	O	O
suture	O	O
materials	O	O
were	O	O
used	O	O
in	O	O
60	O	O
patients	O	O
,	O	O
who	O	O
were	O	O
randomly	O	O
divided	O	O
into	O	O
5	O	O
groups	O	O
of	O	O
12	O	O
.	O	O

In	O	O
each	O	O
group	O	O
,	O	O
silk	O	O
was	O	O
placed	O	O
intraorally	O	O
in	O	O
association	O	O
with	O	O
a	O	O
different	O	O
type	O	O
of	O	O
suture	O	O
(	O	O
ie	O	O
,	O	O
Supramid	O	O
,	O	O
Synthofil	O	O
,	O	O
Ethibond	O	O
Excel	O	O
,	O	O
Ti-cron	O	O
,	O	O
Monocryl	O	O
)	O	O
at	O	O
the	O	O
same	O	O
site	O	O
to	O	O
compare	O	O
microbial	O	O
colonization	O	O
intraindividually	O	O
.	O	O

Eight	O	O
days	O	O
postoperatively	O	O
,	O	O
the	O	O
sutures	O	O
were	O	O
removed	O	O
,	O	O
and	O	O
adhered	O	O
micro-organisms	O	O
were	O	O
isolated	O	O
,	O	O
counted	O	O
,	O	O
and	O	O
identified	O	O
through	O	O
enzymatic	O	O
activities	O	O
and	O	O
fermentation	O	O
of	O	O
sugars	O	O
.	O	O

In	O	O
all	O	O
60	O	O
patients	O	O
,	O	O
silk	O	O
sutures	O	O
exhibited	O	O
the	O	O
smallest	O	O
affinity	O	O
toward	O	O
the	O	O
adhesion	O	O
of	O	O
bacteria	O	O
compared	O	O
with	O	O
considerable	O	O
proliferation	O	O
with	O	O
nonresorbable	O	O
multifilament	O	O
sutures	O	O
(	O	O
Supramid	O	O
,	O	O
Synthofil	O	O
,	O	O
Ethibond	O	O
Excel	O	O
,	O	O
Ti-cron	O	O
)	O	O
.	O	O

On	O	O
the	O	O
contrary	O	O
,	O	O
the	O	O
microbial	O	O
load	O	O
was	O	O
significantly	O	O
lower	O	O
when	O	O
absorbable	O	O
monofilament	O	O
Monocryl	O	O
was	O	O
used	O	O
.	O	O

A	O	O
greater	O	O
quantity	O	O
of	O	O
bacteria	O	O
was	O	O
found	O	O
on	O	O
nonresorbable	O	O
sutures	O	O
than	O	O
on	O	O
absorbable	O	O
ones	O	O
,	O	O
and	O	O
nearly	O	O
2	O	O
times	O	O
more	O	O
facultative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
isolated	O	O
in	O	O
total	O	O
.	O	O

Our	O	O
results	O	O
show	O	O
that	O	O
bacteria	O	O
adhere	O	O
with	O	O
different	O	O
affinity	O	O
to	O	O
various	O	O
types	O	O
of	O	O
suture	O	O
materials	O	O
.	O	O

Absorbable	O	O
silk	O	O
and	O	O
Monocryl	O	O
exhibited	O	O
the	O	O
smallest	O	O
number	O	O
of	O	O
adherent	O	O
bacteria	O	O
.	O	O

Colonization	O	O
by	O	O
pathogens	O	O
on	O	O
sutures	O	O
leads	O	O
to	O	O
the	O	O
recommendation	O	O
that	O	O
sutures	O	O
should	O	O
be	O	O
removed	O	O
as	O	O
early	O	O
as	O	O
possible	O	O
after	O	O
surgery	O	O
is	O	O
performed	O	O
,	O	O
to	O	O
eliminate	O	O
or	O	O
to	O	O
limit	O	O
the	O	O
reservoir	O	O
for	O	O
oral	O	O
pathogens	O	O
.	O	O

This	O	O
recommendation	O	O
is	O	O
dependent	O	O
on	O	O
whether	O	O
the	O	O
suture	O	O
is	O	O
absorbable	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
trial	O	O
was	O	O
to	O	O
measure	O	O
the	O	O
antimicrobial	O	O
effects	O	O
of	O	O
a	O	O
minocycline	O	O
HCl	O	O
microsphere	O	O
(	O	O
MM	O	O
)	O	O
local	O	O
drug-delivery	O	O
system	O	O
when	O	O
used	O	O
as	O	O
an	O	O
adjunct	O	O
to	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
(	O	O
SRP	O	O
)	O	O
.	O	O

DNA	O	O
probe	O	O
analysis	O	O
for	O	O
40	O	O
bacteria	O	O
was	O	O
used	O	O
to	O	O
evaluate	O	O
the	O	O
oral	O	O
bacteria	O	O
of	O	O
127	O	O
subjects	O	O
with	O	O
moderate	O	O
to	O	O
advanced	O	O
chronic	O	O
periodontitis	O	O
.	O	O

Subjects	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
either	O	O
SRP	O	O
alone	O	O
(	O	O
N	O	O
=	O	O
65	O	O
)	O	O
or	O	O
MM	O	O
+	O	O
SRP	O	O
(	O	O
N	O	O
=	O	O
62	O	O
)	O	O
.	O	O

The	O	O
primary	O	O
endpoints	O	O
of	O	O
this	O	O
study	O	O
were	O	O
changes	O	O
in	O	O
numbers	O	O
and	O	O
proportions	O	O
of	O	O
the	O	O
red-complex	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
RCB	B-bacteria	B-bacteria
)	O	O
and	O	O
the	O	O
sum	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
formally	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
relative	O	O
to	O	O
40	O	O
oral	O	O
bacteria	O	O
at	O	O
each	O	O
test	O	O
site	O	O
from	O	O
baseline	O	O
to	O	O
day	O	O
30	O	O
.	O	O

Numbers	O	O
of	O	O
RCB	B-bacteria	B-bacteria
from	O	O
the	O	O
five	O	O
test	O	O
sites	O	O
were	O	O
averaged	O	O
to	O	O
provide	O	O
a	O	O
value	O	O
for	O	O
each	O	O
subject	O	O
.	O	O

MM	O	O
+	O	O
SRP	O	O
reduced	O	O
the	O	O
proportion	O	O
of	O	O
RCB	B-bacteria	B-bacteria
by	O	O
6.49	O	O
%	O	O
and	O	O
the	O	O
numbers	O	O
by	O	O
9.4	O	O
x	O	O
10	O	O
(	O	O
5	O	O
)	O	O
.	O	O

The	O	O
reduction	O	O
in	O	O
RCB	B-bacteria	B-bacteria
proportions	O	O
and	O	O
numbers	O	O
by	O	O
SRP	O	O
alone	O	O
(	O	O
5.03	O	O
%	O	O
and	O	O
5.1	O	O
x	O	O
10	O	O
(	O	O
5	O	O
)	O	O
,	O	O
respectively	O	O
)	O	O
was	O	O
significantly	O	O
less	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
MM	O	O
+	O	O
SRP	O	O
reduced	O	O
probing	O	O
depth	O	O
by	O	O
1.38	O	O
mm	O	O
(	O	O
compared	O	O
to	O	O
1.01	O	O
mm	O	O
by	O	O
SRP	O	O
alone	O	O
)	O	O
,	O	O
bleeding	O	O
on	O	O
probing	O	O
was	O	O
reduced	O	O
by	O	O
25.2	O	O
%	O	O
(	O	O
compared	O	O
to	O	O
13.8	O	O
%	O	O
by	O	O
SRP	O	O
alone	O	O
)	O	O
,	O	O
and	O	O
a	O	O
clinical	O	O
attachment	O	O
level	O	O
gain	O	O
of	O	O
1.16	O	O
mm	O	O
(	O	O
compared	O	O
to	O	O
0.80	O	O
mm	O	O
by	O	O
SRP	O	O
alone	O	O
)	O	O
was	O	O
achieved	O	O
.	O	O

These	O	O
observations	O	O
support	O	O
the	O	O
hypothesis	O	O
that	O	O
RCBs	B-bacteria	B-bacteria
are	O	O
responsible	O	O
for	O	O
periodontal	O	O
disease	O	O
and	O	O
that	O	O
local	O	O
antimicrobial	O	O
therapy	O	O
using	O	O
MM	O	O
+	O	O
SRP	O	O
effectively	O	O
reduces	O	O
numbers	O	O
of	O	O
RCBs	B-bacteria	B-bacteria
and	O	O
their	O	O
proportions	O	O
to	O	O
a	O	O
greater	O	O
extent	O	O
than	O	O
SRP	O	O
alone	O	O
.	O	O

The	O	O
authors	O	O
examined	O	O
the	O	O
tongue	O	O
bacteria	O	O
associated	O	O
with	O	O
oral	O	O
halitosis	O	O
(	O	O
bad	O	O
breath	O	O
originating	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
)	O	O
,	O	O
focusing	O	O
on	O	O
noncultivable	O	O
bacteria-bacteria	O	O
that	O	O
can	O	O
not	O	O
be	O	O
identified	O	O
by	O	O
bacterial	O	O
culture	O	O
techniques	O	O
.	O	O

The	O	O
authors	O	O
took	O	O
samples	O	O
from	O	O
the	O	O
dorsal	O	O
tongue	O	O
surface	O	O
of	O	O
eight	O	O
adult	O	O
subjects	O	O
with	O	O
halitosis	O	O
and	O	O
five	O	O
control	O	O
subjects	O	O
who	O	O
did	O	O
not	O	O
have	O	O
halitosis	O	O
.	O	O

They	O	O
identified	O	O
the	O	O
bacteria	O	O
in	O	O
these	O	O
samples	O	O
by	O	O
using	O	O
both	O	O
anaerobic	O	O
culture	O	O
and	O	O
direct	O	O
amplification	O	O
of	O	O
16S	O	O
ribosomal	O	O
DNA	O	O
,	O	O
a	O	O
method	O	O
that	O	O
can	O	O
identify	O	O
both	O	O
cultivable	O	O
and	O	O
noncultivable	O	O
microorganisms	O	O
.	O	O

They	O	O
analyzed	O	O
the	O	O
resulting	O	O
microbiological	O	O
data	O	O
using	O	O
chi	O	O
(	O	O
2	O	O
)	O	O
and	O	O
correlation	O	O
coefficient	O	O
tests	O	O
.	O	O

Clinical	O	O
measures	O	O
of	O	O
halitosis	O	O
were	O	O
correlated	O	O
highly	O	O
with	O	O
each	O	O
other	O	O
and	O	O
with	O	O
tongue	O	O
coating	O	O
scores	O	O
.	O	O

Of	O	O
4,088	O	O
isolates	O	O
and	O	O
phylotypes	O	O
identified	O	O
from	O	O
the	O	O
13	O	O
subjects	O	O
,	O	O
32	O	O
species	O	O
including	O	O
13	O	O
noncultivable	O	O
species	O	O
were	O	O
found	O	O
only	O	O
in	O	O
subjects	O	O
with	O	O
halitosis	O	O
.	O	O

Solobacterium	B-bacteria	B-bacteria
moorei	E-bacteria	I-bacteria
was	O	O
present	O	O
in	O	O
all	O	O
subjects	O	O
with	O	O
halitosis	O	O
but	O	O
not	O	O
in	O	O
any	O	O
control	O	O
subjects	O	O
.	O	O

Subjects	O	O
with	O	O
halitosis	O	O
harbor	O	O
some	O	O
bacterial	O	O
species	O	O
on	O	O
their	O	O
dorsal	O	O
tongue	O	O
surfaces	O	O
that	O	O
are	O	O
distinct	O	O
from	O	O
bacterial	O	O
species	O	O
found	O	O
in	O	O
control	O	O
subjects	O	O
.	O	O

This	O	O
finding	O	O
is	O	O
consistent	O	O
with	O	O
the	O	O
hypothesis	O	O
that	O	O
halitosis	O	O
has	O	O
a	O	O
microbial	O	O
etiology	O	O
.	O	O

Like	O	O
other	O	O
oral	O	O
diseases	O	O
with	O	O
microbial	O	O
etiology	O	O
,	O	O
halitosis	O	O
may	O	O
be	O	O
amenable	O	O
to	O	O
specific	O	O
and	O	O
nonspecific	O	O
antimicrobial	O	O
therapy	O	O
targeted	O	O
toward	O	O
the	O	O
bacteria	O	O
associated	O	O
with	O	O
it	O	O
.	O	O

Because	O	O
of	O	O
its	O	O
excellent	O	O
osteogenic	O	O
potential	O	O
,	O	O
autogenous	O	O
bone	O	O
is	O	O
the	O	O
preferred	O	O
grafting	O	O
material	O	O
for	O	O
dental	O	O
procedures	O	O
;	O	O
however	O	O
,	O	O
bone	O	O
collected	O	O
in	O	O
osseous	O	O
coagulum	O	O
traps	O	O
is	O	O
subject	O	O
to	O	O
contamination	O	O
by	O	O
oral	O	O
bacteria	O	O
.	O	O

This	O	O
study	O	O
assessed	O	O
bacterial	O	O
contamination	O	O
of	O	O
osseous	O	O
coagulum	O	O
and	O	O
tested	O	O
treatments	O	O
for	O	O
reducing	O	O
contamination	O	O
.	O	O

Fifty	O	O
bone	O	O
samples	O	O
from	O	O
patients	O	O
undergoing	O	O
implant	O	O
osteotomy	O	O
procedures	O	O
were	O	O
collected	O	O
in	O	O
osseous	O	O
coagulum	O	O
traps	O	O
,	O	O
divided	O	O
into	O	O
groups	O	O
of	O	O
10	O	O
,	O	O
and	O	O
rinsed	O	O
with	O	O
normal	O	O
saline	O	O
,	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
,	O	O
or	O	O
50	O	O
mg/mL	O	O
tetracycline	O	O
.	O	O

Twenty	O	O
control	O	O
samples	O	O
received	O	O
no	O	O
treatment	O	O
.	O	O

The	O	O
bone	O	O
samples	O	O
were	O	O
plated	O	O
in	O	O
triplicate	O	O
on	O	O
selective	O	O
and	O	O
differential	O	O
media	O	O
to	O	O
assay	O	O
aerobic	O	O
and	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
potential	O	O
bacterial	B-bacteria	B-bacteria
pathogens	E-bacteria	I-bacteria
,	O	O
including	O	O
staphylococci	B-bacteria	B-bacteria
,	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
enterics	B-bacteria	B-bacteria
,	O	O
and	O	O
black-pigmented	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
BPB	B-bacteria	B-bacteria
)	O	O
.	O	O

Inoculations	O	O
were	O	O
performed	O	O
with	O	O
an	O	O
Autoplate	O	O
4000	O	O
,	O	O
and	O	O
plates	O	O
were	O	O
incubated	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
either	O	O
aerobically	O	O
or	O	O
in	O	O
a	O	O
Coy	O	O
anaerobic	O	O
chamber	O	O
.	O	O

Bacteria	O	O
were	O	O
isolated	O	O
from	O	O
all	O	O
samples	O	O
.	O	O

In	O	O
control	O	O
samples	O	O
,	O	O
the	O	O
mean	O	O
colony-forming	O	O
units	O	O
(	O	O
cfu	O	O
)	O	O
per	O	O
milliliter	O	O
of	O	O
suspended	O	O
osseous	O	O
coagulum	O	O
was	O	O
6.5	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
+/-	O	O
9.6	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
in	O	O
aerobic	O	O
cultures	O	O
and	O	O
4.8	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
+/-	O	O
6.9	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
in	O	O
anaerobic	O	O
cultures	O	O
.	O	O

Viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
46	O	O
samples	O	O
,	O	O
with	O	O
a	O	O
mean	O	O
of	O	O
2.9	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
+/-	O	O
4.1	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
cfu/mL	O	O
.	O	O

Enterics	B-bacteria	B-bacteria
were	O	O
in	O	O
16	O	O
samples	O	O
with	O	O
cfu	O	O
ranging	O	O
from	O	O
200	O	O
cfu/mL	O	O
to	O	O
3.4	O	O
x	O	O
10	O	O
(	O	O
4	O	O
)	O	O
cfu/mL	O	O
.	O	O

Mannitol	B-bacteria	B-bacteria
nonfermenting	I-bacteria	I-bacteria
staphylococci	E-bacteria	I-bacteria
were	O	O
found	O	O
in	O	O
one	O	O
sample	O	O
at	O	O
106	O	O
cfu/mL	O	O
.	O	O

BPB	B-bacteria	B-bacteria
were	O	O
not	O	O
isolated	O	O
.	O	O

A	O	O
Mann-Whitney	O	O
U	O	O
test	O	O
with	O	O
significance	O	O
set	O	O
at	O	O
P	O	O
=	O	O
.05	O	O
determined	O	O
that	O	O
the	O	O
only	O	O
statistically	O	O
significant	O	O
reductions	O	O
in	O	O
bacterial	O	O
numbers	O	O
occurred	O	O
in	O	O
tetracycline-treated	O	O
samples	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
5-fold	O	O
decrease	O	O
,	O	O
P	O	O
=	O	O
.02	O	O
)	O	O
and	O	O
aerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
6-fold	O	O
decrease	O	O
,	O	O
P	O	O
=	O	O
.01	O	O
)	O	O
.	O	O

Tetracycline	O	O
treatments	O	O
effected	O	O
a	O	O
7-fold	O	O
decrease	O	O
in	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
but	O	O
the	O	O
difference	O	O
was	O	O
not	O	O
significant	O	O
(	O	O
P	O	O
=	O	O
.07	O	O
)	O	O
.	O	O

These	O	O
data	O	O
indicate	O	O
significant	O	O
bacterial	O	O
contamination	O	O
of	O	O
bone	O	O
collected	O	O
in	O	O
osseous	O	O
coagulum	O	O
traps	O	O
and	O	O
justify	O	O
further	O	O
research	O	O
into	O	O
methods	O	O
for	O	O
eliminating	O	O
that	O	O
contamination	O	O
.	O	O

Primary	O	O
infection	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
by	O	O
HIV-1	O	O
,	O	O
if	O	O
it	O	O
occurs	O	O
,	O	O
could	O	O
promote	O	O
systemic	O	O
infection	O	O
.	O	O

Most	O	O
primary	O	O
systemic	O	O
infections	O	O
are	O	O
associated	O	O
with	O	O
R5-type	O	O
HIV-1	O	O
targeting	O	O
the	O	O
R5-specific	O	O
coreceptor	O	O
CCR5	O	O
,	O	O
which	O	O
is	O	O
not	O	O
usually	O	O
expressed	O	O
on	O	O
oral	O	O
keratinocytes	O	O
.	O	O

Because	O	O
coinfection	O	O
with	O	O
other	O	O
microbes	O	O
has	O	O
been	O	O
suggested	O	O
to	O	O
modulate	O	O
cellular	O	O
infection	O	O
by	O	O
HIV-1	O	O
,	O	O
we	O	O
hypothesized	O	O
that	O	O
oral	O	O
keratinocytes	O	O
may	O	O
up-regulate	O	O
CCR5	O	O
in	O	O
response	O	O
to	O	O
the	O	O
oral	O	O
endogenous	O	O
pathogen	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
by	O	O
cysteine-protease	O	O
(	O	O
gingipains	O	O
)	O	O
activation	O	O
of	O	O
the	O	O
protease-activated	O	O
receptors	O	O
(	O	O
PARs	O	O
)	O	O
or	O	O
LPS	O	O
signaling	O	O
through	O	O
the	O	O
TLRs	O	O
.	O	O

The	O	O
OKF6/TERT-2-immortalized	O	O
normal	O	O
human	O	O
oral	O	O
keratinocyte	O	O
line	O	O
expressed	O	O
CXCR4	O	O
,	O	O
whereas	O	O
CCR5	O	O
was	O	O
not	O	O
detectable	O	O
.	O	O

When	O	O
exposed	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33277	E-bacteria	I-bacteria
,	O	O
TERT-2	O	O
cells	O	O
induced	O	O
greater	O	O
time-dependent	O	O
expression	O	O
of	O	O
CCR5-specific	O	O
mRNA	O	O
and	O	O
surface	O	O
coreceptors	O	O
than	O	O
CXCR4	O	O
.	O	O

By	O	O
comparing	O	O
arg-	O	O
(	O	O
Rgp	O	O
)	O	O
and	O	O
lys-gingipain	O	O
(	O	O
Kgp	O	O
)	O	O
mutants	O	O
,	O	O
a	O	O
mutant	O	O
deficient	O	O
in	O	O
both	O	O
proteases	O	O
,	O	O
and	O	O
the	O	O
action	O	O
of	O	O
trypsin	O	O
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
Rgp	O	O
was	O	O
strongly	O	O
suggested	O	O
to	O	O
cleave	O	O
PAR-1	O	O
and	O	O
PAR-2	O	O
to	O	O
up-regulate	O	O
CCR5	O	O
.	O	O

CCR5	O	O
was	O	O
also	O	O
slightly	O	O
up-regulated	O	O
by	O	O
an	O	O
isogenic	O	O
gingipain-deficient	O	O
mutant	O	O
,	O	O
suggesting	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
nongingipain-mediated	O	O
mechanism	O	O
.	O	O

Purified	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
LPS	E-bacteria	I-bacteria
also	O	O
up-regulated	O	O
CCR5	O	O
.	O	O

Blocking	O	O
TLR2	O	O
and	O	O
TLR4	O	O
receptors	O	O
with	O	O
Abs	O	O
attenuated	O	O
induction	O	O
of	O	O
CCR5	O	O
,	O	O
suggesting	O	O
LPS	O	O
signaling	O	O
through	O	O
TLRs	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
therefore	O	O
,	O	O
selectively	O	O
up-regulated	O	O
CCR5	O	O
by	O	O
two	O	O
independent	O	O
signaling	O	O
pathways	O	O
,	O	O
Rgp	O	O
acting	O	O
on	O	O
PAR-1	O	O
and	O	O
PAR-2	O	O
,	O	O
and	O	O
LPS	O	O
on	O	O
TLR2	O	O
and	O	O
TLR4	O	O
.	O	O

By	O	O
inducing	O	O
CCR5	O	O
expression	O	O
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
coinfection	O	O
could	O	O
promote	O	O
selective	O	O
R5-type	O	O
HIV-1	O	O
infection	O	O
of	O	O
oral	O	O
keratinocytes	O	O
.	O	O

To	O	O
assess	O	O
the	O	O
effectiveness	O	O
of	O	O
0.2	O	O
%	O	O
chlorhexidine	O	O
gluconate	O	O
mouth	O	O
rinse	O	O
on	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
orthodontic	O	O
patients	O	O
with	O	O
fixed	O	O
appliances	O	O
.	O	O

Twenty	O	O
patients	O	O
,	O	O
aged	O	O
13-18	O	O
,	O	O
with	O	O
fixed	O	O
orthodontic	O	O
appliances	O	O
participated	O	O
in	O	O
the	O	O
study	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
saliva	O	O
samples	O	O
were	O	O
evaluated	O	O
at	O	O
four	O	O
stages	O	O
:	O	O
at	O	O
the	O	O
beginning	O	O
of	O	O
the	O	O
orthodontic	O	O
treatment	O	O
,	O	O
at	O	O
least	O	O
2	O	O
weeks	O	O
after	O	O
the	O	O
bonding	O	O
of	O	O
brackets	O	O
,	O	O
1	O	O
week	O	O
after	O	O
the	O	O
introduction	O	O
of	O	O
0.2	O	O
%	O	O
chlorhexidine	O	O
gluconate	O	O
mouth	O	O
rinse	O	O
,	O	O
and	O	O
at	O	O
the	O	O
fourth	O	O
week	O	O
.	O	O

The	O	O
changes	O	O
in	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
levels	O	O
were	O	O
analyzed	O	O
via	O	O
Wilcoxon	O	O
test	O	O
.	O	O

Increases	O	O
in	O	O
bacterial	O	O
levels	O	O
of	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
were	O	O
detected	O	O
after	O	O
the	O	O
orthodontic	O	O
appliances	O	O
were	O	O
bonded	O	O
.	O	O

A	O	O
significant	O	O
decrease	O	O
in	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
levels	O	O
was	O	O
observed	O	O
1	O	O
week	O	O
after	O	O
the	O	O
introduction	O	O
of	O	O
chlorhexidine	O	O
mouth	O	O
rinse	O	O
.	O	O

An	O	O
0.2	O	O
%	O	O
chlorhexidine	O	O
gluconate	O	O
mouth	O	O
rinse	O	O
decreased	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
levels	O	O
,	O	O
but	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
lactobacilli	B-bacteria	B-bacteria
levels	O	O
.	O	O

This	O	O
paper	O	O
aims	O	O
to	O	O
critically	O	O
review	O	O
current	O	O
knowledge	O	O
about	O	O
the	O	O
key	O	O
factors	O	O
involved	O	O
in	O	O
oral	O	O
colonization	O	O
of	O	O
the	O	O
cariogenic	O	O
group	O	O
of	O	O
bacteria	O	O
,	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
in	O	O
young	O	O
children	O	O
.	O	O

MS	B-bacteria	B-bacteria
,	O	O
consisting	O	O
mainly	O	O
of	O	O
the	O	O
species	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
are	O	O
commonly	O	O
cultured	O	O
from	O	O
the	O	O
mouths	O	O
of	O	O
infants	O	O
,	O	O
with	O	O
prevalence	O	O
of	O	O
infection	O	O
ranging	O	O
from	O	O
around	O	O
30	O	O
per	O	O
cent	O	O
in	O	O
3	O	O
month	O	O
old	O	O
predentate	O	O
children	O	O
to	O	O
over	O	O
80	O	O
per	O	O
cent	O	O
in	O	O
24	O	O
month	O	O
old	O	O
children	O	O
with	O	O
primary	O	O
teeth	O	O
.	O	O

MS	B-bacteria	B-bacteria
is	O	O
usually	O	O
transmitted	O	O
to	O	O
children	O	O
through	O	O
their	O	O
mothers	O	O
,	O	O
and	O	O
the	O	O
risk	O	O
of	O	O
transmission	O	O
increases	O	O
with	O	O
high	O	O
maternal	O	O
salivary	O	O
levels	O	O
of	O	O
MS	B-bacteria	B-bacteria
and	O	O
frequent	O	O
inoculation	O	O
.	O	O

Factors	O	O
that	O	O
affect	O	O
the	O	O
colonization	O	O
of	O	O
MS	B-bacteria	B-bacteria
may	O	O
be	O	O
divided	O	O
into	O	O
bacterial	O	O
virulence	O	O
,	O	O
host-related	O	O
and	O	O
environmental	O	O
factors	O	O
.	O	O

Complex	O	O
interaction	O	O
among	O	O
these	O	O
factors	O	O
determine	O	O
the	O	O
success	O	O
and	O	O
timing	O	O
of	O	O
MS	B-bacteria	B-bacteria
colonization	O	O
in	O	O
the	O	O
child	O	O
.	O	O

As	O	O
clinical	O	O
studies	O	O
have	O	O
shown	O	O
that	O	O
caries	O	O
risk	O	O
is	O	O
correlated	O	O
with	O	O
age	O	O
at	O	O
which	O	O
initial	O	O
MS	B-bacteria	B-bacteria
colonization	O	O
occurred	O	O
,	O	O
strategies	O	O
for	O	O
the	O	O
prevention	O	O
of	O	O
dental	O	O
caries	O	O
should	O	O
include	O	O
timely	O	O
control	O	O
of	O	O
colonization	O	O
of	O	O
the	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
the	O	O
mouths	O	O
of	O	O
young	O	O
children	O	O
.	O	O

Oral	O	O
administration	O	O
of	O	O
artificial	O	O
cell	O	O
microcapsules	O	O
has	O	O
been	O	O
proposed	O	O
for	O	O
various	O	O
therapy	O	O
procedures	O	O
using	O	O
biologically	O	O
active	O	O
materials	O	O
.	O	O

Recently	O	O
we	O	O
have	O	O
designed	O	O
novel	O	O
APPPA	O	O
microcapsules	O	O
using	O	O
alginate	O	O
,	O	O
poly-L-lysine	O	O
,	O	O
pectin	O	O
,	O	O
poly-L-lysine	O	O
and	O	O
alginate	O	O
that	O	O
have	O	O
shown	O	O
superior	O	O
oral	O	O
delivery	O	O
features	O	O
.	O	O

This	O	O
article	O	O
investigates	O	O
,	O	O
in-vitro	O	O
using	O	O
a	O	O
computer	O	O
controlled	O	O
dynamic	O	O
gastrointestinal	O	O
(	O	O
GI	O	O
)	O	O
model	O	O
,	O	O
effects	O	O
of	O	O
APPPA	O	O
microcapsules	O	O
on	O	O
health	O	O
of	O	O
gastrointestinal	O	O
(	O	O
GI	O	O
)	O	O
microbial	O	O
flora	O	O
.	O	O

The	O	O
impact	O	O
of	O	O
APPPA	O	O
microcapsules	O	O
on	O	O
GI	O	O
bacterial	O	O
population	O	O
,	O	O
total	O	O
anaerobes	B-bacteria	B-bacteria
,	O	O
total	O	O
aerobes	B-bacteria	B-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Staphylococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

has	O	O
been	O	O
analyzed	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
effects	O	O
of	O	O
microcapsules	O	O
on	O	O
GI	O	O
microbial	O	O
extracellular	O	O
enzymatic	O	O
activities	O	O
have	O	O
been	O	O
investigated	O	O
.	O	O

Result	O	O
shows	O	O
the	O	O
altered	O	O
activities	O	O
of	O	O
microbial	O	O
flora	O	O
and	O	O
enzymes	O	O
due	O	O
to	O	O
the	O	O
use	O	O
of	O	O
APPPA	O	O
microcapsule	O	O
.	O	O

The	O	O
most	O	O
disparity	O	O
is	O	O
observed	O	O
in	O	O
the	O	O
colon	O	O
ascendans	O	O
microbial	O	O
activities	O	O
.	O	O

This	O	O
study	O	O
would	O	O
have	O	O
significant	O	O
impact	O	O
on	O	O
future	O	O
microcapsule	O	O
design	O	O
.	O	O

However	O	O
,	O	O
further	O	O
in-vivo	O	O
studies	O	O
are	O	O
required	O	O
.	O	O

The	O	O
inhibitory	O	O
role	O	O
of	O	O
TNF-alpha	O	O
on	O	O
survival	O	O
of	O	O
naive	O	O
and	O	O
IL-2	O	O
treated	O	O
NK	O	O
cells	O	O
has	O	O
been	O	O
demonstrated	O	O
in	O	O
the	O	O
past	O	O
.	O	O

However	O	O
,	O	O
its	O	O
effect	O	O
on	O	O
the	O	O
function	O	O
of	O	O
these	O	O
cells	O	O
against	O	O
tumor	O	O
cells	O	O
,	O	O
in	O	O
particular	O	O
against	O	O
oral	O	O
tumors	O	O
has	O	O
not	O	O
been	O	O
established	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
significance	O	O
of	O	O
secreted	O	O
TNF-alpha	O	O
in	O	O
death	O	O
and	O	O
functional	O	O
loss	O	O
of	O	O
splenocytes	O	O
and	O	O
NK	O	O
cells	O	O
in	O	O
ex-vivo	O	O
cultures	O	O
with	O	O
oral	O	O
tumors	O	O
.	O	O

Oral	O	O
tumors	O	O
trigger	O	O
potent	O	O
secretion	O	O
of	O	O
TNF-alpha	O	O
by	O	O
human	O	O
and	O	O
murine	O	O
immune	O	O
effectors	O	O
.	O	O

Absence	O	O
of	O	O
TNF-alpha	O	O
increases	O	O
the	O	O
cytotoxic	O	O
activity	O	O
and	O	O
secretion	O	O
of	O	O
IFN-gamma	O	O
by	O	O
IL-2	O	O
treated	O	O
splenocytes	O	O
and	O	O
NK	O	O
cells	O	O
in	O	O
co-cultures	O	O
with	O	O
MOK	O	O
L2D1+/p53-/-	O	O
oral	O	O
tumor	O	O
cells	O	O
.	O	O

IL-2	O	O
treated	O	O
splenocytes	O	O
and	O	O
NK	O	O
cells	O	O
from	O	O
TNF-alpha	O	O
-/-	O	O
mice	O	O
survive	O	O
and	O	O
proliferate	O	O
more	O	O
when	O	O
compared	O	O
to	O	O
cells	O	O
from	O	O
TNF-alpha	O	O
+/+	O	O
mice	O	O
.	O	O

Cell	O	O
death	O	O
induced	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	B-bacteria	B-bacteria
,	O	O
an	O	O
oral	O	O
bacteria	O	O
,	O	O
in	O	O
TNF-alpha	O	O
-/-	O	O
splenocytes	O	O
are	O	O
considerably	O	O
lower	O	O
than	O	O
that	O	O
induced	O	O
in	O	O
TNF-alpha	O	O
+/+	O	O
splenocytes	O	O
where	O	O
potent	O	O
release	O	O
of	O	O
TNF-alpha	O	O
is	O	O
reproducibly	O	O
observed	O	O
.	O	O

Addition	O	O
of	O	O
exogenous	O	O
rTNF-alpha	O	O
to	O	O
IL-2	O	O
treated	O	O
splenocytes	O	O
and	O	O
NK	O	O
cells	O	O
decreased	O	O
survival	O	O
and	O	O
function	O	O
of	O	O
splenocytes	O	O
and	O	O
NK	O	O
cells	O	O
obtained	O	O
from	O	O
TNF-alpha	O	O
-/-	O	O
mice	O	O
against	O	O
oral	O	O
tumors	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
potent	O	O
induction	O	O
of	O	O
TNF-alpha	O	O
during	O	O
interaction	O	O
of	O	O
immune	O	O
effectors	O	O
with	O	O
oral	O	O
tumors	O	O
and/or	O	O
oral	O	O
bacteria	O	O
is	O	O
an	O	O
important	O	O
factor	O	O
in	O	O
decreasing	O	O
the	O	O
function	O	O
and	O	O
survival	O	O
of	O	O
cytotoxic	O	O
immune	O	O
effectors	O	O
.	O	O

Strategies	O	O
to	O	O
neutralize	O	O
TNF-alpha	O	O
may	O	O
be	O	O
beneficial	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
oral	O	O
cancers	O	O
.	O	O

Probiotics	B-bacteria	B-bacteria
have	O	O
been	O	O
extensively	O	O
studied	O	O
for	O	O
their	O	O
health-promoting	O	O
effects	O	O
.	O	O

The	O	O
main	O	O
field	O	O
of	O	O
research	O	O
has	O	O
been	O	O
in	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
.	O	O

However	O	O
,	O	O
in	O	O
the	O	O
past	O	O
few	O	O
years	O	O
probiotics	B-bacteria	B-bacteria
have	O	O
also	O	O
been	O	O
investigated	O	O
in	O	O
the	O	O
oral	O	O
health	O	O
perspective	O	O
,	O	O
which	O	O
is	O	O
the	O	O
topic	O	O
of	O	O
the	O	O
present	O	O
review	O	O
.	O	O

We	O	O
discuss	O	O
the	O	O
mechanisms	O	O
of	O	O
bacterial	O	O
adhesion	O	O
,	O	O
potential	O	O
of	O	O
probiotics	B-bacteria	B-bacteria
in	O	O
oral	O	O
cavity	O	O
colonization	O	O
,	O	O
interspecies	O	O
interactions	O	O
,	O	O
and	O	O
possible	O	O
effects	O	O
on	O	O
immunomodulation	O	O
,	O	O
and	O	O
means	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
administration	O	O
.	O	O

We	O	O
suggest	O	O
that	O	O
probiotic	B-bacteria	B-bacteria
treatment	O	O
of	O	O
diseases	O	O
other	O	O
than	O	O
dental	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
should	O	O
also	O	O
be	O	O
systematically	O	O
investigated	O	O
.	O	O

In	O	O
general	O	O
,	O	O
hardly	O	O
any	O	O
randomized	O	O
controlled	O	O
trials	O	O
have	O	O
been	O	O
conducted	O	O
in	O	O
this	O	O
area	O	O
and	O	O
the	O	O
studies	O	O
on	O	O
probiotics	B-bacteria	B-bacteria
vs	O	O
oral	O	O
health	O	O
are	O	O
still	O	O
in	O	O
their	O	O
cradle	O	O
.	O	O

Hence	O	O
,	O	O
much	O	O
more	O	O
investigations	O	O
are	O	O
called	O	O
for	O	O
before	O	O
any	O	O
evidence-based	O	O
conclusions	O	O
can	O	O
be	O	O
drawn	O	O
:	O	O
if	O	O
or	O	O
not	O	O
probiotic	B-bacteria	B-bacteria
therapy	O	O
can	O	O
be	O	O
recommended	O	O
for	O	O
oral	O	O
health	O	O
purposes	O	O
.	O	O

Assessment	O	O
of	O	O
the	O	O
presence	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
feces	O	O
after	O	O
oral	O	O
ingestion	O	O
.	O	O

Probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
are	O	O
said	O	O
to	O	O
have	O	O
beneficial	O	O
effects	O	O
on	O	O
the	O	O
host	O	O
.	O	O

As	O	O
a	O	O
precondition	O	O
for	O	O
any	O	O
effect	O	O
,	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
must	O	O
survive	O	O
passage	O	O
through	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
.	O	O

The	O	O
feces	O	O
of	O	O
seven	O	O
volunteers	O	O
were	O	O
analyzed	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
probiotic	O	O
strains	O	O
after	O	O
one	O	O
week	O	O
's	O	O
oral	O	O
ingestion	O	O
of	O	O
each	O	O
of	O	O
six	O	O
commercially	O	O
available	O	O
products	O	O
:	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
Nissle	O	O
0.5-5	O	O
x	O	O
10	O	O
(	O	O
9	O	O
)	O	O
cells	O	O
(	O	O
Mutaflor	O	O
)	O	O
,	O	O
Enterococcus	B-bacteria	B-bacteria
faecium	I-bacteria	I-bacteria
SF	I-bacteria	I-bacteria
68	E-bacteria	I-bacteria
7.5	O	O
x	O	O
10	O	O
(	O	O
7	O	O
)	O	O
cells	O	O
(	O	O
Bioflorin	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
infantis	E-bacteria	I-bacteria
both	O	O
1	O	O
x	O	O
10	O	O
(	O	O
9	O	O
)	O	O
cells	O	O
(	O	O
Infloran	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
longum	E-bacteria	I-bacteria
both	O	O
1	O	O
x	O	O
10	O	O
(	O	O
8	O	O
)	O	O
cells	O	O
(	O	O
Omniflora	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	I-bacteria	I-bacteria
rhamnosus	E-bacteria	I-bacteria
1	O	O
x	O	O
10	O	O
(	O	O
9	O	O
)	O	O
cells	O	O
(	O	O
Antibiophilus	O	O
)	O	O
,	O	O
and	O	O
yoghurt	O	O
enriched	O	O
with	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	I-bacteria	I-bacteria
Immunitas	E-bacteria	I-bacteria
1	O	O
x	O	O
10	O	O
(	O	O
10	O	O
)	O	O
cells	O	O
(	O	O
Actimel	O	O
)	O	O
.	O	O

Ten	O	O
colonies	O	O
were	O	O
selected	O	O
from	O	O
each	O	O
stool	O	O
sample	O	O
,	O	O
and	O	O
DNA	O	O
was	O	O
extracted	O	O
and	O	O
typed	O	O
using	O	O
random	O	O
amplification	O	O
of	O	O
polymorphic	O	O
DNA	O	O
(	O	O
RAPD	O	O
)	O	O
.	O	O

Typing	O	O
patterns	O	O
of	O	O
the	O	O
ingested	O	O
probiotics	B-bacteria	B-bacteria
and	O	O
the	O	O
fecal	O	O
isolates	O	O
were	O	O
compared	O	O
.	O	O

Fingerprints	O	O
identical	O	O
to	O	O
the	O	O
ingested	O	O
probiotic	B-bacteria	B-bacteria
strains	O	O
were	O	O
recovered	O	O
from	O	O
fecal	O	O
samples	O	O
of	O	O
4/7	O	O
volunteers	O	O
after	O	O
one	O	O
week	O	O
of	O	O
Mutaflor	O	O
,	O	O
from	O	O
4/6	O	O
after	O	O
taking	O	O
Bioflorin	O	O
,	O	O
and	O	O
from	O	O
1/6	O	O
after	O	O
Infloran	O	O
.	O	O

Cultivation	O	O
of	O	O
strains	O	O
of	O	O
the	O	O
same	O	O
species	O	O
from	O	O
fecal	O	O
specimens	O	O
was	O	O
negative	O	O
after	O	O
consumption	O	O
of	O	O
Antibiophilus	O	O
,	O	O
Omniflora	O	O
and	O	O
Actimel	O	O
.	O	O

After	O	O
oral	O	O
consumption	O	O
of	O	O
probiotics	B-bacteria	B-bacteria
,	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
enterococci	B-bacteria	B-bacteria
could	O	O
be	O	O
detected	O	O
in	O	O
stool	O	O
samples	O	O
(	O	O
57	O	O
%	O	O
and	O	O
67	O	O
%	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
with	O	O
only	O	O
one	O	O
exception	O	O
,	O	O
ingested	O	O
lactobacilli	B-bacteria	B-bacteria
and	O	O
bifidobacteria	E-bacteria	I-bacteria
could	O	O
not	O	O
be	O	O
detected	O	O
in	O	O
human	O	O
feces	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
the	O	O
susceptibility	O	O
of	O	O
nonperiodontopathic	O	O
and	O	O
periodontopathic	O	O
bacteria	O	O
to	O	O
major	O	O
defense	O	O
mechanisms	O	O
for	O	O
bacterial	O	O
clearance	O	O
in	O	O
gingival	O	O
sulcus	O	O
.	O	O

Twenty	O	O
strains	O	O
of	O	O
13	O	O
oral	O	O
bacterial	O	O
species	O	O
were	O	O
studied	O	O
for	O	O
their	O	O
susceptibility	O	O
to	O	O
phagocytosis	O	O
by	O	O
human	O	O
neutrophils	O	O
and	O	O
to	O	O
the	O	O
antimicrobial	O	O
peptides	O	O
LL-37	O	O
and	O	O
human	O	O
beta	O	O
defensin-3	O	O
.	O	O

The	O	O
minimum	O	O
inhibitory	O	O
concentrations	O	O
of	O	O
LL-37	O	O
and	O	O
human	O	O
beta	O	O
defensin-3	O	O
were	O	O
determined	O	O
by	O	O
a	O	O
liquid	O	O
dilution	O	O
assay	O	O
,	O	O
and	O	O
susceptibility	O	O
to	O	O
phagocytosis	O	O
was	O	O
examined	O	O
by	O	O
a	O	O
flow	O	O
cytometric	O	O
phagocytosis	O	O
assay	O	O
.	O	O

The	O	O
minimum	O	O
inhibitory	O	O
concentrations	O	O
of	O	O
LL-37	O	O
and	O	O
human	O	O
beta	O	O
defensin-3	O	O
varied	O	O
greatly	O	O
,	O	O
depending	O	O
on	O	O
the	O	O
strain	O	O
and	O	O
species	O	O
.	O	O

Although	O	O
a	O	O
significant	O	O
difference	O	O
between	O	O
the	O	O
non-	O	O
and	O	O
periodontopathic	O	O
groups	O	O
was	O	O
not	O	O
observed	O	O
,	O	O
the	O	O
red-complex	O	O
bacteria	O	O
were	O	O
more	O	O
resistant	O	O
to	O	O
LL-37	O	O
than	O	O
the	O	O
others	O	O
(	O	O
p=0.004	O	O
)	O	O
.	O	O

The	O	O
susceptibility	O	O
of	O	O
oral	O	O
bacteria	O	O
to	O	O
phagocytosis	O	O
was	O	O
quite	O	O
variable	O	O
,	O	O
depending	O	O
on	O	O
the	O	O
species	O	O
but	O	O
not	O	O
on	O	O
the	O	O
strains	O	O
.	O	O

The	O	O
periodontopathic	O	O
bacteria	O	O
,	O	O
especially	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
the	O	O
red-complex	O	O
triad	O	O
,	O	O
were	O	O
more	O	O
resistant	O	O
to	O	O
phagocytosis	O	O
than	O	O
were	O	O
the	O	O
nonperiodontopathic	O	O
bacteria	O	O
(	O	O
p=0.0003	O	O
)	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
bacteria	O	O
resistant	O	O
both	O	O
to	O	O
antimicrobial	O	O
peptides	O	O
and	O	O
to	O	O
phagocytosis	O	O
were	O	O
more	O	O
common	O	O
in	O	O
the	O	O
periodontopathic	O	O
group	O	O
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
immune	O	O
evasion	O	O
may	O	O
contribute	O	O
to	O	O
the	O	O
pathogenicity	O	O
of	O	O
some	O	O
periodontopathic	O	O
bacteria	O	O
.	O	O

Antimicrobial	O	O
peptides	O	O
(	O	O
AMPs	O	O
)	O	O
are	O	O
naturally	O	O
occurring	O	O
,	O	O
broad-spectrum	O	O
antimicrobial	O	O
agents	O	O
that	O	O
have	O	O
recently	O	O
been	O	O
examined	O	O
for	O	O
their	O	O
utility	O	O
as	O	O
therapeutic	O	O
antibiotics	O	O
.	O	O

Unfortunately	O	O
,	O	O
they	O	O
are	O	O
expensive	O	O
to	O	O
produce	O	O
and	O	O
are	O	O
often	O	O
sensitive	O	O
to	O	O
protease	O	O
digestion	O	O
.	O	O

To	O	O
address	O	O
this	O	O
problem	O	O
,	O	O
we	O	O
have	O	O
examined	O	O
the	O	O
activity	O	O
of	O	O
a	O	O
peptide	O	O
mimetic	O	O
whose	O	O
design	O	O
was	O	O
based	O	O
on	O	O
the	O	O
structure	O	O
of	O	O
magainin	O	O
,	O	O
exhibiting	O	O
its	O	O
amphiphilic	O	O
structure	O	O
.	O	O

We	O	O
demonstrate	O	O
that	O	O
this	O	O
compound	O	O
,	O	O
meta-phenylene	O	O
ethynylene	O	O
(	O	O
mPE	O	O
)	O	O
,	O	O
exhibits	O	O
antimicrobial	O	O
activity	O	O
at	O	O
nanomolar	O	O
concentrations	O	O
against	O	O
a	O	O
variety	O	O
of	O	O
bacterial	O	O
and	O	O
Candida	O	O
species	O	O
found	O	O
in	O	O
oral	O	O
infections	O	O
.	O	O

Since	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
an	O	O
etiological	O	O
agent	O	O
of	O	O
dental	O	O
caries	O	O
,	O	O
colonizes	O	O
the	O	O
tooth	O	O
surface	O	O
and	O	O
forms	O	O
a	O	O
biofilm	O	O
,	O	O
we	O	O
quantified	O	O
the	O	O
activity	O	O
of	O	O
this	O	O
compound	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
growing	O	O
under	O	O
conditions	O	O
that	O	O
favor	O	O
biofilm	O	O
formation	O	O
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
mPE	O	O
can	O	O
prevent	O	O
the	O	O
formation	O	O
of	O	O
a	O	O
biofilm	O	O
at	O	O
nanomolar	O	O
concentrations	O	O
.	O	O

Incubation	O	O
with	O	O
5	O	O
nM	O	O
mPE	O	O
prevents	O	O
further	O	O
growth	O	O
of	O	O
the	O	O
biofilm	O	O
,	O	O
and	O	O
100	O	O
nM	O	O
mPE	O	O
reduces	O	O
viable	O	O
bacteria	O	O
in	O	O
the	O	O
biofilm	O	O
by	O	O
3	O	O
logs	O	O
.	O	O

Structure-function	O	O
analyses	O	O
suggest	O	O
that	O	O
mPE	O	O
inhibits	O	O
the	O	O
bioactivity	O	O
of	O	O
lipopolysaccharide	O	O
and	O	O
binds	O	O
DNA	O	O
at	O	O
equimolar	O	O
ratios	O	O
,	O	O
suggesting	O	O
that	O	O
it	O	O
may	O	O
act	O	O
both	O	O
as	O	O
a	O	O
membrane-active	O	O
molecule	O	O
,	O	O
similar	O	O
to	O	O
magainin	O	O
,	O	O
and	O	O
as	O	O
an	O	O
intracellular	O	O
antibiotic	O	O
,	O	O
similar	O	O
to	O	O
other	O	O
AMPs	O	O
.	O	O

We	O	O
conclude	O	O
that	O	O
mPE	O	O
and	O	O
similar	O	O
molecules	O	O
display	O	O
great	O	O
potential	O	O
for	O	O
development	O	O
as	O	O
therapeutic	O	O
antimicrobials	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
exhibits	O	O
extensive	O	O
genotypic	O	O
diversity	O	O
,	O	O
but	O	O
the	O	O
role	O	O
of	O	O
this	O	O
variation	O	O
is	O	O
poorly	O	O
understood	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
determine	O	O
the	O	O
number	O	O
and	O	O
distribution	O	O
of	O	O
genotypes	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
isolated	O	O
from	O	O
caries-active	O	O
and	O	O
caries-free	O	O
children	O	O
and	O	O
to	O	O
evaluate	O	O
some	O	O
of	O	O
their	O	O
phenotypic	O	O
traits	O	O
.	O	O

Stimulated	O	O
saliva	O	O
,	O	O
tongue	O	O
surface	O	O
and	O	O
biofilms	O	O
over	O	O
sound	O	O
and	O	O
carious	O	O
teeth	O	O
surfaces	O	O
were	O	O
sampled	O	O
from	O	O
10	O	O
caries-free	O	O
and	O	O
11	O	O
caries-active	O	O
children	O	O
aged	O	O
5-8	O	O
years	O	O
.	O	O

A	O	O
total	O	O
of	O	O
339	O	O
isolates	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
genotyped	O	O
by	O	O
arbitrarily	O	O
primed	O	O
polymerase	O	O
chain	O	O
reaction	O	O
using	O	O
OPA2	O	O
primer	O	O
.	O	O

One	O	O
isolate	O	O
from	O	O
each	O	O
genotype	O	O
was	O	O
tested	O	O
for	O	O
its	O	O
acid	O	O
susceptibility	O	O
and	O	O
its	O	O
ability	O	O
to	O	O
form	O	O
a	O	O
biofilm	O	O
.	O	O

Fifty-one	O	O
distinct	O	O
genotypes	O	O
were	O	O
determined	O	O
,	O	O
one	O	O
to	O	O
three	O	O
genotypes	O	O
in	O	O
each	O	O
oral	O	O
sample	O	O
.	O	O

A	O	O
single	O	O
genotype	O	O
was	O	O
detected	O	O
in	O	O
seven	O	O
children	O	O
,	O	O
whereas	O	O
the	O	O
remaining	O	O
14	O	O
children	O	O
exhibited	O	O
two	O	O
to	O	O
seven	O	O
genotypes	O	O
.	O	O

There	O	O
were	O	O
no	O	O
significant	O	O
differences	O	O
in	O	O
the	O	O
number	O	O
of	O	O
genotypes	O	O
detected	O	O
in	O	O
caries-free	O	O
and	O	O
caries-active	O	O
children	O	O
.	O	O

No	O	O
correlation	O	O
was	O	O
observed	O	O
between	O	O
the	O	O
number	O	O
of	O	O
genotypes	O	O
and	O	O
the	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
salivary	O	O
levels	O	O
.	O	O

Five	O	O
of	O	O
the	O	O
six	O	O
high	O	O
biofilm-forming	O	O
genotypes	O	O
were	O	O
obtained	O	O
from	O	O
caries-active	O	O
children	O	O
,	O	O
although	O	O
the	O	O
differences	O	O
in	O	O
biofilm	O	O
formation	O	O
between	O	O
isolates	O	O
from	O	O
caries-free	O	O
and	O	O
caries-active	O	O
children	O	O
were	O	O
not	O	O
statistically	O	O
significant	O	O
.	O	O

Genotypes	O	O
with	O	O
low	O	O
susceptibility	O	O
to	O	O
acid	O	O
challenge	O	O
were	O	O
statistically	O	O
more	O	O
frequent	O	O
among	O	O
isolates	O	O
from	O	O
caries-active	O	O
children	O	O
than	O	O
among	O	O
those	O	O
from	O	O
caries-free	O	O
children	O	O
.	O	O

The	O	O
present	O	O
data	O	O
suggested	O	O
that	O	O
there	O	O
were	O	O
differences	O	O
in	O	O
the	O	O
distribution	O	O
of	O	O
genotypes	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
according	O	O
to	O	O
the	O	O
oral	O	O
site	O	O
and	O	O
that	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
populations	O	O
differ	O	O
in	O	O
their	O	O
acid	O	O
susceptibility	O	O
and	O	O
ability	O	O
to	O	O
form	O	O
biofilms	O	O
,	O	O
factors	O	O
allowing	O	O
their	O	O
colonization	O	O
of	O	O
sucrose-rich	O	O
environments	O	O
.	O	O

Autoinducer-2	O	O
(	O	O
AI-2	O	O
)	O	O
is	O	O
a	O	O
widespread	O	O
communication-signal	O	O
molecule	O	O
that	O	O
allows	O	O
bacteria	O	O
to	O	O
sense	O	O
and	O	O
react	O	O
to	O	O
environmental	O	O
factors	O	O
.	O	O

In	O	O
some	O	O
streptococci	B-bacteria	B-bacteria
AI-2	O	O
is	O	O
reported	O	O
to	O	O
be	O	O
involved	O	O
in	O	O
virulence	O	O
expression	O	O
and	O	O
biofilm	O	O
formation	O	O
.	O	O

It	O	O
has	O	O
earlier	O	O
been	O	O
shown	O	O
that	O	O
the	O	O
alga	O	O
Delisea	O	O
pulchra	O	O
produces	O	O
bromated	O	O
furanones	O	O
,	O	O
which	O	O
prevent	O	O
bacterial	O	O
colonization	O	O
of	O	O
the	O	O
algae	O	O
.	O	O


We	O	O
have	O	O
previously	O	O
published	O	O
a	O	O
novel	O	O
and	O	O
simple	O	O
synthesis	O	O
of	O	O
(	O	O
Z	O	O
)	O	O
-5-bromomethylene-2	O	O
(	O	O
5H	O	O
)	O	O
-furanone	O	O
.	O	O

In	O	O
this	O	O
study	O	O
we	O	O
showed	O	O
that	O	O
our	O	O
synthesized	O	O
furanone	O	O
inhibited	O	O
biofilm	O	O
formation	O	O
and	O	O
bioluminescence	O	O
induction	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
bioluminescence	O	O
induction	O	O
by	O	O
Vibrio	B-bacteria	B-bacteria
harveyi	I-bacteria	I-bacteria
BB152	E-bacteria	I-bacteria
.	O	O

We	O	O
suggest	O	O
that	O	O
the	O	O
effect	O	O
is	O	O
linked	O	O
to	O	O
interference	O	O
with	O	O
the	O	O
AI-2	O	O
signaling	O	O
pathway	O	O
because	O	O
adding	O	O
furanone	O	O
to	O	O
the	O	O
medium	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
the	O	O
ability	O	O
of	O	O
the	O	O
AI-2-defective	O	O
S.	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
luxS	O	O
and	O	O
S.	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
luxS	O	O
mutants	O	O
to	O	O
form	O	O
biofilms	O	O
.	O	O

Biofilms	O	O
are	O	O
complex	O	O
aggregations	O	O
of	O	O
microorganisms	O	O
attached	O	O
to	O	O
a	O	O
surface	O	O
.	O	O

The	O	O
formation	O	O
of	O	O
biofilms	O	O
might	O	O
facilitate	O	O
certain	O	O
survival	O	O
and	O	O
virulence	O	O
characteristics	O	O
under	O	O
some	O	O
situations	O	O
.	O	O

This	O	O
study	O	O
tested	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
ability	O	O
of	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
to	O	O
form	O	O
biofilms	O	O
is	O	O
related	O	O
to	O	O
the	O	O
source	O	O
of	O	O
the	O	O
strains	O	O
.	O	O

E.	B-bacteria	B-bacteria
faecalis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
recovered	O	O
from	O	O
root	O	O
canals	O	O
(	O	O
n	O	O
=	O	O
33	O	O
)	O	O
,	O	O
the	O	O
oral	O	O
cavity	O	O
(	O	O
n	O	O
=	O	O
21	O	O
)	O	O
,	O	O
and	O	O
non-oral/non-endodontic	O	O
sources	O	O
(	O	O
n	O	O
=	O	O
16	O	O
)	O	O
were	O	O
studied	O	O
.	O	O

Biofilms	O	O
were	O	O
grown	O	O
in	O	O
tryptic	O	O
soy	O	O
broth	O	O
in	O	O
96-well	O	O
plates	O	O
for	O	O
24	O	O
hours	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
,	O	O
fixed	O	O
with	O	O
Bouin	O	O
's	O	O
fixative	O	O
,	O	O
and	O	O
stained	O	O
with	O	O
1	O	O
%	O	O
crystal	O	O
violet	O	O
.	O	O

Optical	O	O
density	O	O
at	O	O
570	O	O
nm	O	O
(	O	O
OD	O	O
(	O	O
570	O	O
)	O	O
)	O	O
was	O	O
measured	O	O
by	O	O
using	O	O
a	O	O
microtiter	O	O
plate	O	O
reader	O	O
.	O	O

Experiments	O	O
were	O	O
performed	O	O
in	O	O
quadruplicate	O	O
on	O	O
three	O	O
occasions	O	O
and	O	O
mean	O	O
OD	O	O
(	O	O
570	O	O
)	O	O
readings	O	O
determined	O	O
for	O	O
each	O	O
strain	O	O
.	O	O

There	O	O
were	O	O
no	O	O
statistically	O	O
significant	O	O
differences	O	O
between	O	O
groups	O	O
(	O	O
p	O	O
=	O	O
0.066	O	O
,	O	O
Kruskal-Wallis	O	O
)	O	O
.	O	O

Within	O	O
the	O	O
root	O	O
canal	O	O
and	O	O
oral	O	O
isolates	O	O
there	O	O
were	O	O
no	O	O
significant	O	O
associations	O	O
between	O	O
biofilm	O	O
formation	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
virulence	O	O
determinants	O	O
asa	O	O
,	O	O
cylA	O	O
,	O	O
esp	O	O
,	O	O
and	O	O
gelE	O	O
.	O	O

Salivary	O	O
occurrence	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
is	O	O
of	O	O
interest	O	O
especially	O	O
in	O	O
children	O	O
as	O	O
a	O	O
risk	O	O
indicator	O	O
for	O	O
the	O	O
transmission	O	O
,	O	O
development	O	O
and	O	O
control	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

We	O	O
assessed	O	O
the	O	O
prevalence	O	O
of	O	O
Aggregatibacter	O	O
actinomycetemcomitans	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
as	O	O
microbial	O	O
complexes	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
children	O	O
with	O	O
mixed	O	O
dentition	O	O
and	O	O
healthy	O	O
gingiva	O	O
.	O	O

Paraffin-stimulated	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
41	O	O
children	O	O
(	O	O
22	O	O
boys	O	O
and	O	O
19	O	O
girls	O	O
)	O	O
,	O	O
aged	O	O
6-13	O	O
years	O	O
old	O	O
.	O	O

Gingival	O	O
health	O	O
was	O	O
determined	O	O
during	O	O
the	O	O
initial	O	O
screening	O	O
exam	O	O
.	O	O

The	O	O
test	O	O
bacteria	O	O
were	O	O
identified	O	O
using	O	O
a	O	O
16S	O	O
rRNA-based	O	O
PCR	O	O
analysis	O	O
.	O	O

P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
frequent	O	O
species	O	O
(	O	O
80	O	O
%	O	O
)	O	O
,	O	O
followed	O	O
by	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
(	O	O
32	O	O
%	O	O
)	O	O
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
24	O	O
%	O	O
)	O	O
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
12	O	O
%	O	O
)	O	O
.	O	O

P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
were	O	O
not	O	O
detected	O	O
.	O	O

P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
was	O	O
also	O	O
common	O	O
species	O	O
in	O	O
combinations	O	O
.	O	O

Paired	O	O
and	O	O
triple	O	O
bacterial	O	O
combinations	O	O
were	O	O
found	O	O
in	O	O
24	O	O
%	O	O
and	O	O
20	O	O
%	O	O
of	O	O
all	O	O
children	O	O
,	O	O
respectively	O	O
.	O	O

There	O	O
was	O	O
no	O	O
positive	O	O
association	O	O
between	O	O
bacterial	O	O
combinations	O	O
in	O	O
colonization	O	O
and	O	O
subject	O	O
's	O	O
gender	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
,	O	O
Fisher	O	O
exact	O	O
test	O	O
)	O	O
.	O	O

The	O	O
salivary	O	O
presence	O	O
of	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
but	O	O
not	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
can	O	O
occur	O	O
in	O	O
childhood	O	O
without	O	O
clinical	O	O
signs	O	O
of	O	O
gingival	O	O
disease	O	O
.	O	O

Thus	O	O
,	O	O
the	O	O
possible	O	O
risk	O	O
of	O	O
bacterial	O	O
transmissions	O	O
through	O	O
saliva	O	O
and	O	O
,	O	O
the	O	O
need	O	O
to	O	O
screen	O	O
for	O	O
periodontal	O	O
pathogens	O	O
should	O	O
be	O	O
considered	O	O
before	O	O
mixed	O	O
dentition	O	O
.	O	O

To	O	O
evaluate	O	O
our	O	O
hypothesis	O	O
that	O	O
non-pathogenic	O	O
bacterial	O	O
flora	O	O
inhibit	O	O
later	O	O
colonization	O	O
with	O	O
methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
in	O	O
extremely	O	O
low	O	O
birth	O	O
weight	O	O
(	O	O
ELBW	O	O
)	O	O
infants	O	O
,	O	O
we	O	O
performed	O	O
a	O	O
retrospective	O	O
investigation	O	O
of	O	O
the	O	O
association	O	O
between	O	O
non-pathogenic	O	O
bacterial	O	O
flora	O	O
and	O	O
later	O	O
inhibition	O	O
of	O	O
colonization	O	O
by	O	O
MRSA	B-bacteria	B-bacteria
in	O	O
ELBW	O	O
infants	O	O
.	O	O

A	O	O
total	O	O
of	O	O
110	O	O
preterm	O	O
infants	O	O
with	O	O
birth	O	O
weight	O	O
<	O	O
1,000	O	O
g	O	O
admitted	O	O
to	O	O
the	O	O
Neonatal	O	O
Intensive	O	O
Care	O	O
Unit	O	O
of	O	O
Nagano	O	O
Children	O	O
's	O	O
Hospital	O	O
from	O	O
January	O	O
1997	O	O
to	O	O
December	O	O
2003	O	O
were	O	O
analyzed	O	O
retrospectively	O	O
with	O	O
regard	O	O
to	O	O
colonization	O	O
by	O	O
MRSA	B-bacteria	B-bacteria
during	O	O
hospitalization	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
incidence	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
colonization	O	O
in	O	O
56	O	O
infants	O	O
with	O	O
non-pathogenic	O	O
bacterial	O	O
flora	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
during	O	O
the	O	O
first	O	O
week	O	O
after	O	O
birth	O	O
and	O	O
compared	O	O
them	O	O
with	O	O
54	O	O
infants	O	O
lacking	O	O
non-pathogenic	O	O
bacteria	O	O
.	O	O

Incidence	O	O
rate	O	O
of	O	O
colonization	O	O
by	O	O
MRSA	B-bacteria	B-bacteria
at	O	O
postnatal	O	O
week	O	O
6	O	O
was	O	O
significantly	O	O
lower	O	O
in	O	O
infants	O	O
with	O	O
non-pathogenic	O	O
bacterial	O	O
flora	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
(	O	O
32.1	O	O
%	O	O
)	O	O
than	O	O
in	O	O
infants	O	O
without	O	O
such	O	O
bacteria	O	O
during	O	O
the	O	O
first	O	O
week	O	O
of	O	O
life	O	O
(	O	O
77.8	O	O
%	O	O
;	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

The	O	O
present	O	O
results	O	O
suggest	O	O
an	O	O
important	O	O
role	O	O
for	O	O
non-pathogenic	O	O
bacterial	O	O
flora	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
during	O	O
early	O	O
life	O	O
in	O	O
prevention	O	O
of	O	O
later	O	O
MRSA	B-bacteria	B-bacteria
colonization	O	O
in	O	O
ELBW	O	O
infants	O	O
.	O	O

Flavors	O	O
and	O	O
natural	O	O
botanic	O	O
extracts	O	O
are	O	O
often	O	O
used	O	O
in	O	O
chewing	O	O
gum	O	O
and	O	O
compressed	O	O
mints	O	O
for	O	O
breath	O	O
freshening	O	O
and	O	O
relief	O	O
of	O	O
oral	O	O
malodor	O	O
.	O	O

The	O	O
oral	O	O
malodor	O	O
is	O	O
a	O	O
result	O	O
of	O	O
bacterial	O	O
putrification	O	O
of	O	O
proteinaceous	O	O
materials	O	O
from	O	O
food	O	O
or	O	O
saliva	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
magnolia	O	O
bark	O	O
extract	O	O
(	O	O
MBE	O	O
)	O	O
and	O	O
its	O	O
two	O	O
main	O	O
components	O	O
,	O	O
magnolol	O	O
and	O	O
honokiol	O	O
,	O	O
were	O	O
evaluated	O	O
by	O	O
the	O	O
minimum	O	O
inhibition	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
test	O	O
.	O	O

The	O	O
inhibitory	O	O
effect	O	O
of	O	O
MBE	O	O
mint	O	O
was	O	O
further	O	O
evaluated	O	O
by	O	O
a	O	O
kill-time	O	O
assay	O	O
study	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
an	O	O
in	O	O
vivo	O	O
study	O	O
was	O	O
performed	O	O
on	O	O
nine	O	O
healthy	O	O
volunteers	O	O
postlunch	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
taken	O	O
before	O	O
and	O	O
after	O	O
subjects	O	O
consumed	O	O
mints	O	O
and	O	O
gum	O	O
,	O	O
with	O	O
and	O	O
without	O	O
MBE	O	O
.	O	O

Listerine	O	O
mouthwash	O	O
was	O	O
included	O	O
as	O	O
a	O	O
positive	O	O
control	O	O
.	O	O

The	O	O
testing	O	O
results	O	O
indicated	O	O
that	O	O
MBE	O	O
and	O	O
its	O	O
two	O	O
main	O	O
constituents	O	O
demonstrated	O	O
a	O	O
strong	O	O
germ-kill	O	O
effect	O	O
against	O	O
bacteria	O	O
responsible	O	O
for	O	O
halitosis	O	O
and	O	O
also	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
bacteria	O	O
involved	O	O
in	O	O
dental	O	O
caries	O	O
formation	O	O
.	O	O

The	O	O
MIC	O	O
of	O	O
magnolol	O	O
,	O	O
honokiol	O	O
,	O	O
and	O	O
MBE	O	O
on	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
ranged	O	O
from	O	O
8	O	O
to	O	O
31	O	O
microg/mL	O	O
.	O	O

Kill-time	O	O
assay	O	O
results	O	O
indicated	O	O
that	O	O
mints	O	O
containing	O	O
0.2	O	O
%	O	O
MBE	O	O
reduced	O	O
more	O	O
than	O	O
99.9	O	O
%	O	O
of	O	O
three	O	O
oral	O	O
bacteria	O	O
within	O	O
5	O	O
min	O	O
of	O	O
treatment	O	O
.	O	O

The	O	O
in	O	O
vivo	O	O
study	O	O
demonstrated	O	O
that	O	O
MBE	O	O
containing	O	O
mints	O	O
reduced	O	O
total	O	O
salivary	O	O
bacteria	O	O
by	O	O
61.6	O	O
%	O	O
at	O	O
30	O	O
min	O	O
and	O	O
33.8	O	O
%	O	O
at	O	O
60	O	O
min	O	O
postconsumption	O	O
.	O	O

In	O	O
comparison	O	O
,	O	O
the	O	O
flavorless	O	O
mint	O	O
reduced	O	O
total	O	O
salivary	O	O
bacteria	O	O
by	O	O
3.6	O	O
%	O	O
at	O	O
30	O	O
min	O	O
and	O	O
increased	O	O
total	O	O
bacteria	O	O
by	O	O
47.9	O	O
%	O	O
at	O	O
60	O	O
min	O	O
.	O	O

The	O	O
MBE	O	O
containing	O	O
chewing	O	O
gum	O	O
reduced	O	O
total	O	O
salivary	O	O
bacteria	O	O
by	O	O
43.0	O	O
%	O	O
at	O	O
40	O	O
min	O	O
,	O	O
while	O	O
placebo	O	O
gum	O	O
reduced	O	O
total	O	O
salivary	O	O
bacteria	O	O
by	O	O
18.0	O	O
%	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
MBE	O	O
demonstrated	O	O
a	O	O
significant	O	O
antibacterial	O	O
activity	O	O
against	O	O
organisms	O	O
responsible	O	O
for	O	O
oral	O	O
malodor	O	O
and	O	O
can	O	O
be	O	O
incorporated	O	O
in	O	O
compressed	O	O
mints	O	O
and	O	O
chewing	O	O
gum	O	O
for	O	O
improved	O	O
breath-freshening	O	O
benefits	O	O
.	O	O

The	O	O
mechanisms	O	O
of	O	O
nitric	O	O
oxide	O	O
(	O	O
NO	O	O
)	O	O
production	O	O
by	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
are	O	O
still	O	O
not	O	O
clearly	O	O
defined	O	O
but	O	O
salivary	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
have	O	O
been	O	O
reported	O	O
to	O	O
generate	O	O
NO	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
clarify	O	O
the	O	O
mechanism	O	O
of	O	O
nitrite	O	O
metabolism	O	O
and	O	O
generation	O	O
of	O	O
NO	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
a	O	O
major	O	O
pathogen	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

We	O	O
searched	O	O
the	O	O
genomic	O	O
database	O	O
of	O	O
oral	O	O
pathogens	O	O
for	O	O
nitrite	O	O
reductase	O	O
and	O	O
used	O	O
a	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
to	O	O
clone	O	O
the	O	O
nirJ	O	O
gene	O	O
from	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
GS5	E-bacteria	I-bacteria
.	O	O

His-tagged	O	O
recombinant	O	O
NirJ	O	O
protein	O	O
was	O	O
expressed	O	O
in	O	O
Escherichia	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
BL21	E-bacteria	I-bacteria
and	O	O
characterized	O	O
.	O	O

We	O	O
constructed	O	O
a	O	O
nirJ	O	O
gene-disrupted	O	O
mutant	O	O
strain	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
DeltanirJ	B-bacteria	B-bacteria
)	O	O
to	O	O
analyze	O	O
the	O	O
physiological	O	O
significance	O	O
of	O	O
nirJ	O	O
.	O	O

S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
generates	O	O
NO	O	O
from	O	O
nitrite	O	O
,	O	O
probably	O	O
as	O	O
a	O	O
result	O	O
of	O	O
the	O	O
possession	O	O
of	O	O
nitrite	O	O
reductase	O	O
.	O	O

We	O	O
cloned	O	O
the	O	O
nirJ	O	O
gene	O	O
from	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
GS5	E-bacteria	I-bacteria
by	O	O
PCR	O	O
.	O	O

The	O	O
recombinant	O	O
NirJ	O	O
protein	O	O
catalyzed	O	O
the	O	O
reduction	O	O
of	O	O
nitrite	O	O
with	O	O
a	O	O
K	O	O
(	O	O
m	O	O
)	O	O
value	O	O
of	O	O
3.37	O	O
microM	O	O
and	O	O
a	O	O
specific	O	O
activity	O	O
of	O	O
2.5	O	O
micromol/min/mg	O	O
of	O	O
protein	O	O
at	O	O
37	O	O
degrees	O	O
C.	O	O
Biochemical	O	O
analysis	O	O
revealed	O	O
that	O	O
the	O	O
nitrite-reducing	O	O
activity	O	O
of	O	O
the	O	O
mutant	O	O
(	O	O
DeltanirJ	B-bacteria	B-bacteria
)	O	O
strain	O	O
was	O	O
significantly	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
the	O	O
wild-type	O	O
strain	O	O
.	O	O

The	O	O
growth	O	O
of	O	O
the	O	O
mutant	O	O
strain	O	O
,	O	O
but	O	O
not	O	O
of	O	O
the	O	O
wild-type	O	O
strain	O	O
,	O	O
was	O	O
strongly	O	O
suppressed	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
physiological	O	O
levels	O	O
of	O	O
nitrite	O	O
(	O	O
approximately	O	O
0.2	O	O
mM	O	O
)	O	O
in	O	O
saliva	O	O
.	O	O

These	O	O
observations	O	O
suggest	O	O
that	O	O
the	O	O
elimination	O	O
of	O	O
nitrite	O	O
and/or	O	O
the	O	O
generation	O	O
of	O	O
NO	O	O
are	O	O
important	O	O
for	O	O
the	O	O
survival	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Elimination	O	O
of	O	O
methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
is	O	O
of	O	O
critical	O	O
importance	O	O
in	O	O
oral	O	O
and	O	O
maxillofacial	O	O
surgery	O	O
because	O	O
control	O	O
is	O	O
very	O	O
difficult	O	O
once	O	O
infection	O	O
of	O	O
an	O	O
oral	O	O
tumor	O	O
or	O	O
oral	O	O
wound	O	O
with	O	O
MRSA	B-bacteria	B-bacteria
is	O	O
established	O	O
.	O	O

We	O	O
retrospectively	O	O
investigated	O	O
the	O	O
risk	O	O
factors	O	O
for	O	O
acquiring	O	O
MRSA	B-bacteria	B-bacteria
in	O	O
518	O	O
patients	O	O
with	O	O
oral	O	O
cancer	O	O
among	O	O
1,877	O	O
inpatients	O	O
in	O	O
our	O	O
department	O	O
between	O	O
1984	O	O
and	O	O
2005	O	O
.	O	O

The	O	O
patients	O	O
with	O	O
oral	O	O
cancer	O	O
demonstrated	O	O
a	O	O
high	O	O
rate	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
colonization	O	O
and	O	O
infection	O	O
(	O	O
77.8	O	O
%	O	O
)	O	O
relative	O	O
to	O	O
the	O	O
population	O	O
as	O	O
a	O	O
whole	O	O
with	O	O
MRSA	B-bacteria	B-bacteria
isolated	O	O
percentage	O	O
in	O	O
our	O	O
department	O	O
after	O	O
1991	O	O
.	O	O

The	O	O
risk	O	O
factors	O	O
for	O	O
MRSA	B-bacteria	B-bacteria
in	O	O
oral	O	O
cancer	O	O
patients	O	O
are	O	O
also	O	O
related	O	O
to	O	O
systemic	O	O
diseases	O	O
and	O	O
physiological	O	O
and	O	O
iatrogenic	O	O
conditions	O	O
,	O	O
including	O	O
cerebrovascular	O	O
diseases	O	O
(	O	O
77.8	O	O
%	O	O
)	O	O
,	O	O
peripheral	O	O
arterial	O	O
catheterization	O	O
(	O	O
69.2	O	O
%	O	O
)	O	O
,	O	O
diabetes	O	O
(	O	O
50.0	O	O
%	O	O
)	O	O
,	O	O
tracheotomy	O	O
(	O	O
50.0	O	O
%	O	O
)	O	O
,	O	O
renal	O	O
failure	O	O
(	O	O
50.0	O	O
%	O	O
)	O	O
,	O	O
long-term	O	O
broad-spectrum	O	O
antibiotic	O	O
use	O	O
(	O	O
45.7	O	O
%	O	O
)	O	O
,	O	O
and	O	O
malnutrition	O	O
(	O	O
43.3	O	O
%	O	O
)	O	O
.	O	O

However	O	O
,	O	O
the	O	O
highest	O	O
risk	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
seems	O	O
to	O	O
be	O	O
related	O	O
to	O	O
poor	O	O
hygienic	O	O
care	O	O
.	O	O

Beginning	O	O
in	O	O
1999	O	O
,	O	O
we	O	O
implemented	O	O
a	O	O
strategy	O	O
for	O	O
reducing	O	O
infection	O	O
by	O	O
MRSA	B-bacteria	B-bacteria
that	O	O
included	O	O
nasal	O	O
mupirocin	O	O
ointment	O	O
for	O	O
patients	O	O
at	O	O
high	O	O
risk	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
;	O	O
since	O	O
then	O	O
,	O	O
the	O	O
detection	O	O
rate	O	O
has	O	O
decreased	O	O
.	O	O

We	O	O
suggest	O	O
that	O	O
the	O	O
administration	O	O
of	O	O
nasal	O	O
mupirocin	O	O
ointment	O	O
and	O	O
provision	O	O
of	O	O
scrupulous	O	O
hygienic	O	O
care	O	O
for	O	O
high-risk	O	O
patients	O	O
are	O	O
useful	O	O
and	O	O
effective	O	O
measures	O	O
for	O	O
decreasing	O	O
the	O	O
incidence	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
infection	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
is	O	O
the	O	O
etiologic	O	O
agent	O	O
of	O	O
dental	O	O
caries	O	O
and	O	O
is	O	O
a	O	O
causative	O	O
agent	O	O
of	O	O
infective	O	O
endocarditis	O	O
.	O	O

While	O	O
the	O	O
mechanisms	O	O
by	O	O
which	O	O
S.	O	O
mutans	O	O
cells	O	O
colonize	O	O
heart	O	O
tissue	O	O
is	O	O
not	O	O
clear	O	O
,	O	O
it	O	O
is	O	O
thought	O	O
that	O	O
bacterial	O	O
binding	O	O
to	O	O
extracellular	O	O
matrix	O	O
and	O	O
blood	O	O
components	O	O
is	O	O
crucial	O	O
in	O	O
the	O	O
development	O	O
of	O	O
endocarditis	O	O
.	O	O

Previously	O	O
,	O	O
we	O	O
have	O	O
demonstrated	O	O
that	O	O
S.	O	O
mutans	O	O
cells	O	O
have	O	O
the	O	O
capacity	O	O
to	O	O
bind	O	O
and	O	O
activate	O	O
plasminogen	O	O
to	O	O
plasmin	O	O
.	O	O

Here	O	O
we	O	O
report	O	O
the	O	O
first	O	O
cloning	O	O
and	O	O
characterization	O	O
of	O	O
an	O	O
alpha-enolase	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
that	O	O
binds	O	O
plasminogen	O	O
.	O	O

The	O	O
functional	O	O
identity	O	O
of	O	O
the	O	O
purified	O	O
recombinant	O	O
alpha-enolase	O	O
protein	O	O
was	O	O
confirmed	O	O
by	O	O
its	O	O
ability	O	O
to	O	O
catalyze	O	O
the	O	O
conversion	O	O
of	O	O
2-phosphoglycerate	O	O
to	O	O
phosphoenolpyruvate	O	O
.	O	O

The	O	O
protein	O	O
exhibited	O	O
a	O	O
Km	O	O
of	O	O
9.5	O	O
mM	O	O
and	O	O
a	O	O
Vmax	O	O
of	O	O
31.0	O	O
mM/min/mg	O	O
.	O	O

The	O	O
alpha-enolase	O	O
protein	O	O
was	O	O
localized	O	O
in	O	O
the	O	O
cytoplasmic	O	O
,	O	O
cell	O	O
wall	O	O
and	O	O
extracellular	O	O
fractions	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Binding	O	O
studies	O	O
using	O	O
an	O	O
immunoblot	O	O
analysis	O	O
revealed	O	O
that	O	O
human	O	O
plasminogen	O	O
binds	O	O
to	O	O
the	O	O
enolase	O	O
enzyme	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

These	O	O
findings	O	O
identify	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
alpha-enolase	O	O
as	O	O
a	O	O
binding	O	O
molecule	O	O
used	O	O
by	O	O
this	O	O
oral	O	O
pathogen	O	O
to	O	O
interact	O	O
with	O	O
the	O	O
blood	O	O
component	O	O
,	O	O
plasminogen	O	O
.	O	O

Further	O	O
studies	O	O
of	O	O
this	O	O
interaction	O	O
may	O	O
be	O	O
critical	O	O
to	O	O
understand	O	O
the	O	O
pathogenesis	O	O
of	O	O
endocarditis	O	O
caused	O	O
by	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Plasma	O	O
and	O	O
salivary	O	O
amoxicillin	O	O
(	O	O
AMO	O	O
)	O	O
concentrations	O	O
were	O	O
quantified	O	O
following	O	O
a	O	O
single	O	O
oral	O	O
dose	O	O
(	O	O
875	O	O
mg	O	O
)	O	O
of	O	O
two	O	O
formulations	O	O
of	O	O
AMO	O	O
(	O	O
Amoxicillin-EMS	O	O
Sigma	O	O
Pharma	O	O
and	O	O
Amoxil	O	O
BD	O	O
875	O	O
mg	O	O
)	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
effect	O	O
of	O	O
amoxicillin	O	O
against	O	O
oral	O	O
microorganisms	O	O
was	O	O
accessed	O	O
.	O	O

The	O	O
open	O	O
,	O	O
randomized	O	O
,	O	O
two-period	O	O
crossover	O	O
study	O	O
was	O	O
carried	O	O
out	O	O
in	O	O
20	O	O
volunteers	O	O
.	O	O

Saliva	O	O
and	O	O
blood	O	O
samples	O	O
were	O	O
collected	O	O
at	O	O
0	O	O
,	O	O
0.5	O	O
,	O	O
1	O	O
,	O	O
2	O	O
,	O	O
4	O	O
,	O	O
8	O	O
and	O	O
12	O	O
h	O	O
after	O	O
drug	O	O
administration	O	O
,	O	O
and	O	O
quantified	O	O
using	O	O
HPLC-ESI-MS	O	O
and	O	O
HPLC	O	O
,	O	O
respectively	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
counts	O	O
,	O	O
anaerobe	B-bacteria	B-bacteria
counts	O	O
and	O	O
total	O	O
microorganism	O	O
counts	O	O
were	O	O
obtained	O	O
.	O	O

No	O	O
differences	O	O
were	O	O
observed	O	O
between	O	O
formulations	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
in	O	O
the	O	O
plasma	O	O
and	O	O
salivary	O	O
AMO	O	O
concentrations	O	O
and	O	O
the	O	O
pharmacokinetic	O	O
parameters	O	O
(	O	O
C	O	O
(	O	O
max	O	O
)	O	O
,	O	O
t	O	O
(	O	O
max	O	O
)	O	O
,	O	O
AUC	O	O
(	O	O
0-8	O	O
)	O	O
,	O	O
and	O	O
AUC	O	O
(	O	O
0-infinity	O	O
)	O	O
)	O	O
also	O	O
showed	O	O
no	O	O
statistically	O	O
significant	O	O
differences	O	O
between	O	O
formulations	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Microorganism	O	O
counts	O	O
for	O	O
the	O	O
two	O	O
formulations	O	O
at	O	O
all	O	O
sampling	O	O
times	O	O
did	O	O
not	O	O
differ	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
but	O	O
all	O	O
microorganism	O	O
counts	O	O
at	O	O
60	O	O
min	O	O
post-dose	O	O
showed	O	O
a	O	O
significant	O	O
decrease	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Amoxicillin	O	O
was	O	O
effective	O	O
in	O	O
reducing	O	O
oral	O	O
microorganism	O	O
levels	O	O
up	O	O
to	O	O
12	O	O
h	O	O
post-dose	O	O
.	O	O

Oral	O	O
epithelium	O	O
is	O	O
a	O	O
stratified	O	O
squamous	O	O
epithelium	O	O
that	O	O
functions	O	O
as	O	O
the	O	O
barrier	O	O
between	O	O
the	O	O
outside	O	O
environment	O	O
and	O	O
the	O	O
host	O	O
.	O	O

In	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
epithelial	O	O
tissues	O	O
are	O	O
constantly	O	O
exposed	O	O
to	O	O
a	O	O
variety	O	O
of	O	O
bacteria	O	O
,	O	O
but	O	O
most	O	O
individuals	O	O
maintain	O	O
healthy	O	O
homeostasis	O	O
.	O	O

Epithelial	O	O
cells	O	O
contribute	O	O
to	O	O
the	O	O
innate	O	O
host	O	O
response	O	O
,	O	O
and	O	O
antimicrobial	O	O
peptide	O	O
expression	O	O
in	O	O
all	O	O
human	O	O
epithelia	O	O
,	O	O
including	O	O
oral	O	O
epithelia	O	O
,	O	O
is	O	O
an	O	O
important	O	O
part	O	O
of	O	O
this	O	O
epithelial	O	O
function	O	O
.	O	O

These	O	O
antimicrobial	O	O
peptides	O	O
have	O	O
a	O	O
broad	O	O
spectrum	O	O
of	O	O
activity	O	O
against	O	O
both	O	O
Gram-negative	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-positive	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
as	O	O
well	O	O
as	O	O
against	O	O
yeast	O	O
and	O	O
viruses	O	O
.	O	O

In	O	O
humans	O	O
these	O	O
antimicrobial	O	O
peptides	O	O
include	O	O
defensins	O	O
and	O	O
a	O	O
cathelicidin	O	O
family	O	O
member	O	O
LL-37	O	O
in	O	O
skin	O	O
and	O	O
oral	O	O
mucosa	O	O
and	O	O
other	O	O
epithelia	O	O
.	O	O

The	O	O
human	O	O
defensins	O	O
include	O	O
the	O	O
alpha-defensins	O	O
of	O	O
intestinal	O	O
and	O	O
neutrophil	O	O
origin	O	O
,	O	O
and	O	O
the	O	O
beta-defensins	O	O
of	O	O
skin	O	O
and	O	O
oral	O	O
mucosa	O	O
and	O	O
other	O	O
epithelia	O	O
.	O	O

Present	O	O
studies	O	O
have	O	O
identified	O	O
specific	O	O
signaling	O	O
routes	O	O
that	O	O
pathogens	O	O
and	O	O
commensals	O	O
take	O	O
in	O	O
stimulating	O	O
these	O	O
innate	O	O
immune	O	O
responses	O	O
,	O	O
and	O	O
this	O	O
may	O	O
open	O	O
the	O	O
way	O	O
for	O	O
development	O	O
of	O	O
new	O	O
therapeutic	O	O
agents	O	O
for	O	O
periodontal	O	O
diseases	O	O
.	O	O

A	O	O
recent	O	O
study	O	O
indicated	O	O
that	O	O
Neisseria	B-bacteria	B-bacteria
subflava	E-bacteria	I-bacteria
,	O	O
one	O	O
of	O	O
the	O	O
commensal	O	O
Neisseria	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
may	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
emergence	O	O
of	O	O
Neisseria	B-bacteria	B-bacteria
gonorrhoeae	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
with	O	O
chromosomally	O	O
mediated	O	O
resistance	O	O
to	O	O
penicillin	O	O
or	O	O
cephalosporin	O	O
by	O	O
the	O	O
horizontal	O	O
genetic	O	O
exchange	O	O
of	O	O
penA	O	O
genes	O	O
encoding	O	O
the	O	O
target	O	O
site	O	O
for	O	O
penicillin	O	O
or	O	O
cephalosporin	O	O
.	O	O

The	O	O
present	O	O
investigation	O	O
examined	O	O
the	O	O
antimicrobial	O	O
susceptibility	O	O
of	O	O
45	O	O
isolates	O	O
of	O	O
N.	B-bacteria	B-bacteria
subflava	E-bacteria	I-bacteria
from	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
Japanese	O	O
men	O	O
and	O	O
women	O	O
to	O	O
various	O	O
agents	O	O
used	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
gonococcal	O	O
infections	O	O
.	O	O

Of	O	O
the	O	O
45	O	O
isolates	O	O
,	O	O
40	O	O
(	O	O
88.9	O	O
%	O	O
)	O	O
and	O	O
4	O	O
(	O	O
8.8	O	O
%	O	O
)	O	O
were	O	O
intermediately	O	O
resistant	O	O
and	O	O
resistant	O	O
to	O	O
penicillin	O	O
,	O	O
respectively	O	O
,	O	O
with	O	O
the	O	O
minimal	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
(	O	O
50	O	O
)	O	O
and	O	O
MIC	O	O
(	O	O
90	O	O
)	O	O
of	O	O
penicillin	O	O
being	O	O
0.5	O	O
mg/l	O	O
and	O	O
1	O	O
mg/l	O	O
,	O	O
respectively	O	O
.	O	O

Of	O	O
the	O	O
45	O	O
isolates	O	O
,	O	O
13	O	O
(	O	O
28.9	O	O
%	O	O
)	O	O
and	O	O
14	O	O
(	O	O
31.1	O	O
%	O	O
)	O	O
were	O	O
resistant	O	O
to	O	O
tetracycline	O	O
and	O	O
ciprofloxacin	O	O
,	O	O
respectively	O	O
,	O	O
and	O	O
3	O	O
(	O	O
6.7	O	O
%	O	O
)	O	O
showed	O	O
reduced	O	O
susceptibility	O	O
to	O	O
cefixime	O	O
(	O	O
although	O	O
the	O	O
susceptibility	O	O
category	O	O
was	O	O
not	O	O
determined	O	O
)	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
several	O	O
isolates	O	O
of	O	O
N.	B-bacteria	B-bacteria
subflava	E-bacteria	I-bacteria
have	O	O
acquired	O	O
resistance	O	O
or	O	O
intermediate	O	O
resistance	O	O
to	O	O
various	O	O
antimicrobial	O	O
agents	O	O
,	O	O
including	O	O
penicillin	O	O
,	O	O
cephalosporin	O	O
,	O	O
tetracycline	O	O
,	O	O
and	O	O
ciprofloxacin	O	O
.	O	O

The	O	O
present	O	O
study	O	O
may	O	O
thus	O	O
confirm	O	O
that	O	O
N.	B-bacteria	B-bacteria
subflava	E-bacteria	I-bacteria
may	O	O
be	O	O
involved	O	O
in	O	O
the	O	O
emergence	O	O
of	O	O
N.	B-bacteria	B-bacteria
gonorrhoeae	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
with	O	O
either	O	O
intermediate	O	O
or	O	O
total	O	O
resistance	O	O
to	O	O
penicillin	O	O
or	O	O
cephalosporin	O	O
by	O	O
the	O	O
horizontal	O	O
genetic	O	O
exchange	O	O
of	O	O
the	O	O
penA	O	O
gene	O	O
.	O	O

Granulicatella	B-bacteria	B-bacteria
elegans	E-bacteria	I-bacteria
is	O	O
a	O	O
member	O	O
of	O	O
normal	O	O
human	O	O
oral	O	O
flora	O	O
and	O	O
is	O	O
thought	O	O
to	O	O
be	O	O
a	O	O
potent	O	O
pathogen	O	O
in	O	O
endocarditis	O	O
,	O	O
especially	O	O
so-called	O	O
``	O	O
culture-negative	O	O
''	O	O
endocarditis	O	O
.	O	O

To	O	O
elucidate	O	O
the	O	O
pathogenicity	O	O
of	O	O
this	O	O
microorganism	O	O
in	O	O
inflammatory	O	O
diseases	O	O
,	O	O
the	O	O
effect	O	O
of	O	O
the	O	O
extracellular	O	O
products	O	O
of	O	O
this	O	O
bacteria	O	O
on	O	O
human	O	O
peripheral	O	O
blood	O	O
mononuclear	O	O
cells	O	O
(	O	O
PBMCs	O	O
)	O	O
was	O	O
examined	O	O
.	O	O

Culture	O	O
supernatants	O	O
produced	O	O
by	O	O
oral	O	O
isolates	O	O
of	O	O
G.	B-bacteria	B-bacteria
elegans	E-bacteria	I-bacteria
strongly	O	O
inhibited	O	O
the	O	O
proliferation	O	O
of	O	O
PBMC	O	O
stimulated	O	O
by	O	O
the	O	O
T-cell	O	O
mitogens	O	O
phytohemagglutinin-P	O	O
,	O	O
phorbol	O	O
12-myristate	O	O
13-acetate	O	O
,	O	O
concanavalin	O	O
A	O	O
,	O	O
and	O	O
staphylococcal	O	O
enterotoxin	O	O
B.	O	O
Purification	O	O
of	O	O
the	O	O
active	O	O
extracellular	O	O
product	O	O
revealed	O	O
that	O	O
a	O	O
fraction	O	O
containing	O	O
proteins	O	O
of	O	O
approximately	O	O
47	O	O
kDa	O	O
showing	O	O
arginine	O	O
deiminase	O	O
activity	O	O
contributed	O	O
to	O	O
the	O	O
inhibition	O	O
of	O	O
PBMC	O	O
proliferation	O	O
.	O	O

In	O	O
order	O	O
to	O	O
characterize	O	O
the	O	O
bacterial	O	O
microbiota	O	O
present	O	O
within	O	O
oral	O	O
cancerous	O	O
lesions	O	O
,	O	O
tumorous	O	O
and	O	O
non-tumorous	O	O
mucosal	O	O
tissue	O	O
specimens	O	O
(	O	O
approx	O	O
.	O	O

1	O	O
cm	O	O
(	O	O
3	O	O
)	O	O
)	O	O
were	O	O
harvested	O	O
from	O	O
ten	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
(	O	O
OSCC	O	O
)	O	O
patients	O	O
at	O	O
the	O	O
time	O	O
of	O	O
surgery	O	O
.	O	O

Any	O	O
microbial	O	O
contamination	O	O
on	O	O
the	O	O
surface	O	O
of	O	O
the	O	O
specimens	O	O
was	O	O
eliminated	O	O
by	O	O
immersion	O	O
in	O	O
Betadine	O	O
and	O	O
washing	O	O
with	O	O
PBS	O	O
.	O	O

Bacteria	O	O
were	O	O
visualized	O	O
within	O	O
sections	O	O
of	O	O
the	O	O
OSCC	O	O
by	O	O
performing	O	O
fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
with	O	O
the	O	O
universal	O	O
oligonucleotide	O	O
probe	O	O
,	O	O
EUB338	O	O
.	O	O

DNA	O	O
was	O	O
extracted	O	O
from	O	O
each	O	O
aseptically	O	O
macerated	O	O
tissue	O	O
specimen	O	O
using	O	O
a	O	O
commercial	O	O
kit	O	O
.	O	O

This	O	O
was	O	O
then	O	O
used	O	O
as	O	O
template	O	O
for	O	O
PCR	O	O
with	O	O
three	O	O
sets	O	O
of	O	O
primers	O	O
,	O	O
targeting	O	O
the	O	O
16S	O	O
rRNA	O	O
genes	O	O
of	O	O
Spirochaetes	B-bacteria	B-bacteria
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
and	O	O
the	O	O
domain	O	O
Bacteria	O	O
.	O	O

PCR	O	O
products	O	O
were	O	O
differentiated	O	O
by	O	O
TA	O	O
cloning	O	O
and	O	O
bacterial	O	O
species	O	O
were	O	O
identified	O	O
by	O	O
partial	O	O
sequencing	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
fragments	O	O
.	O	O

A	O	O
total	O	O
of	O	O
70	O	O
distinct	O	O
taxa	O	O
was	O	O
detected	O	O
:	O	O
52	O	O
different	O	O
phylotypes	O	O
isolated	O	O
from	O	O
the	O	O
tumorous	O	O
tissues	O	O
,	O	O
and	O	O
37	O	O
taxa	O	O
from	O	O
within	O	O
the	O	O
non-tumorous	O	O
specimens	O	O
.	O	O

Differences	O	O
between	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
microbiotas	O	O
within	O	O
the	O	O
tumorous	O	O
and	O	O
non-tumorous	O	O
mucosae	O	O
were	O	O
apparent	O	O
,	O	O
possibly	O	O
indicating	O	O
selective	O	O
growth	O	O
of	O	O
bacteria	O	O
within	O	O
carcinoma	O	O
tissue	O	O
.	O	O

Most	O	O
taxa	O	O
isolated	O	O
from	O	O
within	O	O
the	O	O
tumour	O	O
tissue	O	O
represented	O	O
saccharolytic	O	O
and	O	O
aciduric	O	O
species	O	O
.	O	O

Whether	O	O
the	O	O
presence	O	O
of	O	O
these	O	O
bacteria	O	O
within	O	O
the	O	O
mucosa	O	O
has	O	O
any	O	O
bearing	O	O
on	O	O
the	O	O
carcinogenic	O	O
process	O	O
is	O	O
a	O	O
concept	O	O
worthy	O	O
of	O	O
further	O	O
investigation	O	O
.	O	O

Three	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
Gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
isolated	O	O
from	O	O
human	O	O
oral	O	O
sites	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
and	O	O
were	O	O
found	O	O
to	O	O
comprise	O	O
a	O	O
homogeneous	O	O
group	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
revealed	O	O
the	O	O
strains	O	O
to	O	O
constitute	O	O
a	O	O
novel	O	O
group	O	O
within	O	O
the	O	O
genus	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
,	O	O
most	O	O
closely	O	O
related	O	O
to	O	O
Prevotella	B-bacteria	B-bacteria
oris	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
salivae	E-bacteria	I-bacteria
.	O	O

A	O	O
novel	O	O
species	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
maculosa	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
is	O	O
proposed	O	O
to	O	O
accommodate	O	O
these	O	O
strains	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
maculosa	E-bacteria	I-bacteria
is	O	O
saccharolytic	O	O
and	O	O
produces	O	O
acetic	O	O
and	O	O
succinic	O	O
acids	O	O
as	O	O
end	O	O
products	O	O
of	O	O
fermentation	O	O
.	O	O

The	O	O
G+C	O	O
content	O	O
of	O	O
the	O	O
DNA	O	O
of	O	O
the	O	O
type	O	O
strain	O	O
is	O	O
48	O	O
mol	O	O
%	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
maculosa	E-bacteria	I-bacteria
is	O	O
W1609	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
=DSM	B-bacteria	B-bacteria
19339	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
54766	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
.	O	O

Periodontitis	O	O
is	O	O
a	O	O
common	O	O
oral	O	O
disease	O	O
produced	O	O
by	O	O
bacterial	O	O
species	O	O
that	O	O
reside	O	O
in	O	O
the	O	O
subgingival	O	O
plaque	O	O
.	O	O

These	O	O
microorganisms	O	O
have	O	O
been	O	O
associated	O	O
to	O	O
atherosclerosis	O	O
and	O	O
it	O	O
is	O	O
suggested	O	O
that	O	O
periodontitis	O	O
is	O	O
a	O	O
cardiovascular	O	O
risk	O	O
factor	O	O
.	O	O

To	O	O
isolate	O	O
periodontal	O	O
bacteria	O	O
from	O	O
blood	O	O
and	O	O
atheroma	O	O
samples	O	O
,	O	O
from	O	O
patients	O	O
with	O	O
atherosclerosis	O	O
and	O	O
periodontitis	O	O
.	O	O

Twelve	O	O
patients	O	O
with	O	O
periodontitis	O	O
and	O	O
a	O	O
clinical	O	O
diagnosis	O	O
of	O	O
atherosclerosis	O	O
and	O	O
12	O	O
patients	O	O
with	O	O
periodontitis	O	O
but	O	O
without	O	O
atherosclerosis	O	O
were	O	O
studied	O	O
.	O	O

Blood	O	O
samples	O	O
were	O	O
obtained	O	O
immediately	O	O
before	O	O
and	O	O
after	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
incubated	O	O
in	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
conditions	O	O
.	O	O

One	O	O
week	O	O
after	O	O
scaling	O	O
,	O	O
atheromatous	O	O
plaques	O	O
were	O	O
obtained	O	O
during	O	O
endarterectomy	O	O
in	O	O
the	O	O
12	O	O
patients	O	O
with	O	O
atherosclerosis	O	O
.	O	O

These	O	O
were	O	O
homogenized	O	O
and	O	O
cultured	O	O
for	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Microorganisms	O	O
were	O	O
identified	O	O
by	O	O
means	O	O
ofPCR	O	O
.	O	O

Five	O	O
patients	O	O
with	O	O
and	O	O
two	O	O
without	O	O
atherosclerosis	O	O
,	O	O
had	O	O
bacteremia	O	O
after	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
.	O	O

Bacterial	O	O
species	O	O
isolated	O	O
from	O	O
blood	O	O
samples	O	O
were	O	O
the	O	O
same	O	O
found	O	O
in	O	O
periodontic	O	O
pockets	O	O
.	O	O

Four	O	O
atheromatous	O	O
plaques	O	O
of	O	O
patients	O	O
with	O	O
bacteremia	O	O
yielded	O	O
positive	O	O
cultures	O	O
.	O	O

The	O	O
isolated	O	O
bacteria	O	O
were	O	O
the	O	O
same	O	O
found	O	O
in	O	O
blood	O	O
samples	O	O
and	O	O
periodontal	O	O
pockets	O	O
.	O	O

Bacteremia	O	O
occurred	O	O
in	O	O
seven	O	O
of	O	O
24	O	O
patients	O	O
after	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
.	O	O

In	O	O
four	O	O
patients	O	O
,	O	O
the	O	O
same	O	O
species	O	O
found	O	O
in	O	O
periodontic	O	O
pockets	O	O
and	O	O
blood	O	O
cultures	O	O
were	O	O
detected	O	O
in	O	O
atherosclerotic	O	O
plaques	O	O
obtained	O	O
one	O	O
week	O	O
after	O	O
the	O	O
dental	O	O
procedure	O	O
.	O	O

To	O	O
investigate	O	O
a	O	O
possible	O	O
peroral	O	O
route	O	O
of	O	O
infective	O	O
endocarditis	O	O
(	O	O
IE	O	O
)	O	O
,	O	O
the	O	O
occurrence	O	O
of	O	O
staphylococci	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
was	O	O
examined	O	O
using	O	O
saliva	O	O
and	O	O
supragingival	O	O
plaque	O	O
specimens	O	O
from	O	O
56	O	O
systemically	O	O
and	O	O
periodontally	O	O
healthy	O	O
adults	O	O
aged	O	O
22-43	O	O
years	O	O
old	O	O
(	O	O
27.1+/-5.3	O	O
)	O	O
.	O	O

Nine	O	O
Staphylococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
and	O	O
334	O	O
isolates	O	O
were	O	O
identified	O	O
.	O	O

In	O	O
saliva	O	O
,	O	O
the	O	O
total	O	O
occurrence	O	O
rate	O	O
was	O	O
83.9	O	O
%	O	O
and	O	O
the	O	O
total	O	O
number	O	O
of	O	O
bacteria	O	O
was	O	O
10	O	O
(	O	O
2	O	O
)	O	O
-10	O	O
(	O	O
4	O	O
)	O	O
c.f.u	O	O
.	O	O

ml	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
frequent	O	O
species	O	O
(	O	O
46.4	O	O
%	O	O
)	O	O
,	O	O
followed	O	O
by	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
(	O	O
41.1	O	O
%	O	O
)	O	O
and	O	O
others	O	O
(	O	O
Staphylococcus	B-bacteria	B-bacteria
hominis	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
warneri	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
capitis	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
haemolyticus	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
lugdunensis	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
gallinarum	E-bacteria	I-bacteria
,	O	O
isolation	O	O
frequencies	O	O
ranging	O	O
in	O	O
order	O	O
from	O	O
12.5	O	O
to	O	O
1.8	O	O
%	O	O
)	O	O
.	O	O

A	O	O
similar	O	O
isolation	O	O
tendency	O	O
was	O	O
observed	O	O
in	O	O
supragingival	O	O
plaque	O	O
,	O	O
with	O	O
a	O	O
total	O	O
occurrence	O	O
rate	O	O
of	O	O
73.2	O	O
%	O	O
and	O	O
amounts	O	O
of	O	O
bacteria	O	O
ranging	O	O
from	O	O
10	O	O
(	O	O
2	O	O
)	O	O
to	O	O
10	O	O
(	O	O
5	O	O
)	O	O
c.f.u	O	O
.	O	O

g	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

Four	O	O
common	O	O
Staphylococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
lugdunensis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
hominis	E-bacteria	I-bacteria
)	O	O
were	O	O
isolated	O	O
from	O	O
nasal	O	O
swab	O	O
samples	O	O
taken	O	O
from	O	O
the	O	O
oral	O	O
staphylococci-positive	O	O
subjects	O	O
.	O	O

Genotyping	O	O
of	O	O
all	O	O
18	O	O
combinations	O	O
of	O	O
oral-	O	O
and	O	O
nasal-derived	O	O
isolates	O	O
by	O	O
PFGE	O	O
indicated	O	O
that	O	O
identical	O	O
clones	O	O
or	O	O
close	O	O
relatives	O	O
were	O	O
commonly	O	O
distributed	O	O
in	O	O
these	O	O
two	O	O
cavities	O	O
.	O	O

Since	O	O
the	O	O
provision	O	O
of	O	O
micro-organisms	O	O
from	O	O
the	O	O
nasal	O	O
cavity	O	O
was	O	O
shown	O	O
and	O	O
occurrence	O	O
rates	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
were	O	O
adequate	O	O
,	O	O
these	O	O
results	O	O
suggest	O	O
a	O	O
possible	O	O
peroral	O	O
route	O	O
of	O	O
staphylococcal	O	O
IE	O	O
,	O	O
as	O	O
in	O	O
cases	O	O
of	O	O
viridans	O	O
streptococcal	O	O
IE	O	O
.	O	O

Triterpene	O	O
acids	O	O
(	O	O
ursolic	O	O
,	O	O
oleanoic	O	O
,	O	O
gypsogenic	O	O
,	O	O
and	O	O
sumaresinolic	O	O
acids	O	O
)	O	O
isolated	O	O
from	O	O
Miconia	O	O
species	O	O
,	O	O
along	O	O
with	O	O
a	O	O
mixture	O	O
of	O	O
ursolic	O	O
and	O	O
oleanolic	O	O
acids	O	O
and	O	O
a	O	O
mixture	O	O
of	O	O
maslinic	O	O
and	O	O
2-a-hydroxyursolic	O	O
acids	O	O
,	O	O
as	O	O
well	O	O
as	O	O
ursolic	O	O
acid	O	O
derivatives	O	O
were	O	O
evaluated	O	O
against	O	O
the	O	O
following	O	O
microorganisms	O	O
:	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
which	O	O
are	O	O
potentially	O	O
responsible	O	O
for	O	O
the	O	O
formation	O	O
of	O	O
dental	O	O
caries	O	O
in	O	O
humans	O	O
.	O	O

The	O	O
microdilution	O	O
method	O	O
was	O	O
used	O	O
for	O	O
the	O	O
determination	O	O
of	O	O
the	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
during	O	O
the	O	O
evaluation	O	O
of	O	O
the	O	O
antibacterial	O	O
activity	O	O
.	O	O

All	O	O
the	O	O
isolated	O	O
compounds	O	O
,	O	O
mixtures	O	O
,	O	O
and	O	O
semi-synthetic	O	O
derivatives	O	O
displayed	O	O
activity	O	O
against	O	O
all	O	O
the	O	O
tested	O	O
bacteria	O	O
,	O	O
showing	O	O
that	O	O
they	O	O
are	O	O
promising	O	O
antiplaque	O	O
and	O	O
anticaries	O	O
agents	O	O
.	O	O

Ursolic	O	O
and	O	O
oleanolic	O	O
acids	O	O
displayed	O	O
the	O	O
most	O	O
intense	O	O
antibacterial	O	O
effect	O	O
,	O	O
with	O	O
MIC	O	O
values	O	O
ranging	O	O
from	O	O
30	O	O
microg/mL	O	O
to	O	O
80	O	O
microg/mL	O	O
.	O	O

The	O	O
MIC	O	O
values	O	O
of	O	O
ursolic	O	O
acid	O	O
derivatives	O	O
,	O	O
as	O	O
well	O	O
as	O	O
those	O	O
obtained	O	O
for	O	O
the	O	O
mixture	O	O
of	O	O
ursolic	O	O
and	O	O
oleanolic	O	O
acids	O	O
showed	O	O
that	O	O
these	O	O
compounds	O	O
do	O	O
not	O	O
have	O	O
higher	O	O
antibacterial	O	O
activity	O	O
when	O	O
compared	O	O
with	O	O
the	O	O
activity	O	O
observed	O	O
with	O	O
either	O	O
ursolic	O	O
acid	O	O
or	O	O
oleanolic	O	O
acid	O	O
alone	O	O
.	O	O

With	O	O
regard	O	O
to	O	O
the	O	O
structure-activity	O	O
relationship	O	O
of	O	O
triterpene	O	O
acids	O	O
and	O	O
derivatives	O	O
,	O	O
it	O	O
is	O	O
suggested	O	O
that	O	O
both	O	O
hydroxy	O	O
and	O	O
carboxy	O	O
groups	O	O
present	O	O
in	O	O
the	O	O
triterpenes	O	O
are	O	O
important	O	O
for	O	O
their	O	O
antibacterial	O	O
activity	O	O
against	O	O
oral	O	O
pathogens	O	O
.	O	O

Extracts	O	O
or	O	O
alkaloids	O	O
isolated	O	O
from	O	O
Mahonia	O	O
aquifolium	O	O
exhibit	O	O
antimicrobial	O	O
activity	O	O
against	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
fungi	O	O
,	O	O
and	O	O
protozoa	O	O
.	O	O

In	O	O
this	O	O
study	O	O
the	O	O
bacteriostatic	O	O
and	O	O
bacteriocidal	O	O
activities	O	O
of	O	O
a	O	O
M.	O	O
aquifolium	O	O
extract	O	O
and	O	O
two	O	O
of	O	O
its	O	O
major	O	O
alkaloids	O	O
,	O	O
berberine	O	O
chloride	O	O
and	O	O
oxyacanthine	O	O
sulphate	O	O
,	O	O
were	O	O
tested	O	O
in	O	O
vitro	O	O
against	O	O
nine	O	O
different	O	O
oral	O	O
bacteria	O	O
.	O	O

Minimum	O	O
inhibitory	O	O
concentrations	O	O
were	O	O
in	O	O
the	O	O
range	O	O
from	O	O
<	O	O
or	O	O
=	O	O
0.0031	O	O
%	O	O
to	O	O
0.1993	O	O
%	O	O
for	O	O
the	O	O
M.	O	O
aquifolium	O	O
extract	O	O
,	O	O
from	O	O
0.002	O	O
%	O	O
to	O	O
>	O	O
0.125	O	O
%	O	O
for	O	O
berberine	O	O
chloride	O	O
,	O	O
and	O	O
from	O	O
0.0156	O	O
%	O	O
to	O	O
>	O	O
0.0625	O	O
%	O	O
for	O	O
oxyacanthine	O	O
sulphate	O	O
.	O	O

The	O	O
values	O	O
for	O	O
the	O	O
minimum	O	O
bactericidal	O	O
concentrations	O	O
were	O	O
in	O	O
the	O	O
same	O	O
range	O	O
,	O	O
indicating	O	O
that	O	O
the	O	O
test	O	O
substances	O	O
most	O	O
probably	O	O
acted	O	O
in	O	O
a	O	O
bactericidal	O	O
manner	O	O
.	O	O

The	O	O
most	O	O
susceptible	O	O
bacterium	O	O
against	O	O
all	O	O
three	O	O
test	O	O
substances	O	O
was	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
oral	O	O
epithelium	O	O
functions	O	O
as	O	O
a	O	O
mechanical	O	O
and	O	O
protective	O	O
barrier	O	O
to	O	O
resist	O	O
bacterial	O	O
infection	O	O
.	O	O

beta-Defensins	O	O
are	O	O
a	O	O
group	O	O
of	O	O
antimicrobial	O	O
peptides	O	O
mainly	O	O
produced	O	O
by	O	O
epithelial	O	O
cells	O	O
of	O	O
many	O	O
organs	O	O
including	O	O
skin	O	O
,	O	O
lung	O	O
,	O	O
kidney	O	O
,	O	O
pancreas	O	O
,	O	O
uterus	O	O
,	O	O
eye	O	O
,	O	O
and	O	O
nasal	O	O
and	O	O
oral	O	O
mucosa	O	O
.	O	O

This	O	O
review	O	O
focuses	O	O
on	O	O
beta-defensins	O	O
(	O	O
BDs	O	O
)	O	O
in	O	O
oral	O	O
epithelia	O	O
and	O	O
discusses	O	O
their	O	O
importance	O	O
in	O	O
oral	O	O
epithelial	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

BDs	O	O
exhibit	O	O
antimicrobial	O	O
activity	O	O
against	O	O
oral	O	O
microbes	O	O
including	O	O
periodontitis-related	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
Candida	O	O
,	O	O
and	O	O
papilloma	O	O
virus	O	O
.	O	O

Alterative	O	O
expression	O	O
of	O	O
BDs	O	O
was	O	O
observed	O	O
in	O	O
oral	O	O
epithelial	O	O
diseases	O	O
,	O	O
including	O	O
oral	O	O
inflammatory	O	O
lesions	O	O
with	O	O
and	O	O
without	O	O
microbial	O	O
infection	O	O
and	O	O
oral	O	O
cancer	O	O
.	O	O

BDs	O	O
may	O	O
be	O	O
useful	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
oral	O	O
infectious	O	O
diseases	O	O
,	O	O
ulcerative	O	O
lesions	O	O
,	O	O
and	O	O
cancer	O	O
.	O	O

BDs	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
protection	O	O
against	O	O
oral	O	O
microbes	O	O
and	O	O
may	O	O
be	O	O
used	O	O
in	O	O
clinical	O	O
applications	O	O
.	O	O

Probiotics	B-bacteria	B-bacteria
are	O	O
living	O	O
micro-organisms	O	O
added	O	O
to	O	O
food	O	O
which	O	O
beneficially	O	O
affect	O	O
the	O	O
host	O	O
by	O	O
improving	O	O
its	O	O
intestinal	O	O
microbial	O	O
balance	O	O
.	O	O

This	O	O
paper	O	O
aims	O	O
to	O	O
present	O	O
a	O	O
general	O	O
background	O	O
on	O	O
probiotics	O	O
and	O	O
its	O	O
health	O	O
effects	O	O
in	O	O
children	O	O
,	O	O
and	O	O
to	O	O
examine	O	O
the	O	O
evidence	O	O
for	O	O
oral	O	O
colonization	O	O
and	O	O
the	O	O
possible	O	O
impact	O	O
on	O	O
oral	O	O
health	O	O
in	O	O
children	O	O
and	O	O
young	O	O
adults	O	O
.	O	O

For	O	O
delivery	O	O
and	O	O
general	O	O
health	O	O
effects	O	O
,	O	O
recent	O	O
systematic	O	O
reviews	O	O
,	O	O
meta-analyses	O	O
,	O	O
and	O	O
other	O	O
relevant	O	O
papers	O	O
were	O	O
used	O	O
.	O	O

Concerning	O	O
oral	O	O
installation	O	O
and	O	O
oral	O	O
effects	O	O
,	O	O
a	O	O
broad	O	O
search	O	O
for	O	O
publications	O	O
in	O	O
English	O	O
was	O	O
conducted	O	O
through	O	O
February	O	O
2007	O	O
in	O	O
PubMed	O	O
.	O	O

Studies	O	O
describing	O	O
an	O	O
installation	O	O
or	O	O
intervention	O	O
trial	O	O
in	O	O
humans	O	O
with	O	O
a	O	O
controlled	O	O
design	O	O
and	O	O
an	O	O
oral	O	O
endpoint	O	O
measure	O	O
were	O	O
considered	O	O
.	O	O

Fourteen	O	O
papers	O	O
with	O	O
dental	O	O
focus	O	O
were	O	O
identified	O	O
,	O	O
of	O	O
which	O	O
two	O	O
were	O	O
narrative	O	O
reviews	O	O
.	O	O

Only	O	O
one	O	O
study	O	O
of	O	O
dental	O	O
interest	O	O
was	O	O
conducted	O	O
in	O	O
children	O	O
.	O	O

Four	O	O
papers	O	O
dealt	O	O
with	O	O
oral	O	O
installation	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
and	O	O
although	O	O
detectable	O	O
levels	O	O
were	O	O
found	O	O
in	O	O
saliva	O	O
shortly	O	O
after	O	O
intake	O	O
,	O	O
the	O	O
studies	O	O
failed	O	O
to	O	O
demonstrate	O	O
a	O	O
long-term	O	O
installation	O	O
.	O	O

Seven	O	O
papers	O	O
evaluated	O	O
the	O	O
effect	O	O
of	O	O
lactobacilli-	B-bacteria	B-bacteria
or	I-bacteria	I-bacteria
bifidobacteria-derived	I-bacteria	I-bacteria
probiotics	E-bacteria	I-bacteria
on	O	O
the	O	O
salivary	O	O
levels	O	O
of	O	O
caries-associated	O	O
bacteria	O	O
in	O	O
placebo-controlled	O	O
designs	O	O
.	O	O

All	O	O
but	O	O
one	O	O
reported	O	O
a	O	O
hampering	O	O
effect	O	O
on	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and/or	O	O
yeast	O	O
.	O	O

The	O	O
single	O	O
study	O	O
carried	O	O
out	O	O
in	O	O
early	O	O
childhood	O	O
reported	O	O
a	O	O
significant	O	O
caries	O	O
reduction	O	O
in	O	O
3-	O	O
to	O	O
4-year-old	O	O
children	O	O
after	O	O
7	O	O
months	O	O
of	O	O
daily	O	O
consumption	O	O
of	O	O
probiotic	O	O
milk	O	O
.	O	O

Bacteriotheraphy	O	O
in	O	O
the	O	O
form	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
with	O	O
an	O	O
inhibitory	O	O
effect	O	O
on	O	O
oral	O	O
pathogens	O	O
is	O	O
a	O	O
promising	O	O
concept	O	O
,	O	O
especially	O	O
in	O	O
childhood	O	O
,	O	O
but	O	O
this	O	O
may	O	O
not	O	O
necessarily	O	O
lead	O	O
to	O	O
improved	O	O
oral	O	O
health	O	O
.	O	O

Further	O	O
placebo	O	O
controlled	O	O
trials	O	O
that	O	O
assess	O	O
carefully	O	O
selected	O	O
and	O	O
defined	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
using	O	O
standardized	O	O
outcomes	O	O
are	O	O
needed	O	O
before	O	O
any	O	O
clinical	O	O
recommendations	O	O
can	O	O
be	O	O
made	O	O
.	O	O

To	O	O
investigate	O	O
prospectively	O	O
the	O	O
qualitative	O	O
and	O	O
quantitative	O	O
changes	O	O
in	O	O
oral	O	O
carriage	O	O
of	O	O
yeasts	O	O
and	O	O
coliforms	B-bacteria	B-bacteria
in	O	O
southern	O	O
Chinese	O	O
people	O	O
suffering	O	O
from	O	O
stroke	O	O
.	O	O

In	O	O
56	O	O
elderly	O	O
people	O	O
suffering	O	O
from	O	O
stroke	O	O
in	O	O
a	O	O
rehabilitation	O	O
unit	O	O
of	O	O
a	O	O
general	O	O
medical	O	O
hospital	O	O
in	O	O
Hong	O	O
Kong	O	O
,	O	O
oral	O	O
microbiological	O	O
sampling	O	O
using	O	O
a	O	O
combined	O	O
imprint	O	O
culture	O	O
,	O	O
oral	O	O
rinse	O	O
approach	O	O
and	O	O
clinical	O	O
assessment	O	O
was	O	O
made	O	O
during	O	O
the	O	O
acute	O	O
stroke	O	O
phase	O	O
,	O	O
on	O	O
hospital	O	O
discharge	O	O
and	O	O
6	O	O
months	O	O
later	O	O
.	O	O

The	O	O
oral	O	O
carriage	O	O
of	O	O
yeasts	O	O
increased	O	O
significantly	O	O
during	O	O
acute	O	O
stroke	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
whereas	O	O
coliform	B-bacteria	B-bacteria
carriage	O	O
did	O	O
not	O	O
.	O	O

A	O	O
reduction	O	O
in	O	O
oral	O	O
carriage	O	O
of	O	O
yeasts	O	O
was	O	O
found	O	O
on	O	O
hospital	O	O
discharge	O	O
and	O	O
6	O	O
months	O	O
later	O	O
and	O	O
in	O	O
coliforms	B-bacteria	B-bacteria
at	O	O
the	O	O
6-month	O	O
assessment	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Candida	O	O
albicans	O	O
and	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
were	O	O
the	O	O
predominant	O	O
yeast	O	O
and	O	O
coliform	B-bacteria	B-bacteria
respectively	O	O
.	O	O

Stroke-related	O	O
difficulty	O	O
in	O	O
tooth	O	O
brushing	O	O
and	O	O
denture	O	O
wearing	O	O
were	O	O
associated	O	O
with	O	O
higher	O	O
oral	O	O
yeast	O	O
carriage	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

We	O	O
also	O	O
report	O	O
here	O	O
for	O	O
the	O	O
first	O	O
time	O	O
that	O	O
the	O	O
use	O	O
of	O	O
aspirin	O	O
was	O	O
associated	O	O
with	O	O
lower	O	O
oral	O	O
yeast	O	O
carriage	O	O
in	O	O
people	O	O
suffering	O	O
from	O	O
stroke	O	O
.	O	O

Oral	O	O
yeast	O	O
carriage	O	O
was	O	O
closely	O	O
linked	O	O
to	O	O
the	O	O
level	O	O
of	O	O
stroke-related	O	O
functional	O	O
disability	O	O
that	O	O
improved	O	O
over	O	O
time	O	O
but	O	O
had	O	O
not	O	O
totally	O	O
resolved	O	O
6	O	O
months	O	O
after	O	O
hospital	O	O
discharge	O	O
.	O	O

The	O	O
oral	O	O
reservoir	O	O
of	O	O
yeasts	O	O
and	O	O
coliforms	B-bacteria	B-bacteria
in	O	O
people	O	O
suffering	O	O
from	O	O
stroke	O	O
is	O	O
noteworthy	O	O
by	O	O
care	O	O
providers	O	O
as	O	O
K.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
may	O	O
cause	O	O
aspiration	O	O
pneumonia	O	O
.	O	O

Proton	O	O
pump	O	O
inhibitors	O	O
(	O	O
PPI	O	O
)	O	O
used	O	O
to	O	O
suppress	O	O
acid	O	O
secretion	O	O
in	O	O
the	O	O
stomach	O	O
are	O	O
among	O	O
the	O	O
most	O	O
widely	O	O
prescribed	O	O
medications	O	O
.	O	O

There	O	O
is	O	O
emerging	O	O
evidence	O	O
of	O	O
proton	O	O
secretion	O	O
elsewhere	O	O
in	O	O
the	O	O
aerodigestive	O	O
tract	O	O
,	O	O
and	O	O
acidic	O	O
microenvironments	O	O
are	O	O
integral	O	O
to	O	O
oral	O	O
flora	O	O
such	O	O
as	O	O
Lactobacillus	B-bacteria	B-bacteria
.	O	O

The	O	O
hypothesis	O	O
of	O	O
this	O	O
study	O	O
is	O	O
that	O	O
the	O	O
growth	O	O
rate	O	O
and	O	O
morphology	O	O
of	O	O
oral	O	O
Lactobacillus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
are	O	O
effected	O	O
by	O	O
PPIs	O	O
.	O	O

Nineteen	O	O
different	O	O
strains	O	O
of	O	O
Lactobacilli	B-bacteria	B-bacteria
were	O	O
inoculated	O	O
in	O	O
microtiter	O	O
plates	O	O
at	O	O
pH	O	O
of	O	O
4.5	O	O
to	O	O
6.5	O	O
and	O	O
exposed	O	O
to	O	O
twofold	O	O
dilutions	O	O
of	O	O
pantoprazole	O	O
at	O	O
a	O	O
range	O	O
of	O	O
2.5	O	O
mg/mL	O	O
to	O	O
2.5	O	O
microg/mL	O	O
.	O	O

Bacterial	O	O
growth	O	O
was	O	O
monitored	O	O
,	O	O
and	O	O
the	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
of	O	O
the	O	O
drug	O	O
was	O	O
determined	O	O
for	O	O
the	O	O
strains	O	O
most	O	O
sensitive	O	O
to	O	O
pantoprazole	O	O
.	O	O

In	O	O
the	O	O
unexposed	O	O
(	O	O
control	O	O
)	O	O
group	O	O
,	O	O
nine	O	O
Lactobacilli	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
affected	O	O
by	O	O
pH	O	O
changes	O	O
from	O	O
6.5	O	O
to	O	O
4.5	O	O
.	O	O

In	O	O
the	O	O
group	O	O
exposed	O	O
to	O	O
pantoprazole	O	O
,	O	O
9	O	O
of	O	O
the	O	O
19	O	O
Lactobacilli	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
found	O	O
to	O	O
have	O	O
an	O	O
MIC	O	O
below	O	O
625	O	O
microg/mL	O	O
,	O	O
with	O	O
L.	B-bacteria	B-bacteria
plantarum	I-bacteria	I-bacteria
14917	E-bacteria	I-bacteria
being	O	O
the	O	O
most	O	O
sensitive	O	O
(	O	O
MIC	O	O
=	O	O
20	O	O
microg/mL	O	O
)	O	O
.	O	O

In	O	O
some	O	O
strains	O	O
,	O	O
such	O	O
as	O	O
L.	B-bacteria	B-bacteria
s.	I-bacteria	I-bacteria
salivarius	I-bacteria	I-bacteria
11741	E-bacteria	I-bacteria
,	O	O
Gram-staining	O	O
revealed	O	O
conformational	O	O
changes	O	O
in	O	O
the	O	O
bacteria	O	O
when	O	O
grown	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
pantoprazole	O	O
.	O	O

Growth	O	O
rates	O	O
and	O	O
morphology	O	O
of	O	O
oral	O	O
Lactobacillus	B-bacteria	B-bacteria
are	O	O
affected	O	O
by	O	O
the	O	O
pH	O	O
of	O	O
the	O	O
environment	O	O
.	O	O

Pantoprazole	O	O
at	O	O
supraphysiologic	O	O
doses	O	O
further	O	O
affects	O	O
growth	O	O
rates	O	O
and	O	O
conformation	O	O
in	O	O
some	O	O
strains	O	O
.	O	O

The	O	O
balance	O	O
of	O	O
oral	O	O
flora	O	O
and	O	O
upper	O	O
digestive	O	O
tract	O	O
homeostasis	O	O
may	O	O
be	O	O
affected	O	O
by	O	O
unexpected	O	O
targets	O	O
of	O	O
PPI	O	O
pharmacotherapy	O	O
,	O	O
with	O	O
possible	O	O
unanticipated	O	O
consequences	O	O
.	O	O

(	O	O
i	O	O
)	O	O
To	O	O
assess	O	O
the	O	O
pattern	O	O
of	O	O
early	O	O
bacterial	O	O
colonization	O	O
on	O	O
titanium	O	O
oral	O	O
implants	O	O
after	O	O
installation	O	O
,	O	O
at	O	O
12	O	O
weeks	O	O
and	O	O
at	O	O
12	O	O
months	O	O
,	O	O
(	O	O
ii	O	O
)	O	O
to	O	O
compare	O	O
the	O	O
microbiota	O	O
at	O	O
submucosal	O	O
implant	O	O
sites	O	O
and	O	O
adjacent	O	O
subgingival	O	O
tooth	O	O
sites	O	O
and	O	O
(	O	O
iii	O	O
)	O	O
to	O	O
assess	O	O
whether	O	O
or	O	O
not	O	O
early	O	O
colonization	O	O
was	O	O
predictive	O	O
of	O	O
12-month	O	O
colonization	O	O
patterns	O	O
.	O	O

Submucosal/subgingival	O	O
plaque	O	O
samples	O	O
from	O	O
17	O	O
titanium	O	O
oral	O	O
implants	O	O
and	O	O
adjacent	O	O
teeth	O	O
were	O	O
analyzed	O	O
by	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
30	O	O
min	O	O
,	O	O
12	O	O
weeks	O	O
and	O	O
12	O	O
months	O	O
after	O	O
implant	O	O
installation	O	O
.	O	O

At	O	O
12	O	O
months	O	O
,	O	O
none	O	O
of	O	O
the	O	O
inserted	O	O
implants	O	O
had	O	O
been	O	O
lost	O	O
or	O	O
presented	O	O
with	O	O
signs	O	O
of	O	O
peri-implantitis	O	O
.	O	O

The	O	O
distribution	O	O
of	O	O
sites	O	O
at	O	O
implants	O	O
and	O	O
teeth	O	O
with	O	O
bleeding	O	O
on	O	O
probing	O	O
varied	O	O
between	O	O
2	O	O
%	O	O
and	O	O
11	O	O
%	O	O
.	O	O

Probing	O	O
pocket	O	O
depths	O	O
<	O	O
or	O	O
=3	O	O
mm	O	O
were	O	O
found	O	O
at	O	O
75	O	O
%	O	O
of	O	O
implant	O	O
sites	O	O
.	O	O

At	O	O
12	O	O
months	O	O
,	O	O
the	O	O
sum	O	O
of	O	O
the	O	O
bacterial	O	O
counts	O	O
of	O	O
40	O	O
species	O	O
was	O	O
statistically	O	O
significantly	O	O
higher	O	O
at	O	O
tooth	O	O
compared	O	O
with	O	O
implant	O	O
sites	O	O
(	O	O
mean	O	O
difference	O	O
:	O	O
34.4	O	O
x	O	O
10	O	O
(	O	O
5	O	O
)	O	O
,	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
-0.4	O	O
to	O	O
69.4	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

At	O	O
12	O	O
months	O	O
,	O	O
higher	O	O
individual	O	O
bacterial	O	O
counts	O	O
at	O	O
tooth	O	O
sites	O	O
were	O	O
found	O	O
for	O	O
7/40	O	O
species	O	O
compared	O	O
with	O	O
implant	O	O
sites	O	O
.	O	O

Detection	O	O
or	O	O
lack	O	O
of	O	O
detection	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
at	O	O
implant	O	O
sites	O	O
at	O	O
12	O	O
weeks	O	O
resulted	O	O
in	O	O
the	O	O
highest	O	O
positive	O	O
(	O	O
e.g.	O	O
80	O	O
%	O	O
)	O	O
and	O	O
negative	O	O
(	O	O
e.g.	O	O
90	O	O
%	O	O
)	O	O
predictive	O	O
values	O	O
,	O	O
respectively	O	O
.	O	O

Between	O	O
12	O	O
weeks	O	O
and	O	O
12	O	O
months	O	O
,	O	O
the	O	O
prevalence	O	O
of	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
increased	O	O
statistically	O	O
significantly	O	O
at	O	O
implant	O	O
sites	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Lack	O	O
of	O	O
detection	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
at	O	O
12	O	O
weeks	O	O
yielded	O	O
a	O	O
negative	O	O
predictive	O	O
value	O	O
of	O	O
93.1	O	O
%	O	O
of	O	O
this	O	O
microorganism	O	O
being	O	O
undetectable	O	O
at	O	O
implant	O	O
sites	O	O
at	O	O
12	O	O
months	O	O
.	O	O

Within	O	O
the	O	O
limits	O	O
of	O	O
this	O	O
study	O	O
,	O	O
the	O	O
findings	O	O
showed	O	O
(	O	O
i	O	O
)	O	O
a	O	O
few	O	O
differences	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
bacterial	O	O
species	O	O
between	O	O
implant	O	O
and	O	O
adjacent	O	O
tooth	O	O
sites	O	O
at	O	O
12	O	O
months	O	O
and	O	O
(	O	O
ii	O	O
)	O	O
high	O	O
positive	O	O
and	O	O
negative	O	O
predictive	O	O
values	O	O
for	O	O
selected	O	O
bacterial	O	O
species	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
effectiveness	O	O
of	O	O
oral	O	O
decontamination	O	O
with	O	O
2	O	O
%	O	O
chlorhexidine	O	O
solution	O	O
for	O	O
the	O	O
prevention	O	O
of	O	O
ventilator-associated	O	O
pneumonia	O	O
(	O	O
VAP	O	O
)	O	O
.	O	O

Randomized	O	O
controlled	O	O
trial	O	O
and	O	O
meta-analysis	O	O
.	O	O

A	O	O
tertiary	O	O
care	O	O
university	O	O
hospital	O	O
in	O	O
Bangkok	O	O
,	O	O
Thailand	O	O
.	O	O

Adult	O	O
patients	O	O
who	O	O
received	O	O
mechanical	O	O
ventilation	O	O
and	O	O
who	O	O
were	O	O
hospitalized	O	O
in	O	O
intensive	O	O
care	O	O
units	O	O
and	O	O
general	O	O
medical	O	O
wards	O	O
.	O	O

The	O	O
patients	O	O
were	O	O
randomized	O	O
to	O	O
receive	O	O
oral	O	O
decontamination	O	O
with	O	O
2	O	O
%	O	O
chlorhexidine	O	O
solution	O	O
or	O	O
normal	O	O
saline	O	O
solution	O	O
4	O	O
times	O	O
per	O	O
day	O	O
until	O	O
their	O	O
endotracheal	O	O
tubes	O	O
were	O	O
removed	O	O
.	O	O

The	O	O
outcome	O	O
measures	O	O
were	O	O
the	O	O
development	O	O
of	O	O
VAP	O	O
and	O	O
oropharyngeal	O	O
colonization	O	O
with	O	O
gram-negative	B-bacteria	B-bacteria
bacilli	E-bacteria	I-bacteria
.	O	O

Meta-analysis	O	O
was	O	O
performed	O	O
by	O	O
combining	O	O
the	O	O
results	O	O
of	O	O
the	O	O
present	O	O
study	O	O
with	O	O
those	O	O
from	O	O
another	O	O
randomized	O	O
controlled	O	O
trial	O	O
that	O	O
also	O	O
used	O	O
a	O	O
2	O	O
%	O	O
chlorhexidine	O	O
formulation	O	O
for	O	O
oral	O	O
decontamination	O	O
.	O	O

The	O	O
characteristics	O	O
of	O	O
the	O	O
patients	O	O
in	O	O
the	O	O
chlorhexidine	O	O
group	O	O
(	O	O
n=102	O	O
)	O	O
and	O	O
the	O	O
normal	O	O
saline	O	O
group	O	O
(	O	O
n=105	O	O
)	O	O
were	O	O
not	O	O
significantly	O	O
different	O	O
.	O	O

The	O	O
incidence	O	O
of	O	O
VAP	O	O
in	O	O
the	O	O
chlorhexidine	O	O
group	O	O
was	O	O
4.9	O	O
%	O	O
(	O	O
5	O	O
of	O	O
102	O	O
)	O	O
,	O	O
and	O	O
the	O	O
incidence	O	O
in	O	O
the	O	O
normal	O	O
saline	O	O
group	O	O
was	O	O
11.4	O	O
%	O	O
(	O	O
12	O	O
of	O	O
105	O	O
)	O	O
(	O	O
P=.08	O	O
)	O	O
.	O	O

The	O	O
rate	O	O
of	O	O
VAP	O	O
in	O	O
the	O	O
chlorhexidine	O	O
group	O	O
was	O	O
7	O	O
episodes	O	O
per	O	O
1,000	O	O
ventilator-days	O	O
,	O	O
and	O	O
the	O	O
rate	O	O
in	O	O
the	O	O
normal	O	O
saline	O	O
group	O	O
was	O	O
21	O	O
episodes	O	O
per	O	O
1,000	O	O
ventilator-days	O	O
(	O	O
P=.04	O	O
)	O	O
.	O	O

Irritation	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
was	O	O
observed	O	O
in	O	O
10	O	O
(	O	O
9.8	O	O
%	O	O
)	O	O
of	O	O
the	O	O
patients	O	O
in	O	O
the	O	O
chlorhexidine	O	O
group	O	O
and	O	O
in	O	O
1	O	O
(	O	O
0.9	O	O
%	O	O
)	O	O
of	O	O
the	O	O
patients	O	O
in	O	O
the	O	O
normal	O	O
saline	O	O
group	O	O
(	O	O
P=.001	O	O
)	O	O
.	O	O

Oropharyngeal	O	O
colonization	O	O
with	O	O
gram-negative	B-bacteria	B-bacteria
bacilli	E-bacteria	I-bacteria
was	O	O
either	O	O
reduced	O	O
or	O	O
delayed	O	O
in	O	O
the	O	O
chlorhexidine	O	O
group	O	O
.	O	O

Overall	O	O
mortality	O	O
of	O	O
the	O	O
patients	O	O
did	O	O
not	O	O
differ	O	O
significantly	O	O
between	O	O
the	O	O
groups	O	O
.	O	O

Meta-analysis	O	O
of	O	O
2	O	O
randomized	O	O
controlled	O	O
trials	O	O
revealed	O	O
an	O	O
overall	O	O
relative	O	O
risk	O	O
of	O	O
VAP	O	O
for	O	O
patients	O	O
in	O	O
the	O	O
chlorhexidine	O	O
group	O	O
of	O	O
0.53	O	O
(	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
,	O	O
0.31-0.90	O	O
;	O	O
P=.02	O	O
)	O	O
.	O	O

Oral	O	O
decontamination	O	O
with	O	O
2	O	O
%	O	O
chlorhexidine	O	O
solution	O	O
is	O	O
an	O	O
effective	O	O
and	O	O
safe	O	O
method	O	O
for	O	O
preventing	O	O
VAP	O	O
in	O	O
patients	O	O
who	O	O
receive	O	O
mechanical	O	O
ventilation	O	O
.	O	O

Oral	O	O
microbes	O	O
that	O	O
colonize	O	O
in	O	O
the	O	O
mouths	O	O
of	O	O
humans	O	O
contribute	O	O
to	O	O
disease	O	O
susceptibility	O	O
,	O	O
but	O	O
it	O	O
is	O	O
unclear	O	O
if	O	O
host	O	O
genetic	O	O
factors	O	O
mediate	O	O
colonization	O	O
.	O	O

We	O	O
therefore	O	O
tested	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
levels	O	O
at	O	O
which	O	O
oral	O	O
microbes	O	O
colonize	O	O
in	O	O
the	O	O
mouth	O	O
are	O	O
heritable	O	O
.	O	O

Dental	O	O
plaque	O	O
biofilms	O	O
were	O	O
sampled	O	O
from	O	O
intact	O	O
tooth	O	O
surfaces	O	O
of	O	O
118	O	O
caries-free	O	O
twins	O	O
.	O	O

An	O	O
additional	O	O
86	O	O
caries-active	O	O
twins	O	O
were	O	O
sampled	O	O
for	O	O
plaque	O	O
from	O	O
carious	O	O
lesions	O	O
and	O	O
intact	O	O
tooth	O	O
surfaces	O	O
.	O	O

Using	O	O
a	O	O
reverse	O	O
capture	O	O
checkerboard	O	O
assay	O	O
the	O	O
relative	O	O
abundance	O	O
of	O	O
82	O	O
bacterial	O	O
species	O	O
was	O	O
determined	O	O
.	O	O

An	O	O
integrative	O	O
computational	O	O
predictive	O	O
model	O	O
determined	O	O
microbial	O	O
abundance	O	O
patterns	O	O
of	O	O
microbial	O	O
species	O	O
in	O	O
caries-free	O	O
twins	O	O
as	O	O
compared	O	O
to	O	O
caries-active	O	O
twins	O	O
.	O	O

Heritability	O	O
estimates	O	O
were	O	O
calculated	O	O
for	O	O
the	O	O
relative	O	O
microbial	O	O
abundance	O	O
levels	O	O
of	O	O
the	O	O
microbial	O	O
species	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
10	O	O
species	O	O
were	O	O
significantly	O	O
different	O	O
in	O	O
healthy	O	O
individuals	O	O
than	O	O
in	O	O
caries-active	O	O
individuals	O	O
,	O	O
including	O	O
,	O	O
A.	B-bacteria	B-bacteria
defectiva	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
parasanguinis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis/oralis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
cristatus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

clone	I-bacteria	I-bacteria
CH016	E-bacteria	I-bacteria
,	O	O
G.	B-bacteria	B-bacteria
morbillorum	E-bacteria	I-bacteria
and	O	O
G.	B-bacteria	B-bacteria
haemolysans	E-bacteria	I-bacteria
.	O	O

Moderate	O	O
to	O	O
high	O	O
heritability	O	O
estimates	O	O
were	O	O
found	O	O
for	O	O
these	O	O
species	O	O
(	O	O
h	O	O
(	O	O
2	O	O
)	O	O
=	O	O
56	O	O
%	O	O
-80	O	O
%	O	O
,	O	O
p	O	O
<	O	O
.0001	O	O
)	O	O
.	O	O

Similarity	O	O
of	O	O
the	O	O
overall	O	O
oral	O	O
microbial	O	O
flora	O	O
was	O	O
also	O	O
evident	O	O
in	O	O
caries-free	O	O
twins	O	O
from	O	O
multivariate	O	O
distance	O	O
matrix	O	O
regression	O	O
analysis	O	O
.	O	O

It	O	O
appears	O	O
that	O	O
genetic	O	O
and/or	O	O
familial	O	O
factors	O	O
significantly	O	O
contribute	O	O
to	O	O
the	O	O
colonization	O	O
of	O	O
oral	O	O
beneficial	O	O
species	O	O
in	O	O
twins	O	O
.	O	O

To	O	O
identify	O	O
the	O	O
predictors	O	O
of	O	O
early	O	O
childhood	O	O
caries	O	O
and	O	O
urgent	O	O
dental	O	O
treatment	O	O
need	O	O
among	O	O
primarily	O	O
African-American	O	O
children	O	O
in	O	O
child	O	O
care	O	O
centers	O	O
in	O	O
the	O	O
Delta	O	O
region	O	O
of	O	O
Mississippi	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
replicate	O	O
predictors	O	O
of	O	O
caries	O	O
and	O	O
urgent	O	O
dental	O	O
treatment	O	O
needs	O	O
that	O	O
were	O	O
identified	O	O
in	O	O
an	O	O
earlier	O	O
study	O	O
conducted	O	O
in	O	O
Delta	O	O
child	O	O
care	O	O
centers	O	O
and	O	O
to	O	O
assess	O	O
additional	O	O
caries	O	O
risk	O	O
factors	O	O
not	O	O
collected	O	O
in	O	O
the	O	O
original	O	O
study	O	O
.	O	O

Children	O	O
in	O	O
19	O	O
child	O	O
care	O	O
centers	O	O
were	O	O
examined	O	O
by	O	O
the	O	O
dentists	O	O
,	O	O
and	O	O
the	O	O
parents	O	O
provided	O	O
data	O	O
on	O	O
oral	O	O
health	O	O
practices	O	O
,	O	O
oral	O	O
health	O	O
history	O	O
,	O	O
and	O	O
on	O	O
children	O	O
's	O	O
oral	O	O
health-related	O	O
quality	O	O
of	O	O
life	O	O
(	O	O
QOL	O	O
)	O	O
.	O	O

The	O	O
dentists	O	O
also	O	O
assessed	O	O
visible	O	O
plaque	O	O
and	O	O
tested	O	O
levels	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

Predictors	O	O
of	O	O
caries	O	O
and	O	O
treatment	O	O
need	O	O
among	O	O
children	O	O
24	O	O
to	O	O
71	O	O
months	O	O
of	O	O
age	O	O
were	O	O
examined	O	O
using	O	O
logistic	O	O
regression	O	O
.	O	O

Two	O	O
parent	O	O
predictors	O	O
of	O	O
caries	O	O
identified	O	O
in	O	O
the	O	O
earlier	O	O
study	O	O
(	O	O
parent	O	O
flossing	O	O
and	O	O
soft/sugary	O	O
drink	O	O
consumption	O	O
)	O	O
were	O	O
not	O	O
predictive	O	O
in	O	O
the	O	O
current	O	O
study	O	O
.	O	O

Parent	O	O
history	O	O
of	O	O
abscess	O	O
continued	O	O
to	O	O
predict	O	O
their	O	O
child's	O	O
urgent	O	O
need	O	O
for	O	O
treatment	O	O
.	O	O

Young	O	O
children	O	O
's	O	O
level	O	O
of	O	O
salivary	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
maxillary	O	O
incisor	O	O
visible	O	O
plaque	O	O
,	O	O
and	O	O
parents	O	O
'	O	O
reports	O	O
of	O	O
child	O	O
oral	O	O
health-related	O	O
QOL	O	O
measures	O	O
predicted	O	O
the	O	O
presence	O	O
of	O	O
both	O	O
caries	O	O
and	O	O
urgent	O	O
treatment	O	O
need	O	O
.	O	O

Some	O	O
expected	O	O
predictors	O	O
,	O	O
such	O	O
as	O	O
frequency	O	O
of	O	O
child's	O	O
toothbrushing	O	O
,	O	O
were	O	O
not	O	O
predictive	O	O
of	O	O
caries	O	O
.	O	O

Parental	O	O
abscess	O	O
and	O	O
parent	O	O
's	O	O
report	O	O
of	O	O
the	O	O
child	O	O
's	O	O
oral	O	O
health-related	O	O
OOL	O	O
are	O	O
risk	O	O
indicators	O	O
for	O	O
poor	O	O
oral	O	O
health	O	O
outcomes	O	O
that	O	O
could	O	O
be	O	O
used	O	O
by	O	O
nondental	O	O
personnel	O	O
to	O	O
identify	O	O
young	O	O
children	O	O
in	O	O
need	O	O
of	O	O
early	O	O
preventive	O	O
intervention	O	O
and	O	O
dental	O	O
referral	O	O

Even	O	O
though	O	O
animal	O	O
models	O	O
have	O	O
limitations	O	O
,	O	O
they	O	O
are	O	O
often	O	O
superior	O	O
to	O	O
in	O	O
vitro	O	O
or	O	O
clinical	O	O
studies	O	O
in	O	O
addressing	O	O
mechanistic	O	O
questions	O	O
and	O	O
serve	O	O
as	O	O
an	O	O
essential	O	O
link	O	O
between	O	O
hypotheses	O	O
and	O	O
human	O	O
patients	O	O
.	O	O

Periodontal	O	O
disease	O	O
can	O	O
be	O	O
viewed	O	O
as	O	O
a	O	O
process	O	O
that	O	O
involves	O	O
four	O	O
major	O	O
stages	O	O
:	O	O
bacterial	O	O
colonization	O	O
,	O	O
invasion	O	O
,	O	O
induction	O	O
of	O	O
a	O	O
destructive	O	O
host	O	O
response	O	O
in	O	O
connective	O	O
tissue	O	O
and	O	O
a	O	O
repair	O	O
process	O	O
that	O	O
reduces	O	O
the	O	O
extent	O	O
of	O	O
tissue	O	O
breakdown	O	O
.	O	O

Animal	O	O
studies	O	O
should	O	O
be	O	O
evaluated	O	O
in	O	O
terms	O	O
of	O	O
their	O	O
capacity	O	O
to	O	O
test	O	O
specific	O	O
hypotheses	O	O
rather	O	O
than	O	O
their	O	O
fidelity	O	O
to	O	O
all	O	O
aspects	O	O
of	O	O
periodontal	O	O
disease	O	O
initiation	O	O
and	O	O
progression	O	O
.	O	O

Thus	O	O
,	O	O
each	O	O
of	O	O
the	O	O
models	O	O
described	O	O
below	O	O
can	O	O
be	O	O
adapted	O	O
to	O	O
test	O	O
discrete	O	O
components	O	O
of	O	O
these	O	O
four	O	O
major	O	O
steps	O	O
,	O	O
but	O	O
not	O	O
all	O	O
of	O	O
them	O	O
.	O	O

This	O	O
review	O	O
describes	O	O
five	O	O
different	O	O
animal	O	O
models	O	O
that	O	O
are	O	O
appropriate	O	O
for	O	O
examining	O	O
components	O	O
of	O	O
host-bacteria	O	O
interactions	O	O
that	O	O
can	O	O
lead	O	O
to	O	O
breakdown	O	O
of	O	O
hard	O	O
and	O	O
soft	O	O
connective	O	O
tissue	O	O
or	O	O
conditions	O	O
that	O	O
limit	O	O
its	O	O
repair	O	O
as	O	O
follows	O	O
:	O	O
the	O	O
mouse	O	O
calvarial	O	O
model	O	O
,	O	O
murine	O	O
oral	O	O
gavage	O	O
models	O	O
with	O	O
or	O	O
without	O	O
adoptive	O	O
transfer	O	O
of	O	O
human	O	O
lymphocytes	O	O
,	O	O
rat	O	O
ligature	O	O
model	O	O
and	O	O
rat	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
feeding	O	O
model	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
causes	O	O
dental	O	O
caries	O	O
and	O	O
infective	O	O
endocarditis	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
genomic	O	O
diversity	O	O
among	O	O
serotype	O	O
c	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
laboratory	O	O
and	O	O
clinical	O	O
strains	O	O
and	O	O
to	O	O
characterize	O	O
the	O	O
genetic	O	O
events	O	O
involved	O	O
.	O	O

A	O	O
genome-based	O	O
approach	O	O
using	O	O
PFGE	O	O
coupled	O	O
with	O	O
Southern	O	O
hybridization	O	O
was	O	O
employed	O	O
to	O	O
examine	O	O
a	O	O
total	O	O
of	O	O
58	O	O
serotype	O	O
c	O	O
oral	O	O
and	O	O
blood	O	O
isolates	O	O
and	O	O
seven	O	O
laboratory	O	O
strains	O	O
and	O	O
to	O	O
compare	O	O
them	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
UA159	E-bacteria	I-bacteria
.	O	O

No	O	O
significant	O	O
differences	O	O
were	O	O
found	O	O
in	O	O
the	O	O
phenotypic	O	O
characteristics	O	O
of	O	O
the	O	O
strains	O	O
tested	O	O
,	O	O
except	O	O
that	O	O
some	O	O
of	O	O
the	O	O
strains	O	O
exhibited	O	O
smooth	O	O
rather	O	O
than	O	O
rough	O	O
colony	O	O
morphology	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
PFGE	O	O
profiles	O	O
of	O	O
clinical	O	O
isolates	O	O
,	O	O
from	O	O
either	O	O
diseased	O	O
or	O	O
healthy	O	O
subjects	O	O
,	O	O
exhibited	O	O
diverse	O	O
patterns	O	O
,	O	O
suggesting	O	O
that	O	O
recombination	O	O
or	O	O
point	O	O
mutations	O	O
occurred	O	O
frequently	O	O
in	O	O
vivo	O	O
.	O	O

Diverse	O	O
PFGE	O	O
patterns	O	O
,	O	O
with	O	O
various	O	O
lengths	O	O
of	O	O
insertions	O	O
and	O	O
deletions	O	O
,	O	O
could	O	O
be	O	O
detected	O	O
even	O	O
within	O	O
a	O	O
localized	O	O
chromosomal	O	O
region	O	O
between	O	O
rRNA	O	O
operons	O	O
.	O	O

Comparative	O	O
analysis	O	O
using	O	O
Southern	O	O
hybridization	O	O
with	O	O
specific	O	O
markers	O	O
revealed	O	O
that	O	O
a	O	O
large	O	O
chromosomal	O	O
inversion	O	O
had	O	O
also	O	O
occurred	O	O
between	O	O
rrn	O	O
operons	O	O
in	O	O
25	O	O
strains	O	O
.	O	O

To	O	O
analyse	O	O
the	O	O
microbial	O	O
flora	O	O
in	O	O
specific	O	O
oral	O	O
sites	O	O
in	O	O
13	O	O
dentate	O	O
subjects	O	O
,	O	O
6-8	O	O
months	O	O
after	O	O
completed	O	O
radiation	O	O
therapy	O	O
(	O	O
RT	O	O
group	O	O
)	O	O
and	O	O
in	O	O
13	O	O
matched	O	O
controls	O	O
.	O	O

The	O	O
microflora	O	O
on	O	O
the	O	O
tongue	O	O
,	O	O
buccal	O	O
mucosa	O	O
,	O	O
vestibulum	O	O
,	O	O
supragingival	O	O
plaque	O	O
and	O	O
subgingival	O	O
region	O	O
was	O	O
analysed	O	O
using	O	O
duplicate	O	O
sampling	O	O
and	O	O
cultivation	O	O
technique	O	O
.	O	O

A	O	O
clinical	O	O
examination	O	O
was	O	O
also	O	O
performed	O	O
.	O	O

Candida	O	O
albicans	O	O
was	O	O
found	O	O
in	O	O
one	O	O
or	O	O
more	O	O
sites	O	O
in	O	O
54	O	O
%	O	O
of	O	O
the	O	O
RT	O	O
subjects	O	O
and	O	O
in	O	O
15	O	O
%	O	O
of	O	O
the	O	O
controls	O	O
.	O	O

In	O	O
three	O	O
RT	O	O
subjects	O	O
,	O	O
C.	O	O
albicans	O	O
was	O	O
found	O	O
at	O	O
all	O	O
four	O	O
sites	O	O
analysed	O	O
.	O	O

An	O	O
unexpected	O	O
finding	O	O
was	O	O
that	O	O
enterococci	B-bacteria	B-bacteria
were	O	O
found	O	O
in	O	O
all	O	O
RT	O	O
subjects	O	O
and	O	O
in	O	O
high	O	O
number	O	O
in	O	O
38	O	O
%	O	O
.	O	O

None	O	O
of	O	O
the	O	O
controls	O	O
harboured	O	O
enterococci	B-bacteria	B-bacteria
.	O	O

In	O	O
supragingival	O	O
plaque	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
detected	O	O
in	O	O
92	O	O
%	O	O
of	O	O
the	O	O
RT	O	O
subjects	O	O
and	O	O
the	O	O
number	O	O
and	O	O
proportion	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
extremely	O	O
high	O	O
compared	O	O
with	O	O
the	O	O
controls	O	O
.	O	O

Mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
high	O	O
numbers	O	O
in	O	O
31	O	O
%	O	O
of	O	O
the	O	O
RT	O	O
subjects	O	O
,	O	O
while	O	O
they	O	O
were	O	O
not	O	O
detected	O	O
in	O	O
23	O	O
%	O	O
.	O	O

The	O	O
microbial	O	O
results	O	O
explain	O	O
why	O	O
some	O	O
RT	O	O
subjects	O	O
have	O	O
an	O	O
increased	O	O
susceptibility	O	O
to	O	O
oral	O	O
diseases	O	O
and	O	O
stress	O	O
that	O	O
site-specific	O	O
microbial	O	O
analysis	O	O
is	O	O
an	O	O
important	O	O
diagnostic	O	O
tool	O	O
when	O	O
planning	O	O
oral	O	O
health	O	O
preventive	O	O
care	O	O
for	O	O
RT	O	O
subjects	O	O
.	O	O

Although	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
has	O	O
been	O	O
implicated	O	O
as	O	O
a	O	O
major	O	O
etiological	O	O
agent	O	O
of	O	O
dental	O	O
caries	O	O
,	O	O
our	O	O
cross-sectional	O	O
preliminary	O	O
study	O	O
indicated	O	O
that	O	O
10	O	O
%	O	O
of	O	O
subjects	O	O
with	O	O
rampant	O	O
caries	O	O
in	O	O
permanent	O	O
teeth	O	O
do	O	O
not	O	O
have	O	O
detectable	O	O
levels	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Our	O	O
aims	O	O
were	O	O
to	O	O
use	O	O
molecular	O	O
methods	O	O
to	O	O
detect	O	O
all	O	O
bacterial	O	O
species	O	O
associated	O	O
with	O	O
caries	O	O
in	O	O
primary	O	O
and	O	O
permanent	O	O
teeth	O	O
and	O	O
to	O	O
determine	O	O
the	O	O
bacterial	O	O
profiles	O	O
associated	O	O
with	O	O
different	O	O
disease	O	O
states	O	O
.	O	O

Plaque	O	O
was	O	O
collected	O	O
from	O	O
39	O	O
healthy	O	O
controls	O	O
and	O	O
from	O	O
intact	O	O
enamel	O	O
and	O	O
white-spot	O	O
lesions	O	O
,	O	O
dentin	O	O
lesions	O	O
,	O	O
and	O	O
deep-dentin	O	O
lesions	O	O
in	O	O
each	O	O
of	O	O
51	O	O
subjects	O	O
with	O	O
severe	O	O
caries	O	O
.	O	O

16S	O	O
rRNA	O	O
genes	O	O
were	O	O
PCR	O	O
amplified	O	O
,	O	O
cloned	O	O
,	O	O
and	O	O
sequenced	O	O
to	O	O
determine	O	O
species	O	O
identities	O	O
.	O	O

In	O	O
a	O	O
reverse-capture	O	O
checkerboard	O	O
assay	O	O
,	O	O
243	O	O
samples	O	O
were	O	O
analyzed	O	O
for	O	O
110	O	O
prevalent	O	O
bacterial	O	O
species	O	O
.	O	O

A	O	O
sequencing	O	O
analysis	O	O
of	O	O
1,285	O	O
16S	O	O
rRNA	O	O
clones	O	O
detected	O	O
197	O	O
bacterial	O	O
species/phylotypes	O	O
,	O	O
of	O	O
which	O	O
50	O	O
%	O	O
were	O	O
not	O	O
cultivable	O	O
.	O	O

Twenty-two	O	O
new	O	O
phylotypes	O	O
were	O	O
identified	O	O
.	O	O

PROC	O	O
MIXED	O	O
tests	O	O
revealed	O	O
health-	O	O
and	O	O
disease-associated	O	O
species	O	O
.	O	O

In	O	O
subjects	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
additional	O	O
species	O	O
,	O	O
e.g.	O	O
,	O	O
species	O	O
of	O	O
the	O	O
genera	O	O
Atopobium	B-bacteria	B-bacteria
,	O	O
Propionibacterium	B-bacteria	B-bacteria
,	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
,	O	O
were	O	O
present	O	O
at	O	O
significantly	O	O
higher	O	O
levels	O	O
than	O	O
those	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Lactobacillus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
,	O	O
and	O	O
low-pH	B-bacteria	B-bacteria
non-S.	I-bacteria	I-bacteria
mutans	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
predominant	O	O
in	O	O
subjects	O	O
with	O	O
no	O	O
detectable	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Actinomyces	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
non-S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
predominant	O	O
in	O	O
white-spot	O	O
lesions	O	O
,	O	O
while	O	O
known	O	O
acid	O	O
producers	O	O
were	O	O
found	O	O
at	O	O
their	O	O
highest	O	O
levels	O	O
later	O	O
in	O	O
disease	O	O
.	O	O

Bacterial	O	O
profiles	O	O
change	O	O
with	O	O
disease	O	O
states	O	O
and	O	O
differ	O	O
between	O	O
primary	O	O
and	O	O
secondary	O	O
dentitions	O	O
.	O	O

Bacterial	O	O
species	O	O
other	O	O
than	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
e.g.	O	O
,	O	O
species	O	O
of	O	O
the	O	O
genera	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
,	O	O
and	O	O
Propionibacterium	B-bacteria	B-bacteria
,	O	O
low-pH	B-bacteria	B-bacteria
non-S.	I-bacteria	I-bacteria
mutans	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
Atopobium	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
likely	O	O
play	O	O
important	O	O
roles	O	O
in	O	O
caries	O	O
progression	O	O
.	O	O

Bacteria	O	O
of	O	O
the	O	O
genus	B-bacteria	B-bacteria
Capnocytophaga	E-bacteria	I-bacteria
form	O	O
part	O	O
of	O	O
the	O	O
resident	O	O
oral	O	O
flora	O	O
in	O	O
children	O	O
and	O	O
adults	O	O
.	O	O

They	O	O
are	O	O
recognized	O	O
as	O	O
opportunistic	O	O
pathogens	O	O
of	O	O
various	O	O
extra-oral	O	O
infections	O	O
.	O	O

The	O	O
significance	O	O
of	O	O
individual	O	O
species	O	O
in	O	O
periodontal	O	O
and	O	O
extra-oral	O	O
diseases	O	O
is	O	O
unclear	O	O
,	O	O
due	O	O
to	O	O
the	O	O
inability	O	O
of	O	O
conventional	O	O
phenotypic	O	O
tests	O	O
to	O	O
identify	O	O
clinical	O	O
isolates	O	O
to	O	O
species	O	O
level	O	O
.	O	O

Aiming	O	O
at	O	O
a	O	O
clear	O	O
distinction	O	O
between	O	O
species	O	O
,	O	O
we	O	O
undertook	O	O
a	O	O
phylogenetic	O	O
study	O	O
of	O	O
a	O	O
collection	O	O
of	O	O
102	O	O
Capnocytophaga	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
including	O	O
62	O	O
oral	O	O
isolates	O	O
from	O	O
children	O	O
and	O	O
40	O	O
reference	O	O
strains	O	O
from	O	O
oral	O	O
and	O	O
extra-oral	O	O
infections	O	O
representing	O	O
the	O	O
five	O	O
known	O	O
,	O	O
human	O	O
,	O	O
oral	O	O
Capnocytophaga	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

The	O	O
phylogeny	O	O
was	O	O
estimated	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
multilocus	O	O
enzyme	O	O
electrophoresis	O	O
(	O	O
MLEE	O	O
)	O	O
of	O	O
12	O	O
intracellular	O	O
,	O	O
housekeeping	O	O
enzymes	O	O
and	O	O
by	O	O
partial	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
,	O	O
and	O	O
was	O	O
compared	O	O
to	O	O
phenotypic	O	O
characteristics	O	O
.	O	O

The	O	O
clustering	O	O
profiles	O	O
in	O	O
the	O	O
MLEE	O	O
and	O	O
sequence-based	O	O
dendrograms	O	O
were	O	O
concordant	O	O
and	O	O
allowed	O	O
identification	O	O
of	O	O
isolates	O	O
to	O	O
species	O	O
level	O	O
,	O	O
based	O	O
on	O	O
co-clustering	O	O
with	O	O
reference	O	O
strains	O	O
.	O	O

The	O	O
study	O	O
confirmed	O	O
Capnocytophaga	B-bacteria	B-bacteria
ochracea	E-bacteria	I-bacteria
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
as	O	O
separate	O	O
species	O	O
,	O	O
and	O	O
underlined	O	O
the	O	O
problems	O	O
of	O	O
distinguishing	O	O
between	O	O
them	O	O
by	O	O
conventional	O	O
phenotypic	O	O
tests	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
two	O	O
distinct	O	O
clusters	O	O
of	O	O
oral	O	O
isolates	O	O
from	O	O
children	O	O
indicated	O	O
the	O	O
existence	O	O
of	O	O
novel	O	O
species	O	O
,	O	O
supported	O	O
by	O	O
analysis	O	O
of	O	O
near-full-length	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
and	O	O
by	O	O
DNA-DNA	O	O
hybridization	O	O
results	O	O
.	O	O

One	O	O
cluster	O	O
of	O	O
weakly	O	O
saccharolytic	B-bacteria	B-bacteria
isolates	O	O
without	O	O
the	O	O
ability	O	O
to	O	O
ferment	O	O
sucrose	O	O
is	O	O
proposed	O	O
as	O	O
Capnocytophaga	B-bacteria	B-bacteria
leadbetteri	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
(	O	O
type	O	O
strain	B-bacteria	B-bacteria
AHN8855	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
51857	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=NCTC	B-bacteria	B-bacteria
13375	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
.	O	O

Another	O	O
cluster	O	O
not	O	O
phenotypically	O	O
distinguishable	O	O
from	O	O
C.	B-bacteria	B-bacteria
ochracea	E-bacteria	I-bacteria
and	O	O
C.	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
is	O	O
designated	O	O
Capnocytophaga	B-bacteria	B-bacteria
genospecies	I-bacteria	I-bacteria
AHN8471	E-bacteria	I-bacteria
(	O	O
represented	O	O
by	O	O
strain	B-bacteria	B-bacteria
AHN8471=CCUG	I-bacteria	I-bacteria
51856=NCTC	I-bacteria	I-bacteria
13374	E-bacteria	I-bacteria
)	O	O
.	O	O

The	O	O
roles	O	O
of	O	O
the	O	O
'classical'	O	O
Actinomyces	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

as	O	O
colonizers	O	O
of	O	O
oral	O	O
cavities	O	O
of	O	O
man	O	O
and	O	O
animals	O	O
,	O	O
in	O	O
development	O	O
of	O	O
intra-oral	O	O
infections	O	O
and	O	O
as	O	O
agents	O	O
of	O	O
actinomycosis	O	O
have	O	O
been	O	O
well	O	O
documented	O	O
.	O	O

This	O	O
mini-review	O	O
focuses	O	O
on	O	O
perceptions	O	O
of	O	O
human	O	O
colonization	O	O
and	O	O
infection	O	O
that	O	O
have	O	O
emerged	O	O
in	O	O
the	O	O
past	O	O
decade	O	O
,	O	O
largely	O	O
as	O	O
a	O	O
result	O	O
of	O	O
advances	O	O
in	O	O
classification	O	O
,	O	O
identification	O	O
and	O	O
direct	O	O
detection	O	O
from	O	O
clinical	O	O
material	O	O
.	O	O

Arguably	O	O
,	O	O
of	O	O
the	O	O
greatest	O	O
importance	O	O
is	O	O
the	O	O
recognition	O	O
of	O	O
actinomycosis	O	O
as	O	O
a	O	O
major	O	O
factor	O	O
and	O	O
indicator	O	O
of	O	O
poor	O	O
prognosis	O	O
in	O	O
both	O	O
infected	O	O
osteoradionecrosis	O	O
and	O	O
bisphosphonate-associated	O	O
osteonecrosis	O	O
of	O	O
the	O	O
jaws	O	O
.	O	O

Among	O	O
recently	O	O
described	O	O
species	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
graevenitzii	E-bacteria	I-bacteria
has	O	O
been	O	O
isolated	O	O
almost	O	O
exclusively	O	O
from	O	O
oral	O	O
and	O	O
respiratory	O	O
sites	O	O
and	O	O
may	O	O
be	O	O
a	O	O
causative	O	O
agent	O	O
of	O	O
actinomycosis	O	O
.	O	O

Conversely	O	O
,	O	O
several	O	O
other	O	O
Actinomyces	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

are	O	O
isolated	O	O
commonly	O	O
from	O	O
superficial	O	O
soft	O	O
tissue	O	O
infections	O	O
.	O	O

Members	O	O
of	O	O
the	O	O
genus	O	O
Actinobaculum	B-bacteria	B-bacteria
,	O	O
which	O	O
is	O	O
closely	O	O
related	O	O
to	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
are	O	O
strongly	O	O
associated	O	O
with	O	O
urosepsis	O	O
.	O	O

Isolation	O	O
and	O	O
identification	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
and	O	O
related	O	O
genera	O	O
by	O	O
conventional	O	O
methods	O	O
remain	O	O
difficult	O	O
.	O	O

Diagnosis	O	O
is	O	O
commonly	O	O
belated	O	O
and	O	O
based	O	O
solely	O	O
upon	O	O
histological	O	O
findings	O	O
.	O	O

Development	O	O
of	O	O
direct	O	O
detection	O	O
methods	O	O
may	O	O
aid	O	O
patient	O	O
management	O	O
and	O	O
further	O	O
elucidate	O	O
clinical	O	O
associations	O	O
.	O	O

A	O	O
microscopic	O	O
method	O	O
for	O	O
noninvasively	O	O
visualizing	O	O
the	O	O
action	O	O
of	O	O
an	O	O
antimicrobial	O	O
agent	O	O
inside	O	O
a	O	O
biofilm	O	O
was	O	O
developed	O	O
and	O	O
applied	O	O
to	O	O
describe	O	O
spatial	O	O
and	O	O
temporal	O	O
patterns	O	O
of	O	O
mouthrinse	O	O
activity	O	O
on	O	O
model	O	O
oral	O	O
biofilms	O	O
.	O	O

Three	O	O
species	O	O
biofilms	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
were	O	O
grown	O	O
in	O	O
glass	O	O
capillary	O	O
flow	O	O
cells	O	O
.	O	O

Bacterial	O	O
cells	O	O
were	O	O
stained	O	O
with	O	O
the	O	O
fluorogenic	O	O
esterase	O	O
substrate	O	O
Calcien	O	O
AM	O	O
(	O	O
CAM	O	O
)	O	O
.	O	O

Loss	O	O
of	O	O
green	O	O
fluorescence	O	O
upon	O	O
exposure	O	O
to	O	O
an	O	O
antimicrobial	O	O
formulation	O	O
was	O	O
subsequently	O	O
imaged	O	O
by	O	O
time-lapse	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
.	O	O

When	O	O
an	O	O
antimicrobial	O	O
mouthrinse	O	O
containing	O	O
chlorhexidine	O	O
digluconate	O	O
was	O	O
administered	O	O
,	O	O
a	O	O
gradual	O	O
loss	O	O
of	O	O
green	O	O
fluorescence	O	O
was	O	O
observed	O	O
that	O	O
began	O	O
at	O	O
the	O	O
periphery	O	O
of	O	O
cell	O	O
clusters	O	O
where	O	O
they	O	O
adjoined	O	O
the	O	O
flowing	O	O
bulk	O	O
fluid	O	O
and	O	O
progressed	O	O
inward	O	O
over	O	O
a	O	O
time	O	O
period	O	O
of	O	O
several	O	O
minutes	O	O
.	O	O

Image	O	O
analysis	O	O
was	O	O
performed	O	O
to	O	O
quantify	O	O
a	O	O
penetration	O	O
velocity	O	O
of	O	O
4	O	O
mum/min	O	O
.	O	O

An	O	O
enzyme-based	O	O
antimicrobial	O	O
formulation	O	O
led	O	O
to	O	O
a	O	O
gradual	O	O
,	O	O
continually	O	O
slowing	O	O
loss	O	O
of	O	O
fluorescence	O	O
in	O	O
a	O	O
pattern	O	O
that	O	O
was	O	O
qualitatively	O	O
different	O	O
from	O	O
the	O	O
behavior	O	O
observed	O	O
with	O	O
chlorhexidine	O	O
.	O	O

Ethanol	O	O
at	O	O
11.6	O	O
%	O	O
had	O	O
little	O	O
effect	O	O
on	O	O
the	O	O
biofilm	O	O
.	O	O

None	O	O
of	O	O
these	O	O
treatments	O	O
resulted	O	O
in	O	O
the	O	O
removal	O	O
of	O	O
biomass	O	O
from	O	O
the	O	O
biofilm	O	O
.	O	O

Most	O	O
methods	O	O
to	O	O
measure	O	O
or	O	O
visualize	O	O
antimicrobial	O	O
action	O	O
in	O	O
biofilms	O	O
are	O	O
destructive	O	O
.	O	O

Spatial	O	O
information	O	O
is	O	O
important	O	O
because	O	O
biofilms	O	O
are	O	O
known	O	O
for	O	O
their	O	O
structural	O	O
and	O	O
physiological	O	O
heterogeneity	O	O
.	O	O

The	O	O
CAM	O	O
staining	O	O
technique	O	O
has	O	O
the	O	O
potential	O	O
to	O	O
provide	O	O
information	O	O
about	O	O
the	O	O
rate	O	O
of	O	O
antimicrobial	O	O
penetration	O	O
,	O	O
the	O	O
presence	O	O
of	O	O
tolerant	O	O
subpopulations	O	O
,	O	O
and	O	O
the	O	O
extent	O	O
of	O	O
biomass	O	O
removal	O	O
effected	O	O
by	O	O
a	O	O
treatment	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
whether	O	O
wild-thyme	O	O
(	O	O
Thymus	O	O
serpyllum	O	O
)	O	O
hydrosol	O	O
had	O	O
a	O	O
preserving	O	O
effect	O	O
against	O	O
spoilage	O	O
of	O	O
freshwater	O	O
fish	O	O
.	O	O

Sensorial	O	O
characteristics	O	O
,	O	O
chemical	O	O
freshness	O	O
indicator	O	O
contents	O	O
,	O	O
and	O	O
microbial	O	O
counts	O	O
(	O	O
total	O	O
aerobes	B-bacteria	B-bacteria
,	O	O
psychrotrophics	B-bacteria	B-bacteria
,	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
,	O	O
fecal	B-bacteria	B-bacteria
coliform	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
Aeromonas	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
Pseudomonas	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
)	O	O

of	O	O
whole	O	O
ungutted	O	O
and	O	O
gutted	O	O
Transcaucasian	O	O
barb	O	O
(	O	O
Capoeta	O	O
capoeta	O	O
capoeta	O	O
Guldenstaedt	O	O
,	O	O
1772	O	O
)	O	O
stored	O	O
on	O	O
ice	O	O
produced	O	O
from	O	O
wild-thyme	O	O
hydrosol	O	O
and	O	O
tap	O	O
water	O	O
at	O	O
4	O	O
degrees	O	O
C	O	O
for	O	O
20	O	O
days	O	O
were	O	O
compared	O	O
.	O	O

The	O	O
results	O	O
did	O	O
not	O	O
reveal	O	O
any	O	O
significant	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
differences	O	O
in	O	O
the	O	O
microbial	O	O
counts	O	O
,	O	O
sensorial	O	O
characteristics	O	O
,	O	O
pH	O	O
,	O	O
and	O	O
total	O	O
volatile	O	O
basic	O	O
nitrogen	O	O
values	O	O
between	O	O
gutted	O	O
and	O	O
ungutted	O	O
groups	O	O
.	O	O

Sensory	O	O
evaluation	O	O
and	O	O
microbiological	O	O
and	O	O
chemical	O	O
analyses	O	O
indicated	O	O
that	O	O
the	O	O
storage	O	O
of	O	O
the	O	O
fish	O	O
on	O	O
ice	O	O
produced	O	O
from	O	O
wild-thyme	O	O
hydrosol	O	O
had	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
shelf	O	O
life	O	O
by	O	O
at	O	O
least	O	O
15	O	O
to	O	O
20	O	O
days	O	O
.	O	O

Frequent	O	O
occurrence	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
human	O	O
gastrointestinal	O	O
tract	O	O
and	O	O
its	O	O
persistence	O	O
due	O	O
to	O	O
unsuccessful	O	O
antimicrobial	O	O
therapy	O	O
might	O	O
be	O	O
related	O	O
to	O	O
a	O	O
stage	O	O
in	O	O
the	O	O
life	O	O
cycle	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
which	O	O
the	O	O
bacterium	O	O
establishes	O	O
itself	O	O
as	O	O
an	O	O
intracellular	O	O
symbiont	O	O
in	O	O
yeast	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
occurrence	O	O
of	O	O
non-culturable	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
yeast	O	O
was	O	O
assessed	O	O
by	O	O
targeting	O	O
vacuolating	O	O
cytotoxin	O	O
A	O	O
(	O	O
vacA	O	O
s1s2	O	O
)	O	O
and	O	O
ureAB	O	O
genes	O	O
in	O	O
the	O	O
total	O	O
DNAs	O	O
of	O	O
yeasts	O	O
.	O	O

DNAs	O	O
were	O	O
extracted	O	O
from	O	O
13	O	O
oral	O	O
yeasts	O	O
in	O	O
which	O	O
bacterium-like	O	O
bodies	O	O
,	O	O
suspected	O	O
to	O	O
be	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
were	O	O
observed	O	O
microscopically	O	O
.	O	O

Primers	O	O
were	O	O
recruited	O	O
to	O	O
amplify	O	O
vacA	O	O
s1s2	O	O
and	O	O
ureAB	O	O
genes	O	O
.	O	O

DNAs	O	O
from	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
and	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
were	O	O
used	O	O
as	O	O
controls	O	O
.	O	O

The	O	O
amplicons	O	O
from	O	O
one	O	O
yeast	O	O
and	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
were	O	O
sequenced	O	O
.	O	O

Yeasts	O	O
were	O	O
identified	O	O
as	O	O
Candida	O	O
albicans	O	O
.	O	O

Fragments	O	O
of	O	O
vacA	O	O
s1s2	O	O
and	O	O
ureAB	O	O
genes	O	O
were	O	O
amplified	O	O
from	O	O
13	O	O
yeasts	O	O
.	O	O

The	O	O
size	O	O
of	O	O
PCR	O	O
products	O	O
was	O	O
286	O	O
bp	O	O
for	O	O
vacA	O	O
s1s2	O	O
gene	O	O
and	O	O
406	O	O
bp	O	O
for	O	O
ureAB	O	O
gene	O	O
.	O	O

Similar	O	O
bands	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
control	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
results	O	O
for	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
were	O	O
negative	O	O
.	O	O

The	O	O
data	O	O
from	O	O
sequencing	O	O
of	O	O
PCR	O	O
products	O	O
showed	O	O
about	O	O
98	O	O
%	O	O
homology	O	O
between	O	O
the	O	O
genes	O	O
amplified	O	O
from	O	O
yeast	O	O
and	O	O
those	O	O
from	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
study	O	O
showed	O	O
the	O	O
intracellular	O	O
occurrence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
yeast	O	O
.	O	O

This	O	O
endosymbiotic	O	O
relationship	O	O
might	O	O
explain	O	O
the	O	O
persistence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
the	O	O
consequence	O	O
of	O	O
which	O	O
could	O	O
be	O	O
reinoculation	O	O
of	O	O
the	O	O
stomach	O	O
by	O	O
the	O	O
bacterium	O	O
and	O	O
spread	O	O
of	O	O
infection	O	O
among	O	O
human	O	O
populations	O	O
.	O	O

Type	O	O
1	O	O
diabetes	O	O
mellitus	O	O
(	O	O
T1DM	O	O
)	O	O
is	O	O
an	O	O
auto-immune	O	O
disease	O	O
while	O	O
oral	O	O
administrating	O	O
its	O	O
autoantigens	O	O
could	O	O
be	O	O
a	O	O
treatment	O	O
of	O	O
T1DM	O	O
.	O	O

To	O	O
express	O	O
human	O	O
insulin	O	O
gene	O	O
(	O	O
ins	O	O
)	O	O
in	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
LAB	B-bacteria	B-bacteria
)	O	O
for	O	O
oral	O	O
vaccine	O	O
,	O	O
ins	O	O
gene	O	O
was	O	O
replaced	O	O
by	O	O
LAB	B-bacteria	B-bacteria
bias	O	O
codon	O	O
and	O	O
an	O	O
8-amino-acid-residue	O	O
linker	O	O
peptide	O	O
forming	O	O
a	O	O
beta-turn	O	O
was	O	O
designed	O	O
to	O	O
link	O	O
insulin	O	O
chain	O	O
A	O	O
and	O	O
B	O	O
.	O	O

After	O	O
synthesized	O	O
by	O	O
primer	O	O
annealing	O	O
method	O	O
,	O	O
the	O	O
whole	O	O
ins	O	O
gene	O	O
was	O	O
fused	O	O
with	O	O
signal	O	O
peptide	O	O
sequence	O	O
SP	O	O
(	O	O
Usp45	O	O
)	O	O
,	O	O
subcloned	O	O
into	O	O
a	O	O
LAB	B-bacteria	B-bacteria
secretory	O	O
expressive	O	O
vector	O	O
pSW501	O	O
and	O	O
then	O	O
introduced	O	O
to	O	O
Lactococcus	B-bacteria	B-bacteria
lactis	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
L.	I-bacteria	I-bacteria
lactis	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
MG1363	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
Lb	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
casei	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
ATCC27092	E-bacteria	I-bacteria
respectively	O	O
.	O	O

Western	O	O
blot	O	O
showed	O	O
that	O	O
the	O	O
expression	O	O
product	O	O
(	O	O
SP	O	O
(	O	O
Usp45	O	O
)	O	O
-INS	O	O
protein	O	O
)	O	O
targeted	O	O
mainly	O	O
at	O	O
the	O	O
cell	O	O
wall	O	O
while	O	O
little	O	O
was	O	O
found	O	O
in	O	O
cytoplasm	O	O
or	O	O
supernatant	O	O
.	O	O

The	O	O
highest	O	O
expression	O	O
level	O	O
emerged	O	O
in	O	O
exponential	O	O
phase	O	O
when	O	O
the	O	O
optical	O	O
density	O	O
at	O	O
600nm	O	O
of	O	O
the	O	O
culture	O	O
was	O	O
0.4	O	O
.	O	O

The	O	O
culture	O	O
of	O	O
the	O	O
recombinant	O	O
strain	B-bacteria	B-bacteria
Lb	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

casei/pSW501	E-bacteria	I-bacteria
was	O	O
administered	O	O
to	O	O
non-obese	O	O
diabetic	O	O
(	O	O
NOD	O	O
)	O	O
mice	O	O
orally	O	O
.	O	O

ELISA	O	O
and	O	O
Western	O	O
blot	O	O
results	O	O
showed	O	O
that	O	O
the	O	O
recombinant	O	O
strain	O	O
could	O	O
induce	O	O
SP	O	O
(	O	O
Usp45	O	O
)	O	O
-INS-specific	O	O
antibodies	O	O
and	O	O
raise	O	O
IL-4	O	O
level	O	O
(	O	O
38.583	O	O
+/-	O	O
2.083	O	O
pg/mL	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
in	O	O
the	O	O
mice	O	O
'	O	O
s	O	O
sera	O	O
.	O	O

Expression	O	O
of	O	O
insulin	O	O
in	O	O
the	O	O
food-grade	O	O
vehicle	O	O
LAB	B-bacteria	B-bacteria
could	O	O
induce	O	O
oral	O	O
immune	O	O
tolerance	O	O
in	O	O
NOD	O	O
mice	O	O
and	O	O
protect	O	O
it	O	O
from	O	O
pancreas	O	O
injury	O	O
,	O	O
suggesting	O	O
it	O	O
might	O	O
be	O	O
a	O	O
new	O	O
way	O	O
to	O	O
the	O	O
treatment	O	O
of	O	O
T1DM	O	O
.	O	O

The	O	O
incorporation	O	O
of	O	O
antibacterial	O	O
agents	O	O
into	O	O
adhesive	O	O
systems	O	O
has	O	O
been	O	O
proposed	O	O
to	O	O
eliminate	O	O
residual	O	O
bacteria	O	O
from	O	O
dentine	O	O
.	O	O

This	O	O
study	O	O
used	O	O
the	O	O
agar	O	O
diffusion	O	O
method	O	O
to	O	O
evaluate	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
Clearfil	O	O
Protect	O	O
Bond	O	O
(	O	O
CPB	O	O
)	O	O
,	O	O
Clearfil	O	O
SE	O	O
Bond	O	O
(	O	O
CSEB	O	O
)	O	O
,	O	O
Clearfil	O	O
Tri-S	O	O
Bond	O	O
(	O	O
C3SB	O	O
)	O	O
and	O	O
Xeno-III	O	O
(	O	O
XIII	O	O
)	O	O
self-etching	O	O
adhesive	O	O
systems	O	O
,	O	O
with	O	O
or	O	O
without	O	O
light-activation	O	O
,	O	O
against	O	O
cariogenic	O	O
bacteria	O	O
,	O	O
and	O	O
to	O	O
assess	O	O
the	O	O
influence	O	O
of	O	O
human	O	O
dentine	O	O
on	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
these	O	O
materials	O	O
.	O	O

An	O	O
aliquot	O	O
of	O	O
10	O	O
microl	O	O
per	O	O
material	O	O
(	O	O
and	O	O
individual	O	O
components	O	O
)	O	O
were	O	O
pipetted	O	O
onto	O	O
paper	O	O
and	O	O
dentine	O	O
discs	O	O
distributed	O	O
in	O	O
Petri	O	O
dishes	O	O
containing	O	O
bacterial	O	O
culture	O	O
in	O	O
BHI	O	O
agar	O	O
.	O	O

Positive	O	O
control	O	O
was	O	O
0.2	O	O
%	O	O
chlorhexidine	O	O
digluconate	O	O
(	O	O
CHX	O	O
)	O	O
.	O	O

After	O	O
incubation	O	O
,	O	O
the	O	O
adhesive	O	O
components	O	O
of	O	O
CPB	O	O
and	O	O
CSEB	O	O
,	O	O
liquid	O	O
A	O	O
of	O	O
XIII	O	O
and	O	O
C3SB	O	O
did	O	O
not	O	O
present	O	O
antibacterial	O	O
activity	O	O
when	O	O
applied	O	O
to	O	O
paper	O	O
discs	O	O
.	O	O

The	O	O
non-light-activated	O	O
CPB	O	O
primer+adhesive	O	O
promoted	O	O
the	O	O
greatest	O	O
inhibition	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
whereas	O	O
with	O	O
light-activation	O	O
,	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
between	O	O
primer+adhesive	O	O
and	O	O
primer	O	O
alone	O	O
.	O	O

For	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
CPB	O	O
primer	O	O
presented	O	O
the	O	O
greatest	O	O
antibacterial	O	O
activity	O	O
in	O	O
both	O	O
light-activation	O	O
conditions	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Regarding	O	O
the	O	O
dentine	O	O
discs	O	O
,	O	O
only	O	O
CHX	O	O
promoted	O	O
an	O	O
inhibitory	O	O
effect	O	O
,	O	O
though	O	O
less	O	O
intense	O	O
than	O	O
on	O	O
paper	O	O
discs	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

CHX	O	O
presented	O	O
greater	O	O
antibacterial	O	O
activity	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
than	O	O
against	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Light-activation	O	O
significantly	O	O
reduced	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
the	O	O
self-etching	O	O
adhesive	O	O
systems	O	O
;	O	O
MDPB	O	O
incorporation	O	O
contributed	O	O
to	O	O
the	O	O
effect	O	O
of	O	O
adhesive	O	O
systems	O	O
against	O	O
cariogenic	O	O
bacteria	O	O
;	O	O
the	O	O
components	O	O
eluted	O	O
from	O	O
the	O	O
adhesive	O	O
systems	O	O
were	O	O
not	O	O
capable	O	O
to	O	O
diffuse	O	O
through	O	O
400	O	O
microm-thick	O	O
dentine	O	O
disc	O	O
to	O	O
exert	O	O
their	O	O
antibacterial	O	O
activity	O	O
against	O	O
cariogenic	O	O
bacteria	O	O
.	O	O

Cathelicidins	O	O
are	O	O
antimicrobial	O	O
peptides	O	O
found	O	O
in	O	O
epithelial	O	O
and	O	O
mucosal	O	O
tissues	O	O
as	O	O
well	O	O
as	O	O
the	O	O
secondary	O	O
granules	O	O
of	O	O
neutrophils	O	O
.	O	O

SMAP29	O	O
,	O	O
a	O	O
sheep	O	O
cathelicidin	O	O
,	O	O
has	O	O
differential	O	O
antimicrobial	O	O
properties	O	O
against	O	O
various	O	O
pathogens	O	O
,	O	O
including	O	O
periodontal	O	O
organisms	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
antimicrobial	O	O
properties	O	O
and	O	O
cytotoxicity	O	O
of	O	O
SMAP29	O	O
,	O	O
SMAP28	O	O
,	O	O
and	O	O
three	O	O
congeners	O	O
(	O	O
SMAP18A	O	O
,	O	O
SMAP18D	O	O
,	O	O
and	O	O
SMAP14A	O	O
)	O	O
.	O	O

The	O	O
peptides	O	O
at	O	O
concentrations	O	O
ranging	O	O
from	O	O
0.25	O	O
to	O	O
250	O	O
microg/ml	O	O
were	O	O
tested	O	O
for	O	O
their	O	O
activity	O	O
against	O	O
multiple	O	O
strains	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
using	O	O
a	O	O
radial	O	O
diffusion	O	O
assay	O	O
.	O	O

Cytotoxicity	O	O
of	O	O
keratinocytes	O	O
was	O	O
evaluated	O	O
by	O	O
measuring	O	O
lactate	O	O
dehydrogenase	O	O
release	O	O
after	O	O
incubation	O	O
with	O	O
the	O	O
individual	O	O
peptides	O	O
.	O	O

SMAP28	O	O
,	O	O
thought	O	O
to	O	O
be	O	O
the	O	O
biologically	O	O
active	O	O
peptide	O	O
,	O	O
was	O	O
the	O	O
most	O	O
potent	O	O
antimicrobial	O	O
(	O	O
range	O	O
of	O	O
minimum	O	O
inhibitory	O	O
concentrations	O	O
0.06-7.03	O	O
microg/ml	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
;	O	O
however	O	O
,	O	O
the	O	O
activity	O	O
of	O	O
SMAP28	O	O
and	O	O
SMAP29	O	O
was	O	O
strongly	O	O
associated	O	O
(	O	O
r	O	O
=	O	O
0.933	O	O
)	O	O
.	O	O

The	O	O
congeners	O	O
also	O	O
demonstrated	O	O
antimicrobial	O	O
activity	O	O
against	O	O
the	O	O
bacteria	O	O
tested	O	O
(	O	O
range	O	O
of	O	O
minimum	O	O
inhibitory	O	O
concnetrations	O	O
0.21-79	O	O
microg/ml	O	O
)	O	O
.	O	O

Overall	O	O
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
susceptible	O	O
organism	O	O
,	O	O
while	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
the	O	O
least	O	O
susceptible	O	O
.	O	O

Keratinocyte	O	O
cytotoxicity	O	O
was	O	O
dependent	O	O
on	O	O
peptide	O	O
length	O	O
and	O	O
dose	O	O
.	O	O

SMAP28	O	O
was	O	O
the	O	O
most	O	O
cytotoxic	O	O
,	O	O
while	O	O
SMAP14A	O	O
was	O	O
the	O	O
least	O	O
cytotoxic	O	O
.	O	O

The	O	O
antimicrobial	O	O
activities	O	O
against	O	O
oral	O	O
microorganisms	O	O
and	O	O
the	O	O
minimal	O	O
toxicity	O	O
seen	O	O
in	O	O
this	O	O
study	O	O
suggest	O	O
that	O	O
the	O	O
congeners	O	O
of	O	O
SMAP29	O	O
may	O	O
serve	O	O
as	O	O
an	O	O
alternative	O	O
to	O	O
traditional	O	O
antibiotics	O	O
in	O	O
the	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
periodontal	O	O
and	O	O
other	O	O
oral	O	O
diseases	O	O
.	O	O

Intestinal	B-bacteria	B-bacteria
lactobacilli	E-bacteria	I-bacteria
have	O	O
been	O	O
successfully	O	O
used	O	O
as	O	O
probiotics	B-bacteria	B-bacteria
to	O	O
treat	O	O
gastrointestinal	O	O
disorders	O	O
,	O	O
but	O	O
only	O	O
limited	O	O
data	O	O
are	O	O
available	O	O
for	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
properties	O	O
of	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
to	O	O
combat	O	O
oral	O	O
diseases	O	O
.	O	O

We	O	O
aimed	O	O
to	O	O
characterize	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
for	O	O
their	O	O
potential	O	O
probiotic	B-bacteria	B-bacteria
properties	O	O
according	O	O
to	O	O
the	O	O
international	O	O
guidelines	O	O
for	O	O
the	O	O
evaluation	O	O
of	O	O
probiotics	B-bacteria	B-bacteria
,	O	O
and	O	O
to	O	O
select	O	O
potential	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
for	O	O
oral	O	O
health	O	O
.	O	O

The	O	O
study	O	O
included	O	O
67	O	O
salivary	O	O
and	O	O
subgingival	O	O
lactobacilli	B-bacteria	B-bacteria
of	O	O
10	O	O
species	O	O
,	O	O
isolated	O	O
from	O	O
healthy	O	O
humans	O	O
.	O	O

All	O	O
strains	O	O
were	O	O
identified	O	O
using	O	O
amplified	O	O
ribosomal	O	O
DNA	O	O
restriction	O	O
analysis	O	O
,	O	O
tested	O	O
for	O	O
antimicrobial	O	O
activity	O	O
against	O	O
oral	O	O
pathogens	O	O
,	O	O
tolerance	O	O
of	O	O
low	O	O
pH	O	O
and	O	O
bile	O	O
content	O	O
.	O	O

Thereafter	O	O
,	O	O
the	O	O
lysozyme	O	O
tolerance	O	O
and	O	O
antibiotic	O	O
susceptibility	O	O
of	O	O
22	O	O
potential	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
assessed	O	O
.	O	O

The	O	O
majority	O	O
of	O	O
strains	O	O
suppressed	O	O
the	O	O
growth	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
but	O	O
none	O	O
inhibited	O	O
Candida	O	O
albicans	O	O
.	O	O

The	O	O
lowest	O	O
pH	O	O
tolerated	O	O
by	O	O
lactobacilli	B-bacteria	B-bacteria
following	O	O
4	O	O
h	O	O
of	O	O
incubation	O	O
was	O	O
pH	O	O
2.5	O	O
,	O	O
but	O	O
none	O	O
of	O	O
the	O	O
strains	O	O
grew	O	O
at	O	O
this	O	O
pH	O	O
.	O	O

All	O	O
strains	O	O
tolerated	O	O
a	O	O
high	O	O
concentration	O	O
of	O	O
lysozyme	O	O
(	O	O
10	O	O
mg/ml	O	O
)	O	O
and	O	O
half	O	O
of	O	O
the	O	O
strains	O	O
tolerated	O	O
a	O	O
high	O	O
concentration	O	O
of	O	O
human	O	O
bile	O	O
[	O	O
5	O	O
%	O	O
volume/volume	O	O
(	O	O
V/V	O	O
)	O	O
]	O	O
.	O	O

Four	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
and	O	O
two	O	O
Lactobacillus	B-bacteria	B-bacteria
oris	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
expressed	O	O
resistance	O	O
to	O	O
tetracycline	O	O
and/or	O	O
doxycycline	O	O
.	O	O

Strains	O	O
of	O	O
L.	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
expressed	O	O
both	O	O
high	O	O
antimicrobial	O	O
activity	O	O
and	O	O
high	O	O
tolerance	O	O
of	O	O
environmental	O	O
stress	O	O
.	O	O

The	O	O
absence	O	O
of	O	O
transferable	O	O
antibiotic-resistance	O	O
genes	O	O
in	O	O
L.	B-bacteria	B-bacteria
plantarum	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
remains	O	O
to	O	O
be	O	O
confirmed	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
a	O	O
potential	O	O
for	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
to	O	O
be	O	O
used	O	O
as	O	O
probiotics	B-bacteria	B-bacteria
for	O	O
oral	O	O
health	O	O
.	O	O

It	O	O
is	O	O
unclear	O	O
when	O	O
the	O	O
initial	O	O
colonization	O	O
by	O	O
periodontal	O	O
pathogens	O	O
occurs	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Therefore	O	O
,	O	O
we	O	O
report	O	O
here	O	O
the	O	O
association	O	O
between	O	O
specific	O	O
age	O	O
groups	O	O
and	O	O
the	O	O
time	O	O
when	O	O
the	O	O
initial	O	O
colonization	O	O
by	O	O
periodontal	O	O
pathogens	O	O
occurs	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
such	O	O
groups	O	O
.	O	O

Findings	O	O
are	O	O
based	O	O
on	O	O
an	O	O
epidemiological	O	O
analysis	O	O
of	O	O
the	O	O
prevalence	O	O
of	O	O
five	O	O
periodontal	O	O
pathogens	O	O
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
a	O	O
wide	O	O
range	O	O
of	O	O
age	O	O
populations	O	O
,	O	O
from	O	O
newborn	O	O
to	O	O
elderly	O	O
,	O	O
who	O	O
were	O	O
randomly	O	O
selected	O	O
in	O	O
a	O	O
geographic	O	O
region	O	O
of	O	O
Brazil	O	O
.	O	O

These	O	O
periodontal	O	O
pathogens	O	O
include	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
were	O	O
analyzed	O	O
in	O	O
the	O	O
bacterial	O	O
samples	O	O
isolated	O	O
from	O	O
gingival	O	O
sulcus	O	O
,	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
,	O	O
and	O	O
cheek	O	O
mucosa	O	O
of	O	O
diverse	O	O
age	O	O
groups	O	O
,	O	O
using	O	O
a	O	O
bacterial	O	O
DNA-specific	O	O
PCR	O	O
method	O	O
.	O	O

Results	O	O
indicated	O	O
that	O	O
there	O	O
are	O	O
distinct	O	O
age-related	O	O
groups	O	O
where	O	O
initial	O	O
colonization	O	O
by	O	O
the	O	O
five	O	O
periodontal	O	O
pathogens	O	O
examined	O	O
in	O	O
this	O	O
study	O	O
can	O	O
be	O	O
detected	O	O
and	O	O
that	O	O
the	O	O
presence	O	O
of	O	O
teeth	O	O
is	O	O
a	O	O
permissive	O	O
factor	O	O
for	O	O
colonization	O	O
by	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
.	O	O

Although	O	O
it	O	O
remains	O	O
unclear	O	O
exactly	O	O
how	O	O
or	O	O
when	O	O
target	O	O
pathogens	O	O
colonize	O	O
healthy	O	O
subjects	O	O
,	O	O
an	O	O
understanding	O	O
of	O	O
age-related	O	O
groups	O	O
does	O	O
provide	O	O
a	O	O
potentially	O	O
useful	O	O
tool	O	O
in	O	O
the	O	O
early	O	O
detection	O	O
and	O	O
prevention	O	O
of	O	O
periodontitis	O	O
in	O	O
healthy	O	O
individuals	O	O
.	O	O

To	O	O
assess	O	O
the	O	O
level	O	O
of	O	O
antibiotic	O	O
resistance	O	O
of	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
flora	O	O
of	O	O
children	O	O
with	O	O
a	O	O
history	O	O
of	O	O
rheumatic	O	O
fever	O	O
,	O	O
receiving	O	O
long-term	O	O
monthly	O	O
intramuscular	O	O
benzathine	O	O
penicillin	O	O
G	O	O
prophylaxis	O	O
.	O	O

PATIENTS	O	O
AND	O	O
Oral	O	O
swabs	O	O
from	O	O
patients	O	O
receiving	O	O
monthly	O	O
penicillin	O	O
G	O	O
prophylaxis	O	O
for	O	O
rheumatic	O	O
fever	O	O
were	O	O
cultured	O	O
and	O	O
tested	O	O
for	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

The	O	O
E-test	O	O
was	O	O
used	O	O
to	O	O
test	O	O
susceptibility	O	O
to	O	O
penicillin	O	O
G	O	O
,	O	O
clindamycin	O	O
,	O	O
clarithromycin	O	O
and	O	O
rifampin	O	O
.	O	O

Findings	O	O
were	O	O
compared	O	O
with	O	O
samples	O	O
from	O	O
healthy	O	O
children	O	O
who	O	O
had	O	O
not	O	O
been	O	O
exposed	O	O
to	O	O
antibiotic	O	O
treatment	O	O
for	O	O
at	O	O
least	O	O
2	O	O
months	O	O
.	O	O

Twenty-six	O	O
patients	O	O
and	O	O
20	O	O
control	O	O
children	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Duration	O	O
of	O	O
intramuscular	O	O
antibiotic	O	O
treatment	O	O
ranged	O	O
from	O	O
5	O	O
months	O	O
to	O	O
13.5	O	O
years	O	O
.	O	O

Sixty	O	O
isolates	O	O
of	O	O
viridans	B-bacteria	B-bacteria
streptococci	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
were	O	O
obtained	O	O
,	O	O
with	O	O
a	O	O
similar	O	O
distribution	O	O
in	O	O
the	O	O
two	O	O
groups	O	O
.	O	O

Intermediate	O	O
resistance	O	O
to	O	O
penicillin	O	O
(	O	O
MIC	O	O
0.25-2	O	O
mg/L	O	O
)	O	O
was	O	O
documented	O	O
in	O	O
10	O	O
of	O	O
the	O	O
32	O	O
isolates	O	O
(	O	O
31.2	O	O
%	O	O
)	O	O
in	O	O
the	O	O
study	O	O
group	O	O
,	O	O
and	O	O
high	O	O
resistance	O	O
in	O	O
none	O	O
,	O	O
compared	O	O
to	O	O
seven	O	O
of	O	O
28	O	O
isolates	O	O
(	O	O
25	O	O
%	O	O
)	O	O
with	O	O
intermediate	O	O
or	O	O
high	O	O
resistance	O	O
in	O	O
the	O	O
control	O	O
group	O	O
(	O	O
p=NS	O	O
)	O	O
.	O	O

All	O	O
isolates	O	O
in	O	O
the	O	O
study	O	O
group	O	O
and	O	O
all	O	O
but	O	O
one	O	O
in	O	O
the	O	O
control	O	O
group	O	O
were	O	O
susceptible	O	O
to	O	O
clindamycin	O	O
,	O	O
and	O	O
all	O	O
isolates	O	O
from	O	O
both	O	O
groups	O	O
were	O	O
susceptible	O	O
to	O	O
rifampin	O	O
.	O	O

One	O	O
isolate	O	O
(	O	O
3.1	O	O
%	O	O
)	O	O
in	O	O
the	O	O
study	O	O
group	O	O
and	O	O
two	O	O
(	O	O
7.1	O	O
%	O	O
)	O	O
in	O	O
the	O	O
control	O	O
group	O	O
were	O	O
resistant	O	O
to	O	O
clarithromycin	O	O
.	O	O

Monthly	O	O
Intramuscular	O	O
penicillin	O	O
prophylaxis	O	O
has	O	O
no	O	O
effect	O	O
on	O	O
the	O	O
antibiotic	O	O
susceptibility	O	O
of	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
in	O	O
oral	O	O
flora	O	O
in	O	O
children	O	O
with	O	O
a	O	O
history	O	O
of	O	O
rheumatic	O	O
fever	O	O
,	O	O
receiving	O	O
secondary	O	O
prophylaxis	O	O
after	O	O
rheumatic	O	O
fever	O	O
,	O	O
regardless	O	O
of	O	O
the	O	O
duration	O	O
of	O	O
treatment	O	O
.	O	O

A	O	O
broad	O	O
variety	O	O
of	O	O
microbes	O	O
are	O	O
present	O	O
in	O	O
atherosclerotic	O	O
plaques	O	O
and	O	O
chronic	O	O
bacterial	O	O
infection	O	O
increases	O	O
the	O	O
risk	O	O
of	O	O
atherosclerosis	O	O
by	O	O
mechanisms	O	O
that	O	O
have	O	O
remained	O	O
vague	O	O
.	O	O

One	O	O
possible	O	O
mechanism	O	O
is	O	O
that	O	O
bacteria	O	O
or	O	O
bacterial	O	O
products	O	O
activate	O	O
plaque	O	O
mast	O	O
cells	O	O
that	O	O
are	O	O
known	O	O
to	O	O
participate	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
atherosclerosis	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
show	O	O
by	O	O
real-time	O	O
PCR	O	O
analysis	O	O
and	O	O
ELISA	O	O
that	O	O
Chlamydia	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
(	O	O
Cpn	B-bacteria	B-bacteria
)	O	O
and	O	O
a	O	O
periodontal	O	O
pathogen	O	O
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
Aa	B-bacteria	B-bacteria
)	O	O
,	O	O
both	O	O
induce	O	O
a	O	O
time	O	O
and	O	O
concentration-dependent	O	O
expression	O	O
and	O	O
secretion	O	O
of	O	O
interleukin	O	O
8	O	O
(	O	O
IL-8	O	O
)	O	O
,	O	O
tumour	O	O
necrosis	O	O
factor-alpha	O	O
(	O	O
TNF-alpha	O	O
)	O	O
and	O	O
monocyte	O	O
chemoattractant	O	O
protein-1	O	O
(	O	O
MCP-1	O	O
)	O	O
by	O	O
cultured	O	O
human	O	O
peripheral	O	O
blood-derived	O	O
mast	O	O
cells	O	O
,	O	O
but	O	O
not	O	O
anti-inflammatory	O	O
molecules	O	O
,	O	O
such	O	O
as	O	O
IL-10	O	O
or	O	O
transforming	O	O
growth	O	O
factor	O	O
beta	O	O
1	O	O
(	O	O
TGF-beta	O	O
1	O	O
)	O	O
.	O	O

The	O	O
IL-8	O	O
and	O	O
MCP-1	O	O
responses	O	O
were	O	O
immediate	O	O
,	O	O
whereas	O	O
the	O	O
onset	O	O
of	O	O
TNF-alpha	O	O
secretion	O	O
was	O	O
delayed	O	O
.	O	O

The	O	O
Cpn-mediated	O	O
pro-inflammatory	O	O
effect	O	O
was	O	O
attenuated	O	O
when	O	O
the	O	O
bacteria	O	O
were	O	O
inactivated	O	O
by	O	O
UV-treatment	O	O
.	O	O

Human	O	O
monocyte-derived	O	O
macrophages	O	O
that	O	O
were	O	O
pre-infected	O	O
with	O	O
Cpn	O	O
also	O	O
induced	O	O
a	O	O
significant	O	O
pro-inflammatory	O	O
response	O	O
in	O	O
human	O	O
mast	O	O
cells	O	O
,	O	O
both	O	O
in	O	O
cocultures	O	O
and	O	O
when	O	O
preconditioned	O	O
media	O	O
from	O	O
Cpn-infected	O	O
macrophages	O	O
were	O	O
used	O	O
.	O	O

Intranasal	O	O
and	O	O
intravenous	O	O
administration	O	O
of	O	O
live	O	O
Cpn	B-bacteria	B-bacteria
and	O	O
Aa	B-bacteria	B-bacteria
,	O	O
respectively	O	O
induced	O	O
an	O	O
accumulation	O	O
of	O	O
activated	O	O
mast	O	O
cells	O	O
in	O	O
the	O	O
aortic	O	O
sinus	O	O
of	O	O
apolipoprotein	O	O
E-deficient	O	O
mice	O	O
,	O	O
however	O	O
,	O	O
with	O	O
varying	O	O
responses	O	O
in	O	O
the	O	O
systemic	O	O
levels	O	O
of	O	O
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
and	O	O
TNF-alpha	O	O
.	O	O

Pro-atherogenic	O	O
Cpn	B-bacteria	B-bacteria
and	O	O
Aa	B-bacteria	B-bacteria
induce	O	O
a	O	O
pro-inflammatory	O	O
response	O	O
in	O	O
cultured	O	O
human	O	O
connective	O	O
tissue-type	O	O
mast	O	O
cells	O	O
and	O	O
activation	O	O
of	O	O
mouse	O	O
aortic	O	O
mast	O	O
cells	O	O
in	O	O
vivo	O	O
.	O	O

Plasminogen	O	O
binding	O	O
by	O	O
bacteria	O	O
is	O	O
a	O	O
virulence	O	O
factor	O	O
important	O	O
for	O	O
the	O	O
entry	O	O
and	O	O
dissemination	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
body	O	O
.	O	O

A	O	O
wide	O	O
variety	O	O
of	O	O
bacteria	O	O
bind	O	O
plasminogen	O	O
,	O	O
including	O	O
both	O	O
organisms	O	O
causing	O	O
disease	O	O
and	O	O
components	O	O
of	O	O
the	O	O
normal	O	O
oral	O	O
flora	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
characteristics	O	O
of	O	O
plasminogen	O	O
binding	O	O
by	O	O
six	O	O
clinical	O	O
isolates	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
from	O	O
both	O	O
dental	O	O
plaque	O	O
and	O	O
inflammatory	O	O
lesions	O	O
.	O	O

All	O	O
the	O	O
strains	O	O
bound	O	O
plasminogen	O	O
with	O	O
approximately	O	O
the	O	O
same	O	O
affinity	O	O
,	O	O
and	O	O
binding	O	O
was	O	O
specific	O	O
and	O	O
lysine-dependent	O	O
as	O	O
evidenced	O	O
by	O	O
its	O	O
inhibition	O	O
by	O	O
epsilon-aminocaproic	O	O
acid	O	O
.	O	O

All	O	O
of	O	O
the	O	O
test	O	O
strains	O	O
were	O	O
capable	O	O
of	O	O
activating	O	O
bound	O	O
plasminogen	O	O
to	O	O
plasmin	O	O
without	O	O
the	O	O
addition	O	O
of	O	O
a	O	O
plasminogen	O	O
activator	O	O
,	O	O
and	O	O
subsequent	O	O
analysis	O	O
revealed	O	O
the	O	O
presence	O	O
of	O	O
streptokinase	O	O
in	O	O
all	O	O
strains	O	O
.	O	O

However	O	O
,	O	O
the	O	O
streptococci	B-bacteria	B-bacteria
exhibited	O	O
fibrinolytic	O	O
activity	O	O
only	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
plasminogen	O	O
and	O	O
this	O	O
could	O	O
be	O	O
inhibited	O	O
by	O	O
the	O	O
addition	O	O
of	O	O
epsilon-aminocaproic	O	O
acid	O	O
.	O	O

SDS-PAGE	O	O
and	O	O
2D	O	O
gel	O	O
electrophoresis	O	O
coupled	O	O
with	O	O
plasminogen	O	O
ligand	O	O
blotting	O	O
showed	O	O
that	O	O
only	O	O
a	O	O
subset	O	O
of	O	O
the	O	O
total	O	O
proteins	O	O
(	O	O
2-15	O	O
)	O	O
were	O	O
involved	O	O
in	O	O
the	O	O
binding	O	O
of	O	O
plasminogen	O	O
.	O	O

Partial	O	O
identification	O	O
of	O	O
the	O	O
binding	O	O
proteins	O	O
revealed	O	O
that	O	O
four	O	O
glycolytic	O	O
enzymes	O	O
,	O	O
enolase	O	O
,	O	O
phosphoglycerate	O	O
kinase	O	O
,	O	O
glyceraldehyde-3-phosphate	O	O
dehydrogenase	O	O
and	O	O
phosphoglycerate	O	O
mutase	O	O
,	O	O
were	O	O
predominant	O	O
in	O	O
binding	O	O
plasminogen	O	O
.	O	O

The	O	O
binding	O	O
of	O	O
plasminogen	O	O
by	O	O
bacteria	O	O
from	O	O
pus	O	O
did	O	O
not	O	O
differ	O	O
from	O	O
that	O	O
of	O	O
the	O	O
strains	O	O
from	O	O
supragingival	O	O
plaque	O	O
.	O	O

The	O	O
findings	O	O
illustrate	O	O
how	O	O
apparently	O	O
innocuous	O	O
commensal	O	O
bacteria	O	O
are	O	O
capable	O	O
of	O	O
utilizing	O	O
a	O	O
mechanism	O	O
that	O	O
is	O	O
generally	O	O
regarded	O	O
as	O	O
being	O	O
of	O	O
importance	O	O
to	O	O
pathogenicity	O	O
and	O	O
suggest	O	O
an	O	O
additional	O	O
role	O	O
of	O	O
plasminogen	O	O
binding	O	O
.	O	O

Coaggregation	O	O
assays	O	O
were	O	O
performed	O	O
to	O	O
investigate	O	O
interactions	O	O
between	O	O
oral	O	O
Bifidobacterium	B-bacteria	B-bacteria
adolescentis	E-bacteria	I-bacteria
and	O	O
other	O	O
oral	O	O
bacterial	O	O
species	O	O
.	O	O

Bifidobacterium	B-bacteria	B-bacteria
adolescentis	I-bacteria	I-bacteria
OLB6410	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
saliva	O	O
of	O	O
healthy	O	O
humans	O	O
did	O	O
not	O	O
coaggregate	O	O
with	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
JCM8350	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
OLS3293	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
JCM5708	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
parvula	I-bacteria	I-bacteria
ATCC17745	E-bacteria	I-bacteria
or	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
OB7124	E-bacteria	I-bacteria
,	O	O
but	O	O
it	O	O
did	O	O
coaggregate	O	O
with	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
JCM8532	E-bacteria	I-bacteria
.	O	O

Subsequent	O	O
examination	O	O
of	O	O
biofilm	O	O
formation	O	O
on	O	O
saliva-coated	O	O
hydroxyapatite	O	O
discs	O	O
using	O	O
FISH	O	O
revealed	O	O
that	O	O
B.	B-bacteria	B-bacteria
adolescentis	I-bacteria	I-bacteria
OLB6410	E-bacteria	I-bacteria
could	O	O
not	O	O
directly	O	O
adhere	O	O
to	O	O
the	O	O
coated	O	O
discs	O	O
.	O	O

It	O	O
did	O	O
,	O	O
however	O	O
,	O	O
adhere	O	O
to	O	O
biofilms	O	O
of	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
V.	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
,	O	O
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
although	O	O
it	O	O
did	O	O
not	O	O
coaggregate	O	O
with	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
nor	O	O
with	O	O
V.	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
adhesion	O	O
of	O	O
B.	B-bacteria	B-bacteria
adolescentis	E-bacteria	I-bacteria
to	O	O
tooth	O	O
surfaces	O	O
is	O	O
mediated	O	O
by	O	O
other	O	O
oral	O	O
bacteria	O	O
.	O	O

Heat-	O	O
or	O	O
proteinase	O	O
K-treated	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
could	O	O
not	O	O
coaggregate	O	O
with	O	O
B.	B-bacteria	B-bacteria
adolescentis	E-bacteria	I-bacteria
.	O	O

Similarly	O	O
,	O	O
the	O	O
coaggregation	O	O
and	O	O
coadhesion	O	O
of	O	O
proteinase	O	O
K-treated	O	O
B.	B-bacteria	B-bacteria
adolescentis	E-bacteria	I-bacteria
were	O	O
strongly	O	O
inhibited	O	O
.	O	O

It	O	O
is	O	O
therefore	O	O
probable	O	O
that	O	O
proteinaceous	O	O
factors	O	O
on	O	O
the	O	O
cellular	O	O
surface	O	O
of	O	O
B.	B-bacteria	B-bacteria
adolescentis	E-bacteria	I-bacteria
and	O	O
F.	E-bacteria	I-bacteria
nucleatum	E-bacteria	I-bacteria
are	O	O
involved	O	O
in	O	O
their	O	O
interaction	O	O
.	O	O

The	O	O
data	O	O
presented	O	O
in	O	O
this	O	O
study	O	O
add	O	O
to	O	O
our	O	O
understanding	O	O
of	O	O
bifidobacterial	O	O
colonization	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

Oral	O	O
biofilms	O	O
are	O	O
associated	O	O
with	O	O
the	O	O
most	O	O
common	O	O
infections	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Bacteria	O	O
embedded	O	O
in	O	O
the	O	O
biofilms	O	O
are	O	O
less	O	O
sensitive	O	O
to	O	O
antibacterial	O	O
agents	O	O
than	O	O
planktonic	O	O
bacteria	O	O
are	O	O
.	O	O

Recently	O	O
,	O	O
an	O	O
antibacterial	O	O
synergic	O	O
effect	O	O
of	O	O
noncoherent	O	O
blue	O	O
light	O	O
and	O	O
hydrogen	O	O
peroxide	O	O
(	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
)	O	O
on	O	O
planktonic	B-bacteria	B-bacteria
Streptococcus	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
demonstrated	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
tested	O	O
the	O	O
effect	O	O
of	O	O
a	O	O
combination	O	O
of	O	O
light	O	O
and	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
on	O	O
the	O	O
vitality	O	O
and	O	O
gene	O	O
expression	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
embedded	O	O
in	O	O
biofilm	O	O
.	O	O

Biofilms	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
exposed	O	O
to	O	O
visible	O	O
light	O	O
(	O	O
wavelengths	O	O
,	O	O
400	O	O
to	O	O
500	O	O
nm	O	O
)	O	O
for	O	O
30	O	O
or	O	O
60	O	O
s	O	O
(	O	O
equivalent	O	O
to	O	O
34	O	O
or	O	O
68	O	O
J/cm	O	O
(	O	O
2	O	O
)	O	O
)	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
3	O	O
to	O	O
300	O	O
mM	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
.	O	O

The	O	O
antibacterial	O	O
effect	O	O
was	O	O
assessed	O	O
by	O	O
microbial	O	O
counts	O	O
of	O	O
each	O	O
treated	O	O
sample	O	O
compared	O	O
with	O	O
that	O	O
of	O	O
the	O	O
control	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
light	O	O
combined	O	O
with	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
on	O	O
the	O	O
different	O	O
layers	O	O
of	O	O
the	O	O
biofilm	O	O
was	O	O
evaluated	O	O
by	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
.	O	O

Gene	O	O
expression	O	O
was	O	O
determined	O	O
by	O	O
real-time	O	O
reverse	O	O
transcription-PCR	O	O
.	O	O

Our	O	O
results	O	O
show	O	O
that	O	O
noncoherent	O	O
light	O	O
,	O	O
in	O	O
combination	O	O
with	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
,	O	O
has	O	O
a	O	O
synergistic	O	O
antibacterial	O	O
effect	O	O
through	O	O
all	O	O
of	O	O
the	O	O
layers	O	O
of	O	O
the	O	O
biofilm	O	O
.	O	O

Furthermore	O	O
,	O	O
this	O	O
treatment	O	O
was	O	O
more	O	O
effective	O	O
against	O	O
bacteria	O	O
in	O	O
biofilm	O	O
than	O	O
against	O	O
planktonic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

The	O	O
combined	O	O
light	O	O
and	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
treatment	O	O
up-regulated	O	O
the	O	O
expression	O	O
of	O	O
several	O	O
genes	O	O
such	O	O
as	O	O
gtfB	O	O
,	O	O
brp	O	O
,	O	O
smu630	O	O
,	O	O
and	O	O
comDE	O	O
but	O	O
did	O	O
not	O	O
affect	O	O
relA	O	O
and	O	O
ftf	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
noncoherent	O	O
visible	O	O
light	O	O
in	O	O
combination	O	O
with	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
to	O	O
affect	O	O
bacteria	O	O
in	O	O
deep	O	O
layers	O	O
of	O	O
the	O	O
biofilm	O	O
suggests	O	O
that	O	O
this	O	O
treatment	O	O
may	O	O
be	O	O
applied	O	O
in	O	O
biofilm-related	O	O
diseases	O	O
as	O	O
a	O	O
minimally	O	O
invasive	O	O
antibacterial	O	O
procedure	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
causes	O	O
peptic	O	O
ulcer	O	O
disease	O	O
and	O	O
gastric	O	O
cancer	O	O
,	O	O
and	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
likely	O	O
to	O	O
serve	O	O
as	O	O
a	O	O
reservoir	O	O
for	O	O
this	O	O
pathogen	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
binding	O	O
of	O	O
H.	O	O
pylori	O	O
to	O	O
the	O	O
mucins	O	O
covering	O	O
the	O	O
mucosal	O	O
surfaces	O	O
in	O	O
the	O	O
niches	O	O
along	O	O
the	O	O
oral	O	O
to	O	O
gastric	O	O
infection	O	O
route	O	O
and	O	O
during	O	O
gastric	O	O
disease	O	O
and	O	O
modeled	O	O
the	O	O
outcome	O	O
of	O	O
these	O	O
interactions	O	O
.	O	O

A	O	O
panel	O	O
of	O	O
seven	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
strains	O	O
with	O	O
defined	O	O
binding	O	O
properties	O	O
was	O	O
used	O	O
to	O	O
identify	O	O
binding	O	O
to	O	O
human	O	O
mucins	O	O
from	O	O
saliva	O	O
,	O	O
gastric	O	O
juice	O	O
,	O	O
cardia	O	O
,	O	O
corpus	O	O
,	O	O
and	O	O
antrum	O	O
of	O	O
healthy	O	O
stomachs	O	O
and	O	O
of	O	O
stomachs	O	O
affected	O	O
by	O	O
gastritis	O	O
at	O	O
pH	O	O
7.4	O	O
and	O	O
3.0	O	O
using	O	O
a	O	O
microtiter-based	O	O
method	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
binding	O	O
to	O	O
mucins	O	O
differed	O	O
substantially	O	O
with	O	O
the	O	O
anatomic	O	O
site	O	O
,	O	O
mucin	O	O
type	O	O
,	O	O
pH	O	O
,	O	O
gastritis	O	O
status	O	O
,	O	O
and	O	O
H.	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
all	O	O
having	O	O
effect	O	O
on	O	O
binding	O	O
.	O	O

Mucins	O	O
from	O	O
saliva	O	O
and	O	O
gastric	O	O
juice	O	O
displayed	O	O
the	O	O
most	O	O
diverse	O	O
binding	O	O
patterns	O	O
,	O	O
involving	O	O
four	O	O
modes	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
adhesion	O	O
and	O	O
the	O	O
MUC5B	O	O
,	O	O
MUC7	O	O
,	O	O
and	O	O
MUC5AC	O	O
mucins	O	O
as	O	O
well	O	O
as	O	O
the	O	O
salivary	O	O
agglutinin	O	O
.	O	O

Binding	O	O
occurred	O	O
via	O	O
the	O	O
blood-group	O	O
antigen-binding	O	O
adhesin	O	O
(	O	O
BabA	O	O
)	O	O
,	O	O
the	O	O
sialic	O	O
acid-binding	O	O
adhesin	O	O
(	O	O
SabA	O	O
)	O	O
,	O	O
a	O	O
charge/low	O	O
pH-dependent	O	O
mechanism	O	O
,	O	O
and	O	O
a	O	O
novel	O	O
saliva-binding	O	O
adhesin	O	O
.	O	O

In	O	O
the	O	O
healthy	O	O
gastric	O	O
mucus	O	O
layer	O	O
only	O	O
BabA	O	O
and	O	O
acid/charge	O	O
affect	O	O
binding	O	O
to	O	O
the	O	O
mucins	O	O
,	O	O
whereas	O	O
in	O	O
gastritis	O	O
,	O	O
the	O	O
BabA/Le	O	O
(	O	O
b	O	O
)	O	O
-dependent	O	O
binding	O	O
to	O	O
MUC5AC	O	O
remained	O	O
,	O	O
and	O	O
SabA	O	O
and	O	O
low	O	O
pH	O	O
binding	O	O
increased	O	O
.	O	O

The	O	O
four	O	O
H.	O	O
pylori	O	O
adhesion	O	O
modes	O	O
binding	O	O
to	O	O
mucins	O	O
are	O	O
likely	O	O
to	O	O
play	O	O
different	O	O
roles	O	O
during	O	O
colonization	O	O
of	O	O
the	O	O
oral	O	O
to	O	O
gastric	O	O
niches	O	O
and	O	O
during	O	O
long-term	O	O
infection	O	O
.	O	O

Compare	O	O
the	O	O
microbial	O	O
profiles	O	O
on	O	O
the	O	O
tongue	O	O
dorsum	O	O
in	O	O
patients	O	O
with	O	O
halitosis	O	O
and	O	O
control	O	O
subjects	O	O
in	O	O
a	O	O
UK	O	O
population	O	O
using	O	O
culture-independent	O	O
techniques	O	O
.	O	O

Halitosis	O	O
patients	O	O
were	O	O
screened	O	O
according	O	O
to	O	O
our	O	O
recently	O	O
developed	O	O
recruitment	O	O
protocol	O	O
.	O	O

Scrapings	O	O
from	O	O
the	O	O
tongue	O	O
dorsum	O	O
were	O	O
obtained	O	O
for	O	O
12	O	O
control	O	O
subjects	O	O
and	O	O
20	O	O
halitosis	O	O
patients	O	O
.	O	O

Bacteria	O	O
were	O	O
identified	O	O
by	O	O
PCR	O	O
amplification	O	O
,	O	O
cloning	O	O
and	O	O
sequencing	O	O
of	O	O
16S	O	O
rRNA	O	O
genes	O	O
.	O	O

The	O	O
predominant	O	O
species	O	O
found	O	O
in	O	O
the	O	O
control	O	O
samples	O	O
were	O	O
Lysobacter-type	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
dispar	E-bacteria	I-bacteria
,	O	O
unidentified	O	O
oral	O	O
bacterium	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
,	O	O
Atopobium	B-bacteria	B-bacteria
parvulum	E-bacteria	I-bacteria
and	O	O
Veillonella	B-bacteria	B-bacteria
atypica	E-bacteria	I-bacteria
.	O	O

In	O	O
the	O	O
halitosis	O	O
samples	O	O
,	O	O
Lysobacter-type	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
,	O	O
unidentified	O	O
oral	O	O
bacterium	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
veroralis	B-bacteria	B-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
pallens	E-bacteria	I-bacteria
were	O	O
the	O	O
most	O	O
commonly	O	O
found	O	O
species	O	O
.	O	O

For	O	O
the	O	O
control	O	O
samples	O	O
,	O	O
13-16	O	O
(	O	O
4.7-5.8	O	O
%	O	O
)	O	O
of	O	O
276	O	O
clones	O	O
represented	O	O
uncultured	O	O
species	O	O
,	O	O
whereas	O	O
in	O	O
the	O	O
halitosis	O	O
samples	O	O
,	O	O
this	O	O
proportion	O	O
increased	O	O
to	O	O
6.5-9.6	O	O
%	O	O
(	O	O
36-53	O	O
of	O	O
553	O	O
clones	O	O
)	O	O
.	O	O

In	O	O
the	O	O
control	O	O
samples	O	O
,	O	O
22	O	O
(	O	O
8.0	O	O
%	O	O
)	O	O
of	O	O
276	O	O
clones	O	O
represented	O	O
potentially	O	O
novel	O	O
phylotypes	O	O
,	O	O
and	O	O
in	O	O
the	O	O
halitosis	O	O
samples	O	O
,	O	O
this	O	O
figure	O	O
was	O	O
39	O	O
(	O	O
7.1	O	O
%	O	O
)	O	O
of	O	O
553	O	O
clones	O	O
.	O	O

The	O	O
microflora	O	O
associated	O	O
with	O	O
the	O	O
tongue	O	O
dorsum	O	O
is	O	O
complex	O	O
in	O	O
both	O	O
the	O	O
control	O	O
and	O	O
halitosis	O	O
groups	O	O
,	O	O
but	O	O
several	O	O
key	O	O
species	O	O
predominate	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
presents	O	O
numerous	O	O
surfaces	O	O
for	O	O
microbial	O	O
colonization	O	O
.	O	O

These	O	O
surfaces	O	O
produce	O	O
biofilms	O	O
of	O	O
differing	O	O
complexities	O	O
unique	O	O
to	O	O
each	O	O
individual	O	O
.	O	O

Several	O	O
studies	O	O
have	O	O
looked	O	O
at	O	O
biofilms	O	O
in	O	O
dentate	O	O
patients	O	O
.	O	O

There	O	O
has	O	O
been	O	O
limited	O	O
research	O	O
regarding	O	O
biofilms	O	O
on	O	O
dentures	O	O
or	O	O
soft	O	O
tissues	O	O
of	O	O
edentulous	O	O
patients	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
present	O	O
investigation	O	O
was	O	O
to	O	O
provide	O	O
meaningful	O	O
data	O	O
describing	O	O
microbial	O	O
ecological	O	O
relationships	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
edentulous	O	O
patients	O	O
and	O	O
to	O	O
evaluate	O	O
the	O	O
microbiota	O	O
on	O	O
hard	O	O
and	O	O
soft	O	O
tissue	O	O
surfaces	O	O
and	O	O
saliva	O	O
in	O	O
edentulous	O	O
patients	O	O
wearing	O	O
complete	O	O
dentures	O	O
.	O	O

MATERIALS	O	O
AND	O	O
Sixty-one	O	O
edentulous	O	O
subjects	O	O
with	O	O
complete	O	O
maxillary	O	O
and	O	O
mandibular	O	O
dentures	O	O
were	O	O
recruited	O	O
.	O	O

``	O	O
Supragingival	O	O
''	O	O
biofilm	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
28	O	O
denture	O	O
teeth	O	O
for	O	O
each	O	O
subject	O	O
.	O	O

Biofilm	O	O
samples	O	O
were	O	O
also	O	O
taken	O	O
from	O	O
the	O	O
dorsal	O	O
,	O	O
lateral	O	O
,	O	O
and	O	O
ventral	O	O
surfaces	O	O
of	O	O
the	O	O
tongue	O	O
,	O	O
floor	O	O
of	O	O
mouth	O	O
,	O	O
buccal	O	O
mucosa	O	O
,	O	O
hard	O	O
palate	O	O
,	O	O
vestibule/lip	O	O
,	O	O
``	O	O
attached	O	O
gingiva	O	O
,	O	O
''	O	O
and	O	O
saliva	O	O
.	O	O

Samples	O	O
were	O	O
individually	O	O
analyzed	O	O
for	O	O
their	O	O
content	O	O
of	O	O
41	O	O
bacterial	O	O
species	O	O
using	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

Levels	O	O
and	O	O
proportions	O	O
of	O	O
each	O	O
species	O	O
were	O	O
determined	O	O
for	O	O
every	O	O
sample	O	O
location	O	O
.	O	O

Periodontal	O	O
pathogens	O	O
such	O	O
as	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
clearly	O	O
present	O	O
in	O	O
the	O	O
samples	O	O
from	O	O
the	O	O
edentulous	O	O
subjects	O	O
.	O	O

Microbial	O	O
profiles	O	O
in	O	O
samples	O	O
from	O	O
the	O	O
soft	O	O
tissue	O	O
surfaces	O	O
differed	O	O
among	O	O
site	O	O
locations	O	O
.	O	O

Samples	O	O
from	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
exhibited	O	O
the	O	O
highest	O	O
bacterial	O	O
counts	O	O
followed	O	O
by	O	O
the	O	O
``	O	O
attached	O	O
gingiva	O	O
''	O	O
and	O	O
the	O	O
lateral	O	O
surfaces	O	O
of	O	O
the	O	O
tongue	O	O
,	O	O
while	O	O
the	O	O
lowest	O	O
mean	O	O
counts	O	O
were	O	O
found	O	O
in	O	O
samples	O	O
from	O	O
the	O	O
buccal	O	O
mucosa	O	O
and	O	O
labial	O	O
vestibules	O	O
.	O	O

Using	O	O
cluster	O	O
analysis	O	O
of	O	O
the	O	O
proportions	O	O
of	O	O
the	O	O
test	O	O
species	O	O
,	O	O
three	O	O
clusters	O	O
were	O	O
formed	O	O
.	O	O

The	O	O
first	O	O
cluster	O	O
comprised	O	O
saliva	O	O
,	O	O
supragingival	O	O
plaque	O	O
,	O	O
and	O	O
the	O	O
lateral	O	O
and	O	O
dorsal	O	O
surfaces	O	O
of	O	O
the	O	O
tongue	O	O
.	O	O

The	O	O
second	O	O
cluster	O	O
comprised	O	O
the	O	O
other	O	O
six	O	O
soft	O	O
tissue	O	O
surfaces	O	O
.	O	O

Species	O	O
on	O	O
the	O	O
denture	O	O
palate	O	O
formed	O	O
a	O	O
third	O	O
cluster	O	O
.	O	O

One	O	O
of	O	O
the	O	O
major	O	O
findings	O	O
in	O	O
this	O	O
study	O	O
was	O	O
the	O	O
detection	O	O
of	O	O
periodontal	O	O
pathogens	O	O
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
in	O	O
the	O	O
edentulous	O	O
subjects	O	O
,	O	O
as	O	O
these	O	O
species	O	O
were	O	O
thought	O	O
to	O	O
disappear	O	O
after	O	O
removal	O	O
of	O	O
all	O	O
natural	O	O
teeth	O	O
.	O	O

This	O	O
finding	O	O
has	O	O
implications	O	O
regarding	O	O
future	O	O
dental	O	O
treatment	O	O
and	O	O
the	O	O
general	O	O
health	O	O
of	O	O
individuals	O	O
.	O	O

Distinct	O	O
patterns	O	O
of	O	O
microbial	O	O
colonization	O	O
were	O	O
seen	O	O
on	O	O
the	O	O
different	O	O
soft	O	O
tissue	O	O
surfaces	O	O
.	O	O

Thus	O	O
,	O	O
this	O	O
investigation	O	O
provided	O	O
the	O	O
first	O	O
step	O	O
in	O	O
defining	O	O
the	O	O
organisms	O	O
that	O	O
are	O	O
associated	O	O
with	O	O
edentulous	O	O
patients	O	O
on	O	O
both	O	O
soft	O	O
(	O	O
mucosa	O	O
)	O	O
and	O	O
hard	O	O
surfaces	O	O
(	O	O
denture	O	O
)	O	O
.	O	O

The	O	O
study	O	O
also	O	O
provided	O	O
meaningful	O	O
data	O	O
that	O	O
described	O	O
microbial	O	O
ecological	O	O
relationships	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
edentulous	O	O
subjects	O	O
.	O	O

The	O	O
authors	O	O
believe	O	O
that	O	O
this	O	O
study	O	O
is	O	O
the	O	O
first	O	O
comprehensive	O	O
assessment	O	O
of	O	O
the	O	O
microbiota	O	O
in	O	O
the	O	O
complete	O	O
denture-wearing	O	O
subject	O	O
.	O	O

To	O	O
examine	O	O
phylogenetic	O	O
identity	O	O
and	O	O
metabolic	O	O
activity	O	O
of	O	O
individual	O	O
cells	O	O
in	O	O
complex	O	O
microbial	O	O
communities	O	O
,	O	O
we	O	O
developed	O	O
a	O	O
method	O	O
which	O	O
combines	O	O
rRNA-based	O	O
in	O	O
situ	O	O
hybridization	O	O
with	O	O
stable	O	O
isotope	O	O
imaging	O	O
based	O	O
on	O	O
nanometer-scale	O	O
secondary-ion	O	O
mass	O	O
spectrometry	O	O
(	O	O
NanoSIMS	O	O
)	O	O
.	O	O

Fluorine	O	O
or	O	O
bromine	O	O
atoms	O	O
were	O	O
introduced	O	O
into	O	O
cells	O	O
via	O	O
16S	O	O
rRNA-targeted	O	O
probes	O	O
,	O	O
which	O	O
enabled	O	O
phylogenetic	O	O
identification	O	O
of	O	O
individual	O	O
cells	O	O
by	O	O
NanoSIMS	O	O
imaging	O	O
.	O	O

To	O	O
overcome	O	O
the	O	O
natural	O	O
fluorine	O	O
and	O	O
bromine	O	O
backgrounds	O	O
,	O	O
we	O	O
modified	O	O
the	O	O
current	O	O
catalyzed	O	O
reporter	O	O
deposition	O	O
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
technique	O	O
by	O	O
using	O	O
halogen-containing	O	O
fluorescently	O	O
labeled	O	O
tyramides	O	O
as	O	O
substrates	O	O
for	O	O
the	O	O
enzymatic	O	O
tyramide	O	O
deposition	O	O
.	O	O

Thereby	O	O
,	O	O
we	O	O
obtained	O	O
an	O	O
enhanced	O	O
element	O	O
labeling	O	O
of	O	O
microbial	O	O
cells	O	O
by	O	O
FISH	O	O
(	O	O
EL-FISH	O	O
)	O	O
.	O	O

The	O	O
relative	O	O
cellular	O	O
abundance	O	O
of	O	O
fluorine	O	O
or	O	O
bromine	O	O
after	O	O
EL-FISH	O	O
exceeded	O	O
natural	O	O
background	O	O
concentrations	O	O
by	O	O
up	O	O
to	O	O
180-fold	O	O
and	O	O
allowed	O	O
us	O	O
to	O	O
distinguish	O	O
target	O	O
from	O	O
non-target	O	O
cells	O	O
in	O	O
NanoSIMS	O	O
fluorine	O	O
or	O	O
bromine	O	O
images	O	O
.	O	O

The	O	O
method	O	O
was	O	O
optimized	O	O
on	O	O
single	O	O
cells	O	O
of	O	O
axenic	B-bacteria	B-bacteria
Escherichia	I-bacteria	I-bacteria
coli	E-bacteria	I-bacteria
and	O	O
Vibrio	B-bacteria	B-bacteria
cholerae	E-bacteria	I-bacteria
cultures	O	O
.	O	O

EL-FISH/NanoSIMS	O	O
was	O	O
then	O	O
applied	O	O
to	O	O
study	O	O
interrelationships	O	O
in	O	O
a	O	O
dual-species	O	O
consortium	O	O
consisting	O	O
of	O	O
a	O	O
filamentous	B-bacteria	B-bacteria
cyanobacterium	E-bacteria	I-bacteria
and	O	O
a	O	O
heterotrophic	B-bacteria	B-bacteria
alphaproteobacterium	E-bacteria	I-bacteria
.	O	O

We	O	O
also	O	O
evaluated	O	O
the	O	O
method	O	O
on	O	O
complex	O	O
microbial	O	O
aggregates	O	O
obtained	O	O
from	O	O
human	O	O
oral	O	O
biofilms	O	O
.	O	O

In	O	O
both	O	O
samples	O	O
,	O	O
we	O	O
found	O	O
evidence	O	O
for	O	O
metabolic	O	O
interactions	O	O
by	O	O
visualizing	O	O
the	O	O
fate	O	O
of	O	O
substrates	O	O
labeled	O	O
with	O	O
(	O	O
13	O	O
)	O	O
C-carbon	O	O
and	O	O
(	O	O
15	O	O
)	O	O
N-nitrogen	O	O
,	O	O
while	O	O
individual	O	O
cells	O	O
were	O	O
identified	O	O
simultaneously	O	O
by	O	O
halogen	O	O
labeling	O	O
via	O	O
EL-FISH	O	O
.	O	O

Our	O	O
novel	O	O
approach	O	O
will	O	O
facilitate	O	O
further	O	O
studies	O	O
of	O	O
the	O	O
ecophysiology	O	O
of	O	O
known	O	O
and	O	O
uncultured	O	O
microorganisms	O	O
in	O	O
complex	O	O
environments	O	O
and	O	O
communities	O	O
.	O	O

Studies	O	O
have	O	O
suggested	O	O
that	O	O
oral	O	O
bone	O	O
loss	O	O
is	O	O
independently	O	O
influenced	O	O
by	O	O
local	O	O
and	O	O
systemic	O	O
factors	O	O
,	O	O
including	O	O
osteoporosis	O	O
.	O	O

This	O	O
cross-sectional	O	O
study	O	O
of	O	O
1256	O	O
post-menopausal	O	O
women	O	O
,	O	O
recruited	O	O
from	O	O
the	O	O
Buffalo	O	O
center	O	O
of	O	O
the	O	O
Women	O	O
's	O	O
Health	O	O
Initiative	O	O
Observational	O	O
Study	O	O
,	O	O
evaluated	O	O
the	O	O
influence	O	O
of	O	O
oral	O	O
infection	O	O
and	O	O
age	O	O
on	O	O
the	O	O
associations	O	O
between	O	O
osteoporosis	O	O
and	O	O
oral	O	O
bone	O	O
loss	O	O
.	O	O

Systemic	O	O
bone	O	O
density	O	O
was	O	O
measured	O	O
by	O	O
dual-energy	O	O
x-ray	O	O
absorptiometry	O	O
.	O	O

Alveolar	O	O
crestal	O	O
height	O	O
was	O	O
measured	O	O
from	O	O
standardized	O	O
dental	O	O
radiographs	O	O
.	O	O

Oral	O	O
infection	O	O
was	O	O
assessed	O	O
from	O	O
subgingival	O	O
plaque	O	O
samples	O	O
.	O	O

Total	O	O
forearm	O	O
density	O	O
[	O	O
beta	O	O
(	O	O
SE	O	O
)	O	O
=	O	O
-0.931	O	O
(	O	O
0.447	O	O
)	O	O
,	O	O
p=0.038	O	O
]	O	O
and	O	O
presence	O	O
of	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
[	O	O
beta	O	O
(	O	O
SE	O	O
)	O	O
=0.125	O	O
(	O	O
0.051	O	O
)	O	O
,	O	O
p=0.015	O	O
]	O	O
were	O	O
independently	O	O
associated	O	O
with	O	O
mean	O	O
alveolar	O	O
height	O	O
among	O	O
women	O	O
aged	O	O
<	O	O
70	O	O
years	O	O
after	O	O
confounder	O	O
adjustment	O	O
.	O	O

Women	O	O
aged	O	O
70+	O	O
years	O	O
had	O	O
worse	O	O
oral	O	O
bone	O	O
loss	O	O
,	O	O
in	O	O
general	O	O
,	O	O
but	O	O
neither	O	O
bone	O	O
density	O	O
nor	O	O
oral	O	O
infection	O	O
was	O	O
significantly	O	O
associated	O	O
with	O	O
mean	O	O
alveolar	O	O
height	O	O
in	O	O
this	O	O
age	O	O
group	O	O
.	O	O

Systemic	O	O
bone	O	O
density	O	O
and	O	O
oral	O	O
infection	O	O
independently	O	O
influenced	O	O
oral	O	O
bone	O	O
loss	O	O
in	O	O
post-menopausal	O	O
women	O	O
aged	O	O
<	O	O
70	O	O
years	O	O
.	O	O

Systemic	O	O
infection	O	O
with	O	O
HIV	O	O
occurs	O	O
infrequently	O	O
through	O	O
the	O	O
oral	O	O
route	O	O
.	O	O

The	O	O
frequency	O	O
of	O	O
occurrence	O	O
may	O	O
be	O	O
increased	O	O
by	O	O
concomitant	O	O
bacterial	O	O
infection	O	O
of	O	O
the	O	O
oral	O	O
tissues	O	O
,	O	O
since	O	O
co-infection	O	O
and	O	O
inflammation	O	O
of	O	O
some	O	O
cell	O	O
types	O	O
increases	O	O
HIV-1	O	O
replication	O	O
.	O	O

A	O	O
putative	O	O
periodontal	O	O
pathogen	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
selectively	O	O
up-regulates	O	O
expression	O	O
of	O	O
the	O	O
HIV-1	O	O
coreceptor	O	O
CCR5	O	O
on	O	O
oral	O	O
keratinocytes	O	O
.	O	O

We	O	O
,	O	O
therefore	O	O
,	O	O
hypothesized	O	O
that	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
modulates	O	O
the	O	O
outcome	O	O
of	O	O
HIV	O	O
infection	O	O
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Oral	O	O
and	O	O
tonsil	O	O
epithelial	O	O
cells	O	O
were	O	O
pre-incubated	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
inoculated	O	O
with	O	O
either	O	O
an	O	O
X4-	O	O
or	O	O
R5-type	O	O
HIV-1	O	O
.	O	O

Between	O	O
6	O	O
and	O	O
48	O	O
hours	O	O
post-inoculation	O	O
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
selectively	O	O
increased	O	O
the	O	O
infectivity	O	O
of	O	O
R5-tropic	O	O
HIV-1	O	O
from	O	O
oral	O	O
and	O	O
tonsil	O	O
keratinocytes	O	O
;	O	O
infectivity	O	O
of	O	O
X4-tropic	O	O
HIV-1	O	O
remained	O	O
unchanged	O	O
.	O	O

Oral	O	O
keratinocytes	O	O
appeared	O	O
to	O	O
harbor	O	O
infectious	O	O
HIV-1	O	O
,	O	O
with	O	O
no	O	O
evidence	O	O
of	O	O
productive	O	O
infection	O	O
.	O	O

HIV-1	O	O
was	O	O
harbored	O	O
at	O	O
highest	O	O
levels	O	O
during	O	O
the	O	O
first	O	O
6	O	O
hours	O	O
after	O	O
HIV	O	O
exposure	O	O
and	O	O
decreased	O	O
to	O	O
barely	O	O
detectable	O	O
levels	O	O
at	O	O
48	O	O
hours	O	O
.	O	O

HIV	O	O
did	O	O
not	O	O
appear	O	O
to	O	O
co-localize	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
which	O	O
increased	O	O
selective	O	O
R5-tropic	O	O
HIV-1	O	O
trans	O	O
infection	O	O
from	O	O
keratinocytes	O	O
to	O	O
permissive	O	O
cells	O	O
.	O	O

When	O	O
CCR5	O	O
was	O	O
selectively	O	O
blocked	O	O
,	O	O
HIV-1	O	O
trans	O	O
infection	O	O
was	O	O
reduced	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
up-regulation	O	O
of	O	O
CCR5	O	O
increases	O	O
trans	O	O
infection	O	O
of	O	O
harbored	O	O
R5-tropic	O	O
HIV-1	O	O
from	O	O
oral	O	O
keratinocytes	O	O
to	O	O
permissive	O	O
cells	O	O
.	O	O

Oral	O	O
infections	O	O
such	O	O
as	O	O
periodontitis	O	O
may	O	O
,	O	O
therefore	O	O
,	O	O
increase	O	O
risk	O	O
for	O	O
oral	O	O
infection	O	O
and	O	O
dissemination	O	O
of	O	O
R5-tropic	O	O
HIV-1	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
investigate	O	O
the	O	O
prevalence	O	O
and	O	O
levels	O	O
of	O	O
salivary	O	O
microorganisms	O	O
in	O	O
HIV-positive	O	O
children	O	O
,	O	O
and	O	O
their	O	O
correlation	O	O
to	O	O
HIV	O	O
status	O	O
,	O	O
oral	O	O
lesions	O	O
,	O	O
and	O	O
salivary	O	O
IgA	O	O
levels	O	O
.	O	O

Forty-two	O	O
HIV-positive	O	O
and	O	O
36	O	O
control	O	O
children	O	O
were	O	O
clinically	O	O
examined	O	O
,	O	O
had	O	O
their	O	O
saliva	O	O
collected	O	O
and	O	O
processed	O	O
for	O	O
the	O	O
microbiological	O	O
analysis	O	O
of	O	O
38	O	O
bacterial	O	O
taxa	O	O
by	O	O
the	O	O
checkerboard	O	O
method	O	O
,	O	O
and	O	O
salivary	O	O
IgA	O	O
quantification	O	O
by	O	O
ELISA	O	O
.	O	O

The	O	O
majority	O	O
of	O	O
the	O	O
species	O	O
tested	O	O
were	O	O
more	O	O
prevalent	O	O
in	O	O
control	O	O
children	O	O
than	O	O
in	O	O
the	O	O
HIV	O	O
group	O	O
.	O	O

Mean	O	O
concentration	O	O
of	O	O
total	O	O
salivary	O	O
IgA	O	O
was	O	O
similar	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

High	O	O
levels	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
were	O	O
found	O	O
in	O	O
children	O	O
with	O	O
cheilitis	O	O
and	O	O
herpes	O	O
.	O	O

Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
Corrodens	E-bacteria	I-bacteria
,	O	O
and	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
were	O	O
prevalent	O	O
in	O	O
children	O	O
with	O	O
gingivitis	O	O
,	O	O
while	O	O
Fusobacterium	B-bacteria	B-bacteria
periodonticum	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
were	O	O
significantly	O	O
more	O	O
frequent	O	O
in	O	O
children	O	O
with	O	O
no	O	O
oral	O	O
lesions	O	O
.	O	O

Significant	O	O
negative	O	O
correlations	O	O
between	O	O
salivary	O	O
IgA	O	O
levels	O	O
and	O	O
Eubacterium	B-bacteria	B-bacteria
nodatum	E-bacteria	I-bacteria
and	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
observed	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

HIV-seropositive	O	O
children	O	O
presented	O	O
significantly	O	O
lower	O	O
prevalence	O	O
and	O	O
levels	O	O
of	O	O
several	O	O
bacterial	O	O
species	O	O
in	O	O
saliva	O	O
;	O	O
HIV-positive	O	O
children	O	O
are	O	O
able	O	O
to	O	O
mount	O	O
a	O	O
mucosal	O	O
immune	O	O
response	O	O
;	O	O
HIV-seropositive	O	O
children	O	O
under	O	O
highly	O	O
active	O	O
antiretroviral	O	O
therapy	O	O
presented	O	O
low	O	O
prevalence	O	O
of	O	O
oral	O	O
lesions	O	O
.	O	O

Viral	O	O
and	O	O
bacterial	O	O
associations	O	O
appear	O	O
to	O	O
be	O	O
implicated	O	O
in	O	O
the	O	O
development	O	O
of	O	O
periodontal	O	O
infections	O	O
.	O	O

Little	O	O
information	O	O
is	O	O
available	O	O
describing	O	O
the	O	O
periodontopathic	O	O
agents	O	O
in	O	O
root	O	O
canals	O	O
with	O	O
necrotic	O	O
pulp	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
occurrence	O	O
and	O	O
the	O	O
combinations	O	O
among	O	O
herpes	O	O
simplex	O	O
virus	O	O
type	O	O
1	O	O
(	O	O
HSV-1	O	O
)	O	O
and	O	O
Dialister	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
in	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
and	O	O
necrotic	O	O
pulp	O	O
were	O	O
evaluated	O	O
.	O	O

Clinical	O	O
samples	O	O
from	O	O
healthy	O	O
subjects	O	O
and	O	O
patients	O	O
with	O	O
periodontal	O	O
or	O	O
pulp	O	O
infections	O	O
were	O	O
analyzed	O	O
using	O	O
a	O	O
nested	O	O
polymeras	O	O
chain	O	O
reaction	O	O
PCR	O	O
to	O	O
detect	O	O
HSV	O	O
and	O	O
PCR	O	O
to	O	O
detect	O	O
the	O	O
3	O	O
periodontal	O	O
bacteria	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
was	O	O
observed	O	O
in	O	O
healthy	O	O
,	O	O
chronic	O	O
periodontitis	O	O
,	O	O
and	O	O
necrotic	O	O
pulp	O	O
patients	O	O
.	O	O

HSV	O	O
was	O	O
observed	O	O
in	O	O
periodontitis	O	O
and	O	O
necrotic	O	O
pulp	O	O
patients	O	O
,	O	O
and	O	O
no	O	O
healthy	O	O
subject	O	O
harbored	O	O
D.	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
or	O	O
HSV	O	O
.	O	O

The	O	O
occurrence	O	O
of	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
was	O	O
not	O	O
statistically	O	O
significant	O	O
in	O	O
patients	O	O
with	O	O
necrotic	O	O
pulp	O	O
(	O	O
P	O	O
=	O	O
0.704	O	O
)	O	O
.	O	O

Periodontal	O	O
bacteria	O	O
were	O	O
observed	O	O
varying	O	O
from	O	O
10.3	O	O
%	O	O
to	O	O
20.7	O	O
%	O	O
in	O	O
chronic	O	O
periodontitis	O	O
and	O	O
necrotic	O	O
pulp	O	O
patients	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
Treponema	O	O
denticola	O	O
-	O	O
HSV	O	O
association	O	O
was	O	O
predominant	O	O
in	O	O
patients	O	O
showing	O	O
necrotic	O	O
pulp	O	O
(	O	O
24.1	O	O
%	O	O
)	O	O
;	O	O
however	O	O
,	O	O
HSV	O	O
alone	O	O
was	O	O
observed	O	O
in	O	O
one	O	O
patient	O	O
with	O	O
periodontitis	O	O
and	O	O
in	O	O
another	O	O
patient	O	O
with	O	O
necrotic	O	O
pulp	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
double	O	O
association	O	O
among	O	O
bacteria	O	O
or	O	O
bacteria	O	O
-	O	O
HSV	O	O
could	O	O
indicate	O	O
a	O	O
role	O	O
in	O	O
both	O	O
periodontitis	O	O
and	O	O
necrotic	O	O
pulp	O	O
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
-	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
-	O	O
HSV	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
-	O	O
D.	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
-	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
-	O	O
HSV	O	O
associations	O	O
might	O	O
be	O	O
important	O	O
in	O	O
periodontitis	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
influence	O	O
of	O	O
doxycycline	O	O
therapy	O	O
on	O	O
the	O	O
composition	O	O
and	O	O
antibiotic	O	O
susceptibility	O	O
of	O	O
intestinal	B-bacteria	B-bacteria
bifidobacteria	E-bacteria	I-bacteria
.	O	O

Faecal	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
nine	O	O
subjects	O	O
receiving	O	O
doxycycline	O	O
therapy	O	O
and	O	O
ten	O	O
control	O	O
subjects	O	O
,	O	O
and	O	O
analysed	O	O
for	O	O
bifidobacteria	B-bacteria	B-bacteria
by	O	O
culturing	O	O
and	O	O
PCR-DGGE	O	O
(	O	O
denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
)	O	O
.	O	O

A	O	O
marked	O	O
decrease	O	O
in	O	O
the	O	O
diversity	O	O
(	O	O
average	O	O
number	O	O
of	O	O
amplicons	O	O
detected	O	O
by	O	O
PCR-DGGE	O	O
0.8	O	O
in	O	O
the	O	O
antibiotic	O	O
vs	O	O
4.3	O	O
in	O	O
the	O	O
control	O	O
group	O	O
)	O	O
of	O	O
Bifidobacterium	B-bacteria	B-bacteria
populations	O	O
was	O	O
observed	O	O
during	O	O
doxycycline	O	O
therapy	O	O
.	O	O

The	O	O
proportion	O	O
of	O	O
a	O	O
tetracycline-resistant	O	O
bifidobacterial	O	O
population	O	O
was	O	O
higher	O	O
in	O	O
the	O	O
antibiotic	O	O
group	O	O
than	O	O
in	O	O
the	O	O
control	O	O
group	O	O
(	O	O
83	O	O
%	O	O
vs	O	O
26	O	O
%	O	O
)	O	O
.	O	O

Based	O	O
on	O	O
the	O	O
tet	O	O
gene	O	O
PCR	O	O
,	O	O
resistance	O	O
could	O	O
be	O	O
associated	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
tet	O	O
(	O	O
W	O	O
)	O	O
.	O	O

In	O	O
two	O	O
subjects	O	O
,	O	O
strains	O	O
representing	O	O
highly	O	O
similar	O	O
genetic	O	O
fingerprints	O	O
but	O	O
different	O	O
tetracycline	O	O
susceptibilities	O	O
were	O	O
detected	O	O
.	O	O

A	O	O
mutation	O	O
causing	O	O
lack	O	O
of	O	O
functionality	O	O
in	O	O
the	O	O
tet	O	O
(	O	O
W	O	O
)	O	O
was	O	O
observed	O	O
in	O	O
one	O	O
of	O	O
the	O	O
susceptible	O	O
strains	O	O
.	O	O

Doxycycline	O	O
therapy	O	O
had	O	O
a	O	O
drastic	O	O
effect	O	O
on	O	O
the	O	O
diversity	O	O
and	O	O
tetracycline	O	O
susceptibility	O	O
of	O	O
intestinal	B-bacteria	B-bacteria
Bifidobacterium	E-bacteria	I-bacteria
populations	O	O
.	O	O

The	O	O
use	O	O
of	O	O
broad-spectrum	O	O
antibiotics	O	O
increased	O	O
the	O	O
pool	O	O
of	O	O
tetracycline-resistant	O	O
commensal	O	O
bacteria	O	O
in	O	O
the	O	O
intestine	O	O
.	O	O

The	O	O
detection	O	O
of	O	O
resistance	O	O
genes	O	O
alone	O	O
is	O	O
not	O	O
sufficient	O	O
for	O	O
the	O	O
evaluation	O	O
of	O	O
bacterial	O	O
antibiotic	O	O
resistance	O	O
.	O	O

Model	O	O
systems	O	O
with	O	O
oral	O	O
bacteria	O	O
from	O	O
dental	O	O
plaque	O	O
have	O	O
demonstrated	O	O
that	O	O
the	O	O
utilization	O	O
of	O	O
complex	O	O
glycoproteins	O	O
as	O	O
a	O	O
food	O	O
source	O	O
can	O	O
not	O	O
be	O	O
undertaken	O	O
by	O	O
single	O	O
species	O	O
but	O	O
requires	O	O
concerted	O	O
degradation	O	O
by	O	O
a	O	O
multi-species	O	O
consortium	O	O
,	O	O
with	O	O
each	O	O
member	O	O
contributing	O	O
one	O	O
or	O	O
a	O	O
few	O	O
hydrolytic	O	O
enzymes	O	O
.	O	O

Unlike	O	O
previous	O	O
studies	O	O
,	O	O
the	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
investigation	O	O
was	O	O
to	O	O
explore	O	O
the	O	O
ability	O	O
of	O	O
fresh	O	O
dental	O	O
plaque	O	O
to	O	O
degrade	O	O
salivary	O	O
mucin	O	O
,	O	O
MUC5B	O	O
,	O	O
isolated	O	O
by	O	O
methods	O	O
designed	O	O
to	O	O
retain	O	O
intact	O	O
the	O	O
natural	O	O
polymeric	O	O
structure	O	O
and	O	O
physiological	O	O
conformation	O	O
,	O	O
in	O	O
an	O	O
attempt	O	O
to	O	O
mimic	O	O
the	O	O
naturally	O	O
occurring	O	O
interaction	O	O
between	O	O
the	O	O
oral	O	O
microbiota	O	O
and	O	O
salivary	O	O
mucins	O	O
.	O	O

Human	O	O
salivary	O	O
MUC5B	O	O
was	O	O
isolated	O	O
from	O	O
whole	O	O
saliva	O	O
by	O	O
density-gradient	O	O
centrifugation	O	O
and	O	O
incubated	O	O
with	O	O
freshly	O	O
isolated	O	O
supragingival	O	O
dental	O	O
plaque	O	O
with	O	O
samples	O	O
subjected	O	O
to	O	O
fluorescent	O	O
staining	O	O
for	O	O
viability	O	O
and	O	O
metabolic	O	O
activity	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
degradation	O	O
of	O	O
MUC5B	O	O
oligosaccharide	O	O
side	O	O
chains	O	O
was	O	O
studied	O	O
using	O	O
a	O	O
lectin	O	O
assay	O	O
,	O	O
recognizing	O	O
three	O	O
different	O	O
carbohydrate	O	O
epitopes	O	O
commonly	O	O
found	O	O
on	O	O
mucin	O	O
oligosaccharide	O	O
side	O	O
chains	O	O
.	O	O

The	O	O
addition	O	O
of	O	O
purified	O	O
salivary	O	O
MUC5B	O	O
elicited	O	O
a	O	O
strong	O	O
metabolic	O	O
response	O	O
from	O	O
the	O	O
biofilm	O	O
cells	O	O
,	O	O
whereas	O	O
individual	O	O
strains	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
same	O	O
plaque	O	O
were	O	O
not	O	O
able	O	O
to	O	O
utilize	O	O
the	O	O
MUC5B	O	O
.	O	O

The	O	O
degradation	O	O
of	O	O
terminal	O	O
saccharide	O	O
moieties	O	O
on	O	O
the	O	O
MUC5B	O	O
was	O	O
demonstrated	O	O
by	O	O
a	O	O
marked	O	O
decrease	O	O
in	O	O
both	O	O
sialic	O	O
acid	O	O
and	O	O
fucose	O	O
reactivity	O	O
.	O	O

These	O	O
results	O	O
have	O	O
shown	O	O
that	O	O
dental	O	O
plaque	O	O
is	O	O
capable	O	O
of	O	O
utilizing	O	O
human	O	O
salivary	O	O
MUC5B	O	O
as	O	O
a	O	O
nutrient	O	O
source	O	O
,	O	O
a	O	O
process	O	O
possibly	O	O
requiring	O	O
the	O	O
synergistic	O	O
degradation	O	O
of	O	O
the	O	O
molecule	O	O
by	O	O
a	O	O
consortium	O	O
of	O	O
oral	O	O
bacteria	O	O
in	O	O
the	O	O
plaque	O	O
community	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
BGHO1	E-bacteria	I-bacteria
,	O	O
a	O	O
human	O	O
oral	O	O
isolate	O	O
with	O	O
antagonistic	O	O
activity	O	O
against	O	O
growth	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
Micrococcus	E-bacteria	I-bacteria
flavus	E-bacteria	I-bacteria
,	O	O
and	O	O
Salmonella	B-bacteria	B-bacteria
enteritidis	E-bacteria	I-bacteria
,	O	O
probably	O	O
produces	O	O
more	O	O
than	O	O
one	O	O
proteinaceous	O	O
antimicrobial	O	O
substance	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
the	O	O
purification	O	O
of	O	O
a	O	O
bacteriocin	O	O
,	O	O
named	O	O
LS1	O	O
,	O	O
produced	O	O
by	O	O
L.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
BGHO1	E-bacteria	I-bacteria
.	O	O

A	O	O
simple	O	O
and	O	O
fast	O	O
procedure	O	O
for	O	O
bacteriocin	O	O
purification	O	O
was	O	O
developed	O	O
,	O	O
consisting	O	O
of	O	O
reverse-phase	O	O
chromatography	O	O
of	O	O
the	O	O
ammonium	O	O
sulfate	O	O
precipitate	O	O
of	O	O
cell-free	O	O
culture	O	O
supernatant	O	O
by	O	O
fast	O	O
protein	O	O
liquid	O	O
chromatography	O	O
and	O	O
high-performance	O	O
liquid	O	O
chromatography	O	O
,	O	O
followed	O	O
by	O	O
tricine	O	O
sodium	O	O
dodecyl	O	O
sulfate-polyacrylamide	O	O
gel	O	O
electrophoresis	O	O
(	O	O
SDS-PAGE	O	O
)	O	O
,	O	O
with	O	O
the	O	O
subsequent	O	O
extraction	O	O
of	O	O
bacteriocin	O	O
from	O	O
the	O	O
gel	O	O
.	O	O

The	O	O
supernatant	O	O
of	O	O
L.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
BGHO1	E-bacteria	I-bacteria
culture	O	O
retained	O	O
its	O	O
antimicrobial	O	O
activity	O	O
after	O	O
boiling	O	O
in	O	O
a	O	O
water	O	O
bath	O	O
for	O	O
15	O	O
min	O	O
.	O	O

Its	O	O
antimicrobial	O	O
activity	O	O
was	O	O
also	O	O
maintained	O	O
even	O	O
after	O	O
treatment	O	O
for	O	O
20	O	O
min	O	O
at	O	O
121	O	O
degrees	O	O
C	O	O
in	O	O
an	O	O
autoclave	O	O
.	O	O

Bacteriocin	O	O
LS1	O	O
was	O	O
purified	O	O
to	O	O
homogeneity	O	O
.	O	O

The	O	O
molecular	O	O
mass	O	O
of	O	O
bacteriocin	O	O
LS1	O	O
was	O	O
estimated	O	O
to	O	O
be	O	O
approximately	O	O
10	O	O
kDa	O	O
,	O	O
based	O	O
on	O	O
tricine	O	O
SDS-PAGE	O	O
.	O	O

During	O	O
purification	O	O
,	O	O
another	O	O
compound	O	O
with	O	O
antimicrobial	O	O
activity	O	O
,	O	O
produced	O	O
by	O	O
L.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
BGHO1	E-bacteria	I-bacteria
,	O	O
was	O	O
detected	O	O
.	O	O

The	O	O
molecular	O	O
mass	O	O
of	O	O
this	O	O
compound	O	O
was	O	O
estimated	O	O
to	O	O
be	O	O
approximately	O	O
5	O	O
kDa	O	O
,	O	O
based	O	O
on	O	O
tricine	O	O
SDS-PAGE	O	O
.	O	O

Our	O	O
results	O	O
imply	O	O
that	O	O
LS1	O	O
is	O	O
most	O	O
probably	O	O
a	O	O
new	O	O
bacteriocin	O	O
,	O	O
different	O	O
from	O	O
previously	O	O
described	O	O
bacteriocins	O	O
produced	O	O
by	O	O
L.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

The	O	O
purification	O	O
of	O	O
bacteriocin	O	O
LS1	O	O
enabled	O	O
the	O	O
further	O	O
characterization	O	O
of	O	O
LS1	O	O
on	O	O
both	O	O
the	O	O
molecular	O	O
and	O	O
genetic	O	O
levels	O	O
.	O	O

Bacteraemia	O	O
,	O	O
defined	O	O
as	O	O
the	O	O
presence	O	O
of	O	O
viable	O	O
bacteria	O	O
in	O	O
the	O	O
circulating	O	O
blood	O	O
can	O	O
result	O	O
in	O	O
bloodstream	O	O
infection	O	O
,	O	O
which	O	O
is	O	O
one	O	O
of	O	O
the	O	O
most	O	O
frequent	O	O
and	O	O
challenging	O	O
hospital-acquired	O	O
infections	O	O
.	O	O

Bacteraemia	B-bacteria	B-bacteria
occurs	O	O
in	O	O
healthy	O	O
populations	O	O
with	O	O
manipulation	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
,	O	O
including	O	O
toothbrushing	O	O
.	O	O

Oral	O	O
care	O	O
is	O	O
commonly	O	O
administered	O	O
to	O	O
mechanically	O	O
ventilated	O	O
patients	O	O
,	O	O
it	O	O
is	O	O
important	O	O
to	O	O
determine	O	O
whether	O	O
this	O	O
practice	O	O
contributes	O	O
to	O	O
the	O	O
incidence	O	O
of	O	O
bacteraemia	O	O
.	O	O

This	O	O
paper	O	O
reviews	O	O
the	O	O
literature	O	O
on	O	O
the	O	O
link	O	O
between	O	O
the	O	O
manipulation	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
development	O	O
of	O	O
bacteraemia	O	O
in	O	O
mechanically	O	O
ventilated	O	O
adults	O	O
.	O	O

Searches	O	O
were	O	O
conducted	O	O
using	O	O
Medline	O	O
,	O	O
and	O	O
the	O	O
Cochrane	O	O
Library	O	O
databases	O	O
.	O	O

Article	O	O
inclusion	O	O
criteria	O	O
were	O	O
(	O	O
1	O	O
)	O	O
a	O	O
focus	O	O
on	O	O
mechanical	O	O
ventilation	O	O
and	O	O
critical	O	O
illness	O	O
,	O	O
(	O	O
2	O	O
)	O	O
human	O	O
subjects	O	O
,	O	O
(	O	O
3	O	O
)	O	O
adult	O	O
subjects	O	O
,	O	O
and	O	O
(	O	O
4	O	O
)	O	O
publication	O	O
in	O	O
English	O	O
(	O	O
or	O	O
available	O	O
English	O	O
translation	O	O
)	O	O
.	O	O

Nine	O	O
articles	O	O
met	O	O
inclusion	O	O
criteria	O	O
and	O	O
were	O	O
critiqued	O	O
.	O	O

All	O	O
relied	O	O
upon	O	O
clinical	O	O
data	O	O
as	O	O
outcome	O	O
measures	O	O
;	O	O
many	O	O
were	O	O
retrospective	O	O
.	O	O

The	O	O
three	O	O
organisms	O	O
most	O	O
often	O	O
associated	O	O
with	O	O
nosocomial	O	O
bloodstream	O	O
infections	O	O
were	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
coagulase	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
staphylococci	E-bacteria	I-bacteria
,	O	O
and	O	O
Enterococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Establishing	O	O
the	O	O
origin	O	O
of	O	O
bacteraemia	O	O
was	O	O
problematic	O	O
in	O	O
most	O	O
studies	O	O
.	O	O

Additional	O	O
research	O	O
is	O	O
needed	O	O
to	O	O
understand	O	O
the	O	O
relationship	O	O
of	O	O
oral	O	O
care	O	O
practices	O	O
to	O	O
bacteraemia	O	O
in	O	O
mechanically	O	O
ventilated	O	O
adults	O	O
.	O	O

Evidence	O	O
is	O	O
accumulating	O	O
that	O	O
oral	O	O
bacteria	O	O
are	O	O
associated	O	O
with	O	O
myocardial	O	O
infarctions	O	O
(	O	O
MI	O	O
)	O	O
.	O	O

We	O	O
were	O	O
interested	O	O
in	O	O
studying	O	O
the	O	O
differences	O	O
in	O	O
the	O	O
association	O	O
between	O	O
single	O	O
bacteria	O	O
or	O	O
bacteria	O	O
in	O	O
combination	O	O
and	O	O
the	O	O
relation	O	O
to	O	O
C-reactive	O	O
protein	O	O
(	O	O
CRP	O	O
)	O	O
.	O	O

We	O	O
examined	O	O
the	O	O
levels	O	O
of	O	O
antibodies	O	O
against	O	O
four	O	O
major	O	O
periodontal	O	O
pathogens	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
PG	B-bacteria	B-bacteria
)	O	O
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
AA	B-bacteria	B-bacteria
)	O	O
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
TF	B-bacteria	B-bacteria
)	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
(	O	O
TD	B-bacteria	B-bacteria
)	O	O
and	O	O
CRP	O	O
in	O	O
548	O	O
men	O	O
with	O	O
a	O	O
self-reported	O	O
history	O	O
of	O	O
MI	O	O
to	O	O
625	O	O
controls	O	O
who	O	O
took	O	O
part	O	O
in	O	O
the	O	O
Oslo	O	O
II	O	O
study	O	O
in	O	O
2000	O	O
.	O	O

The	O	O
mean	O	O
levels	O	O
of	O	O
bacterial	O	O
antibodies	O	O
were	O	O
higher	O	O
for	O	O
the	O	O
cases	O	O
than	O	O
the	O	O
controls	O	O
,	O	O
but	O	O
not	O	O
significant	O	O
as	O	O
standard	O	O
deviations	O	O
were	O	O
large	O	O
.	O	O

The	O	O
level	O	O
of	O	O
CRP	O	O
was	O	O
higher	O	O
in	O	O
the	O	O
cases	O	O
than	O	O
the	O	O
controls	O	O
(	O	O
p=0.010	O	O
)	O	O
.	O	O

Logistic	O	O
regression	O	O
analyses	O	O
comparing	O	O
the	O	O
upper	O	O
quartile	O	O
value	O	O
with	O	O
the	O	O
lower	O	O
value	O	O
of	O	O
one	O	O
of	O	O
either	O	O
four	O	O
antibodies	O	O
(	O	O
anti-AA	O	O
,	O	O
anti-TF	O	O
,	O	O
anti-TD	O	O
and	O	O
anti-PG	O	O
)	O	O
were	O	O
significantly	O	O
associated	O	O
(	O	O
p=0.032	O	O
)	O	O
with	O	O
MI	O	O
.	O	O

Equivalent	O	O
analyses	O	O
of	O	O
either	O	O
three	O	O
bacteria	O	O
showed	O	O
significant	O	O
associations	O	O
for	O	O
anti-AA	O	O
,	O	O
anti-TD	O	O
and	O	O
anti-PG	O	O
(	O	O
p=0.036	O	O
)	O	O
and	O	O
anti-AA	O	O
,	O	O
anti-PG	O	O
and	O	O
anti-TF	O	O
(	O	O
p=0.040	O	O
)	O	O
.	O	O

CRP	O	O
showed	O	O
an	O	O
increased	O	O
relative	O	O
risk	O	O
with	O	O
increasing	O	O
quartile	O	O
value	O	O
;	O	O
trend	O	O
,	O	O
p=0.016	O	O
,	O	O
but	O	O
not	O	O
in	O	O
multivariate	O	O
analysis	O	O
including	O	O
the	O	O
oral	O	O
antigens	O	O
.	O	O

No	O	O
single	O	O
bacterium	O	O
but	O	O
rather	O	O
combinations	O	O
were	O	O
related	O	O
to	O	O
increasing	O	O
relative	O	O
risk	O	O
for	O	O
MI	O	O
independent	O	O
of	O	O
known	O	O
cardiovascular	O	O
risk	O	O
factors	O	O
.	O	O

To	O	O
define	O	O
the	O	O
relationship	O	O
between	O	O
salivary	O	O
SIgA	O	O
antibodies	O	O
and	O	O
commensal	O	O
oral	O	O
bacteria	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
reactivity	O	O
of	O	O
SIgA	O	O
antibodies	O	O
from	O	O
the	O	O
saliva	O	O
of	O	O
four	O	O
infants	O	O
with	O	O
their	O	O
own	O	O
colonizing	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
biovar	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
(	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
bv	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
)	O	O
clones	O	O
(	O	O
ribotypes	O	O
)	O	O
.	O	O

Immunoblot	O	O
analysis	O	O
was	O	O
used	O	O
to	O	O
examine	O	O
reactivity	O	O
of	O	O
these	O	O
antibodies	O	O
with	O	O
persistent	O	O
ribotypes	O	O
isolated	O	O
from	O	O
the	O	O
mouths	O	O
of	O	O
the	O	O
infants	O	O
over	O	O
the	O	O
first	O	O
year	O	O
postpartum	O	O
.	O	O

Results	O	O
showed	O	O
that	O	O
the	O	O
pattern	O	O
of	O	O
SIgA	O	O
antibody	O	O
reactivity	O	O
with	O	O
the	O	O
majority	O	O
of	O	O
clones	O	O
increased	O	O
in	O	O
complexity	O	O
after	O	O
colonization	O	O
but	O	O
that	O	O
most	O	O
additional	O	O
bands	O	O
were	O	O
common	O	O
to	O	O
other	O	O
clones	O	O
,	O	O
indicating	O	O
that	O	O
they	O	O
represented	O	O
shared	O	O
antigens	O	O
.	O	O

However	O	O
,	O	O
unique	O	O
bands	O	O
were	O	O
identified	O	O
in	O	O
75	O	O
%	O	O
of	O	O
the	O	O
selected	O	O
persistent	O	O
clones	O	O
.	O	O

We	O	O
hypothesized	O	O
that	O	O
if	O	O
strain-specific	O	O
SIgA	O	O
antibody	O	O
was	O	O
induced	O	O
in	O	O
response	O	O
to	O	O
colonization	O	O
of	O	O
a	O	O
particular	O	O
clone	O	O
and	O	O
contributed	O	O
to	O	O
its	O	O
elimination	O	O
from	O	O
the	O	O
mouth	O	O
,	O	O
then	O	O
the	O	O
appearance	O	O
of	O	O
unique	O	O
bands	O	O
would	O	O
immediately	O	O
precede	O	O
the	O	O
disappearance	O	O
of	O	O
the	O	O
strain	O	O
.	O	O

Seventy-three	O	O
percent	O	O
of	O	O
all	O	O
unique	O	O
bands	O	O
identified	O	O
in	O	O
the	O	O
study	O	O
fulfilled	O	O
this	O	O
criterion	O	O
.	O	O

Because	O	O
the	O	O
mouth	O	O
is	O	O
an	O	O
open	O	O
,	O	O
dynamic	O	O
environment	O	O
and	O	O
multiple	O	O
factors	O	O
are	O	O
believed	O	O
to	O	O
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
immune	O	O
response	O	O
at	O	O
mucosal	O	O
surfaces	O	O
,	O	O
it	O	O
may	O	O
not	O	O
be	O	O
possible	O	O
to	O	O
conclusively	O	O
define	O	O
the	O	O
relationship	O	O
between	O	O
SIgA	O	O
antibody	O	O
and	O	O
commensal	O	O
bacteria	O	O
.	O	O

However	O	O
,	O	O
our	O	O
data	O	O
provide	O	O
evidence	O	O
that	O	O
SIgA	O	O
antibody	O	O
,	O	O
reactive	O	O
with	O	O
unique	O	O
antigens	O	O
of	O	O
their	O	O
own	O	O
colonizing	O	O
strains	O	O
,	O	O
is	O	O
produced	O	O
in	O	O
infants	O	O
and	O	O
may	O	O
point	O	O
to	O	O
a	O	O
role	O	O
of	O	O
this	O	O
antibody	O	O
in	O	O
regulating	O	O
colonization	O	O
by	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
bv	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
.	O	O

The	O	O
effects	O	O
of	O	O
oral	O	O
commensal	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
)	O	O
on	O	O
biofilm	O	O
formation	O	O
by	O	O
cariogenic	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
)	O	O
were	O	O
investigated	O	O
.	O	O

Cell	O	O
suspensions	O	O
were	O	O
cultured	O	O
on	O	O
96-well	O	O
microtiter	O	O
plates	O	O
coated	O	O
with	O	O
or	O	O
without	O	O
salivary	O	O
components	O	O
(	O	O
SC	O	O
)	O	O
,	O	O
and	O	O
in	O	O
flow	O	O
cell	O	O
systems	O	O
coated	O	O
with	O	O
SC	O	O
in	O	O
tryptic	O	O
soy	O	O
broth	O	O
including	O	O
0.25	O	O
%	O	O
sucrose	O	O
without	O	O
dextrose	O	O
(	O	O
TSB	O	O
)	O	O
.	O	O

The	O	O
resultant	O	O
biofilm	O	O
formations	O	O
were	O	O
stained	O	O
using	O	O
safranin	O	O
or	O	O
a	O	O
LIVE/DEAD	O	O
BacLight	O	O
Viability	O	O
Kit	O	O
,	O	O
and	O	O
examined	O	O
with	O	O
absorbance	O	O
at	O	O
492	O	O
nm	O	O
or	O	O
using	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
.	O	O

Mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
biofilms	O	O
were	O	O
formed	O	O
significantly	O	O
on	O	O
the	O	O
polystyrene	O	O
surfaces	O	O
in	O	O
TSB	O	O
.	O	O

Further	O	O
,	O	O
in	O	O
combination	O	O
cultures	O	O
,	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
formed	O	O
a	O	O
sufficient	O	O
biofilm	O	O
when	O	O
cultured	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
when	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
was	O	O
cultured	O	O
with	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
biofilm	O	O
formation	O	O
was	O	O
slightly	O	O
inhibited	O	O
.	O	O

S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
also	O	O
inhibited	O	O
biofilm	O	O
formation	O	O
in	O	O
the	O	O
culture	O	O
with	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
when	O	O
cultured	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
collapsed	O	O
the	O	O
biofilm	O	O
morphology	O	O
and	O	O
inhibited	O	O
volume	O	O
development	O	O
in	O	O
some	O	O
conditions	O	O
when	O	O
cultured	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
or	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
.	O	O

Biofilm	O	O
formation	O	O
by	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
was	O	O
challenged	O	O
and	O	O
collapsed	O	O
on	O	O
the	O	O
whole	O	O
by	O	O
culturing	O	O
with	O	O
each	O	O
of	O	O
the	O	O
other	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
co-culturing	O	O
of	O	O
multiple	O	O
species	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
other	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
has	O	O
physical	O	O
effects	O	O
related	O	O
to	O	O
previous	O	O
attachment	O	O
and	O	O
colonization	O	O
on	O	O
the	O	O
surface	O	O
,	O	O
as	O	O
well	O	O
as	O	O
biological	O	O
effects	O	O
to	O	O
regulate	O	O
biofilm	O	O
formation	O	O
.	O	O

We	O	O
identified	O	O
oral	O	O
bacterial	O	O
species	O	O
in	O	O
blood	O	O
cultures	O	O
following	O	O
single-tooth	O	O
extraction	O	O
and	O	O
tooth	O	O
brushing	O	O
.	O	O

Sequence	O	O
analysis	O	O
of	O	O
16S	O	O
rRNA	O	O
genes	O	O
identified	O	O
98	O	O
different	O	O
bacterial	O	O
species	O	O
recovered	O	O
from	O	O
151	O	O
bacteremic	O	O
subjects	O	O
.	O	O

Of	O	O
interest	O	O
,	O	O
48	O	O
of	O	O
the	O	O
isolates	O	O
represented	O	O
19	O	O
novel	O	O
species	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
,	O	O
Selenomonas	B-bacteria	B-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
.	O	O

This	O	O
study	O	O
investigated	O	O
whether	O	O
an	O	O
improvement	O	O
in	O	O
periodontal	O	O
health	O	O
resulted	O	O
in	O	O
changes	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
periodontopathogenic	O	O
bacteria	O	O
in	O	O
saliva	O	O
and	O	O
tongue	O	O
coatings	O	O
and	O	O
a	O	O
reduction	O	O
in	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSCs	O	O
:	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
and	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
SH	O	O
)	O	O
linked	O	O
to	O	O
oral	O	O
malodour	O	O
.	O	O

The	O	O
subjects	O	O
were	O	O
35	O	O
patients	O	O
who	O	O
visited	O	O
the	O	O
breath	O	O
odour	O	O
clinic	O	O
of	O	O
Kyushu	O	O
Dental	O	O
College	O	O
,	O	O
Japan	O	O
.	O	O

Their	O	O
mean	O	O
age	O	O
was	O	O
51.2+/-18.3	O	O
years	O	O
(	O	O
mean+/-sd	O	O
)	O	O
.	O	O

A	O	O
clinical	O	O
examination	O	O
performed	O	O
at	O	O
baseline	O	O
and	O	O
2	O	O
months	O	O
after	O	O
periodontal	O	O
treatment	O	O
assessed	O	O
VSCs	O	O
in	O	O
mouth	O	O
air	O	O
using	O	O
gas	O	O
chromatography	O	O
,	O	O
periodontal	O	O
probing	O	O
depth	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
(	O	O
BOP	O	O
)	O	O
in	O	O
all	O	O
subjects	O	O
;	O	O
saliva	O	O
and	O	O
tongue	O	O
coatings	O	O
were	O	O
also	O	O
collected	O	O
.	O	O

Genomic	O	O
DNA	O	O
was	O	O
isolated	O	O
from	O	O
the	O	O
samples	O	O
,	O	O
and	O	O
the	O	O
proportions	O	O
of	O	O
five	O	O
periodontopathogenic	O	O
bacteria	O	O
(	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
)	O	O
were	O	O
investigated	O	O
using	O	O
quantitative	O	O
real-time	O	O
PCR	O	O
.	O	O

The	O	O
subjects	O	O
were	O	O
classified	O	O
into	O	O
four	O	O
groups	O	O
based	O	O
on	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
periodontal	O	O
pocket	O	O
of	O	O
more	O	O
than	O	O
4	O	O
mm	O	O
(	O	O
PD	O	O
)	O	O
and	O	O
VSCs	O	O
above	O	O
the	O	O
organoleptic	O	O
threshold	O	O
level	O	O
(	O	O
VSCT	O	O
)	O	O
as	O	O
follows	O	O
:	O	O
-PD/-VSCT	O	O
group	O	O
,	O	O
subjects	O	O
without	O	O
PD	O	O
or	O	O
VSCT	O	O
;	O	O
-PD/+VSCT	O	O
group	O	O
,	O	O
those	O	O
without	O	O
PD	O	O
but	O	O
with	O	O
VSCT	O	O
;	O	O
+PD/-VSCT	O	O
group	O	O
,	O	O
those	O	O
with	O	O
PD	O	O
but	O	O
without	O	O
VSCT	O	O
;	O	O
and	O	O
+PD/+VSCT	O	O
group	O	O
,	O	O
those	O	O
with	O	O
PD	O	O
and	O	O
VSCT	O	O
.	O	O

Although	O	O
the	O	O
mean	O	O
PD	O	O
values	O	O
in	O	O
the	O	O
+PD/-VSCT	O	O
and	O	O
+PD/+VSCT	O	O
groups	O	O
,	O	O
BOP	O	O
in	O	O
the	O	O
+PD/+VSCT	O	O
group	O	O
,	O	O
and	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
and	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
SH	O	O
concentrations	O	O
in	O	O
the	O	O
-PD/+VSCT	O	O
and	O	O
+PD/+VSCT	O	O
groups	O	O
were	O	O
greater	O	O
than	O	O
in	O	O
the	O	O
other	O	O
groups	O	O
at	O	O
baseline	O	O
,	O	O
we	O	O
found	O	O
no	O	O
significant	O	O
difference	O	O
among	O	O
the	O	O
four	O	O
groups	O	O
after	O	O
periodontal	O	O
treatment	O	O
.	O	O

The	O	O
proportion	O	O
of	O	O
periodontopathogenic	O	O
bacteria	O	O
in	O	O
saliva	O	O
was	O	O
higher	O	O
in	O	O
the	O	O
+PD/-VSCT	O	O
and	O	O
+PD/+VSCT	O	O
groups	O	O
than	O	O
in	O	O
the	O	O
-PD/-VSCT	O	O
and	O	O
-PD/+VSCT	O	O
groups	O	O
at	O	O
baseline	O	O
and	O	O
after	O	O
treatment	O	O
,	O	O
but	O	O
the	O	O
proportions	O	O
of	O	O
bacteria	O	O
in	O	O
saliva	O	O
after	O	O
treatment	O	O
were	O	O
reduced	O	O
compared	O	O
to	O	O
the	O	O
baseline	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
differences	O	O
in	O	O
the	O	O
proportions	O	O
of	O	O
the	O	O
five	O	O
target	O	O
bacteria	O	O
in	O	O
the	O	O
tongue	O	O
coating	O	O
were	O	O
not	O	O
as	O	O
apparent	O	O
as	O	O
those	O	O
in	O	O
saliva	O	O
at	O	O
baseline	O	O
or	O	O
after	O	O
treatment	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
periodontopathogenic	O	O
bacteria	O	O
in	O	O
saliva	O	O
may	O	O
reflect	O	O
periodontal	O	O
health	O	O
status	O	O
and	O	O
influence	O	O
VSC	O	O
levels	O	O
in	O	O
mouth	O	O
air	O	O
.	O	O

Previous	O	O
studies	O	O
have	O	O
shown	O	O
that	O	O
while	O	O
performing	O	O
the	O	O
(	O	O
14	O	O
)	O	O
C-urea	O	O
breath	O	O
test	O	O
(	O	O
(	O	O
14	O	O
)	O	O
C-UBT	O	O
)	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
)	O	O
,	O	O
there	O	O
is	O	O
possibility	O	O
of	O	O
false-positive	O	O
results	O	O
due	O	O
to	O	O
the	O	O
other	O	O
urease	B-bacteria	B-bacteria
producing	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
present	O	O
in	O	O
oropharynx	O	O
,	O	O
if	O	O
breath	O	O
samples	O	O
are	O	O
obtained	O	O
within	O	O
30	O	O
min	O	O
after	O	O
administration	O	O
of	O	O
non-capsulated	O	O
(	O	O
14	O	O
)	O	O
C-urea	O	O
.	O	O

Therefore	O	O
,	O	O
we	O	O
have	O	O
exclusively	O	O
evaluated	O	O
the	O	O
kinetics	O	O
of	O	O
(	O	O
14	O	O
)	O	O
carbon	O	O
dioxide	O	O
(	O	O
(	O	O
14	O	O
)	O	O
CO	O	O
(	O	O
2	O	O
)	O	O
)	O	O
excretion	O	O
by	O	O
oral	O	O
commensal	O	O
flora	O	O
to	O	O
theoretically	O	O
propose	O	O
optimum	O	O
breath	O	O
collection	O	O
timings	O	O
for	O	O
(	O	O
14	O	O
)	O	O
C-UBT	O	O
.	O	O

Multiple	O	O
breath	O	O
samples	O	O
up	O	O
to	O	O
15	O	O
min	O	O
were	O	O
collected	O	O
in	O	O
0.25	O	O
mmol	O	O
benzethonium	O	O
hydroxide	O	O
from	O	O
25	O	O
healthy	O	O
volunteers	O	O
after	O	O
they	O	O
withheld	O	O
37	O	O
kBq	O	O
(	O	O
1	O	O
muCi	O	O
)	O	O
of	O	O
(	O	O
14	O	O
)	O	O
C-urea	O	O
in	O	O
their	O	O
mouths	O	O
for	O	O
15	O	O
s	O	O
and	O	O
then	O	O
expectorated	O	O
the	O	O
tracer	O	O
.	O	O

The	O	O
test	O	O
was	O	O
repeated	O	O
on	O	O
the	O	O
same	O	O
subjects	O	O
without	O	O
and	O	O
with	O	O
mouth	O	O
cleansing	O	O
protocols	O	O
.	O	O

Breath	O	O
(	O	O
14	O	O
)	O	O
CO	O	O
(	O	O
2	O	O
)	O	O
content	O	O
was	O	O
measured	O	O
by	O	O
the	O	O
Liquid	O	O
Scintillation	O	O
Counter	O	O
(	O	O
1409	O	O
;	O	O
Wallac	O	O
,	O	O
Turku	O	O
,	O	O
Finland	O	O
)	O	O
and	O	O
results	O	O
were	O	O
expressed	O	O
as	O	O
(	O	O
14	O	O
)	O	O
CO	O	O
(	O	O
2	O	O
)	O	O
excretion	O	O
per	O	O
mmol	O	O
breath	O	O
CO	O	O
(	O	O
2	O	O
)	O	O
(	O	O
%	O	O
administered	O	O
dose	O	O
)	O	O
.	O	O

Peak	O	O
breath	O	O
radioactivity	O	O
at	O	O
1	O	O
min	O	O
in	O	O
the	O	O
former	O	O
protocol	O	O
was	O	O
3.53	O	O
times	O	O
higher	O	O
than	O	O
the	O	O
latter	O	O
which	O	O
declined	O	O
subsequently	O	O
with	O	O
a	O	O
half	O	O
time	O	O
of	O	O
1	O	O
min	O	O
and	O	O
2.5	O	O
min	O	O
,	O	O
and	O	O
reached	O	O
baseline	O	O
levels	O	O
by	O	O
15	O	O
and	O	O
10	O	O
min	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
peak	O	O
radioactivity	O	O
(	O	O
100	O	O
%	O	O
)	O	O
at	O	O
1	O	O
min	O	O
declined	O	O
by	O	O
94	O	O
%	O	O
and	O	O
97.8	O	O
%	O	O
in	O	O
the	O	O
former	O	O
and	O	O
later	O	O
protocols	O	O
,	O	O
respectively	O	O
,	O	O
at	O	O
15	O	O
min	O	O
.	O	O

Although	O	O
magnitude	O	O
of	O	O
the	O	O
peak	O	O
varied	O	O
in	O	O
different	O	O
subjects	O	O
,	O	O
the	O	O
shape	O	O
of	O	O
curve	O	O
remained	O	O
almost	O	O
similar	O	O
in	O	O
all	O	O
cases	O	O
.	O	O

Without	O	O
mouth	O	O
cleansing	O	O
,	O	O
oral	O	O
micro	O	O
flora	O	O
excreted	O	O
more	O	O
(	O	O
14	O	O
)	O	O
CO	O	O
(	O	O
2	O	O
)	O	O
up	O	O
to	O	O
15	O	O
min	O	O
after	O	O
administration	O	O
of	O	O
non-capsulated	O	O
(	O	O
14	O	O
)	O	O
C-urea	O	O
.	O	O

Therefore	O	O
,	O	O
it	O	O
is	O	O
proposed	O	O
that	O	O
two	O	O
breath	O	O
samples	O	O
may	O	O
be	O	O
obtained	O	O
either	O	O
at	O	O
15	O	O
and	O	O
20	O	O
min	O	O
without	O	O
or	O	O
at	O	O
10	O	O
and	O	O
15	O	O
min	O	O
with	O	O
mouth	O	O
cleansing	O	O
protocols	O	O
for	O	O
reliable	O	O
analysis	O	O
of	O	O
(	O	O
14	O	O
)	O	O
C-UBT	O	O
data	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
detection	O	O
.	O	O

The	O	O
induction	O	O
of	O	O
tissue-destructive	O	O
molecules	O	O
from	O	O
neutrophils	O	O
by	O	O
periodontopathic	O	O
bacteria	O	O
has	O	O
been	O	O
suggested	O	O
as	O	O
one	O	O
of	O	O
the	O	O
mechanisms	O	O
of	O	O
periodontal	O	O
destruction	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
whether	O	O
the	O	O
ability	O	O
to	O	O
stimulate	O	O
neutrophils	O	O
is	O	O
an	O	O
authentic	O	O
characteristic	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
.	O	O

We	O	O
evaluated	O	O
,	O	O
along	O	O
with	O	O
phagocytosis	O	O
,	O	O
the	O	O
production	O	O
of	O	O
reactive	O	O
oxygen	O	O
species	O	O
(	O	O
ROS	O	O
)	O	O
,	O	O
matrix	O	O
metalloproteinase-8	O	O
(	O	O
MMP-8	O	O
)	O	O
,	O	O
and	O	O
interleukin-1beta	O	O
by	O	O
neutrophils	O	O
in	O	O
response	O	O
to	O	O
non-periodontopathic	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
periodontopathic	O	O
bacteria	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
in	O	O
the	O	O
absence	O	O
or	O	O
presence	O	O
of	O	O
antibodies	O	O
.	O	O

Phagocytosis	O	O
,	O	O
the	O	O
death	O	O
of	O	O
neutrophils	O	O
,	O	O
and	O	O
intracellular	O	O
ROS	O	O
production	O	O
were	O	O
measured	O	O
by	O	O
flow	O	O
cytometry	O	O
and	O	O
the	O	O
concentrations	O	O
of	O	O
MMP-8	O	O
and	O	O
interleukin-1beta	O	O
secreted	O	O
into	O	O
medium	O	O
were	O	O
determined	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
.	O	O

S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
induced	O	O
greater	O	O
production	O	O
of	O	O
ROS	O	O
,	O	O
MMP-8	O	O
,	O	O
and	O	O
interleukin-1beta	O	O
than	O	O
did	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

The	O	O
levels	O	O
of	O	O
tissue-destructive	O	O
molecules	O	O
produced	O	O
by	O	O
neutrophils	O	O
had	O	O
a	O	O
positive	O	O
correlation	O	O
with	O	O
phagocytosis	O	O
.	O	O

Opsonization	O	O
of	O	O
bacteria	O	O
with	O	O
antibodies	O	O
significantly	O	O
increased	O	O
phagocytosis	O	O
and	O	O
ROS	O	O
production	O	O
and	O	O
release	O	O
,	O	O
thus	O	O
increasing	O	O
both	O	O
bacterial	O	O
clearance	O	O
and	O	O
potential	O	O
tissue	O	O
damage	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
oral	O	O
bacteria	O	O
to	O	O
induce	O	O
tissue-destructive	O	O
molecules	O	O
from	O	O
neutrophils	O	O
is	O	O
not	O	O
an	O	O
inherent	O	O
characteristic	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
,	O	O
which	O	O
would	O	O
provide	O	O
a	O	O
new	O	O
insight	O	O
into	O	O
the	O	O
role	O	O
of	O	O
neutrophils	O	O
in	O	O
periodontal	O	O
destruction	O	O
.	O	O

To	O	O
investigate	O	O
foam	O	O
generation	O	O
during	O	O
brushing	O	O
,	O	O
and	O	O
the	O	O
oral	O	O
debris	O	O
and	O	O
bacteria	O	O
removal	O	O
efficacy	O	O
of	O	O
an	O	O
experimental	O	O
gel-to-foam	O	O
dentifrice	O	O
compared	O	O
to	O	O
a	O	O
commercially-available	O	O
dentifrice	O	O
after	O	O
brushing	O	O
.	O	O

Thirty-four	O	O
subjects	O	O
participated	O	O
in	O	O
this	O	O
blinded	O	O
,	O	O
crossover	O	O
study	O	O
.	O	O

After	O	O
a	O	O
wash-out	O	O
period	O	O
prior	O	O
to	O	O
each	O	O
session	O	O
of	O	O
product	O	O
use	O	O
,	O	O
subjects	O	O
reported	O	O
to	O	O
the	O	O
site	O	O
having	O	O
abstained	O	O
from	O	O
oral	O	O
hygiene	O	O
,	O	O
eating	O	O
and	O	O
drinking	O	O
from	O	O
22:00	O	O
h	O	O
on	O	O
the	O	O
evening	O	O
prior	O	O
to	O	O
treatment	O	O
visits	O	O
.	O	O

The	O	O
subjects	O	O
brushed	O	O
with	O	O
a	O	O
weighed	O	O
dose	O	O
of	O	O
assigned	O	O
paste	O	O
and	O	O
were	O	O
asked	O	O
to	O	O
expectorate	O	O
their	O	O
toothpaste	O	O
slurry	O	O
into	O	O
a	O	O
collection	O	O
vessel	O	O
at	O	O
30	O	O
and	O	O
60	O	O
seconds	O	O
during	O	O
supervised	O	O
brushing	O	O
.	O	O

The	O	O
expectorated	O	O
foam	O	O
was	O	O
measured	O	O
immediately	O	O
,	O	O
after	O	O
which	O	O
subjects	O	O
rinsed	O	O
with	O	O
10	O	O
ml	O	O
of	O	O
sterile	O	O
water	O	O
and	O	O
expectorated	O	O
into	O	O
the	O	O
same	O	O
vessel	O	O
.	O	O

Samples	O	O
were	O	O
placed	O	O
on	O	O
ice	O	O
and	O	O
immediately	O	O
transported	O	O
to	O	O
the	O	O
laboratory	O	O
for	O	O
analysis	O	O
.	O	O

Bacteria	O	O
(	O	O
total	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
VSC-producing	O	O
bacteria	O	O
)	O	O
were	O	O
enumerated	O	O
using	O	O
appropriate	O	O
selective	O	O
media	O	O
.	O	O

To	O	O
calculate	O	O
the	O	O
amount	O	O
of	O	O
debris	O	O
,	O	O
a	O	O
measured	O	O
portion	O	O
of	O	O
the	O	O
sample	O	O
was	O	O
deposited	O	O
onto	O	O
a	O	O
pre-weighed	O	O
dish	O	O
and	O	O
weighed	O	O
.	O	O

Dishes	O	O
were	O	O
dried	O	O
thoroughly	O	O
and	O	O
weighed	O	O
again	O	O
after	O	O
cooling	O	O
.	O	O

Use	O	O
of	O	O
the	O	O
gel-to-foam	O	O
dentifrice	O	O
resulted	O	O
in	O	O
105	O	O
%	O	O
greater	O	O
foam	O	O
volume	O	O
compared	O	O
with	O	O
use	O	O
of	O	O
the	O	O
control	O	O
dentifrice	O	O
(	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
.	O	O

Further	O	O
,	O	O
the	O	O
gel-to-foam	O	O
dentifrice	O	O
removed	O	O
15.77	O	O
%	O	O
more	O	O
debris	O	O
than	O	O
the	O	O
control	O	O
dentifrice	O	O
(	O	O
p-value	O	O
=	O	O
0.0342	O	O
)	O	O
.	O	O

There	O	O
was	O	O
greater	O	O
removal	O	O
of	O	O
total	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
VSC-producing	O	O
bacteria	O	O
by	O	O
the	O	O
gel-to-foam	O	O
dentifrice	O	O
versus	O	O
the	O	O
control	O	O
dentifrice	O	O
(	O	O
p-value	O	O
<	O	O
0.0001	O	O
)	O	O
.	O	O

Single	O	O
use	O	O
of	O	O
a	O	O
gel-to-foam	O	O
dentifrice	O	O
generated	O	O
a	O	O
greater	O	O
volume	O	O
of	O	O
foam	O	O
and	O	O
removed	O	O
a	O	O
greater	O	O
amount	O	O
of	O	O
oral	O	O
debris	O	O
and	O	O
bacteria	O	O
during	O	O
brushing	O	O
than	O	O
a	O	O
standard	O	O
dentifrice	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
topographic	O	O
distribution	O	O
of	O	O
bacterial	O	O
types	O	O
and	O	O
loads	O	O
associated	O	O
with	O	O
mid-morning	O	O
oral	O	O
malodour	O	O
on	O	O
the	O	O
tongue	O	O
surface	O	O
.	O	O

Fifty	O	O
subjects	O	O
with	O	O
good	O	O
oral	O	O
health	O	O
and	O	O
at	O	O
least	O	O
20	O	O
natural	O	O
uncrowned	O	O
teeth	O	O
were	O	O
included	O	O
.	O	O

Samples	O	O
were	O	O
taken	O	O
with	O	O
sterile	O	O
brushes	O	O
from	O	O
the	O	O
dorsal	O	O
anterior	O	O
(	O	O
DA	O	O
)	O	O
,	O	O
dorsal	O	O
middle	O	O
(	O	O
DM	O	O
)	O	O
,	O	O
dorsal	O	O
posterior	O	O
(	O	O
DP	O	O
)	O	O
,	O	O
dorsal	O	O
posterior	O	O
to	O	O
the	O	O
circumvallate	O	O
papillae	O	O
(	O	O
DPCP	O	O
)	O	O
,	O	O
lateral	O	O
posterior	O	O
(	O	O
LP	O	O
)	O	O
and	O	O
ventral	O	O
posterior	O	O
(	O	O
VP	O	O
)	O	O
tongue	O	O
surfaces	O	O
.	O	O

Samples	O	O
were	O	O
cultured	O	O
on	O	O
appropriate	O	O
media	O	O
for	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
aerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
Gram-negative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
volatile	O	O
sulphur	O	O
compound	O	O
(	O	O
VSC	O	O
)	O	O
-producing	O	O
bacteria	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
saliuarius	E-bacteria	I-bacteria
.	O	O

Malodour	O	O
was	O	O
assessed	O	O
by	O	O
trained	O	O
judges	O	O
on	O	O
an	O	O
intensity	O	O
basis	O	O
.	O	O

The	O	O
counts	O	O
of	O	O
all	O	O
bacterial	O	O
groups	O	O
were	O	O
consistently	O	O
highest	O	O
at	O	O
the	O	O
DPCP	O	O
surface	O	O
.	O	O

Mean	O	O
VSC-producing	O	O
bacterial	O	O
counts	O	O
(	O	O
colony	O	O
forming	O	O
units/brush	O	O
x10	O	O
(	O	O
5	O	O
)	O	O
)	O	O
were	O	O
1.45	O	O
,	O	O
5.67	O	O
,	O	O
32.52	O	O
,	O	O
88.94	O	O
,	O	O
6.46	O	O
and	O	O
0.33	O	O
at	O	O
DA	O	O
,	O	O
DM	O	O
,	O	O
DP	O	O
,	O	O
DPCP	O	O
,	O	O
LP	O	O
and	O	O
VP	O	O
surfaces	O	O
,	O	O
respectively	O	O
.	O	O

Anaerobic	O	O
,	O	O
Gram-negative	O	O
and	O	O
VSC	O	O
counts	O	O
at	O	O
DPCP	O	O
surfaces	O	O
increased	O	O
with	O	O
malodour	O	O
intensity	O	O
,	O	O
whereas	O	O
aerobic	O	O
and	O	O
S.	B-bacteria	B-bacteria
saliuarius	E-bacteria	I-bacteria
counts	O	O
decreased	O	O
;	O	O
however	O	O
these	O	O
differences	O	O
were	O	O
not	O	O
statistically	O	O
significant	O	O
.	O	O

It	O	O
is	O	O
concluded	O	O
that	O	O
the	O	O
DPCP	O	O
area	O	O
consistently	O	O
carries	O	O
the	O	O
highest	O	O
load	O	O
of	O	O
bacteria	O	O
capable	O	O
of	O	O
contributing	O	O
to	O	O
oral	O	O
malodour	O	O
.	O	O

The	O	O
study	O	O
demonstrates	O	O
that	O	O
tongue	O	O
surfaces	O	O
not	O	O
accessible	O	O
to	O	O
routine	O	O
oral	O	O
hygiene	O	O
procedures	O	O
can	O	O
significantly	O	O
contribute	O	O
to	O	O
oral	O	O
malodour	O	O
.	O	O

We	O	O
isolated	O	O
oral	O	O
bacteria	O	O
that	O	O
coexisted	O	O
with	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
a	O	O
hamster	O	O
periodontitis	O	O
model	O	O
.	O	O

As	O	O
predominant	O	O
bacteria	O	O
in	O	O
the	O	O
periodontitis	O	O
site	O	O
,	O	O
Collinsella-reltaed	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
,	O	O
Eubacterium-reltaed	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
suis-related	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
parvula-reltaed	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
were	O	O
detected	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
Bacteroides	B-bacteria	B-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
also	O	O
isolated	O	O
predominantly	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
bacterial	O	O
composition	O	O
of	O	O
the	O	O
periodontitis	O	O
site	O	O
in	O	O
hamsters	O	O
is	O	O
complex	O	O
,	O	O
as	O	O
in	O	O
human	O	O
periodontitis	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
compound	O	O
light	O	O
yellow	O	O
Sophora	O	O
root	O	O
collutory	O	O
on	O	O
oral	O	O
erosive	O	O
lichen	O	O
planus	O	O
and	O	O
analyze	O	O
the	O	O
salivary	O	O
microbial	O	O
contents	O	O
and	O	O
proportion	O	O
.	O	O

30	O	O
patients	O	O
with	O	O
oral	O	O
erosive	O	O
lichen	O	O
planus	O	O
were	O	O
chosen	O	O
and	O	O
treated	O	O
with	O	O
compound	O	O
light	O	O
yellow	O	O
Sophora	O	O
root	O	O
collutory	O	O
.	O	O

Pain	O	O
index	O	O
and	O	O
clinical	O	O
symptoms	O	O
were	O	O
observed	O	O
,	O	O
the	O	O
changes	O	O
of	O	O
quantity	O	O
and	O	O
proportion	O	O
of	O	O
salivary	O	O
bacteria	O	O
were	O	O
investigated	O	O
before	O	O
and	O	O
after	O	O
taking	O	O
drugs	O	O
.	O	O

SAS6.12	O	O
software	O	O
package	O	O
was	O	O
used	O	O
for	O	O
statistical	O	O
analysis	O	O
.	O	O

The	O	O
extravasate	O	O
and	O	O
congest	O	O
of	O	O
the	O	O
erosive	O	O
mucous	O	O
membrane	O	O
were	O	O
relieved	O	O
.	O	O

The	O	O
pain	O	O
caused	O	O
by	O	O
erosion	O	O
were	O	O
significantly	O	O
relieved	O	O
after	O	O
taking	O	O
the	O	O
drugs	O	O
.	O	O

The	O	O
quantity	O	O
of	O	O
oral	O	O
Staphylococcus	B-bacteria	B-bacteria
was	O	O
significantly	O	O
decreased	O	O
after	O	O
taking	O	O
the	O	O
drugs	O	O
.	O	O

Oral	O	O
Staphylococcus	B-bacteria	B-bacteria
can	O	O
be	O	O
inhibited	O	O
by	O	O
light	O	O
yellow	O	O
Sophora	O	O
root	O	O
collutory	O	O
.	O	O

The	O	O
use	O	O
of	O	O
compound	O	O
light	O	O
yellow	O	O
Sophora	O	O
root	O	O
collutory	O	O
is	O	O
one	O	O
of	O	O
the	O	O
safe	O	O
and	O	O
effective	O	O
local	O	O
therapies	O	O
on	O	O
oral	O	O
lichen	O	O
planus	O	O
.	O	O

In	O	O
recent	O	O
years	O	O
,	O	O
patients	O	O
have	O	O
benefited	O	O
from	O	O
the	O	O
development	O	O
of	O	O
better	O	O
and	O	O
more	O	O
esthetic	O	O
materials	O	O
,	O	O
including	O	O
all-ceramics	O	O
dental	O	O
restorative	O	O
materials	O	O
.	O	O

Dental	O	O
plaque	O	O
formation	O	O
on	O	O
teeth	O	O
and	O	O
restorative	O	O
materials	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
oral	O	O
diseases	O	O
.	O	O

This	O	O
study	O	O
investigates	O	O
initial	O	O
adhesion	O	O
of	O	O
stationary	O	O
phase	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
to	O	O
different	O	O
all-ceramics	O	O
dental	O	O
restorative	O	O
materials	O	O
.	O	O

The	O	O
saliva-coated	O	O
materials	O	O
were	O	O
incubated	O	O
with	O	O
the	O	O
bacteria	O	O
for	O	O
1	O	O
h	O	O
in	O	O
an	O	O
in	O	O
vitro	O	O
flow	O	O
chamber	O	O
which	O	O
mimics	O	O
environmental	O	O
conditions	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Number	O	O
and	O	O
vitality	O	O
of	O	O
adhering	O	O
bacteria	O	O
were	O	O
determined	O	O
microscopically	O	O
after	O	O
staining	O	O
.	O	O

Surface	O	O
roughness	O	O
and	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
materials	O	O
had	O	O
no	O	O
distinctive	O	O
influence	O	O
on	O	O
bacterial	O	O
adhesion	O	O
.	O	O

However	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
adhered	O	O
about	O	O
tenfold	O	O
less	O	O
numerous	O	O
to	O	O
all	O	O
materials	O	O
than	O	O
the	O	O
other	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Further	O	O
,	O	O
there	O	O
was	O	O
a	O	O
correlation	O	O
between	O	O
bacterial	O	O
vitality	O	O
and	O	O
materials	O	O
'	O	O
glass	O	O
content	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
early	O	O
plaque	O	O
formation	O	O
was	O	O
influenced	O	O
predominantly	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
salivary	O	O
pellicle	O	O
rather	O	O
than	O	O
by	O	O
material	O	O
dependent	O	O
parameters	O	O
whereas	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
all-ceramics	O	O
appeared	O	O
to	O	O
have	O	O
influenced	O	O
the	O	O
percentage	O	O
of	O	O
viable	O	O
cells	O	O
during	O	O
the	O	O
adhesion	O	O
process	O	O
.	O	O

This	O	O
presented	O	O
in	O	O
vitro	O	O
technique	O	O
may	O	O
provide	O	O
a	O	O
useful	O	O
model	O	O
to	O	O
study	O	O
the	O	O
influence	O	O
of	O	O
different	O	O
parameters	O	O
on	O	O
adherence	O	O
of	O	O
oral	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
initially	O	O
colonizes	O	O
the	O	O
oral	O	O
cavity	O	O
by	O	O
interacting	O	O
with	O	O
organisms	O	O
in	O	O
supragingival	O	O
plaque	O	O
,	O	O
such	O	O
as	O	O
the	O	O
oralis	O	O
group	O	O
of	O	O
oral	O	O
streptococci	O	O
.	O	O

This	O	O
interaction	O	O
involves	O	O
the	O	O
association	O	O
of	O	O
the	O	O
streptococcal	O	O
antigen	O	O
I/II	O	O
with	O	O
the	O	O
minor	O	O
fimbrial	O	O
antigen	O	O
(	O	O
Mfa1	O	O
)	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Our	O	O
previous	O	O
studies	O	O
showed	O	O
that	O	O
a	O	O
peptide	O	O
(	O	O
BAR	O	O
)	O	O
derived	O	O
from	O	O
antigen	O	O
I/II	O	O
inhibits	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
adherence	O	O
and	O	O
subsequent	O	O
biofilm	O	O
formation	O	O
on	O	O
streptococcal	O	O
substrates	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
screening	O	O
a	O	O
combinatorial	O	O
peptide	O	O
library	O	O
identified	O	O
select	O	O
amino	O	O
acid	O	O
substitutions	O	O
in	O	O
the	O	O
NITVK	O	O
active	O	O
region	O	O
of	O	O
BAR	O	O
that	O	O
increased	O	O
the	O	O
adherence	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
to	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Here	O	O
we	O	O
report	O	O
that	O	O
incorporating	O	O
these	O	O
residues	O	O
in	O	O
a	O	O
synthetic	O	O
peptide	O	O
results	O	O
in	O	O
more-potent	O	O
inhibition	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
adherence	O	O
and	O	O
biofilm	O	O
formation	O	O
(	O	O
I	O	O
(	O	O
50	O	O
)	O	O
[	O	O
50	O	O
%	O	O
inhibition	O	O
]	O	O
at	O	O
0.52	O	O
microM	O	O
versus	O	O
I	O	O
(	O	O
50	O	O
)	O	O
at	O	O
1.25	O	O
microM	O	O
for	O	O
BAR	O	O
)	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
a	O	O
second	O	O
structural	O	O
motif	O	O
in	O	O
BAR	O	O
,	O	O
comprised	O	O
of	O	O
the	O	O
amino	O	O
acids	O	O
KKVQDLLKK	O	O
,	O	O
was	O	O
shown	O	O
to	O	O
contribute	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
adherence	O	O
to	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Consistent	O	O
with	O	O
this	O	O
,	O	O
the	O	O
KKVQDLLKK	O	O
and	O	O
NITVK	O	O
motifs	O	O
are	O	O
conserved	O	O
only	O	O
in	O	O
antigen	O	O
I/II	O	O
proteins	O	O
expressed	O	O
by	O	O
the	O	O
oralis	O	O
group	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
which	O	O
interact	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Interestingly	O	O
,	O	O
the	O	O
primary	O	O
and	O	O
secondary	O	O
structures	O	O
and	O	O
the	O	O
functional	O	O
characteristics	O	O
of	O	O
the	O	O
amphipathic	O	O
VQDLL	O	O
core	O	O
alpha-helix	O	O
resemble	O	O
the	O	O
consensus	O	O
nuclear	O	O
receptor	O	O
(	O	O
NR	O	O
)	O	O
box	O	O
protein-protein	O	O
interacting	O	O
domain	O	O
sequence	O	O
(	O	O
LXXLL	O	O
)	O	O
of	O	O
eukaryotes	O	O
.	O	O

BAR	O	O
peptides	O	O
containing	O	O
amino	O	O
acid	O	O
substitutions	O	O
with	O	O
the	O	O
potential	O	O
to	O	O
disrupt	O	O
the	O	O
secondary	O	O
structure	O	O
of	O	O
VQDLL	O	O
were	O	O
less-effective	O	O
inhibitors	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
adherence	O	O
and	O	O
biofilm	O	O
formation	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
alpha-helical	O	O
character	O	O
of	O	O
VQDLL	O	O
is	O	O
important	O	O
.	O	O

Furthermore	O	O
,	O	O
replacing	O	O
the	O	O
lysines	O	O
that	O	O
flank	O	O
VQDLL	O	O
with	O	O
acidic	O	O
amino	O	O
acids	O	O
also	O	O
reduced	O	O
inhibitory	O	O
activity	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
association	O	O
of	O	O
VQDLL	O	O
with	O	O
Mfa1	O	O
may	O	O
be	O	O
stabilized	O	O
by	O	O
a	O	O
charge	O	O
clamp	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
Mfa1-interacting	O	O
interface	O	O
of	O	O
streptococcal	O	O
antigen	O	O
I/II	O	O
encompasses	O	O
both	O	O
the	O	O
KKVQDLLKK	O	O
and	O	O
NITVK	O	O
motif	O	O
and	O	O
suggest	O	O
that	O	O
the	O	O
adherence	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
to	O	O
streptococci	B-bacteria	B-bacteria
is	O	O
driven	O	O
by	O	O
a	O	O
protein-protein	O	O
interaction	O	O
domain	O	O
that	O	O
resembles	O	O
the	O	O
eukaryotic	O	O
NR	O	O
box	O	O
.	O	O

Thus	O	O
,	O	O
both	O	O
motifs	O	O
must	O	O
be	O	O
taken	O	O
into	O	O
account	O	O
in	O	O
designing	O	O
potential	O	O
peptidomimetics	O	O
that	O	O
target	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
adherence	O	O
and	O	O
biofilm	O	O
formation	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
two	O	O
different	O	O
methods	O	O
of	O	O
identifying	O	O
oral	O	O
bacteri	O	O
from	O	O
blood	O	O
samples	O	O
after	O	O
dental	O	O
extractions	O	O
.	O	O

Blood	O	O
cultures	O	O
were	O	O
taken	O	O
before	O	O
,	O	O
during	O	O
,	O	O
and	O	O
after	O	O
a	O	O
single	O	O
tooth	O	O
extraction	O	O
in	O	O
30	O	O
subjects	O	O
and	O	O
cultured	O	O
using	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
Bactec	O	O
media	O	O
.	O	O

Positive	O	O
cultures	O	O
from	O	O
22	O	O
subjects	O	O
were	O	O
subcultured	O	O
on	O	O
selective	O	O
and	O	O
nonselective	O	O
media	O	O
,	O	O
resulting	O	O
in	O	O
58	O	O
isolates	O	O
.	O	O

Bacterial	O	O
identification	O	O
was	O	O
performed	O	O
by	O	O
biochemical	O	O
analysis	O	O
and	O	O
sequence	O	O
analysis	O	O
of	O	O
16S	O	O
rRNA	O	O
gene	O	O
.	O	O

Of	O	O
the	O	O
58	O	O
isolates	O	O
,	O	O
only	O	O
10	O	O
(	O	O
17	O	O
%	O	O
)	O	O
were	O	O
the	O	O
same	O	O
species	O	O
by	O	O
both	O	O
methods	O	O
.	O	O

Thirty-two	O	O
(	O	O
55	O	O
%	O	O
)	O	O
belonged	O	O
to	O	O
the	O	O
same	O	O
genus	O	O
but	O	O
different	O	O
species	O	O
,	O	O
and	O	O
16	O	O
(	O	O
28	O	O
%	O	O
)	O	O
showed	O	O
no	O	O
correlation	O	O
at	O	O
all	O	O
.	O	O

There	O	O
were	O	O
31	O	O
and	O	O
40	O	O
diverse	O	O
species	O	O
by	O	O
the	O	O
biochemical	O	O
and	O	O
the	O	O
sequencing	O	O
methods	O	O
,	O	O
respectively	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
were	O	O
the	O	O
dominant	O	O
species	O	O
.	O	O

DNA	O	O
sequencing	O	O
results	O	O
in	O	O
more	O	O
accurate	O	O
identification	O	O
and	O	O
a	O	O
more	O	O
diverse	O	O
population	O	O
of	O	O
bacteria	O	O
from	O	O
bacteremia	O	O
following	O	O
dental	O	O
extractions	O	O
.	O	O

Silent	O	O
aspiration	O	O
of	O	O
oropharyngeal	O	O
pathogenic	O	O
organisms	O	O
is	O	O
a	O	O
significant	O	O
risk	O	O
factor	O	O
causing	O	O
pneumonia	O	O
in	O	O
the	O	O
elderly	O	O
.	O	O

We	O	O
hypothesized	O	O
that	O	O
regular	O	O
oral	O	O
hygiene	O	O
care	O	O
will	O	O
affect	O	O
the	O	O
presence	O	O
of	O	O
oropharyngeal	O	O
bacteria	O	O
.	O	O

Professional	O	O
cleaning	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
and/or	O	O
the	O	O
gargling	O	O
of	O	O
a	O	O
disinfectant	O	O
liquid	O	O
solution	O	O
was	O	O
performed	O	O
over	O	O
a	O	O
five-month	O	O
period	O	O
in	O	O
three	O	O
facilities	O	O
for	O	O
the	O	O
dependent	O	O
elderly	O	O
.	O	O

Total	O	O
oropharyngeal	O	O
bacteria	O	O
,	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
staphylococci	B-bacteria	B-bacteria
,	O	O
Candida	B-bacteria	B-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
,	O	O
and	O	O
black-pigmented	B-bacteria	B-bacteria
Bacteroides	E-bacteria	I-bacteria
species	O	O
were	O	O
monitored	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
these	O	O
oropharyngeal	O	O
bacteria	O	O
decreased	O	O
or	O	O
disappeared	O	O
after	O	O
weekly	O	O
professional	O	O
oral	O	O
health	O	O
care	O	O
,	O	O
i.e.	O	O
,	O	O
cleaning	O	O
of	O	O
teeth	O	O
,	O	O
dentures	O	O
,	O	O
tongue	O	O
,	O	O
and	O	O
oral	O	O
mucous	O	O
membrane	O	O
by	O	O
dental	O	O
hygienists	O	O
.	O	O

After	O	O
lunch	O	O
,	O	O
gargling	O	O
with	O	O
povidone	O	O
iodine	O	O
was	O	O
shown	O	O
to	O	O
be	O	O
less	O	O
effective	O	O
than	O	O
professional	O	O
oral	O	O
care	O	O
.	O	O

These	O	O
findings	O	O
indicate	O	O
that	O	O
weekly	O	O
professional	O	O
mechanical	O	O
cleaning	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
rather	O	O
than	O	O
a	O	O
daily	O	O
chemical	O	O
disinfection	O	O
of	O	O
the	O	O
mouth	O	O
,	O	O
can	O	O
be	O	O
an	O	O
important	O	O
strategy	O	O
to	O	O
prevent	O	O
aspiration	O	O
pneumonia	O	O
in	O	O
the	O	O
dependent	O	O
elderly	O	O
.	O	O

Oral	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
are	O	O
a	O	O
reservoir	O	O
of	O	O
resistance	O	O
genes	O	O
for	O	O
pathogens	O	O
.	O	O

Through	O	O
prolonged	O	O
exposure	O	O
,	O	O
long-acting	O	O
macrolides	O	O
(	O	O
e.g.	O	O
,	O	O
azithromycin	O	O
)	O	O
may	O	O
induce	O	O
the	O	O
resistance	O	O
of	O	O
the	O	O
commensals	O	O
to	O	O
macrolides	O	O
more	O	O
frequently	O	O
than	O	O
macrolides	O	O
with	O	O
a	O	O
shorter	O	O
half-life	O	O
(	O	O
e.g.	O	O
,	O	O
clarithromycin	O	O
)	O	O
.	O	O

In	O	O
a	O	O
prospective	O	O
,	O	O
randomized	O	O
,	O	O
evaluator-blinded	O	O
trial	O	O
in	O	O
healthy	O	O
volunteers	O	O
receiving	O	O
standard	O	O
courses	O	O
of	O	O
either	O	O
azithromycin	O	O
(	O	O
n	O	O
=	O	O
20	O	O
)	O	O
or	O	O
clarithromycin	O	O
(	O	O
n	O	O
=	O	O
20	O	O
)	O	O
,	O	O
we	O	O
compared	O	O
the	O	O
susceptibility	O	O
of	O	O
oral	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
to	O	O
macrolides	O	O
over	O	O
a	O	O
period	O	O
of	O	O
12	O	O
weeks	O	O
.	O	O

There	O	O
was	O	O
a	O	O
significant	O	O
temporal	O	O
increase	O	O
in	O	O
the	O	O
numbers	O	O
of	O	O
resistant	O	O
isolates	O	O
in	O	O
both	O	O
groups	O	O
(	O	O
p	O	O
<	O	O
0.0005	O	O
at	O	O
week	O	O
1	O	O
)	O	O
.	O	O

The	O	O
proportion	O	O
of	O	O
macrolide-resistant	O	O
isolates	O	O
over	O	O
time	O	O
was	O	O
significantly	O	O
higher	O	O
following	O	O
azithromycin	O	O
treatment	O	O
(	O	O
p	O	O
=	O	O
0.0005	O	O
)	O	O
,	O	O
but	O	O
returned	O	O
to	O	O
baseline	O	O
values	O	O
until	O	O
week	O	O
12	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

Temporal	O	O
differential	O	O
effects	O	O
of	O	O
azithromycin	O	O
and	O	O
clarithromycin	O	O
on	O	O
the	O	O
induction	O	O
of	O	O
resistance	O	O
were	O	O
observed	O	O
and	O	O
need	O	O
to	O	O
be	O	O
investigated	O	O
regarding	O	O
their	O	O
effect	O	O
on	O	O
co-colonizing	O	O
pathogens	O	O
.	O	O

A	O	O
relationship	O	O
between	O	O
the	O	O
distribution	O	O
of	O	O
periodontal	O	O
bacteria	O	O
species	O	O
and	O	O
malodor	O	O
in	O	O
children	O	O
has	O	O
not	O	O
been	O	O
sufficiently	O	O
investigated	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
undertaken	O	O
to	O	O
determine	O	O
the	O	O
presence	O	O
of	O	O
3	O	O
periodontopathic	O	O
bacteria	O	O
(	O	O
Prevotella	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
)	O	O
in	O	O
the	O	O
supragingival	O	O
plaques	O	O
of	O	O
3	O	O
to	O	O
16-year-old	O	O
children	O	O
with	O	O
different	O	O
oral	O	O
health	O	O
conditions	O	O
and	O	O
oral	O	O
malodor	O	O
.	O	O

The	O	O
number	O	O
of	O	O
decayed	O	O
and	O	O
filled	O	O
primary	O	O
teeth	O	O
(	O	O
df	O	O
)	O	O
and	O	O
Decayed	O	O
,	O	O
Missing	O	O
and	O	O
Filled	O	O
permanent	O	O
teeth	O	O
(	O	O
DMF	O	O
)	O	O
,	O	O
Papillary	O	O
Marginal	O	O
and	O	O
Attached	O	O
gingivitis	O	O
(	O	O
PMA	O	O
)	O	O
index	O	O
,	O	O
Oral	O	O
Hygiene	O	O
Index	O	O
(	O	O
OHI	O	O
)	O	O
,	O	O
and	O	O
oral	O	O
malodor	O	O
of	O	O
each	O	O
subject	O	O
were	O	O
determined	O	O
prior	O	O
to	O	O
the	O	O
collection	O	O
of	O	O
supragingival	O	O
plaques	O	O
.	O	O

Three	O	O
periodontopathic	O	O
bacteria	O	O
(	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
)	O	O
in	O	O
supragingival	O	O
plaques	O	O
were	O	O
detected	O	O
by	O	O
using	O	O
an	O	O
immunoslot	O	O
blot	O	O
assay	O	O
with	O	O
monoclonal	O	O
antibodies	O	O
specific	O	O
for	O	O
each	O	O
microorganism	O	O
.	O	O


The	O	O
frequencies	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
in	O	O
children	O	O
with	O	O
and	O	O
without	O	O
caries	O	O
were	O	O
not	O	O
significantly	O	O
different	O	O
from	O	O
each	O	O
other	O	O
.	O	O

Positivity	O	O
for	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
for	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
or	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
was	O	O
correlated	O	O
with	O	O
oral	O	O
malodor	O	O
.	O	O

Oral	O	O
malodor	O	O
was	O	O
also	O	O
correlated	O	O
with	O	O
the	O	O
debris	O	O
index	O	O
,	O	O
a	O	O
component	O	O
of	O	O
OHI	O	O
.	O	O

The	O	O
group	O	O
with	O	O
the	O	O
higher	O	O
OHI	O	O
showed	O	O
a	O	O
higher	O	O
prevalence	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
.	O	O

For	O	O
the	O	O
3	O	O
periodontopathic	O	O
bacteria	O	O
in	O	O
the	O	O
subjects	O	O
tested	O	O
,	O	O
plaques	O	O
positive	O	O
for	O	O
any	O	O
of	O	O
them	O	O
were	O	O
not	O	O
age	O	O
related	O	O
.	O	O

However	O	O
the	O	O
frequencies	O	O
of	O	O
all	O	O
3	O	O
periodontopathic	O	O
bacteria	O	O
were	O	O
the	O	O
highest	O	O
in	O	O
the	O	O
3-6-year	O	O
olds	O	O
.	O	O

The	O	O
supragingival	O	O
plaques	O	O
in	O	O
children	O	O
can	O	O
harbor	O	O
3	O	O
species	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
in	O	O
vitro	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
effects	O	O
of	O	O
nicotine	O	O
,	O	O
cotinine	O	O
,	O	O
and	O	O
caffeine	O	O
on	O	O
the	O	O
viability	O	O
of	O	O
some	O	O
oral	O	O
bacterial	O	O
species	O	O
.	O	O

It	O	O
also	O	O
evaluated	O	O
the	O	O
ability	O	O
of	O	O
these	O	O
bacteria	O	O
to	O	O
metabolize	O	O
those	O	O
substances	O	O
.	O	O

Single-species	O	O
biofilms	O	O
of	O	O
Streptococcus	O	O
gordonii	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
or	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
dual-species	O	O
biofilms	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
--	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
--	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
grown	O	O
on	O	O
hydroxyapatite	O	O
discs	O	O
.	O	O

Seven	O	O
species	O	O
were	O	O
studied	O	O
as	O	O
planktonic	O	O
cells	O	O
,	O	O
including	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
species	O	O
mentioned	O	O
above	O	O
.	O	O

The	O	O
viability	O	O
of	O	O
planktonic	O	O
cells	O	O
and	O	O
biofilms	O	O
was	O	O
analyzed	O	O
by	O	O
susceptibility	O	O
tests	O	O
and	O	O
time-kill	O	O
assays	O	O
,	O	O
respectively	O	O
,	O	O
against	O	O
different	O	O
concentrations	O	O
of	O	O
nicotine	O	O
,	O	O
cotinine	O	O
,	O	O
and	O	O
caffeine	O	O
.	O	O

High-performance	O	O
liquid	O	O
chromatography	O	O
was	O	O
performed	O	O
to	O	O
quantify	O	O
nicotine	O	O
,	O	O
cotinine	O	O
,	O	O
and	O	O
caffeine	O	O
concentrations	O	O
in	O	O
the	O	O
culture	O	O
media	O	O
after	O	O
the	O	O
assays	O	O
.	O	O

Susceptibility	O	O
tests	O	O
and	O	O
viability	O	O
assays	O	O
showed	O	O
that	O	O
nicotine	O	O
,	O	O
cotinine	O	O
,	O	O
and	O	O
caffeine	O	O
can	O	O
not	O	O
reduce	O	O
or	O	O
stimulate	O	O
bacterial	O	O
growth	O	O
.	O	O

High-performance	O	O
liquid	O	O
chromatography	O	O
results	O	O
showed	O	O
that	O	O
nicotine	O	O
,	O	O
cotinine	O	O
,	O	O
and	O	O
caffeine	O	O
concentrations	O	O
were	O	O
not	O	O
altered	O	O
after	O	O
bacteria	O	O
exposure	O	O
.	O	O

These	O	O
findings	O	O
indicate	O	O
that	O	O
nicotine	O	O
,	O	O
cotinine	O	O
,	O	O
and	O	O
caffeine	O	O
,	O	O
in	O	O
the	O	O
concentrations	O	O
used	O	O
,	O	O
can	O	O
not	O	O
affect	O	O
significantly	O	O
the	O	O
growth	O	O
of	O	O
these	O	O
oral	O	O
bacterial	O	O
strains	O	O
.	O	O

Moreover	O	O
,	O	O
these	O	O
species	O	O
do	O	O
not	O	O
seem	O	O
to	O	O
metabolize	O	O
these	O	O
substances	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
efficacy	O	O
of	O	O
common	O	O
antiseptic	O	O
mouth	O	O
rinses	O	O
and	O	O
octenidine	O	O
dihydrochloride	O	O
(	O	O
OCT	O	O
)	O	O
.	O	O

The	O	O
antibacterial	O	O
activities	O	O
of	O	O
antiseptics	O	O
against	O	O
total	O	O
and	O	O
cariogenic	O	O
bacteria	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
)	O	O
in	O	O
saliva	O	O
were	O	O
studied	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
.	O	O

After	O	O
unstimulated	O	O
saliva	O	O
was	O	O
collected	O	O
,	O	O
one	O	O
of	O	O
the	O	O
mouth	O	O
rinse	O	O
solutions	O	O
was	O	O
applied	O	O
for	O	O
30seconds	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
15	O	O
,	O	O
30	O	O
,	O	O
60	O	O
,	O	O
and	O	O
120min	O	O
later	O	O
and	O	O
evaluated	O	O
for	O	O
their	O	O
bacterial	O	O
count	O	O
.	O	O

OCT	O	O
had	O	O
a	O	O
significantly	O	O
greater	O	O
inhibitory	O	O
effect	O	O
on	O	O
the	O	O
studied	O	O
bacteria	O	O
than	O	O
0.2	O	O
%	O	O
chlorhexidine	O	O
gluconate	O	O
(	O	O
CHX	O	O
)	O	O
and	O	O
7.5	O	O
%	O	O
polyvinylpyrrolidone-iodine	O	O
complex	O	O
(	O	O
PVP-I	O	O
)	O	O
from	O	O
15min	O	O
to	O	O
120min	O	O
following	O	O
the	O	O
application	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

The	O	O
antiseptic	O	O
efficacy	O	O
of	O	O
0.2	O	O
%	O	O
CHX	O	O
on	O	O
total	O	O
bacteria	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
was	O	O
very	O	O
similar	O	O
to	O	O
the	O	O
efficacy	O	O
observed	O	O
with	O	O
7.5	O	O
%	O	O
PVP-I	O	O
mouth	O	O
solution	O	O
from	O	O
15min	O	O
up	O	O
to	O	O
120min	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
completely	O	O
inhibited	O	O
by	O	O
0.15mg/ml	O	O
PVP-I	O	O
,	O	O
0.5mg/ml	O	O
CHX	O	O
,	O	O
and	O	O
0.1mg/ml	O	O
OCT	O	O
concentrations	O	O
,	O	O
while	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
was	O	O
inhibited	O	O
by	O	O
0.15mg/ml	O	O
PVP-I	O	O
,	O	O
2mg/ml	O	O
CHX	O	O
,	O	O
and	O	O
0.8mg/ml	O	O
OCT	O	O
concentrations	O	O
.	O	O

Lactococcus	B-bacteria	B-bacteria
lactis	I-bacteria	I-bacteria
subspecies	I-bacteria	I-bacteria
lactis	E-bacteria	I-bacteria
was	O	O
inhibited	O	O
with	O	O
0.00313mg/ml	O	O
OCT	O	O
,	O	O
30mg/ml	O	O
PVP-I	O	O
,	O	O
and	O	O
0.0063mg/ml	O	O
CHX	O	O
concentrations	O	O
.	O	O

OCT	O	O
compared	O	O
favorably	O	O
with	O	O
CHX	O	O
and	O	O
PVP-I	O	O
in	O	O
its	O	O
antibacterial	O	O
effects	O	O
,	O	O
both	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Leptotrichia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
typically	O	O
colonize	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
genitourinary	O	O
tract	O	O
.	O	O

These	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
belong	O	O
to	O	O
the	O	O
normal	O	O
flora	O	O
of	O	O
humans	O	O
and	O	O
are	O	O
seldom	O	O
found	O	O
in	O	O
clinically	O	O
significant	O	O
specimens	O	O
.	O	O

However	O	O
,	O	O
on	O	O
rare	O	O
occasions	O	O
,	O	O
Leptotrichia	B-bacteria	B-bacteria
has	O	O
been	O	O
isolated	O	O
from	O	O
blood	O	O
cultures	O	O
of	O	O
patients	O	O
with	O	O
lesions	O	O
in	O	O
the	O	O
oral	O	O
mucosa	O	O
,	O	O
in	O	O
particular	O	O
from	O	O
patients	O	O
with	O	O
neutropenia	O	O
.	O	O

These	O	O
organisms	O	O
should	O	O
be	O	O
considered	O	O
potential	O	O
pathogens	O	O
in	O	O
neutropenic	O	O
patients	O	O
,	O	O
especially	O	O
when	O	O
breaks	O	O
in	O	O
the	O	O
mucosal	O	O
barriers	O	O
are	O	O
present	O	O
through	O	O
which	O	O
they	O	O
frequently	O	O
spread	O	O
to	O	O
the	O	O
bloodstream	O	O
.	O	O

Leptotrichia	B-bacteria	B-bacteria
has	O	O
also	O	O
been	O	O
recovered	O	O
from	O	O
immunocompetent	O	O
persons	O	O
,	O	O
e.g	O	O
.	O	O

patients	O	O
with	O	O
endocarditis	O	O
.	O	O

Although	O	O
their	O	O
role	O	O
in	O	O
infections	O	O
remains	O	O
elusive	O	O
and	O	O
not	O	O
much	O	O
is	O	O
known	O	O
,	O	O
they	O	O
have	O	O
been	O	O
suggested	O	O
as	O	O
emerging	O	O
pathogens	O	O
.	O	O

The	O	O
present	O	O
review	O	O
deals	O	O
with	O	O
taxonomy	O	O
,	O	O
diagnosis	O	O
,	O	O
clinical	O	O
importance	O	O
,	O	O
pathogenesis	O	O
,	O	O
host	O	O
defence	O	O
,	O	O
infection	O	O
control	O	O
,	O	O
and	O	O
spectrum	O	O
of	O	O
Leptotrichia	B-bacteria	B-bacteria
infections	O	O
,	O	O
and	O	O
ends	O	O
with	O	O
a	O	O
few	O	O
typical	O	O
case	O	O
reports	O	O
.	O	O

Currently	O	O
,	O	O
six	O	O
species	O	O
have	O	O
been	O	O
validly	O	O
published	O	O
,	O	O
but	O	O
a	O	O
number	O	O
of	O	O
yet	O	O
uncultivable	O	O
species	O	O
exist	O	O
.	O	O

Molecular	O	O
methods	O	O
recovering	O	O
uncultivable	O	O
species	O	O
should	O	O
be	O	O
used	O	O
to	O	O
get	O	O
a	O	O
real	O	O
idea	O	O
of	O	O
their	O	O
role	O	O
as	O	O
pathogens	O	O
.	O	O

Coaggregation	O	O
is	O	O
believed	O	O
to	O	O
facilitate	O	O
the	O	O
integration	O	O
of	O	O
new	O	O
bacterial	O	O
species	O	O
into	O	O
polymicrobial	O	O
communities	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
coaggregation	O	O
between	O	O
and	O	O
among	O	O
human	O	O
oral	O	O
and	O	O
enteric	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Stationary	O	O
phase	O	O
cultures	O	O
of	O	O
10	O	O
oral	O	O
and	O	O
10	O	O
enteric	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
chosen	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
numerical	O	O
and	O	O
ecological	O	O
significance	O	O
in	O	O
their	O	O
respective	O	O
environments	O	O
together	O	O
with	O	O
their	O	O
ease	O	O
of	O	O
cultivation	O	O
,	O	O
were	O	O
tested	O	O
using	O	O
a	O	O
quantitative	O	O
spectrophotometric	O	O
coaggregation	O	O
assay	O	O
in	O	O
all	O	O
possible	O	O
pairwise	O	O
combinations	O	O
to	O	O
provide	O	O
quantitative	O	O
coaggregation	O	O
scores	O	O
.	O	O

While	O	O
40	O	O
%	O	O
of	O	O
possible	O	O
partnerships	O	O
coaggregated	O	O
strongly	O	O
for	O	O
oral	O	O
strains	O	O
,	O	O
strong	O	O
interactions	O	O
between	O	O
oral	O	O
and	O	O
gut	O	O
strains	O	O
were	O	O
considerably	O	O
less	O	O
common	O	O
(	O	O
4	O	O
%	O	O
incidence	O	O
)	O	O
.	O	O

Coaggregation	O	O
scores	O	O
were	O	O
also	O	O
weak	O	O
between	O	O
members	O	O
of	O	O
the	O	O
intestinal	O	O
microbiota	O	O
(	O	O
7	O	O
%	O	O
incidence	O	O
)	O	O
,	O	O
apart	O	O
from	O	O
Bacteroides	B-bacteria	B-bacteria
fragilis	E-bacteria	I-bacteria
with	O	O
Clostridium	B-bacteria	B-bacteria
perfringens	E-bacteria	I-bacteria
,	O	O
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
adolescentis	I-bacteria	I-bacteria
with	I-bacteria	I-bacteria
C.	I-bacteria	I-bacteria
perfringens	E-bacteria	I-bacteria
.	O	O

Oral	O	O
and	O	O
intestinal	O	O
bacteria	O	O
did	O	O
not	O	O
strongly	O	O
interact	O	O
,	O	O
apart	O	O
from	O	O
B.	B-bacteria	B-bacteria
adolescentis	E-bacteria	I-bacteria
with	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
with	O	O
C.	B-bacteria	B-bacteria
perfringens	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
with	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
.	O	O

Heating	O	O
and	O	O
sugar-addition	O	O
experiments	O	O
indicated	O	O
that	O	O
similar	O	O
to	O	O
oral	O	O
microorganisms	O	O
,	O	O
interactions	O	O
within	O	O
intestinal	O	O
bacteria	O	O
and	O	O
between	O	O
intestinal	O	O
and	O	O
oral	O	O
strains	O	O
were	O	O
mediated	O	O
by	O	O
lectin-carbohydrate	O	O
interactions	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
oral	O	O
mucosal	O	O
lesions	O	O
,	O	O
microbial	O	O
changes	O	O
,	O	O
and	O	O
taste	O	O
disturbances	O	O
induced	O	O
by	O	O
adjuvant	O	O
chemotherapy	O	O
(	O	O
CT	O	O
)	O	O
in	O	O
breast	O	O
cancer	O	O
patients	O	O
during	O	O
and	O	O
1	O	O
year	O	O
after	O	O
treatment	O	O
.	O	O

Forty-five	O	O
consecutive	O	O
breast	O	O
cancer	O	O
patients	O	O
,	O	O
eligible	O	O
for	O	O
adjuvant	O	O
CT	O	O
with	O	O
cyclophosphamide	O	O
,	O	O
epirubicin	O	O
or	O	O
methotrexate	O	O
,	O	O
and	O	O
5-fluorouracil	O	O
were	O	O
followed	O	O
before	O	O
,	O	O
during	O	O
,	O	O
6	O	O
months	O	O
and	O	O
1	O	O
year	O	O
after	O	O
CT	O	O
and	O	O
were	O	O
compared	O	O
to	O	O
a	O	O
control	O	O
group	O	O
of	O	O
31	O	O
breast	O	O
cancer	O	O
patients	O	O
not	O	O
receiving	O	O
adjuvant	O	O
CT.	O	O
During	O	O
CT	O	O
,	O	O
oral	O	O
mucosal	O	O
lesions	O	O
developed	O	O
including	O	O
erythema	O	O
(	O	O
n	O	O
=	O	O
10	O	O
,	O	O
22	O	O
%	O	O
)	O	O
and	O	O
ulceration	O	O
(	O	O
n	O	O
=	O	O
7	O	O
,	O	O
16	O	O
%	O	O
)	O	O
.	O	O

Five	O	O
patients	O	O
(	O	O
11	O	O
%	O	O
)	O	O
were	O	O
diagnosed	O	O
with	O	O
oral	O	O
candidosis	O	O
.	O	O

Scores	O	O
of	O	O
dental	O	O
bacterial	O	O
plaque	O	O
and	O	O
gingival	O	O
inflammation	O	O
increased	O	O
during	O	O
CT	O	O
and	O	O
the	O	O
oral	O	O
microbial	O	O
composition	O	O
changed	O	O
towards	O	O
a	O	O
more	O	O
acidophilic	O	O
flora	O	O
.	O	O

Taste	O	O
disturbances	O	O
were	O	O
experienced	O	O
by	O	O
84	O	O
%	O	O
(	O	O
n	O	O
=	O	O
38	O	O
)	O	O
of	O	O
the	O	O
patients	O	O
in	O	O
the	O	O
CT	O	O
group	O	O
.	O	O

In	O	O
breast	B-bacteria	B-bacteria
cancer	E-bacteria	I-bacteria
patients	O	O
,	O	O
moderate-intensive	O	O
adjuvant	O	O
CT	O	O
caused	O	O
oral	O	O
mucosal	O	O
lesions	O	O
,	O	O
oral	O	O
candidosis	O	O
,	O	O
taste	O	O
disturbances	O	O
and	O	O
a	O	O
more	O	O
acidophilic	O	O
oral	O	O
microflora	O	O
.	O	O

These	O	O
adverse	O	O
effects	O	O
were	O	O
temporary	O	O
and	O	O
the	O	O
majority	O	O
of	O	O
the	O	O
patients	O	O
were	O	O
mildly	O	O
affected	O	O
.	O	O

A	O	O
powder	O	O
preparation	O	O
of	O	O
the	O	O
oral	O	O
probiotic	B-bacteria	B-bacteria
Streptococcus	I-bacteria	I-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
has	O	O
been	O	O
given	O	O
to	O	O
19	O	O
young	O	O
otitis	O	O
media-prone	O	O
children	O	O
following	O	O
a	O	O
3-day	O	O
course	O	O
of	O	O
amoxicillin	O	O
administered	O	O
as	O	O
a	O	O
preliminary	O	O
to	O	O
ventilation	O	O
tube	O	O
placement	O	O
.	O	O

In	O	O
two	O	O
subjects	O	O
,	O	O
the	O	O
use	O	O
of	O	O
strain	B-bacteria	B-bacteria
K12	E-bacteria	I-bacteria
appeared	O	O
to	O	O
effect	O	O
the	O	O
expansion	O	O
of	O	O
an	O	O
indigenous	O	O
population	O	O
of	O	O
inhibitory	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
.	O	O

In	O	O
other	O	O
children	O	O
,	O	O
strain	B-bacteria	B-bacteria
K12	E-bacteria	I-bacteria
colonisation	O	O
extended	O	O
beyond	O	O
the	O	O
oral	O	O
cavity	O	O
to	O	O
also	O	O
include	O	O
the	O	O
nasopharynx	O	O
or	O	O
adenoid	O	O
tissue	O	O
.	O	O

The	O	O
relatively	O	O
low	O	O
proportion	O	O
(	O	O
33	O	O
%	O	O
)	O	O
of	O	O
subjects	O	O
that	O	O
colonised	O	O
was	O	O
attributed	O	O
to	O	O
failure	O	O
of	O	O
the	O	O
amoxicillin	O	O
pre-treatment	O	O
to	O	O
sufficiently	O	O
reduce	O	O
the	O	O
indigenous	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
populations	O	O
prior	O	O
to	O	O
dosing	O	O
with	O	O
strain	B-bacteria	B-bacteria
K12	E-bacteria	I-bacteria
powder	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
are	O	O
frequently	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
are	O	O
associated	O	O
with	O	O
periodontal	O	O
disease	O	O
in	O	O
both	O	O
animals	O	O
and	O	O
humans	O	O
.	O	O

Black	O	O
,	O	O
pigmented	B-bacteria	B-bacteria
Porphyromonas	I-bacteria	I-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

isolated	O	O
from	O	O
the	O	O
gingival	O	O
margins	O	O
of	O	O
selected	O	O
wild	O	O
and	O	O
captive	O	O
Australian	O	O
marsupials	O	O
with	O	O
varying	O	O
degrees	O	O
of	O	O
periodontal	O	O
disease	O	O
(	O	O
brushtail	O	O
possums	O	O
,	O	O
koalas	O	O
and	O	O
macropods	O	O
)	O	O
were	O	O
compared	O	O
phylogenetically	O	O
to	O	O
Porphyromonas	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
from	O	O
non-marsupials	O	O
(	O	O
bear	O	O
,	O	O
wolf	O	O
,	O	O
coyote	O	O
,	O	O
cats	O	O
and	O	O
dogs	O	O
)	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
from	O	O
humans	O	O
using	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
.	O	O

The	O	O
results	O	O
of	O	O
the	O	O
phylogenetic	O	O
analysis	O	O
identified	O	O
three	O	O
distinct	O	O
groups	O	O
of	O	O
strains	O	O
.	O	O

A	O	O
monophyletic	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
group	O	O
(	O	O
Group	O	O
1	O	O
)	O	O
contained	O	O
only	O	O
strains	O	O
isolated	O	O
from	O	O
humans	O	O
and	O	O
a	O	O
Porphyromonas	B-bacteria	B-bacteria
gulae	E-bacteria	I-bacteria
group	O	O
(	O	O
Group	O	O
2	O	O
)	O	O
was	O	O
divided	O	O
into	O	O
three	O	O
distinct	O	O
subclades	O	O
,	O	O
each	O	O
containing	O	O
both	O	O
marsupial	O	O
and	O	O
non-marsupial	O	O
strains	O	O
.	O	O

Group	O	O
3	O	O
,	O	O
which	O	O
contained	O	O
only	O	O
marsupial	O	O
strains	O	O
,	O	O
including	O	O
all	O	O
six	O	O
strains	O	O
isolated	O	O
from	O	O
captive	O	O
koalas	O	O
,	O	O
was	O	O
genetically	O	O
distinct	O	O
from	O	O
P.	B-bacteria	B-bacteria
gulae	E-bacteria	I-bacteria
and	O	O
may	O	O
constitute	O	O
a	O	O
new	O	O
Porphyromonas	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
influence	O	O
of	O	O
urease-positive	B-bacteria	B-bacteria
non-Helicobacter	I-bacteria	I-bacteria
pylori	E-bacteria	I-bacteria
bacteria	O	O
on	O	O
the	O	O
results	O	O
of	O	O
a	O	O
urea	O	O
breath	O	O
test	O	O
(	O	O
UBT	O	O
)	O	O
to	O	O
evaluate	O	O
the	O	O
diagnostic	O	O
utility	O	O
of	O	O
a	O	O
UBT	O	O
using	O	O
film-coated	O	O
[	O	O
(	O	O
13	O	O
)	O	O
C	O	O
]	O	O
urea	O	O
tablets	O	O
.	O	O

The	O	O
UBT	O	O
was	O	O
performed	O	O
in	O	O
102	O	O
patients	O	O
treated	O	O
with	O	O
a	O	O
proton	O	O
pump	O	O
inhibitor	O	O
and	O	O
antibiotics	O	O
for	O	O
the	O	O
eradication	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

Urease-producing	O	O
bacteria	O	O
other	O	O
than	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
were	O	O
isolated	O	O
and	O	O
identified	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
stomach	O	O
.	O	O

In	O	O
4/102	O	O
patients	O	O
,	O	O
the	O	O
UBT	O	O
gave	O	O
false-positive	O	O
results	O	O
.	O	O

These	O	O
false-positive	O	O
results	O	O
were	O	O
found	O	O
to	O	O
be	O	O
caused	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
urease-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
stomach	O	O
.	O	O

Five	O	O
bacterial	O	O
species	O	O
with	O	O
urease	O	O
activity	O	O
(	O	O
Proteus	B-bacteria	B-bacteria
mirabilis	E-bacteria	I-bacteria
,	O	O
Citrobacter	B-bacteria	B-bacteria
freundii	E-bacteria	I-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
Enterobacter	B-bacteria	B-bacteria
cloacae	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
)	O	O
were	O	O
subsequently	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
and/or	O	O
stomach	O	O
.	O	O

As	O	O
there	O	O
was	O	O
no	O	O
correlation	O	O
between	O	O
the	O	O
in	O	O
vitro	O	O
urease	O	O
activity	O	O
of	O	O
urease-positive	B-bacteria	B-bacteria
non-H.	I-bacteria	I-bacteria
pylori	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
the	O	O
UBT	O	O
value	O	O
,	O	O
and	O	O
all	O	O
of	O	O
the	O	O
patients	O	O
with	O	O
a	O	O
false-positive	O	O
UBT	O	O
result	O	O
were	O	O
suffering	O	O
from	O	O
atrophic	O	O
gastritis	O	O
,	O	O
it	O	O
is	O	O
possible	O	O
that	O	O
the	O	O
false-positive	O	O
results	O	O
in	O	O
the	O	O
UBT	O	O
were	O	O
a	O	O
result	O	O
of	O	O
colonization	O	O
of	O	O
urease-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
gastric	O	O
hypochlorhydric	O	O
conditions	O	O
.	O	O

Thus	O	O
,	O	O
for	O	O
the	O	O
diagnosis	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
using	O	O
a	O	O
UBT	O	O
,	O	O
the	O	O
influence	O	O
of	O	O
stomach	O	O
bacteria	O	O
must	O	O
be	O	O
considered	O	O
when	O	O
interpreting	O	O
the	O	O
results	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
confirm	O	O
further	O	O
the	O	O
efficacy	O	O
and	O	O
safety	O	O
of	O	O
levofloxacin	O	O
in	O	O
patients	O	O
with	O	O
chronic	O	O
bacterial	O	O
prostatitis	O	O
(	O	O
CBP	O	O
)	O	O
in	O	O
Europe	O	O
.	O	O

Men	O	O
with	O	O
a	O	O
history	O	O
of	O	O
CBP	O	O
were	O	O
enrolled	O	O
in	O	O
a	O	O
prospective	O	O
,	O	O
multinational	O	O
(	O	O
eight	O	O
countries	O	O
)	O	O
,	O	O
open-label	O	O
study	O	O
to	O	O
receive	O	O
levofloxacin	O	O
500	O	O
mg	O	O
once	O	O
daily	O	O
per	O	O
os	O	O
(	O	O
p.o	O	O
.	O	O
)	O	O

for	O	O
28	O	O
days	O	O
.	O	O

Patients	O	O
were	O	O
followed	O	O
for	O	O
6	O	O
months	O	O
.	O	O

A	O	O
total	O	O
of	O	O
117	O	O
patients	O	O
were	O	O
treated	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
identified	O	O
in	O	O
57/106	O	O
patients	O	O
(	O	O
mainly	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
(	O	O
n=37	O	O
)	O	O
)	O	O
and	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
60/106	O	O
patients	O	O
(	O	O
mainly	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
(	O	O
n=18	O	O
)	O	O
and	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
(	O	O
n=14	O	O
)	O	O
)	O	O
.	O	O

Among	O	O
the	O	O
intention-to-treat	O	O
population	O	O
(	O	O
n=116	O	O
)	O	O
,	O	O
the	O	O
clinical	O	O
success	O	O
rate	O	O
(	O	O
cured	O	O
and	O	O
improved	O	O
patients	O	O
)	O	O
was	O	O
92	O	O
%	O	O
(	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
(	O	O
CI	O	O
)	O	O
84.8-96.5	O	O
%	O	O
)	O	O
,	O	O
77.4	O	O
%	O	O
(	O	O
95	O	O
%	O	O
CI	O	O
68.2-84.9	O	O
%	O	O
)	O	O
,	O	O
66.0	O	O
%	O	O
(	O	O
95	O	O
%	O	O
CI	O	O
56.2-75.0	O	O
%	O	O
)	O	O
and	O	O
61.9	O	O
%	O	O
(	O	O
95	O	O
%	O	O
CI	O	O
51.9-71.2	O	O
%	O	O
)	O	O
at	O	O
5-12	O	O
days	O	O
,	O	O
1	O	O
month	O	O
,	O	O
3	O	O
months	O	O
and	O	O
6	O	O
months	O	O
post	O	O
treatment	O	O
.	O	O

The	O	O
microbiological	O	O
eradication	O	O
rate	O	O
according	O	O
to	O	O
evaluation	O	O
scheme	O	O
II	O	O
was	O	O
82/98	O	O
(	O	O
83.7	O	O
%	O	O
,	O	O
95	O	O
%	O	O
CI	O	O
74.8-90.4	O	O
%	O	O
)	O	O
at	O	O
1	O	O
month	O	O
and	O	O
the	O	O
continued	O	O
eradication	O	O
rate	O	O
was	O	O
52/57	O	O
(	O	O
91.2	O	O
%	O	O
,	O	O
95	O	O
%	O	O
CI	O	O
80.7-97.1	O	O
%	O	O
)	O	O
at	O	O
6	O	O
months	O	O
post	O	O
treatment	O	O
.	O	O

Comparison	O	O
of	O	O
four	O	O
classification	O	O
schemes	O	O
showed	O	O
similar	O	O
results	O	O
.	O	O

Thus	O	O
,	O	O
the	O	O
present	O	O
investigation	O	O
is	O	O
suitably	O	O
comparable	O	O
in	O	O
methods	O	O
and	O	O
results	O	O
to	O	O
previous	O	O
studies	O	O
.	O	O

Levofloxacin	O	O
was	O	O
well	O	O
tolerated	O	O
.	O	O

Four	O	O
patients	O	O
(	O	O
3.4	O	O
%	O	O
)	O	O
discontinued	O	O
therapy	O	O
due	O	O
to	O	O
adverse	O	O
events	O	O
and	O	O
15	O	O
patients	O	O
(	O	O
12.8	O	O
%	O	O
)	O	O
experienced	O	O
at	O	O
least	O	O
one	O	O
adverse	O	O
event	O	O
.	O	O

Levofloxacin	O	O
500	O	O
mg	O	O
p.o	O	O
.	O	O

once	O	O
daily	O	O
for	O	O
28	O	O
days	O	O
is	O	O
clinically	O	O
and	O	O
microbiologically	O	O
effective	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
CBP	O	O
caused	O	O
by	O	O
susceptible	O	O
pathogens	O	O
and	O	O
is	O	O
well	O	O
tolerated	O	O
.	O	O

Hydroxychavicol	O	O
isolated	O	O
from	O	O
the	O	O
chloroform	O	O
extraction	O	O
of	O	O
aqueous	O	O
extract	O	O
of	O	O
Piper	O	O
betle	O	O
leaves	O	O
showed	O	O
inhibitory	O	O
activity	O	O
against	O	O
oral	O	O
cavity	O	O
pathogens	O	O
.	O	O

It	O	O
exhibited	O	O
an	O	O
inhibitory	O	O
effect	O	O
on	O	O
all	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
pathogens	O	O
tested	O	O
(	O	O
MICs	O	O
of	O	O
62.5	O	O
to	O	O
500	O	O
microg/ml	O	O
)	O	O
with	O	O
a	O	O
minimal	O	O
bactericidal	O	O
concentration	O	O
that	O	O
was	O	O
twofold	O	O
greater	O	O
than	O	O
the	O	O
inhibitory	O	O
concentration	O	O
.	O	O

Hydroxychavicol	O	O
exhibited	O	O
concentration-dependent	O	O
killing	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25175	E-bacteria	I-bacteria
up	O	O
to	O	O
4x	O	O
MIC	O	O
and	O	O
also	O	O
prevented	O	O
the	O	O
formation	O	O
of	O	O
water-insoluble	O	O
glucan	O	O
.	O	O

Interestingly	O	O
,	O	O
hydroxychavicol	O	O
exhibited	O	O
an	O	O
extended	O	O
postantibiotic	O	O
effect	O	O
of	O	O
6	O	O
to	O	O
7	O	O
h	O	O
and	O	O
prevented	O	O
the	O	O
emergence	O	O
of	O	O
mutants	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25175	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
15987	E-bacteria	I-bacteria
at	O	O
2x	O	O
MIC	O	O
.	O	O

Furthermore	O	O
,	O	O
it	O	O
also	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
biofilms	O	O
generated	O	O
by	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
and	O	O
reduced	O	O
the	O	O
preformed	O	O
biofilms	O	O
by	O	O
these	O	O
bacteria	O	O
.	O	O

Increased	O	O
uptake	O	O
of	O	O
propidium	O	O
iodide	O	O
by	O	O
hydroxychavicol-treated	O	O
cells	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
indicated	O	O
that	O	O
hydroxychavicol	O	O
probably	O	O
works	O	O
through	O	O
the	O	O
disruption	O	O
of	O	O
the	O	O
permeability	O	O
barrier	O	O
of	O	O
microbial	O	O
membrane	O	O
structures	O	O
.	O	O

Hydroxychavicol	O	O
also	O	O
exhibited	O	O
potent	O	O
antioxidant	O	O
and	O	O
anti-inflammatory	O	O
activities	O	O
.	O	O

This	O	O
was	O	O
evident	O	O
from	O	O
its	O	O
concentration-dependent	O	O
inhibition	O	O
of	O	O
lipid	O	O
peroxidation	O	O
and	O	O
significant	O	O
suppression	O	O
of	O	O
tumor	O	O
necrosis	O	O
factor	O	O
alpha	O	O
expression	O	O
in	O	O
human	O	O
neutrophils	O	O
.	O	O

Its	O	O
efficacy	O	O
against	O	O
adherent	O	O
cells	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
water-insoluble	O	O
glucan	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
sucrose	O	O
suggests	O	O
that	O	O
hydroxychavicol	O	O
would	O	O
be	O	O
a	O	O
useful	O	O
compound	O	O
for	O	O
the	O	O
development	O	O
of	O	O
antibacterial	O	O
agents	O	O
against	O	O
oral	O	O
pathogens	O	O
and	O	O
that	O	O
it	O	O
has	O	O
great	O	O
potential	O	O
for	O	O
use	O	O
in	O	O
mouthwash	O	O
for	O	O
preventing	O	O
and	O	O
treating	O	O
oral	O	O
infections	O	O
.	O	O

The	O	O
use	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
is	O	O
increasing	O	O
worldwide	O	O
and	O	O
at	O	O
least	O	O
some	O	O
of	O	O
them	O	O
can	O	O
transiently	O	O
colonize	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Several	O	O
studies	O	O
have	O	O
shown	O	O
that	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
which	O	O
are	O	O
often	O	O
thought	O	O
of	O	O
in	O	O
relation	O	O
only	O	O
to	O	O
intestinal	O	O
health	O	O
,	O	O
can	O	O
also	O	O
affect	O	O
the	O	O
oral	O	O
ecology	O	O
,	O	O
but	O	O
the	O	O
mechanisms	O	O
for	O	O
this	O	O
are	O	O
largely	O	O
unknown	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
in	O	O
vitro	O	O
if	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
used	O	O
in	O	O
commercial	O	O
products	O	O
affect	O	O
the	O	O
protein	O	O
composition	O	O
of	O	O
the	O	O
salivary	O	O
pellicle	O	O
and	O	O
the	O	O
adherence	O	O
of	O	O
other	O	O
oral	O	O
bacteria	O	O
.	O	O

salivary	O	O
pellicle	O	O
on	O	O
hydroxyapatite	O	O
and	O	O
the	O	O
adhesion	O	O
of	O	O
two	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
were	O	O
used	O	O
as	O	O
a	O	O
model	O	O
.	O	O

Probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
that	O	O
bound	O	O
to	O	O
saliva-coated	O	O
hydroxyapatite	O	O
reduced	O	O
the	O	O
adhesion	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
but	O	O
the	O	O
inhibitory	O	O
effect	O	O
on	O	O
the	O	O
adherence	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
was	O	O
weaker	O	O
.	O	O

salivary	O	O
pellicle	O	O
protein	O	O
composition	O	O
was	O	O
modified	O	O
by	O	O
all	O	O
the	O	O
strains	O	O
tested	O	O
.	O	O

The	O	O
modifications	O	O
in	O	O
the	O	O
pellicle	O	O
affected	O	O
the	O	O
adherence	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
but	O	O
not	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

Two	O	O
of	O	O
the	O	O
proteins	O	O
missing	O	O
from	O	O
the	O	O
pellicles	O	O
made	O	O
of	O	O
saliva-treated	O	O
with	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
identified	O	O
as	O	O
salivary	O	O
agglutinin	O	O
gp340	O	O
and	O	O
salivary	O	O
peroxidase	O	O
.	O	O

All	O	O
bacterial	O	O
strains	O	O
bound	O	O
salivary	O	O
agglutinin	O	O
gp340	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
the	O	O
probiotic	O	O
bacteria	O	O
to	O	O
degrade	O	O
peroxidase	O	O
was	O	O
demonstrated	O	O
with	O	O
purified	O	O
bovine	O	O
lactoperoxidase	O	O
and	O	O
two	O	O
of	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
.	O	O

This	O	O
in	O	O
vitro	O	O
study	O	O
showed	O	O
that	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
used	O	O
in	O	O
commercial	O	O
products	O	O
may	O	O
affect	O	O
the	O	O
oral	O	O
ecology	O	O
by	O	O
specifically	O	O
preventing	O	O
the	O	O
adherence	O	O
of	O	O
other	O	O
bacteria	O	O
and	O	O
by	O	O
modifying	O	O
the	O	O
protein	O	O
composition	O	O
of	O	O
the	O	O
salivary	O	O
pellicle	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
characterize	O	O
a	O	O
novel	O	O
conjugative	O	O
transposon	O	O
Tn6009	O	O
composed	O	O
of	O	O
a	O	O
Tn916	O	O
linked	O	O
to	O	O
a	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
mer	O	O
operon	O	O
in	O	O
representative	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
isolated	O	O
in	O	O
Nigeria	O	O
and	O	O
Portugal	O	O
.	O	O

Eighty-three	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
34	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
screened	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
Tn6009	O	O
using	O	O
DNA-DNA	O	O
hybridization	O	O
,	O	O
PCR	O	O
,	O	O
hybridization	O	O
of	O	O
PCR	O	O
products	O	O
,	O	O
sequencing	O	O
and	O	O
mating	O	O
experiments	O	O
by	O	O
established	O	O
procedures	O	O
.	O	O

Forty-three	O	O
oral	O	O
and	O	O
23	O	O
urine	O	O
Gram-negative	O	O
and	O	O
Gram-positive	O	O
isolates	O	O
carried	O	O
the	O	O
Tn6009	O	O
.	O	O

Sequencing	O	O
was	O	O
performed	O	O
to	O	O
verify	O	O
the	O	O
direct	O	O
linkage	O	O
between	O	O
the	O	O
mer	O	O
resistance	O	O
genes	O	O
and	O	O
the	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
gene	O	O
.	O	O

A	O	O
Nigerian	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
isolated	O	O
from	O	O
a	O	O
urinary	O	O
tract	O	O
infection	O	O
patient	O	O
,	O	O
and	O	O
one	O	O
commensal	O	O
isolate	O	O
from	O	O
each	O	O
of	O	O
the	O	O
other	O	O
Tn6009-positive	O	O
genera	O	O
,	O	O
Serratia	B-bacteria	B-bacteria
liquefaciens	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

and	O	O
Streptococcus	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

isolated	O	O
from	O	O
the	O	O
oral	O	O
and	O	O
urine	O	O
samples	O	O
of	O	O
healthy	O	O
Portuguese	O	O
children	O	O
,	O	O
were	O	O
able	O	O
to	O	O
act	O	O
as	O	O
donors	O	O
and	O	O
conjugally	O	O
transfer	O	O
the	O	O
Tn6009	O	O
to	O	O
the	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	I-bacteria	I-bacteria
JH2-2	E-bacteria	I-bacteria
recipient	O	O
,	O	O
resulting	O	O
in	O	O
tetracycline-	O	O
and	O	O
mercury-resistant	B-bacteria	B-bacteria
E.	I-bacteria	I-bacteria
faecalis	E-bacteria	I-bacteria
transconjugants	O	O
.	O	O

This	O	O
study	O	O
reports	O	O
a	O	O
novel	O	O
non-composite	O	O
conjugative	O	O
transposon	O	O
Tn6009	O	O
containing	O	O
a	O	O
Tn916	O	O
element	O	O
linked	O	O
to	O	O
an	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
mer	O	O
operon	O	O
carrying	O	O
genes	O	O
coding	O	O
for	O	O
inorganic	O	O
mercury	O	O
resistance	O	O
(	O	O
merA	O	O
)	O	O
,	O	O
an	O	O
organic	O	O
mercury	O	O
resistance	O	O
(	O	O
merB	O	O
)	O	O
,	O	O
a	O	O
regulatory	O	O
protein	O	O
(	O	O
merR	O	O
)	O	O
and	O	O
a	O	O
mercury	O	O
transporter	O	O
(	O	O
merT	O	O
)	O	O
.	O	O

This	O	O
transposon	O	O
was	O	O
identified	O	O
in	O	O
66	O	O
isolates	O	O
from	O	O
two	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
three	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
genera	E-bacteria	I-bacteria
and	O	O
is	O	O
the	O	O
first	O	O
transposon	O	O
in	O	O
the	O	O
Tn916	O	O
family	O	O
to	O	O
carry	O	O
the	O	O
Gram-positive	O	O
mer	O	O
genes	O	O
directly	O	O
linked	O	O
to	O	O
the	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
gene	O	O
.	O	O

Bacterial	O	O
vaginosis	O	O
frequently	O	O
persists	O	O
after	O	O
treatment	O	O
.	O	O

The	O	O
role	O	O
of	O	O
newly	O	O
defined	O	O
bacterial	O	O
vaginosis-associated	O	O
bacteria	O	O
(	O	O
BVAB	O	O
)	O	O
,	O	O
which	O	O
have	O	O
a	O	O
specificity	O	O
for	O	O
this	O	O
condition	O	O
of	O	O
97	O	O
%	O	O
or	O	O
greater	O	O
,	O	O
has	O	O
not	O	O
been	O	O
assessed	O	O
.	O	O

To	O	O
define	O	O
risks	O	O
for	O	O
bacterial	O	O
vaginosis	O	O
persistence	O	O
,	O	O
including	O	O
pretreatment	O	O
detection	O	O
of	O	O
specific	O	O
vaginal	O	O
bacteria	O	O
,	O	O
among	O	O
women	O	O
reporting	O	O
sex	O	O
with	O	O
women	O	O
.	O	O

Observational	O	O
cohort	O	O
study	O	O
.	O	O

University-based	O	O
research	O	O
clinic	O	O
.	O	O

335	O	O
women	O	O
age	O	O
16	O	O
to	O	O
29	O	O
years	O	O
reporting	O	O
sex	O	O
with	O	O
at	O	O
least	O	O
1	O	O
woman	O	O
in	O	O
the	O	O
past	O	O
year	O	O
.	O	O

Participants	O	O
were	O	O
recruited	O	O
through	O	O
advertisements	O	O
and	O	O
provider	O	O
referral	O	O
.	O	O

Bacterial	O	O
vaginosis	O	O
was	O	O
treated	O	O
with	O	O
intravaginal	O	O
metronidazole	O	O
gel	O	O
(	O	O
0.75	O	O
%	O	O
)	O	O
,	O	O
37.5	O	O
mg	O	O
nightly	O	O
for	O	O
5	O	O
nights	O	O
.	O	O

Species-specific	O	O
16S	O	O
recombinant	O	O
DNA	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assays	O	O
targeting	O	O
17	O	O
bacterial	O	O
species	O	O
were	O	O
applied	O	O
to	O	O
vaginal	O	O
fluid	O	O
obtained	O	O
at	O	O
baseline	O	O
.	O	O

Test	O	O
of	O	O
cure	O	O
by	O	O
clinical	O	O
criteria	O	O
and	O	O
Gram	O	O
stain	O	O
analysis	O	O
and	O	O
repeated	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assays	O	O
of	O	O
vaginal	O	O
fluid	O	O
were	O	O
performed	O	O
1	O	O
month	O	O
after	O	O
treatment	O	O
,	O	O
and	O	O
interim	O	O
behaviors	O	O
were	O	O
assessed	O	O
by	O	O
using	O	O
computer-assisted	O	O
self-interview	O	O
.	O	O

Of	O	O
335	O	O
women	O	O
,	O	O
24	O	O
%	O	O
of	O	O
whom	O	O
also	O	O
reported	O	O
sex	O	O
with	O	O
men	O	O
within	O	O
3	O	O
months	O	O
before	O	O
enrollment	O	O
,	O	O
131	O	O
(	O	O
39	O	O
%	O	O
)	O	O
had	O	O
bacterial	O	O
vaginosis	O	O
.	O	O

In	O	O
the	O	O
120	O	O
(	O	O
92	O	O
%	O	O
)	O	O
women	O	O
who	O	O
returned	O	O
for	O	O
follow-up	O	O
,	O	O
the	O	O
incidence	O	O
of	O	O
persistent	O	O
bacterial	O	O
vaginosis	O	O
was	O	O
26	O	O
%	O	O
and	O	O
was	O	O
statistically	O	O
significantly	O	O
higher	O	O
in	O	O
women	O	O
with	O	O
baseline	O	O
detection	O	O
of	O	O
3	O	O
Clostridiales	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
designated	O	O
as	O	O
BVAB1	O	O
(	O	O
risk	O	O
ratio	O	O
,	O	O
2.0	O	O
[	O	O
95	O	O
%	O	O
CI	O	O
,	O	O
1.1	O	O
to	O	O
4.0	O	O
]	O	O
)	O	O
,	O	O
BVAB2	O	O
(	O	O
risk	O	O
ratio	O	O
,	O	O
8.7	O	O
[	O	O
CI	O	O
,	O	O
2.5	O	O
to	O	O
infinity	O	O
]	O	O
)	O	O
,	O	O
or	O	O
BVAB3	O	O
(	O	O
risk	O	O
ratio	O	O
,	O	O
3.1	O	O
[	O	O
CI	O	O
,	O	O
1.7	O	O
to	O	O
5.8	O	O
]	O	O
)	O	O
;	O	O
Peptoniphilus	B-bacteria	B-bacteria
lacrimalis	E-bacteria	I-bacteria
(	O	O
risk	O	O
ratio	O	O
,	O	O
3.5	O	O
[	O	O
CI	O	O
,	O	O
1.6	O	O
to	O	O
15.5	O	O
]	O	O
)	O	O
;	O	O
and	O	O
Megasphaera	B-bacteria	B-bacteria
phylotype	E-bacteria	I-bacteria
2	O	O
(	O	O
risk	O	O
ratio	O	O
,	O	O
3.4	O	O
[	O	O
CI	O	O
,	O	O
1.4	O	O
to	O	O
5.5	O	O
]	O	O
)	O	O
.	O	O

Persistence	O	O
was	O	O
lower	O	O
with	O	O
treatment	O	O
adherence	O	O
(	O	O
risk	O	O
ratio	O	O
,	O	O
0.4	O	O
[	O	O
0.2	O	O
to	O	O
0.9	O	O
]	O	O
)	O	O
.	O	O

Detection	O	O
of	O	O
these	O	O
bacteria	O	O
at	O	O
the	O	O
test-of-cure	O	O
visit	O	O
was	O	O
associated	O	O
with	O	O
persistence	O	O
,	O	O
whereas	O	O
posttreatment	O	O
sexual	O	O
activity	O	O
was	O	O
not	O	O
.	O	O

LIMITATIONS	O	O
:	O	O
Findings	O	O
may	O	O
not	O	O
be	O	O
generalizable	O	O
to	O	O
women	O	O
who	O	O
have	O	O
sex	O	O
only	O	O
with	O	O
men	O	O
,	O	O
or	O	O
to	O	O
women	O	O
whose	O	O
bacterial	O	O
vaginosis	O	O
is	O	O
treated	O	O
with	O	O
oral	O	O
antibiotics	O	O
.	O	O

The	O	O
study	O	O
may	O	O
be	O	O
too	O	O
small	O	O
and	O	O
may	O	O
involve	O	O
a	O	O
population	O	O
that	O	O
is	O	O
too	O	O
highly	O	O
selected	O	O
to	O	O
draw	O	O
definitive	O	O
conclusions	O	O
about	O	O
associations	O	O
of	O	O
persistent	O	O
infection	O	O
with	O	O
posttreatment	O	O
sexual	O	O
behaviors	O	O
.	O	O

Persistent	O	O
bacterial	O	O
vaginosis	O	O
is	O	O
associated	O	O
with	O	O
several	O	O
bacteria	O	O
in	O	O
the	O	O
Clostridiales	B-bacteria	B-bacteria
order	O	O
,	O	O
Megasphaera	O	O
phylotype	O	O
2	O	O
,	O	O
and	O	O
P.	O	O
lacrimalis	O	O
,	O	O
suggesting	O	O
that	O	O
vaginal	O	O
microbiology	O	O
at	O	O
diagnosis	O	O
may	O	O
determine	O	O
risk	O	O
for	O	O
antibiotic	O	O
failure	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
oral	O	O
bacteria	O	O
to	O	O
enter	O	O
a	O	O
non-growing	O	O
state	O	O
is	O	O
believed	O	O
to	O	O
be	O	O
an	O	O
important	O	O
mechanism	O	O
for	O	O
survival	O	O
in	O	O
the	O	O
starved	O	O
micro-environments	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
reactivation	O	O
of	O	O
nutrient-deprived	O	O
cells	O	O
of	O	O
two	O	O
oral	O	O
bacteria	O	O
in	O	O
biofilms	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
.	O	O

Non-growing	O	O
cells	O	O
were	O	O
generated	O	O
by	O	O
incubation	O	O
in	O	O
10	O	O
mM	O	O
potassium	O	O
phosphate	O	O
buffer	O	O
for	O	O
24	O	O
h	O	O
and	O	O
the	O	O
results	O	O
were	O	O
compared	O	O
to	O	O
those	O	O
of	O	O
planktonic	O	O
cultures	O	O
.	O	O

When	O	O
both	O	O
types	O	O
of	O	O
cells	O	O
were	O	O
shifted	O	O
from	O	O
a	O	O
rich	O	O
,	O	O
peptone-yeast	O	O
extract-glucose	O	O
(	O	O
PYG	O	O
)	O	O
medium	O	O
to	O	O
buffer	O	O
for	O	O
24	O	O
h	O	O
,	O	O
dehydrogenase	O	O
and	O	O
esterase	O	O
activity	O	O
measured	O	O
by	O	O
the	O	O
fluorescent	O	O
dyes	O	O
5-cyano-2,3-ditolyl-tetrazolium	O	O
chloride	O	O
(	O	O
CTC	O	O
)	O	O
and	O	O
fluorescein	O	O
diacetate	O	O
(	O	O
FDA	O	O
)	O	O
,	O	O
respectively	O	O
,	O	O
was	O	O
absent	O	O
in	O	O
both	O	O
species	O	O
.	O	O

However	O	O
,	O	O
the	O	O
membranes	O	O
of	O	O
the	O	O
vast	O	O
majority	O	O
of	O	O
nutrient-deprived	O	O
cells	O	O
remained	O	O
intact	O	O
as	O	O
assessed	O	O
by	O	O
LIVE/DEAD	O	O
staining	O	O
.	O	O

Metabolic	O	O
reactivation	O	O
of	O	O
the	O	O
nutrient-deprived	O	O
biofilm	O	O
cells	O	O
was	O	O
not	O	O
observed	O	O
for	O	O
at	O	O
least	O	O
48	O	O
h	O	O
following	O	O
addition	O	O
of	O	O
fresh	O	O
PYG	O	O
medium	O	O
,	O	O
whereas	O	O
the	O	O
non-growing	O	O
planktonic	O	O
cultures	O	O
of	O	O
the	O	O
same	O	O
two	O	O
strains	O	O
were	O	O
in	O	O
rapid	O	O
growth	O	O
in	O	O
less	O	O
than	O	O
2	O	O
h.	O	O
At	O	O
72	O	O
h	O	O
,	O	O
the	O	O
S.	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
biofilm	O	O
cells	O	O
had	O	O
recovered	O	O
78	O	O
%	O	O
of	O	O
the	O	O
dehydrogenase	O	O
activity	O	O
and	O	O
61	O	O
%	O	O
of	O	O
the	O	O
esterase	O	O
activity	O	O
and	O	O
the	O	O
biomass	O	O
mm	O	O
(	O	O
-2	O	O
)	O	O
had	O	O
increased	O	O
by	O	O
30-35	O	O
%	O	O
.	O	O

With	O	O
L.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
at	O	O
72	O	O
h	O	O
,	O	O
the	O	O
biofilms	O	O
had	O	O
recovered	O	O
56	O	O
%	O	O
and	O	O
75	O	O
%	O	O
of	O	O
dehydrogenase	O	O
and	O	O
esterase	O	O
activity	O	O
,	O	O
respectively	O	O
.	O	O

Reactivation	O	O
of	O	O
both	O	O
species	O	O
in	O	O
biofilms	O	O
was	O	O
enhanced	O	O
by	O	O
removal	O	O
of	O	O
glucose	O	O
from	O	O
PYG	O	O
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
cells	O	O
were	O	O
particularly	O	O
responsive	O	O
to	O	O
yeast	O	O
extract	O	O
(	O	O
YE	O	O
)	O	O
medium	O	O
.	O	O

The	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
low	O	O
reactivity	O	O
of	O	O
non-growing	O	O
biofilm	O	O
cells	O	O
to	O	O
the	O	O
introduction	O	O
of	O	O
fresh	O	O
nutrients	O	O
may	O	O
be	O	O
a	O	O
survival	O	O
strategy	O	O
employed	O	O
by	O	O
micro-organisms	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Many	O	O
neuropeptides	O	O
are	O	O
similar	O	O
in	O	O
size	O	O
,	O	O
amino	O	O
acid	O	O
composition	O	O
and	O	O
charge	O	O
to	O	O
antimicrobial	O	O
peptides	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
determine	O	O
whether	O	O
the	O	O
neuropeptides	O	O
substance	O	O
P	O	O
(	O	O
SP	O	O
)	O	O
,	O	O
neurokinin	O	O
A	O	O
(	O	O
NKA	O	O
)	O	O
,	O	O
calcitonin	O	O
gene-related	O	O
peptide	O	O
(	O	O
CGRP	O	O
)	O	O
,	O	O
neuropeptide	O	O
Y	O	O
(	O	O
NPY	O	O
)	O	O
and	O	O
vasoactive	O	O
intestinal	O	O
polypeptide	O	O
(	O	O
VIP	O	O
)	O	O
,	O	O
displayed	O	O
antimicrobial	O	O
activity	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Candida	O	O
albicans	O	O
.	O	O

SP	O	O
,	O	O
NPY	O	O
,	O	O
VIP	O	O
and	O	O
CGRP	O	O
displayed	O	O
variable	O	O
degrees	O	O
of	O	O
antimicrobial	O	O
activity	O	O
against	O	O
all	O	O
the	O	O
pathogens	O	O
tested	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

These	O	O
antimicrobial	O	O
activities	O	O
add	O	O
a	O	O
further	O	O
dimension	O	O
to	O	O
the	O	O
immunomodulatory	O	O
roles	O	O
for	O	O
neuropeptides	O	O
in	O	O
the	O	O
inflammatory	O	O
and	O	O
immune	O	O
responses	O	O
.	O	O

Glucosyltransferases	O	O
(	O	O
GTF	O	O
)	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
adherence	O	O
of	O	O
bacteria	O	O
to	O	O
acquired	O	O
pellicle	O	O
.	O	O

Cocoa	O	O
bean	O	O
husk	O	O
extract	O	O
(	O	O
CBHE	O	O
)	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
possess	O	O
anti-glucosyltransferase	O	O
and	O	O
antibacterial	O	O
activity	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
CBHE	O	O
on	O	O
plaque	O	O
accumulation	O	O
and	O	O
mutans	B-bacteria	B-bacteria
streptococcus	E-bacteria	I-bacteria
count	O	O
when	O	O
used	O	O
as	O	O
a	O	O
mouth	O	O
rinse	O	O
by	O	O
children	O	O
.	O	O

Scaling	O	O
of	O	O
the	O	O
teeth	O	O
of	O	O
the	O	O
selected	O	O
children	O	O
was	O	O
done	O	O
and	O	O
the	O	O
children	O	O
were	O	O
instructed	O	O
to	O	O
refrain	O	O
from	O	O
their	O	O
routine	O	O
oral	O	O
hygiene	O	O
practices	O	O
till	O	O
the	O	O
morning	O	O
of	O	O
the	O	O
fourth	O	O
day	O	O
;	O	O
they	O	O
were	O	O
instead	O	O
given	O	O
a	O	O
placebo	O	O
mouth	O	O
rinse	O	O
for	O	O
use	O	O
during	O	O
this	O	O
period	O	O
.	O	O

On	O	O
the	O	O
fourth	O	O
day	O	O
,	O	O
saliva	O	O
was	O	O
collected	O	O
from	O	O
each	O	O
subject	O	O
for	O	O
microbiological	O	O
analysis	O	O
and	O	O
plaque	O	O
was	O	O
disclosed	O	O
and	O	O
scored	O	O
using	O	O
the	O	O
modified	O	O
Quigley	O	O
and	O	O
Hein	O	O
plaque	O	O
index	O	O
;	O	O
later	O	O
,	O	O
the	O	O
teeth	O	O
were	O	O
cleaned	O	O
.	O	O

After	O	O
1	O	O
week	O	O
,	O	O
scaling	O	O
of	O	O
the	O	O
subjects	O	O
was	O	O
done	O	O
and	O	O
they	O	O
were	O	O
given	O	O
CBHE	O	O
mouth	O	O
rinse	O	O
to	O	O
rinse	O	O
their	O	O
mouth	O	O
,	O	O
following	O	O
the	O	O
above	O	O
protocol	O	O
.	O	O

The	O	O
data	O	O
was	O	O
statistically	O	O
analyzed	O	O
using	O	O
Wilcoxon	O	O
's	O	O
signed	O	O
rank	O	O
test	O	O
.	O	O

There	O	O
was	O	O
a	O	O
20.9	O	O
%	O	O
decrease	O	O
in	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
counts	O	O
and	O	O
a	O	O
49.6	O	O
%	O	O
decrease	O	O
in	O	O
plaque	O	O
scores	O	O
in	O	O
the	O	O
CBHE	O	O
group	O	O
as	O	O
compared	O	O
to	O	O
the	O	O
placebo	O	O
group	O	O
,	O	O
which	O	O
was	O	O
highly	O	O
significant	O	O
(	O	O
P	O	O
value	O	O
Conclusion	O	O
:	O	O
CBHE	O	O
is	O	O
highly	O	O
effective	O	O
in	O	O
reducing	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
counts	O	O
and	O	O
plaque	O	O
deposition	O	O
when	O	O
used	O	O
as	O	O
a	O	O
mouth	O	O
rinse	O	O
by	O	O
children	O	O
.	O	O

People	O	O
living	O	O
without	O	O
piped	O	O
water	O	O
and	O	O
sewer	O	O
can	O	O
be	O	O
at	O	O
increased	O	O
risk	O	O
for	O	O
diseases	O	O
transmitted	O	O
via	O	O
the	O	O
fecal-oral	O	O
route	O	O
.	O	O

One	O	O
rural	O	O
Alaskan	O	O
community	O	O
that	O	O
relies	O	O
on	O	O
hauling	O	O
water	O	O
into	O	O
homes	O	O
and	O	O
sewage	O	O
from	O	O
homes	O	O
was	O	O
studied	O	O
to	O	O
determine	O	O
the	O	O
pathways	O	O
of	O	O
fecal	O	O
contamination	O	O
of	O	O
drinking	O	O
water	O	O
and	O	O
the	O	O
human	O	O
environment	O	O
so	O	O
that	O	O
barriers	O	O
can	O	O
be	O	O
established	O	O
to	O	O
protect	O	O
health	O	O
.	O	O

Samples	O	O
were	O	O
tested	O	O
for	O	O
the	O	O
fecal	O	O
indicator	O	O
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
less	O	O
specific	O	O
indicator	O	O
group	O	O
,	O	O
total	O	O
coliforms	B-bacteria	B-bacteria
.	O	O

Shoes	O	O
transported	O	O
fecal	O	O
contamination	O	O
from	O	O
outside	O	O
to	O	O
floor	O	O
material	O	O
inside	O	O
buildings	O	O
.	O	O

Contamination	O	O
in	O	O
puddles	O	O
on	O	O
the	O	O
road	O	O
,	O	O
in	O	O
conjunction	O	O
with	O	O
contamination	O	O
found	O	O
on	O	O
all-terrain	O	O
vehicle	O	O
(	O	O
ATV	O	O
)	O	O
tires	O	O
,	O	O
supports	O	O
vehicle	O	O
traffic	O	O
as	O	O
a	O	O
mechanism	O	O
for	O	O
transporting	O	O
contamination	O	O
from	O	O
the	O	O
dumpsite	O	O
or	O	O
other	O	O
source	O	O
areas	O	O
to	O	O
the	O	O
rest	O	O
of	O	O
the	O	O
community	O	O
.	O	O

The	O	O
abundance	O	O
of	O	O
fecal	O	O
bacteria	O	O
transported	O	O
around	O	O
the	O	O
community	O	O
on	O	O
shoes	O	O
and	O	O
ATV	O	O
tires	O	O
suggests	O	O
that	O	O
centralized	O	O
measures	O	O
for	O	O
waste	O	O
disposal	O	O
as	O	O
well	O	O
as	O	O
shoe	O	O
removal	O	O
in	O	O
buildings	O	O
could	O	O
improve	O	O
sanitation	O	O
and	O	O
health	O	O
in	O	O
the	O	O
community	O	O
.	O	O

Bacterial	O	O
glycosyltransferases	O	O
have	O	O
drawn	O	O
growing	O	O
attention	O	O
as	O	O
economical	O	O
enzymes	O	O
for	O	O
oligosaccharide	O	O
synthesis	O	O
,	O	O
with	O	O
their	O	O
easy	O	O
expression	O	O
and	O	O
relatively	O	O
broad	O	O
substrate	O	O
specificity	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
characterized	O	O
a	O	O
glycosyltransferase	O	O
homolog	O	O
(	O	O
Fnu_GT	O	O
)	O	O
from	O	O
a	O	O
human	O	O
oral	O	O
pathogen	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Bioinformatic	O	O
analysis	O	O
showed	O	O
that	O	O
Fnu_GT	O	O
belongs	O	O
to	O	O
the	O	O
glycosyltransferases	O	O
family	O	O
II	O	O
.	O	O

The	O	O
recombinant	O	O
Fnu_GT	O	O
(	O	O
rFnu_GT	O	O
)	O	O
expressed	O	O
in	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
displayed	O	O
the	O	O
highest	O	O
glycosylation	O	O
activity	O	O
when	O	O
UDP-galactose	O	O
(	O	O
Gal	O	O
)	O	O
was	O	O
used	O	O
as	O	O
a	O	O
donor	O	O
nucleotide-sugar	O	O
with	O	O
heptose	O	O
or	O	O
Nacetylglucosamine	O	O
(	O	O
GlcNAc	O	O
)	O	O
as	O	O
an	O	O
acceptor	O	O
sugar	O	O
.	O	O

Interestingly	O	O
,	O	O
rFnu_GT	O	O
transferred	O	O
the	O	O
galactose	O	O
moiety	O	O
of	O	O
UDP-Gal	O	O
to	O	O
a	O	O
nonreducing	O	O
terminal	O	O
GlcNAc	O	O
attached	O	O
to	O	O
the	O	O
trimannosyl	O	O
core	O	O
glycan	O	O
,	O	O
indicating	O	O
its	O	O
potential	O	O
as	O	O
an	O	O
enzyme	O	O
for	O	O
humantype	O	O
N-glycan	O	O
synthesis	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
is	O	O
was	O	O
to	O	O
evaluate	O	O
anaerobic	O	O
periodontal	O	O
microbes	O	O
in	O	O
120	O	O
postpartum	O	O
mothers	O	O
.	O	O

Group	O	O
I	O	O
consisted	O	O
of	O	O
mothers	O	O
with	O	O
a	O	O
birth	O	O
weight	O	O
of	O	O
less	O	O
than	O	O
2,500g	O	O
and	O	O
gestational	O	O
age	O	O
<	O	O
37	O	O
weeks	O	O
.	O	O

Group	O	O
II	O	O
included	O	O
mothers	O	O
with	O	O
normal	O	O
birth	O	O
weight	O	O
infants	O	O
.	O	O

All	O	O
women	O	O
in	O	O
both	O	O
of	O	O
groups	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
full-mouth	O	O
periodontal	O	O
examination	O	O
to	O	O
determine	O	O
a	O	O
periodontal	O	O
status	O	O
.	O	O

The	O	O
microbial	O	O
investigation	O	O
for	O	O
anaerobic	O	O
bacteria	O	O
of	O	O
deepest	O	O
periodontal	O	O
pockets	O	O
was	O	O
performed	O	O
in	O	O
35	O	O
cases	O	O
of	O	O
periodontits	O	O
.	O	O

A	O	O
significantly	O	O
higher	O	O
incidence	O	O
of	O	O
preterm	O	O
low	O	O
birth	O	O
weight	O	O
cases	O	O
in	O	O
patiens	O	O
with	O	O
periodontitis	O	O
was	O	O
documented	O	O
.	O	O

In	O	O
addition	O	O
higher	O	O
variety	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
of	O	O
periodontal	O	O
pockets	O	O
in	O	O
mothers	O	O
with	O	O
preterm	O	O
low	O	O
birth	O	O
weight	O	O
infants	O	O
comparison	O	O
to	O	O
control	O	O
group	O	O
was	O	O
observed	O	O
.	O	O

Genes	O	O
encoding	O	O
virulence	O	O
determinants	O	O
are	O	O
transferred	O	O
between	O	O
species	O	O
in	O	O
many	O	O
different	O	O
environments	O	O
.	O	O

In	O	O
this	O	O
review	O	O
we	O	O
describe	O	O
gene	O	O
transfer	O	O
events	O	O
to	O	O
and	O	O
from	O	O
different	O	O
species	O	O
of	O	O
bacteria	O	O
,	O	O
from	O	O
bacteria	O	O
to	O	O
plants	O	O
,	O	O
and	O	O
from	O	O
plants	O	O
to	O	O
bacteria	O	O
.	O	O

Examples	O	O
of	O	O
the	O	O
setting	O	O
for	O	O
these	O	O
transfer	O	O
events	O	O
include	O	O
:	O	O
the	O	O
GI	O	O
tract	O	O
,	O	O
the	O	O
rumen	O	O
,	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
in	O	O
food	O	O
matrixes	O	O
.	O	O

As	O	O
a	O	O
case	O	O
study	O	O
,	O	O
the	O	O
flux	O	O
of	O	O
virulence	O	O
factors	O	O
from	O	O
E.coli	B-bacteria	B-bacteria
O157	I-bacteria	I-bacteria
:	I-bacteria	I-bacteria
H7	E-bacteria	I-bacteria
is	O	O
described	O	O
as	O	O
an	O	O
example	O	O
of	O	O
gene	O	O
flow	O	O
in	O	O
the	O	O
environment	O	O
.	O	O

Implants	O	O
showing	O	O
signs	O	O
of	O	O
peri-implantitis	O	O
harbor	O	O
a	O	O
microbiota	O	O
similar	O	O
to	O	O
that	O	O
of	O	O
periodontitis-affected	O	O
teeth	O	O
.	O	O

This	O	O
case	O	O
report	O	O
describes	O	O
the	O	O
subgingival	O	O
microbiota	O	O
of	O	O
a	O	O
45-year-old	O	O
female	O	O
with	O	O
advanced	O	O
periodontitis	O	O
before	O	O
and	O	O
after	O	O
complete	O	O
edentulation	O	O
and	O	O
reconstruction	O	O
with	O	O
dental	O	O
implants	O	O
.	O	O

A	O	O
3-month	O	O
healing	O	O
period	O	O
post	O	O
extraction	O	O
passed	O	O
before	O	O
implants	O	O
were	O	O
placed	O	O
using	O	O
a	O	O
two-stage	O	O
submerged	O	O
implant	O	O
protocol	O	O
.	O	O

At	O	O
4-	O	O
to	O	O
6-month	O	O
recall	O	O
visits	O	O
after	O	O
definitive	O	O
prosthetic	O	O
reconstruction	O	O
,	O	O
some	O	O
implant	O	O
sites	O	O
showed	O	O
bleeding	O	O
on	O	O
probing	O	O
and	O	O
localized	O	O
mucositis	O	O
.	O	O

Microbiological	O	O
culture	O	O
of	O	O
three	O	O
inflamed	O	O
peri-implant	O	O
sites	O	O
showed	O	O
an	O	O
almost	O	O
identical	O	O
spectrum	O	O
of	O	O
pathogens	O	O
,	O	O
including	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
other	O	O
major	O	O
pathogenic	O	O
bacteria	O	O
characteristic	O	O
of	O	O
aggressive	O	O
periodontitis	O	O
.	O	O

As	O	O
natural	O	O
teeth	O	O
were	O	O
absent	O	O
for	O	O
8	O	O
months	O	O
,	O	O
this	O	O
case	O	O
report	O	O
suggests	O	O
that	O	O
periodontal	O	O
pathogens	O	O
can	O	O
be	O	O
retained	O	O
for	O	O
a	O	O
prolonged	O	O
period	O	O
of	O	O
time	O	O
in	O	O
nondental	O	O
sites	O	O
,	O	O
from	O	O
where	O	O
they	O	O
can	O	O
later	O	O
colonize	O	O
and	O	O
compromise	O	O
the	O	O
health	O	O
of	O	O
dental	O	O
implants	O	O
.	O	O

The	O	O
therapeutic	O	O
implications	O	O
of	O	O
this	O	O
finding	O	O
are	O	O
discussed	O	O
.	O	O

Leprosy	O	O
is	O	O
a	O	O
chronic	O	O
infection	O	O
caused	O	O
by	O	O
Mycobacterium	B-bacteria	B-bacteria
leprae	E-bacteria	I-bacteria
,	O	O
a	O	O
bacillus	O	O
that	O	O
presents	O	O
a	O	O
peculiar	O	O
tropism	O	O
for	O	O
the	O	O
skin	O	O
and	O	O
peripheral	O	O
nerves	O	O
.	O	O

The	O	O
clinical	O	O
spectrum	O	O
of	O	O
leprosy	O	O
ranges	O	O
from	O	O
the	O	O
tuberculoid	O	O
form	O	O
(	O	O
TT	O	O
)	O	O
to	O	O
the	O	O
disseminative	O	O
and	O	O
progressive	O	O
lepromatous	O	O
form	O	O
(	O	O
LL	O	O
)	O	O
.	O	O

Oral	O	O
lesions	O	O
are	O	O
rare	O	O
but	O	O
,	O	O
when	O	O
present	O	O
,	O	O
occur	O	O
in	O	O
the	O	O
lepromatous	O	O
form	O	O
.	O	O

This	O	O
article	O	O
describes	O	O
the	O	O
clinical	O	O
and	O	O
microscopic	O	O
findings	O	O
of	O	O
three	O	O
cases	O	O
of	O	O
LL	O	O
with	O	O
oral	O	O
manifestations	O	O
.	O	O

All	O	O
patients	O	O
had	O	O
the	O	O
lepromatous	O	O
form	O	O
and	O	O
their	O	O
leprosy-specific	O	O
oral	O	O
lesions	O	O
occurred	O	O
in	O	O
the	O	O
palate	O	O
.	O	O

The	O	O
diagnosis	O	O
was	O	O
based	O	O
on	O	O
clinical	O	O
,	O	O
serological	O	O
and	O	O
histopathological	O	O
findings	O	O
,	O	O
and	O	O
multidrug	O	O
therapy	O	O
for	O	O
multibacillary	O	O
leprosy	O	O
was	O	O
started	O	O
and	O	O
continued	O	O
for	O	O
24	O	O
months	O	O
.	O	O

All	O	O
patients	O	O
completed	O	O
treatment	O	O
,	O	O
but	O	O
developed	O	O
reaction	O	O
episodes	O	O
which	O	O
were	O	O
treated	O	O
with	O	O
prednisone	O	O
and/or	O	O
thalidomide	O	O
.	O	O

The	O	O
authors	O	O
emphasize	O	O
the	O	O
importance	O	O
of	O	O
oral	O	O
mucosa	O	O
evaluation	O	O
by	O	O
a	O	O
dental	O	O
health	O	O
professional	O	O
during	O	O
patient	O	O
care	O	O
since	O	O
oral	O	O
lesions	O	O
may	O	O
act	O	O
as	O	O
a	O	O
source	O	O
of	O	O
infection	O	O
.	O	O

Two	O	O
kaurane	O	O
diterpenes	O	O
,	O	O
ent-kaur-16	O	O
(	O	O
17	O	O
)	O	O
-en-19-oic	O	O
acid	O	O
(	O	O
KA	O	O
)	O	O
and	O	O
15-beta-isovaleryloxy-ent-kaur-16	O	O
(	O	O
17	O	O
)	O	O
-en-19-oic	O	O
acid	O	O
(	O	O
KA-Ival	O	O
)	O	O
,	O	O
isolated	O	O
from	O	O
Aspilia	O	O
foliacea	O	O
,	O	O
and	O	O
the	O	O
methyl	O	O
ester	O	O
derivative	O	O
of	O	O
KA	O	O
(	O	O
KA-Me	O	O
)	O	O
were	O	O
evaluated	O	O
against	O	O
oral	O	O
pathogens	O	O
.	O	O

KA	O	O
was	O	O
the	O	O
most	O	O
active	O	O
compound	O	O
,	O	O
with	O	O
MIC	O	O
values	O	O
of	O	O
10	O	O
microg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
against	O	O
the	O	O
following	O	O
microorganisms	O	O
:	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
KA	O	O
did	O	O
not	O	O
show	O	O
significant	O	O
activity	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
with	O	O
MIC	O	O
values	O	O
equal	O	O
to	O	O
100	O	O
and	O	O
200	O	O
microg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

Our	O	O
results	O	O
show	O	O
that	O	O
KA	O	O
has	O	O
potential	O	O
to	O	O
be	O	O
used	O	O
as	O	O
a	O	O
prototype	O	O
for	O	O
the	O	O
discovery	O	O
of	O	O
new	O	O
effective	O	O
anti-infection	O	O
agents	O	O
against	O	O
microorganisms	O	O
responsible	O	O
for	O	O
caries	O	O
and	O	O
periodontal	O	O
diseases	O	O
.	O	O

Moreover	O	O
,	O	O
these	O	O
results	O	O
allow	O	O
to	O	O
conclude	O	O
that	O	O
minor	O	O
structural	O	O
differences	O	O
among	O	O
these	O	O
diterpenes	O	O
significantly	O	O
influence	O	O
their	O	O
antimicrobial	O	O
activity	O	O
,	O	O
bringing	O	O
new	O	O
perspectives	O	O
to	O	O
studies	O	O
on	O	O
the	O	O
structure-activity	O	O
relationship	O	O
of	O	O
this	O	O
type	O	O
of	O	O
metabolites	O	O
with	O	O
respect	O	O
to	O	O
caries	O	O
and	O	O
periodontal	O	O
diseases	O	O
.	O	O

Ethanol	O	O
extracts	O	O
of	O	O
eight	O	O
plant	O	O
species	O	O
used	O	O
traditionally	O	O
in	O	O
South	O	O
Africa	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
oral	O	O
diseases	O	O
were	O	O
investigated	O	O
for	O	O
in	O	O
vitro	O	O
antimicrobial	O	O
activity	O	O
against	O	O
oral	O	O
pathogens	O	O
namely	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
,	O	O
Candida	B-bacteria	B-bacteria
albicans	E-bacteria	I-bacteria
,	O	O
Porphyromonus	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Privotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
using	O	O
the	O	O
disk	O	O
diffusion	O	O
method	O	O
.	O	O

Minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
and	O	O
minimum	O	O
bactericidal	O	O
concentration	O	O
(	O	O
MBC	O	O
)	O	O
of	O	O
ethanol	O	O
extracts	O	O
were	O	O
determined	O	O
against	O	O
these	O	O
microorganisms	O	O
using	O	O
micro	O	O
dilution	O	O
.	O	O

The	O	O
cytotoxicity	O	O
and	O	O
therapeutic	O	O
index	O	O
(	O	O
TI	O	O
)	O	O
of	O	O
selected	O	O
active	O	O
extracts	O	O
were	O	O
also	O	O
determined	O	O
.	O	O

Out	O	O
of	O	O
eight	O	O
plants	O	O
,	O	O
six	O	O
(	O	O
Annona	O	O
senegalensis	O	O
,	O	O
Englerophytum	O	O
magalismontanum	O	O
,	O	O
Dicerocarym	O	O
senecioides	O	O
,	O	O
Euclea	O	O
divinorum	O	O
,	O	O
Euclea	O	O
natalensis	O	O
,	O	O
Solanum	O	O
panduriforme	O	O
and	O	O
Parinari	O	O
curatellifolia	O	O
)	O	O
exhibited	O	O
MIC	O	O
values	O	O
ranging	O	O
from	O	O
25.0	O	O
mg/ml	O	O
to	O	O
0.8	O	O
mg/ml	O	O
.	O	O

Gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
found	O	O
to	O	O
be	O	O
more	O	O
resistant	O	O
to	O	O
the	O	O
plant	O	O
extracts	O	O
than	O	O
Gram	B-bacteria	B-bacteria
positive	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
except	O	O
for	O	O
Euclea	O	O
natalensis	O	O
which	O	O
inhibited	O	O
all	O	O
three	O	O
Gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
tested	O	O
in	O	O
this	O	O
study	O	O
.	O	O

All	O	O
plant	O	O
extracts	O	O
showed	O	O
moderate	O	O
cytotoxicity	O	O
on	O	O
the	O	O
Vero	O	O
cell	O	O
line	O	O
.	O	O

The	O	O
fifty	O	O
percent	O	O
inhibitory	O	O
concentration	O	O
(	O	O
IC	O	O
(	O	O
50	O	O
)	O	O
)	O	O
of	O	O
all	O	O
plants	O	O
tested	O	O
range	O	O
from	O	O
92.3	O	O
to	O	O
285.1	O	O
microg/ml	O	O
.	O	O

Mucosal	O	O
surfaces	O	O
are	O	O
the	O	O
primary	O	O
oral	O	O
reservoirs	O	O
of	O	O
Candida	O	O
species	O	O
,	O	O
but	O	O
these	O	O
species	O	O
can	O	O
also	O	O
be	O	O
found	O	O
in	O	O
subgingival	O	O
biofilm	O	O
.	O	O

The	O	O
present	O	O
study	O	O
investigated	O	O
the	O	O
genetic	O	O
diversity	O	O
and	O	O
production	O	O
of	O	O
exoenzymes	O	O
of	O	O
C.	O	O
albicans	O	O
and	O	O
C.	O	O
dubliniensis	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
systemically	O	O
healthy	O	O
patients	O	O
with	O	O
periodontitis	O	O
.	O	O

Fifty-three	O	O
patients	O	O
were	O	O
analysed	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
three	O	O
oral	O	O
cavity	O	O
sites	O	O
(	O	O
periodontal	O	O
pocket	O	O
,	O	O
gingival	O	O
sulci	O	O
and	O	O
oral	O	O
mucosa	O	O
)	O	O
,	O	O
plated	O	O
and	O	O
,	O	O
after	O	O
isolation	O	O
,	O	O
suspect	O	O
strains	O	O
of	O	O
C.	O	O
albicans	O	O
and	O	O
C.	O	O
dubliniensis	O	O
were	O	O
identified	O	O
by	O	O
PCR	O	O
.	O	O

The	O	O
genetic	O	O
diversity	O	O
of	O	O
the	O	O
isolates	O	O
was	O	O
evaluated	O	O
by	O	O
RAPD	O	O
and	O	O
the	O	O
activities	O	O
of	O	O
the	O	O
secreted	O	O
aspartyl	O	O
proteinases	O	O
and	O	O
phospholipases	O	O
were	O	O
evaluated	O	O
by	O	O
the	O	O
agar	O	O
plate	O	O
method	O	O
.	O	O

Twenty-one	O	O
patients	O	O
showed	O	O
positive	O	O
results	O	O
for	O	O
Candida	O	O
spp	O	O
.	O	O

There	O	O
were	O	O
no	O	O
statistically	O	O
significant	O	O
differences	O	O
between	O	O
genders	O	O
,	O	O
or	O	O
between	O	O
sites	O	O
.	O	O

C.	O	O
albicans	O	O
was	O	O
the	O	O
most	O	O
frequently	O	O
found	O	O
specie	O	O
,	O	O
while	O	O
C.	O	O
dubliniensis	O	O
was	O	O
isolated	O	O
from	O	O
the	O	O
periodontal	O	O
pocket	O	O
of	O	O
only	O	O
one	O	O
patient	O	O
.	O	O

Sixteen	O	O
genotypes	O	O
were	O	O
detected	O	O
among	O	O
the	O	O
C.	O	O
albicans	O	O
isolates	O	O
,	O	O
and	O	O
one	O	O
among	O	O
the	O	O
C.	B-bacteria	B-bacteria
dubliniensis	I-bacteria	I-bacteria
isolates	O	O
.	O	O

The	O	O
similarity	O	O
coefficient	O	O
(	O	O
S	O	O
(	O	O
SM	O	O
)	O	O
)	O	O
values	O	O
among	O	O
the	O	O
C.	O	O
albicans	O	O
genotypes	O	O
ranged	O	O
from	O	O
0.684	O	O
to	O	O
1.0	O	O
with	O	O
an	O	O
average	O	O
of	O	O
0.905+/-0.074	O	O
.	O	O

All	O	O
isolates	O	O
produced	O	O
high	O	O
levels	O	O
of	O	O
Saps	O	O
and	O	O
most	O	O
of	O	O
them	O	O
produced	O	O
high	O	O
levels	O	O
of	O	O
phospholipases	O	O
.	O	O

No	O	O
relationship	O	O
was	O	O
found	O	O
between	O	O
the	O	O
genotypes	O	O
and	O	O
the	O	O
pattern	O	O
of	O	O
enzymatic	O	O
production	O	O
.	O	O

There	O	O
was	O	O
no	O	O
association	O	O
between	O	O
specific	O	O
genotypes	O	O
and	O	O
their	O	O
site	O	O
of	O	O
isolation	O	O
.	O	O

The	O	O
results	O	O
of	O	O
the	O	O
present	O	O
study	O	O
suggest	O	O
that	O	O
genetically	O	O
homogeneous	O	O
strains	O	O
of	O	O
C.	O	O
albicans	O	O
are	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
with	O	O
periodontitis	O	O
and	O	O
that	O	O
these	O	O
strains	O	O
are	O	O
capable	O	O
of	O	O
producing	O	O
high	O	O
levels	O	O
of	O	O
exoenzyme	O	O
.	O	O

The	O	O
chewing	O	O
stick	O	O
(	O	O
miswak	O	O
)	O	O
is	O	O
used	O	O
for	O	O
oral	O	O
hygiene	O	O
in	O	O
many	O	O
parts	O	O
of	O	O
the	O	O
world	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
the	O	O
mechanical	O	O
removal	O	O
of	O	O
plaque	O	O
,	O	O
an	O	O
antibacterial	O	O
effect	O	O
has	O	O
been	O	O
postulated	O	O
;	O	O
however	O	O
,	O	O
tests	O	O
of	O	O
miswak	O	O
extract	O	O
from	O	O
Salvadora	O	O
persica	O	O
(	O	O
Arak	O	O
)	O	O
disclosed	O	O
only	O	O
low	O	O
to	O	O
moderate	O	O
antibacterial	O	O
effects	O	O
.	O	O

This	O	O
may	O	O
be	O	O
attributable	O	O
to	O	O
the	O	O
extraction	O	O
process	O	O
.	O	O

Our	O	O
aim	O	O
was	O	O
to	O	O
test	O	O
in	O	O
vitro	O	O
the	O	O
antibacterial	O	O
effect	O	O
of	O	O
miswak	O	O
pieces	O	O
,	O	O
without	O	O
extraction	O	O
,	O	O
on	O	O
bacteria	O	O
implicated	O	O
in	O	O
the	O	O
etiology	O	O
of	O	O
periodontitis	O	O
and	O	O
caries	O	O
.	O	O

Miswak	O	O
pieces	O	O
were	O	O
standardized	O	O
by	O	O
size	O	O
and	O	O
weight	O	O
(	O	O
0.07	O	O
and	O	O
0.14	O	O
g	O	O
)	O	O
and	O	O
tested	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
previously	B-bacteria	B-bacteria
Actinobacillus	I-bacteria	I-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
,	O	O
as	O	O
a	O	O
reference	O	O
,	O	O
Haemophilus	B-bacteria	B-bacteria
influenzae	E-bacteria	I-bacteria
.	O	O

The	O	O
miswak	O	O
pieces	O	O
were	O	O
tested	O	O
in	O	O
two	O	O
ways	O	O
:	O	O
embedded	O	O
in	O	O
the	O	O
agar	O	O
plate	O	O
or	O	O
suspended	O	O
above	O	O
the	O	O
agar	O	O
plate	O	O
.	O	O

The	O	O
inhibitory	O	O
effect	O	O
was	O	O
most	O	O
pronounced	O	O
on	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
and	O	O
H.	B-bacteria	B-bacteria
influenzae	E-bacteria	I-bacteria
,	O	O
less	O	O
on	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
least	O	O
on	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
.	O	O

Suspended	O	O
miswak	O	O
had	O	O
comparable	O	O
or	O	O
stronger	O	O
effects	O	O
than	O	O
miswak	O	O
embedded	O	O
in	O	O
agar	O	O
.	O	O

The	O	O
0.14-g	O	O
suspended	O	O
miswak	O	O
exhibited	O	O
significantly	O	O
greater	O	O
inhibition	O	O
on	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
H.	B-bacteria	B-bacteria
influenzae	E-bacteria	I-bacteria
than	O	O
the	O	O
0.14-g	O	O
miswak	O	O
embedded	O	O
in	O	O
agar	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
and	O	O
P	O	O
<	O	O
0.001	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Miswak	O	O
embedded	O	O
in	O	O
agar	O	O
or	O	O
suspended	O	O
above	O	O
the	O	O
agar	O	O
plate	O	O
had	O	O
strong	O	O
antibacterial	O	O
effects	O	O
against	O	O
all	O	O
bacteria	O	O
tested	O	O
.	O	O

The	O	O
antibacterial	O	O
effect	O	O
of	O	O
suspended	O	O
miswak	O	O
pieces	O	O
suggests	O	O
the	O	O
presence	O	O
of	O	O
volatile	O	O
active	O	O
antibacterial	O	O
compounds	O	O
.	O	O

Three	O	O
strains	B-bacteria	B-bacteria
of	I-bacteria	I-bacteria
anaerobic	E-bacteria	I-bacteria
,	O	O
variably	O	O
pigmenting	O	O
,	O	O
Gram-negative	B-bacteria	B-bacteria
bacilli	E-bacteria	I-bacteria
isolated	O	O
from	O	O
human	O	O
oral	O	O
mucosal	O	O
tissue	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
and	O	O
were	O	O
found	O	O
to	O	O
comprise	O	O
a	O	O
homogeneous	O	O
group	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
and	O	O
DNA-DNA	O	O
hybridization	O	O
revealed	O	O
that	O	O
the	O	O
strains	O	O
constituted	O	O
a	O	O
novel	O	O
group	O	O
within	O	O
the	O	O
genus	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
,	O	O
being	O	O
most	O	O
closely	O	O
related	O	O
to	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
veroralis	E-bacteria	I-bacteria
.	O	O

A	O	O
novel	O	O
species	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
histicola	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
is	O	O
proposed	O	O
to	O	O
accommodate	O	O
these	O	O
strains	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
histicola	E-bacteria	I-bacteria
is	O	O
saccharolytic	O	O
and	O	O
produces	O	O
acetic	O	O
acid	O	O
and	O	O
succinic	O	O
acid	O	O
as	O	O
major	O	O
end	O	O
products	O	O
of	O	O
fermentation	O	O
and	O	O
trace	O	O
to	O	O
minor	O	O
amounts	O	O
of	O	O
isovaleric	O	O
acid	O	O
and	O	O
lactic	O	O
acid	O	O
.	O	O

The	O	O
G+C	O	O
content	O	O
of	O	O
the	O	O
DNA	O	O
of	O	O
the	O	O
type	O	O
strain	O	O
is	O	O
43	O	O
mol	O	O
%	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
histicola	E-bacteria	I-bacteria
is	O	O
T05-04T	B-bacteria	B-bacteria
(	O	O
=DSM	B-bacteria	B-bacteria
19854T=CCUG	I-bacteria	I-bacteria
55407T	E-bacteria	I-bacteria
)	O	O
.	O	O

There	O	O
is	O	O
now	O	O
strong	O	O
evidence	O	O
that	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
can	O	O
regulate	O	O
inflammatory	O	O
immune	O	O
responses	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
analyzed	O	O
whether	O	O
oral	O	O
supplementation	O	O
with	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
bacterial	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
Lactobacillus	B-bacteria	B-bacteria
johnsonii	E-bacteria	I-bacteria
(	O	O
La1	B-bacteria	B-bacteria
)	O	O
could	O	O
interfere	O	O
with	O	O
skin	O	O
immune	O	O
status	O	O
following	O	O
UV	O	O
exposure	O	O
.	O	O

A	O	O
randomized	O	O
,	O	O
double-blind	O	O
,	O	O
placebo	O	O
controlled	O	O
clinical	O	O
trial	O	O
was	O	O
conducted	O	O
with	O	O
54	O	O
healthy	O	O
volunteers	O	O
receiving	O	O
either	O	O
La1	B-bacteria	B-bacteria
or	O	O
placebo	O	O
,	O	O
during	O	O
six	O	O
weeks	O	O
prior	O	O
to	O	O
solar-simulated	O	O
UV	O	O
irradiation	O	O
.	O	O

Blister	O	O
roofs	O	O
and	O	O
skin	O	O
biopsies	O	O
were	O	O
recovered	O	O
1	O	O
,	O	O
4	O	O
and	O	O
10	O	O
days	O	O
after	O	O
UV	O	O
exposure	O	O
from	O	O
un-irradiated	O	O
and	O	O
irradiated	O	O
skin	O	O
and	O	O
used	O	O
for	O	O
immunohistochemical	O	O
analysis	O	O
and	O	O
mixed	O	O
epidermal	O	O
cell	O	O
lymphocyte	O	O
reaction	O	O
(	O	O
MECLR	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

La1	B-bacteria	B-bacteria
supplementation	O	O
did	O	O
not	O	O
prevent	O	O
the	O	O
UV-induced	O	O
phenotypic	O	O
maturation	O	O
of	O	O
Langerhans	O	O
cells	O	O
(	O	O
LCs	O	O
)	O	O
or	O	O
the	O	O
decrease	O	O
in	O	O
MECLR	O	O
in	O	O
irradiated	O	O
skin	O	O
samples	O	O
,	O	O
one	O	O
day	O	O
post-irradiation	O	O
.	O	O

On	O	O
day	O	O
4	O	O
,	O	O
MECLR	O	O
was	O	O
still	O	O
decreased	O	O
in	O	O
the	O	O
placebo	O	O
group	O	O
,	O	O
with	O	O
a	O	O
parallel	O	O
reduction	O	O
in	O	O
the	O	O
CD1a	O	O
LC	O	O
marker	O	O
in	O	O
irradiated	O	O
epidermis	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
the	O	O
allostimulatory	O	O
capacity	O	O
of	O	O
epidermal	O	O
cells	O	O
was	O	O
totally	O	O
recovered	O	O
in	O	O
the	O	O
La1	B-bacteria	B-bacteria
group	O	O
correlating	O	O
with	O	O
the	O	O
normalization	O	O
of	O	O
CD1a	O	O
expression	O	O
within	O	O
the	O	O
epidermis	O	O
.	O	O

For	O	O
the	O	O
first	O	O
time	O	O
,	O	O
the	O	O
results	O	O
provide	O	O
evidence	O	O
that	O	O
ingested	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
accelerate	O	O
the	O	O
recovery	O	O
of	O	O
skin	O	O
immune	O	O
homeostasis	O	O
after	O	O
UV-induced	O	O
immunosuppression	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
has	O	O
been	O	O
suspected	O	O
as	O	O
an	O	O
extra-gastroduodenal	O	O
reservoir	O	O
for	O	O
Helicobacter	O	O
pylori	O	O
infection	O	O
and	O	O
transmission	O	O
,	O	O
but	O	O
conflicting	O	O
evidence	O	O
exists	O	O
regarding	O	O
the	O	O
occurrence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
mouth	O	O
,	O	O
independently	O	O
of	O	O
stomach	O	O
colonization	O	O
.	O	O

Ninety-four	O	O
gastric	O	O
biopsy	O	O
patients	O	O
were	O	O
analysed	O	O
for	O	O
the	O	O
concurrent	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
mouth	O	O
and	O	O
stomach	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
different	O	O
areas	O	O
within	O	O
the	O	O
mouth	O	O
and	O	O
H.	O	O
pylori	O	O
DNA	O	O
was	O	O
amplified	O	O
by	O	O
the	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
and	O	O
verified	O	O
by	O	O
sequencing	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori-specific	O	O
serology	O	O
was	O	O
performed	O	O
,	O	O
and	O	O
stomach	O	O
colonization	O	O
was	O	O
determined	O	O
by	O	O
culture	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
relevant	O	O
dental	O	O
and	O	O
periodontal	O	O
parameters	O	O
,	O	O
as	O	O
well	O	O
as	O	O
general	O	O
health	O	O
parameters	O	O
,	O	O
were	O	O
recorded	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
found	O	O
in	O	O
the	O	O
stomach	O	O
of	O	O
29	O	O
patients	O	O
and	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
16	O	O
patients	O	O
.	O	O

In	O	O
only	O	O
six	O	O
patients	O	O
was	O	O
the	O	O
bacterium	O	O
detected	O	O
simultaneously	O	O
in	O	O
the	O	O
stomach	O	O
and	O	O
mouth	O	O
.	O	O

Notably	O	O
,	O	O
the	O	O
10	O	O
patients	O	O
in	O	O
whom	O	O
the	O	O
bacterium	O	O
was	O	O
found	O	O
solely	O	O
in	O	O
the	O	O
mouth	O	O
did	O	O
not	O	O
have	O	O
serum	O	O
antibodies	O	O
to	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

The	O	O
occurrence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
mouth	O	O
was	O	O
found	O	O
to	O	O
be	O	O
correlated	O	O
neither	O	O
to	O	O
any	O	O
general	O	O
or	O	O
oral	O	O
health	O	O
parameters	O	O
,	O	O
nor	O	O
to	O	O
any	O	O
particular	O	O
site	O	O
of	O	O
collection	O	O
.	O	O

This	O	O
study	O	O
shows	O	O
that	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
can	O	O
occur	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
independently	O	O
of	O	O
stomach	O	O
colonization	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
randomized	O	O
double-blinded	O	O
preliminary	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
clinical	O	O
and	O	O
microbiological	O	O
long-term	O	O
effects	O	O
of	O	O
an	O	O
essential-oil-containing	O	O
mouth	O	O
rinse	O	O
as	O	O
the	O	O
active	O	O
agent	O	O
utilized	O	O
in	O	O
the	O	O
``	O	O
one-stage	O	O
full-mouth	O	O
disinfection	O	O
protocol	O	O
.	O	O
''	O	O

Probing	O	O
pocket	O	O
depth	O	O
and	O	O
plaque	O	O
and	O	O
gingival	O	O
indices	O	O
were	O	O
evaluated	O	O
by	O	O
the	O	O
same	O	O
calibrated	O	O
examiner	O	O
in	O	O
all	O	O
teeth	O	O
of	O	O
20	O	O
moderate	O	O
chronic	O	O
periodontitis	O	O
subjects	O	O
.	O	O

Presence	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
were	O	O
determined	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
in	O	O
nonstimulated	O	O
saliva	O	O
,	O	O
tongue	O	O
dorsum	O	O
,	O	O
and	O	O
pooled	O	O
subgingival	O	O
samples	O	O
.	O	O

The	O	O
subjects	O	O
were	O	O
randomized	O	O
into	O	O
two	O	O
groups	O	O
:	O	O
full-mouth	O	O
disinfection	O	O
plus	O	O
essential	O	O
oils	O	O
(	O	O
Listerine	O	O
)	O	O
or	O	O
full-mouth	O	O
disinfection	O	O
plus	O	O
placebo	O	O
.	O	O

Clinical	O	O
and	O	O
microbial	O	O
parameters	O	O
were	O	O
evaluated	O	O
at	O	O
baseline	O	O
(	O	O
T0	O	O
)	O	O
,	O	O
45	O	O
(	O	O
T1	O	O
)	O	O
and	O	O
180	O	O
(	O	O
T2	O	O
)	O	O
days	O	O
after	O	O
therapy	O	O
and	O	O
analyzed	O	O
using	O	O
analysis	O	O
of	O	O
variance	O	O
,	O	O
Student	O	O
t	O	O
,	O	O
and	O	O
Wilcoxon	O	O
tests	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

No	O	O
significant	O	O
differences	O	O
were	O	O
observed	O	O
between	O	O
groups	O	O
regarding	O	O
clinical	O	O
measurements	O	O
at	O	O
baseline	O	O
.	O	O

However	O	O
,	O	O
in	O	O
the	O	O
later	O	O
examinations	O	O
,	O	O
T1	O	O
and	O	O
T2	O	O
,	O	O
the	O	O
test	O	O
group	O	O
always	O	O
presented	O	O
higher	O	O
reductions	O	O
of	O	O
pocket	O	O
depth	O	O
,	O	O
plaque	O	O
index	O	O
,	O	O
and	O	O
gingival	O	O
index	O	O
compared	O	O
to	O	O
the	O	O
control	O	O
group	O	O
.	O	O

The	O	O
essential-oils	O	O
group	O	O
revealed	O	O
significant	O	O
reduction	O	O
on	O	O
occurrence	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
saliva	O	O
comparing	O	O
baseline	O	O
and	O	O
45	O	O
days	O	O
;	O	O
this	O	O
difference	O	O
still	O	O
remain	O	O
at	O	O
180	O	O
days	O	O
.	O	O

The	O	O
essential-oil-containing	O	O
mouth	O	O
rinse	O	O
demonstrated	O	O
beneficial	O	O
effects	O	O
on	O	O
clinical	O	O
parameters	O	O
.	O	O

Microbiological	O	O
findings	O	O
were	O	O
less	O	O
consistent	O	O
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
preliminary	O	O
study	O	O
suggest	O	O
further	O	O
investigations	O	O
.	O	O

The	O	O
antimicrobial	O	O
and	O	O
biofilm	O	O
formation	O	O
preventive	O	O
properties	O	O
of	O	O
Mentha	O	O
piperita	O	O
and	O	O
Rosmarinus	O	O
officinalis	O	O
essential	O	O
oils	O	O
and	O	O
chlorhexidine	O	O
were	O	O
assessed	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
.	O	O

26	O	O
and	O	O
20	O	O
compounds	O	O
were	O	O
identified	O	O
by	O	O
GC	O	O
and	O	O
GC-MS	O	O
analysis	O	O
in	O	O
hydrodistilled	O	O
oils	O	O
from	O	O
M.	O	O
piperita	O	O
and	O	O
R.	O	O
officinalis	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
minimal	O	O
bactericidal	O	O
concentrations	O	O
(	O	O
MBC	O	O
)	O	O
of	O	O
the	O	O
M.	O	O
piperita	O	O
and	O	O
R.	O	O
officinalis	O	O
oils	O	O
and	O	O
chlorhexidine	O	O
were	O	O
(	O	O
6000	O	O
,	O	O
2000	O	O
,	O	O
8000	O	O
ppm	O	O
)	O	O
and	O	O
(	O	O
1000	O	O
,	O	O
4000	O	O
,	O	O
1000	O	O
ppm	O	O
)	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
,	O	O
respectively	O	O
.	O	O

The	O	O
decimal	O	O
reduction	O	O
time	O	O
(	O	O
D	O	O
)	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
exposed	O	O
to	O	O
the	O	O
oils	O	O
at	O	O
their	O	O
MBC	O	O
levels	O	O
was	O	O
2.8	O	O
min	O	O
while	O	O
chlorhexidine	O	O
showed	O	O
a	O	O
longer	O	O
time	O	O
.	O	O

The	O	O
D	O	O
values	O	O
of	O	O
S.	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
on	O	O
exposure	O	O
to	O	O
the	O	O
MBC	O	O
levels	O	O
of	O	O
M.	O	O
piperita	O	O
and	O	O
R.	O	O
officinalis	O	O
oils	O	O
and	O	O
of	O	O
chlorhexidine	O	O
were	O	O
2.14	O	O
,	O	O
4.28	O	O
and	O	O
2.8	O	O
min	O	O
,	O	O
indicating	O	O
a	O	O
higher	O	O
efficacy	O	O
of	O	O
M.	O	O
piperita	O	O
oil	O	O
.	O	O

Biofilm	O	O
formation	O	O
was	O	O
performed	O	O
by	O	O
growing	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
culture	O	O
with	O	O
and	O	O
without	O	O
essential	O	O
oils	O	O
in	O	O
LB	O	O
medium	O	O
in	O	O
polystyrene	O	O
tubes	O	O
.	O	O

In	O	O
vitro	O	O
biofilm	O	O
inhibitory	O	O
properties	O	O
were	O	O
in	O	O
the	O	O
order	O	O
M.	O	O
piperita	O	O
>	O	O
R.	O	O
officinalis	O	O
>	O	O
chlorhexidine	O	O
.	O	O

In	O	O
vivo	O	O
experiments	O	O
on	O	O
the	O	O
antibiofilm	O	O
properties	O	O
revealed	O	O
that	O	O
all	O	O
concentrations	O	O
of	O	O
the	O	O
oils	O	O
were	O	O
significantly	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
more	O	O
effective	O	O
than	O	O
chlorhexidine	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
essential	O	O
oils	O	O
may	O	O
be	O	O
considered	O	O
as	O	O
safe	O	O
agents	O	O
in	O	O
the	O	O
development	O	O
of	O	O
novel	O	O
antibiofilm	O	O
agents	O	O
.	O	O

to	O	O
compare	O	O
the	O	O
concentration	O	O
and	O	O
serotype	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
saliva	O	O
of	O	O
Down	O	O
syndrome	O	O
(	O	O
DS	O	O
)	O	O
,	O	O
mental	O	O
retarded	O	O
(	O	O
MR	O	O
)	O	O
and	O	O
healthy	O	O
control	O	O
(	O	O
C	O	O
)	O	O
individuals	O	O
of	O	O
the	O	O
Region	O	O
Metropolitana	O	O
Sur	O	O
of	O	O
Santiago	O	O
of	O	O
Chile	O	O
.	O	O

Hundred	O	O
and	O	O
seventy	O	O
nine	O	O
male	O	O
and	O	O
females	O	O
children	O	O
and	O	O
adolescents	O	O
,	O	O
aged	O	O
between	O	O
5	O	O
to	O	O
19	O	O
years	O	O
,	O	O
59	O	O
DS	O	O
,	O	O
60	O	O
MR	O	O
and	O	O
60	O	O
C	O	O
were	O	O
studied	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
cultured	O	O
in	O	O
TYCSB	O	O
agar	O	O
for	O	O
quantification	O	O
,	O	O
biochemical	O	O
and	O	O
serological	O	O
tests	O	O
.	O	O

ANOVA	O	O
and	O	O
Chi-square	O	O
for	O	O
homogeneity	O	O
tests	O	O
were	O	O
applied	O	O
.	O	O

C	O	O
,	O	O
DS	O	O
and	O	O
MR	O	O
presented	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
serotypes	O	O
c	O	O
,	O	O
e	O	O
,	O	O
f	O	O
)	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
(	O	O
d	O	O
,	O	O
g	O	O
,	O	O
h	O	O
)	O	O
,	O	O
but	O	O
only	O	O
among	O	O
DS	O	O
and	O	O
MR	O	O
non-typifiable	O	O
(	O	O
No-tip	O	O
)	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
found	O	O
.	O	O

MR	O	O
and	O	O
DS	O	O
showed	O	O
higher	O	O
bacteria	O	O
concentration	O	O
scores	O	O
than	O	O
C	O	O
(	O	O
P=0.001	O	O
)	O	O
.	O	O

Serotypes	O	O
showed	O	O
a	O	O
significant	O	O
heterogeneity	O	O
of	O	O
concentration	O	O
scores	O	O
:	O	O
d	O	O
,	O	O
g	O	O
,	O	O
h	O	O
showed	O	O
the	O	O
highest	O	O
and	O	O
No-tip	O	O
the	O	O
lowest	O	O
one	O	O
(	O	O
P	O	O
=	O	O
0.037	O	O
)	O	O
.	O	O

No-tip	O	O
bacteria	O	O
were	O	O
absent	O	O
in	O	O
C	O	O
and	O	O
present	O	O
in	O	O
MR	O	O
and	O	O
DS	O	O
;	O	O
this	O	O
result	O	O
indicates	O	O
different	O	O
immune	O	O
and	O	O
ecological	O	O
conditions	O	O
among	O	O
these	O	O
human	O	O
groups	O	O
.	O	O

The	O	O
score	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
saliva	O	O
was	O	O
higher	O	O
in	O	O
DS	O	O
and	O	O
MR	O	O
than	O	O
in	O	O
C	O	O
.	O	O

Probiotics	B-bacteria	B-bacteria
are	O	O
frequently	O	O
used	O	O
for	O	O
multiple	O	O
objectives	O	O
and	O	O
the	O	O
majority	O	O
of	O	O
applications	O	O
are	O	O
performed	O	O
both	O	O
in	O	O
human	O	O
beings	O	O
and	O	O
in	O	O
different	O	O
animals	O	O
.	O	O

The	O	O
specificity	O	O
of	O	O
species	O	O
showed	O	O
by	O	O
the	O	O
members	O	O
of	O	O
the	O	O
indigenous	O	O
microbiotia	O	O
led	O	O
us	O	O
to	O	O
isolate	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
LAB	B-bacteria	B-bacteria
)	O	O
from	O	O
their	O	O
natural	O	O
bovine	O	O
ecosystems	O	O
and	O	O
to	O	O
select	O	O
those	O	O
with	O	O
probiotic	O	O
potentiality	O	O
.	O	O

The	O	O
beneficial	O	O
probiotic	O	O
LAB	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
the	O	O
vaginal	O	O
tract	O	O
and	O	O
mammary	O	O
gland	O	O
of	O	O
adult	O	O
heifers	O	O
,	O	O
faeces	O	O
and	O	O
oral	O	O
cavity	O	O
of	O	O
newborn	O	O
calves	O	O
.	O	O

Bacterial	O	O
strains	O	O
and	O	O
their	O	O
numbers	O	O
varied	O	O
in	O	O
each	O	O
tract	O	O
under	O	O
study	O	O
.	O	O

Their	O	O
surface	O	O
properties	O	O
,	O	O
evaluated	O	O
using	O	O
the	O	O
MATH	O	O
test	O	O
,	O	O
revealed	O	O
that	O	O
the	O	O
higher	O	O
number	O	O
of	O	O
low	O	O
hydrophobic	O	O
strains	O	O
were	O	O
isolated	O	O
from	O	O
vaginal	O	O
tract	O	O
,	O	O
mammary	O	O
gland	O	O
or	O	O
faeces	O	O
.	O	O

The	O	O
capability	O	O
of	O	O
autoaggregation	O	O
also	O	O
differed	O	O
with	O	O
higher	O	O
degree	O	O
in	O	O
those	O	O
isolated	O	O
from	O	O
vagina	O	O
,	O	O
whereas	O	O
those	O	O
that	O	O
originated	O	O
in	O	O
the	O	O
mammary	O	O
gland	O	O
or	O	O
faeces	O	O
showed	O	O
low	O	O
autoaggregation	O	O
characteristics	O	O
.	O	O

The	O	O
production	O	O
of	O	O
antagonistic	O	O
substances	O	O
showed	O	O
that	O	O
the	O	O
production	O	O
of	O	O
hydrogen	O	O
peroxide	O	O
was	O	O
higher	O	O
in	O	O
the	O	O
strains	O	O
isolated	O	O
from	O	O
the	O	O
vaginal	O	O
tract	O	O
,	O	O
while	O	O
those	O	O
able	O	O
to	O	O
produce	O	O
organic	O	O
acid	O	O
were	O	O
isolated	O	O
from	O	O
all	O	O
the	O	O
environments	O	O
.	O	O

A	O	O
few	O	O
strains	O	O
were	O	O
able	O	O
to	O	O
produce	O	O
bacteriocins	O	O
and	O	O
were	O	O
isolated	O	O
only	O	O
from	O	O
the	O	O
mammary	O	O
gland	O	O
and	O	O
faeces	O	O
,	O	O
but	O	O
not	O	O
from	O	O
the	O	O
vaginal	O	O
tract	O	O
.	O	O

Further	O	O
studies	O	O
are	O	O
being	O	O
performed	O	O
to	O	O
complete	O	O
the	O	O
functional	O	O
characterization	O	O
of	O	O
the	O	O
strains	O	O
in	O	O
order	O	O
to	O	O
evaluate	O	O
their	O	O
survival	O	O
in	O	O
the	O	O
environmental	O	O
conditions	O	O
of	O	O
each	O	O
tract	O	O
.	O	O

Finally	O	O
,	O	O
the	O	O
selected	O	O
strains	O	O
could	O	O
be	O	O
combined	O	O
for	O	O
the	O	O
design	O	O
of	O	O
probiotic	O	O
products	O	O
to	O	O
be	O	O
used	O	O
both	O	O
in	O	O
adult	O	O
cows	O	O
and	O	O
in	O	O
neonates	O	O
,	O	O
based	O	O
on	O	O
the	O	O
host-specificity	O	O
,	O	O
due	O	O
to	O	O
their	O	O
autochthonous	O	O
origin	O	O
and	O	O
their	O	O
potential	O	O
use	O	O
in	O	O
the	O	O
tract	O	O
where	O	O
they	O	O
were	O	O
isolated	O	O
.	O	O

Human	O	O
beta-defensin-3	O	O
(	O	O
HBD3	O	O
)	O	O
,	O	O
an	O	O
endogenous	O	O
antimicrobial	O	O
peptide	O	O
,	O	O
has	O	O
strong	O	O
broad-spectrum	O	O
antimicrobial	O	O
activity	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
obtain	O	O
recombinant	O	O
HBD3	O	O
(	O	O
rHBD3	O	O
)	O	O
and	O	O
to	O	O
test	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
antimicrobial	O	O
characteristics	O	O
of	O	O
HBD3	O	O
may	O	O
offer	O	O
an	O	O
advantage	O	O
over	O	O
conventional	O	O
medicine	O	O
in	O	O
reducing	O	O
intracanal	O	O
bacteria	O	O
.	O	O

Genetic	O	O
engineering	O	O
was	O	O
used	O	O
to	O	O
obtain	O	O
active	O	O
rHBD3	O	O
and	O	O
analysis	O	O
revealed	O	O
that	O	O
it	O	O
exhibited	O	O
a	O	O
broad	O	O
spectrum	O	O
of	O	O
antibacterial	O	O
activity	O	O
at	O	O
low	O	O
micromolar	O	O
concentrations	O	O
against	O	O
not	O	O
only	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
but	O	O
also	O	O
against	O	O
some	O	O
critical	O	O
pathogenic	O	O
microbes	O	O
in	O	O
infected	O	O
root	O	O
canals	O	O
,	O	O
including	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
anaerobius	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
Candida	O	O
albicans	O	O
.	O	O

In	O	O
an	O	O
in	O	O
vitro	O	O
antibacterial	O	O
experiment	O	O
,	O	O
rHBD3	O	O
significantly	O	O
eliminated	O	O
pathogenic	O	O
bacteria	O	O
in	O	O
root	O	O
canals	O	O
.	O	O

The	O	O
ratio	O	O
of	O	O
bacterial	O	O
death	O	O
was	O	O
up	O	O
to	O	O
98	O	O
%	O	O
.	O	O

We	O	O
conclude	O	O
that	O	O
HBD3	O	O
has	O	O
the	O	O
potential	O	O
to	O	O
eliminate	O	O
bacteria	O	O
effectively	O	O
and	O	O
rapidly	O	O
in	O	O
the	O	O
local	O	O
microenvironment	O	O
of	O	O
the	O	O
root	O	O
canal	O	O
system	O	O
and	O	O
that	O	O
it	O	O
may	O	O
contribute	O	O
to	O	O
successful	O	O
endodontic	O	O
treatment	O	O
.	O	O

To	O	O
facilitate	O	O
the	O	O
identification	O	O
of	O	O
anaerobes	B-bacteria	B-bacteria
cultivated	O	O
from	O	O
periodontal	O	O
disease	O	O
,	O	O
whole	O	O
cell	O	O
bacterial	O	O
identification	O	O
by	O	O
matrix-assisted	O	O
laser	O	O
desorption/ionization	O	O
time-of-flight	O	O
mass	O	O
spectrometry	O	O
(	O	O
MALDI-TOF-MS	O	O
)	O	O
was	O	O
evaluated	O	O
.	O	O

A	O	O
total	O	O
of	O	O
84	O	O
strains	O	O
(	O	O
nine	O	O
reference	O	O
strains	O	O
and	O	O
75	O	O
recent	O	O
clinical	O	O
isolates	O	O
from	O	O
33	O	O
patients	O	O
with	O	O
aggressive	O	O
periodontitis	O	O
)	O	O
previously	O	O
identified	O	O
with	O	O
phenotypic	O	O
methods	O	O
were	O	O
used	O	O
.	O	O

All	O	O
the	O	O
references	O	O
and	O	O
10	O	O
clinical	O	O
isolates	O	O
belonging	O	O
to	O	O
the	O	O
same	O	O
species	O	O
as	O	O
the	O	O
reference	O	O
strains	O	O
were	O	O
genotypically	O	O
identified	O	O
by	O	O
sequence	O	O
analysis	O	O
of	O	O
the	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
gene	O	O
.	O	O

All	O	O
the	O	O
strains	O	O
were	O	O
then	O	O
analyzed	O	O
using	O	O
MALDI-TOF-MS	O	O
.	O	O

The	O	O
reference	O	O
strains	O	O
of	O	O
anaerobic	O	O
bacteria	O	O
used	O	O
showed	O	O
characteristic	O	O
MALDI-TOF-MS	O	O
spectra	O	O
with	O	O
peaks	O	O
between	O	O
m/z	O	O
2000	O	O
and	O	O
up	O	O
to	O	O
about	O	O
m/z	O	O
13,000	O	O
.	O	O

On	O	O
visual	O	O
inspection	O	O
,	O	O
the	O	O
similarity	O	O
of	O	O
spectra	O	O
produced	O	O
by	O	O
strains	O	O
of	O	O
a	O	O
single	O	O
genus	O	O
could	O	O
be	O	O
recognized	O	O
.	O	O

Obvious	O	O
differences	O	O
between	O	O
spectra	O	O
produced	O	O
by	O	O
strains	O	O
of	O	O
different	O	O
species	O	O
were	O	O
also	O	O
easily	O	O
noticed	O	O
.	O	O

The	O	O
reproducibility	O	O
of	O	O
the	O	O
method	O	O
was	O	O
proved	O	O
by	O	O
the	O	O
similarity	O	O
of	O	O
spectra	O	O
belonging	O	O
to	O	O
the	O	O
same	O	O
species	O	O
.	O	O

The	O	O
spectra	O	O
of	O	O
the	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
identified	O	O
with	O	O
MALDI	O	O
clustered	O	O
together	O	O
and	O	O
clustered	O	O
separately	O	O
from	O	O
the	O	O
spectra	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
proving	O	O
that	O	O
MALDI-TOF-MS	O	O
is	O	O
an	O	O
accurate	O	O
method	O	O
that	O	O
is	O	O
capable	O	O
of	O	O
separating	O	O
these	O	O
two	O	O
species	O	O
.	O	O

The	O	O
quality	O	O
of	O	O
clustering	O	O
was	O	O
characterized	O	O
by	O	O
calculating	O	O
an	O	O
inconsistency	O	O
coefficient	O	O
(	O	O



Our	O	O
results	O	O
suggest	O	O
that	O	O
MALDI-TOF-MS	O	O
might	O	O
become	O	O
a	O	O
useful	O	O
method	O	O
for	O	O
the	O	O
identification	O	O
of	O	O
anaerobic	O	O
bacteria	O	O
,	O	O
especially	O	O
for	O	O
those	O	O
that	O	O
can	O	O
not	O	O
be	O	O
readily	O	O
identified	O	O
by	O	O
biochemical	O	O
analysis	O	O
.	O	O

It	O	O
may	O	O
become	O	O
an	O	O
attractive	O	O
system	O	O
even	O	O
for	O	O
the	O	O
routine	O	O
identification	O	O
of	O	O
clinical	O	O
isolates	O	O
.	O	O

A	O	O
poorly	O	O
described	O	O
bacterium	O	O
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
has	O	O
been	O	O
implicated	O	O
as	O	O
an	O	O
etiological	O	O
agent	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
use	O	O
a	O	O
comparative	O	O
genomics	O	O
approach	O	O
to	O	O
identify	O	O
genes	O	O
that	O	O
contribute	O	O
to	O	O
the	O	O
lifestyle	O	O
of	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
as	O	O
an	O	O
oral	O	O
pathogen	O	O
.	O	O

Suppressive	O	O
subtractive	O	O
hybridization	O	O
was	O	O
used	O	O
to	O	O
identify	O	O
genes	O	O
encoded	O	O
by	O	O
C.	B-bacteria	B-bacteria
rectus	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33238	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
present	O	O
in	O	O
the	O	O
genome	O	O
of	O	O
a	O	O
related	O	O
Campylobacter	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
jejuni	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
11168	E-bacteria	I-bacteria
.	O	O

Suppressive	O	O
subtractive	O	O
hybridization	O	O
identified	O	O
154	O	O
unique	O	O
DNA	O	O
sequences	O	O
from	O	O
the	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
genome	O	O
.	O	O

Ninety-two	O	O
of	O	O
the	O	O
154	O	O
clones	O	O
were	O	O
classified	O	O
as	O	O
C.	B-bacteria	B-bacteria
rectus-specific	E-bacteria	I-bacteria
,	O	O
as	O	O
they	O	O
did	O	O
not	O	O
show	O	O
significant	O	O
sequence	O	O
homology	O	O
to	O	O
genes	O	O
identified	O	O
in	O	O
any	O	O
strain	O	O
of	O	O
C.	B-bacteria	B-bacteria
jejuni	E-bacteria	I-bacteria
(	O	O
blast	O	O
E-value	O	O
>	O	O
1E-3	O	O
)	O	O
.	O	O

blast	O	O
analysis	O	O
predicted	O	O
that	O	O
the	O	O
92	O	O
C.	B-bacteria	B-bacteria
rectus-specific	E-bacteria	I-bacteria
gene	O	O
fragments	O	O
play	O	O
a	O	O
role	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
biological	O	O
processes	O	O
including	O	O
signal	O	O
transduction	O	O
mechanisms	O	O
(	O	O
histidine	O	O
kinase	O	O
,	O	O
response	O	O
regulators	O	O
,	O	O
diguanylate	O	O
cyclases	O	O
,	O	O
chemotaxis	O	O
receptor	O	O
)	O	O
and	O	O
potentially	O	O
virulence	O	O
(	O	O
S-layer	O	O
RTX	O	O
and	O	O
cysteine	O	O
desulfhydrase	O	O
)	O	O
.	O	O

Further	O	O
analysis	O	O
of	O	O
the	O	O
C.	B-bacteria	B-bacteria
rectus-specific	E-bacteria	I-bacteria
clones	O	O
showed	O	O
that	O	O
10	O	O
genes	O	O
had	O	O
Campylobacter	B-bacteria	B-bacteria
homologues	O	O
that	O	O
were	O	O
only	O	O
found	O	O
in	O	O
species	O	O
that	O	O
commonly	O	O
reside	O	O
within	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
humans	O	O
and	O	O
10	O	O
other	O	O
fragments	O	O
shared	O	O
homology	O	O
only	O	O
with	O	O
non-campylobacter	O	O
organisms	O	O
.	O	O

These	O	O
data	O	O
provide	O	O
the	O	O
first	O	O
substantial	O	O
insights	O	O
into	O	O
the	O	O
genomic	O	O
content	O	O
of	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
a	O	O
significant	O	O
oral	O	O
pathogen	O	O
.	O	O

The	O	O
genes	O	O
identified	O	O
in	O	O
this	O	O
study	O	O
are	O	O
a	O	O
valuable	O	O
resource	O	O
for	O	O
initiating	O	O
new	O	O
research	O	O
on	O	O
the	O	O
virulence	O	O
of	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
during	O	O
periodontitis	O	O
.	O	O

Ginger	O	O
(	O	O
Zingiber	O	O
officinale	O	O
Roscoe	O	O
)	O	O
has	O	O
been	O	O
used	O	O
widely	O	O
as	O	O
a	O	O
food	O	O
spice	O	O
and	O	O
an	O	O
herbal	O	O
medicine	O	O
.	O	O

In	O	O
particular	O	O
,	O	O
its	O	O
gingerol-related	O	O
components	O	O
have	O	O
been	O	O
reported	O	O
to	O	O
possess	O	O
antimicrobial	O	O
and	O	O
antifungal	O	O
properties	O	O
,	O	O
as	O	O
well	O	O
as	O	O
several	O	O
pharmaceutical	O	O
properties	O	O
.	O	O

However	O	O
,	O	O
the	O	O
effective	O	O
ginger	O	O
constituents	O	O
that	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
oral	O	O
bacteria	O	O
associated	O	O
with	O	O
periodontitis	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
have	O	O
not	O	O
been	O	O
elucidated	O	O
.	O	O

This	O	O
study	O	O
revealed	O	O
that	O	O
the	O	O
ethanol	O	O
and	O	O
n-hexane	O	O
extracts	O	O
of	O	O
ginger	O	O
exhibited	O	O
antibacterial	O	O
activities	O	O
against	O	O
three	O	O
anaerobic	B-bacteria	B-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
53978	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
endodontalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
35406	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25611	E-bacteria	I-bacteria
,	O	O
causing	O	O
periodontal	O	O
diseases	O	O
.	O	O

Thereafter	O	O
,	O	O
five	O	O
ginger	O	O
constituents	O	O
were	O	O
isolated	O	O
by	O	O
a	O	O
preparative	O	O
high-performance	O	O
liquid	O	O
chromatographic	O	O
method	O	O
from	O	O
the	O	O
active	O	O
silica-gel	O	O
column	O	O
chromatography	O	O
fractions	O	O
,	O	O
elucidated	O	O
their	O	O
structures	O	O
by	O	O
nuclear	O	O
magnetic	O	O
resonance	O	O
spectroscopy	O	O
and	O	O
electrospray	O	O
ionization	O	O
mass	O	O
spectrometry	O	O
and	O	O
their	O	O
antibacterial	O	O
activity	O	O
evaluated	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
two	O	O
highly	O	O
alkylated	O	O
gingerols	O	O
,	O	O
[	O	O
10	O	O
]	O	O
-gingerol	O	O
and	O	O
[	O	O
12	O	O
]	O	O
-gingerol	O	O
effectively	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
these	O	O
oral	O	O
pathogens	O	O
at	O	O
a	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
range	O	O
of	O	O
6-30	O	O
microg/mL	O	O
.	O	O

These	O	O
ginger	O	O
compounds	O	O
also	O	O
killed	O	O
the	O	O
oral	O	O
pathogens	O	O
at	O	O
a	O	O
minimum	O	O
bactericidal	O	O
concentration	O	O
(	O	O
MBC	O	O
)	O	O
range	O	O
of	O	O
4-20	O	O
microg/mL	O	O
,	O	O
but	O	O
not	O	O
the	O	O
other	O	O
ginger	O	O
compounds	O	O
5-acetoxy-	O	O
[	O	O
6	O	O
]	O	O
-gingerol	O	O
,	O	O
3,5-diacetoxy-	O	O
[	O	O
6	O	O
]	O	O
-gingerdiol	O	O
and	O	O
galanolactone	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
evaluate	O	O
the	O	O
efficacy	O	O
of	O	O
semi	O	O
fermented	O	O
and	O	O
non	O	O
fermented	O	O
Camellia	O	O
sinensis	O	O
extracts	O	O
(	O	O
Black	O	O
and	O	O
Green	O	O
tea	O	O
)	O	O
and	O	O
comparison	O	O
between	O	O
them	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25175	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
9811	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
10556	E-bacteria	I-bacteria
that	O	O
are	O	O
responsible	O	O
for	O	O
dental	O	O
caries	O	O
and	O	O
bacteremias	O	O
following	O	O
dental	O	O
manipulations	O	O
.	O	O

Minimum	O	O
inhibitory	O	O
concentrations	O	O
of	O	O
both	O	O
tea	O	O
extracts	O	O
were	O	O
assessed	O	O
by	O	O
Well	O	O
diffusion	O	O
and	O	O
Broth	O	O
dilution	O	O
methods	O	O
and	O	O
examination	O	O
of	O	O
cell	O	O
adherence	O	O
(	O	O
Biofilm	O	O
inhibitory	O	O
concentrations	O	O
)	O	O
was	O	O
observed	O	O
on	O	O
glass	O	O
slides	O	O
under	O	O
phase	O	O
contrast	O	O
microscope	O	O
and	O	O
colony	O	O
counts	O	O
from	O	O
glass	O	O
beads	O	O
.	O	O

Concentration	O	O
of	O	O
1	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
of	O	O
semi	O	O
fermented	O	O
tea	O	O
extract	O	O
was	O	O
completely	O	O
biofilm	O	O
inhibitor	O	O
but	O	O
biofilm	O	O
formation	O	O
by	O	O
these	O	O
bacteria	O	O
was	O	O
seen	O	O
7	O	O
days	O	O
after	O	O
treatment	O	O
with	O	O
1	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
of	O	O
non	O	O
fermented	O	O
Camellia	O	O
sinensis	O	O
on	O	O
glass	O	O
beads	O	O
and	O	O
BIC	O	O
for	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
treated	O	O
with	O	O
this	O	O
extract	O	O
was	O	O
1.5	O	O
,	O	O
2.5	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
of	O	O
semi	O	O
fermented	O	O
and	O	O
3	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
of	O	O
non	O	O
fermented	O	O
extracts	O	O
had	O	O
bactericidal	O	O
effect	O	O
on	O	O
these	O	O
bacteria	O	O
.	O	O

Semi	O	O
fermented	O	O
and	O	O
non	O	O
fermented	O	O
Camellia	O	O
sinensis	O	O
extracts	O	O
were	O	O
able	O	O
to	O	O
prevent	O	O
growth	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Therefore	O	O
dental	O	O
caries	O	O
significantly	O	O
reduce	O	O
and	O	O
the	O	O
efficiency	O	O
of	O	O
semi	O	O
fermented	O	O
tea	O	O
was	O	O
higher	O	O
due	O	O
to	O	O
rich	O	O
content	O	O
of	O	O
volatile	O	O
components	O	O
rather	O	O
than	O	O
non	O	O
fermented	O	O
extracts	O	O
.	O	O

We	O	O
present	O	O
a	O	O
novel	O	O
concept	O	O
on	O	O
carcinogenesis	O	O
mediated	O	O
by	O	O
oral	O	O
microbiota	O	O
.	O	O

Oral	O	O
micro-organisms	O	O
are	O	O
capable	O	O
of	O	O
metabolizing	O	O
alcohol	O	O
to	O	O
acetaldehyde	O	O
.	O	O

This	O	O
finding	O	O
casts	O	O
light	O	O
on	O	O
the	O	O
observed	O	O
association	O	O
between	O	O
poor	O	O
oral	O	O
hygiene	O	O
and	O	O
oral	O	O
cancer	O	O
.	O	O

Ethanol	O	O
,	O	O
as	O	O
such	O	O
,	O	O
is	O	O
not	O	O
carcinogenic	O	O
,	O	O
but	O	O
its	O	O
first	O	O
metabolite	O	O
acetaldehyde	O	O
is	O	O
indisputably	O	O
carcinogenic	O	O
.	O	O

Several	O	O
gastro-intestinal	O	O
microbial	O	O
species	O	O
possess	O	O
the	O	O
enzyme	O	O
alcohol	O	O
dehydrogenase	O	O
(	O	O
ADH	O	O
)	O	O
,	O	O
which	O	O
is	O	O
also	O	O
the	O	O
enzyme	O	O
responsible	O	O
for	O	O
alcohol	O	O
metabolism	O	O
in	O	O
the	O	O
liver	O	O
.	O	O

In	O	O
oral	O	O
microbiota	O	O
,	O	O
we	O	O
observed	O	O
that	O	O
species	O	O
such	O	O
as	O	O
the	O	O
ubiquitous	O	O
viridans	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
Candida	O	O
also	O	O
possess	O	O
ADH	O	O
.	O	O

Ethanol	O	O
can	O	O
be	O	O
detected	O	O
in	O	O
the	O	O
mouth	O	O
hours	O	O
after	O	O
the	O	O
consumption	O	O
of	O	O
alcoholic	O	O
beverages	O	O
.	O	O

Patients	O	O
with	O	O
poor	O	O
oral	O	O
health	O	O
status	O	O
have	O	O
shown	O	O
higher	O	O
salivary	O	O
acetaldehyde	O	O
concentrations	O	O
than	O	O
those	O	O
with	O	O
better	O	O
oral	O	O
health	O	O
.	O	O

It	O	O
is	O	O
thus	O	O
understandable	O	O
that	O	O
ADH-containing	O	O
micro-organisms	O	O
in	O	O
the	O	O
mouth	O	O
present	O	O
a	O	O
risk	O	O
for	O	O
carcinogenic	O	O
acetaldehyde	O	O
production	O	O
,	O	O
with	O	O
subsequent	O	O
potential	O	O
for	O	O
the	O	O
development	O	O
of	O	O
oral	O	O
cancer	O	O
,	O	O
particularly	O	O
among	O	O
heavy	O	O
drinkers	O	O
.	O	O

In	O	O
this	O	O
article	O	O
,	O	O
we	O	O
briefly	O	O
review	O	O
this	O	O
area	O	O
of	O	O
investigation	O	O
and	O	O
conclude	O	O
by	O	O
highlighting	O	O
some	O	O
future	O	O
possibilities	O	O
for	O	O
the	O	O
control	O	O
of	O	O
carcinogenesis	O	O
.	O	O

Generally	O	O
,	O	O
mechanical	O	O
plaque	O	O
control	O	O
without	O	O
chemical	O	O
support	O	O
is	O	O
insufficient	O	O
to	O	O
prevent	O	O
oral	O	O
diseases	O	O
,	O	O
and	O	O
an	O	O
ongoing	O	O
quest	O	O
exists	O	O
for	O	O
new	O	O
antimicrobials	O	O
for	O	O
use	O	O
in	O	O
oral	O	O
healthcare	O	O
.	O	O

Chitosans	O	O
are	O	O
polycationic	O	O
,	O	O
naturally	O	O
occurring	O	O
antimicrobials	O	O
that	O	O
are	O	O
rapidly	O	O
finding	O	O
their	O	O
way	O	O
into	O	O
oral	O	O
healthcare	O	O
.	O	O

In	O	O
this	O	O
study	O	O
we	O	O
determined	O	O
the	O	O
effects	O	O
of	O	O
pellicle	O	O
treatment	O	O
with	O	O
chitosan	O	O
on	O	O
bacterial	O	O
adhesion	O	O
and	O	O
growth	O	O
.	O	O

Chitosan	O	O
caused	O	O
a	O	O
reduction	O	O
in	O	O
bacterial	O	O
adhesion	O	O
and	O	O
was	O	O
responsible	O	O
for	O	O
bacterial	O	O
death	O	O
upon	O	O
contact	O	O
compared	O	O
with	O	O
a	O	O
buffer	O	O
control	O	O
.	O	O

Exposure	O	O
of	O	O
adhering	O	O
bacteria	O	O
to	O	O
a	O	O
chitosan	O	O
solution	O	O
or	O	O
a	O	O
buffer	O	O
control	O	O
did	O	O
not	O	O
cause	O	O
detachment	O	O
,	O	O
but	O	O
the	O	O
chitosan	O	O
solution	O	O
left	O	O
a	O	O
small	O	O
proportion	O	O
of	O	O
the	O	O
adhering	O	O
bacteria	O	O
alive	O	O
.	O	O

Growth	O	O
after	O	O
exposure	O	O
to	O	O
chitosan	O	O
was	O	O
similar	O	O
to	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
ATCC700610	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
HM1	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	I-bacteria	I-bacteria
HG1025	E-bacteria	I-bacteria
)	O	O
or	O	O
less	O	O
than	O	O
(	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
NS	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
HM1	E-bacteria	I-bacteria
)	O	O
that	O	O
of	O	O
the	O	O
control	O	O
,	O	O
while	O	O
biofilm	O	O
viability	O	O
after	O	O
chitosan	O	O
treatment	O	O
was	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
the	O	O
control	O	O
,	O	O
except	O	O
for	O	O
S.	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
HM1	E-bacteria	I-bacteria
.	O	O

Therefore	O	O
,	O	O
chitosan	O	O
is	O	O
a	O	O
promising	O	O
antimicrobial	O	O
for	O	O
use	O	O
in	O	O
oral	O	O
healthcare	O	O
.	O	O

A	O	O
multitude	O	O
of	O	O
molecular	O	O
methods	O	O
are	O	O
currently	O	O
used	O	O
for	O	O
identification	O	O
and	O	O
characterization	O	O
of	O	O
oral	O	O
biofilms	O	O
or	O	O
for	O	O
community	O	O
profiling	O	O
.	O	O

However	O	O
,	O	O
multiplex	O	O
PCR	O	O
techniques	O	O
that	O	O
are	O	O
able	O	O
to	O	O
routinely	O	O
identify	O	O
several	O	O
species	O	O
in	O	O
a	O	O
single	O	O
assay	O	O
are	O	O
not	O	O
available	O	O
.	O	O

Multiplex	O	O
Ligation-dependent	O	O
Probe	O	O
Amplification	O	O
(	O	O
MLPA	O	O
)	O	O
identifies	O	O
up	O	O
to	O	O
45	O	O
unique	O	O
fragments	O	O
in	O	O
a	O	O
single	O	O
tube	O	O
PCR	O	O
.	O	O

Here	O	O
we	O	O
report	O	O
a	O	O
novel	O	O
use	O	O
of	O	O
MLPA	O	O
in	O	O
the	O	O
relative	O	O
quantification	O	O
of	O	O
targeted	O	O
microorganisms	O	O
in	O	O
a	O	O
community	O	O
of	O	O
oral	O	O
microbiota	O	O
.	O	O

We	O	O
designed	O	O
9	O	O
species	O	O
specific	O	O
probes	O	O
for	O	O
:	O	O
Actinomyces	B-bacteria	B-bacteria
gerencseriae	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
;	O	O
and	O	O
genus	O	O
specific	O	O
probes	O	O
for	O	O
selected	O	O
oral	O	O
Streptococci	B-bacteria	B-bacteria
and	O	O
Lactobacilli	B-bacteria	B-bacteria
based	O	O
on	O	O
their	O	O
16S	O	O
rDNA	O	O
sequences	O	O
.	O	O

MLPA	O	O
analysis	O	O
of	O	O
DNA	O	O
pooled	O	O
from	O	O
the	O	O
strains	O	O
showed	O	O
the	O	O
expected	O	O
specific	O	O
MLPA	O	O
products	O	O
.	O	O

Relative	O	O
quantification	O	O
of	O	O
a	O	O
serial	O	O
dilution	O	O
of	O	O
equimolar	O	O
DNA	O	O
showed	O	O
that	O	O
as	O	O
little	O	O
as	O	O
10	O	O
pg	O	O
templates	O	O
can	O	O
be	O	O
detected	O	O
with	O	O
clearly	O	O
discernible	O	O
signals	O	O
.	O	O

Moreover	O	O
,	O	O
a	O	O
2	O	O
to	O	O
7	O	O
%	O	O
divergence	O	O
in	O	O
relative	O	O
signal	O	O
ratio	O	O
of	O	O
amplified	O	O
probes	O	O
observed	O	O
from	O	O
normalized	O	O
peak	O	O
area	O	O
values	O	O
suggests	O	O
MLPA	O	O
can	O	O
be	O	O
a	O	O
cheaper	O	O
alternative	O	O
to	O	O
using	O	O
qPCR	O	O
for	O	O
quantification	O	O
.	O	O

We	O	O
observed	O	O
2	O	O
to	O	O
6	O	O
fold	O	O
fluctuations	O	O
in	O	O
signal	O	O
intensities	O	O
of	O	O
MLPA	O	O
products	O	O
in	O	O
DNAs	O	O
isolated	O	O
from	O	O
multispecies	O	O
biofilms	O	O
grown	O	O
in	O	O
various	O	O
media	O	O
for	O	O
various	O	O
culture	O	O
times	O	O
.	O	O

Furthermore	O	O
,	O	O
MLPA	O	O
analyses	O	O
of	O	O
DNA	O	O
isolated	O	O
from	O	O
saliva	O	O
obtained	O	O
from	O	O
different	O	O
donors	O	O
gave	O	O
a	O	O
varying	O	O
number	O	O
and	O	O
intensity	O	O
of	O	O
signals	O	O
.	O	O

This	O	O
clearly	O	O
shows	O	O
the	O	O
usefulness	O	O
of	O	O
MLPA	O	O
in	O	O
a	O	O
quantitative	O	O
description	O	O
of	O	O
microbial	O	O
shifts	O	O
.	O	O

In	O	O
the	O	O
last	O	O
decade	O	O
,	O	O
as	O	O
a	O	O
result	O	O
of	O	O
the	O	O
widespread	O	O
use	O	O
of	O	O
PCR	O	O
and	O	O
DNA	O	O
sequencing	O	O
,	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
has	O	O
played	O	O
a	O	O
pivotal	O	O
role	O	O
in	O	O
the	O	O
accurate	O	O
identification	O	O
of	O	O
bacterial	O	O
isolates	O	O
and	O	O
the	O	O
discovery	O	O
of	O	O
novel	O	O
bacteria	O	O
in	O	O
clinical	O	O
microbiology	O	O
laboratories	O	O
.	O	O

For	O	O
bacterial	O	O
identification	O	O
,	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
is	O	O
particularly	O	O
important	O	O
in	O	O
the	O	O
case	O	O
of	O	O
bacteria	O	O
with	O	O
unusual	O	O
phenotypic	O	O
profiles	O	O
,	O	O
rare	O	O
bacteria	O	O
,	O	O
slow-growing	O	O
bacteria	O	O
,	O	O
uncultivable	O	O
bacteria	O	O
and	O	O
culture-negative	O	O
infections	O	O
.	O	O

Not	O	O
only	O	O
has	O	O
it	O	O
provided	O	O
insights	O	O
into	O	O
aetiologies	O	O
of	O	O
infectious	O	O
disease	O	O
,	O	O
but	O	O
it	O	O
also	O	O
helps	O	O
clinicians	O	O
in	O	O
choosing	O	O
antibiotics	O	O
and	O	O
in	O	O
determining	O	O
the	O	O
duration	O	O
of	O	O
treatment	O	O
and	O	O
infection	O	O
control	O	O
procedures	O	O
.	O	O

With	O	O
the	O	O
use	O	O
of	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
,	O	O
215	O	O
novel	O	O
bacterial	O	O
species	O	O
,	O	O
29	O	O
of	O	O
which	O	O
belong	O	O
to	O	O
novel	O	O
genera	O	O
,	O	O
have	O	O
been	O	O
discovered	O	O
from	O	O
human	O	O
specimens	O	O
in	O	O
the	O	O
past	O	O
7	O	O
years	O	O
of	O	O
the	O	O
21st	O	O
century	O	O
(	O	O
2001-2007	O	O
)	O	O
.	O	O

One	O	O
hundred	O	O
of	O	O
the	O	O
215	O	O
novel	O	O
species	O	O
,	O	O
15	O	O
belonging	O	O
to	O	O
novel	O	O
genera	O	O
,	O	O
have	O	O
been	O	O
found	O	O
in	O	O
four	O	O
or	O	O
more	O	O
subjects	O	O
.	O	O

The	O	O
largest	O	O
number	O	O
of	O	O
novel	O	O
species	O	O
discovered	O	O
were	O	O
of	O	O
the	O	O
genera	B-bacteria	B-bacteria
Mycobacterium	E-bacteria	I-bacteria
(	O	O
n	O	O
=	O	O
12	O	O
)	O	O
and	O	O
Nocardia	B-bacteria	B-bacteria
(	O	O
n	O	O
=	O	O
6	O	O
)	O	O
.	O	O

The	O	O
oral	O	O
cavity/dental-related	O	O
specimens	O	O
(	O	O
n	O	O
=	O	O
19	O	O
)	O	O
and	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
(	O	O
n	O	O
=	O	O
26	O	O
)	O	O
were	O	O
the	O	O
most	O	O
important	O	O
sites	O	O
for	O	O
discovery	O	O
and/or	O	O
reservoirs	O	O
of	O	O
novel	O	O
species	O	O
.	O	O

Among	O	O
the	O	O
100	O	O
novel	O	O
species	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sinensis	E-bacteria	I-bacteria
,	O	O
Laribacter	B-bacteria	B-bacteria
hongkongensis	E-bacteria	I-bacteria
,	O	O
Clostridium	B-bacteria	B-bacteria
hathewayi	E-bacteria	I-bacteria
and	O	O
Borrelia	B-bacteria	B-bacteria
spielmanii	E-bacteria	I-bacteria
have	O	O
been	O	O
most	O	O
thoroughly	O	O
characterized	O	O
,	O	O
with	O	O
the	O	O
reservoirs	O	O
and	O	O
routes	O	O
of	O	O
transmission	O	O
documented	O	O
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
sinensis	E-bacteria	I-bacteria
,	O	O
L.	B-bacteria	B-bacteria
hongkongensis	E-bacteria	I-bacteria
and	O	O
C.	B-bacteria	B-bacteria
hathewayi	E-bacteria	I-bacteria
have	O	O
been	O	O
found	O	O
globally	O	O
.	O	O

One	O	O
of	O	O
the	O	O
greatest	O	O
hurdles	O	O
in	O	O
putting	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
into	O	O
routine	O	O
use	O	O
in	O	O
clinical	O	O
microbiology	O	O
laboratories	O	O
is	O	O
automation	O	O
of	O	O
the	O	O
technology	O	O
.	O	O

The	O	O
only	O	O
step	O	O
that	O	O
can	O	O
be	O	O
automated	O	O
at	O	O
the	O	O
moment	O	O
is	O	O
input	O	O
of	O	O
the	O	O
16S	O	O
rDNA	O	O
sequence	O	O
of	O	O
the	O	O
bacterial	O	O
isolate	O	O
for	O	O
identification	O	O
into	O	O
one	O	O
of	O	O
the	O	O
software	O	O
packages	O	O
that	O	O
will	O	O
generate	O	O
the	O	O
result	O	O
of	O	O
the	O	O
identity	O	O
of	O	O
the	O	O
isolate	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
its	O	O
sequence	O	O
database	O	O
.	O	O

However	O	O
,	O	O
studies	O	O
on	O	O
the	O	O
accuracy	O	O
of	O	O
the	O	O
software	O	O
packages	O	O
have	O	O
given	O	O
highly	O	O
varied	O	O
results	O	O
,	O	O
and	O	O
interpretation	O	O
of	O	O
results	O	O
remains	O	O
difficult	O	O
for	O	O
most	O	O
technicians	O	O
,	O	O
and	O	O
even	O	O
for	O	O
clinical	O	O
microbiologists	O	O
.	O	O

To	O	O
fully	O	O
utilize	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
in	O	O
clinical	O	O
microbiology	O	O
,	O	O
better	O	O
guidelines	O	O
are	O	O
needed	O	O
for	O	O
interpretation	O	O
of	O	O
the	O	O
identification	O	O
results	O	O
,	O	O
and	O	O
additional/supplementary	O	O
methods	O	O
are	O	O
necessary	O	O
for	O	O
bacterial	O	O
species	O	O
that	O	O
can	O	O
not	O	O
be	O	O
identified	O	O
confidently	O	O
by	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
alone	O	O
.	O	O

To	O	O
obtain	O	O
deeper	O	O
insights	O	O
into	O	O
the	O	O
etiology	O	O
of	O	O
oral	O	O
disease	O	O
,	O	O
an	O	O
understanding	O	O
of	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
surrounding	O	O
bacterial	O	O
environments	O	O
that	O	O
lead	O	O
to	O	O
health	O	O
or	O	O
disease	O	O
is	O	O
required	O	O
,	O	O
which	O	O
is	O	O
attracting	O	O
increasing	O	O
attention	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
bacterial	O	O
compositions	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
200	O	O
subjects	O	O
aged	O	O
15-40	O	O
years	O	O
were	O	O
depicted	O	O
as	O	O
peak	O	O
patterns	O	O
by	O	O
terminal	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
(	O	O
T-RFLP	O	O
)	O	O
analysis	O	O
of	O	O
16S	O	O
rRNA	O	O
genes	O	O
.	O	O

The	O	O
subjects	O	O
were	O	O
classified	O	O
into	O	O
three	O	O
clusters	O	O
by	O	O
partitioning	O	O
around	O	O
medoids	O	O
clustering	O	O
based	O	O
on	O	O
their	O	O
T-RFLP	O	O
profiles	O	O
,	O	O
and	O	O
the	O	O
clinical	O	O
oral	O	O
health	O	O
parameters	O	O
of	O	O
the	O	O
clusters	O	O
were	O	O
compared	O	O
.	O	O

The	O	O
clustering	O	O
of	O	O
the	O	O
T-RFLP	O	O
profiles	O	O
in	O	O
this	O	O
study	O	O
was	O	O
mainly	O	O
based	O	O
on	O	O
differences	O	O
in	O	O
the	O	O
abundance	O	O
distribution	O	O
of	O	O
the	O	O
dominant	O	O
terminal	O	O
restriction	O	O
fragments	O	O
(	O	O
TRFs	O	O
)	O	O
detected	O	O
in	O	O
most	O	O
of	O	O
the	O	O
subjects	O	O
.	O	O

Predicted	O	O
from	O	O
the	O	O
sizes	O	O
of	O	O
the	O	O
TRFs	O	O
,	O	O
the	O	O
characteristically	O	O
more	O	O
predominant	O	O
members	O	O
of	O	O
each	O	O
were	O	O
Prevotella	B-bacteria	B-bacteria
and	O	O
Veillonella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
in	O	O
cluster	O	O
I	O	O
;	O	O
Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
in	O	O
cluster	O	O
II	O	O
and	O	O
Neisseria	B-bacteria	B-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
or	O	O
Aggregatibacter	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
in	O	O
cluster	O	O
III	O	O
.	O	O

The	O	O
parameters	O	O
associated	O	O
with	O	O
periodontal	O	O
disease	O	O
were	O	O
significantly	O	O
different	O	O
among	O	O
the	O	O
clusters	O	O
.	O	O

Clusters	O	O
I	O	O
and	O	O
II	O	O
had	O	O
a	O	O
higher	O	O
percentage	O	O
of	O	O
sites	O	O
of	O	O
periodontal	O	O
pockets	O	O
greater	O	O
than	O	O
4	O	O
mm	O	O
than	O	O
cluster	O	O
III	O	O
,	O	O
and	O	O
cluster	O	O
I	O	O
contained	O	O
sites	O	O
exhibiting	O	O
bleeding	O	O
on	O	O
probing	O	O
more	O	O
often	O	O
than	O	O
cluster	O	O
II	O	O
or	O	O
III	O	O
;	O	O
no	O	O
significant	O	O
differences	O	O
were	O	O
observed	O	O
in	O	O
other	O	O
parameters	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
abundance	O	O
distribution	O	O
of	O	O
commensal	O	O
bacteria	O	O
in	O	O
saliva	O	O
is	O	O
correlated	O	O
with	O	O
periodontal	O	O
health	O	O
,	O	O
and	O	O
might	O	O
be	O	O
involved	O	O
in	O	O
the	O	O
susceptibility	O	O
of	O	O
an	O	O
individual	O	O
to	O	O
periodontal	O	O
disease	O	O
.	O	O

The	O	O
microbiota	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
mucosa	O	O
consists	O	O
of	O	O
a	O	O
myriad	O	O
of	O	O
bacterial	O	O
species	O	O
that	O	O
normally	O	O
exist	O	O
in	O	O
commensal	O	O
harmony	O	O
with	O	O
the	O	O
host	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
an	O	O
aetiological	O	O
agent	O	O
in	O	O
severe	O	O
forms	O	O
of	O	O
periodontitis	O	O
(	O	O
a	O	O
chronic	O	O
inflammatory	O	O
disease	O	O
)	O	O
,	O	O
is	O	O
a	O	O
prominent	O	O
component	O	O
of	O	O
the	O	O
oral	O	O
microbiome	O	O
and	O	O
a	O	O
successful	O	O
colonizer	O	O
of	O	O
the	O	O
oral	O	O
epithelium	O	O
.	O	O

This	O	O
Gram-negative	B-bacteria	B-bacteria
anaerobe	E-bacteria	I-bacteria
can	O	O
also	O	O
exist	O	O
within	O	O
the	O	O
host	O	O
epithelium	O	O
without	O	O
the	O	O
existence	O	O
of	O	O
overt	O	O
disease	O	O
.	O	O

Gingival	O	O
epithelial	O	O
cells	O	O
,	O	O
the	O	O
outer	O	O
lining	O	O
of	O	O
the	O	O
gingival	O	O
mucosa	O	O
,	O	O
which	O	O
function	O	O
as	O	O
an	O	O
important	O	O
part	O	O
of	O	O
the	O	O
innate	O	O
immune	O	O
system	O	O
,	O	O
are	O	O
among	O	O
the	O	O
first	O	O
host	O	O
cells	O	O
colonized	O	O
by	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

This	O	O
review	O	O
describes	O	O
recent	O	O
studies	O	O
implicating	O	O
the	O	O
co-existence	O	O
and	O	O
intracellular	O	O
adaptation	O	O
of	O	O
the	O	O
organism	O	O
in	O	O
these	O	O
target	O	O
host	O	O
cells	O	O
.	O	O

Specifically	O	O
,	O	O
recent	O	O
findings	O	O
on	O	O
the	O	O
putative	O	O
mechanisms	O	O
of	O	O
persistence	O	O
,	O	O
intercellular	O	O
dissemination	O	O
and	O	O
opportunism	O	O
are	O	O
highlighted	O	O
.	O	O

These	O	O
new	O	O
findings	O	O
may	O	O
also	O	O
represent	O	O
an	O	O
original	O	O
and	O	O
valuable	O	O
model	O	O
for	O	O
mechanistic	O	O
characterization	O	O
of	O	O
other	O	O
successful	O	O
host-adapted	O	O
,	O	O
self-limiting	O	O
,	O	O
persistent	O	O
intracellular	O	O
bacteria	O	O
in	O	O
human	O	O
epithelial	O	O
tissues	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
colonization	O	O
of	O	O
Campylobacter	O	O
rectus	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
previously	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
previously	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
in	O	O
the	O	O
tongue	O	O
and	O	O
cheek	O	O
of	O	O
newborns	O	O
and	O	O
elderly	O	O
individuals	O	O
with	O	O
no	O	O
teeth	O	O
.	O	O

Seventy-four	O	O
edentulous	O	O
subjects	O	O
were	O	O
included	O	O
in	O	O
this	O	O
cross-sectional	O	O
study	O	O
.	O	O

Microbiologic	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
and	O	O
cheek	O	O
mucosa	O	O
of	O	O
all	O	O
individuals	O	O
and	O	O
analyzed	O	O
using	O	O
a	O	O
bacterial	O	O
DNA-specific	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
prevalent	O	O
species	O	O
in	O	O
both	O	O
groups	O	O
(	O	O
20.9	O	O
%	O	O
in	O	O
the	O	O
cheek	O	O
of	O	O
newborns	O	O
,	O	O
and	O	O
77.4	O	O
%	O	O
in	O	O
the	O	O
tongue	O	O
of	O	O
elderly	O	O
subjects	O	O
)	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
were	O	O
not	O	O
detected	O	O
in	O	O
any	O	O
of	O	O
the	O	O
43	O	O
newborns	O	O
;	O	O
however	O	O
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
recovered	O	O
from	O	O
the	O	O
tongue	O	O
and	O	O
cheek	O	O
(	O	O
3.2	O	O
%	O	O
)	O	O
of	O	O
elderly	O	O
individuals	O	O
,	O	O
whereas	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
the	O	O
tongue	O	O
(	O	O
9.6	O	O
%	O	O
)	O	O
and	O	O
cheek	O	O
(	O	O
3.2	O	O
%	O	O
)	O	O
of	O	O
elderly	O	O
individuals	O	O
.	O	O

T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
newborns	O	O
as	O	O
well	O	O
as	O	O
elderly	O	O
individuals	O	O
,	O	O
although	O	O
the	O	O
highest	O	O
prevalence	O	O
was	O	O
observed	O	O
in	O	O
the	O	O
tongue	O	O
of	O	O
newborns	O	O
(	O	O
6.9	O	O
%	O	O
)	O	O
and	O	O
elderly	O	O
(	O	O
9.6	O	O
%	O	O
)	O	O
individuals	O	O
.	O	O

A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
was	O	O
not	O	O
found	O	O
in	O	O
the	O	O
tongue	O	O
of	O	O
newborns	O	O
,	O	O
but	O	O
we	O	O
observed	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
in	O	O
the	O	O
cheek	O	O
(	O	O
2.3	O	O
%	O	O
)	O	O
of	O	O
newborns	O	O
and	O	O
in	O	O
the	O	O
tongue	O	O
(	O	O
12.9	O	O
%	O	O
)	O	O
and	O	O
cheek	O	O
(	O	O
6.4	O	O
%	O	O
)	O	O
of	O	O
elderly	O	O
patients	O	O
.	O	O

Although	O	O
we	O	O
did	O	O
not	O	O
detect	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
in	O	O
newborns	O	O
,	O	O
periodontal	O	O
pathogens	O	O
could	O	O
be	O	O
detected	O	O
from	O	O
the	O	O
oral	O	O
mucous	O	O
membranes	O	O
of	O	O
edentulous	O	O
individuals	O	O
.	O	O

Our	O	O
results	O	O
suggest	O	O
that	O	O
major	O	O
attention	O	O
should	O	O
be	O	O
paid	O	O
to	O	O
edentulous	O	O
individuals	O	O
as	O	O
an	O	O
important	O	O
measure	O	O
in	O	O
the	O	O
prevention	O	O
of	O	O
the	O	O
initial	O	O
colonization	O	O
of	O	O
natural	O	O
teeth	O	O
and	O	O
dental	O	O
implants	O	O
by	O	O
periodontal	O	O
pathogens	O	O
.	O	O

Changes	O	O
in	O	O
the	O	O
levels	O	O
of	O	O
female	O	O
sex	O	O
hormones	O	O
during	O	O
the	O	O
menstrual	O	O
cycle	O	O
may	O	O
cause	O	O
cyclic	O	O
differences	O	O
in	O	O
subgingival	O	O
bacterial	O	O
colonization	O	O
patterns	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
test	O	O
the	O	O
hypothesis	O	O
that	O	O
hormonal	O	O
changes	O	O
in	O	O
the	O	O
menstrual	O	O
cycle	O	O
cause	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
microbiota	O	O
.	O	O

Bacterial	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
in	O	O
20	O	O
systemically	O	O
and	O	O
periodontally	O	O
healthy	O	O
women	O	O
using	O	O
no	O	O
hormonal	O	O
contraceptives	O	O
(	O	O
test	O	O
group	O	O
)	O	O
over	O	O
a	O	O
period	O	O
of	O	O
6	O	O
weeks	O	O
.	O	O

Twenty	O	O
age-matched	O	O
systemically	O	O
and	O	O
periodontally	O	O
healthy	O	O
men	O	O
were	O	O
assigned	O	O
to	O	O
the	O	O
control	O	O
group	O	O
.	O	O

Samples	O	O
were	O	O
processed	O	O
by	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
assay	O	O
,	O	O
and	O	O
74	O	O
species	O	O
were	O	O
analyzed	O	O
.	O	O

No	O	O
cyclic	O	O
pattern	O	O
of	O	O
bacterial	O	O
colonization	O	O
was	O	O
identified	O	O
for	O	O
any	O	O
of	O	O
the	O	O
74	O	O
species	O	O
studied	O	O
in	O	O
women	O	O
not	O	O
using	O	O
hormonal	O	O
contraceptives	O	O
.	O	O

Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
previously	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
(	O	O
Y4	B-bacteria	B-bacteria
)	O	O
was	O	O
common	O	O
at	O	O
the	O	O
beginning	O	O
of	O	O
menstruation	O	O
(	O	O
mean	O	O
:	O	O
32	O	O
%	O	O
)	O	O
and	O	O
increased	O	O
during	O	O
the	O	O
following	O	O
2	O	O
weeks	O	O
(	O	O
36	O	O
%	O	O
)	O	O
in	O	O
women	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

No	O	O
cyclic	O	O
differences	O	O
in	O	O
bacterial	O	O
presence	O	O
were	O	O
found	O	O
among	O	O
the	O	O
men	O	O
(	O	O
P	O	O
values	O	O
varied	O	O
between	O	O
0.14	O	O
and	O	O
0.98	O	O
)	O	O
.	O	O

Men	O	O
presented	O	O
with	O	O
significantly	O	O
higher	O	O
bacterial	O	O
counts	O	O
for	O	O
40	O	O
of	O	O
74	O	O
species	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
including	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
but	O	O
not	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
0.15	O	O
)	O	O
or	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
previously	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
(	O	O
P	O	O
=	O	O
0.42	O	O
)	O	O
.	O	O

During	O	O
a	O	O
menstruation	O	O
period	O	O
,	O	O
cyclic	O	O
variation	O	O
in	O	O
the	O	O
subgingival	O	O
microbiota	O	O
of	O	O
periodontally	O	O
healthy	O	O
women	O	O
of	O	O
child-bearing	O	O
age	O	O
who	O	O
were	O	O
not	O	O
using	O	O
oral	O	O
hormonal	O	O
contraceptives	O	O
could	O	O
not	O	O
be	O	O
confirmed	O	O
.	O	O

Male	O	O
control	O	O
subjects	O	O
presented	O	O
with	O	O
higher	O	O
levels	O	O
of	O	O
many	O	O
species	O	O
but	O	O
also	O	O
without	O	O
a	O	O
cyclic	O	O
pattern	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

in	O	O
the	O	O
oral	O	O
cavity	O	O
remains	O	O
controversial	O	O
and	O	O
the	O	O
most	O	O
appropriate	O	O
method	O	O
for	O	O
detection	O	O
of	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
has	O	O
yet	O	O
to	O	O
be	O	O
established	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
four	O	O
different	O	O
primer	O	O
sets	O	O
on	O	O
the	O	O
detection	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
gastric	O	O
biopsies	O	O
and	O	O
oral	O	O
samples	O	O
using	O	O
real-time	O	O
PCR	O	O
.	O	O

Gastric	O	O
biopsy	O	O
and	O	O
oral	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
eight	O	O
patients	O	O
with	O	O
gastric	O	O
symptoms	O	O
.	O	O

DNA	O	O
from	O	O
clinical	O	O
samples	O	O
was	O	O
extracted	O	O
and	O	O
analyzed	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
by	O	O
real-time	O	O
PCR	O	O
(	O	O
LightCycler	O	O
2.0	O	O
)	O	O
using	O	O
four	O	O
pairs	O	O
of	O	O
primers	O	O
which	O	O
targeted	O	O
16S	O	O
rRNA	O	O
(	O	O
16S	O	O
rRNA	O	O
#	O	O
295	O	O
;	O	O
16S	O	O
rRNA	O	O
#	O	O
120	O	O
)	O	O
or	O	O
glmM	O	O
(	O	O
glmM	O	O
#	O	O
294	O	O
;	O	O
glmM	O	O
#	O	O
722	O	O
)	O	O
DNA	O	O
genes	O	O
.	O	O

Three	O	O
H.	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
and	O	O
three	O	O
clinical	O	O
isolates	O	O
served	O	O
as	O	O
reference	O	O
.	O	O

The	O	O
specificities	O	O
of	O	O
the	O	O
four	O	O
primer	O	O
pairs	O	O
were	O	O
examined	O	O
for	O	O
seven	O	O
oral	O	O
microorganisms	O	O
and	O	O
two	O	O
Helicobacter	B-bacteria	B-bacteria
non-pylori	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
.	O	O

Primer	O	O
pair	O	O
16S	O	O
rRNA	O	O
#	O	O
120	O	O
showed	O	O
an	O	O
acceptable	O	O
specificity	O	O
and	O	O
a	O	O
high	O	O
sensitivity	O	O
.	O	O

Primer	O	O
pairs	O	O
glmM	O	O
#	O	O
294	O	O
and	O	O
glmM	O	O
#	O	O
722	O	O
demonstrated	O	O
a	O	O
high	O	O
specificity	O	O
but	O	O
a	O	O
low	O	O
sensitivity	O	O
and	O	O
primer	O	O
pair	O	O
16S	O	O
rRNA	O	O
#	O	O
295	O	O
demonstrated	O	O
a	O	O
poor	O	O
specificity	O	O
but	O	O
acceptable	O	O
sensitivity	O	O
.	O	O

Four	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
positive	O	O
gastric	O	O
biopsies	O	O
were	O	O
demonstrated	O	O
by	O	O
culture	O	O
,	O	O
histology	O	O
and	O	O
real-time	O	O
PCR	O	O
with	O	O
primer	O	O
pairs	O	O
16S	O	O
rRNA	O	O
#	O	O
295	O	O
or	O	O
16S	O	O
rRNA	O	O
#	O	O
120	O	O
.	O	O

No	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
oral	O	O
samples	O	O
,	O	O
either	O	O
by	O	O
culture	O	O
or	O	O
by	O	O
real-time	O	O
PCR	O	O
.	O	O

Of	O	O
the	O	O
four	O	O
different	O	O
primer	O	O
pairs	O	O
examined	O	O
,	O	O
16S	O	O
rRNA	O	O
#	O	O
120	O	O
was	O	O
the	O	O
most	O	O
appropriate	O	O
to	O	O
detect	O	O
H.	B-bacteria	B-bacteria
pylori	B-bacteria	B-bacteria
in	O	O
clinical	O	O
samples	O	O
using	O	O
real-time	O	O
PCR	O	O
.	O	O

Conventional	O	O
culture	O	O
methods	O	O
and	O	O
Multiplex	O	O
PCR	O	O
,	O	O
both	O	O
of	O	O
which	O	O
we	O	O
have	O	O
been	O	O
used	O	O
for	O	O
a	O	O
long	O	O
time	O	O
in	O	O
our	O	O
clinical	O	O
microbiology	O	O
laboratory	O	O
,	O	O
were	O	O
compared	O	O
for	O	O
their	O	O
ability	O	O
to	O	O
detect	O	O
a	O	O
selected	O	O
panel	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
:	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
.	O	O

Tests	O	O
were	O	O
performed	O	O
in	O	O
a	O	O
single	O	O
subgingival	O	O
sample	O	O
taken	O	O
from	O	O
a	O	O
periodontal	O	O
diseased	O	O
site	O	O
with	O	O
a	O	O
probing	O	O
depth	O	O
equal	O	O
to	O	O
or	O	O
greater	O	O
than	O	O
6mm	O	O
.	O	O

The	O	O
results	O	O
were	O	O
compared	O	O
site-by-site	O	O
,	O	O
taking	O	O
into	O	O
account	O	O
the	O	O
quality	O	O
and	O	O
the	O	O
presence	O	O
or	O	O
absence	O	O
of	O	O
pathogens	O	O
.	O	O

529	O	O
samples	O	O
of	O	O
subgingival	O	O
plaque	O	O
were	O	O
analysed	O	O
and	O	O
the	O	O
prevalence	O	O
of	O	O
the	O	O
six	O	O
species	O	O
monitored	O	O
varied	O	O
in	O	O
relation	O	O
to	O	O
the	O	O
species	O	O
itself	O	O
and	O	O
the	O	O
method	O	O
of	O	O
detection	O	O
.	O	O

The	O	O
most	O	O
represented	O	O
species	O	O
is	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
with	O	O
a	O	O
percentage	O	O
of	O	O
positive	O	O
variability	O	O
between	O	O
44.9	O	O
%	O	O
PCR	O	O
and	O	O
46.5	O	O
%	O	O
culture	O	O
test	O	O
.	O	O

Generally	O	O
,	O	O
the	O	O
lowest	O	O
prevalence	O	O
was	O	O
determined	O	O
by	O	O
culture	O	O
test	O	O
,	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
E.	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
which	O	O
,	O	O
unlike	O	O
other	O	O
bacteria	O	O
,	O	O
have	O	O
been	O	O
seen	O	O
in	O	O
higher	O	O
percentages	O	O
in	O	O
culture	O	O
with	O	O
respect	O	O
to	O	O
PCR	O	O
.	O	O

For	O	O
both	O	O
methods	O	O
,	O	O
there	O	O
was	O	O
a	O	O
good	O	O
degree	O	O
of	O	O
accuracy	O	O
in	O	O
the	O	O
determination	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
E.	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

It	O	O
becomes	O	O
weak	O	O
for	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
.	O	O

Both	O	O
culture	O	O
and	O	O
PCR	O	O
techniques	O	O
introduced	O	O
many	O	O
methodological	O	O
problems	O	O
when	O	O
applied	O	O
in	O	O
oral	O	O
microbiology	O	O
,	O	O
but	O	O
the	O	O
ideal	O	O
technique	O	O
for	O	O
accurate	O	O
detection	O	O
of	O	O
pathogens	O	O
in	O	O
subgingival	O	O
plaque	O	O
samples	O	O
has	O	O
yet	O	O
to	O	O
be	O	O
developed	O	O
.	O	O

This	O	O
crossover	O	O
design	O	O
clinical	O	O
study	O	O
compared	O	O
the	O	O
anti-microbial	O	O
effects	O	O
of	O	O
a	O	O
new	O	O
1	O	O
%	O	O
zinc	O	O
citrate	O	O
dentifrice	O	O
with	O	O
a	O	O
control	O	O
formulation	O	O
.	O	O

Thirty	O	O
adults	O	O
completed	O	O
a	O	O
washout	O	O
phase	O	O
and	O	O
baseline	O	O
samples	O	O
of	O	O
dental	O	O
plaque	O	O
,	O	O
buccal	O	O
mucosa	O	O
,	O	O
tongue	O	O
,	O	O
saliva	O	O
,	O	O
and	O	O
plaque	O	O
collected	O	O
to	O	O
enumerate	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Subjects	O	O
were	O	O
randomly	O	O
assigned	O	O
a	O	O
test	O	O
dentifrice	O	O
to	O	O
use	O	O
for	O	O
the	O	O
next	O	O
13	O	O
days	O	O
.	O	O

Oral	O	O
samples	O	O
similar	O	O
to	O	O
the	O	O
baseline	O	O
were	O	O
collected	O	O
on	O	O
day	O	O
14	O	O
prior	O	O
to	O	O
oral	O	O
hygiene	O	O
for	O	O
microbial	O	O
analysis	O	O
.	O	O

The	O	O
subject	O	O
then	O	O
placed	O	O
a	O	O
custom	O	O
intra-oral	O	O
stent	O	O
with	O	O
hydroxyapatite	O	O
(	O	O
HA	O	O
)	O	O
squares	O	O
and	O	O
brushed	O	O
their	O	O
teeth	O	O
with	O	O
their	O	O
assigned	O	O
dentifrice	O	O
.	O	O

Oral	O	O
samples	O	O
and	O	O
HA	O	O
squares	O	O
were	O	O
collected	O	O
5	O	O
h	O	O
later	O	O
for	O	O
microbial	O	O
analyses	O	O
.	O	O

This	O	O
completed	O	O
the	O	O
study	O	O
with	O	O
one	O	O
test	O	O
dentifrice	O	O
.	O	O

The	O	O
entire	O	O
study	O	O
was	O	O
repeated	O	O
with	O	O
the	O	O
alternate	O	O
dentifrice	O	O
after	O	O
a	O	O
second	O	O
washout	O	O
phase	O	O
.	O	O

Whereas	O	O
baseline	O	O
samples	O	O
demonstrated	O	O
no	O	O
significant	O	O
differences	O	O
in	O	O
microbial	O	O
parameters	O	O
between	O	O
the	O	O
two	O	O
treatment	O	O
groups	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
,	O	O
subjects	O	O
provided	O	O
the	O	O
zinc	O	O
citrate	O	O
dentifrice	O	O
demonstrated	O	O
24-52	O	O
%	O	O
reductions	O	O
in	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
streptococci	B-bacteria	B-bacteria
on	O	O
day	O	O
14	O	O
versus	O	O
the	O	O
control	O	O
paste	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

In	O	O
the	O	O
5-h	O	O
post-brushing	O	O
samples	O	O
,	O	O
subjects	O	O
provided	O	O
the	O	O
zinc	O	O
citrate	O	O
toothpaste	O	O
demonstrated	O	O
27-49	O	O
%	O	O
reductions	O	O
for	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Additionally	O	O
,	O	O
in	O	O
situ	O	O
microbial	O	O
biofilm	O	O
formation	O	O
on	O	O
HA	O	O
disks	O	O
was	O	O
significantly	O	O
inhibited	O	O
amongst	O	O
the	O	O
zinc	O	O
citrate	O	O
group	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Significant	O	O
reductions	O	O
in	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
observed	O	O
amongst	O	O
all	O	O
intra-oral	O	O
locations	O	O
along	O	O
with	O	O
in	O	O
situ	O	O
biofilm	O	O
formation	O	O
after	O	O
use	O	O
of	O	O
the	O	O
zinc	O	O
citrate	O	O
dentifrice	O	O
.	O	O

Apical	O	O
periodontitis	O	O
is	O	O
an	O	O
infectious	O	O
disease	O	O
caused	O	O
by	O	O
microorganisms	O	O
colonizing	O	O
the	O	O
root	O	O
canal	O	O
system	O	O
.	O	O

For	O	O
an	O	O
optimal	O	O
outcome	O	O
of	O	O
the	O	O
endodontic	O	O
treatment	O	O
to	O	O
be	O	O
achieved	O	O
,	O	O
bacterial	O	O
populations	O	O
within	O	O
the	O	O
root	O	O
canal	O	O
should	O	O
be	O	O
ideally	O	O
eliminated	O	O
or	O	O
at	O	O
least	O	O
significantly	O	O
reduced	O	O
to	O	O
levels	O	O
that	O	O
are	O	O
compatible	O	O
with	O	O
periradicular	O	O
tissue	O	O
healing	O	O
.	O	O

If	O	O
bacteria	O	O
persist	O	O
after	O	O
chemomechanical	O	O
preparation	O	O
supplemented	O	O
or	O	O
not	O	O
with	O	O
an	O	O
intracanal	O	O
medication	O	O
,	O	O
there	O	O
is	O	O
an	O	O
increased	O	O
risk	O	O
of	O	O
adverse	O	O
outcome	O	O
of	O	O
the	O	O
endodontic	O	O
treatment	O	O
.	O	O

Therefore	O	O
,	O	O
bacterial	O	O
presence	O	O
in	O	O
the	O	O
root	O	O
canal	O	O
at	O	O
the	O	O
time	O	O
of	O	O
filling	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
be	O	O
a	O	O
risk	O	O
factor	O	O
for	O	O
posttreatment	O	O
apical	O	O
periodontitis	O	O
.	O	O

About	O	O
100	O	O
species/phylotypes	O	O
have	O	O
already	O	O
been	O	O
detected	O	O
in	O	O
postinstrumentation	O	O
and/or	O	O
postmedication	O	O
samples	O	O
,	O	O
and	O	O
gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
are	O	O
the	O	O
most	O	O
dominant	O	O
.	O	O

However	O	O
,	O	O
it	O	O
remains	O	O
to	O	O
be	O	O
determined	O	O
by	O	O
longitudinal	O	O
studies	O	O
if	O	O
any	O	O
species/phylotypes	O	O
persisting	O	O
after	O	O
treatment	O	O
procedures	O	O
can	O	O
influence	O	O
outcome	O	O
.	O	O

This	O	O
review	O	O
article	O	O
discusses	O	O
diverse	O	O
aspects	O	O
of	O	O
bacterial	O	O
persistence	O	O
after	O	O
treatment	O	O
,	O	O
including	O	O
the	O	O
microbiology	O	O
,	O	O
bacterial	O	O
strategies	O	O
to	O	O
persist	O	O
,	O	O
the	O	O
requisites	O	O
for	O	O
persisting	O	O
bacteria	O	O
to	O	O
affect	O	O
the	O	O
outcome	O	O
,	O	O
and	O	O
future	O	O
directions	O	O
of	O	O
research	O	O
in	O	O
this	O	O
field	O	O
.	O	O

The	O	O
microbial	O	O
community	O	O
present	O	O
in	O	O
the	O	O
human	O	O
mouth	O	O
is	O	O
engaged	O	O
in	O	O
a	O	O
complex	O	O
network	O	O
of	O	O
diverse	O	O
metabolic	O	O
activities	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
serving	O	O
as	O	O
energy	O	O
and	O	O
building-block	O	O
sources	O	O
,	O	O
metabolites	O	O
are	O	O
key	O	O
players	O	O
in	O	O
interspecies	O	O
and	O	O
host-pathogen	O	O
interactions	O	O
.	O	O

Metabolites	O	O
are	O	O
also	O	O
implicated	O	O
in	O	O
triggering	O	O
the	O	O
local	O	O
inflammatory	O	O
response	O	O
,	O	O
which	O	O
can	O	O
affect	O	O
systemic	O	O
conditions	O	O
such	O	O
as	O	O
atherosclerosis	O	O
,	O	O
obesity	O	O
,	O	O
and	O	O
diabetes	O	O
.	O	O

While	O	O
the	O	O
genome	O	O
of	O	O
several	O	O
oral	O	O
pathogens	O	O
has	O	O
been	O	O
sequenced	O	O
,	O	O
quantitative	O	O
understanding	O	O
of	O	O
the	O	O
metabolic	O	O
functions	O	O
of	O	O
any	O	O
oral	O	O
pathogen	O	O
at	O	O
the	O	O
system	O	O
level	O	O
has	O	O
not	O	O
been	O	O
explored	O	O
yet	O	O
.	O	O

Here	O	O
we	O	O
pursue	O	O
the	O	O
computational	O	O
construction	O	O
and	O	O
analysis	O	O
of	O	O
the	O	O
genome-scale	O	O
metabolic	O	O
network	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
a	O	O
gram-negative	B-bacteria	B-bacteria
anaerobe	E-bacteria	I-bacteria
that	O	O
is	O	O
endemic	O	O
in	O	O
the	O	O
human	O	O
population	O	O
and	O	O
largely	O	O
responsible	O	O
for	O	O
adult	O	O
periodontitis	O	O
.	O	O

Integrating	O	O
information	O	O
from	O	O
the	O	O
genome	O	O
,	O	O
online	O	O
databases	O	O
,	O	O
and	O	O
literature	O	O
screening	O	O
,	O	O
we	O	O
built	O	O
a	O	O
stoichiometric	O	O
model	O	O
that	O	O
encompasses	O	O
679	O	O
metabolic	O	O
reactions	O	O
.	O	O

By	O	O
using	O	O
flux	O	O
balance	O	O
approaches	O	O
and	O	O
automated	O	O
network	O	O
visualization	O	O
,	O	O
we	O	O
analyze	O	O
the	O	O
growth	O	O
capacity	O	O
under	O	O
amino-acid-rich	O	O
medium	O	O
and	O	O
provide	O	O
evidence	O	O
that	O	O
amino	O	O
acid	O	O
preference	O	O
and	O	O
cytotoxic	O	O
by-product	O	O
secretion	O	O
rates	O	O
are	O	O
suitably	O	O
reproduced	O	O
by	O	O
the	O	O
model	O	O
.	O	O

To	O	O
provide	O	O
further	O	O
insight	O	O
into	O	O
the	O	O
basic	O	O
metabolic	O	O
functions	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
suggest	O	O
potential	O	O
drug	O	O
targets	O	O
,	O	O
we	O	O
study	O	O
systematically	O	O
how	O	O
the	O	O
network	O	O
responds	O	O
to	O	O
any	O	O
reaction	O	O
knockout	O	O
.	O	O

We	O	O
focus	O	O
specifically	O	O
on	O	O
the	O	O
lipopolysaccharide	O	O
biosynthesis	O	O
pathway	O	O
and	O	O
identify	O	O
eight	O	O
putative	O	O
targets	O	O
,	O	O
one	O	O
of	O	O
which	O	O
has	O	O
been	O	O
recently	O	O
verified	O	O
experimentally	O	O
.	O	O

The	O	O
current	O	O
model	O	O
,	O	O
which	O	O
is	O	O
amenable	O	O
to	O	O
further	O	O
experimental	O	O
testing	O	O
and	O	O
refinements	O	O
,	O	O
could	O	O
prove	O	O
useful	O	O
in	O	O
evaluating	O	O
the	O	O
oral	O	O
microbiome	O	O
dynamics	O	O
and	O	O
in	O	O
the	O	O
development	O	O
of	O	O
novel	O	O
biomedical	O	O
applications	O	O
.	O	O

Oral	O	O
epithelial	O	O
cells	O	O
may	O	O
be	O	O
invaded	O	O
by	O	O
a	O	O
polymicrobial	O	O
intracellular	O	O
flora	O	O
,	O	O
including	O	O
pathogens	O	O
together	O	O
with	O	O
commensals	O	O
.	O	O

Various	O	O
oral	O	O
pathogens	O	O
can	O	O
induce	O	O
the	O	O
production	O	O
of	O	O
interleukin-8	O	O
,	O	O
a	O	O
potent	O	O
neutrophil	O	O
chemotractant	O	O
,	O	O
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Evidence	O	O
from	O	O
the	O	O
gut	O	O
suggests	O	O
that	O	O
commensal	O	O
species	O	O
may	O	O
modulate	O	O
inflammatory	O	O
responses	O	O
to	O	O
pathogens	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
interleukin-8	O	O
responses	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
to	O	O
an	O	O
oral	O	O
pro-inflammatory	O	O
species	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
in	O	O
combination	O	O
with	O	O
an	O	O
oral	O	O
commensal	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
cristatus	E-bacteria	I-bacteria
.	O	O

KB	O	O
,	O	O
TERT-2	O	O
,	O	O
TR146	O	O
and	O	O
SCC15	O	O
cells	O	O
were	O	O
cocultured	O	O
with	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
cristatus	E-bacteria	I-bacteria
,	O	O
either	O	O
alone	O	O
or	O	O
in	O	O
combination	O	O
,	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
in	O	O
5	O	O
%	O	O
CO2	O	O
under	O	O
various	O	O
conditions	O	O
.	O	O

The	O	O
mRNA	O	O
expression	O	O
of	O	O
interleukin-8	O	O
was	O	O
analyzed	O	O
by	O	O
reverse	O	O
transcription-polymerase	O	O
chain	O	O
reaction	O	O
and	O	O
protein	O	O
secretion	O	O
was	O	O
measured	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
.	O	O

F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
alone	O	O
evoked	O	O
a	O	O
potent	O	O
interleukin-8	O	O
response	O	O
,	O	O
whereas	O	O
S.	B-bacteria	B-bacteria
cristatus	E-bacteria	I-bacteria
alone	O	O
did	O	O
not	O	O
induce	O	O
significant	O	O
interleukin-8	O	O
expression	O	O
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

When	O	O
present	O	O
together	O	O
,	O	O
S.	B-bacteria	B-bacteria
cristatus	E-bacteria	I-bacteria
attenuated	O	O
the	O	O
F.	O	O
nucleatum-induced	O	O
interleukin-8	O	O
production	O	O
in	O	O
the	O	O
four	O	O
oral	O	O
epithelial	O	O
cell	O	O
lines	O	O
to	O	O
varying	O	O
degrees	O	O
.	O	O

The	O	O
inhibitory	O	O
effect	O	O
of	O	O
S.	B-bacteria	B-bacteria
cristatus	E-bacteria	I-bacteria
was	O	O
independent	O	O
of	O	O
its	O	O
viability	O	O
and	O	O
its	O	O
co-aggregation	O	O
with	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
was	O	O
not	O	O
related	O	O
to	O	O
soluble	O	O
bacterial	O	O
products	O	O
and	O	O
appeared	O	O
to	O	O
require	O	O
bacterial	O	O
contact	O	O
with	O	O
epithelial	O	O
cells	O	O
.	O	O

Similar	O	O
effects	O	O
were	O	O
seen	O	O
with	O	O
several	O	O
other	O	O
species	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Our	O	O
data	O	O
suggest	O	O
that	O	O
S.	B-bacteria	B-bacteria
cristatus	E-bacteria	I-bacteria
may	O	O
exert	O	O
immunomodulatory	O	O
effects	O	O
on	O	O
the	O	O
interleukin-8	O	O
response	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
to	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
challenge	O	O
.	O	O

To	O	O
study	O	O
the	O	O
distribution	O	O
and	O	O
drug	O	O
resistance	O	O
of	O	O
the	O	O
isolated	O	O
bacteria	O	O
from	O	O
children	O	O
with	O	O
acute	O	O
respiratory	O	O
infection	O	O
(	O	O
ARI	O	O
)	O	O
in	O	O
Dalian	O	O
.	O	O

Between	O	O
January	O	O
2006	O	O
and	O	O
February	O	O
2007	O	O
,	O	O
930	O	O
children	O	O
with	O	O
ARI	O	O
were	O	O
enrolled	O	O
,	O	O
including	O	O
364	O	O
with	O	O
acute	O	O
upper	O	O
respiratory	O	O
infection	O	O
(	O	O
AURI	O	O
)	O	O
,	O	O
and	O	O
566	O	O
with	O	O
acute	O	O
lower	O	O
respiratory	O	O
infection	O	O
(	O	O
ALRI	O	O
)	O	O
.	O	O

The	O	O
AURI	O	O
children	O	O
,	O	O
who	O	O
did	O	O
not	O	O
receive	O	O
antimicrobial	O	O
agent	O	O
treatment	O	O
or	O	O
received	O	O
oral	O	O
antimicrobial	O	O
agents	O	O
1-2	O	O
times	O	O
,	O	O
had	O	O
bacterial	O	O
cultures	O	O
of	O	O
pharyngeal	O	O
swab	O	O
.	O	O

The	O	O
ALRI	O	O
children	O	O
,	O	O
who	O	O
received	O	O
intravenous	O	O
antibacterial	O	O
agents	O	O
more	O	O
than	O	O
3	O	O
days	O	O
,	O	O
had	O	O
bacterial	O	O
cultures	O	O
of	O	O
sputum	O	O
and	O	O
bronchoalveolar	O	O
lavage	O	O
fluid	O	O
(	O	O
BALF	O	O
)	O	O
.	O	O

Isolated	O	O
bacteria	O	O
were	O	O
identified	O	O
by	O	O
the	O	O
ATB	O	O
system	O	O
(	O	O
Bio-Merieux	O	O
,	O	O
France	O	O
)	O	O
.	O	O

Antimicrobial	O	O
susceptibility	O	O
testing	O	O
was	O	O
carried	O	O
out	O	O
by	O	O
means	O	O
of	O	O
Kirby-bauer	O	O
.	O	O

A	O	O
total	O	O
of	O	O
404	O	O
isolates	O	O
(	O	O
43.4	O	O
%	O	O
)	O	O
were	O	O
identified	O	O
.	O	O

Haemophilus	B-bacteria	B-bacteria
influenzae	E-bacteria	I-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
parainfluenzae	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
accounted	O	O
for	O	O
22.5	O	O
%	O	O
,	O	O
12.1	O	O
%	O	O
and	O	O
7.4	O	O
%	O	O
respectively	O	O
.	O	O

In	O	O
the	O	O
isolates	O	O
from	O	O
AURI	O	O
,	O	O
Haemophilus	B-bacteria	B-bacteria
influenzae	E-bacteria	I-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
parainfluenzae	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
accounted	O	O
for	O	O
43.9	O	O
%	O	O
,	O	O
22.0	O	O
%	O	O
and	O	O
9.1	O	O
%	O	O
respectively	O	O
;	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumonia	E-bacteria	I-bacteria
and	O	O
Nonfermenters	B-bacteria	B-bacteria
accounted	O	O
for	O	O
4.5	O	O
%	O	O
,	O	O
8.3	O	O
%	O	O
and	O	O
3.0	O	O
%	O	O
respectively	O	O
.	O	O

In	O	O
the	O	O
isolates	O	O
from	O	O
ALRI	O	O
,	O	O
Haemophilus	B-bacteria	B-bacteria
influenzae	E-bacteria	I-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
parainfluenzae	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
accounted	O	O
for	O	O
12.1	O	O
%	O	O
,	O	O
7.4	O	O
%	O	O
and	O	O
6.6	O	O
%	O	O
respectively	O	O
;	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
and	O	O
Nonfermenters	B-bacteria	B-bacteria
accounted	O	O
for	O	O
16.9	O	O
%	O	O
,	O	O
13.2	O	O
%	O	O
and	O	O
21.8	O	O
%	O	O
respectively	O	O
.	O	O

The	O	O
resistant	O	O
rates	O	O
of	O	O
Haemophilus	B-bacteria	B-bacteria
to	O	O
ampicillin	O	O
and	O	O
TMP-SMZ	O	O
were	O	O
29.3	O	O
%	O	O
and	O	O
32.9	O	O
%	O	O
respectively	O	O
,	O	O
and	O	O
to	O	O
amoxicillin-clavulanic	O	O
acid	O	O
,	O	O
cefalotin	O	O
,	O	O
cefaclor	O	O
,	O	O
cefuroxime	O	O
and	O	O
cefotaxime	O	O
were	O	O
12.1	O	O
%	O	O
,	O	O
10.0	O	O
%	O	O
,	O	O
10.0	O	O
%	O	O
,	O	O
11.4	O	O
%	O	O
and	O	O
5.7	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
resistant	O	O
rate	O	O
of	O	O
Haemophilus	B-bacteria	B-bacteria
to	O	O
ampicillin	O	O
,	O	O
amoxicillin-clavulanic	O	O
acid	O	O
,	O	O
cefaclor	O	O
,	O	O
tetracycine	O	O
and	O	O
TMP-SMZ	O	O
in	O	O
the	O	O
ALRI	O	O
group	O	O
were	O	O
significantly	O	O
higher	O	O
than	O	O
that	O	O
in	O	O
the	O	O
AURI	O	O
group	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
or	O	O
0.01	O	O
)	O	O
.	O	O

In	O	O
Dalian	O	O
,	O	O
Haemophilus	B-bacteria	B-bacteria
was	O	O
the	O	O
main	O	O
isolate	O	O
of	O	O
children	O	O
with	O	O
ARI	O	O
.	O	O

The	O	O
distribution	O	O
of	O	O
bacteria	O	O
was	O	O
different	O	O
between	O	O
ALRI	O	O
and	O	O
AURI	O	O
.	O	O

In	O	O
ALRI	O	O
,	O	O
Gram-negative	B-bacteria	B-bacteria
bacilli	E-bacteria	I-bacteria
were	O	O
in	O	O
a	O	O
higher	O	O
proportion	O	O
,	O	O
and	O	O
the	O	O
resistant	O	O
rates	O	O
of	O	O
Haemophilus	B-bacteria	B-bacteria
influenzae	E-bacteria	I-bacteria
and	O	O
Haemophilus	B-bacteria	B-bacteria
parainfluenzae	E-bacteria	I-bacteria
to	O	O
ampicillin	O	O
,	O	O
amoxicillin-clavulanic	O	O
acid	O	O
and	O	O
cefaclor	O	O
were	O	O
higher	O	O
.	O	O

Parotid	O	O
secretory	O	O
protein	O	O
(	O	O
PSP	O	O
)	O	O
(	O	O
SPLUNC2	O	O
)	O	O
,	O	O
a	O	O
potential	O	O
host-defense	O	O
protein	O	O
related	O	O
to	O	O
bactericidal/permeability-increasing	O	O
protein	O	O
(	O	O
BPI	O	O
)	O	O
,	O	O
was	O	O
used	O	O
as	O	O
a	O	O
template	O	O
to	O	O
design	O	O
antibacterial	O	O
peptides	O	O
.	O	O

Based	O	O
on	O	O
the	O	O
structure	O	O
of	O	O
BPI	O	O
,	O	O
new	O	O
PSP	O	O
peptides	O	O
were	O	O
designed	O	O
and	O	O
tested	O	O
for	O	O
antibacterial	O	O
activity	O	O
.	O	O

The	O	O
peptides	O	O
did	O	O
not	O	O
exhibit	O	O
significant	O	O
bactericidal	O	O
activity	O	O
or	O	O
inhibit	O	O
growth	O	O
but	O	O
the	O	O
peptide	O	O
GL-13	O	O
induced	O	O
bacterial	O	O
matting	O	O
,	O	O
suggesting	O	O
passive	O	O
agglutination	O	O
of	O	O
bacteria	O	O
.	O	O

GL-13	O	O
was	O	O
shown	O	O
to	O	O
agglutinate	O	O
the	O	O
Gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
Actinobacillus	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Gram	B-bacteria	B-bacteria
positive	I-bacteria	I-bacteria
Streptococcus	I-bacteria	I-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
uncoated	O	O
sheep	O	O
erythrocytes	O	O
.	O	O

Bacterial	O	O
agglutination	O	O
was	O	O
time	O	O
and	O	O
dose-dependent	O	O
and	O	O
involved	O	O
hydrophobic	O	O
interactions	O	O
.	O	O

Variant	O	O
forms	O	O
of	O	O
GL-13	O	O
revealed	O	O
that	O	O
agglutination	O	O
also	O	O
depended	O	O
on	O	O
the	O	O
number	O	O
of	O	O
amine	O	O
groups	O	O
on	O	O
the	O	O
peptide	O	O
.	O	O

GL-13	O	O
inhibited	O	O
the	O	O
adhesion	O	O
of	O	O
bacteria	O	O
to	O	O
plastic	O	O
surfaces	O	O
and	O	O
the	O	O
peptide	O	O
prevented	O	O
the	O	O
spread	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
infection	O	O
in	O	O
a	O	O
lettuce	O	O
leaf	O	O
model	O	O
,	O	O
suggesting	O	O
that	O	O
GL-13	O	O
is	O	O
active	O	O
in	O	O
vivo	O	O
.	O	O

Moreover	O	O
,	O	O
GL-13-induced	O	O
agglutination	O	O
enhanced	O	O
the	O	O
phagocytosis	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
by	O	O
RAW	O	O
264.7	O	O
macrophage	O	O
cells	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
GL-13	O	O
represents	O	O
a	O	O
class	O	O
of	O	O
antimicrobial	O	O
peptides	O	O
,	O	O
which	O	O
do	O	O
not	O	O
directly	O	O
kill	O	O
bacteria	O	O
but	O	O
instead	O	O
reduce	O	O
bacterial	O	O
adhesion	O	O
and	O	O
promote	O	O
agglutination	O	O
,	O	O
leading	O	O
to	O	O
increased	O	O
clearance	O	O
by	O	O
host	O	O
phagocytic	O	O
cells	O	O
.	O	O

Such	O	O
peptides	O	O
may	O	O
cause	O	O
less	O	O
bacterial	O	O
resistance	O	O
than	O	O
traditional	O	O
antibiotic	O	O
peptides	O	O
.	O	O

tet	O	O
(	O	O
32	O	O
)	O	O
Was	O	O
identified	O	O
in	O	O
three	O	O
bacterial	O	O
isolates	O	O
and	O	O
in	O	O
metagenomic	O	O
DNA	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
regions	O	O
immediately	O	O
flanking	O	O
the	O	O
gene	O	O
were	O	O
found	O	O
to	O	O
have	O	O
similarities	O	O
to	O	O
the	O	O
mobile	O	O
elements	O	O
TnB1230	O	O
from	O	O
Butyrivibrio	B-bacteria	B-bacteria
fibrisolvens	E-bacteria	I-bacteria
,	O	O
ATE-3	O	O
from	O	O
Arcanobacterium	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
,	O	O
and	O	O
CTn5	O	O
from	O	O
Clostridium	B-bacteria	B-bacteria
difficile	E-bacteria	I-bacteria
.	O	O

Dental	O	O
caries	O	O
is	O	O
among	O	O
the	O	O
more	O	O
prevalent	O	O
chronic	O	O
human	O	O
infections	O	O
for	O	O
which	O	O
an	O	O
effective	O	O
human	O	O
vaccine	O	O
has	O	O
not	O	O
yet	O	O
been	O	O
achieved	O	O
.	O	O

Enolase	O	O
from	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
has	O	O
been	O	O
identified	O	O
as	O	O
an	O	O
immunomodulatory	O	O
protein	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
used	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
recombinant	O	O
enolase	O	O
(	O	O
rEnolase	O	O
)	O	O
as	O	O
a	O	O
target	O	O
antigen	O	O
and	O	O
assessed	O	O
its	O	O
therapeutic	O	O
effect	O	O
in	O	O
a	O	O
rat	O	O
model	O	O
of	O	O
Dental	O	O
caries	O	O
.	O	O

Wistar	O	O
rats	O	O
that	O	O
were	O	O
fed	O	O
a	O	O
cariogenic	O	O
solid	O	O
diet	O	O
on	O	O
day	O	O
18	O	O
after	O	O
birth	O	O
were	O	O
orally	O	O
infected	O	O
with	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
on	O	O
day	O	O
19	O	O
after	O	O
birth	O	O
and	O	O
for	O	O
5	O	O
consecutive	O	O
days	O	O
thereafter	O	O
.	O	O

Five	O	O
days	O	O
after	O	O
infection	O	O
and	O	O
,	O	O
again	O	O
,	O	O
3	O	O
weeks	O	O
later	O	O
,	O	O
rEnolase	O	O
plus	O	O
alum	O	O
adjuvant	O	O
was	O	O
delivered	O	O
into	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
the	O	O
rats	O	O
.	O	O

A	O	O
sham-immunized	O	O
group	O	O
of	O	O
rats	O	O
was	O	O
contemporarily	O	O
treated	O	O
with	O	O
adjuvant	O	O
alone	O	O
.	O	O

In	O	O
the	O	O
rEnolase-immunized	O	O
rats	O	O
,	O	O
increased	O	O
levels	O	O
of	O	O
salivary	O	O
IgA	O	O
and	O	O
IgG	O	O
antibodies	O	O
specific	O	O
for	O	O
this	O	O
recombinant	O	O
protein	O	O
were	O	O
detected	O	O
.	O	O

A	O	O
significant	O	O
decrease	O	O
in	O	O
sulcal	O	O
,	O	O
proximal	O	O
enamel	O	O
,	O	O
and	O	O
Dental	O	O
caries	O	O
scores	O	O
was	O	O
observed	O	O
in	O	O
these	O	O
animals	O	O
,	O	O
compared	O	O
with	O	O
sham-immunized	O	O
control	O	O
animals	O	O
.	O	O

No	O	O
detectable	O	O
histopathologic	O	O
alterations	O	O
were	O	O
observed	O	O
in	O	O
all	O	O
immunized	O	O
animals	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
antibodies	O	O
produced	O	O
against	O	O
bacterial	O	O
enolase	O	O
did	O	O
not	O	O
react	O	O
with	O	O
human	O	O
enolase	O	O
.	O	O

Overall	O	O
,	O	O
these	O	O
results	O	O
indicate	O	O
that	O	O
rEnolase	O	O
could	O	O
be	O	O
a	O	O
promising	O	O
and	O	O
safe	O	O
candidate	O	O
for	O	O
testing	O	O
in	O	O
trials	O	O
of	O	O
vaccines	O	O
against	O	O
Dental	O	O
caries	O	O
in	O	O
humans	O	O
.	O	O

The	O	O
genome	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
harbours	O	O
13	O	O
two-component	O	O
signal	O	O
transduction	O	O
systems	O	O
(	O	O
TCSTSs	O	O
)	O	O
.	O	O

Of	O	O
these	O	O
,	O	O
a	O	O
peptide-mediated	O	O
quorum-sensing	O	O
system	O	O
,	O	O
ComCDE	O	O
,	O	O
and	O	O
the	O	O
HK/RR11	O	O
two-component	O	O
system	O	O
are	O	O
well	O	O
known	O	O
to	O	O
regulate	O	O
several	O	O
virulence-associated	O	O
traits	O	O
in	O	O
in	O	O
vitro	O	O
experiments	O	O
,	O	O
including	O	O
genetic	O	O
competence	O	O
,	O	O
bacteriocin	O	O
production	O	O
,	O	O
biofilm	O	O
formation	O	O
and	O	O
stress	O	O
responses	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
hypothesis	O	O
that	O	O
inactivation	O	O
of	O	O
ComCDE	O	O
,	O	O
HK/RR11	O	O
or	O	O
both	O	O
systems	O	O
would	O	O
attenuate	O	O
the	O	O
virulence	O	O
and	O	O
cariogenicity	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
simultaneous	O	O
inactivation	O	O
of	O	O
both	O	O
signal	O	O
transduction	O	O
systems	O	O
additively	O	O
attenuated	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
virulence	O	O
and	O	O
cariogenicity	O	O
,	O	O
since	O	O
inactivation	O	O
of	O	O
either	O	O
of	O	O
these	O	O
systems	O	O
alone	O	O
did	O	O
not	O	O
result	O	O
in	O	O
the	O	O
same	O	O
degree	O	O
of	O	O
effect	O	O
.	O	O

The	O	O
double	O	O
deletion	O	O
mutant	O	O
SMcde-hk11	O	O
was	O	O
defective	O	O
in	O	O
genetic	O	O
competence	O	O
,	O	O
had	O	O
a	O	O
reduced	O	O
acid	O	O
production	O	O
,	O	O
was	O	O
unable	O	O
to	O	O
grow	O	O
at	O	O
pH	O	O
5.0	O	O
and	O	O
formed	O	O
an	O	O
abnormal	O	O
biofilm	O	O
with	O	O
reduced	O	O
biomass	O	O
.	O	O

Animal	O	O
studies	O	O
showed	O	O
that	O	O
this	O	O
mutant	O	O
had	O	O
reduced	O	O
capabilities	O	O
for	O	O
oral	O	O
colonization	O	O
,	O	O
succession	O	O
and	O	O
initiation	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

A	O	O
competitive	O	O
index	O	O
(	O	O
CI	O	O
)	O	O
analysis	O	O
using	O	O
a	O	O
mixed-infection	O	O
animal	O	O
model	O	O
revealed	O	O
that	O	O
all	O	O
the	O	O
mutants	O	O
,	O	O
particularly	O	O
SMcde-hk11	O	O
,	O	O
had	O	O
reduced	O	O
fitness	O	O
in	O	O
their	O	O
ecological	O	O
niches	O	O
and	O	O
were	O	O
unable	O	O
to	O	O
compete	O	O
with	O	O
the	O	O
wild-type	O	O
strain	O	O
for	O	O
persistence	O	O
in	O	O
dental	O	O
biofilms	O	O
.	O	O

The	O	O
evidence	O	O
from	O	O
this	O	O
study	O	O
suggests	O	O
that	O	O
the	O	O
ComCDE	O	O
and	O	O
HK/RR11	O	O
signal	O	O
transduction	O	O
systems	O	O
can	O	O
be	O	O
considered	O	O
to	O	O
be	O	O
novel	O	O
targets	O	O
for	O	O
the	O	O
development	O	O
of	O	O
strategies	O	O
in	O	O
the	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
infections	O	O
.	O	O

Little	O	O
is	O	O
known	O	O
regarding	O	O
the	O	O
factors	O	O
that	O	O
affect	O	O
the	O	O
microbial	O	O
composition	O	O
of	O	O
supragingival	O	O
biofilms	O	O
.	O	O

This	O	O
study	O	O
was	O	O
designed	O	O
to	O	O
test	O	O
the	O	O
hypothesis	O	O
that	O	O
tooth	O	O
location	O	O
affects	O	O
the	O	O
microbial	O	O
composition	O	O
of	O	O
supragingival	O	O
plaque	O	O
beyond	O	O
the	O	O
effect	O	O
due	O	O
to	O	O
plaque	O	O
mass	O	O
as	O	O
reflected	O	O
by	O	O
total	O	O
DNA	O	O
probe	O	O
count	O	O
.	O	O

Supragingival	O	O
plaque	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
mesiobuccal	O	O
aspect	O	O
of	O	O
each	O	O
tooth	O	O
in	O	O
187	O	O
subjects	O	O
(	O	O
n	O	O
=	O	O
4745	O	O
samples	O	O
)	O	O
.	O	O

All	O	O
samples	O	O
were	O	O
individually	O	O
analyzed	O	O
for	O	O
their	O	O
content	O	O
of	O	O
40	O	O
bacterial	O	O
species	O	O
using	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

Significance	O	O
of	O	O
differences	O	O
in	O	O
mean	O	O
species	O	O
counts	O	O
and	O	O
proportions	O	O
were	O	O
determined	O	O
among	O	O
tooth	O	O
surfaces	O	O
and	O	O
six	O	O
tooth	O	O
type	O	O
categories	O	O
:	O	O
molars	O	O
,	O	O
bicuspids	O	O
,	O	O
incisors/canines	O	O
in	O	O
the	O	O
mandible	O	O
and	O	O
maxilla	O	O
separately	O	O
using	O	O
the	O	O
Kruskal-Wallis	O	O
test	O	O
.	O	O

Stepwise	O	O
multiple	O	O
linear	O	O
regression	O	O
was	O	O
employed	O	O
to	O	O
examine	O	O
the	O	O
relationship	O	O
between	O	O
species	O	O
proportions	O	O
and	O	O
total	O	O
DNA	O	O
probe	O	O
count	O	O
,	O	O
tooth	O	O
location	O	O
,	O	O
periodontal	O	O
and	O	O
smoking	O	O
status	O	O
,	O	O
age	O	O
and	O	O
sex	O	O
.	O	O

All	O	O
species	O	O
differed	O	O
significantly	O	O
among	O	O
tooth	O	O
types	O	O
and	O	O
among	O	O
the	O	O
six	O	O
tooth	O	O
categories	O	O
.	O	O

Higher	O	O
plaque	O	O
levels	O	O
were	O	O
seen	O	O
on	O	O
molars	O	O
and	O	O
lower	O	O
incisors	O	O
.	O	O

Some	O	O
differences	O	O
observed	O	O
between	O	O
tooth	O	O
types	O	O
could	O	O
be	O	O
partly	O	O
explained	O	O
by	O	O
the	O	O
level	O	O
of	O	O
plaque	O	O
.	O	O

Teeth	O	O
with	O	O
high	O	O
plaque	O	O
mass	O	O
exhibited	O	O
high	O	O
levels	O	O
of	O	O
Capnocytophaga	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
genospecies	I-bacteria	I-bacteria
2	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
and	O	O
Campylobacter	B-bacteria	B-bacteria
showae	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
certain	O	O
species	O	O
,	O	O
such	O	O
as	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
differed	O	O
significantly	O	O
at	O	O
different	O	O
tooth	O	O
locations	O	O
despite	O	O
similarities	O	O
in	O	O
plaque	O	O
mass	O	O
.	O	O

Twenty	O	O
of	O	O
the	O	O
test	O	O
species	O	O
exhibited	O	O
a	O	O
significant	O	O
association	O	O
with	O	O
tooth	O	O
location	O	O
after	O	O
adjusting	O	O
for	O	O
total	O	O
DNA	O	O
probe	O	O
count	O	O
and	O	O
subject	O	O
level	O	O
factors	O	O
.	O	O

While	O	O
plaque	O	O
mass	O	O
was	O	O
associated	O	O
with	O	O
differences	O	O
in	O	O
proportions	O	O
of	O	O
many	O	O
species	O	O
in	O	O
supragingival	O	O
biofilms	O	O
,	O	O
tooth	O	O
location	O	O
also	O	O
was	O	O
strongly	O	O
associated	O	O
with	O	O
species	O	O
proportions	O	O
in	O	O
both	O	O
univariate	O	O
and	O	O
multivariate	O	O
analyses	O	O
.	O	O

Treating	O	O
a	O	O
carious	O	O
tooth	O	O
in	O	O
children	O	O
with	O	O
high	O	O
caries	O	O
experience	O	O
by	O	O
providing	O	O
a	O	O
restoration	O	O
does	O	O
not	O	O
cure	O	O
the	O	O
disease	O	O
.	O	O

If	O	O
the	O	O
unfavorable	O	O
oral	O	O
environment	O	O
that	O	O
caused	O	O
the	O	O
cavity	O	O
persists	O	O
so	O	O
will	O	O
the	O	O
disease	O	O
and	O	O
more	O	O
restorations	O	O
will	O	O
be	O	O
required	O	O
in	O	O
future	O	O
.	O	O

Treating	O	O
the	O	O
oral	O	O
infection	O	O
by	O	O
reducing	O	O
the	O	O
number	O	O
of	O	O
cariogenic	O	O
microorganisms	O	O
and	O	O
establishing	O	O
a	O	O
favorable	O	O
oral	O	O
environment	O	O
to	O	O
promote	O	O
predominantly	O	O
remineralization	O	O
of	O	O
tooth	O	O
structure	O	O
over	O	O
time	O	O
will	O	O
stop	O	O
the	O	O
caries	O	O
process	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
conducted	O	O
:	O	O
(	O	O
1	O	O
)	O	O
To	O	O
evaluate	O	O
the	O	O
efficacy	O	O
of	O	O
povidone-iodine	O	O
and	O	O
chlorhexidine	O	O
mouth	O	O
rinses	O	O
on	O	O
plaque	B-bacteria	B-bacteria
Streptococcus	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
when	O	O
used	O	O
as	O	O
an	O	O
adjunct	O	O
to	O	O
restoration	O	O
.	O	O

(	O	O
2	O	O
)	O	O
To	O	O
compare	O	O
the	O	O
anti-microbial	O	O
effect	O	O
of	O	O
1	O	O
%	O	O
povidone-iodine	O	O
and	O	O
0.2	O	O
%	O	O
chlorhexidine	O	O
mouth	O	O
rinses	O	O
on	O	O
plaque	B-bacteria	B-bacteria
S.	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
count	O	O
.	O	O

STUDY	O	O
Forty-five	O	O
study	O	O
participants	O	O
in	O	O
the	O	O
age	O	O
group	O	O
of	O	O
6-12	O	O
years	O	O
with	O	O
dmft	O	O
(	O	O
decay	O	O
component	O	O
)	O	O
of	O	O
three	O	O
or	O	O
four	O	O
were	O	O
selected	O	O
from	O	O
one	O	O
government	O	O
school	O	O
in	O	O
Bangalore	O	O
city	O	O
.	O	O

They	O	O
were	O	O
divided	O	O
into	O	O
three	O	O
groups	O	O
after	O	O
the	O	O
restorative	O	O
treatment	O	O
.	O	O

Group-A	O	O
,	O	O
Group-B	O	O
,	O	O
and	O	O
Group-C	O	O
received	O	O
1	O	O
%	O	O
povidone-iodine	O	O
mouth	O	O
rinse	O	O
,	O	O
0.2	O	O
%	O	O
chlorhexidine	O	O
mouth	O	O
rinse	O	O
and	O	O
placebo	O	O
mouth	O	O
rinse	O	O
,	O	O
respectively	O	O
,	O	O
twice	O	O
daily	O	O
for	O	O
14	O	O
days	O	O
.	O	O

The	O	O
plaque	O	O
sample	O	O
was	O	O
collected	O	O
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
count	O	O
was	O	O
estimated	O	O
at	O	O
six	O	O
phases	O	O
:	O	O
(	O	O
1	O	O
)	O	O
Baseline	O	O
,	O	O
(	O	O
2	O	O
)	O	O
3	O	O
weeks	O	O
after	O	O
restoration	O	O
,	O	O
(	O	O
3	O	O
)	O	O
First	O	O
day	O	O
after	O	O
mouth	O	O
rinse	O	O
therapy	O	O
,	O	O
(	O	O
4	O	O
)	O	O
15	O	O
days	O	O
after	O	O
mouth	O	O
rinse	O	O
therapy	O	O
,	O	O
(	O	O
5	O	O
)	O	O
1	O	O
month	O	O
and	O	O
(	O	O
6	O	O
)	O	O
3	O	O
months	O	O
after	O	O
mouth	O	O
rinse	O	O
therapy	O	O
After	O	O
the	O	O
restoration	O	O
the	O	O
percentage	O	O
change	O	O
in	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
count	O	O
was	O	O
28.4	O	O
%	O	O
.	O	O

Immediately	O	O
after	O	O
mouth	O	O
rinse	O	O
therapy	O	O
there	O	O
was	O	O
significant	O	O
reduction	O	O
in	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
count	O	O
in	O	O
all	O	O
the	O	O
three	O	O
groups	O	O
.	O	O

After	O	O
which	O	O
the	O	O
count	O	O
started	O	O
to	O	O
increase	O	O
gradually	O	O
and	O	O
after	O	O
3	O	O
months	O	O
the	O	O
bacterial	O	O
counts	O	O
in	O	O
the	O	O
povidone-iodine	O	O
group	O	O
and	O	O
placebo	O	O
group	O	O
were	O	O
almost	O	O
near	O	O
the	O	O
postrestorative	O	O
count	O	O
.	O	O

Mouth	O	O
rinses	O	O
can	O	O
be	O	O
used	O	O
as	O	O
adjunct	O	O
to	O	O
restoration	O	O
for	O	O
short	O	O
duration	O	O
as	O	O
temporary	O	O
measure	O	O
in	O	O
reduction	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
count	O	O
and	O	O
restorations	O	O
provide	O	O
longer	O	O
effect	O	O
.	O	O

In	O	O
case	O	O
a	O	O
mouth	O	O
rinse	O	O
has	O	O
to	O	O
be	O	O
used	O	O
,	O	O
chlorhexidine	O	O
can	O	O
be	O	O
recommended	O	O
as	O	O
it	O	O
has	O	O
shown	O	O
to	O	O
have	O	O
better	O	O
effect	O	O
than	O	O
Povidone-iodine	O	O
and	O	O
placebo	O	O
.	O	O

Periodontitis	O	O
is	O	O
associated	O	O
with	O	O
an	O	O
increased	O	O
risk	O	O
for	O	O
cardiovascular	O	O
diseases	O	O
(	O	O
CVD	O	O
)	O	O
,	O	O
but	O	O
the	O	O
underlying	O	O
mechanisms	O	O
are	O	O
poorly	O	O
understood	O	O
.	O	O

Recently	O	O
,	O	O
we	O	O
showed	O	O
that	O	O
platelets	O	O
from	O	O
periodontitis	O	O
patients	O	O
are	O	O
more	O	O
activated	O	O
than	O	O
those	O	O
from	O	O
controls	O	O
.	O	O

Given	O	O
the	O	O
regularly	O	O
occurring	O	O
bacteremic	O	O
episodes	O	O
in	O	O
periodontitis	O	O
patients	O	O
,	O	O
we	O	O
hypothesized	O	O
that	O	O
platelets	O	O
and/or	O	O
leukocytes	O	O
from	O	O
periodontitis	O	O
patients	O	O
are	O	O
more	O	O
sensitive	O	O
to	O	O
stimulation	O	O
by	O	O
oral	O	O
bacteria	O	O
,	O	O
in	O	O
particular	O	O
the	O	O
known	O	O
periodontal	O	O
pathogens	O	O
,	O	O
than	O	O
platelets	O	O
from	O	O
control	O	O
subjects	O	O
.	O	O

Three-color	O	O
flow	O	O
cytometry	O	O
analysis	O	O
was	O	O
performed	O	O
to	O	O
quantify	O	O
activation	O	O
of	O	O
platelets	O	O
(	O	O
P-selectin	O	O
,	O	O
PAC-1	O	O
,	O	O
CD63	O	O
)	O	O
and	O	O
leukocytes	O	O
(	O	O
CD11b	O	O
)	O	O
in	O	O
whole	O	O
blood	O	O
from	O	O
patients	O	O
with	O	O
periodontitis	O	O
(	O	O
n	O	O
=	O	O
19	O	O
)	O	O
and	O	O
controls	O	O
(	O	O
n	O	O
=	O	O
18	O	O
)	O	O
,	O	O
with	O	O
and	O	O
without	O	O
stimulation	O	O
by	O	O
oral	O	O
bacteria	O	O
.	O	O

Phagocytosis	O	O
was	O	O
assessed	O	O
by	O	O
using	O	O
green-fluorescent	O	O
protein	O	O
(	O	O
GFP	O	O
)	O	O
-expressing	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
Aa	B-bacteria	B-bacteria
)	O	O
.	O	O

Neutrophils	O	O
and	O	O
monocytes	O	O
were	O	O
activated	O	O
by	O	O
all	O	O
species	O	O
of	O	O
oral	O	O
bacteria	O	O
tested	O	O
,	O	O
but	O	O
no	O	O
differences	O	O
were	O	O
observed	O	O
between	O	O
patients	O	O
and	O	O
controls	O	O
.	O	O

In	O	O
response	O	O
to	O	O
several	O	O
species	O	O
of	O	O
oral	O	O
bacteria	O	O
,	O	O
platelets	O	O
from	O	O
periodontitis	O	O
patients	O	O
showed	O	O
,	O	O
compared	O	O
with	O	O
controls	O	O
,	O	O
increased	O	O
exposure	O	O
of	O	O
P-selectin	O	O
(	O	O
P	O	O
=	O	O
0.027	O	O
)	O	O
and	O	O
increased	O	O
formation	O	O
of	O	O
platelet-monocyte	O	O
complexes	O	O
(	O	O
P	O	O
=	O	O
0.040	O	O
)	O	O
.	O	O

Platelet-leukocyte	O	O
complexes	O	O
bound	O	O
and/or	O	O
phagocytosed	O	O
more	O	O
GFP-Aa	O	O
than	O	O
platelet-free	O	O
leukocytes	O	O
(	O	O
for	O	O
neutrophils	O	O
and	O	O
monocytes	O	O
,	O	O
in	O	O
both	O	O
patients	O	O
and	O	O
controls	O	O
,	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

In	O	O
periodontitis	O	O
,	O	O
increased	O	O
platelet	O	O
response	O	O
to	O	O
oral	O	O
bacteria	O	O
is	O	O
paralleled	O	O
by	O	O
increased	O	O
formation	O	O
of	O	O
platelet-leukocyte	O	O
complexes	O	O
with	O	O
elevated	O	O
capacity	O	O
for	O	O
bacterial	O	O
clearance	O	O
.	O	O

We	O	O
speculate	O	O
that	O	O
activated	O	O
platelets	O	O
and	O	O
leukocytes	O	O
might	O	O
contribute	O	O
to	O	O
increased	O	O
atherothrombotic	O	O
activity	O	O
.	O	O

Ventilator-associated	O	O
pneumonia	O	O
(	O	O
VAP	O	O
)	O	O
is	O	O
usually	O	O
caused	O	O
by	O	O
aspiration	O	O
of	O	O
pathogenic	O	O
bacteria	O	O
from	O	O
the	O	O
oropharynx	O	O
.	O	O

Oral	O	O
decontamination	O	O
with	O	O
antiseptics	O	O
,	O	O
such	O	O
as	O	O
chlorhexidine	O	O
(	O	O
CHX	O	O
)	O	O
or	O	O
antibiotics	O	O
,	O	O
has	O	O
been	O	O
used	O	O
as	O	O
prophylaxis	O	O
against	O	O
this	O	O
complication	O	O
.	O	O

We	O	O
hypothesised	O	O
that	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
Lactobacillus	B-bacteria	B-bacteria
plantarum	I-bacteria	I-bacteria
299	E-bacteria	I-bacteria
(	O	O
Lp299	B-bacteria	B-bacteria
)	O	O
would	O	O
be	O	O
as	O	O
efficient	O	O
as	O	O
CHX	O	O
in	O	O
reducing	O	O
the	O	O
pathogenic	O	O
bacterial	O	O
load	O	O
in	O	O
the	O	O
oropharynx	O	O
of	O	O
tracheally	O	O
intubated	O	O
,	O	O
mechanically	O	O
ventilated	O	O
,	O	O
critically	O	O
ill	O	O
patients	O	O
.	O	O

Fifty	O	O
critically	O	O
ill	O	O
patients	O	O
on	O	O
mechanical	O	O
ventilation	O	O
were	O	O
randomised	O	O
to	O	O
either	O	O
oral	O	O
mechanical	O	O
cleansing	O	O
followed	O	O
by	O	O
washing	O	O
with	O	O
0.1	O	O
%	O	O
CHX	O	O
solution	O	O
or	O	O
to	O	O
the	O	O
same	O	O
cleansing	O	O
procedure	O	O
followed	O	O
by	O	O
oral	O	O
application	O	O
of	O	O
an	O	O
emulsion	O	O
of	O	O
Lp299	O	O
.	O	O

Samples	O	O
for	O	O
microbiological	O	O
analyses	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
oropharynx	O	O
and	O	O
trachea	O	O
at	O	O
inclusion	O	O
and	O	O
at	O	O
defined	O	O
intervals	O	O
thereafter	O	O
.	O	O

Potentially	O	O
pathogenic	O	O
bacteria	O	O
that	O	O
were	O	O
not	O	O
present	O	O
at	O	O
inclusion	O	O
were	O	O
identified	O	O
in	O	O
oropharyngeal	O	O
samples	O	O
from	O	O
eight	O	O
of	O	O
the	O	O
patients	O	O
treated	O	O
with	O	O
Lp299	B-bacteria	B-bacteria
and	O	O
13	O	O
of	O	O
those	O	O
treated	O	O
with	O	O
CHX	O	O
(	O	O
p	O	O
=	O	O
0.13	O	O
)	O	O
.	O	O

Analysis	O	O
of	O	O
tracheal	O	O
samples	O	O
yielded	O	O
similar	O	O
results	O	O
.	O	O

Lp299	B-bacteria	B-bacteria
was	O	O
recovered	O	O
from	O	O
the	O	O
oropharynx	O	O
of	O	O
all	O	O
patients	O	O
in	O	O
the	O	O
Lp299	B-bacteria	B-bacteria
group	O	O
.	O	O

In	O	O
this	O	O
pilot	O	O
study	O	O
,	O	O
we	O	O
found	O	O
no	O	O
difference	O	O
between	O	O
the	O	O
effect	O	O
of	O	O
Lp299	B-bacteria	B-bacteria
and	O	O
CHX	O	O
used	O	O
in	O	O
oral	O	O
care	O	O
procedures	O	O
,	O	O
when	O	O
we	O	O
examined	O	O
the	O	O
effects	O	O
of	O	O
those	O	O
agents	O	O
on	O	O
colonisation	O	O
of	O	O
potentially	O	O
pathogenic	O	O
bacteria	O	O
in	O	O
the	O	O
oropharynx	O	O
of	O	O
intubated	O	O
,	O	O
mechanically	O	O
ventilated	O	O
patients	O	O
.	O	O

Processing	O	O
of	O	O
bronchoscopes	O	O
after	O	O
a	O	O
physical	O	O
examination	O	O
has	O	O
to	O	O
eliminate	O	O
all	O	O
micro-organisms	O	O
that	O	O
could	O	O
have	O	O
contaminated	O	O
the	O	O
endoscope	O	O
and	O	O
that	O	O
may	O	O
harm	O	O
the	O	O
following	O	O
patient	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
analysis	O	O
is	O	O
to	O	O
define	O	O
those	O	O
micro-organisms	O	O
that	O	O
may	O	O
contaminate	O	O
the	O	O
bronchoscope	O	O
during	O	O
the	O	O
examination	O	O
and	O	O
that	O	O
may	O	O
cause	O	O
disease	O	O
in	O	O
other	O	O
patients	O	O
.	O	O

Research	O	O
of	O	O
literature	O	O
and	O	O
analysis	O	O
of	O	O
laboratory	O	O
data	O	O
.	O	O

During	O	O
the	O	O
passage	O	O
of	O	O
the	O	O
respiratory	O	O
tract	O	O
the	O	O
bronchoscope	O	O
will	O	O
be	O	O
contaminated	O	O
by	O	O
the	O	O
physiological	O	O
flora	O	O
of	O	O
oral	O	O
cavity	O	O
,	O	O
nasopharynx	O	O
,	O	O
trachea	O	O
,	O	O
bronchi	O	O
,	O	O
and	O	O
pulmonary	O	O
tissues	O	O
.	O	O

Whilst	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
the	O	O
nasopharynx	O	O
and	O	O
the	O	O
pharynx	O	O
are	O	O
the	O	O
habitat	O	O
for	O	O
a	O	O
great	O	O
variety	O	O
of	O	O
bacteria	O	O
the	O	O
lower	O	O
respiratory	O	O
tract	O	O
is	O	O
virtually	O	O
free	O	O
of	O	O
micro-organisms	O	O
.	O	O

However	O	O
,	O	O
in	O	O
ventilated	O	O
patients	O	O
trachea	O	O
and	O	O
bronchi	O	O
can	O	O
become	O	O
colonized	O	O
as	O	O
the	O	O
result	O	O
of	O	O
bypassing	O	O
the	O	O
cleansing	O	O
effect	O	O
of	O	O
the	O	O
ciliated	O	O
epithelium	O	O
.	O	O

In	O	O
addition	O	O
all	O	O
agents	O	O
that	O	O
can	O	O
cause	O	O
bronchitis	O	O
or	O	O
pneumonia	O	O
in	O	O
immunocompromised	O	O
or	O	O
otherwise	O	O
healthy	O	O
individuals	O	O
are	O	O
potential	O	O
contaminants	O	O
of	O	O
bronchoscopes	O	O
.	O	O

These	O	O
microorganisms	O	O
include	O	O
bacteria	O	O
,	O	O
mycobacteria	B-bacteria	B-bacteria
,	O	O
yeasts	O	O
and	O	O
moulds	O	O
,	O	O
enveloped	O	O
and	O	O
non-enveloped	O	O
viruses	O	O
and	O	O
rarely	O	O
parasites	O	O
.	O	O

The	O	O
bronchoscopic	O	O
procedure	O	O
can	O	O
result	O	O
in	O	O
epithelial	O	O
injury	O	O
with	O	O
subsequent	O	O
bleeding	O	O
.	O	O

Therefore	O	O
,	O	O
all	O	O
blood-borne	O	O
pathogens	O	O
,	O	O
e.g.	O	O
HIV	O	O
or	O	O
HBV	O	O
are	O	O
also	O	O
potential	O	O
contaminants	O	O
of	O	O
the	O	O
bronchoscope	O	O
.	O	O

There	O	O
are	O	O
several	O	O
reports	O	O
of	O	O
transmission	O	O
of	O	O
micro-organisms	O	O
due	O	O
to	O	O
incomplete	O	O
or	O	O
faulty	O	O
cleaning	O	O
and	O	O
disinfection	O	O
procedures	O	O
of	O	O
bronchoscopes	O	O
.	O	O

These	O	O
incidents	O	O
include	O	O
nearly	O	O
all	O	O
classes	O	O
of	O	O
micro-organisms	O	O
but	O	O
not	O	O
parasites	O	O
or	O	O
viruses	O	O
.	O	O

However	O	O
,	O	O
the	O	O
incubation	O	O
period	O	O
of	O	O
viruses	O	O
can	O	O
be	O	O
long	O	O
and	O	O
the	O	O
association	O	O
between	O	O
bronchoscopy	O	O
and	O	O
infection	O	O
may	O	O
be	O	O
obscure	O	O
.	O	O

Endospore	O	O
forming	O	O
micro-organisms	O	O
and	O	O
parasites	O	O
are	O	O
not	O	O
part	O	O
of	O	O
the	O	O
normal	O	O
flora	O	O
of	O	O
the	O	O
respiratory	O	O
tract	O	O
and	O	O
may	O	O
rarely	O	O
cause	O	O
disease	O	O
,	O	O
usually	O	O
only	O	O
in	O	O
severely	O	O
immunocompromised	O	O
patients	O	O
,	O	O
but	O	O
transmission	O	O
of	O	O
such	O	O
organisms	O	O
by	O	O
bronchoscopy	O	O
has	O	O
never	O	O
been	O	O
reported	O	O
.	O	O

The	O	O
antimicrobial	O	O
activity	O	O
of	O	O
the	O	O
disinfection	O	O
process	O	O
,	O	O
including	O	O
chemical	O	O
disinfectants	O	O
for	O	O
endoscopes	O	O
has	O	O
to	O	O
include	O	O
bacteria	O	O
,	O	O
fungi	O	O
and	O	O
viruses	O	O
.	O	O

Sporicidal	O	O
activity	O	O
may	O	O
be	O	O
only	O	O
warranted	O	O
in	O	O
specific	O	O
patient	O	O
populations	O	O
,	O	O
i.e.	O	O
after	O	O
bronchoscopy	O	O
of	O	O
suspected	O	O
anthrax	O	O
patients	O	O
or	O	O
before	O	O
examination	O	O
of	O	O
severely	O	O
immunocompromised	O	O
patients	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
characteristics	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
L.	I-bacteria	I-bacteria
plantarum	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
HO-69	E-bacteria	I-bacteria
in	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
adhesion	O	O
ratios	O	O
to	O	O
teeth	O	O
and	O	O
dentine	O	O
surface	O	O
were	O	O
determined	O	O
by	O	O
in	O	O
vitro	O	O
models	O	O
.	O	O

Hydrophobicity	O	O
and	O	O
surface	O	O
charges	O	O
were	O	O
measured	O	O
by	O	O
MATH	O	O
method	O	O
.	O	O

Inhibitory	O	O
activity	O	O
was	O	O
measured	O	O
by	O	O
agar	O	O
well	O	O
diffusion	O	O
method	O	O
.	O	O

The	O	O
adhesion	O	O
ratios	O	O
to	O	O
hard	O	O
tissue	O	O
were	O	O
quite	O	O
low	O	O
.	O	O

The	O	O
hydrophobicity	O	O
and	O	O
surface	O	O
charges	O	O
were	O	O
high	O	O
,	O	O
and	O	O
it	O	O
exhibited	O	O
inhibitory	O	O
activity	O	O
against	O	O
some	O	O
pathogens	O	O
.	O	O

The	O	O
probability	O	O
is	O	O
low	O	O
for	O	O
L.	B-bacteria	B-bacteria
plantarum	I-bacteria	I-bacteria
HO-69	E-bacteria	I-bacteria
to	O	O
initiate	O	O
or	O	O
accelerate	O	O
dental	O	O
caries	O	O
.	O	O

It	O	O
shows	O	O
broad-spectrum	O	O
inhibitory	O	O
activity	O	O
and	O	O
is	O	O
potential	O	O
probiotics	B-bacteria	B-bacteria
applied	O	O
in	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
this	O	O
paper	O	O
we	O	O
have	O	O
developed	O	O
a	O	O
model	O	O
of	O	O
antimicrobial	O	O
effect	O	O
of	O	O
gramicidin	O	O
S.	O	O
This	O	O
model	O	O
has	O	O
allowed	O	O
us	O	O
to	O	O
predict	O	O
the	O	O
dependence	O	O
of	O	O
antimicrobial	O	O
effect	O	O
of	O	O
the	O	O
drug	O	O
applied	O	O
as	O	O
oral	O	O
melting	O	O
tablets	O	O
on	O	O
dosage	O	O
,	O	O
time	O	O
of	O	O
resorption	O	O
and	O	O
minimal	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
of	O	O
the	O	O
drug	O	O
characterizing	O	O
its	O	O
ability	O	O
to	O	O
kill	O	O
different	O	O
bacteria	O	O
.	O	O

The	O	O
model	O	O
has	O	O
been	O	O
employed	O	O
to	O	O
optimize	O	O
dosing	O	O
regime	O	O
of	O	O
gramicidin	O	O
S	O	O
containing	O	O
drug	O	O
Grammidin	O	O
.	O	O

Efficacy	O	O
of	O	O
the	O	O
drug	O	O
has	O	O
been	O	O
studied	O	O
for	O	O
the	O	O
diverse	O	O
gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
with	O	O
different	O	O
MIC	O	O
.	O	O

The	O	O
number	O	O
of	O	O
bacteria	O	O
located	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
killed	O	O
by	O	O
one-pass	O	O
administration	O	O
of	O	O
the	O	O
drug	O	O
(	O	O
resolution	O	O
of	O	O
one	O	O
tablet	O	O
)	O	O
has	O	O
been	O	O
calculated	O	O
under	O	O
condition	O	O
of	O	O
various	O	O
dosing	O	O
regimes	O	O
.	O	O

Based	O	O
on	O	O
the	O	O
simulation	O	O
results	O	O
it	O	O
has	O	O
been	O	O
found	O	O
that	O	O
(	O	O
1	O	O
)	O	O
twofold	O	O
prolongation	O	O
of	O	O
prescribed	O	O
resorption	O	O
time	O	O
(	O	O
from	O	O
30	O	O
to	O	O
60min	O	O
)	O	O
of	O	O
the	O	O
tablet	O	O
comprising	O	O
standard	O	O
dosage	O	O
of	O	O
3mg	O	O
of	O	O
gramicidin	O	O
S	O	O
results	O	O
in	O	O
1.5-fold	O	O
increase	O	O
in	O	O
efficacy	O	O
,	O	O
(	O	O
2	O	O
)	O	O
1.5-fold	O	O
decrease	O	O
in	O	O
gramicidin	O	O
S	O	O
dosage	O	O
(	O	O
from	O	O
3	O	O
to	O	O
2mg	O	O
per	O	O
administration	O	O
)	O	O
under	O	O
condition	O	O
of	O	O
holding	O	O
prescribed	O	O
resorption	O	O
time	O	O
(	O	O
30min	O	O
)	O	O
does	O	O
not	O	O
lead	O	O
to	O	O
any	O	O
considerable	O	O
decrease	O	O
in	O	O
the	O	O
efficacy	O	O
of	O	O
the	O	O
drug	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
paracasei	I-bacteria	I-bacteria
KW3110	E-bacteria	I-bacteria
is	O	O
a	O	O
strain	O	O
which	O	O
has	O	O
been	O	O
reported	O	O
to	O	O
possess	O	O
a	O	O
strong	O	O
antiallergic	O	O
activity	O	O
.	O	O

Since	O	O
many	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
have	O	O
shown	O	O
to	O	O
be	O	O
useful	O	O
as	O	O
the	O	O
probiotics	O	O
,	O	O
the	O	O
possibility	O	O
of	O	O
this	O	O
strain	O	O
for	O	O
use	O	O
as	O	O
a	O	O
probiotic	O	O
was	O	O
studied	O	O
.	O	O

An	O	O
in	O	O
vitro	O	O
test	O	O
showed	O	O
that	O	O
this	O	O
strain	O	O
is	O	O
strong	O	O
enough	O	O
to	O	O
survive	O	O
in	O	O
the	O	O
gastric	O	O
juice	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
this	O	O
strain	O	O
showed	O	O
exceptionally	O	O
strong	O	O
adherence	O	O
to	O	O
human	O	O
intestinal	O	O
epithelial	O	O
cells	O	O
,	O	O
Caco-2	O	O
and	O	O
HT29	O	O
compared	O	O
to	O	O
normal	O	O
L.	B-bacteria	B-bacteria
paracasei	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

Human	O	O
oral	O	O
administration	O	O
testing	O	O
of	O	O
L.	B-bacteria	B-bacteria
paracasei	I-bacteria	I-bacteria
KW3110	E-bacteria	I-bacteria
showed	O	O
that	O	O
this	O	O
strain	O	O
survived	O	O
in	O	O
the	O	O
human	O	O
gut	O	O
and	O	O
increased	O	O
the	O	O
number	O	O
of	O	O
bifidobacteria	B-bacteria	B-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
the	O	O
fecal	O	O
samples	O	O
of	O	O
the	O	O
subjects	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
KW	B-bacteria	B-bacteria
3110	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
50	O	O
%	O	O
of	O	O
the	O	O
subjects	O	O
up	O	O
to	O	O
1	O	O
week	O	O
after	O	O
the	O	O
end	O	O
of	O	O
the	O	O
administration	O	O
test	O	O
.	O	O

These	O	O
results	O	O
showed	O	O
that	O	O
L.	B-bacteria	B-bacteria
paracasei	I-bacteria	I-bacteria
KW3110	E-bacteria	I-bacteria
has	O	O
a	O	O
strong	O	O
ability	O	O
to	O	O
survive	O	O
in	O	O
and	O	O
colonize	O	O
the	O	O
human	O	O
gut	O	O
and	O	O
improve	O	O
the	O	O
human	O	O
intestinal	O	O
microflora	O	O
.	O	O

Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
is	O	O
an	O	O
important	O	O
opportunistic	O	O
bacterial	O	O
pathogen	O	O
,	O	O
causing	O	O
infections	O	O
of	O	O
the	O	O
respiratory	O	O
and	O	O
other	O	O
organ	O	O
systems	O	O
in	O	O
susceptible	O	O
hosts	O	O
.	O	O

P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
infection	O	O
is	O	O
initiated	O	O
by	O	O
adhesion	O	O
to	O	O
and	O	O
invasion	O	O
of	O	O
mucosal	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
failure	O	O
of	O	O
host	O	O
defenses	O	O
to	O	O
eliminate	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
from	O	O
mucosal	O	O
surfaces	O	O
results	O	O
in	O	O
P.	O	O
aeruginosa	O	O
proliferation	O	O
,	O	O
sometimes	O	O
followed	O	O
by	O	O
overt	O	O
infection	O	O
and	O	O
tissue	O	O
destruction	O	O
.	O	O

There	O	O
is	O	O
growing	O	O
evidence	O	O
that	O	O
associates	O	O
poor	O	O
oral	O	O
health	O	O
and	O	O
respiratory	O	O
infection	O	O
.	O	O

An	O	O
in	O	O
vitro	O	O
model	O	O
system	O	O
for	O	O
bacterial	O	O
invasion	O	O
of	O	O
respiratory	O	O
epithelial	O	O
cells	O	O
was	O	O
used	O	O
to	O	O
investigate	O	O
the	O	O
influence	O	O
of	O	O
oral	O	O
bacteria	O	O
on	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
epithelial	O	O
cell	O	O
invasion	O	O
.	O	O

Oral	O	O
pathogens	O	O
including	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
Actinobacillus	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
increased	O	O
invasion	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
into	O	O
HEp-2	O	O
cells	O	O
from	O	O
one-	O	O
to	O	O
threefold	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
non-pathogenic	O	O
oral	O	O
bacteria	O	O
such	O	O
as	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
showed	O	O
no	O	O
significant	O	O
influence	O	O
on	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
invasion	O	O
.	O	O

P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
together	O	O
with	O	O
oral	O	O
bacteria	O	O
stimulated	O	O
greater	O	O
cytokine	O	O
production	O	O
from	O	O
HEp-2	O	O
cells	O	O
than	O	O
did	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
alone	O	O
.	O	O

P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
in	O	O
combination	O	O
with	O	O
periodontal	O	O
pathogens	O	O
also	O	O
increased	O	O
apoptosis	O	O
of	O	O
HEp-2	O	O
cells	O	O
and	O	O
induced	O	O
elevated	O	O
caspase-3	O	O
activity	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
oral	O	O
bacteria	O	O
,	O	O
especially	O	O
periodontal	O	O
pathogens	O	O
,	O	O
may	O	O
foster	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
invasion	O	O
into	O	O
respiratory	O	O
epithelial	O	O
cells	O	O
to	O	O
enhance	O	O
host	O	O
cell	O	O
cytokine	O	O
release	O	O
and	O	O
apoptosis	O	O
.	O	O

Many	O	O
of	O	O
the	O	O
protective	O	O
immune	O	O
responses	O	O
of	O	O
old	O	O
people	O	O
are	O	O
impaired	O	O
and	O	O
this	O	O
leads	O	O
to	O	O
an	O	O
increased	O	O
risk	O	O
of	O	O
oral	O	O
bacterial	O	O
infections	O	O
.	O	O

Little	O	O
is	O	O
known	O	O
about	O	O
the	O	O
interaction	O	O
between	O	O
the	O	O
systemic	O	O
immune	O	O
response	O	O
on	O	O
one	O	O
hand	O	O
and	O	O
oral	O	O
infections	O	O
and	O	O
oral	O	O
diseases	O	O
on	O	O
the	O	O
other	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
conducted	O	O
an	O	O
epidemiological	O	O
study	O	O
of	O	O
the	O	O
independent	O	O
elderly	O	O
to	O	O
determine	O	O
the	O	O
relationships	O	O
between	O	O
activated	O	O
natural	O	O
killer	O	O
(	O	O
NK	O	O
)	O	O
cells	O	O
and	O	O
oral	O	O
bacterial	O	O
infections	O	O
:	O	O
oral	O	O
diseases	O	O
such	O	O
as	O	O
dental	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
.	O	O

One	O	O
hundred	O	O
independent	O	O
elderly	O	O
people	O	O
aged	O	O
77	O	O
years	O	O
old	O	O
(	O	O
53	O	O
males	O	O
,	O	O
47	O	O
females	O	O
)	O	O
were	O	O
examined	O	O
.	O	O

Blood	O	O
samples	O	O
were	O	O
drawn	O	O
,	O	O
and	O	O
activated	O	O
NK	O	O
cells	O	O
were	O	O
evaluated	O	O
using	O	O
CD16	O	O
,	O	O
CD56	O	O
,	O	O
and	O	O
CD69	O	O
monoclonal	O	O
antibodies	O	O
with	O	O
flow	O	O
cytometry	O	O
.	O	O

Bacterial	O	O
counts	O	O
for	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
lactobacillus	B-bacteria	B-bacteria
,	O	O
and	O	O
opportunistic	O	O
pathogens	O	O
were	O	O
performed	O	O
using	O	O
culture	O	O
techniques	O	O
.	O	O

Oral	O	O
disease	O	O
examinations	O	O
were	O	O
performed	O	O
by	O	O
dentists	O	O
.	O	O

A	O	O
larger	O	O
percentage	O	O
of	O	O
CD69	O	O
(	O	O
+	O	O
)	O	O
NK	O	O
cells	O	O
(	O	O
CD16	O	O
(	O	O
+	O	O
)	O	O
CD56	O	O
(	O	O
+	O	O
)	O	O
)	O	O
showed	O	O
significant	O	O
correlations	O	O
to	O	O
the	O	O
isolation	O	O
numbers	O	O
of	O	O
total	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
r=0.409	O	O
,	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
the	O	O
species	O	O
numbers	O	O
of	O	O
opportunistic	O	O
pathogens	O	O
(	O	O
r=-0.318	O	O
,	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
the	O	O
numbers	O	O
of	O	O
decayed	O	O
teeth	O	O
(	O	O
r=-0.223	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
and	O	O
the	O	O
amount	O	O
of	O	O
bridge	O	O
work	O	O
(	O	O
r=0.219	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

A	O	O
higher	O	O
proportion	O	O
of	O	O
CD69	O	O
(	O	O
+	O	O
)	O	O
NK	O	O
cells	O	O
is	O	O
associated	O	O
with	O	O
the	O	O
incidence	O	O
of	O	O
dental	O	O
caries	O	O
and	O	O
the	O	O
number	O	O
of	O	O
opportunistic	O	O
pathogens	O	O
and	O	O
total	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
the	O	O
elderly	O	O
.	O	O

This	O	O
suggests	O	O
that	O	O
the	O	O
proportionate	O	O
number	O	O
of	O	O
CD69	O	O
(	O	O
+	O	O
)	O	O
NK	O	O
cells	O	O
may	O	O
be	O	O
a	O	O
useful	O	O
indicator	O	O
for	O	O
oral	O	O
infection	O	O
in	O	O
elderly	O	O
subjects	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
oral	O	O
cavity	O	O
of	O	O
healthy	O	O
children	O	O
and	O	O
identified	O	O
by	O	O
using	O	O
standard	O	O
bacteriological	O	O
methods	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
show	O	O
the	O	O
prevalent	O	O
of	O	O
Lactobacilli	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
to	O	O
emphasis	O	O
on	O	O
the	O	O
antagonistic	O	O
activity	O	O
of	O	O
oral	O	O
Lactobacilli	B-bacteria	B-bacteria
on	O	O
oral	O	O
pathogens	O	O
.	O	O

Our	O	O
results	O	O
revealed	O	O
that	O	O
a	O	O
variety	O	O
of	O	O
lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
inhabited	O	O
the	O	O
healthy	O	O
oral	O	O
cavity	O	O
of	O	O
children	O	O
and	O	O
quantitative	O	O
assay	O	O
using	O	O
Lactobacillus	B-bacteria	B-bacteria
filtered	O	O
supernatant	O	O
is	O	O
more	O	O
reliable	O	O
than	O	O
Lactobacillus	B-bacteria	B-bacteria
non	O	O
filtered	O	O
supernatant	O	O
for	O	O
screening	O	O
of	O	O
in	O	O
vitro	O	O
antagonistic	O	O
activity	O	O
.	O	O

Recent	O	O
studies	O	O
suggest	O	O
an	O	O
association	O	O
between	O	O
sciatica	O	O
and	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
.	O	O

``	O	O
Modic	O	O
type	O	O
I	O	O
changes	O	O
''	O	O
in	O	O
the	O	O
vertebrae	O	O
are	O	O
closely	O	O
associated	O	O
with	O	O
sciatica	O	O
and	O	O
lower	O	O
back	O	O
pain	O	O
,	O	O
and	O	O
recent	O	O
studies	O	O
have	O	O
questioned	O	O
the	O	O
ability	O	O
of	O	O
conventional	O	O
magnetic	O	O
resonance	O	O
imaging	O	O
(	O	O
MRI	O	O
)	O	O
to	O	O
differentiate	O	O
between	O	O
degenerative	O	O
Modic	O	O
type	O	O
I	O	O
changes	O	O
and	O	O
vertebral	O	O
abnormalities	O	O
caused	O	O
by	O	O
infection	O	O
.	O	O

To	O	O
test	O	O
whether	O	O
bacteria	O	O
could	O	O
be	O	O
cultured	O	O
from	O	O
biopsies	O	O
of	O	O
Modic	O	O
type	O	O
I	O	O
changes	O	O
.	O	O

Twenty-four	O	O
consecutive	O	O
patients	O	O
with	O	O
Modic	O	O
type	O	O
I	O	O
changes	O	O
in	O	O
lumbar	O	O
vertebrae	O	O
had	O	O
a	O	O
biopsy	O	O
taken	O	O
from	O	O
the	O	O
affected	O	O
vertebra	O	O
by	O	O
a	O	O
strict	O	O
aseptic	O	O
procedure	O	O
.	O	O

The	O	O
biopsy	O	O
was	O	O
split	O	O
into	O	O
two	O	O
specimens	O	O
,	O	O
which	O	O
were	O	O
inoculated	O	O
into	O	O
thioglycolate	O	O
agar	O	O
tubes	O	O
in	O	O
the	O	O
surgical	O	O
theatre	O	O
and	O	O
transported	O	O
to	O	O
the	O	O
microbiology	O	O
laboratory	O	O
.	O	O

In	O	O
the	O	O
laboratory	O	O
,	O	O
one	O	O
specimen	O	O
was	O	O
streaked	O	O
onto	O	O
plates	O	O
and	O	O
analyzed	O	O
for	O	O
anaerobic	O	O
and	O	O
aerobic	O	O
culture	O	O
.	O	O

The	O	O
other	O	O
tube	O	O
was	O	O
left	O	O
unopened	O	O
and	O	O
incubated	O	O
directly	O	O
.	O	O

Plates	O	O
and	O	O
tubes	O	O
were	O	O
incubated	O	O
for	O	O
2	O	O
weeks	O	O
and	O	O
observed	O	O
for	O	O
visible	O	O
growth	O	O
.	O	O

None	O	O
of	O	O
the	O	O
biopsies	O	O
yielded	O	O
growth	O	O
of	O	O
anaerobic	O	O
bacteria	O	O
.	O	O

In	O	O
one	O	O
patient	O	O
,	O	O
both	O	O
biopsies	O	O
yielded	O	O
growth	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
,	O	O
and	O	O
in	O	O
another	O	O
patient	O	O
coagulase-negative	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
one	O	O
biopsy	O	O
.	O	O

Both	O	O
patients	O	O
received	O	O
oral	O	O
antibiotics	O	O
without	O	O
convincing	O	O
effect	O	O
on	O	O
symptoms	O	O
.	O	O

Our	O	O
results	O	O
showed	O	O
no	O	O
evidence	O	O
of	O	O
bacteria	O	O
in	O	O
vertebrae	O	O
with	O	O
Modic	O	O
type	O	O
I	O	O
changes	O	O
.	O	O

The	O	O
isolation	O	O
of	O	O
staphylococci	B-bacteria	B-bacteria
from	O	O
two	O	O
patients	O	O
probably	O	O
represented	O	O
contamination	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
strict	O	O
supragingival	O	O
plaque	O	O
control	O	O
on	O	O
the	O	O
subgingival	O	O
microbiota	O	O
in	O	O
smokers	O	O
and	O	O
never-smokers	O	O
.	O	O

Research	O	O
into	O	O
the	O	O
impact	O	O
of	O	O
supragingival	O	O
plaque	O	O
control	O	O
on	O	O
the	O	O
number	O	O
of	O	O
subgingival	O	O
bacteria	O	O
has	O	O
resulted	O	O
in	O	O
contradictory	O	O
findings	O	O
.	O	O

Real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
has	O	O
been	O	O
suggested	O	O
as	O	O
a	O	O
valid	O	O
alternative	O	O
to	O	O
current	O	O
microbiologic	O	O
methods	O	O
based	O	O
on	O	O
bacteria	O	O
cultures	O	O
.	O	O

Forty-five	O	O
subjects	O	O
with	O	O
chronic	O	O
periodontitis	O	O
were	O	O
selected	O	O
.	O	O

Twenty-four	O	O
of	O	O
them	O	O
had	O	O
never	O	O
smoked	O	O
,	O	O
and	O	O
21	O	O
were	O	O
active	O	O
smokers	O	O
.	O	O

Four	O	O
sites	O	O
per	O	O
patient	O	O
were	O	O
selected	O	O
for	O	O
sampling	O	O
.	O	O

Supragingival	O	O
debridement	O	O
was	O	O
performed	O	O
at	O	O
baseline	O	O
,	O	O
and	O	O
the	O	O
subjects	O	O
received	O	O
weekly	O	O
instructions	O	O
on	O	O
oral	O	O
hygiene	O	O
for	O	O
180	O	O
days	O	O
.	O	O

A	O	O
clinical	O	O
examination	O	O
and	O	O
subgingival	O	O
plaque	O	O
sampling	O	O
were	O	O
carried	O	O
out	O	O
at	O	O
baseline	O	O
and	O	O
at	O	O
30	O	O
,	O	O
90	O	O
,	O	O
and	O	O
180	O	O
days	O	O
.	O	O

A	O	O
real-time	O	O
PCR	O	O
assay	O	O
was	O	O
used	O	O
to	O	O
detect	O	O
and	O	O
quantify	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
(	O	O
previously	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
or	O	O
Micromonas	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
)	O	O
,	O	O
Dialister	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
previously	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
,	O	O
and	O	O
the	O	O
total	O	O
bacteria	O	O
load	O	O
(	O	O
eubacteria	O	O
)	O	O
in	O	O
the	O	O
subgingival	O	O
samples	O	O
.	O	O

Statistical	O	O
analysis	O	O
was	O	O
performed	O	O
using	O	O
linear	O	O
models	O	O
adjusted	O	O
for	O	O
the	O	O
clustering	O	O
of	O	O
observations	O	O
within	O	O
individuals	O	O
.	O	O

Smokers	O	O
and	O	O
never-smokers	O	O
exhibited	O	O
a	O	O
similar	O	O
and	O	O
significant	O	O
reduction	O	O
in	O	O
total	O	O
bacteria	O	O
counts	O	O
over	O	O
time	O	O
.	O	O

Irrespective	O	O
of	O	O
smoking	O	O
status	O	O
,	O	O
deep	O	O
sites	O	O
consistently	O	O
harbored	O	O
greater	O	O
quantities	O	O
of	O	O
total	O	O
bacteria	O	O
throughout	O	O
the	O	O
study	O	O
.	O	O

Higher	O	O
numbers	O	O
of	O	O
the	O	O
bacteria	O	O
investigated	O	O
were	O	O
associated	O	O
with	O	O
bleeding	O	O
on	O	O
probing	O	O
.	O	O

Supragingival	O	O
plaque	O	O
control	O	O
markedly	O	O
reduced	O	O
subgingival	O	O
microbiota	O	O
counts	O	O
in	O	O
smokers	O	O
and	O	O
never-smokers	O	O
.	O	O

The	O	O
bacterial	O	O
colonization	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
was	O	O
evaluated	O	O
in	O	O
patients	O	O
with	O	O
asymptomatic	O	O
oral	O	O
lichen	O	O
planus	O	O
(	O	O
OLP	O	O
)	O	O
and	O	O
compared	O	O
to	O	O
the	O	O
microbiologic	O	O
status	O	O
in	O	O
mucosally	O	O
healthy	O	O
subjects	O	O
.	O	O

Bacteria	O	O
from	O	O
patients	O	O
with	O	O
clinically	O	O
and	O	O
histopathologically	O	O
diagnosed	O	O
OLP	O	O
from	O	O
the	O	O
Stomatology	O	O
Service	O	O
,	O	O
Department	O	O
of	O	O
Oral	O	O
Surgery	O	O
and	O	O
Stomatology	O	O
,	O	O
School	O	O
of	O	O
Dental	O	O
Medicine	O	O
,	O	O
University	O	O
of	O	O
Bern	O	O
,	O	O
were	O	O
collected	O	O
with	O	O
a	O	O
non-invasive	O	O
swab	O	O
system	O	O
.	O	O

Samples	O	O
were	O	O
taken	O	O
from	O	O
OLP	O	O
lesions	O	O
on	O	O
the	O	O
gingiva	O	O
and	O	O
from	O	O
non-affected	O	O
sites	O	O
on	O	O
the	O	O
contralateral	O	O
side	O	O
of	O	O
the	O	O
mouth	O	O
.	O	O

The	O	O
control	O	O
population	O	O
did	O	O
not	O	O
have	O	O
OLP	O	O
and	O	O
was	O	O
recruited	O	O
from	O	O
the	O	O
student	O	O
clinic	O	O
.	O	O

All	O	O
samples	O	O
were	O	O
processed	O	O
with	O	O
the	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
method	O	O
using	O	O
well-defined	O	O
bacterial	O	O
species	O	O
for	O	O
the	O	O
analysis	O	O
.	O	O

Significantly	O	O
higher	O	O
bacterial	O	O
counts	O	O
of	O	O
Bacteroides	B-bacteria	B-bacteria
ureolyticus	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
0.001	O	O
)	O	O
,	O	O
Dialister	B-bacteria	B-bacteria
species	O	O
(	O	O
sp	B-bacteria	B-bacteria
.	O	O
)	O	O

(	O	O
P	O	O
=	O	O
0.006	O	O
)	O	O
,	O	O
Staphylococcus	B-bacteria	B-bacteria
haemolyticus	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
0.007	O	O
)	O	O
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
agalactiae	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
0.006	O	O
)	O	O
were	O	O
found	O	O
in	O	O
samples	O	O
taken	O	O
from	O	O
OLP	O	O
lesions	O	O
compared	O	O
to	O	O
sites	O	O
with	O	O
no	O	O
clinical	O	O
evidence	O	O
of	O	O
OLP	O	O
.	O	O

Significantly	O	O
higher	O	O
bacterial	O	O
counts	O	O
were	O	O
found	O	O
for	O	O
Capnocytophaga	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
crispatus	E-bacteria	I-bacteria
,	O	O
Mobiluncus	B-bacteria	B-bacteria
curtisii	E-bacteria	I-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
mucosa	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
bivia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
agalactiae	E-bacteria	I-bacteria
at	O	O
sites	O	O
with	O	O
lesions	O	O
in	O	O
subjects	O	O
with	O	O
OLP	O	O
compared	O	O
to	O	O
sites	O	O
in	O	O
control	O	O
subjects	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Microbiologic	O	O
differences	O	O
were	O	O
found	O	O
between	O	O
sites	O	O
with	O	O
OLP	O	O
and	O	O
sites	O	O
in	O	O
subjects	O	O
without	O	O
a	O	O
diagnosis	O	O
of	O	O
OLP	O	O
.	O	O

Specifically	O	O
,	O	O
higher	O	O
counts	O	O
of	O	O
staphylococci	B-bacteria	B-bacteria
and	O	O
S.	B-bacteria	B-bacteria
agalactiae	E-bacteria	I-bacteria
were	O	O
found	O	O
in	O	O
OLP	O	O
lesions	O	O
.	O	O

Bacteriological	O	O
air	O	O
sampling	O	O
was	O	O
conducted	O	O
at	O	O
25	O	O
dental	O	O
units	O	O
during	O	O
restorative	O	O
treatment	O	O
sessions	O	O
before	O	O
and	O	O
after	O	O
disinfection	O	O
of	O	O
dental	O	O
unit	O	O
waterlines	O	O
(	O	O
DUWL	O	O
)	O	O
with	O	O
hydrogen	O	O
peroxide	O	O
.	O	O

Air	O	O
samples	O	O
for	O	O
determining	O	O
the	O	O
concentration	O	O
and	O	O
species	O	O
composition	O	O
of	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
facultatively	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
collected	O	O
with	O	O
the	O	O
portable	O	O
Reuter	O	O
Centrifugal	O	O
Sampler	O	O
(	O	O
RCS	O	O
Plus	O	O
)	O	O
in	O	O
the	O	O
dental	O	O
operation	O	O
area	O	O
close	O	O
to	O	O
patient	O	O
's	O	O
mouth	O	O
.	O	O

Large	O	O
concentrations	O	O
of	O	O
airborne	O	O
bacteria	O	O
in	O	O
the	O	O
range	O	O
of	O	O
0.35-40.08	O	O
x	O	O
10	O	O
(	O	O
3	O	O
)	O	O
cfu/m	O	O
(	O	O
3	O	O
)	O	O
(	O	O
median	O	O
=	O	O
1.63	O	O
x	O	O
10	O	O
(	O	O
3	O	O
)	O	O
cfu/m	O	O
(	O	O
3	O	O
)	O	O
)	O	O
were	O	O
recorded	O	O
before	O	O
DUWL	O	O
disinfection	O	O
.	O	O

After	O	O
disinfection	O	O
,	O	O
the	O	O
concentrations	O	O
were	O	O
significantly	O	O
lower	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
ranging	O	O
from	O	O
0.51-3.82	O	O
x	O	O
10	O	O
(	O	O
3	O	O
)	O	O
cfu/m	O	O
(	O	O
3	O	O
)	O	O
(	O	O
median	O	O
=	O	O
0.9	O	O
x	O	O
10	O	O
(	O	O
3	O	O
)	O	O
cfu/m	O	O
(	O	O
3	O	O
)	O	O
)	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
were	O	O
most	O	O
numerous	O	O
among	O	O
airborne	O	O
bacteria	O	O
before	O	O
DUWL	O	O
disinfection	O	O
,	O	O
forming	O	O
79.23	O	O
%	O	O
of	O	O
total	O	O
isolates	O	O
.	O	O

The	O	O
remaining	O	O
isolates	O	O
were	O	O
staphylococci/micrococci	B-bacteria	B-bacteria
(	O	O
15.7	O	O
%	O	O
)	O	O
,	O	O
corynebacteria	B-bacteria	B-bacteria
(	O	O
2.3	O	O
%	O	O
)	O	O
,	O	O
endospore-forming	B-bacteria	B-bacteria
bacilli	E-bacteria	I-bacteria
(	O	O
1.45	O	O
%	O	O
)	O	O
,	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
1.31	O	O
%	O	O
)	O	O
,	O	O
and	O	O
actinomycetes	B-bacteria	B-bacteria
(	O	O
0.01	O	O
%	O	O
)	O	O
.	O	O

After	O	O
DUWL	O	O
disinfection	O	O
,	O	O
a	O	O
significant	O	O
decrease	O	O
in	O	O
the	O	O
numbers	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
and	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
was	O	O
noted	O	O
,	O	O
while	O	O
the	O	O
numbers	O	O
of	O	O
other	O	O
types	O	O
of	O	O
bacteria	O	O
were	O	O
unaffected	O	O
.	O	O

Altogether	O	O
,	O	O
50	O	O
species	O	O
or	O	O
genera	O	O
of	O	O
bacteria	O	O
were	O	O
identified	O	O
in	O	O
the	O	O
examined	O	O
air	O	O
samples	O	O
before	O	O
and	O	O
after	O	O
DUWL	O	O
disinfection	O	O
.	O	O

Of	O	O
these	O	O
,	O	O
36	O	O
species	O	O
or	O	O
genera	O	O
are	O	O
considered	O	O
potentially	O	O
pathogenic	O	O
,	O	O
as	O	O
a	O	O
potential	O	O
cause	O	O
of	O	O
infection	O	O
,	O	O
allergic	O	O
disease	O	O
or	O	O
intoxication	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
the	O	O
high	O	O
pollution	O	O
of	O	O
dental	O	O
operation	O	O
area	O	O
with	O	O
bacteria	O	O
indicates	O	O
a	O	O
need	O	O
for	O	O
use	O	O
of	O	O
preventive	O	O
measures	O	O
protecting	O	O
dental	O	O
staff	O	O
and	O	O
patients	O	O
,	O	O
such	O	O
as	O	O
DUWL	O	O
disinfection	O	O
that	O	O
proved	O	O
efficient	O	O
in	O	O
decrease	O	O
of	O	O
exposure	O	O
in	O	O
the	O	O
present	O	O
study	O	O
.	O	O

Periodontitis	O	O
is	O	O
an	O	O
inflammatory	O	O
disease	O	O
of	O	O
the	O	O
supporting	O	O
tissues	O	O
of	O	O
teeth	O	O
and	O	O
is	O	O
a	O	O
major	O	O
cause	O	O
of	O	O
tooth	O	O
loss	O	O
in	O	O
adults	O	O
.	O	O

The	O	O
onset	O	O
and	O	O
progression	O	O
of	O	O
periodontal	O	O
disease	O	O
is	O	O
attributed	O	O
to	O	O
the	O	O
presence	O	O
of	O	O
elevated	O	O
levels	O	O
of	O	O
a	O	O
consortium	O	O
of	O	O
pathogenic	O	O
bacteria	O	O
.	O	O

Gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
mainly	O	O
strict	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
,	O	O
play	O	O
the	O	O
major	O	O
role	O	O
.	O	O

The	O	O
present	O	O
study	O	O
aimed	O	O
to	O	O
assess	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
main	O	O
types	O	O
of	O	O
microorganisms	O	O
involved	O	O
in	O	O
the	O	O
aetiopathogenesis	O	O
of	O	O
periodontal	O	O
disease	O	O
:	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Tanerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
in	O	O
different	O	O
samples	O	O
collected	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
90	O	O
patients	O	O
diagnosed	O	O
with	O	O
Periodontitis	O	O
.	O	O

Bacterial	O	O
DNA	O	O
detection	O	O
was	O	O
performed	O	O
in	O	O
diverse	O	O
biological	O	O
materials	O	O
,	O	O
namely	O	O
in	O	O
dental	O	O
plaque	O	O
,	O	O
gingival	O	O
tissue	O	O
and	O	O
saliva	O	O
,	O	O
by	O	O
means	O	O
of	O	O
multiplex	O	O
PCR	O	O
,	O	O
a	O	O
technique	O	O
that	O	O
allows	O	O
simultaneous	O	O
identification	O	O
of	O	O
two	O	O
different	O	O
bacterial	O	O
genomes	O	O
.	O	O

In	O	O
the	O	O
dental	O	O
plaque	O	O
of	O	O
the	O	O
Periodontitis	O	O
patients	O	O
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
dominated	O	O
.	O	O

In	O	O
the	O	O
gingival	O	O
tissue	O	O
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
were	O	O
the	O	O
microbiota	O	O
most	O	O
frequently	O	O
detected	O	O
,	O	O
whilst	O	O
in	O	O
saliva	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
were	O	O
found	O	O
with	O	O
the	O	O
highest	O	O
percentage	O	O
.	O	O

The	O	O
identification	O	O
of	O	O
microorganisms	O	O
by	O	O
multiplex	O	O
PCR	O	O
is	O	O
specific	O	O
and	O	O
sensitive	O	O
.	O	O

Rapid	O	O
and	O	O
precise	O	O
assessment	O	O
of	O	O
different	O	O
types	O	O
of	O	O
periodontopathogens	O	O
is	O	O
extremely	O	O
important	O	O
for	O	O
early	O	O
detection	O	O
of	O	O
the	O	O
infection	O	O
and	O	O
consequently	O	O
for	O	O
the	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

In	O	O
everyday	O	O
clinical	O	O
practice	O	O
,	O	O
for	O	O
routine	O	O
bacterial	O	O
evaluation	O	O
in	O	O
patients	O	O
with	O	O
periodontal	O	O
disease	O	O
,	O	O
the	O	O
dental	O	O
plaque	O	O
is	O	O
the	O	O
most	O	O
suitable	O	O
biological	O	O
material	O	O
,	O	O
because	O	O
it	O	O
is	O	O
the	O	O
richest	O	O
in	O	O
periodontal	O	O
bacteria	O	O
.	O	O

Dental	O	O
caries	O	O
in	O	O
babies	O	O
and	O	O
toddlers	O	O
is	O	O
called	O	O
Early	O	O
Childhood	O	O
Caries	O	O
(	O	O
ECC	O	O
)	O	O
.	O	O

It	O	O
is	O	O
an	O	O
infectious	O	O
and	O	O
transmissible	O	O
die-to-bacterial	O	O
disease	O	O
.	O	O

Detailed	O	O
knowledge	O	O
regarding	O	O
the	O	O
acquisition	O	O
and	O	O
transmission	O	O
of	O	O
infectious	O	O
agents	O	O
facilitates	O	O
a	O	O
more	O	O
comprehensive	O	O
approach	O	O
toward	O	O
prevention	O	O
.	O	O

Mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
are	O	O
important	O	O
organisms	O	O
in	O	O
the	O	O
initiation	O	O
and	O	O
progression	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

Recent	O	O
evidence	O	O
demonstrates	O	O
that	O	O
these	O	O
bacteria	O	O
are	O	O
found	O	O
in	O	O
the	O	O
mouths	O	O
of	O	O
pre-dentate	O	O
infants	O	O
and	O	O
are	O	O
acquired	O	O
via	O	O
vertical	O	O
and/or	O	O
horizontal	O	O
transmission	O	O
from	O	O
human	O	O
reservoirs	O	O
.	O	O

This	O	O
information	O	O
should	O	O
facilitate	O	O
the	O	O
focusing	O	O
of	O	O
clinical	O	O
interventions	O	O
that	O	O
prevent	O	O
or	O	O
delay	O	O
infant	O	O
infection	O	O
,	O	O
thereby	O	O
reducing	O	O
the	O	O
prevalence	O	O
of	O	O
dental	O	O
caries	O	O
(	O	O
ECC	O	O
)	O	O
in	O	O
babies	O	O
and	O	O
toddlers	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
observe	O	O
the	O	O
coexistence	O	O
of	O	O
periodontal	O	O
bacteria	O	O
DNA	O	O
(	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
in	O	O
coronary	O	O
atheromatous	O	O
plaques	O	O
and	O	O
subgingival	O	O
plaques	O	O
in	O	O
patients	O	O
scheduled	O	O
for	O	O
coronary	O	O
artery	O	O
bypass	O	O
graft	O	O
.	O	O

Coronary	O	O
atheromatous	O	O
plaque	O	O
and	O	O
subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
51	O	O
patients	O	O
and	O	O
examined	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
technique	O	O
with	O	O
specific	O	O
primers	O	O
for	O	O
periodontal	O	O
bacteria	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
33	O	O
%	O	O
)	O	O
,	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
(	O	O
31	O	O
%	O	O
)	O	O
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
18	O	O
%	O	O
)	O	O
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
12	O	O
%	O	O
)	O	O
were	O	O
detected	O	O
while	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
was	O	O
negative	O	O
and	O	O
not	O	O
found	O	O
in	O	O
coronary	O	O
atheromatous	O	O
plaques	O	O
;	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
(	O	O
84	O	O
%	O	O
)	O	O
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
78	O	O
%	O	O
)	O	O
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
59	O	O
%	O	O
)	O	O
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
39	O	O
%	O	O
)	O	O
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
22	O	O
%	O	O
)	O	O
were	O	O
detected	O	O
in	O	O
subgingival	O	O
plaque	O	O
samples	O	O
.	O	O

Coexistence	O	O
of	O	O
periodontal	O	O
bacteria	O	O
DNA	O	O
in	O	O
coronary	O	O
atheromatous	O	O
and	O	O
subgingival	O	O
plaque	O	O
samples	O	O
was	O	O
evidenced	O	O
in	O	O
32	O	O
patients	O	O
.	O	O

The	O	O
coexistence	O	O
of	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
coronary	O	O
atheromatous	O	O
plaques	O	O
and	O	O
the	O	O
subgingival	O	O
plaque	O	O
samples	O	O
in	O	O
CAD	O	O
patients	O	O
could	O	O
suggest	O	O
a	O	O
potential	O	O
role	O	O
for	O	O
periodontal	O	O
pathogenic	O	O
bacteria	O	O
in	O	O
atherosclerosis	O	O
disease	O	O
process	O	O
.	O	O

Maternal	O	O
periodontitis	O	O
has	O	O
emerged	O	O
as	O	O
a	O	O
putative	O	O
risk	O	O
factor	O	O
for	O	O
preterm	O	O
births	O	O
in	O	O
humans	O	O
.	O	O

The	O	O
periodontitis-associated	O	O
dental	O	O
biofilm	O	O
is	O	O
thought	O	O
to	O	O
serve	O	O
as	O	O
an	O	O
important	O	O
source	O	O
of	O	O
oral	O	O
bacteria	O	O
and	O	O
related	O	O
virulence	O	O
factors	O	O
that	O	O
hematogenously	O	O
disseminate	O	O
and	O	O
affect	O	O
the	O	O
fetoplacental	O	O
unit	O	O
;	O	O
however	O	O
the	O	O
underlying	O	O
biological	O	O
mechanisms	O	O
are	O	O
yet	O	O
to	O	O
be	O	O
fully	O	O
elucidated	O	O
.	O	O

This	O	O
study	O	O
hypothesized	O	O
that	O	O
an	O	O
oral	O	O
infection	O	O
with	O	O
the	O	O
human	O	O
periodontal	O	O
pathogens	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
is	O	O
able	O	O
to	O	O
induce	O	O
fetal	O	O
growth	O	O
restriction	O	O
,	O	O
placental	O	O
inflammation	O	O
and	O	O
enhance	O	O
Toll-like	O	O
receptors	O	O
type	O	O
4	O	O
(	O	O
TLR4	O	O
)	O	O
expression	O	O
in	O	O
a	O	O
murine	O	O
pregnancy	O	O
model	O	O
.	O	O

Female	O	O
Balb/C	O	O
mice	O	O
(	O	O
n	O	O
=	O	O
40	O	O
)	O	O
were	O	O
orally	O	O
infected	O	O
with	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
and/or	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
over	O	O
a	O	O
16-week	O	O
period	O	O
and	O	O
mated	O	O
once/week	O	O
.	O	O

Pregnant	O	O
mice	O	O
were	O	O
sacrificed	O	O
at	O	O
embryonic	O	O
day	O	O
(	O	O
E	O	O
)	O	O
16.5	O	O
and	O	O
placentas	O	O
were	O	O
collected	O	O
and	O	O
analyzed	O	O
for	O	O
TLR4	O	O
mRNA	O	O
levels	O	O
and	O	O
qualitative	O	O
protein	O	O
expression	O	O
by	O	O
real-time	O	O
PCR	O	O
and	O	O
immunofluorescence	O	O
.	O	O

TLR4	O	O
mRNA	O	O
expression	O	O
was	O	O
found	O	O
to	O	O
be	O	O
increased	O	O
in	O	O
the	O	O
C.	O	O
rectus-infected	O	O
group	O	O
(	O	O
1.98	O	O
+/-	O	O
0.886-fold	O	O
difference	O	O
,	O	O
P	O	O
<	O	O
0.01	O	O
,	O	O
ANOVA	O	O
)	O	O
compared	O	O
to	O	O
controls	O	O
.	O	O

Microscopic	O	O
analysis	O	O
of	O	O
murine	O	O
placentas	O	O
showed	O	O
enhanced	O	O
immunofluorescence	O	O
of	O	O
TLR4	O	O
in	O	O
trophoblasts	O	O
,	O	O
mainly	O	O
in	O	O
the	O	O
placental	O	O
labyrinth	O	O
layer	O	O
.	O	O

Also	O	O
,	O	O
combined	O	O
oral	O	O
infection	O	O
with	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
significantly	O	O
reduced	O	O
the	O	O
overall	O	O
fecundity	O	O
compared	O	O
to	O	O
controls	O	O
(	O	O
16.7	O	O
%	O	O
vs.	O	O
75	O	O
%	O	O
,	O	O
infected	O	O
vs.	O	O
non-infected	O	O
mice	O	O
respectively	O	O
,	O	O
P	O	O
=	O	O
0.03	O	O
,	O	O
Kaplan-Meier	O	O
)	O	O
.	O	O

The	O	O
results	O	O
supported	O	O
an	O	O
enhanced	O	O
placental	O	O
TLR4	O	O
expression	O	O
after	O	O
oral	O	O
infection	O	O
with	O	O
periodontal	O	O
pathogens	O	O
.	O	O

The	O	O
TLR4	O	O
pathway	O	O
has	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
preterm	O	O
births	O	O
;	O	O
therefore	O	O
the	O	O
abnormal	O	O
regulation	O	O
of	O	O
placental	O	O
TLR4	O	O
may	O	O
give	O	O
new	O	O
insights	O	O
into	O	O
how	O	O
maternal	O	O
periodontitis	O	O
and	O	O
periodontal	O	O
pathogens	O	O
might	O	O
be	O	O
linked	O	O
to	O	O
placental	O	O
inflammation	O	O
and	O	O
preterm	O	O
birth	O	O
pathogenesis	O	O
.	O	O

This	O	O
study	O	O
examined	O	O
the	O	O
ability	O	O
of	O	O
methyl	O	O
gallate	O	O
(	O	O
MG	O	O
)	O	O
and	O	O
gallic	O	O
acid	O	O
(	O	O
GA	O	O
)	O	O
,	O	O
the	O	O
main	O	O
compounds	O	O
of	O	O
gallo-tannins	O	O
in	O	O
Galla	O	O
Rhois	O	O
,	O	O
to	O	O
inhibit	O	O
the	O	O
proliferation	O	O
of	O	O
oral	O	O
bacterial	O	O
and	O	O
the	O	O
in	O	O
vitro	O	O
formation	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
.	O	O

The	O	O
antimicrobial	O	O
activities	O	O
of	O	O
these	O	O
compounds	O	O
were	O	O
evaluated	O	O
in	O	O
vitro	O	O
using	O	O
the	O	O
broth	O	O
microdilution	O	O
method	O	O
and	O	O
a	O	O
beaker-wire	O	O
test	O	O
.	O	O

Both	O	O
MG	O	O
and	O	O
GA	O	O
had	O	O
inhibitory	O	O
effects	O	O
on	O	O
the	O	O
growth	O	O
of	O	O
cariogenic	O	O
(	O	O
MIC	O	O
<	O	O
8	O	O
mg/ml	O	O
)	O	O
and	O	O
periodontopathic	O	O
bacteria	O	O
(	O	O
MIC=1	O	O
mg/ml	O	O
)	O	O
.	O	O

Moreover	O	O
,	O	O
these	O	O
compounds	O	O
significantly	O	O
inhibited	O	O
the	O	O
in	O	O
vitro	O	O
formation	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
(	O	O
MG	O	O
,	O	O
1	O	O
mg/ml	O	O
;	O	O
GA	O	O
,	O	O
4	O	O
mg/ml	O	O
;	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

MG	O	O
was	O	O
more	O	O
effective	O	O
in	O	O
inhibiting	O	O
bacterial	O	O
growth	O	O
and	O	O
the	O	O
formation	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilm	O	O
than	O	O
GA	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
MG	O	O
and	O	O
GA	O	O
can	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
oral	O	O
pathogens	O	O
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilm	O	O
formation	O	O
,	O	O
and	O	O
may	O	O
be	O	O
used	O	O
to	O	O
prevent	O	O
the	O	O
formation	O	O
of	O	O
oral	O	O
biofilms	O	O
.	O	O

We	O	O
evaluated	O	O
the	O	O
ability	O	O
of	O	O
a	O	O
dual-species	O	O
community	O	O
of	O	O
oral	O	O
bacteria	O	O
to	O	O
produce	O	O
the	O	O
universal	O	O
signalling	O	O
molecule	O	O
,	O	O
autoinducer-2	O	O
(	O	O
AI-2	O	O
)	O	O
,	O	O
in	O	O
saliva-fed	O	O
biofilms	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
34	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
34	I-bacteria	I-bacteria
luxS	I-bacteria	I-bacteria
mutant	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
T14V	E-bacteria	I-bacteria
were	O	O
grown	O	O
as	O	O
single-	O	O
and	O	O
dual-species	O	O
biofilms	O	O
within	O	O
sorbarods	O	O
fed	O	O
with	O	O
25	O	O
%	O	O
human	O	O
saliva	O	O
.	O	O

AI-2	O	O
concentration	O	O
in	O	O
biofilm	O	O
effluents	O	O
was	O	O
determined	O	O
by	O	O
the	O	O
Vibrio	B-bacteria	B-bacteria
harveyi	I-bacteria	I-bacteria
BB170	E-bacteria	I-bacteria
bioluminescence	O	O
assay	O	O
.	O	O

After	O	O
homogenizing	O	O
the	O	O
sorbarods	O	O
to	O	O
release	O	O
biofilm	O	O
cells	O	O
,	O	O
cell	O	O
numbers	O	O
were	O	O
determined	O	O
by	O	O
fluorometric	O	O
analysis	O	O
of	O	O
fluorescent	O	O
antibody-labelled	O	O
cells	O	O
.	O	O

After	O	O
48	O	O
h	O	O
,	O	O
dual-species	O	O
biofilm	O	O
communities	O	O
of	O	O
interdigitated	O	O
S.	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
34	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
T14V	E-bacteria	I-bacteria
contained	O	O
3.2	O	O
x	O	O
10	O	O
(	O	O
9	O	O
)	O	O
cells	O	O
:	O	O
fivefold	O	O
more	O	O
than	O	O
single-species	O	O
biofilms	O	O
.	O	O

However	O	O
,	O	O
these	O	O
48-h	O	O
dual-species	O	O
biofilms	O	O
exhibited	O	O
the	O	O
lowest	O	O
concentration	O	O
ratio	O	O
of	O	O
AI-2	O	O
to	O	O
cell	O	O
density	O	O
.	O	O

Oral	O	O
bacteria	O	O
produce	O	O
AI-2	O	O
in	O	O
saliva-fed	O	O
biofilms	O	O
.	O	O

The	O	O
decrease	O	O
of	O	O
more	O	O
than	O	O
10-fold	O	O
in	O	O
concentration	O	O
ratio	O	O
seen	O	O
between	O	O
1	O	O
and	O	O
48	O	O
h	O	O
in	O	O
S.	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
34-A	E-bacteria	I-bacteria
.	O	O

naeslundii	B-bacteria	B-bacteria
T14V	E-bacteria	I-bacteria
biofilms	O	O
suggests	O	O
that	O	O
peak	O	O
production	O	O
of	O	O
AI-2	O	O
occurs	O	O
early	O	O
and	O	O
is	O	O
followed	O	O
by	O	O
a	O	O
very	O	O
low	O	O
steady-state	O	O
level	O	O
.	O	O

High	O	O
oral	O	O
bacterial	O	O
biofilm	O	O
densities	O	O
may	O	O
be	O	O
achieved	O	O
by	O	O
inter-species	O	O
AI-2	O	O
signalling	O	O
.	O	O

We	O	O
propose	O	O
that	O	O
low	O	O
concentrations	O	O
of	O	O
AI-2	O	O
contribute	O	O
to	O	O
the	O	O
establishment	O	O
of	O	O
oral	O	O
commensal	O	O
biofilm	O	O
communities	O	O
.	O	O

Oral	O	O
bacteria	O	O
,	O	O
including	O	O
cariogenic	O	O
and	O	O
periodontal	O	O
pathogens	O	O
,	O	O
are	O	O
thought	O	O
to	O	O
be	O	O
etiological	O	O
factors	O	O
in	O	O
the	O	O
development	O	O
of	O	O
cardiovascular	O	O
diseases	O	O
.	O	O

To	O	O
define	O	O
this	O	O
relationship	O	O
,	O	O
we	O	O
analyzed	O	O
the	O	O
distribution	O	O
of	O	O
oral	O	O
bacterial	O	O
species	O	O
in	O	O
cardiovascular	O	O
specimens	O	O
.	O	O

Following	O	O
acceptance	O	O
into	O	O
the	O	O
study	O	O
,	O	O
203	O	O
consecutive	O	O
patients	O	O
were	O	O
analyzed	O	O
,	O	O
from	O	O
whom	O	O
82	O	O
aortic	O	O
valve	O	O
specimens	O	O
,	O	O
35	O	O
mitral	O	O
valve	O	O
specimens	O	O
,	O	O
and	O	O
86	O	O
aortic	O	O
aneurysmal	O	O
wall	O	O
specimens	O	O
,	O	O
of	O	O
which	O	O
16	O	O
contained	O	O
aneurysmal	O	O
thrombus	O	O
tissues	O	O
,	O	O
were	O	O
obtained	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
a	O	O
total	O	O
of	O	O
58	O	O
dental	O	O
plaque	O	O
specimens	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
same	O	O
group	O	O
of	O	O
patients	O	O
who	O	O
underwent	O	O
heart	O	O
valve	O	O
replacement	O	O
or	O	O
removal	O	O
of	O	O
aortic	O	O
aneurysms	O	O
.	O	O

Bacterial	O	O
DNA	O	O
was	O	O
extracted	O	O
from	O	O
both	O	O
cardiovascular	O	O
tissues	O	O
and	O	O
dental	O	O
plaque	O	O
in	O	O
those	O	O
cases	O	O
and	O	O
then	O	O
species-specific	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assays	O	O
were	O	O
used	O	O
to	O	O
analyze	O	O
the	O	O
occurrences	O	O
of	O	O
six	O	O
oral	O	O
streptococcal	O	O
and	O	O
six	O	O
periodontal	O	O
bacterial	O	O
species	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
frequently	O	O
detected	O	O
species	O	O
in	O	O
the	O	O
cardiovascular	O	O
specimens	O	O
,	O	O
followed	O	O
by	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

As	O	O
for	O	O
dental	O	O
plaque	O	O
specimens	O	O
from	O	O
patients	O	O
who	O	O
underwent	O	O
cardiovascular	O	O
operations	O	O
,	O	O
most	O	O
of	O	O
the	O	O
tested	O	O
periodontitis-related	O	O
species	O	O
as	O	O
well	O	O
as	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
detected	O	O
at	O	O
high	O	O
frequencies	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
positive	O	O
rate	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
cardiovascular	O	O
specimens	O	O
from	O	O
patients	O	O
whose	O	O
dental	O	O
plaque	O	O
specimens	O	O
were	O	O
also	O	O
positive	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
78	O	O
%	O	O
,	O	O
which	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
any	O	O
other	O	O
tested	O	O
species	O	O
when	O	O
the	O	O
same	O	O
analysis	O	O
was	O	O
performed	O	O
.	O	O

Our	O	O
results	O	O
suggest	O	O
that	O	O
specific	O	O
oral	O	O
bacterial	O	O
species	O	O
,	O	O
such	O	O
as	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
are	O	O
related	O	O
to	O	O
bacteremia	O	O
and	O	O
may	O	O
be	O	O
etiologic	O	O
factors	O	O
for	O	O
the	O	O
development	O	O
of	O	O
cardiovascular	O	O
diseases	O	O
.	O	O

Quantative	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
(	O	O
CLSM	O	O
)	O	O
in	O	O
combination	O	O
with	O	O
fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
may	O	O
help	O	O
to	O	O
increase	O	O
our	O	O
knowledge	O	O
about	O	O
biofilm	O	O
formation	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
develop	O	O
and	O	O
evaluate	O	O
a	O	O
stereological	O	O
method	O	O
for	O	O
quantification	O	O
of	O	O
bacteria	O	O
in	O	O
intact	O	O
biofilm	O	O
.	O	O

The	O	O
method	O	O
was	O	O
applied	O	O
in	O	O
a	O	O
quantitative	O	O
study	O	O
of	O	O
the	O	O
proportion	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
relative	O	O
to	O	O
other	O	O
bacteria	O	O
in	O	O
initial	O	O
in-situ-grown	O	O
dental	O	O
biofilms	O	O
as	O	O
a	O	O
function	O	O
of	O	O
time	O	O
.	O	O

Biofilms	O	O
were	O	O
collected	O	O
on	O	O
standardized	O	O
glass	O	O
slabs	O	O
mounted	O	O
in	O	O
intra-oral	O	O
appliances	O	O
and	O	O
worn	O	O
by	O	O
10	O	O
individuals	O	O
for	O	O
6	O	O
,	O	O
12	O	O
,	O	O
24	O	O
,	O	O
and	O	O
48	O	O
h.	O	O
Biofilms	O	O
were	O	O
analysed	O	O
using	O	O
CLSM	O	O
.	O	O

Quantification	O	O
of	O	O
bacteria	O	O
labelled	O	O
with	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
oligonucleotide	O	O
probes	O	O
was	O	O
performed	O	O
with	O	O
stereological	O	O
tools	O	O
:	O	O
the	O	O
unbiased	O	O
counting	O	O
frame	O	O
and	O	O
the	O	O
two-dimensional	O	O
fractionator	O	O
.	O	O

Results	O	O
showed	O	O
a	O	O
notable	O	O
increase	O	O
in	O	O
the	O	O
total	O	O
number	O	O
of	O	O
bacteria	O	O
and	O	O
streptococci	B-bacteria	B-bacteria
over	O	O
time	O	O
,	O	O
with	O	O
a	O	O
considerable	O	O
inter-individual	O	O
variation	O	O
at	O	O
each	O	O
time-point	O	O
.	O	O

After	O	O
48	O	O
h	O	O
there	O	O
was	O	O
a	O	O
12.5-fold	O	O
difference	O	O
between	O	O
individuals	O	O
in	O	O
the	O	O
total	O	O
number	O	O
of	O	O
bacteria	O	O
and	O	O
a	O	O
12.6-fold	O	O
difference	O	O
in	O	O
the	O	O
number	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

The	O	O
number	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
exceeded	O	O
that	O	O
of	O	O
other	O	O
bacteria	O	O
and	O	O
over	O	O
the	O	O
examination	O	O
period	O	O
there	O	O
was	O	O
a	O	O
relatively	O	O
constant	O	O
relationship	O	O
between	O	O
the	O	O
number	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
other	O	O
bacteria	O	O
(	O	O
streptococci	B-bacteria	B-bacteria
vs.	O	O
non-streptococci	O	O
:	O	O
median	O	O
15.2	O	O
;	O	O
minimum	O	O
1.0	O	O
;	O	O
maximum	O	O
89.3	O	O
)	O	O
.	O	O

The	O	O
study	O	O
demonstrates	O	O
that	O	O
the	O	O
combined	O	O
use	O	O
of	O	O
FISH	O	O
and	O	O
stereology	O	O
is	O	O
a	O	O
relevant	O	O
and	O	O
reliable	O	O
tool	O	O
for	O	O
obtaining	O	O
unbiased	O	O
information	O	O
about	O	O
the	O	O
numerical	O	O
contributions	O	O
of	O	O
specific	O	O
bacterial	O	O
populations	O	O
during	O	O
early	O	O
biofilm	O	O
formation	O	O
.	O	O

Although	O	O
commensal	O	O
bacteria	O	O
are	O	O
known	O	O
to	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
proper	O	O
maturation	O	O
of	O	O
the	O	O
immune	O	O
system	O	O
of	O	O
their	O	O
mammalian	O	O
hosts	O	O
,	O	O
the	O	O
molecular	O	O
mechanisms	O	O
underlying	O	O
this	O	O
immunomodulation	O	O
are	O	O
poorly	O	O
characterized	O	O
.	O	O

The	O	O
present	O	O
review	O	O
summarizes	O	O
recent	O	O
findings	O	O
in	O	O
the	O	O
field	O	O
and	O	O
describes	O	O
new	O	O
knowledge	O	O
on	O	O
the	O	O
interplay	O	O
of	O	O
the	O	O
innate	O	O
and	O	O
adaptive	O	O
arms	O	O
of	O	O
the	O	O
immune	O	O
response	O	O
induced	O	O
by	O	O
symbiotic	O	O
bacterial	O	O
carbohydrate	O	O
antigens	O	O
.	O	O

Commensal	O	O
bacteria	O	O
in	O	O
the	O	O
intestine	O	O
not	O	O
only	O	O
interact	O	O
directly	O	O
with	O	O
dendritic	O	O
cells	O	O
but	O	O
also	O	O
engage	O	O
in	O	O
cross-talk	O	O
with	O	O
epithelial	O	O
cells	O	O
.	O	O

These	O	O
interactions	O	O
lead	O	O
to	O	O
the	O	O
induction	O	O
of	O	O
tolerogenic	O	O
antigen-presenting	O	O
cells	O	O
in	O	O
the	O	O
lamina	O	O
propria	O	O
and	O	O
ultimately	O	O
to	O	O
the	O	O
regulation	O	O
of	O	O
functional	O	O
maturation	O	O
of	O	O
effector	O	O
T	O	O
cells	O	O
.	O	O

Upon	O	O
recognition	O	O
of	O	O
capsular	O	O
polysaccharide	O	O
antigens	O	O
of	O	O
commensal	O	O
bacteria	O	O
by	O	O
dendritic	O	O
cells	O	O
(	O	O
through	O	O
toll-like	O	O
receptor	O	O
2	O	O
)	O	O
,	O	O
innate	O	O
immune	O	O
responses	O	O
facilitate	O	O
and	O	O
act	O	O
in	O	O
conjunction	O	O
with	O	O
adaptive	O	O
responses	O	O
to	O	O
promote	O	O
optimal	O	O
Th1	O	O
polarization	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
adaptive	O	O
immunoglobulin	O	O
A	O	O
responses	O	O
to	O	O
symbiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
regulate	O	O
the	O	O
magnitude	O	O
of	O	O
oxidative	O	O
innate	O	O
immune	O	O
responses	O	O
in	O	O
the	O	O
mucosa	O	O
as	O	O
well	O	O
as	O	O
bacterial	O	O
epitope	O	O
expression	O	O
in	O	O
the	O	O
lumen	O	O
.	O	O

Accumulating	O	O
evidence	O	O
is	O	O
elucidating	O	O
surface	O	O
carbohydrate	O	O
structures	O	O
of	O	O
symbiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
that	O	O
drive	O	O
the	O	O
modulation	O	O
of	O	O
the	O	O
intestinal	O	O
immune	O	O
system	O	O
,	O	O
resulting	O	O
in	O	O
mature	O	O
,	O	O
balanced	O	O
immune	O	O
responses	O	O
and	O	O
oral	O	O
tolerance	O	O
.	O	O

Seven	O	O
pimarane	O	O
type-diterpenes	O	O
re-isolated	O	O
from	O	O
Viguiera	O	O
arenaria	O	O
Baker	O	O
and	O	O
two	O	O
semi-synthetic	O	O
pimarane	O	O
derivatives	O	O
were	O	O
evaluated	O	O
in	O	O
vitro	O	O
against	O	O
the	O	O
following	O	O
main	O	O
microorganisms	O	O
responsible	O	O
for	O	O
dental	O	O
caries	O	O
:	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
.	O	O

The	O	O
compounds	O	O
ent-pimara-8	O	O
(	O	O
14	O	O
)	O	O
,15-dien-19-oic	O	O
acid	O	O
(	O	O
PA	O	O
)	O	O
;	O	O
ent-8	O	O
(	O	O
14	O	O
)	O	O
,15-pimaradien-3beta-ol	O	O
;	O	O
ent-15-pimarene-8beta,19-diol	O	O
;	O	O
ent-8	O	O
(	O	O
14	O	O
)	O	O
,15-pimaradien-3beta-acetoxy	O	O
and	O	O
the	O	O
sodium	O	O
salt	O	O
derivative	O	O
of	O	O
PA	O	O
were	O	O
the	O	O
most	O	O
active	O	O
compounds	O	O
,	O	O
displaying	O	O
MIC	O	O
values	O	O
ranging	O	O
from	O	O
2	O	O
to	O	O
8	O	O
microg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

Thus	O	O
,	O	O
this	O	O
class	O	O
of	O	O
compounds	O	O
seems	O	O
promising	O	O
as	O	O
a	O	O
class	O	O
of	O	O
new	O	O
effective	O	O
anticariogenic	O	O
agents	O	O
.	O	O

Furthermore	O	O
,	O	O
our	O	O
results	O	O
also	O	O
allow	O	O
us	O	O
to	O	O
conclude	O	O
that	O	O
minor	O	O
structural	O	O
differences	O	O
among	O	O
these	O	O
diterpenes	O	O
significantly	O	O
influence	O	O
their	O	O
antimicrobial	O	O
activity	O	O
,	O	O
bringing	O	O
new	O	O
perspectives	O	O
to	O	O
the	O	O
discovery	O	O
of	O	O
new	O	O
natural	O	O
compounds	O	O
that	O	O
could	O	O
be	O	O
employed	O	O
in	O	O
the	O	O
development	O	O
of	O	O
oral	O	O
care	O	O
products	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
number	O	O
of	O	O
bacteria	O	O
extruded	O	O
apically	O	O
from	O	O
extracted	O	O
teeth	O	O
ex	O	O
vivo	O	O
after	O	O
canal	O	O
instrumentation	O	O
using	O	O
a	O	O
manual	O	O
technique	O	O
and	O	O
three	O	O
engine-driven	O	O
techniques	O	O
utilizing	O	O
nickel-titanium	O	O
instruments	O	O
(	O	O
K3	O	O
,	O	O
RaCe	O	O
,	O	O
and	O	O
FlexMaster	O	O
)	O	O
.	O	O

Seventy	O	O
extracted	O	O
human	O	O
mandibular	O	O
premolar	O	O
teeth	O	O
with	O	O
similar	O	O
dimensions	O	O
were	O	O
used	O	O
.	O	O

Access	O	O
cavities	O	O
were	O	O
prepared	O	O
and	O	O
root	O	O
canals	O	O
were	O	O
then	O	O
contaminated	O	O
with	O	O
a	O	O
suspension	O	O
of	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
then	O	O
dried	O	O
.	O	O

The	O	O
contaminated	O	O
roots	O	O
were	O	O
divided	O	O
into	O	O
four	O	O
experimental	O	O
groups	O	O
of	O	O
15	O	O
teeth	O	O
each	O	O
and	O	O
one	O	O
control	O	O
group	O	O
of	O	O
10	O	O
teeth	O	O
.	O	O

G1	O	O
.	O	O

RaCe	O	O
group	O	O
:	O	O
the	O	O
root	O	O
canals	O	O
were	O	O
instrumented	O	O
using	O	O
RaCe	O	O
instruments	O	O
.	O	O

G2	O	O
.	O	O

K3	O	O
group	O	O
:	O	O
the	O	O
root	O	O
canals	O	O
were	O	O
instrumented	O	O
using	O	O
K3	O	O
instruments	O	O
.	O	O

G3	O	O
.	O	O

FlexMaster	O	O
group	O	O
:	O	O
the	O	O
root	O	O
canals	O	O
were	O	O
instrumented	O	O
using	O	O
FlexMaster	O	O
instruments	O	O
.	O	O

G4	O	O
.	O	O

Manual	O	O
technique	O	O
group	O	O
:	O	O
the	O	O
root	O	O
canals	O	O
were	O	O
instrumented	O	O
using	O	O
K-type	O	O
stainless	O	O
steel	O	O
instruments	O	O
.	O	O

G5	O	O
.	O	O

no	O	O
instrumentation	O	O
was	O	O
attempted	O	O
.	O	O

Bacteria	O	O
extruded	O	O
from	O	O
the	O	O
apical	O	O
foramen	O	O
during	O	O
instrumentation	O	O
were	O	O
collected	O	O
into	O	O
vials	O	O
.	O	O

The	O	O
resultant	O	O
microbiological	O	O
samples	O	O
were	O	O
removed	O	O
from	O	O
the	O	O
vials	O	O
and	O	O
then	O	O
incubated	O	O
in	O	O
culture	O	O
media	O	O
for	O	O
24	O	O
h.	O	O
The	O	O
number	O	O
of	O	O
colony-forming	O	O
units	O	O
(	O	O
CFU	O	O
)	O	O
was	O	O
determined	O	O
for	O	O
each	O	O
sample	O	O
.	O	O

The	O	O
data	O	O
obtained	O	O
were	O	O
analysed	O	O
using	O	O
the	O	O
Kruskal-Wallis	O	O
one-way	O	O
analysis	O	O
of	O	O
variance	O	O
and	O	O
Mann-Whitney	O	O
U-tests	O	O
,	O	O
with	O	O
alpha	O	O
=	O	O
0.05	O	O
as	O	O
the	O	O
level	O	O
for	O	O
statistical	O	O
significance	O	O
.	O	O

There	O	O
was	O	O
a	O	O
significant	O	O
difference	O	O
between	O	O
experimental-control	O	O
and	O	O
engine-driven-manual	O	O
technique	O	O
groups	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
manual	O	O
technique	O	O
was	O	O
associated	O	O
with	O	O
the	O	O
greatest	O	O
extrusion	O	O
of	O	O
microorganism	O	O
.	O	O

All	O	O
instrumentation	O	O
techniques	O	O
extruded	O	O
intracanal	O	O
bacteria	O	O
apically	O	O
.	O	O

No	O	O
significant	O	O
difference	O	O
was	O	O
found	O	O
in	O	O
the	O	O
number	O	O
of	O	O
CFU	O	O
among	O	O
the	O	O
engine-driven	O	O
techniques	O	O
;	O	O
manual	O	O
techniques	O	O
extruded	O	O
significantly	O	O
more	O	O
microorganisms	O	O
.	O	O

The	O	O
current	O	O
study	O	O
was	O	O
conducted	O	O
to	O	O
determine	O	O
the	O	O
prevalence	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
a	O	O
Chinese	O	O
population	O	O
.	O	O

Nested	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
was	O	O
used	O	O
to	O	O
investigate	O	O
whether	O	O
individuals	O	O
with	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
show	O	O
more	O	O
possibility	O	O
of	O	O
gastric	O	O
infection	O	O
and	O	O
to	O	O
examine	O	O
the	O	O
relationship	O	O
between	O	O
gastric	O	O
H.	O	O
pylori	O	O
infection	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

A	O	O
total	O	O
of	O	O
443	O	O
dyspeptic	O	O
patients	O	O
participated	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Gastric	O	O
H.	O	O
pylori	O	O
infection	O	O
was	O	O
detected	O	O
by	O	O
the	O	O
rapid	O	O
urease	O	O
test	O	O
and	O	O
histology	O	O
with	O	O
Giemsa	O	O
staining	O	O
,	O	O
PCR	O	O
,	O	O
or	O	O
smear	O	O
examination	O	O
,	O	O
whereas	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
was	O	O
observed	O	O
by	O	O
nested	O	O
PCR	O	O
from	O	O
dental	O	O
plaque	O	O
.	O	O

Relevant	O	O
periodontal	O	O
and	O	O
dental	O	O
parameters	O	O
were	O	O
recorded	O	O
in	O	O
the	O	O
process	O	O
of	O	O
oral	O	O
examination	O	O
.	O	O

Of	O	O
the	O	O
443	O	O
study	O	O
patients	O	O
,	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
found	O	O
in	O	O
the	O	O
dental	O	O
plaque	O	O
of	O	O
263	O	O
(	O	O
59.4	O	O
%	O	O
)	O	O
and	O	O
the	O	O
stomach	O	O
of	O	O
273	O	O
(	O	O
61.6	O	O
%	O	O
)	O	O
.	O	O

Additionally	O	O
,	O	O
in	O	O
all	O	O
four	O	O
age	O	O
groups	O	O
,	O	O
the	O	O
prevalence	O	O
of	O	O
gastric	O	O
infection	O	O
was	O	O
significantly	O	O
higher	O	O
among	O	O
the	O	O
patients	O	O
with	O	O
positive	O	O
tests	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
their	O	O
dental	O	O
plaque	O	O
than	O	O
in	O	O
the	O	O
patients	O	O
with	O	O
no	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
their	O	O
dental	O	O
plaque	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
may	O	O
be	O	O
a	O	O
potential	O	O
reservoir	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
prevalence	O	O
of	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
approximated	O	O
that	O	O
of	O	O
gastric	B-bacteria	B-bacteria
H.	I-bacteria	I-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
studied	O	O
population	O	O
.	O	O

Furthermore	O	O
,	O	O
a	O	O
close	O	O
relationship	O	O
may	O	O
exist	O	O
between	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
bacteria	O	O
in	O	O
the	O	O
stomach	O	O
or	O	O
gastric	O	O
infection	O	O
,	O	O
and	O	O
dyspeptic	O	O
patients	O	O
with	O	O
gastric	O	O
infection	O	O
are	O	O
more	O	O
likely	O	O
to	O	O
harbor	B-bacteria	B-bacteria
H.	I-bacteria	I-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
their	O	O
oral	O	O
cavity	O	O
.	O	O

Saliva	O	O
may	O	O
become	O	O
a	O	O
potential	O	O
source	O	O
of	O	O
contamination	O	O
through	O	O
vertical	O	O
and	O	O
horizontal	O	O
transmissions	O	O
as	O	O
well	O	O
as	O	O
cross-infections	O	O
.	O	O

This	O	O
study	O	O
aims	O	O
to	O	O
use	O	O
saliva	O	O
as	O	O
a	O	O
screening	O	O
tool	O	O
to	O	O
detect	O	O
putative	O	O
periodontal	O	O
pathogens	O	O
in	O	O
a	O	O
young	O	O
population	O	O
with	O	O
fairly	O	O
good	O	O
oral	O	O
hygiene	O	O
.	O	O

Stimulated	O	O
saliva	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
134	O	O
dental	O	O
students	O	O
(	O	O
20.5+/-1	O	O
years	O	O
,	O	O
range	O	O
18-22	O	O
years	O	O
)	O	O
.	O	O

Among	O	O
those	O	O
,	O	O
77	O	O
subjects	O	O
also	O	O
completed	O	O
a	O	O
periodontal	O	O
examination	O	O
including	O	O
attachment	O	O
loss	O	O
,	O	O
modified	O	O
dental	O	O
,	O	O
gingival	O	O
and	O	O
plaque	O	O
indices	O	O
(	O	O
AL	O	O
,	O	O
mDI	O	O
,	O	O
GI	O	O
and	O	O
PI	O	O
)	O	O
.	O	O

The	O	O
test	O	O
bacteria	O	O
were	O	O
identified	O	O
using	O	O
a	O	O
16S	O	O
rRNA-based	O	O
PCR	O	O
detection	O	O
method	O	O
.	O	O

One	O	O
or	O	O
more	O	O
of	O	O
the	O	O
test	O	O
bacteria	O	O
was	O	O
found	O	O
in	O	O
67	O	O
%	O	O
of	O	O
the	O	O
subjects	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
was	O	O
detected	O	O
as	O	O
single	O	O
bacterium	O	O
in	O	O
16	O	O
%	O	O
of	O	O
the	O	O
subjects	O	O
followed	O	O
by	O	O
Treponema	O	O
denticola	O	O
(	O	O
4	O	O
%	O	O
)	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
2	O	O
%	O	O
)	O	O
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
formerly	I-bacteria	I-bacteria
Actinobacillus	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
1	O	O
%	O	O
)	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
1	O	O
%	O	O
)	O	O
.	O	O

Two	O	O
or	O	O
more	O	O
pathogens	O	O
were	O	O
detected	O	O
in	O	O
42	O	O
%	O	O
of	O	O
the	O	O
subjects	O	O
.	O	O

Clinical	O	O
examination	O	O
revealed	O	O
health	O	O
with	O	O
no	O	O
attachment	O	O
loss	O	O
(	O	O
AL	O	O
)	O	O
in	O	O
84	O	O
%	O	O
of	O	O
the	O	O
students	O	O
.	O	O

In	O	O
no	O	O
AL	O	O
group	O	O
,	O	O
38	O	O
%	O	O
of	O	O
the	O	O
students	O	O
were	O	O
pathogen	O	O
free	O	O
while	O	O
this	O	O
was	O	O
25	O	O
%	O	O
for	O	O
students	O	O
in	O	O
localized	O	O
AL	O	O
group	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

There	O	O
was	O	O
a	O	O
statistically	O	O
significant	O	O
association	O	O
between	O	O
the	O	O
detection	O	O
of	O	O
salivary	O	O
periodontal	O	O
pathogen	O	O
in	O	O
general	O	O
and	O	O
higher	O	O
PI	O	O
(	O	O
p=0.018	O	O
)	O	O
and	O	O
GI	O	O
(	O	O
p=0.043	O	O
)	O	O
.	O	O

Within	O	O
the	O	O
limits	O	O
of	O	O
this	O	O
study	O	O
,	O	O
it	O	O
is	O	O
possible	O	O
to	O	O
detect	O	O
all	O	O
six	O	O
periodontal	O	O
pathogens	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
dental	O	O
students	O	O
.	O	O

Although	O	O
a	O	O
correlation	O	O
can	O	O
be	O	O
observed	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
salivary	O	O
periodontal	O	O
pathogen	O	O
and	O	O
clinical	O	O
signs	O	O
of	O	O
inflammation	O	O
such	O	O
as	O	O
plaque	O	O
accumulation	O	O
and	O	O
gingival	O	O
bleeding	O	O
,	O	O
detection	O	O
of	O	O
specific	O	O
bacteria	O	O
in	O	O
saliva	O	O
is	O	O
not	O	O
related	O	O
to	O	O
the	O	O
presence	O	O
of	O	O
localized	O	O
AL	O	O
based	O	O
on	O	O
the	O	O
presented	O	O
study	O	O
population	O	O
.	O	O

To	O	O
determine	O	O
characteristics	O	O
of	O	O
microbial	O	O
associations	O	O
and	O	O
degree	O	O
of	O	O
oral	O	O
cavity	O	O
colonization	O	O
by	O	O
different	O	O
biotopes	O	O
in	O	O
healthy	O	O
adolescents	O	O
and	O	O
patients	O	O
with	O	O
chronic	O	O
gastroduodenitis	O	O
.	O	O

Saliva	O	O
,	O	O
dental	O	O
deposit	O	O
,	O	O
content	O	O
of	O	O
tooth-gingival	O	O
cavity	O	O
and	O	O
material	O	O
from	O	O
buccal	O	O
and	O	O
lingual	O	O
mucous	O	O
surfaces	O	O
of	O	O
24	O	O
healthy	O	O
adolescents	O	O
and	O	O
29	O	O
patients	O	O
of	O	O
the	O	O
same	O	O
age	O	O
with	O	O
gastroduodenitis	O	O
were	O	O
used	O	O
for	O	O
bacteriological	O	O
analysis	O	O
.	O	O

Inoculation	O	O
were	O	O
made	O	O
on	O	O
the	O	O
following	O	O
growth	O	O
media	O	O
:	O	O
yolk-salt	O	O
agar	O	O
,	O	O
Endo	O	O
,	O	O
Saburo	O	O
,	O	O
MRS	O	O
as	O	O
well	O	O
as	O	O
on	O	O
Columbia	O	O
and	O	O
Saedler	O	O
blood	O	O
agars	O	O
.	O	O

It	O	O
was	O	O
shown	O	O
that	O	O
rate	O	O
of	O	O
isolation	O	O
of	O	O
peptostreptococci	B-bacteria	B-bacteria
from	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
was	O	O
90	O	O
%	O	O
lower	O	O
compared	O	O
with	O	O
controls	O	O
;	O	O
rate	O	O
of	O	O
isolation	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
and	O	O
stomatococci	B-bacteria	B-bacteria
was	O	O
30	O	O
%	O	O
lower	O	O
,	O	O
whereas	O	O
hemolytic	O	O
Porphyromonas	B-bacteria	B-bacteria
,	O	O
staphylococci	B-bacteria	B-bacteria
and	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
isolated	O	O
20	O	O
%	O	O
more	O	O
frequently	O	O
.	O	O

Concentration	O	O
of	O	O
peptostreptococci	B-bacteria	B-bacteria
and	O	O
streptococci	B-bacteria	B-bacteria
was	O	O
7.0	O	O
lg	O	O
CFU/ml	O	O
,	O	O
whereas	O	O
concentration	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
peptococci	B-bacteria	B-bacteria
and	O	O
staphylococci	B-bacteria	B-bacteria
was	O	O
6.0	O	O
lg	O	O
CFU/ml	O	O
,	O	O
Neisseria	B-bacteria	B-bacteria
--	O	O
5.0	O	O
lg	O	O
CFU/ml	O	O
,	O	O
stomatococci	B-bacteria	B-bacteria
,	O	O
bacilli	B-bacteria	B-bacteria
and	O	O
Candida	O	O
fungi	O	O
--	O	O
4.5	O	O
lg	O	O
CFU/ml	O	O
.	O	O

Decrease	O	O
of	O	O
concentration	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
to	O	O
4.0	O	O
lg	O	O
CFU/ml	O	O
was	O	O
noted	O	O
.	O	O

Compared	O	O
with	O	O
healthy	O	O
group	O	O
of	O	O
children	O	O
,	O	O
widened	O	O
spectrum	O	O
of	O	O
microorganisms	O	O
in	O	O
all	O	O
studied	O	O
biotopes	O	O
of	O	O
oral	O	O
cavity	O	O
was	O	O
observed	O	O
in	O	O
patients	O	O
with	O	O
chronic	O	O
gastroduodenitis	O	O
;	O	O
species	O	O
belonging	O	O
to	O	O
pathogenic	O	O
microflora	O	O
were	O	O
detected	O	O
in	O	O
patients	O	O
more	O	O
frequently	O	O
and	O	O
in	O	O
more	O	O
quantities	O	O
.	O	O

Microbial	O	O
spectrum	O	O
and	O	O
non-specific	O	O
as	O	O
well	O	O
as	O	O
specific	O	O
IgA1	O	O
protease	O	O
activity	O	O
of	O	O
isolated	O	O
microorganisms	O	O
were	O	O
investigated	O	O
in	O	O
gingival	O	O
liquid	O	O
of	O	O
patients	O	O
with	O	O
periodontitis	O	O
.	O	O

Microorganisms	O	O
from	O	O
the	O	O
gingival	O	O
liqud	O	O
of	O	O
these	O	O
patients	O	O
belonged	O	O
to	O	O
conditional-pathogenic	O	O
obligate	O	O
and	O	O
facultatively	O	O
anaerobic	O	O
bacteria	O	O
.	O	O

24	O	O
strains	O	O
of	O	O
microorganisms	O	O
have	O	O
been	O	O
identified	O	O
.	O	O

Nonspecific	O	O
proteolytic	O	O
activity	O	O
was	O	O
found	O	O
in	O	O
the	O	O
following	O	O
microorganisms	O	O
:	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Aerococcus	B-bacteria	B-bacteria
viridans	E-bacteria	I-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
longum	E-bacteria	I-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
subflave	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
parvulus	E-bacteria	I-bacteria
,	O	O
Eubacterium	B-bacteria	B-bacteria
alactolyticum	E-bacteria	I-bacteria
,	O	O
Lactobaccilus	B-bacteria	B-bacteria
catenoforme	E-bacteria	I-bacteria
,	O	O
Bacillus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

Specific	O	O
IgA1-protease	O	O
activity	O	O
and	O	O
lack	O	O
of	O	O
proteolytic	O	O
activity	O	O
towards	O	O
IgG	O	O
was	O	O
found	O	O
in	O	O
Streptococcus	B-bacteria	B-bacteria
acidominimus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
hansenii	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Leptotrychia	B-bacteria	B-bacteria
buccalis	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
haemolyticus	E-bacteria	I-bacteria
and	O	O
Neisseria	B-bacteria	B-bacteria
sicca	E-bacteria	I-bacteria
.	O	O

No	O	O
proteolytic	O	O
activity	O	O
was	O	O
found	O	O
in	O	O
cultivation	O	O
medium	O	O
of	O	O
Eubacterium	B-bacteria	B-bacteria
alactolyticum	E-bacteria	I-bacteria
(	O	O
1	O	O
strain	O	O
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
buccalis	E-bacteria	I-bacteria
,	O	O
Aerococcus	B-bacteria	B-bacteria
viridans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
.	O	O

Nucleic	O	O
acid	O	O
amplification	O	O
tests	O	O
are	O	O
sensitive	O	O
and	O	O
specific	O	O
for	O	O
identifying	O	O
Mycobacterium	B-bacteria	B-bacteria
tuberculosis	E-bacteria	I-bacteria
in	O	O
sputum	O	O
smear-positive	O	O
populations	O	O
,	O	O
but	O	O
they	O	O
are	O	O
less	O	O
sensitive	O	O
in	O	O
sputum	O	O
smear-negative	O	O
populations	O	O
.	O	O

Few	O	O
studies	O	O
have	O	O
assessed	O	O
their	O	O
performance	O	O
among	O	O
patients	O	O
infected	O	O
with	O	O
HIV	O	O
,	O	O
and	O	O
no	O	O
studies	O	O
have	O	O
assessed	O	O
their	O	O
performance	O	O
with	O	O
oral	O	O
wash	O	O
specimens	O	O
,	O	O
which	O	O
may	O	O
be	O	O
easier	O	O
to	O	O
obtain	O	O
than	O	O
sputum	O	O
samples	O	O
.	O	O

We	O	O
performed	O	O
a	O	O
prospective	O	O
study	O	O
involving	O	O
127	O	O
adults	O	O
from	O	O
2	O	O
populations	O	O
who	O	O
were	O	O
undergoing	O	O
evaluation	O	O
for	O	O
respiratory	O	O
complaints	O	O
at	O	O
Mulago	O	O
Hospital	O	O
in	O	O
Kampala	O	O
,	O	O
Uganda	O	O
.	O	O

We	O	O
obtained	O	O
and	O	O
tested	O	O
sputum	O	O
samples	O	O
for	O	O
Mycobacterium	B-bacteria	B-bacteria
tuberculosis	E-bacteria	I-bacteria
,	O	O
and	O	O
we	O	O
simultaneously	O	O
obtained	O	O
oral	O	O
wash	O	O
specimens	O	O
to	O	O
test	O	O
for	O	O
M.	B-bacteria	B-bacteria
tuberculosis	E-bacteria	I-bacteria
DNA	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
amplification	O	O
of	O	O
a	O	O
novel	O	O
locus	O	O
,	O	O
the	O	O
secA1	O	O
gene	O	O
.	O	O

A	O	O
positive	O	O
mycobacterial	O	O
culture	O	O
of	O	O
sputum	O	O
was	O	O
used	O	O
to	O	O
define	O	O
cases	O	O
of	O	O
tuberculosis	O	O
;	O	O
we	O	O
calculated	O	O
the	O	O
sensitivity	O	O
and	O	O
specificity	O	O
of	O	O
the	O	O
PCR	O	O
assay	O	O
with	O	O
sputum	O	O
or	O	O
oral	O	O
wash	O	O
specimens	O	O
in	O	O
reference	O	O
to	O	O
the	O	O
standard	O	O
of	O	O
sputum	O	O
culture	O	O
results	O	O
.	O	O

Tuberculosis	O	O
(	O	O
75	O	O
[	O	O
59	O	O
%	O	O
]	O	O
of	O	O
127	O	O
patients	O	O
)	O	O
and	O	O
HIV	O	O
infection	O	O
(	O	O
58	O	O
[	O	O
46	O	O
%	O	O
]	O	O
of	O	O
126	O	O
patients	O	O
)	O	O
were	O	O
both	O	O
common	O	O
in	O	O
the	O	O
study	O	O
population	O	O
.	O	O

PCR	O	O
of	O	O
sputum	O	O
samples	O	O
was	O	O
highly	O	O
sensitive	O	O
(	O	O
sensitivity	O	O
,	O	O
99	O	O
%	O	O
;	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
,	O	O
93	O	O
%	O	O
-100	O	O
%	O	O
)	O	O
and	O	O
specific	O	O
(	O	O
specificity	O	O
,	O	O
88	O	O
%	O	O
;	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
,	O	O
77	O	O
%	O	O
-96	O	O
%	O	O
)	O	O
for	O	O
detection	O	O
of	O	O
pulmonary	O	O
tuberculosis	O	O
and	O	O
performed	O	O
well	O	O
among	O	O
HIV-infected	O	O
patients	O	O
and	O	O
among	O	O
patients	O	O
with	O	O
negative	O	O
sputum	O	O
smear	O	O
results	O	O
.	O	O

PCR	O	O
of	O	O
oral	O	O
wash	O	O
specimens	O	O
was	O	O
less	O	O
sensitive	O	O
(	O	O
sensitivity	O	O
,	O	O
73	O	O
%	O	O
;	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
,	O	O
62	O	O
%	O	O
-83	O	O
%	O	O
)	O	O
but	O	O
also	O	O
detected	O	O
a	O	O
substantial	O	O
proportion	O	O
of	O	O
tuberculosis	O	O
cases	O	O
.	O	O

PCR	O	O
targeting	O	O
the	O	O
secA1	O	O
gene	O	O
was	O	O
highly	O	O
sensitive	O	O
and	O	O
specific	O	O
for	O	O
identifying	O	O
M.	B-bacteria	B-bacteria
tuberculosis	E-bacteria	I-bacteria
in	O	O
sputum	O	O
samples	O	O
,	O	O
independent	O	O
of	O	O
smear	O	O
or	O	O
HIV	O	O
infection	O	O
status	O	O
.	O	O

Oral	O	O
washes	O	O
showed	O	O
promise	O	O
as	O	O
an	O	O
easily	O	O
obtained	O	O
respiratory	O	O
specimen	O	O
for	O	O
tuberculosis	O	O
diagnosis	O	O
.	O	O

PCR	O	O
of	O	O
sputum	O	O
for	O	O
detection	O	O
of	O	O
the	O	O
secA1	O	O
gene	O	O
could	O	O
be	O	O
a	O	O
rapid	O	O
,	O	O
effective	O	O
diagnostic	O	O
tool	O	O
for	O	O
tuberculosis	O	O
referral	O	O
centers	O	O
.	O	O

Knowledge	O	O
of	O	O
the	O	O
colonization	O	O
patterns	O	O
and	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
can	O	O
lead	O	O
to	O	O
a	O	O
better	O	O
understanding	O	O
of	O	O
disease	O	O
initiation	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
distribution	O	O
of	O	O
selected	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
samples	O	O
from	O	O
five	O	O
different	O	O
oral	O	O
habitats	O	O
in	O	O
young	O	O
Greek	O	O
children	O	O
.	O	O

Ninety-three	O	O
children	O	O
3-12	O	O
years	O	O
old	O	O
(	O	O
mean	O	O
+	O	O
SD	O	O
7.9	O	O
+/-	O	O
2.5	O	O
)	O	O
(	O	O
60.2	O	O
%	O	O
male	O	O
,	O	O
39.8	O	O
%	O	O
female	O	O
)	O	O
participated	O	O
and	O	O
split	O	O
into	O	O
three	O	O
different	O	O
age	O	O
groups	O	O
:	O	O
primary	O	O
(	O	O
3-6	O	O
years	O	O
)	O	O
,	O	O
early	O	O
mixed	O	O
(	O	O
6-9	O	O
years	O	O
)	O	O
,	O	O
and	O	O
mixed	O	O
dentition	O	O
(	O	O
9-12	O	O
years	O	O
)	O	O
.	O	O

Samples	O	O
for	O	O
bacterial	O	O
enumeration	O	O
were	O	O
taken	O	O
from	O	O
saliva	O	O
,	O	O
supragingival	O	O
and	O	O
subgingival	O	O
plaque	O	O
,	O	O
tongue	O	O
dorsum	O	O
,	O	O
and	O	O
soft	O	O
tissues	O	O
from	O	O
each	O	O
child	O	O
,	O	O
and	O	O
were	O	O
further	O	O
analysed	O	O
using	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

Mean	O	O
counts	O	O
and	O	O
proportions	O	O
of	O	O
all	O	O
the	O	O
test	O	O
bacteria	O	O
differed	O	O
significantly	O	O
among	O	O
sample	O	O
locations	O	O
.	O	O

Cariogenic	O	O
bacteria	O	O
were	O	O
present	O	O
in	O	O
almost	O	O
all	O	O
healthy	O	O
children	O	O
.	O	O

Mean	O	O
proportions	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
isolated	O	O
from	O	O
soft	O	O
tissue	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
from	O	O
soft	O	O
tissue	O	O
,	O	O
subgingival	O	O
and	O	O
saliva	O	O
samples	O	O
increased	O	O
significantly	O	O
with	O	O
age	O	O
,	O	O
whereas	O	O
the	O	O
opposite	O	O
was	O	O
seen	O	O
for	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
.	O	O

Cariogenic	O	O
bacteria	O	O
were	O	O
present	O	O
in	O	O
almost	O	O
all	O	O
young	O	O
children	O	O
.	O	O

Soft	O	O
tissues	O	O
,	O	O
saliva	O	O
,	O	O
and	O	O
tongue	O	O
were	O	O
more	O	O
often	O	O
colonized	O	O
by	O	O
cariogenic	B-bacteria	B-bacteria
streptococcal	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
than	O	O
teeth	O	O
.	O	O

These	O	O
surfaces	O	O
may	O	O
serve	O	O
as	O	O
reservoirs	O	O
for	O	O
oral	O	O
pathogens	O	O
,	O	O
requiring	O	O
attention	O	O
during	O	O
preventive	O	O
interventions	O	O
.	O	O

As	O	O
modern	O	O
humans	O	O
(	O	O
Homo	O	O
sapiens	O	O
)	O	O
migrated	O	O
out	O	O
of	O	O
Africa	O	O
to	O	O
different	O	O
parts	O	O
of	O	O
the	O	O
world	O	O
,	O	O
their	O	O
obligate	O	O
indigenous	O	O
bacterial	O	O
biota	O	O
accompanied	O	O
them	O	O
.	O	O

As	O	O
both	O	O
evolved	O	O
,	O	O
the	O	O
accumulations	O	O
of	O	O
mutations	O	O
in	O	O
their	O	O
DNA	O	O
can	O	O
reveal	O	O
their	O	O
phylogenies	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
describe	O	O
the	O	O
evolutionary	O	O
history	O	O
of	O	O
an	O	O
indigenous	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Using	O	O
several	O	O
genetic	O	O
markers	O	O
,	O	O
four	O	O
distinct	O	O
clusters	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
genetic	O	O
traits	O	O
coincide	O	O
with	O	O
individuals	O	O
of	O	O
distinct	O	O
geographic	O	O
or	O	O
racial	O	O
groups	O	O
comprised	O	O
of	O	O
two	O	O
African	O	O
clades	O	O
and	O	O
an	O	O
Asian	O	O
and	O	O
a	O	O
Caucasian	O	O
clade	O	O
.	O	O

The	O	O
evolutionary	O	O
lineage	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
is	O	O
in	O	O
agreement	O	O
with	O	O
anthropological	O	O
artifacts	O	O
marking	O	O
the	O	O
trail	O	O
of	O	O
human	O	O
migrations	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
presence	O	O
of	O	O
Arcobacter	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

in	O	O
different	O	O
biological	O	O
samples	O	O
from	O	O
domestic	O	O
cats	O	O
in	O	O
Southern	O	O
Italy	O	O
by	O	O
using	O	O
a	O	O
species-specific	O	O
PCR	O	O
assay	O	O
and	O	O
thus	O	O
to	O	O
elucidate	O	O
their	O	O
potential	O	O
significance	O	O
as	O	O
sources	O	O
of	O	O
human	O	O
infection	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
prevalence	O	O
of	O	O
Arcobacter	B-bacteria	B-bacteria
DNA	O	O
in	O	O
oral	O	O
swabs	O	O
,	O	O
in	O	O
peripheral	O	O
blood	O	O
samples	O	O
and	O	O
fine	O	O
needle	O	O
lymph	O	O
node	O	O
aspirate	O	O
specimens	O	O
from	O	O
85	O	O
cats	O	O
of	O	O
which	O	O
17	O	O
were	O	O
clinically	O	O
healthy	O	O
and	O	O
68	O	O
had	O	O
clinical	O	O
signs	O	O
of	O	O
oral	O	O
disease	O	O
or	O	O
lymphadenomegaly	O	O
.	O	O

Overall	O	O
,	O	O
molecular	O	O
analysis	O	O
has	O	O
shown	O	O
that	O	O
Arcobacter-specific	O	O
DNA	O	O
was	O	O
found	O	O
in	O	O
78.8	O	O
%	O	O
(	O	O
67	O	O
of	O	O
85	O	O
)	O	O
of	O	O
all	O	O
the	O	O
cats	O	O
.	O	O

In	O	O
the	O	O
67	O	O
Arcobacter-positive	O	O
cats	O	O
,	O	O
66	O	O
(	O	O
77.6	O	O
%	O	O
)	O	O
and	O	O
29	O	O
(	O	O
34.1	O	O
%	O	O
)	O	O
were	O	O
found	O	O
positive	O	O
for	O	O
Arcobacter	B-bacteria	B-bacteria
butzleri	E-bacteria	I-bacteria
and	O	O
Arcobacter	B-bacteria	B-bacteria
cryaerophilus	E-bacteria	I-bacteria
,	O	O
respectively	O	O
.	O	O

None	O	O
of	O	O
the	O	O
examined	O	O
samples	O	O
gave	O	O
a	O	O
PCR	O	O
product	O	O
for	O	O
Arcobacter	B-bacteria	B-bacteria
skirrowii	E-bacteria	I-bacteria
.	O	O

This	O	O
study	O	O
demonstrates	O	O
that	O	O
pet	O	O
cats	O	O
commonly	O	O
carry	O	O
Arcobacter	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

According	O	O
to	O	O
the	O	O
clinical	O	O
data	O	O
,	O	O
the	O	O
Arcobacter	B-bacteria	B-bacteria
detection	O	O
results	O	O
showed	O	O
no	O	O
significant	O	O
difference	O	O
between	O	O
cats	O	O
with	O	O
oral	O	O
pathology	O	O
and	O	O
those	O	O
suffering	O	O
from	O	O
other	O	O
different	O	O
pathologies	O	O
.	O	O

Pet	O	O
cats	O	O
harbour	O	O
Arcobacter	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
their	O	O
dissemination	O	O
in	O	O
the	O	O
domestic	O	O
habitat	O	O
.	O	O

The	O	O
high	O	O
prevalence	O	O
in	O	O
a	O	O
limited	O	O
number	O	O
of	O	O
cat	O	O
samples	O	O
in	O	O
this	O	O
study	O	O
may	O	O
be	O	O
of	O	O
significance	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
test	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
one-stage	O	O
full-mouth	O	O
disinfection	O	O
(	O	O
FMD	O	O
)	O	O
provides	O	O
greater	O	O
clinical	O	O
and	O	O
microbiological	O	O
improvement	O	O
compared	O	O
with	O	O
full-mouth	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
(	O	O
FM-SRP	O	O
)	O	O
within	O	O
24	O	O
h	O	O
and	O	O
quadrant	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
(	O	O
Q-SRP	O	O
)	O	O
in	O	O
patients	O	O
with	O	O
generalized	O	O
chronic	O	O
periodontitis	O	O
.	O	O

Twenty-eight	O	O
patients	O	O
were	O	O
randomized	O	O
into	O	O
three	O	O
groups	O	O
.	O	O

25	O	O
patients	O	O
completed	O	O
the	O	O
study	O	O
and	O	O
were	O	O
the	O	O
basis	O	O
for	O	O
analysis	O	O
.	O	O

The	O	O
Q-SRP	O	O
group	O	O
was	O	O
scaled	O	O
quadrant-wise	O	O
at	O	O
1-week	O	O
intervals	O	O
.	O	O

The	O	O
other	O	O
groups	O	O
received	O	O
a	O	O
one-stage	O	O
full-mouth	O	O
scaling	O	O
with	O	O
(	O	O
FMD	O	O
)	O	O
and	O	O
without	O	O
(	O	O
FM-SRP	O	O
)	O	O
chlorhexidine	O	O
.	O	O

At	O	O
baseline	O	O
,	O	O
after	O	O
1	O	O
,	O	O
2	O	O
,	O	O
4	O	O
and	O	O
8	O	O
months	O	O
clinical	O	O
parameters	O	O
were	O	O
recorded	O	O
and	O	O
microbiological	O	O
analysis	O	O
was	O	O
performed	O	O
.	O	O

All	O	O
three	O	O
treatment	O	O
modalities	O	O
resulted	O	O
in	O	O
significant	O	O
clinical	O	O
improvement	O	O
at	O	O
any	O	O
time	O	O
.	O	O

There	O	O
were	O	O
only	O	O
group	O	O
differences	O	O
after	O	O
1	O	O
and	O	O
2	O	O
months	O	O
:	O	O
in	O	O
the	O	O
FM-SRP	O	O
group	O	O
was	O	O
a	O	O
significantly	O	O
higher	O	O
reduction	O	O
of	O	O
probing	O	O
depth	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
compared	O	O
with	O	O
the	O	O
other	O	O
two	O	O
groups	O	O
.	O	O

The	O	O
bacteria	O	O
could	O	O
be	O	O
reduced	O	O
in	O	O
every	O	O
group	O	O
although	O	O
this	O	O
reduction	O	O
was	O	O
only	O	O
significant	O	O
for	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
in	O	O
the	O	O
FMD	O	O
group	O	O
8	O	O
months	O	O
after	O	O
treatment	O	O
.	O	O

All	O	O
three	O	O
treatment	O	O
modalities	O	O
lead	O	O
to	O	O
an	O	O
improvement	O	O
of	O	O
the	O	O
clinical	O	O
and	O	O
microbiological	O	O
parameters	O	O
,	O	O
however	O	O
,	O	O
without	O	O
significant	O	O
group	O	O
differences	O	O
after	O	O
8	O	O
months	O	O
.	O	O

Alkali	O	O
generation	O	O
by	O	O
oral	O	O
bacteria	O	O
plays	O	O
a	O	O
key	O	O
role	O	O
in	O	O
plaque	O	O
pH	O	O
homeostasis	O	O
and	O	O
may	O	O
be	O	O
a	O	O
major	O	O
impediment	O	O
to	O	O
the	O	O
development	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

To	O	O
determine	O	O
if	O	O
the	O	O
capacity	O	O
of	O	O
oral	O	O
samples	O	O
to	O	O
produce	O	O
ammonia	O	O
from	O	O
arginine	O	O
or	O	O
urea	O	O
was	O	O
related	O	O
to	O	O
caries	O	O
experience	O	O
,	O	O
the	O	O
arginine	O	O
deiminase	O	O
system	O	O
(	O	O
ADS	O	O
)	O	O
and	O	O
urease	O	O
activity	O	O
in	O	O
saliva	O	O
and	O	O
dental	O	O
plaque	O	O
samples	O	O
were	O	O
measured	O	O
in	O	O
45	O	O
adult	O	O
subjects	O	O
.	O	O

The	O	O
subjects	O	O
were	O	O
divided	O	O
into	O	O
three	O	O
groups	O	O
according	O	O
to	O	O
caries	O	O
status	O	O
;	O	O
13	O	O
caries-free	O	O
(	O	O
CF	O	O
)	O	O
individuals	O	O
(	O	O
decayed	O	O
,	O	O
missing	O	O
,	O	O
and	O	O
filled	O	O
teeth	O	O
=	O	O
0	O	O
)	O	O
;	O	O
21	O	O
caries-active	O	O
(	O	O
CA	O	O
)	O	O
individuals	O	O
(	O	O
decayed	O	O
teeth	O	O
>	O	O
or=	O	O
4	O	O
)	O	O
;	O	O
and	O	O
11	O	O
caries-experienced	O	O
(	O	O
CE	O	O
)	O	O
individuals	O	O
(	O	O
decayed	O	O
teeth	O	O
=	O	O
0	O	O
;	O	O
missing	O	O
and	O	O
filled	O	O
teeth	O	O
>	O	O
0	O	O
)	O	O
.	O	O

Real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
was	O	O
used	O	O
to	O	O
quantify	O	O
the	O	O
proportion	O	O
of	O	O
certain	O	O
acid-	O	O
or	O	O
alkali-producing	O	O
organisms	O	O
in	O	O
the	O	O
samples	O	O
.	O	O

The	O	O
amount	O	O
of	O	O
ammonia	O	O
generated	O	O
from	O	O
the	O	O
test	O	O
substrates	O	O
by	O	O
plaque	O	O
samples	O	O
was	O	O
generally	O	O
higher	O	O
than	O	O
that	O	O
produced	O	O
by	O	O
salivary	O	O
samples	O	O
in	O	O
all	O	O
groups	O	O
.	O	O

Significantly	O	O
higher	O	O
levels	O	O
of	O	O
salivary	O	O
ADS	O	O
activity	O	O
and	O	O
plaque	O	O
urease	O	O
activity	O	O
were	O	O
observed	O	O
in	O	O
CF	O	O
subjects	O	O
compared	O	O
to	O	O
CA	O	O
subjects	O	O
(	O	O
P	O	O
=	O	O
0.0004	O	O
and	O	O
P	O	O
=	O	O
0.014	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

The	O	O
proportions	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
from	O	O
saliva	O	O
and	O	O
dental	O	O
plaque	O	O
of	O	O
CA	O	O
subjects	O	O
were	O	O
significantly	O	O
higher	O	O
than	O	O
those	O	O
from	O	O
the	O	O
CF	O	O
group	O	O
(	O	O
P	O	O
=	O	O
0.0153	O	O
and	O	O
P	O	O
=	O	O
0.0009	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

In	O	O
the	O	O
CA	O	O
group	O	O
,	O	O
there	O	O
was	O	O
an	O	O
inverse	O	O
relationship	O	O
between	O	O
urease	O	O
activity	O	O
and	O	O
the	O	O
levels	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.0001	O	O
)	O	O
.	O	O

This	O	O
study	O	O
supports	O	O
the	O	O
theory	O	O
that	O	O
increased	O	O
caries	O	O
risk	O	O
is	O	O
associated	O	O
with	O	O
reduced	O	O
alkali-generating	O	O
capacity	O	O
of	O	O
the	O	O
bacteria	O	O
colonizing	O	O
the	O	O
oral	O	O
cavity	O	O
;	O	O
providing	O	O
compelling	O	O
evidence	O	O
to	O	O
further	O	O
our	O	O
understanding	O	O
of	O	O
oral	O	O
alkali-generation	O	O
in	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
harbors	O	O
a	O	O
diverse	O	O
and	O	O
complex	O	O
microbial	O	O
community	O	O
.	O	O

Bacteria	O	O
accumulate	O	O
on	O	O
both	O	O
the	O	O
hard	O	O
and	O	O
soft	O	O
oral	O	O
tissues	O	O
in	O	O
sessile	O	O
biofilms	O	O
and	O	O
engage	O	O
the	O	O
host	O	O
in	O	O
an	O	O
intricate	O	O
cellular	O	O
dialog	O	O
,	O	O
which	O	O
normally	O	O
constrains	O	O
the	O	O
bacteria	O	O
to	O	O
a	O	O
state	O	O
of	O	O
commensal	O	O
harmony	O	O
.	O	O

Dendritic	O	O
cells	O	O
(	O	O
DCs	O	O
)	O	O
are	O	O
likely	O	O
to	O	O
balance	O	O
tolerance	O	O
and	O	O
active	O	O
immunity	O	O
to	O	O
commensal	O	O
microorganisms	O	O
as	O	O
part	O	O
of	O	O
chronic	O	O
inflammatory	O	O
responses	O	O
.	O	O

While	O	O
the	O	O
role	O	O
played	O	O
by	O	O
DCs	O	O
in	O	O
maintaining	O	O
intestinal	O	O
homeostasis	O	O
has	O	O
been	O	O
investigated	O	O
extensively	O	O
,	O	O
relatively	O	O
little	O	O
is	O	O
known	O	O
about	O	O
DC	O	O
responses	O	O
to	O	O
oral	O	O
bacteria	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
pulsed	O	O
human	O	O
monocyte-derived	O	O
immature	O	O
DCs	O	O
(	O	O
iDCs	O	O
)	O	O
with	O	O
cell	O	O
wall	O	O
extracts	O	O
from	O	O
pathogenic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
commensal	I-bacteria	I-bacteria
gram-positive	I-bacteria	I-bacteria
or	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Although	O	O
all	O	O
bacterial	O	O
extracts	O	O
tested	O	O
induced	O	O
iDCs	O	O
to	O	O
mature	O	O
and	O	O
produce	O	O
cytokines/chemokines	O	O
including	O	O
interleukin-12p40	O	O
,	O	O
tumor	O	O
necrosis	O	O
factor-alpha	O	O
,	O	O
and	O	O
monocyte	O	O
chemoattractant	O	O
protein-1	O	O
(	O	O
MCP-1	O	O
)	O	O
,	O	O
the	O	O
most	O	O
important	O	O
factor	O	O
for	O	O
programming	O	O
DCs	O	O
by	O	O
oral	O	O
bacteria	O	O
was	O	O
whether	O	O
they	O	O
were	O	O
gram-positive	O	O
or	O	O
gram-negative	O	O
,	O	O
not	O	O
whether	O	O
they	O	O
were	O	O
commensal	O	O
or	O	O
pathogenic	O	O
.	O	O

In	O	O
general	O	O
,	O	O
gram-negative	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
except	O	O
for	O	O
periodontopathic	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
stimulated	O	O
DC	O	O
maturation	O	O
and	O	O
cytokine	O	O
production	O	O
at	O	O
lower	O	O
concentrations	O	O
than	O	O
gram-positive	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

The	O	O
threshold	O	O
of	O	O
bacteria	O	O
needed	O	O
to	O	O
stimulate	O	O
chemokine	O	O
production	O	O
was	O	O
100-fold	O	O
to	O	O
1000-fold	O	O
lower	O	O
than	O	O
that	O	O
needed	O	O
to	O	O
induce	O	O
cytokines	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
very	O	O
low	O	O
doses	O	O
of	O	O
oral	O	O
commensal	O	O
bacteria	O	O
triggered	O	O
monocytes	O	O
to	O	O
migrate	O	O
toward	O	O
DC-derived	O	O
MCP-1	O	O
.	O	O

Oral	O	O
commensal	O	O
and	O	O
pathogenic	O	O
bacteria	O	O
do	O	O
not	O	O
differ	O	O
qualitatively	O	O
in	O	O
how	O	O
they	O	O
program	O	O
DCs	O	O
.	O	O

DC-derived	O	O
MCP-1	O	O
induced	O	O
in	O	O
response	O	O
to	O	O
oral	O	O
commensal	O	O
bacteria	O	O
may	O	O
play	O	O
a	O	O
role	O	O
,	O	O
at	O	O
least	O	O
in	O	O
part	O	O
,	O	O
in	O	O
the	O	O
maintenance	O	O
of	O	O
oral	O	O
tissue	O	O
integrity	O	O
by	O	O
attracting	O	O
monocytes	O	O
.	O	O

Ceragenin	O	O
CSA-13	O	O
is	O	O
a	O	O
bile-acid-based	O	O
mimic	O	O
of	O	O
endogenous	O	O
antimicrobial	O	O
peptides	O	O
and	O	O
shares	O	O
a	O	O
mechanism	O	O
of	O	O
action	O	O
with	O	O
many	O	O
of	O	O
these	O	O
antimicrobial	O	O
agents	O	O
.	O	O

Because	O	O
CSA-13	O	O
is	O	O
not	O	O
peptide	O	O
based	O	O
,	O	O
it	O	O
is	O	O
not	O	O
a	O	O
substrate	O	O
for	O	O
the	O	O
proteases	O	O
that	O	O
are	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
which	O	O
are	O	O
capable	O	O
of	O	O
degrading	O	O
antimicrobial	O	O
peptides	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
simplicity	O	O
of	O	O
the	O	O
ceragenins	O	O
makes	O	O
them	O	O
easier	O	O
to	O	O
prepare	O	O
and	O	O
purify	O	O
than	O	O
antimicrobial	O	O
peptides	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
antimicrobial	O	O
activities	O	O
of	O	O
CSA-13	O	O
against	O	O
oral	O	O
pathogens	O	O
and	O	O
found	O	O
that	O	O
this	O	O
compound	O	O
was	O	O
bactericidal	O	O
against	O	O
all	O	O
of	O	O
the	O	O
strains	O	O
tested	O	O
.	O	O

The	O	O
strains	O	O
used	O	O
were	O	O
isolates	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Minimum	O	O
inhibitory	O	O
concentrations	O	O
(	O	O
MIC	O	O
)	O	O
were	O	O
determined	O	O
using	O	O
agar	O	O
dilution	O	O
methods	O	O
.	O	O

In	O	O
susceptibility	O	O
testing	O	O
,	O	O
viable	O	O
counts	O	O
were	O	O
determined	O	O
after	O	O
incubation	O	O
with	O	O
CSA-13	O	O
.	O	O

CSA-13	O	O
was	O	O
potent	O	O
against	O	O
all	O	O
23	O	O
strains	O	O
tested	O	O
with	O	O
MICs	O	O
of	O	O
1-8	O	O
microg/ml	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
1-16	O	O
microg/ml	O	O
for	O	O
24	O	O
strains	O	O
of	O	O
the	O	O
genus	O	O
Porphyromonas	B-bacteria	B-bacteria
.	O	O

The	O	O
MIC	O	O
(	O	O
50	O	O
)	O	O
was	O	O
2	O	O
and	O	O
the	O	O
MIC	O	O
(	O	O
90	O	O
)	O	O
was	O	O
8	O	O
mug/ml	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

MIC	O	O
ranges	O	O
for	O	O
protease-positive	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
cangingivalis	E-bacteria	I-bacteria
were	O	O
2-16	O	O
microg/ml	O	O
,	O	O
and	O	O
1-2	O	O
microg/ml	O	O
for	O	O
protease-negative	O	O
P.	B-bacteria	B-bacteria
circumdentaria	E-bacteria	I-bacteria
.	O	O

CSA-13	O	O
interacted	O	O
with	O	O
lipopolysaccharide-sensitized	O	O
erythrocytes	O	O
at	O	O
a	O	O
concentration	O	O
of	O	O
5.0-20.0	O	O
microg/ml	O	O
.	O	O

CSA-13	O	O
displays	O	O
broad-spectrum	O	O
activity	O	O
against	O	O
cariogenic	O	O
and	O	O
periodontopathic	O	O
bacteria	O	O
.	O	O

CSA-13	O	O
was	O	O
effective	O	O
against	O	O
protease-positive	O	O
Porphyromonas	O	O
.	O	O

It	O	O
was	O	O
shown	O	O
to	O	O
bind	O	O
to	O	O
erythrocytes	O	O
coated	O	O
with	O	O
lipopolysaccharide	O	O
and	O	O
lipoteichoic	O	O
acid	O	O
from	O	O
diverse	O	O
bacterial	O	O
strains	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
CSA-13	O	O
may	O	O
be	O	O
useful	O	O
for	O	O
the	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
oral	O	O
microbial	O	O
diseases	O	O
.	O	O

Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
is	O	O
an	O	O
important	O	O
early	O	O
colonizer	O	O
in	O	O
the	O	O
oral	O	O
biofilm	O	O
and	O	O
consists	O	O
of	O	O
three	O	O
genospecies	O	O
(	O	O
1	O	O
,	O	O
2	O	O
and	O	O
WVA	O	O
963	O	O
)	O	O
which	O	O
can	O	O
not	O	O
be	O	O
readily	O	O
differentiated	O	O
using	O	O
conventional	O	O
phenotypic	O	O
testing	O	O
or	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
.	O	O

We	O	O
have	O	O
investigated	O	O
a	O	O
representative	O	O
collection	O	O
of	O	O
type	O	O
and	O	O
reference	O	O
strains	O	O
and	O	O
clinical	O	O
and	O	O
oral	O	O
isolates	O	O
(	O	O
n=115	O	O
)	O	O
and	O	O
determined	O	O
the	O	O
partial	O	O
gene	O	O
sequences	O	O
of	O	O
six	O	O
housekeeping	O	O
genes	O	O
(	O	O
atpA	O	O
,	O	O
rpoB	O	O
,	O	O
pgi	O	O
,	O	O
metG	O	O
,	O	O
gltA	O	O
and	O	O
gyrA	O	O
)	O	O
.	O	O

These	O	O
sequences	O	O
identified	O	O
the	O	O
three	O	O
genospecies	O	O
and	O	O
differentiated	O	O
them	O	O
from	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
isolated	O	O
from	O	O
rodents	O	O
.	O	O

The	O	O
partial	O	O
sequences	O	O
of	O	O
atpA	O	O
and	O	O
metG	O	O
gave	O	O
best	O	O
separation	O	O
of	O	O
the	O	O
three	O	O
genospecies	O	O
.	O	O

A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
genospecies	O	O
1	O	O
and	O	O
2	O	O
formed	O	O
two	O	O
distinct	O	O
clusters	O	O
,	O	O
well	O	O
separated	O	O
from	O	O
both	O	O
genospecies	O	O
WVA	O	O
963	O	O
and	O	O
A.	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
.	O	O

Analysis	O	O
of	O	O
the	O	O
same	O	O
genes	O	O
in	O	O
other	O	O
oral	O	O
Actinomyces	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
Actinomyces	B-bacteria	B-bacteria
gerencseriae	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
meyeri	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
georgiae	E-bacteria	I-bacteria
)	O	O
indicated	O	O
that	O	O
,	O	O
when	O	O
sequence	O	O
data	O	O
were	O	O
obtained	O	O
,	O	O
these	O	O
species	O	O
each	O	O
exhibited	O	O
<	O	O
90	O	O
%	O	O
similarity	O	O
with	O	O
the	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
genospecies	O	O
.	O	O

Based	O	O
on	O	O
these	O	O
data	O	O
,	O	O
we	O	O
propose	O	O
the	O	O
name	O	O
Actinomyces	B-bacteria	B-bacteria
oris	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
(	O	O
type	B-bacteria	B-bacteria
strain	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
27044	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
34288	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
for	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
genospecies	O	O
2	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
johnsonii	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
(	O	O
type	B-bacteria	B-bacteria
strain	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
49338	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
34287	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
for	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
genospecies	O	O
WVA	O	O
963	O	O
.	O	O

A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
genospecies	O	O
1	O	O
should	O	O
remain	O	O
as	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
sensu	O	O
stricto	O	O
,	O	O
with	O	O
the	O	O
type	B-bacteria	B-bacteria
strain	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
12104	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=NCTC	B-bacteria	B-bacteria
10301	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
2238	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
.	O	O

The	O	O
gut	O	O
associated	O	O
lymphoid	O	O
tissue	O	O
(	O	O
GALT	O	O
)	O	O
is	O	O
anatomical	O	O
and	O	O
functionally	O	O
divided	O	O
in	O	O
inductive	O	O
and	O	O
effectors	O	O
sites	O	O
.	O	O

In	O	O
previous	O	O
works	O	O
we	O	O
demonstrated	O	O
that	O	O
non-pathogenic	O	O
bacteria	O	O
with	O	O
probiotic	O	O
characteristics	O	O
can	O	O
improve	O	O
the	O	O
gut	O	O
mucosal	O	O
immune	O	O
system	O	O
,	O	O
with	O	O
an	O	O
increase	O	O
in	O	O
the	O	O
number	O	O
of	O	O
IgA	O	O
and	O	O
cytokines	O	O
producing	O	O
cells	O	O
in	O	O
the	O	O
effector	O	O
site	O	O
of	O	O
the	O	O
intestine	O	O
.	O	O

In	O	O
the	O	O
present	O	O
work	O	O
we	O	O
studied	O	O
the	O	O
effect	O	O
of	O	O
non-pathogenic	B-bacteria	B-bacteria
Gram	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
+	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
Gram	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
-	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
a	O	O
Gram	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
+	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
probiotic	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
on	O	O
the	O	O
inductor	O	O
site	O	O
(	O	O
PP	O	O
)	O	O
after	O	O
the	O	O
oral	O	O
administration	O	O
to	O	O
BALB/c	O	O
mice	O	O
.	O	O

We	O	O
also	O	O
studied	O	O
some	O	O
signals	O	O
induced	O	O
by	O	O
the	O	O
assayed	O	O
strain	O	O
in	O	O
the	O	O
effectors	O	O
site	O	O
,	O	O
such	O	O
as	O	O
the	O	O
enzyme	O	O
calcineurin	O	O
and	O	O
TLR-9	O	O
as	O	O
a	O	O
way	O	O
to	O	O
understand	O	O
the	O	O
mechanisms	O	O
induced	O	O
in	O	O
such	O	O
bacterial	O	O
stimulation	O	O
.	O	O

The	O	O
implicance	O	O
of	O	O
the	O	O
lipoteichoic	O	O
acid	O	O
(	O	O
LTA	O	O
)	O	O
in	O	O
the	O	O
immunostimulation	O	O
was	O	O
analyzed	O	O
.	O	O

All	O	O
strains	O	O
increased	O	O
the	O	O
number	O	O
of	O	O
IFN-gamma	O	O
and	O	O
TNF-alpha	O	O
(	O	O
+	O	O
)	O	O
cells	O	O
,	O	O
but	O	O
not	O	O
of	O	O
IL-10	O	O
(	O	O
+	O	O
)	O	O
cells	O	O
in	O	O
the	O	O
total	O	O
population	O	O
of	O	O
PP	O	O
.	O	O

The	O	O
release	O	O
of	O	O
IFN-gamma	O	O
and	O	O
TNF-alpha	O	O
was	O	O
only	O	O
induced	O	O
by	O	O
LPS	O	O
stimulation	O	O
.	O	O

All	O	O
assayed	O	O
strains	O	O
increased	O	O
the	O	O
number	O	O
of	O	O
calcineurin	O	O
(	O	O
+	O	O
)	O	O
cells	O	O
,	O	O
while	O	O
only	O	O
Gram	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
+	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
increased	O	O
the	O	O
number	O	O
of	O	O
TLR-9	O	O
(	O	O
+	O	O
)	O	O
cells	O	O
.	O	O

The	O	O
immunostimulatory	O	O
properties	O	O
of	O	O
the	O	O
purified	O	O
LTA	O	O
from	O	O
Gram	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
+	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
was	O	O
evaluated	O	O
on	O	O
a	O	O
monocyte-macrophage	O	O
U937	O	O
cell	O	O
line	O	O
.	O	O

These	O	O
cells	O	O
showed	O	O
capacity	O	O
to	O	O
release	O	O
TNF-alpha	O	O
and	O	O
IL-10	O	O
in	O	O
response	O	O
to	O	O
all	O	O
LTA	O	O
assayed	O	O
in	O	O
a	O	O
dose-dependent	O	O
way	O	O
.	O	O

Gram	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
+	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
induced	O	O
signals	O	O
through	O	O
the	O	O
calcineurin	O	O
enzyme	O	O
able	O	O
to	O	O
activate	O	O
the	O	O
transcriptional	O	O
factor	O	O
NFAT	O	O
and	O	O
through	O	O
TLR-9	O	O
.	O	O

The	O	O
LTA	O	O
molecule	O	O
from	O	O
Gram	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
+	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
would	O	O
not	O	O
be	O	O
the	O	O
only	O	O
structure	O	O
involved	O	O
in	O	O
the	O	O
immunostimulatory	O	O
properties	O	O
observed	O	O
,	O	O
specially	O	O
for	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
strain	E-bacteria	I-bacteria
.	O	O

Periodontitis	O	O
is	O	O
the	O	O
major	O	O
cause	O	O
of	O	O
tooth	O	O
loss	O	O
in	O	O
adults	O	O
and	O	O
is	O	O
linked	O	O
to	O	O
systemic	O	O
illnesses	O	O
,	O	O
such	O	O
as	O	O
cardiovascular	O	O
disease	O	O
and	O	O
stroke	O	O
.	O	O

The	O	O
development	O	O
of	O	O
rapid	O	O
point-of-care	O	O
(	O	O
POC	O	O
)	O	O
chairside	O	O
diagnostics	O	O
has	O	O
the	O	O
potential	O	O
for	O	O
the	O	O
early	O	O
detection	O	O
of	O	O
periodontal	O	O
infection	O	O
and	O	O
progression	O	O
to	O	O
identify	O	O
incipient	O	O
disease	O	O
and	O	O
reduce	O	O
health	O	O
care	O	O
costs	O	O
.	O	O

However	O	O
,	O	O
validation	O	O
of	O	O
effective	O	O
diagnostics	O	O
requires	O	O
the	O	O
identification	O	O
and	O	O
verification	O	O
of	O	O
biomarkers	O	O
correlated	O	O
with	O	O
disease	O	O
progression	O	O
.	O	O

This	O	O
clinical	O	O
study	O	O
sought	O	O
to	O	O
determine	O	O
the	O	O
ability	O	O
of	O	O
putative	O	O
host-	O	O
and	O	O
microbially	O	O
derived	O	O
biomarkers	O	O
to	O	O
identify	O	O
periodontal	O	O
disease	O	O
status	O	O
from	O	O
whole	O	O
saliva	O	O
and	O	O
plaque	O	O
biofilm	O	O
.	O	O

One	O	O
hundred	O	O
human	O	O
subjects	O	O
were	O	O
equally	O	O
recruited	O	O
into	O	O
a	O	O
healthy/gingivitis	O	O
group	O	O
or	O	O
a	O	O
periodontitis	O	O
population	O	O
.	O	O

Whole	O	O
saliva	O	O
was	O	O
collected	O	O
from	O	O
all	O	O
subjects	O	O
and	O	O
analyzed	O	O
using	O	O
antibody	O	O
arrays	O	O
to	O	O
measure	O	O
the	O	O
levels	O	O
of	O	O
multiple	O	O
proinflammatory	O	O
cytokines	O	O
and	O	O
bone	O	O
resorptive/turnover	O	O
markers	O	O
.	O	O

Salivary	O	O
biomarker	O	O
data	O	O
were	O	O
correlated	O	O
to	O	O
comprehensive	O	O
clinical	O	O
,	O	O
radiographic	O	O
,	O	O
and	O	O
microbial	O	O
plaque	O	O
biofilm	O	O
levels	O	O
measured	O	O
by	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
qPCR	O	O
)	O	O
for	O	O
the	O	O
generation	O	O
of	O	O
models	O	O
for	O	O
periodontal	O	O
disease	O	O
identification	O	O
.	O	O

Significantly	O	O
elevated	O	O
levels	O	O
of	O	O
matrix	O	O
metalloproteinase	O	O
(	O	O
MMP	O	O
)	O	O
-8	O	O
and	O	O
-9	O	O
were	O	O
found	O	O
in	O	O
subjects	O	O
with	O	O
advanced	O	O
periodontitis	O	O
with	O	O
Random	O	O
Forest	O	O
importance	O	O
scores	O	O
of	O	O
7.1	O	O
and	O	O
5.1	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
generation	O	O
of	O	O
receiver	O	O
operating	O	O
characteristic	O	O
curves	O	O
demonstrated	O	O
that	O	O
permutations	O	O
of	O	O
salivary	O	O
biomarkers	O	O
and	O	O
pathogen	O	O
biofilm	O	O
values	O	O
augmented	O	O
the	O	O
prediction	O	O
of	O	O
disease	O	O
category	O	O
.	O	O

Multiple	O	O
combinations	O	O
of	O	O
salivary	O	O
biomarkers	O	O
(	O	O
especially	O	O
MMP-8	O	O
and	O	O
-9	O	O
and	O	O
osteoprotegerin	O	O
)	O	O
combined	O	O
with	O	O
red-complex	O	O
anaerobic	O	O
periodontal	O	O
pathogens	O	O
(	O	O
such	O	O
as	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
or	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
provided	O	O
highly	O	O
accurate	O	O
predictions	O	O
of	O	O
periodontal	O	O
disease	O	O
category	O	O
.	O	O

Elevated	O	O
salivary	O	O
MMP-8	O	O
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
biofilm	O	O
levels	O	O
displayed	O	O
robust	O	O
combinatorial	O	O
characteristics	O	O
in	O	O
predicting	O	O
periodontal	O	O
disease	O	O
severity	O	O
(	O	O
area	O	O
under	O	O
the	O	O
curve	O	O
=	O	O
0.88	O	O
;	O	O
odds	O	O
ratio	O	O
=	O	O
24.6	O	O
;	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
:	O	O
5.2	O	O
to	O	O
116.5	O	O
)	O	O
.	O	O

Using	O	O
qPCR	O	O
and	O	O
sensitive	O	O
immunoassays	O	O
,	O	O
we	O	O
identified	O	O
host-	O	O
and	O	O
bacterially	O	O
derived	O	O
biomarkers	O	O
correlated	O	O
with	O	O
periodontal	O	O
disease	O	O
.	O	O

This	O	O
approach	O	O
offers	O	O
significant	O	O
potential	O	O
for	O	O
the	O	O
discovery	O	O
of	O	O
biomarker	O	O
signatures	O	O
useful	O	O
in	O	O
the	O	O
development	O	O
of	O	O
rapid	O	O
POC	O	O
chairside	O	O
diagnostics	O	O
for	O	O
oral	O	O
and	O	O
systemic	O	O
diseases	O	O
.	O	O

Studies	O	O
are	O	O
ongoing	O	O
to	O	O
apply	O	O
this	O	O
approach	O	O
to	O	O
the	O	O
longitudinal	O	O
predictions	O	O
of	O	O
disease	O	O
activity	O	O
.	O	O

Measurement	O	O
of	O	O
salivary	O	O
IgA	O	O
antibody	O	O
(	O	O
PAc-peptide	O	O
antibody	O	O
,	O	O
PPA	O	O
)	O	O
to	O	O
amino	O	O
acid	O	O
residues	O	O
361-386	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
PAc	O	O
,	O	O
which	O	O
possess	O	O
a	O	O
multiple	O	O
binding	O	O
motif	O	O
to	O	O
various	O	O
HLA-DR	O	O
molecules	O	O
and	O	O
a	O	O
B-cell	O	O
epitope	O	O
that	O	O
recognises	O	O
the	O	O
inhibiting	O	O
antibody	O	O
to	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
is	O	O
an	O	O
indicator	O	O
for	O	O
the	O	O
population	O	O
numbers	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
in	O	O
human	O	O
saliva	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
clarify	O	O
the	O	O
role	O	O
of	O	O
PPA	O	O
in	O	O
infection	O	O
control	O	O
of	O	O
MS	B-bacteria	B-bacteria
after	O	O
professional	O	O
oral	O	O
hygiene	O	O
care	O	O
.	O	O

Thirty-nine	O	O
dependently	O	O
living	O	O
institutionalised	O	O
elderly	O	O
subjects	O	O
(	O	O
75.9	O	O
+/-	O	O
7.5	O	O
years	O	O
;	O	O
10	O	O
males	O	O
,	O	O
29	O	O
females	O	O
)	O	O
participated	O	O
in	O	O
the	O	O
study	O	O
.	O	O

The	O	O
measurements	O	O
of	O	O
PPA	O	O
,	O	O
MS	B-bacteria	B-bacteria
,	O	O
total	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
TS	B-bacteria	B-bacteria
)	O	O
and	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
LB	B-bacteria	B-bacteria
)	O	O
were	O	O
performed	O	O
by	O	O
ELISA	O	O
and	O	O
culture	O	O
techniques	O	O
from	O	O
saliva	O	O
,	O	O
plaque	O	O
and	O	O
tongue	O	O
samples	O	O
from	O	O
the	O	O
elderly	O	O
.	O	O

After	O	O
treatment	O	O
using	O	O
professional	O	O
oral	O	O
care	O	O
,	O	O
the	O	O
numbers	O	O
of	O	O
MS	B-bacteria	B-bacteria
decreased	O	O
significantly	O	O
at	O	O
6	O	O
months	O	O
in	O	O
saliva	O	O
and	O	O
tongue	O	O
samples	O	O
from	O	O
the	O	O
group	O	O
not	O	O
having	O	O
PPA	O	O
in	O	O
comparison	O	O
with	O	O
the	O	O
primary	O	O
data	O	O
;	O	O
whereas	O	O
in	O	O
the	O	O
PPA-detected	O	O
group	O	O
,	O	O
a	O	O
significant	O	O
decrease	O	O
in	O	O
MS	B-bacteria	B-bacteria
number	O	O
was	O	O
shown	O	O
immediately	O	O
following	O	O
professional	O	O
care	O	O
at	O	O
1-12	O	O
months	O	O
in	O	O
all	O	O
samples	O	O
.	O	O

There	O	O
was	O	O
little	O	O
difference	O	O
in	O	O
the	O	O
numbers	O	O
of	O	O
LB	B-bacteria	B-bacteria
at	O	O
any	O	O
of	O	O
the	O	O
time	O	O
points	O	O
.	O	O

The	O	O
numbers	O	O
of	O	O
TS	B-bacteria	B-bacteria
decreased	O	O
rapidly	O	O
in	O	O
PPA-not	O	O
detected	O	O
group	O	O
in	O	O
comparison	O	O
with	O	O
the	O	O
PPA-detected	O	O
group	O	O
.	O	O

PPA	O	O
may	O	O
be	O	O
more	O	O
effective	O	O
for	O	O
controlling	O	O
MS	B-bacteria	B-bacteria
number	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
after	O	O
professional	O	O
treatment	O	O
.	O	O

The	O	O
measurement	O	O
of	O	O
PPA	O	O
may	O	O
be	O	O
used	O	O
for	O	O
preventive	O	O
instruction	O	O
to	O	O
dental	O	O
caries	O	O
at	O	O
the	O	O
chair	O	O
side	O	O
in	O	O
the	O	O
clinical	O	O
setting	O	O
.	O	O

The	O	O
study	O	O
was	O	O
conducted	O	O
to	O	O
evaluate	O	O
a	O	O
new	O	O
cefixime-clavulanic	O	O
acid	O	O
combination	O	O
for	O	O
in	O	O
vitro	O	O
susceptibility	O	O
towards	O	O
gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

A	O	O
total	O	O
of	O	O
220	O	O
isolates	O	O
of	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeroginosa	E-bacteria	I-bacteria
,	O	O
Acinetobacter	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
,	O	O
Salmonella	B-bacteria	B-bacteria
enterica	I-bacteria	I-bacteria
serovar	I-bacteria	I-bacteria
Typhi	E-bacteria	I-bacteria
and	O	O
Salmonella	B-bacteria	B-bacteria
enterica	I-bacteria	I-bacteria
serovar	I-bacteria	I-bacteria
Typhimurium	E-bacteria	I-bacteria
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

The	O	O
isolates	O	O
were	O	O
tested	O	O
for	O	O
susceptibility	O	O
towards	O	O
the	O	O
new	O	O
combination	O	O
antimicrobial	O	O
molecule	O	O
cefixime	O	O
with	O	O
clavulanic	O	O
acid	O	O
by	O	O
disk	O	O
diffusion	O	O
and	O	O
Epsilometer	O	O
strip	O	O
(	O	O
E-strip	O	O
)	O	O
Minimum	O	O
Inhibitary	O	O
Concentration	O	O
(	O	O
MIC	O	O
)	O	O
method	O	O
.	O	O

Of	O	O
the	O	O
101	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
K.	B-bacteria	B-bacteria
pneumoniae	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
,	O	O
62.4	O	O
%	O	O
were	O	O
found	O	O
to	O	O
be	O	O
extended	O	O
spectrum	O	O
beta-lactamase	O	O
(	O	O
ESBL	O	O
)	O	O
producers	O	O
.	O	O

Almost	O	O
half	O	O
of	O	O
these	O	O
were	O	O
from	O	O
the	O	O
community	O	O
and	O	O
55.6	O	O
%	O	O
were	O	O
hospital	O	O
isolates	O	O
.	O	O

Of	O	O
the	O	O
ESBL	O	O
isolates	O	O
,	O	O
19	O	O
%	O	O
were	O	O
AmpC	O	O
(	O	O
cephalosporinases	O	O
that	O	O
are	O	O
poorly	O	O
inhibited	O	O
by	O	O
beta	O	O
lactamase	O	O
inhibitor	O	O
)	O	O
producers	O	O
while	O	O
the	O	O
remaining	O	O
81	O	O
%	O	O
were	O	O
non	O	O
AmpC	O	O
ESBL	O	O
producers	O	O
.	O	O

The	O	O
AmpC	O	O
producers	O	O
were	O	O
resistant	O	O
to	O	O
both	O	O
cefixime	O	O
and	O	O
the	O	O
combination	O	O
,	O	O
while	O	O
the	O	O
non-AmpC	O	O
producers	O	O
were	O	O
sensitive	O	O
to	O	O
the	O	O
combination	O	O
.	O	O

The	O	O
addition	O	O
of	O	O
clavulanate	O	O
to	O	O
cefixime	O	O
did	O	O
not	O	O
improve	O	O
the	O	O
sensitivities	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Acinetobacter	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
.	O	O

There	O	O
were	O	O
no	O	O
ESBL	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
among	O	O
the	O	O
S.	B-bacteria	B-bacteria
Typhi	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
,	O	O
all	O	O
of	O	O
which	O	O
were	O	O
sensitive	O	O
to	O	O
cefixime	O	O
.	O	O

Of	O	O
the	O	O
S.	B-bacteria	B-bacteria
Typhimurium	E-bacteria	I-bacteria
,	O	O
88.9	O	O
%	O	O
were	O	O
ESBL	O	O
producers	O	O
and	O	O
all	O	O
of	O	O
these	O	O
were	O	O
resistant	O	O
to	O	O
cefixime	O	O
but	O	O
sensitive	O	O
to	O	O
the	O	O
combination	O	O
.	O	O

The	O	O
combination	O	O
of	O	O
cefixime	O	O
with	O	O
clavulanic	O	O
acid	O	O
offers	O	O
the	O	O
advantage	O	O
of	O	O
oral	O	O
administration	O	O
and	O	O
appears	O	O
to	O	O
be	O	O
a	O	O
viable	O	O
option	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
uncomplicated	O	O
community	O	O
acquired	O	O
infections	O	O
caused	O	O
by	O	O
non-AmpC	B-bacteria	B-bacteria
ESBL	I-bacteria	I-bacteria
producing	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Adrenomedullin	O	O
(	O	O
ADM	O	O
)	O	O
promotes	O	O
epithelial	O	O
cell	O	O
proliferation	O	O
and	O	O
antimicrobial	O	O
activity	O	O
in	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
.	O	O

Since	O	O
ADM	O	O
is	O	O
also	O	O
present	O	O
in	O	O
saliva	O	O
,	O	O
it	O	O
was	O	O
the	O	O
objective	O	O
of	O	O
our	O	O
study	O	O
to	O	O
investigate	O	O
the	O	O
role	O	O
of	O	O
salivary	O	O
ADM	O	O
in	O	O
the	O	O
maintenance	O	O
of	O	O
oral	O	O
health	O	O
.	O	O

We	O	O
found	O	O
mRNA	O	O
for	O	O
ADM	O	O
and	O	O
the	O	O
specific	O	O
receptors	O	O
CRLR-RAMP2	O	O
and	O	O
CRLR-RAMP3	O	O
expressed	O	O
by	O	O
the	O	O
salivary	O	O
glands	O	O
and	O	O
by	O	O
oral	O	O
keratinocytes	O	O
.	O	O

The	O	O
hormone	O	O
was	O	O
detected	O	O
in	O	O
the	O	O
glandular	O	O
tissues	O	O
by	O	O
western	O	O
blot	O	O
,	O	O
being	O	O
slightly	O	O
bigger	O	O
than	O	O
the	O	O
synthetic	O	O
peptide	O	O
,	O	O
indicating	O	O
a	O	O
posttranslational	O	O
modification	O	O
.	O	O

ADM	O	O
was	O	O
localized	O	O
using	O	O
immunohistochemistry	O	O
and	O	O
immunofluorescence	O	O
.	O	O

Staining	O	O
specific	O	O
for	O	O
ADM	O	O
was	O	O
observed	O	O
near	O	O
the	O	O
cell	O	O
nuclei	O	O
of	O	O
the	O	O
salivary	O	O
ducts	O	O
and	O	O
acini	O	O
.	O	O

There	O	O
was	O	O
no	O	O
correlation	O	O
between	O	O
ADM	O	O
from	O	O
matched	O	O
saliva	O	O
and	O	O
serum	O	O
of	O	O
healthy	O	O
volunteers	O	O
.	O	O

The	O	O
physiological	O	O
role	O	O
of	O	O
salivary	O	O
ADM	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
was	O	O
investigated	O	O
by	O	O
incubating	O	O
buccal	O	O
keratinocytes	O	O
with	O	O
ADM	O	O
and	O	O
measurement	O	O
of	O	O
the	O	O
cell	O	O
proliferation	O	O
using	O	O
bromodeoxyuridine	O	O
(	O	O
BrDU	O	O
)	O	O
assays	O	O
.	O	O

There	O	O
was	O	O
a	O	O
significant	O	O
,	O	O
dose	O	O
dependent	O	O
increase	O	O
(	O	O
up	O	O
to	O	O
5-fold	O	O
;	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
of	O	O
the	O	O
BrDU	O	O
incorporation	O	O
after	O	O
stimulation	O	O
with	O	O
ADM	O	O
(	O	O
1.5	O	O
to	O	O
50	O	O
ng/mL	O	O
)	O	O
.	O	O

The	O	O
antibacterial	O	O
properties	O	O
of	O	O
salivary	O	O
ADM	O	O
was	O	O
studied	O	O
by	O	O
incubation	O	O
of	O	O
Gram+	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
yeast	O	O
,	O	O
isolated	O	O
from	O	O
human	O	O
oral	O	O
flora	O	O
,	O	O
with	O	O
ADM	O	O
(	O	O
0.01-1000	O	O
ng/mL	O	O
)	O	O
for	O	O
24	O	O
h.	O	O
Bacterial	O	O
growth	O	O
was	O	O
inhibited	O	O
dose	O	O
dependently	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
whereas	O	O
the	O	O
yeast	O	O
was	O	O
not	O	O
affected	O	O
.	O	O

This	O	O
finding	O	O
was	O	O
consistent	O	O
when	O	O
using	O	O
radial	O	O
growth	O	O
inhibition	O	O
test	O	O
on	O	O
agarose	O	O
plates	O	O
as	O	O
well	O	O
as	O	O
photometric	O	O
measurement	O	O
in	O	O
microtiter	O	O
plates	O	O
.	O	O

Our	O	O
findings	O	O
suggest	O	O
an	O	O
important	O	O
role	O	O
of	O	O
salivary	O	O
ADM	O	O
in	O	O
the	O	O
maintenance	O	O
of	O	O
oral	O	O
health	O	O
,	O	O
being	O	O
involved	O	O
as	O	O
well	O	O
as	O	O
in	O	O
oral	O	O
cell	O	O
proliferation	O	O
and	O	O
anti-bacterial	O	O
defense	O	O
.	O	O

Four	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
Gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
human	O	O
mouth	O	O
were	O	O
characterized	O	O
using	O	O
a	O	O
variety	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
.	O	O

The	O	O
strains	O	O
were	O	O
found	O	O
to	O	O
comprise	O	O
a	O	O
homogeneous	O	O
group	O	O
and	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
revealed	O	O
them	O	O
to	O	O
be	O	O
distinct	O	O
from	O	O
but	O	O
related	O	O
to	O	O
a	O	O
loose	O	O
cluster	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
including	O	O
Prevotella	B-bacteria	B-bacteria
buccalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nanceiensis	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
marshii	E-bacteria	I-bacteria
.	O	O

A	O	O
novel	O	O
species	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
micans	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
is	O	O
proposed	O	O
to	O	O
accommodate	O	O
these	O	O
strains	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
micans	E-bacteria	I-bacteria
is	O	O
saccharolytic	O	O
and	O	O
produces	O	O
acetic	O	O
,	O	O
isovaleric	O	O
and	O	O
succinic	O	O
acids	O	O
and	O	O
minor	O	O
amounts	O	O
of	O	O
isobutyric	O	O
acid	O	O
as	O	O
end	O	O
products	O	O
of	O	O
fermentation	O	O
.	O	O

The	O	O
G+C	O	O
content	O	O
of	O	O
the	O	O
DNA	O	O
of	O	O
the	O	O
type	O	O
strain	O	O
is	O	O
46	O	O
mol	O	O
%	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
micans	E-bacteria	I-bacteria
is	O	O
E7.56	O	O
(	O	O
T	O	O
)	O	O
(	O	O
=DSM	B-bacteria	B-bacteria
21469	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
56105	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
.	O	O

Results	O	O
of	O	O
study	O	O
of	O	O
microecological	O	O
disorders	O	O
in	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
with	O	O
non-specific	O	O
ulcerative	O	O
colitis	O	O
(	O	O
NSUC	O	O
)	O	O
and	O	O
Crohn	O	O
's	O	O
disease	O	O
(	O	O
CD	O	O
)	O	O
and	O	O
control	O	O
subjects	O	O
(	O	O
patients	O	O
with	O	O
hypertension	O	O
)	O	O
.	O	O

Condition	O	O
of	O	O
mucosa	O	O
was	O	O
assessed	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
morphological	O	O
data	O	O
and	O	O
electrophoretic	O	O
mobility	O	O
of	O	O
cell	O	O
nuclei	O	O
,	O	O
whereas	O	O
structure	O	O
of	O	O
microbiocenosis	O	O
and	O	O
metabolic	O	O
activity	O	O
of	O	O
microflora	O	O
--	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
saliva	O	O
bacterial	O	O
culture	O	O
and	O	O
contents	O	O
and	O	O
profile	O	O
of	O	O
volatile	O	O
fat	O	O
acids	O	O
in	O	O
it	O	O
.	O	O

Detection	O	O
rate	O	O
of	O	O
negative	O	O
charge	O	O
of	O	O
the	O	O
cell	O	O
nuclei	O	O
(	O	O
decrease	O	O
of	O	O
functional	O	O
activity	O	O
of	O	O
epithelium	O	O
)	O	O
was	O	O
significantly	O	O
higher	O	O
in	O	O
patients	O	O
with	O	O
NSUC	O	O
and	O	O
CD	O	O
(	O	O
66.6	O	O
%	O	O
)	O	O
compared	O	O
with	O	O
controls	O	O
(	O	O
10	O	O
%	O	O
)	O	O
.	O	O

This	O	O
fact	O	O
was	O	O
directly	O	O
related	O	O
with	O	O
hypercolonization	O	O
of	O	O
oral	O	O
cavity	O	O
by	O	O
Gram-negative	O	O
microflora	O	O
.	O	O

Lesions	O	O
of	O	O
mucosa	O	O
which	O	O
are	O	O
characteristic	O	O
of	O	O
NSUC	O	O
and	O	O
CD	O	O
and	O	O
determined	O	O
by	O	O
pathologic	O	O
immune	O	O
mechanisms	O	O
correlated	O	O
with	O	O
quantity	O	O
of	O	O
pathogenic	O	O
microflora	O	O
(	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
Candida	O	O
)	O	O
.	O	O

Marked	O	O
differences	O	O
of	O	O
chromatograms	O	O
'	O	O
patterns	O	O
were	O	O
observed	O	O
in	O	O
patients	O	O
with	O	O
NSUC	O	O
and	O	O
CD	O	O
indicating	O	O
the	O	O
suppression	O	O
of	O	O
anaerobic	O	O
microflora	O	O
in	O	O
patients	O	O
with	O	O
CD	O	O
and	O	O
hypercolonization	O	O
of	O	O
oral	O	O
cavity	O	O
by	O	O
anaerobic	O	O
microflora	O	O
in	O	O
majority	O	O
of	O	O
patients	O	O
with	O	O
NSUC	O	O
.	O	O

Members	O	O
of	O	O
the	O	O
phylum	O	O
``	O	O
Synergistetes	B-bacteria	B-bacteria
''	O	O
have	O	O
frequently	O	O
been	O	O
detected	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
at	O	O
sites	O	O
of	O	O
dental	O	O
disease	O	O
,	O	O
but	O	O
they	O	O
have	O	O
rarely	O	O
been	O	O
detected	O	O
in	O	O
studies	O	O
of	O	O
oral	O	O
health	O	O
.	O	O

Only	O	O
two	O	O
oral	O	O
``	O	O
Synergistetes	B-bacteria	B-bacteria
''	O	O
taxa	O	O
are	O	O
cultivable	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
were	O	O
to	O	O
investigate	O	O
the	O	O
diversity	O	O
of	O	O
``	O	O
Synergistetes	B-bacteria	B-bacteria
''	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
to	O	O
establish	O	O
whether	O	O
``	O	O
Synergistetes	B-bacteria	B-bacteria
''	O	O
taxa	O	O
are	O	O
more	O	O
strongly	O	O
associated	O	O
with	O	O
periodontitis	O	O
than	O	O
with	O	O
oral	O	O
health	O	O
,	O	O
and	O	O
to	O	O
visualize	O	O
unculturable	O	O
``	O	O
Synergistetes	B-bacteria	B-bacteria
''	O	O
in	O	O
situ	O	O
.	O	O

Sixty	O	O
samples	O	O
(	O	O
saliva	O	O
,	O	O
dental	O	O
plaque	O	O
,	O	O
and	O	O
mucosal	O	O
swabs	O	O
)	O	O
were	O	O
collected	O	O
from	O	O
five	O	O
subjects	O	O
with	O	O
periodontitis	O	O
and	O	O
five	O	O
periodontally	O	O
healthy	O	O
controls	O	O
.	O	O

Using	O	O
phylum-specific	O	O
16S	O	O
rRNA	O	O
gene	O	O
primers	O	O
,	O	O
``	O	O
Synergistetes	B-bacteria	B-bacteria
''	O	O
were	O	O
identified	O	O
by	O	O
PCR	O	O
,	O	O
cloning	O	O
,	O	O
and	O	O
sequencing	O	O
of	O	O
48	O	O
clones	O	O
per	O	O
PCR-positive	O	O
sample	O	O
.	O	O

Subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
labeled	O	O
with	O	O
probes	O	O
targeting	O	O
rRNA	O	O
of	O	O
unculturable	O	O
oral	O	O
``	O	O
Synergistetes	B-bacteria	B-bacteria
''	O	O
using	O	O
fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
.	O	O

Analysis	O	O
of	O	O
1,664	O	O
clones	O	O
revealed	O	O
12	O	O
``	O	O
Synergistetes	B-bacteria	B-bacteria
''	O	O
operational	O	O
taxonomic	O	O
units	O	O
(	O	O
OTUs	O	O
)	O	O
at	O	O
the	O	O
99	O	O
%	O	O
sequence	O	O
identity	O	O
level	O	O
,	O	O
5	O	O
of	O	O
which	O	O
were	O	O
novel	O	O
.	O	O

``	O	O
Synergistetes	B-bacteria	B-bacteria
''	O	O
OTU	O	O
4.2	O	O
was	O	O
found	O	O
in	O	O
significantly	O	O
more	O	O
subjects	O	O
with	O	O
periodontitis	O	O
than	O	O
controls	O	O
(	O	O
P	O	O
=	O	O
0.048	O	O
)	O	O
and	O	O
was	O	O
more	O	O
abundant	O	O
in	O	O
subgingival	O	O
plaque	O	O
at	O	O
diseased	O	O
sites	O	O
than	O	O
at	O	O
healthy	O	O
sites	O	O
in	O	O
subjects	O	O
with	O	O
periodontitis	O	O
(	O	O
P	O	O
=	O	O
0.019	O	O
)	O	O
or	O	O
controls	O	O
(	O	O
P	O	O
=	O	O
0.019	O	O
)	O	O
.	O	O

FISH	O	O
analysis	O	O
revealed	O	O
that	O	O
unculturable	O	O
oral	O	O
``	O	O
Synergistetes	O	O
''	O	O
cells	O	O
were	O	O
large	O	O
curved	O	O
bacilli	O	O
.	O	O

The	O	O
human	O	O
oral	O	O
cavity	O	O
harbors	O	O
a	O	O
diverse	O	O
population	O	O
of	O	O
``	O	O
Synergistetes	O	O
.	O	O
''	O	O

``	O	O
Synergistetes	B-bacteria	B-bacteria
''	O	O
OTU	O	O
4.2	O	O
is	O	O
associated	O	O
with	O	O
periodontitis	O	O
and	O	O
may	O	O
have	O	O
a	O	O
pathogenic	O	O
role	O	O
.	O	O

Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
are	O	O
gram	B-bacteria	B-bacteria
positive	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
cocci	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
frequently	O	O
related	O	O
to	O	O
polymicrobial	O	O
infections	O	O
in	O	O
humans	O	O
.	O	O

Despite	O	O
reports	O	O
about	O	O
phenotypic	O	O
differences	O	O
,	O	O
the	O	O
genotypic	O	O
variation	O	O
of	O	O
P.	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
and	O	O
its	O	O
role	O	O
in	O	O
virulence	O	O
are	O	O
still	O	O
not	O	O
elucidated	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
genotypic	O	O
diversity	O	O
of	O	O
P.	B-bacteria	B-bacteria
micra	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
obtained	O	O
from	O	O
the	O	O
subgingival	O	O
biofilm	O	O
of	O	O
subjects	O	O
with	O	O
different	O	O
periodontal	O	O
conditions	O	O
and	O	O
to	O	O
correlate	O	O
these	O	O
findings	O	O
with	O	O
phenotypic	O	O
traits	O	O
.	O	O

Three	O	O
reference	O	O
strains	O	O
and	O	O
35	O	O
isolates	O	O
of	O	O
P.	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
were	O	O
genotyped	O	O
by	O	O
16S	O	O
rRNA	O	O
PCR-RFLP	O	O
and	O	O
phenotypic	O	O
traits	O	O
such	O	O
as	O	O
collagenase	O	O
production	O	O
,	O	O
elastolytic	O	O
and	O	O
hemolytic	O	O
activities	O	O
were	O	O
evaluated	O	O
.	O	O

16S	O	O
rRNA	O	O
PCR-RFLP	O	O
showed	O	O
that	O	O
P.	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
could	O	O
be	O	O
grouped	O	O
into	O	O
two	O	O
main	O	O
clusters	O	O
:	O	O
C1	O	O
and	O	O
C2	O	O
;	O	O
cluster	O	O
C1	O	O
harbored	O	O
three	O	O
genotypes	O	O
(	O	O
HG1259-like	O	O
,	O	O
HG1467-like	O	O
and	O	O
ICBMO583-like	O	O
)	O	O
while	O	O
cluster	O	O
C2	O	O
harbored	O	O
two	O	O
genotypes	O	O
(	O	O
ATCC33270-like	O	O
and	O	O
ICBMO36	O	O
)	O	O
.	O	O

A	O	O
wide	O	O
variability	O	O
in	O	O
collagenolytic	O	O
activity	O	O
intensities	O	O
was	O	O
observed	O	O
among	O	O
all	O	O
isolates	O	O
,	O	O
while	O	O
elastolytic	O	O
activity	O	O
was	O	O
detected	O	O
in	O	O
only	O	O
two	O	O
isolates	O	O
.	O	O

There	O	O
was	O	O
an	O	O
association	O	O
between	O	O
hemolytic	O	O
activity	O	O
in	O	O
rabbit	O	O
erythrocytes	O	O
and	O	O
cluster	O	O
C2	O	O
.	O	O

There	O	O
was	O	O
an	O	O
association	O	O
between	O	O
hemolytic	O	O
activity	O	O
in	O	O
rabbit	O	O
erythrocytes	O	O
and	O	O
cluster	O	O
C1	O	O
.	O	O

Although	O	O
these	O	O
data	O	O
suggest	O	O
a	O	O
possible	O	O
association	O	O
between	O	O
P.	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
genetic	O	O
diversity	O	O
and	O	O
their	O	O
pathogenic	O	O
potential	O	O
,	O	O
further	O	O
investigations	O	O
are	O	O
needed	O	O
to	O	O
confirm	O	O
this	O	O
hypothesis	O	O
.	O	O

We	O	O
examined	O	O
the	O	O
associations	O	O
between	O	O
preterm	O	O
birth	O	O
and	O	O
low	O	O
birth	O	O
weight	O	O
and	O	O
maternal	O	O
caries	O	O
history	O	O
,	O	O
maternal	O	O
periodontal	O	O
status	O	O
,	O	O
and	O	O
salivary	O	O
levels	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
Lactobacilli	B-bacteria	B-bacteria
.	O	O

This	O	O
study	O	O
was	O	O
a	O	O
matched	O	O
case-control	O	O
study	O	O
in	O	O
women	O	O
during	O	O
their	O	O
pregnancy	O	O
or	O	O
up	O	O
to	O	O
8	O	O
weeks	O	O
after	O	O
delivery	O	O
.	O	O

SUBJECTS	O	O
AND	O	O
Thirty-four	O	O
women	O	O
delivering	O	O
before	O	O
37	O	O
weeks	O	O
gestation	O	O
were	O	O
recruited	O	O
along	O	O
with	O	O
73	O	O
term	O	O
controls	O	O
matched	O	O
for	O	O
age	O	O
and	O	O
race/ethnicity	O	O
.	O	O

Demographic	O	O
and	O	O
obstetric	O	O
information	O	O
was	O	O
collected	O	O
from	O	O
questionnaires	O	O
and	O	O
medical	O	O
records	O	O
and	O	O
oral	O	O
examinations	O	O
along	O	O
with	O	O
commercial	O	O
salivary	O	O
tests	O	O
were	O	O
completed	O	O
within	O	O
the	O	O
study	O	O
groups	O	O
.	O	O

The	O	O
main	O	O
outcome	O	O
variables	O	O
were	O	O
the	O	O
preterm	O	O
birth	O	O
and	O	O
low	O	O
birth	O	O
weight	O	O
status	O	O
.	O	O

The	O	O
independent	O	O
variables	O	O
measured	O	O
were	O	O
the	O	O
salivary	O	O
levels	O	O
of	O	O
Lactobacilli	B-bacteria	B-bacteria
and	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
the	O	O
caries	O	O
and	O	O
periodontal	O	O
status	O	O
of	O	O
the	O	O
subjects	O	O
.	O	O

The	O	O
odds	O	O
ratio	O	O
comparing	O	O
low	O	O
levels	O	O
of	O	O
bacteria	O	O
in	O	O
preterm	O	O
mothers	O	O
and	O	O
controls	O	O
was	O	O
statistically	O	O
significant	O	O
for	O	O
Lactobacilli	B-bacteria	B-bacteria
(	O	O
odds	O	O
ratio	O	O
(	O	O
OR	O	O
)	O	O
=	O	O
3.45	O	O
,	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
(	O	O
CI	O	O
)	O	O
=	O	O
1.27	O	O
to	O	O
10.00	O	O
)	O	O
and	O	O
almost	O	O
significant	O	O
for	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
OR	O	O
=	O	O
2.63	O	O
,	O	O
95	O	O
%	O	O
CI	O	O
=	O	O
0.95	O	O
to	O	O
8.33	O	O
)	O	O
.	O	O

Clinical	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
measures	O	O
did	O	O
not	O	O
differ	O	O
significantly	O	O
between	O	O
groups	O	O
.	O	O

Within	O	O
the	O	O
limitation	O	O
of	O	O
our	O	O
study	O	O
,	O	O
low	O	O
levels	O	O
of	O	O
Lactobacilli	B-bacteria	B-bacteria
in	O	O
saliva	O	O
were	O	O
found	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
preterm	O	O
birth	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
describe	O	O
the	O	O
bacterial	O	O
diversity	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
the	O	O
elderly	O	O
without	O	O
root	O	O
caries	O	O
using	O	O
bacterial	O	O
microarrays	O	O
,	O	O
and	O	O
to	O	O
determine	O	O
the	O	O
site-	O	O
and	O	O
subject-specificity	O	O
of	O	O
bacterial	O	O
colonization	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
tongue	O	O
dorsum	O	O
,	O	O
mucosa	O	O
of	O	O
the	O	O
buccal	O	O
fold	O	O
,	O	O
hard	O	O
palate	O	O
,	O	O
supragingival	O	O
plaque	O	O
from	O	O
sound	O	O
root	O	O
surfaces	O	O
,	O	O
and	O	O
subgingival	O	O
plaque	O	O
from	O	O
the	O	O
same	O	O
roots	O	O
.	O	O

A	O	O
new	O	O
16	O	O
S	O	O
rRNA	O	O
gene-based	O	O
microarray	O	O
method	O	O
was	O	O
used	O	O
for	O	O
the	O	O
simultaneous	O	O
detection	O	O
of	O	O
approximately	O	O
300	O	O
bacterial	O	O
species	O	O
.	O	O

Overall	O	O
,	O	O
175	O	O
species	O	O
and	O	O
clusters	O	O
were	O	O
detected	O	O
,	O	O
representing	O	O
eight	O	O
phyla	O	O
.	O	O

Species	O	O
belonging	O	O
to	O	O
the	O	O
genera	B-bacteria	B-bacteria
Streptococcus	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
were	O	O
common	O	O
in	O	O
all	O	O
sites	O	O
.	O	O

The	O	O
number	O	O
of	O	O
species	O	O
per	O	O
subject	O	O
varied	O	O
from	O	O
51	O	O
to	O	O
81	O	O
.	O	O

Statistical	O	O
analyses	O	O
revealed	O	O
about	O	O
40	O	O
species	O	O
or	O	O
clusters	O	O
with	O	O
significant	O	O
associations	O	O
with	O	O
at	O	O
least	O	O
one	O	O
of	O	O
the	O	O
sites	O	O
.	O	O

The	O	O
bacterial	O	O
diversity	O	O
was	O	O
highest	O	O
in	O	O
the	O	O
cheek	O	O
and	O	O
palate	O	O
regions	O	O
.	O	O

Species	O	O
typically	O	O
associated	O	O
with	O	O
caries	O	O
and	O	O
periodontitis	O	O
were	O	O
detected	O	O
rarely	O	O
or	O	O
not	O	O
at	O	O
all	O	O
.	O	O

The	O	O
oral	O	O
bacterial	O	O
flora	O	O
of	O	O
the	O	O
elderly	O	O
appears	O	O
to	O	O
be	O	O
diverse	O	O
,	O	O
and	O	O
,	O	O
to	O	O
a	O	O
large	O	O
extent	O	O
,	O	O
site-	O	O
rather	O	O
than	O	O
subject-specific	O	O
.	O	O

Surface	O	O
adhesion	O	O
plays	O	O
an	O	O
essential	O	O
part	O	O
in	O	O
the	O	O
survival	O	O
of	O	O
the	O	O
commensal	O	O
organism	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
as	O	O
well	O	O
as	O	O
during	O	O
opportunistic	O	O
infections	O	O
such	O	O
as	O	O
endocarditis	O	O
.	O	O

At	O	O
least	O	O
two	O	O
types	O	O
of	O	O
cell	O	O
surface	O	O
protein	O	O
involved	O	O
in	O	O
adhesion	O	O
are	O	O
found	O	O
on	O	O
the	O	O
surface	O	O
of	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
:	O	O
those	O	O
anchored	O	O
via	O	O
an	O	O
LPXTG	O	O
motif	O	O
by	O	O
the	O	O
enzyme	O	O
sortase	O	O
A	O	O
(	O	O
SrtA	O	O
)	O	O
and	O	O
those	O	O
associated	O	O
with	O	O
the	O	O
cell	O	O
surface	O	O
by	O	O
,	O	O
as	O	O
yet	O	O
,	O	O
unknown	O	O
mechanisms	O	O
.	O	O

In	O	O
srtA	O	O
(	O	O
-	O	O
)	O	O
mutants	O	O
,	O	O
LPXTG-containing	O	O
proteins	O	O
have	O	O
been	O	O
shown	O	O
to	O	O
be	O	O
released	O	O
rather	O	O
than	O	O
cross-linked	O	O
to	O	O
the	O	O
cell	O	O
wall	O	O
.	O	O

We	O	O
have	O	O
therefore	O	O
used	O	O
2D	O	O
gel	O	O
electrophoresis	O	O
of	O	O
released	O	O
proteins	O	O
from	O	O
an	O	O
srtA	O	O
(	O	O
-	O	O
)	O	O
mutant	O	O
as	O	O
well	O	O
as	O	O
the	O	O
wild-type	O	O
strain	O	O
,	O	O
followed	O	O
by	O	O
peptide	O	O
identification	O	O
by	O	O
MS	O	O
,	O	O
to	O	O
identify	O	O
a	O	O
set	O	O
of	O	O
novel	O	O
proteins	O	O
predicted	O	O
to	O	O
be	O	O
present	O	O
on	O	O
the	O	O
surface	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
DL1	E-bacteria	I-bacteria
.	O	O

This	O	O
includes	O	O
two	O	O
large	O	O
LPXTG-linked	O	O
proteins	O	O
(	O	O
SGO_0707	O	O
and	O	O
SGO_1487	O	O
)	O	O
,	O	O
which	O	O
both	O	O
contain	O	O
tandemly	O	O
repeated	O	O
sequences	O	O
similar	O	O
to	O	O
those	O	O
present	O	O
in	O	O
known	O	O
fibrillar	O	O
adhesins	O	O
.	O	O

A	O	O
5'-nucleotidase	O	O
and	O	O
a	O	O
protein	O	O
with	O	O
a	O	O
putative	O	O
collagen-binding	O	O
domain	O	O
,	O	O
both	O	O
containing	O	O
LPXTG	O	O
motifs	O	O
,	O	O
were	O	O
also	O	O
identified	O	O
.	O	O

Anchorless	O	O
proteins	O	O
with	O	O
known	O	O
chaperone	O	O
,	O	O
stress	O	O
response	O	O
and	O	O
elongation	O	O
factor	O	O
functions	O	O
,	O	O
apparently	O	O
responsible	O	O
for	O	O
bacterial	O	O
binding	O	O
to	O	O
keratinocytes	O	O
and	O	O
saliva-coated	O	O
surfaces	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
the	O	O
LPXTG-linked	O	O
adhesins	O	O
,	O	O
were	O	O
also	O	O
associated	O	O
with	O	O
the	O	O
cell	O	O
surface	O	O
.	O	O

These	O	O
data	O	O
reveal	O	O
a	O	O
range	O	O
of	O	O
proteins	O	O
to	O	O
be	O	O
present	O	O
on	O	O
the	O	O
S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
DL1	E-bacteria	I-bacteria
cell	O	O
surface	O	O
,	O	O
the	O	O
expression	O	O
of	O	O
which	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
adhesion	O	O
to	O	O
epithelia	O	O
and	O	O
which	O	O
represent	O	O
likely	O	O
candidates	O	O
for	O	O
novel	O	O
virulence	O	O
factors	O	O
in	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
microbiologically	O	O
analyze	O	O
oral	O	O
mucosal	O	O
samples	O	O
collected	O	O
during	O	O
2	O	O
years	O	O
from	O	O
patients	O	O
with	O	O
oral	O	O
mucosal	O	O
complaints	O	O
.	O	O

Mucosal	O	O
scraping	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
297	O	O
patients	O	O
and	O	O
semiquantified	O	O
by	O	O
culture	O	O
for	O	O
detection	O	O
of	O	O
opportunistic	O	O
microorganisms	O	O
e.g	O	O
.	O	O

Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
enterococci	B-bacteria	B-bacteria
,	O	O
aerobic	B-bacteria	B-bacteria
Gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
(	O	O
AGNB	B-bacteria	B-bacteria
)	O	O
and	O	O
yeasts	O	O
.	O	O

Antibiotic	O	O
susceptibility	O	O
test	O	O
was	O	O
performed	O	O
.	O	O

Altogether	O	O
297	O	O
patients	O	O
were	O	O
sampled	O	O
(	O	O
mean	O	O
age	O	O
56.8	O	O
+/-	O	O
20.7	O	O
)	O	O
.	O	O

Among	O	O
the	O	O
110	O	O
patients	O	O
with	O	O
known	O	O
medical	O	O
condition	O	O
,	O	O
48	O	O
were	O	O
systemically	O	O
immunocompromised	O	O
,	O	O
35	O	O
had	O	O
systemic	O	O
diseases	O	O
,	O	O
and	O	O
27	O	O
had	O	O
only	O	O
local	O	O
oral	O	O
complaints	O	O
.	O	O

Opportunists	O	O
in	O	O
moderate	O	O
growth	O	O
or	O	O
more	O	O
were	O	O
present	O	O
commonly	O	O
in	O	O
all	O	O
three	O	O
groups	O	O
and	O	O
most	O	O
frequent	O	O
in	O	O
the	O	O
immunocompromised	O	O
patients	O	O
(	O	O
66.7	O	O
%	O	O
)	O	O
.	O	O

Candida	O	O
species	O	O
were	O	O
the	O	O
most	O	O
frequent	O	O
opportunist	O	O
(	O	O
68.8	O	O
%	O	O
)	O	O
,	O	O
however	O	O
,	O	O
their	O	O
level	O	O
was	O	O
low	O	O
and	O	O
combinations	O	O
with	O	O
bacterial	O	O
opportunists	O	O
were	O	O
common	O	O
(	O	O
39.6	O	O
%	O	O
)	O	O
.	O	O

All	O	O
bacterial	O	O
opportunists	O	O
tested	O	O
were	O	O
antibiotic	O	O
multiresistant	O	O
.	O	O

Follow-up	O	O
samples	O	O
were	O	O
collected	O	O
in	O	O
23	O	O
cases	O	O
out	O	O
of	O	O
which	O	O
seven	O	O
showed	O	O
still	O	O
presence	O	O
of	O	O
opportunists	O	O
in	O	O
heavy	O	O
growth	O	O
despite	O	O
repeated	O	O
treatment	O	O
with	O	O
ciprofloxacin	O	O
.	O	O

This	O	O
study	O	O
showed	O	O
a	O	O
frequent	O	O
presence	O	O
of	O	O
bacterial	O	O
and	O	O
fungal	O	O
opportunists	O	O
in	O	O
patients	O	O
with	O	O
oral	O	O
mucosal	O	O
complaints	O	O
,	O	O
which	O	O
were	O	O
most	O	O
common	O	O
in	O	O
immunocompromised	O	O
individuals	O	O
,	O	O
however	O	O
,	O	O
also	O	O
frequent	O	O
in	O	O
patients	O	O
with	O	O
local	O	O
oral	O	O
complaints	O	O
only	O	O
.	O	O

Systematic	O	O
evaluation	O	O
of	O	O
different	O	O
treatment	O	O
strategies	O	O
is	O	O
needed	O	O
.	O	O

Polyphenols	O	O
are	O	O
antibacterial	O	O
and	O	O
anti-oxidative	O	O
natural	O	O
agents	O	O
.	O	O

The	O	O
present	O	O
in	O	O
situ	O	O
study	O	O
aimed	O	O
to	O	O
investigate	O	O
the	O	O
effect	O	O
of	O	O
different	O	O
polyphenolic	O	O
beverages	O	O
on	O	O
initial	O	O
bacterial	O	O
adherence	O	O
to	O	O
enamel	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Initial	O	O
biofilm	O	O
formation	O	O
was	O	O
performed	O	O
on	O	O
bovine	O	O
enamel	O	O
specimens	O	O
mounted	O	O
buccally	O	O
on	O	O
individual	O	O
upper	O	O
jaw	O	O
splints	O	O
and	O	O
carried	O	O
by	O	O
six	O	O
subjects	O	O
.	O	O

After	O	O
1	O	O
min	O	O
of	O	O
pellicle	O	O
formation	O	O
,	O	O
oral	O	O
rinses	O	O
with	O	O
black	O	O
tea	O	O
,	O	O
green	O	O
tea	O	O
,	O	O
grape	O	O
juice	O	O
,	O	O
Cistus	O	O
tea	O	O
or	O	O
red	O	O
wine	O	O
were	O	O
performed	O	O
for	O	O
10	O	O
min	O	O
.	O	O

Afterwards	O	O
the	O	O
slabs	O	O
were	O	O
carried	O	O
for	O	O
another	O	O
19	O	O
or	O	O
109	O	O
min	O	O
,	O	O
respectively	O	O
.	O	O

Samples	O	O
exposed	O	O
to	O	O
the	O	O
oral	O	O
fluids	O	O
for	O	O
30	O	O
and	O	O
120	O	O
min	O	O
served	O	O
as	O	O
controls	O	O
.	O	O

Following	O	O
intraoral	O	O
exposure	O	O
,	O	O
the	O	O
slabs	O	O
were	O	O
rinsed	O	O
with	O	O
saline	O	O
solution	O	O
.	O	O

The	O	O
amount	O	O
of	O	O
adherent	O	O
bacteria	O	O
was	O	O
determined	O	O
with	O	O
DAPI-staining	O	O
(	O	O
4',6-diamidino-2-phenylindole	O	O
)	O	O
and	O	O
with	O	O
fluorescence-in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
of	O	O
eubacteria	B-bacteria	B-bacteria
and	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Rinses	O	O
with	O	O
all	O	O
beverages	O	O
reduced	O	O
the	O	O
amount	O	O
of	O	O
detectable	O	O
bacteria	O	O
.	O	O

Lowest	O	O
number	O	O
of	O	O
adherent	O	O
bacteria	O	O
was	O	O
found	O	O
following	O	O
rinses	O	O
with	O	O
red	O	O
wine	O	O
,	O	O
Cistus	O	O
tea	O	O
and	O	O
black	O	O
tea	O	O
as	O	O
measured	O	O
with	O	O
DAPI	O	O
(	O	O
up	O	O
to	O	O
66	O	O
%	O	O
reduction	O	O
of	O	O
adherent	O	O
bacteria	O	O
vs.	O	O
controls	O	O
)	O	O
.	O	O

Also	O	O
FISH	O	O
revealed	O	O
significant	O	O
impact	O	O
of	O	O
most	O	O
tested	O	O
beverages	O	O
.	O	O

Rinses	O	O
with	O	O
certain	O	O
polyphenolic	O	O
beverages	O	O
as	O	O
well	O	O
as	O	O
consumption	O	O
of	O	O
these	O	O
foodstuffs	O	O
may	O	O
contribute	O	O
to	O	O
prevention	O	O
of	O	O
biofilm	O	O
induced	O	O
diseases	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

To	O	O
establish	O	O
the	O	O
effects	O	O
of	O	O
three	O	O
factors	O	O
:	O	O
previous	O	O
caries	O	O
experience	O	O
;	O	O
colonization	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
;	O	O
and	O	O
final	O	O
pH	O	O
on	O	O
autologous	O	O
lactobacilli-mediated	O	O
inhibition	O	O
against	O	O
a	O	O
panel	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
in	O	O
young	O	O
subjects	O	O
with	O	O
different	O	O
caries	O	O
experiences	O	O
.	O	O

The	O	O
inhibition	O	O
capacity	O	O
was	O	O
determined	O	O
by	O	O
the	O	O
use	O	O
of	O	O
the	O	O
agar	O	O
overlay	O	O
method	O	O
and	O	O
the	O	O
final	O	O
pH	O	O
in	O	O
culture	O	O
medium	O	O
was	O	O
measured	O	O
after	O	O
20	O	O
h.	O	O
Using	O	O
a	O	O
logistic	O	O
regression	O	O
model	O	O
,	O	O
the	O	O
risk	O	O
of	O	O
having	O	O
an	O	O
incomplete	O	O
lactobacilli-mediated	O	O
inhibition	O	O
was	O	O
calculated	O	O
.	O	O

All	O	O
three	O	O
factors	O	O
significantly	O	O
influenced	O	O
the	O	O
interference	O	O
outcome	O	O
in	O	O
the	O	O
order	O	O
;	O	O
final	O	O
pH	O	O
of	O	O
the	O	O
Lactobacillus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
,	O	O
oral	O	O
colonization	O	O
of	O	O
autologous	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
caries	O	O
experience	O	O
.	O	O

A	O	O
high	O	O
risk	O	O
occurred	O	O
at	O	O
a	O	O
lower	O	O
pH	O	O
and	O	O
at	O	O
a	O	O
wider	O	O
pH	O	O
range	O	O
for	O	O
individuals	O	O
with	O	O
previous	O	O
caries	O	O
experience	O	O
and	O	O
autologous	O	O
colonization	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
compared	O	O
with	O	O
caries-free	O	O
subjects	O	O
who	O	O
were	O	O
not	O	O
colonized	O	O
.	O	O

At	O	O
a	O	O
final	O	O
pH	O	O
of	O	O
4.0	O	O
,	O	O
this	O	O
risk	O	O
was	O	O
approximately	O	O
eight	O	O
times	O	O
higher	O	O
than	O	O
that	O	O
of	O	O
the	O	O
latter	O	O
group	O	O
.	O	O

Two	O	O
mutans	B-bacteria	B-bacteria
Streptococcus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
in	O	O
the	O	O
test	O	O
panel	O	O
demonstrated	O	O
high	O	O
individual	O	O
predictive	O	O
values	O	O
of	O	O
inhibition	O	O
mediated	O	O
by	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
.	O	O

Generation	O	O
of	O	O
a	O	O
low	O	O
pH	O	O
either	O	O
directly	O	O
via	O	O
organic	O	O
acid	O	O
production	O	O
and/or	O	O
production	O	O
of	O	O
bacteriocins	O	O
or	O	O
metabolites	O	O
at	O	O
a	O	O
low	O	O
pH	O	O
may	O	O
promote	O	O
mutans	B-bacteria	B-bacteria
Streptococcus	E-bacteria	I-bacteria
growth	O	O
inhibition	O	O
,	O	O
in	O	O
vitro	O	O
.	O	O

Furthermore	O	O
,	O	O
a	O	O
shift	O	O
of	O	O
pH	O	O
range	O	O
for	O	O
the	O	O
risk	O	O
of	O	O
incomplete	O	O
inhibition	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
suggests	O	O
a	O	O
less	O	O
effective	O	O
inhibition	O	O
at	O	O
a	O	O
wider	O	O
pH	O	O
range	O	O
for	O	O
naturally	O	O
occurring	O	O
lactobacilli	B-bacteria	B-bacteria
from	O	O
individuals	O	O
with	O	O
earlier	O	O
caries	O	O
experience	O	O
containing	O	O
own	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Four	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
and	O	O
were	O	O
found	O	O
to	O	O
comprise	O	O
a	O	O
homogeneous	O	O
group	O	O
distinct	O	O
from	O	O
any	O	O
species	O	O
with	O	O
validly	O	O
published	O	O
names	O	O
.	O	O

16S	O	O
rRNA	O	O
and	O	O
23S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analyses	O	O
and	O	O
DNA-DNA	O	O
reassociation	O	O
data	O	O
revealed	O	O
that	O	O
the	O	O
strains	O	O
constituted	O	O
a	O	O
novel	O	O
group	O	O
within	O	O
the	O	O
phylum	B-bacteria	B-bacteria
'Synergistetes	I-bacteria	I-bacteria
'	E-bacteria	I-bacteria
and	O	O
were	O	O
most	O	O
closely	O	O
related	O	O
to	O	O
Jonquetella	B-bacteria	B-bacteria
anthropi	E-bacteria	I-bacteria
.	O	O

Two	O	O
libraries	O	O
of	O	O
randomly	O	O
cloned	O	O
DNA	O	O
were	O	O
prepared	O	O
from	O	O
strain	B-bacteria	B-bacteria
W5455	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
were	O	O
sequenced	O	O
to	O	O
provide	O	O
a	O	O
genome	O	O
survey	O	O
as	O	O
a	O	O
resource	O	O
for	O	O
metagenomic	O	O
studies	O	O
.	O	O

A	O	O
new	O	O
genus	O	O
and	O	O
novel	O	O
species	O	O
,	O	O
Pyramidobacter	B-bacteria	B-bacteria
piscolens	I-bacteria	I-bacteria
gen.	I-bacteria	I-bacteria
nov.	I-bacteria	I-bacteria
,	O	O
sp	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
is	O	O
proposed	O	O
to	O	O
accommodate	O	O
these	O	O
strains	O	O
.	O	O

The	O	O
genus	B-bacteria	B-bacteria
Pyramidobacter	E-bacteria	I-bacteria
comprises	O	O
strains	O	O
that	O	O
are	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
non-motile	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
asaccharolytic	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
that	O	O
produce	O	O
acetic	O	O
and	O	O
isovaleric	O	O
acids	O	O
and	O	O
minor	O	O
to	O	O
trace	O	O
amounts	O	O
of	O	O
propionic	O	O
,	O	O
isobutyric	O	O
,	O	O
succinic	O	O
and	O	O
phenylacetic	O	O
acids	O	O
as	O	O
end	O	O
products	O	O
of	O	O
metabolism	O	O
.	O	O

P.	B-bacteria	B-bacteria
piscolens	I-bacteria	I-bacteria
gen.	I-bacteria	I-bacteria
nov.	E-bacteria	I-bacteria
,	O	O
sp	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
produced	O	O
hydrogen	O	O
sulphide	O	O
but	O	O
was	O	O
otherwise	O	O
largely	O	O
biochemically	O	O
unreactive	O	O
.	O	O

Growth	O	O
was	O	O
stimulated	O	O
by	O	O
the	O	O
addition	O	O
of	O	O
glycine	O	O
to	O	O
broth	O	O
media	O	O
.	O	O

The	O	O
G+C	O	O
content	O	O
of	O	O
the	O	O
DNA	O	O
of	O	O
the	O	O
type	O	O
strain	O	O
was	O	O
59	O	O
mol	O	O
%	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
of	O	O
Pyramidobacter	B-bacteria	B-bacteria
piscolens	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
is	O	O
W5455	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
=DSM	B-bacteria	B-bacteria
21147	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
55836	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
.	O	O

The	O	O
combined	O	O
use	O	O
of	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
(	O	O
CLSM	O	O
)	O	O
and	O	O
fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
offers	O	O
new	O	O
opportunities	O	O
for	O	O
analysis	O	O
of	O	O
the	O	O
spatial	O	O
relationships	O	O
and	O	O
temporal	O	O
changes	O	O
of	O	O
specific	O	O
members	O	O
of	O	O
the	O	O
microbiota	O	O
of	O	O
intact	O	O
dental	O	O
biofilms	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
analyse	O	O
the	O	O
patterns	O	O
of	O	O
colonization	O	O
and	O	O
population	O	O
dynamics	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
compared	O	O
to	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
other	O	O
bacteria	O	O
during	O	O
the	O	O
initial	O	O
48	O	O
h	O	O
of	O	O
biofilm	O	O
formation	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Biofilms	O	O
developed	O	O
on	O	O
standardized	O	O
glass	O	O
slabs	O	O
mounted	O	O
in	O	O
intra-oral	O	O
appliances	O	O
worn	O	O
by	O	O
ten	O	O
individuals	O	O
for	O	O
6	O	O
,	O	O
12	O	O
,	O	O
24	O	O
and	O	O
48	O	O
h.	O	O
The	O	O
biofilms	O	O
were	O	O
subsequently	O	O
labelled	O	O
with	O	O
probes	O	O
against	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
(	O	O
ACT476	B-bacteria	B-bacteria
)	O	O
,	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
STR405	B-bacteria	B-bacteria
)	O	O
or	O	O
all	O	O
bacteria	O	O
(	O	O
EUB338	O	O
)	O	O
,	O	O
and	O	O
were	O	O
analysed	O	O
by	O	O
CLSM	O	O
.	O	O

Labelled	O	O
bacteria	O	O
were	O	O
quantified	O	O
by	O	O
stereological	O	O
tools	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
a	O	O
notable	O	O
increase	O	O
in	O	O
the	O	O
number	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
over	O	O
time	O	O
,	O	O
with	O	O
a	O	O
tendency	O	O
towards	O	O
a	O	O
slower	O	O
growth	O	O
rate	O	O
for	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
compared	O	O
with	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
was	O	O
located	O	O
mainly	O	O
in	O	O
the	O	O
inner	O	O
part	O	O
of	O	O
the	O	O
multilayered	O	O
biofilm	O	O
,	O	O
indicating	O	O
that	O	O
it	O	O
is	O	O
one	O	O
of	O	O
the	O	O
species	O	O
that	O	O
attaches	O	O
directly	O	O
to	O	O
the	O	O
acquired	O	O
pellicle	O	O
.	O	O

The	O	O
participation	O	O
of	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
in	O	O
the	O	O
initial	O	O
stages	O	O
of	O	O
dental	O	O
biofilm	O	O
formation	O	O
may	O	O
have	O	O
important	O	O
ecological	O	O
consequences	O	O
.	O	O

TGF-beta1	O	O
exerts	O	O
diverse	O	O
functions	O	O
in	O	O
tooth	O	O
development	O	O
and	O	O
tissue	O	O
repair	O	O
,	O	O
but	O	O
its	O	O
role	O	O
in	O	O
microbial	O	O
defenses	O	O
of	O	O
the	O	O
tooth	O	O
is	O	O
not	O	O
well-understood	O	O
.	O	O

Odontoblasts	O	O
extending	O	O
their	O	O
cellular	O	O
processes	O	O
into	O	O
the	O	O
dentin	O	O
are	O	O
the	O	O
first	O	O
cells	O	O
to	O	O
recognize	O	O
signals	O	O
from	O	O
TGF-beta1	O	O
and	O	O
bacteria	O	O
in	O	O
carious	O	O
dentin	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
determine	O	O
the	O	O
role	O	O
of	O	O
TGF-beta1	O	O
in	O	O
modulating	O	O
odontoblast	O	O
responses	O	O
to	O	O
oral	O	O
bacteria	O	O
.	O	O

We	O	O
show	O	O
that	O	O
these	O	O
responses	O	O
depend	O	O
upon	O	O
the	O	O
expression	O	O
levels	O	O
of	O	O
microbial	O	O
recognition	O	O
receptors	O	O
TLR2	O	O
and	O	O
TLR4	O	O
on	O	O
the	O	O
cell	O	O
surface	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
activated	O	O
both	O	O
TLRs	O	O
,	O	O
but	O	O
TLR4	O	O
played	O	O
a	O	O
greater	O	O
role	O	O
.	O	O

Lack	O	O
of	O	O
cell-surface	O	O
TLR2	O	O
was	O	O
associated	O	O
with	O	O
poor	O	O
response	O	O
to	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
.	O	O

TGF-beta1	O	O
inhibited	O	O
TLR2	O	O
and	O	O
TLR4	O	O
expression	O	O
and	O	O
attenuated	O	O
odontoblast	O	O
responses	O	O
.	O	O

Our	O	O
findings	O	O
suggest	O	O
that	O	O
the	O	O
balance	O	O
between	O	O
TLR-mediated	O	O
inflammation	O	O
and	O	O
TGF-beta1	O	O
anti-inflammatory	O	O
activity	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
pulpal	O	O
inflammation	O	O
.	O	O

This	O	O
study	O	O
was	O	O
performed	O	O
to	O	O
detect	O	O
the	O	O
opportunistic	O	O
bacteria	O	O
and	O	O
fungi	O	O
from	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
orthodontic	O	O
patients	O	O
and	O	O
examine	O	O
the	O	O
ability	O	O
of	O	O
the	O	O
organisms	O	O
to	O	O
adhere	O	O
to	O	O
saliva-coated	O	O
metallic	O	O
brackets	O	O
.	O	O

Opportunistic	O	O
bacteria	O	O
and	O	O
fungi	O	O
were	O	O
isolated	O	O
from	O	O
58	O	O
patients	O	O
(	O	O
orthodontic	O	O
group	O	O
:	O	O
42	O	O
;	O	O
non-orthodontic	O	O
group	O	O
:	O	O
16	O	O
)	O	O
using	O	O
culture	O	O
methods	O	O
and	O	O
were	O	O
identified	O	O
based	O	O
on	O	O
their	O	O
biochemical	O	O
and	O	O
enzymatic	O	O
profiles	O	O
.	O	O

Seven	O	O
opportunistic	O	O
and	O	O
four	O	O
streptococcal	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
tested	O	O
for	O	O
their	O	O
ability	O	O
to	O	O
adhere	O	O
to	O	O
saliva-coated	O	O
metallic	O	O
brackets	O	O
.	O	O

More	O	O
opportunistic	O	O
bacteria	O	O
and	O	O
fungi	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
orthodontic	O	O
group	O	O
than	O	O
in	O	O
the	O	O
non-orthodontic	O	O
group	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Opportunistic	O	O
bacteria	O	O
adhered	O	O
to	O	O
saliva-coated	O	O
metallic	O	O
brackets	O	O
to	O	O
the	O	O
same	O	O
degree	O	O
as	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

The	O	O
isolation	O	O
frequencies	O	O
of	O	O
opportunistic	O	O
bacteria	O	O
and	O	O
fungi	O	O
increase	O	O
during	O	O
orthodontic	O	O
treatment	O	O
,	O	O
suggesting	O	O
the	O	O
importance	O	O
of	O	O
paying	O	O
special	O	O
attention	O	O
to	O	O
oral	O	O
hygiene	O	O
in	O	O
orthodontic	O	O
patients	O	O
to	O	O
prevent	O	O
periodontal	O	O
disease	O	O
and	O	O
the	O	O
aggravation	O	O
of	O	O
systemic	O	O
disease	O	O
in	O	O
immunocompromised	O	O
conditions	O	O
.	O	O

Knowledge	O	O
of	O	O
the	O	O
early	O	O
oral	O	O
colonization	O	O
patterns	O	O
could	O	O
provide	O	O
a	O	O
better	O	O
understanding	O	O
of	O	O
oral	O	O
biofilm	O	O
development	O	O
and	O	O
disease	O	O
initiation	O	O
that	O	O
in	O	O
turn	O	O
could	O	O
be	O	O
the	O	O
basis	O	O
for	O	O
early	O	O
preventive	O	O
programmes	O	O
.	O	O

Microbial	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
five	O	O
different	O	O
oral	O	O
habitats	O	O
from	O	O
a	O	O
total	O	O
of	O	O
93	O	O
children	O	O
(	O	O
age	O	O
3-12	O	O
years	O	O
)	O	O
,	O	O
attending	O	O
the	O	O
Dental	O	O
School	O	O
of	O	O
the	O	O
University	O	O
of	O	O
Athens	O	O
,	O	O
who	O	O
were	O	O
split	O	O
into	O	O
three	O	O
age	O	O
groups	O	O
.	O	O

A	O	O
total	O	O
of	O	O
38	O	O
microbial	O	O
species	O	O
were	O	O
sought	O	O
out	O	O
by	O	O
the	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
technique	O	O
.	O	O

All	O	O
of	O	O
the	O	O
test	O	O
species	O	O
,	O	O
except	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
differed	O	O
significantly	O	O
among	O	O
sample	O	O
locations	O	O
providing	O	O
quite	O	O
distinct	O	O
microbial	O	O
profiles	O	O
for	O	O
the	O	O
different	O	O
oral	O	O
surfaces	O	O
.	O	O

Supragingival	O	O
and	O	O
subgingival	O	O
plaque	O	O
had	O	O
similar	O	O
profiles	O	O
and	O	O
exhibited	O	O
higher	O	O
proportions	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
species	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
Green	I-bacteria	I-bacteria
complex	E-bacteria	I-bacteria
while	O	O
soft	O	O
tissue	O	O
samples	O	O
were	O	O
dominated	O	O
by	O	O
streptococci	B-bacteria	B-bacteria
of	O	O
the	O	O
Yellow	O	O
complex	O	O
.	O	O

The	O	O
profiles	O	O
of	O	O
the	O	O
tongue	O	O
dorsum	O	O
and	O	O
saliva	O	O
were	O	O
also	O	O
similar	O	O
.	O	O

Many	O	O
of	O	O
the	O	O
species	O	O
were	O	O
in	O	O
similar	O	O
proportions	O	O
in	O	O
all	O	O
three	O	O
age	O	O
groups	O	O
for	O	O
a	O	O
given	O	O
location	O	O
.	O	O

Periodontal	O	O
pathogens	O	O
showed	O	O
increases	O	O
in	O	O
proportions	O	O
with	O	O
increasing	O	O
age	O	O
.	O	O

Specifically	O	O
,	O	O
the	O	O
Red	O	O
complex	O	O
species	O	O
(	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
showed	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
proportion	O	O
with	O	O
age	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
in	O	O
all	O	O
sample	O	O
locations	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
a	O	O
pattern	O	O
of	O	O
colonization	O	O
in	O	O
children	O	O
similar	O	O
to	O	O
that	O	O
previously	O	O
found	O	O
in	O	O
adults	O	O
.	O	O

Differences	O	O
in	O	O
the	O	O
profile	O	O
between	O	O
age	O	O
groups	O	O
suggest	O	O
a	O	O
gradual	O	O
maturation	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
,	O	O
with	O	O
it	O	O
being	O	O
made	O	O
up	O	O
of	O	O
an	O	O
increasing	O	O
number	O	O
of	O	O
Orange	O	O
and	O	O
Red	O	O
complex	O	O
species	O	O
.	O	O

We	O	O
investigated	O	O
receptor	O	O
activator	O	O
of	O	O
nuclear	O	O
factor-kappaB	O	O
ligand	O	O
(	O	O
RANKL	O	O
)	O	O
expression	O	O
by	O	O
B	O	O
lymphocytes	O	O
during	O	O
early	O	O
and	O	O
late	O	O
aspects	O	O
of	O	O
the	O	O
immune	O	O
response	O	O
to	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	B-bacteria	B-bacteria
,	O	O
a	O	O
gram-negative	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacterium	E-bacteria	I-bacteria
associated	O	O
with	O	O
aggressive	O	O
periodontal	O	O
disease	O	O
.	O	O

Expression	O	O
of	O	O
messenger	O	O
RNA	O	O
transcripts	O	O
(	O	O
tumor	O	O
necrosis	O	O
factor-alpha	O	O
,	O	O
Toll-like	O	O
receptors	O	O
4	O	O
and	O	O
9	O	O
,	O	O
interleukins	O	O
4	O	O
and	O	O
10	O	O
,	O	O
and	O	O
RANKL	O	O
)	O	O
involved	O	O
in	O	O
early	O	O
(	O	O
1-day	O	O
)	O	O
and	O	O
late	O	O
(	O	O
10-day	O	O
)	O	O
responses	O	O
in	O	O
cultured	O	O
rat	O	O
splenocytes	O	O
was	O	O
examined	O	O
by	O	O
reverse	O	O
transcription-polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
RT-PCR	O	O
)	O	O
.	O	O

The	O	O
immune	O	O
cell	O	O
distribution	O	O
(	O	O
T	O	O
,	O	O
B	O	O
,	O	O
and	O	O
natural	O	O
killer	O	O
cells	O	O
and	O	O
macrophages	O	O
)	O	O
in	O	O
cultured	O	O
rat	O	O
splenocytes	O	O
and	O	O
RANKL	O	O
expression	O	O
in	O	O
B	O	O
cells	O	O
were	O	O
determined	O	O
by	O	O
flow	O	O
cytometric	O	O
analyses	O	O
.	O	O

B-cell	O	O
capacity	O	O
for	O	O
induction	O	O
of	O	O
osteoclast	O	O
differentiation	O	O
was	O	O
evaluated	O	O
by	O	O
coculture	O	O
with	O	O
RAW	O	O
264.7	O	O
cells	O	O
followed	O	O
by	O	O
a	O	O
tartrate-resistant	O	O
acid	O	O
phosphatase	O	O
(	O	O
TRAP	O	O
)	O	O
activity	O	O
assay	O	O
.	O	O

The	O	O
expression	O	O
levels	O	O
of	O	O
interleukins	O	O
4	O	O
and	O	O
10	O	O
in	O	O
cultured	O	O
cells	O	O
were	O	O
not	O	O
changed	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
until	O	O
cultured	O	O
for	O	O
3	O	O
days	O	O
,	O	O
and	O	O
peaked	O	O
after	O	O
7	O	O
days	O	O
.	O	O

After	O	O
culture	O	O
for	O	O
10	O	O
days	O	O
,	O	O
the	O	O
percentages	O	O
of	O	O
B	O	O
and	O	O
T	O	O
cells	O	O
,	O	O
the	O	O
overall	O	O
RANKL	O	O
messenger	O	O
RNA	O	O
transcripts	O	O
,	O	O
and	O	O
the	O	O
percentage	O	O
of	O	O
RANKL-expressing	O	O
immunoglobulin	O	O
G-positive	O	O
cells	O	O
were	O	O
significantly	O	O
increased	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

These	O	O
increases	O	O
were	O	O
considerably	O	O
greater	O	O
in	O	O
cells	O	O
isolated	O	O
from	O	O
A.	O	O
actinomycetemcomitans-immunized	O	O
animals	O	O
than	O	O
from	O	O
non-immunized	O	O
animals	O	O
.	O	O

RAW	O	O
264.7	O	O
cells	O	O
demonstrated	O	O
significantly	O	O
increased	O	O
TRAP	O	O
activity	O	O
when	O	O
cocultured	O	O
with	O	O
B	O	O
cells	O	O
from	O	O
A.	O	O
actinomycetemcomitans-immunized	O	O
animals	O	O
.	O	O

The	O	O
addition	O	O
of	O	O
human	O	O
osteoprotegerin-Fc	O	O
to	O	O
the	O	O
culture	O	O
significantly	O	O
diminished	O	O
such	O	O
increases	O	O
.	O	O

This	O	O
study	O	O
suggests	O	O
that	O	O
B-lymphocyte	O	O
involvement	O	O
in	O	O
the	O	O
immune	O	O
response	O	O
to	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
through	O	O
upregulation	O	O
of	O	O
RANKL	O	O
expression	O	O
potentially	O	O
contribute	O	O
to	O	O
bone	O	O
resorption	O	O
in	O	O
periodontal	O	O
disease	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
is	O	O
very	O	O
prevalent	O	O
in	O	O
Brazil	O	O
,	O	O
infecting	O	O
almost	O	O
65	O	O
%	O	O
of	O	O
the	O	O
population	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
presence	O	O
of	O	O
this	O	O
bacterium	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
with	O	O
functional	O	O
dyspepsia	O	O
(	O	O
epigastric	O	O
pain	O	O
syndrome	O	O
)	O	O
,	O	O
establish	O	O
the	O	O
main	O	O
sites	O	O
of	O	O
infection	O	O
in	O	O
the	O	O
mouth	O	O
,	O	O
and	O	O
assess	O	O
the	O	O
frequency	O	O
of	O	O
cagA	O	O
and	O	O
vacA	O	O
genotypes	O	O
of	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

All	O	O
43	O	O
outpatients	O	O
with	O	O
epigastric	O	O
pain	O	O
syndrome	O	O
,	O	O
who	O	O
entered	O	O
the	O	O
study	O	O
,	O	O
were	O	O
submitted	O	O
to	O	O
upper	O	O
gastrointestinal	O	O
endoscopy	O	O
to	O	O
rule	O	O
out	O	O
organic	O	O
diseases	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
in	O	O
the	O	O
stomach	O	O
was	O	O
confirmed	O	O
by	O	O
a	O	O
rapid	O	O
urease	O	O
test	O	O
and	O	O
urea	O	O
breath	O	O
tests	O	O
.	O	O

Samples	O	O
of	O	O
saliva	O	O
,	O	O
the	O	O
tongue	O	O
dorsum	O	O
and	O	O
supragingival	O	O
dental	O	O
plaque	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
each	O	O
subject	O	O
and	O	O
subgingival	O	O
dental	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
patients	O	O
with	O	O
periodontitis	O	O
;	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
was	O	O
verified	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
using	O	O
primers	O	O
that	O	O
amplify	O	O
the	O	O
DNA	O	O
sequence	O	O
of	O	O
a	O	O
species-specific	O	O
antigen	O	O
present	O	O
in	O	O
all	O	O
H.	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
;	O	O
primers	O	O
that	O	O
amplify	O	O
a	O	O
region	O	O
of	O	O
urease	O	O
gene	O	O
,	O	O
and	O	O
primers	O	O
for	O	O
cagA	O	O
and	O	O
vacA	O	O
(	O	O
m1	O	O
,	O	O
m2	O	O
,	O	O
s1a	O	O
,	O	O
s1b	O	O
,	O	O
s2	O	O
)	O	O
genotyping	O	O
.	O	O

Thirty	O	O
patients	O	O
harbored	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
stomach	O	O
,	O	O
but	O	O
it	O	O
was	O	O
not	O	O
possible	O	O
to	O	O
detect	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
any	O	O
oral	O	O
samples	O	O
using	O	O
P1/P2	O	O
and	O	O
Urease	O	O
A/B	O	O
.	O	O

The	O	O
genotype	O	O
cagA	O	O
was	O	O
also	O	O
negative	O	O
in	O	O
all	O	O
samples	O	O
and	O	O
vacA	O	O
genotype	O	O
could	O	O
not	O	O
be	O	O
characterized	O	O
(	O	O
s-m-	O	O
)	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
may	O	O
not	O	O
be	O	O
a	O	O
reservoir	O	O
for	O	O
H.	O	O
pylori	O	O
in	O	O
patients	O	O
with	O	O
epigastric	O	O
pain	O	O
syndrome	O	O
,	O	O
the	O	O
bacterium	O	O
being	O	O
detected	O	O
exclusively	O	O
in	O	O
the	O	O
stomach	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
is	O	O
a	O	O
member	O	O
of	O	O
the	O	O
normal	O	O
human	O	O
oral	O	O
microbiota	O	O
,	O	O
capable	O	O
of	O	O
opportunistic	O	O
pathogenicity	O	O
;	O	O
like	O	O
related	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
it	O	O
exhibits	O	O
appreciable	O	O
phenotypic	O	O
and	O	O
genetic	O	O
variation	O	O
.	O	O

A	O	O
multilocus	O	O
sequence	O	O
typing	O	O
(	O	O
MLST	O	O
)	O	O
scheme	O	O
for	O	O
S.	O	O
oralis	O	O
was	O	O
developed	O	O
and	O	O
the	O	O
resultant	O	O
data	O	O
analysed	O	O
to	O	O
examine	O	O
the	O	O
population	O	O
structure	O	O
of	O	O
the	O	O
species	O	O
.	O	O

Analysis	O	O
of	O	O
113	O	O
isolates	O	O
,	O	O
confirmed	O	O
as	O	O
belonging	O	O
to	O	O
the	O	O
S.	O	O
oralis/mitis	O	O
group	O	O
by	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
,	O	O
characterized	O	O
the	O	O
population	O	O
as	O	O
highly	O	O
diverse	O	O
and	O	O
undergoing	O	O
inter-	O	O
and	O	O
intra-species	O	O
recombination	O	O
with	O	O
a	O	O
probable	O	O
clonal	O	O
complex	O	O
structure	O	O
.	O	O

ClonalFrame	O	O
analysis	O	O
of	O	O
these	O	O
S.	O	O
oralis	O	O
isolates	O	O
along	O	O
with	O	O
examples	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
pseudopneumoniae	E-bacteria	I-bacteria
grouped	O	O
the	O	O
named	O	O
species	O	O
into	O	O
distinct	O	O
,	O	O
coherent	O	O
populations	O	O
and	O	O
did	O	O
not	O	O
support	O	O
the	O	O
clustering	O	O
of	O	O
S.	B-bacteria	B-bacteria
pseudopneumoniae	E-bacteria	I-bacteria
with	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
as	O	O
reported	O	O
previously	O	O
using	O	O
distance-based	O	O
methods	O	O
.	O	O

Analysis	O	O
of	O	O
the	O	O
individual	O	O
loci	O	O
suggested	O	O
that	O	O
this	O	O
discrepancy	O	O
was	O	O
due	O	O
to	O	O
the	O	O
possible	O	O
hybrid	O	O
nature	O	O
of	O	O
S.	B-bacteria	B-bacteria
pseudopneumoniae	E-bacteria	I-bacteria
.	O	O

This	O	O
randomized	O	O
clinical	O	O
trial	O	O
evaluated	O	O
the	O	O
effects	O	O
of	O	O
an	O	O
essential	O	O
oils-containing	O	O
mouthrinse	O	O
for	O	O
full-mouth	O	O
disinfection	O	O
.	O	O

Fifty	O	O
patients	O	O
were	O	O
assigned	O	O
to	O	O
receive	O	O
full-mouth	O	O
disinfection	O	O
with	O	O
either	O	O
essential	O	O
oils	O	O
or	O	O
placebo	O	O
.	O	O

At	O	O
baseline	O	O
,	O	O
2	O	O
and	O	O
6	O	O
months	O	O
of	O	O
treatment	O	O
the	O	O
primary	O	O
outcomes	O	O
probing	O	O
depth	O	O
(	O	O
PD	O	O
)	O	O
,	O	O
plaque	O	O
index	O	O
(	O	O
PlI	O	O
)	O	O
and	O	O
modified	O	O
gingival	O	O
index	O	O
(	O	O
MGI	O	O
)	O	O
were	O	O
monitored	O	O
.	O	O

Additional	O	O
monitoring	O	O
included	O	O
bacterial	O	O
presence	O	O
(	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
)	O	O
in	O	O
subgingival	O	O
,	O	O
saliva	O	O
and	O	O
tongue	O	O
samples	O	O
;	O	O
flows	O	O
,	O	O
pH	O	O
,	O	O
total	O	O
protein	O	O
and	O	O
alkaline	O	O
phosphatase	O	O
salivary	O	O
levels	O	O
.	O	O

The	O	O
following	O	O
statistics	O	O
were	O	O
used	O	O
:	O	O
ANOVA	O	O
,	O	O
Student	O	O
's	O	O
t-test	O	O
,	O	O
chi	O	O
(	O	O
2	O	O
)	O	O
and	O	O
Kruskal-Wallis	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Mean	O	O
PD	O	O
>	O	O
or=3.5	O	O
mm	O	O
was	O	O
reduced	O	O
over	O	O
time	O	O
in	O	O
both	O	O
the	O	O
placebo	O	O
and	O	O
the	O	O
test	O	O
groups	O	O
,	O	O
but	O	O
there	O	O
was	O	O
no	O	O
difference	O	O
in	O	O
PD	O	O
reduction	O	O
between	O	O
groups	O	O
at	O	O
2	O	O
and	O	O
6	O	O
months	O	O
.	O	O

At	O	O
2	O	O
and	O	O
6	O	O
months	O	O
,	O	O
PlI	O	O
and	O	O
MGI	O	O
showed	O	O
greater	O	O
reductions	O	O
in	O	O
the	O	O
test	O	O
group	O	O
than	O	O
in	O	O
the	O	O
placebo	O	O
group	O	O
.	O	O

Porphyromona	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
not	O	O
reduced	O	O
in	O	O
any	O	O
site	O	O
.	O	O

At	O	O
6	O	O
months	O	O
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
increased	O	O
in	O	O
both	O	O
groups	O	O
,	O	O
while	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
decreased	O	O
subgingivally	O	O
in	O	O
the	O	O
test	O	O
group	O	O
.	O	O

S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
increased	O	O
,	O	O
except	O	O
subgingivally	O	O
,	O	O
in	O	O
the	O	O
placebo	O	O
group	O	O
.	O	O

Salivary	O	O
pH	O	O
and	O	O
flows	O	O
were	O	O
not	O	O
altered	O	O
.	O	O

Total	O	O
protein	O	O
reduced	O	O
only	O	O
in	O	O
the	O	O
test	O	O
group	O	O
.	O	O

Alkaline	O	O
phosphatase	O	O
did	O	O
not	O	O
change	O	O
in	O	O
either	O	O
group	O	O
.	O	O

Essential	O	O
oils	O	O
for	O	O
full-mouth	O	O
disinfection	O	O
showed	O	O
clinical	O	O
benefits	O	O
,	O	O
namely	O	O
reducing	O	O
plaque	O	O
and	O	O
gingival	O	O
inflammation	O	O
without	O	O
altering	O	O
basic	O	O
salivary	O	O
parameters	O	O
.	O	O

To	O	O
purify	O	O
and	O	O
partially	O	O
characterize	O	O
a	O	O
bacteriocin	O	O
produced	O	O
by	O	O
a	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
.	O	O
Following	O	O
protein	O	O
precipitation	O	O
the	O	O
effect	O	O
of	O	O
different	O	O
treatments	O	O
on	O	O
a	O	O
bacteriocin	O	O
produced	O	O
by	O	O
a	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
named	O	O
P12.2	B-bacteria	B-bacteria
isolated	O	O
from	O	O
a	O	O
patient	O	O
with	O	O
periodontitis	O	O
was	O	O
evaluated	O	O
.	O	O

The	O	O
antagonistic	O	O
activity	O	O
of	O	O
the	O	O
intracellular	O	O
fraction	O	O
obtained	O	O
at	O	O
80	O	O
%	O	O
ammonium	O	O
sulphate	O	O
was	O	O
preserved	O	O
at	O	O
pH	O	O
values	O	O
from	O	O
6.0	O	O
to	O	O
9.0	O	O
and	O	O
showed	O	O
to	O	O
be	O	O
sensitive	O	O
to	O	O
high	O	O
temperatures	O	O
and	O	O
to	O	O
treatment	O	O
with	O	O
proteases	O	O
.	O	O

The	O	O
fraction	O	O
was	O	O
submitted	O	O
to	O	O
sequential	O	O
steps	O	O
of	O	O
gel	O	O
filtration	O	O
,	O	O
ion	O	O
exchange	O	O
,	O	O
and	O	O
reverse	O	O
phase	O	O
chromatography	O	O
,	O	O
and	O	O
SDS-PAGE	O	O
.	O	O

Data	O	O
obtained	O	O
by	O	O
mass	O	O
spectrometry	O	O
revealed	O	O
that	O	O
the	O	O
molecular	O	O
mass	O	O
of	O	O
the	O	O
protein	O	O
was	O	O
27,296	O	O
Da	O	O
.	O	O

For	O	O
the	O	O
first	O	O
time	O	O
a	O	O
bacteriocin	O	O
produced	O	O
by	O	O
a	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
was	O	O
purified	O	O
and	O	O
characterized	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
description	O	O
on	O	O
characterization	O	O
of	O	O
a	O	O
bacteriocin	O	O
produced	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

It	O	O
is	O	O
possible	O	O
that	O	O
the	O	O
bacteriocin	O	O
plays	O	O
a	O	O
role	O	O
in	O	O
the	O	O
regulation	O	O
of	O	O
population	O	O
levels	O	O
of	O	O
periodontopathic	O	O
organisms	O	O
.	O	O

Bacteria	O	O
settled	O	O
in	O	O
the	O	O
apical	O	O
root	O	O
canal	O	O
are	O	O
in	O	O
a	O	O
privileged	O	O
position	O	O
to	O	O
inflict	O	O
damage	O	O
to	O	O
the	O	O
periradicular	O	O
tissues	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
species	O	O
identified	O	O
in	O	O
this	O	O
region	O	O
can	O	O
be	O	O
of	O	O
special	O	O
relevance	O	O
for	O	O
the	O	O
pathogenesis	O	O
of	O	O
apical	O	O
periodontitis	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
occurrence	O	O
and	O	O
levels	O	O
of	O	O
several	O	O
bacterial	O	O
taxa	O	O
in	O	O
the	O	O
apical	O	O
root	O	O
canal	O	O
of	O	O
teeth	O	O
with	O	O
apical	O	O
periodontitis	O	O
.	O	O

DNA	O	O
extracts	O	O
from	O	O
samples	O	O
taken	O	O
from	O	O
the	O	O
apical	O	O
part	O	O
of	O	O
the	O	O
root	O	O
canal	O	O
of	O	O
extracted	O	O
teeth	O	O
evincing	O	O
chronic	O	O
apical	O	O
periodontitis	O	O
lesions	O	O
served	O	O
as	O	O
templates	O	O
for	O	O
analysis	O	O
of	O	O
the	O	O
presence	O	O
and	O	O
levels	O	O
of	O	O
28	O	O
bacterial	O	O
species/phylotypes	O	O
using	O	O
a	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
gene-based	O	O
reverse-capture	O	O
checkerboard	O	O
hybridization	O	O
assay	O	O
.	O	O

Bacterial	O	O
DNA	O	O
was	O	O
detected	O	O
in	O	O
19	O	O
out	O	O
of	O	O
20	O	O
samples	O	O
.	O	O

Detected	O	O
taxa	O	O
included	O	O
Pseudoramibacter	B-bacteria	B-bacteria
alactolyticus	E-bacteria	I-bacteria
(	O	O
32	O	O
%	O	O
)	O	O
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
clone	I-bacteria	I-bacteria
X083	E-bacteria	I-bacteria
(	O	O
26	O	O
%	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
21	O	O
%	O	O
)	O	O
,	O	O
Olsenella	B-bacteria	B-bacteria
uli	E-bacteria	I-bacteria
(	O	O
10.5	O	O
%	O	O
)	O	O
,	O	O
Synergistes	B-bacteria	B-bacteria
clone	I-bacteria	I-bacteria
BA121	E-bacteria	I-bacteria
(	O	O
10.5	O	O
%	O	O
)	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
10.5	O	O
%	O	O
)	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
endodontalis	E-bacteria	I-bacteria
(	O	O
10.5	O	O
%	O	O
)	O	O
,	O	O
Dialister	B-bacteria	B-bacteria
clone	I-bacteria	I-bacteria
BS016	E-bacteria	I-bacteria
(	O	O
5	O	O
%	O	O
)	O	O
,	O	O
Filifactor	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
(	O	O
5	O	O
%	O	O
)	O	O
,	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
(	O	O
5	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
(	O	O
5	O	O
%	O	O
)	O	O
.	O	O

Of	O	O
these	O	O
,	O	O
only	O	O
Bacteroidetes	B-bacteria	B-bacteria
clone	I-bacteria	I-bacteria
X083	E-bacteria	I-bacteria
and	O	O
Synergistes	B-bacteria	B-bacteria
clone	I-bacteria	I-bacteria
BA121	E-bacteria	I-bacteria
were	O	O
found	O	O
at	O	O
levels	O	O
above	O	O
10	O	O
(	O	O
5	O	O
)	O	O
.	O	O

Occurrence	O	O
of	O	O
these	O	O
bacterial	O	O
taxa	O	O
in	O	O
the	O	O
apical	O	O
part	O	O
of	O	O
infected	O	O
root	O	O
canals	O	O
indicates	O	O
their	O	O
potential	O	O
pathogenetic	O	O
role	O	O
in	O	O
the	O	O
etiology	O	O
of	O	O
apical	O	O
periodontitis	O	O
.	O	O

The	O	O
oral	O	O
microbial	O	O
flora	O	O
comprises	O	O
one	O	O
of	O	O
the	O	O
most	O	O
diverse	O	O
human-associated	O	O
biofilms	O	O
.	O	O

Its	O	O
development	O	O
is	O	O
heavily	O	O
influenced	O	O
by	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
which	O	O
are	O	O
considered	O	O
the	O	O
main	O	O
group	O	O
of	O	O
early	O	O
colonizers	O	O
.	O	O

Their	O	O
initial	O	O
attachment	O	O
determines	O	O
the	O	O
composition	O	O
of	O	O
later	O	O
colonizers	O	O
in	O	O
the	O	O
oral	O	O
biofilm	O	O
and	O	O
impacts	O	O
the	O	O
health	O	O
or	O	O
disease	O	O
status	O	O
of	O	O
the	O	O
host	O	O
.	O	O

Thus	O	O
,	O	O
the	O	O
role	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
the	O	O
development	O	O
of	O	O
oral	O	O
diseases	O	O
is	O	O
best	O	O
described	O	O
in	O	O
the	O	O
context	O	O
of	O	O
bacterial	O	O
ecology	O	O
,	O	O
which	O	O
itself	O	O
is	O	O
further	O	O
influenced	O	O
by	O	O
interactions	O	O
with	O	O
host	O	O
epithelial	O	O
cells	O	O
,	O	O
the	O	O
immune	O	O
system	O	O
,	O	O
and	O	O
salivary	O	O
components	O	O
.	O	O

The	O	O
tractability	O	O
of	O	O
the	O	O
oral	O	O
biofilm	O	O
makes	O	O
it	O	O
an	O	O
excellent	O	O
model	O	O
system	O	O
for	O	O
studies	O	O
of	O	O
complex	O	O
,	O	O
biofilm-associated	O	O
polymicrobial	O	O
diseases	O	O
.	O	O

Using	O	O
this	O	O
system	O	O
,	O	O
numerous	O	O
cooperative	O	O
and	O	O
antagonistic	O	O
bacterial	O	O
interactions	O	O
have	O	O
been	O	O
demonstrated	O	O
to	O	O
occur	O	O
within	O	O
the	O	O
community	O	O
and	O	O
with	O	O
the	O	O
host	O	O
.	O	O

In	O	O
this	O	O
review	O	O
,	O	O
several	O	O
recent	O	O
identified	O	O
interactions	O	O
are	O	O
presented	O	O
.	O	O

The	O	O
oral	O	O
microbial	O	O
consortium	O	O
is	O	O
the	O	O
most	O	O
characterized	O	O
polymicrobial	O	O
microbial	O	O
community	O	O
associated	O	O
with	O	O
the	O	O
human	O	O
host	O	O
.	O	O

Extensive	O	O
sampling	O	O
of	O	O
both	O	O
microbial	O	O
and	O	O
tissue	O	O
samples	O	O
has	O	O
demonstrated	O	O
that	O	O
there	O	O
is	O	O
a	O	O
strong	O	O
association	O	O
between	O	O
the	O	O
type	O	O
of	O	O
microbial	O	O
community	O	O
found	O	O
in	O	O
the	O	O
gingival	O	O
crevice	O	O
and	O	O
the	O	O
status	O	O
of	O	O
innate	O	O
host	O	O
mediator	O	O
expression	O	O
.	O	O

The	O	O
strong	O	O
clinical	O	O
association	O	O
between	O	O
the	O	O
microbial	O	O
community	O	O
and	O	O
the	O	O
innate	O	O
host	O	O
response	O	O
in	O	O
both	O	O
clinically	O	O
healthy	O	O
and	O	O
diseased	O	O
tissue	O	O
suggests	O	O
that	O	O
the	O	O
oral	O	O
consortium	O	O
has	O	O
a	O	O
direct	O	O
effect	O	O
on	O	O
periodontal	O	O
tissue	O	O
expression	O	O
of	O	O
innate	O	O
defense	O	O
mediators	O	O
.	O	O

A	O	O
preliminary	O	O
study	O	O
in	O	O
germ-free	O	O
mice	O	O
has	O	O
demonstrated	O	O
that	O	O
the	O	O
oral	O	O
commensal	O	O
consortium	O	O
has	O	O
direct	O	O
effect	O	O
on	O	O
IL-1beta	O	O
expression	O	O
,	O	O
indicating	O	O
that	O	O
this	O	O
microbial	O	O
community	O	O
may	O	O
contribute	O	O
to	O	O
the	O	O
strong	O	O
protective	O	O
status	O	O
of	O	O
healthy	O	O
gingival	O	O
tissue	O	O
.	O	O

Likewise	O	O
,	O	O
the	O	O
lipopolysaccharide	O	O
composition	O	O
and	O	O
invasion	O	O
characteristics	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
an	O	O
oral	O	O
bacterium	O	O
strongly	O	O
associated	O	O
with	O	O
periodontitis	O	O
,	O	O
suggest	O	O
that	O	O
it	O	O
may	O	O
be	O	O
a	O	O
keystone	O	O
member	O	O
of	O	O
the	O	O
oral	O	O
microbial	O	O
community	O	O
and	O	O
facilitate	O	O
a	O	O
destructive	O	O
change	O	O
in	O	O
the	O	O
protective	O	O
gingival	O	O
innate	O	O
host	O	O
status	O	O
.	O	O

This	O	O
study	O	O
was	O	O
designed	O	O
to	O	O
evaluate	O	O
whether	O	O
the	O	O
oral	O	O
administration	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
could	O	O
change	O	O
the	O	O
bacterial	O	O
population	O	O
in	O	O
supra/subgingival	O	O
plaque	O	O
.	O	O

Sixty-six	O	O
healthy	O	O
volunteers	O	O
without	O	O
severe	O	O
periodontitis	O	O
were	O	O
randomized	O	O
into	O	O
two	O	O
groups	O	O
to	O	O
receive	O	O
lactobacilli	B-bacteria	B-bacteria
or	O	O
placebo	O	O
for	O	O
8	O	O
weeks	O	O
(	O	O
8W	O	O
)	O	O
:	O	O
the	O	O
test	O	O
group	O	O
(	O	O
n=34	O	O
)	O	O
received	O	O
2.01	O	O
x	O	O
10	O	O
(	O	O
9	O	O
)	O	O
CFU/day	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
WB21	E-bacteria	I-bacteria
and	O	O
xylitol	O	O
in	O	O
tablets	O	O
;	O	O
the	O	O
control	O	O
group	O	O
(	O	O
n=32	O	O
)	O	O
received	O	O
placebo	O	O
with	O	O
xylitol	O	O
.	O	O

Supra/subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
at	O	O
the	O	O
baseline	O	O
and	O	O
after	O	O
4	O	O
weeks	O	O
(	O	O
4W	O	O
)	O	O
and	O	O
8W	O	O
.	O	O

The	O	O
bacterial	O	O
amounts	O	O
in	O	O
plaque	O	O
samples	O	O
were	O	O
analysed	O	O
by	O	O
quantitative	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

The	O	O
numerical	O	O
sum	O	O
of	O	O
five	O	O
selected	O	O
periodontopathic	O	O
bacteria	O	O
in	O	O
the	O	O
test	O	O
group	O	O
was	O	O
decreased	O	O
significantly	O	O
in	O	O
subgingival	O	O
plaque	O	O
at	O	O
4W	O	O
[	O	O
odds	O	O
ratio	O	O
(	O	O
OR	O	O
)	O	O
=3.13	O	O
,	O	O
95	O	O
%	O	O
confidence	O	O
intervals	O	O
(	O	O
CI	O	O
)	O	O
=1.28-7.65	O	O
,	O	O
p=0.012	O	O
]	O	O
.	O	O

Multivariate	O	O
analysis	O	O
showed	O	O
that	O	O
significantly	O	O
higher	O	O
odds	O	O
were	O	O
obtained	O	O
for	O	O
the	O	O
reduction	O	O
of	O	O
Tannerella	O	O
forsythia	O	O
in	O	O
subgingival	O	O
plaque	O	O
of	O	O
the	O	O
test	O	O
group	O	O
at	O	O
both	O	O
4W	O	O
(	O	O
OR=6.69	O	O
,	O	O
95	O	O
%	O	O
CI=2.51-17.9	O	O
,	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
and	O	O
8W	O	O
(	O	O
OR=3.67	O	O
,	O	O
95	O	O
%	O	O
CI=1.45-9.26	O	O
,	O	O
p=0.006	O	O
)	O	O
.	O	O

Oral	O	O
administration	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
lactobacilli	E-bacteria	I-bacteria
reduced	O	O
the	O	O
numerical	O	O
sum	O	O
of	O	O
five	O	O
selected	O	O
periodontopathic	O	O
bacteria	O	O
and	O	O
could	O	O
contribute	O	O
to	O	O
the	O	O
beneficial	O	O
effects	O	O
on	O	O
periodontal	O	O
conditions	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
is	O	O
a	O	O
periodontal	O	O
pathogen	O	O
that	O	O
resides	O	O
in	O	O
a	O	O
complex	O	O
multispecies	O	O
microbial	O	O
biofilm	O	O
community	O	O
known	O	O
as	O	O
dental	O	O
plaque	O	O
.	O	O

Confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
showed	O	O
that	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
can	O	O
assemble	O	O
into	O	O
communities	O	O
in	O	O
vitro	O	O
with	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
common	O	O
constituents	O	O
of	O	O
dental	O	O
plaque	O	O
.	O	O

Whole	O	O
cell	O	O
quantitative	O	O
proteomics	O	O
,	O	O
along	O	O
with	O	O
mutant	O	O
construction	O	O
and	O	O
analysis	O	O
,	O	O
were	O	O
conducted	O	O
to	O	O
investigate	O	O
how	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
adapts	O	O
to	O	O
this	O	O
three	O	O
species	O	O
community	O	O
.	O	O

1156	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
proteins	O	O
were	O	O
detected	O	O
qualitatively	O	O
during	O	O
comparison	O	O
of	O	O
the	O	O
three	O	O
species	O	O
model	O	O
community	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
incubated	O	O
alone	O	O
under	O	O
the	O	O
same	O	O
conditions	O	O
.	O	O

Integration	O	O
of	O	O
spectral	O	O
counting	O	O
and	O	O
summed	O	O
signal	O	O
intensity	O	O
analyses	O	O
of	O	O
the	O	O
dataset	O	O
showed	O	O
that	O	O
403	O	O
proteins	O	O
were	O	O
down-regulated	O	O
and	O	O
89	O	O
proteins	O	O
up-regulated	O	O
.	O	O

The	O	O
proteomics	O	O
results	O	O
were	O	O
inspected	O	O
manually	O	O
and	O	O
an	O	O
ontology	O	O
analysis	O	O
conducted	O	O
using	O	O
DAVID	O	O
.	O	O

Significant	O	O
decreases	O	O
were	O	O
seen	O	O
in	O	O
proteins	O	O
involved	O	O
in	O	O
cell	O	O
shape	O	O
and	O	O
the	O	O
formation	O	O
of	O	O
the	O	O
cell	O	O
envelope	O	O
,	O	O
as	O	O
well	O	O
as	O	O
thiamine	O	O
,	O	O
cobalamin	O	O
,	O	O
and	O	O
pyrimidine	O	O
synthesis	O	O
and	O	O
DNA	O	O
repair	O	O
.	O	O

An	O	O
overall	O	O
increase	O	O
was	O	O
seen	O	O
in	O	O
proteins	O	O
involved	O	O
in	O	O
protein	O	O
synthesis	O	O
.	O	O

HmuR	O	O
,	O	O
a	O	O
TonB	O	O
dependent	O	O
outer	O	O
membrane	O	O
receptor	O	O
,	O	O
was	O	O
up-regulated	O	O
in	O	O
the	O	O
community	O	O
and	O	O
an	O	O
hmuR	O	O
deficient	O	O
mutant	O	O
was	O	O
deficient	O	O
in	O	O
three	O	O
species	O	O
community	O	O
formation	O	O
,	O	O
but	O	O
was	O	O
unimpaired	O	O
in	O	O
its	O	O
ability	O	O
to	O	O
form	O	O
mono-	O	O
or	O	O
dual-species	O	O
biofilms	O	O
.	O	O

Collectively	O	O
,	O	O
these	O	O
results	O	O
indicate	O	O
that	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
can	O	O
assemble	O	O
into	O	O
a	O	O
heterotypic	O	O
community	O	O
with	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
and	O	O
that	O	O
a	O	O
community	O	O
lifestyle	O	O
provides	O	O
physiologic	O	O
support	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Proteins	O	O
such	O	O
as	O	O
HmuR	O	O
,	O	O
that	O	O
are	O	O
up-regulated	O	O
,	O	O
can	O	O
be	O	O
necessary	O	O
for	O	O
community	O	O
structure	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
correlation	O	O
between	O	O
the	O	O
changes	O	O
in	O	O
oral	O	O
microflora	O	O
and	O	O
recurrent	O	O
oral	O	O
ulcers	O	O
(	O	O
ROU	O	O
)	O	O
.	O	O

Salivary	O	O
sample	O	O
were	O	O
collected	O	O
from	O	O
ROU	O	O
patients	O	O
with	O	O
oral	O	O
ulcers	O	O
(	O	O
group	O	O
T	O	O
)	O	O
and	O	O
those	O	O
with	O	O
ulcer	O	O
healing	O	O
(	O	O
group	O	O
C	O	O
)	O	O
as	O	O
well	O	O
as	O	O
from	O	O
ROU-free	O	O
individuals	O	O
(	O	O
group	O	O
N	O	O
)	O	O
.	O	O

The	O	O
quantity	O	O
of	O	O
3	O	O
common	O	O
bacteria	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
and	O	O
Neisseria	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
)	O	O

in	O	O
the	O	O
salivary	O	O
samples	O	O
was	O	O
detected	O	O
and	O	O
compared	O	O
between	O	O
the	O	O
3	O	O
groups	O	O
.	O	O

The	O	O
quantities	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
7.30-/+0.89	O	O
copies/ml	O	O
)	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
8.29-/+0.77	O	O
copies/ml	O	O
)	O	O
in	O	O
group	O	O
T	O	O
were	O	O
significantly	O	O
lower	O	O
than	O	O
those	O	O
in	O	O
group	O	O
N	O	O
(	O	O
8.15-/+0.55	O	O
and	O	O
8.93-/+0.76	O	O
copies/ml	O	O
,	O	O
respectively	O	O
,	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
but	O	O
similar	O	O
with	O	O
those	O	O
in	O	O
group	O	O
C.	O	O
The	O	O
quantity	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
7.51-/+0.81	O	O
copies/ml	O	O
)	O	O
in	O	O
group	O	O
C	O	O
was	O	O
significantly	O	O
lower	O	O
than	O	O
that	O	O
in	O	O
group	O	O
N	O	O
(	O	O
8.15-/+0.55	O	O
copies/ml	O	O
,	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
but	O	O
the	O	O
quantity	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

was	O	O
similar	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
.	O	O

No	O	O
significant	O	O
difference	O	O
were	O	O
found	O	O
in	O	O
the	O	O
quantity	O	O
of	O	O
Neisseria	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

between	O	O
the	O	O
3	O	O
groups	O	O
.	O	O

The	O	O
quantity	O	O
of	O	O
oral	O	O
microflora	O	O
differs	O	O
significantly	O	O
between	O	O
patients	O	O
with	O	O
recurrent	O	O
oral	O	O
ulcers	O	O
and	O	O
normal	O	O
individuals	O	O
,	O	O
suggesting	O	O
a	O	O
possible	O	O
correlation	O	O
between	O	O
oral	O	O
microfora	O	O
and	O	O
recurrent	O	O
oral	O	O
ulcers	O	O
.	O	O

Separation	O	O
of	O	O
bacterial	O	O
DNA	O	O
from	O	O
human	O	O
DNA	O	O
in	O	O
clinical	O	O
samples	O	O
may	O	O
have	O	O
an	O	O
important	O	O
impact	O	O
on	O	O
downstream	O	O
applications	O	O
,	O	O
involving	O	O
microbial	O	O
diagnostic	O	O
systems	O	O
.	O	O

We	O	O
evaluated	O	O
two	O	O
commercially	O	O
available	O	O
reagents	O	O
(	O	O
MolYsis	O	O
)	O	O
,	O	O
Molzym	O	O
GmbH	O	O
&	O	O
Co.	O	O
KG	O	O
,	O	O
Bremen	O	O
and	O	O
Pureprove	O	O
,	O	O
SIRS-Lab	O	O
GmbH	O	O
,	O	O
Jena	O	O
,	O	O
both	O	O
Germany	O	O
)	O	O
for	O	O
their	O	O
potential	O	O
to	O	O
isolate	O	O
and	O	O
purify	O	O
bacterial	O	O
DNA	O	O
from	O	O
human	O	O
DNA	O	O
.	O	O

We	O	O
chose	O	O
oral	O	O
samples	O	O
,	O	O
which	O	O
usually	O	O
contain	O	O
very	O	O
high	O	O
amounts	O	O
of	O	O
both	O	O
human	O	O
and	O	O
bacterial	O	O
cells	O	O
.	O	O

Three	O	O
different	O	O
DNA	O	O
preparations	O	O
each	O	O
were	O	O
made	O	O
from	O	O
eight	O	O
caries	O	O
and	O	O
eight	O	O
periodontal	O	O
specimens	O	O
using	O	O
the	O	O
two	O	O
reagents	O	O
above	O	O
and	O	O
a	O	O
conventional	O	O
DNA	O	O
extraction	O	O
strategy	O	O
as	O	O
reference	O	O
.	O	O

Based	O	O
on	O	O
target-specific	O	O
real-time-quantitative	O	O
PCR	O	O
assays	O	O
we	O	O
compared	O	O
the	O	O
reduction	O	O
of	O	O
human	O	O
DNA	O	O
versus	O	O
loss	O	O
of	O	O
bacterial	O	O
DNA	O	O
.	O	O

Human	O	O
DNA	O	O
was	O	O
monitored	O	O
by	O	O
targeting	O	O
the	O	O
beta-2-microglobulin	O	O
gene	O	O
,	O	O
while	O	O
bacteria	O	O
were	O	O
monitored	O	O
by	O	O
targeting	O	O
16S	O	O
rDNA	O	O
(	O	O
total	O	O
bacteria	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
or	O	O
the	O	O
glycosyltransferase	O	O
gene	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
)	O	O
.	O	O

We	O	O
found	O	O
that	O	O
in	O	O
most	O	O
cases	O	O
at	O	O
least	O	O
90	O	O
%	O	O
of	O	O
human	O	O
DNA	O	O
could	O	O
successfully	O	O
be	O	O
removed	O	O
,	O	O
with	O	O
complete	O	O
removal	O	O
in	O	O
eight	O	O
of	O	O
16	O	O
cases	O	O
using	O	O
MolYsis	O	O
,	O	O
and	O	O
two	O	O
(	O	O
of	O	O
16	O	O
)	O	O
cases	O	O
using	O	O
Pureprove	O	O
.	O	O

Conversely	O	O
,	O	O
detection	O	O
of	O	O
bacterial	O	O
DNA	O	O
was	O	O
possible	O	O
in	O	O
all	O	O
cases	O	O
with	O	O
a	O	O
recovery	O	O
rate	O	O
generally	O	O
ranging	O	O
from	O	O
35	O	O
%	O	O
to	O	O
50	O	O
%	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
both	O	O
strategies	O	O
have	O	O
the	O	O
potential	O	O
to	O	O
reduce	O	O
background	O	O
interference	O	O
from	O	O
the	O	O
host	O	O
DNA	O	O
which	O	O
may	O	O
be	O	O
of	O	O
remarkable	O	O
value	O	O
for	O	O
nucleic-acid	O	O
based	O	O
microbial	O	O
diagnostic	O	O
systems	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
in	O	O
vitro	O	O
abilities	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
derived	O	O
from	O	O
consumer	O	O
products	O	O
to	O	O
coaggregate	O	O
with	O	O
caries-associated	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

Six	O	O
lactobacillus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
(	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
(	O	O
CCUG	B-bacteria	B-bacteria
5917	E-bacteria	I-bacteria
)	O	O
,	O	O
L.	B-bacteria	B-bacteria
plantarum	I-bacteria	I-bacteria
299v	E-bacteria	I-bacteria
,	O	O
L.	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
GG	E-bacteria	I-bacteria
and	O	O
LB21	B-bacteria	B-bacteria
,	O	O
L.	B-bacteria	B-bacteria
paracasei	I-bacteria	I-bacteria
F19	E-bacteria	I-bacteria
,	O	O
L.	B-bacteria	B-bacteria
reuteri	I-bacteria	I-bacteria
PTA5289	E-bacteria	I-bacteria
)	O	O
were	O	O
cultivated	O	O
under	O	O
anaerobic	O	O
conditions	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
in	O	O
Man	O	O
Rogosa	O	O
Sharpe	O	O
(	O	O
MSB	O	O
)	O	O
broth	O	O
for	O	O
24	O	O
h.	O	O
Four	O	O
strains	O	O
of	O	O
human	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
Ingbritt	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
ATCC	B-bacteria	B-bacteria
25175	E-bacteria	I-bacteria
)	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
GS-5	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
(	O	O
ATCC	B-bacteria	B-bacteria
33478	E-bacteria	I-bacteria
)	O	O
were	O	O
similarly	O	O
grown	O	O
in	O	O
Brain	O	O
Heart	O	O
Infusion	O	O
(	O	O
BHI	O	O
)	O	O
broth	O	O
.	O	O

A	O	O
gastrointestinal	O	O
pathogen	O	O
(	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
)	O	O
was	O	O
aerobically	O	O
cultivated	O	O
on	O	O
BHI	O	O
broth	O	O
as	O	O
a	O	O
positive	O	O
control	O	O
.	O	O

After	O	O
incubation	O	O
,	O	O
the	O	O
bacteria	O	O
were	O	O
aerobically	O	O
harvested	O	O
,	O	O
washed	O	O
,	O	O
and	O	O
suspended	O	O
in	O	O
10	O	O
mmol/l	O	O
phosphate-buffered	O	O
saline	O	O
(	O	O
pH	O	O
7.2	O	O
)	O	O
.	O	O

The	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
characterized	O	O
with	O	O
the	O	O
API	O	O
50	O	O
CH	O	O
system	O	O
to	O	O
confirm	O	O
their	O	O
identity	O	O
.	O	O

Coaggregation	O	O
was	O	O
determined	O	O
by	O	O
spectrophotometry	O	O
in	O	O
mixtures	O	O
and	O	O
bacterial	O	O
suspensions	O	O
alone	O	O
after	O	O
1	O	O
,	O	O
2	O	O
,	O	O
4	O	O
,	O	O
and	O	O
24	O	O
h	O	O
and	O	O
expressed	O	O
as	O	O
the	O	O
aggregation	O	O
ratio	O	O
(	O	O
%	O	O
)	O	O
.	O	O

All	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
showed	O	O
coaggregation	O	O
abilities	O	O
with	O	O
the	O	O
oral	O	O
pathogens	O	O
and	O	O
the	O	O
results	O	O
were	O	O
strain	O	O
specific	O	O
and	O	O
dependent	O	O
on	O	O
time	O	O
.	O	O

S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
GS-5	E-bacteria	I-bacteria
exhibited	O	O
a	O	O
significantly	O	O
higher	O	O
ability	O	O
to	O	O
coaggregate	O	O
with	O	O
all	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
than	O	O
the	O	O
other	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

The	O	O
differences	O	O
among	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
modest	O	O
with	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
being	O	O
the	O	O
most	O	O
prone	O	O
and	O	O
L.	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
LB21	E-bacteria	I-bacteria
the	O	O
least	O	O
prone	O	O
to	O	O
coaggregate	O	O
with	O	O
the	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

The	O	O
results	O	O
demonstrated	O	O
different	O	O
abilities	O	O
of	O	O
lactobacilli-derived	B-bacteria	B-bacteria
probiotic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
to	O	O
coaggregate	O	O
with	O	O
selected	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Aggregation	O	O
assays	O	O
may	O	O
be	O	O
a	O	O
useful	O	O
complement	O	O
for	O	O
screening	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
candidates	O	O
with	O	O
possible	O	O
anti-caries	O	O
properties	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
whether	O	O
Lactobacillus	B-bacteria	B-bacteria
reuteri	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
55730	E-bacteria	I-bacteria
can	O	O
be	O	O
detected	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
after	O	O
discontinuation	O	O
of	O	O
administration	O	O
of	O	O
a	O	O
product	O	O
prepared	O	O
with	O	O
this	O	O
bacterium	O	O
.	O	O

The	O	O
study	O	O
consisted	O	O
of	O	O
three	O	O
2-week	O	O
periods	O	O
:	O	O
clearance	O	O
period	O	O
,	O	O
intervention	O	O
period	O	O
,	O	O
and	O	O
post-treatment	O	O
period	O	O
.	O	O

Twenty-five	O	O
volunteers	O	O
consumed	O	O
a	O	O
chewable	O	O
tablet	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
55730	E-bacteria	I-bacteria
(	O	O
10	O	O
(	O	O
8	O	O
)	O	O
cfu/tablet	O	O
)	O	O
during	O	O
a	O	O
14-day	O	O
trial	O	O
period	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
and	O	O
cultured	O	O
onto	O	O
MRS	O	O
agar	O	O
after	O	O
a	O	O
clearance	O	O
period	O	O
of	O	O
2	O	O
weeks	O	O
and	O	O
then	O	O
daily	O	O
after	O	O
a	O	O
2-week	O	O
intervention	O	O
period	O	O
for	O	O
as	O	O
long	O	O
as	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
was	O	O
found	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
colonies	O	O
were	O	O
analysed	O	O
in	O	O
saliva	O	O
samples	O	O
.	O	O

The	O	O
analysis	O	O
was	O	O
performed	O	O
using	O	O
selective	O	O
media	O	O
for	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
followed	O	O
by	O	O
confirmation	O	O
using	O	O
the	O	O
specific	O	O
detection	O	O
of	O	O
reuterin	O	O
produced	O	O
by	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
.	O	O

The	O	O
number	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
carriers	O	O
decreased	O	O
gradually	O	O
,	O	O
and	O	O
after	O	O
1	O	O
week	O	O
only	O	O
8	O	O
%	O	O
of	O	O
the	O	O
subjects	O	O
harboured	O	O
the	O	O
bacterium	O	O
.	O	O

After	O	O
5	O	O
weeks	O	O
,	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
was	O	O
not	O	O
detected	O	O
in	O	O
any	O	O
of	O	O
the	O	O
subjects	O	O
.	O	O

Consuming	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
for	O	O
2	O	O
weeks	O	O
does	O	O
not	O	O
seem	O	O
to	O	O
be	O	O
sufficient	O	O
for	O	O
permanent	O	O
colonization	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

To	O	O
conduct	O	O
a	O	O
pilot	O	O
human	O	O
clinical	O	O
trial	O	O
to	O	O
assess	O	O
the	O	O
safety	O	O
and	O	O
to	O	O
test	O	O
the	O	O
ability	O	O
of	O	O
a	O	O
probiotic	B-bacteria	B-bacteria
mouthwash	O	O
,	O	O
ProBiora	O	O
(	O	O
3	O	O
)	O	O
,	O	O
to	O	O
affect	O	O
the	O	O
levels	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
certain	O	O
known	O	O
periodontal	O	O
pathogens	O	O
in	O	O
the	O	O
mouth	O	O
when	O	O
administered	O	O
twice	O	O
daily	O	O
over	O	O
a	O	O
period	O	O
of	O	O
4	O	O
weeks	O	O
.	O	O
The	O	O
mouthwash	O	O
contained	O	O
three	O	O
specific	O	O
strains	O	O
of	O	O
naturally	O	O
occurring	O	O
oral	O	O
bacteria	O	O
and	O	O
was	O	O
tested	O	O
at	O	O
two	O	O
dose	O	O
levels	O	O
:	O	O
10	O	O
(	O	O
6	O	O
)	O	O
and	O	O
10	O	O
(	O	O
8	O	O
)	O	O
colony	O	O
forming	O	O
units	O	O
each	O	O
of	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

oralis	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
KJ3sm	E-bacteria	I-bacteria
,	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

uberis	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
KJ2sm	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
spontaneous	B-bacteria	B-bacteria
lactic	I-bacteria	I-bacteria
acid-deficient	I-bacteria	I-bacteria
variant	I-bacteria	I-bacteria
of	I-bacteria	I-bacteria
Strep	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

rattus	E-bacteria	I-bacteria
,	O	O
strain	B-bacteria	B-bacteria
JH145	E-bacteria	I-bacteria
.	O	O

Substantial	O	O
decreases	O	O
in	O	O
the	O	O
levels	O	O
of	O	O
the	O	O
marker	O	O
bacteria	O	O
were	O	O
observed	O	O
.	O	O

No	O	O
safety	O	O
issues	O	O
were	O	O
noted	O	O
with	O	O
the	O	O
twice	O	O
daily	O	O
application	O	O
of	O	O
this	O	O
mouthwash	O	O
.	O	O

Despite	O	O
the	O	O
small	O	O
number	O	O
of	O	O
subjects	O	O
and	O	O
the	O	O
use	O	O
of	O	O
young	O	O
,	O	O
orally	O	O
healthy	O	O
adults	O	O
,	O	O
along	O	O
with	O	O
the	O	O
inherent	O	O
variability	O	O
in	O	O
the	O	O
microbiological	O	O
measurements	O	O
,	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
mouthwash	O	O
was	O	O
able	O	O
to	O	O
substantially	O	O
affect	O	O
the	O	O
levels	O	O
of	O	O
dental	O	O
pathogens	O	O
in	O	O
saliva	O	O
and	O	O
periodontal	O	O
pathogens	O	O
in	O	O
subgingival	O	O
plaque	O	O
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
pilot	O	O
human	O	O
study	O	O
suggest	O	O
that	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
mouthwash	O	O
product	O	O
may	O	O
be	O	O
safe	O	O
for	O	O
daily	O	O
use	O	O
as	O	O
an	O	O
aid	O	O
in	O	O
maintaining	O	O
both	O	O
dental	O	O
and	O	O
periodontal	O	O
health	O	O
.	O	O

Microbial	O	O
association	O	O
distinctive	O	O
features	O	O
and	O	O
colonization	O	O
degree	O	O
of	O	O
different	O	O
oral	O	O
cavity	O	O
biotope	O	O
were	O	O
established	O	O
in	O	O
healthy	O	O
teenagers	O	O
and	O	O
patients	O	O
with	O	O
chronic	O	O
gastritis	O	O
and	O	O
gastroduodenitis	O	O
.	O	O

There	O	O
were	O	O
studied	O	O
mucous	O	O
membrane	O	O
surfaces	O	O
of	O	O
cheek	O	O
,	O	O
tongue	O	O
,	O	O
content	O	O
of	O	O
gingival	O	O
crevice	O	O
,	O	O
oral	O	O
fluid	O	O
and	O	O
dental	O	O
plaque	O	O
of	O	O
24	O	O
healthy	O	O
persons	O	O
of	O	O
the	O	O
age	O	O
12-17	O	O
years	O	O
and	O	O
29	O	O
patients	O	O
of	O	O
the	O	O
same	O	O
age	O	O
with	O	O
gastritis	O	O
and	O	O
gastroduodenitis	O	O
.	O	O

On	O	O
the	O	O
mucous	O	O
membranes	O	O
of	O	O
the	O	O
ill	O	O
teenagers	O	O
there	O	O
were	O	O
found	O	O
Porphiromonas	O	O
type	O	O
bacteria	O	O
,	O	O
20	O	O
%	O	O
more	O	O
Staphylococcus	B-bacteria	B-bacteria
,	O	O
90	O	O
%	O	O
less	O	O
Peptostreptococcus	B-bacteria	B-bacteria
,	O	O
30	O	O
%	O	O
less	O	O
Lactobacillus	B-bacteria	B-bacteria
,	O	O
20	O	O
%	O	O
less	O	O
Veillonella	B-bacteria	B-bacteria
and	O	O
Stomatococcus	B-bacteria	B-bacteria
.	O	O

In	O	O
saliva	O	O
anaerobic	B-bacteria	B-bacteria
Peptostreptococcus	E-bacteria	I-bacteria
and	O	O
facultative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
Streptococcus	E-bacteria	I-bacteria
(	O	O
7	O	O
lg	O	O
COE/ml	O	O
)	O	O
;	O	O
Porphiromonas	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Peptococcus	B-bacteria	B-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
(	O	O
6	O	O
lg	O	O
COE/ml	O	O
)	O	O
;	O	O
Neisseria	B-bacteria	B-bacteria
(	O	O
5	O	O
lg	O	O
COE/ml	O	O
)	O	O
;	O	O
Stomatococcus	B-bacteria	B-bacteria
,	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
and	O	O
Bacillus	B-bacteria	B-bacteria
(	O	O
4.6	O	O
lg	O	O
COE/ml	O	O
)	O	O
;	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
Candida	O	O
(	O	O
4	O	O
lg	O	O
COE/ml	O	O
)	O	O
predominated	O	O
.	O	O

In	O	O
patients	O	O
with	O	O
chronic	O	O
pathology	O	O
in	O	O
all	O	O
tested	O	O
biotopes	O	O
there	O	O
was	O	O
found	O	O
the	O	O
increase	O	O
of	O	O
the	O	O
whole	O	O
microbiota	O	O
spectra	O	O
(	O	O
representatives	O	O
of	O	O
opportunistic	O	O
pathogenic	O	O
microfiora	O	O
were	O	O
detected	O	O
more	O	O
often	O	O
)	O	O
as	O	O
well	O	O
as	O	O
the	O	O
bacteria	O	O
number	O	O
if	O	O
compared	O	O
with	O	O
healthy	O	O
teenagers	O	O
.	O	O

Our	O	O
study	O	O
demonstrates	O	O
that	O	O
staurosporine	O	O
(	O	O
STS	O	O
)	O	O
,	O	O
a	O	O
protein	O	O
kinase	O	O
inhibitor	O	O
from	O	O
Streptomyces	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
induces	O	O
apoptosis	O	O
in	O	O
human	O	O
papillomavirus	O	O
positive	O	O
oral	O	O
carcinoma	O	O
cells	O	O
(	O	O
KB	O	O
)	O	O
in	O	O
a	O	O
dose	O	O
dependent	O	O
manner	O	O
.	O	O

Growth	O	O
inhibition	O	O
studies	O	O
revealed	O	O
an	O	O
IC	O	O
(	O	O
50	O	O
)	O	O
value	O	O
of	O	O
approximately	O	O
100	O	O
nM	O	O
.	O	O

STS	O	O
induced	O	O
marked	O	O
nuclear	O	O
fragmentation	O	O
and	O	O
inter-nucleosomal	O	O
cleavage	O	O
compared	O	O
to	O	O
untreated	O	O
cells	O	O
.	O	O

It	O	O
also	O	O
caused	O	O
dose	O	O
dependent	O	O
disruption	O	O
of	O	O
mitochondrial	O	O
membrane	O	O
potential	O	O
and	O	O
activation	O	O
of	O	O
caspase-3	O	O
,	O	O
indicating	O	O
involvement	O	O
of	O	O
mitochondria-mediated	O	O
cell	O	O
death	O	O
signaling	O	O
in	O	O
KB	O	O
cell	O	O
apoptosis	O	O
.	O	O

We	O	O
found	O	O
time-dependent	O	O
arrest	O	O
of	O	O
the	O	O
KB	O	O
cells	O	O
at	O	O
G2/M	O	O
phase	O	O
of	O	O
cell	O	O
cycle	O	O
.	O	O

Using	O	O
fluorescence	O	O
microscopy	O	O
,	O	O
we	O	O
have	O	O
further	O	O
shown	O	O
that	O	O
STS	O	O
treatment	O	O
disrupts	O	O
microtubules	O	O
and	O	O
reorganizes	O	O
F-actin	O	O
after	O	O
6h	O	O
exposure	O	O
.	O	O

Taken	O	O
together	O	O
,	O	O
our	O	O
results	O	O
suggest	O	O
that	O	O
STS	O	O
induces	O	O
mitochondria-mediated	O	O
KB	O	O
cell	O	O
apoptosis	O	O
at	O	O
G2/M	O	O
phase	O	O
by	O	O
altering	O	O
cell	O	O
cytoskeletal	O	O
network	O	O
.	O	O

Bacterial	O	O
vaginosis	O	O
(	O	O
BV	O	O
)	O	O
is	O	O
a	O	O
common	O	O
condition	O	O
that	O	O
is	O	O
associated	O	O
with	O	O
preterm	O	O
birth	O	O
and	O	O
acquisition	O	O
of	O	O
complex	O	O
communities	O	O
of	O	O
vaginal	O	O
bacteria	O	O
that	O	O
include	O	O
several	O	O
fastidious	O	O
species	O	O
.	O	O

Treatment	O	O
of	O	O
BV	O	O
in	O	O
pregnancy	O	O
has	O	O
mixed	O	O
effects	O	O
on	O	O
the	O	O
risk	O	O
of	O	O
preterm	O	O
delivery	O	O
,	O	O
which	O	O
some	O	O
hypothesize	O	O
is	O	O
due	O	O
to	O	O
variable	O	O
antibiotic	O	O
efficacy	O	O
for	O	O
the	O	O
fastidious	O	O
bacteria	O	O
.	O	O

Both	O	O
oral	O	O
and	O	O
intravaginal	O	O
metronidazole	O	O
can	O	O
be	O	O
used	O	O
to	O	O
treat	O	O
bacterial	O	O
vaginosis	O	O
in	O	O
pregnancy	O	O
,	O	O
but	O	O
little	O	O
is	O	O
known	O	O
about	O	O
the	O	O
impact	O	O
of	O	O
different	O	O
routes	O	O
of	O	O
antibiotic	O	O
administration	O	O
on	O	O
concentrations	O	O
of	O	O
fastidious	O	O
vaginal	O	O
bacteria	O	O
.	O	O

This	O	O
was	O	O
a	O	O
sub-study	O	O
of	O	O
a	O	O
larger	O	O
randomized	O	O
trial	O	O
of	O	O
oral	O	O
versus	O	O
vaginal	O	O
metronidazole	O	O
for	O	O
treatment	O	O
of	O	O
BV	O	O
in	O	O
pregnancy	O	O
.	O	O

Fifty-three	O	O
women	O	O
were	O	O
evaluated	O	O
,	O	O
including	O	O
30	O	O
women	O	O
who	O	O
received	O	O
oral	O	O
metronidazole	O	O
and	O	O
23	O	O
who	O	O
received	O	O
intravaginal	O	O
metronidazole	O	O
.	O	O

Bacterial	O	O
taxon-specific	O	O
quantitative	O	O
PCR	O	O
assays	O	O
were	O	O
used	O	O
to	O	O
measure	O	O
concentrations	O	O
of	O	O
bacterial	O	O
vaginosis	O	O
associated	O	O
bacterium	O	O
(	O	O
BVAB	O	O
)	O	O
1	O	O
,	O	O
2	O	O
,	O	O
and	O	O
3	O	O
,	O	O
Gardnerella	B-bacteria	B-bacteria
vaginalis	E-bacteria	I-bacteria
,	O	O
Atopobium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Leptotrichia/Sneathia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Megasphaera	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
crispatus	E-bacteria	I-bacteria
before	O	O
and	O	O
after	O	O
antibiotic	O	O
treatment	O	O
.	O	O

Concentrations	O	O
of	O	O
Leptotrichia	B-bacteria	B-bacteria
and	O	O
Sneathia	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
the	O	O
fastidious	O	O
Clostridia-like	B-bacteria	B-bacteria
bacterium	E-bacteria	I-bacteria
designated	O	O
BVAB1	O	O
decreased	O	O
significantly	O	O
with	O	O
oral	O	O
(	O	O
p	O	O
=	O	O
.002	O	O
,	O	O
p	O	O
=	O	O
.02	O	O
)	O	O
but	O	O
not	O	O
vaginal	O	O
therapy	O	O
(	O	O
p	O	O
=	O	O
.141	O	O
,	O	O
p	O	O
=	O	O
.126	O	O
)	O	O
.	O	O

The	O	O
fastidious	O	O
bacterium	O	O
BVAB3	O	O
did	O	O
not	O	O
significantly	O	O
decrease	O	O
with	O	O
either	O	O
treatment	O	O
.	O	O

Concentrations	O	O
of	O	O
Atopobium	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
reportedly	O	O
resistant	O	O
to	O	O
metronidazole	O	O
in	O	O
vitro	O	O
,	O	O
dropped	O	O
significantly	O	O
with	O	O
oral	O	O
(	O	O
p	O	O
=	O	O
.002	O	O
)	O	O
and	O	O
vaginal	O	O
(	O	O
p	O	O
=	O	O
.001	O	O
)	O	O
treatment	O	O
.	O	O

There	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
in	O	O
the	O	O
magnitude	O	O
of	O	O
change	O	O
in	O	O
bacterial	O	O
concentrations	O	O
between	O	O
oral	O	O
and	O	O
vaginal	O	O
treatment	O	O
arms	O	O
for	O	O
any	O	O
of	O	O
the	O	O
bacterial	O	O
species	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
crispatus	O	O
concentrations	O	O
did	O	O
not	O	O
change	O	O
.	O	O

Both	O	O
oral	O	O
and	O	O
vaginal	O	O
metronidazole	O	O
therapy	O	O
in	O	O
pregnant	O	O
women	O	O
result	O	O
in	O	O
a	O	O
significant	O	O
decrease	O	O
in	O	O
concentrations	O	O
of	O	O
most	O	O
BV-associated	O	O
anaerobic	O	O
bacteria	O	O
,	O	O
with	O	O
the	O	O
exception	O	O
that	O	O
Leptotrichia	B-bacteria	B-bacteria
,	O	O
Sneathia	B-bacteria	B-bacteria
and	O	O
BVAB1	O	O
do	O	O
not	O	O
significantly	O	O
decrease	O	O
with	O	O
vaginal	O	O
metronidazole	O	O
therapy	O	O
.	O	O

These	O	O
data	O	O
suggest	O	O
that	O	O
the	O	O
route	O	O
of	O	O
antibiotic	O	O
administration	O	O
has	O	O
a	O	O
minor	O	O
impact	O	O
on	O	O
bacterial	O	O
eradication	O	O
in	O	O
pregnant	O	O
women	O	O
with	O	O
BV	O	O
.	O	O

This	O	O
trial	O	O
is	O	O
registered	O	O
with	O	O
ClinicalTrials.gov	O	O
,	O	O
number	O	O
NCT00153517	O	O
.	O	O

The	O	O
bacterial	O	O
colonization	O	O
of	O	O
teeth	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
StrepM	B-bacteria	B-bacteria
)	O	O
represents	O	O
a	O	O
major	O	O
risk	O	O
factor	O	O
for	O	O
the	O	O
development	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

At	O	O
present	O	O
,	O	O
no	O	O
clinical	O	O
studies	O	O
have	O	O
explored	O	O
the	O	O
effect	O	O
of	O	O
a	O	O
combined	O	O
mechanical-chemical	O	O
antisepsis	O	O
protocol	O	O
in	O	O
a	O	O
periodontally-healthy	O	O
population	O	O
and	O	O
the	O	O
pattern	O	O
of	O	O
recolonization	O	O
of	O	O
StrepM	B-bacteria	B-bacteria
in	O	O
subjects	O	O
whose	O	O
StrepM	B-bacteria	B-bacteria
infection	O	O
was	O	O
successfully	O	O
eradicated	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
designed	O	O
in	O	O
order	O	O
to	O	O
1	O	O
)	O	O
determine	O	O
the	O	O
salivary	O	O
and	O	O
plaque	O	O
changes	O	O
in	O	O
StrepM	B-bacteria	B-bacteria
content	O	O
after	O	O
a	O	O
combined	O	O
mechanical/chemical	O	O
antisepsis	O	O
protocol	O	O
;	O	O
and	O	O
2	O	O
)	O	O
evaluate	O	O
the	O	O
pattern	O	O
of	O	O
recolonization	O	O
when	O	O
StrepM	B-bacteria	B-bacteria
was	O	O
successfully	O	O
eradicated	O	O
from	O	O
saliva	O	O
and	O	O
plaque	O	O
.	O	O

Thirty-five	O	O
periodontally-healthy	O	O
and	O	O
caries-susceptible	O	O
subjects	O	O
successfully	O	O
entered	O	O
and	O	O
concluded	O	O
the	O	O
study	O	O
.	O	O

At	O	O
baseline	O	O
,	O	O
non-surgical	O	O
periodontal	O	O
therapy	O	O
was	O	O
performed	O	O
according	O	O
to	O	O
the	O	O
principles	O	O
of	O	O
full	O	O
mouth	O	O
disinfection	O	O
.	O	O

Adjunctive	O	O
home-based	O	O
rinsing	O	O
with	O	O
a	O	O
0.2	O	O
%	O	O
chlorhexidine	O	O
mouthrinse	O	O
was	O	O
requested	O	O
for	O	O
the	O	O
following	O	O
week	O	O
.	O	O

StrepM	B-bacteria	B-bacteria
concentration	O	O
was	O	O
assessed	O	O
in	O	O
saliva	O	O
and	O	O
plaque	O	O
at	O	O
the	O	O
initial	O	O
contact	O	O
appointment	O	O
,	O	O
at	O	O
baseline	O	O
,	O	O
and	O	O
1-week	O	O
,	O	O
1-month	O	O
,	O	O
3-month	O	O
and	O	O
6-month	O	O
follow-up	O	O
.	O	O

A	O	O
significant	O	O
effect	O	O
of	O	O
''time	O	O
''	O	O
on	O	O
StrepM	B-bacteria	B-bacteria
concentration	O	O
in	O	O
saliva	O	O
and	O	O
plaque	O	O
was	O	O
observed	O	O
(	O	O
P	O	O
<	O	O
0.000	O	O
)	O	O
.	O	O

In	O	O
subjects	O	O
with	O	O
successful	O	O
eradication	O	O
of	O	O
StrepM	B-bacteria	B-bacteria
at	O	O
1	O	O
week	O	O
(	O	O
N=17	O	O
plaque	O	O
samples	O	O
)	O	O
,	O	O
StrepM	B-bacteria	B-bacteria
infection	O	O
recurrence	O	O
occurred	O	O
within	O	O
3-6	O	O
months	O	O
.	O	O

The	O	O
results	O	O
of	O	O
the	O	O
present	O	O
study	O	O
demonstrated	O	O
that	O	O
1	O	O
)	O	O
the	O	O
application	O	O
of	O	O
the	O	O
investigated	O	O
mechanical/chemical	O	O
antisepsis	O	O
protocol	O	O
can	O	O
effectively	O	O
reduce	O	O
StrepM	B-bacteria	B-bacteria
colonies	O	O
in	O	O
saliva	O	O
and	O	O
plaque	O	O
of	O	O
periodontally	O	O
healthy	O	O
subjects	O	O
;	O	O
and	O	O
2	O	O
)	O	O
in	O	O
plaque	O	O
samples	O	O
,	O	O
StrepM	B-bacteria	B-bacteria
infection	O	O
recurrence	O	O
tends	O	O
to	O	O
occur	O	O
within	O	O
3-6	O	O
months	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
absolute	O	O
and	O	O
relative	O	O
antibacterial	O	O
activity	O	O
of	O	O
octenidine	O	O
dihydrochloride	O	O
(	O	O
OCT	O	O
)	O	O
against	O	O
total	O	O
and	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
saliva	O	O
samples	O	O
of	O	O
patients	O	O
with	O	O
fixed	O	O
orthodontic	O	O
appliances	O	O
during	O	O
5	O	O
days	O	O
of	O	O
usage	O	O
.	O	O

The	O	O
study	O	O
group	O	O
consisted	O	O
of	O	O
5	O	O
male	O	O
and	O	O
13	O	O
female	O	O
subjects	O	O
who	O	O
were	O	O
selected	O	O
from	O	O
patients	O	O
in	O	O
the	O	O
Clinic	O	O
of	O	O
Orthodontics	O	O
.	O	O

Each	O	O
patient	O	O
was	O	O
given	O	O
physiologic	O	O
saline	O	O
(	O	O
PS	O	O
)	O	O
,	O	O
chlorhexidine	O	O
gluconate	O	O
(	O	O
CHX	O	O
)	O	O
,	O	O
polyvinylpyrrolidone-iodine	O	O
complex	O	O
(	O	O
PVP-I	O	O
)	O	O
,	O	O
and	O	O
OCT	O	O
every	O	O
morning	O	O
for	O	O
5	O	O
days	O	O
,	O	O
each	O	O
separated	O	O
by	O	O
a	O	O
2-week	O	O
interval	O	O
.	O	O

Total	O	O
and	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
saliva	O	O
samples	O	O
of	O	O
orthodontically	O	O
treated	O	O
patients	O	O
with	O	O
fixed	O	O
appliances	O	O
were	O	O
collected	O	O
during	O	O
5	O	O
days	O	O
of	O	O
usage	O	O
.	O	O

Unstimulated	O	O
saliva	O	O
was	O	O
collected	O	O
as	O	O
a	O	O
baseline	O	O
sample	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
at	O	O
15	O	O
minutes	O	O
,	O	O
and	O	O
on	O	O
the	O	O
second	O	O
,	O	O
third	O	O
,	O	O
and	O	O
fifth	O	O
day	O	O
after	O	O
rinsing	O	O
the	O	O
mouth	O	O
with	O	O
any	O	O
of	O	O
the	O	O
solutions	O	O
for	O	O
30	O	O
seconds	O	O
,	O	O
and	O	O
bacterial	O	O
counts	O	O
were	O	O
detected	O	O
.	O	O

OCT	O	O
showed	O	O
an	O	O
ultimate	O	O
reduction	O	O
of	O	O
total	O	O
viable	O	O
oral	O	O
bacteria	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
vivo	O	O
.	O	O

OCT	O	O
also	O	O
had	O	O
a	O	O
significantly	O	O
greater	O	O
inhibitory	O	O
effect	O	O
than	O	O
0.2	O	O
%	O	O
CHX	O	O
and	O	O
7.5	O	O
%	O	O
PVP-I	O	O
,	O	O
from	O	O
the	O	O
beginning	O	O
of	O	O
the	O	O
study	O	O
until	O	O
the	O	O
fifth	O	O
day	O	O
after	O	O
the	O	O
orthodontic	O	O
appliances	O	O
were	O	O
bonded	O	O
(	O	O
P	O	O
<	O	O
.1	O	O
)	O	O
.	O	O

OCT	O	O
compared	O	O
favorably	O	O
with	O	O
respect	O	O
to	O	O
CHX	O	O
and	O	O
PVP-I	O	O
complex	O	O
in	O	O
orthodontically	O	O
treated	O	O
patients	O	O
with	O	O
fixed	O	O
appliances	O	O
(	O	O
P	O	O
<	O	O
/=	O	O
.1	O	O
)	O	O
.	O	O

Infective	O	O
endocarditis	O	O
(	O	O
IE	O	O
)	O	O
is	O	O
a	O	O
rare	O	O
but	O	O
life-threatening	O	O
infection	O	O
.	O	O

Bacteremia	O	O
with	O	O
organisms	O	O
known	O	O
to	O	O
cause	O	O
IE	O	O
occurs	O	O
commonly	O	O
in	O	O
association	O	O
with	O	O
invasive	O	O
dental	O	O
origin	O	O
.	O	O

Despite	O	O
daily	O	O
oral	O	O
activities	O	O
as	O	O
well	O	O
as	O	O
professional	O	O
dental	O	O
treatments	O	O
inducing	O	O
bacteremia	O	O
and	O	O
the	O	O
dental	O	O
bacteremia	O	O
as	O	O
a	O	O
risk	O	O
factor	O	O
of	O	O
IE	O	O
,	O	O
the	O	O
details	O	O
of	O	O
dental	O	O
bacteria	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
IE	O	O
are	O	O
far	O	O
from	O	O
elucidation	O	O
to	O	O
date	O	O
.	O	O

How	O	O
do	O	O
a	O	O
few	O	O
microorganisms	O	O
survive	O	O
host	O	O
defenses	O	O
or	O	O
escape	O	O
from	O	O
antibiotic	O	O
attacking	O	O
to	O	O
seed	O	O
target	O	O
organs	O	O
and	O	O
cause	O	O
distant	O	O
infections	O	O
?	O	O

Why	O	O
are	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
more	O	O
frequently	O	O
detected	O	O
than	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
IE	O	O
?	O	O

Cell	O	O
wall-deficient	O	O
bacteria	O	O
(	O	O
CWDB	O	O
)	O	O
were	O	O
traditionally	O	O
defined	O	O
as	O	O
bacteria	O	O
with	O	O
altered	O	O
morphology	O	O
and	O	O
consistent	O	O
with	O	O
damaged	O	O
or	O	O
absent	O	O
cell	O	O
wall	O	O
structures	O	O
identified	O	O
by	O	O
EM	O	O
.	O	O

A	O	O
number	O	O
of	O	O
case	O	O
reports	O	O
and	O	O
laboratory	O	O
studies	O	O
suggest	O	O
that	O	O
CWDB	O	O
may	O	O
be	O	O
found	O	O
in	O	O
the	O	O
peripheral	O	O
blood	O	O
of	O	O
patients	O	O
with	O	O
IE	O	O
,	O	O
and	O	O
may	O	O
also	O	O
be	O	O
demonstrated	O	O
in	O	O
vegetations	O	O
on	O	O
the	O	O
valves	O	O
of	O	O
patients	O	O
with	O	O
IE	O	O
.	O	O

CWDB	O	O
,	O	O
in	O	O
vitro	O	O
,	O	O
are	O	O
resistant	O	O
to	O	O
antibiotics	O	O
that	O	O
act	O	O
on	O	O
cell	O	O
wall	O	O
biosynthesis	O	O
.	O	O

Recent	O	O
studies	O	O
indicate	O	O
that	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
S.	I-bacteria	I-bacteria
mutans	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
the	O	O
major	O	O
cariogenic	O	O
bacterium	O	O
,	O	O
isolated	O	O
from	O	O
the	O	O
infected	O	O
valve	O	O
were	O	O
deficient	O	O
in	O	O
some	O	O
wall-associated	O	O
proteins	O	O
which	O	O
are	O	O
main	O	O
cariogenic	O	O
virulence	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
deficient	O	O
stains	O	O
exhibited	O	O
less	O	O
susceptible	O	O
to	O	O
antibiotics	O	O
that	O	O
act	O	O
on	O	O
cell	O	O
wall	O	O
biosynthesis	O	O
.	O	O

Further	O	O
,	O	O
the	O	O
cloned	O	O
deficient	O	O
mutans	O	O
were	O	O
less	O	O
susceptible	O	O
to	O	O
phagocytosis	O	O
by	O	O
human	O	O
polymorphonuclear	O	O
leukocytes	O	O
but	O	O
to	O	O
possess	O	O
higher	O	O
platelet	O	O
aggregation	O	O
properties	O	O
than	O	O
their	O	O
parent	O	O
strains	O	O
.	O	O

As	O	O
outlined	O	O
above	O	O
,	O	O
we	O	O
hypothesize	O	O
that	O	O
defect	O	O
of	O	O
cell	O	O
wall	O	O
construction	O	O
may	O	O
shield	O	O
oral	O	O
bacteria's	O	O
survival	O	O
in	O	O
bloodstream	O	O
and	O	O
cause	O	O
IE	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
has	O	O
been	O	O
considered	O	O
a	O	O
potential	O	O
reservoir	O	O
for	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
H	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
)	O	O
,	O	O
from	O	O
where	O	O
the	O	O
organism	O	O
causes	O	O
recurrent	O	O
gastric	O	O
infections	O	O
.	O	O

With	O	O
this	O	O
case-control	O	O
study	O	O
we	O	O
tried	O	O
to	O	O
evaluate	O	O
the	O	O
role	O	O
of	O	O
H	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
etiology	O	O
of	O	O
mucosal	O	O
inflammation	O	O
,	O	O
a	O	O
condition	O	O
that	O	O
compounds	O	O
the	O	O
morbid	O	O
state	O	O
associated	O	O
with	O	O
oral	O	O
submucous	O	O
fibrosis	O	O
(	O	O
OSF	O	O
)	O	O
.	O	O

Subjects	O	O
(	O	O
n	O	O
=	O	O
150	O	O
)	O	O
were	O	O
selected	O	O
following	O	O
institutional	O	O
regulations	O	O
on	O	O
sample	O	O
collection	O	O
and	O	O
grouped	O	O
into	O	O
test	O	O
cases	O	O
and	O	O
positive	O	O
and	O	O
negative	O	O
controls	O	O
based	O	O
on	O	O
the	O	O
presence	O	O
of	O	O
mucosal	O	O
fibrosis	O	O
and	O	O
inflammation	O	O
.	O	O

The	O	O
negative	O	O
controls	O	O
had	O	O
none	O	O
of	O	O
the	O	O
clinical	O	O
signs	O	O
.	O	O

All	O	O
patients	O	O
underwent	O	O
an	O	O
oral	O	O
examination	O	O
as	O	O
well	O	O
as	O	O
tests	O	O
to	O	O
assess	O	O
oral	O	O
hygiene/periodontal	O	O
disease	O	O
status	O	O
;	O	O
a	O	O
rapid	O	O
urease	O	O
test	O	O
(	O	O
RUT	O	O
)	O	O
of	O	O
plaque	O	O
samples	O	O
was	O	O
also	O	O
done	O	O
to	O	O
estimate	O	O
the	O	O
H	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
bacterial	O	O
load	O	O
.	O	O

We	O	O
used	O	O
univariate	O	O
and	O	O
mutivariate	O	O
logistic	O	O
regression	O	O
for	O	O
statistical	O	O
analysis	O	O
of	O	O
the	O	O
data	O	O
and	O	O
calculated	O	O
the	O	O
odds	O	O
ratios	O	O
to	O	O
assess	O	O
the	O	O
risk	O	O
posed	O	O
by	O	O
the	O	O
different	O	O
variables	O	O
.	O	O

The	O	O
RUT	O	O
results	O	O
differed	O	O
significantly	O	O
between	O	O
the	O	O
groups	O	O
,	O	O
reflecting	O	O
the	O	O
variations	O	O
in	O	O
the	O	O
bacterial	O	O
loads	O	O
in	O	O
each	O	O
category	O	O
.	O	O

The	O	O
test	O	O
was	O	O
positive	O	O
in	O	O
52	O	O
%	O	O
in	O	O
the	O	O
positive	O	O
controls	O	O
(	O	O
where	O	O
nonspecific	O	O
inflammation	O	O
of	O	O
oral	O	O
mucosa	O	O
was	O	O
seen	O	O
unassociated	O	O
with	O	O
fibrosis	O	O
)	O	O
,	O	O
in	O	O
46	O	O
%	O	O
of	O	O
the	O	O
test	O	O
cases	O	O
,	O	O
and	O	O
in	O	O
18	O	O
%	O	O
of	O	O
the	O	O
negative	O	O
controls	O	O
(	O	O
healthy	O	O
volunteers	O	O
)	O	O
(	O	O
chi2	O	O
=	O	O
13.887	O	O
;	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

A	O	O
positive	O	O
correlation	O	O
was	O	O
seen	O	O
between	O	O
the	O	O
oral	O	O
hygiene/periodontal	O	O
disease	O	O
indices	O	O
and	O	O
RUT	O	O
reactivity	O	O
in	O	O
all	O	O
the	O	O
three	O	O
groups	O	O
.	O	O

The	O	O
contribution	O	O
of	O	O
the	O	O
H	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
dental	O	O
plaque	O	O
to	O	O
mucosal	O	O
inflammation	O	O
and	O	O
periodontal	O	O
disease	O	O
was	O	O
significant	O	O
.	O	O

Logistic	O	O
regression	O	O
analysis	O	O
showed	O	O
gastrointestinal	O	O
disease	O	O
and	O	O
poor	O	O
oral	O	O
hygiene	O	O
as	O	O
being	O	O
the	O	O
greatest	O	O
risk	O	O
factors	O	O
for	O	O
bacterial	O	O
colonization	O	O
,	O	O
irrespective	O	O
of	O	O
the	O	O
subject	O	O
groups	O	O
.	O	O

A	O	O
positive	O	O
correlation	O	O
exists	O	O
between	O	O
RUT	O	O
reactivity	O	O
and	O	O
the	O	O
frequency	O	O
of	O	O
mucosal	O	O
inflammation	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
review	O	O
is	O	O
to	O	O
evaluate	O	O
the	O	O
association	O	O
between	O	O
rheumatoid	O	O
arthritis	O	O
(	O	O
RA	O	O
)	O	O
and	O	O
periodontopathic	O	O
bacteria	O	O
.	O	O

Clinical	O	O
studies	O	O
of	O	O
RA	O	O
and	O	O
periodontal	O	O
disease	O	O
have	O	O
provided	O	O
evidence	O	O
for	O	O
a	O	O
significant	O	O
association	O	O
between	O	O
the	O	O
two	O	O
disorders	O	O
.	O	O

Patients	O	O
with	O	O
long-standing	O	O
active	O	O
RA	O	O
have	O	O
a	O	O
substantially	O	O
increased	O	O
frequency	O	O
of	O	O
periodontal	O	O
disease	O	O
compared	O	O
with	O	O
that	O	O
among	O	O
healthy	O	O
subjects	O	O
.	O	O

High	O	O
levels	O	O
of	O	O
oral	O	O
anaerobic	O	O
bacterial	O	O
antibodies	O	O
have	O	O
been	O	O
found	O	O
in	O	O
the	O	O
serum	O	O
and	O	O
synovial	O	O
fluid	O	O
of	O	O
RA	O	O
patients	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
have	O	O
been	O	O
identified	O	O
in	O	O
RA	O	O
synovial	O	O
fluid	O	O
.	O	O

Ornidazole	O	O
,	O	O
levofloxacin	O	O
,	O	O
and	O	O
clarithromycin	O	O
are	O	O
used	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
infections	O	O
caused	O	O
by	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

These	O	O
antibiotics	O	O
have	O	O
been	O	O
shown	O	O
to	O	O
be	O	O
effective	O	O
against	O	O
RA	O	O
.	O	O

The	O	O
evidence	O	O
in	O	O
this	O	O
review	O	O
indicates	O	O
that	O	O
oral	O	O
bacteria	O	O
directly	O	O
associate	O	O
with	O	O
etiopathogenesis	O	O
of	O	O
RA	O	O
.	O	O

The	O	O
degradation	O	O
of	O	O
complex	O	O
substrates	O	O
,	O	O
like	O	O
salivary	O	O
mucins	O	O
,	O	O
requires	O	O
an	O	O
arsenal	O	O
of	O	O
glycosidases	O	O
and	O	O
proteases	O	O
to	O	O
sequentially	O	O
degrade	O	O
the	O	O
oligosaccharides	O	O
and	O	O
polypeptide	O	O
backbone	O	O
.	O	O

The	O	O
mucin	O	O
MUC5B	O	O
is	O	O
a	O	O
complex	O	O
oligomeric	O	O
glycoprotein	O	O
,	O	O
heterogeneous	O	O
in	O	O
molecular	O	O
mass	O	O
(	O	O
14-40	O	O
x	O	O
10	O	O
(	O	O
6	O	O
)	O	O
Da	O	O
)	O	O
,	O	O
with	O	O
a	O	O
diverse	O	O
repertoire	O	O
of	O	O
oligosaccharides	O	O
,	O	O
differing	O	O
in	O	O
composition	O	O
and	O	O
charge	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
whether	O	O
proteolytic	O	O
degradation	O	O
of	O	O
the	O	O
mucin	O	O
polypeptide	O	O
backbone	O	O
could	O	O
be	O	O
identified	O	O
and	O	O
if	O	O
cooperation	O	O
of	O	O
dental	O	O
biofilm	O	O
bacteria	O	O
was	O	O
required	O	O
.	O	O

Cooperative	O	O
bacteria-mediated	O	O
proteolysis	O	O
of	O	O
MUC5B	O	O
was	O	O
determined	O	O
by	O	O
comparing	O	O
individual	O	O
species	O	O
and	O	O
mixed	O	O
consortia	O	O
of	O	O
strains	O	O
isolated	O	O
from	O	O
supragingival	O	O
plaque	O	O
,	O	O
and	O	O
freshly	O	O
harvested	O	O
supragingival	O	O
plaque	O	O
.	O	O

Proteolytic	O	O
activity	O	O
was	O	O
analysed	O	O
using	O	O
fluorescent	O	O
labelled	O	O
substrate	O	O
and	O	O
by	O	O
visualizing	O	O
mucin	O	O
degradation	O	O
by	O	O
SDS-PAGE	O	O
.	O	O

Dental	O	O
plaque	O	O
degraded	O	O
the	O	O
polypeptide	O	O
backbone	O	O
of	O	O
the	O	O
salivary	O	O
MUC5B	O	O
mucin	O	O
.	O	O

The	O	O
mucin	O	O
was	O	O
also	O	O
degraded	O	O
by	O	O
a	O	O
specific	O	O
consortium	O	O
of	O	O
isolated	O	O
species	O	O
from	O	O
supragingival	O	O
plaque	O	O
,	O	O
although	O	O
individual	O	O
species	O	O
and	O	O
other	O	O
consortia	O	O
did	O	O
not	O	O
.	O	O

Certain	O	O
bacteria	O	O
in	O	O
supragingival	O	O
dental	O	O
plaque	O	O
therefore	O	O
cooperate	O	O
as	O	O
a	O	O
consortium	O	O
to	O	O
proteolyse	O	O
human	O	O
salivary	O	O
MUC5B	O	O
and	O	O
hydrolyse	O	O
glycosides	O	O
.	O	O

Recent	O	O
progress	O	O
in	O	O
identification	O	O
of	O	O
oral	O	O
microorganisms	O	O
has	O	O
shown	O	O
that	O	O
the	O	O
oropharynx	O	O
can	O	O
be	O	O
a	O	O
site	O	O
of	O	O
origin	O	O
for	O	O
dissemination	O	O
of	O	O
pathogenic	O	O
organisms	O	O
to	O	O
distant	O	O
body	O	O
sites	O	O
,	O	O
such	O	O
as	O	O
the	O	O
lungs	O	O
.	O	O

To	O	O
compare	O	O
the	O	O
oropharyngeal	O	O
microbiological	O	O
profile	O	O
,	O	O
duration	O	O
of	O	O
mechanical	O	O
ventilation	O	O
,	O	O
and	O	O
length	O	O
of	O	O
stay	O	O
in	O	O
the	O	O
intensive	O	O
care	O	O
unit	O	O
of	O	O
children	O	O
receiving	O	O
mechanical	O	O
ventilation	O	O
who	O	O
had	O	O
pharmacological	O	O
or	O	O
nonpharmacological	O	O
oral	O	O
care	O	O
.	O	O

A	O	O
randomized	O	O
and	O	O
controlled	O	O
study	O	O
was	O	O
performed	O	O
in	O	O
a	O	O
pediatric	O	O
intensive	O	O
unit	O	O
in	O	O
Sao	O	O
Paulo	O	O
,	O	O
Brazil	O	O
.	O	O

A	O	O
total	O	O
of	O	O
56	O	O
children	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
an	O	O
experimental	O	O
group	O	O
(	O	O
n=27	O	O
,	O	O
48	O	O
%	O	O
)	O	O
that	O	O
received	O	O
oral	O	O
care	O	O
with	O	O
use	O	O
of	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
digluconate	O	O
or	O	O
a	O	O
control	O	O
group	O	O
(	O	O
n=29	O	O
,	O	O
52	O	O
%	O	O
)	O	O
that	O	O
received	O	O
oral	O	O
care	O	O
without	O	O
an	O	O
antiseptic	O	O
.	O	O

Oropharyngeal	O	O
secretions	O	O
were	O	O
collected	O	O
and	O	O
cultured	O	O
on	O	O
days	O	O
0	O	O
,	O	O
2	O	O
,	O	O
and	O	O
4	O	O
,	O	O
and	O	O
at	O	O
discharge	O	O
.	O	O

The	O	O
2	O	O
groups	O	O
had	O	O
similar	O	O
demographic	O	O
characteristics	O	O
,	O	O
preexisting	O	O
underlying	O	O
diseases	O	O
,	O	O
and	O	O
pharmacological	O	O
,	O	O
nutritional	O	O
,	O	O
and	O	O
ventilatory	O	O
support	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
the	O	O
predominant	O	O
pathogens	O	O
:	O	O
Acinetobacter	B-bacteria	B-bacteria
baumannii	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
and	O	O
Enter-obacter	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

The	O	O
2	O	O
groups	O	O
did	O	O
not	O	O
differ	O	O
significantly	O	O
in	O	O
the	O	O
colonization	O	O
of	O	O
normal	O	O
(	O	O
P=	O	O
.72	O	O
)	O	O
or	O	O
pathogenic	O	O
(	O	O
P=	O	O
.62	O	O
)	O	O
flora	O	O
,	O	O
in	O	O
the	O	O
duration	O	O
of	O	O
mechanical	O	O
ventilation	O	O
(	O	O
P=	O	O
.67	O	O
)	O	O
,	O	O
or	O	O
in	O	O
length	O	O
of	O	O
stay	O	O
in	O	O
the	O	O
intensive	O	O
care	O	O
(	O	O
P=	O	O
.22	O	O
)	O	O
.	O	O

Use	O	O
of	O	O
chlorhexidine	O	O
combined	O	O
with	O	O
nonpharmacological	O	O
oral	O	O
care	O	O
did	O	O
not	O	O
decrease	O	O
the	O	O
colonization	O	O
profile	O	O
,	O	O
duration	O	O
of	O	O
mechanical	O	O
ventilation	O	O
,	O	O
or	O	O
length	O	O
of	O	O
stay	O	O
in	O	O
critically	O	O
ill	O	O
children	O	O
receiving	O	O
mechanical	O	O
ventilation	O	O
.	O	O

Although	O	O
oral	O	O
health	O	O
affects	O	O
systemic	O	O
health	O	O
,	O	O
studies	O	O
of	O	O
oral	O	O
health	O	O
during	O	O
intubation	O	O
among	O	O
critically	O	O
ill	O	O
neuroscience	O	O
patients	O	O
are	O	O
lacking	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
effect	O	O
of	O	O
oral	O	O
care	O	O
on	O	O
intracranial	O	O
pressure	O	O
among	O	O
critically	O	O
ill	O	O
patients	O	O
in	O	O
a	O	O
neuroscience	O	O
intensive	O	O
care	O	O
unit	O	O
is	O	O
unknown	O	O
.	O	O

To	O	O
describe	O	O
changes	O	O
in	O	O
oral	O	O
health	O	O
and	O	O
development	O	O
of	O	O
ventilator-associated	O	O
pneumonia	O	O
during	O	O
intubation	O	O
among	O	O
patients	O	O
in	O	O
a	O	O
neuroscience	O	O
intensive	O	O
care	O	O
unit	O	O
and	O	O
to	O	O
assess	O	O
the	O	O
influence	O	O
of	O	O
oral	O	O
care	O	O
on	O	O
intracranial	O	O
pressure	O	O
.	O	O

Data	O	O
on	O	O
45	O	O
consecutive	O	O
intubated	O	O
patients	O	O
admitted	O	O
to	O	O
a	O	O
neuroscience	O	O
intensive	O	O
care	O	O
unit	O	O
during	O	O
1	O	O
year	O	O
were	O	O
collected	O	O
by	O	O
using	O	O
oral	O	O
cultures	O	O
and	O	O
the	O	O
Oral	O	O
Assessment	O	O
Guide	O	O
throughout	O	O
intubation	O	O
and	O	O
48	O	O
hours	O	O
after	O	O
extubation	O	O
.	O	O

Occurrence	O	O
of	O	O
ventilator-associated	O	O
pneumonia	O	O
and	O	O
intracranial	O	O
pressures	O	O
associated	O	O
with	O	O
oral	O	O
care	O	O
were	O	O
recorded	O	O
.	O	O

Oral	O	O
health	O	O
,	O	O
assessed	O	O
by	O	O
the	O	O
Oral	O	O
Assessment	O	O
Guide	O	O
,	O	O
deteriorated	O	O
significantly	O	O
during	O	O
intubation	O	O
and	O	O
improved	O	O
to	O	O
almost	O	O
baseline	O	O
levels	O	O
48	O	O
hours	O	O
after	O	O
extubation	O	O
.	O	O

During	O	O
intubation	O	O
,	O	O
occurrence	O	O
of	O	O
oral	O	O
gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
yeast	O	O
increased	O	O
.	O	O

The	O	O
incidence	O	O
of	O	O
ventilator-associated	O	O
pneumonia	O	O
was	O	O
24	O	O
%	O	O
among	O	O
patients	O	O
enrolled	O	O
for	O	O
4	O	O
to	O	O
10	O	O
days	O	O
.	O	O

During	O	O
or	O	O
after	O	O
879	O	O
instances	O	O
of	O	O
oral	O	O
care	O	O
,	O	O
overall	O	O
intracranial	O	O
pressure	O	O
did	O	O
not	O	O
increase	O	O
.	O	O

Among	O	O
30	O	O
instances	O	O
in	O	O
which	O	O
intracranial	O	O
pressure	O	O
was	O	O
greater	O	O
than	O	O
20	O	O
mm	O	O
Hg	O	O
before	O	O
oral	O	O
care	O	O
,	O	O
pressure	O	O
decreased	O	O
during	O	O
and	O	O
30	O	O
minutes	O	O
after	O	O
the	O	O
procedure	O	O
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
.	O	O

Intubation	O	O
may	O	O
contribute	O	O
to	O	O
worsening	O	O
of	O	O
oral	O	O
health	O	O
among	O	O
patients	O	O
in	O	O
neuroscience	O	O
intensive	O	O
care	O	O
units	O	O
.	O	O

Execution	O	O
of	O	O
oral	O	O
care	O	O
does	O	O
not	O	O
seem	O	O
to	O	O
affect	O	O
intracranial	O	O
pressure	O	O
adversely	O	O
.	O	O

Oral	O	O
care	O	O
should	O	O
be	O	O
explored	O	O
further	O	O
to	O	O
promote	O	O
good	O	O
oral	O	O
and	O	O
systemic	O	O
health	O	O
in	O	O
patients	O	O
in	O	O
neuroscience	O	O
intensive	O	O
care	O	O
units	O	O
and	O	O
to	O	O
determine	O	O
its	O	O
effect	O	O
on	O	O
ventilator-associated	O	O
pneumonia	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
a	O	O
commensal	O	O
opportunistic	O	O
oral	O	O
bacterium	O	O
,	O	O
is	O	O
capable	O	O
of	O	O
invading	O	O
gingival	O	O
epithelial	O	O
cells	O	O
,	O	O
but	O	O
the	O	O
entrance	O	O
into	O	O
human	O	O
primary	O	O
oral	O	O
fibroblast	O	O
cells	O	O
has	O	O
not	O	O
been	O	O
documented	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
ability	O	O
of	O	O
three	O	O
strains	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ssp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nucleatum	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ssp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

polymorphum	E-bacteria	I-bacteria
,	O	O
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ssp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

vincentii	E-bacteria	I-bacteria
)	O	O
to	O	O
enter	O	O
gingival	O	O
fibroblasts	O	O
(	O	O
GFs	O	O
)	O	O
and	O	O
periodontal	O	O
ligament	O	O
fibroblasts	O	O
(	O	O
PLFs	O	O
)	O	O
.	O	O

GFs	O	O
and	O	O
PLFs	O	O
were	O	O
cocultured	O	O
for	O	O
various	O	O
periods	O	O
of	O	O
time	O	O
with	O	O
different	O	O
strains	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Scanning	O	O
and	O	O
transmission	O	O
electron	O	O
microscopy	O	O
,	O	O
together	O	O
with	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
,	O	O
were	O	O
used	O	O
to	O	O
visualize	O	O
the	O	O
entrance	O	O
and	O	O
presence	O	O
of	O	O
bacteria	O	O
in	O	O
host	O	O
cells	O	O
.	O	O

Flow	O	O
cytometry	O	O
was	O	O
performed	O	O
to	O	O
compare	O	O
the	O	O
load	O	O
of	O	O
internalized	O	O
bacteria	O	O
in	O	O
GFs	O	O
and	O	O
PLFs	O	O
exposed	O	O
for	O	O
3	O	O
and	O	O
5	O	O
hours	O	O
to	O	O
live	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
labeled	O	O
with	O	O
fluorescein	O	O
isothiocyanate	O	O
.	O	O

All	O	O
three	O	O
strains	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
were	O	O
found	O	O
entering	O	O
and	O	O
located	O	O
in	O	O
the	O	O
cytoplasm	O	O
of	O	O
GFs	O	O
and	O	O
PLFs	O	O
after	O	O
1	O	O
hour	O	O
of	O	O
exposure	O	O
.	O	O

Flow	O	O
cytometry	O	O
tests	O	O
revealed	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
the	O	O
fluorescent	O	O
signal	O	O
,	O	O
compared	O	O
to	O	O
baseline	O	O
,	O	O
derived	O	O
from	O	O
bacteria	O	O
internalized	O	O
in	O	O
fibroblasts	O	O
exposed	O	O
for	O	O
3	O	O
hours	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
;	O	O
a	O	O
further	O	O
increase	O	O
was	O	O
found	O	O
at	O	O
5	O	O
hours	O	O
.	O	O

The	O	O
greatest	O	O
bacterial	O	O
mass	O	O
in	O	O
exposed	O	O
fibroblasts	O	O
of	O	O
both	O	O
types	O	O
was	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ssp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

polymorphum	E-bacteria	I-bacteria
;	O	O
the	O	O
smallest	O	O
was	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ssp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

vincentii	E-bacteria	I-bacteria
.	O	O

Although	O	O
not	O	O
statistically	O	O
significant	O	O
,	O	O
PLFs	O	O
had	O	O
a	O	O
higher	O	O
bacterial	O	O
load	O	O
than	O	O
corresponding	O	O
GFs	O	O
.	O	O

F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
capable	O	O
of	O	O
entering	O	O
GFs	O	O
and	O	O
PLFs	O	O
in	O	O
a	O	O
manner	O	O
that	O	O
is	O	O
dependent	O	O
on	O	O
the	O	O
cell	O	O
type	O	O
and	O	O
the	O	O
bacterial	O	O
strain	O	O
.	O	O

In	O	O
vitro	O	O
plaque	O	O
removal	O	O
studies	O	O
require	O	O
biofilm	O	O
models	O	O
that	O	O
resemble	O	O
in	O	O
vivo	O	O
dental	O	O
plaque	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
compare	O	O
contact	O	O
and	O	O
non-contact	O	O
removal	O	O
of	O	O
single	O	O
and	O	O
dual-species	O	O
biofilms	O	O
as	O	O
well	O	O
as	O	O
of	O	O
biofilms	O	O
grown	O	O
from	O	O
human	O	O
whole	O	O
saliva	O	O
in	O	O
vitro	O	O
using	O	O
different	O	O
biofilm	O	O
models	O	O
.	O	O

Bacteria	O	O
were	O	O
adhered	O	O
to	O	O
a	O	O
salivary	O	O
pellicle	O	O
for	O	O
2	O	O
h	O	O
or	O	O
grown	O	O
after	O	O
adhesion	O	O
for	O	O
16	O	O
h	O	O
,	O	O
after	O	O
which	O	O
,	O	O
their	O	O
removal	O	O
was	O	O
evaluated	O	O
.	O	O

In	O	O
a	O	O
contact	O	O
mode	O	O
,	O	O
no	O	O
differences	O	O
were	O	O
observed	O	O
between	O	O
the	O	O
manual	O	O
,	O	O
rotating	O	O
,	O	O
or	O	O
sonic	O	O
brushing	O	O
;	O	O
and	O	O
removal	O	O
was	O	O
on	O	O
average	O	O
39	O	O
%	O	O
,	O	O
84	O	O
%	O	O
,	O	O
and	O	O
95	O	O
%	O	O
for	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
respectively	O	O
,	O	O
and	O	O
90	O	O
%	O	O
and	O	O
54	O	O
%	O	O
for	O	O
the	O	O
dual-	O	O
and	O	O
multi-species	O	O
biofilms	O	O
,	O	O
respectively	O	O
.	O	O

However	O	O
,	O	O
in	O	O
a	O	O
non-contact	O	O
mode	O	O
,	O	O
rotating	O	O
and	O	O
sonic	O	O
brushes	O	O
still	O	O
removed	O	O
considerable	O	O
numbers	O	O
of	O	O
bacteria	O	O
(	O	O
24-40	O	O
%	O	O
)	O	O
,	O	O
while	O	O
the	O	O
manual	O	O
brush	O	O
as	O	O
a	O	O
control	O	O
(	O	O
5-11	O	O
%	O	O
)	O	O
did	O	O
not	O	O
.	O	O

Single	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
dual-species	O	O
(	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
)	O	O
biofilms	O	O
were	O	O
more	O	O
difficult	O	O
to	O	O
remove	O	O
after	O	O
16	O	O
h	O	O
growth	O	O
than	O	O
after	O	O
2	O	O
h	O	O
adhesion	O	O
(	O	O
on	O	O
average	O	O
,	O	O
62	O	O
%	O	O
and	O	O
93	O	O
%	O	O
for	O	O
16-	O	O
and	O	O
2-h-old	O	O
biofilms	O	O
,	O	O
respectively	O	O
)	O	O
,	O	O
while	O	O
in	O	O
contrast	O	O
,	O	O
biofilms	O	O
grown	O	O
from	O	O
whole	O	O
saliva	O	O
were	O	O
easier	O	O
to	O	O
remove	O	O
(	O	O
97	O	O
%	O	O
after	O	O
16	O	O
h	O	O
and	O	O
54	O	O
%	O	O
after	O	O
2	O	O
h	O	O
of	O	O
growth	O	O
)	O	O
.	O	O

Considering	O	O
the	O	O
strong	O	O
adhesion	O	O
of	O	O
dual-species	O	O
biofilms	O	O
and	O	O
their	O	O
easier	O	O
more	O	O
reproducible	O	O
growth	O	O
compared	O	O
with	O	O
biofilms	O	O
grown	O	O
from	O	O
whole	O	O
saliva	O	O
,	O	O
dual-species	O	O
biofilms	O	O
of	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
are	O	O
suggested	O	O
to	O	O
be	O	O
preferred	O	O
for	O	O
use	O	O
in	O	O
mechanical	O	O
plaque	O	O
removal	O	O
studies	O	O
in	O	O
vitro	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
whether	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
from	O	O
endodontic	O	O
patients	O	O
(	O	O
from	O	O
saliva	O	O
and	O	O
from	O	O
a	O	O
root	O	O
canal	O	O
)	O	O
are	O	O
able	O	O
to	O	O
prevail	O	O
against	O	O
salivary	O	O
bacteria	O	O
when	O	O
grown	O	O
in	O	O
coculture	O	O
in	O	O
a	O	O
biofilm	O	O
reactor	O	O
.	O	O

Saliva	O	O
that	O	O
was	O	O
tested	O	O
to	O	O
be	O	O
free	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
was	O	O
used	O	O
as	O	O
the	O	O
inoculum	O	O
.	O	O

The	O	O
fate	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
was	O	O
examined	O	O
by	O	O
using	O	O
culture	O	O
techniques	O	O
and	O	O
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
.	O	O

The	O	O
root	O	O
canal	O	O
isolate	O	O
accounted	O	O
for	O	O
37.4	O	O
%	O	O
of	O	O
the	O	O
biofilm	O	O
and	O	O
31.9	O	O
%	O	O
of	O	O
the	O	O
planktonic	O	O
phase	O	O
when	O	O
examined	O	O
by	O	O
the	O	O
culture	O	O
technique	O	O
,	O	O
whereas	O	O
the	O	O
proportions	O	O
examined	O	O
by	O	O
FISH	O	O
showed	O	O
15.3	O	O
%	O	O
in	O	O
the	O	O
biofilm	O	O
and	O	O
11.7	O	O
%	O	O
in	O	O
the	O	O
planktonic	O	O
phase	O	O
.	O	O

The	O	O
saliva	O	O
isolate	O	O
(	O	O
as	O	O
examined	O	O
by	O	O
the	O	O
culture	O	O
technique	O	O
)	O	O
accounted	O	O
for	O	O
32.4	O	O
%	O	O
in	O	O
the	O	O
biofilm	O	O
and	O	O
27.1	O	O
%	O	O
in	O	O
the	O	O
planktonic	O	O
phase	O	O
,	O	O
respectively	O	O
,	O	O
compared	O	O
with	O	O
14.1	O	O
%	O	O
in	O	O
the	O	O
biofilm	O	O
and	O	O
9.5	O	O
%	O	O
in	O	O
the	O	O
planktonic	O	O
phase	O	O
when	O	O
examined	O	O
by	O	O
FISH	O	O
analysis	O	O
.	O	O

These	O	O
results	O	O
led	O	O
to	O	O
the	O	O
suggestion	O	O
that	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
could	O	O
persist	O	O
in	O	O
the	O	O
biofilm	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

Because	O	O
of	O	O
the	O	O
ubiquitous	O	O
presence	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
root	O	O
canal	O	O
infections	O	O
may	O	O
arise	O	O
from	O	O
different	O	O
sources	O	O
.	O	O

Members	O	O
of	O	O
the	O	O
genus	B-bacteria	B-bacteria
Veillonella	E-bacteria	I-bacteria
can	O	O
not	O	O
be	O	O
reliably	O	O
distinguished	O	O
by	O	O
their	O	O
biochemical	O	O
characteristics	O	O
and	O	O
phenotypic	O	O
features	O	O
.	O	O

Moreover	O	O
,	O	O
DNA-DNA	O	O
hybridization	O	O
and	O	O
sequence	O	O
analyses	O	O
of	O	O
the	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
gene	O	O
including	O	O
random	O	O
fragment	O	O
length	O	O
polymorphism	O	O
analysis	O	O
,	O	O
are	O	O
complex	O	O
and	O	O
time-consuming	O	O
procedures	O	O
that	O	O
are	O	O
not	O	O
well-suited	O	O
to	O	O
identifying	O	O
oral	O	O
species	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
:	O	O
Veillonella	B-bacteria	B-bacteria
atypica	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
denticariosi	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
dispar	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
rogosae	E-bacteria	I-bacteria
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
five	O	O
forward	O	O
primers	O	O
and	O	O
a	O	O
reverse	O	O
primer	O	O
were	O	O
designed	O	O
for	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
according	O	O
to	O	O
the	O	O
partial	O	O
sequences	O	O
of	O	O
the	O	O
rpoB	O	O
genes	O	O
of	O	O
these	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

The	O	O
forward	O	O
primers	O	O
were	O	O
species-specific	O	O
for	O	O
these	O	O
five	O	O
Veillonella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
and	O	O
could	O	O
produce	O	O
specific	O	O
amplicons	O	O
when	O	O
used	O	O
together	O	O
with	O	O
reverse	O	O
primer	O	O
and	O	O
individual	O	O
DNA	O	O
templates	O	O
of	O	O
these	O	O
species	O	O
in	O	O
PCR	O	O
.	O	O

These	O	O
primer	O	O
pairs	O	O
were	O	O
also	O	O
found	O	O
to	O	O
discriminate	O	O
between	O	O
the	O	O
respective	O	O
species	O	O
,	O	O
and	O	O
the	O	O
Veillonella	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
human	O	O
oral	O	O
cavities	O	O
were	O	O
successfully	O	O
assigned	O	O
to	O	O
one	O	O
of	O	O
the	O	O
five	O	O
oral	O	O
species	O	O
of	O	O
the	O	O
genus	O	O
Veillonella	B-bacteria	B-bacteria
based	O	O
on	O	O
their	O	O
specific	O	O
products	O	O
by	O	O
PCR	O	O
.	O	O

A	O	O
simple	O	O
two-step	O	O
PCR	O	O
procedure	O	O
using	O	O
the	O	O
five	O	O
sets	O	O
of	O	O
primer	O	O
pairs	O	O
developed	O	O
in	O	O
the	O	O
present	O	O
study	O	O
is	O	O
a	O	O
rapid	O	O
and	O	O
reliable	O	O
method	O	O
for	O	O
the	O	O
identification	O	O
of	O	O
the	O	O
recognized	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
bacteriostatic	O	O
effect	O	O
of	O	O
Piper	O	O
betle	O	O
and	O	O
Psidium	O	O
guajava	O	O
extracts	O	O
on	O	O
selected	O	O
early	O	O
dental	O	O
plaque	O	O
bacteria	O	O
was	O	O
investigated	O	O
based	O	O
on	O	O
changes	O	O
in	O	O
the	O	O
doubling	O	O
time	O	O
(	O	O
g	O	O
)	O	O
and	O	O
specific	O	O
growth	O	O
rates	O	O
(	O	O
micro	O	O
)	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
cultured	O	O
in	O	O
Brain	O	O
Heart	O	O
Infusion	O	O
(	O	O
BHI	O	O
)	O	O
in	O	O
the	O	O
presence	O	O
and	O	O
absence	O	O
of	O	O
the	O	O
extracts	O	O
.	O	O

The	O	O
growth	O	O
of	O	O
bacteria	O	O
was	O	O
monitored	O	O
periodically	O	O
every	O	O
15	O	O
min	O	O
over	O	O
a	O	O
period	O	O
of	O	O
9	O	O
h	O	O
to	O	O
allow	O	O
for	O	O
a	O	O
complete	O	O
growth	O	O
cycle	O	O
.	O	O

Growth	O	O
profiles	O	O
of	O	O
the	O	O
bacteria	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
extracts	O	O
were	O	O
compared	O	O
to	O	O
those	O	O
in	O	O
the	O	O
absence	O	O
and	O	O
deviation	O	O
in	O	O
the	O	O
g	O	O
and	O	O
micro	O	O
were	O	O
determined	O	O
and	O	O
analyzed	O	O
.	O	O

It	O	O
was	O	O
found	O	O
that	O	O
the	O	O
g	O	O
and	O	O
mu	O	O
were	O	O
affected	O	O
by	O	O
both	O	O
extracts	O	O
.	O	O

At	O	O
4	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
of	O	O
P.	B-bacteria	B-bacteria
betle	E-bacteria	I-bacteria
the	O	O
g-values	O	O
for	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
were	O	O
increased	O	O
by	O	O
12.0-	O	O
and	O	O
10.4-fold	O	O
,	O	O
respectively	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

At	O	O
similar	O	O
concentration	O	O
P.	B-bacteria	B-bacteria
guajava	E-bacteria	I-bacteria
increased	O	O
the	O	O
g-value	O	O
by	O	O
1.8-	O	O
and	O	O
2.6	O	O
-fold	O	O
,	O	O
respectively	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
effect	O	O
on	O	O
Actinomyces	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

was	O	O
observed	O	O
at	O	O
a	O	O
much	O	O
lower	O	O
magnitude	O	O
.	O	O

It	O	O
appears	O	O
that	O	O
P.	B-bacteria	B-bacteria
betle	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
guajava	E-bacteria	I-bacteria
extracts	O	O
have	O	O
bacteriostatic	O	O
effect	O	O
on	O	O
the	O	O
plaque	O	O
bacteria	O	O
by	O	O
creating	O	O
a	O	O
stressed	O	O
environment	O	O
that	O	O
had	O	O
suppressed	O	O
the	O	O
growth	O	O
and	O	O
propagation	O	O
of	O	O
the	O	O
cells	O	O
.	O	O

Within	O	O
the	O	O
context	O	O
of	O	O
the	O	O
dental	O	O
plaque	O	O
,	O	O
this	O	O
would	O	O
ensure	O	O
the	O	O
attainment	O	O
of	O	O
thin	O	O
and	O	O
healthy	O	O
plaque	O	O
.	O	O

Thus	O	O
,	O	O
decoctions	O	O
of	O	O
these	O	O
plants	O	O
would	O	O
be	O	O
suitable	O	O
if	O	O
used	O	O
in	O	O
the	O	O
control	O	O
of	O	O
dental	O	O
plaque	O	O
.	O	O

The	O	O
world-wide	O	O
explosion	O	O
of	O	O
overweight	O	O
people	O	O
has	O	O
been	O	O
called	O	O
an	O	O
epidemic	O	O
.	O	O

The	O	O
inflammatory	O	O
nature	O	O
of	O	O
obesity	O	O
is	O	O
widely	O	O
recognized	O	O
.	O	O

Could	O	O
it	O	O
really	O	O
be	O	O
an	O	O
epidemic	O	O
involving	O	O
an	O	O
infectious	O	O
agent	O	O
?	O	O

In	O	O
this	O	O
climate	O	O
of	O	O
concern	O	O
over	O	O
the	O	O
increasing	O	O
prevalence	O	O
of	O	O
overweight	O	O
conditions	O	O
in	O	O
our	O	O
society	O	O
,	O	O
we	O	O
focus	O	O
on	O	O
the	O	O
possible	O	O
role	O	O
of	O	O
oral	O	O
bacteria	O	O
as	O	O
a	O	O
potential	O	O
direct	O	O
contributor	O	O
to	O	O
obesity	O	O
.	O	O

To	O	O
investigate	O	O
this	O	O
possibility	O	O
,	O	O
we	O	O
measured	O	O
salivary	O	O
bacterial	O	O
populations	O	O
of	O	O
overweight	O	O
women	O	O
.	O	O

Saliva	O	O
was	O	O
collected	O	O
from	O	O
313	O	O
women	O	O
with	O	O
a	O	O
body	O	O
mass	O	O
index	O	O
between	O	O
27	O	O
and	O	O
32	O	O
,	O	O
and	O	O
bacterial	O	O
populations	O	O
were	O	O
measured	O	O
by	O	O
DNA	O	O
probe	O	O
analysis	O	O
.	O	O

Levels	O	O
in	O	O
this	O	O
group	O	O
were	O	O
compared	O	O
with	O	O
data	O	O
from	O	O
a	O	O
population	O	O
of	O	O
232	O	O
healthy	O	O
individuals	O	O
from	O	O
periodontal	O	O
disease	O	O
studies	O	O
.	O	O

The	O	O
median	O	O
percentage	O	O
difference	O	O
of	O	O
7	O	O
of	O	O
the	O	O
40	O	O
bacterial	O	O
species	O	O
measured	O	O
was	O	O
greater	O	O
than	O	O
2	O	O
%	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
overweight	O	O
women	O	O
.	O	O

Classification	O	O
tree	O	O
analysis	O	O
of	O	O
salivary	O	O
microbiological	O	O
composition	O	O
revealed	O	O
that	O	O
98.4	O	O
%	O	O
of	O	O
the	O	O
overweight	O	O
women	O	O
could	O	O
be	O	O
identified	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
single	O	O
bacterial	O	O
species	O	O
(	O	O
Selenomonas	B-bacteria	B-bacteria
noxia	E-bacteria	I-bacteria
)	O	O
at	O	O
levels	O	O
greater	O	O
than	O	O
1.05	O	O
%	O	O
of	O	O
the	O	O
total	O	O
salivary	O	O
bacteria	O	O
.	O	O

Analysis	O	O
of	O	O
these	O	O
data	O	O
suggests	O	O
that	O	O
the	O	O
composition	O	O
of	O	O
salivary	O	O
bacteria	O	O
changes	O	O
in	O	O
overweight	O	O
women	O	O
.	O	O

It	O	O
seems	O	O
likely	O	O
that	O	O
these	O	O
bacterial	O	O
species	O	O
could	O	O
serve	O	O
as	O	O
biological	O	O
indicators	O	O
of	O	O
a	O	O
developing	O	O
overweight	O	O
condition	O	O
.	O	O

Of	O	O
even	O	O
greater	O	O
interest	O	O
,	O	O
and	O	O
the	O	O
subject	O	O
of	O	O
future	O	O
research	O	O
,	O	O
is	O	O
the	O	O
possibility	O	O
that	O	O
oral	O	O
bacteria	O	O
may	O	O
participate	O	O
in	O	O
the	O	O
pathology	O	O
that	O	O
leads	O	O
to	O	O
obesity	O	O
.	O	O

Beach	O	O
sand	O	O
contains	O	O
fecal	O	O
indicator	O	O
bacteria	O	O
,	O	O
often	O	O
in	O	O
densities	O	O
greatly	O	O
exceeding	O	O
the	O	O
adjacent	O	O
swimming	O	O
waters	O	O
.	O	O

We	O	O
examined	O	O
the	O	O
transferability	O	O
of	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
F+	O	O
coliphage	O	O
(	O	O
MS2	O	O
)	O	O
from	O	O
beach	O	O
sand	O	O
to	O	O
hands	O	O
in	O	O
order	O	O
to	O	O
estimate	O	O
the	O	O
potential	O	O
subsequent	O	O
health	O	O
risk	O	O
.	O	O

Sand	O	O
with	O	O
high	O	O
initial	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
concentrations	O	O
was	O	O
collected	O	O
from	O	O
a	O	O
Chicago	O	O
beach	O	O
.	O	O

Individuals	O	O
manipulated	O	O
the	O	O
sand	O	O
for	O	O
60	O	O
seconds	O	O
,	O	O
and	O	O
rinse	O	O
water	O	O
was	O	O
analysed	O	O
for	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
coliphage	O	O
.	O	O

E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
densities	O	O
transferred	O	O
were	O	O
correlated	O	O
with	O	O
density	O	O
in	O	O
sand	O	O
rather	O	O
than	O	O
surface	O	O
area	O	O
of	O	O
an	O	O
individual	O	O
's	O	O
hand	O	O
,	O	O
and	O	O
the	O	O
amount	O	O
of	O	O
coliphage	O	O
transferred	O	O
from	O	O
seeded	O	O
sand	O	O
was	O	O
different	O	O
among	O	O
individuals	O	O
.	O	O

In	O	O
sequential	O	O
rinsing	O	O
,	O	O
percentage	O	O
reduction	O	O
was	O	O
92	O	O
%	O	O
for	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
98	O	O
%	O	O
for	O	O
coliphage	O	O
.	O	O

Using	O	O
dose-response	O	O
estimates	O	O
developed	O	O
for	O	O
swimming	O	O
water	O	O
,	O	O
it	O	O
was	O	O
determined	O	O
that	O	O
the	O	O
number	O	O
of	O	O
individuals	O	O
per	O	O
thousand	O	O
that	O	O
would	O	O
develop	O	O
gastrointestinal	O	O
symptoms	O	O
would	O	O
be	O	O
11	O	O
if	O	O
all	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
on	O	O
the	O	O
fingertip	O	O
were	O	O
ingested	O	O
or	O	O
33	O	O
if	O	O
all	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
on	O	O
the	O	O
hand	O	O
were	O	O
ingested	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
beach	O	O
sand	O	O
may	O	O
be	O	O
an	O	O
important	O	O
medium	O	O
for	O	O
microbial	O	O
exposure	O	O
;	O	O
bacteria	O	O
transfer	O	O
is	O	O
related	O	O
to	O	O
initial	O	O
concentration	O	O
in	O	O
the	O	O
sand	O	O
;	O	O
and	O	O
rinsing	O	O
may	O	O
be	O	O
effective	O	O
in	O	O
limiting	O	O
oral	O	O
exposure	O	O
to	O	O
sand-borne	O	O
microbes	O	O
of	O	O
human	O	O
concern	O	O
.	O	O

Photodynamic	O	O
therapy	O	O
has	O	O
been	O	O
advocated	O	O
as	O	O
an	O	O
alternative	O	O
to	O	O
antimicrobial	O	O
agents	O	O
to	O	O
suppress	O	O
subgingival	O	O
species	O	O
and	O	O
to	O	O
treat	O	O
periodontitis	O	O
.	O	O

Bacteria	O	O
located	O	O
within	O	O
dense	O	O
biofilms	O	O
,	O	O
such	O	O
as	O	O
those	O	O
encountered	O	O
in	O	O
dental	O	O
plaque	O	O
,	O	O
have	O	O
been	O	O
found	O	O
to	O	O
be	O	O
relatively	O	O
resistant	O	O
to	O	O
antimicrobial	O	O
therapy	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
ability	O	O
of	O	O
photodynamic	O	O
therapy	O	O
to	O	O
reduce	O	O
the	O	O
number	O	O
of	O	O
bacteria	O	O
in	O	O
biofilms	O	O
by	O	O
comparing	O	O
the	O	O
photodynamic	O	O
effects	O	O
of	O	O
methylene	O	O
blue	O	O
on	O	O
human	O	O
dental	O	O
plaque	O	O
microorganisms	O	O
in	O	O
the	O	O
planktonic	O	O
phase	O	O
and	O	O
in	O	O
biofilms	O	O
.	O	O

Dental	O	O
plaque	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
10	O	O
subjects	O	O
with	O	O
chronic	O	O
periodontitis	O	O
.	O	O

Suspensions	O	O
of	O	O
plaque	O	O
microorganisms	O	O
from	O	O
five	O	O
subjects	O	O
were	O	O
sensitized	O	O
with	O	O
methylene	O	O
blue	O	O
(	O	O
25	O	O
microg/mL	O	O
)	O	O
for	O	O
5	O	O
min	O	O
then	O	O
exposed	O	O
to	O	O
red	O	O
light	O	O
.	O	O

Multispecies	O	O
microbial	O	O
biofilms	O	O
developed	O	O
from	O	O
the	O	O
same	O	O
plaque	O	O
samples	O	O
were	O	O
also	O	O
exposed	O	O
to	O	O
methylene	O	O
blue	O	O
(	O	O
25	O	O
microg/mL	O	O
)	O	O
and	O	O
the	O	O
same	O	O
light	O	O
conditions	O	O
as	O	O
their	O	O
planktonic	O	O
counterparts	O	O
.	O	O

In	O	O
a	O	O
second	O	O
set	O	O
of	O	O
experiments	O	O
,	O	O
biofilms	O	O
were	O	O
developed	O	O
with	O	O
plaque	O	O
bacteria	O	O
from	O	O
five	O	O
subjects	O	O
,	O	O
sensitized	O	O
with	O	O
25	O	O
or	O	O
50	O	O
microg/mL	O	O
of	O	O
methylene	O	O
blue	O	O
and	O	O
then	O	O
exposed	O	O
to	O	O
red	O	O
light	O	O
.	O	O

After	O	O
photodynamic	O	O
therapy	O	O
,	O	O
survival	O	O
fractions	O	O
were	O	O
calculated	O	O
by	O	O
counting	O	O
the	O	O
number	O	O
of	O	O
colony-forming	O	O
units	O	O
.	O	O

Photodynamic	O	O
therapy	O	O
killed	O	O
approximately	O	O
63	O	O
%	O	O
of	O	O
bacteria	O	O
present	O	O
in	O	O
suspension	O	O
.	O	O

By	O	O
contrast	O	O
,	O	O
in	O	O
biofilms	O	O
,	O	O
photodynamic	O	O
therapy	O	O
had	O	O
much	O	O
less	O	O
of	O	O
an	O	O
effect	O	O
on	O	O
the	O	O
viability	O	O
of	O	O
bacteria	O	O
(	O	O
32	O	O
%	O	O
maximal	O	O
killing	O	O
)	O	O
.	O	O

Oral	O	O
bacteria	O	O
in	O	O
biofilms	O	O
are	O	O
affected	O	O
less	O	O
by	O	O
photodynamic	O	O
therapy	O	O
than	O	O
bacteria	O	O
in	O	O
the	O	O
planktonic	O	O
phase	O	O
.	O	O

The	O	O
antibacterial	O	O
effect	O	O
of	O	O
photodynamic	O	O
therapy	O	O
is	O	O
reduced	O	O
in	O	O
biofilm	O	O
bacteria	O	O
but	O	O
not	O	O
to	O	O
the	O	O
same	O	O
degree	O	O
as	O	O
has	O	O
been	O	O
reported	O	O
for	O	O
treatment	O	O
with	O	O
antibiotics	O	O
under	O	O
similar	O	O
conditions	O	O
.	O	O

Three	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
pleomorphic	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
Gram-positive-staining	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
,	O	O
which	O	O
were	O	O
isolated	O	O
from	O	O
human	O	O
carious	O	O
dentine	O	O
,	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
and	O	O
were	O	O
found	O	O
to	O	O
comprise	O	O
a	O	O
homogeneous	O	O
group	O	O
.	O	O

The	O	O
strains	O	O
were	O	O
saccharolytic	O	O
and	O	O
produced	O	O
acetic	O	O
and	O	O
propionic	O	O
acids	O	O
in	O	O
large	O	O
amounts	O	O
,	O	O
and	O	O
succinic	O	O
acid	O	O
in	O	O
moderate	O	O
amounts	O	O
,	O	O
as	O	O
the	O	O
end	O	O
products	O	O
of	O	O
fermentation	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
and	O	O
RpoB	O	O
protein	O	O
sequence	O	O
analyses	O	O
revealed	O	O
that	O	O
the	O	O
strains	O	O
constituted	O	O
a	O	O
novel	O	O
group	O	O
within	O	O
the	O	O
genus	B-bacteria	B-bacteria
Propionibacterium	E-bacteria	I-bacteria
,	O	O
most	O	O
closely	O	O
related	O	O
to	O	O
Propionibacterium	B-bacteria	B-bacteria
australiense	E-bacteria	I-bacteria
but	O	O
sharing	O	O
only	O	O
8	O	O
%	O	O
DNA-DNA	O	O
relatedness	O	O
with	O	O
the	O	O
type	O	O
strain	O	O
of	O	O
that	O	O
species	O	O
.	O	O

Therefore	O	O
,	O	O
a	O	O
novel	O	O
species	O	O
,	O	O
Propionibacterium	B-bacteria	B-bacteria
acidifaciens	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
is	O	O
proposed	O	O
to	O	O
accommodate	O	O
these	O	O
strains	O	O
.	O	O

The	O	O
DNA	O	O
G+C	O	O
content	O	O
of	O	O
the	O	O
type	O	O
strain	O	O
is	O	O
70	O	O
mol	O	O
%	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
is	O	O
C3M_31	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
=DSM	B-bacteria	B-bacteria
21887	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
57100	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
monitor	O	O
changes	O	O
in	O	O
oral	O	O
health	O	O
and	O	O
oral	O	O
biofilm	O	O
composition	O	O
in	O	O
vivo	O	O
during	O	O
an	O	O
experiment	O	O
simulating	O	O
prehistoric	O	O
lifestyle	O	O
and	O	O
diet	O	O
and	O	O
poor	O	O
oral	O	O
hygiene	O	O
.	O	O

Thirteen	O	O
subjects	O	O
lived	O	O
for	O	O
a	O	O
period	O	O
of	O	O
8	O	O
weeks	O	O
under	O	O
Neolithic	O	O
conditions	O	O
.	O	O

The	O	O
following	O	O
clinical	O	O
parameters	O	O
were	O	O
recorded	O	O
before	O	O
and	O	O
after	O	O
the	O	O
project	O	O
:	O	O
gingival	O	O
and	O	O
plaque	O	O
index	O	O
(	O	O
Loe	O	O
and	O	O
Silness	O	O
,	O	O
Acta	O	O
Odontol	O	O
Scand	O	O
21:533	O	O
,	O	O
1963	O	O
;	O	O
Silness	O	O
and	O	O
Loe	O	O
,	O	O
Acta	O	O
Odontol	O	O
Scand	O	O
22:121-135	O	O
,	O	O
1964	O	O
)	O	O
,	O	O
probing	O	O
pocket	O	O
depth	O	O
,	O	O
and	O	O
bleeding	O	O
upon	O	O
probing	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
supragingival	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
both	O	O
before	O	O
and	O	O
after	O	O
the	O	O
project	O	O
and	O	O
were	O	O
analysed	O	O
quantitatively	O	O
using	O	O
multiplex	O	O
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
and	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
.	O	O

The	O	O
following	O	O
plaque	O	O
bacteria	O	O
were	O	O
evaluated	O	O
:	O	O
Streptococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
.	O	O

The	O	O
plaque	O	O
index	O	O
increased	O	O
significantly	O	O
from	O	O
1.12	O	O
up	O	O
to	O	O
1.55	O	O
over	O	O
the	O	O
8-week	O	O
period	O	O
(	O	O
gingival	O	O
index	O	O
before	O	O
,	O	O
0.46	O	O
;	O	O
after	O	O
,	O	O
0.93	O	O
;	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

A	O	O
strong	O	O
correlation	O	O
of	O	O
both	O	O
indices	O	O
was	O	O
recorded	O	O
before	O	O
(	O	O
r	O	O
=	O	O
0.77	O	O
)	O	O
and	O	O
after	O	O
(	O	O
r	O	O
=	O	O
0.83	O	O
)	O	O
participation	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Each	O	O
of	O	O
the	O	O
children	O	O
in	O	O
the	O	O
study	O	O
showed	O	O
a	O	O
progression	O	O
of	O	O
carious	O	O
lesions	O	O
and/or	O	O
new	O	O
areas	O	O
of	O	O
demineralisation	O	O
.	O	O

The	O	O
probing	O	O
pocket	O	O
depth	O	O
and	O	O
bleeding	O	O
upon	O	O
probing	O	O
were	O	O
not	O	O
affected	O	O
.	O	O

All	O	O
subjects	O	O
yielded	O	O
an	O	O
intra-individual	O	O
shift	O	O
in	O	O
biofilm	O	O
composition	O	O
.	O	O

The	O	O
proportion	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
decreased	O	O
across	O	O
all	O	O
subjects	O	O
.	O	O

The	O	O
proportion	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

increased	O	O
among	O	O
the	O	O
children	O	O
.	O	O

Poor	O	O
oral	O	O
hygiene	O	O
and	O	O
change	O	O
of	O	O
diet	O	O
lead	O	O
to	O	O
an	O	O
increase	O	O
in	O	O
oral	O	O
plaque	O	O
and	O	O
gingival	O	O
inflammation	O	O
.	O	O

The	O	O
inter-individual	O	O
comparison	O	O
indicated	O	O
a	O	O
shift	O	O
in	O	O
bacterial	O	O
composition	O	O
.	O	O

Bacillus	B-bacteria	B-bacteria
subtilis	E-bacteria	I-bacteria
is	O	O
an	O	O
effective	O	O
probiotic	B-bacteria	B-bacteria
product	O	O
for	O	O
prevention	O	O
of	O	O
enteric	O	O
infections	O	O
both	O	O
in	O	O
humans	O	O
and	O	O
animals	O	O
.	O	O

We	O	O
hypothesized	O	O
that	O	O
a	O	O
mouth	O	O
rinse	O	O
containing	O	O
Bacillus	B-bacteria	B-bacteria
subtilis	O	O
should	O	O
adhere	O	O
to	O	O
and	O	O
colonize	O	O
part	O	O
of	O	O
the	O	O
oral	O	O
bacteria	O	O
on	O	O
periodontal	O	O
tissue	O	O
.	O	O

The	O	O
rinsing	O	O
ability	O	O
of	O	O
Extraction	O	O
300E	O	O
(	O	O
containing	O	O
Bacillus	B-bacteria	B-bacteria
subtilis	E-bacteria	I-bacteria
:	O	O
E-300	O	O
)	O	O
was	O	O
compared	O	O
with	O	O
that	O	O
of	O	O
a	O	O
mouth	O	O
wash	O	O
liquid	O	O
,	O	O
Neosteline	O	O
Green	O	O
(	O	O
benzethonium	O	O
chloride	O	O
;	O	O
NG	O	O
)	O	O
that	O	O
is	O	O
commonly	O	O
used	O	O
in	O	O
Japan	O	O
.	O	O

Compared	O	O
with	O	O
NG	O	O
rinsing	O	O
,	O	O
E-300	O	O
rinsing	O	O
resulted	O	O
in	O	O
a	O	O
marked	O	O
change	O	O
in	O	O
the	O	O
BANA-score	O	O
.	O	O

The	O	O
mean	O	O
BANA	O	O
values	O	O
(	O	O
score	O	O
+/-	O	O
SD	O	O
)	O	O
over	O	O
the	O	O
course	O	O
of	O	O
the	O	O
study	O	O
from	O	O
0	O	O
to	O	O
30	O	O
days	O	O
were	O	O
1.52	O	O
+/-	O	O
0.51	O	O
(	O	O
p	O	O
<	O	O
or	O	O
=	O	O
0.1	O	O
)	O	O
and	O	O
0.30	O	O
+/-	O	O
0.47	O	O
(	O	O
p	O	O
<	O	O
or	O	O
=	O	O
0.01	O	O
)	O	O
for	O	O
E-300	O	O
,	O	O
and	O	O
1.56	O	O
+/-	O	O
0.51	O	O
and	O	O
0.93	O	O
+/-	O	O
0.68	O	O
for	O	O
NG	O	O
,	O	O
respectively	O	O
.	O	O

Gingival	O	O
Index	O	O
also	O	O
had	O	O
improvement	O	O
,	O	O
while	O	O
probing	O	O
pocket	O	O
depth	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
showed	O	O
small	O	O
improvements	O	O
.	O	O

Mouth	O	O
rinsing	O	O
with	O	O
E-300	O	O
significantly	O	O
reduced	O	O
periodontal	O	O
pathogens	O	O
compared	O	O
with	O	O
NG	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
Bacillus	B-bacteria	B-bacteria
subtilis	E-bacteria	I-bacteria
is	O	O
an	O	O
appropriate	O	O
mouth	O	O
rinse	O	O
for	O	O
patients	O	O
with	O	O
periodontitis	O	O
.	O	O

Two	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
pigmented	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
non-spore-forming	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
Gram-stain-negative	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
rod-shaped	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
,	O	O
OMA31	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
OMA130	B-bacteria	B-bacteria
,	O	O
were	O	O
characterized	O	O
by	O	O
determining	O	O
their	O	O
phenotypic	O	O
and	O	O
biochemical	O	O
features	O	O
,	O	O
cellular	O	O
fatty	O	O
acid	O	O
profiles	O	O
and	O	O
phylogenetic	O	O
positions	O	O
based	O	O
on	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
showed	O	O
that	O	O
the	O	O
new	O	O
isolates	O	O
belonged	O	O
to	O	O
a	O	O
single	O	O
species	O	O
of	O	O
the	O	O
genus	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
.	O	O

The	O	O
two	O	O
isolates	O	O
showed	O	O
100	O	O
%	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
similarity	O	O
with	O	O
each	O	O
other	O	O
and	O	O
were	O	O
most	O	O
closely	O	O
related	O	O
to	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25611	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
with	O	O
96.4	O	O
%	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
similarity	O	O
;	O	O
the	O	O
next	O	O
most	O	O
closely	O	O
related	O	O
strains	O	O
to	O	O
the	O	O
isolates	O	O
were	O	O
Prevotella	B-bacteria	B-bacteria
pallens	I-bacteria	I-bacteria
AHN	I-bacteria	I-bacteria
10371	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
96.1	O	O
%	O	O
)	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
falsenii	I-bacteria	I-bacteria
JCM	I-bacteria	I-bacteria
15124	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
95.3	O	O
%	O	O
)	O	O
.	O	O

Phenotypic	B-bacteria	B-bacteria
and	O	O
biochemical	O	O
characteristics	O	O
of	O	O
the	O	O
isolates	O	O
were	O	O
the	O	O
same	O	O
as	O	O
those	O	O
of	O	O
P.	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
JCM	I-bacteria	I-bacteria
12248	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
,	O	O
P.	B-bacteria	B-bacteria
falsenii	I-bacteria	I-bacteria
JCM	I-bacteria	I-bacteria
15124	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	I-bacteria	I-bacteria
JCM	I-bacteria	I-bacteria
12250	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
.	O	O

The	O	O
isolates	O	O
could	O	O
be	O	O
differentiated	O	O
from	O	O
P.	B-bacteria	B-bacteria
pallens	I-bacteria	I-bacteria
JCM	I-bacteria	I-bacteria
11140	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
by	O	O
mannose	O	O
fermentation	O	O
and	O	O
alpha-fucosidase	O	O
activity	O	O
.	O	O

Conventional	O	O
biochemical	O	O
tests	O	O
were	O	O
unable	O	O
to	O	O
differentiate	O	O
the	O	O
new	O	O
isolates	O	O
from	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
falsenii	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
hsp60	O	O
gene	O	O
sequence	O	O
analysis	O	O
suggested	O	O
that	O	O
strain	B-bacteria	B-bacteria
OMA31	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
was	O	O
not	O	O
a	O	O
representative	O	O
of	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
pallens	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
falsenii	E-bacteria	I-bacteria
or	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
.	O	O

Based	O	O
on	O	O
these	O	O
data	O	O
,	O	O
a	O	O
novel	O	O
species	O	O
of	O	O
the	O	O
genus	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
aurantiaca	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
is	O	O
proposed	O	O
,	O	O
with	O	O
OMA31	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
=JCM	B-bacteria	B-bacteria
15754	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
57723	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
as	O	O
the	O	O
type	O	O
strain	O	O
.	O	O

Lichen	O	O
planus	O	O
(	O	O
LP	O	O
)	O	O
is	O	O
a	O	O
mucocutaneous	O	O
disease	O	O
of	O	O
unknown	O	O
aetiology	O	O
,	O	O
which	O	O
may	O	O
involve	O	O
the	O	O
gastrointestinal	O	O
(	O	O
GI	O	O
)	O	O
mucosa	O	O
.	O	O

The	O	O
association	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
with	O	O
LP	O	O
has	O	O
been	O	O
a	O	O
subject	O	O
of	O	O
debate	O	O
.	O	O

To	O	O
investigate	O	O
upper	O	O
GI	O	O
findings	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
GI	O	O
mucosa	O	O
and	O	O
oral	O	O
LP	O	O
(	O	O
OLP	O	O
)	O	O
.	O	O

Oral	O	O
biopsies	O	O
from	O	O
20	O	O
patients	O	O
with	O	O
erosive	O	O
OLP	O	O
and	O	O
20	O	O
with	O	O
non-erosive	O	O
OLP	O	O
were	O	O
investigated	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
by	O	O
histopathological	O	O
examination	O	O
and	O	O
PCR	O	O
.	O	O

Upper	O	O
GI	O	O
endoscopy	O	O
and	O	O
GI	O	O
mucosal	O	O
biopsies	O	O
were	O	O
examined	O	O
for	O	O
LP	O	O
lesions	O	O
and/or	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

The	O	O
endoscopic	O	O
findings	O	O
of	O	O
both	O	O
groups	O	O
were	O	O
oesophagitis	O	O
,	O	O
antral	O	O
gastritis	O	O
and	O	O
duodenitis	O	O
.	O	O

No	O	O
LP	O	O
or	O	O
LP-like	O	O
changes	O	O
were	O	O
found	O	O
in	O	O
the	O	O
upper	O	O
GI	O	O
mucosa	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
found	O	O
by	O	O
histopathological	O	O
examination	O	O
in	O	O
the	O	O
gastric	O	O
mucosa	O	O
of	O	O
18	O	O
patients	O	O
(	O	O
45	O	O
%	O	O
)	O	O
,	O	O
with	O	O
equal	O	O
distribution	O	O
in	O	O
both	O	O
the	O	O
control	O	O
and	O	O
study	O	O
groups	O	O
.	O	O

Positive	O	O
PCR	O	O
results	O	O
were	O	O
obtained	O	O
from	O	O
biopsy	O	O
specimens	O	O
of	O	O
oral	O	O
lesions	O	O
in	O	O
all	O	O
patients	O	O
with	O	O
erosive	O	O
OLP	O	O
and	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
stomach	O	O
(	O	O
9	O	O
patients	O	O
)	O	O
,	O	O
but	O	O
in	O	O
none	O	O
of	O	O
the	O	O
patients	O	O
with	O	O
non-erosive	O	O
OLP	O	O
(	O	O
P	O	O
=	O	O
0.001	O	O
)	O	O
.	O	O

We	O	O
did	O	O
not	O	O
find	O	O
any	O	O
difference	O	O
in	O	O
symptoms	O	O
,	O	O
endoscopic	O	O
findings	O	O
and	O	O
histopathological	O	O
results	O	O
between	O	O
patients	O	O
with	O	O
erosive	O	O
and	O	O
non-erosive	O	O
OLP	O	O
.	O	O

However	O	O
,	O	O
the	O	O
concomitant	O	O
presence	O	O
of	O	O
erosive	O	O
OLP	O	O
,	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
nucleic	O	O
acid	O	O
in	O	O
erosive	O	O
OLP	O	O
and	O	O
the	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
organisms	O	O
in	O	O
gastric	O	O
mucosa	O	O
implies	O	O
a	O	O
possible	O	O
pathogenic	O	O
connection	O	O
between	O	O
this	O	O
bacterium	O	O
and	O	O
erosive	O	O
OLP	O	O
.	O	O

A	O	O
predominant	O	O
kgp	O	O
biovar	O	O
colonized	O	O
subgingival	O	O
sites	O	O
and	O	O
buccal	O	O
and	O	O
tongue	O	O
mucosa	O	O
in	O	O
45	O	O
of	O	O
56	O	O
adults	O	O
in	O	O
an	O	O
isolated	O	O
community	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
biovars	O	O
381	O	O
,	O	O
W83	O	O
,	O	O
and	O	O
W83v	O	O
,	O	O
but	O	O
not	O	O
HG66	O	O
,	O	O
correlated	O	O
with	O	O
the	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
load	O	O
at	O	O
diseased	O	O
sites	O	O
.	O	O

Biovars	O	O
W83	O	O
and	O	O
W83v	O	O
poorly	O	O
colonized	O	O
tongue	O	O
and	O	O
buccal	O	O
mucosa	O	O
.	O	O

to	O	O
determine	O	O
the	O	O
simultaneous	O	O
presence	O	O
of	O	O
H.	O	O
pylori	O	O
in	O	O
both	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
gastric	O	O
mucosal	O	O
in	O	O
patients	O	O
suffering	O	O
digestive	O	O
pathologies	O	O
and	O	O
to	O	O
establish	O	O
the	O	O
possible	O	O
association	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
H.	O	O
pylori	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
gingivoperiodontal	O	O
pathology	O	O
.	O	O

Patients	O	O
with	O	O
gastric	O	O
symptoms	O	O
(	O	O
case	O	O
group	O	O
)	O	O
and	O	O
asymptomatic	O	O
patients	O	O
(	O	O
control	O	O
group	O	O
)	O	O
seen	O	O
at	O	O
the	O	O
Gastroenterology	O	O
Department	O	O
of	O	O
Dr.	O	O
Julio	O	O
C.	O	O
Perrando	O	O
Hospital	O	O
(	O	O
Resistencia	O	O
,	O	O
Argentina	O	O
)	O	O
were	O	O
selected	O	O
.	O	O

Dental	O	O
plaque	O	O
and	O	O
saliva	O	O
samples	O	O
from	O	O
both	O	O
groups	O	O
were	O	O
obtained	O	O
.	O	O

In	O	O
the	O	O
case	O	O
group	O	O
,	O	O
gastric	O	O
biopsy	O	O
samples	O	O
were	O	O
also	O	O
taken	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
gastric	O	O
biopsies	O	O
by	O	O
histological	O	O
stains	O	O
,	O	O
and	O	O
Polymerase	O	O
Chain	O	O
Reaction	O	O
(	O	O
PCR	O	O
)	O	O
was	O	O
carried	O	O
out	O	O
on	O	O
the	O	O
oral	O	O
samples	O	O
.	O	O

Among	O	O
the	O	O
98	O	O
patients	O	O
(	O	O
43	O	O
cases	O	O
and	O	O
55	O	O
controls	O	O
)	O	O
,	O	O
196	O	O
oral	O	O
samples	O	O
(	O	O
saliva	O	O
98	O	O
,	O	O
dental	O	O
plaque	O	O
98	O	O
)	O	O
and	O	O
43	O	O
gastric	O	O
biopsias	O	O
were	O	O
obtained	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
oral	O	O
samples	O	O
in	O	O
18/98	O	O
patients	O	O
,	O	O
in	O	O
gastric	O	O
biopsies	O	O
in	O	O
38/43	O	O
patients	O	O
,	O	O
and	O	O
in	O	O
both	O	O
samples	O	O
in	O	O
15/43	O	O
patients	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
suffering	O	O
digestive	O	O
pathologies	O	O
is	O	O
more	O	O
frequent	O	O
in	O	O
those	O	O
patients	O	O
harbouring	O	O
a	O	O
gingivoperiodontal	O	O
disease	O	O
,	O	O
and	O	O
this	O	O
fact	O	O
could	O	O
represent	O	O
an	O	O
obstacle	O	O
for	O	O
the	O	O
eradication	O	O
of	O	O
the	O	O
bacterium	O	O
.	O	O

At	O	O
the	O	O
same	O	O
time	O	O
,	O	O
it	O	O
could	O	O
constitute	O	O
a	O	O
risk	O	O
factor	O	O
for	O	O
gastrointestinal	O	O
reinfection	O	O
after	O	O
treatment	O	O
.	O	O

Toxoplasma	O	O
gondii	O	O
is	O	O
a	O	O
universally	O	O
distributed	O	O
pathogen	O	O
that	O	O
infects	O	O
over	O	O
one	O	O
billion	O	O
people	O	O
worldwide	O	O
.	O	O

Host	O	O
resistance	O	O
to	O	O
this	O	O
protozoan	O	O
parasite	O	O
depends	O	O
on	O	O
a	O	O
Th1	O	O
immune	O	O
response	O	O
with	O	O
potent	O	O
production	O	O
of	O	O
the	O	O
cytokines	O	O
interleukin-12	O	O
and	O	O
interferon	O	O
gamma	O	O
.	O	O

Although	O	O
Toll-like	O	O
receptor	O	O
11	O	O
(	O	O
TLR11	O	O
)	O	O
plays	O	O
a	O	O
major	O	O
role	O	O
in	O	O
controlling	O	O
Th1	O	O
immunity	O	O
to	O	O
this	O	O
pathogen	O	O
in	O	O
mice	O	O
,	O	O
this	O	O
innate	O	O
immune	O	O
receptor	O	O
is	O	O
nonfunctional	O	O
in	O	O
humans	O	O
,	O	O
and	O	O
the	O	O
mechanisms	O	O
of	O	O
TLR11-independent	O	O
sensing	O	O
of	O	O
T.	B-bacteria	B-bacteria
gondii	E-bacteria	I-bacteria
remain	O	O
elusive	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
show	O	O
that	O	O
oral	O	O
infection	O	O
by	O	O
T.	B-bacteria	B-bacteria
gondii	E-bacteria	I-bacteria
triggers	O	O
a	O	O
TLR11-independent	O	O
but	O	O
MyD88-dependent	O	O
Th1	O	O
response	O	O
that	O	O
is	O	O
impaired	O	O
in	O	O
TLR2xTLR4	O	O
double	O	O
knockout	O	O
and	O	O
TLR9	O	O
single	O	O
knockout	O	O
mice	O	O
.	O	O

These	O	O
mucosal	O	O
innate	O	O
and	O	O
adaptive	O	O
immune	O	O
responses	O	O
to	O	O
T.	B-bacteria	B-bacteria
gondii	E-bacteria	I-bacteria
rely	O	O
on	O	O
the	O	O
indirect	O	O
stimulation	O	O
of	O	O
dendritic	O	O
cells	O	O
by	O	O
normal	O	O
gut	O	O
microflora	O	O
.	O	O

Thus	O	O
,	O	O
our	O	O
results	O	O
reveal	O	O
that	O	O
gut	O	O
commensal	O	O
bacteria	O	O
can	O	O
serve	O	O
as	O	O
molecular	O	O
adjuvants	O	O
during	O	O
parasitic	O	O
infection	O	O
,	O	O
providing	O	O
indirect	O	O
immunostimulation	O	O
that	O	O
protects	O	O
against	O	O
T.	B-bacteria	B-bacteria
gondii	E-bacteria	I-bacteria
in	O	O
the	O	O
absence	O	O
of	O	O
TLR11	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
is	O	O
a	O	O
dominant	O	O
genus	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
,	O	O
making	O	O
up	O	O
about	O	O
20	O	O
%	O	O
of	O	O
the	O	O
more	O	O
than	O	O
800	O	O
species	O	O
of	O	O
bacteria	O	O
that	O	O
have	O	O
been	O	O
identified	O	O
,	O	O
and	O	O
about	O	O
80	O	O
%	O	O
of	O	O
the	O	O
early	O	O
biofilm	O	O
colonizers	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
include	O	O
both	O	O
health-compatible	O	O
(	O	O
e.g	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
)	O	O
and	O	O
pathogenic	O	O
strains	O	O
(	O	O
e.g	O	O
.	O	O

the	O	O
cariogenic	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
)	O	O
.	O	O

Because	O	O
the	O	O
streptococci	B-bacteria	B-bacteria
have	O	O
similar	O	O
metabolic	O	O
requirements	O	O
,	O	O
they	O	O
have	O	O
developed	O	O
defence	O	O
strategies	O	O
that	O	O
lead	O	O
to	O	O
antagonism	O	O
(	O	O
also	O	O
known	O	O
as	O	O
bacterial	O	O
interference	O	O
)	O	O
.	O	O

S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
expresses	O	O
bacteriocins	O	O
that	O	O
are	O	O
cytotoxic	O	O
toward	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
whereas	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
differentially	O	O
produce	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
(	O	O
under	O	O
aerobic	O	O
growth	O	O
conditions	O	O
)	O	O
,	O	O
which	O	O
is	O	O
relatively	O	O
toxic	O	O
toward	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Superimposed	O	O
on	O	O
the	O	O
inter-bacterial	O	O
combat	O	O
are	O	O
the	O	O
effects	O	O
of	O	O
the	O	O
host	O	O
defensive	O	O
mechanisms	O	O
.	O	O

We	O	O
report	O	O
here	O	O
on	O	O
the	O	O
multifarious	O	O
effects	O	O
of	O	O
bovine	O	O
lactoperoxidase	O	O
(	O	O
bLPO	O	O
)	O	O
on	O	O
the	O	O
antagonism	O	O
between	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
versus	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Some	O	O
of	O	O
the	O	O
effects	O	O
are	O	O
apparently	O	O
counterproductive	O	O
with	O	O
respect	O	O
to	O	O
maintaining	O	O
a	O	O
health-compatible	O	O
population	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

For	O	O
example	O	O
,	O	O
the	O	O
bLPO	O	O
system	O	O
(	O	O
comprised	O	O
of	O	O
bLPO+SCN	O	O
(	O	O
-	O	O
)	O	O
+H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
)	O	O
destroys	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
,	O	O
thereby	O	O
abolishing	O	O
the	O	O
ability	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
to	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Furthermore	O	O
,	O	O
bLPO	O	O
protein	O	O
(	O	O
with	O	O
or	O	O
without	O	O
its	O	O
substrate	O	O
)	O	O
inhibits	O	O
bacterial	O	O
growth	O	O
in	O	O
a	O	O
biofilm	O	O
assay	O	O
,	O	O
but	O	O
sucrose	O	O
negates	O	O
the	O	O
inhibitory	O	O
effects	O	O
of	O	O
the	O	O
bLPO	O	O
protein	O	O
,	O	O
thereby	O	O
facilitating	O	O
adherence	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
lieu	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
.	O	O

Our	O	O
findings	O	O
may	O	O
be	O	O
relevant	O	O
to	O	O
environmental	O	O
pressures	O	O
that	O	O
select	O	O
early	O	O
supragingival	O	O
colonizers	O	O
.	O	O

Human	O	O
cells	O	O
express	O	O
membrane-bound	O	O
complement	O	O
regulatory	O	O
proteins	O	O
to	O	O
prevent	O	O
complement-mediated	O	O
autologous	O	O
tissue	O	O
damage	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
hypothesized	O	O
that	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
the	O	O
major	O	O
etiological	O	O
agent	O	O
of	O	O
chronic	O	O
periodontitis	O	O
,	O	O
causes	O	O
the	O	O
shedding	O	O
or	O	O
proteolysis	O	O
of	O	O
the	O	O
complement	O	O
regulatory	O	O
protein	O	O
CD46	O	O
expressed	O	O
by	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Oral	O	O
epithelial	O	O
cells	O	O
were	O	O
treated	O	O
with	O	O
a	O	O
culture	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
before	O	O
measurement	O	O
of	O	O
membrane-bound	O	O
and	O	O
shedt	O	O
CD46	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
(	O	O
ELISA	O	O
)	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
soluble	O	O
recombinant	O	O
CD46	O	O
on	O	O
secretion	O	O
of	O	O
interleukin-8	O	O
(	O	O
IL-8	O	O
)	O	O
by	O	O
epithelial	O	O
cells	O	O
was	O	O
evaluated	O	O
by	O	O
ELISA	O	O
.	O	O

The	O	O
susceptibility	O	O
of	O	O
soluble	O	O
recombinant	O	O
CD46	O	O
to	O	O
proteolytic	O	O
degradation	O	O
by	O	O
cells	O	O
and	O	O
purified	O	O
Lys-gingipain	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
investigated	O	O
by	O	O
sodium	O	O
dodecyl	O	O
sulfate-polyacrylamide	O	O
gel	O	O
electrophoresis/western	O	O
immunoblotting	O	O
analysis	O	O
.	O	O

Oral	O	O
epithelial	O	O
cells	O	O
treated	O	O
with	O	O
a	O	O
culture	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
showed	O	O
a	O	O
lower	O	O
reactivity	O	O
with	O	O
antibodies	O	O
directed	O	O
to	O	O
CD46	O	O
.	O	O

ELISA	O	O
revealed	O	O
that	O	O
such	O	O
a	O	O
treatment	O	O
resulted	O	O
in	O	O
increased	O	O
amounts	O	O
of	O	O
CD46	O	O
in	O	O
the	O	O
conditioned	O	O
media	O	O
suggesting	O	O
that	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
caused	O	O
the	O	O
shedding	O	O
of	O	O
membrane-anchored	O	O
CD46	O	O
.	O	O

Stimulation	O	O
of	O	O
epithelial	O	O
cells	O	O
with	O	O
soluble	O	O
recombinant	O	O
CD46	O	O
induced	O	O
IL-8	O	O
secretion	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
.	O	O

Whole	O	O
cells	O	O
and	O	O
purified	O	O
Lys-gingipain	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
degraded	O	O
recombinant	O	O
CD46	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
.	O	O

This	O	O
study	O	O
showed	O	O
the	O	O
ability	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
to	O	O
induce	O	O
the	O	O
shedding/	O	O
proteolysis	O	O
of	O	O
CD46	O	O
from	O	O
the	O	O
surface	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

This	O	O
may	O	O
render	O	O
host	O	O
cells	O	O
susceptible	O	O
to	O	O
the	O	O
complement	O	O
system	O	O
and	O	O
contribute	O	O
to	O	O
tissue	O	O
damage	O	O
and	O	O
the	O	O
inflammatory	O	O
process	O	O
in	O	O
periodontitis	O	O
.	O	O

The	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
(	O	O
HIV	O	O
)	O	O
can	O	O
integrate	O	O
into	O	O
T	O	O
cells	O	O
,	O	O
macrophages	O	O
and	O	O
dendritic	O	O
cells	O	O
resulting	O	O
in	O	O
a	O	O
latent	O	O
infection	O	O
.	O	O

Reports	O	O
have	O	O
also	O	O
demonstrated	O	O
that	O	O
various	O	O
microbial	O	O
and	O	O
host	O	O
cell	O	O
factors	O	O
can	O	O
trigger	O	O
HIV	O	O
reactivation	O	O
leading	O	O
to	O	O
HIV	O	O
recrudescence	O	O
,	O	O
potentially	O	O
undermining	O	O
highly	O	O
active	O	O
antiretroviral	O	O
therapies	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
capacity	O	O
of	O	O
oral	O	O
bacteria	O	O
associated	O	O
with	O	O
chronic	O	O
periodontal	O	O
infections	O	O
to	O	O
stimulate	O	O
HIV	O	O
promoter	O	O
activation	O	O
in	O	O
various	O	O
cell	O	O
models	O	O
of	O	O
HIV	O	O
latency	O	O
.	O	O

T	O	O
cells	O	O
(	O	O
1G5	O	O
)	O	O
challenged	O	O
with	O	O
oral	O	O
bacteria	O	O
demonstrated	O	O
a	O	O
dose-response	O	O
of	O	O
HIV	O	O
promoter	O	O
activation	O	O
with	O	O
a	O	O
subset	O	O
of	O	O
the	O	O
bacteria	O	O
,	O	O
as	O	O
well	O	O
as	O	O
kinetics	O	O
that	O	O
were	O	O
generally	O	O
similar	O	O
irrespective	O	O
of	O	O
the	O	O
stimuli	O	O
.	O	O

Direct	O	O
bacterial	O	O
challenge	O	O
of	O	O
the	O	O
T	O	O
cells	O	O
resulted	O	O
in	O	O
increased	O	O
activation	O	O
of	O	O
approximately	O	O
1.5-	O	O
to	O	O
7-fold	O	O
over	O	O
controls	O	O
.	O	O

Challenge	O	O
of	O	O
macrophages	O	O
(	O	O
BF24	O	O
)	O	O
indicated	O	O
different	O	O
kinetics	O	O
for	O	O
individual	O	O
bacteria	O	O
and	O	O
resulted	O	O
in	O	O
consistent	O	O
increases	O	O
in	O	O
promoter	O	O
activation	O	O
of	O	O
five	O	O
fold	O	O
to	O	O
six	O	O
fold	O	O
over	O	O
basal	O	O
levels	O	O
for	O	O
all	O	O
bacteria	O	O
except	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Dendritic	O	O
cells	O	O
showed	O	O
increases	O	O
in	O	O
HIV	O	O
reactivation	O	O
of	O	O
7-	O	O
to	O	O
34-fold	O	O
specific	O	O
for	O	O
individual	O	O
species	O	O
of	O	O
bacteria	O	O
.	O	O

These	O	O
results	O	O
suggested	O	O
that	O	O
oral	O	O
bacteria	O	O
have	O	O
the	O	O
capability	O	O
to	O	O
reactivate	O	O
HIV	O	O
from	O	O
latently	O	O
infected	O	O
cells	O	O
,	O	O
showing	O	O
a	O	O
relationship	O	O
of	O	O
mature	O	O
dendritic	O	O
cells	O	O
>	O	O
immature	O	O
dendritic	O	O
cells	O	O
>	O	O
macrophages	O	O
>	O	O
or	O	O
=	O	O
T	O	O
cells	O	O
.	O	O

Expression	O	O
of	O	O
various	O	O
pattern	O	O
recognition	O	O
receptors	O	O
on	O	O
these	O	O
various	O	O
cell	O	O
types	O	O
may	O	O
provide	O	O
insight	O	O
into	O	O
the	O	O
primary	O	O
receptors/signaling	O	O
pathways	O	O
used	O	O
for	O	O
reactivation	O	O
by	O	O
the	O	O
bacteria	O	O
.	O	O

Lactoferrin	O	O
(	O	O
Lf	O	O
)	O	O
,	O	O
an	O	O
iron-binding	O	O
salivary	O	O
glycoprotein	O	O
,	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
human	O	O
innate	O	O
defense	O	O
against	O	O
local	O	O
mucosal	O	O
infection	O	O
.	O	O

We	O	O
hypothesized	O	O
that	O	O
Lf	O	O
interferes	O	O
with	O	O
initial	O	O
oral	O	O
bacterial	O	O
attachment	O	O
to	O	O
surfaces	O	O
by	O	O
iron	O	O
sequestration	O	O
,	O	O
so	O	O
inhibiting	O	O
subsequent	O	O
biofilm	O	O
formation	O	O
.	O	O

The	O	O
objective	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
effect	O	O
of	O	O
Lf	O	O
on	O	O
the	O	O
early	O	O
stages	O	O
of	O	O
single-species	O	O
and	O	O
multi-species	O	O
oral	O	O
biofilm	O	O
development	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
used	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Glass	O	O
disks	O	O
of	O	O
a	O	O
two-track	O	O
flow	O	O
cell	O	O
coated	O	O
with	O	O
flowing	O	O
artificial	O	O
saliva	O	O
(	O	O
0.3	O	O
ml/min	O	O
)	O	O
with	O	O
and	O	O
without	O	O
Lf	O	O
(	O	O
100	O	O
microg/ml	O	O
)	O	O
were	O	O
used	O	O
for	O	O
studying	O	O
bacterial	O	O
attachment	O	O
(	O	O
3	O	O
h	O	O
,	O	O
37	O	O
degrees	O	O
C	O	O
)	O	O
.	O	O

Attachment	O	O
was	O	O
also	O	O
examined	O	O
by	O	O
incubating	O	O
single	O	O
or	O	O
multiple	O	O
species	O	O
of	O	O
test	O	O
bacteria	O	O
(	O	O
10	O	O
(	O	O
7	O	O
)	O	O
colony-forming	O	O
units/ml	O	O
)	O	O
with	O	O
Lf-coated	O	O
(	O	O
20-100	O	O
microg/ml	O	O
)	O	O
and	O	O
uncoated	O	O
glass	O	O
slides	O	O
.	O	O

The	O	O
effects	O	O
of	O	O
beta-lactoglobulin	O	O
,	O	O
2,2'-dipyridyl	O	O
(	O	O
25-100	O	O
microg/ml	O	O
)	O	O
,	O	O
an	O	O
iron	O	O
chelator	O	O
,	O	O
and	O	O
FeCl3	O	O
on	O	O
attachment	O	O
were	O	O
also	O	O
examined	O	O
.	O	O

Lf	O	O
inhibited	O	O
the	O	O
initial	O	O
attachment	O	O
of	O	O
S.	O	O
gordonii	O	O
(	O	O
50.3	O	O
%	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
but	O	O
not	O	O
that	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
the	O	O
attachment	O	O
of	O	O
a	O	O
dual-species	O	O
biofilm	O	O
containing	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
(	O	O
i.e	O	O
.	O	O

S.	B-bacteria	B-bacteria
gordonii/F	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nucleatum	E-bacteria	I-bacteria
or	O	O
S.	B-bacteria	B-bacteria
gordonii/P	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

gingivalis	E-bacteria	I-bacteria
)	O	O
was	O	O
significantly	O	O
reduced	O	O
(	O	O
48.7	O	O
%	O	O
or	O	O
62.1	O	O
%	O	O
,	O	O
respectively	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
Lf	O	O
.	O	O

beta-Lactoglobulin	O	O
did	O	O
not	O	O
affect	O	O
the	O	O
attachment	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

In	O	O
the	O	O
presence	O	O
of	O	O
100	O	O
microm	O	O
2,2'-dipyridyl	O	O
,	O	O
attachment	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
was	O	O
reduced	O	O
by	O	O
53.87	O	O
%	O	O
.	O	O

No	O	O
reduction	O	O
in	O	O
attachment	O	O
was	O	O
noted	O	O
in	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
pretreated	O	O
with	O	O
Lf	O	O
(	O	O
100	O	O
microg/ml	O	O
)	O	O
and	O	O
FeCl3	O	O
(	O	O
20-200	O	O
microm	O	O
)	O	O
.	O	O

Lf	O	O
suppresses	O	O
initial	O	O
attachment	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
coaggregates	O	O
by	O	O
iron	O	O
sequestration	O	O
.	O	O

This	O	O
may	O	O
lead	O	O
to	O	O
subsequent	O	O
inhibition	O	O
of	O	O
oral	O	O
biofilm	O	O
development	O	O
.	O	O

Increasing	O	O
evidence	O	O
suggests	O	O
a	O	O
role	O	O
for	O	O
methanogenic	B-bacteria	B-bacteria
archaea	E-bacteria	I-bacteria
(	O	O
methanogens	B-bacteria	B-bacteria
)	O	O
in	O	O
human	O	O
health	O	O
and	O	O
disease	O	O
via	O	O
syntrophic	O	O
interactions	O	O
with	O	O
bacteria	O	O
.	O	O

Here	O	O
we	O	O
assessed	O	O
the	O	O
prevalence	O	O
and	O	O
distribution	O	O
of	O	O
methanogens	O	O
and	O	O
possible	O	O
associations	O	O
with	O	O
bacteria	O	O
in	O	O
oral	O	O
biofilms	O	O
.	O	O

Forty-four	O	O
periodontal	O	O
and	O	O
32	O	O
endodontic	O	O
samples	O	O
from	O	O
necrotic	O	O
teeth	O	O
with	O	O
radiographic	O	O
evidence	O	O
of	O	O
apical	O	O
periodontitis	O	O
were	O	O
analysed	O	O
.	O	O

Terminal	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
analysis	O	O
based	O	O
on	O	O
the	O	O
mcrA	O	O
gene	O	O
,	O	O
specific	O	O
to	O	O
methanogens	B-bacteria	B-bacteria
,	O	O
was	O	O
applied	O	O
.	O	O

The	O	O
prevalence	O	O
and	O	O
amounts	O	O
of	O	O
methanogens	B-bacteria	B-bacteria
in	O	O
endodontic	O	O
samples	O	O
were	O	O
compared	O	O
with	O	O
those	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Treponema	E-bacteria	I-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Synergistes	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

based	O	O
on	O	O
real-time	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reactions	O	O
.	O	O

Besides	O	O
dominance	O	O
of	O	O
the	O	O
mcrA	O	O
gene	O	O
corresponding	O	O
to	O	O
Methanobrevibacter	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
one	O	O
mcrA	O	O
gene	O	O
type	O	O
,	O	O
for	O	O
which	O	O
no	O	O
cultivated	O	O
member	O	O
has	O	O
been	O	O
reported	O	O
previously	O	O
,	O	O
was	O	O
identified	O	O
in	O	O
five	O	O
periodontal	O	O
samples	O	O
and	O	O
one	O	O
endodontic	O	O
sample	O	O
.	O	O

Rates	O	O
of	O	O
non-synonymous	O	O
vs.	O	O
synonymous	O	O
nucleotide	O	O
substitutions	O	O
suggest	O	O
that	O	O
this	O	O
mcrA	O	O
gene	O	O
type	O	O
codes	O	O
for	O	O
a	O	O
functionally	O	O
active	O	O
methyl-coenzyme	O	O
M	O	O
reductase	O	O
.	O	O

Methanobrevibacter	B-bacteria	B-bacteria
smithii	E-bacteria	I-bacteria
,	O	O
the	O	O
prominent	O	O
methanogen	B-bacteria	B-bacteria
in	O	O
the	O	O
human	O	O
gut	O	O
system	O	O
,	O	O
was	O	O
not	O	O
detected	O	O
.	O	O

Mean	O	O
proportions	O	O
of	O	O
methanogens	B-bacteria	B-bacteria
were	O	O
comparable	O	O
to	O	O
Synergistes	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

ranging	O	O
from	O	O
0.5	O	O
to	O	O
1.0	O	O
%	O	O
of	O	O
the	O	O
total	O	O
microbial	O	O
community	O	O
.	O	O

Treponema	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

dominated	O	O
with	O	O
a	O	O
mean	O	O
proportion	O	O
of	O	O
10	O	O
%	O	O
,	O	O
while	O	O
the	O	O
mean	O	O
proportions	O	O
of	O	O
the	O	O
other	O	O
endodontic	O	O
pathogens	O	O
were	O	O
below	O	O
0.1	O	O
%	O	O
.	O	O

A	O	O
positive	O	O
association	O	O
between	O	O
methanogens	B-bacteria	B-bacteria
and	O	O
Synergistes	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

was	O	O
found	O	O
.	O	O

Our	O	O
data	O	O
provide	O	O
evidence	O	O
of	O	O
a	O	O
novel	O	O
,	O	O
as	O	O
yet	O	O
uncultured	O	O
methanogenic	B-bacteria	B-bacteria
phylotype	E-bacteria	I-bacteria
in	O	O
association	O	O
with	O	O
oral	O	O
infections	O	O
,	O	O
and	O	O
indicate	O	O
possible	O	O
interactions	O	O
between	O	O
methanogens	B-bacteria	B-bacteria
and	O	O
Synergistes	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
the	O	O
nature	O	O
of	O	O
which	O	O
deserves	O	O
further	O	O
investigation	O	O
.	O	O

This	O	O
study	O	O
compared	O	O
the	O	O
subgingival	O	O
microbiota	O	O
of	O	O
subjects	O	O
with	O	O
refractory	O	O
periodontitis	O	O
(	O	O
RP	O	O
)	O	O
to	O	O
those	O	O
in	O	O
subjects	O	O
with	O	O
treatable	O	O
periodontitis	O	O
(	O	O
GRs	O	O
=	O	O
good	O	O
responders	O	O
)	O	O
or	O	O
periodontal	O	O
health	O	O
(	O	O
PH	O	O
)	O	O
using	O	O
the	O	O
Human	O	O
Oral	O	O
Microbe	O	O
Identification	O	O
Microarray	O	O
(	O	O
HOMIM	O	O
)	O	O
.	O	O

At	O	O
baseline	O	O
,	O	O
subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
47	O	O
subjects	O	O
with	O	O
periodontitis	O	O
and	O	O
20	O	O
individuals	O	O
with	O	O
PH	O	O
and	O	O
analyzed	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
300	O	O
species	O	O
by	O	O
HOMIM	O	O
.	O	O

The	O	O
subjects	O	O
with	O	O
periodontitis	O	O
were	O	O
classified	O	O
as	O	O
having	O	O
RP	O	O
(	O	O
n	O	O
=	O	O
17	O	O
)	O	O
based	O	O
on	O	O
mean	O	O
attachment	O	O
loss	O	O
(	O	O
AL	O	O
)	O	O
and/or	O	O
more	O	O
than	O	O
three	O	O
sites	O	O
with	O	O
AL	O	O
>	O	O
or=2.5	O	O
mm	O	O
after	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
,	O	O
surgery	O	O
,	O	O
and	O	O
systemically	O	O
administered	O	O
amoxicillin	O	O
and	O	O
metronidazole	O	O
or	O	O
as	O	O
GRs	O	O
(	O	O
n	O	O
=	O	O
30	O	O
)	O	O
based	O	O
on	O	O
mean	O	O
attachment	O	O
gain	O	O
and	O	O
no	O	O
sites	O	O
with	O	O
AL	O	O
>	O	O
or=2.5	O	O
mm	O	O
after	O	O
treatment	O	O
.	O	O

Significant	O	O
differences	O	O
in	O	O
taxa	O	O
among	O	O
the	O	O
groups	O	O
were	O	O
sought	O	O
using	O	O
the	O	O
Kruskal-Wallis	O	O
and	O	O
chi	O	O
(	O	O
2	O	O
)	O	O
tests	O	O
.	O	O

More	O	O
species	O	O
were	O	O
detected	O	O
in	O	O
patients	O	O
with	O	O
disease	O	O
(	O	O
GR	O	O
or	O	O
RP	O	O
)	O	O
than	O	O
in	O	O
those	O	O
without	O	O
disease	O	O
(	O	O
PH	O	O
)	O	O
.	O	O

Subjects	O	O
with	O	O
RP	O	O
were	O	O
distinguished	O	O
from	O	O
GRs	O	O
or	O	O
those	O	O
with	O	O
PH	O	O
by	O	O
a	O	O
significantly	O	O
higher	O	O
frequency	O	O
of	O	O
putative	O	O
periodontal	O	O
pathogens	O	O
,	O	O
such	O	O
as	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
(	O	O
previously	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
or	O	O
Micromonas	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
)	O	O
,	O	O
Campylobacter	B-bacteria	B-bacteria
gracilis	E-bacteria	I-bacteria
,	O	O
Eubacterium	B-bacteria	B-bacteria
nodatum	E-bacteria	I-bacteria
,	O	O
Selenomonas	B-bacteria	B-bacteria
noxia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
previously	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
unusual	O	O
species	O	O
(	O	O
Pseudoramibacter	B-bacteria	B-bacteria
alactolyticus	E-bacteria	I-bacteria
,	O	O
TM7	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

oral	O	O
taxon	O	O
[	O	O
OT	O	O
]	O	O
346/356	O	O
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

OT	O	O
272/274	O	O
,	O	O
Solobacterium	B-bacteria	B-bacteria
moorei	E-bacteria	I-bacteria
,	O	O
Desulfobulbus	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

OT	O	O
041	O	O
,	O	O
Brevundimonas	B-bacteria	B-bacteria
diminuta	E-bacteria	I-bacteria
,	O	O
Sphaerocytophaga	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

OT	O	O
337	O	O
,	O	O
Shuttleworthia	B-bacteria	B-bacteria
satelles	E-bacteria	I-bacteria
,	O	O
Filifactor	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
,	O	O
Dialister	B-bacteria	B-bacteria
invisus/pneumosintes	E-bacteria	I-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
adiacens	E-bacteria	I-bacteria
,	O	O
Mogibacterium	B-bacteria	B-bacteria
timidum	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
atypica	E-bacteria	I-bacteria
,	O	O
Mycoplasma	B-bacteria	B-bacteria
salivarium	E-bacteria	I-bacteria
,	O	O
Synergistes	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

cluster	O	O
II	O	O
,	O	O
and	O	O
Acidaminococcaceae	B-bacteria	B-bacteria
[	I-bacteria	I-bacteria
G-1	I-bacteria	I-bacteria
]	I-bacteria	I-bacteria
sp	E-bacteria	I-bacteria
.	O	O

OT	O	O
132/150/155/148/135	O	O
)	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Species	O	O
that	O	O
were	O	O
more	O	O
prevalent	O	O
in	O	O
subjects	O	O
with	O	O
PH	O	O
than	O	O
in	O	O
patients	O	O
with	O	O
periodontitis	O	O
included	O	O
Actinomyces	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

OT	O	O
170	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

cluster	O	O
I	O	O
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
,	O	O
Cardiobacterium	B-bacteria	B-bacteria
hominis	E-bacteria	I-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
parainfluenzae	E-bacteria	I-bacteria
,	O	O
Lautropia	B-bacteria	B-bacteria
mirabilis	E-bacteria	I-bacteria
,	O	O
Propionibacterium	B-bacteria	B-bacteria
propionicum	E-bacteria	I-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
dentocariosa/mucilaginosa	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

As	O	O
determined	O	O
by	O	O
HOMIM	O	O
,	O	O
patients	O	O
with	O	O
RP	O	O
presented	O	O
a	O	O
distinct	O	O
microbial	O	O
profile	O	O
compared	O	O
to	O	O
patients	O	O
in	O	O
the	O	O
GR	O	O
and	O	O
PH	O	O
groups	O	O
.	O	O

We	O	O
have	O	O
analyzed	O	O
the	O	O
total	O	O
metagenomic	O	O
DNA	O	O
from	O	O
both	O	O
human	O	O
oral	O	O
and	O	O
fecal	O	O
samples	O	O
derived	O	O
from	O	O
healthy	O	O
volunteers	O	O
from	O	O
six	O	O
European	O	O
countries	O	O
to	O	O
determine	O	O
the	O	O
molecular	O	O
basis	O	O
for	O	O
tetracycline	O	O
and	O	O
erythromycin	O	O
resistance	O	O
.	O	O

We	O	O
have	O	O
determined	O	O
that	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
and	O	O
tet	O	O
(	O	O
W	O	O
)	O	O
are	O	O
the	O	O
most	O	O
prevalent	O	O
tetracycline	O	O
resistance	O	O
genes	O	O
assayed	O	O
for	O	O
in	O	O
the	O	O
oral	O	O
and	O	O
fecal	O	O
metagenomes	O	O
,	O	O
respectively	O	O
.	O	O

Additionally	O	O
,	O	O
tet	O	O
(	O	O
Q	O	O
)	O	O
,	O	O
tet	O	O
(	O	O
O	O	O
)	O	O
,	O	O
and	O	O
tet	O	O
(	O	O
O/32/O	O	O
)	O	O
have	O	O
been	O	O
shown	O	O
to	O	O
be	O	O
common	O	O
.	O	O

We	O	O
have	O	O
also	O	O
shown	O	O
that	O	O
erm	O	O
(	O	O
B	O	O
)	O	O
,	O	O
erm	O	O
(	O	O
V	O	O
)	O	O
,	O	O
and	O	O
erm	O	O
(	O	O
E	O	O
)	O	O
are	O	O
common	O	O
erythromycin	O	O
resistance	O	O
genes	O	O
present	O	O
in	O	O
these	O	O
environments	O	O
.	O	O

Further	O	O
,	O	O
we	O	O
have	O	O
demonstrated	O	O
the	O	O
ubiquitous	O	O
presence	O	O
of	O	O
the	O	O
Tn916	O	O
integrase	O	O
in	O	O
the	O	O
oral	O	O
metagenomes	O	O
and	O	O
the	O	O
Tn4451	O	O
and	O	O
Tn1549	O	O
integrase	O	O
genes	O	O
within	O	O
the	O	O
fecal	O	O
metagenomes	O	O
.	O	O

To	O	O
characterize	O	O
the	O	O
clinical	O	O
manifestations	O	O
of	O	O
Actinomyces-associated	O	O
lesions	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
and	O	O
jawbones	O	O
,	O	O
and	O	O
to	O	O
correlate	O	O
the	O	O
clinical	O	O
course	O	O
and	O	O
treatment	O	O
requirements	O	O
with	O	O
the	O	O
findings	O	O
of	O	O
histomorphometric	O	O
analysis	O	O
.	O	O

The	O	O
study	O	O
was	O	O
a	O	O
10-year	O	O
retrospective	O	O
analysis	O	O
of	O	O
archived	O	O
cases	O	O
with	O	O
microscopic	O	O
identification	O	O
of	O	O
Actinomyces	O	O
infection	O	O
.	O	O

Actinomyces	B-bacteria	B-bacteria
colonies	O	O
were	O	O
identified	O	O
,	O	O
using	O	O
hematoxylin-eosin	O	O
,	O	O
Gram	O	O
,	O	O
and	O	O
periodic	O	O
acid-Schiff	O	O
stains	O	O
,	O	O
exhibiting	O	O
filamentous	O	O
morphology	O	O
with	O	O
color	O	O
variation	O	O
between	O	O
center	O	O
and	O	O
periphery	O	O
.	O	O

Only	O	O
colonies	O	O
with	O	O
adjacent	O	O
tissue	O	O
reaction	O	O
(	O	O
inflammation	O	O
,	O	O
fibrosis	O	O
)	O	O
were	O	O
analyzed	O	O
.	O	O

Actinomyces	B-bacteria	B-bacteria
density	O	O
(	O	O
AD	O	O
)	O	O
was	O	O
calculated	O	O
by	O	O
dividing	O	O
total	O	O
number	O	O
of	O	O
colonies	O	O
by	O	O
tissue	O	O
surface	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
relative	O	O
surface	O	O
(	O	O
ARS	O	O
)	O	O
was	O	O
calculated	O	O
by	O	O
dividing	O	O
total	O	O
bacterial	O	O
surface	O	O
by	O	O
tissue	O	O
surface	O	O
.	O	O

The	O	O
study	O	O
included	O	O
106	O	O
cases	O	O
(	O	O
48	O	O
male	O	O
,	O	O
58	O	O
female	O	O
;	O	O
aged	O	O
13-84	O	O
years	O	O
,	O	O
mean	O	O
50.5	O	O
years	O	O
)	O	O
.	O	O

Cases	O	O
presented	O	O
a	O	O
wide	O	O
clinical	O	O
spectrum	O	O
,	O	O
involving	O	O
jawbone	O	O
and/or	O	O
oral	O	O
soft	O	O
tissues	O	O
.	O	O

Cases	O	O
included	O	O
osteomyelitis	O	O
associated	O	O
with	O	O
bisphosphonates	O	O
,	O	O
osteoradionecrosis	O	O
,	O	O
osteomyelitis	O	O
unrelated	O	O
to	O	O
radiation	O	O
or	O	O
bisphosphonates	O	O
,	O	O
periapical	O	O
lesions	O	O
,	O	O
odontogenic	O	O
cysts	O	O
,	O	O
periimplantitis	O	O
,	O	O
and	O	O
lesion	O	O
mimicking	O	O
periodontal	O	O
disease	O	O
.	O	O

The	O	O
AD	O	O
correlated	O	O
with	O	O
median	O	O
length	O	O
of	O	O
antibiotic	O	O
treatment	O	O
(	O	O
R	O	O
=	O	O
0.284	O	O
;	O	O
P	O	O
=	O	O
.028	O	O
)	O	O
.	O	O

Because	O	O
we	O	O
were	O	O
able	O	O
to	O	O
identify	O	O
106	O	O
such	O	O
cases	O	O
,	O	O
the	O	O
results	O	O
indicate	O	O
that	O	O
Actinomyces-associated	O	O
lesions	O	O
may	O	O
not	O	O
be	O	O
as	O	O
rare	O	O
as	O	O
would	O	O
be	O	O
expected	O	O
from	O	O
the	O	O
relatively	O	O
low	O	O
number	O	O
of	O	O
cases	O	O
in	O	O
the	O	O
literature	O	O
.	O	O

Actinomyces-associated	O	O
lesions	O	O
presented	O	O
in	O	O
a	O	O
wide	O	O
spectrum	O	O
of	O	O
clinical	O	O
settings	O	O
and	O	O
a	O	O
variety	O	O
of	O	O
contributing	O	O
factors	O	O
.	O	O

Quantitative	O	O
analysis	O	O
of	O	O
the	O	O
number	O	O
of	O	O
bacterial	O	O
colonies	O	O
(	O	O
representing	O	O
bacterial	O	O
load	O	O
)	O	O
could	O	O
help	O	O
in	O	O
evaluating	O	O
the	O	O
aggressive	O	O
potential	O	O
of	O	O
the	O	O
lesion	O	O
and	O	O
help	O	O
in	O	O
treatment	O	O
planning	O	O
.	O	O

Dental	O	O
plaque	O	O
biofilms	O	O
are	O	O
colonized	O	O
by	O	O
respiratory	O	O
pathogens	O	O
in	O	O
mechanically-ventilated	O	O
intensive	O	O
care	O	O
unit	O	O
patients	O	O
.	O	O

Thus	O	O
,	O	O
improvements	O	O
in	O	O
oral	O	O
hygiene	O	O
in	O	O
these	O	O
patients	O	O
may	O	O
prevent	O	O
ventilator-associated	O	O
pneumonia	O	O
.	O	O

The	O	O
goal	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
minimum	O	O
frequency	O	O
(	O	O
once	O	O
or	O	O
twice	O	O
a	O	O
day	O	O
)	O	O
for	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
gluconate	O	O
application	O	O
necessary	O	O
to	O	O
reduce	O	O
oral	O	O
colonization	O	O
by	O	O
pathogens	O	O
in	O	O
175	O	O
intubated	O	O
patients	O	O
in	O	O
a	O	O
trauma	O	O
intensive	O	O
care	O	O
unit	O	O
.	O	O

A	O	O
randomized	O	O
,	O	O
double-blind	O	O
,	O	O
placebo-controlled	O	O
clinical	O	O
trial	O	O
tested	O	O
oral	O	O
topical	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
gluconate	O	O
or	O	O
placebo	O	O
(	O	O
vehicle	O	O
alone	O	O
)	O	O
,	O	O
applied	O	O
once	O	O
or	O	O
twice	O	O
a	O	O
day	O	O
by	O	O
staff	O	O
nurses	O	O
.	O	O

Quantitation	O	O
of	O	O
colonization	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
by	O	O
respiratory	O	O
pathogens	O	O
(	O	O
teeth/denture/buccal	O	O
mucosa	O	O
)	O	O
was	O	O
measured	O	O
.	O	O

Subjects	O	O
were	O	O
recruited	O	O
from	O	O
1	O	O
March	O	O
,	O	O
2004	O	O
until	O	O
30	O	O
November	O	O
,	O	O
2007	O	O
.	O	O

While	O	O
175	O	O
subjects	O	O
were	O	O
randomized	O	O
,	O	O
microbiologic	O	O
baseline	O	O
data	O	O
was	O	O
available	O	O
for	O	O
146	O	O
subjects	O	O
,	O	O
with	O	O
115	O	O
subjects	O	O
having	O	O
full	O	O
outcome	O	O
assessment	O	O
after	O	O
at	O	O
least	O	O
48	O	O
hours	O	O
.	O	O

Chlorhexidine	O	O
reduced	O	O
the	O	O
number	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
the	O	O
total	O	O
number	O	O
of	O	O
enterics	B-bacteria	B-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
or	O	O
Acinetobacter	B-bacteria	B-bacteria
in	O	O
the	O	O
dental	O	O
plaque	O	O
of	O	O
test	O	O
subjects	O	O
.	O	O

A	O	O
non-significant	O	O
reduction	O	O
in	O	O
pneumonia	O	O
rate	O	O
was	O	O
noted	O	O
in	O	O
groups	O	O
treated	O	O
with	O	O
chlorhexidine	O	O
compared	O	O
with	O	O
the	O	O
placebo	O	O
group	O	O
(	O	O
OR	O	O
=	O	O
0.54	O	O
,	O	O
95	O	O
%	O	O
CI	O	O
:	O	O
0.23	O	O
to	O	O
1.25	O	O
,	O	O
P	O	O
=	O	O
0.15	O	O
)	O	O
.	O	O

No	O	O
evidence	O	O
for	O	O
resistance	O	O
to	O	O
chlorhexidine	O	O
was	O	O
noted	O	O
,	O	O
and	O	O
no	O	O
adverse	O	O
events	O	O
were	O	O
observed	O	O
.	O	O

No	O	O
differences	O	O
were	O	O
noted	O	O
in	O	O
microbiologic	O	O
or	O	O
clinical	O	O
outcomes	O	O
between	O	O
treatment	O	O
arms	O	O
.	O	O

While	O	O
decontamination	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
with	O	O
chlorhexidine	O	O
did	O	O
not	O	O
reduce	O	O
the	O	O
total	O	O
number	O	O
of	O	O
potential	O	O
respiratory	O	O
pathogens	O	O
,	O	O
it	O	O
did	O	O
reduce	O	O
the	O	O
number	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
in	O	O
dental	O	O
plaque	O	O
of	O	O
trauma	O	O
intensive	O	O
care	O	O
patients	O	O
.	O	O

The	O	O
human	O	O
gastrointestinal	O	O
tract	O	O
is	O	O
home	O	O
to	O	O
hundreds	O	O
of	O	O
species	O	O
of	O	O
bacteria	O	O
and	O	O
the	O	O
balance	O	O
between	O	O
beneficial	O	O
and	O	O
pathogenic	O	O
bacteria	O	O
plays	O	O
a	O	O
critical	O	O
role	O	O
in	O	O
human	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

The	O	O
human	O	O
infant	O	O
,	O	O
however	O	O
,	O	O
is	O	O
born	O	O
with	O	O
a	O	O
sterile	O	O
gut	O	O
and	O	O
the	O	O
complex	O	O
gastrointestinal	O	O
host/bacterial	O	O
ecosystem	O	O
is	O	O
only	O	O
established	O	O
after	O	O
birth	O	O
by	O	O
rapid	O	O
bacterial	O	O
colonization	O	O
.	O	O

Composition	O	O
of	O	O
newborn	O	O
gut	O	O
flora	O	O
depends	O	O
on	O	O
several	O	O
factors	O	O
including	O	O
type	O	O
of	O	O
birth	O	O
(	O	O
Ceasarian	O	O
or	O	O
natural	O	O
)	O	O
,	O	O
manner	O	O
of	O	O
early	O	O
feeding	O	O
(	O	O
breast	O	O
milk	O	O
or	O	O
formula	O	O
)	O	O
,	O	O
and	O	O
exposure	O	O
to	O	O
local	O	O
,	O	O
physical	O	O
environment	O	O
.	O	O

Imbalance	O	O
in	O	O
normal	O	O
,	O	O
healthy	O	O
gut	O	O
flora	O	O
contributes	O	O
to	O	O
several	O	O
adult	O	O
human	O	O
diseases	O	O
including	O	O
inflammatory	O	O
bowel	O	O
(	O	O
ulcerative	O	O
colitis	O	O
and	O	O
Crohn's	O	O
disease	O	O
)	O	O
and	O	O
Clostridium	B-bacteria	B-bacteria
difficile	E-bacteria	I-bacteria
associated	O	O
disease	O	O
,	O	O
and	O	O
early	O	O
childhood	O	O
diseases	O	O
such	O	O
as	O	O
necrotizing	O	O
enterocolitis	O	O
.	O	O

As	O	O
a	O	O
first	O	O
step	O	O
towards	O	O
characterization	O	O
of	O	O
the	O	O
role	O	O
of	O	O
gut	O	O
bacteria	O	O
in	O	O
human	O	O
health	O	O
and	O	O
disease	O	O
,	O	O
we	O	O
conducted	O	O
an	O	O
850	O	O
MHz	O	O
(	O	O
1	O	O
)	O	O
H	O	O
nuclear	O	O
magnetic	O	O
resonance	O	O
spectroscopy	O	O
study	O	O
to	O	O
monitor	O	O
changes	O	O
in	O	O
metabolic	O	O
profiles	O	O
of	O	O
urine	O	O
and	O	O
fecal	O	O
extracts	O	O
of	O	O
15	O	O
mice	O	O
following	O	O
gut	O	O
sterilization	O	O
by	O	O
the	O	O
broad-spectrum	O	O
antibiotic	O	O
enrofloxacin	O	O
(	O	O
also	O	O
known	O	O
as	O	O
Baytril	O	O
)	O	O
.	O	O

Ten	O	O
metabolites	O	O
changed	O	O
in	O	O
urine	O	O
following	O	O
enrofloxacin	O	O
treatment	O	O
including	O	O
decreased	O	O
acetate	O	O
due	O	O
to	O	O
loss	O	O
of	O	O
microbial	O	O
catabolism	O	O
of	O	O
sugars	O	O
and	O	O
polysaccharides	O	O
,	O	O
decreased	O	O
trimethylamine-N-oxide	O	O
due	O	O
to	O	O
loss	O	O
of	O	O
microbial	O	O
catabolism	O	O
of	O	O
choline	O	O
,	O	O
and	O	O
increased	O	O
creatine	O	O
and	O	O
creatinine	O	O
due	O	O
to	O	O
loss	O	O
of	O	O
microbial	O	O
enzyme	O	O
degradation	O	O
.	O	O

Eight	O	O
metabolites	O	O
changed	O	O
in	O	O
fecal	O	O
extracts	O	O
of	O	O
mice	O	O
treated	O	O
with	O	O
enrofloxacin	O	O
including	O	O
depletion	O	O
of	O	O
amino	O	O
acids	O	O
produced	O	O
by	O	O
microbial	O	O
proteases	O	O
,	O	O
reduction	O	O
in	O	O
metabolites	O	O
generated	O	O
by	O	O
lactate-utilizing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
and	O	O
increased	O	O
urea	O	O
caused	O	O
by	O	O
loss	O	O
of	O	O
microbial	O	O
ureases	O	O
.	O	O

Mouth	O	O
dryness	O	O
is	O	O
one	O	O
of	O	O
the	O	O
major	O	O
problems	O	O
that	O	O
can	O	O
lead	O	O
to	O	O
several	O	O
oral	O	O
diseases	O	O
such	O	O
as	O	O
dental	O	O
caries	O	O
,	O	O
periodontitis	O	O
and	O	O
oral	O	O
infection	O	O
.	O	O

Mouth	O	O
dryness	O	O
has	O	O
also	O	O
been	O	O
associated	O	O
with	O	O
type	O	O
2	O	O
diabetes	O	O
mellitus	O	O
(	O	O
DM	O	O
)	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
prevalence	O	O
of	O	O
xerostomia	O	O
(	O	O
feeling	O	O
of	O	O
mouth	O	O
dryness	O	O
)	O	O
,	O	O
hyposalivation	O	O
(	O	O
the	O	O
reduction	O	O
of	O	O
saliva	O	O
)	O	O
,	O	O
and	O	O
oral	O	O
microbiota	O	O
in	O	O
Thai	O	O
patients	O	O
with	O	O
type	O	O
2	O	O
DM	O	O
.	O	O

One	O	O
hundred	O	O
and	O	O
fifty-four	O	O
ambulatory	O	O
patients	O	O
with	O	O
type	O	O
2	O	O
DM	O	O
and	O	O
50	O	O
non-diabetic	O	O
control	O	O
subjects	O	O
were	O	O
interviewed	O	O
for	O	O
symptoms	O	O
of	O	O
xerostomia	O	O
.	O	O

The	O	O
medical	O	O
records	O	O
of	O	O
these	O	O
subjects	O	O
were	O	O
reviewed	O	O
for	O	O
pertinent	O	O
medical	O	O
history	O	O
and	O	O
laboratory	O	O
investigations	O	O
regarding	O	O
their	O	O
diabetic	O	O
control	O	O
.	O	O

Oral	O	O
examination	O	O
and	O	O
measurement	O	O
of	O	O
hyposalivation	O	O
using	O	O
a	O	O
modified	O	O
Schirmer	O	O
test	O	O
(	O	O
MST	O	O
)	O	O
were	O	O
performed	O	O
The	O	O
presence	O	O
of	O	O
oral	O	O
microbial	O	O
flora	O	O
was	O	O
investigated	O	O
using	O	O
a	O	O
modified	O	O
dip-slide	O	O
test	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
xerostomia	O	O
was	O	O
62	O	O
%	O	O
in	O	O
patients	O	O
with	O	O
type	O	O
2	O	O
DM	O	O
compared	O	O
with	O	O
36	O	O
%	O	O
in	O	O
the	O	O
nondiabetic	O	O
control	O	O
group	O	O
(	O	O
p	O	O
=	O	O
0.001	O	O
)	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
hyposalivation	O	O
(	O	O
defined	O	O
as	O	O
MST	O	O
values	O	O
<	O	O
or	O	O
=	O	O
25	O	O
mm	O	O
at	O	O
3	O	O
min	O	O
)	O	O
was	O	O
46	O	O
%	O	O
in	O	O
the	O	O
patient	O	O
group	O	O
,	O	O
whereas	O	O
only	O	O
28	O	O
%	O	O
of	O	O
the	O	O
control	O	O
group	O	O
had	O	O
hyposalivation	O	O
(	O	O
p	O	O
=	O	O
0.03	O	O
)	O	O
.	O	O

Patients	O	O
with	O	O
hyposalivation	O	O
had	O	O
significantly	O	O
higher	O	O
numbers	O	O
of	O	O
mutans	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
spp	O	O
.	O	O

in	O	O
the	O	O
saliva	O	O
compared	O	O
with	O	O
those	O	O
without	O	O
hyposalivation	O	O
.	O	O

These	O	O
results	O	O
suggested	O	O
that	O	O
xerostomia	O	O
and	O	O
hyposalivation	O	O
were	O	O
prevalent	O	O
in	O	O
patients	O	O
with	O	O
type	O	O
2	O	O
DM	O	O
and	O	O
were	O	O
associated	O	O
with	O	O
higher	O	O
numbers	O	O
of	O	O
oral	O	O
pathogens	O	O
in	O	O
the	O	O
saliva	O	O
.	O	O

Betel	O	O
chewing	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
predispose	O	O
to	O	O
periodontal	O	O
disease	O	O
and	O	O
oral	O	O
cancer	O	O
.	O	O

Studies	O	O
show	O	O
that	O	O
people	O	O
with	O	O
gum	O	O
disease	O	O
are	O	O
more	O	O
likely	O	O
to	O	O
test	O	O
positive	O	O
for	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
)	O	O
.	O	O

It	O	O
is	O	O
not	O	O
known	O	O
if	O	O
the	O	O
lesions	O	O
produced	O	O
by	O	O
betel	O	O
quid	O	O
and	O	O
the	O	O
resulting	O	O
,	O	O
chemical	O	O
changes	O	O
predispose	O	O
to	O	O
colonization	O	O
by	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

Further	O	O
the	O	O
role	O	O
of	O	O
this	O	O
organism	O	O
in	O	O
oral	O	O
cancer	O	O
is	O	O
not	O	O
known	O	O
.	O	O

Our	O	O
objective	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
lesions	O	O
of	O	O
thirty	O	O
oral	O	O
cancer	O	O
patients	O	O
and	O	O
to	O	O
determine	O	O
the	O	O
presence	O	O
of	O	O
IgG	O	O
antibodies	O	O
to	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
cancer	O	O
patients	O	O
who	O	O
are	O	O
betel	O	O
chewers	O	O
and	O	O
non	O	O
betel	O	O
chewers	O	O
,	O	O
healthy	O	O
betel	O	O
chewers	O	O
and	O	O
healthy	O	O
non-betel	O	O
chewers	O	O
and	O	O
to	O	O
compare	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
these	O	O
four	O	O
groups	O	O
.	O	O

This	O	O
case	O	O
control	O	O
study	O	O
was	O	O
conducted	O	O
at	O	O
the	O	O
Cancer	O	O
Institute	O	O
Maharagama	O	O
and	O	O
the	O	O
Department	O	O
of	O	O
Microbiology	O	O
,	O	O
Faculty	O	O
of	O	O
Medical	O	O
Sciences	O	O
,	O	O
University	O	O
of	O	O
Sri	O	O
Jayewardenepura	O	O
.	O	O

One	O	O
hundred	O	O
and	O	O
seventy	O	O
three	O	O
subjects	O	O
,	O	O
of	O	O
whom	O	O
fifty	O	O
three	O	O
were	O	O
patients	O	O
presenting	O	O
with	O	O
oral	O	O
cancer	O	O
to	O	O
the	O	O
Cancer	O	O
Institute	O	O
Maharagama	O	O
,	O	O
sixty	O	O
healthy	O	O
betel	O	O
chewers	O	O
and	O	O
sixty	O	O
healthy	O	O
non-betel	O	O
chewers	O	O
from	O	O
the	O	O
Religious	O	O
and	O	O
Welfare	O	O
Service	O	O
Centre	O	O
Maharagama	O	O
were	O	O
tested	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
by	O	O
serology	O	O
.	O	O

Thirty	O	O
oral	O	O
biopsies	O	O
from	O	O
oral	O	O
cancer	O	O
patients	O	O
were	O	O
cultured	O	O
under	O	O
microaerophilic	O	O
condition	O	O
to	O	O
isolate	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

The	O	O
statistic	O	O
used	O	O
was	O	O
Chi-square	O	O
test	O	O
.	O	O

Of	O	O
the	O	O
fifty-three	O	O
oral	O	O
cancer	O	O
patients	O	O
,	O	O
forty-four	O	O
were	O	O
betel	O	O
chewers	O	O
.	O	O

Among	O	O
the	O	O
53	O	O
oral	O	O
cancer	O	O
patients	O	O
examined	O	O
,	O	O
ten	O	O
of	O	O
forty-four	O	O
(	O	O
10/44	O	O
=	O	O
22.7	O	O
%	O	O
)	O	O
patients	O	O
who	O	O
are	O	O
betel	O	O
chewers	O	O
and	O	O
four	O	O
of	O	O
nine	O	O
(	O	O
4/9	O	O
=	O	O
44.4	O	O
%	O	O
)	O	O
patients	O	O
who	O	O
are	O	O
non-betel	O	O
chewers	O	O
were	O	O
detected	O	O
positive	O	O
for	O	O
IgG	O	O
antibody	O	O
against	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

In	O	O
the	O	O
healthy	O	O
group	O	O
(	O	O
betel	O	O
chewers	O	O
and	O	O
non	O	O
betel	O	O
chewers	O	O
)	O	O
ten	O	O
(	O	O
16.7	O	O
%	O	O
)	O	O
of	O	O
the	O	O
healthy	O	O
betel	O	O
chewers	O	O
tested	O	O
positive	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
by	O	O
serology	O	O
.	O	O

None	O	O
of	O	O
the	O	O
healthy	O	O
non-betel	O	O
chewers	O	O
tested	O	O
positive	O	O
for	O	O
H.	B-bacteria	B-bacteria
pyloriFourteen	E-bacteria	I-bacteria
[	O	O
26.4	O	O
%	O	O
]	O	O
of	O	O
oral	O	O
cancer	O	O
patients	O	O
tested	O	O
positive	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
by	O	O
serology	O	O
,	O	O
of	O	O
which	O	O
two	O	O
were	O	O
also	O	O
culture	O	O
positive	O	O
(	O	O
Only	O	O
thirty	O	O
samples	O	O
were	O	O
cultured	O	O
)	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
betel	O	O
chewers	O	O
(	O	O
with	O	O
or	O	O
without	O	O
cancer	O	O
)	O	O
compared	O	O
to	O	O
non-betel	O	O
chewers	O	O
was	O	O
statistically	O	O
significant	O	O
.	O	O

(	O	O
Chi-square	O	O
test	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
The	O	O
use	O	O
of	O	O
tobacco	O	O
and	O	O
areca	O	O
nut	O	O
in	O	O
betel	O	O
chewers	O	O
was	O	O
significant	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

There	O	O
is	O	O
a	O	O
significant	O	O
higher	O	O
proportion	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
betel	O	O
chewers	O	O
compared	O	O
to	O	O
non-betel	O	O
chewers	O	O
but	O	O
not	O	O
between	O	O
oral	O	O
cancer	O	O
patients	O	O
compared	O	O
to	O	O
patients	O	O
without	O	O
oral	O	O
cancer	O	O
.	O	O

Hence	O	O
Betel	O	O
chewing	O	O
may	O	O
predispose	O	O
to	O	O
colonisation	O	O
with	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
digestive	O	O
tract	O	O
through	O	O
swallowing	O	O
the	O	O
quid	O	O
or	O	O
during	O	O
betel	O	O
chewing	O	O
.	O	O

We	O	O
present	O	O
a	O	O
case	O	O
series	O	O
of	O	O
5	O	O
patients	O	O
admitted	O	O
over	O	O
5	O	O
months	O	O
to	O	O
Queen	O	O
Elizabeth	O	O
Central	O	O
Hospital	O	O
who	O	O
had	O	O
sustained	O	O
injuries	O	O
from	O	O
a	O	O
crocodile	O	O
bite	O	O
.	O	O

Three	O	O
patients	O	O
required	O	O
amputation	O	O
of	O	O
a	O	O
limb	O	O
.	O	O

The	O	O
severe	O	O
soft	O	O
tissue	O	O
injury	O	O
associated	O	O
with	O	O
a	O	O
crocodile	O	O
bite	O	O
and	O	O
the	O	O
unusual	O	O
normal	O	O
oral	O	O
flora	O	O
of	O	O
the	O	O
crocodile	O	O
create	O	O
challenges	O	O
in	O	O
treatment	O	O
.	O	O

Progressive	O	O
tissue	O	O
destruction	O	O
and	O	O
haemolysis	O	O
are	O	O
complications	O	O
of	O	O
such	O	O
infected	O	O
wounds	O	O
.	O	O

An	O	O
antibiotic	O	O
regime	O	O
is	O	O
recommended	O	O
that	O	O
covers	O	O
gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
,	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
may	O	O
include	O	O
doxycycline	O	O
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
need	O	O
to	O	O
have	O	O
a	O	O
low	O	O
threshold	O	O
for	O	O
early	O	O
amputation	O	O
.	O	O

In	O	O
our	O	O
study	O	O
of	O	O
nursing	O	O
home	O	O
residents	O	O
with	O	O
clinically	O	O
suspected	O	O
urinary	O	O
tract	O	O
infection	O	O
who	O	O
did	O	O
not	O	O
require	O	O
the	O	O
use	O	O
of	O	O
an	O	O
indwelling	O	O
catheter	O	O
,	O	O
we	O	O
identified	O	O
bacteria	O	O
isolated	O	O
from	O	O
urine	O	O
samples	O	O
,	O	O
the	O	O
resistance	O	O
patterns	O	O
of	O	O
these	O	O
isolated	O	O
bacteria	O	O
,	O	O
and	O	O
the	O	O
antibiotic	O	O
therapy	O	O
prescribed	O	O
to	O	O
the	O	O
residents	O	O
.	O	O

Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
the	O	O
predominant	O	O
organism	O	O
isolated	O	O
,	O	O
frequently	O	O
was	O	O
resistant	O	O
to	O	O
commonly	O	O
prescribed	O	O
oral	O	O
antibiotics	O	O
.	O	O

Trimethoprim-sulfamethoxazole	O	O
remains	O	O
the	O	O
best	O	O
empiric	O	O
antimicrobial	O	O
therapy	O	O
for	O	O
a	O	O
urinary	O	O
tract	O	O
infection	O	O
,	O	O
but	O	O
nitrofurantoin	O	O
should	O	O
be	O	O
considered	O	O
if	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
is	O	O
identified	O	O
.	O	O

To	O	O
date	O	O
,	O	O
metagenomic	O	O
studies	O	O
have	O	O
relied	O	O
on	O	O
the	O	O
utilization	O	O
and	O	O
analysis	O	O
of	O	O
reads	O	O
obtained	O	O
using	O	O
454	O	O
pyrosequencing	O	O
to	O	O
replace	O	O
conventional	O	O
Sanger	O	O
sequencing	O	O
.	O	O

After	O	O
extensively	O	O
scanning	O	O
the	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
(	O	O
rRNA	O	O
)	O	O
gene	O	O
,	O	O
we	O	O
identified	O	O
the	O	O
V5	O	O
hypervariable	O	O
region	O	O
as	O	O
a	O	O
short	O	O
region	O	O
providing	O	O
reliable	O	O
identification	O	O
of	O	O
bacterial	O	O
sequences	O	O
available	O	O
in	O	O
public	O	O
databases	O	O
such	O	O
as	O	O
the	O	O
Human	O	O
Oral	O	O
Microbiome	O	O
Database	O	O
.	O	O

We	O	O
amplified	O	O
samples	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
three	O	O
healthy	O	O
individuals	O	O
using	O	O
primers	O	O
covering	O	O
an	O	O
approximately	O	O
82-base	O	O
segment	O	O
of	O	O
the	O	O
V5	O	O
loop	O	O
,	O	O
and	O	O
sequenced	O	O
using	O	O
the	O	O
Illumina	O	O
technology	O	O
in	O	O
a	O	O
single	O	O
orientation	O	O
.	O	O

We	O	O
identified	O	O
135	O	O
genera	O	O
or	O	O
higher	O	O
taxonomic	O	O
ranks	O	O
from	O	O
the	O	O
resulting	O	O
1,373,824	O	O
sequences	O	O
.	O	O

While	O	O
the	O	O
abundances	O	O
of	O	O
the	O	O
most	O	O
common	O	O
phyla	O	O
(	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
Proteobacteria	B-bacteria	B-bacteria
,	O	O
Actinobacteria	B-bacteria	B-bacteria
,	O	O
Fusobacteria	B-bacteria	B-bacteria
and	O	O
TM7	B-bacteria	B-bacteria
)	O	O
are	O	O
largely	O	O
comparable	O	O
to	O	O
previous	O	O
studies	O	O
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
were	O	O
less	O	O
present	O	O
.	O	O

Potential	O	O
sources	O	O
for	O	O
this	O	O
difference	O	O
include	O	O
classification	O	O
bias	O	O
in	O	O
this	O	O
region	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
,	O	O
human	O	O
sample	O	O
variation	O	O
,	O	O
sample	O	O
preparation	O	O
and	O	O
primer	O	O
bias	O	O
.	O	O

Using	O	O
an	O	O
Illumina	O	O
sequencing	O	O
approach	O	O
,	O	O
we	O	O
achieved	O	O
a	O	O
much	O	O
greater	O	O
depth	O	O
of	O	O
coverage	O	O
than	O	O
previous	O	O
oral	O	O
microbiota	O	O
studies	O	O
,	O	O
allowing	O	O
us	O	O
to	O	O
identify	O	O
several	O	O
taxa	O	O
not	O	O
yet	O	O
discovered	O	O
in	O	O
these	O	O
types	O	O
of	O	O
samples	O	O
,	O	O
and	O	O
to	O	O
assess	O	O
that	O	O
at	O	O
least	O	O
30,000	O	O
additional	O	O
reads	O	O
would	O	O
be	O	O
required	O	O
to	O	O
identify	O	O
only	O	O
one	O	O
additional	O	O
phylotype	O	O
.	O	O

The	O	O
evolution	O	O
of	O	O
high-throughput	O	O
sequencing	O	O
technologies1	O	O
,	O	O
and	O	O
their	O	O
subsequent	O	O
improvements	O	O
in	O	O
read	O	O
length	O	O
enable	O	O
the	O	O
utilization	O	O
of	O	O
different	O	O
platforms	O	O
for	O	O
studying	O	O
communities	O	O
of	O	O
complex	O	O
flora	O	O
.	O	O

Access	O	O
to	O	O
large	O	O
amounts	O	O
of	O	O
data	O	O
is	O	O
already	O	O
leading	O	O
to	O	O
a	O	O
better	O	O
representation	O	O
of	O	O
sample	O	O
diversity	O	O
at	O	O
a	O	O
reasonable	O	O
cost	O	O
.	O	O

Infection	O	O
of	O	O
Galleria	O	O
mellonella	O	O
by	O	O
feeding	O	O
a	O	O
mixture	O	O
of	O	O
Bacillus	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
spores	O	O
or	O	O
vegetative	O	O
bacteria	O	O
in	O	O
association	O	O
with	O	O
the	O	O
toxin	O	O
Cry1C	O	O
results	O	O
in	O	O
high	O	O
levels	O	O
of	O	O
larval	O	O
mortality	O	O
.	O	O

Under	O	O
these	O	O
conditions	O	O
the	O	O
toxin	O	O
or	O	O
bacteria	O	O
have	O	O
minimal	O	O
effects	O	O
on	O	O
the	O	O
larva	O	O
when	O	O
inoculated	O	O
separately	O	O
.	O	O

In	O	O
order	O	O
to	O	O
evaluate	O	O
whether	O	O
G.	O	O
mellonella	O	O
can	O	O
function	O	O
as	O	O
an	O	O
oral	O	O
infection	O	O
model	O	O
for	O	O
human	O	O
and	O	O
entomo-bacterial	O	O
pathogens	O	O
,	O	O
we	O	O
tested	O	O
strains	O	O
of	O	O
Bacillus	B-bacteria	B-bacteria
cereus	E-bacteria	I-bacteria
,	O	O
Bacillus	B-bacteria	B-bacteria
anthracis	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
Listeria	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
a	O	O
Drosophila	B-bacteria	B-bacteria
targeting	I-bacteria	I-bacteria
Pseudomonas	I-bacteria	I-bacteria
entomophila	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
.	O	O

Six	O	O
B.	B-bacteria	B-bacteria
cereus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
(	O	O
5	O	O
diarrheal	O	O
,	O	O
1	O	O
environmental	O	O
isolate	O	O
)	O	O
were	O	O
first	O	O
screened	O	O
in	O	O
2nd	O	O
instar	O	O
G.	O	O
mellonella	O	O
larvae	O	O
by	O	O
free	O	O
ingestion	O	O
and	O	O
four	O	O
of	O	O
them	O	O
were	O	O
analyzed	O	O
by	O	O
force-feeding	O	O
5th	O	O
instar	O	O
larvae	O	O
.	O	O

The	O	O
virulence	O	O
of	O	O
these	O	O
B.	B-bacteria	B-bacteria
cereus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
did	O	O
not	O	O
differ	O	O
from	O	O
the	O	O
B.	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
virulent	O	O
reference	O	O
strain	B-bacteria	B-bacteria
407Cry	E-bacteria	I-bacteria
(	O	O
-	O	O
)	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
strain	O	O
D19	O	O
(	O	O
NVH391/98	O	O
)	O	O
that	O	O
showed	O	O
a	O	O
lower	O	O
virulence	O	O
.	O	O

Following	O	O
force-feeding	O	O
,	O	O
5th	O	O
instar	O	O
G.	O	O
mellonella	O	O
larvae	O	O
survived	O	O
infection	O	O
with	O	O
B.	B-bacteria	B-bacteria
anthracis	E-bacteria	I-bacteria
,	O	O
L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
,	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
aeruginosa	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
in	O	O
contrast	O	O
to	O	O
the	O	O
P.	B-bacteria	B-bacteria
entomophila	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
which	O	O
led	O	O
to	O	O
high	O	O
mortality	O	O
even	O	O
without	O	O
Cry1C	O	O
toxin	O	O
co-ingestion	O	O
.	O	O

Thus	O	O
,	O	O
specific	O	O
virulence	O	O
factors	O	O
adapted	O	O
to	O	O
the	O	O
insect	O	O
intestine	O	O
might	O	O
exist	O	O
in	O	O
B.	B-bacteria	B-bacteria
thuringiensis/B	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

cereus	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
entomophila	E-bacteria	I-bacteria
.	O	O

This	O	O
suggests	O	O
a	O	O
co-evolution	O	O
between	O	O
host	O	O
and	O	O
pathogens	O	O
and	O	O
supports	O	O
the	O	O
close	O	O
links	O	O
between	O	O
B.	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
and	O	O
B.	B-bacteria	B-bacteria
cereus	E-bacteria	I-bacteria
and	O	O
more	O	O
distant	O	O
links	O	O
to	O	O
their	O	O
relative	O	O
B.	B-bacteria	B-bacteria
anthracis	E-bacteria	I-bacteria
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
a	O	O
type	O	O
of	O	O
Gram-negative	O	O
periodontopathogen	O	O
,	O	O
causes	O	O
periodontal	O	O
disease	O	O
by	O	O
activating	O	O
intracellular	O	O
signaling	O	O
pathways	O	O
that	O	O
produce	O	O
excessive	O	O
inflammatory	O	O
responses	O	O
such	O	O
as	O	O
matrix	O	O
metalloproteinases	O	O
(	O	O
MMPs	O	O
)	O	O
.	O	O

Recently	O	O
,	O	O
we	O	O
reported	O	O
that	O	O
panduratin	O	O
A	O	O
,	O	O
a	O	O
chalcone	O	O
compound	O	O
isolated	O	O
from	O	O
Kaempferia	O	O
pandurata	O	O
ROXB.	O	O
,	O	O
caused	O	O
the	O	O
decreased	O	O
levels	O	O
of	O	O
MMP-9	O	O
secretion	O	O
,	O	O
protein	O	O
,	O	O
and	O	O
gene	O	O
expression	O	O
in	O	O
human	O	O
oral	O	O
epidermoid	O	O
KB	O	O
cells	O	O
exposed	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
supernatant	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
clarified	O	O
if	O	O
mitogen-activated	O	O
protein	O	O
kinase	O	O
(	O	O
MAPK	O	O
)	O	O
signaling	O	O
mediated	O	O
MMP-9	O	O
expression	O	O
by	O	O
examining	O	O
the	O	O
effect	O	O
of	O	O
specific	O	O
MAPK	O	O
inhibitors	O	O
,	O	O
i.e	O	O
.	O	O

U0126	O	O
,	O	O
SB203580	O	O
,	O	O
and	O	O
SP600125	O	O
,	O	O
on	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
supernatant-stimulated	O	O
MMP-9	O	O
expression	O	O
in	O	O
KB	O	O
cells	O	O
.	O	O

We	O	O
next	O	O
elucidated	O	O
the	O	O
molecular	O	O
mechanism	O	O
by	O	O
which	O	O
panduratin	O	O
A	O	O
attenuated	O	O
signaling	O	O
pathways	O	O
involved	O	O
in	O	O
MMP-9	O	O
expression	O	O
by	O	O
performing	O	O
gelatin	O	O
zymography	O	O
,	O	O
Western	O	O
blotting	O	O
,	O	O
reverse	O	O
transcription-polymerase	O	O
chain	O	O
reaction	O	O
,	O	O
and	O	O
promoter	O	O
assays	O	O
.	O	O

Exposure	O	O
of	O	O
KB	O	O
cells	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
supernatant	O	O
up-regulated	O	O
the	O	O
expression	O	O
of	O	O
MMP-9	O	O
protein	O	O
and	O	O
gene	O	O
,	O	O
and	O	O
activation	O	O
of	O	O
activator	O	O
protein-1	O	O
(	O	O
AP-1	O	O
)	O	O
element	O	O
,	O	O
MAPK	O	O
phosphorylation	O	O
(	O	O
extracellular	O	O
signal-related	O	O
kinase	O	O
1/2	O	O
(	O	O
ERK1/2	O	O
)	O	O
,	O	O
p38	O	O
,	O	O
and	O	O
c-Jun	O	O
N-terminal	O	O
kinase	O	O
(	O	O
JNK	O	O
)	O	O
)	O	O
,	O	O
and	O	O
transcription	O	O
factors	O	O
(	O	O
Elk1	O	O
,	O	O
c-Jun	O	O
,	O	O
and	O	O
c-Fos	O	O
)	O	O
.	O	O

A	O	O
JNK	O	O
inhibitor	O	O
(	O	O
SP600125	O	O
)	O	O
significantly	O	O
attenuated	O	O
MMP-9	O	O
gene	O	O
expression	O	O
and	O	O
AP-1	O	O
activity	O	O
in	O	O
KB	O	O
cells	O	O
in	O	O
response	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
supernatant	O	O
.	O	O

Similar	O	O
to	O	O
SP600125	O	O
,	O	O
panduratin	O	O
A	O	O
was	O	O
found	O	O
to	O	O
strongly	O	O
suppress	O	O
the	O	O
level	O	O
of	O	O
phosphorylated	O	O
JNK	O	O
and	O	O
block	O	O
AP-1	O	O
activity	O	O
in	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
supernatant-stimulated	O	O
KB	O	O
cells	O	O
.	O	O

In	O	O
summary	O	O
,	O	O
JNK	O	O
and	O	O
AP-1	O	O
are	O	O
the	O	O
major	O	O
signaling	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
supernatant-stimulated	O	O
MMP-9	O	O
expression	O	O
in	O	O
KB	O	O
cells	O	O
,	O	O
and	O	O
panduratin	O	O
A	O	O
markedly	O	O
down-regulates	O	O
MMP-9	O	O
expression	O	O
through	O	O
inhibition	O	O
of	O	O
these	O	O
signaling	O	O
.	O	O

Periodontitis	O	O
is	O	O
a	O	O
polymicrobial	O	O
infection	O	O
caused	O	O
by	O	O
selected	O	O
gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
including	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Host	O	O
cell	O	O
invasion	O	O
by	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
has	O	O
been	O	O
proposed	O	O
as	O	O
a	O	O
possible	O	O
mechanism	O	O
of	O	O
pathogenesis	O	O
in	O	O
periodontitis	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
assess	O	O
the	O	O
influence	O	O
of	O	O
periodontopathogens	O	O
on	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
invasion	O	O
of	O	O
gingival	O	O
epithelial	O	O
cells	O	O
in	O	O
polymicrobial	O	O
infection	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
tested	O	O
for	O	O
its	O	O
ability	O	O
to	O	O
invade	O	O
a	O	O
human	O	O
gingival	O	O
epithelial	O	O
cell	O	O
line	O	O
Ca9-22	O	O
in	O	O
co-infection	O	O
with	O	O
periodontopathogens	O	O
,	O	O
using	O	O
an	O	O
antibiotic	O	O
protection	O	O
assay	O	O
.	O	O

Among	O	O
the	O	O
pathogens	O	O
tested	O	O
,	O	O
only	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
demonstrated	O	O
the	O	O
ability	O	O
to	O	O
significantly	O	O
promote	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
invasion	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

This	O	O
increased	O	O
invasion	O	O
was	O	O
confirmed	O	O
by	O	O
confocal	O	O
scanning	O	O
laser	O	O
microscopy	O	O
utilizing	O	O
a	O	O
dual	O	O
labeling	O	O
technique	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
co-infection	O	O
with	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
or	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
attenuated	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
invasion	O	O
.	O	O

The	O	O
fusobacterial	O	O
enhancement	O	O
of	O	O
host	O	O
cell	O	O
invasion	O	O
was	O	O
not	O	O
observed	O	O
in	O	O
co-incubation	O	O
with	O	O
other	O	O
periodontopathogens	O	O
tested	O	O
.	O	O

These	O	O
results	O	O
suggested	O	O
that	O	O
complex	O	O
synergistic	O	O
or	O	O
antagonistic	O	O
physiologic	O	O
mechanisms	O	O
are	O	O
intimately	O	O
involved	O	O
in	O	O
host	O	O
cell	O	O
invasion	O	O
by	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
polymicrobial	O	O
infection	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
patterns	O	O
of	O	O
microbial	O	O
infection	O	O
on	O	O
the	O	O
apical	O	O
external	O	O
root	O	O
surfaces	O	O
of	O	O
treated	O	O
and	O	O
untreated	O	O
teeth	O	O
associated	O	O
with	O	O
chronic	O	O
apical	O	O
periodontitis	O	O
and	O	O
to	O	O
study	O	O
bacteria	O	O
in	O	O
the	O	O
biofilm	O	O
in	O	O
order	O	O
to	O	O
find	O	O
out	O	O
the	O	O
species	O	O
,	O	O
constitution	O	O
and	O	O
origination	O	O
of	O	O
bacteria	O	O
in	O	O
periapical	O	O
biofilm	O	O
.	O	O

Ten	O	O
teeth	O	O
with	O	O
chronic	O	O
apical	O	O
periodontitis	O	O
from	O	O
patients	O	O
of	O	O
the	O	O
Department	O	O
of	O	O
Stomatology	O	O
of	O	O
People	O	O
's	O	O
Hospital	O	O
,	O	O
Peking	O	O
University	O	O
:	O	O
5	O	O
untreated	O	O
teeth	O	O
with	O	O
a	O	O
radiographically	O	O
visible	O	O
chronic	O	O
periradicular	O	O
lesions	O	O
and	O	O
5	O	O
teeth	O	O
with	O	O
extensive	O	O
carious	O	O
lesions	O	O
,	O	O
radiolucent	O	O
lesions	O	O
of	O	O
varying	O	O
sizes	O	O
and	O	O
attached	O	O
periradicular	O	O
tissues	O	O
were	O	O
selected	O	O
for	O	O
study	O	O
.	O	O

Using	O	O
aseptic	O	O
techniques	O	O
and	O	O
sterile	O	O
instruments	O	O
,	O	O
bacterial	O	O
samples	O	O
of	O	O
the	O	O
root	O	O
canals	O	O
were	O	O
taken	O	O
,	O	O
inoculated	O	O
and	O	O
separated	O	O
according	O	O
to	O	O
usual	O	O
practice	O	O
.	O	O

After	O	O
extraction	O	O
,	O	O
ten	O	O
teeth	O	O
were	O	O
fixed	O	O
and	O	O
the	O	O
apical	O	O
5	O	O
mm	O	O
portion	O	O
of	O	O
one	O	O
root	O	O
was	O	O
sectioned	O	O
.	O	O

Root	O	O
tips	O	O
were	O	O
dehydrated	O	O
,	O	O
sputter	O	O
coated	O	O
with	O	O
gold	O	O
,	O	O
and	O	O
then	O	O
examined	O	O
for	O	O
the	O	O
occurrence	O	O
of	O	O
bacteria	O	O
on	O	O
the	O	O
apical	O	O
root	O	O
surfaces	O	O
using	O	O
scanning	O	O
electron	O	O
microscope	O	O
.	O	O

Five	O	O
healthy	O	O
teeth	O	O
with	O	O
vital	O	O
pulp	O	O
were	O	O
used	O	O
as	O	O
controls	O	O
.	O	O

Microbial	O	O
study	O	O
showed	O	O
that	O	O
ten	O	O
specimens	O	O
yielded	O	O
bacterial	O	O
growth	O	O
.	O	O

The	O	O
most	O	O
prevalent	O	O
bacteria	O	O
were	O	O
P.	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nueleatum	E-bacteria	I-bacteria
.	O	O

In	O	O
the	O	O
5	O	O
untreated	O	O
teeth	O	O
,	O	O
bacterial	O	O
cells	O	O
were	O	O
usually	O	O
observed	O	O
close	O	O
to	O	O
the	O	O
apical	O	O
foramen	O	O
in	O	O
only	O	O
1	O	O
specimen	O	O
.	O	O

Morphologically	O	O
,	O	O
these	O	O
bacteria	O	O
consisted	O	O
of	O	O
cocci	B-bacteria	B-bacteria
.	O	O

In	O	O
the	O	O
5	O	O
treated	O	O
teeth	O	O
,	O	O
a	O	O
dense	O	O
bacterial	O	O
aggregation	O	O
composed	O	O
mainly	O	O
of	O	O
cocci	B-bacteria	B-bacteria
and	O	O
rods	B-bacteria	B-bacteria
was	O	O
observed	O	O
surrounding	O	O
the	O	O
apical	O	O
foramen	O	O
of	O	O
all	O	O
specimens	O	O
.	O	O

Besides	O	O
rods	B-bacteria	B-bacteria
,	O	O
other	O	O
bacterial	O	O
morphological	O	O
types	O	O
were	O	O
recognized	O	O
,	O	O
including	O	O
coaggregations	O	O
of	O	O
cocci	B-bacteria	B-bacteria
and	O	O
filaments	B-bacteria	B-bacteria
,	O	O
characterizing	O	O
a	O	O
fully	O	O
developed	O	O
``	O	O
corn-cob	O	O
''	O	O
.	O	O

No	O	O
microorganisms	O	O
were	O	O
found	O	O
in	O	O
the	O	O
healthy	O	O
controls	O	O
.	O	O

Bacterial	O	O
biofilm	O	O
was	O	O
always	O	O
present	O	O
in	O	O
teeth	O	O
with	O	O
post-treatment	O	O
endodontic	O	O
disease	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
apical	O	O
bacterial	O	O
biofilm	O	O
is	O	O
clinically	O	O
important	O	O
,	O	O
and	O	O
it	O	O
may	O	O
cause	O	O
failure	O	O
of	O	O
endodontic	O	O
treatment	O	O
as	O	O
a	O	O
consequence	O	O
of	O	O
persistent	O	O
infection	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
safety	O	O
of	O	O
two	O	O
probiotic	B-bacteria	B-bacteria
bacterial	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
Shirota	E-bacteria	I-bacteria
(	O	O
LcS	B-bacteria	B-bacteria
)	O	O
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
breve	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
Yakult	E-bacteria	I-bacteria
(	O	O
BbY	B-bacteria	B-bacteria
)	O	O
,	O	O
these	O	O
probiotics	B-bacteria	B-bacteria
were	O	O
orally	O	O
administered	O	O
to	O	O
Lewis	O	O
rats	O	O
with	O	O
experimental	O	O
autoimmune	O	O
encephalomyelitis	O	O
(	O	O
EAE	O	O
)	O	O
,	O	O
the	O	O
experimental	O	O
model	O	O
of	O	O
human	O	O
multiple	O	O
sclerosis	O	O
.	O	O

We	O	O
examined	O	O
three	O	O
experimental	O	O
designs	O	O
by	O	O
combining	O	O
different	O	O
antigen	O	O
types	O	O
and	O	O
probiotic	B-bacteria	B-bacteria
administration	O	O
periods	O	O
:	O	O
(	O	O
1	O	O
)	O	O
EAE	O	O
was	O	O
induced	O	O
with	O	O
a	O	O
homogenate	O	O
of	O	O
guinea	O	O
pig	O	O
spinal	O	O
cord	O	O
as	O	O
the	O	O
sensitizing	O	O
antigen	O	O
,	O	O
and	O	O
LcS	B-bacteria	B-bacteria
was	O	O
orally	O	O
administered	O	O
from	O	O
one	O	O
week	O	O
before	O	O
this	O	O
sensitization	O	O
until	O	O
the	O	O
end	O	O
of	O	O
the	O	O
experiment	O	O
;	O	O
(	O	O
2	O	O
)	O	O
EAE	O	O
was	O	O
induced	O	O
using	O	O
guinea	O	O
pig	O	O
originated	O	O
myelin	O	O
basic	O	O
protein	O	O
(	O	O
MBP	O	O
)	O	O
as	O	O
the	O	O
sensitizing	O	O
antigen	O	O
,	O	O
and	O	O
LcS	B-bacteria	B-bacteria
was	O	O
orally	O	O
administered	O	O
from	O	O
one	O	O
week	O	O
before	O	O
this	O	O
sensitization	O	O
to	O	O
the	O	O
end	O	O
of	O	O
the	O	O
experiment	O	O
;	O	O
(	O	O
3	O	O
)	O	O
EAE	O	O
was	O	O
induced	O	O
using	O	O
guinea	O	O
pig	O	O
MBP	O	O
as	O	O
the	O	O
sensitizing	O	O
antigen	O	O
,	O	O
and	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
(	O	O
LcS	B-bacteria	B-bacteria
and	O	O
BbY	B-bacteria	B-bacteria
)	O	O
were	O	O
administered	O	O
starting	O	O
in	O	O
infancy	O	O
(	O	O
two	O	O
weeks	O	O
old	O	O
)	O	O
and	O	O
continued	O	O
until	O	O
the	O	O
end	O	O
of	O	O
the	O	O
experiment	O	O
.	O	O

In	O	O
experiment	O	O
1	O	O
,	O	O
oral	O	O
administration	O	O
of	O	O
LcS	B-bacteria	B-bacteria
tended	O	O
to	O	O
suppress	O	O
the	O	O
development	O	O
of	O	O
neurological	O	O
symptoms	O	O
.	O	O

Differences	O	O
in	O	O
neurological	O	O
symptoms	O	O
between	O	O
the	O	O
control	O	O
group	O	O
and	O	O
the	O	O
administration	O	O
groups	O	O
did	O	O
not	O	O
reach	O	O
statistical	O	O
significance	O	O
in	O	O
experiments	O	O
2	O	O
and	O	O
3	O	O
.	O	O

These	O	O
results	O	O
support	O	O
the	O	O
notion	O	O
that	O	O
neither	O	O
LcS	B-bacteria	B-bacteria
nor	O	O
BbY	B-bacteria	B-bacteria
exacerbates	O	O
autoimmune	O	O
disease	O	O
.	O	O

In	O	O
Mexico	O	O
,	O	O
more	O	O
than	O	O
80	O	O
%	O	O
of	O	O
the	O	O
population	O	O
is	O	O
infected	O	O
with	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

The	O	O
frequency	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
detection	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
unknown	O	O
,	O	O
as	O	O
its	O	O
relationship	O	O
with	O	O
gastroesophageal	O	O
pathology	O	O
.	O	O

To	O	O
detect	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
Mexican	O	O
population	O	O
by	O	O
PCR	O	O
and	O	O
to	O	O
determine	O	O
its	O	O
association	O	O
with	O	O
gastroesophageal	O	O
disease	O	O
.	O	O

Patients	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
with	O	O
different	O	O
clinic	O	O
conditions	O	O
from	O	O
whom	O	O
gastric	O	O
biopsy	O	O
,	O	O
dental	O	O
plaque	O	O
,	O	O
and	O	O
saliva	O	O
samples	O	O
were	O	O
taken	O	O
and	O	O
analyzed	O	O
.	O	O

The	O	O
first	O	O
group	O	O
comprised	O	O
of	O	O
hospitalized	O	O
patients	O	O
,	O	O
the	O	O
majority	O	O
of	O	O
whom	O	O
were	O	O
diagnosed	O	O
with	O	O
gastroesophageal	O	O
disease	O	O
,	O	O
while	O	O
the	O	O
second	O	O
group	O	O
was	O	O
selected	O	O
from	O	O
a	O	O
dental	O	O
clinic	O	O
(	O	O
ambulatory	O	O
population	O	O
)	O	O
the	O	O
majority	O	O
of	O	O
whom	O	O
appeared	O	O
to	O	O
be	O	O
healthy	O	O
subjects	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
gastric	O	O
biopsy	O	O
,	O	O
dental	O	O
plaque	O	O
and	O	O
saliva	O	O
samples	O	O
by	O	O
PCR	O	O
using	O	O
a	O	O
set	O	O
of	O	O
specific	O	O
primers	O	O
for	O	O
the	O	O
signal	O	O
sequence	O	O
of	O	O
the	O	O
vacuolating	O	O
cytotoxin	O	O
gene	O	O
;	O	O
detection	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
general	O	O
was	O	O
higher	O	O
in	O	O
gastric	O	O
biopsy	O	O
and	O	O
dental	O	O
plaque	O	O
samples	O	O
than	O	O
in	O	O
saliva	O	O
samples	O	O
.	O	O

Detection	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
significantly	O	O
(	O	O
P	O	O
=	O	O
0.0001	O	O
)	O	O
associated	O	O
with	O	O
patients	O	O
presenting	O	O
gastroesophageal	O	O
disease	O	O
,	O	O
while	O	O
healthy	O	O
subjects	O	O
and	O	O
those	O	O
with	O	O
other	O	O
non-gastric	O	O
disease	O	O
do	O	O
not	O	O
present	O	O
with	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
their	O	O
oral	O	O
cavity	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
detection	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
associated	O	O
to	O	O
gastroesophageal	O	O
disease	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
it	O	O
is	O	O
suggested	O	O
that	O	O
all	O	O
patients	O	O
presenting	O	O
gastric	O	O
symptoms	O	O
and	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
detection	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
would	O	O
begin	O	O
bacterial	O	O
treatment	O	O
immediately	O	O
.	O	O

Mouse	O	O
prolactin-inducible	O	O
protein	O	O
(	O	O
mPIP	O	O
)	O	O
is	O	O
secreted	O	O
in	O	O
mouse	O	O
saliva	O	O
and	O	O
has	O	O
been	O	O
found	O	O
to	O	O
bind	O	O
oral	O	O
bacteria	O	O
,	O	O
showing	O	O
the	O	O
highest	O	O
affinity	O	O
for	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Comparisons	O	O
between	O	O
the	O	O
oral	O	O
flora	O	O
of	O	O
mPIP	O	O
knockout	O	O
mice	O	O
and	O	O
their	O	O
wild-type	O	O
controls	O	O
showed	O	O
differences	O	O
in	O	O
the	O	O
genera	O	O
colonizing	O	O
the	O	O
two	O	O
groups	O	O
of	O	O
mice	O	O
.	O	O

These	O	O
findings	O	O
suggested	O	O
a	O	O
role	O	O
for	O	O
mPIP	O	O
in	O	O
the	O	O
colonization	O	O
of	O	O
the	O	O
mouse	O	O
oral	O	O
cavity	O	O
,	O	O
possibly	O	O
modulating	O	O
the	O	O
oral	O	O
flora	O	O
.	O	O

In	O	O
this	O	O
in	O	O
vitro	O	O
study	O	O
,	O	O
we	O	O
focused	O	O
on	O	O
the	O	O
contribution	O	O
of	O	O
this	O	O
protein	O	O
to	O	O
aggregation	O	O
of	O	O
oral	O	O
bacteria	O	O
,	O	O
a	O	O
process	O	O
thought	O	O
to	O	O
promote	O	O
the	O	O
clearance	O	O
of	O	O
bacteria	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
one	O	O
that	O	O
could	O	O
influence	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
bacterial	O	O
community	O	O
.	O	O

The	O	O
aggregation	O	O
of	O	O
selected	O	O
human	O	O
and	O	O
mouse	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
was	O	O
measured	O	O
spectrophotometrically	O	O
.	O	O

The	O	O
aggregation	O	O
of	O	O
oral	O	O
bacteria	O	O
by	O	O
saliva	O	O
from	O	O
mPIP	O	O
knockout	O	O
mice	O	O
,	O	O
which	O	O
lack	O	O
mPIP	O	O
,	O	O
was	O	O
compared	O	O
with	O	O
that	O	O
of	O	O
saliva	O	O
from	O	O
wild-type	O	O
mice	O	O
.	O	O

Both	O	O
wild-type	O	O
saliva	O	O
and	O	O
mPIP	O	O
knockout	O	O
mouse	O	O
saliva	O	O
induced	O	O
aggregation	O	O
of	O	O
human	O	O
strain	B-bacteria	B-bacteria
Streptococcus	I-bacteria	I-bacteria
gordonii	I-bacteria	I-bacteria
SK120	E-bacteria	I-bacteria
and	O	O
mouse	O	O
streptococci	B-bacteria	B-bacteria
strains	I-bacteria	I-bacteria
M105/6	E-bacteria	I-bacteria
and	O	O
M106/2	B-bacteria	B-bacteria
.	O	O

Bacterial	O	O
aggregation	O	O
induced	O	O
by	O	O
the	O	O
saliva	O	O
of	O	O
wild-type	O	O
mice	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
the	O	O
aggregation	O	O
induced	O	O
by	O	O
saliva	O	O
from	O	O
mPIP	O	O
knockout	O	O
mice	O	O
for	O	O
all	O	O
the	O	O
bacterial	O	O
strains	O	O
.	O	O

In	O	O
this	O	O
study	O	O
it	O	O
was	O	O
confirmed	O	O
that	O	O
mPIP	O	O
plays	O	O
a	O	O
role	O	O
in	O	O
the	O	O
aggregation	O	O
of	O	O
oral	O	O
bacteria	O	O
.	O	O

The	O	O
salivary	O	O
components	O	O
promoting	O	O
aggregation	O	O
of	O	O
oral	O	O
bacteria	O	O
are	O	O
considered	O	O
to	O	O
be	O	O
part	O	O
of	O	O
the	O	O
oral	O	O
defense	O	O
mechanisms	O	O
so	O	O
these	O	O
findings	O	O
provide	O	O
insight	O	O
into	O	O
a	O	O
possible	O	O
function	O	O
of	O	O
mPIP	O	O
in	O	O
host	O	O
defense	O	O
by	O	O
promoting	O	O
aggregation	O	O
of	O	O
oral	O	O
bacteria	O	O
.	O	O

Weak	O	O
oral	O	O
bacteria	O	O
,	O	O
such	O	O
as	O	O
periodontal	O	O
bacteria	O	O
,	O	O
have	O	O
been	O	O
found	O	O
in	O	O
various	O	O
vascular	O	O
lesions	O	O
,	O	O
including	O	O
atheroma	O	O
,	O	O
the	O	O
thrombus	O	O
of	O	O
the	O	O
occluded	O	O
artery	O	O
of	O	O
Buerger	O	O
's	O	O
disease	O	O
,	O	O
the	O	O
abdominal	O	O
aortic	O	O
aneurismal	O	O
wall	O	O
and	O	O
varicose	O	O
veins	O	O
.	O	O

Serum	O	O
titer	O	O
levels	O	O
of	O	O
each	O	O
bacterium	O	O
are	O	O
now	O	O
available	O	O
and	O	O
have	O	O
shown	O	O
a	O	O
significant	O	O
relationship	O	O
between	O	O
severity	O	O
and	O	O
individual	O	O
differences	O	O
.	O	O

The	O	O
Medline	O	O
and	O	O
Tokyo	O	O
Medical	O	O
and	O	O
Dental	O	O
University	O	O
databases	O	O
were	O	O
searched	O	O
to	O	O
identify	O	O
the	O	O
literature	O	O
currently	O	O
available	O	O
on	O	O
oral	O	O
bacteria	O	O
and	O	O
vascular	O	O
diseases	O	O
.	O	O

It	O	O
is	O	O
estimated	O	O
that	O	O
lymph	B-bacteria	B-bacteria
vessel	I-bacteria	I-bacteria
openings	I-bacteria	I-bacteria
trap	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
en	O	O
route	O	O
from	O	O
the	O	O
mouth	O	O
to	O	O
the	O	O
bloodstream	O	O
and	O	O
then	O	O
carry	O	O
them	O	O
to	O	O
the	O	O
vein	O	O
of	O	O
the	O	O
venous	O	O
angle	O	O
near	O	O
the	O	O
supraclavicular	O	O
area	O	O
.	O	O

In	O	O
the	O	O
case	O	O
of	O	O
periodontal	O	O
bacteria	O	O
,	O	O
a	O	O
typical	O	O
bacterium	O	O
,	O	O
such	O	O
as	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
strongly	O	O
activates	O	O
platelets	O	O
and	O	O
makes	O	O
them	O	O
mass	O	O
,	O	O
including	O	O
the	O	O
bacteria	O	O
without	O	O
phagocytosis	O	O
.	O	O

Simultaneously	O	O
,	O	O
cytokines	O	O
and	O	O
serotonin	O	O
are	O	O
discharged	O	O
.	O	O

Platelet	O	O
engulfment	O	O
was	O	O
clearly	O	O
demonstrated	O	O
by	O	O
electron	O	O
microscopy	O	O
analysis	O	O
.	O	O

An	O	O
animal	O	O
study	O	O
using	O	O
rats	O	O
showed	O	O
the	O	O
formation	O	O
of	O	O
a	O	O
small	O	O
arterial	O	O
thrombus	O	O
after	O	O
continuous	O	O
intravenous	O	O
infusion	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
for	O	O
2-4	O	O
wk	O	O
.	O	O

Weak	O	O
oral	O	O
bacteria	O	O
,	O	O
such	O	O
as	O	O
periodontal	O	O
bacteria	O	O
,	O	O
may	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
development	O	O
of	O	O
various	O	O
vascular	O	O
diseases	O	O
,	O	O
such	O	O
as	O	O
Buerger	O	O
's	O	O
disease	O	O
,	O	O
atherosclerosis	O	O
and	O	O
varicose	O	O
veins	O	O
,	O	O
through	O	O
bacteremia	O	O
.	O	O

Dental	O	O
caries	O	O
disproportionately	O	O
affects	O	O
disadvantaged	O	O
subjects	O	O
.	O	O

This	O	O
study	O	O
hypothesized	O	O
that	O	O
there	O	O
were	O	O
greater	O	O
caries	O	O
extent	O	O
and	O	O
higher	O	O
levels	O	O
of	O	O
caries-associated	O	O
and	O	O
anaerobic	B-bacteria	B-bacteria
subgingival	I-bacteria	I-bacteria
bacterial	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
in	O	O
oral	O	O
samples	O	O
of	O	O
Hispanic	O	O
and	O	O
immigrant	O	O
children	O	O
compared	O	O
with	O	O
non-Hispanic	O	O
and	O	O
US	O	O
born	O	O
children	O	O
.	O	O

Children	O	O
from	O	O
a	O	O
school-based	O	O
dental	O	O
clinic	O	O
serving	O	O
a	O	O
community	O	O
with	O	O
a	O	O
large	O	O
Hispanic	O	O
component	O	O
were	O	O
examined	O	O
,	O	O
and	O	O
the	O	O
extent	O	O
of	O	O
caries	O	O
was	O	O
recorded	O	O
.	O	O

Microbial	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
teeth	O	O
and	O	O
the	O	O
tongues	O	O
of	O	O
children	O	O
.	O	O

Samples	O	O
were	O	O
analyzed	O	O
using	O	O
DNA	O	O
probes	O	O
to	O	O
18	O	O
oral	O	O
bacterial	O	O
species	O	O
.	O	O

Seventy	O	O
five	O	O
children	O	O
were	O	O
examined	O	O
.	O	O

Extent	O	O
of	O	O
caries	O	O
increased	O	O
with	O	O
child	O	O
age	O	O
in	O	O
immigrant	O	O
,	O	O
but	O	O
not	O	O
in	O	O
US	O	O
born	O	O
or	O	O
Hispanic	O	O
children	O	O
.	O	O

There	O	O
were	O	O
no	O	O
differences	O	O
in	O	O
the	O	O
microbiota	O	O
based	O	O
on	O	O
ethnicity	O	O
or	O	O
whether	O	O
the	O	O
child	O	O
was	O	O
born	O	O
in	O	O
US	O	O
or	O	O
not	O	O
.	O	O

There	O	O
was	O	O
a	O	O
higher	O	O
species	O	O
detection	O	O
frequency	O	O
from	O	O
teeth	O	O
than	O	O
tongue	O	O
samples	O	O
.	O	O

Levels	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
other	O	O
Streptococcus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
increased	O	O
with	O	O
caries	O	O
extent	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
Selenomonas	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
were	O	O
detected	O	O
at	O	O
low	O	O
levels	O	O
in	O	O
these	O	O
children	O	O
.	O	O

We	O	O
conclude	O	O
that	O	O
,	O	O
while	O	O
there	O	O
was	O	O
a	O	O
high	O	O
rate	O	O
of	O	O
dental	O	O
caries	O	O
in	O	O
disadvantaged	O	O
school	O	O
children	O	O
,	O	O
there	O	O
were	O	O
no	O	O
differences	O	O
in	O	O
the	O	O
caries-associated	O	O
microbiota	O	O
,	O	O
including	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
based	O	O
on	O	O
ethnicity	O	O
or	O	O
immigration	O	O
status	O	O
.	O	O

Furthermore	O	O
,	O	O
while	O	O
anaerobic	O	O
subgingival	O	O
,	O	O
periodontal	O	O
pathogens	O	O
were	O	O
also	O	O
detected	O	O
in	O	O
children	O	O
,	O	O
there	O	O
was	O	O
no	O	O
difference	O	O
in	O	O
species	O	O
detection	O	O
based	O	O
on	O	O
ethnicity	O	O
or	O	O
immigration	O	O
status	O	O
.	O	O

Increased	O	O
levels	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
including	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
however	O	O
,	O	O
were	O	O
detected	O	O
with	O	O
high	O	O
caries	O	O
levels	O	O
.	O	O

This	O	O
suggested	O	O
that	O	O
while	O	O
it	O	O
is	O	O
beneficial	O	O
to	O	O
target	O	O
preventive	O	O
and	O	O
treatment	O	O
programs	O	O
to	O	O
disadvantaged	O	O
populations	O	O
,	O	O
there	O	O
is	O	O
likely	O	O
no	O	O
additional	O	O
benefit	O	O
to	O	O
focus	O	O
on	O	O
subgroups	O	O
within	O	O
a	O	O
population	O	O
already	O	O
at	O	O
high	O	O
risk	O	O
for	O	O
dental	O	O
disease	O	O
.	O	O

Human	O	O
odontoblasts	O	O
trigger	O	O
immune	O	O
response	O	O
s	O	O
to	O	O
oral	O	O
bacteria	O	O
that	O	O
invade	O	O
dental	O	O
tissues	O	O
during	O	O
the	O	O
caries	O	O
process	O	O
.	O	O

To	O	O
date	O	O
,	O	O
their	O	O
ability	O	O
to	O	O
regulate	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
nucleotide-binding	O	O
domain	O	O
leucine-rich	O	O
repeat	O	O
containing	O	O
receptor	O	O
NOD2	O	O
when	O	O
challenged	O	O
by	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
is	O	O
unknown	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
NOD2	O	O
expression	O	O
in	O	O
healthy	O	O
and	O	O
inflamed	O	O
human	O	O
dental	O	O
pulps	O	O
challenged	O	O
by	O	O
bacteria	O	O
,	O	O
and	O	O
in	O	O
cultured	O	O
odontoblast-like	O	O
cells	O	O
stimulated	O	O
with	O	O
lipoteichoic	O	O
acid	O	O
(	O	O
LTA	O	O
)	O	O
,	O	O
a	O	O
Toll-like	O	O
receptor	O	O
(	O	O
TLR	O	O
)	O	O
2	O	O
agonist	O	O
which	O	O
is	O	O
specific	O	O
for	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

We	O	O
found	O	O
that	O	O
NOD2	O	O
gene	O	O
expression	O	O
was	O	O
significantly	O	O
up-regulated	O	O
in	O	O
pulps	O	O
with	O	O
acute	O	O
inflammation	O	O
compared	O	O
to	O	O
healthy	O	O
ones	O	O
.	O	O

In	O	O
vitro	O	O
,	O	O
LTA	O	O
augmented	O	O
NOD2	O	O
gene	O	O
expression	O	O
and	O	O
protein	O	O
level	O	O
in	O	O
odontoblast-like	O	O
cells	O	O
.	O	O

The	O	O
increase	O	O
was	O	O
more	O	O
pronounced	O	O
in	O	O
odontoblast-like	O	O
cells	O	O
compared	O	O
to	O	O
dental	O	O
pulp	O	O
fibroblasts	O	O
.	O	O

Blocking	O	O
experiments	O	O
in	O	O
odontoblast-like	O	O
cells	O	O
with	O	O
anti-TLR2	O	O
antibody	O	O
strongly	O	O
reduced	O	O
the	O	O
NOD2	O	O
gene	O	O
expression	O	O
increase	O	O
,	O	O
whereas	O	O
stimulation	O	O
with	O	O
the	O	O
synthetic	O	O
TLR2	O	O
ligand	O	O
Pam	O	O
(	O	O
2	O	O
)	O	O
CSK	O	O
(	O	O
4	O	O
)	O	O
confirmed	O	O
NOD2	O	O
gene	O	O
up-regulation	O	O
following	O	O
TLR2	O	O
engagement	O	O
.	O	O

These	O	O
data	O	O
suggest	O	O
that	O	O
NOD2	O	O
up-regulation	O	O
is	O	O
part	O	O
of	O	O
the	O	O
odontoblast	O	O
immune	O	O
response	O	O
to	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
might	O	O
be	O	O
important	O	O
in	O	O
protecting	O	O
human	O	O
dental	O	O
pulp	O	O
from	O	O
the	O	O
deleterious	O	O
effects	O	O
of	O	O
cariogenic	O	O
pathogens	O	O
.	O	O

Nitrogen-containing	O	O
bisphosphonates	O	O
such	O	O
as	O	O
zoledronic	O	O
acid	O	O
(	O	O
ZOL	O	O
)	O	O
and	O	O
pamidronate	O	O
have	O	O
been	O	O
widely	O	O
and	O	O
successfully	O	O
used	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
cancer	O	O
patients	O	O
with	O	O
bone	O	O
metastases	O	O
and/or	O	O
hypercalcemia	O	O
.	O	O

Accumulating	O	O
recent	O	O
reports	O	O
have	O	O
shown	O	O
that	O	O
cancer	O	O
patients	O	O
who	O	O
have	O	O
received	O	O
these	O	O
bisphosphonates	O	O
occasionally	O	O
manifest	O	O
bisphosphonate-related	O	O
osteonecrosis	O	O
of	O	O
the	O	O
jaw	O	O
(	O	O
BRONJ	O	O
)	O	O
following	O	O
dental	O	O
treatments	O	O
,	O	O
including	O	O
tooth	O	O
extraction	O	O
.	O	O

However	O	O
,	O	O
little	O	O
is	O	O
known	O	O
about	O	O
the	O	O
pathogenesis	O	O
of	O	O
BRONJ	O	O
to	O	O
date	O	O
.	O	O

Here	O	O
,	O	O
to	O	O
understand	O	O
the	O	O
underlying	O	O
pathogenesis	O	O
of	O	O
BRONJ	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
effects	O	O
of	O	O
ZOL	O	O
on	O	O
wound	O	O
healing	O	O
of	O	O
the	O	O
tooth	O	O
extraction	O	O
socket	O	O
using	O	O
a	O	O
mouse	O	O
tooth	O	O
extraction	O	O
model	O	O
.	O	O

Histomorphometrical	O	O
analysis	O	O
revealed	O	O
that	O	O
the	O	O
amount	O	O
of	O	O
new	O	O
bone	O	O
and	O	O
the	O	O
numbers	O	O
of	O	O
blood	O	O
vessels	O	O
in	O	O
the	O	O
socket	O	O
were	O	O
significantly	O	O
decreased	O	O
in	O	O
ZOL-treated	O	O
mice	O	O
compared	O	O
to	O	O
control	O	O
mice	O	O
.	O	O

Consistent	O	O
with	O	O
these	O	O
results	O	O
,	O	O
ZOL	O	O
significantly	O	O
inhibited	O	O
angiogenesis	O	O
induced	O	O
by	O	O
vascular	O	O
endothelial	O	O
growth	O	O
factor	O	O
in	O	O
vivo	O	O
and	O	O
the	O	O
proliferation	O	O
of	O	O
endothelial	O	O
cells	O	O
in	O	O
culture	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
etidronate	O	O
,	O	O
a	O	O
non-nitrogen-containing	O	O
bisphosphonate	O	O
,	O	O
showed	O	O
no	O	O
effects	O	O
on	O	O
osteogenesis	O	O
and	O	O
angiogenesis	O	O
in	O	O
the	O	O
socket	O	O
.	O	O

ZOL	O	O
also	O	O
suppressed	O	O
the	O	O
migration	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
,	O	O
which	O	O
is	O	O
a	O	O
crucial	O	O
step	O	O
for	O	O
tooth	O	O
socket	O	O
closure	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
ZOL	O	O
promoted	O	O
the	O	O
adherence	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
to	O	O
hydroxyapatite	O	O
and	O	O
the	O	O
proliferation	O	O
of	O	O
oral	O	O
bacteria	O	O
obtained	O	O
from	O	O
healthy	O	O
individuals	O	O
,	O	O
suggesting	O	O
that	O	O
ZOL	O	O
may	O	O
increase	O	O
the	O	O
bacterial	O	O
infection	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
our	O	O
data	O	O
suggest	O	O
that	O	O
ZOL	O	O
delays	O	O
wound	O	O
healing	O	O
of	O	O
the	O	O
tooth	O	O
extraction	O	O
socket	O	O
by	O	O
inhibiting	O	O
osteogenesis	O	O
and	O	O
angiogenesis	O	O
.	O	O

Our	O	O
data	O	O
also	O	O
suggest	O	O
that	O	O
ZOL	O	O
alters	O	O
oral	O	O
bacterial	O	O
behaviors	O	O
.	O	O

These	O	O
actions	O	O
of	O	O
ZOL	O	O
may	O	O
be	O	O
relevant	O	O
to	O	O
the	O	O
pathogenesis	O	O
of	O	O
BRONJ	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
10	O	O
%	O	O
and	O	O
37	O	O
%	O	O
carbamide	O	O
peroxide	O	O
during	O	O
dental	O	O
bleaching	O	O
in	O	O
three	O	O
different	O	O
modes	O	O
.	O	O

This	O	O
five-week	O	O
double-blind	O	O
randomized	O	O
controlled	O	O
trial	O	O
included	O	O
32	O	O
volunteers	O	O
assigned	O	O
to	O	O
four	O	O
groups	O	O
(	O	O
n	O	O
=	O	O
8	O	O
)	O	O
.	O	O

Each	O	O
group	O	O
received	O	O
bleaching	O	O
agents	O	O
or	O	O
placebo	O	O
as	O	O
an	O	O
in-office	O	O
and	O	O
at-home	O	O
treatment	O	O
.	O	O

The	O	O
dental	O	O
bleaching	O	O
techniques	O	O
were	O	O
:	O	O
In-office	O	O
bleaching	O	O
(	O	O
37	O	O
%	O	O
carbamide	O	O
peroxide	O	O
:	O	O
CP37	O	O
)	O	O
;	O	O
at-home	O	O
bleaching	O	O
(	O	O
10	O	O
%	O	O
carbamide	O	O
peroxide	O	O
:	O	O
CP10	O	O
)	O	O
and	O	O
the	O	O
association	O	O
of	O	O
both	O	O
(	O	O
CP37	O	O
and	O	O
CP10	O	O
)	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
right	O	O
before	O	O
(	O	O
baseline	O	O
)	O	O
,	O	O
right	O	O
after	O	O
,	O	O
12	O	O
hours	O	O
after	O	O
,	O	O
and	O	O
seven	O	O
days	O	O
after	O	O
the	O	O
treatment	O	O
.	O	O

Counts	O	O
of	O	O
total	O	O
microorganisms	O	O
,	O	O
Streptococci	B-bacteria	B-bacteria
,	O	O
and	O	O
Mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
carried	O	O
out	O	O
.	O	O

Friedman	O	O
test	O	O
(	O	O
alpha	O	O
=	O	O
0.05	O	O
)	O	O
was	O	O
used	O	O
to	O	O
compare	O	O
the	O	O
microorganism	O	O
counts	O	O
.	O	O

The	O	O
number	O	O
of	O	O
the	O	O
all	O	O
oral	O	O
microorganisms	O	O
remained	O	O
stable	O	O
during	O	O
all	O	O
experiment	O	O
.	O	O

No	O	O
bleaching	O	O
agent	O	O
(	O	O
CP37	O	O
,	O	O
CP10	O	O
or	O	O
the	O	O
combination	O	O
of	O	O
both	O	O
)	O	O
was	O	O
able	O	O
to	O	O
reduce	O	O
the	O	O
oral	O	O
microorganisms	O	O
tested	O	O
.	O	O

Hydrogen	O	O
sulfide	O	O
is	O	O
one	O	O
of	O	O
the	O	O
predominant	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSCs	O	O
)	O	O
produced	O	O
by	O	O
oral	O	O
bacteria	B-bacteria	B-bacteria
.	O	O

This	O	O
study	O	O
developed	O	O
and	O	O
evaluated	O	O
a	O	O
system	O	O
for	O	O
detecting	O	O
hydrogen	O	O
sulfide	O	O
production	O	O
by	O	O
oral	O	O
bacteria	O	O
.	O	O

L-methionine-alpha-deamino-gamma-mercaptomethane-lyase	O	O
(	O	O
METase	O	O
)	O	O
and	O	O
beta	O	O
carbon-sulfur	O	O
(	O	O
beta	O	O
C-S	O	O
)	O	O
lyase	O	O
were	O	O
used	O	O
to	O	O
degrade	O	O
homocysteine	O	O
and	O	O
cysteine	O	O
,	O	O
respectively	O	O
,	O	O
to	O	O
produce	O	O
hydrogen	O	O
sulfide	O	O
.	O	O

Enzymatic	O	O
reactions	O	O
resulting	O	O
in	O	O
hydrogen	O	O
sulfide	O	O
production	O	O
were	O	O
assayed	O	O
by	O	O
reaction	O	O
with	O	O
bismuth	O	O
trichloride	O	O
,	O	O
which	O	O
forms	O	O
a	O	O
black	O	O
precipitate	O	O
when	O	O
mixed	O	O
with	O	O
hydrogen	O	O
sulfide	O	O
.	O	O

The	O	O
enzymatic	O	O
activities	O	O
of	O	O
various	O	O
oral	O	O
bacteria	O	O
that	O	O
result	O	O
in	O	O
hydrogen	O	O
sulfide	O	O
production	O	O
and	O	O
the	O	O
capacity	O	O
of	O	O
bacteria	O	O
from	O	O
periodontal	O	O
sites	O	O
to	O	O
form	O	O
hydrogen	O	O
sulfide	O	O
in	O	O
reaction	O	O
mixtures	O	O
containing	O	O
L-cysteine	O	O
or	O	O
DL-homocysteine	O	O
were	O	O
assayed	O	O
.	O	O

With	O	O
L-cysteine	O	O
as	O	O
the	O	O
substrate	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
anginosus	I-bacteria	I-bacteria
FW73	E-bacteria	I-bacteria
produced	O	O
the	O	O
most	O	O
hydrogen	O	O
sulfide	O	O
,	O	O
whereas	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
American	I-bacteria	I-bacteria
Type	I-bacteria	I-bacteria
Culture	I-bacteria	I-bacteria
Collection	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
33277	E-bacteria	I-bacteria
and	O	O
W83	B-bacteria	B-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
10953	E-bacteria	I-bacteria
produced	O	O
approximately	O	O
35	O	O
%	O	O
of	O	O
the	O	O
amount	O	O
produced	O	O
by	O	O
the	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
strains	O	O
.	O	O

Finally	O	O
,	O	O
the	O	O
hydrogen	O	O
sulfide	O	O
found	O	O
in	O	O
subgingival	O	O
plaque	O	O
was	O	O
analyzed	O	O
.	O	O

Using	O	O
bismuth	O	O
trichloride	O	O
,	O	O
the	O	O
hydrogen	O	O
sulfide	O	O
produced	O	O
by	O	O
oral	O	O
bacteria	O	O
was	O	O
visually	O	O
detectable	O	O
as	O	O
a	O	O
black	O	O
precipitate	O	O
.	O	O

Hydrogen	O	O
sulfide	O	O
production	O	O
by	O	O
oral	O	O
bacteria	O	O
was	O	O
easily	O	O
analyzed	O	O
using	O	O
bismuth	O	O
trichloride	O	O
.	O	O

However	O	O
,	O	O
further	O	O
innovation	O	O
is	O	O
required	O	O
for	O	O
practical	O	O
use	O	O
.	O	O

To	O	O
investigate	O	O
if	O	O
oral	O	O
health	O	O
parameters	O	O
were	O	O
impaired	O	O
in	O	O
patients	O	O
with	O	O
myocardial	O	O
infarction	O	O
(	O	O
MI	O	O
)	O	O
and	O	O
if	O	O
there	O	O
was	O	O
an	O	O
association	O	O
with	O	O
serum	O	O
antibody	O	O
levels	O	O
against	O	O
the	O	O
periodontal	O	O
pathogens	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
Pg	B-bacteria	B-bacteria
)	O	O
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
Aa	B-bacteria	B-bacteria
)	O	O
.	O	O

A	O	O
case-control	O	O
study	O	O
consisting	O	O
of	O	O
100	O	O
patients	O	O
with	O	O
MI	O	O
and	O	O
100	O	O
age-	O	O
and	O	O
sex-matched	O	O
controls	O	O
from	O	O
the	O	O
same	O	O
geographic	O	O
area	O	O
was	O	O
investigated	O	O
regarding	O	O
oral	O	O
health	O	O
.	O	O

The	O	O
MI	O	O
group	O	O
had	O	O
significantly	O	O
more	O	O
periodontal	O	O
bone	O	O
loss	O	O
(	O	O
PBL	O	O
)	O	O
,	O	O
number	O	O
of	O	O
deepened	O	O
pockets	O	O
(	O	O
NDP	O	O
)	O	O
,	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
(	O	O
BOP	O	O
)	O	O
,	O	O
and	O	O
lower	O	O
number	O	O
of	O	O
teeth	O	O
(	O	O
NT	O	O
)	O	O
than	O	O
the	O	O
controls	O	O
.	O	O

After	O	O
adjustment	O	O
for	O	O
known	O	O
cardiovascular	O	O
risk	O	O
factors	O	O
NT	O	O
,	O	O
BOP	O	O
,	O	O
and	O	O
NDP	O	O
still	O	O
remained	O	O
significantly	O	O
related	O	O
to	O	O
MI	O	O
(	O	O
p=0.014	O	O
,	O	O
p=0.02	O	O
,	O	O
and	O	O
p=0.0069	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

IgG	O	O
antibody	O	O
levels	O	O
against	O	O
Pg	O	O
were	O	O
higher	O	O
in	O	O
subjects	O	O
with	O	O
MI	O	O
(	O	O
p=0.043	O	O
)	O	O
,	O	O
as	O	O
well	O	O
as	O	O
in	O	O
those	O	O
with	O	O
>	O	O
4	O	O
deepened	O	O
pockets	O	O
(	O	O
p=0.05	O	O
)	O	O
,	O	O
BOP	O	O
>	O	O
20	O	O
%	O	O
(	O	O
p=0.001	O	O
)	O	O
and	O	O
PBL	O	O
(	O	O
p=0.0003	O	O
)	O	O
.	O	O

However	O	O
,	O	O
indicating	O	O
a	O	O
causal	O	O
pathway	O	O
,	O	O
the	O	O
relationship	O	O
between	O	O
MI	O	O
and	O	O
Pg	O	O
IgG	O	O
disappeared	O	O
when	O	O
the	O	O
oral	O	O
parameters	O	O
were	O	O
included	O	O
in	O	O
the	O	O
logistic	O	O
regression	O	O
model	O	O
(	O	O
p=0.69	O	O
)	O	O
.	O	O

No	O	O
correlation	O	O
was	O	O
seen	O	O
between	O	O
MI	O	O
and	O	O
Aa	O	O
in	O	O
the	O	O
present	O	O
study	O	O
.	O	O

Patients	O	O
with	O	O
MI	O	O
had	O	O
an	O	O
impaired	O	O
oral	O	O
health	O	O
compared	O	O
to	O	O
controls	O	O
.	O	O

Furthermore	O	O
,	O	O
IgG	O	O
levels	O	O
against	O	O
Pg	O	O
were	O	O
related	O	O
to	O	O
both	O	O
MI	O	O
and	O	O
oral	O	O
health	O	O
,	O	O
suggesting	O	O
this	O	O
pathogen	O	O
as	O	O
a	O	O
possible	O	O
link	O	O
between	O	O
oral	O	O
health	O	O
and	O	O
CVD	O	O
.	O	O

A	O	O
modified	O	O
titanium	O	O
surface	O	O
,	O	O
anodized	O	O
after	O	O
being	O	O
discharged	O	O
in	O	O
electrolytes	O	O
,	O	O
provides	O	O
antibacterial	O	O
activity	O	O
against	O	O
oral	O	O
bacteria	O	O
as	O	O
well	O	O
as	O	O
osteoconductivity	O	O
.	O	O

However	O	O
,	O	O
the	O	O
mechanism	O	O
of	O	O
this	O	O
antibacterial	O	O
effect	O	O
against	O	O
oral	O	O
bacteria	O	O
is	O	O
still	O	O
unclear	O	O
.	O	O

This	O	O
study	O	O
aims	O	O
to	O	O
investigate	O	O
whether	O	O
it	O	O
is	O	O
the	O	O
chloride	O	O
or	O	O
the	O	O
hydrophilicity	O	O
properties	O	O
of	O	O
the	O	O
anodized	O	O
titanium	O	O
,	O	O
which	O	O
is	O	O
effective	O	O
against	O	O
the	O	O
oral	O	O
bacteria	O	O
.	O	O

Titanium	O	O
plates	O	O
are	O	O
anodized	O	O
in	O	O
various	O	O
electrolytes	O	O
with	O	O
or	O	O
without	O	O
chloride	O	O
and	O	O
are	O	O
characterized	O	O
.	O	O

Then	O	O
the	O	O
survival	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
on	O	O
each	O	O
specimen	O	O
is	O	O
evaluated	O	O
.	O	O

The	O	O
results	O	O
demonstrate	O	O
that	O	O
the	O	O
peroxidation	O	O
effects	O	O
of	O	O
HClO	O	O
generated	O	O
from	O	O
the	O	O
TiCl	O	O
(	O	O
3	O	O
)	O	O
formed	O	O
on	O	O
the	O	O
titanium	O	O
surface	O	O
anodized	O	O
in	O	O
various	O	O
chloride	O	O
solutions	O	O
efficiently	O	O
killed	O	O
adherent	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
on	O	O
the	O	O
surface	O	O
whereas	O	O
the	O	O
presence	O	O
of	O	O
hydrophilicity	O	O
alone	O	O
do	O	O
not	O	O
demonstrate	O	O
antibacterial	O	O
activity	O	O
.	O	O

This	O	O
method	O	O
of	O	O
anodizing	O	O
titanium	O	O
surface	O	O
in	O	O
a	O	O
chloride	O	O
solution	O	O
may	O	O
provide	O	O
a	O	O
novel	O	O
strategy	O	O
for	O	O
use	O	O
in	O	O
orthopedic	O	O
or	O	O
dental	O	O
implant	O	O
systems	O	O
.	O	O

To	O	O
monitor	O	O
the	O	O
intra-oral	O	O
microbiological	O	O
changes	O	O
after	O	O
full-mouth	O	O
extraction	O	O
using	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
qPCR	O	O
)	O	O
.	O	O

Nine	O	O
patients	O	O
with	O	O
severe	O	O
,	O	O
aggressive	O	O
periodontitis	O	O
,	O	O
for	O	O
whom	O	O
a	O	O
full-mouth	O	O
tooth	O	O
extraction	O	O
was	O	O
the	O	O
only	O	O
remaining	O	O
treatment	O	O
option	O	O
were	O	O
recruited	O	O
.	O	O

Before	O	O
and	O	O
6	O	O
months	O	O
after	O	O
extraction	O	O
,	O	O
microbial	O	O
samples	O	O
were	O	O
obtained	O	O
(	O	O
tongue	O	O
,	O	O
saliva	O	O
and	O	O
subgingival	O	O
plaque	O	O
)	O	O
and	O	O
analysed	O	O
by	O	O
qPCR	O	O
.	O	O

The	O	O
elimination	O	O
of	O	O
subgingival	O	O
niches	O	O
,	O	O
by	O	O
extraction	O	O
of	O	O
all	O	O
natural	O	O
teeth	O	O
,	O	O
resulted	O	O
in	O	O
a	O	O
3-log	O	O
reduction	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
more	O	O
modest	O	O
reductions	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
the	O	O
detection	O	O
frequencies	O	O
of	O	O
these	O	O
periodontopathogens	O	O
in	O	O
saliva	O	O
and	O	O
on	O	O
the	O	O
tongue	O	O
remained	O	O
unchanged	O	O
after	O	O
full-mouth	O	O
tooth	O	O
extraction	O	O
.	O	O

In	O	O
contrast	O	O
to	O	O
what	O	O
has	O	O
been	O	O
believed	O	O
so	O	O
far	O	O
,	O	O
full-mouth	O	O
tooth	O	O
extraction	O	O
does	O	O
not	O	O
result	O	O
in	O	O
eradication	O	O
of	O	O
all	O	O
periodontopathogens	O	O
but	O	O
only	O	O
in	O	O
a	O	O
significant	O	O
reduction	O	O
.	O	O

The	O	O
clinical	O	O
consequences	O	O
of	O	O
this	O	O
observation	O	O
remain	O	O
speculative	O	O
.	O	O

Hydrogen	O	O
sulfide	O	O
(	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
)	O	O
,	O	O
a	O	O
volatile	O	O
sulfur	O	O
compound	O	O
,	O	O
is	O	O
implicated	O	O
as	O	O
a	O	O
cause	O	O
of	O	O
inflammation	O	O
,	O	O
especially	O	O
when	O	O
it	O	O
is	O	O
produced	O	O
by	O	O
bacteria	O	O
colonizing	O	O
gastrointestinal	O	O
organs	O	O
.	O	O

However	O	O
,	O	O
it	O	O
is	O	O
unclear	O	O
if	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
produced	O	O
by	O	O
periodontal	O	O
pathogens	O	O
affects	O	O
the	O	O
inflammatory	O	O
responses	O	O
mediated	O	O
by	O	O
oral/gingival	O	O
epithelial	O	O
cells	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
were	O	O
(	O	O
1	O	O
)	O	O
to	O	O
compare	O	O
the	O	O
in	O	O
vitro	O	O
production	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
among	O	O
14	O	O
strains	O	O
of	O	O
oral	O	O
bacteria	O	O
and	O	O
(	O	O
2	O	O
)	O	O
to	O	O
evaluate	O	O
the	O	O
effects	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
on	O	O
inflammatory	O	O
response	O	O
induced	O	O
in	O	O
host	O	O
oral/gingival	O	O
epithelial	O	O
cells	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
Pg	B-bacteria	B-bacteria
)	O	O
produced	O	O
the	O	O
most	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
in	O	O
culture	O	O
,	O	O
which	O	O
,	O	O
in	O	O
turn	O	O
,	O	O
resulted	O	O
in	O	O
the	O	O
promotion	O	O
of	O	O
proinflammatory	O	O
cytokine	O	O
IL-8	O	O
from	O	O
both	O	O
gingival	O	O
and	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
up-regulation	O	O
of	O	O
IL-8	O	O
expression	O	O
was	O	O
reproduced	O	O
by	O	O
the	O	O
exogenously	O	O
applied	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S.	O	O
Furthermore	O	O
,	O	O
the	O	O
mutant	O	O
strains	O	O
of	O	O
Pg	B-bacteria	B-bacteria
that	O	O
do	O	O
not	O	O
produce	O	O
major	O	O
soluble	O	O
virulent	O	O
factors	O	O
,	O	O
i.e	O	O
.	O	O

gingipains	O	O
,	O	O
still	O	O
showed	O	O
the	O	O
production	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
promotion	O	O
of	O	O
epithelial	O	O
IL-8	O	O
production	O	O
,	O	O
which	O	O
was	O	O
abrogated	O	O
by	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
scavenging	O	O
reagents	O	O
.	O	O

These	O	O
results	O	O
demonstrated	O	O
that	O	O
Pg	B-bacteria	B-bacteria
produces	O	O
a	O	O
concentration	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
capable	O	O
of	O	O
up-regulating	O	O
IL-8	O	O
expression	O	O
induced	O	O
in	O	O
gingival	O	O
and	O	O
oral	O	O
epithelial	O	O
cells	O	O
,	O	O
revealing	O	O
a	O	O
possible	O	O
mechanism	O	O
that	O	O
may	O	O
promote	O	O
the	O	O
inflammation	O	O
in	O	O
periodontal	O	O
disease	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
correlate	O	O
the	O	O
presence	O	O
of	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
,	O	O
Pseudomonadaceae	B-bacteria	B-bacteria
,	O	O
Moraxellaceae	B-bacteria	B-bacteria
and	O	O
Xanthomonadaceae	B-bacteria	B-bacteria
on	O	O
the	O	O
posterior	O	O
dorsum	O	O
of	O	O
the	O	O
human	O	O
tongue	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
tongue	O	O
coating	O	O
,	O	O
gender	O	O
,	O	O
age	O	O
,	O	O
smoking	O	O
habit	O	O
and	O	O
denture	O	O
use	O	O
.	O	O

Bacteria	O	O
were	O	O
isolated	O	O
from	O	O
the	O	O
posterior	O	O
tongue	O	O
dorsum	O	O
of	O	O
100	O	O
individuals	O	O
in	O	O
MacConkey	O	O
agar	O	O
medium	O	O
and	O	O
were	O	O
identified	O	O
by	O	O
the	O	O
API	O	O
20E	O	O
system	O	O
(	O	O
Biolab-Merieux	O	O
)	O	O
.	O	O

43	O	O
%	O	O
of	O	O
the	O	O
individuals	O	O
,	O	O
presented	O	O
the	O	O
target	O	O
microorganisms	O	O
on	O	O
the	O	O
tongue	O	O
dorsum	O	O
,	O	O
with	O	O
greater	O	O
prevalence	O	O
among	O	O
individuals	O	O
between	O	O
40	O	O
and	O	O
50	O	O
years	O	O
of	O	O
age	O	O
(	O	O
p	O	O
=	O	O
0.001	O	O
)	O	O
and	O	O
non-smokers	O	O
(	O	O
p=0.0485	O	O
)	O	O
.	O	O

A	O	O
higher	O	O
prevalence	O	O
of	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
and	O	O
Pseudomonadaceae	B-bacteria	B-bacteria
was	O	O
observed	O	O
on	O	O
the	O	O
tongue	O	O
dorsum	O	O
of	O	O
the	O	O
individuals	O	O
evaluated	O	O
.	O	O

There	O	O
was	O	O
no	O	O
correlation	O	O
between	O	O
these	O	O
species	O	O
and	O	O
the	O	O
presence	O	O
and	O	O
thickness	O	O
of	O	O
tongue	O	O
coating	O	O
,	O	O
gender	O	O
and	O	O
presence	O	O
of	O	O
dentures	O	O
.	O	O

The	O	O
incidence	O	O
of	O	O
potential	O	O
periodontal	O	O
pathogens	O	O
(	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
formerly	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
ochracea	E-bacteria	I-bacteria
)	O	O
was	O	O
monitored	O	O
in	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
and	O	O
in	O	O
healthy	O	O
control	O	O
subjects	O	O
.	O	O

Two	O	O
types	O	O
of	O	O
studies	O	O
were	O	O
carried	O	O
out	O	O
in	O	O
which	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
bacterial	O	O
communities	O	O
in	O	O
different	O	O
niches	O	O
of	O	O
the	O	O
same	O	O
oral	O	O
cavity	O	O
ecosystem	O	O
was	O	O
investigated	O	O
.	O	O

Fluctuation	O	O
or	O	O
at	O	O
least	O	O
pronounced	O	O
quantitative	O	O
changes	O	O
in	O	O
the	O	O
incidence	O	O
of	O	O
individual	O	O
species	O	O
in	O	O
time	O	O
were	O	O
documented	O	O
in	O	O
the	O	O
long-term	O	O
study	O	O
as	O	O
well	O	O
as	O	O
after	O	O
the	O	O
local	O	O
administration	O	O
of	O	O
antibacterial	O	O
drug	O	O
Chlo-Site	O	O
or	O	O
Metronidazole	O	O
.	O	O

Even	O	O
within	O	O
two	O	O
weeks	O	O
,	O	O
a	O	O
turnover	O	O
of	O	O
the	O	O
monitored	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
separate	O	O
niches	O	O
of	O	O
the	O	O
oral	O	O
biotope	O	O
can	O	O
be	O	O
detected	O	O
.	O	O

A	O	O
relatively	O	O
high	O	O
incidence	O	O
of	O	O
the	O	O
tested	O	O
periopathogens	O	O
in	O	O
the	O	O
clinically	O	O
healthy	O	O
teeth	O	O
of	O	O
patients	O	O
implies	O	O
that	O	O
even	O	O
the	O	O
``	O	O
healthy	O	O
''	O	O
niches	O	O
in	O	O
the	O	O
periodontal	O	O
biotope	O	O
function	O	O
as	O	O
a	O	O
dynamic	O	O
reservoir	O	O
of	O	O
periopathogenic	O	O
microorganisms	O	O
.	O	O

This	O	O
should	O	O
be	O	O
kept	O	O
in	O	O
mind	O	O
when	O	O
a	O	O
local	O	O
application	O	O
of	O	O
antibacterial	O	O
compounds	O	O
is	O	O
used	O	O
in	O	O
the	O	O
therapy	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

To	O	O
assess	O	O
the	O	O
prevalence	O	O
of	O	O
oral	O	O
colonisation	O	O
by	O	O
bacterial	O	O
respiratory	O	O
pathogens	O	O
in	O	O
hospitalised	O	O
patients	O	O
.	O	O

Thirty	O	O
patients	O	O
undergoing	O	O
myocardium	O	O
revascularisation	O	O
surgery	O	O
were	O	O
evaluated	O	O
.	O	O

At	O	O
baseline	O	O
(	O	O
pre-operative	O	O
phase	O	O
)	O	O
,	O	O
full-mouth	O	O
clinical	O	O
periodontal	O	O
assessment	O	O
was	O	O
performed	O	O
.	O	O

Saliva	O	O
and	O	O
biofilm	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
subjects	O	O
at	O	O
baseline	O	O
and	O	O
at	O	O
the	O	O
post-operative	O	O
phase	O	O
,	O	O
after	O	O
orotracheal	O	O
extubation	O	O
.	O	O

DNA	O	O
was	O	O
extracted	O	O
from	O	O
samples	O	O
and	O	O
species	O	O
of	O	O
Acinetobacter	B-bacteria	B-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	O	O
and	O	O
Dialister	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
were	O	O
detected	O	O
by	O	O
PCR	O	O
or	O	O
culture	O	O
(	O	O
for	O	O
staphylococci	B-bacteria	B-bacteria
isolates	O	O
)	O	O
.	O	O

Most	O	O
of	O	O
the	O	O
subjects	O	O
were	O	O
males	O	O
,	O	O
with	O	O
history	O	O
of	O	O
hypertension	O	O
and	O	O
smoking	O	O
.	O	O

Thirteen	O	O
were	O	O
edentulous	O	O
(	O	O
ED	O	O
)	O	O
and	O	O
17	O	O
were	O	O
dentate	O	O
(	O	O
DE	O	O
)	O	O
,	O	O
with	O	O
moderate	O	O
chronic	O	O
periodontitis	O	O
.	O	O

The	O	O
most	O	O
prevalent	O	O
bacteria	O	O
in	O	O
saliva	O	O
were	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
85.7	O	O
%	O	O
)	O	O
,	O	O
Pseudomonas	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
83.8	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Acinetobacter	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
53.3	O	O
%	O	O
)	O	O
.	O	O

There	O	O
was	O	O
a	O	O
trend	O	O
for	O	O
D.	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
to	O	O
be	O	O
more	O	O
frequently	O	O
detected	O	O
in	O	O
DE	O	O
(	O	O
43.7	O	O
%	O	O
)	O	O
than	O	O
ED	O	O
(	O	O
11.5	O	O
%	O	O
)	O	O
patients	O	O
.	O	O

In	O	O
plaque	O	O
samples	O	O
,	O	O
DE	O	O
with	O	O
>	O	O
14	O	O
teeth	O	O
showed	O	O
a	O	O
higher	O	O
prevalence	O	O
of	O	O
Pseudomonas	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
100	O	O
%	O	O
)	O	O
than	O	O
individuals	O	O
with	O	O
<	O	O
or	O	O
=14	O	O
teeth	O	O
(	O	O
69.1	O	O
%	O	O
;	O	O
p=0.048	O	O
)	O	O
.	O	O

Conversely	O	O
,	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
was	O	O
more	O	O
prevalent	O	O
in	O	O
subjects	O	O
with	O	O
fewer	O	O
teeth	O	O
(	O	O
35.5	O	O
%	O	O
)	O	O
than	O	O
with	O	O
>	O	O
14	O	O
teeth	O	O
(	O	O
5.7	O	O
%	O	O
;	O	O
p=0.037	O	O
)	O	O
.	O	O

All	O	O
staphylococci	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
were	O	O
coagulase-negative	O	O
,	O	O
and	O	O
about	O	O
11	O	O
%	O	O
were	O	O
positive	O	O
for	O	O
the	O	O
mecA	O	O
gene	O	O
.	O	O

These	O	O
mecA-positive	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
showed	O	O
a	O	O
tendency	O	O
to	O	O
increase	O	O
in	O	O
all	O	O
samples	O	O
,	O	O
whereas	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
reduced	O	O
after	O	O
surgery	O	O
.	O	O

A	O	O
strong	O	O
correlation	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
Acinetobacter	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Pseudomonas	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

was	O	O
observed	O	O
(	O	O
rho=0.886	O	O
,	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
of	O	O
hospitalised	O	O
patients	O	O
harbours	O	O
high	O	O
frequencies	O	O
of	O	O
bacterial	O	O
respiratory	O	O
pathogens	O	O
,	O	O
supporting	O	O
its	O	O
potential	O	O
role	O	O
as	O	O
a	O	O
reservoir	O	O
for	O	O
these	O	O
species	O	O
.	O	O

Two	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
Gram-stain-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
(	O	O
D033B-12-2	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
D080A-01	B-bacteria	B-bacteria
)	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
and	O	O
were	O	O
found	O	O
to	O	O
be	O	O
distinct	O	O
from	O	O
any	O	O
previously	O	O
described	O	O
species	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
revealed	O	O
that	O	O
the	O	O
strains	O	O
were	O	O
related	O	O
most	O	O
closely	O	O
to	O	O
the	O	O
type	O	O
strain	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
marshii	E-bacteria	I-bacteria
(	O	O
93.5	O	O
%	O	O
sequence	O	O
identity	O	O
)	O	O
.	O	O

The	O	O
novel	O	O
strains	O	O
were	O	O
saccharolytic	O	O
and	O	O
produced	O	O
acetic	O	O
acid	O	O
and	O	O
succinic	O	O
acid	O	O
as	O	O
end	O	O
products	O	O
of	O	O
fermentation	O	O
.	O	O

The	O	O
principal	O	O
cellular	O	O
long-chain	O	O
fatty	O	O
acids	O	O
were	O	O
C	O	O
(	O	O
1	O	O
)	O	O
(	O	O
6	O	O
)	O	O
:	O	O
(	O	O
0	O	O
)	O	O
)	O	O
,	O	O
iso-C	O	O
(	O	O
1	O	O
)	O	O
(	O	O
4	O	O
)	O	O
:	O	O
(	O	O
0	O	O
)	O	O
,	O	O
C	O	O
(	O	O
1	O	O
)	O	O
(	O	O
4	O	O
)	O	O
:	O	O
(	O	O
0	O	O
)	O	O
,	O	O
anteiso-C	O	O
(	O	O
1	O	O
)	O	O
(	O	O
5	O	O
)	O	O
:	O	O
(	O	O
0	O	O
)	O	O
,	O	O
iso-C	O	O
(	O	O
1	O	O
)	O	O
(	O	O
6	O	O
)	O	O
:	O	O
(	O	O
0	O	O
)	O	O
and	O	O
C	O	O
(	O	O
1	O	O
)	O	O
(	O	O
6	O	O
)	O	O
:	O	O
(	O	O
0	O	O
)	O	O
)	O	O
3-OH	O	O
.	O	O

The	O	O
G+C	O	O
content	O	O
of	O	O
the	O	O
DNA	O	O
of	O	O
strain	B-bacteria	B-bacteria
D033B-12-2	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
was	O	O
44	O	O
mol	O	O
%	O	O
.	O	O

Strains	B-bacteria	B-bacteria
D033B-12-2	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
D080A-01	B-bacteria	B-bacteria
are	O	O
considered	O	O
to	O	O
represent	O	O
a	O	O
single	O	O
novel	O	O
species	O	O
of	O	O
the	O	O
genus	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
,	O	O
for	O	O
which	O	O
the	O	O
name	O	O
Prevotella	B-bacteria	B-bacteria
saccharolytica	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
is	O	O
proposed	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
is	O	O
D033B-12-2	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
=DSM	B-bacteria	B-bacteria
22473	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=CCUG	B-bacteria	B-bacteria
57944	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
.	O	O

We	O	O
reported	O	O
previously	O	O
that	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
one	O	O
of	O	O
the	O	O
periodontal	O	O
pathogens	O	O
,	O	O
suppresses	O	O
the	O	O
expression	O	O
of	O	O
human	O	O
beta-defensins	O	O
(	O	O
HBDs	O	O
)	O	O
in	O	O
human	O	O
gingival	O	O
epithelial	O	O
cells	O	O
.	O	O

To	O	O
identify	O	O
the	O	O
mechanisms	O	O
involved	O	O
in	O	O
this	O	O
suppression	O	O
,	O	O
immortalized	O	O
and	O	O
normal	O	O
human	O	O
gingival	O	O
epithelial	O	O
cells	O	O
were	O	O
infected	O	O
with	O	O
live	O	O
or	O	O
heat-killed	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
for	O	O
24	O	O
h	O	O
,	O	O
and	O	O
then	O	O
the	O	O
expression	O	O
of	O	O
HBDs	O	O
was	O	O
examined	O	O
by	O	O
real-time	O	O
RT-PCR	O	O
.	O	O

Live	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
suppressed	O	O
the	O	O
expression	O	O
of	O	O
HBD-3	O	O
substantially	O	O
and	O	O
also	O	O
suppressed	O	O
the	O	O
expression	O	O
of	O	O
HBD-1	O	O
and	O	O
HBD-2	O	O
.	O	O

However	O	O
,	O	O
heat-killed	O	O
bacteria	O	O
did	O	O
not	O	O
produce	O	O
a	O	O
suppressive	O	O
effect	O	O
but	O	O
instead	O	O
slightly	O	O
upregulated	O	O
the	O	O
levels	O	O
of	O	O
HBD-2	O	O
and	O	O
HBD-3	O	O
.	O	O

In	O	O
contrast	O	O
to	O	O
live	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
which	O	O
reduced	O	O
the	O	O
activation	O	O
of	O	O
mitogen-activated	O	O
protein	O	O
kinase	O	O
(	O	O
MAPK	O	O
)	O	O
and	O	O
NF-kappaB	O	O
within	O	O
an	O	O
hour	O	O
of	O	O
infection	O	O
,	O	O
heat-killed	O	O
bacteria	O	O
did	O	O
not	O	O
show	O	O
any	O	O
inhibitory	O	O
effect	O	O
on	O	O
the	O	O
MAPK	O	O
and	O	O
NF-kappaB	O	O
signaling	O	O
pathways	O	O
.	O	O

Knockdown	O	O
of	O	O
Toll-like	O	O
receptor	O	O
2	O	O
(	O	O
TLR2	O	O
)	O	O
via	O	O
RNA	O	O
interference	O	O
abolished	O	O
the	O	O
suppressive	O	O
effect	O	O
of	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
on	O	O
the	O	O
expression	O	O
of	O	O
HBD-3	O	O
.	O	O

Heat-killed	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
but	O	O
not	O	O
live	O	O
bacteria	O	O
could	O	O
activate	O	O
TLR2	O	O
in	O	O
CHO/CD14/TLR2	O	O
reporter	O	O
cells	O	O
,	O	O
suggesting	O	O
that	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
contains	O	O
a	O	O
heat-labile	O	O
inhibitor	O	O
(	O	O
s	O	O
)	O	O
of	O	O
TLR2	O	O
in	O	O
addition	O	O
to	O	O
ligands	O	O
recognized	O	O
by	O	O
TLR2	O	O
.	O	O

Indeed	O	O
,	O	O
live	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
was	O	O
able	O	O
to	O	O
inhibit	O	O
TLR2	O	O
activation	O	O
by	O	O
Pam	O	O
(	O	O
3	O	O
)	O	O
CSK	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
suppressed	O	O
the	O	O
expression	O	O
of	O	O
HBD-3	O	O
by	O	O
inhibiting	O	O
the	O	O
TLR2	O	O
axis	O	O
in	O	O
gingival	O	O
epithelial	O	O
cells	O	O
.	O	O

These	O	O
results	O	O
may	O	O
provide	O	O
new	O	O
insight	O	O
into	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontitis	O	O
caused	O	O
by	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

Most	O	O
studies	O	O
examining	O	O
the	O	O
commensal	O	O
human	O	O
oral	O	O
microbiome	O	O
are	O	O
focused	O	O
on	O	O
disease	O	O
or	O	O
are	O	O
limited	O	O
in	O	O
methodology	O	O
.	O	O

In	O	O
order	O	O
to	O	O
diagnose	O	O
and	O	O
treat	O	O
diseases	O	O
at	O	O
an	O	O
early	O	O
and	O	O
reversible	O	O
stage	O	O
an	O	O
in-depth	O	O
definition	O	O
of	O	O
health	O	O
is	O	O
indispensible	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
therefore	O	O
was	O	O
to	O	O
define	O	O
the	O	O
healthy	O	O
oral	O	O
microbiome	O	O
using	O	O
recent	O	O
advances	O	O
in	O	O
sequencing	O	O
technology	O	O
(	O	O
454	O	O
pyrosequencing	O	O
)	O	O
.	O	O

We	O	O
sampled	O	O
and	O	O
sequenced	O	O
microbiomes	O	O
from	O	O
several	O	O
intraoral	O	O
niches	O	O
(	O	O
dental	O	O
surfaces	O	O
,	O	O
cheek	O	O
,	O	O
hard	O	O
palate	O	O
,	O	O
tongue	O	O
and	O	O
saliva	O	O
)	O	O
in	O	O
three	O	O
healthy	O	O
individuals	O	O
.	O	O

Within	O	O
an	O	O
individual	O	O
oral	O	O
cavity	O	O
,	O	O
we	O	O
found	O	O
over	O	O
3600	O	O
unique	O	O
sequences	O	O
,	O	O
over	O	O
500	O	O
different	O	O
OTUs	O	O
or	O	O
``	O	O
species-level	O	O
''	O	O
phylotypes	O	O
(	O	O
sequences	O	O
that	O	O
clustered	O	O
at	O	O
3	O	O
%	O	O
genetic	O	O
difference	O	O
)	O	O
and	O	O
88	O	O
-	O	O
104	O	O
higher	O	O
taxa	O	O
(	O	O
genus	O	O
or	O	O
more	O	O
inclusive	O	O
taxon	O	O
)	O	O
.	O	O

The	O	O
predominant	O	O
taxa	O	O
belonged	O	O
to	O	O
Firmicutes	B-bacteria	B-bacteria
(	O	O
genus	B-bacteria	B-bacteria
Streptococcus	E-bacteria	I-bacteria
,	O	O
family	B-bacteria	B-bacteria
Veillonellaceae	E-bacteria	I-bacteria
,	O	O
genus	B-bacteria	B-bacteria
Granulicatella	E-bacteria	I-bacteria
)	O	O
,	O	O
Proteobacteria	B-bacteria	B-bacteria
(	O	O
genus	B-bacteria	B-bacteria
Neisseria	E-bacteria	I-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
)	O	O
,	O	O
Actinobacteria	B-bacteria	B-bacteria
(	O	O
genus	B-bacteria	B-bacteria
Corynebacterium	E-bacteria	I-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
)	O	O
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
(	O	O
genus	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
)	O	O
and	O	O
Fusobacteria	B-bacteria	B-bacteria
(	O	O
genus	B-bacteria	B-bacteria
Fusobacterium	E-bacteria	I-bacteria
)	O	O
.Each	O	O
individual	O	O
sample	O	O
harboured	O	O
on	O	O
average	O	O
266	O	O
``	O	O
species-level	O	O
''	O	O
phylotypes	O	O
(	O	O
SD	O	O
67	O	O
;	O	O
range	O	O
123	O	O
-	O	O
326	O	O
)	O	O
with	O	O
cheek	O	O
samples	O	O
being	O	O
the	O	O
least	O	O
diverse	O	O
and	O	O
the	O	O
dental	O	O
samples	O	O
from	O	O
approximal	O	O
surfaces	O	O
showing	O	O
the	O	O
highest	O	O
diversity	O	O
.	O	O

Principal	O	O
component	O	O
analysis	O	O
discriminated	O	O
the	O	O
profiles	O	O
of	O	O
the	O	O
samples	O	O
originating	O	O
from	O	O
shedding	O	O
surfaces	O	O
(	O	O
mucosa	O	O
of	O	O
tongue	O	O
,	O	O
cheek	O	O
and	O	O
palate	O	O
)	O	O
from	O	O
the	O	O
samples	O	O
that	O	O
were	O	O
obtained	O	O
from	O	O
solid	O	O
surfaces	O	O
(	O	O
teeth	O	O
)	O	O
.There	O	O
was	O	O
a	O	O
large	O	O
overlap	O	O
in	O	O
the	O	O
higher	O	O
taxa	O	O
,	O	O
``	O	O
species-level	O	O
''	O	O
phylotypes	O	O
and	O	O
unique	O	O
sequences	O	O
among	O	O
the	O	O
three	O	O
microbiomes	O	O
:	O	O
84	O	O
%	O	O
of	O	O
the	O	O
higher	O	O
taxa	O	O
,	O	O
75	O	O
%	O	O
of	O	O
the	O	O
OTUs	O	O
and	O	O
65	O	O
%	O	O
of	O	O
the	O	O
unique	O	O
sequences	O	O
were	O	O
present	O	O
in	O	O
at	O	O
least	O	O
two	O	O
of	O	O
the	O	O
three	O	O
microbiomes	O	O
.	O	O

The	O	O
three	O	O
individuals	O	O
shared	O	O
1660	O	O
of	O	O
6315	O	O
unique	O	O
sequences	O	O
.	O	O

These	O	O
1660	O	O
sequences	O	O
(	O	O
the	O	O
``	O	O
core	O	O
microbiome	O	O
''	O	O
)	O	O
contributed	O	O
66	O	O
%	O	O
of	O	O
the	O	O
reads	O	O
.	O	O

The	O	O
overlapping	O	O
OTUs	O	O
contributed	O	O
to	O	O
94	O	O
%	O	O
of	O	O
the	O	O
reads	O	O
,	O	O
while	O	O
nearly	O	O
all	O	O
reads	O	O
(	O	O
99.8	O	O
%	O	O
)	O	O
belonged	O	O
to	O	O
the	O	O
shared	O	O
higher	O	O
taxa	O	O
.	O	O

We	O	O
obtained	O	O
the	O	O
first	O	O
insight	O	O
into	O	O
the	O	O
diversity	O	O
and	O	O
uniqueness	O	O
of	O	O
individual	O	O
oral	O	O
microbiomes	O	O
at	O	O
a	O	O
resolution	O	O
of	O	O
next-generation	O	O
sequencing	O	O
.	O	O

We	O	O
showed	O	O
that	O	O
a	O	O
major	O	O
proportion	O	O
of	O	O
bacterial	O	O
sequences	O	O
of	O	O
unrelated	O	O
healthy	O	O
individuals	O	O
is	O	O
identical	O	O
,	O	O
supporting	O	O
the	O	O
concept	O	O
of	O	O
a	O	O
core	O	O
microbiome	O	O
at	O	O
health	O	O
.	O	O

This	O	O
study	O	O
identified	O	O
the	O	O
bacterial	O	O
taxa	O	O
enduring	O	O
endodontic	O	O
treatment	O	O
procedures	O	O
by	O	O
using	O	O
a	O	O
combined	O	O
16S	O	O
ribosomal	O	O
RNA-based	O	O
reverse-transcriptase	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
RT-PCR	O	O
)	O	O
and	O	O
reverse-capture	O	O
checkerboard	O	O
hybridization	O	O
approach	O	O
.	O	O

Samples	O	O
were	O	O
taken	O	O
from	O	O
infected	O	O
canals	O	O
of	O	O
15	O	O
teeth	O	O
with	O	O
apical	O	O
periodontitis	O	O
before	O	O
treatment	O	O
(	O	O
S1	O	O
)	O	O
,	O	O
after	O	O
chemomechanical	O	O
preparation	O	O
with	O	O
NaOCl	O	O
as	O	O
the	O	O
irrigant	O	O
(	O	O
S2	O	O
)	O	O
,	O	O
and	O	O
after	O	O
interappointment	O	O
medication	O	O
with	O	O
a	O	O
calcium	O	O
hydroxide	O	O
paste	O	O
(	O	O
S3	O	O
)	O	O
.	O	O

Bacterial	O	O
presence	O	O
was	O	O
first	O	O
screened	O	O
by	O	O
a	O	O
DNA-based	O	O
single	O	O
PCR	O	O
assay	O	O
.	O	O

RNA	O	O
extracts	O	O
were	O	O
subjected	O	O
to	O	O
RT-PCR	O	O
,	O	O
and	O	O
the	O	O
resulting	O	O
products	O	O
were	O	O
surveyed	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
28	O	O
targeted	O	O
taxa	O	O
by	O	O
using	O	O
the	O	O
checkerboard	O	O
method	O	O
.	O	O

Bacteria	O	O
were	O	O
found	O	O
in	O	O
all	O	O
S1	O	O
samples	O	O
.	O	O

Detectable	O	O
levels	O	O
of	O	O
bacterial	O	O
ribosomal	O	O
RNA	O	O
,	O	O
used	O	O
as	O	O
an	O	O
indicator	O	O
of	O	O
viability	O	O
,	O	O
were	O	O
observed	O	O
in	O	O
60	O	O
%	O	O
of	O	O
the	O	O
cases	O	O
after	O	O
chemomechanical	O	O
preparation	O	O
and	O	O
53	O	O
%	O	O
after	O	O
intracanal	O	O
medication	O	O
.	O	O

The	O	O
most	O	O
prevalent	O	O
taxa	O	O
in	O	O
S1	O	O
were	O	O
Olsenella	B-bacteria	B-bacteria
uli	E-bacteria	I-bacteria
(	O	O
67	O	O
%	O	O
)	O	O
,	O	O
Pyramidobacter	B-bacteria	B-bacteria
piscolens	E-bacteria	I-bacteria
(	O	O
60	O	O
%	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
53	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Bacteroidetes	B-bacteria	B-bacteria
clone	I-bacteria	I-bacteria
X083	E-bacteria	I-bacteria
(	O	O
53	O	O
%	O	O
)	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
47	O	O
%	O	O
)	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
40	O	O
%	O	O
)	O	O
,	O	O
and	O	O
O.	B-bacteria	B-bacteria
uli	E-bacteria	I-bacteria
(	O	O
33	O	O
%	O	O
)	O	O
prevailed	O	O
in	O	O
S2	O	O
,	O	O
whereas	O	O
Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
47	O	O
%	O	O
)	O	O
,	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
(	O	O
27	O	O
%	O	O
)	O	O
,	O	O
and	O	O
O.	B-bacteria	B-bacteria
uli	E-bacteria	I-bacteria
(	O	O
27	O	O
%	O	O
)	O	O
were	O	O
the	O	O
most	O	O
frequent	O	O
taxa	O	O
in	O	O
S3	O	O
.	O	O

The	O	O
present	O	O
study	O	O
with	O	O
a	O	O
combined	O	O
molecular	O	O
approach	O	O
revealed	O	O
that	O	O
bacterial	O	O
diversity	O	O
was	O	O
overall	O	O
markedly	O	O
reduced	O	O
by	O	O
treatment	O	O
procedures	O	O
.	O	O

Although	O	O
bacterial	O	O
taxa	O	O
more	O	O
frequently	O	O
identified	O	O
in	O	O
post-treatment	O	O
samples	O	O
emerge	O	O
as	O	O
potential	O	O
risk	O	O
factors	O	O
for	O	O
persistent	O	O
disease	O	O
,	O	O
this	O	O
remains	O	O
to	O	O
be	O	O
determined	O	O
by	O	O
longitudinal	O	O
studies	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
is	O	O
a	O	O
predominant	O	O
bacterium	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
and	O	O
occasionally	O	O
causes	O	O
infective	O	O
endocarditis	O	O
.	O	O

We	O	O
identified	O	O
a	O	O
unique	O	O
cell	O	O
surface	O	O
polymeric	O	O
structure	O	O
named	O	O
pili	O	O
in	O	O
this	O	O
species	O	O
and	O	O
investigated	O	O
its	O	O
functions	O	O
in	O	O
regard	O	O
to	O	O
its	O	O
potential	O	O
virulence	O	O
.	O	O

Pili	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
SK36	E-bacteria	I-bacteria
were	O	O
shown	O	O
to	O	O
be	O	O
composed	O	O
of	O	O
three	O	O
distinctive	O	O
pilus	O	O
proteins	O	O
(	O	O
PilA	O	O
,	O	O
PilB	O	O
,	O	O
and	O	O
PilC	O	O
)	O	O
,	O	O
and	O	O
a	O	O
pili-deficient	O	O
mutant	O	O
demonstrated	O	O
reduced	O	O
bacterial	O	O
adherence	O	O
to	O	O
HeLa	O	O
and	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

PilC	O	O
showed	O	O
a	O	O
binding	O	O
ability	O	O
to	O	O
fibronectin	O	O
,	O	O
suggesting	O	O
that	O	O
pili	O	O
are	O	O
involved	O	O
in	O	O
colonization	O	O
by	O	O
this	O	O
species	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
ATCC10556	B-bacteria	B-bacteria
,	O	O
a	O	O
standard	O	O
S.	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
,	O	O
was	O	O
unable	O	O
to	O	O
produce	O	O
pili	O	O
due	O	O
to	O	O
defective	O	O
pilus	O	O
genes	O	O
,	O	O
which	O	O
indicates	O	O
a	O	O
diversity	O	O
of	O	O
pilus	O	O
expression	O	O
among	O	O
various	O	O
S.	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

Shear-enhanced	O	O
adhesion	O	O
,	O	O
although	O	O
not	O	O
observed	O	O
for	O	O
fimbria-mediated	O	O
adhesion	O	O
of	O	O
oral	O	O
Actinomyces	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
was	O	O
noted	O	O
for	O	O
Hsa-mediated	O	O
adhesion	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
to	O	O
sialic	O	O
acid-containing	O	O
receptors	O	O
,	O	O
an	O	O
interaction	O	O
implicated	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
infective	O	O
endocarditis	O	O
.	O	O

Bifidobacteria	B-bacteria	B-bacteria
,	O	O
one	O	O
of	O	O
the	O	O
relatively	O	O
dominant	O	O
components	O	O
of	O	O
the	O	O
human	O	O
intestinal	O	O
microbiota	O	O
,	O	O
are	O	O
considered	O	O
one	O	O
of	O	O
the	O	O
key	O	O
groups	O	O
of	O	O
beneficial	O	O
intestinal	O	O
bacteria	O	O
(	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
)	O	O
.	O	O

However	O	O
,	O	O
in	O	O
addition	O	O
to	O	O
health-promoting	O	O
taxa	O	O
,	O	O
the	O	O
genus	B-bacteria	B-bacteria
Bifidobacterium	E-bacteria	I-bacteria
also	O	O
includes	O	O
Bifidobacterium	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
,	O	O
an	O	O
opportunistic	O	O
cariogenic	O	O
pathogen	O	O
.	O	O

The	O	O
genetic	O	O
basis	O	O
for	O	O
the	O	O
ability	O	O
of	O	O
B.	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
to	O	O
survive	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
contribute	O	O
to	O	O
caries	O	O
development	O	O
is	O	O
not	O	O
understood	O	O
.	O	O

The	O	O
genome	O	O
of	O	O
B.	B-bacteria	B-bacteria
dentium	I-bacteria	I-bacteria
Bd1	E-bacteria	I-bacteria
,	O	O
a	O	O
strain	O	O
isolated	O	O
from	O	O
dental	O	O
caries	O	O
,	O	O
was	O	O
sequenced	O	O
to	O	O
completion	O	O
to	O	O
uncover	O	O
a	O	O
single	O	O
circular	O	O
2,636,368	O	O
base	O	O
pair	O	O
chromosome	O	O
with	O	O
2,143	O	O
predicted	O	O
open	O	O
reading	O	O
frames	O	O
.	O	O

Annotation	O	O
of	O	O
the	O	O
genome	O	O
sequence	O	O
revealed	O	O
multiple	O	O
ways	O	O
in	O	O
which	O	O
B.	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
has	O	O
adapted	O	O
to	O	O
the	O	O
oral	O	O
environment	O	O
through	O	O
specialized	O	O
nutrient	O	O
acquisition	O	O
,	O	O
defences	O	O
against	O	O
antimicrobials	O	O
,	O	O
and	O	O
gene	O	O
products	O	O
that	O	O
increase	O	O
fitness	O	O
and	O	O
competitiveness	O	O
within	O	O
the	O	O
oral	O	O
niche	O	O
.	O	O

B.	B-bacteria	B-bacteria
dentium	I-bacteria	I-bacteria
Bd1	E-bacteria	I-bacteria
was	O	O
shown	O	O
to	O	O
metabolize	O	O
a	O	O
wide	O	O
variety	O	O
of	O	O
carbohydrates	O	O
,	O	O
consistent	O	O
with	O	O
genome-based	O	O
predictions	O	O
,	O	O
while	O	O
colonization	O	O
and	O	O
persistence	O	O
factors	O	O
implicated	O	O
in	O	O
tissue	O	O
adhesion	O	O
,	O	O
acid	O	O
tolerance	O	O
,	O	O
and	O	O
the	O	O
metabolism	O	O
of	O	O
human	O	O
saliva-derived	O	O
compounds	O	O
were	O	O
also	O	O
identified	O	O
.	O	O

Global	O	O
transcriptome	O	O
analysis	O	O
demonstrated	O	O
that	O	O
many	O	O
of	O	O
the	O	O
genes	O	O
encoding	O	O
these	O	O
predicted	O	O
traits	O	O
are	O	O
highly	O	O
expressed	O	O
under	O	O
relevant	O	O
physiological	O	O
conditions	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
report	O	O
to	O	O
identify	O	O
,	O	O
through	O	O
various	O	O
genomic	O	O
approaches	O	O
,	O	O
specific	O	O
genetic	O	O
adaptations	O	O
of	O	O
a	O	O
Bifidobacterium	B-bacteria	B-bacteria
taxon	E-bacteria	I-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
dentium	I-bacteria	I-bacteria
Bd1	E-bacteria	I-bacteria
,	O	O
to	O	O
a	O	O
lifestyle	O	O
as	O	O
a	O	O
cariogenic	O	O
microorganism	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
silico	O	O
analysis	O	O
and	O	O
comparative	O	O
genomic	O	O
hybridization	O	O
experiments	O	O
clearly	O	O
reveal	O	O
a	O	O
high	O	O
level	O	O
of	O	O
genome	O	O
conservation	O	O
among	O	O
various	O	O
B.	B-bacteria	B-bacteria
dentium	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

The	O	O
data	O	O
indicate	O	O
that	O	O
the	O	O
genome	O	O
of	O	O
this	O	O
opportunistic	O	O
cariogen	O	O
has	O	O
evolved	O	O
through	O	O
a	O	O
very	O	O
limited	O	O
number	O	O
of	O	O
horizontal	O	O
gene	O	O
acquisition	O	O
events	O	O
,	O	O
highlighting	O	O
the	O	O
narrow	O	O
boundaries	O	O
that	O	O
separate	O	O
commensals	O	O
from	O	O
opportunistic	O	O
pathogens	O	O
.	O	O

Seasonal	O	O
changes	O	O
in	O	O
day	O	O
length	O	O
(	O	O
i.e.	O	O
,	O	O
photoperiod	O	O
)	O	O
provide	O	O
animals	O	O
with	O	O
a	O	O
reliable	O	O
environmental	O	O
cue	O	O
to	O	O
determine	O	O
time	O	O
of	O	O
year	O	O
,	O	O
and	O	O
many	O	O
physiological	O	O
changes	O	O
occur	O	O
in	O	O
laboratory	O	O
animals	O	O
simply	O	O
by	O	O
extending	O	O
or	O	O
shortening	O	O
day	O	O
length	O	O
.	O	O

Male	O	O
Siberian	O	O
hamsters	O	O
(	O	O
Phodopus	O	O
sungorus	O	O
)	O	O
housed	O	O
in	O	O
long	O	O
summer-like	O	O
day	O	O
lengths	O	O
have	O	O
significantly	O	O
elevated	O	O
body	O	O
and	O	O
fat	O	O
masses	O	O
compared	O	O
to	O	O
short-day	O	O
hamsters	O	O
.	O	O

Because	O	O
others	O	O
have	O	O
demonstrated	O	O
that	O	O
the	O	O
intestinal	O	O
microbiota	O	O
of	O	O
humans	O	O
and	O	O
rodents	O	O
promotes	O	O
host	O	O
adiposity	O	O
,	O	O
we	O	O
hypothesized	O	O
that	O	O
photoperiod-induced	O	O
changes	O	O
in	O	O
body	O	O
and	O	O
fat	O	O
masses	O	O
could	O	O
be	O	O
associated	O	O
with	O	O
changes	O	O
in	O	O
the	O	O
microbial	O	O
composition	O	O
in	O	O
the	O	O
intestines	O	O
.	O	O

We	O	O
used	O	O
bacterial	O	O
tag-encoded	O	O
FLX	O	O
amplicon	O	O
pyrosequencing	O	O
(	O	O
bTEFAP	O	O
)	O	O
to	O	O
assess	O	O
microbial	O	O
diversity	O	O
in	O	O
the	O	O
cecal	O	O
contents	O	O
of	O	O
hamsters	O	O
;	O	O
long	O	O
days	O	O
significantly	O	O
increased	O	O
the	O	O
relative	O	O
abundance	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
phylum	B-bacteria	B-bacteria
Proteobacteria	E-bacteria	I-bacteria
.	O	O

This	O	O
effect	O	O
was	O	O
primarily	O	O
due	O	O
to	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
the	O	O
abundance	O	O
of	O	O
the	O	O
genus	O	O
Citrobacter	B-bacteria	B-bacteria
,	O	O
with	O	O
both	O	O
the	O	O
abundance	O	O
of	O	O
Proteobacteria	B-bacteria	B-bacteria
and	O	O
Citrobacter	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

significantly	O	O
correlated	O	O
with	O	O
body	O	O
mass	O	O
and	O	O
with	O	O
inguinal	O	O
fat	O	O
mass	O	O
.	O	O

In	O	O
general	O	O
,	O	O
the	O	O
abundance	O	O
of	O	O
the	O	O
Firmicutes	B-bacteria	B-bacteria
phylum	E-bacteria	I-bacteria
was	O	O
inversely	O	O
associated	O	O
with	O	O
body	O	O
mass	O	O
.	O	O

These	O	O
data	O	O
indicate	O	O
that	O	O
the	O	O
intestinal	O	O
microbiota	O	O
are	O	O
responsive	O	O
to	O	O
changes	O	O
in	O	O
photoperiod	O	O
and	O	O
suggest	O	O
that	O	O
these	O	O
changes	O	O
may	O	O
in	O	O
part	O	O
influence	O	O
photoperiodic	O	O
changes	O	O
in	O	O
body	O	O
and	O	O
fat	O	O
masses	O	O
.	O	O

Epidemiologic	O	O
studies	O	O
of	O	O
periodontal	O	O
infection	O	O
as	O	O
a	O	O
risk	O	O
factor	O	O
for	O	O
cardiovascular	O	O
disease	O	O
often	O	O
use	O	O
clinical	O	O
periodontal	O	O
measures	O	O
as	O	O
a	O	O
surrogate	O	O
for	O	O
the	O	O
underlying	O	O
bacterial	O	O
exposure	O	O
of	O	O
interest	O	O
.	O	O

There	O	O
are	O	O
currently	O	O
no	O	O
methodological	O	O
studies	O	O
evaluating	O	O
which	O	O
clinical	O	O
periodontal	O	O
measures	O	O
best	O	O
reflect	O	O
the	O	O
levels	O	O
of	O	O
subgingival	O	O
bacterial	O	O
colonization	O	O
in	O	O
population-based	O	O
settings	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
characteristics	O	O
of	O	O
clinical	O	O
periodontal	O	O
definitions	O	O
that	O	O
were	O	O
most	O	O
representative	O	O
of	O	O
exposure	O	O
to	O	O
bacterial	O	O
species	O	O
that	O	O
are	O	O
believed	O	O
to	O	O
be	O	O
either	O	O
markers	O	O
,	O	O
or	O	O
themselves	O	O
etiologic	O	O
,	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

706	O	O
men	O	O
and	O	O
women	O	O
aged	O	O
>	O	O
or=	O	O
55	O	O
years	O	O
,	O	O
residing	O	O
in	O	O
northern	O	O
Manhattan	O	O
were	O	O
enrolled	O	O
.	O	O

Using	O	O
DNA-DNA	O	O
checkerboard	O	O
hybridization	O	O
in	O	O
subgingival	O	O
biofilms	O	O
,	O	O
standardized	O	O
values	O	O
for	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
were	O	O
averaged	O	O
within	O	O
mouth	O	O
and	O	O
summed	O	O
to	O	O
define	O	O
``	O	O
bacterial	O	O
burden	O	O
''	O	O
.	O	O

Correlations	O	O
of	O	O
bacterial	O	O
burden	O	O
with	O	O
clinical	O	O
periodontal	O	O
constructs	O	O
defined	O	O
by	O	O
the	O	O
severity	O	O
and	O	O
extent	O	O
of	O	O
attachment	O	O
loss	O	O
(	O	O
AL	O	O
)	O	O
,	O	O
pocket	O	O
depth	O	O
(	O	O
PD	O	O
)	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
(	O	O
BOP	O	O
)	O	O
were	O	O
assessed	O	O
.	O	O

Clinical	O	O
periodontal	O	O
constructs	O	O
demonstrating	O	O
the	O	O
highest	O	O
correlations	O	O
with	O	O
bacterial	O	O
burden	O	O
were	O	O
:	O	O
i	O	O
)	O	O
percent	O	O
of	O	O
sites	O	O
with	O	O
BOP	O	O
(	O	O
r	O	O
=	O	O
0.62	O	O
)	O	O
;	O	O
ii	O	O
)	O	O
percent	O	O
of	O	O
sites	O	O
with	O	O
PD	O	O
>	O	O
or=	O	O
3	O	O
mm	O	O
(	O	O
r	O	O
=	O	O
0.61	O	O
)	O	O
;	O	O
and	O	O
iii	O	O
)	O	O
number	O	O
of	O	O
sites	O	O
with	O	O
BOP	O	O
(	O	O
r	O	O
=	O	O
0.59	O	O
)	O	O
.	O	O

Increasing	O	O
PD	O	O
or	O	O
AL	O	O
severity	O	O
thresholds	O	O
consistently	O	O
attenuated	O	O
correlations	O	O
,	O	O
i.e.	O	O
,	O	O
the	O	O
correlation	O	O
of	O	O
bacterial	O	O
burden	O	O
with	O	O
the	O	O
percent	O	O
of	O	O
sites	O	O
with	O	O
PD	O	O
>	O	O
or=	O	O
8	O	O
mm	O	O
was	O	O
only	O	O
r	O	O
=	O	O
0.16	O	O
.	O	O

Clinical	O	O
exposure	O	O
definitions	O	O
of	O	O
periodontal	O	O
disease	O	O
should	O	O
incorporate	O	O
relatively	O	O
shallow	O	O
pockets	O	O
to	O	O
best	O	O
reflect	O	O
whole	O	O
mouth	O	O
exposure	O	O
to	O	O
bacterial	O	O
burden	O	O
.	O	O

It	O	O
has	O	O
been	O	O
suggested	O	O
that	O	O
use	O	O
of	O	O
systemic	O	O
antibiotics	O	O
should	O	O
be	O	O
limited	O	O
to	O	O
patients	O	O
with	O	O
specific	O	O
microbiologic	O	O
profiles	O	O
.	O	O

The	O	O
main	O	O
purpose	O	O
of	O	O
the	O	O
present	O	O
analysis	O	O
was	O	O
to	O	O
study	O	O
whether	O	O
microbiologic	O	O
testing	O	O
before	O	O
therapy	O	O
was	O	O
of	O	O
value	O	O
in	O	O
predicting	O	O
which	O	O
patients	O	O
would	O	O
specifically	O	O
benefit	O	O
from	O	O
adjunctive	O	O
amoxicillin	O	O
and	O	O
metronidazole	O	O
,	O	O
given	O	O
in	O	O
the	O	O
context	O	O
of	O	O
full-mouth	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
(	O	O
SRP	O	O
)	O	O
within	O	O
48	O	O
hours	O	O
.	O	O

This	O	O
was	O	O
a	O	O
6-month	O	O
,	O	O
single-center	O	O
,	O	O
double-masked	O	O
,	O	O
placebo-controlled	O	O
,	O	O
randomized	O	O
longitudinal	O	O
study	O	O
.	O	O

Fifty-one	O	O
patients	O	O
received	O	O
full-mouth	O	O
periodontal	O	O
debridement	O	O
,	O	O
performed	O	O
within	O	O
48	O	O
hours	O	O
;	O	O
then	O	O
,	O	O
25	O	O
subjects	O	O
received	O	O
metronidazole	O	O
,	O	O
500	O	O
mg	O	O
,	O	O
and	O	O
amoxicillin	O	O
,	O	O
375	O	O
mg	O	O
,	O	O
three	O	O
times	O	O
a	O	O
day	O	O
for	O	O
7	O	O
days	O	O
,	O	O
and	O	O
26	O	O
received	O	O
a	O	O
placebo	O	O
(	O	O
control	O	O
group	O	O
)	O	O
.	O	O

Pooled	O	O
microbiologic	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
deepest	O	O
pocket	O	O
at	O	O
baseline	O	O
in	O	O
each	O	O
quadrant	O	O
before	O	O
and	O	O
6	O	O
months	O	O
after	O	O
treatment	O	O
.	O	O

Six	O	O
periodontal	O	O
pathogens	O	O
were	O	O
quantified	O	O
by	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

Forty-seven	O	O
patients	O	O
were	O	O
followed	O	O
for	O	O
6	O	O
months	O	O
.	O	O

After	O	O
treatment	O	O
,	O	O
test	O	O
subjects	O	O
had	O	O
a	O	O
substantially	O	O
lower	O	O
mean	O	O
number	O	O
of	O	O
persisting	O	O
sites	O	O
with	O	O
probing	O	O
depth	O	O
>	O	O
4	O	O
mm	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
than	O	O
did	O	O
control	O	O
subjects	O	O
(	O	O
0.4	O	O
versus	O	O
3.0	O	O
;	O	O
P	O	O
=	O	O
0.005	O	O
;	O	O
month	O	O
6	O	O
)	O	O
.	O	O

Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
previously	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
could	O	O
not	O	O
be	O	O
detected	O	O
in	O	O
the	O	O
antibiotic	O	O
group	O	O
after	O	O
treatment	O	O
.	O	O

However	O	O
,	O	O
in	O	O
the	O	O
placebo	O	O
group	O	O
,	O	O
three	O	O
of	O	O
six	O	O
subjects	O	O
positive	O	O
for	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
continued	O	O
to	O	O
be	O	O
positive	O	O
.	O	O

Lower	O	O
frequencies	O	O
were	O	O
also	O	O
noted	O	O
in	O	O
the	O	O
test	O	O
group	O	O
for	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
0.013	O	O
)	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
previously	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
(	O	O
P	O	O
=	O	O
0.007	O	O
)	O	O
.	O	O

However	O	O
,	O	O
even	O	O
subjects	O	O
testing	O	O
negative	O	O
for	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
at	O	O
baseline	O	O
had	O	O
a	O	O
significantly	O	O
better	O	O
primary	O	O
clinical	O	O
outcome	O	O
if	O	O
they	O	O
received	O	O
the	O	O
active	O	O
drugs	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
six	O	O
putative	O	O
periodontal	O	O
pathogens	O	O
(	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
)	O	O
quantified	O	O
prior	O	O
to	O	O
therapy	O	O
was	O	O
not	O	O
correlated	O	O
with	O	O
the	O	O
outcome	O	O
of	O	O
full-mouth	O	O
SRP	O	O
with	O	O
or	O	O
without	O	O
amoxicillin	O	O
and	O	O
metronidazole	O	O
.	O	O

Excellent	O	O
clinical	O	O
results	O	O
in	O	O
the	O	O
antibiotics	O	O
group	O	O
were	O	O
obtained	O	O
regardless	O	O
of	O	O
the	O	O
presence	O	O
or	O	O
absence	O	O
of	O	O
six	O	O
classic	O	O
periodontal	O	O
periopathogens	O	O
prior	O	O
to	O	O
treatment	O	O
.	O	O

The	O	O
intestinal	O	O
ecosystem	O	O
is	O	O
formed	O	O
by	O	O
a	O	O
complex	O	O
,	O	O
yet	O	O
highly	O	O
characteristic	O	O
microbial	O	O
community	O	O
.	O	O

The	O	O
parameters	O	O
defining	O	O
whether	O	O
this	O	O
community	O	O
permits	O	O
invasion	O	O
of	O	O
a	O	O
new	O	O
bacterial	O	O
species	O	O
are	O	O
unclear	O	O
.	O	O

In	O	O
particular	O	O
,	O	O
inhibition	O	O
of	O	O
enteropathogen	O	O
infection	O	O
by	O	O
the	O	O
gut	O	O
microbiota	O	O
(	O	O
=	O	O
colonization	O	O
resistance	O	O
)	O	O
is	O	O
poorly	O	O
understood	O	O
.	O	O

To	O	O
analyze	O	O
the	O	O
mechanisms	O	O
of	O	O
microbiota-mediated	O	O
protection	O	O
from	O	O
Salmonella	B-bacteria	B-bacteria
enterica	E-bacteria	I-bacteria
induced	O	O
enterocolitis	O	O
,	O	O
we	O	O
used	O	O
a	O	O
mouse	O	O
infection	O	O
model	O	O
and	O	O
large	O	O
scale	O	O
high-throughput	O	O
pyrosequencing	O	O
.	O	O

In	O	O
contrast	O	O
to	O	O
conventional	O	O
mice	O	O
(	O	O
CON	O	O
)	O	O
,	O	O
mice	O	O
with	O	O
a	O	O
gut	O	O
microbiota	O	O
of	O	O
low	O	O
complexity	O	O
(	O	O
LCM	O	O
)	O	O
were	O	O
highly	O	O
susceptible	O	O
to	O	O
S.	B-bacteria	B-bacteria
enterica	E-bacteria	I-bacteria
induced	O	O
colonization	O	O
and	O	O
enterocolitis	O	O
.	O	O

Colonization	O	O
resistance	O	O
was	O	O
partially	O	O
restored	O	O
in	O	O
LCM-animals	O	O
by	O	O
co-housing	O	O
with	O	O
conventional	O	O
mice	O	O
for	O	O
21	O	O
days	O	O
(	O	O
LCM	O	O
(	O	O
con21	O	O
)	O	O
)	O	O
.	O	O

16S	O	O
rRNA	O	O
sequence	O	O
analysis	O	O
comparing	O	O
LCM	O	O
,	O	O
LCM	O	O
(	O	O
con21	O	O
)	O	O
and	O	O
CON	O	O
gut	O	O
microbiota	O	O
revealed	O	O
that	O	O
gut	O	O
microbiota	O	O
complexity	O	O
increased	O	O
upon	O	O
conventionalization	O	O
and	O	O
correlated	O	O
with	O	O
increased	O	O
resistance	O	O
to	O	O
S.	B-bacteria	B-bacteria
enterica	E-bacteria	I-bacteria
infection	O	O
.	O	O

Comparative	O	O
microbiota	O	O
analysis	O	O
of	O	O
mice	O	O
with	O	O
varying	O	O
degrees	O	O
of	O	O
colonization	O	O
resistance	O	O
allowed	O	O
us	O	O
to	O	O
identify	O	O
intestinal	O	O
ecosystem	O	O
characteristics	O	O
associated	O	O
with	O	O
susceptibility	O	O
to	O	O
S.	B-bacteria	B-bacteria
enterica	E-bacteria	I-bacteria
infection	O	O
.	O	O

Moreover	O	O
,	O	O
this	O	O
system	O	O
enabled	O	O
us	O	O
to	O	O
gain	O	O
further	O	O
insights	O	O
into	O	O
the	O	O
general	O	O
principles	O	O
of	O	O
gut	O	O
ecosystem	O	O
invasion	O	O
by	O	O
non-pathogenic	O	O
,	O	O
commensal	O	O
bacteria	O	O
.	O	O

Mice	O	O
harboring	O	O
high	O	O
commensal	B-bacteria	B-bacteria
E.	I-bacteria	I-bacteria
coli	E-bacteria	I-bacteria
densities	O	O
were	O	O
more	O	O
susceptible	O	O
to	O	O
S.	B-bacteria	B-bacteria
enterica	E-bacteria	I-bacteria
induced	O	O
gut	O	O
inflammation	O	O
.	O	O

Similarly	O	O
,	O	O
mice	O	O
with	O	O
high	O	O
titers	O	O
of	O	O
Lactobacilli	B-bacteria	B-bacteria
were	O	O
more	O	O
efficiently	O	O
colonized	O	O
by	O	O
a	O	O
commensal	O	O
Lactobacillus	B-bacteria	B-bacteria
reuteri	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
RR	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
after	O	O
oral	O	O
inoculation	O	O
.	O	O

Upon	O	O
examination	O	O
of	O	O
16S	O	O
rRNA	O	O
sequence	O	O
data	O	O
from	O	O
9	O	O
CON	O	O
mice	O	O
we	O	O
found	O	O
that	O	O
closely	O	O
related	O	O
phylotypes	O	O
generally	O	O
display	O	O
significantly	O	O
correlated	O	O
abundances	O	O
(	O	O
co-occurrence	O	O
)	O	O
,	O	O
more	O	O
so	O	O
than	O	O
distantly	O	O
related	O	O
phylotypes	O	O
.	O	O

Thus	O	O
,	O	O
in	O	O
essence	O	O
,	O	O
the	O	O
presence	O	O
of	O	O
closely	O	O
related	O	O
species	O	O
can	O	O
increase	O	O
the	O	O
chance	O	O
of	O	O
invasion	O	O
of	O	O
newly	O	O
incoming	O	O
species	O	O
into	O	O
the	O	O
gut	O	O
ecosystem	O	O
.	O	O

We	O	O
provide	O	O
evidence	O	O
that	O	O
this	O	O
principle	O	O
might	O	O
be	O	O
of	O	O
general	O	O
validity	O	O
for	O	O
invasion	O	O
of	O	O
bacteria	O	O
in	O	O
preformed	O	O
gut	O	O
ecosystems	O	O
.	O	O

This	O	O
might	O	O
be	O	O
of	O	O
relevance	O	O
for	O	O
human	O	O
enteropathogen	O	O
infections	O	O
as	O	O
well	O	O
as	O	O
therapeutic	O	O
use	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
commensal	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

To	O	O
explore	O	O
a	O	O
selected-media	O	O
of	O	O
Bifidobacterium	B-bacteria	B-bacteria
from	O	O
oral	O	O
cavity	O	O
,	O	O
to	O	O
detect	O	O
the	O	O
distribution	O	O
of	O	O
Bifidobacterium	B-bacteria	B-bacteria
in	O	O
different	O	O
sites	O	O
of	O	O
children	O	O
and	O	O
primarily	O	O
investigate	O	O
the	O	O
relationship	O	O
between	O	O
oral	O	O
Bifidobacterium	B-bacteria	B-bacteria
and	O	O
early	O	O
childhood	O	O
caries	O	O
.	O	O

70	O	O
children	O	O
aged	O	O
from	O	O
3	O	O
to	O	O
5-year-old	O	O
were	O	O
selected	O	O
,	O	O
30	O	O
children	O	O
were	O	O
caries-free	O	O
and	O	O
40	O	O
were	O	O
severe	O	O
early	O	O
childhood	O	O
caries	O	O
(	O	O
S-ECC	O	O
)	O	O
.	O	O

Saliva	O	O
was	O	O
collected	O	O
and	O	O
plaque	O	O
samples	O	O
from	O	O
the	O	O
30	O	O
healthy	O	O
subjects	O	O
were	O	O
pooled	O	O
.	O	O

For	O	O
S-ECC	O	O
group	O	O
,	O	O
plaques	O	O
were	O	O
collected	O	O
separately	O	O
from	O	O
four	O	O
different	O	O
sites	O	O
as	O	O
follows	O	O
:	O	O
Saliva	O	O
,	O	O
surfaces	O	O
of	O	O
intact	O	O
enamel	O	O
,	O	O
surfaces	O	O
of	O	O
white	O	O
spot-lesions	O	O
,	O	O
and	O	O
deep	O	O
dentin-lesions	O	O
.	O	O

Samples	O	O
would	O	O
be	O	O
grown	O	O
in	O	O
the	O	O
selected-media	O	O
,	O	O
and	O	O
the	O	O
whole	O	O
DNA	O	O
of	O	O
bacteria	O	O
was	O	O
extracted	O	O
.	O	O

Polymerase	O	O
chain	O	O
reaction	O	O
was	O	O
performed	O	O
with	O	O
specific	O	O
primers	O	O
and	O	O
the	O	O
results	O	O
were	O	O
analyzed	O	O
by	O	O
the	O	O
electrophoresis	O	O
.	O	O

Bifidobacterium	B-bacteria	B-bacteria
were	O	O
detected	O	O
0	O	O
in	O	O
the	O	O
caries-free	O	O
children	O	O
,	O	O
while	O	O
47.5	O	O
%	O	O
in	O	O
the	O	O
S-ECC	O	O
group	O	O
.	O	O

There	O	O
was	O	O
significant	O	O
difference	O	O
between	O	O
two	O	O
groups	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
and	O	O
there	O	O
was	O	O
no	O	O
difference	O	O
between	O	O
different	O	O
sites	O	O
of	O	O
teeth	O	O
in	O	O
S-ECC	O	O
group	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

27.5	O	O
%	O	O
Bifidobacterium	B-bacteria	B-bacteria
were	O	O
detected	O	O
in	O	O
saliva	O	O
,	O	O
27.5	O	O
%	O	O
on	O	O
surfaces	O	O
of	O	O
intact	O	O
enamel	O	O
,	O	O
20.0	O	O
%	O	O
on	O	O
surfaces	O	O
of	O	O
white	O	O
spot-lesions	O	O
and	O	O
22.5	O	O
%	O	O
in	O	O
deep	O	O
dentin-lesions	O	O
.	O	O

10	O	O
%	O	O
Bifidobacterium	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
saliva	O	O
,	O	O
7.5	O	O
%	O	O
on	O	O
surfaces	O	O
of	O	O
intact	O	O
enamel	O	O
,	O	O
7.5	O	O
%	O	O
on	O	O
surfaces	O	O
of	O	O
white	O	O
spot-lesions	O	O
and	O	O
10.0	O	O
%	O	O
in	O	O
deep	O	O
dentin-lesions	O	O
.	O	O

One	O	O
type	O	O
of	O	O
modified	O	O
selected	O	O
media	O	O
of	O	O
Bifidobacterium	B-bacteria	B-bacteria
in	O	O
oral	O	O
cavity	O	O
was	O	O
explored	O	O
.	O	O

Bifidobacterium	B-bacteria	B-bacteria
may	O	O
be	O	O
related	O	O
to	O	O
the	O	O
occurrence	O	O
of	O	O
the	O	O
S-ECC	O	O
and	O	O
has	O	O
nothing	O	O
to	O	O
do	O	O
with	O	O
different	O	O
sites	O	O
of	O	O
teeth	O	O
in	O	O
children	O	O
.	O	O

Members	O	O
of	O	O
the	O	O
phylum	O	O
Synergistetes	O	O
have	O	O
been	O	O
demonstrated	O	O
in	O	O
several	O	O
environmental	O	O
ecosystems	O	O
and	O	O
mammalian	O	O
microflorae	O	O
by	O	O
culture-independent	O	O
methods	O	O
.	O	O

In	O	O
the	O	O
past	O	O
few	O	O
years	O	O
,	O	O
the	O	O
clinical	O	O
relevance	O	O
of	O	O
some	O	O
uncultivated	O	O
phylotypes	O	O
has	O	O
been	O	O
demonstrated	O	O
in	O	O
endodontic	O	O
infections	O	O
,	O	O
and	O	O
uncultured	O	O
Synergistetes	O	O
have	O	O
been	O	O
demonstrated	O	O
in	O	O
human	O	O
mouth	O	O
,	O	O
gut	O	O
and	O	O
skin	O	O
microbiota	O	O
.	O	O

However	O	O
,	O	O
Synergistetes	O	O
are	O	O
rarely	O	O
cultured	O	O
from	O	O
human	O	O
samples	O	O
,	O	O
and	O	O
only	O	O
17	O	O
isolates	O	O
are	O	O
currently	O	O
reported	O	O
.	O	O

Twelve	O	O
members	O	O
of	O	O
Synergistetes	O	O
isolated	O	O
in	O	O
the	O	O
course	O	O
of	O	O
various	O	O
infectious	O	O
processes	O	O
,	O	O
including	O	O
3	O	O
Jonquetella	B-bacteria	B-bacteria
anthropi	E-bacteria	I-bacteria
,	O	O
2	O	O
Cloacibacillus	B-bacteria	B-bacteria
evryensis	E-bacteria	I-bacteria
,	O	O
2	O	O
Pyramidobacter	B-bacteria	B-bacteria
piscolens	E-bacteria	I-bacteria
and	O	O
5	O	O
unidentified	O	O
strains	O	O
,	O	O
as	O	O
well	O	O
as	O	O
56	O	O
clones	O	O
obtained	O	O
by	O	O
specific	O	O
PCR	O	O
from	O	O
the	O	O
normal	O	O
vaginal	O	O
microflora	O	O
,	O	O
were	O	O
studied	O	O
.	O	O

16S	O	O
rRNA	O	O
gene-based	O	O
phylogeny	O	O
showed	O	O
that	O	O
the	O	O
clones	O	O
were	O	O
grouped	O	O
into	O	O
3	O	O
clusters	O	O
,	O	O
corresponding	O	O
to	O	O
the	O	O
genus	B-bacteria	B-bacteria
Jonquetella	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
piscolens	E-bacteria	I-bacteria
and	O	O
one	O	O
novel	O	O
Synergistetes	O	O
taxon	O	O
.	O	O

The	O	O
presence	O	O
and	O	O
diversity	O	O
of	O	O
Synergistetes	O	O
were	O	O
reported	O	O
for	O	O
the	O	O
first	O	O
time	O	O
in	O	O
the	O	O
vaginal	O	O
microflora	O	O
.	O	O

Synergistetes	O	O
were	O	O
found	O	O
in	O	O
healthy	O	O
patients	O	O
,	O	O
suggesting	O	O
that	O	O
they	O	O
could	O	O
play	O	O
a	O	O
functional	O	O
role	O	O
in	O	O
human	O	O
microflorae	O	O
,	O	O
but	O	O
may	O	O
also	O	O
act	O	O
as	O	O
opportunistic	O	O
pathogens	O	O
.	O	O

Studying	O	O
the	O	O
phylogenetic	O	O
relationships	O	O
between	O	O
environmental	O	O
and	O	O
mammalian	O	O
strains	O	O
and	O	O
clones	O	O
revealed	O	O
clearly	O	O
delineated	O	O
independent	O	O
lineages	O	O
according	O	O
to	O	O
the	O	O
origin	O	O
of	O	O
the	O	O
sequences	O	O
.	O	O

Campylobacter	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
C.	B-bacteria	B-bacteria
jejuni	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
fetus	E-bacteria	I-bacteria
)	O	O
are	O	O
enteric	O	O
abortifacient	O	O
bacteria	O	O
in	O	O
humans	O	O
and	O	O
ungulates	O	O
.	O	O

Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
is	O	O
a	O	O
periodontal	O	O
pathogen	O	O
associated	O	O
with	O	O
human	O	O
fetal	O	O
exposure	O	O
and	O	O
adverse	O	O
pregnancy	O	O
outcomes	O	O
including	O	O
preterm	O	O
delivery	O	O
.	O	O

Experiments	O	O
in	O	O
pregnant	O	O
mice	O	O
have	O	O
demonstrated	O	O
that	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
can	O	O
translocate	O	O
from	O	O
a	O	O
distant	O	O
site	O	O
of	O	O
infection	O	O
to	O	O
the	O	O
placenta	O	O
to	O	O
induce	O	O
fetal	O	O
growth	O	O
restriction	O	O
and	O	O
impair	O	O
placental	O	O
development	O	O
.	O	O

However	O	O
,	O	O
placental	O	O
tissues	O	O
from	O	O
human	O	O
,	O	O
small-for-gestational	O	O
age	O	O
deliveries	O	O
have	O	O
not	O	O
been	O	O
reported	O	O
to	O	O
harbor	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
despite	O	O
evidence	O	O
of	O	O
maternal	O	O
infection	O	O
and	O	O
fetal	O	O
exposure	O	O
by	O	O
fetal	O	O
IgM	O	O
response	O	O
.	O	O

This	O	O
investigation	O	O
examined	O	O
the	O	O
temporal	O	O
relationship	O	O
between	O	O
the	O	O
placental	O	O
translocation	O	O
of	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
and	O	O
the	O	O
effects	O	O
on	O	O
fetal	O	O
growth	O	O
in	O	O
mice	O	O
.	O	O

BALB/c	O	O
mice	O	O
were	O	O
infected	O	O
at	O	O
gestational	O	O
day	O	O
E7.5	O	O
to	O	O
examine	O	O
placental	O	O
translocation	O	O
of	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
by	O	O
immunohistology	O	O
.	O	O

C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
significantly	O	O
decreased	O	O
fetoplacental	O	O
weight	O	O
at	O	O
E14.5	O	O
and	O	O
at	O	O
E16.5	O	O
.	O	O

C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
63	O	O
%	O	O
of	O	O
placentas	O	O
at	O	O
E14.5	O	O
,	O	O
but	O	O
not	O	O
at	O	O
E16.5	O	O
.	O	O

In	O	O
in	O	O
vitro	O	O
trophoblast	O	O
invasion	O	O
assays	O	O
,	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
was	O	O
able	O	O
to	O	O
effectively	O	O
invade	O	O
human	O	O
trophoblasts	O	O
(	O	O
BeWo	O	O
)	O	O
but	O	O
not	O	O
murine	O	O
trophoblasts	O	O
(	O	O
SM9-1	O	O
)	O	O
,	O	O
and	O	O
showed	O	O
a	O	O
trend	O	O
for	O	O
more	O	O
invasiveness	O	O
than	O	O
C.	B-bacteria	B-bacteria
jejuni	E-bacteria	I-bacteria
.	O	O

C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
challenge	O	O
significantly	O	O
upregulated	O	O
both	O	O
mRNA	O	O
and	O	O
protein	O	O
levels	O	O
of	O	O
IL-6	O	O
and	O	O
TNFalpha	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
in	O	O
human	O	O
trophoblasts	O	O
,	O	O
but	O	O
did	O	O
not	O	O
increase	O	O
cytokine	O	O
expression	O	O
in	O	O
murine	O	O
cells	O	O
,	O	O
suggesting	O	O
a	O	O
correlation	O	O
between	O	O
invasion	O	O
and	O	O
cytokine	O	O
activation	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
the	O	O
trophoblast-invasive	O	O
trait	O	O
of	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
that	O	O
appears	O	O
limited	O	O
to	O	O
human	O	O
trophoblasts	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
facilitating	O	O
bacterial	O	O
translocation	O	O
and	O	O
placental	O	O
inflammation	O	O
during	O	O
early	O	O
gestation	O	O
.	O	O

Intrauterine	O	O
infection	O	O
is	O	O
a	O	O
recognized	O	O
cause	O	O
of	O	O
adverse	O	O
pregnancy	O	O
outcome	O	O
,	O	O
but	O	O
the	O	O
source	O	O
of	O	O
infection	O	O
is	O	O
often	O	O
undetermined	O	O
.	O	O

We	O	O
report	O	O
a	O	O
case	O	O
of	O	O
stillbirth	O	O
caused	O	O
by	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
that	O	O
originated	O	O
in	O	O
the	O	O
mother's	O	O
mouth	O	O
.	O	O

A	O	O
woman	O	O
with	O	O
pregnancy-associated	O	O
gingivitis	O	O
experienced	O	O
an	O	O
upper	O	O
respiratory	O	O
tract	O	O
infection	O	O
at	O	O
term	O	O
,	O	O
followed	O	O
by	O	O
stillbirth	O	O
a	O	O
few	O	O
days	O	O
later	O	O
.	O	O

F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
isolated	O	O
from	O	O
the	O	O
placenta	O	O
and	O	O
the	O	O
fetus	O	O
.	O	O

Examination	O	O
of	O	O
different	O	O
microbial	O	O
floras	O	O
from	O	O
the	O	O
mother	O	O
identified	O	O
the	O	O
same	O	O
clone	O	O
in	O	O
her	O	O
subgingival	O	O
plaque	O	O
but	O	O
not	O	O
in	O	O
the	O	O
supragingival	O	O
plaque	O	O
,	O	O
vagina	O	O
,	O	O
or	O	O
rectum	O	O
.	O	O

F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
may	O	O
have	O	O
translocated	O	O
from	O	O
the	O	O
mother	O	O
's	O	O
mouth	O	O
to	O	O
the	O	O
uterus	O	O
when	O	O
the	O	O
immune	O	O
system	O	O
was	O	O
weakened	O	O
during	O	O
the	O	O
respiratory	O	O
infection	O	O
.	O	O

This	O	O
case	O	O
sheds	O	O
light	O	O
on	O	O
patient	O	O
management	O	O
for	O	O
those	O	O
with	O	O
pregnancy-associated	O	O
gingivitis	O	O
.	O	O

Carious	O	O
tissue	O	O
fluoresces	O	O
with	O	O
a	O	O
wavelength	O	O
different	O	O
from	O	O
sound	O	O
tissue	O	O
when	O	O
stimulated	O	O
by	O	O
light	O	O
with	O	O
a	O	O
wavelength	O	O
of	O	O
655	O	O
nm	O	O
.	O	O

This	O	O
difference	O	O
is	O	O
thought	O	O
to	O	O
have	O	O
a	O	O
bacterial	O	O
origin	O	O
rather	O	O
than	O	O
indicating	O	O
demineralization	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
measure	O	O
fluorescence	O	O
emitted	O	O
by	O	O
normal	O	O
cultivable	O	O
caries-associated	O	O
bacterial	O	O
flora	O	O
and	O	O
typical	O	O
porphyrin-producing	O	O
bacteria	O	O
with	O	O
DIAGNOdent	O	O
,	O	O
and	O	O
to	O	O
verify	O	O
earlier	O	O
findings	O	O
that	O	O
demineralization	O	O
of	O	O
the	O	O
dental	O	O
hard	O	O
tissue	O	O
does	O	O
not	O	O
affect	O	O
DIAGNOdent	O	O
readings	O	O
.	O	O

Bacterial	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
five	O	O
occlusal	O	O
caries	O	O
lesions	O	O
in	O	O
three	O	O
subjects	O	O
.	O	O

From	O	O
these	O	O
,	O	O
mixed	O	O
anaerobic	O	O
flora	O	O
,	O	O
Lactobacilli	B-bacteria	B-bacteria
and	O	O
mutans	B-bacteria	B-bacteria
Streptococci	E-bacteria	I-bacteria
were	O	O
cultured	O	O
in	O	O
up	O	O
to	O	O
three	O	O
different	O	O
kinds	O	O
of	O	O
culture	O	O
medium	O	O
.	O	O

Colonies	O	O
of	O	O
Lactobacilli	B-bacteria	B-bacteria
and	O	O
mutans	B-bacteria	B-bacteria
Streptococci	E-bacteria	I-bacteria
were	O	O
also	O	O
measured	O	O
after	O	O
transferring	O	O
them	O	O
to	O	O
glass	O	O
slides	O	O
.	O	O

Laboratory	O	O
teaching	O	O
strains	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
were	O	O
cultured	O	O
anaerobically	O	O
and	O	O
fluorescence	O	O
measured	O	O
directly	O	O
after	O	O
an	O	O
appropriate	O	O
incubation	O	O
period	O	O
.	O	O

Sound	O	O
enamel	O	O
surfaces	O	O
of	O	O
15	O	O
extracted	O	O
premolars	O	O
were	O	O
demineralized	O	O
and	O	O
changes	O	O
in	O	O
fluorescence	O	O
measured	O	O
.	O	O

DIAGNOdent	O	O
readings	O	O
>	O	O
20	O	O
were	O	O
only	O	O
obtained	O	O
from	O	O
young	O	O
colonies	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
and	O	O
from	O	O
colonies	O	O
of	O	O
mutans	B-bacteria	B-bacteria
Streptococci	E-bacteria	I-bacteria
cultured	O	O
on	O	O
mitis-salivarius-bacitracin	O	O
agar	O	O
.	O	O

Higher	O	O
measurements	O	O
were	O	O
obtained	O	O
as	O	O
the	O	O
bacterial	O	O
colonies	O	O
aged	O	O
.	O	O

Lower	O	O
measurements	O	O
were	O	O
obtained	O	O
after	O	O
transferring	O	O
colonies	O	O
to	O	O
glass	O	O
slides	O	O
.	O	O

Demineralization	O	O
of	O	O
enamel	O	O
did	O	O
not	O	O
affect	O	O
the	O	O
DIAGNOdent	O	O
measurements	O	O
.	O	O

The	O	O
change	O	O
in	O	O
fluorescence	O	O
measured	O	O
with	O	O
DIAGNOdent	O	O
has	O	O
a	O	O
bacterial	O	O
origin	O	O
rather	O	O
than	O	O
occurring	O	O
as	O	O
a	O	O
result	O	O
of	O	O
demineralization	O	O
.	O	O

The	O	O
measurements	O	O
are	O	O
presumably	O	O
dependent	O	O
on	O	O
bacterial	O	O
metabolites	O	O
rather	O	O
than	O	O
bacteria	O	O
themselves	O	O
,	O	O
and	O	O
probably	O	O
record	O	O
synergistic	O	O
effects	O	O
during	O	O
the	O	O
carious	O	O
process	O	O
rather	O	O
than	O	O
the	O	O
quantity	O	O
or	O	O
species	O	O
of	O	O
bacteria	O	O
involved	O	O
.	O	O

Eleven	O	O
clinical	O	O
strains	O	O
isolated	O	O
from	O	O
infected	O	O
wound	O	O
specimens	O	O
were	O	O
subjected	O	O
to	O	O
polyphasic	O	O
taxonomic	O	O
analysis	O	O
.	O	O

Sequence	O	O
analysis	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
showed	O	O
that	O	O
all	O	O
11	O	O
strains	O	O
were	O	O
phylogenetically	O	O
related	O	O
to	O	O
Slackia	O	O
exigua	O	O
.	O	O

Additionally	O	O
,	O	O
conventional	O	O
and	O	O
biochemical	O	O
tests	O	O
of	O	O
6	O	O
of	O	O
the	O	O
11	O	O
strains	O	O
were	O	O
performed	O	O
as	O	O
supplementary	O	O
methods	O	O
to	O	O
obtain	O	O
phenotypic	O	O
identification	O	O
by	O	O
comparison	O	O
with	O	O
the	O	O
phenotypes	O	O
of	O	O
the	O	O
relevant	O	O
type	O	O
strains	O	O
.	O	O

S.	B-bacteria	B-bacteria
exigua	E-bacteria	I-bacteria
has	O	O
been	O	O
considered	O	O
an	O	O
oral	O	O
bacterial	O	O
species	O	O
in	O	O
the	O	O
family	O	O
Coriobacteriaceae	O	O
.	O	O

This	O	O
organism	O	O
is	O	O
fastidious	O	O
and	O	O
grows	O	O
poorly	O	O
,	O	O
so	O	O
it	O	O
may	O	O
easily	O	O
be	O	O
overlooked	O	O
.	O	O

The	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
and	O	O
the	O	O
biochemical	O	O
characteristics	O	O
of	O	O
four	O	O
of	O	O
the	O	O
S.	B-bacteria	B-bacteria
exigua	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
for	O	O
this	O	O
study	O	O
from	O	O
various	O	O
infections	O	O
indicative	O	O
of	O	O
an	O	O
intestinal	O	O
source	O	O
were	O	O
almost	O	O
identical	O	O
to	O	O
those	O	O
of	O	O
the	O	O
validated	O	O
S.	B-bacteria	B-bacteria
exigua	I-bacteria	I-bacteria
type	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
from	O	O
an	O	O
oral	O	O
source	O	O
and	O	O
two	O	O
of	O	O
the	O	O
S.	B-bacteria	B-bacteria
exigua	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
from	O	O
oral	O	O
sources	O	O
evaluated	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Thus	O	O
,	O	O
we	O	O
show	O	O
for	O	O
the	O	O
first	O	O
time	O	O
that	O	O
S.	B-bacteria	B-bacteria
exigua	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
can	O	O
be	O	O
isolated	O	O
from	O	O
extraoral	O	O
infections	O	O
as	O	O
well	O	O
as	O	O
from	O	O
oral	O	O
infections	O	O
.	O	O

The	O	O
profiles	O	O
of	O	O
susceptibility	O	O
to	O	O
selected	O	O
antimicrobials	O	O
of	O	O
this	O	O
species	O	O
were	O	O
also	O	O
investigated	O	O
for	O	O
the	O	O
first	O	O
time	O	O
.	O	O

Studies	O	O
with	O	O
cetylpyridinium	O	O
chloride	O	O
(	O	O
CPC	O	O
)	O	O
mouth	O	O
rinses	O	O
that	O	O
range	O	O
from	O	O
1	O	O
use	O	O
to	O	O
6	O	O
months	O	O
of	O	O
use	O	O
have	O	O
documented	O	O
the	O	O
clinical	O	O
efficacy	O	O
of	O	O
these	O	O
formulations	O	O
on	O	O
supragingival	O	O
plaque	O	O
and	O	O
gingivitis	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
the	O	O
effects	O	O
of	O	O
a	O	O
commercially	O	O
available	O	O
mouth	O	O
rinse	O	O
containing	O	O
0.05	O	O
%	O	O
CPC	O	O
versus	O	O
a	O	O
fluoride	O	O
mouth	O	O
rinse	O	O
on	O	O
the	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
found	O	O
in	O	O
dental	O	O
plaque	O	O
.	O	O

Antimicrobial	O	O
effects	O	O
on	O	O
the	O	O
organisms	O	O
of	O	O
the	O	O
supragingival	O	O
plaque	O	O
,	O	O
a	O	O
natural	O	O
biofilm	O	O
,	O	O
were	O	O
determined	O	O
after	O	O
1	O	O
use	O	O
and	O	O
after	O	O
14	O	O
days	O	O
of	O	O
use	O	O
of	O	O
each	O	O
mouth	O	O
rinse	O	O
.	O	O

After	O	O
enrollment	O	O
,	O	O
adult	O	O
subjects	O	O
from	O	O
China	O	O
completed	O	O
a	O	O
1-week	O	O
washout	O	O
period	O	O
and	O	O
provided	O	O
baseline	O	O
samples	O	O
of	O	O
supragingival	O	O
plaque	O	O
for	O	O
analysis	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Subjects	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
receive	O	O
a	O	O
commercially	O	O
available	O	O
mouth	O	O
rinse	O	O
formulated	O	O
with	O	O
0.05	O	O
%	O	O
CPC	O	O
or	O	O
a	O	O
fluoride	O	O
mouth	O	O
rinse	O	O
.	O	O

Subjects	O	O
were	O	O
assigned	O	O
to	O	O
each	O	O
group	O	O
according	O	O
to	O	O
a	O	O
computer-generated	O	O
randomization	O	O
sequence	O	O
.	O	O

They	O	O
were	O	O
instructed	O	O
to	O	O
rinse	O	O
with	O	O
20	O	O
mL	O	O
of	O	O
either	O	O
the	O	O
CPC	O	O
or	O	O
the	O	O
fluoride	O	O
mouth	O	O
rinse	O	O
for	O	O
30	O	O
seconds	O	O
.	O	O

Microbiologic	O	O
analyses	O	O
of	O	O
dental	O	O
plaque	O	O
samples	O	O
were	O	O
conducted	O	O
12	O	O
hours	O	O
after	O	O
the	O	O
first	O	O
use	O	O
of	O	O
assigned	O	O
mouth	O	O
rinse	O	O
.	O	O

Subjects	O	O
were	O	O
instructed	O	O
to	O	O
continue	O	O
twice-daily	O	O
rinsing	O	O
with	O	O
their	O	O
assigned	O	O
mouth	O	O
rinse	O	O
for	O	O
the	O	O
next	O	O
14	O	O
days	O	O
in	O	O
addition	O	O
to	O	O
brushing	O	O
their	O	O
teeth	O	O
with	O	O
a	O	O
commercial	O	O
fluoride	O	O
toothpaste	O	O
.	O	O

Dental	O	O
plaque	O	O
samples	O	O
for	O	O
microbiologic	O	O
analyses	O	O
were	O	O
collected	O	O
on	O	O
day	O	O
15	O	O
;	O	O
this	O	O
was	O	O
done	O	O
12	O	O
hours	O	O
after	O	O
the	O	O
final	O	O
use	O	O
of	O	O
the	O	O
assigned	O	O
mouth	O	O
rinses	O	O
.	O	O

A	O	O
dentist	O	O
conducted	O	O
oral	O	O
examinations	O	O
before	O	O
each	O	O
sample	O	O
collection	O	O
to	O	O
evaluate	O	O
hard	O	O
and	O	O
soft	O	O
tissue	O	O
health	O	O
over	O	O
the	O	O
course	O	O
of	O	O
the	O	O
study	O	O
.	O	O

The	O	O
study	O	O
included	O	O
117	O	O
adults	O	O
(	O	O
62	O	O
females	O	O
,	O	O
mean	O	O
age	O	O
,	O	O
28.70	O	O
years	O	O
;	O	O
55	O	O
males	O	O
,	O	O
mean	O	O
age	O	O
,	O	O
30.41	O	O
years	O	O
)	O	O
.	O	O

Subjects	O	O
rinsing	O	O
with	O	O
the	O	O
CPC	O	O
mouthwash	O	O
(	O	O
n	O	O
=	O	O
58	O	O
;	O	O
mean	O	O
age	O	O
,	O	O
29.41	O	O
years	O	O
)	O	O
reported	O	O
significant	O	O
reductions	O	O
in	O	O
anaerobic	O	O
bacteria	O	O
versus	O	O
those	O	O
issued	O	O
the	O	O
fluoride	O	O
rinse	O	O
(	O	O
n	O	O
=	O	O
59	O	O
;	O	O
mean	O	O
age	O	O
,	O	O
29.61	O	O
years	O	O
)	O	O
12	O	O
hours	O	O
after	O	O
1	O	O
use	O	O
and	O	O
12	O	O
hours	O	O
after	O	O
14	O	O
days	O	O
of	O	O
use	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

The	O	O
mean	O	O
percent	O	O
reduction	O	O
in	O	O
anaerobic	O	O
bacteria	O	O
between	O	O
the	O	O
CPC	O	O
mouth	O	O
rinse	O	O
and	O	O
the	O	O
fluoride	O	O
mouth	O	O
rinse	O	O
was	O	O
29.98	O	O
%	O	O
after	O	O
1	O	O
use	O	O
and	O	O
57.90	O	O
%	O	O
after	O	O
14	O	O
days	O	O
of	O	O
use	O	O
.	O	O

All	O	O
enrolled	O	O
subjects	O	O
completed	O	O
the	O	O
study	O	O
without	O	O
any	O	O
adverse	O	O
events	O	O
.	O	O

Use	O	O
of	O	O
the	O	O
CPC	O	O
mouth	O	O
rinse	O	O
was	O	O
associated	O	O
with	O	O
significant	O	O
reductions	O	O
in	O	O
the	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
of	O	O
supragingival	O	O
plaque	O	O
compared	O	O
with	O	O
fluoride	O	O
mouth	O	O
rinse	O	O
use	O	O
in	O	O
these	O	O
adult	O	O
subjects	O	O
.	O	O

Bacterial	O	O
metabolites	O	O
demineralize	O	O
dental	O	O
hard	O	O
tissues	O	O
,	O	O
and	O	O
soluble	O	O
factors	O	O
lead	O	O
to	O	O
tertiary	O	O
dentinogenesis	O	O
in	O	O
the	O	O
area	O	O
of	O	O
the	O	O
dentin-pulp	O	O
complex	O	O
.	O	O

However	O	O
,	O	O
it	O	O
is	O	O
unclear	O	O
whether	O	O
the	O	O
oral	O	O
bacteria	O	O
are	O	O
directly	O	O
involved	O	O
in	O	O
the	O	O
differentiation	O	O
of	O	O
dental	O	O
pulp	O	O
cells	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
evaluated	O	O
the	O	O
effect	O	O
of	O	O
oral	O	O
bacterial	O	O
extracts	O	O
on	O	O
cellular	O	O
differentiation	O	O
in	O	O
human	O	O
dental	O	O
pulp-derived	O	O
cells	O	O
(	O	O
hDPC	O	O
)	O	O
.	O	O

The	O	O
hDPC	O	O
were	O	O
obtained	O	O
from	O	O
third	O	O
molar	O	O
teeth	O	O
,	O	O
and	O	O
the	O	O
cells	O	O
were	O	O
subcultured	O	O
.	O	O

The	O	O
sonicated	O	O
extracts	O	O
were	O	O
obtained	O	O
from	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
gram-negative	O	O
)	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
gram-positive	O	O
)	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
bacterial	O	O
extracts	O	O
on	O	O
cellular	O	O
growth	O	O
and	O	O
differentiation	O	O
in	O	O
hDPC	O	O
were	O	O
tested	O	O
.	O	O

Alkaline	O	O
phosphatase	O	O
activity	O	O
and	O	O
bone	O	O
sialoprotein	O	O
(	O	O
BSP	O	O
)	O	O
gene	O	O
expression	O	O
were	O	O
increased	O	O
in	O	O
hDPC	O	O
exposed	O	O
to	O	O
low	O	O
concentrations	O	O
of	O	O
both	O	O
sonicated	O	O
extracts	O	O
,	O	O
whereas	O	O
the	O	O
activity	O	O
was	O	O
decreased	O	O
upon	O	O
exposure	O	O
to	O	O
high	O	O
concentrations	O	O
of	O	O
sonicated	O	O
extracts	O	O
from	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
evidence	O	O
that	O	O
oral	O	O
bacteria	O	O
have	O	O
a	O	O
positive	O	O
effect	O	O
on	O	O
cellular	O	O
differentiation	O	O
in	O	O
hPDC	O	O
.	O	O

Interactions	O	O
between	O	O
periodontal	O	O
bacteria	O	O
and	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
can	O	O
lead	O	O
to	O	O
the	O	O
activation	O	O
and	O	O
expression	O	O
of	O	O
a	O	O
variety	O	O
of	O	O
inflammatory	O	O
mediators	O	O
in	O	O
epithelial	O	O
cells	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
is	O	O
a	O	O
filamentous	O	O
human	O	O
pathogen	O	O
that	O	O
is	O	O
strongly	O	O
associated	O	O
with	O	O
periodontal	O	O
diseases	O	O
.	O	O

This	O	O
study	O	O
examined	O	O
the	O	O
effects	O	O
of	O	O
methyl	O	O
gallate	O	O
(	O	O
MG	O	O
)	O	O
and	O	O
gallic	O	O
acid	O	O
(	O	O
GA	O	O
)	O	O
on	O	O
the	O	O
production	O	O
of	O	O
inflammatory	O	O
mediators	O	O
,	O	O
interleukin	O	O
(	O	O
IL	O	O
)	O	O
-6	O	O
and	O	O
IL-8	O	O
,	O	O
by	O	O
oral	O	O
epithelial	O	O
cells	O	O
stimulated	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

In	O	O
a	O	O
real-time	O	O
reverse	O	O
transcription-polymerase	O	O
chain	O	O
reaction	O	O
and	O	O
an	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
,	O	O
live	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
induced	O	O
high	O	O
levels	O	O
of	O	O
gene	O	O
expression	O	O
and	O	O
protein	O	O
release	O	O
of	O	O
IL-6	O	O
and	O	O
IL-8	O	O
.	O	O

The	O	O
effects	O	O
of	O	O
MG	O	O
and	O	O
GA	O	O
were	O	O
examined	O	O
by	O	O
treating	O	O
KB	O	O
oral	O	O
epithelial	O	O
cells	O	O
with	O	O
MG	O	O
and	O	O
GA	O	O
and	O	O
stimulating	O	O
them	O	O
with	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

MG	O	O
and	O	O
GA	O	O
inhibited	O	O
significantly	O	O
the	O	O
increases	O	O
in	O	O
the	O	O
IL-6	O	O
and	O	O
IL-8	O	O
gene	O	O
and	O	O
protein	O	O
levels	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
.	O	O

These	O	O
Compounds	O	O
also	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

No	O	O
visible	O	O
effects	O	O
of	O	O
MG	O	O
and	O	O
GA	O	O
on	O	O
the	O	O
adhesion	O	O
and	O	O
invasion	O	O
of	O	O
KB	O	O
cells	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
were	O	O
observed	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
both	O	O
MG	O	O
and	O	O
GA	O	O
inhibit	O	O
IL-6	O	O
and	O	O
IL-8	O	O
production	O	O
from	O	O
F.	O	O
nucleatum-activated	O	O
KB	O	O
cells	O	O
.	O	O

Previous	O	O
research	O	O
has	O	O
shown	O	O
the	O	O
oxidizing	O	O
properties	O	O
and	O	O
microbiological	O	O
efficacies	O	O
of	O	O
chlorine	O	O
dioxide	O	O
(	O	O
ClO2	O	O
)	O	O
.	O	O

Its	O	O
clinical	O	O
efficacies	O	O
on	O	O
oral	O	O
malodor	O	O
have	O	O
been	O	O
evaluated	O	O
and	O	O
reported	O	O
only	O	O
in	O	O
short	O	O
duration	O	O
trials	O	O
,	O	O
moreover	O	O
,	O	O
no	O	O
clinical	O	O
studies	O	O
have	O	O
investigated	O	O
its	O	O
microbiological	O	O
efficacies	O	O
on	O	O
periodontal	O	O
and	O	O
malodorous	O	O
bacteria	O	O
.	O	O

Thus	O	O
,	O	O
the	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
assess	O	O
the	O	O
inhibitory	O	O
effects	O	O
of	O	O
a	O	O
mouthwash	O	O
containing	O	O
ClO2	O	O
used	O	O
for	O	O
7	O	O
days	O	O
on	O	O
morning	O	O
oral	O	O
malodor	O	O
and	O	O
on	O	O
salivary	O	O
periodontal	O	O
and	O	O
malodorous	O	O
bacteria	O	O
.	O	O

A	O	O
randomized	O	O
,	O	O
double	O	O
blind	O	O
,	O	O
crossover	O	O
,	O	O
placebo-controlled	O	O
trial	O	O
was	O	O
conducted	O	O
among	O	O
15	O	O
healthy	O	O
male	O	O
volunteers	O	O
,	O	O
who	O	O
were	O	O
divided	O	O
into	O	O
2	O	O
groups	O	O
.	O	O

Subjects	O	O
were	O	O
instructed	O	O
to	O	O
rinse	O	O
with	O	O
the	O	O
experimental	O	O
mouthwash	O	O
containing	O	O
ClO2	O	O
or	O	O
the	O	O
placebo	O	O
mouthwash	O	O
,	O	O
without	O	O
ClO2	O	O
,	O	O
twice	O	O
per	O	O
day	O	O
for	O	O
7	O	O
days	O	O
.	O	O

After	O	O
a	O	O
one	O	O
week	O	O
washout	O	O
period	O	O
,	O	O
each	O	O
group	O	O
then	O	O
used	O	O
the	O	O
opposite	O	O
mouthwash	O	O
for	O	O
7	O	O
days	O	O
.	O	O

At	O	O
baseline	O	O
and	O	O
after	O	O
7	O	O
days	O	O
,	O	O
oral	O	O
malodor	O	O
was	O	O
evaluated	O	O
with	O	O
Organoleptic	O	O
measurement	O	O
(	O	O
OM	O	O
)	O	O
,	O	O
and	O	O
analyzed	O	O
the	O	O
concentrations	O	O
of	O	O
hydrogen	O	O
sulfide	O	O
(	O	O
H2S	O	O
)	O	O
,	O	O
methyl	O	O
mercaptan	O	O
(	O	O
CH3SH	O	O
)	O	O
and	O	O
dimethyl	O	O
sulfide	O	O
(	O	O
(	O	O
CH3	O	O
)	O	O
2S	O	O
)	O	O
,	O	O
the	O	O
main	O	O
VSCs	O	O
of	O	O
human	O	O
oral	O	O
malodor	O	O
,	O	O
were	O	O
assessed	O	O
by	O	O
gas	O	O
chromatography	O	O
(	O	O
GC	O	O
)	O	O
.	O	O

Clinical	O	O
outcome	O	O
variables	O	O
included	O	O
plaque	O	O
and	O	O
gingival	O	O
indices	O	O
,	O	O
and	O	O
tongue	O	O
coating	O	O
index	O	O
.	O	O

The	O	O
samples	O	O
of	O	O
saliva	O	O
were	O	O
microbiologically	O	O
investigated	O	O
.	O	O

Quantitative	O	O
and	O	O
qualitative	O	O
analyses	O	O
were	O	O
performed	O	O
using	O	O
the	O	O
polymerase	O	O
chain	O	O
reaction-Invader	O	O
method	O	O
.	O	O

RESULTS	O	O
AND	O	O
The	O	O
baseline	O	O
oral	O	O
condition	O	O
in	O	O
healthy	O	O
subjects	O	O
in	O	O
the	O	O
2	O	O
groups	O	O
did	O	O
not	O	O
differ	O	O
significantly	O	O
.	O	O

After	O	O
rinsing	O	O
with	O	O
the	O	O
mouthwash	O	O
containing	O	O
ClO2	O	O
for	O	O
7	O	O
days	O	O
,	O	O
morning	O	O
bad	O	O
breath	O	O
decreased	O	O
as	O	O
measured	O	O
by	O	O
the	O	O
OM	O	O
and	O	O
reduced	O	O
the	O	O
concentrations	O	O
of	O	O
H2S	O	O
,	O	O
CH3SH	O	O
and	O	O
(	O	O
CH3	O	O
)	O	O
2S	O	O
measured	O	O
by	O	O
GC	O	O
,	O	O
were	O	O
found	O	O
.	O	O

Moreover	O	O
ClO2	O	O
mouthwash	O	O
used	O	O
over	O	O
a	O	O
7-day	O	O
period	O	O
appeared	O	O
effective	O	O
in	O	O
reducing	O	O
plaque	O	O
,	O	O
tongue	O	O
coating	O	O
accumulation	O	O
and	O	O
the	O	O
counts	O	O
of	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
in	O	O
saliva	O	O
.	O	O

Future	O	O
research	O	O
is	O	O
needed	O	O
to	O	O
examine	O	O
long-term	O	O
effects	O	O
,	O	O
as	O	O
well	O	O
as	O	O
effects	O	O
on	O	O
periodontal	O	O
diseases	O	O
and	O	O
plaque	O	O
accumulation	O	O
in	O	O
a	O	O
well-defined	O	O
sample	O	O
of	O	O
halitosis	O	O
patients	O	O
and	O	O
broader	O	O
population	O	O
samples	O	O
.	O	O

ClinicalTrials.gov	O	O
NCT00748943	O	O
.	O	O

Fixed	O	O
orthodontic	O	O
appliances	O	O
can	O	O
alter	O	O
the	O	O
subgingival	O	O
microbiota	O	O
.	O	O

Our	O	O
aim	O	O
was	O	O
to	O	O
compare	O	O
the	O	O
subgingival	O	O
microbiota	O	O
and	O	O
clinical	O	O
parameters	O	O
in	O	O
adolescent	O	O
subjects	O	O
at	O	O
sites	O	O
of	O	O
teeth	O	O
treated	O	O
with	O	O
orthodontic	O	O
bands	O	O
with	O	O
margins	O	O
at	O	O
(	O	O
OBM	O	O
)	O	O
or	O	O
below	O	O
the	O	O
gingival	O	O
margin	O	O
(	O	O
OBSM	O	O
)	O	O
,	O	O
or	O	O
with	O	O
brackets	O	O
(	O	O
OBR	O	O
)	O	O
.	O	O

Microbial	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
33	O	O
subjects	O	O
(	O	O
ages	O	O
,	O	O
12-18	O	O
years	O	O
)	O	O
in	O	O
treatment	O	O
more	O	O
than	O	O
6	O	O
months	O	O
.	O	O

The	O	O
microbiota	O	O
was	O	O
assessed	O	O
by	O	O
the	O	O
DNA-DNA	O	O
checkerboard	O	O
hybridization	O	O
method	O	O
.	O	O

Bacterial	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
83	O	O
OBR,103	O	O
OBSM	O	O
,	O	O
and	O	O
54	O	O
OBM	O	O
sites	O	O
.	O	O

Probing	O	O
pocket	O	O
depths	O	O
differed	O	O
by	O	O
orthodontic	O	O
type	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
with	O	O
mean	O	O
values	O	O
of	O	O
2.9	O	O
mm	O	O
(	O	O
SD	O	O
,	O	O
0.6	O	O
)	O	O
at	O	O
OBSM	O	O
sites	O	O
,	O	O
2.5	O	O
mm	O	O
(	O	O
SD	O	O
,	O	O
0.6	O	O
)	O	O
at	O	O
OBM	O	O
sites	O	O
,	O	O
and	O	O
2.3	O	O
mm	O	O
(	O	O
SD	O	O
,	O	O
0.5	O	O
)	O	O
at	O	O
OBR	O	O
sites	O	O
.	O	O

Only	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
had	O	O
higher	O	O
levels	O	O
at	O	O
OBR	O	O
sites	O	O
,	O	O
whereas	O	O
Neisseria	B-bacteria	B-bacteria
mucosa	O	O
had	O	O
higher	O	O
levels	O	O
at	O	O
sites	O	O
treated	O	O
with	O	O
OBSM	O	O
or	O	O
OBM	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
was	O	O
found	O	O
in	O	O
25	O	O
%	O	O
of	O	O
sites	O	O
independent	O	O
of	O	O
the	O	O
appliance	O	O
.	O	O

Different	O	O
types	O	O
of	O	O
orthodontic	O	O
appliances	O	O
cause	O	O
minor	O	O
differences	O	O
in	O	O
the	O	O
subgingival	O	O
microbiota	O	O
(	O	O
A	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
and	O	O
A	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
)	O	O
and	O	O
higher	O	O
levels	O	O
at	O	O
sites	O	O
treated	O	O
with	O	O
orthodontic	O	O
brackets	O	O
.	O	O

More	O	O
sites	O	O
with	O	O
bleeding	O	O
on	O	O
probing	O	O
and	O	O
deeper	O	O
pockets	O	O
were	O	O
found	O	O
around	O	O
orthodontic	O	O
bands	O	O
.	O	O

Lactoferrin	O	O
(	O	O
LF	O	O
)	O	O
is	O	O
a	O	O
component	O	O
of	O	O
saliva	O	O
and	O	O
is	O	O
suspected	O	O
to	O	O
be	O	O
a	O	O
defense	O	O
factor	O	O
against	O	O
oral	O	O
pathogens	O	O
including	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Candida	O	O
albicans	O	O
.	O	O

Periodontitis	O	O
is	O	O
a	O	O
very	O	O
common	O	O
oral	O	O
disease	O	O
caused	O	O
by	O	O
periodontopathic	O	O
bacteria	O	O
.	O	O

Antimicrobial	O	O
activities	O	O
and	O	O
other	O	O
biological	O	O
effects	O	O
of	O	O
LF	O	O
against	O	O
representative	O	O
periodontopathic	O	O
bacteria	O	O
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
have	O	O
been	O	O
widely	O	O
studied	O	O
.	O	O

Association	O	O
of	O	O
polymorphisms	O	O
in	O	O
LF	O	O
with	O	O
incidence	O	O
of	O	O
aggressive	O	O
periodontitis	O	O
and	O	O
the	O	O
role	O	O
of	O	O
LF	O	O
in	O	O
the	O	O
gingival	O	O
crevicular	O	O
fluid	O	O
as	O	O
a	O	O
marker	O	O
of	O	O
periodontitis	O	O
severity	O	O
have	O	O
also	O	O
been	O	O
reported	O	O
.	O	O

Periodontopathic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
reside	O	O
as	O	O
a	O	O
biofilm	O	O
in	O	O
supragingival	O	O
and	O	O
subgingival	O	O
plaque	O	O
.	O	O

Our	O	O
recent	O	O
study	O	O
indicated	O	O
that	O	O
LF	O	O
exhibits	O	O
antibacterial	O	O
activity	O	O
against	O	O
planktonic	O	O
forms	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
at	O	O
higher	O	O
concentrations	O	O
,	O	O
and	O	O
furthermore	O	O
,	O	O
LF	O	O
effectively	O	O
inhibits	O	O
biofilm	O	O
formation	O	O
and	O	O
reduces	O	O
the	O	O
established	O	O
biofilm	O	O
of	O	O
these	O	O
bacteria	O	O
at	O	O
physiological	O	O
concentrations	O	O
.	O	O

A	O	O
small-scale	O	O
clinical	O	O
study	O	O
indicated	O	O
that	O	O
oral	O	O
administration	O	O
of	O	O
bovine	O	O
LF	O	O
reduces	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
in	O	O
the	O	O
subgingival	O	O
plaque	O	O
of	O	O
chronic	O	O
periodontitis	O	O
patients	O	O
.	O	O

LF	O	O
seems	O	O
to	O	O
be	O	O
a	O	O
biofilm	O	O
inhibitor	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
influence	O	O
of	O	O
oral	O	O
status	O	O
on	O	O
halitosis	O	O
,	O	O
the	O	O
relationship	O	O
between	O	O
halitosis	O	O
and	O	O
periodontopathic	O	O
bacteria	O	O
present	O	O
in	O	O
plaque	O	O
on	O	O
the	O	O
tongue	O	O
and	O	O
the	O	O
subgingival	O	O
sulcus	O	O
was	O	O
examined	O	O
in	O	O
62	O	O
periodontally	O	O
healthy	O	O
adults	O	O
.	O	O

Halitosis	O	O
indicators	O	O
used	O	O
were	O	O
the	O	O
organoleptic	O	O
score	O	O
;	O	O
gas	O	O
chromatography	O	O
results	O	O
[	O	O
total	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSCs	O	O
)	O	O
=	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
+	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
SH	O	O
+	O	O
(	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
)	O	O
(	O	O
2	O	O
)	O	O
S	O	O
]	O	O
;	O	O
Halimeter	O	O
values	O	O
;	O	O
and	O	O
the	O	O
results	O	O
of	O	O
three	O	O
clinical	O	O
tests	O	O
,	O	O
plaque	O	O
control	O	O
record	O	O
(	O	O
PlCR	O	O
)	O	O
,	O	O
plaque	O	O
index	O	O
(	O	O
PlI	O	O
)	O	O
,	O	O
and	O	O
tongue	O	O
coat	O	O
status	O	O
.	O	O

Significant	O	O
correlations	O	O
with	O	O
organoleptic	O	O
scores	O	O
was	O	O
observed	O	O
for	O	O
PlCR	O	O
,	O	O
PlI	O	O
,	O	O
tongue	O	O
coat	O	O
status	O	O
,	O	O
VSC	O	O
amounts	O	O
,	O	O
and	O	O
Halimeter	O	O
values	O	O
,	O	O
indicating	O	O
that	O	O
halitosis	O	O
in	O	O
periodontally	O	O
healthy	O	O
subjects	O	O
tended	O	O
to	O	O
originate	O	O
from	O	O
tongue	O	O
plaque	O	O
deposits	O	O
.	O	O

Polymerase	O	O
chain	O	O
reaction	O	O
analysis	O	O
was	O	O
used	O	O
to	O	O
detect	O	O
six	O	O
periodontopathic	O	O
bacteria	O	O
(	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
from	O	O
the	O	O
tongue	O	O
and	O	O
subgingival	O	O
plaque	O	O
.	O	O

Significant	O	O
effects	O	O
on	O	O
the	O	O
organoleptic	O	O
scores	O	O
,	O	O
tongue	O	O
coat	O	O
status	O	O
,	O	O
total	O	O
VSC	O	O
,	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
and	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
SH	O	O
amounts	O	O
,	O	O
and	O	O
Halimeter	O	O
values	O	O
were	O	O
observed	O	O
only	O	O
for	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
only	O	O
in	O	O
the	O	O
tongue	O	O
plaque	O	O
,	O	O
not	O	O
in	O	O
the	O	O
subgingival	O	O
plaque	O	O
.	O	O

Thus	O	O
,	O	O
therapies	O	O
developed	O	O
to	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
these	O	O
bacteria	O	O
may	O	O
lead	O	O
to	O	O
future	O	O
treatments	O	O
of	O	O
halitosis	O	O
.	O	O

Distinguishing	O	O
expirated	O	O
bloodstains	O	O
(	O	O
blood	O	O
forced	O	O
by	O	O
airflow	O	O
out	O	O
of	O	O
the	O	O
nose	O	O
,	O	O
mouth	O	O
or	O	O
a	O	O
chest	O	O
wound	O	O
)	O	O
from	O	O
impact	O	O
spatter	O	O
(	O	O
blood	O	O
from	O	O
gunshots	O	O
,	O	O
explosives	O	O
,	O	O
blunt	O	O
force	O	O
trauma	O	O
and/or	O	O
machinery	O	O
accidents	O	O
)	O	O
is	O	O
an	O	O
important	O	O
challenge	O	O
in	O	O
forensic	O	O
science	O	O
.	O	O

Streptococcal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
are	O	O
only	O	O
found	O	O
in	O	O
the	O	O
human	O	O
mouth	O	O
and	O	O
saliva	O	O
.	O	O

This	O	O
study	O	O
developed	O	O
a	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
method	O	O
that	O	O
detects	O	O
DNA	O	O
from	O	O
these	O	O
bacteria	O	O
as	O	O
a	O	O
sensitive	O	O
tool	O	O
to	O	O
detect	O	O
the	O	O
presence	O	O
of	O	O
saliva	O	O
.	O	O

The	O	O
PCR	O	O
method	O	O
was	O	O
very	O	O
specific	O	O
to	O	O
human	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
with	O	O
no	O	O
PCR	O	O
product	O	O
being	O	O
made	O	O
from	O	O
human	O	O
DNA	O	O
or	O	O
DNA	O	O
from	O	O
other	O	O
microbes	O	O
that	O	O
were	O	O
tested	O	O
.	O	O

It	O	O
was	O	O
also	O	O
very	O	O
sensitive	O	O
,	O	O
detecting	O	O
as	O	O
little	O	O
as	O	O
60	O	O
fg	O	O
of	O	O
target	O	O
DNA	O	O
.	O	O

The	O	O
PCR	O	O
amplification	O	O
gave	O	O
product	O	O
with	O	O
99	O	O
out	O	O
of	O	O
100	O	O
saliva	O	O
samples	O	O
tested	O	O
.	O	O

PCR	O	O
was	O	O
not	O	O
inhibited	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
blood	O	O
and	O	O
could	O	O
detect	O	O
target	O	O
DNA	O	O
in	O	O
expirated	O	O
bloodstains	O	O
in	O	O
a	O	O
range	O	O
of	O	O
materials	O	O
and	O	O
for	O	O
up	O	O
to	O	O
92	O	O
days	O	O
after	O	O
deposit	O	O
on	O	O
cardboard	O	O
or	O	O
cotton	O	O
fabric	O	O
.	O	O

In	O	O
a	O	O
blind	O	O
trial	O	O
,	O	O
the	O	O
PCR	O	O
method	O	O
was	O	O
able	O	O
to	O	O
distinguish	O	O
three	O	O
mock	O	O
forensic	O	O
samples	O	O
that	O	O
contained	O	O
expirated	O	O
blood	O	O
from	O	O
four	O	O
that	O	O
did	O	O
not	O	O
.	O	O

Our	O	O
data	O	O
show	O	O
that	O	O
bacteria	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
can	O	O
be	O	O
detected	O	O
in	O	O
bloodstains	O	O
that	O	O
contain	O	O
saliva	O	O
and	O	O
therefore	O	O
can	O	O
potentially	O	O
be	O	O
used	O	O
as	O	O
a	O	O
marker	O	O
in	O	O
forensic	O	O
work	O	O
to	O	O
distinguish	O	O
mouth-expirated	O	O
bloodstains	O	O
from	O	O
other	O	O
types	O	O
of	O	O
bloodstains	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
specific	O	O
sequences	O	O
within	O	O
three	O	O
genes	O	O
(	O	O
3D	O	O
,	O	O
VP4	O	O
and	O	O
2B	O	O
)	O	O
of	O	O
the	O	O
foot-and-mouth	O	O
disease	O	O
virus	O	O
(	O	O
FMDV	O	O
)	O	O
genome	O	O
were	O	O
determined	O	O
to	O	O
be	O	O
effective	O	O
RNAi	O	O
targets	O	O
.	O	O

These	O	O
sequences	O	O
are	O	O
highly	O	O
conserved	O	O
among	O	O
different	O	O
serotype	O	O
viruses	O	O
based	O	O
on	O	O
sequence	O	O
analysis	O	O
.	O	O

Small	O	O
interfering	O	O
RNA	O	O
(	O	O
siRNA	O	O
)	O	O
-expressing	O	O
plasmids	O	O
(	O	O
p3D-NT19	O	O
,	O	O
p3D-NT56	O	O
,	O	O
pVP4-NT19	O	O
,	O	O
pVP4-NT65	O	O
and	O	O
p2B-NT25	O	O
)	O	O
were	O	O
constructed	O	O
to	O	O
express	O	O
siRNA	O	O
targeting	O	O
3D	O	O
,	O	O
VP4	O	O
and	O	O
2B	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
antiviral	O	O
potential	O	O
of	O	O
these	O	O
siRNA	O	O
for	O	O
various	O	O
FMDV	O	O
isolates	O	O
was	O	O
investigated	O	O
in	O	O
baby	O	O
hamster	O	O
kidney	O	O
(	O	O
BHK-21	O	O
)	O	O
cells	O	O
and	O	O
suckling	O	O
mice	O	O
.	O	O

The	O	O
results	O	O
show	O	O
that	O	O
these	O	O
siRNA	O	O
inhibited	O	O
virus	O	O
yield	O	O
10-	O	O
to	O	O
300-fold	O	O
for	O	O
different	O	O
FMDV	O	O
isolates	O	O
of	O	O
serotype	O	O
O	O	O
and	O	O
serotype	O	O
Asia	O	O
I	O	O
at	O	O
48	O	O
h	O	O
post	O	O
infection	O	O
in	O	O
BHK-21	O	O
cells	O	O
compared	O	O
to	O	O
control	O	O
cells	O	O
.	O	O

In	O	O
suckling	O	O
mice	O	O
,	O	O
p3D-NT56	O	O
and	O	O
p2B-NT25	O	O
delayed	O	O
the	O	O
death	O	O
of	O	O
mice	O	O
.	O	O

Twenty	O	O
percent	O	O
to	O	O
40	O	O
%	O	O
of	O	O
the	O	O
animals	O	O
that	O	O
received	O	O
a	O	O
single	O	O
siRNA	O	O
dose	O	O
survived	O	O
5	O	O
days	O	O
post	O	O
infection	O	O
with	O	O
serotype	O	O
O	O	O
or	O	O
serotype	O	O
Asia	O	O
I	O	O
.	O	O

We	O	O
used	O	O
an	O	O
attenuated	O	O
Salmonella	B-bacteria	B-bacteria
choleraesuis	E-bacteria	I-bacteria
(	O	O
C500	O	O
)	O	O
vaccine	O	O
strain	O	O
,	O	O
to	O	O
carry	O	O
the	O	O
plasmid	O	O
that	O	O
expresses	O	O
siRNA	O	O
directed	O	O
against	O	O
the	O	O
polymerase	O	O
gene	O	O
3D	O	O
(	O	O
p3D-NT56	O	O
)	O	O
of	O	O
FMDV	O	O
.	O	O

We	O	O
used	O	O
guinea	O	O
pigs	O	O
to	O	O
evaluate	O	O
the	O	O
inhibitory	O	O
effects	O	O
of	O	O
recombinant	O	O
S.	B-bacteria	B-bacteria
cho	E-bacteria	I-bacteria
(	O	O
p3D-NT56/S	O	O
.	O	O

cho	O	O
)	O	O
on	O	O
FMDV	O	O
infection	O	O
.	O	O

The	O	O
results	O	O
show	O	O
that	O	O
80	O	O
%	O	O
of	O	O
guinea	O	O
pigs	O	O
inoculated	O	O
with	O	O
10	O	O
(	O	O
9	O	O
)	O	O
CFU	O	O
of	O	O
p3D-NT56/S	O	O
.	O	O

cho	O	O
and	O	O
challenged	O	O
36	O	O
h	O	O
later	O	O
with	O	O
50	O	O
ID	O	O
(	O	O
50	O	O
)	O	O
of	O	O
homologous	O	O
FMDV	O	O
were	O	O
protected	O	O
.	O	O

We	O	O
also	O	O
measured	O	O
the	O	O
antiviral	O	O
activity	O	O
of	O	O
p3D-NT56/S	O	O
.	O	O

cho	O	O
in	O	O
swine	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
that	O	O
100	O	O
%	O	O
of	O	O
the	O	O
animals	O	O
treated	O	O
with	O	O
5	O	O
x	O	O
10	O	O
(	O	O
9	O	O
)	O	O
CFU	O	O
of	O	O
p3D-NT56/S	O	O
.	O	O

cho	O	O
were	O	O
protected	O	O
in	O	O
9	O	O
days	O	O
.	O	O

Although	O	O
many	O	O
clinical	O	O
trials	O	O
on	O	O
human	O	O
papillomavirus	O	O
(	O	O
HPV	O	O
)	O	O
therapeutic	O	O
vaccines	O	O
have	O	O
been	O	O
performed	O	O
,	O	O
clinical	O	O
responses	O	O
have	O	O
not	O	O
been	O	O
consistent	O	O
.	O	O

We	O	O
have	O	O
addressed	O	O
mucosal	O	O
cytotoxic	O	O
cellular	O	O
immune	O	O
responses	O	O
to	O	O
HPV16	O	O
E7	O	O
after	O	O
oral	O	O
immunization	O	O
of	O	O
mice	O	O
with	O	O
recombinant	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
expressing	O	O
HPV16	O	O
E7	O	O
(	O	O
LacE7	O	O
)	O	O
.	O	O

C57BL/6	O	O
mice	O	O
were	O	O
orally	O	O
exposed	O	O
to	O	O
0.1-100mg/head	O	O
of	O	O
attenuated	O	O
LacE7	O	O
or	O	O
vehicle	O	O
(	O	O
Lac	O	O
)	O	O
vaccines	O	O
at	O	O
weeks	O	O
1	O	O
,	O	O
2	O	O
,	O	O
4	O	O
,	O	O
and	O	O
8	O	O
.	O	O

Responses	O	O
to	O	O
subcutaneous	O	O
or	O	O
intramuscular	O	O
injection	O	O
of	O	O
an	O	O
HPV16	O	O
E7	O	O
fusion	O	O
protein	O	O
using	O	O
the	O	O
same	O	O
timing	O	O
protocol	O	O
were	O	O
used	O	O
for	O	O
comparison	O	O
.	O	O

Oral	O	O
immunization	O	O
with	O	O
LacE7	O	O
elicited	O	O
E7-specific	O	O
IFN	O	O
gamma-producing	O	O
cells	O	O
(	O	O
T	O	O
cells	O	O
with	O	O
E7-type	O	O
1	O	O
immune	O	O
responses	O	O
)	O	O
among	O	O
integrin	O	O
alpha	O	O
4	O	O
beta	O	O
7	O	O
(	O	O
+	O	O
)	O	O
mucosal	O	O
lymphocytes	O	O
collected	O	O
from	O	O
gut	O	O
mucosa	O	O
.	O	O

An	O	O
induction	O	O
of	O	O
E7-specific	O	O
granzyme	O	O
B-producing	O	O
cells	O	O
(	O	O
E7-CTL	O	O
)	O	O
exhibiting	O	O
killer	O	O
responses	O	O
toward	O	O
HPV16	O	O
E7-positive	O	O
cells	O	O
was	O	O
also	O	O
observed	O	O
.	O	O

The	O	O
induction	O	O
of	O	O
T	O	O
cells	O	O
with	O	O
specific	O	O
mucosal	O	O
E7-type	O	O
1	O	O
immune	O	O
responses	O	O
was	O	O
greater	O	O
after	O	O
oral	O	O
immunization	O	O
with	O	O
LacE7	O	O
when	O	O
compared	O	O
to	O	O
subcutaneous	O	O
or	O	O
intramuscular	O	O
antigen	O	O
delivery	O	O
.	O	O

Oral	O	O
immunization	O	O
with	O	O
Lactobacillus-based	O	O
vaccines	O	O
was	O	O
also	O	O
able	O	O
to	O	O
induce	O	O
mucosal	O	O
cytotoxic	O	O
cellular	O	O
immune	O	O
responses	O	O
.	O	O

This	O	O
novel	O	O
approach	O	O
at	O	O
a	O	O
therapeutic	O	O
HPV	O	O
vaccine	O	O
may	O	O
achieve	O	O
more	O	O
effective	O	O
clinical	O	O
responses	O	O
through	O	O
its	O	O
induction	O	O
of	O	O
mucosal	O	O
E7-specific	O	O
CTL	O	O
.	O	O

Probiotics	B-bacteria	B-bacteria
or	O	O
health-beneficial	O	O
bacteria	O	O
have	O	O
only	O	O
recently	O	O
been	O	O
introduced	O	O
in	O	O
dentistry	O	O
and	O	O
oral	O	O
medicine	O	O
after	O	O
years	O	O
of	O	O
successful	O	O
use	O	O
in	O	O
mainly	O	O
gastro-intestinal	O	O
disorders	O	O
.	O	O

The	O	O
concept	O	O
of	O	O
bacteriotherapy	O	O
and	O	O
use	O	O
of	O	O
health-beneficial	O	O
micro-organisms	O	O
to	O	O
heal	O	O
diseases	O	O
or	O	O
support	O	O
immune	O	O
function	O	O
was	O	O
first	O	O
introduced	O	O
in	O	O
the	O	O
beginning	O	O
of	O	O
the	O	O
20th	O	O
century	O	O
.	O	O

Later	O	O
the	O	O
concept	O	O
lead	O	O
to	O	O
the	O	O
development	O	O
of	O	O
modem	O	O
dairy	O	O
industry	O	O
and	O	O
even	O	O
today	O	O
most	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
are	O	O
lactobacilli	B-bacteria	B-bacteria
or	O	O
bifidobacteria	B-bacteria	B-bacteria
used	O	O
in	O	O
milk	O	O
fermentation	O	O
.	O	O

The	O	O
mechanisms	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
action	O	O
are	O	O
mainly	O	O
unknown	O	O
but	O	O
the	O	O
inter-microbial	O	O
species	O	O
interactions	O	O
are	O	O
supposed	O	O
to	O	O
play	O	O
a	O	O
key	O	O
role	O	O
in	O	O
this	O	O
together	O	O
with	O	O
their	O	O
immuno-stimulatory	O	O
effects	O	O
.	O	O

The	O	O
introduction	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
the	O	O
mouth	O	O
calls	O	O
for	O	O
ascertainment	O	O
of	O	O
their	O	O
particular	O	O
safety	O	O
.	O	O

Since	O	O
acid	O	O
production	O	O
from	O	O
sugar	O	O
is	O	O
detrimental	O	O
to	O	O
teeth	O	O
,	O	O
care	O	O
must	O	O
be	O	O
taken	O	O
not	O	O
to	O	O
select	O	O
strains	O	O
with	O	O
high	O	O
fermentation	O	O
capacity	O	O
.	O	O

The	O	O
first	O	O
randomized	O	O
controlled	O	O
trials	O	O
have	O	O
nevertheless	O	O
shown	O	O
that	O	O
probiotics	O	O
may	O	O
control	O	O
dental	O	O
caries	O	O
in	O	O
children	O	O
due	O	O
to	O	O
their	O	O
inhibitory	O	O
action	O	O
against	O	O
cariogenic	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Less	O	O
evidence	O	O
exists	O	O
on	O	O
their	O	O
role	O	O
in	O	O
periodontal	O	O
disease	O	O
or	O	O
oral	O	O
yeast	O	O
infections	O	O
.	O	O

Furthermore	O	O
the	O	O
best	O	O
vehicles	O	O
for	O	O
oral	O	O
probiotic	B-bacteria	B-bacteria
applications	O	O
need	O	O
to	O	O
be	O	O
assessed	O	O
.	O	O

So	O	O
far	O	O
mainly	O	O
dairy	O	O
products	O	O
have	O	O
been	O	O
investigated	O	O
but	O	O
other	O	O
means	O	O
such	O	O
as	O	O
probiotics	B-bacteria	B-bacteria
in	O	O
chewing	O	O
gums	O	O
or	O	O
lozenges	O	O
have	O	O
also	O	O
been	O	O
studied	O	O
.	O	O

From	O	O
the	O	O
clinical	O	O
practitioner	O	O
's	O	O
point	O	O
of	O	O
view	O	O
direct	O	O
recommendations	O	O
for	O	O
the	O	O
use	O	O
of	O	O
probiotics	O	O
can	O	O
not	O	O
yet	O	O
be	O	O
given	O	O
.	O	O

However	O	O
,	O	O
scientific	O	O
evidence	O	O
so	O	O
far	O	O
indicates	O	O
that	O	O
probiotic	B-bacteria	B-bacteria
therapy	O	O
may	O	O
be	O	O
a	O	O
reality	O	O
also	O	O
in	O	O
dentistry	O	O
and	O	O
oral	O	O
medicine	O	O
in	O	O
the	O	O
future	O	O
.	O	O

The	O	O
periodontal	O	O
pathogens	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
are	O	O
strongly	O	O
associated	O	O
with	O	O
periodontal	O	O
disease	O	O
and	O	O
are	O	O
highly	O	O
prevalent	O	O
in	O	O
humans	O	O
with	O	O
periodontitis	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

have	O	O
also	O	O
been	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
cats	O	O
.	O	O

The	O	O
oral	O	O
microflora	O	O
in	O	O
animals	O	O
was	O	O
compared	O	O
with	O	O
those	O	O
in	O	O
humans	O	O
in	O	O
earlier	O	O
studies	O	O
,	O	O
but	O	O
no	O	O
studies	O	O
are	O	O
available	O	O
on	O	O
the	O	O
comparison	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
from	O	O
pets	O	O
and	O	O
their	O	O
respective	O	O
owners	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
presence	O	O
of	O	O
these	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
microflora	O	O
of	O	O
cats	O	O
and	O	O
their	O	O
owners	O	O
,	O	O
since	O	O
animal	O	O
to	O	O
human	O	O
transmission	O	O
,	O	O
or	O	O
vice	O	O
versa	O	O
,	O	O
of	O	O
oral	O	O
pathogens	O	O
could	O	O
have	O	O
public	O	O
health	O	O
implications	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
prevalence	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gulae	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
microflora	O	O
of	O	O
cats	O	O
and	O	O
their	O	O
owners	O	O
,	O	O
using	O	O
culture	O	O
and	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
.	O	O

All	O	O
Porphyromonas	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
from	O	O
cats	O	O
(	O	O
n=64	O	O
)	O	O
were	O	O
catalase	O	O
positive	O	O
,	O	O
whereas	O	O
the	O	O
Porphyromonas	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
from	O	O
owners	O	O
(	O	O
n=7	O	O
)	O	O
were	O	O
catalase	O	O
negative	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
isolates	O	O
from	O	O
cats	O	O
were	O	O
P.	B-bacteria	B-bacteria
gulae	E-bacteria	I-bacteria
whereas	O	O
those	O	O
from	O	O
the	O	O
owners	O	O
were	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
was	O	O
recovered	O	O
from	O	O
both	O	O
cats	O	O
(	O	O
n=63	O	O
)	O	O
and	O	O
owners	O	O
(	O	O
n=31	O	O
)	O	O
;	O	O
the	O	O
proportion	O	O
of	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
relative	O	O
to	O	O
the	O	O
total	O	O
CFU	O	O
was	O	O
higher	O	O
in	O	O
cats	O	O
with	O	O
periodontitis	O	O
than	O	O
in	O	O
cats	O	O
without	O	O
periodontal	O	O
disease	O	O
.	O	O

Genotyping	O	O
of	O	O
T.	B-bacteria	B-bacteria
forsythia	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
(	O	O
n=54	O	O
)	O	O
in	O	O
six	O	O
cat/owner	O	O
couples	O	O
showed	O	O
that	O	O
in	O	O
one	O	O
cat/owner	O	O
couple	O	O
the	O	O
T.	B-bacteria	B-bacteria
forsythia	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
(	O	O
n=6	O	O
)	O	O
were	O	O
identical	O	O
.	O	O

These	O	O
T.	B-bacteria	B-bacteria
forsythia	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
were	O	O
all	O	O
catalase	O	O
positive	O	O
,	O	O
which	O	O
led	O	O
us	O	O
to	O	O
hypothesize	O	O
that	O	O
transmission	O	O
from	O	O
cats	O	O
to	O	O
owners	O	O
had	O	O
occurred	O	O
and	O	O
that	O	O
cats	O	O
may	O	O
be	O	O
a	O	O
reservoir	O	O
of	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
.	O	O

Periodontitis	O	O
and	O	O
caries	O	O
are	O	O
infectious	O	O
diseases	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
which	O	O
oral	O	O
biofilms	O	O
play	O	O
a	O	O
causative	O	O
role	O	O
.	O	O

Moreover	O	O
,	O	O
oral	O	O
biofilms	O	O
are	O	O
widely	O	O
studied	O	O
as	O	O
model	O	O
systems	O	O
for	O	O
bacterial	O	O
adhesion	O	O
,	O	O
biofilm	O	O
development	O	O
,	O	O
and	O	O
biofilm	O	O
resistance	O	O
to	O	O
antibiotics	O	O
,	O	O
due	O	O
to	O	O
their	O	O
widespread	O	O
presence	O	O
and	O	O
accessibility	O	O
.	O	O

Despite	O	O
descriptions	O	O
of	O	O
initial	O	O
plaque	O	O
formation	O	O
on	O	O
the	O	O
tooth	O	O
surface	O	O
,	O	O
studies	O	O
on	O	O
mature	O	O
plaque	O	O
and	O	O
plaque	O	O
structure	O	O
below	O	O
the	O	O
gum	O	O
are	O	O
limited	O	O
to	O	O
landmark	O	O
studies	O	O
from	O	O
the	O	O
1970s	O	O
,	O	O
without	O	O
appreciating	O	O
the	O	O
breadth	O	O
of	O	O
microbial	O	O
diversity	O	O
in	O	O
the	O	O
plaque	O	O
.	O	O

We	O	O
used	O	O
fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
to	O	O
localize	O	O
in	O	O
vivo	O	O
the	O	O
most	O	O
abundant	O	O
species	O	O
from	O	O
different	O	O
phyla	O	O
and	O	O
species	O	O
associated	O	O
with	O	O
periodontitis	O	O
on	O	O
seven	O	O
embedded	O	O
teeth	O	O
obtained	O	O
from	O	O
four	O	O
different	O	O
subjects	O	O
.	O	O

The	O	O
data	O	O
showed	O	O
convincingly	O	O
the	O	O
dominance	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Spirochaetes	B-bacteria	B-bacteria
,	O	O
and	O	O
Synergistetes	B-bacteria	B-bacteria
in	O	O
subgingival	O	O
plaque	O	O
.	O	O

The	O	O
latter	O	O
proved	O	O
to	O	O
be	O	O
new	O	O
with	O	O
a	O	O
possibly	O	O
important	O	O
role	O	O
in	O	O
host-pathogen	O	O
interaction	O	O
due	O	O
to	O	O
its	O	O
localization	O	O
in	O	O
close	O	O
proximity	O	O
to	O	O
immune	O	O
cells	O	O
.	O	O

The	O	O
present	O	O
study	O	O
identified	O	O
for	O	O
the	O	O
first	O	O
time	O	O
in	O	O
vivo	O	O
that	O	O
Lactobacillus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

are	O	O
the	O	O
central	O	O
cells	O	O
of	O	O
bacterial	O	O
aggregates	O	O
in	O	O
subgingival	O	O
plaque	O	O
,	O	O
and	O	O
that	O	O
Streptococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
the	O	O
yeast	O	O
Candida	O	O
albicans	O	O
form	O	O
corncob	O	O
structures	O	O
in	O	O
supragingival	O	O
plaque	O	O
.	O	O

Finally	O	O
,	O	O
periodontal	O	O
pathogens	O	O
colonize	O	O
already	O	O
formed	O	O
biofilms	O	O
and	O	O
form	O	O
microcolonies	O	O
therein	O	O
.	O	O

These	O	O
in	O	O
vivo	O	O
observations	O	O
on	O	O
oral	O	O
biofilms	O	O
provide	O	O
a	O	O
clear	O	O
vision	O	O
on	O	O
biofilm	O	O
architecture	O	O
and	O	O
the	O	O
spatial	O	O
distribution	O	O
of	O	O
predominant	O	O
species	O	O
.	O	O

Irritable	O	O
bowel	O	O
syndrome	O	O
(	O	O
IBS	O	O
)	O	O
reflects	O	O
several	O	O
pathogenetic	O	O
entities	O	O
including	O	O
a	O	O
subgroup	O	O
with	O	O
low-grade	O	O
colonic	O	O
inflammation	O	O
.	O	O

We	O	O
propose	O	O
that	O	O
pathogenic	O	O
bacteria	O	O
act	O	O
as	O	O
triggers	O	O
and	O	O
that	O	O
disturbances	O	O
of	O	O
commensal	O	O
bacteria	O	O
maintain	O	O
low-grade	O	O
inflammation	O	O
,	O	O
that	O	O
in	O	O
turn	O	O
leads	O	O
to	O	O
dysfunction	O	O
in	O	O
the	O	O
gut	O	O
or	O	O
brain	O	O
.	O	O

Studies	O	O
were	O	O
performed	O	O
in	O	O
mice	O	O
under	O	O
specific	O	O
pathogen-free	O	O
conditions	O	O
.	O	O

Visceral	O	O
pain	O	O
was	O	O
assessed	O	O
by	O	O
the	O	O
visceromotor	O	O
response	O	O
and	O	O
motility	O	O
was	O	O
assessed	O	O
by	O	O
in	O	O
vivo	O	O
fluoroscopy	O	O
and	O	O
in	O	O
vitro	O	O
by	O	O
muscle	O	O
contractility	O	O
.	O	O

Brain	O	O
chemistry	O	O
was	O	O
assessed	O	O
by	O	O
in	O	O
situ	O	O
hybridization	O	O
and	O	O
behavior	O	O
by	O	O
standard	O	O
tests	O	O
.	O	O

The	O	O
microbiota	O	O
was	O	O
monitored	O	O
using	O	O
16s-based	O	O
RT-PCR	O	O
and	O	O
DGGE	O	O
.	O	O

Mice	O	O
transiently	O	O
infected	O	O
with	O	O
the	O	O
nematode	O	O
Trichinella	O	O
spiralis	O	O
exhibited	O	O
changes	O	O
in	O	O
motility	O	O
and	O	O
in	O	O
visceral	O	O
perception	O	O
that	O	O
persisted	O	O
for	O	O
up	O	O
to	O	O
6	O	O
weeks	O	O
post-infection	O	O
.	O	O

This	O	O
was	O	O
accompanied	O	O
by	O	O
alterations	O	O
in	O	O
the	O	O
microbiota	O	O
and	O	O
an	O	O
upregulation	O	O
of	O	O
cyclooxygenase-2	O	O
which	O	O
could	O	O
be	O	O
reversed	O	O
by	O	O
treatment	O	O
with	O	O
anti-inflammatory	O	O
agents	O	O
or	O	O
selected	O	O
probiotics	B-bacteria	B-bacteria
.	O	O

To	O	O
investigate	O	O
the	O	O
contribution	O	O
of	O	O
the	O	O
microbiota	O	O
,	O	O
we	O	O
treated	O	O
mice	O	O
with	O	O
oral	O	O
antibiotics	O	O
and	O	O
monitored	O	O
visceral	O	O
perception	O	O
and	O	O
behavior	O	O
.	O	O

Antibiotic	O	O
therapy	O	O
produced	O	O
substantial	O	O
changes	O	O
in	O	O
the	O	O
microbiota	O	O
,	O	O
a	O	O
small	O	O
increment	O	O
in	O	O
inflammatory	O	O
activity	O	O
and	O	O
an	O	O
increase	O	O
in	O	O
substance	O	O
P	O	O
or	O	O
pain	O	O
perception	O	O
.	O	O

Oral	O	O
,	O	O
but	O	O
not	O	O
systemic	O	O
antibiotic	O	O
treatment	O	O
,	O	O
produced	O	O
changes	O	O
in	O	O
brain	O	O
chemistry	O	O
and	O	O
an	O	O
increase	O	O
in	O	O
anxiety-like	O	O
behavior	O	O
.	O	O

These	O	O
studies	O	O
provide	O	O
proof	O	O
of	O	O
concept	O	O
that	O	O
pathogenic	O	O
microbes	O	O
can	O	O
induce	O	O
persistent	O	O
gut	O	O
dysfunction	O	O
and	O	O
that	O	O
changes	O	O
in	O	O
microbial	O	O
composition	O	O
of	O	O
the	O	O
gut	O	O
can	O	O
maintain	O	O
gut	O	O
dysfunction	O	O
as	O	O
well	O	O
as	O	O
induce	O	O
behavioral	O	O
changes	O	O
reminiscent	O	O
of	O	O
the	O	O
psychiatric	O	O
comorbidity	O	O
that	O	O
occurs	O	O
in	O	O
up	O	O
to	O	O
60	O	O
%	O	O
of	O	O
irritable	O	O
bowel	O	O
syndrome	O	O
patients	O	O
.	O	O

Protease-activated	O	O
receptors	O	O
(	O	O
PARs	O	O
)	O	O
,	O	O
nucleotide-binding	O	O
oligomerization	O	O
domain	O	O
(	O	O
NOD	O	O
)	O	O
receptors	O	O
and	O	O
Toll-like	O	O
receptors	O	O
(	O	O
TLRs	O	O
)	O	O
play	O	O
a	O	O
role	O	O
in	O	O
innate	O	O
immunity	O	O
,	O	O
but	O	O
little	O	O
is	O	O
known	O	O
about	O	O
interaction	O	O
between	O	O
these	O	O
receptors	O	O
.	O	O

The	O	O
goal	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
how	O	O
silencing	O	O
one	O	O
receptor	O	O
affects	O	O
the	O	O
expression	O	O
of	O	O
other	O	O
receptors	O	O
and	O	O
downstream	O	O
innate	O	O
immune	O	O
markers	O	O
in	O	O
response	O	O
to	O	O
bacteria	O	O
.	O	O

Human	O	O
gingival	O	O
epithelial	O	O
cells	O	O
(	O	O
GECs	O	O
)	O	O
were	O	O
transfected	O	O
with	O	O
siRNA	O	O
specific	O	O
for	O	O
PAR1	O	O
or	O	O
PAR2	O	O
,	O	O
then	O	O
stimulated	O	O
with	O	O
periopathogen	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
bridging	O	O
organism	O	O
between	O	O
pathogens	O	O
and	O	O
non-pathogens	B-bacteria	B-bacteria
Fusobacterium	I-bacteria	I-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
or	O	O
non-pathogen	B-bacteria	B-bacteria
Streptococcus	I-bacteria	I-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

PAR1	O	O
or	O	O
PAR2	O	O
knock-down	O	O
resulted	O	O
in	O	O
up-regulated	O	O
NOD1	O	O
and	O	O
NOD2	O	O
expression	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
or	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
stimulation	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
as	O	O
well	O	O
as	O	O
enhanced	O	O
TLR2	O	O
and	O	O
TLR4	O	O
expression	O	O
when	O	O
cells	O	O
were	O	O
stimulated	O	O
by	O	O
bacteria	O	O
that	O	O
utilize	O	O
TLR2	O	O
or	O	O
TLR4	O	O
,	O	O
respectively	O	O
.	O	O

Involvement	O	O
of	O	O
PARs	O	O
for	O	O
induction	O	O
of	O	O
CC	O	O
chemokine	O	O
ligand	O	O
20	O	O
(	O	O
CCL20	O	O
)	O	O
,	O	O
a	O	O
cytokine	O	O
with	O	O
antimicrobial	O	O
properties	O	O
,	O	O
was	O	O
observed	O	O
following	O	O
stimulation	O	O
of	O	O
the	O	O
three	O	O
bacterial	O	O
species	O	O
.	O	O

Furthermore	O	O
,	O	O
results	O	O
from	O	O
multiple	O	O
cytokine	O	O
ELISA	O	O
array	O	O
showed	O	O
receptors	O	O
utilized	O	O
in	O	O
the	O	O
induction	O	O
of	O	O
various	O	O
innate	O	O
immune	O	O
markers	O	O
are	O	O
tailored	O	O
to	O	O
individual	O	O
bacterium	O	O
tested	O	O
.	O	O

Our	O	O
data	O	O
suggest	O	O
complex	O	O
interplay	O	O
of	O	O
several	O	O
receptors	O	O
is	O	O
required	O	O
for	O	O
appropriate	O	O
innate	O	O
immune	O	O
responses	O	O
to	O	O
the	O	O
different	O	O
types	O	O
of	O	O
bacteria	O	O
present	O	O
within	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
that	O	O
receptor	O	O
expression	O	O
itself	O	O
is	O	O
altered	O	O
depending	O	O
on	O	O
which	O	O
organism	O	O
the	O	O
cell	O	O
encounters	O	O
.	O	O

To	O	O
compare	O	O
the	O	O
effects	O	O
of	O	O
a	O	O
new	O	O
gel-to-foam	O	O
dentifrice	O	O
to	O	O
two	O	O
standard	O	O
fluoride	O	O
control	O	O
dentifrices	O	O
on	O	O
foam	O	O
generation	O	O
,	O	O
levels	O	O
of	O	O
total	O	O
viable	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
total	O	O
viable	O	O
volatile	O	O
sulfur	O	O
compound	O	O
(	O	O
VSC	O	O
)	O	O
-producing	O	O
bacteria	O	O
in	O	O
expectorate	O	O
after	O	O
brushing	O	O
.	O	O

36	O	O
subjects	O	O
participated	O	O
in	O	O
this	O	O
investigator-blind	O	O
,	O	O
randomized	O	O
,	O	O
crossover	O	O
study	O	O
.	O	O

After	O	O
a	O	O
1-week	O	O
wash-out	O	O
period	O	O
prior	O	O
to	O	O
each	O	O
product	O	O
use	O	O
,	O	O
participants	O	O
reported	O	O
to	O	O
the	O	O
test	O	O
site	O	O
having	O	O
refrained	O	O
from	O	O
oral	O	O
hygiene	O	O
,	O	O
eating	O	O
and	O	O
drinking	O	O
on	O	O
the	O	O
morning	O	O
prior	O	O
to	O	O
the	O	O
visit	O	O
.	O	O

Subjects	O	O
brushed	O	O
with	O	O
a	O	O
full	O	O
ribbon	O	O
of	O	O
assigned	O	O
dentifrice	O	O
(	O	O
Aquafresh	O	O
Iso-active	O	O
,	O	O
Aquafresh	O	O
Extreme	O	O
Clean	O	O
or	O	O
Aquafresh	O	O
Fresh	O	O
&	O	O
Minty	O	O
)	O	O
,	O	O
then	O	O
expectorated	O	O
the	O	O
slurry	O	O
into	O	O
a	O	O
collection	O	O
vessel	O	O
after	O	O
30	O	O
and	O	O
60	O	O
seconds	O	O
of	O	O
supervised	O	O
brushing	O	O
.	O	O

Total	O	O
foam	O	O
volume	O	O
was	O	O
immediately	O	O
measured	O	O
.	O	O

Subjects	O	O
then	O	O
rinsed	O	O
with	O	O
sterile	O	O
water	O	O
for	O	O
10	O	O
seconds	O	O
and	O	O
expectorated	O	O
into	O	O
the	O	O
same	O	O
vessel	O	O
,	O	O
which	O	O
was	O	O
processed	O	O
for	O	O
microbiological	O	O
analysis	O	O
.	O	O

Total	O	O
viable	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
total	O	O
viable	O	O
VSC-producing	O	O
bacteria	O	O
were	O	O
enumerated	O	O
using	O	O
appropriate	O	O
selective	O	O
media	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
difference	O	O
was	O	O
indicated	O	O
between	O	O
the	O	O
gel-to-foam	O	O
dentifrice	O	O
and	O	O
either	O	O
of	O	O
the	O	O
control	O	O
dentifrices	O	O
with	O	O
respect	O	O
to	O	O
the	O	O
level	O	O
of	O	O
total	O	O
viable	O	O
anaerobes	B-bacteria	B-bacteria
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
level	O	O
of	O	O
total	O	O
viable	O	O
VSC-producing	O	O
bacteria	O	O
was	O	O
statistically	O	O
significantly	O	O
lower	O	O
for	O	O
the	O	O
gel-to-foam	O	O
dentifrice	O	O
(	O	O
Aquafresh	O	O
Iso-active	O	O
)	O	O
than	O	O
for	O	O
one	O	O
of	O	O
the	O	O
control	O	O
dentifrices	O	O
(	O	O
Aquafresh	O	O
Fresh	O	O
&	O	O
Minty	O	O
)	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
and	O	O
numerically	O	O
lower	O	O
for	O	O
the	O	O
gel-to-foam	O	O
dentifrice	O	O
than	O	O
for	O	O
the	O	O
other	O	O
control	O	O
dentifrice	O	O
(	O	O
Aquafresh	O	O
Extreme	O	O
Clean	O	O
)	O	O
(	O	O
P	O	O
=	O	O
0.0526	O	O
)	O	O
.	O	O

Use	O	O
of	O	O
the	O	O
gel-to-foam	O	O
dentifrice	O	O
resulted	O	O
in	O	O
statistically	O	O
significantly	O	O
greater	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
foam	O	O
generation	O	O
than	O	O
the	O	O
two	O	O
control	O	O
dentifrices	O	O
.	O	O

Oral	O	O
malodor	O	O
develops	O	O
mostly	O	O
from	O	O
the	O	O
metabolic	O	O
activities	O	O
of	O	O
indigenous	O	O
bacterial	O	O
populations	O	O
within	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
but	O	O
whether	O	O
healthy	O	O
or	O	O
oral	O	O
malodor-related	O	O
patterns	O	O
of	O	O
the	O	O
global	O	O
bacterial	O	O
composition	O	O
exist	O	O
remains	O	O
unclear	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
bacterial	O	O
compositions	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
240	O	O
subjects	O	O
complaining	O	O
of	O	O
oral	O	O
malodor	O	O
were	O	O
divided	O	O
into	O	O
groups	O	O
based	O	O
on	O	O
terminal-restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
(	O	O
T-RFLP	O	O
)	O	O
profiles	O	O
using	O	O
hierarchical	O	O
cluster	O	O
analysis	O	O
,	O	O
and	O	O
the	O	O
patterns	O	O
of	O	O
the	O	O
microbial	O	O
community	O	O
composition	O	O
of	O	O
those	O	O
exhibiting	O	O
higher	O	O
and	O	O
lower	O	O
malodor	O	O
were	O	O
explored	O	O
.	O	O

Four	O	O
types	O	O
of	O	O
bacterial	O	O
community	O	O
compositions	O	O
were	O	O
detected	O	O
(	O	O
clusters	O	O
I	O	O
,	O	O
II	O	O
,	O	O
III	O	O
,	O	O
and	O	O
IV	O	O
)	O	O
.	O	O

Two	O	O
parameters	O	O
for	O	O
measuring	O	O
oral	O	O
malodor	O	O
intensity	O	O
(	O	O
the	O	O
concentration	O	O
of	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
in	O	O
mouth	O	O
air	O	O
and	O	O
the	O	O
organoleptic	O	O
score	O	O
)	O	O
were	O	O
noticeably	O	O
lower	O	O
in	O	O
cluster	O	O
I	O	O
than	O	O
in	O	O
the	O	O
other	O	O
clusters	O	O
.	O	O

Using	O	O
multivariate	O	O
analysis	O	O
,	O	O
the	O	O
differences	O	O
in	O	O
the	O	O
levels	O	O
of	O	O
oral	O	O
malodor	O	O
were	O	O
significant	O	O
after	O	O
adjustment	O	O
for	O	O
potential	O	O
confounding	O	O
factors	O	O
such	O	O
as	O	O
total	O	O
bacterial	O	O
count	O	O
,	O	O
mean	O	O
periodontal	O	O
pocket	O	O
depth	O	O
,	O	O
and	O	O
tongue	O	O
coating	O	O
score	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Among	O	O
the	O	O
four	O	O
clusters	O	O
with	O	O
different	O	O
proportions	O	O
of	O	O
indigenous	O	O
members	O	O
,	O	O
the	O	O
T-RFLP	O	O
profiles	O	O
of	O	O
cluster	O	O
I	O	O
were	O	O
implicated	O	O
as	O	O
the	O	O
bacterial	O	O
populations	O	O
with	O	O
higher	O	O
proportions	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
species	O	O
than	O	O
those	O	O
of	O	O
the	O	O
other	O	O
clusters	O	O
.	O	O

These	O	O
results	O	O
clearly	O	O
correlate	O	O
the	O	O
global	O	O
composition	O	O
of	O	O
indigenous	O	O
bacterial	O	O
populations	O	O
with	O	O
the	O	O
severity	O	O
of	O	O
oral	O	O
malodor	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
may	O	O
represent	O	O
a	O	O
site	O	O
of	O	O
colonization	O	O
by	O	O
antibiotic-resistant	O	O
bacteria	O	O
,	O	O
such	O	O
as	O	O
methicillin-resistant	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
(	O	O
MRS	B-bacteria	B-bacteria
)	O	O
.	O	O

To	O	O
define	O	O
the	O	O
prevalence	O	O
of	O	O
staphylococci	B-bacteria	B-bacteria
and	O	O
MRS	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
an	O	O
observational	O	O
study	O	O
was	O	O
carried	O	O
out	O	O
in	O	O
the	O	O
city	O	O
of	O	O
Bari	O	O
(	O	O
Italy	O	O
)	O	O
.	O	O

Sixty	O	O
subjects	O	O
were	O	O
asked	O	O
to	O	O
provide	O	O
oral	O	O
samples	O	O
and	O	O
a	O	O
questionnaire	O	O
about	O	O
risk	O	O
factors	O	O
of	O	O
colonization	O	O
by	O	O
MRS.	B-bacteria	B-bacteria
An	O	O
enrichment	O	O
medium	O	O
specific	O	O
for	O	O
staphylococci	B-bacteria	B-bacteria
was	O	O
used	O	O
for	O	O
the	O	O
isolation	O	O
.	O	O

Swabs	O	O
and	O	O
corresponding	O	O
questionnaires	O	O
were	O	O
available	O	O
from	O	O
36	O	O
out	O	O
of	O	O
60	O	O
patients	O	O
.	O	O

Staphylococci	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
seven	O	O
out	O	O
of	O	O
36	O	O
samples	O	O
(	O	O
prevalence	O	O
19.4	O	O
%	O	O
)	O	O
.	O	O

Among	O	O
the	O	O
seven	O	O
staphylococcal	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
,	O	O
three	O	O
were	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
and	O	O
one	O	O
strain	O	O
,	O	O
belonging	O	O
to	O	O
S.	B-bacteria	B-bacteria
epidermidis	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
,	O	O
was	O	O
found	O	O
to	O	O
be	O	O
MR	O	O
(	O	O
1.7	O	O
%	O	O
)	O	O
.	O	O

No	O	O
methicillin-resistant	B-bacteria	B-bacteria
S.	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
were	O	O
isolated	O	O
.	O	O

Five	O	O
out	O	O
of	O	O
seven	O	O
staphylococcal	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
exhibited	O	O
resistance	O	O
to	O	O
more	O	O
than	O	O
two	O	O
classes	O	O
of	O	O
non-beta-lactams	O	O
antimicrobials	O	O
.	O	O

None	O	O
of	O	O
the	O	O
risk	O	O
factors	O	O
analysed	O	O
correlated	O	O
with	O	O
the	O	O
status	O	O
of	O	O
MRS	B-bacteria	B-bacteria
carriers	O	O
,	O	O
except	O	O
the	O	O
presence	O	O
of	O	O
oral	O	O
disease	O	O
.	O	O

The	O	O
results	O	O
underline	O	O
the	O	O
potential	O	O
role	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
as	O	O
a	O	O
reservoir	O	O
of	O	O
staphylococci	B-bacteria	B-bacteria
.	O	O

Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
is	O	O
an	O	O
important	O	O
pathogen	O	O
that	O	O
forms	O	O
biofilm	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
22	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
have	O	O
been	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
Tunisian	O	O
children	O	O
and	O	O
investigated	O	O
for	O	O
slime	O	O
production	O	O
using	O	O
Congo	O	O
red	O	O
agar	O	O
method	O	O
(	O	O
CRA	O	O
)	O	O
and	O	O
semi	O	O
quantitative	O	O
adherence	O	O
assay	O	O
.	O	O

The	O	O
hydrophobicity	O	O
of	O	O
strains	O	O
was	O	O
evaluated	O	O
by	O	O
the	O	O
microbial	O	O
adhesion	O	O
to	O	O
solvent	O	O
(	O	O
MATS	O	O
)	O	O
test	O	O
.	O	O

The	O	O
adherence	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
to	O	O
Hep2	O	O
cells	O	O
was	O	O
examined	O	O
by	O	O
light	O	O
microscopy	O	O
.	O	O

The	O	O
genes	O	O
implicated	O	O
in	O	O
adhesion	O	O
(	O	O
icaA	O	O
,	O	O
icaD	O	O
,	O	O
fnbA	O	O
,	O	O
cna	O	O
,	O	O
clfA	O	O
)	O	O
were	O	O
detected	O	O
.	O	O

Polymerase	O	O
chain	O	O
reaction	O	O
was	O	O
used	O	O
.	O	O

The	O	O
affinity	O	O
to	O	O
hexadecane	O	O
was	O	O
low	O	O
proving	O	O
a	O	O
hydrophilic	O	O
character	O	O
of	O	O
all	O	O
the	O	O
studied	O	O
strains	O	O
.	O	O

Qualitative	O	O
biofilm	O	O
production	O	O
revealed	O	O
that	O	O
50	O	O
%	O	O
of	O	O
strains	O	O
were	O	O
slime	O	O
producers	O	O
.	O	O

The	O	O
result	O	O
of	O	O
OD	O	O
(	O	O
570	O	O
)	O	O
showed	O	O
that	O	O
four	O	O
strains	O	O
isolated	O	O
from	O	O
the	O	O
caries-active	O	O
children	O	O
were	O	O
highly	O	O
biofilm	O	O
positive	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
50	O	O
%	O	O
of	O	O
strains	O	O
were	O	O
icaA	O	O
and	O	O
icaD	O	O
positive	O	O
.	O	O

The	O	O
fnbA	O	O
gene	O	O
was	O	O
present	O	O
in	O	O
59.1	O	O
%	O	O
of	O	O
isolated	O	O
strains	O	O
.	O	O

Furthermore	O	O
,	O	O
54.5	O	O
%	O	O
of	O	O
strains	O	O
harboured	O	O
the	O	O
cna	O	O
gene	O	O
,	O	O
9.1	O	O
%	O	O
were	O	O
clfA	O	O
positive	O	O
and	O	O
50	O	O
%	O	O
were	O	O
hla	O	O
positive	O	O
.	O	O

Quantitative	O	O
adherence	O	O
varied	O	O
considerably	O	O
among	O	O
the	O	O
tested	O	O
strains	O	O
.	O	O

All	O	O
strains	O	O
showed	O	O
adherence	O	O
to	O	O
Hep2	O	O
cells	O	O
.	O	O

However	O	O
,	O	O
the	O	O
level	O	O
of	O	O
adhesion	O	O
varied	O	O
between	O	O
strains	O	O
as	O	O
follows	O	O
.	O	O

Seven	O	O
strains	O	O
were	O	O
defined	O	O
as	O	O
moderately	O	O
adherent	O	O
,	O	O
nine	O	O
as	O	O
strongly	O	O
adherent	O	O
and	O	O
six	O	O
as	O	O
weakly	O	O
adherent	O	O
.	O	O

The	O	O
percentage	O	O
of	O	O
infected	O	O
cells	O	O
ranged	O	O
from	O	O
15+/-0.0376	O	O
(	O	O
B374	O	O
)	O	O
to	O	O
96+/-0.019	O	O
(	O	O
B295	O	O
)	O	O
and	O	O
the	O	O
total	O	O
number	O	O
of	O	O
bacteria	O	O
per	O	O
100	O	O
cells	O	O
ranged	O	O
from	O	O
15+/-5.1	O	O
(	O	O
B374	O	O
)	O	O
to	O	O
1824+/-30.1	O	O
(	O	O
B295	O	O
)	O	O
.	O	O

This	O	O
pilot	O	O
study	O	O
determined	O	O
the	O	O
profile	O	O
of	O	O
the	O	O
oral	O	O
bacterial	O	O
flora	O	O
in	O	O
an	O	O
outpatient	O	O
cancer	O	O
population	O	O
before	O	O
and	O	O
after	O	O
chemotherapy	O	O
using	O	O
molecular	O	O
techniques	O	O
.	O	O

We	O	O
recruited	O	O
9	O	O
newly	O	O
diagnosed	O	O
breast	O	O
cancer	O	O
patients	O	O
scheduled	O	O
for	O	O
induction	O	O
chemotherapy	O	O
.	O	O

All	O	O
were	O	O
seen	O	O
immediately	O	O
before	O	O
chemotherapy	O	O
,	O	O
and	O	O
7	O	O
to	O	O
14	O	O
days	O	O
later	O	O
.	O	O

At	O	O
both	O	O
visits	O	O
,	O	O
we	O	O
performed	O	O
oral	O	O
evaluations	O	O
and	O	O
obtained	O	O
mucositis	O	O
grading	O	O
(	O	O
with	O	O
the	O	O
World	O	O
Health	O	O
Organization	O	O
[	O	O
WHO	O	O
]	O	O
scale	O	O
)	O	O
,	O	O
absolute	O	O
neutrophil	O	O
counts	O	O
(	O	O
ANC	O	O
)	O	O
,	O	O
and	O	O
bacterial	O	O
samples	O	O
from	O	O
the	O	O
buccal	O	O
mucosa	O	O
.	O	O

Bacterial	O	O
DNA	O	O
was	O	O
isolated	O	O
,	O	O
and	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
gene	O	O
clonal	O	O
libraries	O	O
were	O	O
constructed	O	O
.	O	O

Sequences	O	O
of	O	O
genes	O	O
in	O	O
the	O	O
library	O	O
were	O	O
used	O	O
to	O	O
determine	O	O
species	O	O
identity	O	O
by	O	O
comparison	O	O
to	O	O
known	O	O
sequences	O	O
.	O	O

After	O	O
chemotherapy	O	O
,	O	O
WHO	O	O
scores	O	O
of	O	O
0	O	O
and	O	O
1	O	O
were	O	O
in	O	O
3	O	O
and	O	O
6	O	O
patients	O	O
,	O	O
respectively	O	O
,	O	O
and	O	O
mean	O	O
ANC	O	O
(	O	O
+/-SD	O	O
)	O	O
dropped	O	O
from	O	O
3326	O	O
+/-	O	O
463	O	O
to	O	O
1091	O	O
+/-	O	O
1082	O	O
cells/mm	O	O
(	O	O
3	O	O
)	O	O
.	O	O

From	O	O
pre-	O	O
and	O	O
post-chemotherapy	O	O
samples	O	O
,	O	O
41	O	O
species	O	O
were	O	O
detected	O	O
,	O	O
with	O	O
a	O	O
predominance	O	O
of	O	O
Gemella	B-bacteria	B-bacteria
haemolysans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
.	O	O

More	O	O
than	O	O
85	O	O
%	O	O
of	O	O
species	O	O
have	O	O
not	O	O
been	O	O
previously	O	O
identified	O	O
in	O	O
chemotherapy	O	O
patients	O	O
.	O	O

Seven	O	O
species	O	O
appeared	O	O
exclusively	O	O
before	O	O
chemotherapy	O	O
and	O	O
25	O	O
after	O	O
chemotherapy	O	O
.	O	O

After	O	O
chemotherapy	O	O
,	O	O
the	O	O
number	O	O
of	O	O
species	O	O
per	O	O
patient	O	O
increased	O	O
by	O	O
a	O	O
mean	O	O
of	O	O
2.6	O	O
(	O	O
SD	O	O
=	O	O
4.7	O	O
,	O	O
P	O	O
=	O	O
.052	O	O
)	O	O
.	O	O

We	O	O
identified	O	O
species	O	O
not	O	O
previously	O	O
identified	O	O
in	O	O
chemotherapy	O	O
patients	O	O
.	O	O

Our	O	O
results	O	O
suggest	O	O
a	O	O
shift	O	O
to	O	O
a	O	O
more	O	O
complex	O	O
oral	O	O
bacterial	O	O
profile	O	O
in	O	O
patients	O	O
undergoing	O	O
cancer	O	O
chemotherapy	O	O
.	O	O

Bacterial	O	O
and	O	O
host	O	O
cell	O	O
products	O	O
during	O	O
coinfections	O	O
of	O	O
Human	O	O
Immunodeficiency	O	O
Virus	O	O
type	O	O
1-positive	O	O
(	O	O
HIV-1	O	O
(	O	O
+	O	O
)	O	O
)	O	O
patients	O	O
regulate	O	O
HIV-1	O	O
recrudescence	O	O
in	O	O
latently	O	O
infected	O	O
cells	O	O
(	O	O
e.g	O	O
.	O	O

T	O	O
cells	O	O
,	O	O
monocytes/macrophages	O	O
)	O	O
,	O	O
impacting	O	O
highly	O	O
active	O	O
antiretroviral	O	O
therapy	O	O
(	O	O
HAART	O	O
)	O	O
failure	O	O
and	O	O
progression	O	O
of	O	O
acquired	O	O
immunodeficiency	O	O
syndrome	O	O
.	O	O

A	O	O
high	O	O
frequency	O	O
of	O	O
oral	O	O
opportunistic	O	O
infections	O	O
(	O	O
e.g	O	O
.	O	O

periodontitis	O	O
)	O	O
in	O	O
HIV-1	O	O
(	O	O
+	O	O
)	O	O
patients	O	O
has	O	O
been	O	O
demonstrated	O	O
;	O	O
however	O	O
,	O	O
their	O	O
potential	O	O
to	O	O
impact	O	O
HIV-1	O	O
exacerbation	O	O
is	O	O
unclear	O	O
.	O	O

We	O	O
sought	O	O
to	O	O
determine	O	O
the	O	O
ability	O	O
of	O	O
supernatants	O	O
derived	O	O
from	O	O
oral	O	O
epithelial	O	O
cells	O	O
(	O	O
OKF4	O	O
)	O	O
and	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
(	O	O
Gin-4	O	O
)	O	O
challenged	O	O
with	O	O
periodontal	O	O
pathogens	O	O
,	O	O
to	O	O
modulate	O	O
the	O	O
HIV-1	O	O
promoter	O	O
activation	O	O
in	O	O
monocytes/macrophages	O	O
.	O	O

BF24	O	O
monocytes/macrophages	O	O
transfected	O	O
with	O	O
the	O	O
HIV-1	O	O
promoter	O	O
driving	O	O
the	O	O
expression	O	O
of	O	O
chloramphenicol	O	O
acetyltransferase	O	O
(	O	O
CAT	O	O
)	O	O
were	O	O
stimulated	O	O
with	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
or	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
in	O	O
the	O	O
presence	O	O
of	O	O
supernatants	O	O
from	O	O
OKF4	O	O
or	O	O
Gin4	O	O
cells	O	O
either	O	O
unstimulated	O	O
or	O	O
previously	O	O
pulsed	O	O
with	O	O
bacteria	O	O
.	O	O

CAT	O	O
levels	O	O
were	O	O
determined	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
and	O	O
cytokine	O	O
production	O	O
was	O	O
evaluated	O	O
by	O	O
Luminex	O	O
beadlyte	O	O
assays	O	O
.	O	O

OKF4	O	O
and	O	O
Gin4	O	O
supernatants	O	O
enhanced	O	O
HIV-1	O	O
promoter	O	O
activation	O	O
particularly	O	O
related	O	O
to	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
challenge	O	O
.	O	O

An	O	O
additive	O	O
effect	O	O
was	O	O
observed	O	O
in	O	O
HIV-1	O	O
promoter	O	O
activation	O	O
when	O	O
monocytes/macrophages	O	O
were	O	O
simultaneously	O	O
stimulated	O	O
with	O	O
gingival	O	O
cell	O	O
supernatants	O	O
and	O	O
bacterial	O	O
extracts	O	O
.	O	O

OKF4	O	O
cells	O	O
produced	O	O
higher	O	O
levels	O	O
of	O	O
granulocyte-macrophage	O	O
colony-stimulating	O	O
factor	O	O
(	O	O
GM-CSF	O	O
)	O	O
and	O	O
interleukins	O	O
-6	O	O
and	O	O
-8	O	O
in	O	O
response	O	O
to	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Preincubation	O	O
of	O	O
OKF4	O	O
supernatants	O	O
with	O	O
anti-GM-CSF	O	O
reduced	O	O
the	O	O
additive	O	O
effect	O	O
in	O	O
periodontopathogen-induced	O	O
HIV-1	O	O
promoter	O	O
activation	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
soluble	O	O
mediators	O	O
produced	O	O
by	O	O
gingival	O	O
resident	O	O
cells	O	O
in	O	O
response	O	O
to	O	O
periodontopathogens	O	O
could	O	O
contribute	O	O
to	O	O
HIV-1	O	O
promoter	O	O
activation	O	O
in	O	O
monocytes/macrophages	O	O
,	O	O
albeit	O	O
this	O	O
effect	O	O
is	O	O
most	O	O
notable	O	O
following	O	O
direct	O	O
stimulation	O	O
of	O	O
the	O	O
cells	O	O
with	O	O
oral	O	O
gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

The	O	O
presence	O	O
of	O	O
periodontal	O	O
pathogens	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
may	O	O
impact	O	O
implant	O	O
survival	O	O
.	O	O

Therefore	O	O
,	O	O
this	O	O
study	O	O
aimed	O	O
to	O	O
determine	O	O
the	O	O
prevalence	O	O
of	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
and	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
in	O	O
a	O	O
specific	O	O
elderly	O	O
population	O	O
with	O	O
a	O	O
history	O	O
of	O	O
periodontitis	O	O
who	O	O
have	O	O
never	O	O
worn	O	O
dentures	O	O
.	O	O

Thirty	O	O
dentate	O	O
subjects	O	O
(	O	O
mean	O	O
age	O	O
61.7+/-7.05	O	O
years	O	O
)	O	O
and	O	O
30	O	O
edentulous	O	O
subjects	O	O
(	O	O
mean	O	O
age	O	O
65.8+/-8.05	O	O
years	O	O
)	O	O
were	O	O
included	O	O
in	O	O
this	O	O
cross-sectional	O	O
study	O	O
.	O	O

Microbiological	O	O
samples	O	O
of	O	O
cheek	O	O
mucosa	O	O
and	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
were	O	O
taken	O	O
from	O	O
all	O	O
subjects	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
sulcus	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
dentate	O	O
group	O	O
.	O	O

All	O	O
samples	O	O
were	O	O
analysed	O	O
using	O	O
a	O	O
bacterial	O	O
DNA-specific	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

All	O	O
the	O	O
pathogens	O	O
studied	O	O
were	O	O
detected	O	O
in	O	O
dentate	O	O
and	O	O
edentulous	O	O
subjects	O	O
.	O	O

When	O	O
cheek	O	O
and	O	O
tongue	O	O
samples	O	O
were	O	O
combined	O	O
,	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
E.	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
presented	O	O
with	O	O
a	O	O
similar	O	O
prevalence	O	O
in	O	O
both	O	O
groups	O	O
,	O	O
whereas	O	O
the	O	O
other	O	O
species	O	O
were	O	O
more	O	O
prevalent	O	O
specifically	O	O
in	O	O
the	O	O
dentate	O	O
group	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

In	O	O
dentate	O	O
subjects	O	O
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
were	O	O
present	O	O
in	O	O
higher	O	O
frequencies	O	O
in	O	O
the	O	O
cheek	O	O
mucosa	O	O
(	O	O
26.67	O	O
%	O	O
and	O	O
66.67	O	O
%	O	O
,	O	O
respectively	O	O
)	O	O
,	O	O
whereas	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
were	O	O
more	O	O
prevalent	O	O
in	O	O
the	O	O
tongue	O	O
samples	O	O
(	O	O
26.67	O	O
%	O	O
and	O	O
56.67	O	O
%	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Periodontal	O	O
pathogens	O	O
may	O	O
persist	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
edentulous	O	O
subjects	O	O
who	O	O
have	O	O
had	O	O
periodontal	O	O
disease	O	O
,	O	O
even	O	O
1	O	O
year	O	O
after	O	O
the	O	O
extraction	O	O
of	O	O
all	O	O
teeth	O	O
and	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
other	O	O
hard	O	O
surfaces	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
clinically	O	O
and	O	O
microbiologically	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
photodynamic	O	O
therapy	O	O
(	O	O
PDT	O	O
)	O	O
as	O	O
a	O	O
full-mouth	O	O
procedure	O	O
in	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum-infected	O	O
patients	O	O
with	O	O
periodontitis	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
PDT	O	O
is	O	O
administered	O	O
adjuvantly	O	O
after	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
(	O	O
SRP	O	O
)	O	O
to	O	O
patients	O	O
with	O	O
localized	O	O
chronic	O	O
periodontitis	O	O
(	O	O
LCP	O	O
)	O	O
.	O	O

Twenty-four	O	O
patients	O	O
,	O	O
in	O	O
whom	O	O
only	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
detected	O	O
by	O	O
baseline	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
after	O	O
SRP	O	O
,	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
PDT	O	O
and	O	O
control	O	O
groups	O	O
.	O	O

PDT	O	O
was	O	O
carried	O	O
out	O	O
once	O	O
as	O	O
a	O	O
full-mouth	O	O
disinfection	O	O
in	O	O
the	O	O
test	O	O
group	O	O
.	O	O

The	O	O
control	O	O
group	O	O
was	O	O
treated	O	O
with	O	O
the	O	O
photosensitizer	O	O
solution	O	O
,	O	O
but	O	O
without	O	O
laser	O	O
irradiation	O	O
.	O	O

In	O	O
all	O	O
subjects	O	O
,	O	O
the	O	O
clinical	O	O
parameters	O	O
plaque	O	O
index	O	O
,	O	O
reddening	O	O
,	O	O
bleeding	O	O
on	O	O
probing	O	O
(	O	O
BOP	O	O
)	O	O
,	O	O
probing	O	O
depth	O	O
(	O	O
PD	O	O
)	O	O
,	O	O
gingival	O	O
recession	O	O
,	O	O
and	O	O
clinical	O	O
attachment	O	O
level	O	O
(	O	O
CAL	O	O
)	O	O
were	O	O
determined	O	O
at	O	O
the	O	O
baseline	O	O
examination	O	O
and	O	O
at	O	O
1	O	O
,	O	O
4	O	O
,	O	O
and	O	O
12	O	O
weeks	O	O
after	O	O
PDT	O	O
.	O	O

Quantitative	O	O
analysis	O	O
of	O	O
the	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
DNA	O	O
concentration	O	O
was	O	O
performed	O	O
by	O	O
competitive	O	O
PCR	O	O
.	O	O

All	O	O
clinical	O	O
indices	O	O
were	O	O
calculated	O	O
for	O	O
each	O	O
test	O	O
and	O	O
control	O	O
subject	O	O
as	O	O
were	O	O
the	O	O
median	O	O
and	O	O
interquartile	O	O
range	O	O
of	O	O
each	O	O
group	O	O
.	O	O

In	O	O
patients	O	O
with	O	O
LCP	O	O
who	O	O
received	O	O
PDT	O	O
treatment	O	O
,	O	O
significant	O	O
reductions	O	O
in	O	O
reddening	O	O
,	O	O
BOP	O	O
,	O	O
and	O	O
mean	O	O
PD	O	O
and	O	O
CAL	O	O
were	O	O
observed	O	O
during	O	O
the	O	O
observation	O	O
period	O	O
and	O	O
with	O	O
respect	O	O
to	O	O
controls	O	O
.	O	O

Four	O	O
and	O	O
12	O	O
weeks	O	O
after	O	O
PDT	O	O
,	O	O
the	O	O
mean	O	O
PD	O	O
and	O	O
CAL	O	O
showed	O	O
significant	O	O
differences	O	O
from	O	O
baseline	O	O
values	O	O
and	O	O
from	O	O
those	O	O
of	O	O
the	O	O
control	O	O
group	O	O
.	O	O

In	O	O
the	O	O
PDT	O	O
group	O	O
,	O	O
12	O	O
weeks	O	O
after	O	O
treatment	O	O
,	O	O
the	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
DNA	O	O
concentration	O	O
was	O	O
found	O	O
to	O	O
be	O	O
significantly	O	O
reduced	O	O
compared	O	O
to	O	O
the	O	O
baseline	O	O
level	O	O
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
study	O	O
show	O	O
that	O	O
the	O	O
adjuvant	O	O
application	O	O
of	O	O
the	O	O
described	O	O
PDT	O	O
method	O	O
is	O	O
appropriate	O	O
to	O	O
reduce	O	O
periodontal	O	O
inflammatory	O	O
symptoms	O	O
and	O	O
to	O	O
successfully	O	O
treat	O	O
infection	O	O
with	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

The	O	O
present	O	O
study	O	O
evaluates	O	O
the	O	O
survival	O	O
capability	O	O
of	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
in	O	O
an	O	O
aerobic	O	O
environment	O	O
and	O	O
compares	O	O
the	O	O
invasive	O	O
capability	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
in	O	O
biofilm	O	O
and	O	O
planktonic	O	O
forms	O	O
in	O	O
an	O	O
organotypic	O	O
cell	O	O
culture	O	O
(	O	O
OCC	O	O
)	O	O
model	O	O
.	O	O

Biofilms	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
American	I-bacteria	I-bacteria
Type	I-bacteria	I-bacteria
Culture	I-bacteria	I-bacteria
Collection	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
25586	E-bacteria	I-bacteria
or	O	O
Anaerobe	B-bacteria	B-bacteria
Helsinki	I-bacteria	I-bacteria
Negative	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
AHN	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
9508	E-bacteria	I-bacteria
were	O	O
produced	O	O
by	O	O
culturing	O	O
on	O	O
semipermeable	O	O
membranes	O	O
on	O	O
brucella	B-bacteria	B-bacteria
agar	O	O
plates	O	O
.	O	O

The	O	O
oxygen	O	O
tolerance	O	O
of	O	O
the	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
was	O	O
examined	O	O
by	O	O
incubating	O	O
3-day-old	O	O
anaerobically	O	O
grown	O	O
biofilms	O	O
in	O	O
an	O	O
aerobic	O	O
environment	O	O
(	O	O
CO	O	O
(	O	O
2	O	O
)	O	O
[	O	O
5	O	O
%	O	O
in	O	O
air	O	O
]	O	O
incubator	O	O
)	O	O
for	O	O
an	O	O
additional	O	O
48	O	O
hours	O	O
.	O	O

The	O	O
OCC	O	O
model	O	O
was	O	O
constructed	O	O
by	O	O
seeding	O	O
keratinocytes	O	O
on	O	O
a	O	O
fibroblast-containing	O	O
collagen	O	O
gel	O	O
.	O	O

In	O	O
invasion	O	O
assays	O	O
,	O	O
a	O	O
3-day-old	O	O
anaerobically	O	O
grown	O	O
biofilm	O	O
(	O	O
and	O	O
planktonic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
solution	O	O
as	O	O
the	O	O
control	O	O
)	O	O
was	O	O
placed	O	O
upside	O	O
down	O	O
on	O	O
the	O	O
top	O	O
of	O	O
OCC	O	O
and	O	O
incubated	O	O
under	O	O
5	O	O
%	O	O
CO	O	O
(	O	O
2	O	O
)	O	O
for	O	O
24	O	O
hours	O	O
.	O	O

Invasion	O	O
of	O	O
the	O	O
bacteria	O	O
and	O	O
morphologic	O	O
changes	O	O
in	O	O
OCC	O	O
were	O	O
assessed	O	O
using	O	O
hematoxylin	O	O
and	O	O
eosin	O	O
,	O	O
Ki-67	O	O
,	O	O
and	O	O
periodic	O	O
acid-Schiff	O	O
stainings	O	O
.	O	O

In	O	O
biofilms	O	O
,	O	O
both	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
continuously	O	O
increased	O	O
their	O	O
cell	O	O
numbers	O	O
in	O	O
an	O	O
aerobic	O	O
environment	O	O
for	O	O
48	O	O
hours	O	O
.	O	O

After	O	O
incubating	O	O
the	O	O
bacterial	O	O
biofilm	O	O
in	O	O
contact	O	O
with	O	O
the	O	O
OCC	O	O
model	O	O
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
AHN	I-bacteria	I-bacteria
9508	E-bacteria	I-bacteria
was	O	O
able	O	O
to	O	O
pass	O	O
through	O	O
the	O	O
epithelial/basement	O	O
membrane	O	O
barrier	O	O
and	O	O
invade	O	O
the	O	O
collagen	O	O
matrix	O	O
.	O	O

The	O	O
invasiveness	O	O
of	O	O
biofilm	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25586	E-bacteria	I-bacteria
was	O	O
limited	O	O
to	O	O
the	O	O
epithelium	O	O
.	O	O

Cytotoxic	O	O
effects	O	O
and	O	O
invasiveness	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
on	O	O
the	O	O
OCC	O	O
were	O	O
much	O	O
stronger	O	O
when	O	O
the	O	O
bacteria	O	O
were	O	O
in	O	O
biofilms	O	O
than	O	O
in	O	O
the	O	O
planktonic	O	O
form	O	O
.	O	O

Biofilm	O	O
formation	O	O
regulates	O	O
the	O	O
survival	O	O
and	O	O
invasiveness	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
in	O	O
an	O	O
aerobic	O	O
environment	O	O
.	O	O

During	O	O
oral	O	O
procedures	O	O
,	O	O
microorganisms	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
may	O	O
contaminate	O	O
nearby	O	O
surfaces	O	O
.	O	O

The	O	O
authors	O	O
evaluated	O	O
the	O	O
efficacy	O	O
of	O	O
a	O	O
commercial	O	O
preprocedural	O	O
mouthrinse	O	O
containing	O	O
0.05	O	O
percent	O	O
cetylpyridinium	O	O
chloride	O	O
(	O	O
CPC	O	O
)	O	O
in	O	O
reducing	O	O
the	O	O
levels	O	O
and	O	O
composition	O	O
of	O	O
viable	O	O
bacteria	O	O
in	O	O
oral	O	O
spatter	O	O
.	O	O

The	O	O
authors	O	O
randomly	O	O
assigned	O	O
60	O	O
participants	O	O
receiving	O	O
oral	O	O
prophylaxis	O	O
with	O	O
an	O	O
ultrasonic	O	O
scaler	O	O
to	O	O
one	O	O
of	O	O
four	O	O
groups	O	O
:	O	O
a	O	O
preprocedural	O	O
rinse	O	O
solution	O	O
containing	O	O
0.05	O	O
percent	O	O
CPC	O	O
,	O	O
0.12	O	O
percent	O	O
chlorhexidine	O	O
(	O	O
CHX	O	O
)	O	O
or	O	O
water	O	O
,	O	O
or	O	O
no	O	O
rinsing	O	O
.	O	O

Airborne	O	O
microorganisms	O	O
were	O	O
collected	O	O
on	O	O
blood	O	O
agar	O	O
plates	O	O
.	O	O

The	O	O
composition	O	O
of	O	O
the	O	O
spatter	O	O
was	O	O
analyzed	O	O
for	O	O
39	O	O
oral	O	O
bacterial	O	O
species	O	O
by	O	O
means	O	O
of	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

CPC	O	O
and	O	O
CHX	O	O
were	O	O
equally	O	O
effective	O	O
in	O	O
lowering	O	O
the	O	O
levels	O	O
of	O	O
spatter	O	O
bacteria	O	O
and	O	O
performed	O	O
better	O	O
than	O	O
water	O	O
and	O	O
no	O	O
rinsing	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
,	O	O
Kruskal-Wallis	O	O
test	O	O
)	O	O
.	O	O

The	O	O
composition	O	O
of	O	O
the	O	O
spatter	O	O
from	O	O
the	O	O
control	O	O
groups	O	O
showed	O	O
higher	O	O
proportions	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
,	O	O
Kruskal-Wallis	O	O
test	O	O
)	O	O
of	O	O
Fusobacterium	O	O
species	O	O
and	O	O
lower	O	O
proportions	O	O
of	O	O
Capnocytophaga	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
when	O	O
compared	O	O
with	O	O
the	O	O
spatter	O	O
from	O	O
the	O	O
CPC	O	O
and	O	O
CHX	O	O
groups	O	O
.	O	O

A	O	O
commercial	O	O
mouthrinse	O	O
containing	O	O
0.05	O	O
percent	O	O
CPC	O	O
when	O	O
used	O	O
as	O	O
a	O	O
preprocedural	O	O
mouthrinse	O	O
was	O	O
equally	O	O
effective	O	O
as	O	O
CHX	O	O
in	O	O
reducing	O	O
the	O	O
levels	O	O
of	O	O
spatter	O	O
bacteria	O	O
generated	O	O
during	O	O
ultrasonic	O	O
scaling	O	O
.	O	O

Owing	O	O
to	O	O
its	O	O
strong	O	O
antibacterial	O	O
effect	O	O
and	O	O
the	O	O
fact	O	O
that	O	O
it	O	O
has	O	O
fewer	O	O
side	O	O
effects	O	O
than	O	O
CHX	O	O
,	O	O
a	O	O
solution	O	O
containing	O	O
0.05	O	O
percent	O	O
CPC	O	O
may	O	O
be	O	O
a	O	O
good	O	O
alternative	O	O
to	O	O
that	O	O
containing	O	O
0.12	O	O
CHX	O	O
as	O	O
a	O	O
preprocedural	O	O
mouthrinse	O	O
used	O	O
to	O	O
help	O	O
decrease	O	O
the	O	O
level	O	O
of	O	O
contamination	O	O
in	O	O
spatter	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
full	O	O
mouth	O	O
rehabilitation	O	O
on	O	O
the	O	O
amount	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
children	O	O
with	O	O
Early	O	O
Childhood	O	O
Caries	O	O
.	O	O


Thirty-nine	O	O
children	O	O
between	O	O
2	O	O
and	O	O
5	O	O
years	O	O
old	O	O
treated	O	O
under	O	O
general	O	O
anaesthesia	O	O
participated	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Prior	O	O
to	O	O
treatment	O	O
two	O	O
baselines	O	O
samples	O	O
were	O	O
collected	O	O
,	O	O
one	O	O
of	O	O
dental	O	O
plaque	O	O
and	O	O
one	O	O
of	O	O
saliva	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
samples	O	O
were	O	O
obtained	O	O
one	O	O
week	O	O
post	O	O
operatively	O	O
,	O	O
and	O	O
then	O	O
three	O	O
months	O	O
later	O	O
.	O	O

In	O	O
each	O	O
sampling	O	O
,	O	O
the	O	O
amount	O	O
and	O	O
the	O	O
concentration	O	O
(	O	O
cfu/ml	O	O
)	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
evaluated	O	O
.	O	O

The	O	O
findings	O	O
demonstrate	O	O
that	O	O
the	O	O
operative	O	O
procedures	O	O
under	O	O
general	O	O
anaesthesia	O	O
,	O	O
significantly	O	O
decrease	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
the	O	O
concentration	O	O
(	O	O
cfu/ml	O	O
)	O	O
and	O	O
the	O	O
amount	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
for	O	O
at	O	O
least	O	O
three	O	O
months	O	O
.	O	O

After	O	O
three	O	O
months	O	O
,	O	O
saliva	O	O
concentrations	O	O
and	O	O
plaque	O	O
colony	O	O
numbers	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
increased	O	O
significantly	O	O
in	O	O
relation	O	O
to	O	O
one	O	O
week	O	O
post-operatively	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

However	O	O
,	O	O
none	O	O
of	O	O
the	O	O
saliva	O	O
or	O	O
plaque	O	O
samples	O	O
collected	O	O
three	O	O
months	O	O
following	O	O
treatment	O	O
reached	O	O
the	O	O
pretreatment	O	O
levels	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
any	O	O
of	O	O
our	O	O
subjects	O	O
.	O	O

The	O	O
data	O	O
indicates	O	O
that	O	O
full	O	O
mouth	O	O
rehabilitation	O	O
under	O	O
general	O	O
anaesthesia	O	O
produces	O	O
a	O	O
statistically	O	O
significant	O	O
decrease	O	O
in	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
levels	O	O
for	O	O
at	O	O
least	O	O
three	O	O
months	O	O
.	O	O

The	O	O
indigenous	O	O
bacteria	O	O
create	O	O
natural	O	O
cohabitation	O	O
niches	O	O
together	O	O
with	O	O
mucosal	O	O
Abs	O	O
in	O	O
the	O	O
gastrointestinal	O	O
(	O	O
GI	O	O
)	O	O
tract	O	O
.	O	O

Here	O	O
we	O	O
report	O	O
that	O	O
opportunistic	O	O
bacteria	O	O
,	O	O
largely	O	O
Alcaligenes	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
specifically	O	O
inhabit	O	O
host	O	O
Peyer	O	O
's	O	O
patches	O	O
(	O	O
PPs	O	O
)	O	O
and	O	O
isolated	O	O
lymphoid	O	O
follicles	O	O
,	O	O
with	O	O
the	O	O
associated	O	O
preferential	O	O
induction	O	O
of	O	O
antigen-specific	O	O
mucosal	O	O
IgA	O	O
Abs	O	O
in	O	O
the	O	O
GI	O	O
tract	O	O
.	O	O

Alcaligenes	O	O
were	O	O
identified	O	O
as	O	O
the	O	O
dominant	O	O
bacteria	O	O
on	O	O
the	O	O
interior	O	O
of	O	O
PPs	O	O
from	O	O
naive	O	O
,	O	O
specific-pathogen-free	O	O
but	O	O
not	O	O
from	O	O
germ-free	O	O
mice	O	O
.	O	O

Oral	O	O
transfer	O	O
of	O	O
intratissue	O	O
uncultured	O	O
Alcaligenes	B-bacteria	B-bacteria
into	O	O
germ-free	O	O
mice	O	O
resulted	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
Alcaligenes	B-bacteria	B-bacteria
inside	O	O
the	O	O
PPs	O	O
of	O	O
recipients	O	O
.	O	O

This	O	O
result	O	O
was	O	O
further	O	O
supported	O	O
by	O	O
the	O	O
induction	O	O
of	O	O
antigen-specific	O	O
Ab-producing	O	O
cells	O	O
in	O	O
the	O	O
mucosal	O	O
(	O	O
e.g.	O	O
,	O	O
PPs	O	O
)	O	O
but	O	O
not	O	O
systemic	O	O
compartment	O	O
(	O	O
e.g.	O	O
,	O	O
spleen	O	O
)	O	O
.	O	O

The	O	O
preferential	O	O
presence	O	O
of	O	O
Alcaligenes	B-bacteria	B-bacteria
inside	O	O
PPs	O	O
and	O	O
the	O	O
associated	O	O
induction	O	O
of	O	O
intestinal	O	O
secretory	O	O
IgA	O	O
Abs	O	O
were	O	O
also	O	O
observed	O	O
in	O	O
both	O	O
monkeys	O	O
and	O	O
humans	O	O
.	O	O

Localized	O	O
mucosal	O	O
Ab-mediated	O	O
symbiotic	O	O
immune	O	O
responses	O	O
were	O	O
supported	O	O
by	O	O
Alcaligenes-stimulated	O	O
CD11c	O	O
(	O	O
+	O	O
)	O	O
dendritic	O	O
cells	O	O
(	O	O
DCs	O	O
)	O	O
producing	O	O
the	O	O
Ab-enhancing	O	O
cytokines	O	O
TGF-beta	O	O
,	O	O
B-cell-activating	O	O
factor	O	O
belonging	O	O
to	O	O
the	O	O
TNF	O	O
family	O	O
,	O	O
and	O	O
IL-6	O	O
in	O	O
PPs	O	O
.	O	O

These	O	O
CD11c	O	O
(	O	O
+	O	O
)	O	O
DCs	O	O
did	O	O
not	O	O
migrate	O	O
beyond	O	O
the	O	O
draining	O	O
mesenteric	O	O
lymph	O	O
nodes	O	O
.	O	O

In	O	O
the	O	O
absence	O	O
of	O	O
antigen-specific	O	O
mucosal	O	O
Abs	O	O
,	O	O
the	O	O
presence	O	O
of	O	O
Alcaligenes	O	O
in	O	O
PPs	O	O
was	O	O
greatly	O	O
diminished	O	O
.	O	O

Thus	O	O
,	O	O
indigenous	O	O
opportunistic	O	O
bacteria	O	O
uniquely	O	O
inhabit	O	O
PPs	O	O
,	O	O
leading	O	O
to	O	O
PP-DCs-initiated	O	O
,	O	O
local	O	O
antigen-specific	O	O
Ab	O	O
production	O	O
;	O	O
this	O	O
may	O	O
involve	O	O
the	O	O
creation	O	O
of	O	O
an	O	O
optimal	O	O
symbiotic	O	O
environment	O	O
on	O	O
the	O	O
interior	O	O
of	O	O
the	O	O
PPs	O	O
.	O	O

Increasing	O	O
awareness	O	O
of	O	O
hazards	O	O
associated	O	O
with	O	O
the	O	O
use	O	O
of	O	O
antibiotic	O	O
and	O	O
chemical	O	O
agents	O	O
has	O	O
accelerated	O	O
investigations	O	O
into	O	O
plants	O	O
and	O	O
their	O	O
extracts	O	O
as	O	O
new	O	O
sources	O	O
of	O	O
antimicrobial	O	O
agents	O	O
.	O	O

Therefore	O	O
,	O	O
this	O	O
study	O	O
aimed	O	O
at	O	O
determining	O	O
the	O	O
effects	O	O
of	O	O
oil	O	O
and	O	O
95	O	O
%	O	O
ethanol	O	O
extracts	O	O
of	O	O
Boesenbergia	O	O
pandurata	O	O
rhizomes	O	O
and	O	O
Piper	O	O
sarmentosum	O	O
leaf	O	O
against	O	O
four	O	O
oral	O	O
pathogens	O	O
which	O	O
were	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Candida	O	O
albicans	O	O
.	O	O

Employing	O	O
the	O	O
disc	O	O
diffusion	O	O
and	O	O
broth	O	O
microdilution	O	O
methods	O	O
,	O	O
the	O	O
results	O	O
showed	O	O
that	O	O
B.	O	O
pandurata	O	O
oil	O	O
(	O	O
BPO	O	O
)	O	O
was	O	O
the	O	O
most	O	O
effective	O	O
extract	O	O
against	O	O
C.	O	O
albicans	O	O
.	O	O

Time-kill	O	O
assay	O	O
with	O	O
the	O	O
BPO	O	O
demonstrated	O	O
killing	O	O
of	O	O
C.	O	O
albicans	O	O
at	O	O
concentrations	O	O
equal	O	O
to	O	O
2	O	O
and	O	O
2.5	O	O
times	O	O
the	O	O
MIC	O	O
.	O	O

The	O	O
times	O	O
required	O	O
to	O	O
reach	O	O
the	O	O
fungicidal	O	O
endpoint	O	O
at	O	O
2	O	O
and	O	O
2.5	O	O
times	O	O
the	O	O
MIC	O	O
were	O	O
60	O	O
and	O	O
44	O	O
min	O	O
,	O	O
respectively	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
our	O	O
results	O	O
also	O	O
demonstrated	O	O
that	O	O
the	O	O
BPO	O	O
possesses	O	O
potent	O	O
anti-Candida	O	O
biofilm	O	O
activity	O	O
in	O	O
vitro	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
BPO	O	O
could	O	O
be	O	O
considered	O	O
as	O	O
a	O	O
natural	O	O
antifungal	O	O
agent	O	O
against	O	O
Candida	O	O
infections	O	O
and	O	O
has	O	O
significant	O	O
potential	O	O
for	O	O
further	O	O
investigation	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
evaluate	O	O
the	O	O
influence	O	O
of	O	O
oral	O	O
contraceptive	O	O
(	O	O
OC	O	O
)	O	O
use	O	O
on	O	O
the	O	O
subgingival	O	O
occurrence	O	O
of	O	O
specific	O	O
periodontopathogens	O	O
and	O	O
the	O	O
host	O	O
's	O	O
periodontal	O	O
status	O	O
.	O	O

Ninety-two	O	O
females	O	O
aged	O	O
19	O	O
to	O	O
40	O	O
years	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

They	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
,	O	O
OC	O	O
users	O	O
and	O	O
non-users	O	O
,	O	O
and	O	O
subgrouped	O	O
according	O	O
to	O	O
the	O	O
most	O	O
severe	O	O
periodontal	O	O
condition	O	O
and	O	O
duration	O	O
of	O	O
OC	O	O
usage	O	O
.	O	O

A	O	O
pooled	O	O
subgingival	O	O
sample	O	O
from	O	O
each	O	O
subject	O	O
was	O	O
cultured	O	O
to	O	O
investigate	O	O
the	O	O
presence	O	O
of	O	O
Candida	O	O
species	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
previously	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
.	O	O

OC	O	O
users	O	O
,	O	O
particularly	O	O
smokers	O	O
,	O	O
show	O	O
a	O	O
statistically	O	O
significant	O	O
increase	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
severe	O	O
periodontitis	O	O
.	O	O

OC	O	O
users	O	O
had	O	O
deeper	O	O
probing	O	O
depths	O	O
(	O	O
>	O	O
or=5	O	O
mm	O	O
)	O	O
than	O	O
non-users	O	O
.	O	O

Moreover	O	O
,	O	O
OC	O	O
users	O	O
had	O	O
higher	O	O
gingival	O	O
index	O	O
scores	O	O
and	O	O
clinical	O	O
attachment	O	O
loss	O	O
,	O	O
>	O	O
or=2	O	O
and	O	O
>	O	O
or=5	O	O
mm	O	O
,	O	O
respectively	O	O
,	O	O
than	O	O
non-users	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Patients	O	O
taking	O	O
OCs	O	O
had	O	O
significantly	O	O
higher	O	O
numbers	O	O
of	O	O
cultures	O	O
positive	O	O
for	O	O
Candida	O	O
.	O	O

Seven	O	O
Candida	O	O
species	O	O
were	O	O
isolated	O	O
.	O	O

Subgingival	O	O
Candida	O	O
was	O	O
associated	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
in	O	O
82.9	O	O
%	O	O
and	O	O
85.4	O	O
%	O	O
,	O	O
respectively	O	O
,	O	O
in	O	O
patients	O	O
taking	O	O
OCs	O	O
.	O	O

A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
was	O	O
isolated	O	O
in	O	O
patients	O	O
with	O	O
moderate	O	O
and	O	O
severe	O	O
periodontitis	O	O
and	O	O
was	O	O
associated	O	O
with	O	O
subgingival	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
.	O	O

OC	O	O
use	O	O
may	O	O
increase	O	O
the	O	O
risk	O	O
of	O	O
severe	O	O
periodontitis	O	O
and	O	O
seems	O	O
to	O	O
cause	O	O
a	O	O
selection	O	O
of	O	O
certain	O	O
Candida	O	O
species	O	O
in	O	O
periodontal	O	O
pockets	O	O
.	O	O

OC	O	O
users	O	O
showed	O	O
a	O	O
higher	O	O
prevalence	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
compared	O	O
to	O	O
non-users	O	O
.	O	O

C.	O	O
albicans	O	O
,	O	O
C.	O	O
parapsilosis	O	O
,	O	O
C.	O	O
krusei	O	O
,	O	O
C.	O	O
tropicalis	E-bacteria	I-bacteria
,	O	O
and	O	O
C.	O	O
glabrata	O	O
were	O	O
the	O	O
species	O	O
with	O	O
the	O	O
ability	O	O
to	O	O
survive	O	O
in	O	O
the	O	O
conditions	O	O
created	O	O
by	O	O
the	O	O
sex	O	O
hormones	O	O
after	O	O
3	O	O
years	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
adhesion	O	O
and	O	O
invasion	O	O
of	O	O
periodontopathogenic	O	O
bacteria	O	O
in	O	O
varied	O	O
mixed	O	O
infections	O	O
and	O	O
the	O	O
release	O	O
of	O	O
interleukins	O	O
from	O	O
an	O	O
epithelial	O	O
cell	O	O
line	O	O
(	O	O
KB	O	O
cells	O	O
)	O	O
.	O	O

KB	O	O
cells	O	O
were	O	O
co-cultured	O	O
with	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33277	E-bacteria	I-bacteria
and	O	O
M5-1-2	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
43037	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
35405	E-bacteria	I-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25586	E-bacteria	I-bacteria
in	O	O
single	O	O
and	O	O
mixed	O	O
infections	O	O
.	O	O

The	O	O
numbers	O	O
of	O	O
adherent	O	O
and	O	O
internalized	O	O
bacteria	O	O
were	O	O
determined	O	O
up	O	O
to	O	O
18	O	O
h	O	O
after	O	O
bacterial	O	O
exposure	O	O
.	O	O

Additionally	O	O
,	O	O
the	O	O
mRNA	O	O
expression	O	O
and	O	O
concentrations	O	O
of	O	O
released	O	O
interleukin	O	O
(	O	O
IL	O	O
)	O	O
-6	O	O
and	O	O
IL-8	O	O
were	O	O
measured	O	O
.	O	O

All	O	O
periodontopathogenic	O	O
bacteria	O	O
adhered	O	O
and	O	O
internalized	O	O
in	O	O
different	O	O
numbers	O	O
to	O	O
KB	O	O
cells	O	O
,	O	O
but	O	O
individually	O	O
without	O	O
any	O	O
evidence	O	O
of	O	O
co-aggregation	O	O
also	O	O
to	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

High	O	O
levels	O	O
of	O	O
epithelial	O	O
mRNA	O	O
of	O	O
IL-6	O	O
and	O	O
IL-8	O	O
were	O	O
detectable	O	O
after	O	O
all	O	O
bacterial	O	O
challenges	O	O
.	O	O

After	O	O
the	O	O
mixed	O	O
infection	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33277	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25586	E-bacteria	I-bacteria
the	O	O
highest	O	O
levels	O	O
of	O	O
released	O	O
interleukins	O	O
were	O	O
found	O	O
.	O	O

No	O	O
IL-6	O	O
and	O	O
IL-8	O	O
were	O	O
detectable	O	O
after	O	O
the	O	O
mixed	O	O
infection	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
M5-1-2	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25586	E-bacteria	I-bacteria
and	O	O
the	O	O
fourfold	O	O
infection	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
33277	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
denticola	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
35405	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
forsythia	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
43037	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25586	E-bacteria	I-bacteria
.	O	O

Anaerobic	B-bacteria	B-bacteria
periodontopathogenic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
promote	O	O
the	O	O
release	O	O
of	O	O
IL-6	O	O
and	O	O
IL-8	O	O
by	O	O
epithelial	O	O
cells	O	O
.	O	O

Despite	O	O
a	O	O
continuous	O	O
epithelial	O	O
expression	O	O
of	O	O
IL-8	O	O
mRNA	O	O
by	O	O
all	O	O
bacterial	O	O
infections	O	O
these	O	O
effects	O	O
are	O	O
temporary	O	O
because	O	O
of	O	O
the	O	O
time-dependent	O	O
degradation	O	O
of	O	O
cytokines	O	O
by	O	O
bacterial	O	O
proteases	O	O
.	O	O

Mixed	O	O
infections	O	O
have	O	O
a	O	O
stronger	O	O
virulence	O	O
potential	O	O
than	O	O
single	O	O
bacteria	O	O
.	O	O

Further	O	O
research	O	O
is	O	O
necessary	O	O
to	O	O
evaluate	O	O
the	O	O
role	O	O
of	O	O
mixed	O	O
infections	O	O
and	O	O
biofilms	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontitis	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
is	O	O
a	O	O
major	O	O
pathogen	O	O
of	O	O
dental	O	O
caries	O	O
and	O	O
occasionally	O	O
isolated	O	O
from	O	O
the	O	O
blood	O	O
of	O	O
patients	O	O
with	O	O
infective	O	O
endocarditis	O	O
,	O	O
though	O	O
the	O	O
association	O	O
of	O	O
its	O	O
cell-surface	O	O
glucosyltransferases	O	O
(	O	O
GTFB	O	O
,	O	O
GTFC	O	O
,	O	O
and	O	O
GTFD	O	O
)	O	O
with	O	O
pathogenicity	O	O
for	O	O
infective	O	O
endocarditis	O	O
remains	O	O
to	O	O
be	O	O
elucidated	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
contribution	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
GTFs	O	O
to	O	O
platelet	O	O
aggregation	O	O
and	O	O
analysed	O	O
GTF	O	O
expression	O	O
profiles	O	O
in	O	O
a	O	O
large	O	O
number	O	O
of	O	O
clinical	O	O
oral	O	O
isolates	O	O
.	O	O

The	O	O
platelet	O	O
aggregation	O	O
properties	O	O
of	O	O
GTF-defective	O	O
isogenic	O	O
mutant	O	O
strains	O	O
constructed	O	O
from	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
reference	O	O
strain	B-bacteria	B-bacteria
MT8148	E-bacteria	I-bacteria
were	O	O
evaluated	O	O
using	O	O
whole	O	O
blood	O	O
and	O	O
platelet-rich	O	O
plasma	O	O
(	O	O
PRP	O	O
)	O	O
taken	O	O
from	O	O
mice	O	O
,	O	O
as	O	O
well	O	O
as	O	O
human	O	O
PRP	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
GTF	O	O
expression	O	O
profiles	O	O
for	O	O
396	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
396	O	O
subjects	O	O
were	O	O
analysed	O	O
by	O	O
western	O	O
blotting	O	O
using	O	O
antisera	O	O
specific	O	O
for	O	O
each	O	O
GTF	O	O
.	O	O

The	O	O
platelet	O	O
aggregation	O	O
activities	O	O
of	O	O
the	O	O
GTF-defective	O	O
isogenic	O	O
mutants	O	O
were	O	O
significantly	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
MT8148	B-bacteria	B-bacteria
when	O	O
added	O	O
to	O	O
a	O	O
large	O	O
number	O	O
of	O	O
cells	O	O
.	O	O

Western	O	O
blotting	O	O
revealed	O	O
no	O	O
strains	O	O
without	O	O
GTF	O	O
expression	O	O
,	O	O
though	O	O
six	O	O
strains	O	O
had	O	O
alterations	O	O
of	O	O
GTFB	O	O
and	O	O
GTFC	O	O
as	O	O
compared	O	O
to	O	O
MT8148	B-bacteria	B-bacteria
.	O	O

PCR	O	O
analyses	O	O
indicated	O	O
that	O	O
the	O	O
gtfB-gtfC	O	O
region	O	O
length	O	O
was	O	O
approximately	O	O
4.5	O	O
kb	O	O
shorter	O	O
in	O	O
those	O	O
strains	O	O
as	O	O
compared	O	O
to	O	O
MT8148	B-bacteria	B-bacteria
.	O	O

These	O	O
were	O	O
designated	O	O
as	O	O
``	O	O
GTFBC-fusion	O	O
''	O	O
strains	O	O
and	O	O
they	O	O
demonstrated	O	O
lower	O	O
levels	O	O
of	O	O
platelet	O	O
aggregation	O	O
.	O	O

Our	O	O
findings	O	O
indicate	O	O
that	O	O
GTFs	O	O
are	O	O
associated	O	O
with	O	O
platelet	O	O
aggregation	O	O
.	O	O

Although	O	O
the	O	O
clinical	O	O
detection	O	O
frequency	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
with	O	O
altered	O	O
expressions	O	O
is	O	O
extremely	O	O
low	O	O
,	O	O
GTFBC-fusion	O	O
strains	O	O
have	O	O
activities	O	O
similar	O	O
to	O	O
GTF-defective	O	O
mutant	O	O
strains	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
is	O	O
an	O	O
important	O	O
factor	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
numerous	O	O
diseases	O	O
including	O	O
gastro-intestinal	O	O
,	O	O
metabolic	O	O
and	O	O
vascular	O	O
disorders	O	O
.	O	O

Therefore	O	O
,	O	O
identification	O	O
of	O	O
individuals	O	O
at	O	O
risk	O	O
of	O	O
this	O	O
infection	O	O
remains	O	O
of	O	O
critical	O	O
importance	O	O
.	O	O

Dentists	O	O
and	O	O
dental	O	O
professionals	O	O
may	O	O
be	O	O
at	O	O
increased	O	O
risk	O	O
due	O	O
to	O	O
the	O	O
contact	O	O
with	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
where	O	O
it	O	O
may	O	O
serve	O	O
as	O	O
reservoir	O	O
for	O	O
gastric	O	O
infections	O	O
and	O	O
participate	O	O
in	O	O
the	O	O
pathogenesis	O	O
oral	O	O
mucosal	O	O
lesions	O	O
and	O	O
ulceration	O	O
.	O	O

However	O	O
,	O	O
evidence	O	O
regarding	O	O
the	O	O
occurrence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infections	O	O
and	O	O
colonization	O	O
in	O	O
dentists	O	O
is	O	O
conflicting	O	O
,	O	O
but	O	O
has	O	O
been	O	O
based	O	O
mainly	O	O
on	O	O
serological	O	O
studies	O	O
,	O	O
which	O	O
carry	O	O
significant	O	O
limitations	O	O
.	O	O

Therefore	O	O
,	O	O
we	O	O
attempted	O	O
to	O	O
characterize	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
in	O	O
practising	O	O
dentists	O	O
in	O	O
relation	O	O
to	O	O
the	O	O
duration	O	O
of	O	O
their	O	O
work	O	O
as	O	O
dental	O	O
professionals	O	O
.	O	O

Moreover	O	O
,	O	O
apart	O	O
from	O	O
seropositivity	O	O
,	O	O
which	O	O
was	O	O
used	O	O
by	O	O
majority	O	O
of	O	O
previous	O	O
studies	O	O
,	O	O
we	O	O
have	O	O
performed	O	O
urea-breath	O	O
test	O	O
(	O	O
UBT	O	O
)	O	O
,	O	O
which	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
represent	O	O
active	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
in	O	O
stomach	O	O
as	O	O
well	O	O
as	O	O
the	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
culture	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

We	O	O
found	O	O
that	O	O
while	O	O
the	O	O
occurrence	O	O
of	O	O
either	O	O
gastric	O	O
or	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
dentists	O	O
is	O	O
not	O	O
greater	O	O
than	O	O
in	O	O
general	O	O
population	O	O
,	O	O
it	O	O
seems	O	O
that	O	O
in	O	O
male	O	O
dentists	O	O
there	O	O
is	O	O
a	O	O
greater	O	O
risk	O	O
of	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
.	O	O

Moreover	O	O
,	O	O
we	O	O
found	O	O
a	O	O
relationship	O	O
between	O	O
the	O	O
length	O	O
of	O	O
dentist	O	O
occupation	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
gingival	O	O
sulcus	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
while	O	O
overall	O	O
occurrence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
dentists	O	O
did	O	O
not	O	O
differ	O	O
from	O	O
that	O	O
reported	O	O
for	O	O
stomach	O	O
or	O	O
oral	O	O
cavity	O	O
in	O	O
general	O	O
population	O	O
,	O	O
there	O	O
was	O	O
an	O	O
increased	O	O
occurrence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
male	O	O
dentists	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
this	O	O
germ	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
appears	O	O
to	O	O
be	O	O
related	O	O
to	O	O
the	O	O
length	O	O
of	O	O
professional	O	O
exposure	O	O
.	O	O

Oral	O	O
immunotherapy	O	O
with	O	O
inactivated	O	O
non-typeable	B-bacteria	B-bacteria
Haemophilus	I-bacteria	I-bacteria
influenzae	E-bacteria	I-bacteria
(	O	O
NTHi	B-bacteria	B-bacteria
)	O	O
prevents	O	O
exacerbations	O	O
of	O	O
chronic	O	O
obstructive	O	O
pulmonary	O	O
disease	O	O
,	O	O
but	O	O
the	O	O
mechanism	O	O
is	O	O
unclear	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
mechanism	O	O
of	O	O
protection	O	O
.	O	O

This	O	O
was	O	O
a	O	O
placebo	O	O
versus	O	O
active	O	O
prospective	O	O
study	O	O
over	O	O
3	O	O
months	O	O
in	O	O
64	O	O
smokers	O	O
.	O	O

The	O	O
active	O	O
treatment	O	O
was	O	O
three	O	O
courses	O	O
of	O	O
oral	O	O
NTHi	B-bacteria	B-bacteria
given	O	O
at	O	O
monthly	O	O
intervals	O	O
,	O	O
followed	O	O
by	O	O
measurement	O	O
of	O	O
bacteriological	O	O
and	O	O
immunological	O	O
parameters	O	O
.	O	O

The	O	O
results	O	O
can	O	O
be	O	O
summarized	O	O
:	O	O
(	O	O
i	O	O
)	O	O
NTHi-specific	O	O
T	O	O
cells	O	O
increased	O	O
in	O	O
the	O	O
placebo	O	O
treatment	O	O
group	O	O
over	O	O
time	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
;	O	O
(	O	O
ii	O	O
)	O	O
the	O	O
T`	O	O
cell	O	O
response	O	O
in	O	O
the	O	O
oral	O	O
NTHi	B-bacteria	B-bacteria
group	O	O
started	O	O
earlier	O	O
than	O	O
that	O	O
in	O	O
the	O	O
placebo	O	O
group	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
;	O	O
and	O	O
(	O	O
iii	O	O
)	O	O
serum	O	O
NTHi-specific	O	O
immunoglobulin	O	O
(	O	O
Ig	O	O
)	O	O
G	O	O
had	O	O
significantly	O	O
greater	O	O
variation	O	O
in	O	O
the	O	O
placebo	O	O
group	O	O
(	O	O
P	O	O
<	O	O
0.0001	O	O
)	O	O
.	O	O

The	O	O
increase	O	O
in	O	O
antibody	O	O
in	O	O
placebos	O	O
over	O	O
time	O	O
correlated	O	O
with	O	O
exposure	O	O
to	O	O
live	O	O
H.	B-bacteria	B-bacteria
influenzae	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
determined	O	O
from	O	O
culture	O	O
of	O	O
gargles	O	O
;	O	O
(	O	O
iv	O	O
)	O	O
reduction	O	O
in	O	O
saliva	O	O
lysozyme	O	O
over	O	O
time	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
was	O	O
detected	O	O
only	O	O
in	O	O
the	O	O
oral	O	O
NTHi	B-bacteria	B-bacteria
treatment	O	O
group	O	O
.	O	O

These	O	O
data	O	O
are	O	O
consistent	O	O
with	O	O
T	O	O
cell	O	O
priming	O	O
of	O	O
gut	O	O
lymphoid	O	O
tissue	O	O
by	O	O
aspiration	O	O
of	O	O
bronchus	O	O
content	O	O
into	O	O
the	O	O
gut	O	O
,	O	O
with	O	O
oral	O	O
immunotherapy	O	O
augmenting	O	O
this	O	O
process	O	O
leading	O	O
to	O	O
enhanced	O	O
bronchus	O	O
protection	O	O
.	O	O

The	O	O
evidence	O	O
for	O	O
protection	O	O
was	O	O
a	O	O
stable	O	O
IgG	O	O
antibody	O	O
level	O	O
through	O	O
the	O	O
study	O	O
in	O	O
the	O	O
oral	O	O
NTHi	B-bacteria	B-bacteria
treatment	O	O
group	O	O
,	O	O
contrasting	O	O
with	O	O
an	O	O
increase	O	O
in	O	O
antibody	O	O
correlating	O	O
with	O	O
exposure	O	O
of	O	O
the	O	O
airways	O	O
to	O	O
H.	B-bacteria	B-bacteria
influenzae	E-bacteria	I-bacteria
in	O	O
the	O	O
placebo	O	O
group	O	O
.	O	O

Saliva	O	O
lysozyme	O	O
was	O	O
a	O	O
useful	O	O
biomarker	O	O
of	O	O
mucosal	O	O
inflammation	O	O
,	O	O
falling	O	O
after	O	O
oral	O	O
NTHi	B-bacteria	B-bacteria
consistent	O	O
with	O	O
a	O	O
reduction	O	O
in	O	O
the	O	O
level	O	O
of	O	O
intralumenal	O	O
inflammation	O	O
.	O	O

This	O	O
study	O	O
examined	O	O
caries	O	O
level	O	O
,	O	O
amount	O	O
of	O	O
calculus	O	O
,	O	O
and	O	O
oral	O	O
microbial	O	O
environment	O	O
in	O	O
gastrostomy	O	O
tube	O	O
(	O	O
GT	O	O
)	O	O
-fed	O	O
children	O	O
compared	O	O
with	O	O
healthy	O	O
children	O	O
and	O	O
children	O	O
with	O	O
disabilities	O	O
orally	O	O
fed	O	O
(	O	O
PO	O	O
)	O	O
.	O	O

STUDY	O	O
The	O	O
study	O	O
group	O	O
consisted	O	O
of	O	O
12	O	O
GT-fed	O	O
children	O	O
and	O	O
the	O	O
two	O	O
control	O	O
groups	O	O
consisted	O	O
of	O	O
16	O	O
children	O	O
with	O	O
disabilities	O	O
orally	O	O
fed	O	O
and	O	O
17	O	O
healthy	O	O
children	O	O
.	O	O

DMF-T/dmf-t	O	O
index	O	O
,	O	O
calculus	O	O
index	O	O
,	O	O
Mutans	B-bacteria	B-bacteria
Streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
,	O	O
Lactobacilli	B-bacteria	B-bacteria
(	O	O
LB	B-bacteria	B-bacteria
)	O	O
levels	O	O
and	O	O
salivary	O	O
buffer	O	O
capacity	O	O
were	O	O
examined	O	O
.	O	O

DMF-T/dmf-t	O	O
index	O	O
was	O	O
significantly	O	O
lower	O	O
in	O	O
the	O	O
tube-fed	O	O
group	O	O
.	O	O

Calculus	O	O
index	O	O
was	O	O
highest	O	O
in	O	O
the	O	O
tube-fed	O	O
group	O	O
.	O	O

MS	B-bacteria	B-bacteria
and	O	O
LB	B-bacteria	B-bacteria
levels	O	O
were	O	O
the	O	O
lowest	O	O
in	O	O
the	O	O
tube-fed	O	O
children	O	O
.	O	O

Correlation	O	O
was	O	O
found	O	O
between	O	O
MS	B-bacteria	B-bacteria
and	O	O
DMF-T/dmf-t.	O	O
Tube-fed	O	O
children	O	O
demonstrated	O	O
significantly	O	O
higher	O	O
calculus	O	O
levels	O	O
and	O	O
less	O	O
caries	O	O
,	O	O
MS	B-bacteria	B-bacteria
,	O	O
and	O	O
LB	B-bacteria	B-bacteria
levels	O	O
then	O	O
healthy	O	O
children	O	O
or	O	O
children	O	O
with	O	O
disabilities	O	O
eating	O	O
PO	O	O
.	O	O

It	O	O
has	O	O
been	O	O
demonstrated	O	O
that	O	O
smoking	O	O
cessation	O	O
alters	O	O
the	O	O
subgingival	O	O
microbial	O	O
profile	O	O
;	O	O
however	O	O
,	O	O
the	O	O
response	O	O
of	O	O
individual	O	O
bacteria	O	O
within	O	O
this	O	O
ecosystem	O	O
has	O	O
not	O	O
been	O	O
well	O	O
studied	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
investigation	O	O
,	O	O
therefore	O	O
,	O	O
was	O	O
to	O	O
longitudinally	O	O
examine	O	O
the	O	O
effect	O	O
of	O	O
smoking	O	O
cessation	O	O
on	O	O
the	O	O
prevalence	O	O
and	O	O
levels	O	O
of	O	O
selected	O	O
subgingival	O	O
bacteria	O	O
using	O	O
molecular	O	O
approaches	O	O
for	O	O
bacterial	O	O
identification	O	O
and	O	O
enumeration	O	O
.	O	O

Subgingival	O	O
plaque	O	O
was	O	O
collected	O	O
from	O	O
22	O	O
smokers	O	O
at	O	O
the	O	O
baseline	O	O
and	O	O
12	O	O
months	O	O
following	O	O
periodontal	O	O
nonsurgical	O	O
management	O	O
and	O	O
smoking	O	O
cessation	O	O
counseling	O	O
.	O	O

The	O	O
prevalence	O	O
and	O	O
abundance	O	O
of	O	O
selected	O	O
organisms	O	O
were	O	O
examined	O	O
using	O	O
nested	O	O
PCR	O	O
and	O	O
multiplexed	O	O
bead-based	O	O
flow	O	O
cytometry	O	O
.	O	O

Eleven	O	O
subjects	O	O
successfully	O	O
quit	O	O
smoking	O	O
over	O	O
12	O	O
months	O	O
(	O	O
quitters	O	O
)	O	O
,	O	O
while	O	O
11	O	O
continued	O	O
to	O	O
smoke	O	O
throughout	O	O
(	O	O
smokers	O	O
)	O	O
.	O	O

Smoking	O	O
cessation	O	O
led	O	O
to	O	O
a	O	O
decrease	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
endodontalis	E-bacteria	I-bacteria
and	O	O
Dialister	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
at	O	O
12	O	O
months	O	O
and	O	O
in	O	O
the	O	O
levels	O	O
of	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
,	O	O
Filifactor	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

Smoking	O	O
cessation	O	O
also	O	O
led	O	O
to	O	O
an	O	O
increase	O	O
in	O	O
the	O	O
levels	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
.	O	O

Following	O	O
nonsurgical	O	O
periodontal	O	O
therapy	O	O
and	O	O
smoking	O	O
cessation	O	O
,	O	O
the	O	O
subgingival	O	O
microbiome	O	O
is	O	O
recolonized	O	O
by	O	O
a	O	O
greater	O	O
number	O	O
of	O	O
health-associated	O	O
species	O	O
and	O	O
there	O	O
are	O	O
a	O	O
significantly	O	O
lower	O	O
prevalence	O	O
and	O	O
abundance	O	O
of	O	O
putative	O	O
periodontal	O	O
pathogens	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
a	O	O
critical	O	O
role	O	O
for	O	O
smoking	O	O
cessation	O	O
counseling	O	O
in	O	O
periodontal	O	O
therapy	O	O
for	O	O
smokers	O	O
in	O	O
order	O	O
to	O	O
effectively	O	O
alter	O	O
the	O	O
subgingival	O	O
microbiome	O	O
.	O	O

To	O	O
study	O	O
a	O	O
possible	O	O
influence	O	O
of	O	O
betel	O	O
chewing	O	O
on	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
in	O	O
plaque	O	O
and	O	O
saliva	O	O
and	O	O
on	O	O
oral	O	O
health	O	O
parameters	O	O
as	O	O
well	O	O
as	O	O
a	O	O
possible	O	O
betel	O	O
effect	O	O
on	O	O
oral	O	O
bacteria	O	O
in	O	O
vitro	O	O
.	O	O

Thirty-two	O	O
adults	O	O
(	O	O
16	O	O
betel	O	O
chewers	O	O
and	O	O
16	O	O
non-betel-chewing	O	O
controls	O	O
)	O	O
of	O	O
the	O	O
Karen	O	O
Hill	O	O
tribe	O	O
in	O	O
Thailand	O	O
were	O	O
investigated	O	O
.	O	O

Saliva	O	O
samples	O	O
and	O	O
2	O	O
pooled	O	O
supragingival	O	O
plaque	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
each	O	O
individual	O	O
for	O	O
microbial	O	O
analysis	O	O
with	O	O
culture	O	O
and	O	O
4	O	O
subgingival	O	O
samples	O	O
for	O	O
analysis	O	O
with	O	O
the	O	O
DNA-DNA	O	O
hybridization	O	O
method	O	O
against	O	O
12	O	O
periodontitis	B-bacteria	B-bacteria
associated	I-bacteria	I-bacteria
bacterial	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
.	O	O

Caries	O	O
(	O	O
DMFS	O	O
)	O	O
,	O	O
plaque	O	O
(	O	O
PlI	O	O
%	O	O
)	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
(	O	O
%	O	O
BoP	O	O
)	O	O
was	O	O
registered	O	O
as	O	O
well	O	O
as	O	O
number	O	O
of	O	O
sites	O	O
with	O	O
>	O	O
5mm	O	O
probing	O	O
pocket	O	O
depth	O	O
(	O	O
PPD	O	O
)	O	O
.	O	O

Water	O	O
extract	O	O
of	O	O
the	O	O
betel	O	O
(	O	O
areca	O	O
chatechu	O	O
)	O	O
nut	O	O
was	O	O
tested	O	O
for	O	O
its	O	O
antimicrobial	O	O
effect	O	O
in	O	O
vitro	O	O
against	O	O
10	O	O
oral	O	O
bacterial	O	O
species	O	O
with	O	O
the	O	O
agar	O	O
diffusion	O	O
method	O	O
.	O	O

An	O	O
antimicrobial	O	O
effect	O	O
of	O	O
betel	O	O
nut	O	O
water	O	O
extract	O	O
was	O	O
found	O	O
on	O	O
the	O	O
oral	O	O
microorganisms	O	O
in	O	O
vitro	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
saliva	O	O
were	O	O
low	O	O
or	O	O
absent	O	O
in	O	O
both	O	O
chewers	O	O
and	O	O
controls	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
the	O	O
periodontitis	O	O
associated	O	O
bacteria	O	O
was	O	O
>	O	O
90	O	O
%	O	O
.	O	O

Betel	O	O
chewers	O	O
had	O	O
significantly	O	O
lower	O	O
levels	O	O
of	O	O
some	O	O
bacteria	O	O
in	O	O
subgingival	O	O
plaque	O	O
(	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
p	O	O
<	O	O
0.001	O	O
)	O	O
than	O	O
non-chewers	O	O
.	O	O

This	O	O
study	O	O
population	O	O
was	O	O
low	O	O
in	O	O
missing	O	O
teeth	O	O
(	O	O
mean	O	O
0.7	O	O
and	O	O
0.3	O	O
)	O	O
,	O	O
caries	O	O
decay	O	O
(	O	O
DS	O	O
2.1	O	O
vs	O	O
1.6	O	O
)	O	O
,	O	O
and	O	O
number	O	O
of	O	O
deep	O	O
pockets	O	O
(	O	O
mean	O	O
1.9	O	O
vs	O	O
1.3	O	O
)	O	O
.	O	O

Great	O	O
variation	O	O
in	O	O
oral	O	O
hygiene	O	O
(	O	O
PlI	O	O
and	O	O
BoP	O	O
)	O	O
between	O	O
the	O	O
subjects	O	O
was	O	O
seen	O	O
.	O	O

An	O	O
antimicrobial	O	O
effect	O	O
of	O	O
the	O	O
betel	O	O
nut	O	O
was	O	O
found	O	O
in	O	O
vitro	O	O
and	O	O
with	O	O
a	O	O
possible	O	O
effect	O	O
also	O	O
in	O	O
vivo	O	O
;	O	O
however	O	O
it	O	O
did	O	O
not	O	O
seem	O	O
to	O	O
influence	O	O
clinical	O	O
parameters	O	O
such	O	O
as	O	O
plaque	O	O
index	O	O
,	O	O
caries	O	O
prevalence	O	O
(	O	O
DMFS	O	O
)	O	O
,	O	O
bleeding	O	O
on	O	O
probing	O	O
and	O	O
number	O	O
of	O	O
deep	O	O
pockets	O	O
.	O	O

The	O	O
number	O	O
of	O	O
incidents	O	O
involving	O	O
sharks	O	O
and	O	O
humans	O	O
at	O	O
beaches	O	O
in	O	O
Recife	O	O
,	O	O
on	O	O
the	O	O
north-eastern	O	O
Brazilian	O	O
coast	O	O
,	O	O
is	O	O
among	O	O
the	O	O
highest	O	O
worldwide	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
wound	O	O
infections	O	O
in	O	O
survivors	O	O
are	O	O
common	O	O
;	O	O
but	O	O
the	O	O
nature	O	O
and	O	O
risk	O	O
of	O	O
the	O	O
aetiological	O	O
agents	O	O
is	O	O
unknown	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
81	O	O
potential	O	O
bacterial	O	O
pathogens	O	O
were	O	O
identified	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
sharks	O	O
involved	O	O
in	O	O
attacks	O	O
in	O	O
Recife	O	O
,	O	O
and	O	O
were	O	O
subjected	O	O
to	O	O
antibiotic	O	O
susceptibility	O	O
tests	O	O
using	O	O
the	O	O
standardized	O	O
disc-diffusion	O	O
method	O	O
.	O	O

The	O	O
majority	O	O
were	O	O
enterobacteria	B-bacteria	B-bacteria
such	O	O
as	O	O
Enterobacter	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Citrobacter	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Proteus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Providencia	B-bacteria	B-bacteria
alcalifaciens	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Moellerella	B-bacteria	B-bacteria
wisconcensis	E-bacteria	I-bacteria
and	O	O
Leclercia	B-bacteria	B-bacteria
adecarboxylata	E-bacteria	I-bacteria
.	O	O

Other	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
included	O	O
Vibrio	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Burkholderia	B-bacteria	B-bacteria
cepaciaQ	E-bacteria	I-bacteria
,	O	O
Acinetobacter	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Pseudomonas	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

In	O	O
addition	O	O
,	O	O
coagulase-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
coagulase-negative	I-bacteria	I-bacteria
Staphylococcus	I-bacteria	I-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Micrococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
identified	O	O
,	O	O
besides	O	O
Streptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

from	O	O
the	O	O
viridans	B-bacteria	B-bacteria
group	E-bacteria	I-bacteria
.	O	O

Resistance	O	O
was	O	O
especially	O	O
found	O	O
in	O	O
the	O	O
Proteus	B-bacteria	B-bacteria
mirabilis	E-bacteria	I-bacteria
and	O	O
Citrobacter	B-bacteria	B-bacteria
freundii	E-bacteria	I-bacteria
,	O	O
and	O	O
ranged	O	O
from	O	O
4	O	O
to	O	O
6	O	O
antibiotics	O	O
out	O	O
of	O	O
the	O	O
13	O	O
tested	O	O
.	O	O

Gentamicin	O	O
and	O	O
vancomycin	O	O
were	O	O
the	O	O
most	O	O
effective	O	O
against	O	O
Gram-positive	B-bacteria	B-bacteria
cocci	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
whereas	O	O
levofloxacin	O	O
was	O	O
fully	O	O
inhibitory	O	O
against	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

These	O	O
data	O	O
are	O	O
discussed	O	O
in	O	O
light	O	O
of	O	O
a	O	O
retrospective	O	O
evaluation	O	O
of	O	O
the	O	O
medical	O	O
records	O	O
of	O	O
three	O	O
shark	O	O
victims	O	O
treated	O	O
at	O	O
Restauracao	O	O
Hospital	O	O
in	O	O
Recife	O	O
.	O	O

An	O	O
important	O	O
risk	O	O
factor	O	O
for	O	O
nosocomial	O	O
infection	O	O
in	O	O
an	O	O
intensive	O	O
care	O	O
unit	O	O
(	O	O
ICU	O	O
)	O	O
is	O	O
prior	O	O
colonization	O	O
.	O	O

This	O	O
study	O	O
was	O	O
undertaken	O	O
to	O	O
determine	O	O
the	O	O
spectrum	O	O
of	O	O
bacterial	O	O
colonization	O	O
and	O	O
predisposing	O	O
risk	O	O
factors	O	O
in	O	O
patients	O	O
being	O	O
admitted	O	O
to	O	O
an	O	O
ICU	O	O
in	O	O
India	O	O
,	O	O
with	O	O
special	O	O
emphasis	O	O
on	O	O
extended-spectrum	O	O
beta-lactamase	O	O
(	O	O
ESBL	O	O
)	O	O
-	O	O
and	O	O
metallo-beta-lactamase	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
MBL	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
-producing	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Nasal	O	O
,	O	O
oral	O	O
and	O	O
rectal	O	O
swab	O	O
samples	O	O
were	O	O
collected	O	O
and	O	O
processed	O	O
for	O	O
isolation	O	O
of	O	O
ESBL-producing	B-bacteria	B-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
MBL-producing	B-bacteria	B-bacteria
Pseudomonas	I-bacteria	I-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Acinetobacter	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Bacterial	O	O
colonization	O	O
(	O	O
of	O	O
one	O	O
or	O	O
more	O	O
sites	O	O
)	O	O
on	O	O
admission	O	O
was	O	O
detected	O	O
in	O	O
51	O	O
out	O	O
of	O	O
96	O	O
patients	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Non-fermenters	O	O
,	O	O
i.e	O	O
.	O	O

P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Acinetobacter	B-bacteria	B-bacteria
baumannii	E-bacteria	I-bacteria
,	O	O
were	O	O
the	O	O
most	O	O
common	O	O
colonizers	O	O
,	O	O
present	O	O
in	O	O
37	O	O
patients	O	O
,	O	O
with	O	O
simultaneous	O	O
colonization	O	O
in	O	O
12	O	O
patients	O	O
.	O	O

A	O	O
total	O	O
of	O	O
16	O	O
patients	O	O
were	O	O
colonized	O	O
with	O	O
MBL-producing	O	O
members	O	O
of	O	O
the	O	O
family	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
,	O	O
out	O	O
of	O	O
which	O	O
11	O	O
isolates	O	O
(	O	O
from	O	O
5	O	O
patients	O	O
)	O	O
were	O	O
also	O	O
carrying	O	O
ESBL-encoding	O	O
genes	O	O
.	O	O

As	O	O
for	O	O
MBLs	O	O
,	O	O
most	O	O
of	O	O
our	O	O
patients	O	O
have	O	O
shown	O	O
colonization	O	O
with	O	O
ESBL-producing	O	O
bacteria	O	O
.	O	O

On	O	O
admission	O	O
,	O	O
47	O	O
of	O	O
51	O	O
patients	O	O
(	O	O
92	O	O
%	O	O
)	O	O
have	O	O
been	O	O
colonized	O	O
by	O	O
ESBL-producing	O	O
members	O	O
of	O	O
the	O	O
family	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
,	O	O
at	O	O
one	O	O
or	O	O
more	O	O
of	O	O
the	O	O
three	O	O
anatomical	O	O
sites	O	O
.	O	O

The	O	O
most	O	O
common	O	O
MBL	O	O
subtype	O	O
was	O	O
bla	O	O
(	O	O
IMP	O	O
)	O	O
(	O	O
51.56	O	O
%	O	O
)	O	O
,	O	O
whereas	O	O
bla	O	O
(	O	O
CTX	O	O
)	O	O
was	O	O
the	O	O
most	O	O
common	O	O
gene	O	O
(	O	O
84.9	O	O
%	O	O
)	O	O
identified	O	O
among	O	O
ESBL	O	O
producers	O	O
.	O	O

Risk	O	O
factors	O	O
for	O	O
colonization	O	O
on	O	O
admission	O	O
to	O	O
the	O	O
ICU	O	O
were	O	O
hospitalization	O	O
for	O	O
more	O	O
than	O	O
48	O	O
h	O	O
,	O	O
use	O	O
of	O	O
>	O	O
or=3	O	O
groups	O	O
of	O	O
antibiotics	O	O
,	O	O
co-morbidities	O	O
and	O	O
mechanical	O	O
ventilation	O	O
for	O	O
more	O	O
than	O	O
48	O	O
h	O	O
prior	O	O
to	O	O
ICU	O	O
admission	O	O
.	O	O

There	O	O
is	O	O
an	O	O
increasing	O	O
incidence	O	O
of	O	O
MBLs	O	O
and	O	O
ESBLs	O	O
in	O	O
the	O	O
Indian	O	O
population	O	O
.	O	O

The	O	O
identified	O	O
risk	O	O
factors	O	O
can	O	O
be	O	O
used	O	O
as	O	O
a	O	O
guide	O	O
for	O	O
empiric	O	O
antibiotic	O	O
therapy	O	O
targeted	O	O
to	O	O
these	O	O
resistant	O	O
bacteria	O	O
.	O	O

Xylitol-sweetened	O	O
chewing	O	O
gum	O	O
has	O	O
cariostatic	O	O
properties	O	O
,	O	O
but	O	O
is	O	O
not	O	O
suitable	O	O
for	O	O
all	O	O
patients	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
effect	O	O
of	O	O
xylitol	O	O
rinse	O	O
on	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
levels	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

One	O	O
hundred	O	O
and	O	O
five	O	O
subjects	O	O
with	O	O
high	O	O
salivary	O	O
MS	B-bacteria	B-bacteria
levels	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
one	O	O
of	O	O
three	O	O
groups	O	O
.	O	O

Subjects	O	O
in	O	O
the	O	O
positive	O	O
control	O	O
group	O	O
(	O	O
N	O	O
=	O	O
35	O	O
)	O	O
chewed	O	O
two	O	O
xylitol	O	O
gum	O	O
pellets	O	O
for	O	O
at	O	O
least	O	O
5	O	O
minutes	O	O
three	O	O
times	O	O
daily	O	O
(	O	O
xylitol	O	O
dose	O	O
:	O	O
4.3g/day	O	O
)	O	O
.	O	O

The	O	O
experimental	O	O
group	O	O
(	O	O
N	O	O
=	O	O
36	O	O
)	O	O
rinsed	O	O
with	O	O
20	O	O
mL	O	O
of	O	O
an	O	O
aqueous	O	O
solution	O	O
of	O	O
xylitol	O	O
twice	O	O
daily	O	O
for	O	O
60	O	O
seconds	O	O
(	O	O
dose	O	O
:	O	O
4.4	O	O
g/day	O	O
)	O	O
.	O	O

The	O	O
negative	O	O
control	O	O
group	O	O
(	O	O
N	O	O
=	O	O
34	O	O
)	O	O
used	O	O
neither	O	O
product	O	O
.	O	O

No	O	O
attempt	O	O
was	O	O
made	O	O
to	O	O
change	O	O
the	O	O
subjects	O	O
'	O	O
diet	O	O
.	O	O

Mean	O	O
MS	B-bacteria	B-bacteria
levels	O	O
at	O	O
baseline	O	O
were	O	O
5.6	O	O
(	O	O
0.1	O	O
)	O	O
in	O	O
positive	O	O
control	O	O
,	O	O
5.4	O	O
(	O	O
0.1	O	O
)	O	O
in	O	O
experimental	O	O
,	O	O
and	O	O
5.5	O	O
(	O	O
0.1	O	O
)	O	O
in	O	O
negative	O	O
control	O	O
groups	O	O
.	O	O

After	O	O
3	O	O
months	O	O
,	O	O
MS	B-bacteria	B-bacteria
levels	O	O
were	O	O
4.4	O	O
(	O	O
0.2	O	O
)	O	O
,	O	O
4.4	O	O
(	O	O
0.2	O	O
)	O	O
,	O	O
and	O	O
4.9	O	O
(	O	O
0.2	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

Differences	O	O
between	O	O
groups	O	O
were	O	O
not	O	O
significant	O	O
by	O	O
ANOVA	O	O
(	O	O
p	O	O
=	O	O
.2	O	O
)	O	O
;	O	O
however	O	O
,	O	O
MS	B-bacteria	B-bacteria
levels	O	O
tended	O	O
to	O	O
be	O	O
lower	O	O
in	O	O
the	O	O
experimental	O	O
and	O	O
positive	O	O
control	O	O
groups	O	O
.	O	O

Xylitol	O	O
rinse	O	O
and	O	O
chewing	O	O
gum	O	O
caused	O	O
a	O	O
similar	O	O
but	O	O
statistically	O	O
insignificant	O	O
reduction	O	O
in	O	O
MS	B-bacteria	B-bacteria
levels	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

The	O	O
research	O	O
described	O	O
here	O	O
was	O	O
aimed	O	O
at	O	O
the	O	O
selection	O	O
of	O	O
oral	O	O
bacteria	O	O
that	O	O
displayed	O	O
properties	O	O
compatible	O	O
with	O	O
their	O	O
potential	O	O
use	O	O
as	O	O
probiotics	O	O
for	O	O
the	O	O
pharyngeal	O	O
mucosa	O	O
.	O	O

We	O	O
included	O	O
in	O	O
the	O	O
study	O	O
56	O	O
bacteria	O	O
newly	O	O
isolated	O	O
from	O	O
the	O	O
pharynges	O	O
of	O	O
healthy	O	O
donors	O	O
,	O	O
which	O	O
were	O	O
identified	O	O
at	O	O
the	O	O
intraspecies	O	O
level	O	O
and	O	O
characterized	O	O
in	O	O
vitro	O	O
for	O	O
their	O	O
probiotic	O	O
potential	O	O
.	O	O

The	O	O
experiments	O	O
led	O	O
us	O	O
to	O	O
select	O	O
two	O	O
potential	O	O
probiotic	B-bacteria	B-bacteria
bacterial	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
(	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
RS1	E-bacteria	I-bacteria
and	O	O
ST3	B-bacteria	B-bacteria
)	O	O
and	O	O
to	O	O
compare	O	O
them	O	O
with	O	O
the	O	O
prototype	O	O
oral	O	O
probiotic	B-bacteria	B-bacteria
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
.	O	O

All	O	O
three	O	O
strains	O	O
efficiently	O	O
bound	O	O
to	O	O
FaDu	O	O
human	O	O
epithelial	O	O
pharyngeal	O	O
cells	O	O
and	O	O
thereby	O	O
antagonized	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
adhesion	O	O
and	O	O
growth	O	O
.	O	O

All	O	O
were	O	O
sensitive	O	O
to	O	O
a	O	O
variety	O	O
of	O	O
antibiotics	O	O
routinely	O	O
used	O	O
for	O	O
the	O	O
control	O	O
of	O	O
upper	O	O
respiratory	O	O
tract	O	O
infections	O	O
.	O	O

Immunological	O	O
in	O	O
vitro	O	O
testing	O	O
on	O	O
a	O	O
FaDu	O	O
layer	O	O
revealed	O	O
different	O	O
responses	O	O
to	O	O
RS1	B-bacteria	B-bacteria
,	O	O
ST3	B-bacteria	B-bacteria
,	O	O
and	O	O
K12	B-bacteria	B-bacteria
.	O	O

RS1	B-bacteria	B-bacteria
and	O	O
ST3	B-bacteria	B-bacteria
modulated	O	O
NF-kappaB	O	O
activation	O	O
and	O	O
biased	O	O
proinflammatory	O	O
cytokines	O	O
at	O	O
baseline	O	O
and	O	O
after	O	O
interleukin-1beta	O	O
(	O	O
IL-1beta	O	O
)	O	O
induction	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
we	O	O
suggest	O	O
that	O	O
the	O	O
selected	O	O
commensal	O	O
streptococci	B-bacteria	B-bacteria
represent	O	O
potential	O	O
pharyngeal	O	O
probiotic	B-bacteria	B-bacteria
candidates	O	O
.	O	O

They	O	O
could	O	O
display	O	O
a	O	O
good	O	O
degree	O	O
of	O	O
adaptation	O	O
to	O	O
the	O	O
host	O	O
and	O	O
possess	O	O
potential	O	O
immunomodulatory	O	O
and	O	O
anti-inflammatory	O	O
properties	O	O
.	O	O

Our	O	O
study	O	O
was	O	O
conducted	O	O
to	O	O
evaluate	O	O
the	O	O
potent	O	O
protective	O	O
effects	O	O
of	O	O
oral	O	O
administration	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
Lactobacillus	E-bacteria	I-bacteria
strains	O	O
against	O	O
influenza	O	O
virus	O	O
(	O	O
Flu	O	O
)	O	O
infection	O	O
in	O	O
a	O	O
mouse	O	O
model	O	O
.	O	O

Lyophilized	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
GG	E-bacteria	I-bacteria
(	O	O
LGG	B-bacteria	B-bacteria
)	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	I-bacteria	I-bacteria
TMC0356	E-bacteria	I-bacteria
(	O	O
TMC0356	B-bacteria	B-bacteria
)	O	O
were	O	O
orally	O	O
administered	O	O
to	O	O
BALB/c	O	O
mice	O	O
for	O	O
19	O	O
days	O	O
.	O	O

The	O	O
test	O	O
mice	O	O
were	O	O
intranasally	O	O
infected	O	O
with	O	O
Flu	O	O
A/PR/8/34	O	O
(	O	O
H1N1	O	O
)	O	O
on	O	O
day	O	O
14	O	O
,	O	O
and	O	O
any	O	O
changes	O	O
in	O	O
clinical	O	O
symptoms	O	O
were	O	O
monitored	O	O
.	O	O

After	O	O
6	O	O
days	O	O
of	O	O
infection	O	O
,	O	O
the	O	O
mice	O	O
were	O	O
killed	O	O
and	O	O
pulmonary	O	O
virus	O	O
titres	O	O
were	O	O
determined	O	O
.	O	O

The	O	O
clinical	O	O
symptom	O	O
scores	O	O
of	O	O
mice	O	O
administered	O	O
oral	O	O
LGG	B-bacteria	B-bacteria
and	O	O
TMC0356	B-bacteria	B-bacteria
were	O	O
significantly	O	O
ameliorated	O	O
,	O	O
compared	O	O
to	O	O
those	O	O
of	O	O
the	O	O
control	O	O
mice	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

The	O	O
pulmonary	O	O
virus	O	O
titres	O	O
of	O	O
the	O	O
mice	O	O
fed	O	O
LGG	O	O
and	O	O
TMC0356	O	O
were	O	O
also	O	O
significantly	O	O
decreased	O	O
compared	O	O
to	O	O
those	O	O
of	O	O
control	O	O
mice	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
oral	O	O
administration	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
such	O	O
as	O	O
LGG	B-bacteria	B-bacteria
and	O	O
TMC0356	B-bacteria	B-bacteria
,	O	O
might	O	O
protect	O	O
a	O	O
host	O	O
animal	O	O
against	O	O
Flu	O	O
infection	O	O
.	O	O

These	O	O
results	O	O
demonstrate	O	O
that	O	O
oral	O	O
administration	O	O
of	O	O
selected	O	O
lactobacilli	B-bacteria	B-bacteria
might	O	O
protect	O	O
host	O	O
animals	O	O
from	O	O
Flu	O	O
infection	O	O
by	O	O
interactions	O	O
with	O	O
gut	O	O
immunity	O	O
.	O	O

Clinical	O	O
studies	O	O
with	O	O
dentifrices	O	O
formulated	O	O
with	O	O
antimicrobial	O	O
ingredients	O	O
typically	O	O
examine	O	O
the	O	O
effects	O	O
of	O	O
their	O	O
use	O	O
on	O	O
clinical	O	O
parameters	O	O
of	O	O
dental	O	O
plaque	O	O
and	O	O
gingivitis	O	O
.	O	O

The	O	O
effects	O	O
of	O	O
routine	O	O
use	O	O
of	O	O
these	O	O
formulations	O	O
on	O	O
the	O	O
microorganisms	O	O
found	O	O
in	O	O
the	O	O
distinct	O	O
regions	O	O
of	O	O
the	O	O
human	O	O
mouth	O	O
remain	O	O
unexplored	O	O
.	O	O

The	O	O
present	O	O
cross-over	O	O
design	O	O
clinical	O	O
study	O	O
compared	O	O
the	O	O
effects	O	O
of	O	O
brushing	O	O
with	O	O
a	O	O
recently	O	O
formulated	O	O
dentifrice	O	O
with	O	O
1	O	O
%	O	O
zinc	O	O
citrate	O	O
to	O	O
a	O	O
control	O	O
dentifrice	O	O
on	O	O
oral	O	O
bacteria	O	O
found	O	O
in	O	O
oral	O	O
niches	O	O
.	O	O

A	O	O
total	O	O
of	O	O
35	O	O
adults	O	O
completed	O	O
a	O	O
1-week	O	O
wash-out	O	O
phase	O	O
prior	O	O
to	O	O
providing	O	O
baseline	O	O
samples	O	O
of	O	O
dental	O	O
plaque	O	O
on	O	O
the	O	O
teeth	O	O
,	O	O
gums	O	O
,	O	O
saliva	O	O
and	O	O
scrapings	O	O
from	O	O
cheeks	O	O
and	O	O
tongue	O	O
to	O	O
quantify	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Subjects	O	O
brushed	O	O
twice	O	O
daily	O	O
with	O	O
a	O	O
randomly	O	O
assigned	O	O
test	O	O
dentifrice	O	O
for	O	O
the	O	O
next	O	O
13	O	O
days	O	O
.	O	O

On	O	O
the	O	O
14th	O	O
day	O	O
,	O	O
they	O	O
arrived	O	O
at	O	O
the	O	O
dental	O	O
clinic	O	O
prior	O	O
to	O	O
oral	O	O
hygiene	O	O
and	O	O
provided	O	O
samples	O	O
similar	O	O
to	O	O
baseline	O	O
samples	O	O
for	O	O
microbiological	O	O
examinations	O	O
.	O	O

Subjects	O	O
brushed	O	O
with	O	O
the	O	O
test	O	O
formulation	O	O
they	O	O
used	O	O
in	O	O
the	O	O
previous	O	O
13	O	O
days	O	O
,	O	O
prior	O	O
to	O	O
providing	O	O
additional	O	O
samples	O	O
at	O	O
5-h	O	O
post-brushing	O	O
for	O	O
microbial	O	O
assessments	O	O
.	O	O

An	O	O
additional	O	O
wash-out	O	O
phase	O	O
was	O	O
assigned	O	O
to	O	O
subjects	O	O
prior	O	O
to	O	O
completing	O	O
the	O	O
study	O	O
with	O	O
the	O	O
alternate	O	O
test	O	O
dentifrice	O	O
.	O	O

Analyses	O	O
of	O	O
log10-transformed	O	O
microbial	O	O
counts	O	O
indicated	O	O
no	O	O
statistical	O	O
differences	O	O
in	O	O
the	O	O
baseline	O	O
samples	O	O
from	O	O
each	O	O
oral	O	O
site	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
,	O	O
while	O	O
brushing	O	O
with	O	O
the	O	O
zinc	O	O
citrate	O	O
dentifrice	O	O
resulted	O	O
in	O	O
a	O	O
significant	O	O
reduction	O	O
in	O	O
bacteria	O	O
in	O	O
each	O	O
post-brushing	O	O
oral	O	O
site	O	O
versus	O	O
the	O	O
control	O	O
paste	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Brushing	O	O
with	O	O
the	O	O
zinc	O	O
citrate	O	O
dentifrice	O	O
resulted	O	O
in	O	O
38.56	O	O
%	O	O
,	O	O
23.57	O	O
%	O	O
,	O	O
26.24	O	O
%	O	O
and	O	O
29.1	O	O
%	O	O
decreases	O	O
in	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
from	O	O
dental	O	O
plaque	O	O
,	O	O
tongue	O	O
,	O	O
cheek	O	O
and	O	O
saliva	O	O
,	O	O
respectively	O	O
,	O	O
in	O	O
the	O	O
overnight	O	O
samples	O	O
collected	O	O
on	O	O
the	O	O
14th	O	O
day	O	O
versus	O	O
the	O	O
control	O	O
.	O	O

Similarly	O	O
,	O	O
the	O	O
5-h	O	O
post-brushing	O	O
samples	O	O
indicated	O	O
24.8	O	O
%	O	O
,	O	O
34.25	O	O
%	O	O
,	O	O
37.98	O	O
%	O	O
and	O	O
38.31	O	O
%	O	O
reductions	O	O
in	O	O
anaerobic	O	O
organisms	O	O
when	O	O
compared	O	O
with	O	O
control	O	O
.	O	O

Toothbrushing	O	O
with	O	O
the	O	O
zinc	O	O
citrate	O	O
formulation	O	O
resulted	O	O
in	O	O
significant	O	O
reductions	O	O
in	O	O
oral	O	O
bacteria	O	O
from	O	O
all	O	O
of	O	O
the	O	O
intraoral	O	O
locations	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
six	O	O
kinds	O	O
of	O	O
natural	O	O
herbs	O	O
in	O	O
Yunnan	O	O
on	O	O
normal	O	O
oral	O	O
predominant	O	O
bacteria	O	O
in	O	O
vitro	O	O
.	O	O

Agar	O	O
dilution	O	O
method	O	O
,	O	O
the	O	O
antimicrobial	O	O
susceptibility	O	O
testing	O	O
of	O	O
anaerobes	B-bacteria	B-bacteria
which	O	O
was	O	O
recommended	O	O
by	O	O
National	O	O
Committee	O	O
for	O	O
Clinical	O	O
Laboratory	O	O
Standard	O	O
(	O	O
NCCLs	O	O
)	O	O
,	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
antimicrobial	O	O
susceptibility	O	O
of	O	O
herbs	O	O
to	O	O
21	O	O
kinds	O	O
of	O	O
oral	O	O
model	O	O
strains	O	O
and	O	O
clinical	O	O
isolates	O	O
.	O	O

The	O	O
results	O	O
were	O	O
expressed	O	O
by	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
.	O	O

All	O	O
six	O	O
kinds	O	O
of	O	O
herbs	O	O
were	O	O
effective	O	O
to	O	O
the	O	O
oral	O	O
predominant	O	O
bacteria	O	O
.	O	O

For	O	O
the	O	O
ten	O	O
kinds	O	O
of	O	O
cariogenic	O	O
bacteria	O	O
,	O	O
the	O	O
MIC	O	O
of	O	O
caesalpinia	O	O
sappan	O	O
lignum	O	O
was	O	O
between	O	O
5-10	O	O
mg	O	O
x	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
,	O	O
and	O	O
the	O	O
MIC	O	O
of	O	O
other	O	O
herbs	O	O
was	O	O
above	O	O
20	O	O
mg	O	O
x	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

For	O	O
the	O	O
eleven	O	O
kinds	O	O
of	O	O
predominant	O	O
bacteria	O	O
which	O	O
normally	O	O
involved	O	O
in	O	O
pulp	O	O
periapical	O	O
disease	O	O
and	O	O
periodontitis	O	O
,	O	O
the	O	O
MIC	O	O
of	O	O
caesalpinia	O	O
sappan	O	O
lignum	O	O
was	O	O
below	O	O
0.062	O	O
5	O	O
mg	O	O
x	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
,	O	O
and	O	O
the	O	O
MIC	O	O
of	O	O
the	O	O
terminalia	O	O
chebula	O	O
retz	O	O
was	O	O
between	O	O
10-20	O	O
mg	O	O
x	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
,	O	O
and	O	O
the	O	O
others	O	O
were	O	O
above	O	O
20	O	O
mg	O	O
x	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

The	O	O
six	O	O
kinds	O	O
of	O	O
herbs	O	O
in	O	O
Yunnan	O	O
could	O	O
be	O	O
used	O	O
in	O	O
treatment	O	O
or	O	O
prevention	O	O
of	O	O
oral	O	O
bacterial	O	O
diseases	O	O
.	O	O

This	O	O
study	O	O
was	O	O
conducted	O	O
to	O	O
determine	O	O
if	O	O
microbial	O	O
infection	O	O
was	O	O
a	O	O
significant	O	O
factor	O	O
in	O	O
patients	O	O
with	O	O
undiagnosed	O	O
craniofacial	O	O
pain	O	O
.	O	O

Of	O	O
the	O	O
150	O	O
patients	O	O
from	O	O
whom	O	O
intra-bony	O	O
cultures	O	O
were	O	O
obtained	O	O
,	O	O
23	O	O
different	O	O
groups	O	O
of	O	O
isolates	O	O
were	O	O
obtained	O	O
.	O	O

There	O	O
were	O	O
49	O	O
(	O	O
32.67	O	O
%	O	O
)	O	O
patients	O	O
whose	O	O
cultures	O	O
exhibited	O	O
growth	O	O
of	O	O
microbes	O	O
other	O	O
than	O	O
routine	O	O
oral	O	O
flora	O	O
,	O	O
mixed	O	O
skin	O	O
flora	O	O
or	O	O
routine	O	O
respiratory	O	O
flora	O	O
.	O	O

The	O	O
most	O	O
common	O	O
was	O	O
of	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
11	O	O
or	O	O
22.91	O	O
%	O	O
)	O	O
of	O	O
the	O	O
49	O	O
.	O	O

Sixty-seven	O	O
(	O	O
67	O	O
)	O	O
(	O	O
44.67	O	O
%	O	O
)	O	O
of	O	O
the	O	O
total	O	O
cultures	O	O
demonstrated	O	O
the	O	O
growth	O	O
of	O	O
mixed	O	O
skin	O	O
flora	O	O
,	O	O
nineteen	O	O
(	O	O
12.67	O	O
%	O	O
)	O	O
demonstrated	O	O
the	O	O
growth	O	O
of	O	O
routine	O	O
respiratory	O	O
flora	O	O
and	O	O
sixteen	O	O
(	O	O
10.67	O	O
%	O	O
)	O	O
demonstrated	O	O
the	O	O
growth	O	O
of	O	O
routine	O	O
oral	O	O
flora	O	O
.	O	O

No	O	O
bacterial	O	O
isolates	O	O
were	O	O
found	O	O
in	O	O
16	O	O
(	O	O
10.67	O	O
%	O	O
)	O	O
cultures	O	O
.	O	O

The	O	O
most	O	O
common	O	O
histological	O	O
diagnoses	O	O
of	O	O
those	O	O
who	O	O
exhibited	O	O
pathogenic	O	O
microbial	O	O
growth	O	O
were	O	O
,	O	O
in	O	O
order	O	O
:	O	O
1.	O	O
focal	O	O
osteoporotic	O	O
marrow	O	O
defect	O	O
;	O	O
2.	O	O
ischemic	O	O
osteonecrosis	O	O
;	O	O
and	O	O
3.	O	O
chronic	O	O
nonsuppurative	O	O
osteomyelitis	O	O
.	O	O

To	O	O
elucidate	O	O
the	O	O
effects	O	O
of	O	O
mucosal	O	O
care	O	O
on	O	O
colonization	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
infection	O	O
of	O	O
Candida	O	O
species	O	O
,	O	O
we	O	O
randomized	O	O
50	O	O
functionally	O	O
dependent	O	O
nursing	O	O
home	O	O
residents	O	O
,	O	O
mean	O	O
age	O	O
76.1	O	O
(	O	O
+/-7.8	O	O
years	O	O
)	O	O
,	O	O
76	O	O
%	O	O
females	O	O
,	O	O
to	O	O
receive	O	O
oral	O	O
professional	O	O
care	O	O
with	O	O
or	O	O
without	O	O
mucosal	O	O
care	O	O
.	O	O

During	O	O
12	O	O
months	O	O
of	O	O
follow-up	O	O
,	O	O
significant	O	O
reduction	O	O
in	O	O
the	O	O
numbers	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
in	O	O
saliva	O	O
and	O	O
dental	O	O
plaque	O	O
samples	O	O
were	O	O
observed	O	O
in	O	O
both	O	O
treatment	O	O
groups	O	O
.	O	O

However	O	O
,	O	O
there	O	O
was	O	O
no	O	O
reduction	O	O
in	O	O
the	O	O
numbers	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
in	O	O
tongue	O	O
samples	O	O
in	O	O
the	O	O
non-mucosal	O	O
group	O	O
(	O	O
p=0.150	O	O
)	O	O
.	O	O

In	O	O
the	O	O
comparison	O	O
between	O	O
the	O	O
treatment	O	O
with	O	O
and	O	O
without	O	O
mucosal	O	O
care	O	O
,	O	O
the	O	O
treatment	O	O
with	O	O
mucosal	O	O
care	O	O
showed	O	O
a	O	O
significant	O	O
inhibition	O	O
effects	O	O
on	O	O
numbers	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
on	O	O
the	O	O
tongue	O	O
surface	O	O
at	O	O
6	O	O
months	O	O
after	O	O
the	O	O
treatment	O	O
as	O	O
compared	O	O
with	O	O
the	O	O
treatment	O	O
without	O	O
mucosal	O	O
care	O	O
(	O	O
p=0.043	O	O
)	O	O
.	O	O

Mucosal	O	O
care	O	O
was	O	O
not	O	O
associated	O	O
with	O	O
any	O	O
significant	O	O
reduction	O	O
in	O	O
the	O	O
rate	O	O
of	O	O
opportunistic	O	O
infection	O	O
with	O	O
Candida	O	O
species	O	O
in	O	O
any	O	O
of	O	O
the	O	O
three	O	O
sites	O	O
.	O	O

However	O	O
,	O	O
more	O	O
subjects	O	O
without	O	O
mucosal	O	O
care	O	O
had	O	O
Candida	O	O
infection	O	O
in	O	O
dental	O	O
plaque	O	O
during	O	O
the	O	O
follow-up	O	O
(	O	O
p=0.046	O	O
)	O	O
.	O	O

Professional	O	O
dental	O	O
care	O	O
with	O	O
(	O	O
versus	O	O
without	O	O
)	O	O
mucosal	O	O
care	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
colonization	O	O
in	O	O
saliva	O	O
or	O	O
plaque	O	O
.	O	O

Lack	O	O
of	O	O
mucosal	O	O
care	O	O
seemed	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
higher	O	O
rates	O	O
opportunistic	O	O
infections	O	O
with	O	O
Candida	O	O
species	O	O
.	O	O

Two	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
and	O	O
were	O	O
found	O	O
to	O	O
belong	O	O
to	O	O
two	O	O
separate	O	O
taxa	O	O
.	O	O

Phylogenetic	O	O
analysis	O	O
of	O	O
full-length	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
showed	O	O
that	O	O
the	O	O
strains	O	O
were	O	O
both	O	O
related	O	O
to	O	O
,	O	O
but	O	O
distinct	O	O
from	O	O
,	O	O
the	O	O
type	O	O
strain	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
.	O	O

Two	O	O
novel	O	O
species	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
fusca	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
scopos	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
are	O	O
proposed	O	O
to	O	O
accommodate	O	O
these	O	O
strains	O	O
.	O	O

Both	O	O
strains	O	O
were	O	O
saccharolytic	O	O
and	O	O
produced	O	O
acetic	O	O
and	O	O
succinic	O	O
acids	O	O
,	O	O
with	O	O
lesser	O	O
amounts	O	O
of	O	O
lactic	O	O
and	O	O
isovaleric	O	O
acids	O	O
,	O	O
as	O	O
end	O	O
products	O	O
of	O	O
fermentation	O	O
,	O	O
and	O	O
both	O	O
were	O	O
sensitive	O	O
to	O	O
20	O	O
%	O	O
bile	O	O
.	O	O

The	O	O
principal	O	O
cellular	O	O
long-chain	O	O
fatty	O	O
acids	O	O
of	O	O
both	O	O
strains	O	O
were	O	O
ai-C	O	O
(	O	O
15	O	O
:	O	O
0	O	O
)	O	O
,	O	O
3-OH	O	O
i-C	O	O
(	O	O
17	O	O
:	O	O
0	O	O
)	O	O
,	O	O
3-OH	O	O
C	O	O
(	O	O
16	O	O
:	O	O
0	O	O
)	O	O
,	O	O
i-C	O	O
(	O	O
15	O	O
:	O	O
0	O	O
)	O	O
and	O	O
C	O	O
(	O	O
16	O	O
:	O	O
0	O	O
)	O	O
.	O	O

The	O	O
DNA	O	O
G+C	O	O
contents	O	O
of	O	O
the	O	O
type	O	O
strains	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
fusca	E-bacteria	I-bacteria
(	O	O
W1435	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
=	O	O
DSM	B-bacteria	B-bacteria
22504	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=	O	O
CCUG	B-bacteria	B-bacteria
57946	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
scopos	E-bacteria	I-bacteria
(	O	O
W2052	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
=	O	O
DSM	B-bacteria	B-bacteria
22613	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=	O	O
CCUG	B-bacteria	B-bacteria
57945	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
were	O	O
43	O	O
and	O	O
41	O	O
mol	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
two	O	O
species	O	O
could	O	O
be	O	O
differentiated	O	O
by	O	O
gelatin	O	O
hydrolysis	O	O
,	O	O
cellobiose	O	O
and	O	O
ribose	O	O
fermentation	O	O
,	O	O
and	O	O
production	O	O
of	O	O
beta-glucosidase	O	O
.	O	O

It	O	O
has	O	O
been	O	O
reported	O	O
that	O	O
DNA	O	O
of	O	O
oral	O	O
bacterial	O	O
species	O	O
,	O	O
such	O	O
as	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
was	O	O
detected	O	O
frequently	O	O
in	O	O
specimens	O	O
of	O	O
arteriosclerotic	O	O
vessels	O	O
.	O	O

However	O	O
,	O	O
the	O	O
source	O	O
of	O	O
DNA	O	O
,	O	O
whether	O	O
from	O	O
live	O	O
intact	O	O
bacteria	O	O
or	O	O
a	O	O
part	O	O
of	O	O
the	O	O
bacteria	O	O
,	O	O
has	O	O
not	O	O
been	O	O
identified	O	O
yet	O	O
.	O	O

Moreover	O	O
,	O	O
there	O	O
was	O	O
no	O	O
precise	O	O
evidence	O	O
concerning	O	O
involvement	O	O
of	O	O
oral	O	O
bacteria	O	O
in	O	O
the	O	O
progression	O	O
of	O	O
arteriosclerosis	O	O
.	O	O

We	O	O
tried	O	O
to	O	O
clarify	O	O
the	O	O
involvement	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
on	O	O
the	O	O
mechanisms	O	O
of	O	O
development	O	O
of	O	O
aortic	O	O
intimal	O	O
hyperplasia	O	O
.	O	O

Intravenous	O	O
administration	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
dramatically	O	O
induced	O	O
intimal	O	O
hyperplasia	O	O
in	O	O
the	O	O
mouse	O	O
model	O	O
with	O	O
photochemical	O	O
impairment	O	O
of	O	O
the	O	O
femoral	O	O
artery	O	O
.	O	O

However	O	O
there	O	O
were	O	O
no	O	O
changes	O	O
identified	O	O
in	O	O
the	O	O
mice	O	O
without	O	O
aortic	O	O
impairment	O	O
,	O	O
even	O	O
with	O	O
the	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
infection	O	O
.	O	O

Concomitantly	O	O
,	O	O
S100	O	O
calcium-binding	O	O
protein	O	O
A9	O	O
(	O	O
S100A9	O	O
)	O	O
and	O	O
the	O	O
embryonic	O	O
isoform	O	O
of	O	O
myosin	O	O
heavy	O	O
chain	O	O
(	O	O
SMemb	O	O
)	O	O
,	O	O
a	O	O
proliferative	O	O
phenotypic	O	O
marker	O	O
of	O	O
smooth	O	O
muscle	O	O
cells	O	O
,	O	O
were	O	O
significantly	O	O
overexpressed	O	O
on	O	O
the	O	O
surfaces	O	O
of	O	O
smooth	O	O
muscle	O	O
cells	O	O
present	O	O
in	O	O
the	O	O
injured	O	O
blood	O	O
vessels	O	O
.	O	O

Similarly	O	O
,	O	O
increased	O	O
expressions	O	O
of	O	O
S100A9	O	O
and	O	O
SMemb	O	O
proteins	O	O
were	O	O
observed	O	O
in	O	O
aneurismal	O	O
specimens	O	O
obtained	O	O
from	O	O
P.	O	O
gingivalis-infected	O	O
patients	O	O
.	O	O

We	O	O
found	O	O
that	O	O
bacteremia	O	O
induced	O	O
by	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
leads	O	O
to	O	O
intimal	O	O
hyperplasia	O	O
associated	O	O
with	O	O
overexpressions	O	O
of	O	O
S100A9	O	O
and	O	O
SMemb	O	O
.	O	O

Our	O	O
results	O	O
strongly	O	O
suggest	O	O
that	O	O
oral-hematogenous	O	O
spreading	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
is	O	O
a	O	O
causative	O	O
event	O	O
in	O	O
the	O	O
development	O	O
of	O	O
aortic	O	O
hyperplasia	O	O
in	O	O
periodontitis	O	O
patients	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
is	O	O
generally	O	O
known	O	O
as	O	O
a	O	O
pathogen	O	O
of	O	O
dental	O	O
caries	O	O
,	O	O
and	O	O
it	O	O
is	O	O
also	O	O
considered	O	O
to	O	O
cause	O	O
bacteremia	O	O
and	O	O
infective	O	O
endocarditis	O	O
(	O	O
IE	O	O
)	O	O
.	O	O

S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
previously	O	O
classified	O	O
into	O	O
3	O	O
serotypes	O	O
,	O	O
c	O	O
,	O	O
e	O	O
,	O	O
and	O	O
f	O	O
,	O	O
due	O	O
to	O	O
the	O	O
different	O	O
chemical	O	O
compositions	O	O
of	O	O
the	O	O
serotype-specific	O	O
polysaccharides	O	O
,	O	O
which	O	O
are	O	O
composed	O	O
of	O	O
a	O	O
rhamnose	O	O
backbone	O	O
and	O	O
glucose	O	O
side	O	O
chains	O	O
.	O	O

We	O	O
recently	O	O
designated	O	O
non-c/e/f	O	O
serotype	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
as	O	O
novel	O	O
serotype	O	O
k	O	O
,	O	O
which	O	O
is	O	O
characterized	O	O
by	O	O
a	O	O
drastic	O	O
reduction	O	O
in	O	O
the	O	O
amount	O	O
of	O	O
the	O	O
glucose	O	O
side	O	O
chain	O	O
.	O	O

A	O	O
common	O	O
biological	O	O
feature	O	O
of	O	O
novel	O	O
serotype-k	O	O
strains	O	O
is	O	O
a	O	O
lower	O	O
level	O	O
of	O	O
cariogenicity	O	O
due	O	O
to	O	O
alterations	O	O
of	O	O
several	O	O
major	O	O
cell	O	O
surface	O	O
protein	O	O
antigens	O	O
.	O	O

As	O	O
for	O	O
virulence	O	O
in	O	O
blood	O	O
,	O	O
these	O	O
strains	O	O
survive	O	O
in	O	O
blood	O	O
for	O	O
a	O	O
longer	O	O
duration	O	O
due	O	O
to	O	O
lower	O	O
antigenicity	O	O
,	O	O
while	O	O
the	O	O
detection	O	O
rate	O	O
of	O	O
all	O	O
strains	O	O
carrying	O	O
the	O	O
gene	O	O
encoding	O	O
collagen-binding	O	O
adhesin	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
be	O	O
high	O	O
.	O	O

Furthermore	O	O
,	O	O
molecular	O	O
biological	O	O
analyses	O	O
of	O	O
infected	O	O
heart	O	O
valve	O	O
specimens	O	O
obtained	O	O
from	O	O
IE	O	O
patients	O	O
revealed	O	O
a	O	O
high	O	O
detection	O	O
rate	O	O
of	O	O
serotype-k	B-bacteria	B-bacteria
S.	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Together	O	O
,	O	O
these	O	O
findings	O	O
suggest	O	O
that	O	O
serotype-k	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
show	O	O
low	O	O
cariogenicity	O	O
but	O	O
high	O	O
virulence	O	O
in	O	O
blood	O	O
as	O	O
compared	O	O
to	O	O
the	O	O
other	O	O
serotypes	O	O
,	O	O
due	O	O
to	O	O
alterations	O	O
of	O	O
several	O	O
cell	O	O
surface	O	O
structures	O	O
.	O	O

Accumulating	O	O
evidence	O	O
suggests	O	O
the	O	O
involvement	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
,	O	O
a	O	O
periodontal	O	O
pathogen	O	O
,	O	O
in	O	O
cardiovascular	O	O
diseases	O	O
.	O	O

Clinical	O	O
specimens	O	O
of	O	O
aneurysmal	O	O
tissue	O	O
and	O	O
dental	O	O
plaque	O	O
collected	O	O
from	O	O
patients	O	O
infected	O	O
with	O	O
or	O	O
without	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
analyzed	O	O
.	O	O

The	O	O
number	O	O
of	O	O
aneurysms	O	O
in	O	O
the	O	O
distal	O	O
aorta	O	O
in	O	O
the	O	O
P.	O	O
gingivalis-infected	O	O
group	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
that	O	O
in	O	O
the	O	O
non-infected	O	O
group	O	O
.	O	O

Cellular	O	O
accumulation	O	O
of	O	O
adipocytes	O	O
in	O	O
aneurysms	O	O
was	O	O
less	O	O
frequently	O	O
identified	O	O
in	O	O
the	O	O
infected	O	O
group	O	O
.	O	O

The	O	O
expression	O	O
of	O	O
embryonic	O	O
myosin	O	O
heavy	O	O
chain	O	O
isoform	O	O
,	O	O
a	O	O
phenotypic	O	O
marker	O	O
for	O	O
proliferative	O	O
smooth	O	O
muscle	O	O
cells	O	O
,	O	O
was	O	O
higher	O	O
in	O	O
the	O	O
P.	O	O
gingivalis-infected	O	O
group	O	O
than	O	O
the	O	O
non-infected	O	O
group	O	O
.	O	O

Clinical	O	O
and	O	O
histopathological	O	O
features	O	O
of	O	O
aortic	O	O
aneurysms	O	O
associated	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
infection	O	O
are	O	O
different	O	O
from	O	O
those	O	O
present	O	O
in	O	O
non-infected	O	O
patients	O	O
.	O	O

The	O	O
major	O	O
characteristic	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
infection	O	O
associated	O	O
with	O	O
aneurysms	O	O
is	O	O
smooth	O	O
muscle	O	O
cell	O	O
proliferation	O	O
in	O	O
the	O	O
distal	O	O
aorta	O	O
.	O	O

Bifidobacteria	B-bacteria	B-bacteria
are	O	O
aciduric	O	O
bacteria	O	O
that	O	O
might	O	O
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
caries	O	O
process	O	O
.	O	O

To	O	O
test	O	O
the	O	O
hypothesis	O	O
that	O	O
Bifidobacteria	B-bacteria	B-bacteria
behave	O	O
as	O	O
caries-associated	O	O
organisms	O	O
,	O	O
as	O	O
predicted	O	O
by	O	O
the	O	O
ecological	O	O
plaque	O	O
hypothesis	O	O
,	O	O
we	O	O
determined	O	O
salivary	O	O
levels	O	O
of	O	O
Bifidobacteria	B-bacteria	B-bacteria
and	O	O
caries-associated	O	O
organisms	O	O
for	O	O
156	O	O
older	O	O
adults	O	O
.	O	O

Salivary	O	O
levels	O	O
of	O	O
Bifidobacteria	B-bacteria	B-bacteria
,	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
and	O	O
yeasts	O	O
were	O	O
correlated	O	O
with	O	O
each	O	O
other	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
negatively	O	O
correlated	O	O
with	O	O
salivary	O	O
flow	O	O
rate	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
and	O	O
positively	O	O
correlated	O	O
with	O	O
plaque	O	O
index	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Salivary	O	O
Bifidobacteria	B-bacteria	B-bacteria
levels	O	O
were	O	O
positively	O	O
associated	O	O
with	O	O
the	O	O
number	O	O
of	O	O
filled	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
and	O	O
decayed	O	O
(	O	O
p	O	O
=	O	O
0.036	O	O
)	O	O
tooth	O	O
surfaces	O	O
and	O	O
negatively	O	O
associated	O	O
with	O	O
number	O	O
of	O	O
teeth	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
and	O	O
salivary	O	O
flow	O	O
rate	O	O
(	O	O
p	O	O
=	O	O
0.049	O	O
)	O	O
.	O	O

In	O	O
regression	O	O
analyses	O	O
,	O	O
caries	O	O
experience	O	O
was	O	O
significantly	O	O
associated	O	O
with	O	O
only	O	O
salivary	O	O
Bifidobacteria	B-bacteria	B-bacteria
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
and	O	O
yeast	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
levels	O	O
and	O	O
the	O	O
individual	O	O
's	O	O
age	O	O
(	O	O
p	O	O
=	O	O
0.021	O	O
)	O	O
.	O	O

Bifidobacteria	B-bacteria	B-bacteria
should	O	O
be	O	O
regarded	O	O
as	O	O
caries-associated	O	O
organisms	O	O
whose	O	O
role	O	O
in	O	O
the	O	O
caries	O	O
process	O	O
and	O	O
as	O	O
markers	O	O
of	O	O
caries	O	O
risk	O	O
requires	O	O
further	O	O
investigation	O	O
.	O	O

A	O	O
straight	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
non-sporulating	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
Gram-variable	I-bacteria	I-bacteria
bacillus	E-bacteria	I-bacteria
(	O	O
HKU24	O	O
(	O	O
T	O	O
)	O	O
)	O	O
was	O	O
recovered	O	O
from	O	O
the	O	O
blood	O	O
culture	O	O
of	O	O
a	O	O
patient	O	O
with	O	O
metastatic	O	O
breast	O	O
carcinoma	O	O
.	O	O

After	O	O
repeated	O	O
subculturing	O	O
in	O	O
BACTEC	O	O
Plus	O	O
Anaerobic/F	O	O
blood	O	O
culture	O	O
broth	O	O
,	O	O
HKU24	O	O
(	O	O
T	O	O
)	O	O
grew	O	O
on	O	O
brucella	O	O
agar	O	O
as	O	O
non-hemolytic	O	O
,	O	O
pinpoint	O	O
colonies	O	O
after	O	O
96	O	O
h	O	O
of	O	O
incubation	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
in	O	O
an	O	O
anaerobic	O	O
environment	O	O
and	O	O
aerobic	O	O
environment	O	O
with	O	O
5	O	O
%	O	O
CO2	O	O
.	O	O

Growth	O	O
was	O	O
enhanced	O	O
with	O	O
a	O	O
streak	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

HKU24	O	O
(	O	O
T	O	O
)	O	O
was	O	O
non-motile	O	O
and	O	O
catalase-negative	O	O
,	O	O
but	O	O
positive	O	O
for	O	O
alkaline	O	O
phosphatase	O	O
,	O	O
beta-glucosidase	O	O
,	O	O
and	O	O
alpha-glucosidase	O	O
.	O	O

It	O	O
hydrolyzed	O	O
phenylphosphonate	O	O
and	O	O
reduced	O	O
resazurin	O	O
.	O	O

16S	O	O
rRNA	O	O
,	O	O
groEL	O	O
,	O	O
gyrB	O	O
,	O	O
recA	O	O
,	O	O
and	O	O
rpoB	O	O
sequencing	O	O
showed	O	O
that	O	O
HKU24	O	O
(	O	O
T	O	O
)	O	O
occupies	O	O
a	O	O
distinct	O	O
phylogenetic	O	O
position	O	O
among	O	O
the	O	O
Leptotrichia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
being	O	O
most	O	O
closely	O	O
related	O	O
to	O	O
Leptotrichia	B-bacteria	B-bacteria
trevisanii	E-bacteria	I-bacteria
.	O	O

Using	O	O
HKU24	O	O
(	O	O
T	O	O
)	O	O
groEL	O	O
,	O	O
gyrB	O	O
,	O	O
recA	O	O
,	O	O
and	O	O
rpoB	O	O
gene-specific	O	O
primers	O	O
,	O	O
fragments	O	O
of	O	O
these	O	O
genes	O	O
were	O	O
amplified	O	O
from	O	O
one	O	O
of	O	O
20	O	O
oral	O	O
specimens	O	O
.	O	O

Based	O	O
on	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
characteristics	O	O
,	O	O
we	O	O
propose	O	O
a	O	O
new	O	O
species	O	O
,	O	O
Leptotrichia	B-bacteria	B-bacteria
hongkongensis	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
to	O	O
describe	O	O
this	O	O
bacterium	O	O
.	O	O

Endotracheal	O	O
(	O	O
ET	O	O
)	O	O
tubes	O	O
accumulate	O	O
a	O	O
biofilm	O	O
during	O	O
use	O	O
,	O	O
which	O	O
can	O	O
harbor	O	O
potentially	O	O
pathogenic	O	O
microorganisms	O	O
.	O	O

The	O	O
enrichment	O	O
of	O	O
pathogenic	O	O
strains	O	O
in	O	O
the	O	O
biofilm	O	O
may	O	O
lead	O	O
to	O	O
ventilator-associated	O	O
pneumonia	O	O
(	O	O
VAP	O	O
)	O	O
with	O	O
an	O	O
increased	O	O
morbidity	O	O
rate	O	O
in	O	O
intensive	O	O
care	O	O
units	O	O
.	O	O

We	O	O
used	O	O
quantitative	O	O
PCR	O	O
(	O	O
qPCR	O	O
)	O	O
and	O	O
gene	O	O
surveys	O	O
targeting	O	O
16S	O	O
rRNA	O	O
genes	O	O
to	O	O
quantify	O	O
and	O	O
identify	O	O
the	O	O
bacterial	O	O
community	O	O
to	O	O
detect	O	O
fastidious/nonculturable	O	O
organisms	O	O
present	O	O
among	O	O
extubated	O	O
ET	O	O
tubes	O	O
.	O	O

We	O	O
collected	O	O
eight	O	O
ET	O	O
tubes	O	O
with	O	O
intubation	O	O
periods	O	O
between	O	O
12	O	O
h	O	O
and	O	O
23	O	O
d	O	O
from	O	O
different	O	O
patients	O	O
in	O	O
a	O	O
surgical	O	O
and	O	O
a	O	O
medical	O	O
intensive	O	O
care	O	O
unit	O	O
.	O	O

Our	O	O
qPCR	O	O
data	O	O
showed	O	O
that	O	O
ET	O	O
tubes	O	O
were	O	O
colonized	O	O
within	O	O
24	O	O
h.	O	O
However	O	O
,	O	O
the	O	O
variation	O	O
between	O	O
patients	O	O
was	O	O
too	O	O
high	O	O
to	O	O
find	O	O
a	O	O
positive	O	O
correlation	O	O
between	O	O
the	O	O
bacterial	O	O
load	O	O
and	O	O
intubation	O	O
period	O	O
.	O	O

We	O	O
obtained	O	O
1263	O	O
near	O	O
full-length	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
from	O	O
the	O	O
diverse	O	O
bacterial	O	O
communities	O	O
.	O	O

Over	O	O
70	O	O
%	O	O
of	O	O
these	O	O
sequences	O	O
were	O	O
associated	O	O
with	O	O
genera	O	O
of	O	O
typical	O	O
oral	O	O
flora	O	O
,	O	O
while	O	O
only	O	O
6	O	O
%	O	O
were	O	O
associated	O	O
with	O	O
gastrointestinal	O	O
flora	O	O
.	O	O

The	O	O
most	O	O
common	O	O
genus	O	O
identified	O	O
was	O	O
Streptococcus	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
348/1263	I-bacteria	I-bacteria
)	E-bacteria	I-bacteria
,	O	O
followed	O	O
by	O	O
Prevotella	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
179/1263	I-bacteria	I-bacteria
)	E-bacteria	I-bacteria
,	O	O
and	O	O
Neisseria	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
143/1263	I-bacteria	I-bacteria
)	E-bacteria	I-bacteria
with	O	O
the	O	O
highest	O	O
relative	O	O
concentrations	O	O
for	O	O
ET	O	O
tubes	O	O
with	O	O
short	O	O
intubation	O	O
periods	O	O
,	O	O
indicating	O	O
oral	O	O
inoculation	O	O
of	O	O
the	O	O
ET	O	O
tubes	O	O
.	O	O

Our	O	O
study	O	O
also	O	O
shows	O	O
that	O	O
even	O	O
though	O	O
potentially	O	O
pathogenic	O	O
bacteria	O	O
existed	O	O
in	O	O
ET	O	O
tube	O	O
biofilms	O	O
within	O	O
24	O	O
h	O	O
of	O	O
intubation	O	O
,	O	O
a	O	O
longer	O	O
intubation	O	O
period	O	O
increases	O	O
the	O	O
opportunity	O	O
for	O	O
these	O	O
organisms	O	O
to	O	O
proliferate	O	O
.	O	O

In	O	O
the	O	O
ET	O	O
tube	O	O
that	O	O
was	O	O
in	O	O
place	O	O
for	O	O
23	O	O
d	O	O
,	O	O
95	O	O
%	O	O
of	O	O
the	O	O
sequences	O	O
belonged	O	O
to	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
which	O	O
is	O	O
a	O	O
bacterial	O	O
pathogen	O	O
that	O	O
is	O	O
known	O	O
to	O	O
out	O	O
compete	O	O
commensal	O	O
bacteria	O	O
in	O	O
biofilms	O	O
,	O	O
especially	O	O
during	O	O
periods	O	O
of	O	O
antibiotic	O	O
treatment	O	O
.	O	O

Harboring	O	O
such	O	O
pathogens	O	O
in	O	O
ET	O	O
biofilms	O	O
may	O	O
increase	O	O
the	O	O
chance	O	O
of	O	O
VAP	O	O
,	O	O
and	O	O
should	O	O
be	O	O
aggressively	O	O
monitored	O	O
and	O	O
prevented	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
pattern	O	O
of	O	O
oral	O	O
bacterial	O	O
flora	O	O
and	O	O
their	O	O
sensitivity	O	O
to	O	O
antibiotics	O	O
in	O	O
freshly	O	O
captured	O	O
native	O	O
snakes	O	O
in	O	O
Hong	O	O
Kong	O	O
SAR	O	O
,	O	O
People's	O	O
Republic	O	O
of	O	O
China	O	O
.	O	O

Healthy	O	O
native	O	O
snakes	O	O
were	O	O
captured	O	O
and	O	O
kept	O	O
in	O	O
a	O	O
designated	O	O
centre	O	O
.	O	O

Snake	O	O
species	O	O
were	O	O
identified	O	O
by	O	O
experienced	O	O
herpetologists	O	O
.	O	O

Mouth	O	O
swabs	O	O
were	O	O
taken	O	O
by	O	O
the	O	O
veterinarian	O	O
using	O	O
strict	O	O
aseptic	O	O
techniques	O	O
.	O	O

The	O	O
snakes	O	O
were	O	O
released	O	O
back	O	O
to	O	O
the	O	O
wild	O	O
immediately	O	O
after	O	O
the	O	O
above	O	O
procedure	O	O
.	O	O

Swabs	O	O
were	O	O
sent	O	O
for	O	O
microbiological	O	O
studies	O	O
of	O	O
bacterial	O	O
culture	O	O
and	O	O
antibiotic	O	O
sensitivity	O	O
.	O	O

47	O	O
venomous	O	O
snakes	O	O
of	O	O
the	O	O
families	O	O
Colubridae	O	O
,	O	O
Elapidae	O	O
and	O	O
Viperidae	O	O
and	O	O
53	O	O
non-medically	O	O
important	O	O
snakes	O	O
were	O	O
captured	O	O
.	O	O

406	O	O
bacterial	O	O
isolates	O	O
of	O	O
72	O	O
different	O	O
species	O	O
were	O	O
cultured	O	O
:	O	O
these	O	O
included	O	O
gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
positive	I-bacteria	I-bacteria
bacterial	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
and	O	O
also	O	O
anaerobic	B-bacteria	B-bacteria
bacterial	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
.	O	O

With	O	O
the	O	O
exception	O	O
of	O	O
the	O	O
white-lipped	O	O
pit	O	O
viper	O	O
(	O	O
Cryptelytrops	O	O
albolabris	O	O
)	O	O
,	O	O
venomous	O	O
snakes	O	O
harboured	O	O
more	O	O
pathogenic	O	O
bacteria	O	O
and	O	O
total	O	O
bacteria	O	O
species	O	O
compared	O	O
to	O	O
the	O	O
non-medically	O	O
important	O	O
species	O	O
.	O	O

Of	O	O
the	O	O
venomous	O	O
snakes	O	O
,	O	O
the	O	O
Chinese	O	O
cobra	O	O
(	O	O
Naja	O	O
atra	O	O
)	O	O
harboured	O	O
the	O	O
largest	O	O
number	O	O
of	O	O
bacterial	O	O
species	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
all	O	O
gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
associated	O	O
with	O	O
wound	O	O
infection	O	O
were	O	O
sensitive	O	O
to	O	O
levofloxacin	O	O
,	O	O
netilmicin	O	O
and	O	O
piperacillin/tazobactam	O	O
.	O	O

Many	O	O
gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
the	O	O
study	O	O
were	O	O
not	O	O
sensitive	O	O
to	O	O
cefuroxime	O	O
axetil	O	O
.	O	O

Amoxicillin/clavulanic	O	O
acid	O	O
was	O	O
an	O	O
appropriate	O	O
choice	O	O
to	O	O
cover	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
anaerobes	B-bacteria	B-bacteria
.	O	O

In	O	O
the	O	O
presence	O	O
of	O	O
wound	O	O
infection	O	O
from	O	O
snakebite	O	O
injury	O	O
in	O	O
Hong	O	O
Kong	O	O
,	O	O
first	O	O
line	O	O
empirical	O	O
antibiotics	O	O
include	O	O
amoxicillin/clavulanic	O	O
acid	O	O
plus	O	O
levofloxacin	O	O
.	O	O

Prophylactic	O	O
antibiotics	O	O
may	O	O
be	O	O
considered	O	O
in	O	O
selected	O	O
cases	O	O
of	O	O
Chinese	O	O
cobra	O	O
(	O	O
N.	O	O
atra	O	O
)	O	O
bite	O	O
,	O	O
otherwise	O	O
prophylactic	O	O
antibiotics	O	O
are	O	O
not	O	O
recommended	O	O
in	O	O
snakebite	O	O
unless	O	O
tissue	O	O
necrosis	O	O
is	O	O
present	O	O
.	O	O

A	O	O
70-year-old	O	O
woman	O	O
who	O	O
had	O	O
for	O	O
five	O	O
years	O	O
been	O	O
treated	O	O
with	O	O
tumour	O	O
necrosis	O	O
factor	O	O
(	O	O
TNF	O	O
)	O	O
-a-inhibitors	O	O
for	O	O
rheumatoid	O	O
arthritis	O	O
was	O	O
admitted	O	O
because	O	O
of	O	O
treatment-refractory	O	O
oral	O	O
ulcerations	O	O
and	O	O
persisting	O	O
considerable	O	O
soft-tissue	O	O
swelling	O	O
over	O	O
the	O	O
left	O	O
maxilla	O	O
.	O	O

Multiple	O	O
mucosal	O	O
biopsies	O	O
from	O	O
the	O	O
left	O	O
maxillary	O	O
sinus	O	O
revealed	O	O
necrotizing	O	O
granulomatous	O	O
inflammation	O	O
suspicious	O	O
of	O	O
mycobacterial	O	O
infection	O	O
.	O	O

This	O	O
was	O	O
subsequently	O	O
confirmed	O	O
in	O	O
concurrent	O	O
microbiological	O	O
cultures	O	O
and	O	O
ultimately	O	O
identified	O	O
as	O	O
Mycobacterium	B-bacteria	B-bacteria
bovis	E-bacteria	I-bacteria
.	O	O

This	O	O
species	O	O
of	O	O
the	O	O
mycobacterium	B-bacteria	B-bacteria
tuberculosis	E-bacteria	I-bacteria
complex	O	O
has	O	O
in	O	O
recent	O	O
times	O	O
rarely	O	O
been	O	O
seen	O	O
in	O	O
clinical	O	O
practice	O	O
in	O	O
Germany	O	O
.	O	O

On	O	O
further	O	O
questioning	O	O
the	O	O
patient	O	O
reported	O	O
that	O	O
she	O	O
had	O	O
been	O	O
treated	O	O
for	O	O
``	O	O
lung	O	O
disease	O	O
''	O	O
as	O	O
a	O	O
schoolgirl	O	O
.	O	O

The	O	O
patient	O	O
was	O	O
isolated	O	O
and	O	O
quadruple	O	O
therapy	O	O
with	O	O
isoniazide	O	O
(	O	O
INH	O	O
)	O	O
,	O	O
rifampin	O	O
(	O	O
RMP	O	O
)	O	O
,	O	O
ethambutol	O	O
(	O	O
EMB	O	O
)	O	O
and	O	O
pyrazinamide	O	O
(	O	O
PZA	O	O
)	O	O
was	O	O
initiated	O	O
.	O	O

Rapid	O	O
improvement	O	O
of	O	O
her	O	O
condition	O	O
occurred	O	O
within	O	O
two	O	O
weeks	O	O
.	O	O

When	O	O
microbiological	O	O
sub-typing	O	O
using	O	O
16s-RNA	O	O
sequencing	O	O
had	O	O
confirmed	O	O
M.	B-bacteria	B-bacteria
bovis	E-bacteria	I-bacteria
,	O	O
PZA	O	O
was	O	O
replaced	O	O
by	O	O
moxifloxacin	O	O
.	O	O

When	O	O
investigating	O	O
the	O	O
cause	O	O
of	O	O
treatment-refractory	O	O
infections	O	O
and	O	O
ulcerations	O	O
,	O	O
particularly	O	O
among	O	O
immunosuppressed	O	O
patients	O	O
,	O	O
consideration	O	O
should	O	O
always	O	O
be	O	O
given	O	O
to	O	O
mycobacterial	O	O
infections	O	O
.	O	O

Detailed	O	O
and	O	O
targeted	O	O
history-taking	O	O
is	O	O
vital	O	O
.	O	O

Use	O	O
of	O	O
oral	O	O
antiseptics	O	O
decreases	O	O
the	O	O
bacterial	O	O
load	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

To	O	O
compare	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
3	O	O
novel	O	O
oral	O	O
antiseptics	O	O
with	O	O
that	O	O
of	O	O
chlorhexidine	O	O
,	O	O
which	O	O
is	O	O
considered	O	O
the	O	O
``	O	O
gold	O	O
standard	O	O
''	O	O
of	O	O
oral	O	O
hygiene	O	O
.	O	O

Comparative	O	O
in	O	O
vitro	O	O
study	O	O
.	O	O

Four	O	O
common	O	O
oral	O	O
microorganisms	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
)	O	O
were	O	O
tested	O	O
under	O	O
standard	O	O
conditions	O	O
and	O	O
at	O	O
different	O	O
concentrations	O	O
,	O	O
by	O	O
use	O	O
of	O	O
a	O	O
broth	O	O
dilution	O	O
assay	O	O
and	O	O
an	O	O
agar	O	O
diffusion	O	O
assay	O	O
and	O	O
by	O	O
calculating	O	O
the	O	O
log10	O	O
reduction	O	O
factor	O	O
(	O	O
RF	O	O
)	O	O
.	O	O

The	O	O
antimicrobial	O	O
activity	O	O
of	O	O
each	O	O
antiseptic	O	O
was	O	O
assessed	O	O
by	O	O
counting	O	O
the	O	O
difference	O	O
in	O	O
bacterial	O	O
densities	O	O
(	O	O
ie	O	O
,	O	O
the	O	O
log10	O	O
number	O	O
of	O	O
colony-forming	O	O
units	O	O
of	O	O
bacteria	O	O
)	O	O
before	O	O
and	O	O
after	O	O
the	O	O
disinfection	O	O
process	O	O
.	O	O

The	O	O
oral	O	O
antiseptics	O	O
containing	O	O
octenidine	O	O
(	O	O
with	O	O
an	O	O
RF	O	O
in	O	O
the	O	O
range	O	O
of	O	O
7.1-8.24	O	O
CFU/mL	O	O
)	O	O
and	O	O
polyhexamethylene	O	O
biguanide	O	O
(	O	O
with	O	O
an	O	O
RF	O	O
in	O	O
the	O	O
range	O	O
of	O	O
7.1-8.24	O	O
CFU/mL	O	O
)	O	O
demonstrated	O	O
antimicrobial	O	O
activity	O	O
comparable	O	O
to	O	O
that	O	O
of	O	O
chlorhexidine	O	O
(	O	O
with	O	O
an	O	O
RF	O	O
in	O	O
the	O	O
range	O	O
of	O	O
1.03-8.24	O	O
CFU/mL	O	O
)	O	O
,	O	O
whereas	O	O
the	O	O
mouth	O	O
rinse	O	O
containing	O	O
Citroxx	O	O
(	O	O
Citroxx	O	O
Biosciences	O	O
;	O	O
with	O	O
an	O	O
RF	O	O
in	O	O
the	O	O
range	O	O
of	O	O
0.22-1.36	O	O
CFU/mL	O	O
)	O	O
showed	O	O
significantly	O	O
weaker	O	O
antimicrobial	O	O
efficacy	O	O
.	O	O

Overall	O	O
,	O	O
octenidine	O	O
and	O	O
polyhexamethylene	O	O
biguanide	O	O
were	O	O
more	O	O
active	O	O
at	O	O
lower	O	O
concentrations.conclusion	O	O
.	O	O

Oral	O	O
antiseptics	O	O
containing	O	O
the	O	O
antimicrobial	O	O
agent	O	O
octenidine	O	O
or	O	O
polyhexamethylene	O	O
biguanide	O	O
may	O	O
be	O	O
considered	O	O
as	O	O
potent	O	O
alternatives	O	O
to	O	O
chlorhexidine-based	O	O
preparations	O	O
.	O	O

This	O	O
investigation	O	O
assessed	O	O
regional	O	O
differences	O	O
in	O	O
dental	O	O
plaque	O	O
and	O	O
gingivitis	O	O
within	O	O
the	O	O
human	O	O
dentition	O	O
in	O	O
conjunction	O	O
with	O	O
microbiological	O	O
analyses	O	O
of	O	O
dental	O	O
plaque	O	O
.	O	O

Forty-one	O	O
adults	O	O
(	O	O
23	O	O
males	O	O
and	O	O
18	O	O
females	O	O
;	O	O
age	O	O
range	O	O
19-44	O	O
years	O	O
)	O	O
were	O	O
enrolled	O	O
,	O	O
and	O	O
a	O	O
calibrated	O	O
dental	O	O
examiner	O	O
completed	O	O
whole	O	O
mouth	O	O
examinations	O	O
for	O	O
dental	O	O
plaque	O	O
(	O	O
PI	O	O
)	O	O
and	O	O
gingivitis	O	O
(	O	O
GI	O	O
)	O	O
using	O	O
the	O	O
Turesky	O	O
modification	O	O
of	O	O
the	O	O
Quigley-Hein	O	O
Index	O	O
(	O	O
TMQH	O	O
)	O	O
and	O	O
the	O	O
L6e-Silness	O	O
(	O	O
LS	O	O
)	O	O
Index	O	O
,	O	O
respectively	O	O
.	O	O

Dental	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
anterior	O	O
surfaces	O	O
and	O	O
posterior	O	O
teeth	O	O
to	O	O
determine	O	O
viable	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

During	O	O
this	O	O
visit	O	O
,	O	O
subjects	O	O
underwent	O	O
a	O	O
whole	O	O
mouth	O	O
dental	O	O
prophylaxis	O	O
and	O	O
were	O	O
provided	O	O
a	O	O
marketed	O	O
fluoride	O	O
dentifrice	O	O
for	O	O
twice-daily	O	O
oral	O	O
hygiene	O	O
.	O	O

Subjects	O	O
were	O	O
recalled	O	O
on	O	O
day	O	O
15	O	O
and	O	O
day	O	O
30	O	O
for	O	O
whole	O	O
mouth	O	O
assessments	O	O
of	O	O
PI	O	O
and	O	O
GI	O	O
,	O	O
followed	O	O
by	O	O
the	O	O
collection	O	O
of	O	O
dental	O	O
plaque	O	O
from	O	O
the	O	O
anterior	O	O
and	O	O
posterior	O	O
teeth	O	O
for	O	O
microbiological	O	O
analyses	O	O
during	O	O
these	O	O
visits	O	O
.	O	O

Low	O	O
plaque	O	O
and	O	O
gingival	O	O
scores	O	O
were	O	O
common	O	O
on	O	O
anterior	O	O
surfaces	O	O
,	O	O
in	O	O
contrast	O	O
to	O	O
greater	O	O
frequencies	O	O
of	O	O
higher	O	O
PI	O	O
and	O	O
GI	O	O
scores	O	O
on	O	O
the	O	O
posterior	O	O
regions	O	O
or	O	O
the	O	O
entire	O	O
dentition	O	O
.	O	O

Correspondingly	O	O
,	O	O
mean	O	O
scores	O	O
for	O	O
PI	O	O
and	O	O
GI	O	O
were	O	O
significantly	O	O
lower	O	O
among	O	O
the	O	O
anterior	O	O
surfaces	O	O
in	O	O
comparison	O	O
to	O	O
all	O	O
other	O	O
regions	O	O
of	O	O
the	O	O
mouth	O	O
(	O	O
posterior	O	O
,	O	O
Ramfjord	O	O
surfaces	O	O
,	O	O
or	O	O
the	O	O
entire	O	O
dentition	O	O
)	O	O
over	O	O
each	O	O
phase	O	O
of	O	O
the	O	O
study	O	O
(	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
.	O	O

While	O	O
prophylaxis	O	O
resulted	O	O
in	O	O
lower	O	O
clinical	O	O
scores	O	O
from	O	O
baseline	O	O
to	O	O
the	O	O
day-15	O	O
recall	O	O
visit	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
anterior	O	O
surfaces	O	O
demonstrated	O	O
lower	O	O
scores	O	O
than	O	O
posterior	O	O
regions	O	O
during	O	O
this	O	O
recall	O	O
visit	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Although	O	O
dental	O	O
plaque	O	O
scores	O	O
increased	O	O
from	O	O
the	O	O
day-15	O	O
to	O	O
the	O	O
day-30	O	O
evaluations	O	O
,	O	O
gingival	O	O
scores	O	O
maintained	O	O
broad	O	O
reductions	O	O
,	O	O
with	O	O
anterior	O	O
scores	O	O
consistently	O	O
lower	O	O
than	O	O
the	O	O
corresponding	O	O
posterior	O	O
regions	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Microbiological	O	O
analyses	O	O
indicated	O	O
significantly	O	O
lower	O	O
numbers	O	O
of	O	O
viable	O	O
bacteria	O	O
from	O	O
the	O	O
anterior	O	O
surfaces	O	O
in	O	O
comparison	O	O
to	O	O
posterior	O	O
regions	O	O
at	O	O
both	O	O
recall	O	O
visits	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Anterior	O	O
surfaces	O	O
routinely	O	O
demonstrated	O	O
lower	O	O
levels	O	O
of	O	O
dental	O	O
plaque	O	O
scores	O	O
than	O	O
the	O	O
other	O	O
regions	O	O
of	O	O
the	O	O
dentition	O	O
.	O	O

Higher	O	O
gingival	O	O
inflammation	O	O
levels	O	O
were	O	O
also	O	O
correlated	O	O
with	O	O
increased	O	O
plaque	O	O
deposits	O	O
associated	O	O
with	O	O
posterior	O	O
teeth	O	O
.	O	O

Microbiological	O	O
analyses	O	O
confirm	O	O
clinical	O	O
observations	O	O
with	O	O
significantly	O	O
higher	O	O
numbers	O	O
of	O	O
viable	O	O
bacteria	O	O
in	O	O
the	O	O
dental	O	O
plaque	O	O
collected	O	O
from	O	O
the	O	O
posterior	O	O
regions	O	O
.	O	O

The	O	O
human	O	O
dentition	O	O
demonstrates	O	O
significant	O	O
regional	O	O
differences	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
dental	O	O
plaque	O	O
,	O	O
gingivitis	O	O
,	O	O
and	O	O
corresponding	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
with	O	O
posterior	O	O
surfaces	O	O
consistently	O	O
reporting	O	O
higher	O	O
scores	O	O
than	O	O
the	O	O
anterior	O	O
regions	O	O
.	O	O

These	O	O
consistent	O	O
differences	O	O
should	O	O
be	O	O
taken	O	O
into	O	O
account	O	O
in	O	O
performing	O	O
plaque	O	O
and	O	O
gingivitis	O	O
studies	O	O
when	O	O
assessing	O	O
the	O	O
efficacy	O	O
of	O	O
oral	O	O
health	O	O
products	O	O
for	O	O
controlling	O	O
dental	O	O
health	O	O
.	O	O

periodontitis	O	O
is	O	O
a	O	O
bacterially	O	O
induced	O	O
chronic	O	O
inflammatory	O	O
disease	O	O
.	O	O

Toll-like	O	O
receptors	O	O
(	O	O
TLRs	O	O
)	O	O
,	O	O
which	O	O
could	O	O
recognize	O	O
microbial	O	O
pathogens	O	O
,	O	O
are	O	O
important	O	O
components	O	O
in	O	O
the	O	O
innate	O	O
and	O	O
adaptive	O	O
immune	O	O
systems	O	O
.	O	O

Both	O	O
qualitatively	O	O
and	O	O
quantitatively	O	O
distinct	O	O
immune	O	O
responses	O	O
might	O	O
result	O	O
from	O	O
different	O	O
bacteria	O	O
stimulation	O	O
and	O	O
the	O	O
triggering	O	O
of	O	O
different	O	O
TLRs	O	O
.	O	O

This	O	O
study	O	O
explores	O	O
the	O	O
interaction	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
previously	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
with	O	O
TLR2	O	O
and	O	O
TLR4	O	O
.	O	O

We	O	O
studied	O	O
the	O	O
gene	O	O
expression	O	O
changes	O	O
of	O	O
TLR2	O	O
and	O	O
TLR4	O	O
and	O	O
cytokine	O	O
production	O	O
(	O	O
interleukin-1beta	O	O
,	O	O
-6	O	O
,	O	O
-8	O	O
,	O	O
-10	O	O
,	O	O
and	O	O
tumor	O	O
necrosis	O	O
factor-alpha	O	O
)	O	O
in	O	O
human	O	O
periodontal	O	O
ligament	O	O
cells	O	O
(	O	O
HPDLCs	O	O
)	O	O
stimulated	O	O
with	O	O
heat-killed	O	O
bacteria	O	O
or	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
in	O	O
the	O	O
presence	O	O
or	O	O
absence	O	O
of	O	O
monoclonal	O	O
antibodies	O	O
to	O	O
TLR2	O	O
or	O	O
TLR4	O	O
(	O	O
anti-TLR2/4	O	O
mAb	O	O
)	O	O
.	O	O

Both	O	O
test	O	O
bacteria	O	O
and	O	O
10	O	O
microg/ml	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS	O	O
treatment	O	O
increased	O	O
the	O	O
gene	O	O
expression	O	O
of	O	O
TLR2	O	O
and	O	O
TLR4	O	O
and	O	O
cytokine	O	O
production	O	O
in	O	O
HPDLCs	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
these	O	O
upregulations	O	O
could	O	O
be	O	O
blocked	O	O
by	O	O
anti-TLR2/4	O	O
mAb	O	O
.	O	O

However	O	O
,	O	O
the	O	O
expression	O	O
of	O	O
TLR4	O	O
mRNA	O	O
in	O	O
HPDLCs	O	O
stimulated	O	O
with	O	O
1	O	O
microg/ml	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS	O	O
was	O	O
not	O	O
increased	O	O
.	O	O

No	O	O
differences	O	O
were	O	O
found	O	O
in	O	O
the	O	O
cytokine	O	O
production	O	O
caused	O	O
by	O	O
1	O	O
microg/ml	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS	O	O
treatment	O	O
in	O	O
the	O	O
presence	O	O
or	O	O
absence	O	O
of	O	O
anti-TLR4	O	O
mAb	O	O
.	O	O

These	O	O
patterns	O	O
of	O	O
gene	O	O
expression	O	O
and	O	O
cytokine	O	O
production	O	O
indicate	O	O
that	O	O
Gram-negative	B-bacteria	B-bacteria
periodontal	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
or	O	O
their	O	O
LPS	O	O
might	O	O
play	O	O
a	O	O
role	O	O
in	O	O
triggering	O	O
TLR2	O	O
and/or	O	O
TLR4	O	O
,	O	O
and	O	O
be	O	O
of	O	O
importance	O	O
for	O	O
the	O	O
immune	O	O
responses	O	O
in	O	O
periodontitis	O	O
.	O	O

Coagulase-negative	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
(	O	O
CoNS	B-bacteria	B-bacteria
)	O	O
are	O	O
frequently	O	O
isolated	O	O
from	O	O
blood	O	O
cultures	O	O
of	O	O
hematopoietic	O	O
cell	O	O
transplantation	O	O
(	O	O
HCT	O	O
)	O	O
patients	O	O
.	O	O

Generally	O	O
,	O	O
the	O	O
use	O	O
of	O	O
central	O	O
venous	O	O
catheters	O	O
is	O	O
recognized	O	O
as	O	O
a	O	O
significant	O	O
risk	O	O
factor	O	O
for	O	O
CoNS	B-bacteria	B-bacteria
infection	O	O
,	O	O
while	O	O
the	O	O
impact	O	O
of	O	O
CoNS	B-bacteria	B-bacteria
infection	O	O
from	O	O
oral	O	O
ulcerative	O	O
mucositis	O	O
,	O	O
which	O	O
occurs	O	O
frequently	O	O
in	O	O
HCT	O	O
,	O	O
may	O	O
be	O	O
underestimated	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
bacteria	O	O
on	O	O
the	O	O
buccal	O	O
mucosa	O	O
after	O	O
HCT	O	O
.	O	O

Sixty-one	O	O
patients	O	O
were	O	O
examined	O	O
for	O	O
bacteria	O	O
on	O	O
the	O	O
buccal	O	O
mucosa	O	O
routinely	O	O
once	O	O
a	O	O
week	O	O
from	O	O
1	O	O
week	O	O
before	O	O
to	O	O
3	O	O
weeks	O	O
after	O	O
allogeneic	O	O
HCT	O	O
.	O	O

Subjects	O	O
were	O	O
divided	O	O
into	O	O
groups	O	O
with	O	O
short	O	O
and	O	O
long	O	O
periods	O	O
of	O	O
antibiotic	O	O
use	O	O
,	O	O
and	O	O
differences	O	O
in	O	O
bacterial	O	O
substitution	O	O
were	O	O
evaluated	O	O
.	O	O

The	O	O
relationships	O	O
between	O	O
type	O	O
of	O	O
HCT	O	O
(	O	O
conventional	O	O
HCT	O	O
or	O	O
RIST	O	O
)	O	O
and	O	O
bacterial	O	O
substitution	O	O
were	O	O
also	O	O
evaluated	O	O
.	O	O

The	O	O
changes	O	O
in	O	O
detection	O	O
frequencies	O	O
of	O	O
CoNS	B-bacteria	B-bacteria
and	O	O
alpha-streptococci	B-bacteria	B-bacteria
from	O	O
before	O	O
to	O	O
3	O	O
weeks	O	O
after	O	O
HCT	O	O
were	O	O
significant	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
,	O	O
chi	O	O
(	O	O
2	O	O
)	O	O
test	O	O
)	O	O
:	O	O
14.5-53.3	O	O
%	O	O
and	O	O
92.7-53.1	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

Significant	O	O
bacterial	O	O
substitution	O	O
of	O	O
CoNS	B-bacteria	B-bacteria
for	O	O
streptococci	B-bacteria	B-bacteria
was	O	O
observed	O	O
in	O	O
the	O	O
long-term	O	O
antibiotic	O	O
use	O	O
group	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
,	O	O
chi	O	O
(	O	O
2	O	O
)	O	O
test	O	O
)	O	O
,	O	O
but	O	O
also	O	O
occurred	O	O
in	O	O
cases	O	O
with	O	O
short-term	O	O
or	O	O
no	O	O
antibiotic	O	O
use	O	O
.	O	O

No	O	O
relationships	O	O
between	O	O
type	O	O
of	O	O
HCT	O	O
(	O	O
conventional	O	O
HCT	O	O
or	O	O
RIST	O	O
)	O	O
were	O	O
observed	O	O
.	O	O

Bacterial	O	O
substitution	O	O
of	O	O
CoNS	B-bacteria	B-bacteria
for	O	O
streptococci	B-bacteria	B-bacteria
occurred	O	O
frequently	O	O
on	O	O
the	O	O
buccal	O	O
mucosa	O	O
after	O	O
HCT	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
antibiotic	O	O
use	O	O
,	O	O
environmental	O	O
factors	O	O
may	O	O
be	O	O
involved	O	O
in	O	O
bacterial	O	O
substitution	O	O
.	O	O

It	O	O
is	O	O
important	O	O
to	O	O
consider	O	O
the	O	O
presence	O	O
of	O	O
oral	O	O
mucositis	O	O
in	O	O
CoNS	B-bacteria	B-bacteria
infection	O	O
after	O	O
HCT	O	O
.	O	O

Approximately	O	O
10-20	O	O
%	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
have	O	O
been	O	O
reported	O	O
to	O	O
possess	O	O
collagen-binding	O	O
properties	O	O
,	O	O
whereas	O	O
other	O	O
species	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
with	O	O
those	O	O
properties	O	O
remain	O	O
to	O	O
be	O	O
elucidated	O	O
.	O	O

Aim	O	O
.	O	O

To	O	O
identify	O	O
strains	O	O
with	O	O
collagen-binding	O	O
properties	O	O
and	O	O
analyse	O	O
their	O	O
characteristics	O	O
in	O	O
comparison	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

A	O	O
total	O	O
of	O	O
110	O	O
expectorated	O	O
saliva	O	O
specimens	O	O
were	O	O
collected	O	O
from	O	O
55	O	O
pairs	O	O
of	O	O
mothers	O	O
and	O	O
their	O	O
children	O	O
.	O	O

Bacterial	O	O
strains	O	O
with	O	O
collagen-binding	O	O
properties	O	O
were	O	O
isolated	O	O
and	O	O
the	O	O
species	O	O
specified	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
strains	O	O
with	O	O
collagen-binding	O	O
properties	O	O
isolated	O	O
from	O	O
mother-child	O	O
pairs	O	O
were	O	O
analysed	O	O
using	O	O
molecular	O	O
biological	O	O
approaches	O	O
.	O	O

The	O	O
detection	O	O
frequency	O	O
of	O	O
strains	O	O
with	O	O
collagen-binding	O	O
properties	O	O
was	O	O
shown	O	O
to	O	O
be	O	O
40.9	O	O
%	O	O
,	O	O
among	O	O
which	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
frequently	O	O
detected	O	O
,	O	O
followed	O	O
by	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

The	O	O
collagen-binding	O	O
activity	O	O
of	O	O
the	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
group	O	O
was	O	O
the	O	O
highest	O	O
,	O	O
followed	O	O
by	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
.	O	O

In	O	O
addition	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
from	O	O
3	O	O
and	O	O
1	O	O
mother-child	O	O
pairs	O	O
,	O	O
respectively	O	O
,	O	O
were	O	O
shown	O	O
to	O	O
be	O	O
the	O	O
same	O	O
clones	O	O
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
are	O	O
major	O	O
species	O	O
with	O	O
collagen-binding	O	O
properties	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
that	O	O
strains	O	O
with	O	O
such	O	O
properties	O	O
may	O	O
be	O	O
related	O	O
to	O	O
mother-child	O	O
transmission	O	O
.	O	O

The	O	O
microbiota	O	O
of	O	O
the	O	O
denture	O	O
plaque	O	O
biofilm	O	O
colonizing	O	O
the	O	O
fitting	O	O
surface	O	O
of	O	O
dentures	O	O
in	O	O
edentulous	O	O
subjects	O	O
with	O	O
healthy	O	O
palates	O	O
(	O	O
n	O	O
=	O	O
20	O	O
)	O	O
and	O	O
in	O	O
edentulous	O	O
subjects	O	O
with	O	O
denture	O	O
stomatitis	O	O
(	O	O
n	O	O
=	O	O
20	O	O
)	O	O
was	O	O
studied	O	O
.	O	O

The	O	O
numbers	O	O
of	O	O
bacteria	O	O
colonizing	O	O
the	O	O
dentures	O	O
of	O	O
healthy	O	O
subjects	O	O
was	O	O
significantly	O	O
less	O	O
than	O	O
the	O	O
numbers	O	O
colonizing	O	O
the	O	O
dentures	O	O
of	O	O
stomatitis	O	O
subjects	O	O
.	O	O

The	O	O
proportions	O	O
and	O	O
frequency	O	O
of	O	O
isolation	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
bifidobacteria	B-bacteria	B-bacteria
and	O	O
yeasts	O	O
were	O	O
significantly	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
greater	O	O
in	O	O
the	O	O
subjects	O	O
with	O	O
denture	O	O
stomatitis	O	O
.	O	O

The	O	O
proportions	O	O
of	O	O
these	O	O
organisms	O	O
in	O	O
the	O	O
denture	O	O
plaque	O	O
biofilm	O	O
of	O	O
the	O	O
subjects	O	O
with	O	O
denture	O	O
stomatitis	O	O
were	O	O
similar	O	O
to	O	O
those	O	O
found	O	O
in	O	O
carious	O	O
lesions	O	O
,	O	O
indicating	O	O
that	O	O
the	O	O
site	O	O
is	O	O
a	O	O
low	O	O
pH	O	O
environment	O	O
.	O	O

The	O	O
predominant	O	O
bifidobacterial	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
in	O	O
the	O	O
mouths	O	O
of	O	O
dentate	O	O
subjects	O	O
is	O	O
Bifidobacterium	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
but	O	O
in	O	O
the	O	O
edentulous	O	O
subjects	O	O
wearing	O	O
dentures	O	O
B.	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
was	O	O
isolated	O	O
from	O	O
only	O	O
one	O	O
of	O	O
the	O	O
20	O	O
subjects	O	O
with	O	O
denture	O	O
stomatitis	O	O
and	O	O
from	O	O
none	O	O
of	O	O
the	O	O
20	O	O
subjects	O	O
with	O	O
healthy	O	O
palates	O	O
.	O	O

Instead	O	O
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
breve	E-bacteria	I-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
scardovii	E-bacteria	I-bacteria
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
longum	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

longum	O	O
were	O	O
isolated	O	O
.	O	O

Only	O	O
a	O	O
single	O	O
non-oral	O	O
bifidobacterial	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
was	O	O
isolated	O	O
from	O	O
each	O	O
individual	O	O
and	O	O
repetitive	O	O
extragenic	O	O
palindromic-	O	O
and	O	O
BOX-polymerase	O	O
chain	O	O
reaction	O	O
typing	O	O
methods	O	O
indicated	O	O
that	O	O
the	O	O
same	O	O
genotypes	O	O
were	O	O
shared	O	O
between	O	O
subjects	O	O
.	O	O

Using	O	O
deferred	O	O
antagonism	O	O
spot	O	O
plate	O	O
assays	O	O
,	O	O
interspecies	O	O
inhibition	O	O
was	O	O
demonstrated	O	O
between	O	O
oral	O	O
isolates	O	O
of	O	O
B.	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
,	O	O
B.	B-bacteria	B-bacteria
breve	E-bacteria	I-bacteria
,	O	O
B.	B-bacteria	B-bacteria
scardovii	E-bacteria	I-bacteria
and	O	O
B.	B-bacteria	B-bacteria
longum	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

longum	E-bacteria	I-bacteria
.	O	O

Here	O	O
we	O	O
have	O	O
shown	O	O
that	O	O
bifidobacteria	B-bacteria	B-bacteria
and	O	O
caries-associated	O	O
microbiota	O	O
are	O	O
present	O	O
in	O	O
denture	O	O
plaque	O	O
at	O	O
levels	O	O
similar	O	O
to	O	O
those	O	O
of	O	O
carious	O	O
lesions	O	O
and	O	O
B.	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
can	O	O
not	O	O
be	O	O
maintained	O	O
in	O	O
an	O	O
edentulous	O	O
mouth	O	O
.	O	O

This	O	O
study	O	O
is	O	O
to	O	O
assess	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
omega-6	O	O
,	O	O
-7	O	O
,	O	O
-9	O	O
(	O	O
n-6	O	O
,	O	O
n-7	O	O
,	O	O
n-9	O	O
)	O	O
fatty	O	O
acids	O	O
against	O	O
various	O	O
oral	O	O
microorganisms	O	O
.	O	O

The	O	O
n-6	O	O
,	O	O
n-7	O	O
,	O	O
n-9	O	O
fatty	O	O
acids	O	O
,	O	O
such	O	O
as	O	O
gamma-linoleic	O	O
acid	O	O
(	O	O
GLA	O	O
)	O	O
,	O	O
linoleic	O	O
acid	O	O
(	O	O
LA	O	O
)	O	O
,	O	O
arachidonic	O	O
acid	O	O
(	O	O
ARA	O	O
)	O	O
,	O	O
palmitoleic	O	O
acid	O	O
(	O	O
PA	O	O
)	O	O
,	O	O
and	O	O
oleic	O	O
acid	O	O
(	O	O
OA	O	O
)	O	O
,	O	O
their	O	O
fatty	O	O
acid	O	O
ethyl	O	O
esters	O	O
,	O	O
GLA-EE	O	O
,	O	O
LA-EE	O	O
,	O	O
ARA-EE	O	O
,	O	O
PA-EE	O	O
,	O	O
OA-EE	O	O
,	O	O
and	O	O
their	O	O
fatty	O	O
acid	O	O
methyl	O	O
esters	O	O
,	O	O
GLA-ME	O	O
,	O	O
LA-ME	O	O
,	O	O
ARA-ME	O	O
,	O	O
PA-ME	O	O
,	O	O
OA-ME	O	O
,	O	O
were	O	O
investigated	O	O
for	O	O
antimicrobial	O	O
activity	O	O
against	O	O
oral	O	O
pathogens	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Various	O	O
concentrations	O	O
of	O	O
the	O	O
fatty	O	O
acids	O	O
,	O	O
their	O	O
methyl	O	O
and	O	O
ethyl	O	O
esters	O	O
were	O	O
tested	O	O
against	O	O
various	O	O
oral	O	O
pathogens	O	O
in	O	O
96-well	O	O
plates	O	O
and	O	O
blood-agar	O	O
plate	O	O
.	O	O

The	O	O
plates	O	O
were	O	O
incubated	O	O
anaerobically	O	O
or	O	O
aerobically	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
48h	O	O
,	O	O
and	O	O
the	O	O
colony	O	O
forming	O	O
units	O	O
(	O	O
CFU	O	O
)	O	O
were	O	O
determined	O	O
.	O	O

The	O	O
data	O	O
demonstrated	O	O
that	O	O
select	O	O
n-6	O	O
,	O	O
n-7	O	O
,	O	O
n-9	O	O
fatty	O	O
acids	O	O
and	O	O
their	O	O
esters	O	O
exhibited	O	O
strong	O	O
antimicrobial	O	O
activity	O	O
against	O	O
these	O	O
oral	O	O
microorganisms	O	O
,	O	O
demonstrating	O	O
some	O	O
specificity	O	O
for	O	O
individual	O	O
microbial	O	O
species	O	O
.	O	O

The	O	O
potential	O	O
use	O	O
or	O	O
the	O	O
combinations	O	O
of	O	O
the	O	O
n-6	O	O
,	O	O
n-7	O	O
,	O	O
n-9	O	O
fatty	O	O
acids	O	O
and/or	O	O
their	O	O
esters	O	O
,	O	O
provided	O	O
in	O	O
a	O	O
local	O	O
delivery	O	O
vehicle	O	O
to	O	O
infected	O	O
sites	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
could	O	O
be	O	O
considered	O	O
as	O	O
an	O	O
additional	O	O
therapeutic	O	O
approach	O	O
to	O	O
improving	O	O
oral	O	O
health	O	O
.	O	O

Non-clinical	O	O
studies	O	O
,	O	O
focusing	O	O
on	O	O
the	O	O
pharmacodynamics	O	O
(	O	O
PD	O	O
)	O	O
,	O	O
pharmacokinetics	O	O
(	O	O
PK	O	O
)	O	O
and	O	O
safety	O	O
pharmacology	O	O
of	O	O
genetically	O	O
modified	O	O
Lactococcus	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
(	O	O
L.	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
)	O	O
bacteria	O	O
,	O	O
engineered	O	O
to	O	O
secrete	O	O
human	O	O
Trefoil	O	O
Factor	O	O
1	O	O
(	O	O
hTFF1	O	O
)	O	O
,	O	O
were	O	O
performed	O	O
to	O	O
provide	O	O
proof-of-concept	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
oral	O	O
mucositis	O	O
(	O	O
OM	O	O
)	O	O
patients	O	O
.	O	O

L.	B-bacteria	B-bacteria
lactis	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
sAGX0085	E-bacteria	I-bacteria
was	O	O
constructed	O	O
by	O	O
stably	O	O
inserting	O	O
an	O	O
htff1	O	O
expression	O	O
cassette	O	O
into	O	O
the	O	O
bacterial	O	O
genome	O	O
,	O	O
and	O	O
clinically	O	O
formulated	O	O
as	O	O
a	O	O
mouth	O	O
rinse	O	O
(	O	O
coded	O	O
AG013	O	O
)	O	O
.	O	O

PD	O	O
studies	O	O
,	O	O
using	O	O
different	O	O
oral	O	O
dosing	O	O
regimens	O	O
,	O	O
were	O	O
performed	O	O
in	O	O
a	O	O
clinically	O	O
relevant	O	O
hamster	O	O
model	O	O
for	O	O
radiation-induced	O	O
OM	O	O
.	O	O

The	O	O
PK	O	O
profile	O	O
was	O	O
assessed	O	O
in	O	O
healthy	O	O
hamsters	O	O
and	O	O
in	O	O
hamsters	O	O
with	O	O
radiation-induced	O	O
OM	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
safety	O	O
pharmacology	O	O
studies	O	O
were	O	O
conducted	O	O
,	O	O
in	O	O
pooled	O	O
,	O	O
complement-preserved	O	O
human	O	O
serum	O	O
,	O	O
and	O	O
in	O	O
neutropenic	O	O
hamsters	O	O
and	O	O
rats	O	O
respectively	O	O
.	O	O

Topical	O	O
administration	O	O
of	O	O
L.	B-bacteria	B-bacteria
lactis	I-bacteria	I-bacteria
sAGX0085/AG013	E-bacteria	I-bacteria
to	O	O
the	O	O
oral	O	O
mucosa	O	O
significantly	O	O
reduced	O	O
the	O	O
severity	O	O
and	O	O
course	O	O
of	O	O
radiation-induced	O	O
OM	O	O
.	O	O

PK	O	O
studies	O	O
demonstrated	O	O
that	O	O
both	O	O
living	O	O
L.	B-bacteria	B-bacteria
lactis	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
hTFF1	O	O
secreted	O	O
,	O	O
could	O	O
be	O	O
recovered	O	O
from	O	O
the	O	O
administration	O	O
site	O	O
for	O	O
maximum	O	O
24h	O	O
post-dosing	O	O
,	O	O
without	O	O
systemic	O	O
exposure	O	O
.	O	O

The	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
safety	O	O
pharmacology	O	O
studies	O	O
confirmed	O	O
that	O	O
L.	B-bacteria	B-bacteria
lactis	I-bacteria	I-bacteria
sAGX0085	E-bacteria	I-bacteria
could	O	O
not	O	O
survive	O	O
in	O	O
systemic	O	O
circulation	O	O
,	O	O
not	O	O
even	O	O
under	O	O
neutropenic	O	O
conditions	O	O
.	O	O

The	O	O
results	O	O
from	O	O
the	O	O
PD	O	O
,	O	O
PK	O	O
and	O	O
safety	O	O
pharmacology	O	O
studies	O	O
reported	O	O
here	O	O
indicate	O	O
that	O	O
in	O	O
situ	O	O
secretion	O	O
of	O	O
hTFF1	O	O
by	O	O
topically	O	O
administered	O	O
L.	B-bacteria	B-bacteria
lactis	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
provides	O	O
a	O	O
safe	O	O
and	O	O
efficacious	O	O
therapeutic	O	O
tool	O	O
for	O	O
the	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
OM	O	O
.	O	O

The	O	O
human	O	O
oropharynx	O	O
is	O	O
a	O	O
reservoir	O	O
for	O	O
many	O	O
potential	O	O
pathogens	O	O
,	O	O
including	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
that	O	O
cause	O	O
endocarditis	O	O
.	O	O

Although	O	O
oropharyngeal	O	O
microbes	O	O
have	O	O
been	O	O
well	O	O
described	O	O
,	O	O
viral	O	O
communities	O	O
are	O	O
essentially	O	O
uncharacterized	O	O
.	O	O

We	O	O
conducted	O	O
a	O	O
metagenomic	O	O
study	O	O
to	O	O
determine	O	O
the	O	O
composition	O	O
of	O	O
oropharyngeal	O	O
DNA	O	O
viral	O	O
communities	O	O
(	O	O
both	O	O
phage	O	O
and	O	O
eukaryotic	O	O
viruses	O	O
)	O	O
in	O	O
healthy	O	O
individuals	O	O
and	O	O
to	O	O
evaluate	O	O
oropharyngeal	O	O
swabs	O	O
as	O	O
a	O	O
rapid	O	O
method	O	O
for	O	O
viral	O	O
detection	O	O
.	O	O

Viral	O	O
DNA	O	O
was	O	O
extracted	O	O
from	O	O
19	O	O
pooled	O	O
oropharyngeal	O	O
swabs	O	O
and	O	O
sequenced	O	O
.	O	O

Viral	O	O
communities	O	O
consisted	O	O
almost	O	O
exclusively	O	O
of	O	O
phage	O	O
,	O	O
and	O	O
complete	O	O
genomes	O	O
of	O	O
several	O	O
phage	O	O
were	O	O
recovered	O	O
,	O	O
including	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
phage	O	O
T3	O	O
,	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	B-bacteria	B-bacteria
phage	O	O
PA6	O	O
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
phage	O	O
SM1	O	O
.	O	O

Phage	O	O
relative	O	O
abundances	O	O
changed	O	O
dramatically	O	O
depending	O	O
on	O	O
whether	O	O
samples	O	O
were	O	O
chloroform	O	O
treated	O	O
or	O	O
filtered	O	O
to	O	O
remove	O	O
microbial	O	O
contamination	O	O
.	O	O

pblA	O	O
and	O	O
pblB	O	O
genes	O	O
of	O	O
phage	O	O
SM1	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
metagenomes	O	O
.	O	O

pblA	O	O
and	O	O
pblB	O	O
mediate	O	O
the	O	O
attachment	O	O
of	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
to	O	O
platelets	O	O
and	O	O
play	O	O
a	O	O
significant	O	O
role	O	O
in	O	O
S.	O	O
mitis	O	O
virulence	O	O
in	O	O
the	O	O
endocardium	O	O
,	O	O
but	O	O
have	O	O
never	O	O
previously	O	O
been	O	O
detected	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

These	O	O
genes	O	O
were	O	O
also	O	O
identified	O	O
in	O	O
salivary	O	O
metagenomes	O	O
from	O	O
three	O	O
individuals	O	O
at	O	O
three	O	O
time	O	O
points	O	O
and	O	O
in	O	O
individual	O	O
saliva	O	O
samples	O	O
by	O	O
PCR	O	O
.	O	O

Additionally	O	O
,	O	O
we	O	O
demonstrate	O	O
that	O	O
phage	O	O
SM1	O	O
can	O	O
be	O	O
induced	O	O
by	O	O
commonly	O	O
ingested	O	O
substances	O	O
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
a	O	O
reservoir	O	O
for	O	O
pblA	O	O
and	O	O
pblB	O	O
genes	O	O
and	O	O
for	O	O
phage	O	O
SM1	O	O
itself	O	O
.	O	O

Further	O	O
studies	O	O
will	O	O
determine	O	O
the	O	O
association	O	O
between	O	O
pblA	O	O
and	O	O
pblB	O	O
genes	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
risk	O	O
of	O	O
endocarditis	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
is	O	O
inhabited	O	O
by	O	O
over	O	O
500	O	O
different	O	O
bacterial	O	O
species	O	O
that	O	O
normally	O	O
exist	O	O
in	O	O
ecological	O	O
balance	O	O
both	O	O
with	O	O
each	O	O
other	O	O
and	O	O
with	O	O
the	O	O
host	O	O
.	O	O

When	O	O
this	O	O
equilibrium	O	O
is	O	O
disturbed	O	O
,	O	O
an	O	O
overgrowth	O	O
of	O	O
individual	O	O
organisms	O	O
can	O	O
occur	O	O
,	O	O
which	O	O
,	O	O
in	O	O
turn	O	O
,	O	O
can	O	O
lead	O	O
to	O	O
the	O	O
onset	O	O
of	O	O
pathological	O	O
processes	O	O
,	O	O
notably	O	O
dental	O	O
caries	O	O
and	O	O
periodontitis	O	O
.	O	O

Generally	O	O
,	O	O
bacteraemias	O	O
occur	O	O
more	O	O
frequently	O	O
in	O	O
individuals	O	O
with	O	O
periodontal	O	O
disease	O	O
,	O	O
and	O	O
these	O	O
bacteraemias	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
development	O	O
of	O	O
a	O	O
range	O	O
of	O	O
systemic	O	O
diseases	O	O
,	O	O
including	O	O
atherothrombotic	O	O
disorders	O	O
.	O	O

The	O	O
mechanism	O	O
underlying	O	O
this	O	O
relationship	O	O
remains	O	O
to	O	O
be	O	O
precisely	O	O
defined	O	O
,	O	O
although	O	O
studies	O	O
have	O	O
shown	O	O
a	O	O
link	O	O
between	O	O
bacteria	O	O
of	O	O
oral	O	O
origin	O	O
and	O	O
platelet	O	O
activation	O	O
.	O	O

Several	O	O
orally	O	O
derived	O	O
species	O	O
of	O	O
bacteria	O	O
interact	O	O
with	O	O
platelets	O	O
,	O	O
including	O	O
those	O	O
of	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
(	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
agalactiae	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
)	O	O
and	O	O
Staphylococcus	B-bacteria	B-bacteria
(	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
capitis	E-bacteria	I-bacteria
)	O	O
genera	O	O
,	O	O
as	O	O
well	O	O
as	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

In	O	O
addition	O	O
,	O	O
some	O	O
members	O	O
of	O	O
both	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
and	O	O
the	O	O
Staphylococcus	B-bacteria	B-bacteria
genera	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
can	O	O
activate	O	O
platelets	O	O
in	O	O
vitro	O	O
.	O	O

The	O	O
current	O	O
review	O	O
describes	O	O
the	O	O
heterogeneous	O	O
mechanisms	O	O
of	O	O
platelet	O	O
activation	O	O
employed	O	O
by	O	O
individual	O	O
bacterial	O	O
species	O	O
.	O	O

The	O	O
pathological	O	O
and	O	O
clinical	O	O
implications	O	O
of	O	O
platelet	O	O
activation	O	O
by	O	O
orally	O	O
derived	O	O
bacteria	O	O
are	O	O
discussed	O	O
.	O	O

Dentistry	O	O
has	O	O
undergone	O	O
a	O	O
shift	O	O
in	O	O
caries	O	O
management	O	O
toward	O	O
prevention	O	O
and	O	O
improved	O	O
oral	O	O
hygiene	O	O
and	O	O
diagnosis	O	O
.	O	O

Caries	O	O
prevention	O	O
now	O	O
represents	O	O
one	O	O
of	O	O
the	O	O
most	O	O
important	O	O
aspects	O	O
of	O	O
modern	O	O
dental	O	O
practice	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
cross-sectional	O	O
study	O	O
was	O	O
to	O	O
demonstrate	O	O
the	O	O
use	O	O
of	O	O
adenosine	O	O
triphosphate-	O	O
(	O	O
ATP-	O	O
)	O	O
driven	O	O
bioluminescence	O	O
as	O	O
an	O	O
innovative	O	O
tool	O	O
for	O	O
the	O	O
rapid	O	O
chairside	O	O
enumeration	O	O
of	O	O
oral	O	O
bacteria	O	O
(	O	O
including	O	O
plague	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
)	O	O
and	O	O
assessment	O	O
of	O	O
oral	O	O
hygiene	O	O
and	O	O
caries	O	O
risk	O	O
.	O	O

Thirty-three	O	O
pediatric	O	O
patients	O	O
(	O	O
7-	O	O
to	O	O
12-year-old	O	O
males	O	O
and	O	O
females	O	O
)	O	O
were	O	O
examined	O	O
,	O	O
and	O	O
plague	O	O
specimens	O	O
,	O	O
in	O	O
addition	O	O
to	O	O
stimulated	O	O
saliva	O	O
,	O	O
were	O	O
collected	O	O
from	O	O
representative	O	O
teeth	O	O
within	O	O
each	O	O
quadrant	O	O
.	O	O

Oral	O	O
specimens	O	O
(	O	O
n=150	O	O
specimens	O	O
)	O	O
were	O	O
assessed	O	O
by	O	O
plating	O	O
on	O	O
enriched	O	O
and	O	O
selective	O	O
agars	O	O
,	O	O
to	O	O
enumerate	O	O
total	O	O
bacteria	O	O
and	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
and	O	O
subjected	O	O
to	O	O
adenosine	O	O
triphosphate-	O	O
(	O	O
ATP-	O	O
)	O	O
driven	O	O
bioluminescence	O	O
determinations	O	O
using	O	O
a	O	O
luciferase-based	O	O
assay	O	O
system	O	O
.	O	O

Statistical	O	O
correlations	O	O
,	O	O
linking	O	O
ATP	O	O
values	O	O
to	O	O
numbers	O	O
of	O	O
total	O	O
bacteria	O	O
,	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
yielded	O	O
highly	O	O
significant	O	O
r	O	O
values	O	O
of	O	O
0.854	O	O
,	O	O
0.840	O	O
,	O	O
and	O	O
0.796	O	O
,	O	O
respectively	O	O
Our	O	O
clinical	O	O
data	O	O
is	O	O
consistent	O	O
with	O	O
the	O	O
hypothesis	O	O
that	O	O
ATP	O	O
measurements	O	O
have	O	O
a	O	O
strong	O	O
statistical	O	O
association	O	O
with	O	O
bacterial	O	O
number	O	O
in	O	O
plague	O	O
and	O	O
saliva	O	O
specimens	O	O
,	O	O
including	O	O
numbers	O	O
for	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
and	O	O
may	O	O
be	O	O
used	O	O
as	O	O
a	O	O
potential	O	O
assessment	O	O
tool	O	O
for	O	O
oral	O	O
hygiene	O	O
and	O	O
caries	O	O
risk	O	O
in	O	O
children	O	O
.	O	O

To	O	O
assess	O	O
the	O	O
distribution	O	O
of	O	O
elevated	O	O
antibody	O	O
titres	O	O
to	O	O
multiple	O	O
periodontal	O	O
bacteria	O	O
,	O	O
including	O	O
established/putative	O	O
pathogens	O	O
and	O	O
health-related	O	O
species	O	O
,	O	O
by	O	O
selected	O	O
demographic	O	O
,	O	O
behavioural	O	O
,	O	O
and	O	O
oral-	O	O
and	O	O
general	O	O
health-related	O	O
characteristics	O	O
.	O	O

Data	O	O
from	O	O
8153	O	O
>	O	O
or=40-year-old	O	O
participants	O	O
from	O	O
the	O	O
third	O	O
National	O	O
Health	O	O
and	O	O
Nutrition	O	O
Examination	O	O
Survey	O	O
were	O	O
used	O	O
,	O	O
including	O	O
1588	O	O
edentulous	O	O
individuals	O	O
.	O	O

We	O	O
used	O	O
checkerboard	O	O
immunoblotting	O	O
to	O	O
assess	O	O
serum	O	O
IgG	O	O
levels	O	O
to	O	O
19	O	O
periodontal	O	O
species	O	O
.	O	O

Thresholds	O	O
for	O	O
elevated	O	O
antibody	O	O
responses	O	O
were	O	O
defined	O	O
for	O	O
each	O	O
species	O	O
using	O	O
the	O	O
90th	O	O
percentile	O	O
titre	O	O
in	O	O
periodontal	O	O
healthy	O	O
participants	O	O
,	O	O
using	O	O
two	O	O
alternative	O	O
definitions	O	O
of	O	O
periodontitis	O	O
.	O	O

Edentulous	O	O
individuals	O	O
showed	O	O
lower	O	O
antibody	O	O
responses	O	O
than	O	O
dentate	O	O
participants	O	O
,	O	O
notably	O	O
for	O	O
titres	O	O
to	O	O
``	O	O
red	O	O
complex	O	O
''	O	O
species	O	O
and	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

Elevated	O	O
titres	O	O
to	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
twice	O	O
as	O	O
prevalent	O	O
in	O	O
participants	O	O
with	O	O
periodontitis	O	O
than	O	O
in	O	O
periodontal	O	O
healthy	O	O
individuals	O	O
.	O	O

Non-Hispanic	O	O
blacks	O	O
and	O	O
Mexican-Americans	O	O
were	O	O
more	O	O
likely	O	O
to	O	O
display	O	O
elevated	O	O
titres	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
compared	O	O
with	O	O
non-Hispanic	O	O
whites	O	O
(	O	O
22.9	O	O
%	O	O
versus	O	O
19.4	O	O
%	O	O
versus	O	O
9.5	O	O
%	O	O
)	O	O
.	O	O

Current	O	O
smokers	O	O
were	O	O
significantly	O	O
less	O	O
likely	O	O
to	O	O
exhibit	O	O
high	O	O
titres	O	O
to	O	O
multiple	O	O
bacteria	O	O
than	O	O
never	O	O
smokers	O	O
.	O	O

Demographic	O	O
,	O	O
behavioural	O	O
,	O	O
and	O	O
oral-	O	O
and	O	O
general	O	O
health-related	O	O
characteristics	O	O
were	O	O
strong	O	O
determinants	O	O
of	O	O
systemic	O	O
antibody	O	O
responses	O	O
to	O	O
periodontal	O	O
bacteria	O	O
in	O	O
a	O	O
nationally	O	O
representative	O	O
sample	O	O
of	O	O
US	O	O
adults	O	O
.	O	O

Upon	O	O
delivery	O	O
,	O	O
the	O	O
neonate	O	O
is	O	O
exposed	O	O
for	O	O
the	O	O
first	O	O
time	O	O
to	O	O
a	O	O
wide	O	O
array	O	O
of	O	O
microbes	O	O
from	O	O
a	O	O
variety	O	O
of	O	O
sources	O	O
,	O	O
including	O	O
maternal	O	O
bacteria	O	O
.	O	O

Although	O	O
prior	O	O
studies	O	O
have	O	O
suggested	O	O
that	O	O
delivery	O	O
mode	O	O
shapes	O	O
the	O	O
microbiota	O	O
's	O	O
establishment	O	O
and	O	O
,	O	O
subsequently	O	O
,	O	O
its	O	O
role	O	O
in	O	O
child	O	O
health	O	O
,	O	O
most	O	O
researchers	O	O
have	O	O
focused	O	O
on	O	O
specific	O	O
bacterial	O	O
taxa	O	O
or	O	O
on	O	O
a	O	O
single	O	O
body	O	O
habitat	O	O
,	O	O
the	O	O
gut	O	O
.	O	O

Thus	O	O
,	O	O
the	O	O
initiation	O	O
stage	O	O
of	O	O
human	O	O
microbiome	O	O
development	O	O
remains	O	O
obscure	O	O
.	O	O

The	O	O
goal	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
obtain	O	O
a	O	O
community-wide	O	O
perspective	O	O
on	O	O
the	O	O
influence	O	O
of	O	O
delivery	O	O
mode	O	O
and	O	O
body	O	O
habitat	O	O
on	O	O
the	O	O
neonate	O	O
's	O	O
first	O	O
microbiota	O	O
.	O	O

We	O	O
used	O	O
multiplexed	O	O
16S	O	O
rRNA	O	O
gene	O	O
pyrosequencing	O	O
to	O	O
characterize	O	O
bacterial	O	O
communities	O	O
from	O	O
mothers	O	O
and	O	O
their	O	O
newborn	O	O
babies	O	O
,	O	O
four	O	O
born	O	O
vaginally	O	O
and	O	O
six	O	O
born	O	O
via	O	O
Cesarean	O	O
section	O	O
.	O	O

Mothers	O	O
'	O	O
skin	O	O
,	O	O
oral	O	O
mucosa	O	O
,	O	O
and	O	O
vagina	O	O
were	O	O
sampled	O	O
1	O	O
h	O	O
before	O	O
delivery	O	O
,	O	O
and	O	O
neonates	O	O
'	O	O
skin	O	O
,	O	O
oral	O	O
mucosa	O	O
,	O	O
and	O	O
nasopharyngeal	O	O
aspirate	O	O
were	O	O
sampled	O	O
<	O	O
5	O	O
min	O	O
,	O	O
and	O	O
meconium	O	O
<	O	O
24	O	O
h	O	O
,	O	O
after	O	O
delivery	O	O
.	O	O

We	O	O
found	O	O
that	O	O
in	O	O
direct	O	O
contrast	O	O
to	O	O
the	O	O
highly	O	O
differentiated	O	O
communities	O	O
of	O	O
their	O	O
mothers	O	O
,	O	O
neonates	O	O
harbored	O	O
bacterial	O	O
communities	O	O
that	O	O
were	O	O
undifferentiated	O	O
across	O	O
multiple	O	O
body	O	O
habitats	O	O
,	O	O
regardless	O	O
of	O	O
delivery	O	O
mode	O	O
.	O	O

Our	O	O
results	O	O
also	O	O
show	O	O
that	O	O
vaginally	O	O
delivered	O	O
infants	O	O
acquired	O	O
bacterial	O	O
communities	O	O
resembling	O	O
their	O	O
own	O	O
mother's	O	O
vaginal	O	O
microbiota	O	O
,	O	O
dominated	O	O
by	O	O
Lactobacillus	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
or	O	O
Sneathia	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
C-section	O	O
infants	O	O
harbored	O	O
bacterial	O	O
communities	O	O
similar	O	O
to	O	O
those	O	O
found	O	O
on	O	O
the	O	O
skin	O	O
surface	O	O
,	O	O
dominated	O	O
by	O	O
Staphylococcus	B-bacteria	B-bacteria
,	O	O
Corynebacterium	B-bacteria	B-bacteria
,	O	O
and	O	O
Propionibacterium	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

These	O	O
findings	O	O
establish	O	O
an	O	O
important	O	O
baseline	O	O
for	O	O
studies	O	O
tracking	O	O
the	O	O
human	O	O
microbiome	O	O
's	O	O
successional	O	O
development	O	O
in	O	O
different	O	O
body	O	O
habitats	O	O
following	O	O
different	O	O
delivery	O	O
modes	O	O
,	O	O
and	O	O
their	O	O
associated	O	O
effects	O	O
on	O	O
infant	O	O
health	O	O
.	O	O

In	O	O
the	O	O
human	O	O
mouth	O	O
,	O	O
fungi	O	O
and	O	O
several	O	O
hundred	O	O
species	O	O
of	O	O
bacteria	O	O
coexist	O	O
.	O	O

Here	O	O
we	O	O
report	O	O
a	O	O
case	O	O
of	O	O
interkingdom	O	O
signaling	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
:	O	O
A	O	O
compound	O	O
excreted	O	O
by	O	O
the	O	O
caries	O	O
bacterium	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
inhibits	O	O
the	O	O
morphological	O	O
transition	O	O
from	O	O
yeast	O	O
to	O	O
hyphae	O	O
,	O	O
an	O	O
important	O	O
virulence	O	O
trait	O	O
,	O	O
in	O	O
the	O	O
opportunistic	O	O
fungus	O	O
Candida	O	O
albicans	O	O
.	O	O

The	O	O
compound	O	O
excreted	O	O
by	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
originally	O	O
studied	O	O
because	O	O
it	O	O
inhibited	O	O
signaling	O	O
by	O	O
the	O	O
universal	O	O
bacterial	O	O
signal	O	O
autoinducer-2	O	O
(	O	O
AI-2	O	O
)	O	O
,	O	O
determined	O	O
by	O	O
the	O	O
luminescence	O	O
of	O	O
a	O	O
Vibrio	B-bacteria	B-bacteria
harveyi	E-bacteria	I-bacteria
sensor	O	O
strain	O	O
.	O	O

The	O	O
inhibitor	O	O
was	O	O
purified	O	O
from	O	O
cell-free	O	O
culture	O	O
supernatants	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
guided	O	O
by	O	O
its	O	O
activity	O	O
.	O	O

Its	O	O
chemical	O	O
structure	O	O
was	O	O
elucidated	O	O
by	O	O
using	O	O
NMR	O	O
spectroscopy	O	O
and	O	O
GC-MS	O	O
and	O	O
proved	O	O
to	O	O
be	O	O
trans-2-decenoic	O	O
acid	O	O
.	O	O

We	O	O
show	O	O
that	O	O
trans-2-decenoic	O	O
acid	O	O
does	O	O
not	O	O
inhibit	O	O
AI-2-specific	O	O
signaling	O	O
,	O	O
but	O	O
rather	O	O
the	O	O
luciferase	O	O
reaction	O	O
used	O	O
for	O	O
its	O	O
detection	O	O
.	O	O

A	O	O
potential	O	O
biological	O	O
role	O	O
of	O	O
trans-2-decenoic	O	O
acid	O	O
was	O	O
then	O	O
discovered	O	O
.	O	O

It	O	O
is	O	O
able	O	O
to	O	O
suppress	O	O
the	O	O
transition	O	O
from	O	O
yeast	O	O
to	O	O
hyphal	O	O
morphology	O	O
in	O	O
the	O	O
opportunistic	O	O
human	O	O
pathogen	O	O
Candida	O	O
albicans	O	O
at	O	O
concentrations	O	O
that	O	O
do	O	O
not	O	O
affect	O	O
growth	O	O
.	O	O

The	O	O
expression	O	O
of	O	O
HWP1	O	O
,	O	O
a	O	O
hyphal-specific	O	O
signature	O	O
gene	O	O
of	O	O
C.	O	O
albicans	O	O
,	O	O
is	O	O
abolished	O	O
by	O	O
trans-2-decenoic	O	O
acid	O	O
.	O	O

trans-2-Decenoic	O	O
acid	O	O
is	O	O
structurally	O	O
similar	O	O
to	O	O
the	O	O
diffusible	O	O
signal	O	O
factor	O	O
(	O	O
DSF	O	O
)	O	O
family	O	O
of	O	O
interkingdom-signaling	O	O
molecules	O	O
and	O	O
is	O	O
the	O	O
first	O	O
member	O	O
of	O	O
this	O	O
family	O	O
from	O	O
a	O	O
Gram-positive	B-bacteria	B-bacteria
organism	E-bacteria	I-bacteria
(	O	O
Streptococcus	B-bacteria	B-bacteria
DSF	E-bacteria	I-bacteria
,	O	O
SDSF	B-bacteria	B-bacteria
)	O	O
.	O	O

SDSF	B-bacteria	B-bacteria
activity	O	O
was	O	O
also	O	O
found	O	O
in	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
in	O	O
other	O	O
oral	O	O
bacteria	O	O
.	O	O

SDSF	B-bacteria	B-bacteria
could	O	O
be	O	O
relevant	O	O
in	O	O
shaping	O	O
multispecies	O	O
Candida	O	O
bacteria	O	O
biofilms	O	O
in	O	O
the	O	O
human	O	O
body	O	O
.	O	O

Several	O	O
methods	O	O
for	O	O
determining	O	O
the	O	O
diversity	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
were	O	O
evaluated	O	O
with	O	O
the	O	O
purpose	O	O
of	O	O
developing	O	O
a	O	O
realistic	O	O
approach	O	O
for	O	O
further	O	O
studies	O	O
.	O	O

The	O	O
patient	O	O
population	O	O
was	O	O
comprised	O	O
of	O	O
young	O	O
children	O	O
with	O	O
an	O	O
oral	O	O
disease	O	O
called	O	O
severe	O	O
early	O	O
childhood	O	O
caries	O	O
.	O	O

The	O	O
ultimate	O	O
goal	O	O
of	O	O
these	O	O
studies	O	O
was	O	O
to	O	O
ascertain	O	O
the	O	O
role	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
the	O	O
caries	O	O
process	O	O
.	O	O

To	O	O
accomplish	O	O
that	O	O
goal	O	O
,	O	O
we	O	O
evaluated	O	O
several	O	O
methods	O	O
and	O	O
approaches	O	O
for	O	O
determining	O	O
diversity	O	O
including	O	O
AP-PCR	O	O
,	O	O
chromosomal	O	O
DNA	O	O
fingerprinting	O	O
,	O	O
denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
,	O	O
and	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
.	O	O

Central	O	O
to	O	O
these	O	O
methods	O	O
was	O	O
the	O	O
gathering	O	O
and	O	O
screening	O	O
of	O	O
isolates	O	O
from	O	O
cultivation	O	O
medium	O	O
.	O	O

Using	O	O
various	O	O
estimates	O	O
of	O	O
diversity	O	O
,	O	O
we	O	O
addressed	O	O
the	O	O
question	O	O
as	O	O
to	O	O
how	O	O
many	O	O
isolates	O	O
represent	O	O
the	O	O
overall	O	O
diversity	O	O
and	O	O
how	O	O
cultivation	O	O
compares	O	O
to	O	O
non-cultivation	O	O
techniques	O	O
.	O	O

Finally	O	O
,	O	O
we	O	O
proposed	O	O
a	O	O
working	O	O
approach	O	O
for	O	O
achieving	O	O
the	O	O
goals	O	O
outlined	O	O
framed	O	O
by	O	O
both	O	O
practical	O	O
constraints	O	O
in	O	O
terms	O	O
of	O	O
time	O	O
,	O	O
effort	O	O
and	O	O
efficacy	O	O
while	O	O
yielding	O	O
a	O	O
reliable	O	O
outcome	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
is	O	O
a	O	O
facultative	O	O
member	O	O
of	O	O
the	O	O
oral	O	O
plaque	O	O
and	O	O
is	O	O
associated	O	O
with	O	O
dental	O	O
caries	O	O
.	O	O

It	O	O
is	O	O
able	O	O
to	O	O
survive	O	O
long	O	O
periods	O	O
of	O	O
sugar	O	O
starvation	O	O
.	O	O

We	O	O
show	O	O
here	O	O
that	O	O
inactivation	O	O
of	O	O
pdhD	O	O
,	O	O
putatively	O	O
encoding	O	O
a	O	O
subunit	O	O
of	O	O
the	O	O
pyruvate	O	O
dehydrogenase	O	O
complex	O	O
,	O	O
impairs	O	O
survival	O	O
of	O	O
both	O	O
batch	O	O
cultures	O	O
and	O	O
biofilms	O	O
.	O	O

We	O	O
show	O	O
that	O	O
pdhD	O	O
and	O	O
the	O	O
downstream	O	O
genes	O	O
pdhA	O	O
,	O	O
pdhB	O	O
,	O	O
and	O	O
pdhC	O	O
form	O	O
an	O	O
operon	O	O
that	O	O
is	O	O
predominantly	O	O
transcribed	O	O
in	O	O
stationary	O	O
phase	O	O
.	O	O

Analysis	O	O
with	O	O
fluorescent	O	O
reporters	O	O
revealed	O	O
a	O	O
bimodal	O	O
expression	O	O
pattern	O	O
for	O	O
the	O	O
pdh	O	O
promoter	O	O
,	O	O
with	O	O
less	O	O
than	O	O
1	O	O
%	O	O
of	O	O
stationary-phase	O	O
populations	O	O
expressing	O	O
pdh	O	O
.	O	O

When	O	O
it	O	O
was	O	O
first	O	O
detected	O	O
,	O	O
after	O	O
1	O	O
day	O	O
of	O	O
sugar	O	O
starvation	O	O
in	O	O
batch	O	O
culture	O	O
,	O	O
expression	O	O
was	O	O
mostly	O	O
in	O	O
individual	O	O
bacteria	O	O
.	O	O

At	O	O
later	O	O
times	O	O
,	O	O
expressing	O	O
bacteria	O	O
were	O	O
often	O	O
in	O	O
chains	O	O
.	O	O

The	O	O
lengths	O	O
of	O	O
the	O	O
chains	O	O
increased	O	O
with	O	O
time	O	O
.	O	O

We	O	O
infer	O	O
that	O	O
the	O	O
pdh-expressing	O	O
subpopulation	O	O
is	O	O
able	O	O
grow	O	O
and	O	O
divide	O	O
and	O	O
to	O	O
persist	O	O
for	O	O
extended	O	O
times	O	O
in	O	O
stationary	O	O
phase	O	O
.	O	O

Laser	O	O
light	O	O
can	O	O
be	O	O
used	O	O
during	O	O
endodontic	O	O
procedures	O	O
to	O	O
sterilize	O	O
the	O	O
root	O	O
canal	O	O
by	O	O
destroying	O	O
bacteria	O	O
.	O	O

Previous	O	O
in-vitro	O	O
studies	O	O
that	O	O
investigated	O	O
the	O	O
mechanism	O	O
of	O	O
the	O	O
destruction	O	O
of	O	O
bacteria	O	O
inhabiting	O	O
the	O	O
root	O	O
canal	O	O
by	O	O
1,064-nm	O	O
Nd	O	O
:	O	O
YAG	O	O
and	O	O
808-nm	O	O
diode	O	O
laser	O	O
light	O	O
used	O	O
substrates	O	O
that	O	O
absorb	O	O
light	O	O
in	O	O
the	O	O
near-infrared	O	O
(	O	O
NIR	O	O
)	O	O
spectrum	O	O
.	O	O

These	O	O
substrates	O	O
heat	O	O
the	O	O
bacterial	O	O
microenvironment	O	O
,	O	O
which	O	O
possibly	O	O
contributes	O	O
to	O	O
cell	O	O
death	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
direct	O	O
effect	O	O
of	O	O
laser	O	O
light	O	O
on	O	O
the	O	O
bacterial	O	O
sample	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
detrimental	O	O
heating	O	O
,	O	O
a	O	O
sapphire	O	O
substrate	O	O
,	O	O
which	O	O
is	O	O
virtually	O	O
transparent	O	O
in	O	O
NIR	O	O
spectrum	O	O
,	O	O
was	O	O
inoculated	O	O
with	O	O
bacterial	O	O
samples	O	O
and	O	O
subjected	O	O
to	O	O
laser	O	O
irradiation	O	O
at	O	O
1,064	O	O
nm	O	O
(	O	O
1.5	O	O
W	O	O
,	O	O
15	O	O
Hz	O	O
)	O	O
and	O	O
at	O	O
808	O	O
nm	O	O
(	O	O
1.5	O	O
W	O	O
,	O	O
20	O	O
Hz	O	O
)	O	O
.	O	O

Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
used	O	O
.	O	O

E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
were	O	O
largely	O	O
unaffected	O	O
by	O	O
laser	O	O
light	O	O
.	O	O

The	O	O
viability	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
a	O	O
pigmented	O	O
bacterium	O	O
,	O	O
was	O	O
directly	O	O
affected	O	O
by	O	O
both	O	O
NIR	O	O
wavelengths	O	O
(	O	O
a	O	O
57	O	O
%	O	O
decrease	O	O
of	O	O
viability	O	O
at	O	O
1,064	O	O
nm	O	O
and	O	O
a	O	O
31	O	O
%	O	O
decrease	O	O
at	O	O
808	O	O
nm	O	O
)	O	O
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
primary	O	O
mediator	O	O
of	O	O
cell	O	O
death	O	O
appears	O	O
to	O	O
be	O	O
the	O	O
interaction	O	O
between	O	O
NIR	O	O
laser	O	O
light	O	O
and	O	O
the	O	O
bacterial	O	O
microenvironment	O	O
,	O	O
most	O	O
likely	O	O
in	O	O
the	O	O
form	O	O
of	O	O
heating	O	O
.	O	O

Our	O	O
research	O	O
suggests	O	O
that	O	O
when	O	O
optimizing	O	O
the	O	O
efficacy	O	O
of	O	O
laser-assisted	O	O
endodontic	O	O
sterilization	O	O
of	O	O
the	O	O
root	O	O
canal	O	O
,	O	O
the	O	O
optical	O	O
characteristics	O	O
of	O	O
the	O	O
bacterial	O	O
microenvironment	O	O
play	O	O
a	O	O
key	O	O
role	O	O
,	O	O
as	O	O
nonpigmented	O	O
bacteria	O	O
appear	O	O
to	O	O
be	O	O
virtually	O	O
transparent	O	O
at	O	O
808	O	O
nm	O	O
and	O	O
1,064	O	O
nm	O	O
.	O	O

Histoplasmosis	O	O
is	O	O
a	O	O
deep	O	O
mycosis	O	O
caused	O	O
by	O	O
Histoplasma	O	O
capsulatum	O	O
,	O	O
which	O	O
is	O	O
endemic	O	O
in	O	O
many	O	O
areas	O	O
of	O	O
the	O	O
world	O	O
but	O	O
is	O	O
relatively	O	O
rare	O	O
in	O	O
China	O	O
.	O	O

Although	O	O
the	O	O
majority	O	O
of	O	O
cases	O	O
present	O	O
as	O	O
a	O	O
mild	O	O
to	O	O
moderate	O	O
flu-like	O	O
disease	O	O
requiring	O	O
only	O	O
supportive	O	O
therapy	O	O
,	O	O
approximately	O	O
1	O	O
%	O	O
of	O	O
patients	O	O
experience	O	O
more	O	O
serious	O	O
pulmonary	O	O
and	O	O
extrapulmonary	O	O
disease	O	O
,	O	O
which	O	O
can	O	O
be	O	O
life-threatening	O	O
if	O	O
diagnosis	O	O
is	O	O
delayed	O	O
or	O	O
the	O	O
treatment	O	O
is	O	O
not	O	O
initiated	O	O
rapidly	O	O
.	O	O

Definitive	O	O
diagnosis	O	O
is	O	O
usually	O	O
made	O	O
by	O	O
a	O	O
combination	O	O
of	O	O
culture	O	O
,	O	O
detection	O	O
of	O	O
the	O	O
organism	O	O
in	O	O
tissues	O	O
,	O	O
measurement	O	O
of	O	O
antibodies	O	O
,	O	O
and	O	O
detection	O	O
of	O	O
antigen	O	O
.	O	O

We	O	O
present	O	O
the	O	O
case	O	O
of	O	O
a	O	O
51-year-old	O	O
patient	O	O
who	O	O
presented	O	O
with	O	O
histoplasmosis	O	O
only	O	O
,	O	O
with	O	O
several	O	O
ulcerated	O	O
lesions	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
without	O	O
HIV	O	O
infection	O	O
,	O	O
who	O	O
did	O	O
not	O	O
show	O	O
any	O	O
detectable	O	O
signs	O	O
and	O	O
symptoms	O	O
of	O	O
systemic	O	O
disease	O	O
or	O	O
extra-oral	O	O
manifestations	O	O
.	O	O

Histopathological	O	O
analysis	O	O
indicated	O	O
a	O	O
chronic	O	O
inflammatory	O	O
process	O	O
with	O	O
granulomas	O	O
with	O	O
yeast-like	O	O
organisms	O	O
.	O	O

Isolation	O	O
of	O	O
H.	O	O
capsulatum	O	O
and	O	O
molecular	O	O
identification	O	O
provided	O	O
the	O	O
definitive	O	O
diagnosis	O	O
.	O	O

Treatment	O	O
with	O	O
oral	O	O
itraconazole	O	O
led	O	O
to	O	O
remission	O	O
of	O	O
the	O	O
oral	O	O
lesions	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
Chinese	O	O
case	O	O
report	O	O
of	O	O
localized	O	O
histoplasmosis	O	O
with	O	O
lesions	O	O
restricted	O	O
to	O	O
the	O	O
mouth	O	O
in	O	O
an	O	O
HIV-negative	O	O
patient	O	O
.	O	O

Oral	O	O
microbiota	O	O
plays	O	O
a	O	O
vital	O	O
role	O	O
in	O	O
maintaining	O	O
the	O	O
homeostasis	O	O
of	O	O
oral	O	O
cavity	O	O
.	O	O

Dental	O	O
caries	O	O
are	O	O
among	O	O
the	O	O
most	O	O
common	O	O
oral	O	O
diseases	O	O
in	O	O
children	O	O
and	O	O
pathogenic	O	O
bacteria	O	O
contribute	O	O
to	O	O
the	O	O
development	O	O
of	O	O
the	O	O
disease	O	O
.	O	O

However	O	O
,	O	O
the	O	O
overall	O	O
structure	O	O
of	O	O
bacterial	O	O
communities	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
from	O	O
children	O	O
with	O	O
dental	O	O
caries	O	O
has	O	O
not	O	O
been	O	O
explored	O	O
deeply	O	O
heretofore	O	O
.	O	O

We	O	O
used	O	O
high-throughput	O	O
barcoded	O	O
pyrosequencing	O	O
and	O	O
PCR-denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
(	O	O
DGGE	O	O
)	O	O
to	O	O
examine	O	O
bacterial	O	O
diversity	O	O
of	O	O
oral	O	O
microbiota	O	O
in	O	O
saliva	O	O
and	O	O
supragingival	O	O
plaques	O	O
from	O	O
60	O	O
children	O	O
aged	O	O
3	O	O
to	O	O
6	O	O
years	O	O
old	O	O
with	O	O
and	O	O
without	O	O
dental	O	O
caries	O	O
from	O	O
China	O	O
.	O	O

The	O	O
multiplex	O	O
barcoded	O	O
pyrosequencing	O	O
was	O	O
performed	O	O
in	O	O
a	O	O
single	O	O
run	O	O
,	O	O
with	O	O
multiple	O	O
samples	O	O
tagged	O	O
uniquely	O	O
by	O	O
multiplex	O	O
identifiers	O	O
.	O	O

As	O	O
PCR-DGGE	O	O
analysis	O	O
is	O	O
a	O	O
conventional	O	O
molecular	O	O
ecological	O	O
approach	O	O
,	O	O
this	O	O
analysis	O	O
was	O	O
also	O	O
performed	O	O
on	O	O
the	O	O
same	O	O
samples	O	O
and	O	O
the	O	O
results	O	O
of	O	O
both	O	O
approaches	O	O
were	O	O
compared	O	O
.	O	O

A	O	O
total	O	O
of	O	O
186,787	O	O
high-quality	O	O
sequences	O	O
were	O	O
obtained	O	O
for	O	O
evaluating	O	O
bacterial	O	O
diversity	O	O
and	O	O
41,905	O	O
unique	O	O
sequences	O	O
represented	O	O
all	O	O
phylotypes	O	O
.	O	O

We	O	O
found	O	O
that	O	O
the	O	O
oral	O	O
microbiota	O	O
in	O	O
children	O	O
was	O	O
far	O	O
more	O	O
diverse	O	O
than	O	O
previous	O	O
studies	O	O
reported	O	O
,	O	O
and	O	O
more	O	O
than	O	O
200	O	O
genera	O	O
belonging	O	O
to	O	O
ten	O	O
phyla	O	O
were	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
phylotypes	O	O
in	O	O
saliva	O	O
and	O	O
supragingival	O	O
plaques	O	O
were	O	O
significantly	O	O
different	O	O
and	O	O
could	O	O
be	O	O
divided	O	O
into	O	O
two	O	O
distinct	O	O
clusters	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
bacterial	O	O
diversity	O	O
in	O	O
oral	O	O
microbiome	O	O
analyzed	O	O
by	O	O
PCR-DGGE	O	O
and	O	O
barcoded	O	O
pyrosequencing	O	O
was	O	O
employed	O	O
to	O	O
cross	O	O
validate	O	O
the	O	O
data	O	O
sets	O	O
.	O	O

The	O	O
genera	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
,	O	O
Leptotrichia	B-bacteria	B-bacteria
,	O	O
and	O	O
Thiomonas	B-bacteria	B-bacteria
in	O	O
plaques	O	O
were	O	O
significantly	O	O
associated	O	O
with	O	O
dental	O	O
caries	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
there	O	O
was	O	O
no	O	O
one	O	O
specific	O	O
pathogen	O	O
but	O	O
rather	O	O
pathogenic	O	O
populations	O	O
in	O	O
plaque	O	O
that	O	O
significantly	O	O
correlated	O	O
with	O	O
dental	O	O
caries	O	O
.	O	O

The	O	O
enormous	O	O
diversity	O	O
of	O	O
oral	O	O
microbiota	O	O
allowed	O	O
for	O	O
a	O	O
better	O	O
understanding	O	O
of	O	O
oral	O	O
microecosystem	O	O
,	O	O
and	O	O
these	O	O
pathogenic	O	O
populations	O	O
in	O	O
plaque	O	O
provide	O	O
new	O	O
insights	O	O
into	O	O
the	O	O
etiology	O	O
of	O	O
dental	O	O
caries	O	O
and	O	O
suggest	O	O
new	O	O
targets	O	O
for	O	O
interventions	O	O
of	O	O
the	O	O
disease	O	O
.	O	O

This	O	O
study	O	O
was	O	O
designed	O	O
to	O	O
explore	O	O
the	O	O
biological	O	O
characteristics	O	O
of	O	O
a	O	O
new	O	O
oral	O	O
streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
Streptococcus	B-bacteria	B-bacteria
oligofermentans	E-bacteria	I-bacteria
.	O	O

Plaque	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
caries-free	O	O
and	O	O
caries-active	O	O
subjects	O	O
.	O	O

S.	B-bacteria	B-bacteria
oligofermentans	E-bacteria	I-bacteria
was	O	O
selectively	O	O
grown	O	O
on	O	O
Mitis	O	O
salivarius	O	O
agar	O	O
plates	O	O
and	O	O
identified	O	O
by	O	O
using	O	O
2-step	O	O
PCR	O	O
and	O	O
was	O	O
isolated	O	O
from	O	O
38	O	O
%	O	O
of	O	O
18	O	O
subjects	O	O
.	O	O

Isolates	O	O
were	O	O
found	O	O
mostly	O	O
on	O	O
healthy	O	O
tooth	O	O
surfaces	O	O
.	O	O

S.	B-bacteria	B-bacteria
oligofermentans	E-bacteria	I-bacteria
had	O	O
weaker	O	O
abilities	O	O
in	O	O
acid	O	O
production	O	O
and	O	O
demineralizing	O	O
hydroxyapatite	O	O
.	O	O

When	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
coincubated	O	O
with	O	O
S.	B-bacteria	B-bacteria
oligofermentans	E-bacteria	I-bacteria
,	O	O
total	O	O
number	O	O
,	O	O
acid	O	O
production	O	O
and	O	O
calcium	O	O
release	O	O
were	O	O
significantly	O	O
inhibited	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
inhibition	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
could	O	O
be	O	O
a	O	O
beneficial	O	O
biological	O	O
characteristic	O	O
of	O	O
S.	B-bacteria	B-bacteria
oligofermentans	E-bacteria	I-bacteria
in	O	O
oral	O	O
microecology	O	O
.	O	O

Epithelial	O	O
cells	O	O
and	O	O
dendritic	O	O
cells	O	O
(	O	O
DCs	O	O
)	O	O
both	O	O
initiate	O	O
and	O	O
contribute	O	O
to	O	O
innate	O	O
immune	O	O
responses	O	O
to	O	O
bacteria	O	O
.	O	O

However	O	O
,	O	O
much	O	O
less	O	O
is	O	O
known	O	O
about	O	O
the	O	O
coordinated	O	O
regulation	O	O
of	O	O
innate	O	O
immune	O	O
responses	O	O
between	O	O
GECs	O	O
and	O	O
immune	O	O
cells	O	O
,	O	O
particularly	O	O
DCs	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
conducted	O	O
to	O	O
investigate	O	O
whether	O	O
their	O	O
responses	O	O
are	O	O
coordinated	O	O
and	O	O
are	O	O
bacteria-specific	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
beta-defensin	O	O
antimicrobial	O	O
peptides	O	O
hBD1	O	O
,	O	O
hBD2	O	O
and	O	O
hBD3	O	O
were	O	O
expressed	O	O
by	O	O
immature	O	O
DCs	O	O
as	O	O
well	O	O
as	O	O
gingival	O	O
epithelial	O	O
cells	O	O
(	O	O
GECs	O	O
)	O	O
.	O	O

HBD1	O	O
,	O	O
hBD2	O	O
and	O	O
hBD3	O	O
are	O	O
upregulated	O	O
in	O	O
DCs	O	O
while	O	O
hBD2	O	O
and	O	O
hBD3	O	O
are	O	O
upregulated	O	O
in	O	O
GECs	O	O
in	O	O
response	O	O
to	O	O
bacterial	O	O
stimulation	O	O
.	O	O

Responses	O	O
of	O	O
both	O	O
cell	O	O
types	O	O
were	O	O
bacteria-specific	O	O
,	O	O
as	O	O
demonstrated	O	O
by	O	O
distinctive	O	O
profiles	O	O
of	O	O
hBDs	O	O
mRNA	O	O
expression	O	O
and	O	O
secreted	O	O
cytokines	O	O
and	O	O
chemokines	O	O
in	O	O
response	O	O
to	O	O
cell	O	O
wall	O	O
preparations	O	O
of	O	O
various	O	O
bacteria	O	O
of	O	O
different	O	O
pathogenicity	O	O
:	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
regulation	O	O
of	O	O
expression	O	O
of	O	O
hBD2	O	O
,	O	O
IL-8	O	O
,	O	O
CXCL2/GRObeta	O	O
and	O	O
CCL-20/MIP3alpha	O	O
by	O	O
GECs	O	O
was	O	O
greatly	O	O
enhanced	O	O
by	O	O
conditioned	O	O
medium	O	O
from	O	O
bacterially	O	O
activated	O	O
DCs	O	O
.	O	O

This	O	O
enhancement	O	O
was	O	O
primarily	O	O
mediated	O	O
via	O	O
IL-1beta	O	O
,	O	O
since	O	O
induction	O	O
was	O	O
largely	O	O
attenuated	O	O
by	O	O
IL-1	O	O
receptor	O	O
antagonist	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
defensins	O	O
influence	O	O
DCs	O	O
by	O	O
eliciting	O	O
differential	O	O
cytokine	O	O
and	O	O
chemokine	O	O
secretion	O	O
.	O	O

HBD2	O	O
significantly	O	O
induced	O	O
IL-6	O	O
,	O	O
while	O	O
hBD3	O	O
induced	O	O
MCP-1	O	O
to	O	O
approximately	O	O
the	O	O
same	O	O
extent	O	O
as	O	O
LPS	O	O
,	O	O
suggesting	O	O
a	O	O
unique	O	O
role	O	O
in	O	O
immune	O	O
responses	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
cytokines	O	O
,	O	O
chemokines	O	O
and	O	O
beta-defensins	O	O
are	O	O
involved	O	O
in	O	O
interaction	O	O
of	O	O
these	O	O
two	O	O
cell	O	O
types	O	O
,	O	O
and	O	O
the	O	O
responses	O	O
are	O	O
bacteria-specific	O	O
.	O	O

Differential	O	O
and	O	O
coordinated	O	O
regulation	O	O
between	O	O
GECs	O	O
and	O	O
DCs	O	O
may	O	O
be	O	O
important	O	O
in	O	O
regulation	O	O
of	O	O
innate	O	O
immune	O	O
homeostasis	O	O
and	O	O
response	O	O
to	O	O
pathogens	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
human	O	O
mouth	O	O
is	O	O
host	O	O
to	O	O
a	O	O
diverse	O	O
collection	O	O
of	O	O
microorganisms	O	O
including	O	O
bacteria	O	O
,	O	O
viruses	O	O
,	O	O
fungi	O	O
and	O	O
protozoa	O	O
.	O	O

Recent	O	O
advances	O	O
using	O	O
molecular	O	O
methods	O	O
for	O	O
the	O	O
analysis	O	O
of	O	O
complex	O	O
bacterial	O	O
communities	O	O
have	O	O
demonstrated	O	O
the	O	O
richness	O	O
of	O	O
the	O	O
oral	O	O
bacterial	O	O
biota	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
numerous	O	O
previously	O	O
undescribed	O	O
lineages	O	O
.	O	O

Dental	O	O
plaque	O	O
forms	O	O
in	O	O
a	O	O
structured	O	O
way	O	O
with	O	O
pioneer	O	O
species	O	O
able	O	O
to	O	O
colonise	O	O
pellicle-coated	O	O
enamel	O	O
followed	O	O
by	O	O
secondary	O	O
plaque	O	O
formers	O	O
such	O	O
as	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
that	O	O
have	O	O
the	O	O
capability	O	O
of	O	O
coaggregating	O	O
with	O	O
a	O	O
range	O	O
of	O	O
other	O	O
genera	O	O
and	O	O
species	O	O
.	O	O

The	O	O
mature	O	O
plaque	O	O
biofilm	O	O
has	O	O
many	O	O
features	O	O
of	O	O
multicellular	O	O
organisms	O	O
with	O	O
the	O	O
constituent	O	O
organisms	O	O
cooperating	O	O
to	O	O
make	O	O
nutrients	O	O
available	O	O
and	O	O
resist	O	O
environmental	O	O
stresses	O	O
,	O	O
and	O	O
communicating	O	O
to	O	O
regulate	O	O
their	O	O
overall	O	O
numbers	O	O
.	O	O

Control	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
to	O	O
prevent	O	O
disease	O	O
has	O	O
conventionally	O	O
been	O	O
by	O	O
mechanical	O	O
means	O	O
augmented	O	O
with	O	O
toothpastes	O	O
and	O	O
mouthrinses	O	O
,	O	O
but	O	O
improved	O	O
knowledge	O	O
of	O	O
oral	O	O
microbial	O	O
ecology	O	O
is	O	O
allowing	O	O
the	O	O
development	O	O
of	O	O
pre	O	O
and	O	O
pro-biotic	O	O
approaches	O	O
.	O	O

Other	O	O
possibilities	O	O
include	O	O
interference	O	O
with	O	O
the	O	O
plaque	O	O
formation	O	O
process	O	O
and	O	O
the	O	O
perturbation	O	O
of	O	O
bacterial	O	O
communication	O	O
networks	O	O
.	O	O

We	O	O
aimed	O	O
to	O	O
determine	O	O
oral	O	O
microflora	O	O
of	O	O
patients	O	O
on	O	O
long-term	O	O
hemodialysis	O	O
and	O	O
kidney	O	O
transplant	O	O
recipients	O	O
,	O	O
and	O	O
to	O	O
compare	O	O
them	O	O
with	O	O
individuals	O	O
without	O	O
kidney	O	O
disease	O	O
.	O	O

We	O	O
studied	O	O
on	O	O
3	O	O
groups	O	O
including	O	O
patients	O	O
on	O	O
at	O	O
least	O	O
6	O	O
months	O	O
of	O	O
hemodialysis	O	O
,	O	O
kidney	O	O
transplant	O	O
recipients	O	O
for	O	O
more	O	O
than	O	O
2	O	O
years	O	O
,	O	O
and	O	O
controls	O	O
with	O	O
a	O	O
normal	O	O
kidney	O	O
function	O	O
.	O	O

Staining	O	O
and	O	O
culture	O	O
were	O	O
applied	O	O
for	O	O
samples	O	O
from	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
and	O	O
the	O	O
oral	O	O
floor	O	O
in	O	O
order	O	O
to	O	O
detect	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
Candida	O	O
.	O	O

The	O	O
participants	O	O
were	O	O
49	O	O
patients	O	O
on	O	O
hemodialysis	O	O
,	O	O
50	O	O
kidney	O	O
transplant	O	O
recipients	O	O
,	O	O
and	O	O
50	O	O
volunteers	O	O
in	O	O
the	O	O
control	O	O
group	O	O
.	O	O

The	O	O
abundance	O	O
of	O	O
Candida	O	O
was	O	O
significantly	O	O
higher	O	O
in	O	O
the	O	O
hemodialysis	O	O
and	O	O
transplant	O	O
groups	O	O
compared	O	O
with	O	O
the	O	O
control	O	O
group	O	O
.	O	O

The	O	O
mean	O	O
of	O	O
various	O	O
microorganisms	O	O
was	O	O
found	O	O
to	O	O
be	O	O
significantly	O	O
higher	O	O
in	O	O
the	O	O
hemodialysis	O	O
group	O	O
than	O	O
the	O	O
control	O	O
group	O	O
(	O	O
P	O	O
=	O	O
.03	O	O
)	O	O
;	O	O
however	O	O
,	O	O
the	O	O
frequency	O	O
of	O	O
these	O	O
microorganisms	O	O
in	O	O
the	O	O
transplant	O	O
group	O	O
was	O	O
lower	O	O
than	O	O
that	O	O
in	O	O
the	O	O
hemodialysis	O	O
group	O	O
.	O	O

Adjusting	O	O
for	O	O
confounding	O	O
factors	O	O
,	O	O
the	O	O
odds	O	O
of	O	O
having	O	O
Candida	O	O
in	O	O
the	O	O
hemodialysis	O	O
and	O	O
transplant	O	O
groups	O	O
were	O	O
3.54	O	O
(	O	O
95	O	O
%	O	O
CI	O	O
,	O	O
1.21	O	O
to	O	O
10.41	O	O
)	O	O
and	O	O
3.49	O	O
(	O	O
95	O	O
%	O	O
CI	O	O
,	O	O
1.27	O	O
to	O	O
9.18	O	O
)	O	O
times	O	O
higher	O	O
compared	O	O
to	O	O
the	O	O
control	O	O
group	O	O
,	O	O
respectively	O	O
.	O	O

Hemodialysis	O	O
and	O	O
kidney	O	O
transplantation	O	O
could	O	O
affect	O	O
oral	O	O
microflora	O	O
.	O	O

Candida	O	O
was	O	O
significantly	O	O
more	O	O
frequent	O	O
in	O	O
these	O	O
patients	O	O
compared	O	O
to	O	O
healthy	O	O
adults	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Lactobacilli	B-bacteria	B-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
,	O	O
and	O	O
Candida	O	O
is	O	O
seen	O	O
slightly	O	O
less	O	O
frequently	O	O
after	O	O
kidney	O	O
transplantation	O	O
,	O	O
which	O	O
might	O	O
be	O	O
in	O	O
favor	O	O
of	O	O
promising	O	O
effects	O	O
of	O	O
kidney	O	O
transplantation	O	O
on	O	O
oral	O	O
microflora	O	O
.	O	O

Within	O	O
the	O	O
same	O	O
human	O	O
gastrointestinal	O	O
tract	O	O
,	O	O
substantial	O	O
differences	O	O
in	O	O
the	O	O
bacterial	O	O
species	O	O
that	O	O
inhabit	O	O
oral	O	O
cavity	O	O
and	O	O
intestinal	O	O
tract	O	O
have	O	O
been	O	O
noted	O	O
.	O	O

Previous	O	O
research	O	O
primarily	O	O
attributed	O	O
the	O	O
differences	O	O
to	O	O
the	O	O
influences	O	O
of	O	O
host	O	O
environments	O	O
and	O	O
nutritional	O	O
availabilities	O	O
(	O	O
``	O	O
host	O	O
habitat	O	O
''	O	O
effect	O	O
)	O	O
.	O	O

Our	O	O
recent	O	O
study	O	O
indicated	O	O
that	O	O
,	O	O
other	O	O
than	O	O
the	O	O
host	O	O
habitat	O	O
effect	O	O
,	O	O
an	O	O
existing	O	O
microbial	O	O
community	O	O
could	O	O
impose	O	O
a	O	O
selective	O	O
pressure	O	O
on	O	O
incoming	O	O
foreign	O	O
bacterial	O	O
species	O	O
independent	O	O
of	O	O
host-mediated	O	O
selection	O	O
(	O	O
``	O	O
community	O	O
selection	O	O
''	O	O
effect	O	O
)	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
employed	O	O
in	O	O
vitro	O	O
microbial	O	O
floras	O	O
representing	O	O
microorganisms	O	O
that	O	O
inhabit	O	O
the	O	O
oral	O	O
cavities	O	O
and	O	O
intestinal	O	O
tract	O	O
of	O	O
mice	O	O
in	O	O
combination	O	O
with	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
as	O	O
a	O	O
model	O	O
intestinal	B-bacteria	B-bacteria
bacterium	E-bacteria	I-bacteria
and	O	O
demonstrated	O	O
that	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
displays	O	O
a	O	O
striking	O	O
community	O	O
preference	O	O
.	O	O

It	O	O
thrived	O	O
when	O	O
introduced	O	O
into	O	O
the	O	O
intestinal	O	O
microbial	O	O
community	O	O
and	O	O
survived	O	O
poorly	O	O
in	O	O
the	O	O
microbial	O	O
flora	O	O
of	O	O
foreign	O	O
origin	O	O
(	O	O
oral	O	O
community	O	O
)	O	O
.	O	O

A	O	O
more	O	O
detailed	O	O
examination	O	O
of	O	O
this	O	O
phenomenon	O	O
showed	O	O
that	O	O
the	O	O
oral	O	O
community	O	O
produced	O	O
oxygen-free	O	O
radicals	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
wild-type	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
while	O	O
mutants	O	O
deficient	O	O
in	O	O
lipopolysaccharides	O	O
(	O	O
LPS	O	O
)	O	O
did	O	O
not	O	O
trigger	O	O
significant	O	O
production	O	O
of	O	O
these	O	O
cell-damaging	O	O
agents	O	O
.	O	O

Furthermore	O	O
,	O	O
mutants	O	O
of	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
defective	O	O
in	O	O
the	O	O
oxidative	O	O
stress	O	O
response	O	O
experienced	O	O
a	O	O
more	O	O
drastic	O	O
reduction	O	O
in	O	O
viability	O	O
when	O	O
cocultivated	O	O
with	O	O
the	O	O
oral	O	O
flora	O	O
,	O	O
while	O	O
the	O	O
exogenous	O	O
addition	O	O
of	O	O
the	O	O
antioxidant	O	O
vitamin	O	O
C	O	O
was	O	O
able	O	O
to	O	O
rescue	O	O
it	O	O
.	O	O

We	O	O
concluded	O	O
that	O	O
the	O	O
oral-derived	O	O
microbial	O	O
community	O	O
senses	O	O
the	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
LPS	O	O
and	O	O
kills	O	O
the	O	O
bacterium	O	O
with	O	O
oxygen-free	O	O
radicals	O	O
.	O	O

This	O	O
study	O	O
reveals	O	O
a	O	O
new	O	O
mechanism	O	O
of	O	O
community	O	O
invasion	O	O
resistance	O	O
employed	O	O
by	O	O
established	O	O
microflora	O	O
to	O	O
defend	O	O
their	O	O
domains	O	O
.	O	O

Dental	O	O
plaque	O	O
is	O	O
the	O	O
biofilm	O	O
found	O	O
naturally	O	O
on	O	O
teeth	O	O
.	O	O

Dental	O	O
plaque	O	O
is	O	O
also	O	O
implicated	O	O
in	O	O
dental	O	O
caries	O	O
,	O	O
which	O	O
is	O	O
associated	O	O
with	O	O
shifts	O	O
in	O	O
the	O	O
microbial	O	O
balance	O	O
of	O	O
the	O	O
biofilm	O	O
resulting	O	O
in	O	O
increased	O	O
proportions	O	O
of	O	O
acid	O	O
producing	O	O
and	O	O
acid	O	O
tolerating	O	O
bacteria	O	O
,	O	O
especially	O	O
(	O	O
but	O	O
not	O	O
exclusively	O	O
)	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
.	O	O

The	O	O
regular	O	O
intake	O	O
of	O	O
fermentable	O	O
dietary	O	O
sugars	O	O
,	O	O
or	O	O
impaired	O	O
saliva	O	O
flow	O	O
,	O	O
produces	O	O
persistent	O	O
conditions	O	O
of	O	O
low	O	O
pH	O	O
within	O	O
the	O	O
biofilm	O	O
,	O	O
which	O	O
selects	O	O
for	O	O
these	O	O
cariogenic	O	O
bacteria	O	O
.	O	O

Clinicians	O	O
should	O	O
prevent	O	O
this	O	O
disruption	O	O
to	O	O
the	O	O
natural	O	O
microbial	O	O
balance	O	O
of	O	O
the	O	O
biofilm	O	O
(	O	O
relevant	O	O
approaches	O	O
are	O	O
described	O	O
)	O	O
rather	O	O
than	O	O
merely	O	O
treating	O	O
its	O	O
consequences	O	O
by	O	O
restoring	O	O
cavities	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
antibacterial	O	O
effect	O	O
of	O	O
a	O	O
resin	O	O
composite	O	O
matrix	O	O
with	O	O
or	O	O
without	O	O
incorporated	O	O
triclosan	O	O
(	O	O
0.3	O	O
wt	O	O
%	O	O
)	O	O
on	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
.	O	O

In	O	O
the	O	O
quantitative	O	O
assay	O	O
,	O	O
bacterial	O	O
suspensions	O	O
were	O	O
filled	O	O
into	O	O
20-mul	O	O
cavities	O	O
within	O	O
temporary	O	O
restorative	O	O
resins	O	O
.	O	O

After	O	O
0	O	O
,	O	O
4	O	O
,	O	O
8	O	O
,	O	O
12	O	O
,	O	O
24	O	O
and	O	O
48	O	O
h	O	O
of	O	O
incubation	O	O
,	O	O
the	O	O
suspensions	O	O
were	O	O
removed	O	O
from	O	O
the	O	O
restoratives	O	O
and	O	O
the	O	O
numbers	O	O
of	O	O
viable	O	O
bacteria	O	O
were	O	O
determined	O	O
.	O	O

Bacterial	O	O
suspensions	O	O
incubated	O	O
without	O	O
restoratives	O	O
served	O	O
as	O	O
the	O	O
controls	O	O
.	O	O

Ten	O	O
replicates	O	O
were	O	O
carried	O	O
out	O	O
for	O	O
each	O	O
experiment	O	O
.	O	O

The	O	O
resin	O	O
composite	O	O
containing	O	O
triclosan	O	O
demonstrated	O	O
variable	O	O
degrees	O	O
of	O	O
antibacterial	O	O
activity	O	O
against	O	O
the	O	O
microorganisms	O	O
,	O	O
revealing	O	O
a	O	O
significant	O	O
inhibitory	O	O
effect	O	O
on	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
within	O	O
12	O	O
h	O	O
compared	O	O
to	O	O
the	O	O
control	O	O
.	O	O

The	O	O
viable	O	O
counts	O	O
of	O	O
A.	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
significantly	O	O
decreased	O	O
after	O	O
24	O	O
h.	O	O
A	O	O
significant	O	O
reduction	O	O
of	O	O
L.	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
was	O	O
observed	O	O
after	O	O
48	O	O
h.	O	O
The	O	O
unloaded	O	O
resin	O	O
composite	O	O
did	O	O
not	O	O
reveal	O	O
a	O	O
marked	O	O
antibacterial	O	O
effect	O	O
.	O	O

The	O	O
resin	O	O
composite	O	O
loaded	O	O
with	O	O
triclosan	O	O
might	O	O
be	O	O
beneficial	O	O
in	O	O
preventing	O	O
cavity	O	O
contamination	O	O
and	O	O
minimizing	O	O
the	O	O
risk	O	O
of	O	O
pulpal	O	O
irritation	O	O
in	O	O
the	O	O
short-term	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
can	O	O
act	O	O
as	O	O
a	O	O
reservoir	O	O
of	O	O
certain	O	O
pathogens	O	O
that	O	O
can	O	O
cause	O	O
systemic	O	O
infections	O	O
.	O	O

The	O	O
periodontal	O	O
pocket	O	O
is	O	O
an	O	O
ecological	O	O
niche	O	O
appropriate	O	O
for	O	O
hosting	O	O
microorganisms	O	O
that	O	O
could	O	O
act	O	O
as	O	O
opportunistic	O	O
pathogens	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
and	O	O
Candida	O	O
spp	O	O
to	O	O
form	O	O
a	O	O
biofilm	O	O
and	O	O
live	O	O
within	O	O
certain	O	O
niches	O	O
allows	O	O
them	O	O
to	O	O
develop	O	O
mechanisms	O	O
that	O	O
increase	O	O
persistence	O	O
,	O	O
such	O	O
as	O	O
the	O	O
evasion	O	O
of	O	O
host	O	O
defenses	O	O
and	O	O
antibiotic	O	O
efficacy	O	O
.	O	O

These	O	O
microorganisms	O	O
can	O	O
easily	O	O
be	O	O
or	O	O
become	O	O
resistant	O	O
to	O	O
antibiotics	O	O
and	O	O
lead	O	O
to	O	O
superinfection	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
were	O	O
to	O	O
assess	O	O
the	O	O
presence	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
in	O	O
biofilm	O	O
in	O	O
subgingival	O	O
plaque	O	O
and	O	O
oral	O	O
cavity	O	O
of	O	O
individuals	O	O
with	O	O
gingival-periodontal	O	O
disease	O	O
,	O	O
to	O	O
identify	O	O
isolates	O	O
and	O	O
the	O	O
relationship	O	O
with	O	O
Candida	O	O
spp	O	O
.	O	O

The	O	O
study	O	O
included	O	O
eighty-two	O	O
patients	O	O
,	O	O
aged	O	O
18-70	O	O
years	O	O
with	O	O
periodontal	O	O
disease	O	O
and	O	O
at	O	O
least	O	O
two	O	O
sites	O	O
with	O	O
probing	O	O
depth	O	O
>	O	O
or	O	O
=	O	O
3	O	O
mm	O	O
.	O	O

Participants	O	O
'	O	O
data	O	O
were	O	O
evaluated	O	O
individually	O	O
.	O	O

Subgingival	O	O
biofilm	O	O
samples	O	O
were	O	O
obtained	O	O
using	O	O
Gracey	O	O
curettes	O	O
7/8	O	O
,	O	O
after	O	O
supragingival	O	O
biofilm	O	O
removal	O	O
,	O	O
and	O	O
a	O	O
sample	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
(	O	O
buccal	O	O
mucosa	O	O
,	O	O
tongue	O	O
and	O	O
cheek	O	O
mucosa	O	O
)	O	O
by	O	O
sterile	O	O
swab	O	O
.	O	O

Of	O	O
all	O	O
the	O	O
patients	O	O
studied	O	O
,	O	O
42.7	O	O
%	O	O
exhibited	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
in	O	O
the	O	O
periodontal	O	O
pocket	O	O
and	O	O
69.5	O	O
%	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
while	O	O
25.6	O	O
%	O	O
exhibited	O	O
Candida	O	O
spp	O	O
in	O	O
the	O	O
periodontal	O	O
pocket	O	O
and	O	O
42.7	O	O
%	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

However	O	O
,	O	O
13.4	O	O
%	O	O
had	O	O
both	O	O
microorganisms	O	O
in	O	O
the	O	O
periodontal	O	O
pocket	O	O
and	O	O
36.6	O	O
%	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
13.4	O	O
%	O	O
in	O	O
the	O	O
periodontal	O	O
pocket	O	O
and	O	O
15.8	O	O
%	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Candida	O	O
albicans	O	O
was	O	O
the	O	O
most	O	O
prevalent	O	O
yeast	O	O
in	O	O
the	O	O
periodontal	O	O
pocket	O	O
(	O	O
76.2	O	O
%	O	O
)	O	O
and	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
(	O	O
63.0	O	O
%	O	O
)	O	O
.	O	O

The	O	O
human	O	O
oral	O	O
cavity	O	O
contains	O	O
a	O	O
number	O	O
of	O	O
different	O	O
habitats	O	O
,	O	O
including	O	O
the	O	O
teeth	O	O
,	O	O
gingival	O	O
sulcus	O	O
,	O	O
tongue	O	O
,	O	O
cheeks	O	O
,	O	O
hard	O	O
and	O	O
soft	O	O
palates	O	O
,	O	O
and	O	O
tonsils	O	O
,	O	O
which	O	O
are	O	O
colonized	O	O
by	O	O
bacteria	O	O
.	O	O

The	O	O
oral	O	O
microbiome	O	O
is	O	O
comprised	O	O
of	O	O
over	O	O
600	O	O
prevalent	O	O
taxa	O	O
at	O	O
the	O	O
species	O	O
level	O	O
,	O	O
with	O	O
distinct	O	O
subsets	O	O
predominating	O	O
at	O	O
different	O	O
habitats	O	O
.	O	O

The	O	O
oral	O	O
microbiome	O	O
has	O	O
been	O	O
extensively	O	O
characterized	O	O
by	O	O
cultivation	O	O
and	O	O
culture-independent	O	O
molecular	O	O
methods	O	O
such	O	O
as	O	O
16S	O	O
rRNA	O	O
cloning	O	O
.	O	O

Unfortunately	O	O
,	O	O
the	O	O
vast	O	O
majority	O	O
of	O	O
unnamed	O	O
oral	O	O
taxa	O	O
are	O	O
referenced	O	O
by	O	O
clone	O	O
numbers	O	O
or	O	O
16S	O	O
rRNA	O	O
GenBank	O	O
accession	O	O
numbers	O	O
,	O	O
often	O	O
without	O	O
taxonomic	O	O
anchors	O	O
.	O	O

The	O	O
first	O	O
aim	O	O
of	O	O
this	O	O
research	O	O
was	O	O
to	O	O
collect	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
into	O	O
a	O	O
curated	O	O
phylogeny-based	O	O
database	O	O
,	O	O
the	O	O
Human	O	O
Oral	O	O
Microbiome	O	O
Database	O	O
(	O	O
HOMD	O	O
)	O	O
,	O	O
and	O	O
make	O	O
it	O	O
web	O	O
accessible	O	O
(	O	O
www.homd.org	O	O
)	O	O
.	O	O

The	O	O
HOMD	O	O
includes	O	O
619	O	O
taxa	O	O
in	O	O
13	O	O
phyla	O	O
,	O	O
as	O	O
follows	O	O
:	O	O
Actinobacteria	B-bacteria	B-bacteria
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
,	O	O
Chlamydiae	B-bacteria	B-bacteria
,	O	O
Chloroflexi	B-bacteria	B-bacteria
,	O	O
Euryarchaeota	B-bacteria	B-bacteria
,	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
Fusobacteria	B-bacteria	B-bacteria
,	O	O
Proteobacteria	B-bacteria	B-bacteria
,	O	O
Spirochaetes	B-bacteria	B-bacteria
,	O	O
SR1	B-bacteria	B-bacteria
,	O	O
Synergistetes	B-bacteria	B-bacteria
,	O	O
Tenericutes	B-bacteria	B-bacteria
,	O	O
and	O	O
TM7	B-bacteria	B-bacteria
.	O	O

The	O	O
second	O	O
aim	O	O
was	O	O
to	O	O
analyze	O	O
36,043	O	O
16S	O	O
rRNA	O	O
gene	O	O
clones	O	O
isolated	O	O
from	O	O
studies	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
to	O	O
determine	O	O
the	O	O
relative	O	O
abundance	O	O
of	O	O
taxa	O	O
and	O	O
identify	O	O
novel	O	O
candidate	O	O
taxa	O	O
.	O	O

The	O	O
analysis	O	O
identified	O	O
1,179	O	O
taxa	O	O
,	O	O
of	O	O
which	O	O
24	O	O
%	O	O
were	O	O
named	O	O
,	O	O
8	O	O
%	O	O
were	O	O
cultivated	O	O
but	O	O
unnamed	O	O
,	O	O
and	O	O
68	O	O
%	O	O
were	O	O
uncultivated	O	O
phylotypes	O	O
.	O	O

Upon	O	O
validation	O	O
,	O	O
434	O	O
novel	O	O
,	O	O
nonsingleton	O	O
taxa	O	O
will	O	O
be	O	O
added	O	O
to	O	O
the	O	O
HOMD	O	O
.	O	O

The	O	O
number	O	O
of	O	O
taxa	O	O
needed	O	O
to	O	O
account	O	O
for	O	O
90	O	O
%	O	O
,	O	O
95	O	O
%	O	O
,	O	O
or	O	O
99	O	O
%	O	O
of	O	O
the	O	O
clones	O	O
examined	O	O
is	O	O
259	O	O
,	O	O
413	O	O
,	O	O
and	O	O
875	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
HOMD	O	O
is	O	O
the	O	O
first	O	O
curated	O	O
description	O	O
of	O	O
a	O	O
human-associated	O	O
microbiome	O	O
and	O	O
provides	O	O
tools	O	O
for	O	O
use	O	O
in	O	O
understanding	O	O
the	O	O
role	O	O
of	O	O
the	O	O
microbiome	O	O
in	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

To	O	O
characterize	O	O
the	O	O
normal	O	O
bacterial	O	O
flora	O	O
and	O	O
evaluate	O	O
the	O	O
presence	O	O
of	O	O
periodontopathogenic	O	O
bacteria	O	O
around	O	O
dental	O	O
implants	O	O
and	O	O
to	O	O
correlate	O	O
them	O	O
with	O	O
the	O	O
periodontal	O	O
flora	O	O
or	O	O
,	O	O
in	O	O
completely	O	O
edentulous	O	O
patients	O	O
,	O	O
the	O	O
alveolar	O	O
gingival	O	O
flora	O	O
.	O	O

Clinical	O	O
and	O	O
radiographic	O	O
parameters	O	O
were	O	O
recorded	O	O
to	O	O
exclude	O	O
peri-implantitis	O	O
in	O	O
34	O	O
partially	O	O
edentulous	O	O
and	O	O
19	O	O
completely	O	O
edentulous	O	O
patients	O	O
.	O	O

Partially	O	O
edentulous	O	O
patients	O	O
were	O	O
subdivided	O	O
into	O	O
two	O	O
subgroups	O	O
based	O	O
on	O	O
the	O	O
depth	O	O
of	O	O
the	O	O
periodontal	O	O
pocket	O	O
:	O	O
<	O	O
/=	O	O
4	O	O
mm	O	O
(	O	O
n	O	O
=	O	O
19	O	O
)	O	O
and	O	O
>	O	O
4	O	O
mm	O	O
(	O	O
n	O	O
=	O	O
15	O	O
)	O	O
.	O	O

Microbial	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
peri-implant	O	O
sulci	O	O
,	O	O
the	O	O
deepest	O	O
periodontal	O	O
sulci	O	O
,	O	O
and	O	O
,	O	O
for	O	O
completely	O	O
edentulous	O	O
patients	O	O
,	O	O
from	O	O
the	O	O
alveolar	O	O
gingiva	O	O
.	O	O

Predominant	O	O
aerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
determined	O	O
by	O	O
microbiologic	O	O
culturing	O	O
,	O	O
and	O	O
multiplex	O	O
polymerase	O	O
chain	O	O
reaction	O	O
was	O	O
used	O	O
to	O	O
detect	O	O
five	O	O
periodontopathogenic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
:	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

In	O	O
all	O	O
the	O	O
examined	O	O
patients	O	O
,	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
the	O	O
most	O	O
frequent	O	O
aerobic	O	O
peri-implant	O	O
bacteria	O	O
.	O	O

The	O	O
frequency	O	O
of	O	O
four	O	O
periodontopathogenic	O	O
bacteria	O	O
in	O	O
tooth	O	O
sulci	O	O
(	O	O
A	B-bacteria	B-bacteria
actino	E-bacteria	I-bacteria
?	O	O
mycetemcomitans	O	O
,	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
T	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
T	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
was	O	O
significantly	O	O
higher	O	O
around	O	O
natural	O	O
teeth	O	O
with	O	O
deeper	O	O
periodontal	O	O
pockets	O	O
,	O	O
but	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
in	O	O
the	O	O
frequency	O	O
of	O	O
the	O	O
same	O	O
bacteria	O	O
in	O	O
peri-implant	O	O
sulci	O	O
in	O	O
the	O	O
two	O	O
partially	O	O
edentulous	O	O
subgroups	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
there	O	O
were	O	O
no	O	O
such	O	O
bacteria	O	O
in	O	O
the	O	O
peri-implant	O	O
sulci	O	O
or	O	O
the	O	O
alveolar	O	O
gingiva	O	O
of	O	O
completely	O	O
edentulous	O	O
patients	O	O
.	O	O

In	O	O
healthy	O	O
peri-implant	O	O
sulci	O	O
,	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
constitute	O	O
the	O	O
predominant	O	O
bacterial	O	O
flora	O	O
.	O	O

In	O	O
partially	O	O
edentulous	O	O
patients	O	O
four	O	O
periodontopathogenic	O	O
bacteria	O	O
were	O	O
detected	O	O
around	O	O
implants	O	O
,	O	O
and	O	O
none	O	O
of	O	O
these	O	O
bacteria	O	O
were	O	O
found	O	O
around	O	O
implants	O	O
in	O	O
completely	O	O
edentulous	O	O
patients	O	O
.	O	O

The	O	O
antibacterial	O	O
properties	O	O
of	O	O
self-etching	O	O
adhesive	O	O
systems	O	O
constitute	O	O
an	O	O
important	O	O
issue	O	O
in	O	O
operative	O	O
dentistry	O	O
,	O	O
since	O	O
viable	O	O
bacteria	O	O
can	O	O
still	O	O
be	O	O
present	O	O
after	O	O
cavity	O	O
preparation	O	O
.	O	O

The	O	O
current	O	O
study	O	O
evaluated	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
five	O	O
one-step	O	O
self-etching	O	O
adhesives	O	O
(	O	O
SEAs	O	O
)	O	O
and	O	O
four	O	O
self-etching	O	O
primers	O	O
(	O	O
SEPs	O	O
)	O	O
against	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Clearfil	O	O
S3	O	O
(	O	O
S3	O	O
)	O	O
,	O	O
One-Up	O	O
Bond	O	O
F	O	O
Plus	O	O
(	O	O
OU	O	O
)	O	O
,	O	O
Futurabond	O	O
NR	O	O
(	O	O
FB	O	O
)	O	O
,	O	O
GBond	O	O
(	O	O
GB	O	O
)	O	O
,	O	O
Xeno	O	O
IV	O	O
(	O	O
X4	O	O
)	O	O
,	O	O
Clearfil	O	O
SE	O	O
Bond	O	O
(	O	O
SE	O	O
)	O	O
,	O	O
Clearfil	O	O
Protect	O	O
Bond	O	O
(	O	O
PB	O	O
)	O	O
,	O	O
Adper	O	O
SE	O	O
Plus	O	O
(	O	O
AS	O	O
)	O	O
and	O	O
AdheSE	O	O
(	O	O
AD	O	O
)	O	O
were	O	O
tested	O	O
for	O	O
antibacterial	O	O
activity	O	O
against	O	O
five	O	O
streptococci	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
:	O	O
S	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
S	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
S	B-bacteria	B-bacteria
cricetus	E-bacteria	I-bacteria
,	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
.	O	O

Chlorhexidine	O	O
(	O	O
0.12	O	O
%	O	O
)	O	O
and	O	O
phosphoric	O	O
acid	O	O
(	O	O
37	O	O
%	O	O
)	O	O
gel	O	O
were	O	O
used	O	O
as	O	O
control	O	O
.	O	O

The	O	O
agar	O	O
diffusion	O	O
test	O	O
method	O	O
was	O	O
used	O	O
.	O	O

Plates	O	O
containing	O	O
BHI	O	O
agar	O	O
and	O	O
300	O	O
uL	O	O
of	O	O
bacterial	O	O
cell	O	O
suspension	O	O
(	O	O
0.5	O	O
MacFarland	O	O
)	O	O
were	O	O
prepared	O	O
.	O	O

Holes	O	O
6	O	O
mm	O	O
in	O	O
diameter	O	O
were	O	O
made	O	O
and	O	O
partially	O	O
filled	O	O
with	O	O
bacteriological	O	O
agar	O	O
.	O	O

Then	O	O
,	O	O
10	O	O
uL	O	O
of	O	O
each	O	O
SEA	O	O
or	O	O
SEP	O	O
was	O	O
dropped	O	O
and	O	O
the	O	O
plates	O	O
were	O	O
incubated	O	O
under	O	O
microaerophilic	O	O
atmosphere	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
48	O	O
hours	O	O
and	O	O
the	O	O
diameter	O	O
of	O	O
each	O	O
halo	O	O
was	O	O
registered	O	O
.	O	O

The	O	O
results	O	O
were	O	O
analyzed	O	O
by	O	O
two-way	O	O
ANOVA	O	O
and	O	O
Tukey	O	O
test	O	O
.	O	O

PB	O	O
exhibited	O	O
the	O	O
most	O	O
effective	O	O
antibacterial	O	O
activity	O	O
against	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

The	O	O
performances	O	O
of	O	O
SE	O	O
and	O	O
FB	O	O
were	O	O
similar	O	O
or	O	O
better	O	O
than	O	O
chlorhexidine	O	O
for	O	O
all	O	O
bacteria	O	O
.	O	O

S3	O	O
,	O	O
X4	O	O
,	O	O
AS	O	O
,	O	O
AD	O	O
,	O	O
OU	O	O
and	O	O
GB	O	O
showed	O	O
significantly	O	O
lower	O	O
inhibition	O	O
values	O	O
.	O	O

Among	O	O
the	O	O
species	O	O
tested	O	O
,	O	O
S	O	O
oralis	O	O
was	O	O
the	O	O
most	O	O
sensitive	O	O
to	O	O
all	O	O
self-etching	O	O
adhesive	O	O
systems	O	O
;	O	O
on	O	O
the	O	O
other	O	O
hand	O	O
,	O	O
S	B-bacteria	B-bacteria
cricetus	E-bacteria	I-bacteria
,	O	O
S	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
were	O	O
more	O	O
resistant	O	O
.	O	O

Among	O	O
the	O	O
self-etching	O	O
adhesive	O	O
systems	O	O
evaluated	O	O
,	O	O
Clearfil	O	O
Protect	O	O
Bond	O	O
exhibited	O	O
the	O	O
most	O	O
effective	O	O
antibacterial	O	O
activity	O	O
against	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Colonization	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
is	O	O
associated	O	O
with	O	O
increased	O	O
risk	O	O
of	O	O
systemic	O	O
diseases	O	O
.	O	O

However	O	O
,	O	O
few	O	O
studies	O	O
have	O	O
investigated	O	O
the	O	O
relationships	O	O
between	O	O
oral	O	O
status	O	O
factors	O	O
and	O	O
health-related	O	O
quality	O	O
of	O	O
life	O	O
(	O	O
HR-QOL	O	O
)	O	O
and	O	O
the	O	O
prevalence	O	O
of	O	O
such	O	O
bacteria	O	O
in	O	O
elderly	O	O
individuals	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
prevalence	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
in	O	O
165	O	O
community-dwelling	O	O
functionally	O	O
independent	O	O
85-year-old	O	O
Japanese	O	O
individuals	O	O
(	O	O
93	O	O
dentate	O	O
,	O	O
72	O	O
edentulous	O	O
)	O	O
and	O	O
the	O	O
relationship	O	O
to	O	O
oral	O	O
status	O	O
,	O	O
including	O	O
oral	O	O
malodour	O	O
and	O	O
HR-QOL	O	O
.	O	O

All	O	O
four	O	O
of	O	O
the	O	O
studied	O	O
periodontopathic	O	O
bacteria	O	O
were	O	O
found	O	O
more	O	O
frequently	O	O
in	O	O
tongue	O	O
coating	O	O
samples	O	O
from	O	O
dentate	O	O
than	O	O
edentulous	O	O
subjects	O	O
,	O	O
and	O	O
the	O	O
prevalence	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
was	O	O
significantly	O	O
related	O	O
to	O	O
the	O	O
number	O	O
of	O	O
teeth	O	O
with	O	O
a	O	O
periodontal	O	O
pocket	O	O
depth	O	O
>	O	O
/=4	O	O
mm	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
the	O	O
existence	O	O
of	O	O
a	O	O
stable	O	O
circulation	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
between	O	O
the	O	O
gingival	O	O
sulcus	O	O
and	O	O
tongue	O	O
coating	O	O
over	O	O
time	O	O
with	O	O
teeth	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
presence	O	O
of	O	O
teeth	O	O
with	O	O
a	O	O
deep	O	O
pocket	O	O
and	O	O
colonization	O	O
of	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
were	O	O
positively	O	O
related	O	O
to	O	O
the	O	O
level	O	O
of	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
SH	O	O
,	O	O
whilst	O	O
the	O	O
number	O	O
of	O	O
present	O	O
teeth	O	O
contributed	O	O
positively	O	O
to	O	O
HR-QOL	O	O
,	O	O
especially	O	O
with	O	O
regard	O	O
to	O	O
mental	O	O
health	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
as	O	O
the	O	O
dentate	O	O
state	O	O
can	O	O
retain	O	O
colonization	O	O
of	O	O
periodontopathic	O	O
pathogens	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
both	O	O
periodontal	O	O
treatment	O	O
and	O	O
tongue	O	O
care	O	O
are	O	O
important	O	O
for	O	O
maintaining	O	O
a	O	O
healthy	O	O
oral	O	O
status	O	O
in	O	O
the	O	O
elderly	O	O
,	O	O
and	O	O
possibly	O	O
result	O	O
in	O	O
avoidance	O	O
of	O	O
risk	O	O
for	O	O
tooth	O	O
loss	O	O
and	O	O
decline	O	O
in	O	O
HR-QOL	O	O
,	O	O
as	O	O
well	O	O
as	O	O
protecting	O	O
from	O	O
systemic	O	O
diseases	O	O
.	O	O

Beneficial	O	O
findings	O	O
concerning	O	O
probiotics	B-bacteria	B-bacteria
are	O	O
increasing	O	O
day	O	O
by	O	O
day	O	O
.	O	O

However	O	O
,	O	O
one	O	O
of	O	O
the	O	O
most	O	O
important	O	O
parameter	O	O
which	O	O
affects	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
activity	O	O
of	O	O
a	O	O
microorganism	O	O
is	O	O
its	O	O
survival	O	O
during	O	O
the	O	O
gastroduodenal	O	O
transit	O	O
.	O	O

Some	O	O
microencapsulation	O	O
techniques	O	O
could	O	O
be	O	O
applied	O	O
to	O	O
bacterial	O	O
cells	O	O
to	O	O
improve	O	O
this	O	O
parameter	O	O
.	O	O

A	O	O
comparison	O	O
between	O	O
the	O	O
intestinal	O	O
colonization	O	O
by	O	O
microencapsulated	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
the	O	O
same	O	O
not	O	O
microencapsulated	O	O
strains	O	O
has	O	O
been	O	O
conducted	O	O
in	O	O
a	O	O
double	O	O
blind	O	O
,	O	O
randomized	O	O
,	O	O
cross-over	O	O
study	O	O
.	O	O

The	O	O
study	O	O
(	O	O
April	O	O
to	O	O
July	O	O
2005	O	O
)	O	O
involved	O	O
44	O	O
healthy	O	O
volunteers	O	O
.	O	O

In	O	O
particular	O	O
,	O	O
participants	O	O
were	O	O
divided	O	O
into	O	O
2	O	O
groups	O	O
:	O	O
group	O	O
A	O	O
(	O	O
21	O	O
participants	O	O
)	O	O
received	O	O
a	O	O
mix	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
Lactobacillus	B-bacteria	B-bacteria
plantarum	I-bacteria	I-bacteria
LP01	E-bacteria	I-bacteria
(	O	O
LMG	B-bacteria	B-bacteria
P-21021	E-bacteria	I-bacteria
)	O	O
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
breve	I-bacteria	I-bacteria
BR03	E-bacteria	I-bacteria
(	O	O
DSM	B-bacteria	B-bacteria
16604	E-bacteria	I-bacteria
)	O	O
in	O	O
an	O	O
uncoated	O	O
form	O	O
,	O	O
group	O	O
B	O	O
(	O	O
23	O	O
participants	O	O
)	O	O
was	O	O
given	O	O
the	O	O
same	O	O
strains	O	O
microencapsulated	O	O
with	O	O
a	O	O
gastroresistant	O	O
material	O	O
.	O	O

The	O	O
not	B-bacteria	B-bacteria
microencapsulated	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
were	O	O
administered	O	O
at	O	O
5	O	O
x	O	O
10	O	O
(	O	O
9	O	O
)	O	O
colony	O	O
forming	O	O
units/strain/d	O	O
for	O	O
21	O	O
days	O	O
,	O	O
whereas	O	O
the	O	O
microencapsulated	O	O
bacteria	O	O
were	O	O
given	O	O
at	O	O
1	O	O
x	O	O
10	O	O
(	O	O
9	O	O
)	O	O
colony	O	O
forming	O	O
units/strain/d	O	O
for	O	O
21	O	O
days	O	O
.	O	O

At	O	O
the	O	O
end	O	O
of	O	O
the	O	O
first	O	O
period	O	O
of	O	O
treatment	O	O
with	O	O
probiotics	B-bacteria	B-bacteria
a	O	O
3	O	O
weeks	O	O
washout	O	O
phase	O	O
has	O	O
been	O	O
included	O	O
in	O	O
the	O	O
study	O	O
protocol	O	O
.	O	O

At	O	O
the	O	O
end	O	O
of	O	O
the	O	O
washout	O	O
period	O	O
the	O	O
groups	O	O
were	O	O
crossed	O	O
:	O	O
in	O	O
detail	O	O
,	O	O
group	O	O
A	O	O
had	O	O
the	O	O
microencapsulated	O	O
and	O	O
group	O	O
B	O	O
the	O	O
uncoated	O	O
bacteria	O	O
.	O	O

The	O	O
administered	O	O
amounts	O	O
of	O	O
each	O	O
strain	O	O
were	O	O
the	O	O
same	O	O
as	O	O
the	O	O
first	O	O
treatment	O	O
.	O	O

The	O	O
quantitative	O	O
evaluation	O	O
of	O	O
intestinal	O	O
colonization	O	O
by	O	O
strains	O	O
microencapsulated	O	O
or	O	O
not	O	O
microencapsulated	O	O
was	O	O
made	O	O
by	O	O
fecal	O	O
samples	O	O
examination	O	O
at	O	O
the	O	O
beginning	O	O
of	O	O
the	O	O
clinical	O	O
trial	O	O
,	O	O
after	O	O
10	O	O
and	O	O
21	O	O
days	O	O
of	O	O
each	O	O
treatment	O	O
period	O	O
.	O	O

In	O	O
particular	O	O
,	O	O
fecal	O	O
heterofermentative	B-bacteria	B-bacteria
Lactobacilli	E-bacteria	I-bacteria
and	O	O
Bifidobacteria	B-bacteria	B-bacteria
have	O	O
been	O	O
counted	O	O
.	O	O

A	O	O
statistically	O	O
significant	O	O
increase	O	O
in	O	O
the	O	O
fecal	O	O
amounts	O	O
of	O	O
Lactobacilli	B-bacteria	B-bacteria
and	O	O
Bifidobacteria	B-bacteria	B-bacteria
was	O	O
recorded	O	O
in	O	O
both	O	O
groups	O	O
at	O	O
the	O	O
end	O	O
of	O	O
each	O	O
treatment	O	O
compared	O	O
with	O	O
d0	O	O
or	O	O
d42	O	O
(	O	O
P	O	O
<	O	O
0.0001	O	O
and	O	O
P	O	O
<	O	O
0.0001	O	O
at	O	O
d21	O	O
,	O	O
P	O	O
<	O	O
0.0001	O	O
and	O	O
P	O	O
<	O	O
0.0001	O	O
at	O	O
d63	O	O
for	O	O
Lactobacilli	B-bacteria	B-bacteria
and	O	O
Bifidobacteria	B-bacteria	B-bacteria
,	O	O
respectively	O	O
)	O	O
,	O	O
confirming	O	O
the	O	O
ability	O	O
of	O	O
the	O	O
2	O	O
strains	O	O
to	O	O
colonize	O	O
the	O	O
human	O	O
gut	O	O
,	O	O
either	O	O
in	O	O
a	O	O
gastroprotected	O	O
form	O	O
or	O	O
not	O	O
.	O	O

Participants	O	O
treated	O	O
with	O	O
the	O	O
microencapsulated	O	O
bacteria	O	O
reported	O	O
a	O	O
kinetics	O	O
of	O	O
intestinal	O	O
colonization	O	O
quite	O	O
similar	O	O
to	O	O
participants	O	O
who	O	O
received	O	O
not	O	O
coated	O	O
strains	O	O
.	O	O

Probiotics	B-bacteria	B-bacteria
are	O	O
able	O	O
to	O	O
exert	O	O
many	O	O
different	O	O
beneficial	O	O
effects	O	O
on	O	O
the	O	O
human	O	O
host	O	O
.	O	O

These	O	O
effects	O	O
are	O	O
mediated	O	O
by	O	O
the	O	O
number	O	O
of	O	O
viable	O	O
cells	O	O
which	O	O
reach	O	O
the	O	O
gut	O	O
.	O	O

The	O	O
microencapsulation	O	O
technique	O	O
used	O	O
in	O	O
this	O	O
study	O	O
is	O	O
a	O	O
valid	O	O
strategy	O	O
to	O	O
significantly	O	O
improve	O	O
gastroresistance	O	O
of	O	O
strains	O	O
,	O	O
thus	O	O
enhancing	O	O
their	O	O
probiotic	B-bacteria	B-bacteria
activity	O	O
and	O	O
allowing	O	O
the	O	O
use	O	O
of	O	O
a	O	O
5	O	O
times	O	O
lower	O	O
amount	O	O
.	O	O

The	O	O
oral	O	O
and	O	O
dental	O	O
complications	O	O
arising	O	O
in	O	O
cancer	O	O
patients	O	O
can	O	O
be	O	O
attributable	O	O
to	O	O
the	O	O
malignant	O	O
disease	O	O
itself	O	O
and	O	O
to	O	O
the	O	O
various	O	O
modalities	O	O
of	O	O
cancer	O	O
therapy	O	O
.	O	O

Up	O	O
to	O	O
37.2	O	O
%	O	O
of	O	O
all	O	O
patients	O	O
receiving	O	O
cancer	O	O
chemotherapy	O	O
develop	O	O
acute	O	O
oral	O	O
complications	O	O
and	O	O
up	O	O
to	O	O
31.1	O	O
%	O	O
of	O	O
all	O	O
patients	O	O
receiving	O	O
cancer	O	O
radiotherapy	O	O
develop	O	O
acute	O	O
oral	O	O
manifestations	O	O
.	O	O

Oral	O	O
complications	O	O
may	O	O
result	O	O
in	O	O
significant	O	O
morbidity	O	O
,	O	O
impaired	O	O
nutrition	O	O
,	O	O
treatment	O	O
delays	O	O
,	O	O
and	O	O
dose	O	O
reductions	O	O
which	O	O
are	O	O
affecting	O	O
the	O	O
prognosis	O	O
of	O	O
the	O	O
primary	O	O
disease	O	O
.	O	O

We	O	O
investigated	O	O
312	O	O
cases	O	O
of	O	O
blood	O	O
dyscrasia	O	O
which	O	O
296	O	O
cases	O	O
had	O	O
oral	O	O
manifestations	O	O
(	O	O
86.2	O	O
%	O	O
)	O	O
.	O	O

They	O	O
had	O	O
a	O	O
mean	O	O
age	O	O
of	O	O
40,6	O	O
years	O	O
(	O	O
range	O	O
from	O	O
7	O	O
to	O	O
86	O	O
years	O	O
)	O	O
.	O	O

The	O	O
male	O	O
to	O	O
female	O	O
ratio	O	O
was	O	O
1.0:0.75	O	O
(	O	O
178/134	O	O
)	O	O
.	O	O

Data	O	O
were	O	O
statistically	O	O
analyzed	O	O
by	O	O
t	O	O
test	O	O
,	O	O
chi-square	O	O
,	O	O
Wilcoxon	O	O
,	O	O
Kruskal-Wallis	O	O
and	O	O
two-tailed	O	O
exact	O	O
Fischer	O	O
,	O	O
using	O	O
the	O	O
SPSS	O	O
program	O	O
,	O	O
at	O	O
a	O	O
significance	O	O
level	O	O
of	O	O
5	O	O
%	O	O
.	O	O

Oral	O	O
complications	O	O
are	O	O
frequently	O	O
encountered	O	O
in	O	O
patients	O	O
receiving	O	O
anticancer	O	O
therapy	O	O
and	O	O
these	O	O
complications	O	O
may	O	O
result	O	O
in	O	O
significant	O	O
morbidity	O	O
,	O	O
treatment	O	O
delays	O	O
,	O	O
dose	O	O
reductions	O	O
,	O	O
and	O	O
nutritional	O	O
deficiencies	O	O
.	O	O

The	O	O
acute	O	O
effects	O	O
of	O	O
anticancer	O	O
chemotherapy	O	O
upon	O	O
the	O	O
oral	O	O
cavity	O	O
include	O	O
mucositis	O	O
,	O	O
infection	O	O
,	O	O
hemorrhage	O	O
,	O	O
xerostomia	O	O
and	O	O
nutritional	O	O
deficiencies	O	O
.	O	O

Patients	O	O
which	O	O
undergo	O	O
radiotherapy	O	O
,	O	O
specific	O	O
in	O	O
head	O	O
and	O	O
neck	O	O
carcinomas	O	O
,	O	O
display	O	O
a	O	O
30-60	O	O
%	O	O
incidence	O	O
of	O	O
the	O	O
oral	O	O
manifestations	O	O
.	O	O

The	O	O
antineoplastic	O	O
therapy	O	O
will	O	O
interfere	O	O
with	O	O
the	O	O
turnover	O	O
of	O	O
the	O	O
epithelial	O	O
cells	O	O
,	O	O
followed	O	O
by	O	O
mucosal	O	O
injury	O	O
,	O	O
later	O	O
by	O	O
infections	O	O
,	O	O
due	O	O
to	O	O
indirect	O	O
invasion	O	O
of	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
fungal	O	O
species	O	O
,	O	O
as	O	O
most	O	O
of	O	O
the	O	O
anti-cancer	O	O
drugs	O	O
cause	O	O
immunological	O	O
changes	O	O
.	O	O

The	O	O
mucosal	O	O
surface	O	O
that	O	O
is	O	O
the	O	O
oral	O	O
cavity	O	O
may	O	O
provide	O	O
insight	O	O
into	O	O
the	O	O
immune	O	O
function	O	O
of	O	O
the	O	O
patient	O	O
.	O	O

Differential	O	O
diagnosis	O	O
is	O	O
important	O	O
as	O	O
many	O	O
disorders	O	O
may	O	O
manifest	O	O
themselves	O	O
similarly	O	O
in	O	O
the	O	O
buccal	O	O
area	O	O
.	O	O

Aggregatibacter	B-bacteria	B-bacteria
(	O	O
formerly	I-bacteria	I-bacteria
Actinobacillus	I-bacteria	I-bacteria
)	O	O
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
to	O	O
a	O	O
lesser	O	O
extent	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
are	O	O
Gram-negative	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
that	O	O
are	O	O
associated	O	O
with	O	O
destructive	O	O
periodontitis	O	O
.	O	O

Studies	O	O
from	O	O
different	O	O
parts	O	O
of	O	O
the	O	O
world	O	O
have	O	O
shown	O	O
variable	O	O
detection	O	O
rates	O	O
of	O	O
periodontal	O	O
organisms	O	O
.	O	O

Hardly	O	O
any	O	O
data	O	O
exist	O	O
on	O	O
their	O	O
carriage	O	O
in	O	O
children	O	O
living	O	O
in	O	O
the	O	O
Middle	O	O
East	O	O
.	O	O

This	O	O
study	O	O
was	O	O
designed	O	O
to	O	O
determine	O	O
the	O	O
detection	O	O
of	O	O
these	O	O
species	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
240	O	O
generally	O	O
healthy	O	O
Kuwaiti	O	O
children	O	O
,	O	O
divided	O	O
into	O	O
five	O	O
age	O	O
groups	O	O
:	O	O
<	O	O
6	O	O
years	O	O
(	O	O
n=40	O	O
)	O	O
,	O	O
6-9	O	O
years	O	O
(	O	O
n=60	O	O
)	O	O
,	O	O
10-12	O	O
years	O	O
(	O	O
n=40	O	O
)	O	O
,	O	O
13-15	O	O
years	O	O
(	O	O
n=40	O	O
)	O	O
and	O	O
16-18	O	O
years	O	O
(	O	O
n=60	O	O
)	O	O
.	O	O

Saliva	O	O
was	O	O
used	O	O
as	O	O
the	O	O
microbiological	O	O
specimen	O	O
,	O	O
and	O	O
the	O	O
samples	O	O
were	O	O
analyzed	O	O
by	O	O
molecular	O	O
methods	O	O
using	O	O
multiplex	O	O
PCR	O	O
.	O	O

A	O	O
total	O	O
of	O	O
185	O	O
(	O	O
77.1	O	O
%	O	O
)	O	O
of	O	O
the	O	O
240	O	O
children	O	O
were	O	O
colonized	O	O
by	O	O
at	O	O
least	O	O
one	O	O
of	O	O
the	O	O
target	O	O
periodontal	O	O
bacteria	O	O
.	O	O

In	O	O
all	O	O
age	O	O
groups	O	O
,	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
prominent	O	O
and	O	O
detected	O	O
in	O	O
saliva	O	O
of	O	O
15	O	O
%	O	O
,	O	O
32	O	O
%	O	O
,	O	O
63	O	O
%	O	O
,	O	O
50	O	O
%	O	O
,	O	O
and	O	O
47	O	O
%	O	O
of	O	O
the	O	O
children	O	O
at	O	O
the	O	O
five	O	O
age	O	O
groups	O	O
,	O	O
respectively	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
detected	O	O
only	O	O
occasionally	O	O
.	O	O

Only	O	O
few	O	O
pathogens	O	O
were	O	O
found	O	O
before	O	O
the	O	O
permanent	O	O
dentition	O	O
,	O	O
i.e	O	O
.	O	O

at	O	O
the	O	O
age	O	O
of	O	O
<	O	O
6	O	O
years	O	O
.	O	O

The	O	O
highest	O	O
carriage	O	O
rates	O	O
were	O	O
from	O	O
the	O	O
groups	O	O
between	O	O
6	O	O
and	O	O
15	O	O
years	O	O
of	O	O
age	O	O
.	O	O

The	O	O
salivary	O	O
carriage	O	O
of	O	O
the	O	O
pathogens	O	O
was	O	O
essentially	O	O
similar	O	O
in	O	O
the	O	O
age	O	O
groups	O	O
of	O	O
10-12	O	O
years	O	O
and	O	O
13-15	O	O
years	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
except	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
the	O	O
examined	O	O
periodontal	O	O
pathogens	O	O
are	O	O
relatively	O	O
common	O	O
findings	O	O
in	O	O
Kuwaiti	O	O
children	O	O
and	O	O
colonize	O	O
the	O	O
oral	O	O
cavity	O	O
from	O	O
childhood	O	O
onwards	O	O
.	O	O

Colonization	O	O
and	O	O
infection	O	O
of	O	O
the	O	O
human	O	O
host	O	O
by	O	O
opportunistic	O	O
pathogen	O	O
Candida	O	O
albicans	O	O
derive	O	O
from	O	O
an	O	O
ability	O	O
of	O	O
this	O	O
fungus	O	O
to	O	O
colonize	O	O
mucosal	O	O
tissues	O	O
and	O	O
prosthetic	O	O
devices	O	O
within	O	O
the	O	O
polymicrobial	O	O
communities	O	O
present	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
functions	O	O
of	O	O
C.	O	O
albicans	O	O
cell	O	O
wall	O	O
proteins	O	O
in	O	O
interactions	O	O
with	O	O
host	O	O
or	O	O
bacterial	O	O
molecules	O	O
,	O	O
Saccharomyces	O	O
cerevisiae	O	O
was	O	O
utilized	O	O
as	O	O
a	O	O
surrogate	O	O
host	O	O
to	O	O
express	O	O
C.	O	O
albicans	O	O
cell	O	O
wall	O	O
proteins	O	O
Als3p	O	O
,	O	O
Eap1p	O	O
,	O	O
Hwp1p	O	O
,	O	O
and	O	O
Rbt1p	O	O
.	O	O

Salivary	O	O
pellicle	O	O
and	O	O
fibrinogen	O	O
were	O	O
identified	O	O
as	O	O
novel	O	O
substrata	O	O
for	O	O
Als3p	O	O
and	O	O
Hwp1p	O	O
,	O	O
while	O	O
only	O	O
Als3p	O	O
mediated	O	O
adherence	O	O
of	O	O
S.	O	O
cerevisiae	O	O
to	O	O
basement	O	O
membrane	O	O
collagen	O	O
type	O	O
IV	O	O
.	O	O

Parental	O	O
S.	O	O
cerevisiae	O	O
cells	O	O
failed	O	O
to	O	O
form	O	O
biofilms	O	O
on	O	O
Salivary	O	O
pellicle	O	O
,	O	O
polystyrene	O	O
,	O	O
or	O	O
silicone	O	O
,	O	O
but	O	O
cells	O	O
expressing	O	O
Als3p	O	O
or	O	O
Hwp1p	O	O
exhibited	O	O
significant	O	O
attachment	O	O
to	O	O
each	O	O
surface	O	O
.	O	O

Virulence	O	O
factor	O	O
Rbt1p	O	O
also	O	O
conferred	O	O
lower-level	O	O
binding	O	O
to	O	O
Salivary	O	O
pellicle	O	O
and	O	O
polystyrene	O	O
.	O	O

S.	O	O
cerevisiae	O	O
cells	O	O
expressing	O	O
Eap1p	O	O
formed	O	O
robust	O	O
biofilms	O	O
upon	O	O
polystyrene	O	O
surfaces	O	O
but	O	O
not	O	O
Salivary	O	O
pellicle	O	O
.	O	O

Proteins	O	O
Als3p	O	O
and	O	O
Eap1p	O	O
,	O	O
and	O	O
to	O	O
a	O	O
lesser	O	O
degree	O	O
Hwp1p	O	O
,	O	O
conferred	O	O
upon	O	O
S.	O	O
cerevisiae	O	O
the	O	O
ability	O	O
to	O	O
bind	O	O
cells	O	O
of	O	O
the	O	O
oral	O	O
primary	O	O
colonizing	O	O
bacterium	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

These	O	O
interactions	O	O
,	O	O
which	O	O
occurred	O	O
independently	O	O
of	O	O
amyloid	O	O
aggregate	O	O
formation	O	O
,	O	O
provide	O	O
the	O	O
first	O	O
examples	O	O
of	O	O
specific	O	O
C.	O	O
albicans	O	O
surface	O	O
proteins	O	O
serving	O	O
as	O	O
receptors	O	O
for	O	O
bacterial	O	O
adhesins	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
did	O	O
not	O	O
bind	O	O
parental	O	O
S.	O	O
cerevisiae	O	O
or	O	O
cells	O	O
expressing	O	O
Rbt1p	O	O
.	O	O

Taken	O	O
collectively	O	O
,	O	O
these	O	O
data	O	O
suggest	O	O
that	O	O
a	O	O
network	O	O
of	O	O
cell	O	O
wall	O	O
proteins	O	O
comprising	O	O
Als3p	O	O
,	O	O
Hwp1p	O	O
,	O	O
and	O	O
Eap1p	O	O
,	O	O
with	O	O
complementary	O	O
adhesive	O	O
functions	O	O
,	O	O
promotes	O	O
interactions	O	O
of	O	O
C.	O	O
albicans	O	O
with	O	O
host	O	O
and	O	O
bacterial	O	O
molecules	O	O
,	O	O
thus	O	O
leading	O	O
to	O	O
effective	O	O
colonization	O	O
within	O	O
polymicrobial	O	O
communities	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
research	O	O
were	O	O
to	O	O
determine	O	O
the	O	O
prevalence	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
and	O	O
its	O	O
vacA	O	O
genotypes	O	O
in	O	O
oral	O	O
cavity	O	O
in	O	O
persons	O	O
without	O	O
dyspepsia	O	O
and	O	O
to	O	O
establish	O	O
the	O	O
association	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
cavity	O	O
and	O	O
oral	O	O
hygiene	O	O
.	O	O

The	O	O
seroprevalence	O	O
of	O	O
anti-H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
antibodies	O	O
and	O	O
its	O	O
associated	O	O
factors	O	O
were	O	O
analyzed	O	O
too	O	O
.	O	O

For	O	O
the	O	O
study	O	O
,	O	O
200	O	O
adults	O	O
without	O	O
dyspepsia	O	O
symptoms	O	O
were	O	O
selected	O	O
.	O	O

Dental	O	O
plaque	O	O
and	O	O
saliva	O	O
samples	O	O
from	O	O
each	O	O
subject	O	O
were	O	O
obtained	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
detection	O	O
in	O	O
oral	O	O
samples	O	O
was	O	O
carried	O	O
out	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
and	O	O
for	O	O
vacA	O	O
genotyping	O	O
a	O	O
semi-nested	O	O
and	O	O
nested	O	O
PCR	O	O
was	O	O
used	O	O
.	O	O

The	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
(	O	O
ELISA	O	O
)	O	O
was	O	O
used	O	O
to	O	O
detect	O	O
anti-H.	O	O
pylori	O	O
IgG	O	O
and	O	O
IgM	O	O
.	O	O

The	O	O
data	O	O
were	O	O
analyzed	O	O
with	O	O
Chi	O	O
square	O	O
and	O	O
Fisher	O	O
exact	O	O
test	O	O
and	O	O
the	O	O
statistical	O	O
significance	O	O
was	O	O
set	O	O
to	O	O
0.05	O	O
.	O	O

Of	O	O
200	O	O
subjects	O	O
tested	O	O
,	O	O
124	O	O
(	O	O
62	O	O
%	O	O
)	O	O
were	O	O
seropositive	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
34	O	O
subjects	O	O
(	O	O
17	O	O
%	O	O
)	O	O
and	O	O
vacA	O	O
allelotypes	O	O
were	O	O
typified	O	O
in	O	O
12	O	O
of	O	O
those	O	O
samples	O	O
.	O	O

The	O	O
s1	O	O
allele	O	O
was	O	O
detected	O	O
in	O	O
8	O	O
(	O	O
66.7	O	O
%	O	O
)	O	O
samples	O	O
and	O	O
in	O	O
one	O	O
of	O	O
them	O	O
m1	O	O
y	O	O
m2	O	O
alleles	O	O
were	O	O
found	O	O
.	O	O

In	O	O
four	O	O
subjects	O	O
vacA	O	O
m1	O	O
subtypes	O	O
were	O	O
found	O	O
and	O	O
in	O	O
two	O	O
of	O	O
those	O	O
both	O	O
m1	O	O
and	O	O
m2	O	O
alleles	O	O
were	O	O
detected	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
H.	O	O
pylori	O	O
in	O	O
oral	O	O
cavity	O	O
was	O	O
higher	O	O
(	O	O
18.5	O	O
%	O	O
)	O	O
among	O	O
seropositive	O	O
subjects	O	O
compared	O	O
with	O	O
seronegative	O	O
persons	O	O
.	O	O

No	O	O
association	O	O
was	O	O
found	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
and	O	O
oral	O	O
hygiene	O	O
habits	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
cavity	O	O
is	O	O
more	O	O
frequent	O	O
in	O	O
seropositive	O	O
subjects	O	O
without	O	O
dyspepsia	O	O
symptoms	O	O
and	O	O
could	O	O
represent	O	O
the	O	O
source	O	O
of	O	O
gastric	O	O
infection	O	O
and	O	O
bacterial	O	O
transmission	O	O
.	O	O

The	O	O
data	O	O
suggest	O	O
that	O	O
more	O	O
than	O	O
one	O	O
H.	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
may	O	O
exist	O	O
in	O	O
the	O	O
mouth	O	O
of	O	O
asymptomatic	O	O
persons	O	O
.	O	O

Colonization	O	O
of	O	O
surfaces	O	O
in	O	O
the	O	O
human	O	O
body	O	O
by	O	O
microorganisms	O	O
is	O	O
an	O	O
early	O	O
,	O	O
essential	O	O
,	O	O
step	O	O
in	O	O
the	O	O
initiation	O	O
of	O	O
infectious	O	O
disease	O	O
.	O	O

We	O	O
have	O	O
developed	O	O
in	O	O
vitro	O	O
assays	O	O
to	O	O
investigate	O	O
interactions	O	O
between	O	O
yeast	O	O
or	O	O
bacterial	O	O
cells	O	O
and	O	O
human	O	O
tissues	O	O
,	O	O
fluids	O	O
,	O	O
or	O	O
prostheses	O	O
.	O	O

Such	O	O
assays	O	O
can	O	O
be	O	O
used	O	O
to	O	O
identify	O	O
the	O	O
adhesins	O	O
,	O	O
ligands	O	O
,	O	O
and	O	O
receptors	O	O
involved	O	O
in	O	O
these	O	O
interactions	O	O
,	O	O
for	O	O
example	O	O
by	O	O
determining	O	O
which	O	O
components	O	O
of	O	O
the	O	O
microbe	O	O
or	O	O
human	O	O
tissue/fluid	O	O
interfere	O	O
with	O	O
adherence	O	O
in	O	O
the	O	O
assay	O	O
.	O	O

The	O	O
assays	O	O
can	O	O
also	O	O
be	O	O
applied	O	O
to	O	O
finding	O	O
ways	O	O
of	O	O
preventing	O	O
adhesion	O	O
,	O	O
and	O	O
subsequent	O	O
disease	O	O
,	O	O
by	O	O
investigating	O	O
the	O	O
effects	O	O
of	O	O
different	O	O
conditions	O	O
and	O	O
added	O	O
compounds	O	O
on	O	O
adherence	O	O
in	O	O
the	O	O
in	O	O
vitro	O	O
assays	O	O
.	O	O

We	O	O
describe	O	O
six	O	O
assays	O	O
for	O	O
measuring	O	O
adhesion	O	O
of	O	O
the	O	O
oral	O	O
yeast	O	O
Candida	O	O
albicans	O	O
,	O	O
a	O	O
common	O	O
commensal	O	O
and	O	O
opportunistic	O	O
pathogen	O	O
,	O	O
or	O	O
the	O	O
bacterium	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
,	O	O
which	O	O
is	O	O
not	O	O
normally	O	O
pathogenic	O	O
but	O	O
is	O	O
known	O	O
to	O	O
form	O	O
biofilms	O	O
on	O	O
medical	O	O
prostheses	O	O
.	O	O

The	O	O
assays	O	O
described	O	O
represent	O	O
two	O	O
approaches	O	O
to	O	O
investigating	O	O
adhesion	O	O
;	O	O
retention	O	O
at	O	O
a	O	O
fixed	O	O
time	O	O
point	O	O
following	O	O
liquid	O	O
washes	O	O
;	O	O
and	O	O
retention	O	O
against	O	O
a	O	O
continuous	O	O
flow	O	O
of	O	O
medium	O	O
.	O	O

Most	O	O
bacteria	O	O
in	O	O
nature	O	O
exist	O	O
in	O	O
multispecies	O	O
communities	O	O
known	O	O
as	O	O
biofilms	O	O
.	O	O

In	O	O
the	O	O
natural	O	O
habitat	O	O
where	O	O
resources	O	O
(	O	O
nutrient	O	O
,	O	O
space	O	O
,	O	O
etc	O	O
.	O	O
)	O	O

are	O	O
usually	O	O
limited	O	O
,	O	O
individual	O	O
species	O	O
must	O	O
compete	O	O
or	O	O
collaborate	O	O
with	O	O
other	O	O
neighboring	O	O
species	O	O
in	O	O
order	O	O
to	O	O
perpetuate	O	O
in	O	O
the	O	O
multispecies	O	O
community	O	O
.	O	O

The	O	O
human	O	O
oral	O	O
cavity	O	O
is	O	O
colonized	O	O
by	O	O
>	O	O
700	O	O
microbial	O	O
species	O	O
known	O	O
as	O	O
the	O	O
indigenous	O	O
microflora	O	O
.	O	O

This	O	O
indigenous	O	O
flora	O	O
normally	O	O
maintains	O	O
an	O	O
ecological	O	O
balance	O	O
through	O	O
antagonistic	O	O
as	O	O
well	O	O
as	O	O
mutualistic	O	O
interspecies	O	O
interactions	O	O
.	O	O

However	O	O
,	O	O
environmental	O	O
perturbation	O	O
may	O	O
disrupt	O	O
this	O	O
balance	O	O
,	O	O
leading	O	O
to	O	O
overgrowth	O	O
of	O	O
pathogenic	O	O
species	O	O
,	O	O
which	O	O
could	O	O
in	O	O
turn	O	O
initiate	O	O
diseases	O	O
such	O	O
as	O	O
dental	O	O
caries	O	O
(	O	O
tooth	O	O
decay	O	O
)	O	O
and	O	O
periodontitis	O	O
(	O	O
gum	O	O
disease	O	O
)	O	O
.	O	O

Understanding	O	O
the	O	O
mechanisms	O	O
of	O	O
diversity	O	O
maintenance	O	O
may	O	O
help	O	O
development	O	O
of	O	O
novel	O	O
approaches	O	O
to	O	O
manage	O	O
these	O	O
``	O	O
polymicrobial	O	O
diseases	O	O
.	O	O
''	O	O

In	O	O
this	O	O
chapter	O	O
,	O	O
we	O	O
will	O	O
focus	O	O
on	O	O
a	O	O
well-characterized	O	O
form	O	O
of	O	O
biochemical	O	O
warfare	O	O
:	O	O
bacteriocins	O	O
produced	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
a	O	O
primary	O	O
dental	O	O
caries	O	O
pathogen	O	O
,	O	O
and	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
produced	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
an	O	O
oral	O	O
commensal	O	O
.	O	O

We	O	O
will	O	O
describe	O	O
detailed	O	O
methodologies	O	O
on	O	O
the	O	O
competition	O	O
assay	O	O
,	O	O
isolation	O	O
,	O	O
purification	O	O
,	O	O
and	O	O
characterization	O	O
of	O	O
bacteriocins	O	O
.	O	O

The	O	O
microbiological	O	O
effects	O	O
of	O	O
biocidal	O	O
products	O	O
used	O	O
for	O	O
the	O	O
enhancement	O	O
of	O	O
oral	O	O
hygiene	O	O
relate	O	O
to	O	O
the	O	O
active	O	O
compound	O	O
(	O	O
s	O	O
)	O	O
as	O	O
well	O	O
as	O	O
other	O	O
formulation	O	O
components	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
test	O	O
the	O	O
specificities	O	O
of	O	O
selected	O	O
actives	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
multiple	O	O
excipients	O	O
.	O	O

Salivary	O	O
ecosystems	O	O
were	O	O
maintained	O	O
in	O	O
tissue	O	O
culture	O	O
plate-based	O	O
hydroxyapatite	O	O
disc	O	O
models	O	O
(	O	O
HDMs	O	O
)	O	O
and	O	O
modified	O	O
drip-flow	O	O
biofilm	O	O
reactors	O	O
(	O	O
MDFRs	O	O
)	O	O
.	O	O

Test	O	O
compounds	O	O
stannous	O	O
fluoride	O	O
(	O	O
SF	O	O
)	O	O
,	O	O
SDS	O	O
,	O	O
triclosan	O	O
(	O	O
TCS	O	O
)	O	O
,	O	O
zinc	O	O
lactate	O	O
(	O	O
ZL	O	O
)	O	O
and	O	O
ZL	O	O
with	O	O
SF	O	O
in	O	O
combination	O	O
(	O	O
ZLSF	O	O
)	O	O
were	O	O
delivered	O	O
to	O	O
the	O	O
HDMs	O	O
once	O	O
and	O	O
four	O	O
times	O	O
daily	O	O
for	O	O
6	O	O
days	O	O
to	O	O
MDFRs	O	O
.	O	O

Plaques	O	O
were	O	O
characterized	O	O
by	O	O
differential	O	O
viable	O	O
counting	O	O
and	O	O
PCR-denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
(	O	O
DGGE	O	O
)	O	O
.	O	O

TCS	O	O
and	O	O
SDS	O	O
were	O	O
the	O	O
most	O	O
effective	O	O
compounds	O	O
against	O	O
HDM	O	O
plaques	O	O
,	O	O
significantly	O	O
reducing	O	O
total	O	O
viable	O	O
counts	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
whilst	O	O
SF	O	O
,	O	O
ZL	O	O
and	O	O
ZLSF	O	O
were	O	O
comparatively	O	O
ineffective	O	O
.	O	O

TCS	O	O
exhibited	O	O
specificity	O	O
for	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
and	O	O
Gram-negative	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
following	O	O
a	O	O
single	O	O
dosing	O	O
and	O	O
also	O	O
on	O	O
repeated	O	O
dosing	O	O
in	O	O
MDFRs	O	O
.	O	O

In	O	O
contrast	O	O
to	O	O
single	O	O
exposures	O	O
,	O	O
multiple	O	O
dosing	O	O
with	O	O
ZLSF	O	O
also	O	O
significantly	O	O
reduced	O	O
all	O	O
bacterial	O	O
groups	O	O
,	O	O
whilst	O	O
SF	O	O
and	O	O
ZL	O	O
caused	O	O
significant	O	O
but	O	O
transient	O	O
reductions	O	O
.	O	O

According	O	O
to	O	O
PCR-DGGE	O	O
analyses	O	O
,	O	O
significant	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
reductions	O	O
in	O	O
eubacterial	O	O
diversity	O	O
occurred	O	O
following	O	O
6	O	O
day	O	O
dosing	O	O
with	O	O
both	O	O
TCS	O	O
and	O	O
ZLSF	O	O
.	O	O

Concordance	O	O
of	O	O
MDFR	O	O
eubacterial	O	O
profiles	O	O
with	O	O
salivary	O	O
inocula	O	O
ranged	O	O
between	O	O
58	O	O
and	O	O
97	O	O
%	O	O
.	O	O

TCS	O	O
and	O	O
ZL	O	O
(	O	O
SF	O	O
)	O	O
exhibited	O	O
similar	O	O
specificities	O	O
to	O	O
those	O	O
reported	O	O
for	O	O
formulations	O	O
.	O	O

TCS	O	O
was	O	O
the	O	O
most	O	O
potent	O	O
antibacterial	O	O
,	O	O
after	O	O
single	O	O
and	O	O
multiple	O	O
dosage	O	O
regimens	O	O
.	O	O

Enterotoxigenic	B-bacteria	B-bacteria
Escherichia	I-bacteria	I-bacteria
coli	E-bacteria	I-bacteria
(	O	O
ETEC	B-bacteria	B-bacteria
)	O	O
is	O	O
an	O	O
important	O	O
cause	O	O
of	O	O
diarrheal	O	O
disease	O	O
and	O	O
deaths	O	O
among	O	O
children	O	O
in	O	O
developing	O	O
countries	O	O
and	O	O
the	O	O
major	O	O
cause	O	O
of	O	O
traveller	O	O
's	O	O
diarrhea	O	O
.	O	O

Since	O	O
surface	O	O
protein	O	O
colonization	O	O
factors	O	O
(	O	O
CFs	O	O
)	O	O
of	O	O
ETEC	B-bacteria	B-bacteria
are	O	O
important	O	O
for	O	O
pathogenicity	O	O
and	O	O
immune	O	O
protection	O	O
is	O	O
mainly	O	O
mediated	O	O
by	O	O
locally	O	O
produced	O	O
IgA	O	O
antibodies	O	O
in	O	O
the	O	O
gut	O	O
,	O	O
much	O	O
effort	O	O
has	O	O
focused	O	O
on	O	O
the	O	O
development	O	O
of	O	O
an	O	O
oral	O	O
CF-based	O	O
vaccine	O	O
.	O	O

We	O	O
have	O	O
recently	O	O
described	O	O
the	O	O
development	O	O
of	O	O
recombinant	O	O
strains	O	O
over-expressing	O	O
CFA/I	O	O
;	O	O
the	O	O
most	O	O
prevalent	O	O
CF	O	O
among	O	O
human	O	O
clinical	O	O
ETEC	B-bacteria	B-bacteria
isolates	O	O
.	O	O

Here	O	O
,	O	O
non-toxigenic	O	O
recombinant	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
over-expressing	O	O
Coli	O	O
surface	O	O
antigen	O	O
2	O	O
(	O	O
CS2	O	O
)	O	O
,	O	O
CS4	O	O
,	O	O
CS5	O	O
,	O	O
and	O	O
CS6	O	O
,	O	O
either	O	O
alone	O	O
,	O	O
or	O	O
each	O	O
in	O	O
combination	O	O
with	O	O
CFA/I	O	O
were	O	O
constructed	O	O
by	O	O
cloning	O	O
the	O	O
genes	O	O
required	O	O
for	O	O
expression	O	O
and	O	O
assembly	O	O
of	O	O
each	O	O
CF	O	O
into	O	O
expression	O	O
vectors	O	O
harboring	O	O
a	O	O
strong	O	O
promoter	O	O
.	O	O

Immunological	O	O
assays	O	O
showed	O	O
that	O	O
recombinant	O	O
strains	O	O
expressing	O	O
single	O	O
CFs	O	O
produced	O	O
those	O	O
in	O	O
significantly	O	O
larger	O	O
amounts	O	O
than	O	O
did	O	O
corresponding	O	O
naturally	O	O
high	O	O
producing	O	O
reference	O	O
strains	O	O
.	O	O

Recombinant	O	O
strains	O	O
co-expressing	O	O
CFA/I	O	O
together	O	O
with	O	O
another	O	O
CF	O	O
also	O	O
expressed	O	O
significantly	O	O
larger	O	O
amounts	O	O
of	O	O
both	O	O
CFs	O	O
compared	O	O
with	O	O
the	O	O
corresponding	O	O
references	O	O
strains	O	O
.	O	O

Further	O	O
,	O	O
when	O	O
tested	O	O
in	O	O
mice	O	O
,	O	O
oral	O	O
immunization	O	O
with	O	O
formalin-killed	O	O
recombinant	O	O
bacteria	O	O
co-expressing	O	O
one	O	O
such	O	O
double-expression	O	O
CF	O	O
pair	O	O
,	O	O
CFA/I+CS2	O	O
,	O	O
induced	O	O
specific	O	O
serum	O	O
IgG+IgM	O	O
and	O	O
fecal	O	O
IgA	O	O
antibody	O	O
responses	O	O
against	O	O
both	O	O
CFs	O	O
exceeding	O	O
the	O	O
responses	O	O
induced	O	O
by	O	O
immunizations	O	O
with	O	O
natural	O	O
reference	O	O
strains	O	O
expressing	O	O
CFA/I	O	O
and	O	O
CS2	O	O
,	O	O
respectively	O	O
.	O	O

We	O	O
conclude	O	O
that	O	O
the	O	O
described	O	O
type	O	O
of	O	O
recombinant	O	O
bacteria	O	O
over-expressing	O	O
major	O	O
CFs	O	O
of	O	O
ETEC	B-bacteria	B-bacteria
,	O	O
alone	O	O
or	O	O
in	O	O
combination	O	O
,	O	O
may	O	O
be	O	O
useful	O	O
as	O	O
candidate	O	O
strains	O	O
for	O	O
use	O	O
in	O	O
an	O	O
oral	O	O
whole-cell	O	O
CF-ETEC	B-bacteria	B-bacteria
vaccine	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
polymicrobial	O	O
infection	O	O
of	O	O
periodontal	O	O
disease	O	O
,	O	O
which	O	O
elicits	O	O
inflammatory	O	O
mediators/cytokines/chemokines	O	O
in	O	O
the	O	O
local	O	O
gingival	O	O
tissues	O	O
,	O	O
and	O	O
a	O	O
polybacterial	O	O
challenge	O	O
of	O	O
antigen-presenting	O	O
cells	O	O
,	O	O
e.g	O	O
.	O	O

macrophages	O	O
and	O	O
dendritic	O	O
cells	O	O
(	O	O
DCs	O	O
)	O	O
,	O	O
at	O	O
the	O	O
mucosal	O	O
surface	O	O
.	O	O

The	O	O
cytokine/chemokine	O	O
profiles	O	O
of	O	O
human	O	O
macrophages	O	O
and	O	O
DCs	O	O
in	O	O
response	O	O
to	O	O
polybacterial	O	O
challenges	O	O
were	O	O
investigated	O	O
.	O	O

Oral	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
elicited	O	O
significantly	O	O
greater	O	O
IL-8	O	O
levels	O	O
from	O	O
macrophages	O	O
,	O	O
compared	O	O
to	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
did	O	O
not	O	O
show	O	O
synergism	O	O
in	O	O
inducing	O	O
this	O	O
chemokine	O	O
from	O	O
macrophages	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
pairs	O	O
of	O	O
oral	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
elicited	O	O
synergistic	O	O
production	O	O
of	O	O
IL-8	O	O
by	O	O
macrophages	O	O
.	O	O

Similar	O	O
results	O	O
were	O	O
not	O	O
observed	O	O
with	O	O
TNFalpha	O	O
,	O	O
which	O	O
only	O	O
appeared	O	O
additive	O	O
with	O	O
the	O	O
polybacterial	O	O
challenge	O	O
.	O	O

Selected	O	O
Gram-negative	O	O
bacterial	O	O
pairs	O	O
synergized	O	O
in	O	O
IL-6	O	O
production	O	O
by	O	O
immature	O	O
DCs	O	O
.	O	O

In	O	O
mature	O	O
DCs	O	O
(	O	O
mDCs	O	O
)	O	O
,	O	O
a	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis/Fusobacterium	I-bacteria	I-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
intermedia/F	E-bacteria	I-bacteria
.	O	O

nucleatum	B-bacteria	B-bacteria
polybacterial	O	O
challenge	O	O
resulted	O	O
in	O	O
significant	O	O
synergism	O	O
for	O	O
IL-6	O	O
and	O	O
TNFalpha	O	O
levels	O	O
.	O	O

However	O	O
,	O	O
only	O	O
the	O	O
Pi/Fn	O	O
combination	O	O
synergized	O	O
for	O	O
IL-12	O	O
production	O	O
and	O	O
there	O	O
appeared	O	O
to	O	O
be	O	O
no	O	O
polybacterial	O	O
effect	O	O
on	O	O
IL-10	O	O
production	O	O
by	O	O
the	O	O
mDCs	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
a	O	O
polybacterial	O	O
challenge	O	O
of	O	O
cells	O	O
linking	O	O
innate	O	O
and	O	O
adaptive	O	O
immune	O	O
responses	O	O
results	O	O
in	O	O
varied	O	O
response	O	O
profiles	O	O
that	O	O
are	O	O
dependent	O	O
upon	O	O
the	O	O
characteristics	O	O
of	O	O
the	O	O
microorganisms	O	O
that	O	O
are	O	O
components	O	O
of	O	O
the	O	O
polybacterial	O	O
complex	O	O
.	O	O

The	O	O
nose	O	O
and	O	O
throat	O	O
are	O	O
important	O	O
sites	O	O
of	O	O
pathogen	O	O
colonization	O	O
,	O	O
yet	O	O
the	O	O
microbiota	O	O
of	O	O
both	O	O
is	O	O
relatively	O	O
unexplored	O	O
by	O	O
culture-independent	O	O
approaches	O	O
.	O	O

We	O	O
examined	O	O
the	O	O
bacterial	O	O
microbiota	O	O
of	O	O
the	O	O
nostril	O	O
and	O	O
posterior	O	O
wall	O	O
of	O	O
the	O	O
oropharynx	O	O
from	O	O
seven	O	O
healthy	O	O
adults	O	O
using	O	O
two	O	O
culture-independent	O	O
methods	O	O
,	O	O
a	O	O
16S	O	O
rRNA	O	O
gene	O	O
microarray	O	O
(	O	O
PhyloChip	O	O
)	O	O
and	O	O
16S	O	O
rRNA	O	O
gene	O	O
clone	O	O
libraries	O	O
.	O	O

While	O	O
the	O	O
bacterial	O	O
microbiota	O	O
of	O	O
the	O	O
oropharynx	O	O
was	O	O
richer	O	O
than	O	O
that	O	O
of	O	O
the	O	O
nostril	O	O
,	O	O
the	O	O
oropharyngeal	O	O
microbiota	O	O
varied	O	O
less	O	O
among	O	O
participants	O	O
than	O	O
did	O	O
nostril	O	O
microbiota	O	O
.	O	O

A	O	O
few	O	O
phyla	O	O
accounted	O	O
for	O	O
the	O	O
majority	O	O
of	O	O
the	O	O
bacteria	O	O
detected	O	O
at	O	O
each	O	O
site	O	O
:	O	O
Firmicutes	B-bacteria	B-bacteria
and	O	O
Actinobacteria	B-bacteria	B-bacteria
in	O	O
the	O	O
nostril	O	O
and	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
Proteobacteria	B-bacteria	B-bacteria
,	O	O
and	O	O
Bacteroidetes	B-bacteria	B-bacteria
in	O	O
the	O	O
oropharynx	O	O
.	O	O

Compared	O	O
to	O	O
culture-independent	O	O
surveys	O	O
of	O	O
microbiota	O	O
from	O	O
other	O	O
body	O	O
sites	O	O
,	O	O
the	O	O
microbiota	O	O
of	O	O
the	O	O
nostril	O	O
and	O	O
oropharynx	O	O
show	O	O
distinct	O	O
phylum-level	O	O
distribution	O	O
patterns	O	O
,	O	O
supporting	O	O
niche-specific	O	O
colonization	O	O
at	O	O
discrete	O	O
anatomical	O	O
sites	O	O
.	O	O

In	O	O
the	O	O
nostril	O	O
,	O	O
the	O	O
distribution	O	O
of	O	O
Actinobacteria	B-bacteria	B-bacteria
and	O	O
Firmicutes	B-bacteria	B-bacteria
was	O	O
reminiscent	O	O
of	O	O
that	O	O
of	O	O
skin	O	O
,	O	O
though	O	O
Proteobacteria	B-bacteria	B-bacteria
were	O	O
much	O	O
less	O	O
prevalent	O	O
.	O	O

The	O	O
distribution	O	O
of	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
Proteobacteria	B-bacteria	B-bacteria
,	O	O
and	O	O
Bacteroidetes	B-bacteria	B-bacteria
in	O	O
the	O	O
oropharynx	O	O
was	O	O
most	O	O
similar	O	O
to	O	O
that	O	O
in	O	O
saliva	O	O
,	O	O
with	O	O
more	O	O
Proteobacteria	B-bacteria	B-bacteria
than	O	O
in	O	O
the	O	O
distal	O	O
esophagus	O	O
or	O	O
mouth	O	O
.	O	O

While	O	O
Firmicutes	B-bacteria	B-bacteria
were	O	O
prevalent	O	O
at	O	O
both	O	O
sites	O	O
,	O	O
distinct	O	O
families	O	O
within	O	O
this	O	O
phylum	O	O
dominated	O	O
numerically	O	O
in	O	O
each	O	O
.	O	O

At	O	O
both	O	O
sites	O	O
there	O	O
was	O	O
an	O	O
inverse	O	O
correlation	O	O
between	O	O
the	O	O
prevalences	O	O
of	O	O
Firmicutes	B-bacteria	B-bacteria
and	O	O
another	O	O
phylum	O	O
:	O	O
in	O	O
the	O	O
oropharynx	O	O
,	O	O
Firmicutes	B-bacteria	B-bacteria
and	O	O
Proteobacteria	B-bacteria	B-bacteria
,	O	O
and	O	O
in	O	O
the	O	O
nostril	O	O
,	O	O
Firmicutes	B-bacteria	B-bacteria
and	O	O
Actinobacteria	B-bacteria	B-bacteria
.	O	O

In	O	O
the	O	O
nostril	O	O
,	O	O
this	O	O
inverse	O	O
correlation	O	O
existed	O	O
between	O	O
the	O	O
Firmicutes	B-bacteria	B-bacteria
family	I-bacteria	I-bacteria
Staphylococcaceae	E-bacteria	I-bacteria
and	O	O
Actinobacteria	B-bacteria	B-bacteria
families	E-bacteria	I-bacteria
,	O	O
suggesting	O	O
potential	O	O
antagonism	O	O
between	O	O
these	O	O
groups	O	O
.	O	O

Oral	O	O
Bifidobacteriaceae	B-bacteria	B-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
longum	E-bacteria	I-bacteria
,	O	O
are	O	O
known	O	O
to	O	O
be	O	O
isolated	O	O
together	O	O
with	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
from	O	O
caries	O	O
lesions	O	O
,	O	O
suggesting	O	O
that	O	O
these	O	O
Bifidobacteriaceae	B-bacteria	B-bacteria
are	O	O
caries	O	O
associated	O	O
and	O	O
acid	O	O
resistant	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
investigate	O	O
effects	O	O
of	O	O
acidification	O	O
on	O	O
B.	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
and	O	O
B.	B-bacteria	B-bacteria
longum	E-bacteria	I-bacteria
,	O	O
and	O	O
to	O	O
compare	O	O
them	O	O
with	O	O
those	O	O
on	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
.	O	O

Effects	O	O
of	O	O
acidification	O	O
,	O	O
growth	O	O
ability	O	O
in	O	O
a	O	O
complex	O	O
medium	O	O
at	O	O
a	O	O
pH	O	O
of	O	O
4.0-8.0	O	O
,	O	O
cell	O	O
viability	O	O
in	O	O
2-morpholinoethanesulfonic	O	O
acid	O	O
monohydrate	O	O
(	O	O
MES	O	O
)	O	O
-KOH	O	O
buffer	O	O
at	O	O
pH	O	O
4.0	O	O
,	O	O
as	O	O
well	O	O
as	O	O
stability	O	O
of	O	O
intracellular	O	O
pH	O	O
(	O	O
pH	O	O
(	O	O
in	O	O
)	O	O
)	O	O
at	O	O
an	O	O
extracellular	O	O
pH	O	O
of	O	O
3.5-8.0	O	O
estimated	O	O
using	O	O
a	O	O
fluorescent	O	O
dye	O	O
,	O	O
5	O	O
(	O	O
6	O	O
)	O	O
-carboxyfluorescein	O	O
diacetate	O	O
N-succinimidyl	O	O
ester	O	O
in	O	O
MES-KOH	O	O
,	O	O
3-	O	O
(	O	O
N-morpholino	O	O
)	O	O
propanesulfonic	O	O
acid-KOH	O	O
or	O	O
N	O	O
,	O	O
N-bis	O	O
(	O	O
2-hydroxyethyl	O	O
)	O	O
glycine-KOH	O	O
buffer	O	O
,	O	O
were	O	O
investigated	O	O
.	O	O

B.	B-bacteria	B-bacteria
longum	E-bacteria	I-bacteria
grew	O	O
as	O	O
well	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
over	O	O
a	O	O
wide	O	O
pH	O	O
range	O	O
,	O	O
whereas	O	O
B.	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
grew	O	O
best	O	O
in	O	O
the	O	O
narrow	O	O
pH	O	O
range	O	O
around	O	O
neutral	O	O
.	O	O

The	O	O
cell	O	O
viability	O	O
of	O	O
B.	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
decreased	O	O
significantly	O	O
after	O	O
2	O	O
h	O	O
of	O	O
acidification	O	O
at	O	O
a	O	O
pH	O	O
of	O	O
4.0	O	O
,	O	O
but	O	O
this	O	O
was	O	O
significantly	O	O
less	O	O
than	O	O
that	O	O
of	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
whereas	O	O
B.	B-bacteria	B-bacteria
longum	E-bacteria	I-bacteria
maintained	O	O
almost	O	O
100	O	O
%	O	O
viability	O	O
.	O	O

The	O	O
pH	O	O
(	O	O
in	O	O
)	O	O
was	O	O
close	O	O
to	O	O
the	O	O
extracellular	O	O
pH	O	O
at	O	O
pH	O	O
of	O	O
5.5-7.5	O	O
in	O	O
the	O	O
Bifidobacterium	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
,	O	O
while	O	O
at	O	O
a	O	O
pH	O	O
of	O	O
<	O	O
5.0	O	O
,	O	O
the	O	O
pH	O	O
(	O	O
in	O	O
)	O	O
was	O	O
higher	O	O
than	O	O
the	O	O
extracellular	O	O
pH	O	O
in	O	O
all	O	O
the	O	O
strains	O	O
,	O	O
but	O	O
the	O	O
pH	O	O
(	O	O
in	O	O
)	O	O
maintenance	O	O
ability	O	O
of	O	O
Bifidobacterium	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
was	O	O
higher	O	O
than	O	O
that	O	O
of	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
.	O	O

The	O	O
high	O	O
survival	O	O
rate	O	O
and	O	O
pH	O	O
(	O	O
in	O	O
)	O	O
maintenance	O	O
ability	O	O
of	O	O
bifidobacteria	O	O
comparable	O	O
to	O	O
that	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
the	O	O
acidic	O	O
environment	O	O
may	O	O
account	O	O
for	O	O
why	O	O
bifidobacteria	B-bacteria	B-bacteria
exist	O	O
as	O	O
stable	O	O
species	O	O
in	O	O
acidic	O	O
caries	O	O
lesions	O	O
together	O	O
with	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

We	O	O
investigated	O	O
the	O	O
effect	O	O
of	O	O
the	O	O
bacterial	O	O
flora	O	O
of	O	O
the	O	O
nose	O	O
and	O	O
throat	O	O
on	O	O
the	O	O
outcome	O	O
of	O	O
the	O	O
initial	O	O
repairs	O	O
of	O	O
the	O	O
cleft	O	O
palate	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
prophylactic	O	O
antibiotics	O	O
.	O	O

A	O	O
retrospective	O	O
review	O	O
of	O	O
90	O	O
procedures	O	O
in	O	O
66	O	O
patients	O	O
who	O	O
had	O	O
cleft	O	O
palate	O	O
repair	O	O
between	O	O
April	O	O
2005	O	O
and	O	O
June	O	O
2007	O	O
was	O	O
conducted	O	O
at	O	O
Booth	O	O
Hall	O	O
Children	O	O
's	O	O
Hospital	O	O
,	O	O
Manchester	O	O
,	O	O
U.K	O	O
.	O	O

Both	O	O
isolated	O	O
cleft	O	O
palate	O	O
and	O	O
cleft	O	O
lip	O	O
and	O	O
palate	O	O
patients	O	O
were	O	O
included	O	O
.	O	O

Exclusion	O	O
criteria	O	O
included	O	O
syndromic	O	O
cases	O	O
,	O	O
other	O	O
medical	O	O
disorders	O	O
,	O	O
and	O	O
revisions	O	O
of	O	O
previous	O	O
cleft	O	O
palate	O	O
repairs	O	O
.	O	O

Nose	O	O
and	O	O
throat	O	O
swabs	O	O
were	O	O
taken	O	O
on	O	O
admission	O	O
.	O	O

Benzyl	O	O
penicillin	O	O
and	O	O
flucloxacillin	O	O
were	O	O
given	O	O
perioperatively	O	O
.	O	O

The	O	O
occurrence	O	O
of	O	O
oronasal	O	O
fistulas	O	O
was	O	O
correlated	O	O
with	O	O
the	O	O
bacteria	O	O
grown	O	O
on	O	O
culture	O	O
.	O	O

The	O	O
oronasal	O	O
fistula	O	O
rate	O	O
was	O	O
15.9	O	O
%	O	O
.	O	O

The	O	O
highest	O	O
fistula	O	O
rate	O	O
in	O	O
procedures	O	O
with	O	O
positive	O	O
swabs	O	O
was	O	O
seen	O	O
with	O	O
Moraxella	B-bacteria	B-bacteria
catarrhalis	E-bacteria	I-bacteria
.	O	O

M.	B-bacteria	B-bacteria
catarrhalis	E-bacteria	I-bacteria
has	O	O
not	O	O
been	O	O
previously	O	O
recognized	O	O
as	O	O
a	O	O
pathogen	O	O
in	O	O
cleft	O	O
palate	O	O
repairs	O	O
.	O	O

This	O	O
study	O	O
demonstrates	O	O
a	O	O
higher	O	O
fistula	O	O
rate	O	O
in	O	O
procedures	O	O
positive	O	O
for	O	O
M.	B-bacteria	B-bacteria
catarrhalis	E-bacteria	I-bacteria
.	O	O

Other	O	O
factors	O	O
that	O	O
may	O	O
have	O	O
contributed	O	O
to	O	O
the	O	O
fistula	O	O
formation	O	O
include	O	O
the	O	O
severity	O	O
of	O	O
the	O	O
initial	O	O
cleft	O	O
and	O	O
technical	O	O
factors	O	O
.	O	O

Further	O	O
study	O	O
is	O	O
required	O	O
before	O	O
a	O	O
definitive	O	O
link	O	O
can	O	O
be	O	O
established	O	O
.	O	O

In	O	O
this	O	O
study	O	O
the	O	O
presence	O	O
of	O	O
periodontopathic	O	O
pathogens	O	O
in	O	O
atheromatous	O	O
plaques	O	O
removed	O	O
from	O	O
coronary	O	O
arteries	O	O
of	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
and	O	O
periodontally	O	O
healthy	O	O
subjects	O	O
by	O	O
PCR	O	O
was	O	O
detected	O	O
.	O	O

Our	O	O
results	O	O
indicate	O	O
a	O	O
significant	O	O
association	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
atheromas	O	O
,	O	O
and	O	O
the	O	O
periodontal	O	O
bacteria	O	O
in	O	O
oral	O	O
biofilm	O	O
may	O	O
find	O	O
a	O	O
way	O	O
to	O	O
reach	O	O
arteries	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
are	O	O
members	O	O
of	O	O
the	O	O
bacterial	O	O
oral	O	O
flora	O	O
and	O	O
are	O	O
opportunistic	O	O
pathogens	O	O
in	O	O
polymicrobial	O	O
infections	O	O
of	O	O
soft	O	O
tissues	O	O
.	O	O

Antibiotic	O	O
resistance	O	O
to	O	O
tetracyclines	O	O
is	O	O
common	O	O
in	O	O
these	O	O
bacteria	O	O
,	O	O
and	O	O
the	O	O
gene	O	O
encoding	O	O
this	O	O
resistance	O	O
has	O	O
been	O	O
previously	O	O
identified	O	O
as	O	O
tetQ	O	O
.	O	O

The	O	O
tetQ	O	O
gene	O	O
is	O	O
also	O	O
found	O	O
on	O	O
conjugative	O	O
transposons	O	O
in	O	O
the	O	O
intestinal	O	O
Bacteroides	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
;	O	O
whether	O	O
these	O	O
related	O	O
bacteria	O	O
have	O	O
transmitted	O	O
tetQ	O	O
to	O	O
Prevotella	B-bacteria	B-bacteria
is	O	O
unknown	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
describe	O	O
our	O	O
genetic	O	O
analysis	O	O
of	O	O
mobile	O	O
tetQ	O	O
elements	O	O
in	O	O
oral	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
mobile	O	O
elements	O	O
encoding	O	O
tetQ	O	O
in	O	O
oral	O	O
species	O	O
are	O	O
distinct	O	O
from	O	O
those	O	O
found	O	O
in	O	O
the	O	O
Bacteroides	B-bacteria	B-bacteria
.	O	O

The	O	O
intestinal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
may	O	O
act	O	O
as	O	O
a	O	O
reservoir	O	O
for	O	O
the	O	O
tetQ	O	O
gene	O	O
,	O	O
but	O	O
Prevotella	B-bacteria	B-bacteria
has	O	O
incorporated	O	O
this	O	O
gene	O	O
into	O	O
an	O	O
IS21-family	O	O
transposon	O	O
.	O	O

This	O	O
transposon	O	O
is	O	O
present	O	O
in	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
from	O	O
more	O	O
than	O	O
one	O	O
geographical	O	O
location	O	O
,	O	O
implying	O	O
that	O	O
the	O	O
mechanism	O	O
of	O	O
tetQ	O	O
spread	O	O
between	O	O
oral	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
is	O	O
highly	O	O
conserved	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
identify	O	O
cultivable	O	O
microorganisms	O	O
from	O	O
primary	O	O
teeth	O	O
with	O	O
necrotic	O	O
pulps	O	O
.	O	O

This	O	O
experimental	O	O
study	O	O
included	O	O
21	O	O
patients	O	O
of	O	O
both	O	O
sexes	O	O
between	O	O
4	O	O
and	O	O
7	O	O
years	O	O
of	O	O
age	O	O
with	O	O
necrotic	O	O
pulps	O	O
in	O	O
primary	O	O
teeth	O	O
.	O	O

Twenty-one	O	O
maxillary	O	O
and	O	O
mandibular	O	O
molars	O	O
containing	O	O
at	O	O
least	O	O
1	O	O
necrotic	O	O
canal	O	O
,	O	O
an	O	O
abscess	O	O
or	O	O
sinus	O	O
tract	O	O
,	O	O
one	O	O
or	O	O
more	O	O
radiolucent	O	O
areas	O	O
in	O	O
the	O	O
furcation	O	O
or	O	O
periapical	O	O
region	O	O
,	O	O
teeth	O	O
having	O	O
at	O	O
least	O	O
two	O	O
thirds	O	O
of	O	O
root	O	O
length	O	O
,	O	O
and	O	O
carious	O	O
lesions	O	O
directly	O	O
exposed	O	O
to	O	O
the	O	O
oral	O	O
environment	O	O
were	O	O
included	O	O
.	O	O

After	O	O
antisepsis	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
anesthesia	O	O
of	O	O
the	O	O
affected	O	O
tooth	O	O
,	O	O
and	O	O
isolation	O	O
and	O	O
disinfection	O	O
of	O	O
the	O	O
operative	O	O
field	O	O
,	O	O
3	O	O
sterile	O	O
absorbent	O	O
paper	O	O
points	O	O
were	O	O
sequentially	O	O
placed	O	O
for	O	O
30	O	O
seconds	O	O
for	O	O
the	O	O
collection	O	O
of	O	O
samples	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
immediately	O	O
processed	O	O
in	O	O
an	O	O
anaerobic	O	O
chamber	O	O
,	O	O
and	O	O
all	O	O
isolated	O	O
microorganisms	O	O
were	O	O
identified	O	O
.	O	O

Anaerobic	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
anaerobic	B-bacteria	B-bacteria
facultative	E-bacteria	I-bacteria
and	O	O
moderate	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
)	O	O
were	O	O
isolated	O	O
in	O	O
all	O	O
root	O	O
canals	O	O
;	O	O
68.4	O	O
%	O	O
of	O	O
root	O	O
canal	O	O
samples	O	O
studied	O	O
showed	O	O
a	O	O
polymicrobial	O	O
nature	O	O
.	O	O

Most	O	O
of	O	O
the	O	O
isolate	O	O
consisted	O	O
of	O	O
Bifidobacterium	B-bacteria	B-bacteria
Spp2	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
.	O	O

Other	O	O
less	O	O
frequently	O	O
encountered	O	O
species	O	O
were	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
,	O	O
Clostridium	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
albicans	O	O
.	O	O

Results	O	O
indicate	O	O
the	O	O
existence	O	O
of	O	O
combinations	O	O
of	O	O
bacterial	O	O
species	O	O
in	O	O
root	O	O
canal	O	O
infections	O	O
of	O	O
the	O	O
primary	O	O
dentition	O	O
with	O	O
necrotic	O	O
pulps	O	O
,	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
predominating	O	O
.	O	O

Protease	O	O
inhibitor	O	O
cocktails	O	O
are	O	O
routinely	O	O
added	O	O
to	O	O
clinical	O	O
samples	O	O
used	O	O
for	O	O
proteomic	O	O
studies	O	O
to	O	O
inactivate	O	O
proteases	O	O
.	O	O

As	O	O
these	O	O
same	O	O
samples	O	O
are	O	O
often	O	O
used	O	O
for	O	O
microbial	O	O
studies	O	O
,	O	O
we	O	O
determined	O	O
whether	O	O
the	O	O
addition	O	O
of	O	O
protease	O	O
inhibitors	O	O
could	O	O
affect	O	O
the	O	O
quantitative	O	O
or	O	O
qualitative	O	O
assessment	O	O
of	O	O
microbial	O	O
profiles	O	O
.	O	O

Twenty-two	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
and	O	O
processed	O	O
immediately	O	O
with	O	O
or	O	O
without	O	O
the	O	O
addition	O	O
of	O	O
a	O	O
protease	O	O
inhibitor	O	O
cocktail	O	O
.	O	O

